PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Joo, HM; Nam, SY; Yang, KH; Kim, CS; Jin, YW; Kim, JY				Joo, Hae Mi; Nam, Seon Young; Yang, Kwang Hee; Kim, Cha Soon; Jin, Young Woo; Kim, Ji Young			The Effects of Low-dose Ionizing Radiation in the Activated Rat Basophilic Leukemia (RBL-2H3) Mast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN IMMUNE-SYSTEM; ATOPIC-DERMATITIS; LIPID RAFTS; IGE; SUPPRESSION; RECEPTOR; RELEASE; ALPHA	Mast cells play important roles in many biological responses, such as those during allergic diseases and inflammatory disorders. Although laser and UV irradiation have immunosuppressive effects on inflammatory diseases by suppressing mast cells, little is known about the effects of gamma-ionizing radiation on mast cells. In this study, we investigated the effects of gamma-ionizing radiation on RBL-2H3 cells, a convenient model system for studying regulated secretion by mast cells. Low-dose radiation ( < 0.1 gray (Gy)) did not induce cell death, but high-dose radiation ( > 0.5 Gy) induced apoptosis. Low-dose ionizing radiation significantly suppressed the release of mediators (histamine, beta-hexosaminidase, IL-4, and tumor necrosis factor-alpha) from immunoglobulin E (IgE)-sensitized RBL-2H3 cells. To determine the mechanism of mediator release inhibition by ionizing radiation, we examined the activation of intracellular signaling molecules such as Lyn, Syk, phospholipase C gamma, PKCs, and MAPK, and intracellular free calcium concentrations ([Ca2+](i)). The phosphorylation of signaling molecules following stimulation of high-affinity IgE receptor I (Fc epsilon RI) was specifically inhibited by low-dose ionizing radiation (0.01 Gy). These results were due to the suppression of Fc epsilon RI expression by the low-dose ionizing radiation. Therefore, low-dose ionizing radiation (0.01 Gy) may function as a novel inhibitor of mast cell activation.	[Joo, Hae Mi; Nam, Seon Young; Yang, Kwang Hee; Kim, Cha Soon; Jin, Young Woo; Kim, Ji Young] Korea Hydro & Nucl Power Co Ltd, Radiat Hlth Res Inst, Radiat Effect Res Team, Seoul 132703, South Korea	Korea Hydro & Nuclear Power	Kim, JY (corresponding author), Korea Hydro & Nucl Power Co Ltd, Radiat Hlth Res Inst, Radiat Effect Res Team, 388-1 Ssangmun Dong, Seoul 132703, South Korea.	jykim@khnp.co.kr			Korea Hydro and Nuclear Power Co., Ltd. [E09NS02]; Ministry of Knowledge Economy, Republic of Korea [2010T100100303]	Korea Hydro and Nuclear Power Co., Ltd.; Ministry of Knowledge Economy, Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of KoreaGeneral Electric)	This work was supported by Grant E09NS02 from the Korea Hydro and Nuclear Power Co., Ltd. and Grant 2010T100100303 from the Ministry of Knowledge Economy, Republic of Korea.	AKIYAMA M, 1995, INT J RADIAT BIOL, V68, P497, DOI 10.1080/09553009514551491; Asai K, 2000, J HISTOCHEM CYTOCHEM, V48, P1705, DOI 10.1177/002215540004801213; BARANES D, 1991, BLOOD, V78, P2354; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Gurish MF, 2001, J EXP MED, V194, pF1, DOI 10.1084/jem.194.1.F1; Hanneman KK, 2006, DERMATOL CLIN, V24, P19, DOI 10.1016/j.det.2005.08.003; Harrington NP, 1997, CLIN EXP IMMUNOL, V107, P417, DOI 10.1111/j.1365-2249.1997.272-ce1158.x; JECKLER J, 1988, BRIT J DERMATOL, V119, P697, DOI 10.1111/j.1365-2133.1988.tb03490.x; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; KITAMURA Y, 1989, ANNU REV IMMUNOL, V7, P59, DOI 10.1146/annurev.iy.07.040189.000423; LEALBERUMEN I, 1994, J IMMUNOL, V152, P5468; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; McCurdy JD, 2001, J LEUKOCYTE BIOL, V70, P977; McGlade JP, 2007, CLIN EXP ALLERGY, V37, P1267, DOI 10.1111/j.1365-2222.2007.02750.x; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Molfetta R, 2010, MOL IMMUNOL, V47, P2427, DOI 10.1016/j.molimm.2010.06.003; Molfetta R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005604; Norval M, 2008, PHOTOCHEM PHOTOBIOL, V84, P19, DOI 10.1111/j.1751-1097.2007.00239.x; Nowosielska EM, 2010, DOSE-RESPONSE, V8, P209, DOI 10.2203/dose-response.09-016.Nowosielska; Oka T, 2004, AM J PHYSIOL-CELL PH, V286, pC256, DOI 10.1152/ajpcell.00197.2003; Oliver C, 2007, J HISTOCHEM CYTOCHEM, V55, P315, DOI 10.1369/jhc.6A7037.2006; Passante E, 2009, INFLAMM RES, V58, P737, DOI 10.1007/s00011-009-0074-y; Souza AMMS, 2008, EXP CELL RES, V314, P2515, DOI 10.1016/j.yexcr.2008.05.014; Siraganian R. P., 1980, HISTAMINE RELEASE AS; Suzuki Y, 2003, J IMMUNOL, V171, P6119, DOI 10.4049/jimmunol.171.11.6119; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; Wulf HC, 1998, PHOTODERMATOL PHOTO, V14, P1, DOI 10.1111/j.1600-0781.1998.tb00001.x; Zhang C, 1997, J BIOL CHEM, V272, P13397, DOI 10.1074/jbc.272.20.13397	28	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27789	27795		10.1074/jbc.M112.378497	http://dx.doi.org/10.1074/jbc.M112.378497			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22700973	hybrid, Green Published			2022-12-25	WOS:000307840700052
J	Wheatley, RW; Zheng, RB; Richards, MR; Lowary, TL; Ng, KKS				Wheatley, Robert W.; Zheng, Ruixiang Blake; Richards, Michele R.; Lowary, Todd L.; Ng, Kenneth K. S.			Tetrameric Structure of the GlfT2 Galactofuranosyltransferase Reveals a Scaffold for the Assembly of Mycobacterial Arabinogalactan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; CRYSTAL-STRUCTURE; TUBERCULOSIS ARABINOGALACTAN; LENGTH CONTROL; UDP-GALNAC; BIOSYNTHESIS; GLYCOSYLTRANSFERASES; IDENTIFICATION; POLYMERASE; TARGET	Biosynthesis of the mycobacterial cell wall relies on the activities of many enzymes, including several glycosyltransferases (GTs). The polymerizing galactofuranosyltransferase GlfT2 (Rv3808c) synthesizes the bulk of the galactan portion of the mycolyl-arabinogalactan complex, which is the largest component of the mycobacterial cell wall. We used x-ray crystallography to determine the 2.45-angstrom resolution crystal structure of GlfT2, revealing an unprecedented multidomain structure in which an N-terminal beta-barrel domain and two primarily alpha-helical C-terminal domains flank a central GT-A domain. The kidney- shaped protomers assemble into a C-4-symmetric homotetramer with an open central core and a surface containing exposed hydrophobic and positively charged residues likely involved with membrane binding. The structure of a 3.1-angstrom resolution complex of GlfT2 withUDPreveals a distinctive mode of nucleotide recognition. In addition, models for the binding of UDP-galactofuranose and acceptor substrates in combination with site-directed mutagenesis and kinetic studies suggest a mechanism that explains the unique ability of GlfT2 to generate alternating beta-(1 -> 5) and beta-(1 -> 6) glycosidic linkages using a single active site. The topology imposed by docking a tetrameric assembly onto a membrane bilayer also provides novel insights into aspects of processivity and chain length regulation in this and possibly other polymerizing GTs.	[Zheng, Ruixiang Blake; Richards, Michele R.; Lowary, Todd L.] Univ Alberta, Dept Chem, Gunning Lemieux Chem Ctr, Edmonton, AB T6G 2G2, Canada; [Wheatley, Robert W.; Ng, Kenneth K. S.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Wheatley, Robert W.; Zheng, Ruixiang Blake; Richards, Michele R.; Lowary, Todd L.; Ng, Kenneth K. S.] Univ Calgary, Alberta Glyc Ctr, Calgary, AB T2N 1N4, Canada	University of Alberta; University of Calgary; University of Calgary	Lowary, TL (corresponding author), Univ Alberta, Dept Chem, Gunning Lemieux Chem Ctr, Edmonton, AB T6G 2G2, Canada.	tlowary@ualberta.ca; ngk@ucalgary.ca	Richards, Mickey/E-8140-2011; Lowary, Todd L/F-9608-2019	Richards, Mickey/0000-0002-1973-5678; Lowary, Todd L/0000-0002-8331-8211; Ng, Kenneth K.S./0000-0001-7280-8445	Alberta Glycomics Centre; Natural Sciences and Engineering Research Council; Alberta Heritage Foundation for Medical Research Senior Scholar Award; Department of Energy Office of Biological and Environmental Research; National Institutes of Health from NIGMS [P41GM103393]; NCRR [P41RR001209]; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	Alberta Glycomics Centre; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Heritage Foundation for Medical Research Senior Scholar Award(Alberta Heritage Foundation for Medical Research); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the Alberta Glycomics Centre, the Natural Sciences and Engineering Research Council Discovery grants (to T. L. L. and K. K. S. N.), and the Alberta Heritage Foundation for Medical Research Senior Scholar Award (to K. K. S. N.).; We acknowledge the help of the staff at the Stanford Synchrotron Radiation Laboratory and the Canadian Light Source for providing access to the synchrotron radiation beamlines used for crystal screening and data collection at various stages of this project. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research, and by National Institutes of Health Grant P41GM103393 from NIGMS and Grant P41RR001209 from NCRR. Portions of the research described in this paper were performed using beamline 08ID-1 at the Canadian Light Source, which is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bae B, 2008, J BIOL CHEM, V283, P12415, DOI 10.1074/jbc.M706513200; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; BASS JB, 1994, AM J RESP CRIT CARE, V149, P1359, DOI 10.1164/ajrccm.149.5.8173779; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Belanger AE, 1996, P NATL ACAD SCI USA, V93, P11919, DOI 10.1073/pnas.93.21.11919; Belanova M, 2008, J BACTERIOL, V190, P1141, DOI 10.1128/JB.01326-07; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Burkert U., 1982, MOL MECH, DOI 10.1002/jcc.540040420; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; Czjzek M, 2001, J BIOL CHEM, V276, P48580, DOI 10.1074/jbc.M109142200; Dover LG, 2011, J MED CHEM, V54, P6157, DOI 10.1021/jm200305q; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FRISCH MJ, 1984, J CHEM PHYS, V80, P3265, DOI 10.1063/1.447079; Fritz TA, 2004, P NATL ACAD SCI USA, V101, P15307, DOI 10.1073/pnas.0405657101; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Kremer L, 2001, J BIOL CHEM, V276, P26430, DOI 10.1074/jbc.M102022200; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Levengood MR, 2011, J AM CHEM SOC, V133, P12758, DOI 10.1021/ja204448t; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; May JF, 2012, BIOCHEMISTRY-US, V51, P1148, DOI 10.1021/bi201820p; May JF, 2009, P NATL ACAD SCI USA, V106, P11851, DOI 10.1073/pnas.0901407106; Mikusova K, 2000, J BIOL CHEM, V275, P33890, DOI 10.1074/jbc.M006875200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nachega JB, 2003, CLIN INFECT DIS, V36, pS24, DOI 10.1086/344657; Osawa T, 2009, BIOCHEM BIOPH RES CO, V378, P10, DOI 10.1016/j.bbrc.2008.08.121; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan F, 2001, J BACTERIOL, V183, P3991, DOI 10.1128/JB.183.13.3991-3998.2001; Pedersen LC, 2003, J BIOL CHEM, V278, P14420, DOI 10.1074/jbc.M210532200; Pesnot T, 2010, NAT CHEM BIOL, V6, P321, DOI 10.1038/nchembio.343; Petrova P, 2001, BIOPOLYMERS, V58, P617, DOI 10.1002/1097-0282(200106)58:7<617::AID-BIP1035>3.0.CO;2-1; Ponstingl H, 2005, PROG BIOPHYS MOL BIO, V89, P9, DOI 10.1016/j.pbiomolbio.2004.07.010; Poulin MB, 2012, ORG BIOMOL CHEM, V10, P4074, DOI 10.1039/c2ob25159k; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Raman J, 2008, J BIOL CHEM, V283, P22942, DOI 10.1074/jbc.M803387200; Rassolov VA, 2001, J COMPUT CHEM, V22, P976, DOI 10.1002/jcc.1058; Richards MR, 2009, CHEMBIOCHEM, V10, P1920, DOI 10.1002/cbic.200900208; Rose NL, 2008, CARBOHYD RES, V343, P2130, DOI 10.1016/j.carres.2008.03.023; Rose NL, 2006, J AM CHEM SOC, V128, P6721, DOI 10.1021/ja058254d; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sunna A, 2001, BIOCHEM J, V356, P791, DOI 10.1042/0264-6021:3560791; Szczepina MG, 2010, BIOORGAN MED CHEM, V18, P5123, DOI 10.1016/j.bmc.2010.05.069; Szczepina MG, 2009, CHEMBIOCHEM, V10, P2052, DOI 10.1002/cbic.200900202; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839	54	49	51	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28132	28143		10.1074/jbc.M112.347484	http://dx.doi.org/10.1074/jbc.M112.347484			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22707726	Green Published, hybrid			2022-12-25	WOS:000307840700086
J	Clementi, EA; Marks, LR; Duffey, ME; Hakansson, AP				Clementi, Emily A.; Marks, Laura R.; Duffey, Michael E.; Hakansson, Anders P.			A Novel Initiation Mechanism of Death in Streptococcus pneumoniae Induced by the Human Milk Protein-Lipid Complex HAMLET and Activated during Physiological Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-LACTALBUMIN; CALCIUM REGULATION; GENOME SEQUENCE; ION CHANNELS; APOPTOSIS; BIOFILMS; MEMBRANE; KINASE; K+; TRANSFORMATION	To cause colonization or infection, most bacteria grow in biofilms where differentiation and death of subpopulations is critical for optimal survival of the whole population. However, little is known about initiation of bacterial death under physiological conditions. Membrane depolarization has been suggested, but never shown to be involved, due to the difficulty of performing such studies in bacteria and the paucity of information that exists regarding ion transport mechanisms in prokaryotes. In this study, we performed the first extensive investigation of ion transport and membrane depolarization in a bacterial system. We found that HAMLET, a human milk protein-lipid complex, kills Streptococcus pneumoniae (the pneumococcus) in a manner that shares features with activation of physiological death from starvation. Addition of HAMLET to pneumococci dissipated membrane polarity, but depolarization per se was not enough to trigger death. Rather, both HAMLET- and starvation-induced death of pneumococci specifically required a sodium-dependent calcium influx, as shown using calcium and sodium transport inhibitors. This mechanism was verified under low sodium conditions, and in the presence of ionomycin or monensin, which enhanced pneumococcal sensitivity to HAMLET- and starvation-induced death. Pneumococcal death was also inhibited by kinase inhibitors, and indicated the involvement of Ser/Thr kinases in these processes. The importance of this activation mechanism was made evident, as dysregulation and manipulation of physiological death was detrimental to biofilm formation, a hallmark of bacterial colonization. Overall, our findings provide novel information on the role of ion transport during bacterial death, with the potential to uncover future antimicrobial targets.	[Clementi, Emily A.; Marks, Laura R.; Hakansson, Anders P.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14214 USA; [Duffey, Michael E.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA; [Hakansson, Anders P.] SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14214 USA; [Hakansson, Anders P.] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Hakansson, AP (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, 145 BRB,3435 Main St, Buffalo, NY 14214 USA.	andersh@buffalo.edu	Hakansson, Anders P/AAX-1225-2020; Hakansson, Anders/H-8190-2014	Hakansson, Anders P/0000-0002-2834-6009; Hakansson, Anders/0000-0002-2834-6009; Marks, Laura/0000-0002-5317-443X	National Institutes of Health (NIDCD) Fellowship [F31DC011218]; Bill and Melinda Gates Foundation Grant [53085]; J. R. Oishei Foundation; American Lung Association Grant [RG-123721-N]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC011218] Funding Source: NIH RePORTER	National Institutes of Health (NIDCD) Fellowship; Bill and Melinda Gates Foundation Grant(Bill & Melinda Gates Foundation); J. R. Oishei Foundation; American Lung Association Grant; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health (NIDCD) Fellowship F31DC011218 (to E. A. C.), Bill and Melinda Gates Foundation Grant 53085, the J. R. Oishei Foundation, and American Lung Association Grant RG-123721-N (to A. P. H.).	Andres MT, 2008, ANTIMICROB AGENTS CH, V52, P4081, DOI 10.1128/AAC.01597-07; ANIANSSON G, 1994, PEDIATR INFECT DIS J, V13, P183, DOI 10.1097/00006454-199403000-00003; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; BAKKER EP, 1980, J BIOL CHEM, V255, P433; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; BERRY AM, 1989, INFECT IMMUN, V57, P2324, DOI 10.1128/IAI.57.8.2324-2330.1989; Bortner CD, 2007, ARCH BIOCHEM BIOPHYS, V462, P176, DOI 10.1016/j.abb.2007.01.020; Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; Brnjic S, 2010, MOL BIOSYST, V6, P767, DOI 10.1039/b920805d; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.biochem.56.1.395; Claverys JP, 2007, NAT REV MICROBIOL, V5, P219, DOI 10.1038/nrmicro1613; Corratge-Faillie C, 2010, CELL MOL LIFE SCI, V67, P2511, DOI 10.1007/s00018-010-0317-7; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Franks CJ, 2002, J NEUROPHYSIOL, V87, P954, DOI 10.1152/jn.00233.2001; Frias MJ, 2009, J BACTERIOL, V191, P5428, DOI 10.1128/JB.00477-09; FUTSAETHER CM, 1994, CAN J MICROBIOL, V40, P439, DOI 10.1139/m94-072; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Giorgi C, 2008, CURR MOL MED, V8, P119; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hakansson A, 1999, EXP CELL RES, V246, P451, DOI 10.1006/excr.1998.4265; Hakansson A, 2000, MOL MICROBIOL, V35, P589, DOI 10.1046/j.1365-2958.2000.01728.x; Hakansson A, 1999, THESIS LUND U LUND; Hakansson AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017717; Hanson LA, 1998, ANN ALLERG ASTHMA IM, V81, P523, DOI 10.1016/S1081-1206(10)62704-4; HAROLD FM, 1972, BACTERIOL REV, V36, P172, DOI 10.1128/MMBR.36.2.172-230.1972; Hsu YC, 2011, CELL SIGNAL, V23, P2013, DOI 10.1016/j.cellsig.2011.07.015; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; Johansen HK, 2000, J ANTIMICROB CHEMOTH, V46, P973, DOI 10.1093/jac/46.6.973; JOLLIFFE LK, 1981, CELL, V25, P753, DOI 10.1016/0092-8674(81)90183-5; Kohler C, 2001, EUR J BIOCHEM, V268, P186, DOI 10.1046/j.1432-1327.2001.01870.x; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Lehen'kyi V, 2011, AM J PHYSIOL-CELL PH, V301, pC1281, DOI 10.1152/ajpcell.00249.2011; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Lopez D, 2009, MOL MICROBIOL, V74, P609, DOI 10.1111/j.1365-2958.2009.06882.x; Margulis L, 1975, Symp Soc Exp Biol, P21; Marks L. R., 2012, INFECT IMMU IN PRESS; Miyamoto S, 2005, J BIOL CHEM, V280, P38505, DOI 10.1074/jbc.M505223200; Nashida T, 2011, NEUROCHEM INT, V59, P51, DOI 10.1016/j.neuint.2011.03.026; Neef J, 2011, INFECT IMMUN, V79, P2314, DOI 10.1128/IAI.00677-10; Novakova L, 2005, FEBS J, V272, P1243, DOI 10.1111/j.1742-4658.2005.04560.x; Petit PX, 1998, FEBS LETT, V426, P111, DOI 10.1016/S0014-5793(98)00318-4; Ranjit DK, 2011, J BACTERIOL, V193, P2468, DOI 10.1128/JB.01545-10; Rosch JW, 2008, MOL MICROBIOL, V70, P435, DOI 10.1111/j.1365-2958.2008.06425.x; Smith R J, 1995, Adv Microb Physiol, V37, P83, DOI 10.1016/S0065-2911(08)60144-7; Spat A, 2009, ACTA PHYSIOL, V195, P139, DOI 10.1111/j.1748-1716.2008.01928.x; Spangler SK, 1997, J ANTIMICROB CHEMOTH, V39, P141, DOI 10.1093/jac/39.2.141; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Svensson M, 2003, PROTEIN SCI, V12, P2805, DOI 10.1110/ps.0231103; Svensson M, 1999, J BIOL CHEM, V274, P6388, DOI 10.1074/jbc.274.10.6388; SZABO I, 1992, BIOCHIM BIOPHYS ACTA, V1112, P29, DOI 10.1016/0005-2736(92)90250-P; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Thomas VC, 2009, MOL MICROBIOL, V72, P1022, DOI 10.1111/j.1365-2958.2009.06703.x; TISA LS, 1995, J BACTERIOL, V177, P7112, DOI 10.1128/jb.177.24.7112-7118.1995; TROMBE MC, 1993, J GEN MICROBIOL, V139, P433, DOI 10.1099/00221287-139-3-433; TROMBE MC, 1992, J GEN MICROBIOL, V138, P77, DOI 10.1099/00221287-138-1-77; TROMBE MC, 1994, J BACTERIOL, V176, P1992, DOI 10.1128/jb.176.7.1992-1996.1994; TROMBE MC, 1984, J BACTERIOL, V158, P1109, DOI 10.1128/JB.158.3.1109-1114.1984; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Werthen M, 2001, J BIOL CHEM, V276, P6468, DOI 10.1074/jbc.M009223200; Wolcott RD, 2008, JAMA-J AM MED ASSOC, V299, P2682, DOI 10.1001/jama.299.22.2682; ZORATTI M, 1990, BIOCHEM BIOPH RES CO, V168, P443, DOI 10.1016/0006-291X(90)92341-V	65	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27168	27182		10.1074/jbc.M112.371070	http://dx.doi.org/10.1074/jbc.M112.371070			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700972	hybrid, Green Published			2022-12-25	WOS:000307386000069
J	Espelund, M; Minge, MA; Gabrielsen, TM; Nederbragt, AJ; Shalchian-Tabrizi, K; Otis, C; Turmel, M; Lemieux, C; Jakobsen, KS				Espelund, Mari; Minge, Marianne A.; Gabrielsen, Tove M.; Nederbragt, Alexander J.; Shalchian-Tabrizi, Kamran; Otis, Christian; Turmel, Monique; Lemieux, Claude; Jakobsen, Kjetill S.			Genome Fragmentation Is Not Confined to the Peridinin Plastid in Dinoflagellates	PLOS ONE			English	Article							CHLOROPHYLL-A; GREEN DINOFLAGELLATE; GENE MINICIRCLES; LARGE SUBUNIT; CHLOROPLAST; APICOMPLEXAN; EVOLUTIONARY; SEQUENCE; ORIGIN; RNA	When plastids are transferred between eukaryote lineages through series of endosymbiosis, their environment changes dramatically. Comparison of dinoflagellate plastids that originated from different algal groups has revealed convergent evolution, suggesting that the host environment mainly influences the evolution of the newly acquired organelle. Recently the genome from the anomalously pigmented dinoflagellate Karlodinium veneficum plastid was uncovered as a conventional chromosome. To determine if this haptophyte-derived plastid contains additional chromosomal fragments that resemble the mini-circles of the peridin-containing plastids, we have investigated its genome by in-depth sequencing using 454 pyrosequencing technology, PCR and clone library analysis. Sequence analyses show several genes with significantly higher copy numbers than present in the chromosome. These genes are most likely extrachromosomal fragments, and the ones with highest copy numbers include genes encoding the chaperone DnaK(Hsp70), the rubisco large subunit (rbcL), and two tRNAs (trnE and trnM). In addition, some photosystem genes such as psaB, psaA, psbB and psbD are overrepresented. Most of the dnaK and rbcL sequences are found as shortened or fragmented gene sequences, typically missing the 3'-terminal portion. Both dnaK and rbcL are associated with a common sequence element consisting of about 120 bp of highly conserved AT-rich sequence followed by a trnE gene, possibly serving as a control region. Decatenation assays and Southern blot analysis indicate that the extrachromosomal plastid sequences do not have the same organization or lengths as the minicircles of the peridinin dinoflagellates. The fragmentation of the haptophyte-derived plastid genome K. veneficum suggests that it is likely a sign of a host-driven process shaping the plastid genomes of dinoflagellates.	[Espelund, Mari; Minge, Marianne A.; Gabrielsen, Tove M.; Nederbragt, Alexander J.; Jakobsen, Kjetill S.] Univ Oslo, CEES, Dept Biol, Oslo, Norway; [Shalchian-Tabrizi, Kamran; Jakobsen, Kjetill S.] Univ Oslo, MERG, Dept Biol, Oslo, Norway; [Otis, Christian; Turmel, Monique; Lemieux, Claude] Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada	University of Oslo; University of Oslo; Laval University	Espelund, M (corresponding author), Norwegian Def Res Estab FFI, Kjeller, Norway.	k.s.jakobsen@bio.uio.no	Turmel, Monique/AAC-9752-2020; Lemieux, Claude/L-8831-2015	Turmel, Monique/0000-0001-7060-035X; Lemieux, Claude/0000-0001-9580-8042; Nederbragt, Lex/0000-0001-5539-0999	Research Council of Norway; Natural Sciences and Engineering Research Council of Canada; University of Oslo	Research Council of Norway(Research Council of Norway); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Oslo	The project was supported by a grant from The Research Council of Norway to KSJ and by a grant from the Natural Sciences and Engineering Research Council of Canada (to MT and CL). KST received starting grants from University of Oslo and travelling grants from The Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; Barbrook AC, 2006, TRENDS PLANT SCI, V11, P101, DOI 10.1016/j.tplants.2005.12.004; Bergholtz T, 2006, J PHYCOL, V42, P170, DOI 10.1111/j.1529-8817.2006.00172.x; Cohen I, 2005, PLANT PHYSIOL, V137, P738, DOI 10.1104/pp.104.056341; Donaher N, 2009, GENOME BIOL EVOL, V1, P439, DOI 10.1093/gbe/evp047; Elbrachter M, 1996, PHYCOLOGIA, V35, P381, DOI 10.2216/i0031-8884-35-5-381.1; Fast NM, 2001, MOL BIOL EVOL, V18, P418, DOI 10.1093/oxfordjournals.molbev.a003818; Gabrielsen TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019132; GALAU GA, 1986, PLANT MOL BIOL, V7, P155, DOI 10.1007/BF00021327; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Hackett JD, 2004, AM J BOT, V91, P1523, DOI 10.3732/ajb.91.10.1523; Hansen G, 2007, PHYCOL RES, V55, P25, DOI 10.1111/j.1440-1835.2006.00442.x; Hoffmann JH, 2004, EMBO J, V23, P160, DOI 10.1038/sj.emboj.7600016; Howe CJ, 2007, PROTIST, V158, P121, DOI 10.1016/j.protis.2007.02.002; Iida S, 2010, PLANT CELL PHYSIOL, V51, P1869, DOI 10.1093/pcp/pcq152; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; KATO J, 1992, J BIOL CHEM, V267, P25676; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keeling PJ, 2004, AM J BOT, V91, P1481, DOI 10.3732/ajb.91.10.1481; Kim E, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-73; Koumandou VL, 2007, PROTIST, V158, P89, DOI 10.1016/j.protis.2006.08.003; Koumandou VL, 2004, TRENDS GENET, V20, P261, DOI 10.1016/j.tig.2004.03.008; Krause K, 2008, CURR GENET, V54, P111, DOI 10.1007/s00294-008-0208-8; Kumar AM, 1996, TRENDS PLANT SCI, V1, P371, DOI 10.1016/S1360-1385(96)80311-6; Laatsch T, 2004, MOL BIOL EVOL, V21, P1318, DOI 10.1093/molbev/msh127; Le QH, 1997, MOL GEN GENET, V255, P595, DOI 10.1007/s004380050533; Leung SK, 2009, NUCLEIC ACIDS RES; Liu BY, 2005, TRENDS PARASITOL, V21, P363, DOI 10.1016/j.pt.2005.06.008; Maddison WP, 1992, MACCLADE VERSION 3 A; Minge MA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-191; Nosenko T, 2006, MOL BIOL EVOL, V23, P2026, DOI 10.1093/molbev/msl074; Patron NJ, 2006, J MOL BIOL, V357, P1373, DOI 10.1016/j.jmb.2006.01.084; Reichman JR, 2003, MOL BIOL EVOL, V20, P2143, DOI 10.1093/molbev/msg233; Saldarriaga JF, 2001, J MOL EVOL, V53, P204, DOI 10.1007/s002390010210; Sambrook J, 1989, MOL CLONING LAB MANU, V3; Sambrook J., 1989, MOL CLONING LAB MANU, V1; Sambrook J, 1989, MOL CLONING LAB MANU, V2; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SCHNEPF E, 1988, BOT ACTA, V101, P196, DOI 10.1111/j.1438-8677.1988.tb00033.x; Shalchian-Tabrizi K, 2006, MOL BIOL EVOL, V23, P1504, DOI 10.1093/molbev/msl011; Slamovits CH, 2007, J MOL BIOL, V372, P356, DOI 10.1016/j.jmb.2007.06.085; Takishita K, 2002, PROTIST, V153, P293, DOI 10.1078/1434-4610-00106; Takishita K, 2008, GENE, V410, P26, DOI 10.1016/j.gene.2007.11.008; Tengs T, 2000, MOL BIOL EVOL, V17, P718, DOI 10.1093/oxfordjournals.molbev.a026350; Waller RF, 2009, BIOESSAYS, V31, P237, DOI 10.1002/bies.200800164; WATANABE M M, 1991, Journal of Phycology, V27, P75; WATANABE MM, 1990, J PHYCOL, V26, P741, DOI 10.1111/j.0022-3646.1990.00741.x; WATANABE MM, 1987, J PHYCOL, V23, P382, DOI 10.1111/j.1529-8817.1987.tb04148.x; Yosef I, 2004, J BIOL CHEM, V279, P10148, DOI 10.1074/jbc.M308602200; Zhang ZD, 1999, NATURE, V400, P155, DOI 10.1038/22099; Zhang ZD, 2001, MOL BIOL EVOL, V18, P1558, DOI 10.1093/oxfordjournals.molbev.a003942	51	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38809	10.1371/journal.pone.0038809	http://dx.doi.org/10.1371/journal.pone.0038809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719952	Green Submitted, Green Published, gold			2022-12-25	WOS:000305583300052
J	Zhang, YR; Cuevas, S; Asico, LD; Escano, C; Yang, Y; Pascua, AM; Wang, XY; Jones, JE; Grandy, D; Eisner, G; Jose, PA; Armando, I				Zhang, Yanrong; Cuevas, Santiago; Asico, Laureano D.; Escano, Crisanto; Yang, Yu; Pascua, Annabelle M.; Wang, Xiaoyan; Jones, John E.; Grandy, David; Eisner, Gilbert; Jose, Pedro A.; Armando, Ines			Deficient Dopamine D-2 Receptor Function Causes Renal Inflammation Independently of High Blood Pressure	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; BRAIN-DEAD RATS; D2 RECEPTOR; DEPENDENT HYPERTENSION; TAQI POLYMORPHISM; GENE DRD2; T-CELLS; ANGIOTENSIN; EXPRESSION	Renal dopamine receptors participate in the regulation of blood pressure. Genetic factors, including polymorphisms of the dopamine D-2 receptor gene (DRD2) are associated with essential hypertension, but the mechanisms of their contribution are incompletely understood. Mice lacking Drd2 (D-2(-/-)) have elevated blood pressure, increased renal expression of inflammatory factors, and renal injury. We tested the hypothesis that decreased dopamine D-2 receptor (D2R) function increases vulnerability to renal inflammation independently of blood pressure, is an immediate cause of renal injury, and contributes to the subsequent development of hypertension. In D-2(-/-) mice, treatment with apocynin normalized blood pressure and decreased oxidative stress, but did not affect the expression of inflammatory factors. In mouse RPTCs Drd2 silencing increased the expression of TNF alpha and MCP-1, while treatment with a D2R agonist abolished the angiotensin II-induced increase in TNF-alpha and MCP-1. In uni-nephrectomized wild-type mice, selective Drd2 silencing by subcapsular infusion of Drd2 siRNA into the remaining kidney produced the same increase in renal cytokines/chemokines that occurs after Drd2 deletion, increased the expression of markers of renal injury, and increased blood pressure. Moreover, in mice with two intact kidneys, short-term Drd2 silencing in one kidney, leaving the other kidney undisturbed, induced inflammatory factors and markers of renal injury in the treated kidney without increasing blood pressure. Our results demonstrate that the impact of decreased D2R function on renal inflammation is a primary effect, not necessarily associated with enhanced oxidant activity, or blood pressure; renal damage is the cause, not the result, of hypertension. Deficient renal D2R function may be of clinical relevance since common polymorphisms of the human DRD2 gene result in decreased D2R expression and function.	[Zhang, Yanrong; Cuevas, Santiago; Asico, Laureano D.; Escano, Crisanto; Yang, Yu; Pascua, Annabelle M.; Wang, Xiaoyan; Jones, John E.; Jose, Pedro A.; Armando, Ines] Univ Maryland, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21201 USA; [Grandy, David] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; [Eisner, Gilbert] Georgetown Univ, Med Ctr, Dept Med, Washington, DC 20007 USA	University System of Maryland; University of Maryland Baltimore; Oregon Health & Science University; Georgetown University	Zhang, YR (corresponding author), Univ Maryland, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21201 USA.	iarmando@medicine.umaryland.edu	Asico, Laureano/AAM-6321-2020; Cuevas, Santiago/AAG-4985-2021; Wang, Xiaoyan/GOK-1663-2022	Cuevas, Santiago/0000-0002-0832-5446; Wang, Xiaoyan/0000-0001-7406-5008	National Institutes of Health [HL068686, HL023081, HL074940, HL092196, DK039308, DK090918]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL023081, P01HL074940, P01HL068686, R01HL023081, R01HL092196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090918, R01DK039308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the National Institutes of Health, HL068686, HL023081, HL074940, HL092196, DK039308 and DK090918 (www.NIH.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Armando I, 2007, HYPERTENSION, V49, P672, DOI 10.1161/01.HYP.0000254486.00883.3d; Bach F, 2002, ACTA ANAESTH SCAND, V46, P1227, DOI 10.1034/j.1399-6576.2002.461010.x; Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; BENDELE AM, 1991, J PHARMACOL EXP THER, V259, P169; Besser MJ, 2005, J NEUROIMMUNOL, V169, P161, DOI 10.1016/j.jneuroim.2005.07.013; Birnbaum J, 2006, CRIT CARE, V10, DOI 10.1186/cc5011; Bonecchi R, 2009, FRONT BIOSCI-LANDMRK, V14, P540, DOI 10.2741/3261; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Dempsey PW, 2003, CYTOKINE GROWTH F R, V14, P193, DOI 10.1016/S1359-6101(03)00021-2; Donnahoo KK, 1999, J UROLOGY, V162, P196, DOI 10.1097/00005392-199907000-00068; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Fang YJ, 2005, INT J CARDIOL, V102, P111, DOI 10.1016/j.ijcard.2004.05.010; Ferguson SM, 2003, J NEUROCHEM, V86, P33, DOI 10.1046/j.1471-4159.2003.01815.x; Ghosh MC, 2003, INT IMMUNOPHARMACOL, V3, P1019, DOI 10.1016/S1567-5769(03)00100-0; Harrison DG, 2011, HYPERTENSION, V57, P132, DOI 10.1161/HYPERTENSIONAHA.110.163576; Hasko G, 2002, J NEUROIMMUNOL, V122, P34, DOI 10.1016/S0165-5728(01)00459-3; Hoeger S, 2008, TRANSPL INT, V21, P1072, DOI 10.1111/j.1432-2277.2008.00725.x; Hoeger S, 2007, TRANSPL INT, V20, P790, DOI 10.1111/j.1432-2277.2007.00510.x; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Jose PA, 2010, BBA-MOL BASIS DIS, V1802, P1259, DOI 10.1016/j.bbadis.2010.02.004; Laengle UW, 2006, EXP EYE RES, V83, P1335, DOI 10.1016/j.exer.2006.07.008; Lavender P, 2000, CHEM IMMUNOL, V78, P16; Lea WB, 2009, KIDNEY INT, V75, P936, DOI 10.1038/ki.2009.9; Levite M, 2008, CURR OPIN PHARMACOL, V8, P460, DOI 10.1016/j.coph.2008.05.001; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li XX, 2001, HYPERTENSION, V38, P303, DOI 10.1161/01.HYP.38.3.303; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MORIKAWA K, 1994, CLIN EXP IMMUNOL, V95, P514; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Patel NSA, 2005, J PHARMACOL EXP THER, V312, P1170, DOI 10.1124/jpet.104.078659; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Prasad P, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-26; Ritchie T, 2003, NEUROCHEM RES, V28, P73, DOI 10.1023/A:1021648128758; Romagnani P, 1999, J AM SOC NEPHROL, V10, P2518; Rosmond R, 2001, J HUM HYPERTENS, V15, P553, DOI 10.1038/sj.jhh.1001231; Ruiz-Ortega M, 2002, KIDNEY INT S, V82, pS12, DOI [10.1046/j.1523-1755.62.s82.4.x, DOI 10.1046/J.1523-1755.62.S82.4.X]; Segerer S, 2007, SEMIN NEPHROL, V27, P260, DOI 10.1016/j.semnephrol.2007.02.003; Shahid M, 2010, AM J PHYSIOL-RENAL, V299, pF217, DOI 10.1152/ajprenal.00611.2009; Takeuchi Y, 2003, J NEUROCHEM, V85, P729, DOI 10.1046/j.1471-4159.2003.01711.x; Thomas GN, 2001, CLIN ENDOCRINOL, V55, P605, DOI 10.1046/j.1365-2265.2001.01404.x; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; Tian N, 2007, AM J PHYSIOL-HEART C, V293, pH3388, DOI 10.1152/ajpheart.00981.2007; Wang YP, 2004, KIDNEY INT, V66, P655, DOI 10.1111/j.1523-1755.2004.00786.x; Woost PG, 2006, IN VITRO CELL DEV-AN, V42, P189; Yang M, 2003, MOL PHARMACOL, V64, P447, DOI 10.1124/mol.64.2.447; Yang SL, 2012, AM J PHYSIOL-RENAL, V302, pF742, DOI 10.1152/ajprenal.00583.2011; Yoneda M, 2005, HYPERTENSION, V46, P58, DOI 10.1161/01.HYP.0000171587.44736.ba; Zeng CY, 2008, AM J PHYSIOL-HEART C, V294, pH551, DOI 10.1152/ajpheart.01036.2007; Zhang MZ, 2011, J CLIN INVEST, V121, P2845, DOI 10.1172/JCI57324; Zheng L, 2008, J HISTOCHEM CYTOCHEM, V56, P517, DOI 10.1369/jhc.7A7368.2008; Zhu JF, 2010, IMMUNOL CELL BIOL, V88, P244, DOI 10.1038/icb.2009.114; Zhu XH, 1997, CYTOKINE, V9, P437, DOI 10.1006/cyto.1996.0186	54	29	29	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38745	10.1371/journal.pone.0038745	http://dx.doi.org/10.1371/journal.pone.0038745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719934	Green Published, Green Submitted, gold			2022-12-25	WOS:000305347800016
J	Martin, J; Sykes, S; Young, S; Kota, K; Sanka, R; Sheth, N; Orvis, J; Sodergren, E; Wang, ZY; Weinstock, GM; Mitreva, M				Martin, John; Sykes, Sean; Young, Sarah; Kota, Karthik; Sanka, Ravi; Sheth, Nihar; Orvis, Joshua; Sodergren, Erica; Wang, Zhengyuan; Weinstock, George M.; Mitreva, Makedonka			Optimizing Read Mapping to Reference Genomes to Determine Composition and Species Prevalence in Microbial Communities	PLOS ONE			English	Article							SEQUENCE; ALIGNMENT	The Human Microbiome Project (HMP) aims to characterize the microbial communities of 18 body sites from healthy individuals. To accomplish this, the HMP generated two types of shotgun data: reference shotgun sequences isolated from different anatomical sites on the human body and shotgun metagenomic sequences from the microbial communities of each site. The alignment strategy for characterizing these metagenomic communities using available reference sequence is important to the success of HMP data analysis. Six next-generation aligners were used to align a community of known composition against a database comprising reference organisms known to be present in that community. All aligners report nearly complete genome coverage (>97%) for strains with over 6X depth of coverage, however they differ in speed, memory requirement and ease of use issues such as database size limitations and supported mapping strategies. The selected aligner was tested across a range of parameters to maximize sensitivity while maintaining a low false positive rate. We found that constraining alignment length had more impact on sensitivity than does constraining similarity in all cases tested. However, when reference species were replaced with phylogenetic neighbors, similarity begins to play a larger role in detection. We also show that choosing the top hit randomly when multiple, equally strong mappings are available increases overall sensitivity at the expense of taxonomic resolution. The results of this study identified a strategy that was used to map over 3 tera-bases of microbial sequence against a database of more than 5,000 reference genomes in just over a month.	[Martin, John; Kota, Karthik; Sodergren, Erica; Wang, Zhengyuan; Weinstock, George M.; Mitreva, Makedonka] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63130 USA; [Sykes, Sean; Young, Sarah] MIT & Harvard, Broad Inst, Cambridge, MA USA; [Sanka, Ravi] J Craig Venter Inst, Rockville, MD USA; [Sheth, Nihar] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Orvis, Joshua] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Sodergren, Erica; Weinstock, George M.; Mitreva, Makedonka] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; J. Craig Venter Institute; Virginia Commonwealth University; University System of Maryland; University of Maryland Baltimore; Washington University (WUSTL)	Martin, J (corresponding author), Washington Univ, Sch Med, Genome Inst, St Louis, MO 63130 USA.	mmitreva@watson.wustl.edu	Wang, Zhengyuan/GWV-6069-2022; wang, zhengyuan/HGA-0435-2022; Weinstock, George M/C-6314-2013	wang, zhengyuan/0000-0002-8447-9674; Weinstock, George M/0000-0002-2997-4592; Sykes, Sean/0000-0001-8344-5176; Mitreva, Makedonka/0000-0001-9572-3436	National Institutes of Health (NIH) [NIH-NHGRI U54HG003079, U54HG004968];  [U54HG004969];  [U54AI084844];  [NIH-NIAID UH3AI083263]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004969, U54HG004968, U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI084844, UH3AI083263] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research at Washington University was supported by National Institutes of Health (NIH) grants NIH-NHGRI U54HG003079 and U54HG004968, at the Broad Institute by grant U54HG004969, at the J. Craig Venter Institute U54AI084844 and research at Virginia Commonwealth University was supported by grant NIH-NIAID UH3AI083263. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HANCOCK JM, 1994, COMPUT APPL BIOSCI, V10, P67; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Kumar Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-240; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Makarova KS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000955; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; Reumers J, 2012, NAT BIOTECHNOL, V30, P61, DOI 10.1038/nbt.2053; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571	24	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e36427	10.1371/journal.pone.0036427	http://dx.doi.org/10.1371/journal.pone.0036427			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719831	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000305341900009
J	Fineberg, SK; Datta, P; Stein, CS; Davidson, BL				Fineberg, Sarah K.; Datta, Poppy; Stein, Colleen S.; Davidson, Beverly L.			MiR-34a Represses Numbl in Murine Neural Progenitor Cells and Antagonizes Neuronal Differentiation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TUMOR-SUPPRESSOR NETWORK; MICRORNA EXPRESSION; STEM-CELLS; MIRNA EXPRESSION; GENE-EXPRESSION; MOUSE; NOTCH; P53; APOPTOSIS	MicroRNA (miRNA) function is required for normal animal development, in particular in differentiation pathways from stem cell and precursor populations. In neurogenesis, it is becoming increasingly appreciated that miRNAs act at many stages to ensure proper progression. In this study we examined the role of miR-34a in neural progenitor cells (NPC) derived from murine embryonic cortex. We found that over-expression of miR-34a in NPC significantly reduced the neuron yield upon in vitro induction of differentiation. MiR-34a has several predicted targets in the Notch pathway, which operates to balance progenitor self-renewal and differentiation during cortical neurogenesis. We tested several Notch pathway players for regulation by miR-34a in undifferentiated NPC, and found that mRNA and protein levels of Numbl, a negative regulator of Notch signaling, as well as two downstream pro-neural genes usually blocked by Notch signaling, NeuroD1 and Mash1, were diminished, while Notch1 and Cbf1 transcripts were enhanced by miR-34a over-expression. Using a luciferase reporter assay, we verified the Numbl 3'-UTR as a direct miR-34a target. Correspondingly, knock-down of endogenous miR-34a resulted in increased Numbl, NeuroD1 and Mash1, and reduced Notch1 transcript levels. Together these results implicate Numbl as a physiologically relevant target of miR-34a in NPC, allowing for enhanced Notch signaling and inhibition of neuronal differentiation. This work extends our understanding of miR-34a-mediated control of cell differentiation from cancer to mammalian nervous system development.	[Fineberg, Sarah K.; Stein, Colleen S.; Davidson, Beverly L.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Datta, Poppy; Davidson, Beverly L.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Davidson, Beverly L.] Univ Iowa, Deparment Neurol, Iowa City, IA 52242 USA; [Fineberg, Sarah K.] Univ Iowa, Med Scientist Training Program, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Fineberg, SK (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	beverly-davidson@uiowa.edu	Datta, Poppy/AAE-9178-2020; Fineberg, Sarah/X-1060-2019	Fineberg, Sarah/0000-0001-6024-6721; Datta, Poppy/0000-0003-4989-0975; Davidson, Beverly/0000-0002-3715-6290	March of Dimes; Roy J. Carver Trust;  [DA025132]; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA025132] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); Roy J. Carver Trust; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Support by the March of Dimes, the Roy J. Carver Trust (BLD) and DA025132. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimirah F, 2007, NEOPLASIA, V9, P427, DOI 10.1593/neo.07211; Aranha MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021396; Aranha MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-514; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Bian S, 2011, MOL NEUROBIOL; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Caviness VS, 2009, TRENDS NEUROSCI, V32, P443, DOI 10.1016/j.tins.2009.05.003; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chapman G, 2006, J CELL BIOL, V175, P535, DOI 10.1083/jcb.200602009; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; Harper SQ, 2006, J VIROL, V80, P9371, DOI 10.1128/JVI.00958-06; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Hebert SS, 2010, HUM MOL GENET, V19, P3959, DOI 10.1093/hmg/ddq311; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hohjoh H, 2007, GENE, V391, P39, DOI 10.1016/j.gene.2006.11.018; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Li XK, 2010, NAT REV NEUROSCI, V11, P329, DOI 10.1038/nrn2739; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Liu CM, 2010, CELL STEM CELL, V6, P433, DOI 10.1016/j.stem.2010.02.017; Liu LN, 2011, BIOCHEM BIOPH RES CO, V413, P426, DOI 10.1016/j.bbrc.2011.08.108; Menon SG, 2003, CANCER RES, V63, P2109; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Olsen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007225; Pang RTK, 2010, CARCINOGENESIS, V31, P1037, DOI 10.1093/carcin/bgq066; Petersen PH, 2006, DEV NEUROSCI-BASEL, V28, P156, DOI 10.1159/000090761; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Shen Q, 2002, DEVELOPMENT, V129, P4843; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Thatcher EJ, 2007, DEV DYNAM, V236, P2172, DOI 10.1002/dvdy.21211; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Tivnan A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-33; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yi R, 2011, J CELL SCI, V124, P1775, DOI 10.1242/jcs.069104; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zhong WM, 1997, DEVELOPMENT, V124, P1887	51	48	50	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38562	10.1371/journal.pone.0038562	http://dx.doi.org/10.1371/journal.pone.0038562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701667	Green Published, gold, Green Submitted			2022-12-25	WOS:000305337600030
J	Nozza, S; Pogliaghi, M; Chiappetta, S; Spagnuolo, V; Fontana, G; Razzari, C; Tambussi, G; Faioni, EM				Nozza, Silvia; Pogliaghi, Manuela; Chiappetta, Stefania; Spagnuolo, Vincenzo; Fontana, Gessica; Razzari, Cristina; Tambussi, Giuseppe; Faioni, Elena Maria			Levels of Soluble Endothelial Protein C Receptor Are Associated with CD4(+) Changes in Maraviroc-Treated HIV-Infected Patients	PLOS ONE			English	Article							THROMBOMODULIN; INFLAMMATION; RISK	Background: Inflammation is a key feature of HIV infection and is correlated with long-term negative cardiovascular outcomes. Therapy-induced increases in CD4(+) cell counts can control inflammation, as shown by decreases of coagulation and inflammation markers during efficacious therapy. Maraviroc, a CCR5-antagonist, has resulted in larger increases in CD4(+) counts both in naive and experienced subjects compared to traditional antiretroviral therapy. Objectives and Methods: To examine if a member of the protein C anticoagulant and anti-inflammatory pathway, and marker of coagulation and inflammation, the soluble endothelial protein C receptor, is modified by infection and therapy-related variables in patients treated with Maraviroc. Endothelial protein C receptor, together with other established markers of inflammation and coagulation (CRP, IL-6, D-dimer and soluble thrombomodulin) was studied in 43 patients on traditional antiretroviral therapy and in 45 on Maraviroc during 48 weeks of follow-up. Results: Soluble endothelial protein C receptor was the only marker that could discriminate at least partially between patients with a good response to Maraviroc and patients who did not respond with an adequate increase in CD4(+) cell counts (more than 500 cells/mu L by week 48). Conclusions: Elevated levels of soluble endothelial protein C receptor, a sensitive marker of endothelial damage, indicated a low level of inflammation and coagulation activation in Maraviroc treated patients not picked up by other widely used markers. Persistent elevated levels of this marker at 48 weeks from beginning of treatment with Maraviroc were related to a poor increase in CD4(+) cells.	[Nozza, Silvia; Pogliaghi, Manuela; Chiappetta, Stefania; Spagnuolo, Vincenzo; Tambussi, Giuseppe] Ist Sci San Raffaele, Div Immunol Transplant & Infect Dis, Dept Infect & Trop Dis, I-20132 Milan, Italy; [Fontana, Gessica; Razzari, Cristina; Faioni, Elena Maria] Univ Milano & Med, Dipartimento Med Chirurgia & Odontoiatria, Milan, Italy; Azienda Osped San Paolo Polo Univ, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Nozza, S (corresponding author), Ist Sci San Raffaele, Div Immunol Transplant & Infect Dis, Dept Infect & Trop Dis, I-20132 Milan, Italy.	silvia.nozza@hsr.it	NOZZA, SILVIA/AAC-5445-2022; Chiappetta, Stefania/E-8874-2013	Chiappetta, Stefania/0000-0002-8304-4927; Tambussi, Giuseppe/0000-0002-0604-2960; Spagnuolo, Vincenzo/0000-0002-9656-7217; Nozza, Silvia/0000-0002-2673-2731; FAIONI, ELENA MARIA/0000-0001-8731-6531	European Union; NEAT [LSHP-CT-2006-037570]; AIDS Program, Italian Ministry of Health [40H34]; ViiV Healthcare	European Union(European Commission); NEAT; AIDS Program, Italian Ministry of Health; ViiV Healthcare	The study was supported by a grant under the European Union 6th Framework Programme, contract Acronim: NEAT, Number: LSHP-CT-2006-037570 and a grant under the AIDS Program, Italian Ministry of Health: Grant Number 40H34. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Silvia Nozza and Giuseppe Tambussi have received travel grants and consultancy fees from ViiV Healthcare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Calmy A, 2009, AIDS, V23, P929, DOI 10.1097/QAD.0b013e32832995fa; Cooper DA, 2010, J INFECT DIS, V201, P803, DOI 10.1086/650697; Esmon CT, 2006, SEMIN THROMB HEMOST, V32, P49, DOI 10.1055/s-2006-939554; Esmon CT, 1999, HAEMATOLOGICA, V84, P363; Faioni EM, 2004, CRIT CARE MED, V32, pS266, DOI 10.1097/01.CCM.0000128032.85396.83; Funderburg N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013188; Gu JM, 2000, BLOOD, V95, P1687, DOI 10.1182/blood.V95.5.1687.005k08_1687_1693; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Ho JE, 2009, HEART, V95, P1193, DOI 10.1136/hrt.2008.161463; Ireland H, 2005, ATHEROSCLEROSIS, V183, P283, DOI 10.1016/j.atherosclerosis.2005.02.028; Kaplan RC, 2008, AIDS, V22, P1615, DOI 10.1097/QAD.0b013e328300581d; Kline ER, 2008, AM J PHYSIOL-HEART C, V294, pH2792, DOI 10.1152/ajpheart.91447.2007; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Kurosawa S, 1998, BLOOD, V91, P725, DOI 10.1182/blood.V91.2.725; MacInnes A, 2011, HIV CLIN TRIALS, V12, P24, DOI 10.1310/hct1201-24; Montes R, 2005, J THROMB HAEMOST, V3, P1454, DOI 10.1111/j.1538-7836.2005.01297.x; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Nixon DE, 2010, CURR OPIN HIV AIDS, V5, P498, DOI 10.1097/COH.0b013e32833ed6f4; Solages A, 2006, CLIN INFECT DIS, V42, P1325, DOI 10.1086/503261; Wilkin T, 2010, 17 C RETR OPP INF SA	20	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e37032	10.1371/journal.pone.0037032	http://dx.doi.org/10.1371/journal.pone.0037032			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715361	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336800002
J	Cuevas-Ramos, D; Almeda-Valdes, P; Meza-Arana, CE; Brito-Cordova, G; Gomez-Perez, FJ; Mehta, R; Oseguera-Moguel, J; Aguilar-Salinas, CA				Cuevas-Ramos, Daniel; Almeda-Valdes, Paloma; Elena Meza-Arana, Clara; Brito-Cordova, Griselda; Gomez-Perez, Francisco J.; Mehta, Roopa; Oseguera-Moguel, Jorge; Aguilar-Salinas, Carlos A.			Exercise Increases Serum Fibroblast Growth Factor 21 (FGF21) Levels	PLOS ONE			English	Article							FATTY-ACID-METABOLISM; PPAR-ALPHA; PHYSICAL-ACTIVITY; LIPID MOBILIZATION; LIPOLYSIS; INSULIN; REGULATOR; GLUCOSE; FIBROBLAST-GROWTH-FACTOR-21; PGC-1-ALPHA	Background: Fibroblast growth factor 21 (FGF21) increases glucose uptake. It is unknown if FGF21 serum levels are affected by exercise. Methodology/Principal Findings: This was a comparative longitudinal study. Anthropometric and biochemical evaluation were carried out before and after a bout of exercise and repeated after two weeks of daily supervised exercise. The study sample was composed of 60 sedentary young healthy women. The mean age was 24 +/- 3.7 years old, and the mean BMI was 21.4 +/- 7.0 kg/m(2). The anthropometric characteristics did not change after two weeks of exercise. FGF21 levels significantly increased after two weeks of exercise (276.8 ng/l (142.8-568.6) vs. (460.8 (298.2-742.1), p<0.0001)). The delta (final-basal) log of serum FGF21, adjusted for BMI, showed a significant positive correlation with basal glucose (r = 0.23, p = 0.04), mean maximal heart rate (MHR) (r = 0.54, p<0.0001), mean METs (r = 0.40, p = 0.002), delta plasma epinephrine (r = 0.53, p<0.0001) and delta plasma FFAs (r = 0.35, p = 0.006). A stepwise linear regression model showed that glucose, MHR, METs, FFAs, and epinephrine, were factors independently associated with the increment in FGF21 after the exercise program (F = 4.32; r(2) = 0.64, p<0.0001). Conclusions: Serum FGF21 levels significantly increased after two weeks of physical activity. This increment correlated positively with clinical parameters related to the adrenergic and lipolytic response to exercise.	[Cuevas-Ramos, Daniel; Almeda-Valdes, Paloma; Brito-Cordova, Griselda; Gomez-Perez, Francisco J.; Mehta, Roopa; Aguilar-Salinas, Carlos A.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Endocrinol & Metab, Mexico City, DF, Mexico; [Elena Meza-Arana, Clara] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Internal Med, Mexico City, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Cuevas-Ramos, D (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Endocrinol & Metab, Mexico City, DF, Mexico.	caguilarsalinas@yahoo.com	Almeda-Valdes, Paloma/AAJ-8023-2020; Salinas, Carlos A Aguilar/AAL-4491-2020; Mehta, Roopa/AAI-7458-2021	Almeda-Valdes, Paloma/0000-0002-9701-5879; 	Comite Nacional de Ciencia y Tecnologia (CONACYT)	Comite Nacional de Ciencia y Tecnologia (CONACYT)	This work was supported by the Comite Nacional de Ciencia y Tecnologia (CONACYT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; Chen W, 2011, J BIOL CHEM, V286, P34559, DOI 10.1074/jbc.M111.285965; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Cuevas-Ramos D, 2010, EUR J ENDOCRINOL, V163, P469, DOI 10.1530/EJE-10-0454; de Glisezinski I, 2009, J PHYSIOL-LONDON, V587, P3393, DOI 10.1113/jphysiol.2009.168906; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Henderson GC, 2007, J PHYSIOL-LONDON, V584, P963, DOI 10.1113/jphysiol.2007.137331; Hill J, 2002, BRIT MED J, V324, P1084, DOI 10.1136/bmj.324.7345.1084; Hojman P, 2009, DIABETES, V58, P2797, DOI 10.2337/db09-0713; Hom GJ, 2001, J PHARMACOL EXP THER, V297, P299; Horton TJ, 2009, J APPL PHYSIOL, V107, P200, DOI 10.1152/japplphysiol.90812.2008; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Li L, 2011, DIABETES, V60, P157, DOI 10.2337/db10-0331; Lopez-Alvarenga JC, 2001, SALUD PUBLICA MEXICO, V43, P306; LUND S, 1995, P NATL ACAD SCI USA, V92, P5817, DOI 10.1073/pnas.92.13.5817; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Mai K, 2009, DIABETES, V58, P1532, DOI 10.2337/db08-1775; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Schoenberg KM, 2011, ENDOCRINOLOGY, V152, P4652, DOI 10.1210/en.2011-1425; Tremblay MS, 2010, APPL PHYSIOL NUTR ME, V35, P725, DOI 10.1139/H10-079; Uebanso T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022976; WAHRENBERG H, 1991, EUR J CLIN INVEST, V21, P534, DOI 10.1111/j.1365-2362.1991.tb01406.x; Yan HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024895; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	29	114	121	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38022	10.1371/journal.pone.0038022	http://dx.doi.org/10.1371/journal.pone.0038022			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701542	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500073
J	Haines, RJ; Corbin, KD; Pendleton, LC; Eichler, DC				Haines, Ricci J.; Corbin, Karen D.; Pendleton, Laura C.; Eichler, Duane C.			Protein Kinase C alpha Phosphorylates a Novel Argininosuccinate Synthase Site at Serine 328 during Calcium-dependent Stimulation of Endothelial Nitric-oxide Synthase in Vascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; PKC-ALPHA; ACTIVATION; ENOS; EXPRESSION; RELEASE; CA2+; AKT	Endothelial nitric-oxide synthase (eNOS) utilizes L-arginine as its principal substrate, converting it to L-citrulline and nitric oxide (NO). L-Citrulline is recycled to L-arginine by two enzymes, argininosuccinate synthase (AS) and argininosuccinate lyase, providing the substrate arginine for eNOS and NO production in endothelial cells. Together, these three enzymes, eNOS, AS, and argininosuccinate lyase, make up the citrulline-NO cycle. Although AS catalyzes the rate-limiting step in NO production, little is known about the regulation of AS in endothelial cells beyond the level of transcription. In this study, we showed that AS Ser-328 phosphorylation was coordinately regulated with eNOS Ser-1179 phosphorylation when bovine aortic endothelial cells were stimulated by either a calcium ionophore or thapsigargin to produce NO. Furthermore, using in vitro kinase assay, kinase inhibition studies, as well as protein kinase C alpha (PKC alpha) knockdown experiments, we demonstrate that the calcium-dependent phosphorylation of AS Ser-328 is mediated by PKC alpha. Collectively, these findings suggest that phosphorylation of AS at Ser-328 is regulated in accordance with the calcium-dependent regulation of eNOS under conditions that promote NO production and are in keeping with the rate-limiting role of AS in the citrulline-NO cycle of vascular endothelial cells.	[Haines, Ricci J.; Pendleton, Laura C.; Eichler, Duane C.] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL 33612 USA; [Corbin, Karen D.] Univ N Carolina Chapel Hill, Inst Nutr Res, Kannapolis, NC 28081 USA; [Corbin, Karen D.] Univ N Carolina Chapel Hill, Dept Nutr, Kannapolis, NC 28081 USA	State University System of Florida; University of South Florida; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Eichler, DC (corresponding author), Univ S Florida, Dept Mol Med, Morsani Coll Med, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	deichler@health.usf.edu		Corbin, Karen/0000-0003-2065-0003	National Institutes of Health [R01 HL083153-01A2]; James Esther King Biomedical Research Program Grant, Florida Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James Esther King Biomedical Research Program Grant, Florida Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL083153-01A2 (to Duane C. Eichler). This work was also supported by the James Esther King Biomedical Research Program Grant, Florida Department of Health (to Duane C. Eichler).	Brouet A, 2001, J BIOL CHEM, V276, P32663, DOI 10.1074/jbc.M101371200; Collingwood MA, 2008, OLIGONUCLEOTIDES, V18, P187, DOI 10.1089/oli.2008.0123; Corbin KD, 2008, BIOCHEM BIOPH RES CO, V377, P1042, DOI 10.1016/j.bbrc.2008.10.056; Dimmeler S, 2000, FEBS LETT, V477, P258, DOI 10.1016/S0014-5793(00)01657-4; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Flam BR, 2001, NITRIC OXIDE-BIOL CH, V5, P187, DOI 10.1006/niox.2001.0340; Flam BR, 2007, NITRIC OXIDE-BIOL CH, V17, P115, DOI 10.1016/j.niox.2007.07.001; Fleming I, 2010, PFLUG ARCH EUR J PHY, V459, P793, DOI 10.1007/s00424-009-0767-7; Goodwin BL, 2004, J BIOL CHEM, V279, P18353, DOI 10.1074/jbc.M308160200; Goodwin BL, 2008, BIOCHEM BIOPH RES CO, V370, P254, DOI 10.1016/j.bbrc.2008.03.089; Goodwin BL, 2007, AM J PHYSIOL-HEART C, V293, pH1115, DOI 10.1152/ajpheart.01100.2006; GOSPODAROWICZ D, 1976, P NATL ACAD SCI USA, V73, P4120, DOI 10.1073/pnas.73.11.4120; Haines RJ, 2012, BIOCHEM BIOPH RES CO, V421, P9, DOI 10.1016/j.bbrc.2012.03.074; Haines Ricci J, 2011, Int J Biochem Mol Biol, V2, P8; Imami K, 2008, ANAL SCI, V24, P161, DOI 10.2116/analsci.24.161; Kroll J, 1999, BIOCHEM BIOPH RES CO, V265, P636, DOI 10.1006/bbrc.1999.1729; Li H, 2001, AM J PHYSIOL-ENDOC M, V280, pE75, DOI 10.1152/ajpendo.2001.280.1.E75; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; MISKO TP, 1993, ANAL BIOCHEM, V214, P11, DOI 10.1006/abio.1993.1449; Montagnani M, 2002, MOL ENDOCRINOL, V16, P1931, DOI 10.1210/me.2002-0074; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Partovian C, 2005, CIRC RES, V97, P482, DOI 10.1161/01.RES.0000179775.04114.45; Pendleton LC, 2002, J BIOL CHEM, V277, P25363, DOI 10.1074/jbc.M111677200; Prabhakar P, 1998, J BIOL CHEM, V273, P27383, DOI 10.1074/jbc.273.42.27383; Rask-Madsen C, 2008, ARTERIOSCL THROM VAS, V28, P919, DOI 10.1161/ATVBAHA.108.162842; Rask-Madsen C, 2007, NAT CLIN PRACT ENDOC, V3, P46, DOI 10.1038/ncpendmet0366; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Simon A, 2003, CIRC RES, V93, P813, DOI 10.1161/01.RES.0000097761.19223.0D; Tran Q. -K., 2006, V176, P145; Xiao ZH, 2011, J BIOL CHEM, V286, P20100, DOI 10.1074/jbc.M111.220236; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871	34	7	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26168	26176		10.1074/jbc.M112.378794	http://dx.doi.org/10.1074/jbc.M112.378794			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22696221	Green Published, hybrid			2022-12-25	WOS:000306916300044
J	Hamerton, I; Howlin, BJ; Kamyszek, G				Hamerton, Ian; Howlin, Brendan J.; Kamyszek, Grzegorz			Predicting Glass Transition Temperatures of Polyarylethersulphones Using QSPR Methods	PLOS ONE			English	Article							AROMATIC POLY(ETHER SULFONE)S; POLY(ARYLENE ETHER SULFONES); MOLECULAR SIMULATION; GAS-TRANSPORT; POLYSULFONE; BLENDS; POLYETHERSULFONES; POLYMERS; KETONE)S	The technique of Quantitative Structure Property Relationships has been applied to the glass transition temperatures of polyarylethersulphones. A general equation is reported that calculates the glass transition temperatures with acceptable accuracy (correlation coefficients of between 90-67%, indicating an error of 10-30% with regard to experimentally determined values) for a series of 42 reported polyarylethersulphones. This method is quite simple in assumption and relies on a relatively small number of parameters associated with the structural unit of the polymer: the number of rotatable bonds, the dipole moment, the heat of formation, the HOMO eigenvalue, the molar mass and molar volume. For smaller subsets of the main group (based on families of derivatives containing different substituents) the model can be simplified further to an equation that uses the volume of the substituents as the principal variable.	[Hamerton, Ian; Howlin, Brendan J.; Kamyszek, Grzegorz] Univ Surrey, Dept Chem, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England	University of Surrey	Hamerton, I (corresponding author), Univ Surrey, Dept Chem, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England.	b.howlin@surrey.ac.uk	Howlin, Brendan J/F-3343-2011; Hamerton, Ian/AAV-8918-2021	Howlin, Brendan J/0000-0002-9398-7152; Hamerton, Ian/0000-0003-3113-0345				*ACC INC, QUANTA; ANDREWS SM, 1992, J POLYM SCI POL CHEM, V30, P221, DOI 10.1002/pola.1992.080300206; ATTWOOD TE, 1981, POLYMER, V22, P1096, DOI 10.1016/0032-3861(81)90299-8; ATTWOOD TE, 1977, POLYMER, V18, P359, DOI 10.1016/0032-3861(77)90083-0; Attwood TE, 1977, POLYMER, V18, P35; Baron L, 1970, MAKROMOL CHEM, V140, P83; Brostow W, 2008, MATER LETT, V62, P3152, DOI 10.1016/j.matlet.2008.02.008; Clendinning RA, 1988, POLYM PREP-ACS, V32, P166; Cotter R.J., 1995, ENG PLASTICS HDB POL; Cotter RJ, 1989, US Patent, Patent No. [4,849,503, 4849503]; Farnham A. G., 1973, Brit. Pat., Patent No. [1,078,234, 1078234]; FLETCHER R, 1964, COMPUT J, V7, P149, DOI 10.1093/comjnl/7.2.149; GHOSAL K, 1992, J MEMBRANE SCI, V72, P91, DOI 10.1016/0376-7388(92)80058-R; GOH SH, 1992, POLYM BULL, V29, P521, DOI 10.1007/BF00296713; Hamerton I, 2006, POLYMER, V47, P690, DOI 10.1016/j.polymer.2005.11.082; HAMERTON I, 1995, J MOL GRAPHICS, V13, P14, DOI 10.1016/0263-7855(94)00009-H; Hamerton I, 1996, MODEL SIMUL MATER SC, V4, P151, DOI 10.1088/0965-0393/4/2/003; Hamerton I, 1996, MACROMOL THEOR SIMUL, V5, P305, DOI 10.1002/mats.1996.040050211; Hamerton I, 2011, HANDBOOK OF BENZOXAZINE RESINS, P127, DOI 10.1016/B978-0-444-53790-4.00050-3; Hartmann LA, 1979, US Patent, Patent No. [4,156,068, 4156068]; Howlin BJ, 2012, PLOS1 IN PRESS; Hsaio BS, 1991, ACS POLYM PREP, V32, P258; Ivin KJ, 1968, ADV MACROMOL CHEM, V1, P335; JOHNSON RN, 1967, J POLYM SCI A1, V5, P2375, DOI 10.1002/pol.1967.150050916; Jones M. E. B., 1962, Brit. Pat., Patent No. [1,016,245, 1016245]; KAMPS KMP, 1992, J MEMBRANE SCI, V74, P193, DOI 10.1016/0376-7388(92)87083-A; KIM WG, 1992, J MACROMOL SCI PURE, VA29, P1141, DOI 10.1080/10601329208054147; KOEHLER MG, 1989, POLYMER, V30, P116, DOI 10.1016/0032-3861(89)90392-3; Lee JA, 1993, POLYM PREP-ACS, V34, P570; Maresca LM, 1984, US Patent number, Patent No. [4,473,684, 4473684]; MATSUO S, 1993, J POLYM SCI POL CHEM, V31, P3439, DOI 10.1002/pola.1993.080311333; MCHATTIE JS, 1991, POLYMER, V32, P840, DOI 10.1016/0032-3861(91)90508-G; Mohanty DK, 1982, POLYM PREPRINTS, V23, P284; O'Shea FX, 1974, Can Patent, Patent No. [946,091, 946091]; Pauling L., 1960, NATURE CHEM BOND, V3rd; PERCEC V, 1991, J POLYM SCI POL CHEM, V29, P965, DOI 10.1002/pola.1991.080290703; PODKOSCIELNY W, 1991, ANGEW MAKROMOL CHEM, V188, P143, DOI 10.1002/apmc.1991.051880113; ROBESON LM, 1983, J APPL POLYM SCI, V28, P2925, DOI 10.1002/app.1983.070280920; Robeson LM, 1975, POLYM PREPR AM CHEM, V16, P476; Robeson M, 1975, ACS, V169, P90; ROSE JB, 1974, POLYMER, V15, P456, DOI 10.1016/0032-3861(74)90111-6; ROSE JB, 1974, CHIMIA, V28, P561; Rose JB, 1968, CHEM IND, V15, P461; Schmidt M, 1998, J POLYM SCI POL PHYS, V36, P1061, DOI 10.1002/(SICI)1099-0488(19980430)36:6<1061::AID-POLB14>3.0.CO;2-4; Stewart JJ, 1990, COMPUT AIDED MOL DES, V4, P1, DOI DOI 10.1007/BF0; TAM CM, 1993, J MEMBRANE SCI, V78, P123; UEDA M, 1991, POLYM J, V23, P297, DOI 10.1295/polymj.23.297; UEDA M, 1993, J POLYM SCI POL CHEM, V31, P853, DOI 10.1002/pola.1993.080310402; VanKrevelen DW, 2009, PROPERTIES OF POLYMERS: THEIR CORRELATION WITH CHEMICAL STRUCTURE; THEIR NUMERICAL ESTIMATION AND PREDICTION FROM ADDITIVE GROUP CONTRIBUTIONS, P1; Vogel H. A., 1963, Brit. Pat., Patent No. [1,060,546, 1060546]; VOGEL HA, 1970, J POLYM SCI A1, V8, P2035, DOI 10.1002/pol.1970.150080812; Wham GK, 1991, POLYM PREPR, V32, P389	52	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38424	10.1371/journal.pone.0038424	http://dx.doi.org/10.1371/journal.pone.0038424			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719884	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350000016
J	Carter, GG; Logsdon, R; Arnold, BD; Menchaca, A; Medellin, RA				Carter, Gerald G.; Logsdon, Ryane; Arnold, Bryan D.; Menchaca, Angelica; Medellin, Rodrigo A.			Adult Vampire Bats Produce Contact Calls When Isolated: Acoustic Variation by Species, Population, Colony, and Individual	PLOS ONE			English	Article							SPEAR-NOSED BATS; SOCIAL CALLS; ECHOLOCATION CALLS; DESMODUS-ROTUNDUS; SPATIAL ORIENTATION; BEHAVIORAL CONTEXT; COMMUNICATION; CONSPECIFICS; DISCRIMINATION; PHYLLOSTOMIDAE	Background: Bat pups produce individually distinct isolation calls to facilitate maternal recognition. Increasing evidence suggests that, in group-living bat species, adults often use similar calls to maintain contact. We investigated if isolated adults from all three species of the highly cooperative vampire bats (Phyllostomidae: Desmodontinae) would produce vocally distinct contact calls when physically isolated. Methods/Principal Findings: We assessed variation in contact calls recorded from isolated captive and wild-caught adult common vampire bats (Desmodus rotundus), white-winged vampire bats (Diaemus youngi) and hairy-legged vampire bats (Diphylla ecaudata). We compared species-typical contact call structure, and used information theory and permuted discriminate function analyses to examine call structure variation, and to determine if the individuality of contact calls is encoded by different call features across species and populations. We found that isolated adult vampire bats produce contact calls that vary by species, population, colony, and individual. However, much variation occurred within a single context and individual. We estimated signature information for captive Diaemus (same colony), captive Desmodus (same colony), and wild Desmodus (different colonies) at 3.21, 3.26, and 3.88 bits, respectively. Contact calls from a captive colony of Desmodus were less individually distinct than calls from wild-caught Desmodus from different colonies. Both the degree of individuality and parameters encoding individuality differed between the bats from a single captive colony and the wild-caught individuals from different groups. This result is consistent with, but not sufficient evidence of, vocal convergence in groups. Conclusion: Our results show that adult vampire bats of all three species produce highly variable contact calls when isolated. Contact calls contain sufficient information for vocal discrimination, but also possess more intra-individual variation than is required for the sole purpose of identifying individuals.	[Carter, Gerald G.] Univ Maryland, College Pk, MD 20742 USA; [Carter, Gerald G.] Org Bat Conservat, Bloomfield Hills, MI USA; [Logsdon, Ryane] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Arnold, Bryan D.] Murray State Univ, Dept Biol Sci, Murray, KY 42071 USA; [Menchaca, Angelica; Medellin, Rodrigo A.] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City, DF, Mexico	University System of Maryland; University of Maryland College Park; University of Rochester; Murray State University; Universidad Nacional Autonoma de Mexico	Carter, GG (corresponding author), Univ Maryland, College Pk, MD 20742 USA.	gcarter@umd.edu			Cosmos Club Foundation of Washington DC; American Society of Mammalogists; Explorer's Club, Washington Group; National Academy of Sciences	Cosmos Club Foundation of Washington DC; American Society of Mammalogists; Explorer's Club, Washington Group; National Academy of Sciences	This work was supported by research grants from the Cosmos Club Foundation of Washington DC, the American Society of Mammalogists, and the Explorer's Club, Washington Group, and the National Academy of Sciences, administered by Sigma Xi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Arnold BD, 2011, BEHAV ECOL SOCIOBIOL, V65, P1581, DOI 10.1007/s00265-011-1168-4; BARCLAY RMR, 1982, BEHAV ECOL SOCIOBIOL, V10, P271, DOI 10.1007/BF00302816; BEECHER MD, 1989, ANIM BEHAV, V38, P248, DOI 10.1016/S0003-3472(89)80087-9; Betke M, 2008, J MAMMAL, V89, P18, DOI 10.1644/07-MAMM-A-011.1; Bohn KM, 2008, J ACOUST SOC AM, V124, P1838, DOI 10.1121/1.2953314; Bohn KM, 2007, ANIM BEHAV, V73, P423, DOI 10.1016/j.anbehav.2006.09.003; Bohn KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006746; Bohn KM, 2006, BIOL LETT-UK, V2, P561, DOI 10.1098/rsbl.2006.0501; Bohn KM, 2004, J COMP PHYSIOL A, V190, P185, DOI 10.1007/s00359-003-0485-0; Boughman JW, 1998, ANIM BEHAV, V55, P1717, DOI 10.1006/anbe.1997.0721; Boughman JW, 1998, P ROY SOC B-BIOL SCI, V265, P227, DOI 10.1098/rspb.1998.0286; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; CALDWELL MC, 1965, NATURE, V207, P434, DOI 10.1038/207434a0; Carter GG, 2009, CAN J ZOOL, V87, P604, DOI 10.1139/Z09-051; Carter GG, 2008, ANIM BEHAV, V76, P1343, DOI 10.1016/j.anbehav.2008.04.023; Chaverri G, 2010, BIOL LETTERS, V6, P441, DOI 10.1098/rsbl.2009.0964; Chen SF, 2009, P ROY SOC B-BIOL SCI, V276, P3901, DOI 10.1098/rspb.2009.1185; Cortopassi KA, 2006, ANIM BEHAV, V71, P1141, DOI 10.1016/j.anbehav.2005.09.011; Dechmann DKN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009012; Dechmann DKN, 2009, P ROY SOC B-BIOL SCI, V276, P2721, DOI 10.1098/rspb.2009.0473; Dechmann DKN, 2002, CONSERV GENET, V3, P455, DOI 10.1023/A:1020574400398; Elizalde-Arellano C, 2007, ACTA CHIROPTEROL, V9, P314, DOI 10.3161/1733-5329(2007)9[314:FSBITH]2.0.CO;2; ESSER KH, 1989, ETHOLOGY, V82, P156; ESSER KH, 1994, NEUROREPORT, V5, P1718, DOI 10.1097/00001756-199409080-00007; Furmankiewicz J, 2011, ETHOLOGY, V117, P480, DOI 10.1111/j.1439-0310.2011.01897.x; Gillam EH, 2012, ANIM BEHAV, V83, P269, DOI 10.1016/j.anbehav.2011.11.002; GOULD E, 1973, J MAMMAL, V54, P998, DOI 10.2307/1379103; Gould E, 1997, BIOL BATS NEW WORLD, P247; Groger U, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-18; Hoffmann FF, 2007, CAN J ZOOL, V85, P863, DOI 10.1139/Z07-069; HOLM S, 1979, SCAND J STAT, V6, P65; Janik VM, 2000, ANIM BEHAV, V60, P1, DOI 10.1006/anbe.2000.1410; JONES G, 1993, P ROY SOC B-BIOL SCI, V252, P125, DOI 10.1098/rspb.1993.0055; Jones G, 2011, J COMP PHYSIOL A, V197, P447, DOI 10.1007/s00359-010-0565-x; Kerth G, 2008, BIOSCIENCE, V58, P737, DOI 10.1641/B580810; Knornschild M, 2007, ANIM BEHAV, V74, P1055, DOI 10.1016/j.anbehav.2006.12.024; Knornschild M, 2010, BIOL LETTERS, V6, P156, DOI 10.1098/rsbl.2009.0685; Manser MB, 2002, TRENDS COGN SCI, V6, P55, DOI 10.1016/S1364-6613(00)01840-4; MCCRACKEN GF, 1984, SCIENCE, V223, P1090, DOI 10.1126/science.223.4640.1090; Moss CF, 2006, PLOS BIOL, V4, P615, DOI 10.1371/journal.pbio.0040079; Mundry R, 2007, ANIM BEHAV, V74, P965, DOI 10.1016/j.anbehav.2006.12.028; Nicastro N, 2003, J COMP PSYCHOL, V117, P44, DOI 10.1037/0735-7036.117.1.44; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Piaggio AJ, 2008, MOL ECOL RESOUR, V8, P440, DOI 10.1111/j.1471-8286.2007.01986.x; Pongracz P, 2005, J COMP PSYCHOL, V119, P136, DOI 10.1037/0735-7036.119.2.136; Rendall D, 2003, J ACOUST SOC AM, V113, P3390, DOI 10.1121/1.1568942; SAILLER H, 1978, Z SAUGETIERKD, V43, P249; SCHERRER JA, 1993, ANIM BEHAV, V46, P847, DOI 10.1006/anbe.1993.1270; SCHMIDT U, 1973, Zeitschrift fuer Saeugetierkunde, V38, P14; Schmidt U, 1972, ZOOL BEITR, V23, P310; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Schoner CR, 2010, BEHAV ECOL SOCIOBIOL, V64, P2053, DOI 10.1007/s00265-010-1019-8; Sugiura H, 2007, AM J PRIMATOL, V69, P1412, DOI 10.1002/ajp.20447; SUTHERS RA, 1965, J EXP ZOOL, V158, P319, DOI 10.1002/jez.1401580307; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Tschapka M, 1999, Z SAUGETIERKD, V64, P239; Weigl R., 2005, KLEINE SENCKENBERG R; Weiss DJ, 2001, J COMP PSYCHOL, V115, P258, DOI 10.1037/0735-7036.115.3.258; WILKINSON GS, 1986, ANIM BEHAV, V34, P1880, DOI 10.1016/S0003-3472(86)80274-3; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0; Wilkinson GS, 2003, ANIMAL SOCIAL COMPLEXITY, P322; WILKINSON GS, 1985, BEHAV ECOL SOCIOBIOL, V17, P111; Wilkinson GS, 1998, ANIM BEHAV, V55, P337, DOI 10.1006/anbe.1997.0557	64	42	43	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38791	10.1371/journal.pone.0038791	http://dx.doi.org/10.1371/journal.pone.0038791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719947	Green Published, Green Submitted, gold			2022-12-25	WOS:000305347800019
J	Nishishita, N; Shikamura, M; Takenaka, C; Takada, N; Fusak, N; Kawamata, S				Nishishita, Naoki; Shikamura, Masayuki; Takenaka, Chiemi; Takada, Nozomi; Fusak, Noemi; Kawamata, Shin			Generation of Virus-Free Induced Pluripotent Stem Cell Clones on a Synthetic Matrix via a Single Cell Subcloning in the Naive State	PLOS ONE			English	Article							SENDAI-VIRUS; INDUCTION; FIBROBLASTS	CD34+ cord blood cells can be reprogrammed effectively on dishes coated with a synthetic RGD motif polymer (PronectinF (R)) using a temperature sensitive Sendai virus vector (SeV TS7) carrying reprogramming factors OCT3/4, SOX2, KLF4 and c-MYC. Dish-shaped human ES cell-like colonies emerged in serum-free primate ES cell medium (supplemented with bFGF) in 20% O2 culture conditions. The copy numbers of SeV TS7 vectors in the cytoplasm were drastically reduced by a temperature shift at 38 degrees C for three days. Then, single cells from colonies were seeded on PronectinF (R)-coated 96-well plates and cultured under naive culture conditions (N2B27-based medium supplemented with LIF, forskolin, a MAPK inhibitor, and a GSK inhibitor in 5% O2) for cloning purpose. Dome-shaped mouse ES cell-like colonies from single cells emerged on PronectinF (R)-coated dishes. These cells were collected and cultured again in primate ES cell medium supplemented with bFGF in 20% O2 and maintained on PronectinF (R)-coated dishes. Cells were assessed for reprogramming, including the absence of residual SeV and their potential for three germ layer differentiation. Generation of virus-free induced pluripotent stem cell (iPSC) clones from single cells under feeder-free conditions will solve some of the safety concerns related to use of xeno- or allogeneic-material in culture, and contribute to the characterization and the standardization of iPS cells intended for use in a clinical setting.	[Nishishita, Naoki; Takenaka, Chiemi; Kawamata, Shin] Riken Ctr Dev Biol, Chuo Ku, Kobe, Hyogo, Japan; [Nishishita, Naoki; Shikamura, Masayuki; Takenaka, Chiemi; Takada, Nozomi; Kawamata, Shin] Fdn Biomed Res & Innovat, Chuo Ku, Kobe, Hyogo, Japan; [Fusak, Noemi] DNAVEC Corp, Tsukuba, Ibaragi, Japan; [Fusak, Noemi] Japanese Sci & Technol Agcy, Kawaguchi, Saitama, Japan	RIKEN; Institute for Biomedical Research & Innovation (IBRI); DNAVEC Corporation; Japan Science & Technology Agency (JST)	Nishishita, N (corresponding author), Riken Ctr Dev Biol, Chuo Ku, Minatojima Minamimachi, Kobe, Hyogo, Japan.	kawamata@fbri.org		kawamata, shin/0000-0001-5148-1949	JST Tokyo Japan; JSPS [2210853]; S-Innovation project of JST Tokyo Japan	JST Tokyo Japan; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); S-Innovation project of JST Tokyo Japan	This work was supported by the Regulatory Science Study for Safety issue for pluripotent stem cells of JST Tokyo Japan (2010-2014) and a Grant-in-Aid for JSPS Fellows 2210853 and S-Innovation project of JST Tokyo Japan (2009-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hakala H, 2009, TISSUE ENG PT A, V15, P1775, DOI 10.1089/ten.tea.2008.0316; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Meng XM, 2012, MOL THER, V20, P408, DOI 10.1038/mt.2011.258; Nishishita N, 2011, EMBRYONIC STEM CELL, P399; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takenaka C, 2010, EXP HEMATOL, V38, P154, DOI 10.1016/j.exphem.2009.11.003; Wernet P, 2011, EXP HEMATOL, P1099; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Zhou HY, 2010, J BIOL CHEM, V285, P29676, DOI 10.1074/jbc.C110.150599	23	30	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38389	10.1371/journal.pone.0038389	http://dx.doi.org/10.1371/journal.pone.0038389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719883	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900026
J	Prieto-Marquez, A; Chiappe, LM; Joshi, SH				Prieto-Marquez, Albert; Chiappe, Luis M.; Joshi, Shantanu H.			The Lambeosaurine Dinosaur Magnapaulia laticaudus from the Late Cretaceous of Baja California, Northwestern Mexico	PLOS ONE			English	Article							ARAL SEA REGION; HADROSAURIAN DINOSAUR; HYPACROSAURUS-ALTISPINUS; HISTORICAL BIOGEOGRAPHY; NORTHEASTERN CHINA; ORNITHOPODA; ORNITHISCHIA; ANATOMY; PHYLOGENY; KAZAKSTAN	The taxonomy, osteology, phylogenetic position, and historical biogeography of the lambeosaurine hadrosaurid Magnapaulia laticaudus (new combination) are revised. The diagnosis of this species is amended on the basis on two autapomorphies (i.e., longest haemal arches of proximal caudal vertebrae being at least four times longer than the height of their respective centra; base of prezygapophyses in caudal vertebrae merging to form a bowl-shaped surface) and a unique combination of characters (i.e., downturned cranioventral process of the maxilla; tear-shaped external naris with length/width ratio between 1.85 and 2.85; neural spines of dorsal, sacral, and proximal caudal vertebrae being at least four times the height of their respective centra). A maximum parsimony analysis supports a sister taxon relationship between M. laticaudus and Velafrons coahuilensis. Both taxa constitute a clade of southern North American lambeosaurines, which forms a sister relationship with the diverse clade of helmet-crested lambeosaurines from northern North America that includes well-known genera like Corythosaurus, Lambeosaurus, and Hypacrosaurus. According to the results of a Dispersal-Vicariance analysis, southern North American lambeosaurines split from the northern forms via vicariance from a common ancestor that lived in both the northern and southern regions of the continent.	[Prieto-Marquez, Albert] Bayer Staatssammlung Palaontol & Geol, Munich, Germany; [Chiappe, Luis M.] Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA USA; [Joshi, Shantanu H.] UCLA Sch Med, Lab Neuro Imaging, Dept Neurol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Prieto-Marquez, A (corresponding author), Bayer Staatssammlung Palaontol & Geol, Munich, Germany.	redshore@gmail.com	Prieto-Marquez, Albert/AAA-1470-2019; Joshi, Sudhanshu/L-2284-2019	Joshi, Sudhanshu/0000-0003-4748-5001; Prieto-Marquez, Albert/0000-0002-4836-4052; Chiappe, Luis/0000-0001-9661-0601	Dinosaur Institute at the Natural History Museum of Los Angeles County; Alexander von Humboldt Foundation; National Science Foundation [EAR 0207744, DBI 0446224]; Ministry of Education and Science of Spain [CGL2011-30069-C02-01]	Dinosaur Institute at the Natural History Museum of Los Angeles County; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); National Science Foundation(National Science Foundation (NSF)); Ministry of Education and Science of Spain(Spanish Government)	Funds for this project were provided by the Dinosaur Institute at the Natural History Museum of Los Angeles County, the Alexander von Humboldt Foundation, the National Science Foundation (EAR 0207744 and DBI 0446224 grants presented to G. Erickson), and the Ministry of Education and Science of Spain (CGL2011-30069-C02-01 grant presented to A. Galobart). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BG, 1998, J VERTEBR PALEONTOL, V18, P739, DOI 10.1080/02724634.1998.10011102; Averianov AO, 2007, CRETACEOUS RES, V28, P532, DOI 10.1016/j.cretres.2006.08.008; AVERIANOV AO, 1995, NEUES JB GEOLOGIE PA, P65; BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; Brett-Surman Michael K., 2007, P135; BRETTSURMAN MK, 1979, NATURE, V277, P560, DOI 10.1038/277560a0; Brink KS, 2011, THESIS U CALGARY; Brodkorb P., 1976, Smithsonian Contributions to Paleobiology, VNo. 27, P67; Brown B, 1916, B AM MUS NAT HIST, V35, P709; Brown B, 1910, B AM MUS NAT HIST, V31, P131; Cope E.D., 1869, T AM PHIL SOC, V14, P1; Cope ED, 1885, AM NAT, V19, P1208; Coria R.A., 2009, THESIS U NACL LUJAN; Donoghue M. J, 1992, ANN MISSOURI BOT GAR, V79, P672, DOI 10.2307/2399772; Evans DC, 2010, ZOOL J LINN SOC-LOND, V159, P398, DOI 10.1111/j.1096-3642.2009.00611.x; Evans DC, 2009, ANAT REC, V292, P1315, DOI 10.1002/ar.20984; Evans DC., 2007, THESIS U TORONTO; Fang, 2001, SHANTUNGOSAURUS GIGA; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gates TA, 2007, J VERTEBR PALEONTOL, V27, P917, DOI 10.1671/0272-4634(2007)27[917:VCANLH]2.0.CO;2; Gates TA, 2007, ZOOL J LINN SOC-LOND, V151, P351, DOI 10.1111/j.1096-3642.2007.00349.x; Godefroit P, 2004, ACTA PALAEONTOL POL, V49, P585; Godefroit P, 2000, CR ACAD SCI II A, V330, P875, DOI 10.1016/S1251-8050(00)00214-7; Godefroit P, 2003, C R PALEVOL, V2, P143, DOI 10.1016/S1631-0683(03)00017-4; Godefroit P, 2008, ACTA PALAEONTOL POL, V53, P47, DOI 10.4202/app.2008.0103; Godefroit P, 2012, ACTA PALAEONTOL POL, V57, P527, DOI 10.4202/app.2011.0051; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Herrero Lucia, 2010, PalArch's Journal of Vertebrate Palaeontology, V7, P1; Hong JP, 1999, ISL ARC, V8, P80, DOI 10.1046/j.1440-1738.1999.00226.x; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; HORNER JR, 1984, J PALEONTOL, V58, P270; Joshi SH, 2007, P IEEE C COMP VIS PA, V17, P1; Joshi SH, 2007, LECT NOTES COMPUT SC, V4679, P387; Joshi SH, 2011, BIOL J LINN SOC, V104, P217, DOI 10.1111/j.1095-8312.2011.01704.x; Kordikova EG, 2001, J PALEONTOL, V75, P390, DOI 10.1666/0022-3360(2001)075<0390:SVFTLC>2.0.CO;2; Lambe L., 1914, Ottawa Naturalist, V27; Lillegraven J.A., 1972, Contributions Sci, VNo. 232, P1; LUCAS SG, 2006, NEW MEXICO MUSEUM NA, V35, P293; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; Manning PL, 2009, P ROY SOC B-BIOL SCI, V276, P3429, DOI 10.1098/rspb.2009.0812; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Milner A.R., 1984, 3 S MESOZOIC TERREST, P145; MOLNAR RE, 1974, J PALEONTOL, V48, P1009; Montellano M, 2005, J VERTEBR PALEONTOL, V25, p93A; MORRIS WJ, 1981, J PALEONTOL, V55, P453; MORRIS WJ, 1972, J PALEONTOL, V46, P777; MORRIS WJ, 1978, J PALEONTOL, V52, P200; MORRIS WJ, 1967, SCIENCE, V155, P1539, DOI 10.1126/science.155.3769.1539; MORRIS WJ, 1973, J PALEONTOL, V47, P551; Morris WJ, 1976, NATL GEOGRAPHIC RES, P305; MORRIS WJ, 1974, GUIDEBOOK GEOLOGY PE, P60; Negro G, 2001, PALEOBIOS S2, V21, P96; Novas F. E., 2009, AGE DINOSAURS S AM; NYDAM RL, 1999, UTAH GEOLOGICAL SURV, P303; Osborn H. F., 1912, Memoirs of the American Museum of Natural History New York, V1; Ostrom J. H., 1962, Postilla, VNo. 62, P1; Owen R., 1842, 11 M BRIT ASS ADV SC, P66; PARKS WA, 1923, U TORONTO STUDIES GE, V15, P5; Pinna G., 1979, MEM SOC ITAL SCI NAT, V22, P33; Powell J.E., 1987, 10 C GEOL ARG ACT, P149; Prieto-Marquez A, 2008, THESIS FLORIDA STATE; Prieto-Marquez A, 2006, J VERTEBR PALEONTOL, V26, P929, DOI 10.1671/0272-4634(2006)26[929:HDFTLC]2.0.CO;2; Prieto-Marquez A, 2007, J VERTEBR PALEONTOL, V27, p131A; Prieto-Marquez A, 2011, ZOOTAXA, P61; Prieto-Marquez A, 2011, J PALEONTOL, V85, P468, DOI 10.1666/10-106.1; Prieto-Marquez A, 2010, AM MUS NOVIT, P1, DOI 10.1206/3694.2; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P503, DOI 10.1111/j.1096-3642.2010.00642.x; Prieto-Marquez A, 2009, CRETACEOUS RES, V30, P1238, DOI 10.1016/j.cretres.2009.06.005; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; RONQUIST F, 1996, DIVA VERSION 1 1 COM; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Srivastava A, 2011, IEEE T PATTERN ANAL, V33, P1415, DOI 10.1109/TPAMI.2010.184; Sullivan R.M., 1999, NEW MEXICO MUSEUM NA, V15, P1; Sullivan RM., 2011, NEW MEXICO MUSEUM NA, V53, P405; SULLIVAN RM, 2006, NEW MEXICO MUSEUM NA, V35, P7; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Versluys J., 1923, Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft, V38, P1; Wagner JR, 2009, J VERTEBR PALEONTOL, V29, P605, DOI 10.1671/039.029.0208; Wegweiser MD, 2006, NEW MEXICO MUSEUM NA, V35, P1422; WEISHAMPEL DB, 1981, J PALEONTOL, V55, P1046; Wideman NK, 2001, PALEOBIOS, V21, P134; You HL, 2003, ACTA GEOL SIN-ENGL, V77, P148; YOUNG CC, 1958, PALAEONTOLOGIA SIN C, V16, P53; Young F. W., 1985, ENCY STAT SCI, V5, P649	87	34	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38207	10.1371/journal.pone.0038207	http://dx.doi.org/10.1371/journal.pone.0038207			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719869	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340000014
J	Singh, AK; Mukhopadhyay, C; Biswas, S; Singh, VK; Mukhopadhyay, CK				Singh, Amit Kumar; Mukhopadhyay, Chaitali; Biswas, Sudipta; Singh, Vandana Kumari; Mukhopadhyay, Chinmay K.			Intracellular Pathogen Leishmania donovani Activates Hypoxia Inducible Factor-1 by Dual Mechanism for Survival Advantage within Macrophage	PLOS ONE			English	Article							NF-KAPPA-B; PROLYL HYDROXYLATION; INNATE IMMUNITY; FACTOR HIF; HIF-1-ALPHA; METABOLISM; EXPRESSION; AMAZONENSIS; FAMILY; GROWTH	Recent evidence established a crucial role for mammalian oxygen sensing transcription factor hypoxia inducible factor-1 (HIF-1) in innate immunity against intracellular pathogens. In response to most of these pathogens host phagocytes increase transcription of HIF-1 alpha, the regulatory component of HIF-1 to express various effector molecules against invaders. Leishmania donovani (LD), a protozoan parasite and the causative agent of fatal visceral leishmaniasis resides in macrophages within mammalian host. The mechanism of HIF-1 activation or its role in determining the fate of LD in infected macrophages is still not known. To determine that J774 macrophages were infected with LD and about four-fold increase in HIF-1 activity and HIF-1 alpha expression were detected. A strong increase in HIF-1 alpha expression and nuclear localization was also detected in LD-infected J774 cells, peritoneal macrophages and spleen derived macrophages of LD-infected BALB/c mice. A two-fold increase in HIF-1 alpha mRNA was detected in LD-infected macrophages suggesting involvement of a transcriptional mechanism that was confirmed by promoter activity. We further revealed that LD also induced HIF-1 alpha expression by depleting host cellular iron pool to affect prolyl hydroxylase activity resulting in to stabilization of HIF-1 alpha. To determine the role of HIF-1 on intracellular LD, cells were transfected with HIF-1 alpha siRNA to attenuate its expression and then infected with LD. Although, initial infection rate of LD in HIF-1 alpha attenuated cells was not affected but intracellular growth of LD was significantly inhibited; while, over-expression of stabilized form of HIF-1 alpha promoted intracellular growth of LD in host macrophage. Our results strongly suggest that LD activates HIF-1 by dual mechanism for its survival advantage within macrophage.	[Singh, Amit Kumar; Mukhopadhyay, Chaitali; Biswas, Sudipta; Singh, Vandana Kumari; Mukhopadhyay, Chinmay K.] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Singh, AK (corresponding author), Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India.	ckm2300@mail.jnu.ac.in			Wellcome Trust, UK in terms of International Senior Research Fellowship [073617]; Department of Biotechnology, India [BT/PR14798/MED/29/226/2010]; CSIR, India	Wellcome Trust, UK in terms of International Senior Research Fellowship; Department of Biotechnology, India(Department of Biotechnology (DBT) India); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	The work was supported by the financial assistance from The Wellcome Trust, UK in terms of International Senior Research Fellowship (Ref. 073617) and Department of Biotechnology, India (BT/PR14798/MED/29/226/2010) to CKM. AKS, SB and VKS acknowledge the support of fellowships from CSIR, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Arrais-Silva WW, 2005, EXP MOL PATHOL, V78, P49, DOI 10.1016/j.yexmp.2004.09.002; Bajou K, 2008, CANCER CELL, V14, P324, DOI 10.1016/j.ccr.2008.08.012; Bayele HK, 2007, BLOOD, V110, P3039, DOI 10.1182/blood-2006-12-063289; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Biswas S, 2007, AM J PHYSIOL-HEART C, V292, pH758, DOI 10.1152/ajpheart.00718.2006; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Burchmore RJS, 2003, P NATL ACAD SCI USA, V100, P3901, DOI 10.1073/pnas.0630165100; CHANG KP, 1980, SCIENCE, V209, P1240, DOI 10.1126/science.7403880; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Chen ZB, 2009, MED ONCOL, V26, P365, DOI 10.1007/s12032-008-9130-7; Contreras I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001148; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Das NK, 2009, CELL MICROBIOL, V11, P83, DOI 10.1111/j.1462-5822.2008.01241.x; Degrossoli A, 2007, IMMUNOL LETT, V114, P119, DOI 10.1016/j.imlet.2007.09.009; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Forget G, 2006, INFECT IMMUN, V74, P6272, DOI 10.1128/IAI.00853-05; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Ghosh S, 2002, INFECT IMMUN, V70, P6828, DOI 10.1128/IAI.70.12.6828-6838.2002; Haeberle HA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003352; Hartmann H, 2008, GASTROENTEROLOGY, V134, P756, DOI 10.1053/j.gastro.2007.12.008; Huynh C, 2006, J EXP MED, V203, P2363, DOI 10.1084/jem.20060559; Hwang IIL, 2006, J VIROL, V80, P10712, DOI 10.1128/JVI.01014-06; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7; Lin MT, 2008, J BIOL CHEM, V283, P15807, DOI 10.1074/jbc.M708933200; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McConville MJ, 2007, TRENDS PARASITOL, V23, P368, DOI 10.1016/j.pt.2007.06.009; McNeill LA, 2005, ANAL BIOCHEM, V336, P125, DOI 10.1016/j.ab.2004.09.019; Mukhopadhyay CK, 2010, METHODS IN REDOX SIGNALING, P118; Mukhopadhyay CK, 2000, J BIOL CHEM, V275, P21048, DOI 10.1074/jbc.M000636200; MUKKADA AJ, 1985, SCIENCE, V229, P1099, DOI 10.1126/science.4035350; Naderer T, 2008, CELL MICROBIOL, V10, P301, DOI 10.1111/j.1462-5822.2007.01096.x; Nasimuzzaman M, 2007, J VIROL, V81, P10249, DOI 10.1128/JVI.00763-07; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Ruhland A, 2007, CELL MICROBIOL, V9, P84, DOI 10.1111/j.1462-5822.2006.00769.x; Semenza GL, 2007, DRUG DISCOV TODAY, V12, P853, DOI 10.1016/j.drudis.2007.08.006; Sen S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002229; Singh VK, 2004, BIOCHEM BIOPH RES CO, V322, P1086, DOI [10.1016/j.bbrc.2004.08.016, 10.1016/j.bbrc.2004.08.020]; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Werth N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011576; Wiley M, 2010, J BIOL CHEM, V285, P26852, DOI 10.1074/jbc.M110.147041; Zarember KA, 2005, J CLIN INVEST, V115, P1702, DOI 10.1172/JCI25740; Zinkernagel AS, 2007, J MOL MED, V85, P1339, DOI 10.1007/s00109-007-0282-2	50	51	54	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38489	10.1371/journal.pone.0038489	http://dx.doi.org/10.1371/journal.pone.0038489			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701652	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340000025
J	Rakette, S; Donat, S; Ohlsen, K; Stehle, T				Rakette, Sonja; Donat, Stefanie; Ohlsen, Knut; Stehle, Thilo			Structural Analysis of Staphylococcus aureus Serine/Threonine Kinase PknB	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CRYSTAL-STRUCTURE; ACTIVATION MECHANISM; ANTIBIOTIC-RESISTANCE; CATALYTIC SUBUNIT; DOMAIN; PHOSPHATASES; EXPRESSION; INHIBITOR; SEQUENCE	Effective treatment of infections caused by the bacterium Staphylococcus aureus remains a worldwide challenge, in part due to the constant emergence of new strains that are resistant to antibiotics. The serine/threonine kinase PknB is of particular relevance to the life cycle of S. aureus as it is involved in the regulation of purine biosynthesis, autolysis, and other central metabolic processes of the bacterium. We have determined the crystal structure of the kinase domain of PknB in complex with a non-hydrolyzable analog of the substrate ATP at 3.0 angstrom resolution. Although the purified PknB kinase is active in solution, it crystallized in an inactive, autoinhibited state. Comparison with other bacterial kinases provides insights into the determinants of catalysis, interactions of PknB with ligands, and the pathway of activation.	[Rakette, Sonja; Stehle, Thilo] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Donat, Stefanie; Ohlsen, Knut] Univ Wurzburg, Inst Mol Infect Biol, Wurzburg, Germany; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	Eberhard Karls University of Tubingen; University of Wurzburg; Vanderbilt University	Rakette, S (corresponding author), Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany.	thilo.stehle@uni-tuebingen.de			Collaborative Research Grant from Deutsche Forschungsgemeinschaft [SFB-TR34]	Collaborative Research Grant from Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Collaborative Research Grant SFB-TR34 from the Deutsche Forschungsgemeinschaft via grants to KO and TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aguilar J, 2010, MEDICINE, V89, P117, DOI 10.1097/MD.0b013e3181d5453d; Alber T, 2009, CURR OPIN STRUC BIOL, V19, P650, DOI 10.1016/j.sbi.2009.10.017; Av-Gay Y, 1999, INFECT IMMUN, V67, P5676, DOI 10.1128/IAI.67.11.5676-5682.1999; BOHACH GA, 1990, CRIT REV MICROBIOL, V17, P251, DOI 10.3109/10408419009105728; BOSSEMEYER D, 1994, TRENDS BIOCHEM SCI, V19, P201, DOI 10.1016/0968-0004(94)90022-1; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; COX S, 1994, CURR OPIN STRUC BIOL, V4, P893, DOI 10.1016/0959-440X(94)90272-0; De Lencastre H, 1999, MICROB DRUG RESIST, V5, P163, DOI 10.1089/mdr.1999.5.163; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; Deftereos Savas P, 2009, Cases J, V2, P8293, DOI 10.4076/1757-1626-2-8293; Donat S, 2009, J BACTERIOL, V191, P4056, DOI 10.1128/JB.00117-09; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Gordon E, 2000, J MOL BIOL, V299, P477, DOI 10.1006/jmbi.2000.3740; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hansra NK, 2011, DERMATOL THER, V24, P263, DOI 10.1111/j.1529-8019.2011.01402.x; Hubbard SR, 1999, NAT STRUCT BIOL, V6, P711, DOI 10.1038/11468; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KARLSSON R, 1993, ACTA CRYSTALLOGR D, V49, P381, DOI 10.1107/S0907444993002306; Kennelly PJ, 2002, FEMS MICROBIOL LETT, V206, P1, DOI 10.1016/S0378-1097(01)00479-7; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Lomas-Lopez R, 2007, FEMS MICROBIOL LETT, V272, P35, DOI 10.1111/j.1574-6968.2007.00742.x; Lombana TN, 2010, STRUCTURE, V18, P1667, DOI 10.1016/j.str.2010.09.019; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mieczkowski C, 2008, EMBO J, V27, P3186, DOI 10.1038/emboj.2008.236; Miller M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009057; Ortiz-Lombardia M, 2003, J BIOL CHEM, V278, P13094, DOI 10.1074/jbc.M300660200; Otto M, 2010, MED RES REV, V30, P1, DOI 10.1002/med.20160; Paracuellos P, 2010, J MOL BIOL, V404, P847, DOI 10.1016/j.jmb.2010.10.012; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Ruggiero A, 2011, BIOCHEM J, V435, P33, DOI 10.1042/BJ20101643; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SchulzeGahmen U, 1996, J MED CHEM, V39, P4540, DOI 10.1021/jm960402a; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tamber S, 2010, INFECT IMMUN, V78, P3637, DOI 10.1128/IAI.00296-10; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Truong-Bolduc QC, 2010, J BACTERIOL, V192, P2525, DOI 10.1128/JB.00018-10; Wehenkel A, 2006, FEBS LETT, V580, P3018, DOI 10.1016/j.febslet.2006.04.046; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	52	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e39136	10.1371/journal.pone.0039136	http://dx.doi.org/10.1371/journal.pone.0039136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701750	Green Submitted, Green Published, gold			2022-12-25	WOS:000305337600070
J	Wang, C; Pan, Y; Zhang, QY; Wang, FM; Kong, LD				Wang, Chuang; Pan, Ying; Zhang, Qing-Yu; Wang, Fu-Meng; Kong, Ling-Dong			Quercetin and Allopurinol Ameliorate Kidney Injury in STZ-Treated Rats with Regulation of Renal NLRP3 Inflammasome Activation and Lipid Accumulation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SERUM URIC-ACID; DIABETIC-NEPHROPATHY; CELL-DEATH; METABOLISM; EXPRESSION; CARNITINE; OBESITY; GLOMERULOSCLEROSIS; INTERLEUKIN-18	Hyperuricemia, hyperlipidemia and inflammation are associated with diabetic nephropathy. The NLRP3 inflammasome-mediated inflammation is recently recognized in the development of kidney injury. Urate and lipid are considered as danger signals in the NLRP3 inflammasome activation. Although dietary flavonoid quercetin and allopurinol alleviate hyperuricemia, dyslipidmia and inflammation, their nephroprotective effects are currently unknown. In this study, we used streptozotocin (STZ)-induced diabetic nephropathy model with hyperuricemia and dyslipidemia in rats, and found over-expression of renal inflammasome components NLRP3, apoptosis-associated speck-like protein and Caspase-1, resulting in elevation of IL-1 beta and IL-18, with subsequently deteriorated renal injury. These findings demonstrated the possible association between renal NLRP3 inflammasome activation and lipid accumulation to superimpose causes of nephrotoxicity in STZ-treated rats. The treatment of quercetin and allopurinol regulated renal urate transport-related proteins to reduce hyperuricemia, and lipid metabolism-related genes to alleviate kidney lipid accumulation in STZ-treated rats. Furthermore, quercetin and allopurinol were found to suppress renal NLRP3 inflammasome activation, at least partly, via their anti-hyperuricemic and anti-dyslipidemic effects, resulting in the amelioration of STZ-induced the superimposed nephrotoxicity in rats. These results may provide a basis for the prevention of diabetes-associated nephrotoxicity with urate-lowering agents such as quercetin and allopurinol.	[Wang, Chuang; Pan, Ying; Zhang, Qing-Yu; Wang, Fu-Meng; Kong, Ling-Dong] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China	Nanjing University	Wang, C (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.	kongld@nju.edu.cn			National Natural Science Foundation of China [NSFC 81025025]; National Basic Research Program of China 973 Program [2012CB517600, 2012CB517602]; Jinagsu Natural Science Foundation [BK2010365]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China); Jinagsu Natural Science Foundation; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by grants from National Natural Science Foundation of China (NSFC 81025025), National Basic Research Program of China 973 Program No. 2012CB517600 (No. 2012CB517602), Jinagsu Natural Science Foundation (BK2010365) and Program for Changjiang Scholars and Innovative Research Team in University (IRT1020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Raheem IT, 2009, BIOL PHARM BULL, V32, P61, DOI 10.1248/bpb.32.61; Anjaneyulu M, 2004, CLIN EXP PHARMACOL P, V31, P244, DOI 10.1111/j.1440-1681.2004.03982.x; Arlehamn CSL, 2010, J BIOL CHEM, V285, P10508, DOI 10.1074/jbc.M109.067298; Ayodele OE, 2004, J NATL MED ASSOC, V96, P1445; Cheng QQ, 2008, MOL PHARMACEUT, V5, P77, DOI 10.1021/mp700114j; Chuang CC, 2010, AM J CLIN NUTR, V92, P1511, DOI 10.3945/ajcn.2010.29807; Dinarello CA, 2010, CURR OPIN ENDOCRINOL, V17, P314, DOI 10.1097/MED.0b013e32833bf6dc; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Edwards RL, 2007, J NUTR, V137, P2405, DOI 10.1093/jn/137.11.2405; Ergun O, 2001, UROL RES, V29, P186, DOI 10.1007/s002400100176; Eskandari HG, 2004, DIABETES RES CLIN PR, V66, P129, DOI 10.1016/j.diabres.2004.03.005; ESTEVEZ EC, 1990, CLIN RHEUMATOL, V9, P28, DOI 10.1007/BF02030237; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Frigerio F, 2010, DIABETOLOGIA, V53, P331, DOI 10.1007/s00125-009-1590-6; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Guan YF, 2001, KIDNEY INT, V60, P14, DOI 10.1046/j.1523-1755.2001.00766.x; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; Hiukka A, 2010, NAT REV ENDOCRINOL, V6, P454, DOI 10.1038/nrendo.2010.89; Hostetler HA, 2008, J BIOL CHEM, V283, P2246, DOI 10.1074/jbc.M705138200; Hovind P, 2011, J RENAL NUTR, V21, P124, DOI 10.1053/j.jrn.2010.10.024; Hovind P, 2009, DIABETES, V58, P1668, DOI 10.2337/db09-0014; Hu QH, 2009, AM J PHYSIOL-RENAL, V297, pF1080, DOI 10.1152/ajprenal.90767.2008; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Joosten LAB, 2010, ARTHRITIS RHEUM-US, V62, P3237, DOI 10.1002/art.27667; Keembiyehetty C, 2006, MOL ENDOCRINOL, V20, P686, DOI 10.1210/me.2005-0010; Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5; Kobori M, 2011, MOL NUTR FOOD RES, V55, P530, DOI 10.1002/mnfr.201000392; Kosugi T, 2009, AM J PHYSIOL-RENAL, V297, pF481, DOI 10.1152/ajprenal.00092.2009; Kraynak AR, 1995, TOXICOL APPL PHARM, V135, P279, DOI 10.1006/taap.1995.1234; Krzystanek M, 2010, J BIOL CHEM, V285, P10583, DOI 10.1074/jbc.M109.078006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahesh T, 2004, PHYTOTHER RES, V18, P123, DOI 10.1002/ptr.1374; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Minami M, 2005, BLOOD PRESSURE, V14, P120, DOI 10.1080/08037050510008878; Momeni A, 2010, IRAN J KIDNEY DIS, V4, P128; Moriwaki Y, 2003, METABOLISM, V52, P605, DOI 10.1053/meta.2003.50096; Murea M, 2010, CLIN J AM SOC NEPHRO, V5, P2373, DOI 10.2215/CJN.08160910; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Olusi SO, 2003, HORM RES, V60, P29, DOI 10.1159/000070824; Park CW, 2006, DIABETES, V55, P885, DOI 10.2337/diabetes.55.04.06.db05-1329; PARK J, 2008, FASEB J, V22, pLB707; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Poulain-Godefroy O, 2008, AM J PHYSIOL-REG I, V295, pR1, DOI 10.1152/ajpregu.00926.2007; Power RA, 2007, DIABETOLOGIA, V50, P824, DOI 10.1007/s00125-007-0605-4; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Reungjui S, 2007, J AM SOC NEPHROL, V18, P2724, DOI 10.1681/ASN.2007040416; Rivera L, 2008, OBESITY, V16, P2081, DOI 10.1038/oby.2008.315; Shigeoka AA, 2010, J IMMUNOL, V185, P6277, DOI 10.4049/jimmunol.1002330; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Sun LJ, 2002, J BIOL CHEM, V277, P18919, DOI 10.1074/jbc.M110650200; Tamai I, 2000, J BIOL CHEM, V275, P40064, DOI 10.1074/jbc.M005340200; Tesch GH, 2007, NEPHROLOGY, V12, P261, DOI 10.1111/j.1440-1797.2007.00796.x; Tone A, 2005, DIABETOLOGIA, V48, P2402, DOI 10.1007/s00125-005-1945-6; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wu CH, 2009, MOL NUTR FOOD RES, V53, P984, DOI 10.1002/mnfr.200800495; Zager RA, 2005, KIDNEY INT, V67, P111, DOI 10.1111/j.1523-1755.2005.00061.x; Zager RA, 2001, KIDNEY INT, V59, P1750, DOI 10.1046/j.1523-1755.2001.0590051750.x	66	155	172	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38285	10.1371/journal.pone.0038285	http://dx.doi.org/10.1371/journal.pone.0038285			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701621	Green Submitted, Green Published, gold			2022-12-25	WOS:000305337600019
J	Sanchez-Sampedro, L; Gomez, CE; Mejias-Perez, E; Sorzano, COS; Esteban, M				Sanchez-Sampedro, Lucas; Elena Gomez, Carmen; Mejias-Perez, Ernesto; Sorzano, Carlos Oscar S.; Esteban, Mariano			High Quality Long-Term CD4(+) and CD8(+) Effector Memory Populations Stimulated by DNA-LACK/MVA-LACK Regimen in Leishmania major BALB/c Model of Infection	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PRIME-BOOST VACCINATION; T-CELLS; IFN-GAMMA; VISCERAL LEISHMANIASIS; PROTECTIVE IMMUNITY; INDUCTION; MICE; VECTOR; IMMUNIZATION	Heterologous vaccination based on priming with a plasmid DNA vector and boosting with an attenuated vaccinia virus MVA recombinant, with both vectors expressing the Leishmania infantum LACK antigen (DNA-LACK and MVA-LACK), has shown efficacy conferring protection in murine and canine models against cutaneus and visceral leishmaniasis, but the immune parameters of protection remain ill defined. Here we performed by flow cytometry an in depth analysis of the T cell populations induced in BALB/c mice during the vaccination protocol DNA-LACK/MVA-LACK, as well as after challenge with L. major parasites. In the adaptive response, there is a polyfunctional CD4(+) and CD8(+) T cell activation against LACK antigen. At the memory phase the heterologous vaccination induces high quality LACK-specific long-term CD4(+) and CD8(+) effector memory cells. After parasite challenge, there is a moderate boosting of LACK-specific CD4(+) and CD8(+) T cells. Anti-vector responses were largely CD8(+)-mediated. The immune parameters induced against LACK and triggered by the combined vaccination DNA/MVA protocol, like polyfunctionality of CD4(+) and CD8(+) T cells with an effector phenotype, could be relevant in protection against leishmaniasis.	[Sanchez-Sampedro, Lucas; Elena Gomez, Carmen; Mejias-Perez, Ernesto; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain; [Sorzano, Carlos Oscar S.] CSIC, Ctr Nacl Biotecnol, Biocomp Unit, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Sanchez-Sampedro, L (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain.	mesteban@cnb.csic.es	S. Sorzano, Carlos Oscar/ABE-4884-2021; Gomez, Carmen Elena/K-1940-2014; Sorzano, Carlos Oscar S S./F-2639-2016; Esteban, Mariano/ABG-5375-2020	S. Sorzano, Carlos Oscar/0000-0002-9473-283X; Gomez, Carmen Elena/0000-0002-5414-7935; Sorzano, Carlos Oscar S S./0000-0002-9473-283X; Esteban, Mariano/0000-0003-0846-2827; Mejias Perez, Ernesto/0000-0002-5208-8177	Foundation Botin; Ministry of Science and Technology;  [SAF2008-02036]	Foundation Botin; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); 	This investigation was supported by research grant SAF2008-02036 and Foundation Botin. LSS and EMP were supported by PhD Fellowships from the Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SB, 2004, VACCINE, V22, P1631, DOI 10.1016/j.vaccine.2003.10.046; Bogdan C, 1990, EUROPEAN J IMMUNOLOG, P1131; Cote-Sierra J, 2002, INFECT IMMUN, V70, P240, DOI 10.1128/IAI.70.1.240-248.2002; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Darrah PA, 2010, J EXP MED, V207, P1421, DOI 10.1084/jem.20092532; Dondji B, 2005, INFECT IMMUN, V73, P5286, DOI 10.1128/IAI.73.8.5286-5289.2005; Doroud D, 2011, J CONTROL RELEASE, V153, P154, DOI 10.1016/j.jconrel.2011.04.011; Duthie MS, 2012, VACCINE, V30, P134, DOI 10.1016/j.vaccine.2011.11.005; Faria DR, 2009, PARASITE IMMUNOL, V31, P432, DOI 10.1111/j.1365-3024.2009.01125.x; Ferlin WG, 1998, EUR J IMMUNOL, V28, P525, DOI 10.1002/(SICI)1521-4141(199802)28:02&lt;525::AID-IMMU525&gt;3.0.CO;2-M; Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395; Gherardi MM, 2004, J IMMUNOL, V172, P6209, DOI 10.4049/jimmunol.172.10.6209; Gonzalez-Aseguinolaza G, 1999, EUR J BIOCHEM, V259, P909, DOI 10.1046/j.1432-1327.1999.00122.x; GREEN SJ, 1990, J IMMUNOL, V145, P4290; Haque A, 2010, J IMMUNOL, V184, P2583, DOI 10.4049/jimmunol.0903080; Julia V, 1996, SCIENCE, V274, P421, DOI 10.1126/science.274.5286.421; Keesen TSL, 2011, CLIN EXP IMMUNOL, V165, P338, DOI 10.1111/j.1365-2249.2011.04430.x; Khamesipour A, 2012, MICROBES INFECT, V14, P702, DOI 10.1016/j.micinf.2012.02.006; Launois P, 1997, IMMUNITY, V6, P541, DOI 10.1016/S1074-7613(00)80342-8; Launois P, 2007, MICROBES INFECT, V9, P1260, DOI 10.1016/j.micinf.2007.05.017; LIEW FY, 1990, J IMMUNOL, V145, P4306; LIEW FY, 1991, IMMUNOLOGY, V74, P304; Najera JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011406; Macedo ABB, 2012, CLIN EXP IMMUNOL, V167, P505, DOI 10.1111/j.1365-2249.2011.04536.x; Melby PC, 2001, INFECT IMMUN, V69, P4719, DOI 10.1128/IAI.69.8.4719-4725.2001; Mooij P, 2008, J VIROL, V82, P2975, DOI 10.1128/JVI.02216-07; MOUGNEAU E, 1995, SCIENCE, V268, P563, DOI 10.1126/science.7725103; Murray HW, 2000, INFECT IMMUN, V68, P6289, DOI 10.1128/IAI.68.11.6289-6293.2000; Papadogiannakis E, 2010, VET J, V186, P262, DOI 10.1016/j.tvjl.2009.08.001; Perez-Jimenez E, 2006, MICROBES INFECT, V8, P810, DOI 10.1016/j.micinf.2005.10.004; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Pingel S, 1999, J EXP MED, V189, P1111, DOI 10.1084/jem.189.7.1111; Ramos I, 2008, VACCINE, V26, P333, DOI 10.1016/j.vaccine.2007.11.021; Ramos I, 2009, VACCINE, V27, P6695, DOI 10.1016/j.vaccine.2009.08.091; Ramsay AJ, 1997, IMMUNOL CELL BIOL, V75, P382, DOI 10.1038/icb.1997.60; Reiner SL, 1998, J IMMUNOL, V160, P884; Reyes-Sandoval A, 2011, J IMMUNOL, V187, P1347, DOI 10.4049/jimmunol.1100302; Rigato PO, 2011, INFECT IMMUN, V79, P2120, DOI 10.1128/IAI.01190-10; Rostami MN, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000845; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Tapia E, 2003, MICROBES INFECT, V5, P73, DOI 10.1016/S1286-4579(02)00077-1; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Wilhelm P, 2001, J IMMUNOL, V166, P4012, DOI 10.4049/jimmunol.166.6.4012; World Health O, 2004, SCI WORK GROUP REP L; Xin L, 2011, PARASITE IMMUNOL, V33, P170, DOI 10.1111/j.1365-3024.2010.01268.x	46	23	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38859	10.1371/journal.pone.0038859	http://dx.doi.org/10.1371/journal.pone.0038859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715418	gold, Green Published			2022-12-25	WOS:000305336800060
J	Schino, G; Marini, C				Schino, Gabriele; Marini, Claudia			Self-Protective Function of Post-Conflict Bystander Affiliation in Mandrills	PLOS ONE			English	Article							POSTCONFLICT 3RD-PARTY AFFILIATION; DISPLACEMENT ACTIVITIES; CHIMPANZEES; RECONCILIATION; CONSOLATION; PATTERNS; MACAQUES; PRIMATES; PROPOSAL; EMPATHY	Background: Affiliative interactions exchanged between victims of aggression and individuals not involved in the original aggression (bystanders) have been observed in various species. Three hypothetical functions have been proposed for these interactions: consolation, self-protection and substitute reconciliation, but data to test them are scanty. Methodology/Principal Findings: We conducted post-conflict and matched control observations on a captive group of mandrills (Mandrillus sphinx). We found that victims often redirected aggression to bystanders, that they received most affiliation from those bystanders that were frequently the target of redirection, and that bystander affiliation reduced the likelihood of redirection. Bystander affiliation did not reduce the victim's distress (as measured by its scratching rates) and was not received primarily from kin/friends. Finally, bystander affiliation did not reduce the likelihood of renewed aggression from the original aggressor. Conclusions/Significance: These results provide support for the self-protection hypothesis but not for the consolation and substitute reconciliation hypotheses.	[Schino, Gabriele] CNR, Ist Sci & Tecnol Cogniz, Rome, Italy; [Marini, Claudia] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); Sapienza University Rome	Schino, G (corresponding author), CNR, Ist Sci & Tecnol Cogniz, Rome, Italy.	gabriele.schino@enea.it	Schino, Gabriele/B-7569-2015	Schino, Gabriele/0000-0002-5011-4896				Allison PD, 2009, FIXED EFFECTS REGRES; AURELI F, 1991, ETHOLOGY, V89, P89; Aureli F., 2000, NATURAL CONFLICT RES; Aureli F., EVOLUTION P IN PRESS; Call J, 2002, ANIM BEHAV, V63, P209, DOI 10.1006/anbe.2001.1908; Cheney DL, 2007, BABOON METAPHYSICS; Cleasby IR, 2011, BEHAV ECOL SOCIOBIOL, V65, P2361, DOI 10.1007/s00265-011-1254-7; Cleves M., 2008, INTRO SURVIVAL ANAL; Cools AKA, 2008, ETHOLOGY, V114, P53, DOI 10.1111/j.1439-0310.2007.01443.x; Das M., 2000, NATURAL CONFLICT RES, P263; De Marco A, 2010, ANIM BEHAV, V80, P197, DOI 10.1016/j.anbehav.2010.04.016; De Waal Frans B. M., 1996, P80; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; DEWAAL FBM, 1983, BEHAVIOUR, V85, P224, DOI 10.1163/156853983X00237; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Fraser ON, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010605; Fraser Orlaith N, 2009, Commun Integr Biol, V2, P285; Harcourt AH., 1992, COALITIONS ALLIANCES; Judge PG, 2005, ANIM BEHAV, V69, P1345, DOI 10.1016/j.anbehav.2004.08.016; Koski SE, 2007, ANIM BEHAV, V73, P133, DOI 10.1016/j.anbehav.2006.04.009; Koski SE, 2010, EUR J DEV PSYCHOL, V7, P38, DOI 10.1080/17405620902986991; Koski SE, 2009, AM J PRIMATOL, V71, P409, DOI 10.1002/ajp.20668; MAESTRIPIERI D, 1992, ANIM BEHAV, V44, P967, DOI 10.1016/S0003-3472(05)80592-5; Palagi E, 2009, ANIM BEHAV, V78, P979, DOI 10.1016/j.anbehav.2009.07.017; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Romero T, 2010, J COMP PSYCHOL, V124, P278, DOI 10.1037/a0019144; Romero T, 2010, P NATL ACAD SCI USA, V107, P12110, DOI 10.1073/pnas.1006991107; Schino G, 1996, ANXIETY, V2, P186; Schino G, 2004, J COMP PSYCHOL, V118, P340, DOI 10.1037/0735-7036.118.3.340; Schino G, 2011, ANIM BEHAV, V81, P1009, DOI 10.1016/j.anbehav.2011.02.004; Seed AM, 2007, CURR BIOL, V17, P152, DOI 10.1016/j.cub.2006.11.025; StataCorp, 2009, STAT STAT SOFTW REL; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; VEENEMA HC, 1994, BEHAV PROCESS, V31, P29, DOI 10.1016/0376-6357(94)90035-3; Watts David P., 2000, P281; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wittig RM, 2007, P R SOC B, V274, P1109, DOI 10.1098/rspb.2006.0203; Wittig RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013995	38	21	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38936	10.1371/journal.pone.0038936	http://dx.doi.org/10.1371/journal.pone.0038936			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715420	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336800062
J	Du, H; Feng, BR; Yang, SS; Huang, YB; Tang, YX				Du, Hai; Feng, Bo-Run; Yang, Si-Si; Huang, Yu-Bi; Tang, Yi-Xiong			The R2R3-MYB Transcription Factor Gene Family in Maize	PLOS ONE			English	Article							DNA-BINDING DOMAIN; GAMYB-LIKE GENES; MYB GENES; GLUCOSINOLATE BIOSYNTHESIS; MOLECULAR CHARACTERIZATION; ALEURONE CELLS; ZEA-MAYS; C-MYB; ARABIDOPSIS; ENCODES	MYB proteins comprise a large family of plant transcription factors, members of which perform a variety of functions in plant biological processes. To date, no genome-wide characterization of this gene family has been conducted in maize (Zea mays). In the present study, we performed a comprehensive computational analysis, to yield a complete overview of the R2R3-MYB gene family in maize, including the phylogeny, expression patterns, and also its structural and functional characteristics. The MYB gene structure in maize and Arabidopsis were highly conserved, indicating that they were originally compact in size. Subgroup-specific conserved motifs outside the MYB domain may reflect functional conservation. The genome distribution strongly supports the hypothesis that segmental and tandem duplication contribute to the expansion of maize MYB genes. We also performed an updated and comprehensive classification of the R2R3-MYB gene families in maize and other plant species. The result revealed that the functions were conserved between maize MYB genes and their putative orthologs, demonstrating the origin and evolutionary diversification of plant MYB genes. Species-specific groups/subgroups may evolve or be lost during evolution, resulting in functional divergence. Expression profile study indicated that maize R2R3-MYB genes exhibit a variety of expression patterns, suggesting diverse functions. Furthermore, computational prediction potential targets of maize microRNAs (miRNAs) revealed that miR159, miR319, and miR160 may be implicated in regulating maize R2R3-MYB genes, suggesting roles of these miRNAs in post-transcriptional regulation and transcription networks. Our comparative analysis of R2R3-MYB genes in maize confirm and extend the sequence and functional characteristics of this gene family, and will facilitate future functional analysis of the MYB gene family in maize.	[Du, Hai; Huang, Yu-Bi] Sichuan Agr Univ, Maize Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Maize SW Reg, Chengdu, Sichuan, Peoples R China; [Du, Hai; Tang, Yi-Xiong] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China	Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Du, H (corresponding author), Sichuan Agr Univ, Maize Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Maize SW Reg, Chengdu, Sichuan, Peoples R China.	yubihuang@sohu.com; tangyx@mail.caas.net.cn	Du, Hai/AHD-1445-2022	Du, Hai/0000-0003-4274-5724	State Key Basic Research and Development Plan of China [2011Cb100100, 2011Cb100106]; National Natural Science Foundation of China	State Key Basic Research and Development Plan of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This project was supported by the State Key Basic Research and Development Plan of China (2011Cb100100 and 2011Cb100106) and the National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm).	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Akagi T, 2010, PLANTA, V232, P1045, DOI 10.1007/s00425-010-1241-7; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Aya K, 2009, PLANT CELL, V21, P1453, DOI 10.1105/tpc.108.062935; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Ballester AR, 2010, PLANT PHYSIOL, V152, P71, DOI 10.1104/pp.109.147322; Baumann K, 2007, DEVELOPMENT, V134, P1691, DOI 10.1242/dev.02836; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Boddu J, 2006, PLANT MOL BIOL, V60, P185, DOI 10.1007/s11103-005-3568-1; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; Cai H, 2011, MOL BIOTECHNOL; Celenza JL, 2005, PLANT PHYSIOL, V137, P253, DOI 10.1104/pp.104.054395; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Colquhoun TA, 2011, J EXP BOT, V62, P1133, DOI 10.1093/jxb/erq342; CONE KC, 1993, PLANT CELL, V5, P1795, DOI 10.1105/tpc.5.12.1795; Czemmel S, 2009, PLANT PHYSIOL, V151, P1513, DOI 10.1104/pp.109.142059; Dias AP, 2003, PLANT PHYSIOL, V131, P610, DOI 10.1104/pp.012047; Dubos C, 2008, PLANT J, V55, P940, DOI 10.1111/j.1365-313X.2008.03564.x; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Durbarry A, 2005, PLANT PHYSIOL, V137, P297, DOI 10.1104/pp.104.053165; Feng CP, 2004, PLANT SCI, V167, P1099, DOI 10.1016/j.plantsci.2004.06.014; Fornale S, 2006, PLANT MOL BIOL, V62, P809, DOI 10.1007/s11103-006-9058-2; Gigolashvili T, 2008, NEW PHYTOL, V177, P627, DOI 10.1111/j.1469-8137.2007.02295.x; Gigolashvili T, 2007, PLANT J, V51, P247, DOI 10.1111/j.1365-313X.2007.03133.x; Gigolashvili T, 2007, PLANT J, V50, P886, DOI 10.1111/j.1365-313X.2007.03099.x; Gocal GFW, 1999, PLANT PHYSIOL, V119, P1271, DOI 10.1104/pp.119.4.1271; Gocal GFW, 2001, PLANT PHYSIOL, V127, P1682, DOI 10.1104/pp.010442; Gong XM, 2008, PLANTA, V228, P563, DOI 10.1007/s00425-008-0759-4; Grotewold E, 2000, P NATL ACAD SCI USA, V97, P13579, DOI 10.1073/pnas.250379897; GROTEWOLD E, 1991, P NATL ACAD SCI USA, V88, P4587, DOI 10.1073/pnas.88.11.4587; GUBLER F, 1995, PLANT CELL, V7, P1879, DOI 10.1105/tpc.7.11.1879; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hegvold AB, 1996, NUCLEIC ACIDS RES, V24, P3990, DOI 10.1093/nar/24.20.3990; Heine GF, 2007, MOL BIOTECHNOL, V37, P155, DOI 10.1007/s12033-007-0061-x; Heine GF, 2004, J BIOL CHEM, V279, P37878, DOI 10.1074/jbc.M405166200; Jaffe FW, 2007, J EXP BOT, V58, P1515, DOI 10.1093/jxb/erm020; Jakoby MJ, 2008, PLANT PHYSIOL, V148, P1583, DOI 10.1104/pp.108.126979; Jiang CZ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r46; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Kaneko M, 2004, PLANT CELL, V16, P33, DOI 10.1105/tpc.017327; Keller T, 2006, PLANT CELL, V18, P598, DOI 10.1105/tpc.105.038588; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; Koltai H, 2000, PLANT J, V22, P455, DOI 10.1046/j.1365-313X.2000.00754.x; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Legay S, 2010, NEW PHYTOL, V188, P774, DOI 10.1111/j.1469-8137.2010.03432.x; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Li SF, 2009, PLANT CELL, V21, P72, DOI 10.1105/tpc.108.063503; Lipsick JS, 1996, ONCOGENE, V13, P223; Ma QH, 2011, BIOCHIMIE, V93, P1179, DOI 10.1016/j.biochi.2011.04.012; MAROCCO A, 1989, MOL GEN GENET, V216, P183, DOI 10.1007/BF00334354; Martienssen RA, 2004, CURR OPIN PLANT BIOL, V7, P102, DOI 10.1016/j.pbi.2004.01.010; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Matus JT, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-83; Mehrtens F, 2005, PLANT PHYSIOL, V138, P1083, DOI 10.1104/pp.104.058032; Mellway RD, 2009, PLANT PHYSIOL, V150, P924, DOI 10.1104/pp.109.139071; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Morimoto R, 2009, PLANT MOL BIOL, V69, P273, DOI 10.1007/s11103-008-9422-5; Muller D, 2006, PLANT CELL, V18, P586, DOI 10.1105/tpc.105.038745; Murray F, 2003, PLANT J, V33, P481, DOI 10.1046/j.1365-313X.2003.01641.x; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; NODA K, 1994, NATURE, V369, P661, DOI 10.1038/369661a0; OGATA K, 1995, NAT STRUCT BIOL, V2, P309, DOI 10.1038/nsb0495-309; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Palmer LE, 2003, SCIENCE, V302, P2115, DOI 10.1126/science.1091265; Payne CT, 2000, GENETICS, V156, P1349; PAZARES J, 1987, EMBO J, V6, P3553, DOI 10.1002/j.1460-2075.1987.tb02684.x; Perez-Rodriguez M, 2005, DEVELOPMENT, V132, P359, DOI 10.1242/dev.01584; Pilu R, 2003, PLANT J, V36, P510, DOI 10.1046/j.1365-313X.2003.01898.x; Preston J, 2004, PLANT J, V40, P979, DOI 10.1111/j.1365-313X.2004.02280.x; Pu L, 2008, GENETICS, V180, P811, DOI 10.1534/genetics.108.093070; Rabinowicz PD, 1999, GENETICS, V153, P427; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Saitoh K, 2004, GENETICS, V168, P997, DOI 10.1534/genetics.103.018390; Schmitz G, 2002, P NATL ACAD SCI USA, V99, P1064, DOI 10.1073/pnas.022516199; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; SHARP PA, 1981, CELL, V23, P643, DOI 10.1016/0092-8674(81)90425-6; Sonbol FM, 2009, PLANT MOL BIOL, V70, P283, DOI 10.1007/s11103-009-9473-2; Sonderby IE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001322; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Tominaga R, 2007, PLANT CELL, V19, P2264, DOI 10.1105/tpc.106.045732; Tsiantis M, 1999, SCIENCE, V284, P154, DOI 10.1126/science.284.5411.154; Tsuji H, 2006, PLANT J, V47, P427, DOI 10.1111/j.1365-313X.2006.02795.x; van Aalten DMF, 1998, METHODS, V14, P318, DOI 10.1006/meth.1998.0587; Waites R, 1998, CELL, V93, P779, DOI 10.1016/S0092-8674(00)81439-7; Walker AR, 1999, PLANT CELL, V11, P1337, DOI 10.1105/tpc.11.7.1337; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Williams CE, 1997, J BIOL CHEM, V272, P563, DOI 10.1074/jbc.272.1.563; Woodger FJ, 2003, PLANT J, V33, P707, DOI 10.1046/j.1365-313X.2003.01663.x; Zhang F, 2005, PLANT CELL, V17, P903, DOI 10.1105/tpc.104.029660; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; Zhang LC, 2012, J EXP BOT, V63, P203, DOI 10.1093/jxb/err264; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zimmermann IM, 2004, PLANT J, V40, P22, DOI 10.1111/j.1365-313X.2004.02183.x	100	170	196	19	142	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2012	7	6							e37463	10.1371/journal.pone.0037463	http://dx.doi.org/10.1371/journal.pone.0037463			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959XO	22719841	Green Published, Green Submitted, gold			2022-12-25	WOS:000305351700006
J	Frolov, RV; Singh, S				Frolov, Roman V.; Singh, Satpal			Inhibition of Ion Channels and Heart Beat in Drosophila by Selective COX-2 Inhibitor SC-791	PLOS ONE			English	Article							SENSITIVE CALCIUM-CHANNELS; LARVAL MUSCLES; CYCLOOXYGENASE-2 INHIBITION; PHARMACOLOGICAL ANALYSIS; RYANODINE RECEPTOR; CARDIAC-PACEMAKER; POTASSIUM CURRENT; MEDIATED PATHWAY; CELECOXIB; MODULATION	Recent findings suggest that modulation of ion channels might be implicated in some of the clinical effects of coxibs, selective inhibitors of cyclooxygenase-2 (COX-2). Celecoxib and its inactive analog 2,5-dimethyl-celecoxib, but not rofecoxib, can suppress or augment ionic currents and alter functioning of neurons and myocytes. To better understand these unexpected effects, we have recently investigated the mechanism of inhibition of human K(v)2.1 channels by a highly selective COX-2 inhibitor SC-791. In this study we have further explored the SC-791 action on ion channels and heartbeat in Drosophila, which lacks cyclooxygenases and thus can serve as a convenient model to study COX-2-independent mechanisms of coxibs. Using intracellular recordings in combination with a pharmacological approach and utilizing available Drosophila mutants, we found that SC-791 inhibited voltage-activated K+ and L-type Ca2+ channels in larval body-wall muscles and reduced heart rate in a concentration-dependent manner. Unlike celecoxib and several other K+ channel blockers, SC-791 did not induce arrhythmia. Instead, application of SC-791 resulted in a dramatic slowing of contractions and, at higher concentrations, in progressively weaker contractions with gradual cessation of heartbeat. Isradipine, a selective blocker of L-type Ca2+ channels, showed a similar pattern of heart arrest, though no prolongation of contractions was observed. Ryanodine was the only channel modulating compound of those tested additionally that was capable of slowing contractions. Like SC-791, ryanodine reduced heart rate without arrhythmia. However, it could not stop heartbeat completely even at 500 mu M, the highest concentration used. The magnitude of heart rate reduction, when SC-791 and ryanodine were applied together, was smaller than expected for independent mechanisms, raising the possibility that SC-791 might be interfering with excitation-contraction coupling in Drosophila heart.	[Frolov, Roman V.; Singh, Satpal] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14260 USA; [Frolov, Roman V.] Univ Oulu, Dept Phys Sci, Div Biophys, Oulu, Finland	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Oulu	Frolov, RV (corresponding author), SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14260 USA.	rvfrolov@gmail.com	Frolov, Roman/H-8099-2012; Frolov, Roman/I-3889-2016	Frolov, Roman/0000-0002-7431-5297	National Science Foundation, USA [MCB-0094477, MCB-0322461]	National Science Foundation, USA(National Science Foundation (NSF))	This work was supported by the National Science Foundation, USA, grant numbers MCB-0094477 and MCB-0322461 (http://nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias II O, 2011, CHANNELS AUSTIN, V5; BATE M, 1990, DEVELOPMENT, V110, P791; Bhattacharya A, 1999, J NEUROBIOL, V39, P491, DOI 10.1002/(SICI)1097-4695(19990615)39:4<491::AID-NEU3>3.0.CO;2-6; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Blomme EAG, 2003, BRIT J DERMATOL, V148, P211, DOI 10.1046/j.1365-2133.2003.05065.x; Brueggemann LI, 2009, MOL PHARMACOL, V76, P1053, DOI 10.1124/mol.109.057844; Chopra M, 2000, J NEUROGENET, V14, P107, DOI 10.3109/01677060009083478; Dogne JM, 2007, CURR TOP MED CHEM, V7, P885, DOI 10.2174/156802607780636717; Dressler V, 1999, COMPUT BIOMED RES, V32, P145, DOI 10.1006/cbmr.1999.1509; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Frolov RV, 2010, BRIT J PHARMACOL, V159, P405, DOI 10.1111/j.1476-5381.2009.00539.x; Frolov R.V., 2008, NEUROSCIENCE; Frolov RV, 2008, J BIOL CHEM, V283, P1518, DOI 10.1074/jbc.M708100200; Frolov RV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026344; Frolov RV, 2010, BRAIN RES, V1359, P67, DOI 10.1016/j.brainres.2010.08.062; GIELOW ML, 1995, J NEUROSCI, V15, P6085; Grosch S, 2006, JNCI-J NATL CANCER I, V98, P736, DOI 10.1093/jnci/djj206; GU GG, 1995, J NEUROBIOL, V28, P269, DOI 10.1002/neu.480280302; Gu GG, 1997, J NEUROBIOL, V33, P265, DOI 10.1002/(SICI)1097-4695(199709)33:3<265::AID-NEU5>3.0.CO;2-#; Hardy MM, 2003, J PHARMACOL EXP THER, V304, P959, DOI 10.1124/jpet.102.044545; Hasinoff BB, 2007, CARDIOVASC TOXICOL, V7, P19, DOI 10.1007/s12012-007-0002-8; Hegde P, 1999, J BIOL CHEM, V274, P22109, DOI 10.1074/jbc.274.31.22109; Jeong HS, 2010, ONCOL REP, V24, P351, DOI 10.3892/or_00000866; Johnson E, 2002, J COMP PHYSIOL B, V172, P227, DOI 10.1007/s00360-001-0246-8; Johnson E, 1997, J COMP PHYSIOL B, V167, P89, DOI 10.1007/s003600050051; Johnson E, 1998, J NEUROGENET, V12, P1, DOI 10.3109/01677069809108552; Macias A, 2010, J MOL CELL CARDIOL, V49, P984, DOI 10.1016/j.yjmcc.2010.09.012; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Park SY, 2007, BRAIN RES, V1148, P53, DOI 10.1016/j.brainres.2007.02.023; Peron S, 2009, COMP BIOCHEM PHYS A, V154, P173, DOI 10.1016/j.cbpa.2009.04.626; Petraitis V, 2009, ANTIMICROB AGENTS CH, V53, P2382, DOI 10.1128/AAC.00329-09; Robbins J, 1999, GENET RES, V74, P121, DOI 10.1017/S0016672399003924; Sanyal S, 2006, J COMP PHYSIOL B, V176, P253, DOI 10.1007/s00360-005-0046-7; Singh A, 1999, J NEUROSCI, V19, P6838, DOI 10.1523/JNEUROSCI.19-16-06838.1999; Singh S, 1999, INT REV NEUROBIOL, V43, P191, DOI 10.1016/S0074-7742(08)60546-2; Sullivan KMC, 2000, P NATL ACAD SCI USA, V97, P5942, DOI 10.1073/pnas.110145997; Tripp CS, 2003, J INVEST DERMATOL, V121, P853, DOI 10.1046/j.1523-1747.2003.12495.x; Yefi R, 2011, J CELL BIOCHEM, V112, P3167, DOI 10.1002/jcb.23247; Zhang Y, 2007, PHARMACOL RES, V56, P267, DOI 10.1016/j.phrs.2007.07.004	39	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38759	10.1371/journal.pone.0038759	http://dx.doi.org/10.1371/journal.pone.0038759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701705	Green Published, gold, Green Submitted			2022-12-25	WOS:000305348400094
J	Krajewski, S; Kurz, J; Geisler, T; Peter, K; Wendel, HP; Straub, A				Krajewski, Stefanie; Kurz, Julia; Geisler, Tobias; Peter, Karlheinz; Wendel, Hans Peter; Straub, Andreas			Combined Blockade of ADP Receptors and PI3-Kinase p110 beta Fully Prevents Platelet and Leukocyte Activation during Hypothermic Extracorporeal Circulation	PLOS ONE			English	Article							GLYCOPROTEIN IB; CARDIOPULMONARY BYPASS; P2 RECEPTORS; MICROPARTICLES; INHIBITION; EXPRESSION; BINDING; BLOOD; IDENTIFICATION; AGGREGATION	Extracorporeal circulation (ECC) and hypothermia are used to maintain stable circulatory parameters and improve the ischemia tolerance of patients in cardiac surgery. However, ECC and hypothermia induce activation mechanisms in platelets and leukocytes, which are mediated by the platelet agonist ADP and the phosphoinositide-3-kinase (PI3K) p110 beta. Under clinical conditions these processes are associated with life-threatening complications including thromboembolism and inflammation. This study analyzes effects of ADP receptor P2Y12 and P2Y1 blockade and PI3K p110 beta inhibition on platelets and granulocytes during hypothermic ECC. Human blood was treated with the P2Y12 antagonist 2-MeSAMP, the P2Y1 antagonist MRS2179, the PI3K p110 beta inhibitor TGX-221, combinations thereof, or PBS and propylene glycol (controls). Under static in vitro conditions a concentration-dependent effect regarding the inhibition of ADP-induced platelet activation was found using 2-MeSAMP or TGX-221. Further inhibition of ADP-mediated effects was achieved with MRS2179. Next, blood was circulated in an ex vivo ECC model at 28 degrees C for 30 minutes and various platelet and granulocyte markers were investigated using flow cytometry, ELISA and platelet count analysis. GPIIb/IIIa activation induced by hypothermic ECC was inhibited using TGX-221 alone or in combination with P2Y blockers (p<0.05), while no effect of hypothermic ECC or antiplatelet agents on GPIIb/IIIa and GPIb alpha expression and von Willebrand factor binding was observed. Sole P2Y and PI3K blockade or a combination thereof inhibited P-selectin expression on platelets and platelet-derived microparticles during hypothermic ECC (p<0.05). P2Y blockade alone or combined with TGX-221 prevented ECC-induced platelet-granulocyte aggregate formation (p<0.05). Platelet adhesion to the ECC surface, platelet loss and Mac-1 expression on granulocytes were inhibited by combined P2Y and PI3K blockade (p<0.05). Combined blockade of P2Y12, P2Y1 and PI3K p110 beta completely inhibits hypothermic ECC-induced activation processes. This novel finding warrants further studies and the development of suitable pharmacological agents to decrease ECC- and hypothermia-associated complications in clinical applications.	[Krajewski, Stefanie; Kurz, Julia; Straub, Andreas] Univ Tubingen, Dept Anesthesiol & Intens Care Med, Tubingen, Germany; [Geisler, Tobias] Univ Tubingen, Dept Cardiol, Tubingen, Germany; [Peter, Karlheinz] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Wendel, Hans Peter] Univ Tubingen, Dept Thorac Cardiac & Vasc Surg, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Baker Heart and Diabetes Institute; Eberhard Karls University of Tubingen	Krajewski, S (corresponding author), Univ Tubingen, Dept Anesthesiol & Intens Care Med, Tubingen, Germany.	krajewski@thg-lab.de	Geisler, Tobias/AAO-4472-2020; Krajewski, Stefanie/AAF-1877-2019; Peter, Karlheinz/E-8772-2010; /S-2765-2019	Peter, Karlheinz/0000-0002-8040-2258; /0000-0002-8040-2258	German Research Association (Deutsche Forschungsgemeinschaft) [STR 687/2-1]; Australian Research Council	German Research Association (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Australian Research Council(Australian Research Council)	This study was funded by the German Research Association (Deutsche Forschungsgemeinschaft; Grant number: STR 687/2-1). K. Peter was supported by a Future Fellowship of the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS CS, 1990, BLOOD, V75, P128; Andrews RK, 2004, IUBMB LIFE, V56, P13, DOI 10.1080/15216540310001649831; Andrews RK, 2003, INT J BIOCHEM CELL B, V35, P1170, DOI 10.1016/S1357-2725(02)00280-7; Baurand A, 2001, EUR J PHARMACOL, V412, P213, DOI 10.1016/S0014-2999(01)00733-6; Bergmeier W, 2004, CIRC RES, V95, P677, DOI 10.1161/01.RES.0000143899.73453.11; Bhatt DL, 2009, NEW ENGL J MED, V361, P2330, DOI 10.1056/NEJMoa0908629; Bird JE, 2011, THROMB RES, V127, P560, DOI 10.1016/j.thromres.2011.02.007; Cattaneo M, 2009, J THROMB HAEMOST, V7, P262, DOI 10.1111/j.1538-7836.2009.03382.x; Cattaneo M, 2010, INTERN EMERG MED, V5, P385, DOI 10.1007/s11739-010-0363-z; Cosemans JMEM, 2006, BLOOD, V108, P3045, DOI 10.1182/blood-2006-03-006338; de Rossi LW, 2001, ANESTH ANALG, V93, P635, DOI 10.1097/00000539-200109000-00020; Evangelista V, 1996, BLOOD, V88, P4183, DOI 10.1182/blood.V88.11.4183.bloodjournal88114183; Forlow SB, 2000, BLOOD, V95, P1317, DOI 10.1182/blood.V95.4.1317.004k30_1317_1323; Gachet C, 2008, THROMB HAEMOSTASIS, V99, P466, DOI 10.1160/TH07-11-0673; Gardiner EE, 2007, J THROMB HAEMOST, V5, P1530, DOI 10.1111/j.1538-7836.2007.02590.x; Gawaz M, 2004, CARDIOVASC RES, V61, P498, DOI 10.1016/j.cardiores.2003.11.036; Gawaz M, 1999, CIRCULATION, V99, P2; Hall MW, 2002, AM J HEMATOL, V69, P45, DOI 10.1002/ajh.10018; Hechler B, 2011, PURINERG SIGNAL, V7, P293, DOI 10.1007/s11302-011-9247-6; Hiramatsu Y, 1997, J THORAC CARDIOV SUR, V113, P182, DOI 10.1016/S0022-5223(97)70414-8; Hyde JAJ, 1998, PERFUSION-UK, V13, P389, DOI 10.1177/026765919801300603; Jackson SF, 2006, CELL MOL LIFE SCI, V63, P1085, DOI 10.1007/s00018-006-6001-2; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jacobson KA, 2010, DRUG DISCOV TODAY, V15, P570, DOI 10.1016/j.drudis.2010.05.011; Jantzen HM, 1999, THROMB HAEMOSTASIS, V81, P111; Jy W, 1995, BLOOD CELL MOL DIS, V21, p231a; Jy WC, 1995, BLOOD CELL MOL DIS, V21, P217, DOI 10.1006/bcmd.1995.0025; Krajewski S, 2012, BRIT J ANAESTH, V108, P912, DOI 10.1093/bja/aer518; Larson MK, 2003, BLOOD, V101, P1409, DOI 10.1182/blood-2002-05-1533; Martins PAD, 2006, J LEUKOCYTE BIOL, V79, P499, DOI 10.1189/jlb.0605318; Maxwell MJ, 2006, ARTERIOSCL THROM VAS, V26, P663, DOI 10.1161/01.ATV.0000201931.16535.e1; May AE, 2008, ARTERIOSCL THROM VAS, V28, pS5, DOI 10.1161/ATVBAHA.107.158915; MCCRARY JK, 1995, ANN BIOMED ENG, V23, P787, DOI 10.1007/BF02584477; MICHELSON AD, 1991, BLOOD, V77, P770; Moal V, 2003, NEPHROL DIAL TRANSPL, V18, P1834, DOI 10.1093/ndt/gfg185; Paparella D, 2004, INTENS CARE MED, V30, P1873, DOI 10.1007/s00134-004-2388-0; Peter K, 2000, CIRCULATION, V102, P1490, DOI 10.1161/01.CIR.102.13.1490; Rahman M, 2009, ANN SURG, V250, P783, DOI 10.1097/SLA.0b013e3181bd95b7; Rajagopalan S, 2008, ANESTHESIOLOGY, V108, P71, DOI 10.1097/01.anes.0000296719.73450.52; RINDER CS, 1991, ANESTHESIOLOGY, V75, P388, DOI 10.1097/00000542-199109000-00002; RUGGERI ZM, 1983, J CLIN INVEST, V72, P1, DOI 10.1172/JCI110946; Straub A, 2008, THROMB RES, V122, P383, DOI 10.1016/j.thromres.2008.01.001; Straub A, 2008, THROMB HAEMOSTASIS, V99, P609, DOI 10.1160/TH07-07-0452; Straub A, 2007, THROMB HAEMOSTASIS, V97, P608, DOI 10.1160/TH06-10-0563; Straub A, 2011, ARTERIOSCL THROM VAS, V31, P1607, DOI 10.1161/ATVBAHA.111.226373; Straub A, 2010, THROMB HAEMOSTASIS, V103, P466, DOI 10.1160/TH09-05-0325; WACHTFOGEL YT, 1987, BLOOD, V69, P324; Weerasinghe A, 1998, ANN THORAC SURG, V66, P2145, DOI 10.1016/S0003-4975(98)00749-8; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	49	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38455	10.1371/journal.pone.0038455	http://dx.doi.org/10.1371/journal.pone.0038455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701645	Green Published, Green Submitted, gold			2022-12-25	WOS:000305348400060
J	Valero-Cabre, A; Wattiez, N; Monfort, M; Francois, C; Rivaud-Pechoux, S; Gaymard, B; Pouget, P				Valero-Cabre, Antoni; Wattiez, Nicolas; Monfort, Morgane; Francois, Chantal; Rivaud-Pechoux, Sophie; Gaymard, Bertrand; Pouget, Pierre			Frontal Non-Invasive Neurostimulation Modulates Antisaccade Preparation in Non-Human Primates	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; POSTERIOR PARIETAL CORTEX; MEMORY-GUIDED SACCADES; EYE FIELD; ELECTRICAL-STIMULATION; VISUAL-CORTEX; CORTICOSPINAL OUTPUT; OWL MONKEYS; RAT-BRAIN; MOTOR	A combination of oculometric measurements, invasive electrophysiological recordings and microstimulation have proven instrumental to study the role of the Frontal Eye Field (FEF) in saccadic activity. We hereby gauged the ability of a non-invasive neurostimulation technology, Transcranial Magnetic Stimulation (TMS), to causally interfere with frontal activity in two macaque rhesus monkeys trained to perform a saccadic antisaccade task. We show that online single pulse TMS significantly modulated antisaccade latencies. Such effects proved dependent on TMS site (effects on FEF but not on an actively stimulated control site), TMS modality (present under active but not sham TMS on the FEF area), TMS intensity (intensities of at least 40% of the TMS machine maximal output required), TMS timing (more robust for pulses delivered at 150 ms than at 100 post target onset) and visual hemifield (relative latency decreases mainly for ipsilateral AS). Our results demonstrate the feasibility of using TMS to causally modulate antisaccade-associated computations in the non-human primate brain and support the use of this approach in monkeys to study brain function and its non-invasive neuromodulation for exploratory and therapeutic purposes.	[Valero-Cabre, Antoni; Wattiez, Nicolas; Monfort, Morgane; Francois, Chantal; Rivaud-Pechoux, Sophie; Gaymard, Bertrand; Pouget, Pierre] Univ Paris 06, CNRS, INSERM, Inst Cerveau & Moelle ICM,UMR 7225,UMRS 975, Paris, France; [Valero-Cabre, Antoni] Boston Univ, Sch Med, Lab Cerebral Dynam Plast & Rehabil, Boston, MA 02118 USA; [Valero-Cabre, Antoni] Open Univ Catalonia UOC, Cognit Neurosci & Informat Technol Res Program, Barcelona, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Boston University; UOC Universitat Oberta de Catalunya	Valero-Cabre, A (corresponding author), Univ Paris 06, CNRS, INSERM, Inst Cerveau & Moelle ICM,UMR 7225,UMRS 975, Paris, France.	antoni.valerocabre@upmc.fr; pierre.pouget@upmc.fr	Pouget, Pierre/N-8031-2019	Pouget, Pierre/0000-0002-4721-7376; Valero-Cabre, Antoni/0000-0002-5033-2279	Centre National de la Recherche Scientifique, Institut des Sciences Biologiques, Projets Exploratoires Premier Soutien; USA, National Institute of Neurological Disorders and Stroke [R21NSS062317]; european Funding Program FP6; l'Agence National pour la recherche: project eraNET-NEURON BEYONDVIS	Centre National de la Recherche Scientifique, Institut des Sciences Biologiques, Projets Exploratoires Premier Soutien; USA, National Institute of Neurological Disorders and Stroke; european Funding Program FP6; l'Agence National pour la recherche: project eraNET-NEURON BEYONDVIS	This work has been made possible thanks to funding provided by Centre National de la Recherche Scientifique, Institut des Sciences Biologiques, Projets Exploratoires Premier Soutien, 2010. The work of AV-C was also supported by USA, National Institute of Neurological Disorders and Stroke R21NSS062317 and the european Funding Program FP6 and l'Agence National pour la recherche: project eraNET-NEURON BEYONDVIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2007, SCIENCE, V317, P1918, DOI 10.1126/science.1146426; AMASSIAN VE, 1990, ELECTROEN CLIN NEURO, V77, P390, DOI 10.1016/0168-5597(90)90061-H; Amaya F, 2010, CLIN NEUROPHYSIOL, V121, P2143, DOI 10.1016/j.clinph.2010.03.058; Armstrong KM, 2006, NEURON, V50, P791, DOI 10.1016/j.neuron.2006.05.010; Aydin-Abidin S, 2006, J PHYSL; BAKER SN, 1995, J PHYSIOL-LONDON, V488, P795, DOI 10.1113/jphysiol.1995.sp021011; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Burman DD, 1997, J NEUROPHYSIOL, V77, P2252, DOI 10.1152/jn.1997.77.5.2252; Campana G, 2007, NEUROPSYCHOLOGIA, V45, P2340, DOI 10.1016/j.neuropsychologia.2007.02.009; Condy C, 2005, BIOL PSYCHIAT, V57, P366, DOI 10.1016/j.biopsych.2004.10.036; Corbetta M, 1998, PHILOS T ROY SOC B, V353, P1353, DOI 10.1098/rstb.1998.0289; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Gaymard B, 1999, EXP BRAIN RES, V129, P288, DOI 10.1007/s002210050899; Gerits A, 2011, EXP BRAIN RES, V212, P143, DOI 10.1007/s00221-011-2710-3; Ghaly RF, 1999, NEUROL RES, V21, P714, DOI 10.1080/01616412.1999.11741003; GOULD HJ, 1986, J COMP NEUROL, V247, P297, DOI 10.1002/cne.902470303; Grosbras MH, 2003, EUR J NEUROSCI, V18, P3121, DOI 10.1111/j.1460-9568.2003.03055.x; Grosbras MH, 2002, J COGNITIVE NEUROSCI, V14, P1109, DOI 10.1162/089892902320474553; Hayashi T, 2004, ANN NEUROL, V56, P77, DOI 10.1002/ana.20151; HUERTA MF, 1987, J COMP NEUROL, V265, P332, DOI 10.1002/cne.902650304; Izawa Y, 2004, J NEUROPHYSIOL, V92, P2248, DOI 10.1152/jn.01021.2003; Izawa Y, 2004, J NEUROPHYSIOL, V92, P2261, DOI 10.1152/jn.00085.2004; Ji RR, 1998, P NATL ACAD SCI USA, V95, P15635, DOI 10.1073/pnas.95.26.15635; Jing HK, 2000, CLIN NEUROPHYSIOL, V111, P1620, DOI 10.1016/S1388-2457(00)00357-6; Kleim JA, 2007, NAT PROTOC, V2, P1675, DOI 10.1038/nprot.2007.206; Liebetanz D, 2003, J PSYCHIATR RES, V37, P277, DOI 10.1016/S0022-3956(03)00017-7; Logothetis NK, NAT NEUROSCI, V13, P1283; Luft AR, 2001, EXP BRAIN RES, V140, P112, DOI 10.1007/s002210100805; Mantovani M, 2006, NEUROCHEM INT, V49, P347, DOI 10.1016/j.neuint.2006.02.008; MARROCCO RT, 1978, BRAIN RES, V146, P23, DOI 10.1016/0006-8993(78)90215-9; Moliadze V, 2003, J PHYSIOL-LONDON, V553, P665, DOI 10.1113/jphysiol.2003.050153; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Muri RM, 2008, PROG BRAIN RES, V171, P413, DOI 10.1016/S0079-6123(08)00660-2; MURI RM, 1991, EXP BRAIN RES, V86, P219; Nagel M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-89; Neggers SFW, 2007, J NEUROPHYSIOL, V98, P2765, DOI 10.1152/jn.00357.2007; Nyffeler T, 2008, PROG BRAIN RES, V171, P429, DOI 10.1016/S0079-6123(08)00663-8; O'Shea J, 2004, J COGNITIVE NEUROSCI, V16, P1060, DOI 10.1162/0898929041502634; Olk B, 2006, CEREB CORTEX, V16, P76, DOI 10.1093/cercor/bhi085; Pascual- Leone A, 2001, HDB TRANSCRANIAL MAG; Post A, 1999, EUR J NEUROSCI, V11, P3247, DOI 10.1046/j.1460-9568.1999.00747.x; RIVAUD S, 1994, EXP BRAIN RES, V102, P110; Ro T, 2003, EXP BRAIN RES, V150, P290, DOI 10.1007/s00221-003-1470-0; Ro T, 2002, J CLIN EXP NEUROPSYC, V24, P930, DOI 10.1076/jcen.24.7.930.8385; Ro T, 1999, NEUROPSYCHOLOGIA, V37, P225; SHIBUTANI H, 1984, EXP BRAIN RES, V55, P1; Silvanto J, 2006, J NEUROPHYSIOL, V96, P941, DOI 10.1152/jn.00015.2006; Thickbroom GW, 1996, J NEUROL SCI, V144, P114, DOI 10.1016/S0022-510X(96)00194-3; Valero-Cabre A, 2006, EXP BRAIN RES, V172, P14, DOI 10.1007/s00221-005-0307-4; Valero-Cabre A, 2005, EXP BRAIN RES, V163, P1, DOI 10.1007/s00221-004-2140-6; Valero-Cabre A, 2008, EUR J NEUROSCI, V27, P765, DOI 10.1111/j.1460-9568.2008.06045.x; Valero-Cabre A, 2007, EXP BRAIN RES, V176, P603, DOI 10.1007/s00221-006-0639-8; Wagner T, 2007, ANNU REV BIOMED ENG, V9, P527, DOI 10.1146/annurev.bioeng.9.061206.133100; WESSEL K, 1991, EXP BRAIN RES, V86, P216	55	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38674	10.1371/journal.pone.0038674	http://dx.doi.org/10.1371/journal.pone.0038674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701691	gold, Green Published, Green Submitted			2022-12-25	WOS:000305348400083
J	Haruki, H; Gonzalez, MR; Johnsson, K				Haruki, Hirohito; Gonzalez, Monica Rengifo; Johnsson, Kai			Exploiting Ligand-Protein Conjugates to Monitor Ligand-Receptor Interactions	PLOS ONE			English	Article							THROUGHPUT SCREENING ASSAYS; DIHYDROFOLATE-REDUCTASE; FLUORESCENCE POLARIZATION; ESCHERICHIA-COLI; SMALL MOLECULES; IN-VIVO; BINDING; EXPRESSION; AFFINITY; CELLS	We introduce three assays for analyzing ligand-receptor interactions based on the specific conjugation of ligands to SNAP-tag fusion proteins. Conjugation of ligands to different SNAP-tag fusions permits the validation of suspected interactions in cell extracts and fixed cells as well as the establishment of high-throughput assays. The different assays allow the analysis of strong and weak interactions. Conversion of ligands into SNAP-tag substrates thus provides access to a powerful toolbox for the analysis of their interactions with proteins.	[Haruki, Hirohito; Gonzalez, Monica Rengifo; Johnsson, Kai] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, Inst Bioengn, Natl Ctr Competence Res NCCR Chem Biol, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Haruki, H (corresponding author), Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, Inst Bioengn, Natl Ctr Competence Res NCCR Chem Biol, CH-1015 Lausanne, Switzerland.	kai.johnsson@epfl.ch	johnsson, kai/P-4222-2014	johnsson, kai/0000-0002-8002-1981	Swiss National Science Foundation [205320_132813]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (205320_132813). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; APPLEMAN JR, 1988, J BIOL CHEM, V263, P9187; Backliwal G, 2008, BIOTECHNOL BIOENG, V101, P182, DOI 10.1002/bit.21882; Backliwal G, 2008, BIOTECHNOL BIOENG, V99, P721, DOI 10.1002/bit.21596; Brun MA, 2009, J AM CHEM SOC, V131, P5873, DOI 10.1021/ja900149e; Chidley C, 2011, NAT CHEM BIOL, V7, P375, DOI [10.1038/NCHEMBIO.557, 10.1038/nchembio.557]; de Jong LAA, 2005, J CHROMATOGR B, V829, P1, DOI 10.1016/j.jchromb.2005.10.002; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Gautier A, 2009, J AM CHEM SOC, V131, P17954, DOI 10.1021/ja907818q; Gendreizig S, 2003, J AM CHEM SOC, V125, P14970, DOI 10.1021/ja037883p; Haruki H, 2006, J VIROL, V80, P794, DOI 10.1128/JVI.80.2.794-801.2006; Holdgate GA, 2010, J STRUCT BIOL, V172, P142, DOI 10.1016/j.jsb.2010.06.024; Huang XY, 2003, J BIOMOL SCREEN, V8, P34, DOI 10.1177/1087057102239666; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Larry EM, 1988, ANAL BIOCHEM, V174, P101; Lehto M, 2004, CELL TISSUE RES, V315, P39, DOI 10.1007/s00441-003-0817-y; MAYER RJ, 1986, P NATL ACAD SCI USA, V83, P7718, DOI 10.1073/pnas.83.20.7718; MURPHY DJ, 1989, BIOCHEMISTRY-US, V28, P3025, DOI 10.1021/bi00433a043; Riddle SM, 2006, ANAL BIOCHEM, V356, P108, DOI 10.1016/j.ab.2006.05.017; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; STONE SR, 1986, BIOCHIM BIOPHYS ACTA, V869, P275, DOI 10.1016/0167-4838(86)90067-1; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhu ZR, 2009, J BIOMOL SCREEN, V14, P1157, DOI 10.1177/1087057109350114	29	14	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37598	10.1371/journal.pone.0037598	http://dx.doi.org/10.1371/journal.pone.0037598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701522	gold, Green Submitted, Green Published			2022-12-25	WOS:000305338500043
J	Knaus, T; Eger, E; Koop, J; Stipsits, S; Kinsland, CL; Ealick, SE; Macheroux, P				Knaus, Tanja; Eger, Elisabeth; Koop, Julia; Stipsits, Steve; Kinsland, Cynthia L.; Ealick, Steven E.; Macheroux, Peter			Reverse Structural Genomics AN UNUSUAL FLAVIN-BINDING SITE IN A PUTATIVE PROTEASE FROM BACTEROIDES THETAIOTAOMICRON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; FLAVOPROTEINS; FLAVOENZYMES; DODECIN; DJ-1; MECHANISM; CHAPERONE; DISEASE	The structure of a putative protease from Bacteroides thetaiotaomicron features an unprecedented binding site for flavin mononucleotide. The flavin isoalloxazine ring is sandwiched between two tryptophan residues in the interface of the dimeric protein. We characterized the recombinant protein with regard to its affinity for naturally occurring flavin derivatives and several chemically modified flavin analogs. Dissociation constants were determined by isothermal titration calorimetry. The protein has high affinity to naturally occurring flavin derivatives, such as riboflavin, FMN, and FAD, as well as lumichrome, a photodegradation product of flavins. Similarly, chemically modified flavin analogs showed high affinity to the protein in the nanomolar range. Replacement of the tryptophan by phenylalanine gave rise to much weaker binding, whereas in the tryptophan to alanine variant, flavin binding was abolished. We propose that the protein is an unspecific scavenger of flavin compounds and may serve as a storage protein in vivo.	[Knaus, Tanja; Eger, Elisabeth; Koop, Julia; Stipsits, Steve; Macheroux, Peter] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Kinsland, Cynthia L.; Ealick, Steven E.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14850 USA	Graz University of Technology; Cornell University	Macheroux, P (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12, A-8010 Graz, Austria.	peter.macheroux@tugraz.at	Macheroux, Peter/AAB-5157-2019	Macheroux, Peter/0000-0002-0242-454X; Knaus, Tanja/0000-0001-9942-9226	Graz University of Technology	Graz University of Technology	This work was supported by funds from Graz University of Technology (to P.M.).	Bornemann S, 2002, NAT PROD REP, V19, P761, DOI 10.1039/b108916c; CAIRNS WL, 1971, J AM CHEM SOC, V93, P2772; CHOONG YS, 1981, J BIOL CHEM, V256, P8671; Comstock LE, 2003, BIOESSAYS, V25, P926, DOI 10.1002/bies.10350; Fagan RL, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P37; FITZPATRICK PF, 1985, J BIOL CHEM, V260, P8483; GHISLA S, 1986, BIOCHEM J, V239, P1; Grininger M, 2006, J MOL BIOL, V364, P561, DOI 10.1016/j.jmb.2006.08.083; Grininger M, 2009, J BIOL CHEM, V284, P13068, DOI 10.1074/jbc.M808063200; Le HT, 2012, J BIOL CHEM, V287, P5861, DOI 10.1074/jbc.M111.299198; Honbou K, 2003, J BIOL CHEM, V278, P31380, DOI 10.1074/jbc.M305878200; Huerta C, 2009, J MOL BIOL, V389, P388, DOI 10.1016/j.jmb.2009.04.022; Joosten V, 2007, CURR OPIN CHEM BIOL, V11, P195, DOI 10.1016/j.cbpa.2007.01.010; Kommoju PR, 2011, BIOCHEMISTRY-US, V50, P5521, DOI 10.1021/bi200388g; Macheroux P, 1999, METH MOL B, V131, P1; Macheroux P, 2011, FEBS J, V278, P2625, DOI 10.1111/j.1742-4658.2011.08202.x; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Malki A, 2005, J BIOL CHEM, V280, P14420, DOI 10.1074/jbc.M408296200; Mansoorabadi SO, 2007, J ORG CHEM, V72, P6329, DOI 10.1021/jo0703092; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P9, DOI 10.1021/bi00594a002; MATSUI K, 1974, J NUTR SCI VITAMINOL, V20, P411; MCCORMICK DB, 1977, PHOTOCHEM PHOTOBIOL, V26, P169, DOI 10.1111/j.1751-1097.1977.tb07471.x; McDonald CA, 2011, J AM CHEM SOC, V133, P16809, DOI 10.1021/ja2081873; Meissner B, 2007, J BIOL CHEM, V282, P33142, DOI 10.1074/jbc.M704951200; Muller F., 1988, VITAMINE; Parkin G, 2004, CHEM REV, V104, P699, DOI 10.1021/cr0206263; Quigley PM, 2003, P NATL ACAD SCI USA, V100, P3137, DOI 10.1073/pnas.0530312100; SPENCER R, 1977, BIOCHEMISTRY-US, V16, P3586, DOI 10.1021/bi00635a014; SPENCER R, 1976, BIOCHEMISTRY-US, V15, P1043, DOI 10.1021/bi00650a015; Tao X, 2003, J BIOL CHEM, V278, P31372, DOI 10.1074/jbc.M304221200; Wei Y, 2007, PLOS COMPUT BIOL, V3, P120, DOI 10.1371/journal.pcbi.0030010; WHITBY LG, 1954, BIOCHEM J, V57, P390, DOI 10.1042/bj0570390	32	3	3	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27490	27498		10.1074/jbc.M112.355388	http://dx.doi.org/10.1074/jbc.M112.355388			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718753	Green Published, hybrid			2022-12-25	WOS:000307840700025
J	Ren, H; Zhao, YL; Dwyer, DS; Peoples, RW				Ren, Hong; Zhao, Yulin; Dwyer, Donard S.; Peoples, Robert W.			Interactions among Positions in the Third and Fourth Membrane-associated Domains at the Intersubunit Interface of the N-Methyl-D-aspartate Receptor Forming Sites of Alcohol Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NR1/NR2B NMDA RECEPTORS; ETHANOL INHIBITION; HIPPOCAMPAL-NEURONS; GLUTAMATE RECEPTORS; SINGLE-CHANNEL; NR2A SUBUNIT; FYN-KINASE; M4 DOMAINS; M3; SENSITIVITY	The N-methyl-D-aspartate (NMDA) glutamate receptor is a major target of ethanol in the brain. Previous studies have identified positions in the third and fourth membrane-associated (M) domains of the NMDA receptor GluN1 and GluN2A subunits that influence alcohol sensitivity. The predicted structure of the NMDA receptor, based on that of the related GluA2 subunit, indicates a close apposition of the alcohol-sensitive positions in M3 and M4 between the two subunit types. We tested the hypothesis that these positions interact to regulate receptor kinetics and ethanol sensitivity by using dual substitution mutants. In single-substitution mutants, we found that a position in both subunits adjacent to one previously identified, GluN1(Gly-638) and GluN2A(Phe-636), can strongly regulate ethanol sensitivity. Significant interactions affecting ethanol inhibition and receptor deactivation were observed at four pairs of positions in GluN1/GluN2A: Gly-638/Met-823, Phe-639/Leu-824, Met-818/Phe-636, and Leu-819/Phe-637; the latter pair also interacted with respect to desensitization. Two interactions involved a position in M4 of both subunits, GluN1(Met-818) and GluN2A(Leu-824), that does not by itself alter ethanol sensitivity, whereas a previously identified ethanol-sensitive position, GluN2A(Ala-825), did not unequivocally interact with any other position tested. These results also indicate a shift by one position of the predicted alignment of the GluN1 M4 domain. These findings have allowed for the refinement of the NMDA receptor M domain structure, demonstrate that this region can influence apparent agonist affinity, and support the existence of four sites of alcohol action on the NMDA receptor, each consisting of five amino acids at the M3-M4 domain intersubunit interfaces.	[Ren, Hong; Zhao, Yulin; Peoples, Robert W.] Marquette Univ, Dept Biomed Sci, Milwaukee, WI 53201 USA; [Dwyer, Donard S.] Louisiana State Univ, Hlth Sci Ctr, Dept Psychiat, Shreveport, LA 71130 USA	Marquette University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Peoples, RW (corresponding author), Marquette Univ, Dept Biomed Sci, SC 446,POB 1881, Milwaukee, WI 53201 USA.	robert.peoples@marquette.edu			National Institutes of Health [AA015203-01A1, AA015203-06A1]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA015203-01A1 and AA015203-06A1 (to R.W.P.).	Alvestad RM, 2003, J BIOL CHEM, V278, P11020, DOI 10.1074/jbc.M210167200; Anders DL, 1999, J NEUROCHEM, V72, P1389, DOI 10.1046/j.1471-4159.1999.721389.x; BALSTER RL, 1992, EUR J PHARMACOL, V222, P39, DOI 10.1016/0014-2999(92)90460-L; Banke TG, 2003, NAT NEUROSCI, V6, P144, DOI 10.1038/nn1000; Blanke ML, 2008, MOL PHARMACOL, V74, P454, DOI 10.1124/mol.107.044115; Chang HR, 2008, J NEUROSCI, V28, P1546, DOI 10.1523/JNEUROSCI.3485-07.2008; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Dickerson D, 2010, J PSYCHOPHARMACOL, V24, P203, DOI 10.1177/0269881108098612; DILDY JE, 1989, BRAIN RES, V499, P383, DOI 10.1016/0006-8993(89)90789-0; Dingledine R, 1999, PHARMACOL REV, V51, P7; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; GOTHERT M, 1989, N-S ARCH PHARMACOL, V340, P516; GRANT KA, 1991, BEHAV PHARMACOL, V2, P87; GRANT KA, 1993, J PHARMACOL EXP THER, V264, P1241; Hicklin TR, 2011, P NATL ACAD SCI USA, V108, P6650, DOI 10.1073/pnas.1017856108; Hodge CW, 1998, PSYCHOPHARMACOLOGY, V139, P95, DOI 10.1007/s002130050694; HOFFMAN PL, 1989, J NEUROCHEM, V52, P1937, DOI 10.1111/j.1471-4159.1989.tb07280.x; Honse Y, 2004, NEUROPHARMACOLOGY, V46, P647, DOI 10.1016/j.neuropharm.2003.11.006; Jones KS, 2002, J NEUROSCI, V22, P2044, DOI 10.1523/JNEUROSCI.22-06-02044.2002; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; Krupitsky EM, 2007, AM J PSYCHIAT, V164, P519, DOI 10.1176/appi.ajp.164.3.519; Krystal JH, 2003, PHARMACOL THERAPEUT, V99, P79, DOI 10.1016/S0163-7258(03)00054-8; Krystal JH, 1998, ARCH GEN PSYCHIAT, V55, P354, DOI 10.1001/archpsyc.55.4.354; Laha KT, 2011, MOL PHARMACOL, V79, P662, DOI 10.1124/mol.110.068619; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; LOVINGER DM, 1990, J NEUROSCI, V10, P1372; Maldve RE, 2002, NAT NEUROSCI, V5, P641, DOI 10.1038/nn877; Miyakawa T, 1997, SCIENCE, V278, P698, DOI 10.1126/science.278.5338.698; Peoples R.W., 2003, GLUTAMATE ADDICTION, P343; Peoples RW, 2000, NEUROPHARMACOLOGY, V39, P1681, DOI 10.1016/S0028-3908(00)00067-8; Peoples RW, 1996, ANNU REV PHARMACOL, V36, P185, DOI 10.1146/annurev.pa.36.040196.001153; Peoples RW, 1997, BRIT J PHARMACOL, V122, P1035, DOI 10.1038/sj.bjp.0701483; Qian A, 2002, PHYSIOL BEHAV, V77, P577, DOI 10.1016/S0031-9384(02)00906-X; Ren H, 2007, BRIT J PHARMACOL, V151, P749, DOI 10.1038/sj.bjp.0707254; Ren H, 2003, J BIOL CHEM, V278, P48815, DOI 10.1074/jbc.M302097200; Ren H, 2003, J BIOL CHEM, V278, P276, DOI 10.1074/jbc.M209486200; Ren H, 2008, J BIOL CHEM, V283, P8250, DOI 10.1074/jbc.M705933200; Ronald KM, 2001, J BIOL CHEM, V276, P44729, DOI 10.1074/jbc.M102800200; Salous AK, 2009, BRIT J PHARMACOL, V158, P1395, DOI 10.1111/j.1476-5381.2009.00397.x; Salussolia CL, 2011, J NEUROSCI, V31, P11295, DOI 10.1523/JNEUROSCI.5612-10.2011; SANGER DJ, 1993, BEHAV PHARMACOL, V4, P523; SCHECHTER MD, 1993, ALCOHOL, V10, P197, DOI 10.1016/0741-8329(93)90035-M; Schorge S, 2005, J PHYSIOL-LONDON, V569, P395, DOI 10.1113/jphysiol.2005.095349; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; Smothers CT, 2006, ALCOHOL CLIN EXP RES, V30, P523, DOI 10.1111/j.1530-0277.2006.00058.x; Sobolevsky AI, 2002, NEURON, V33, P75, DOI 10.1016/S0896-6273(01)00560-8; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Talukder I, 2011, J GEN PHYSIOL, V138, P179, DOI 10.1085/jgp.201110623; Terhag J, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00117; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; Woodward JJ, 1999, NEUROCHEM INT, V35, P107, DOI 10.1016/S0197-0186(99)00052-2; Wright JM, 1996, BRAIN RES, V738, P249, DOI 10.1016/S0006-8993(96)00780-9; Xu MF, 2012, J PHARMACOL EXP THER, V340, P218, DOI 10.1124/jpet.111.187179; Yaka R, 2003, ALCOHOL CLIN EXP RES, V27, P1736, DOI 10.1097/01.ALC.0000095924.87729.D8; Yuan HJ, 2005, J BIOL CHEM, V280, P29708, DOI 10.1074/jbc.M414215200; Zhou Y, 2005, J NEUROSCI, V25, P7914, DOI 10.1523/JNEUROSCI.1471-05.2005	58	34	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27302	27312		10.1074/jbc.M111.338921	http://dx.doi.org/10.1074/jbc.M111.338921			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22715100	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000307840700003
J	Scheer, E; Delbac, F; Tora, L; Moras, D; Romier, C				Scheer, Elisabeth; Delbac, Frederic; Tora, Laszlo; Moras, Dino; Romier, Christophe			TFIID TAF6-TAF9 Complex Formation Involves the HEAT Repeat-containing C-terminal Domain of TAF6 and Is Modulated by TAF5 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TATA-BINDING PROTEIN; HISTONE-FOLD; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; YEAST; COMPONENTS; OCTAMER; CORE; IDENTIFICATION	The general transcription factor TFIID recognizes specifically the core promoter of genes transcribed by eukaryotic RNA polymerase II, nucleating the assembly of the preinitiation complex at the transcription start site. However, the understanding in molecular terms of TFIID assembly and function remains poorly understood. Histone fold motifs have been shown to be extremely important for the heterodimerization of many TFIID subunits. However, these subunits display several evolutionary conserved noncanonical features when compared with histones, including additional regions whose role is unknown. Here we show that the conserved additional C-terminal region of TFIID subunit TAF6 can be divided into two domains: a small middle domain (TAF6M) and a large C-terminal domain (TAF6C). Our crystal structure of the TAF6C domain from Antonospora locustae at 1.9 angstrom resolution reveals the presence of five conserved HEAT repeats. Based on these data, we designed several mutants that were introduced into full-length human TAF6. Surprisingly, the mutants affect the interaction between TAF6 and TAF9, suggesting that the formation of the complex between these two TFIID subunits do not only depend on their histone fold motifs. In addition, the same mutants affect even more strongly the interaction between TAF6 and TAF9 in the context of a TAF5-TAF6-TAF9 complex. Expression of these mutants in HeLa cells reveals that most of them are unstable, suggesting their poor incorporation within endogenous TFIID. Taken together, our results suggest that the conserved additional domains in histone fold-containing subunits of TFIID and of co-activator SAGA are important for the assembly of these complexes.	[Moras, Dino; Romier, Christophe] Univ Strasbourg UDS, IGBMC, CNRS, INSERM,Dept Biol Integrat, F-67404 Illkirch Graffenstaden, France; [Scheer, Elisabeth; Tora, Laszlo] Univ Strasbourg UDS, IGBMC, CNRS, INSERM,Dept Genom Fonct & Canc, F-67404 Illkirch Graffenstaden, France; [Delbac, Frederic] Univ Clermont Ferrand, Clermont Univ, Lab Microorganismes Genome & Environm, F-63000 Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Romier, C (corresponding author), Univ Strasbourg UDS, IGBMC, CNRS, INSERM,Dept Biol Integrat, 1 Rue Laurent Fries,BP 10142, F-67404 Illkirch Graffenstaden, France.	romier@igbmc.fr	Tora, Laszlo/E-9999-2018	Tora, Laszlo/0000-0001-7398-2250; Romier, Christophe/0000-0002-3680-935X	CNRS; INSERM; Universite de Strasbourg; European Commission SPINE2-Complexes project [LSHG-CT-2006-031220]; Agence Nationale de la Recherche (ANR) [ANR-09-BLAN-0052]; European Union (EU) (EUTRACC) [LSHG-CT-2007-037445]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Strasbourg; European Commission SPINE2-Complexes project(European Commission); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); European Union (EU) (EUTRACC)	This work was supported by institutional funds from the CNRS, the INSERM, and the Universite de Strasbourg. Further funding was provided by the European Commission SPINE2-Complexes project (Contract LSHG-CT-2006-031220) (to C. R. and D. M.) and by grants from the Agence Nationale de la Recherche (ANR) (ANR-09-BLAN-0052) and the European Union (EU) (EUTRACC, LSHG-CT-2007-037445) (to L. T.).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Bell B, 2001, MOL CELL, V8, P591, DOI 10.1016/S1097-2765(01)00325-2; Birck C, 1998, CELL, V94, P239, DOI 10.1016/S0092-8674(00)81423-3; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Cler E, 2009, CELL MOL LIFE SCI, V66, P2123, DOI 10.1007/s00018-009-0009-3; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Demeny MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000316; Diebold ML, 2011, J STRUCT BIOL, V175, P178, DOI 10.1016/j.jsb.2011.02.001; Diebold ML, 2010, EMBO J, V29, P3979, DOI 10.1038/emboj.2010.272; Diebold ML, 2010, J BIOL CHEM, V285, P38389, DOI 10.1074/jbc.M110.146696; Dubrovskaya V, 1996, EMBO J, V15, P3702, DOI 10.1002/j.1460-2075.1996.tb00740.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frontini M, 2005, MOL CELL BIOL, V25, P4638, DOI 10.1128/MCB.25.11.4638-4649.2005; Gangloff YG, 2000, MOL CELL BIOL, V20, P340, DOI 10.1128/MCB.20.1.340-351.2000; Gangloff YG, 2001, TRENDS BIOCHEM SCI, V26, P250, DOI 10.1016/S0968-0004(00)01741-2; Gangloff YG, 2001, MOL CELL BIOL, V21, P1841, DOI 10.1128/MCB.21.5.1841-1853.2001; Gangloff YG, 2001, MOL CELL BIOL, V21, P5109, DOI 10.1128/MCB.21.15.5109-5121.2001; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; HISATAKE K, 1995, P NATL ACAD SCI USA, V92, P8195, DOI 10.1073/pnas.92.18.8195; Hoffmann A, 1996, NATURE, V380, P356, DOI 10.1038/380356a0; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; KOKUBO T, 1994, NATURE, V367, P484, DOI 10.1038/367484a0; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lavigne AC, 1999, MOL CELL BIOL, V19, P5050; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papai G, 2010, NATURE, V465, P956, DOI 10.1038/nature09080; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Romier C, 2007, J MOL BIOL, V368, P1292, DOI 10.1016/j.jmb.2007.02.039; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; Selleck W, 2001, NAT STRUCT BIOL, V8, P695, DOI 10.1038/90408; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Thuault S, 2002, J BIOL CHEM, V277, P45510, DOI 10.1074/jbc.M206556200; van Ingen H, 2008, STRUCTURE, V16, P1245, DOI 10.1016/j.str.2008.04.015; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang XP, 2007, P NATL ACAD SCI USA, V104, P7839, DOI 10.1073/pnas.0608570104; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; WEINZIERL ROJ, 1993, EMBO J, V12, P5303, DOI 10.1002/j.1460-2075.1993.tb06226.x; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; Wollmann P, 2011, NATURE, V475, P403, DOI 10.1038/nature10215; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Wright KJ, 2009, P NATL ACAD SCI USA, V106, P55, DOI 10.1073/pnas.0811914106; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0; Zhou JM, 1998, P NATL ACAD SCI USA, V95, P13483, DOI 10.1073/pnas.95.23.13483	55	23	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27580	27592		10.1074/jbc.M112.379206	http://dx.doi.org/10.1074/jbc.M112.379206			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22696218	hybrid, Green Published			2022-12-25	WOS:000307840700033
J	Ding, JJ; Wang, W; Feng, H; Zhang, Y; Wang, DC				Ding, Jingjin; Wang, Wei; Feng, Han; Zhang, Ying; Wang, Da-Cheng			Structural Insights into the Pseudomonas aeruginosa Type VI Virulence Effector Tse1 Bacteriolysis and Self-protection Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAILED PHAGES; SECRETION; SUPERFAMILY; SUBSTRATE; ENZYMES; RIPA	Recently, it was identified that Pseudomonas aeruginosa competes with rival cells to gain a growth advantage using a novel mechanism that includes two interrelated processes as follows: employing type VI secretion system (T6SS) virulence effectors to lyse other bacteria, and at the same time producing specialized immunity proteins to inactivate their cognate effectors for self-protection against mutual toxicity. To explore the structural basis of these processes in the context of functional performance, the crystal structures of the T6SS virulence effector Tse1 and its complex with the corresponding immunity protein Tsi1 were determined, which, in association with mutagenesis and Biacore analyses, provided a molecular platform to resolve the relevant structural questions. The results indicated that Tse1 features a papain-like structure and conserved catalytic site with distinct substrate-binding sites to hydrolyze its murein peptide substrate. The immunity protein Tsi1 interacts with Tse1 via a unique interactive recognition mode to shield Tse1 from its physiological substrate. These findings reveal both the structural mechanisms for bacteriolysis and the self-protection against the T6SS effector Tse1. These mechanisms are significant not only by contributing to a novel understanding of niche competition among bacteria but also in providing a structural basis for antibacterial agent design and the development of new strategies to fight P. aeruginosa.	[Ding, Jingjin; Wang, Wei; Feng, Han; Zhang, Ying; Wang, Da-Cheng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 10010, Peoples R China; [Wang, Wei; Feng, Han] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, DC (corresponding author), Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, 15 Datun Rd, Beijing 100101, Peoples R China.	dcwang@ibp.ac.cn	Wang, Wei/W-3720-2019	Wang, Wei/0000-0002-6346-2216; Ding, Jingjin/0000-0001-9941-7997	Chinese Ministry of Science and Technology 973 Program [2011CB910304, 2011CB911103]; National Natural Science Foundation of China [31100535]; Chinese Academy of Sciences [KSCX2-EW-J-3]	Chinese Ministry of Science and Technology 973 Program(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by Chinese Ministry of Science and Technology 973 Program Grants 2011CB910304 and 2011CB911103, National Natural Science Foundation of China Grant 31100535, and Chinese Academy of Sciences Grant KSCX2-EW-J-3.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Aramini JM, 2008, BIOCHEMISTRY-US, V47, P9715, DOI 10.1021/bi8010779; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Both D, 2011, J MOL BIOL, V413, P247, DOI 10.1016/j.jmb.2011.08.014; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gjodsbol Kristine, 2006, Int Wound J, V3, P225, DOI 10.1111/j.1742-481X.2006.00159.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Kanamaru S, 2009, P NATL ACAD SCI USA, V106, P4067, DOI 10.1073/pnas.0901205106; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Nakajima Y, 2008, J BACTERIOL, V190, P7819, DOI 10.1128/JB.02010-07; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Reid G, 2001, TRENDS MICROBIOL, V9, P424, DOI 10.1016/S0966-842X(01)02132-1; Ruggiero A, 2010, STRUCTURE, V18, P1184, DOI 10.1016/j.str.2010.06.007; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Smith TJ, 2000, MICROBIOL-UK, V146, P249, DOI 10.1099/00221287-146-2-249; STORER AC, 1994, METHOD ENZYMOL, V244, P486; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1354, DOI 10.1107/S1744309110021214; Xu QP, 2009, STRUCTURE, V17, P303, DOI 10.1016/j.str.2008.12.008	34	36	39	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26911	26920		10.1074/jbc.M112.368043	http://dx.doi.org/10.1074/jbc.M112.368043			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700987	hybrid, Green Published			2022-12-25	WOS:000307386000039
J	Newman, ER; Kneale, GG; Ravelli, RBG; Karuppasamy, M; Nejadasl, FK; Taylor, IA; McGeehan, JE				Newman, Emily R.; Kneale, G. Geoff; Ravelli, Raimond B. G.; Karuppasamy, Manikandan; Nejadasl, Fatemeh Karimi; Taylor, Ian A.; McGeehan, John E.			Large Multimeric Assemblies of Nucleosome Assembly Protein and Histones Revealed by Small-angle X-ray Scattering and Electron Microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEDIMENTATION-VELOCITY; CRYSTAL-STRUCTURE; IN-VITRO; CHROMATIN; CHAPERONE; PARTICLE; NAP1; COMPLEXES; BINDING; STATES	The nucleosome assembly protein (NAP) family represents a key group of histone chaperones that are essential for cell viability. Several x-ray structures of NAP1 dimers are available; however, there are currently no structures of this ubiquitous chaperone in complex with histones. We have characterized NAP1 from Xenopus laevis and reveal that it forms discrete multimers with histones H2A/H2B and H3/H4 at a stoichiometry of one NAP dimer to one histone fold dimer. These complexes have been characterized by size exclusion chromatography, analytical ultracentrifugation, multiangle laser light scattering, and small-angle x-ray scattering to reveal their oligomeric assembly states in solution. By employing single-particle cryo-electron microscopy, we visualized these complexes for the first time and show that they form heterogeneous ring-like structures, potentially acting as large scaffolds for histone assembly and exchange.	[Newman, Emily R.; Kneale, G. Geoff; McGeehan, John E.] Univ Portsmouth, Sch Biol Sci, Inst Biomed & Biomol Sci, Biophys Labs, Portsmouth PO1 2DY, Hants, England; [Ravelli, Raimond B. G.; Karuppasamy, Manikandan; Nejadasl, Fatemeh Karimi] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; [Taylor, Ian A.] MRC Natl Inst Med Res, Div Mol Struct, London NW7 1AA, England	University of Portsmouth; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; MRC National Institute for Medical Research	McGeehan, JE (corresponding author), Univ Portsmouth, Sch Biol Sci, Inst Biomed & Biomol Sci, Biophys Labs, Portsmouth PO1 2DY, Hants, England.	john.mcgeehan@port.ac.uk	Karuppasamy, Manikandan/D-2053-2014	McGeehan, John/0000-0002-6750-1462; Ravelli, Raimond/0000-0001-6056-5888	Research Councils UK fellowship; University of Portsmouth Institute of Biomedical and Biomolecular Science bursary; Netherlands Organisation for Scientific Research [016.072.321]; MRC [MC_U117565647] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E500595/1] Funding Source: researchfish; Medical Research Council [MC_U117565647] Funding Source: researchfish	Research Councils UK fellowship(UK Research & Innovation (UKRI)); University of Portsmouth Institute of Biomedical and Biomolecular Science bursary; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Research Councils UK fellowship (to J. E. M.), a University of Portsmouth Institute of Biomedical and Biomolecular Science bursary (to E. R. N.), and Netherlands Organisation for Scientific Research Project 016.072.321 (to R. B. G. R., M. K., and F. K. N.).	Akey CW, 2003, CURR OPIN STRUC BIOL, V13, P6, DOI 10.1016/S0959-440X(03)00002-2; Altman R, 1997, J CELL BIOL, V138, P119, DOI 10.1083/jcb.138.1.119; Andrews AJ, 2008, J BIOL CHEM, V283, P32412, DOI 10.1074/jbc.M805918200; Bowman A, 2011, MOL CELL, V41, P398, DOI 10.1016/j.molcel.2011.01.025; De Carlo S, 2010, METHOD ENZYMOL, V481, P127, DOI 10.1016/S0076-6879(10)81006-7; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Friedeberg C., 2005, THESIS U PORTSMOUTH; Friedeberg C, 2006, NUCLEIC ACIDS RES, V34, P4893, DOI 10.1093/nar/gkl434; Fyodorov DV, 2003, METHOD ENZYMOL, V371, P499; Gill J, 2009, J BIOL CHEM, V284, P10076, DOI 10.1074/jbc.M808633200; Hondele M, 2011, CURR OPIN STRUC BIOL, V21, P698, DOI 10.1016/j.sbi.2011.10.003; ISHIMI Y, 1983, J BIOCHEM-TOKYO, V94, P735, DOI 10.1093/oxfordjournals.jbchem.a134414; Ito T, 1996, MOL CELL BIOL, V16, P3112; Karantza V, 1996, BIOCHEMISTRY-US, V35, P2037, DOI 10.1021/bi9518858; Karuppasamy M, 2011, J SYNCHROTRON RADIAT, V18, P398, DOI 10.1107/S090904951100820X; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kepert JF, 2005, J BIOL CHEM, V280, P34063, DOI 10.1074/jbc.M507322200; KLEINSCHMIDT JA, 1990, EMBO J, V9, P1309, DOI 10.1002/j.1460-2075.1990.tb08240.x; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krogan NJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-313; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McBryant SJ, 2004, BIOCHEMISTRY-US, V43, P10592, DOI 10.1021/bi035881b; McBryant SJ, 2003, J BIOL CHEM, V278, P44574, DOI 10.1074/jbc.M305636200; McQuibban GA, 1998, J BIOL CHEM, V273, P6582, DOI 10.1074/jbc.273.11.6582; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Noda M, 2011, BIOCHEM J, V436, P101, DOI 10.1042/BJ20102063; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Park YJ, 2005, J BIOL CHEM, V280, P1817, DOI 10.1074/jbc.M411347200; Park YJ, 2008, J MOL BIOL, V375, P1076, DOI 10.1016/j.jmb.2007.11.031; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Rattner BP, 2009, MOL CELL, V34, P620, DOI 10.1016/j.molcel.2009.04.014; Santos SF, 2003, J COLLOID INTERF SCI, V262, P400, DOI 10.1016/S0021-9797(03)00109-7; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stark H, 2010, METHOD ENZYMOL, V481, P109, DOI 10.1016/S0076-6879(10)81005-5; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Taneva SG, 2008, BIOCHEMISTRY-US, V47, P13897, DOI 10.1021/bi800975r; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Torigoe SE, 2011, MOL CELL, V43, P638, DOI 10.1016/j.molcel.2011.07.017; Toth KF, 2005, J BIOL CHEM, V280, P15690, DOI 10.1074/jbc.M413329200; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Tyler JK, 2002, EUR J BIOCHEM, V269, P2268, DOI 10.1046/j.1432-1033.2002.02890.x; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zhou Z, 2008, NAT STRUCT MOL BIOL, V15, P868, DOI 10.1038/nsmb.1465; Zlatanova J, 2007, FASEB J, V21, P1294, DOI 10.1096/fj.06-7199rev	48	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26657	26665		10.1074/jbc.M112.340422	http://dx.doi.org/10.1074/jbc.M112.340422			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707715	Green Published, hybrid			2022-12-25	WOS:000307386000017
J	Buss, C; Entringer, S; Davis, EP; Hobel, CJ; Swanson, JM; Wadhwa, PD; Sandman, CA				Buss, Claudia; Entringer, Sonja; Davis, Elysia Poggi; Hobel, Calvin J.; Swanson, James M.; Wadhwa, Pathik D.; Sandman, Curt A.			Impaired Executive Function Mediates the Association between Maternal Pre-Pregnancy Body Mass Index and Child ADHD Symptoms	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; PRETERM BIRTH; BEHAVIOR CHECKLIST; GESTATIONAL-AGE; WEIGHT-GAIN; PREGNANCY; BRAIN; INFLAMMATION; OBESITY	Background: Increasing evidence suggests exposure to adverse conditions in intrauterine life may increase the risk of developing attention-deficit/hyperactivity disorder (ADHD) in childhood. High maternal pre-pregnancy body mass index (BMI) has been shown to predict child ADHD symptoms, however the neurocognitive processes underlying this relationship are not known. The aim of the present study was to test the hypothesis that this association is mediated by alterations in child executive function. Methodology/Principal Findings: A population-based cohort of 174 children (mean age = 7.3 +/- 0.9 (SD) yrs, 55% girls) was evaluated for ADHD symptoms using the Child Behavior Checklist, and for neurocognitive function using the Go/No-go task. This cohort had been followed prospectively from early gestation and birth through infancy and childhood with serial measures of maternal and child prenatal and postnatal factors. Maternal pre-pregnancy BMI was a significant predictor of child ADHD symptoms (F-(1,F-158)=4.80, p=0.03) and of child performance on the Go/No-go task (F-(1,F-157)=8.37, p=0.004) after controlling for key potential confounding variables. A test of the mediation model revealed that the association between higher maternal pre-pregnancy BMI and child ADHD symptoms was mediated by impaired executive function (inefficient/less attentive processing; Sobel Test: t=2.39 (+/- 0.002, SEM), p=0.02). Conclusions/Significance: To the best of our knowledge this is the first study to report that maternal pre-pregnancy BMI-related alterations in child neurocognitive function may mediate its effects on ADHD risk. The finding is clinically significant and may extrapolate to an approximately 2.8-fold increase in the prevalence of ADHD among children of obese compared to those of non-obese mothers. These results add further evidence to the growing awareness that neurodevelopmental disorders such as ADHD may have their foundations very early in life.	[Buss, Claudia; Entringer, Sonja; Davis, Elysia Poggi; Swanson, James M.; Wadhwa, Pathik D.] Univ Calif Irvine, Sch Med, Dept Pediat, Irvine, CA 92717 USA; [Davis, Elysia Poggi; Wadhwa, Pathik D.; Sandman, Curt A.] Univ Calif Irvine, Sch Med, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Wadhwa, Pathik D.] Univ Calif Irvine, Sch Med, Dept Obstet & Gynecol, Irvine, CA 92717 USA; [Wadhwa, Pathik D.] Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92717 USA; [Hobel, Calvin J.] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Los Angeles, CA 90048 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Cedars Sinai Medical Center	Buss, C (corresponding author), Univ Calif Irvine, Sch Med, Dept Pediat, Irvine, CA 92717 USA.	cbuss@uci.edu; sentring@uci.edu	Entringer, Sonja/ABB-9405-2020; Buss, Claudia/ABC-3687-2020	Buss, Claudia/0000-0002-8738-3133; Davis, Elysia/0000-0001-6345-9271; Entringer, Sonja/0000-0002-9926-7076	US PHS National Institutes of Health (NIH) [NS-41298, HD-51852, HD-28413]; NIH [RO1 MH-091351, RO1 HD-065825, R01 HD-050662, RO1 HD-06028]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060628, R01HD065825] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028413, R01HD050662, R01HD051852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041298] Funding Source: NIH RePORTER	US PHS National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by US PHS National Institutes of Health (NIH) grants NS-41298, HD-51852 and HD-28413 to CAS. Additional effort for the preparation of this manuscript was supported by NIH grants RO1 MH-091351 to CB, RO1 HD-065825 to SE, R01 HD-050662 to EPD, and RO1 HD-06028 to PDW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 2001, J CONSULT CLIN PSYCH, V69, P699, DOI 10.1037/0022-006X.69.4.699; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Antonow-Schlorke I, 2011, P NATL ACAD SCI USA, V108, P3011, DOI 10.1073/pnas.1009838108; Baerwald KD, 1998, J NEUROSCI RES, V52, P230, DOI 10.1002/(SICI)1097-4547(19980415)52:2<230::AID-JNR11>3.3.CO;2-P; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Basu S, 2011, OBESITY, V19, P476, DOI 10.1038/oby.2010.215; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BIEDERMAN J, 1993, J CHILD PSYCHOL PSYC, V34, P1241, DOI 10.1111/j.1469-7610.1993.tb01785.x; Bilbo SD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.014.2009; Bouret SG, 2010, NESTLE NUTR WORKS SE, V65, P25, DOI 10.1159/000281143; Brion MJ, 2011, PEDIATRICS, V127, pE202, DOI 10.1542/peds.2010-0651; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Button TMM, 2007, EARLY HUM DEV, V83, P727, DOI 10.1016/j.earlhumdev.2007.07.006; Castle Lon, 2007, J Atten Disord, V10, P335, DOI 10.1177/1087054707299597; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; CHEN WJ, 1994, J CONSULT CLIN PSYCH, V62, P1017, DOI 10.1037/0022-006X.62.5.1017; Crampton SJ, 2011, J NEUROCHEM; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Entringer S, 2011, DIABETES, V60, pA118; Entringer S, 2010, CURR OPIN ENDOCRINOL, V17, P507, DOI 10.1097/MED.0b013e3283405921; Epstein JN, 2003, J ABNORM CHILD PSYCH, V31, P543, DOI 10.1023/A:1025405216339; Froehlich TE, 2011, CURR PSYCHIAT REP; Glover V, 2011, J CHILD PSYCHOL PSYC, V52, P356, DOI 10.1111/j.1469-7610.2011.02371.x; Golan HM, 2005, NEUROPHARMACOLOGY, V48, P903, DOI 10.1016/j.neuropharm.2004.12.023; Graciarena M, 2010, BRAIN BEHAV IMMUN, V24, P1301, DOI 10.1016/j.bbi.2010.06.005; Grayson BE, 2010, ENDOCRINOLOGY, V151, P1622, DOI 10.1210/en.2009-1019; Huda SS, 2010, SEMIN FETAL NEONAT M, V15, P70, DOI 10.1016/j.siny.2009.09.006; Huizink AC, 2006, NEUROSCI BIOBEHAV R, V30, P24, DOI 10.1016/j.neubiorev.2005.04.005; Institute of Medicine (IOM), 2009, WEIGHT GAIN PREGN RE; Konycheva G, 2011, NUTR RES, V31, P790, DOI 10.1016/j.nutres.2011.09.015; Kraemer HC, 2003, J AM ACAD CHILD PSY, V42, P1524, DOI 10.1097/00004583-200312000-00022; Lahti J, 2006, J CHILD PSYCHOL PSYC, V47, P1167, DOI 10.1111/j.1469-7610.2006.01661.x; Lampert T L, 2004, J Atten Disord, V8, P63, DOI 10.1177/108705470400800204; Li JO, 2010, EUR CHILD ADOLES PSY, V19, P747, DOI 10.1007/s00787-010-0113-9; Lindstrom K, 2011, PEDIATRICS, V127, P858, DOI 10.1542/peds.2010-1279; Linnet KM, 2006, ARCH DIS CHILD, V91, P655, DOI 10.1136/adc.2005.088872; Linnet KM, 2003, AM J PSYCHIAT, V160, P1028, DOI 10.1176/appi.ajp.160.6.1028; Lu MC, 2004, AM J OBSTET GYNECOL, V191, P691, DOI 10.1016/j.ajog.2004.04.018; Mardones F, 2005, MATERN CHILD NUTR, V1, P77, DOI 10.1111/j.1740-8709.2005.00013.x; Mullane JC, 2009, CHILD NEUROPSYCHOL, V15, P321, DOI 10.1080/09297040802348028; Nigg JT, 2005, BIOL PSYCHIAT, V57, P1424, DOI 10.1016/j.biopsych.2004.11.011; Nomura Y, 2012, ARCH PEDIAT ADOLESC; OBRIEN GD, 1981, AM J OBSTET GYNECOL, V139, P540, DOI 10.1016/0002-9378(81)90514-7; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; Pastor Patricia N, 2008, Vital Health Stat 10, P1; Poelmans G, 2011, AM J PSYCHIAT, V168, P365, DOI 10.1176/appi.ajp.2010.10070948; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Rodriguez A, 2008, INT J OBESITY, V32, P550, DOI 10.1038/sj.ijo.0803741; Rodriguez A, 2010, J CHILD PSYCHOL PSYC, V51, P134, DOI 10.1111/j.1469-7610.2009.02133.x; Sandman Curt A, 2011, Int J Pept, V2011, P837596, DOI 10.1155/2011/837596; Short SJ, 2010, BIOL PSYCHIAT, V67, P965, DOI 10.1016/j.biopsych.2009.11.026; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Sommer KS, 2000, ADOLESCENCE, V35, P87; Swanson JD, 2008, J CHILD PSYCHOL PSYC, V49, P1009, DOI 10.1111/j.1469-7610.2008.02014.x; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Townsend JT, 1983, STOCHASTIC MODELLING; van der Toorn SLM, 2010, EUR CHILD ADOLES PSY, V19, P379, DOI 10.1007/s00787-009-0062-3; Van Lieshout RJ, 2011, OBES REV, V12, pe548, DOI 10.1111/j.1467-789X.2010.00850.x; Vuillermot S, 2010, J NEUROSCI, V30, P1270, DOI 10.1523/JNEUROSCI.5408-09.2010; Wadhwa PD, 2011, CLIN PERINATOL, V38, P351, DOI 10.1016/j.clp.2011.06.007; Wadhwa PD, 2004, AM J OBSTET GYNECOL, V191, P1063, DOI 10.1016/j.ajog.2004.06.070; Wechsler D., 2012, WAIS 4 KASIKIRJA; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Willette AA, 2011, BEHAV BRAIN RES, V219, P108, DOI 10.1016/j.bbr.2010.12.023; World Health Organization, 2009, GLOB DAT BAS BOD MAS; Yan X, 2011, INFLAMM BOWEL DIS, V17, P1513, DOI 10.1002/ibd.21539; Zeisel SH, 2011, SEMIN CELL DEV BIOL, V22, P624, DOI 10.1016/j.semcdb.2011.06.002	71	93	95	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e37758	10.1371/journal.pone.0037758	http://dx.doi.org/10.1371/journal.pone.0037758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719848	Green Published, gold			2022-12-25	WOS:000305350000008
J	Lu, RJ; Yu, XY; Wang, W; Duan, XJ; Zhang, LL; Zhou, WM; Xu, J; Xu, LJ; Hu, Q; Lu, JX; Ruan, L; Wang, Z; Tan, WJ				Lu, Roujian; Yu, Xiaoyan; Wang, Wen; Duan, Xijie; Zhang, Linglin; Zhou, Weimin; Xu, Jin; Xu, Lingjie; Hu, Qin; Lu, Jianxin; Ruan, Li; Wang, Zhong; Tan, Wenjie			Characterization of Human Coronavirus Etiology in Chinese Adults with Acute Upper Respiratory Tract Infection by Real-Time RT-PCR Assays	PLOS ONE			English	Article							HUMAN BOCAVIRUS; CHILDREN; HKU1; ILLNESS; IDENTIFICATION; DIAGNOSIS; VIRUSES; DISEASE; IMPACT; NL63	Background: In addition to SARS associated coronaviruses, 4 non-SARS related human coronaviruses (HCoVs) are recognized as common respiratory pathogens. The etiology and clinical impact of HCoVs in Chinese adults with acute upper respiratory tract infection (URTI) needs to be characterized systematically by molecular detection with excellent sensitivity. Methodology/Principal Findings: In this study, we detected 4 non-SARS related HCoV species by real-time RT-PCR in 981 nasopharyngeal swabs collected from March 2009 to February 2011. All specimens were also tested for the presence of other common respiratory viruses and newly identified viruses, human metapneumovirus (hMPV) and human bocavirus (HBoV). 157 of the 981 (16.0%) nasopharyngeal swabs were positive for HCoVs. The species detected were 229E (96 cases, 9.8%), OC43 (42 cases, 4.3%), HKU1 (16 cases, 1.6%) and NL63 (11 cases, 1.1%). HCoV-229E was circulated in 21 of the 24 months of surveillance. The detection rates for both OC43 and NL63 were showed significantly year-to-year variation between 2009/10 and 2010/11, respectively (P<0.001 and P = 0.003), and there was a higher detection frequency of HKU1 in patients aged over 60 years (P = 0.03). 48 of 157(30.57%) HCoV positive patients were co-infected. Undifferentiated human rhinoviruses and influenza (Flu) A were the most common viruses detected (more than 35%) in HCoV co-infections. Respiratory syncytial virus (RSV), human parainfluenza virus (PIV) and HBoV were detected in very low rate (less than 1%) among adult patients with URTI. Conclusions/Significance: All 4 non-SARS-associated HCoVs were more frequently detected by real-time RT-PCR assay in adults with URTI in Beijing and HCoV-229E led to the most prevalent infection. Our study also suggested that all non-SARS-associated HCoVs contribute significantly to URTI in adult patients in China.	[Lu, Roujian; Yu, Xiaoyan; Wang, Wen; Zhang, Linglin; Zhou, Weimin; Hu, Qin; Ruan, Li; Tan, Wenjie] China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Duan, Xijie; Xu, Jin; Xu, Lingjie; Wang, Zhong] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Yu, Xiaoyan; Hu, Qin; Lu, Jianxin] Wenzhou Med Coll, Minist Educ, Key Lab Lab Med, Zhejiang, Peoples R China; [Yu, Xiaoyan; Hu, Qin; Lu, Jianxin] Wenzhou Med Coll, Inst Med Virol, Zhejiang, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Wenzhou Medical University; Wenzhou Medical University	Lu, RJ (corresponding author), China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	wangzhong523@vip.163.com; tanwj28@yahoo.cn			National Natural Science Foundation of China [81100062]; 973 Program of China [2011CB504704]; Control and Prevention of Major Infectious Diseases Program in China [2011ZX10004-001]; China-Australia Health and HIV/AIDS Facility [CAHHF EID07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program of China(National Basic Research Program of China); Control and Prevention of Major Infectious Diseases Program in China; China-Australia Health and HIV/AIDS Facility	This work was funded by the Project of the National Natural Science Foundation of China (81100062); 973 Program of China (Grant numbers: 2011CB504704); the Control and Prevention of Major Infectious Diseases Program in China (2011ZX10004-001) and China-Australia Health and HIV/AIDS Facility (CAHHF EID07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellei N, 2008, J MED VIROL, V80, P1824, DOI 10.1002/jmv.21295; Dare RK, 2007, J INFECT DIS, V196, P1321, DOI 10.1086/521308; Dominguez SR, 2009, J MED VIROL, V81, P1597, DOI 10.1002/jmv.21541; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Druce J, 2005, J MED VIROL, V75, P122, DOI 10.1002/jmv.20246; Esper F, 2006, EMERG INFECT DIS, V12, P775, DOI 10.3201/eid1205.051316; Esposito S, 2006, J MED VIROL, V78, P1609, DOI 10.1002/jmv.20745; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P6212, DOI 10.1073/pnas.0400762101; Garbino J, 2006, CLIN INFECT DIS, V43, P1009, DOI 10.1086/507898; Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10; Gerna G, 2007, J CLIN VIROL, V38, P244, DOI 10.1016/j.jcv.2006.12.008; Gorse GJ, 2009, J INFECT DIS, V199, P847, DOI 10.1086/597122; Greenberg SB, 2011, SEMIN RESP CRIT CARE, V32, P433, DOI 10.1055/s-0031-1283283; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; Koetz A, 2006, CLIN MICROBIOL INFEC, V12, P1089, DOI 10.1111/j.1469-0691.2006.01506.x; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kuypers J, 2007, PEDIATRICS, V119, pE70, DOI 10.1542/peds.2006-1406; Lau SKP, 2006, J CLIN MICROBIOL, V44, P2063, DOI 10.1128/JCM.02614-05; Mackay IM, 2003, J CLIN MICROBIOL, V41, P100, DOI 10.1128/JCM.41.1.100-105.2003; Mahony JB, 2011, CRIT REV CL LAB SCI, V48, P217, DOI 10.3109/10408363.2011.640976; Makela MJ, 1998, J CLIN MICROBIOL, V36, P539; Manning A, 2006, J INFECT DIS, V194, P1283, DOI 10.1086/508219; Nokso-Koivisto J, 2000, PEDIATR INFECT DIS J, V19, P164, DOI 10.1097/00006454-200002000-00016; Pene F, 2003, CLIN INFECT DIS, V37, P929, DOI 10.1086/377612; Pyrc K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032582; Ren LL, 2011, J MED VIROL, V83, P291, DOI 10.1002/jmv.21956; Risku M, 2010, J CLIN VIROL, V48, P27, DOI 10.1016/j.jcv.2010.02.013; Shao XP, 2007, J CLIN VIROL, V40, P207, DOI 10.1016/j.jcv.2007.08.007; Sloots TP, 2006, J CLIN VIROL, V35, P99, DOI 10.1016/j.jcv.2005.09.008; Suzuki A, 2005, PEDIATR INFECT DIS J, V24, P645, DOI 10.1097/01.inf.0000168846.71517.ee; Talbot HKB, 2009, J MED VIROL, V81, P853, DOI 10.1002/jmv.21443; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; Vabret A, 2003, CLIN INFECT DIS, V36, P985, DOI 10.1086/374222; Vabret A, 2008, J PAEDIATR CHILD H, V44, P176, DOI 10.1111/j.1440-1754.2007.01246.x; van der Hoek L, 2005, PLOS MED, V2, P764, DOI 10.1371/journal.pmed.0020240; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Yu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032174	38	47	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38638	10.1371/journal.pone.0038638	http://dx.doi.org/10.1371/journal.pone.0038638			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719912	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350000018
J	Zhang, L; Cheng, DX; Tao, N; Zhao, M; Zhang, F; Yuan, YL; Qiu, XP				Zhang, Li; Cheng, Dangxiao; Tao, Ning; Zhao, Min; Zhang, Fan; Yuan, Yulin; Qiu, Xiaoping			Distribution of HLA-A, -B and-DRB1 Genes and Haplotypes in the Tujia Population Living in the Wufeng Region of Hubei Province, China	PLOS ONE			English	Article							FREQUENCIES	Background: The distribution of HLA alleles and haplotypes varies widely between different ethnic populations and geographic areas. Before any genetic marker can be used in a disease-associated study it is therefore essential to investigate allelic frequencies and establish a genetic database. Methodology/Principal Findings: This is the first report of HLA typing in the Tujia group using the Luminex HLA-SSO method HLA-A, -B and -DRB1 allelic distributions were determined in 124 unrelated healthy Tujia individuals, and haplotypic frequencies and linkage disequilibrium parameters were estimated using the maximum-likelihood method. In total 10 alleles were detected at the HLA-A locus, 21 alleles at the HLA-B locus and 14 alleles at the HLA-DRB1 locus. The most frequently observed alleles in the HLA-I group were HLA-A*02 (35.48%), A*11 (28.23%), A*24 (15.73%); HLA-B*40 (25.00%), B*46 (16.13%), and B*15 (15.73%). Among HLA-DRB1 alleles, high frequencies of HLA-DRB1*09 (25.81%) were observed, followed by HLA-DRB1*15 (12.9%), and DRB1*12 (10.89%). The two-locus haplotypes at the highest frequency were A*02-B*46A (8.47%), followed by A*11-B*40 (7.66%), A*02-B*40 (8.87%), A*11-B*15 (6.45%), A*02-B*15 (6.05%), B*40-DRB1*09 (9.27%) and B*46-DRB1*09 (6.45%). The most common three-locus haplotypes found in the Tujia population were A*02-B*46-DRB1*09 (4.84%) and A*02-B*40-DRB1*09 (4.03%). Fourteen two-loci haplotypes had significant linkage disequilibrium. Construction of a neighbor-joining phylogenetic tree and principal component analysis using the allelic frequencies at HLA-A was performed to compare the Tujia group and twelve other previously reported populations. The Tujia population in the Wufeng of Hubei Province had the closest genetic relationship with the central Han population, and then to the Shui, the Miao, the southern Han and the northern Han ethnic groups. Conclusions/Significance: These results will become a valuable source of data for tracing population migration, planning clinical organ transplantation, carrying out HLA-linked disease-associated studies and forensic identification.	[Zhang, Li; Zhao, Min; Qiu, Xiaoping] Wuhan Univ, Sch Med, Inst Virol, Wuhan 430072, Hubei, Peoples R China; [Cheng, Dangxiao] Univ Toronto, Toronto, ON, Canada; [Tao, Ning] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China; [Zhang, Fan] Wuhan Univ, Zhongnan Hosp, Wuhan 430072, Hubei, Peoples R China; [Yuan, Yulin] Wuhan Univ, Sch Med, Dept Dissect, Wuhan 430072, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Wuhan University; University of Toronto; Chinese Academy of Sciences; Institute of Biophysics, CAS; Wuhan University; Wuhan University	Qiu, XP (corresponding author), Wuhan Univ, Sch Med, Inst Virol, Wuhan 430072, Hubei, Peoples R China.	xpingqiu429@gmail.com	Tao, Ning/AAK-7068-2021	Tao, Ning/0000-0002-0021-4995	National Nature Science Foundation of China [30872935]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Nature Science Foundation of China (No, 30872935). Web of the National Nature Science Foundation of China is http://www.nsfc.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boquan H, 1999, GUIZHOU ETHINIC STUD, V78, P83; Chao D, 2004, ETHNO NATL STUD, V6, P1; Chen S, 2007, HUM IMMUNOL, V68, P928, DOI 10.1016/j.humimm.2007.09.006; Chun-mei S, 2010, PLOS ONE, V5; Chunmei S, 2008, J 4 MIL MED U, V29, P1540; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Guang Dan P, 1995, ETHNOLOGICAL CORPORA; HATTEMER HH, 1982, THEOR APPL GENET, V62, P219, DOI 10.1007/BF00276242; Ivanova M, 2002, TISSUE ANTIGENS, V60, P496, DOI 10.1034/j.1399-0039.2002.600605.x; Lee J, 1990, HLA SYSTEM NEW APPRO, V6, P141; Qiu XP, 2011, ASIAN PAC J CANCER P, V12, P2597; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shankarkumar U, 2003, TISSUE ANTIGENS, V62, P542, DOI 10.1046/j.1399-0039.2003.00118.x; Shaw CK, 1999, TISSUE ANTIGENS, V53, P51, DOI 10.1034/j.1399-0039.1999.530106.x; Shengzhong Z, 2001, J HUBEI U NATL PHYLO, V19, P51; Shi L, 2010, INT J IMMUNOGENET, V37, P467, DOI 10.1111/j.1744-313X.2010.00949.x; Xie Xuan-Hua, 2004, Acta Genetica Sinica, V31, P1023; [赵桐茂 Zhao Tongmao], 2003, [中国输血杂志, Chinese Journal of Blood Transfusion], V16, P381; Zou Jie, 2011, Fudan Xuebao (Yixueban), V38, P204, DOI 10.3969/j.issn.1672-8467.2011.03.004	19	4	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38774	10.1371/journal.pone.0038774	http://dx.doi.org/10.1371/journal.pone.0038774			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719940	Green Published, Green Submitted, gold			2022-12-25	WOS:000305347800017
J	Goll, J; Thiagarajan, M; Abubucker, S; Huttenhower, C; Yooseph, S; Methe, BA				Goll, Johannes; Thiagarajan, Mathangi; Abubucker, Sahar; Huttenhower, Curtis; Yooseph, Shibu; Methe, Barbara A.			A Case Study for Large-Scale Human Microbiome Analysis Using JCVI's Metagenomics Reports (METAREP)	PLOS ONE			English	Article							OCEAN SAMPLING EXPEDITION; PROTEIN GLYCOSYLATION; GENE; PYRUVATE; CATALOG; GENOMES; TOOL	As metagenomic studies continue to increase in their number, sequence volume and complexity, the scalability of biological analysis frameworks has become a rate-limiting factor to meaningful data interpretation. To address this issue, we have developed JCVI Metagenomics Reports (METAREP) as an open source tool to query, browse, and compare extremely large volumes of metagenomic annotations. Here we present improvements to this software including the implementation of a dynamic weighting of taxonomic and functional annotation, support for distributed searches, advanced clustering routines, and integration of additional annotation input formats. The utility of these improvements to data interpretation are demonstrated through the application of multiple comparative analysis strategies to shotgun metagenomic data produced by the National Institutes of Health Roadmap for Biomedical Research Human Microbiome Project (HMP) (http://nihroadmap.nih.gov). Specifically, the scalability of the dynamic weighting feature is evaluated and established by its application to the analysis of over 400 million weighted gene annotations derived from 14 billion short reads as predicted by the HMP Unified Metabolic Analysis Network (HUMAnN) pipeline. Further, the capacity of METAREP to facilitate the identification and simultaneous comparison of taxonomic and functional annotations including biological pathway and individual enzyme abundances from hundreds of community samples is demonstrated by providing scenarios that describe how these data can be mined to answer biological questions related to the human microbiome. These strategies provide users with a reference of how to conduct similar large-scale metagenomic analyses using METAREP with their own sequence data, while in this study they reveal insights into the nature and extent of variation in taxonomic and functional profiles across body habitats and individuals. Over one thousand HMP WGS datasets and the latest open source code are available at http://www.jcvi.org/hmp-metarep.	[Goll, Johannes; Thiagarajan, Mathangi; Methe, Barbara A.] J Craig Venter Inst, Rockville, MD USA; [Yooseph, Shibu] J Craig Venter Inst, San Diego, CA USA; [Abubucker, Sahar] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA; [Huttenhower, Curtis] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	J. Craig Venter Institute; J. Craig Venter Institute; Washington University (WUSTL); Harvard University; Harvard T.H. Chan School of Public Health	Goll, J (corresponding author), J Craig Venter Inst, Rockville, MD USA.	bmethe@jcvi.org		Huttenhower, Curtis/0000-0002-1110-0096; Yooseph, Shibu/0000-0001-5581-5002	National Institutes of Health [N01 AI 30071, U54-AI084844]; Genome Institute at the Washington University School of Medicine [U54HG004968]; Harvard School of Public Health [1R01HG005969]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968, R01HG005969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI084844] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genome Institute at the Washington University School of Medicine; Harvard School of Public Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by National Institutes of Health (http://www.nih.gov/) contracts and grants: J. Craig Venter Institute (contract # N01 AI 30071 and award # U54-AI084844); Genome Institute at the Washington University School of Medicine (award # U54HG004968); Harvard School of Public Health (award # 1R01HG005969). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Abubucker S, METABOLIC R IN PRESS; [Anonymous], HIGH THROUG IN PRESS; Arnau J, 1997, J BACTERIOL, V179, P5884, DOI 10.1128/jb.179.18.5884-5891.1997; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bertin PN, 2011, ISME J; Buckel W, 2006, ANNU REV MICROBIOL, V60, P27, DOI 10.1146/annurev.micro.60.080805.142216; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Cardenas E, 2010, APPL ENVIRON MICROB, V76, P6778, DOI 10.1128/AEM.01097-10; Caspi R, 2011, NUCL ACIDS RES; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DATTA A, 1991, BIOCHEM BIOPH RES CO, V176, P517, DOI 10.1016/0006-291X(91)90955-7; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Eddy Sean R, 2009, Genome Inform, V23, P205; Fell DA, 2000, NAT BIOTECHNOL, V18, P1121, DOI 10.1038/81025; Feng XY, 2010, J BIOL CHEM, V285, P39544, DOI 10.1074/jbc.M110.162958; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI 10.4056/sigs.1433550; Glass EM, 2010, COLD SPRING HARB PRO, V2010; Goll J, 2010, BIOINFORMATICS, V26, P2631, DOI 10.1093/bioinformatics/btq455; Hassan BH, 2011, J BIOL CHEM, V286, P8263, DOI 10.1074/jbc.M110.194191; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Keitel J, COMPREHENSI IN PRESS; Leibig M, 2011, J BACTERIOL, V193, P952, DOI 10.1128/JB.01161-10; Mager DL, 2003, J CLIN PERIODONTOL, V30, P644, DOI 10.1034/j.1600-051X.2003.00376.x; Martinez JL, 2011, FEMS MICROBIOL REV, V35, P768, DOI 10.1111/j.1574-6976.2011.00282.x; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Orvis J, 2010, BIOINFORMATICS, V26, P1488, DOI 10.1093/bioinformatics/btq167; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Szymanski CM, 2002, INFECT IMMUN, V70, P2242, DOI 10.1128/IAI.70.4.2242-2244.2002; Tanenbaum DM, 2010, STAND GENOMIC SCI, V2, P229, DOI 10.4056/sigs.651139; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yooseph S, 2007, PLOS BIOL, V5, pe16, DOI DOI 10.1371/journal.pbio.0050016	43	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e29044	10.1371/journal.pone.0029044	http://dx.doi.org/10.1371/journal.pone.0029044			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719821	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341900004
J	Holland, JT; Harper, JC; Dolan, PL; Manginell, MM; Arango, DC; Rawlings, JA; Apblett, CA; Brozik, SM				Holland, J. Todd; Harper, Jason C.; Dolan, Patricia L.; Manginell, Monica M.; Arango, Dulce C.; Rawlings, Julia A.; Apblett, Christopher A.; Brozik, Susan M.			Rational Redesign of Glucose Oxidase for Improved Catalytic Function and Stability	PLOS ONE			English	Article							DIRECTED EVOLUTION; ELECTROCHEMICAL OXIDATION; PLATINUM-ELECTRODES; HYDROGEN-PEROXIDE; PENICILLIUM AMAGASAKIENSE; ASPERGILLUS-NIGER; BIOFUEL CELL; ENZYMES; DEHYDROGENASE; MECHANISM	Glucose oxidase (GOx) is an enzymatic workhorse used in the food and wine industries to combat microbial contamination, to produce wines with lowered alcohol content, as the recognition element in amperometric glucose sensors, and as an anodic catalyst in biofuel cells. It is naturally produced by several species of fungi, and genetic variants are known to differ considerably in both stability and activity. Two of the more widely studied glucose oxidases come from the species Aspergillus niger (A. niger) and Penicillium amagasakiense (P. amag.), which have both had their respective genes isolated and sequenced. GOx from A. niger is known to be more stable than GOx from P. amag., while GOx from P. amag. has a six-fold superior substrate affinity (K-M) and nearly four-fold greater catalytic rate (k(cat)). Here we sought to combine genetic elements from these two varieties to produce an enzyme displaying both superior catalytic capacity and stability. A comparison of the genes from the two organisms revealed 17 residues that differ between their active sites and cofactor binding regions. Fifteen of these residues in a parental A. niger GOx were altered to either mirror the corresponding residues in P. amag. GOx, or mutated into all possible amino acids via saturation mutagenesis. Ultimately, four mutants were identified with significantly improved catalytic activity. A single point mutation from threonine to serine at amino acid 132 (mutant T132S, numbering includes leader peptide) led to a three-fold improvement in k(cat) at the expense of a 3% loss of substrate affinity (increase in apparent K-M for glucose) resulting in a specify constant (k(cat)/K-M) of 23.8 (mM(-1) . s(-1)) compared to 8.39 for the parental (A. niger) GOx and 170 for the P. amag. GOx. Three other mutant enzymes were also identified that had improvements in overall catalysis: V42Y, and the double mutants T132S/T56V and T132S/V42Y, with specificity constants of 31.5, 32.2, and 31.8 mM(-1) . s(-1), respectively. The thermal stability of these mutants was also measured and showed moderate improvement over the parental strain.	[Holland, J. Todd; Harper, Jason C.; Dolan, Patricia L.; Manginell, Monica M.; Arango, Dulce C.; Rawlings, Julia A.; Apblett, Christopher A.; Brozik, Susan M.] Sandia Natl Labs, Albuquerque, NM 87185 USA	United States Department of Energy (DOE); Sandia National Laboratories	Brozik, SM (corresponding author), Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA.	smbrozi@sandia.gov			Sandia National Laboratories (SNL) Lab Directed Research and Development Program (LDRD); U.S. Department of Energy's National Nuclear Security Administration [DE-AC04-94AL85000]	Sandia National Laboratories (SNL) Lab Directed Research and Development Program (LDRD); U.S. Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration)	This study was funded by the Sandia National Laboratories (SNL) Lab Directed Research and Development Program (LDRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Blake Simmons, Suzanne Ma, Julia Crawford-Dibble, and Joanne Volponi at SNL CA and Swapnil Chhabra (Lawrence Berkeley National Laboratory) for discussion and collaboration as part of the Bio Micro Fuel Cell (B mu FC) Laboratory Directed Research and Development (LDRD) Grand Challenge. Sandia National Laboratories is a multi-program laboratory operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Company, for the U.S. Department of Energy's National Nuclear Security Administration under contract DE-AC04-94AL85000.	Bao LL, 2002, ANAL CHEM, V74, P1144, DOI 10.1021/ac0106086; Bornscheuer UT, 1998, ANGEW CHEM INT EDIT, V37, P3105, DOI 10.1002/(SICI)1521-3773(19981204)37:22<3105::AID-ANIE3105>3.0.CO;2-#; Chen LQ, 2002, BIOSENS BIOELECTRON, V17, P851, DOI 10.1016/S0956-5663(02)00051-9; Glieder A, 2002, NAT BIOTECHNOL, V20, P1135, DOI 10.1038/nbt744; Hall SB, 1998, ELECTROCHIM ACTA, V43, P2015, DOI 10.1016/S0013-4686(97)10116-5; Hall SB, 1999, ELECTROCHIM ACTA, V44, P2455, DOI 10.1016/S0013-4686(98)00369-7; Hall SB, 1998, ELECTROCHIM ACTA, V43, P579, DOI 10.1016/S0013-4686(97)00125-4; Hall SB, 1999, ELECTROCHIM ACTA, V44, P4573, DOI 10.1016/S0013-4686(99)00183-8; Halliwell CM, 2002, BIOELECTROCHEMISTRY, V55, P21, DOI 10.1016/S1567-5394(01)00172-4; KALISZ HM, 1991, BIOCHIM BIOPHYS ACTA, V1080, P138, DOI 10.1016/0167-4838(91)90140-U; Kalisz HM, 1997, APPL MICROBIOL BIOT, V47, P502, DOI 10.1007/s002530050963; Kiess M, 1998, EUR J BIOCHEM, V252, P90, DOI 10.1046/j.1432-1327.1998.2520090.x; Lin ZL, 1999, BIOTECHNOL PROGR, V15, P467, DOI 10.1021/bp990037r; Lutz S, 2004, CURR OPIN BIOTECH, V15, P291, DOI 10.1016/j.copbio.2004.05.004; Meyer M, 1998, J COMPUT AID MOL DES, V12, P425, DOI 10.1023/A:1008020124326; Orville AM, 2009, BIOCHEMISTRY-US, V48, P720, DOI 10.1021/bi801918u; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; Sun LH, 2002, CHEMBIOCHEM, V3, P781, DOI 10.1002/1439-7633(20020802)3:8<781::AID-CBIC781>3.0.CO;2-8; Wong TS, 2003, CURR OPIN BIOTECH, V14, P590, DOI 10.1016/j.copbio.2003.09.008; YANG L, 1995, ANAL CHEM, V67, P1326, DOI 10.1021/ac00104a005; Zhao HM, 1999, PROTEIN ENG, V12, P47, DOI 10.1093/protein/12.1.47; Zhu Ziwei, 2007, Biotechnology Journal, V2, P241, DOI 10.1002/biot.200600185; Zhu ZW, 2006, BIOSENS BIOELECTRON, V21, P2046, DOI 10.1016/j.bios.2005.11.018	24	21	26	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e37924	10.1371/journal.pone.0037924	http://dx.doi.org/10.1371/journal.pone.0037924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719855	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900016
J	Kozlov, IA; Thomsen, ER; Munchel, SE; Villegas, P; Capek, P; Gower, AJ; Pond, SJK; Chudin, E; Chee, MS				Kozlov, Igor A.; Thomsen, Elliot R.; Munchel, Sarah E.; Villegas, Patricia; Capek, Petr; Gower, Austin J.; Pond, Stephanie J. K.; Chudin, Eugene; Chee, Mark S.			A Highly Scalable Peptide-Based Assay System for Proteomics	PLOS ONE			English	Article							IN-VITRO SELECTION; HEPATITIS-C VIRUS; MESSENGER-RNA DISPLAY; PHAGE DISPLAY; TYROSINE PHOSPHORYLATION; PROTEIN-PHOSPHORYLATION; MASS-SPECTROMETRY; COMBINATORIAL SYNTHESIS; CLINICAL-APPLICATIONS; FUNCTIONAL PROTEINS	We report a scalable and cost-effective technology for generating and screening high-complexity customizable peptide sets. The peptides are made as peptide-cDNA fusions by in vitro transcription/translation from pools of DNA templates generated by microarray-based synthesis. This approach enables large custom sets of peptides to be designed in silico, manufactured cost-effectively in parallel, and assayed efficiently in a multiplexed fashion. The utility of our peptide-cDNA fusion pools was demonstrated in two activity-based assays designed to discover protease and kinase substrates. In the protease assay, cleaved peptide substrates were separated from uncleaved and identified by digital sequencing of their cognate cDNAs. We screened the 3,011 amino acid HCV proteome for susceptibility to cleavage by the HCV NS3/4A protease and identified all 3 known trans cleavage sites with high specificity. In the kinase assay, peptide substrates phosphorylated by tyrosine kinases were captured and identified by sequencing of their cDNAs. We screened a pool of 3,243 peptides against Abl kinase and showed that phosphorylation events detected were specific and consistent with the known substrate preferences of Abl kinase. Our approach is scalable and adaptable to other protein-based assays.	[Kozlov, Igor A.; Thomsen, Elliot R.; Munchel, Sarah E.; Villegas, Patricia; Capek, Petr; Gower, Austin J.; Pond, Stephanie J. K.; Chudin, Eugene; Chee, Mark S.] Prognosys Biosci Inc, La Jolla, CA USA		Kozlov, IA (corresponding author), Prognosys Biosci Inc, La Jolla, CA USA.	ikozlov@prognosysbio.com	Capek, Petr/G-1303-2012		National Institute of General Medical Sciences [R43GM085884, R43GM090392]; National Human Genome Research Institute [HG004284]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R43HG004284, R44HG004284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM085884, R43GM085884, R44GM090392, R43GM090392] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by awards R43GM085884 and R43GM090392 from the National Institute of General Medical Sciences to I. A. K. and HG004284 from the National Human Genome Research Institute to M. S. C. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanchy R, 2008, J PROTEOME RES, V7, P3900, DOI 10.1021/pr800198w; BARTENSCHLAGER R, 1995, J VIROL, V69, P198, DOI 10.1128/JVI.69.1.198-205.1995; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bertschinger J, 2007, PROTEIN ENG DES SEL, V20, P57, DOI 10.1093/protein/gzl055; Beyer M, 2007, SCIENCE, V318, P1888, DOI 10.1126/science.1149751; Blanco-Canosa JB, 2008, ANGEW CHEM INT EDIT, V47, P6851, DOI 10.1002/anie.200705471; Blight KJ, 1998, ANTIVIR THER, V3, P71; Bohmer FD, 2009, BRIT J HAEMATOL, V144, P127, DOI 10.1111/j.1365-2141.2008.07408.x; Bonetta L, 2005, NAT METHODS, V2, P225, DOI 10.1038/nmeth0305-225; Boschetti E, 2009, PROTEOMICS, V9, P1492, DOI 10.1002/pmic.200800389; Breitling F, 2009, MOL BIOSYST, V5, P224, DOI 10.1039/b819850k; Brown KC, 2010, CURR PHARM DESIGN, V16, P1040, DOI 10.2174/138161210790963788; Chen SH, 2005, CURR MED CHEM, V12, P2317, DOI 10.2174/0929867054864769; Chong PK, 2008, PROTEOMICS, V8, P4370, DOI 10.1002/pmic.200800051; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Collins MO, 2007, PROTEOMICS, V7, P2751, DOI 10.1002/pmic.200700145; de Figueiredo P, 2004, PROTEOMICS, V4, P3128, DOI 10.1002/pmic.200300842; Dente L, 1997, J MOL BIOL, V269, P694, DOI 10.1006/jmbi.1997.1073; Diks SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000777; Dinkel H, 2011, NUCLEIC ACIDS RES, V39, pD261, DOI 10.1093/nar/gkq1104; Estephan E, 2009, BIOTECHNOL BIOENG, V104, P1121, DOI 10.1002/bit.22478; Finlay WJJ, 2011, METHODS MOL BIOL, V681, P87, DOI 10.1007/978-1-60761-913-0_6; Frankel A, 2003, CHEM BIOL, V10, P1043, DOI 10.1016/j.chembiol.2003.11.004; George J, 2003, J BIOMOL SCREEN, V8, P72, DOI 10.1177/1087057102239778; Goto Y, 2011, NAT PROTOC, V6, P779, DOI 10.1038/nprot.2011.331; HAHM B, 1995, J VIROL, V69, P2534, DOI 10.1128/JVI.69.4.2534-2539.1995; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Hattori S, 2008, EXPERT REV PROTEOMIC, V5, P497, DOI 10.1586/14789450.5.3.497; He M, 2008, NAT METHODS, V5, P175, DOI [10.1038/nmeth.1178, 10.1038/NMETH.1178]; He MY, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.15.e73; Heibeck TH, 2009, J PROTEOME RES, V8, P3852, DOI 10.1021/pr900044c; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Jalal S, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254pl1; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Jorgensen C, 2009, SCIENCE, V326, P1502, DOI 10.1126/science.1176615; Jung JP, 2010, BIOPOLYMERS, V94, P49, DOI 10.1002/bip.21326; Keefe AD, 2001, NATURE, V410, P715, DOI 10.1038/35070613; Kong Y, 2009, J THEOR BIOL, V259, P641, DOI 10.1016/j.jtbi.2009.04.008; Kozlov IA, 2006, COMB CHEM HIGH T SCR, V9, P481, DOI 10.2174/138620706777698535; Kurz M, 2001, CHEMBIOCHEM, V2, P666, DOI 10.1002/1439-7633(20010903)2:9<666::AID-CBIC666>3.0.CO;2-#; Kwong AD, 1999, ANTIVIR RES, V41, P65; Kwong AD, 2011, NAT BIOTECHNOL, V29, P993, DOI 10.1038/nbt.2020; Lahm A, 2002, CURR DRUG TARGETS, V3, P281, DOI 10.2174/1389450023347650; Larman HB, 2011, NAT BIOTECHNOL, V29, P535, DOI 10.1038/nbt.1856; Lee S, 2010, BIOCHEMISTRY-US, V49, P1364, DOI 10.1021/bi901135x; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Mahler M, 2010, ANN NY ACAD SCI, V1183, P267, DOI 10.1111/j.1749-6632.2009.05127.x; Manning Brendan D, 2002, Sci STKE, V2002, ppe49, DOI 10.1126/stke.2002.162.pe49; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; MATTHEWS DJ, 1993, SCIENCE, V260, P1113, DOI 10.1126/science.8493554; Miyamoto-Sato E, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng078; Odegrip R, 2004, P NATL ACAD SCI USA, V101, P2806, DOI 10.1073/pnas.0400219101; Ohta A, 2008, CURR OPIN CHEM BIOL, V12, P159, DOI 10.1016/j.cbpa.2007.12.009; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Paradela A, 2008, J PROTEOME RES, V7, P1809, DOI 10.1021/pr7006544; Parikh K, 2010, CANCER RES, V70, P2575, DOI 10.1158/0008-5472.CAN-09-3989; Peck SC, 2006, PLANT J, V45, P512, DOI 10.1111/j.1365-313X.2005.02613.x; PIELES U, 1989, NUCLEIC ACIDS RES, V17, P285, DOI 10.1093/nar/17.1.285; Piersma SR, 2010, ANAL BIOANAL CHEM, V397, P3163, DOI 10.1007/s00216-010-3784-7; Pogson M, 2009, CURR OPIN BIOTECH, V20, P390, DOI 10.1016/j.copbio.2009.07.003; Ramachandran N, 2004, SCIENCE, V305, P86, DOI 10.1126/science.1097639; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Rothman DM, 2005, TRENDS CELL BIOL, V15, P502, DOI 10.1016/j.tcb.2005.07.003; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Ryan KJ., 2004, SHERRIS MED MICROBIO; Rychlewski L, 2004, J MOL BIOL, V336, P307, DOI 10.1016/j.jmb.2003.12.052; Salomon AR, 2003, P NATL ACAD SCI USA, V100, P443, DOI 10.1073/pnas.2436191100; Scholle MD, 2006, CHEMBIOCHEM, V7, P834, DOI 10.1002/cbic.200500427; Schutkowski M, 2005, CHEMBIOCHEM, V6, P513, DOI 10.1002/cbic.200400314; Sergeeva A, 2006, ADV DRUG DELIVER REV, V58, P1622, DOI 10.1016/j.addr.2006.09.018; Shiryaev SA, 2007, BIOCHEM J, V401, P743, DOI 10.1042/BJ20061136; Shiryaev SA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040029, 10.1371/journal.pone.0035759]; Shivange AV, 2009, CURR OPIN CHEM BIOL, V13, P19, DOI 10.1016/j.cbpa.2009.01.019; Shults MD, 2007, CHEMBIOCHEM, V8, P933, DOI 10.1002/cbic.200600522; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Stadler V, 2008, ANGEW CHEM INT EDIT, V47, P7132, DOI 10.1002/anie.200801616; Steinkuhler C, 1996, J VIROL, V70, P6694; Steuber H, 2010, CURR TOP MED CHEM, V10, P323, DOI 10.2174/156802610790725470; Stuible M, 2008, J BIOL CHEM, V283, P15740, DOI 10.1074/jbc.M710534200; Szardenings M, 2003, J RECEPT SIG TRANSD, V23, P307, DOI 10.1081/RRS-120026973; Takahashi Terry T., 2009, V535, P293, DOI 10.1007/978-1-59745-557-2_17; Tao SC, 2006, NAT BIOTECHNOL, V24, P1253, DOI 10.1038/nbt1249; Tolbert TJ, 2002, ANGEW CHEM INT EDIT, V41, P2171, DOI 10.1002/1521-3773(20020617)41:12<2171::AID-ANIE2171>3.0.CO;2-Q; Ueda T, 2010, METHODS MOL BIOL, V607, P219, DOI 10.1007/978-1-60327-331-2_18; Ullman CG, 2011, BRIEF FUNCT GENOMICS, V10, P125, DOI 10.1093/bfgp/elr010; UY R, 1977, SCIENCE, V198, P890, DOI 10.1126/science.337487; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Wetterstrand KA, 2011, DNA SEQUENCING COSTS; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; Whitney M, 2010, J BIOL CHEM, V285, P22532, DOI 10.1074/jbc.M110.138297; Winssinger N, 2004, CHEM BIOL, V11, P1351, DOI 10.1016/j.chembiol.2004.07.015; Xu LH, 2002, CHEM BIOL, V9, P933, DOI 10.1016/S1074-5521(02)00187-4; Yamagishi Y, 2011, CHEM BIOL, V18, P1562, DOI 10.1016/j.chembiol.2011.09.013; Yang CY, 2008, BIOINFORMATICS, V24, pI14, DOI 10.1093/bioinformatics/btn297; Yen M, 2007, BIOTECHNIQUES, V43, P31, DOI 10.2144/000112502; Yonezawa M, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng119	103	13	38	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e37441	10.1371/journal.pone.0037441	http://dx.doi.org/10.1371/journal.pone.0037441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701568	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340000003
J	Brault, S; Bideau, B; Kulpa, R; Craig, CM				Brault, Sebastien; Bideau, Benoit; Kulpa, Richard; Craig, Cathy M.			Detecting Deception in Movement: The Case of the Side-Step in Rugby	PLOS ONE			English	Article							HUMAN JOINT MOTION; BIOLOGICAL MOTION; ISB RECOMMENDATION; COORDINATE SYSTEMS; VISUAL-PERCEPTION; GAIT PERCEPTION; ANTICIPATION; RECOGNITION; FRAMEWORK; GENDER	Although coordinated patterns of body movement can be used to communicate action intention, they can also be used to deceive. Often known as deceptive movements, these unpredictable patterns of body movement can give a competitive advantage to an attacker when trying to outwit a defender. In this particular study, we immersed novice and expert rugby players in an interactive virtual rugby environment to understand how the dynamics of deceptive body movement influence a defending player's decisions about how and when to act. When asked to judge final running direction, expert players who were found to tune into prospective tau-based information specified in the dynamics of 'honest' movement signals (Centre of Mass), performed significantly better than novices who tuned into the dynamics of 'deceptive' movement signals (upper trunk yaw and out-foot placement) (p<.001). These findings were further corroborated in a second experiment where players were able to move as if to intercept or 'tackle' the virtual attacker. An analysis of action responses showed that experts waited significantly longer before initiating movement (p<.001). By waiting longer and picking up more information that would inform about future running direction these experts made significantly fewer errors (p<.05). In this paper we not only present a mathematical model that describes how deception in body-based movement is detected, but we also show how perceptual expertise is manifested in action expertise. We conclude that being able to tune into the 'honest' information specifying true running action intention gives a strong competitive advantage.	[Brault, Sebastien; Bideau, Benoit; Kulpa, Richard] Univ Rennes 2, Ecole Normale Super Cachan, M2S Mouvement Sport Sante Lab, F-35043 Rennes, France; [Craig, Cathy M.] Queens Univ Belfast, Sch Psychol, Belfast BT7 1NN, Antrim, North Ireland	UDICE-French Research Universities; Universite Paris Saclay; Universite Rennes 2; Queens University Belfast	Brault, S (corresponding author), Univ Rennes 2, Ecole Normale Super Cachan, M2S Mouvement Sport Sante Lab, F-35043 Rennes, France.	sb.brault@gmail.com; cathy.craig@qub.ac.uk	Craig, Cathy/D-9833-2014; Bideau, Benoit/AAD-2052-2020	Craig, Cathy/0000-0001-5509-1120; 	International Doctoral College; European University of Brittany; British Council Alliance Travel fund; European Research Council [210007-TEMPUS_G]	International Doctoral College; European University of Brittany; British Council Alliance Travel fund; European Research Council(European Research Council (ERC)European Commission)	This study was partially supported by the International Doctoral College, European University of Brittany and the British Council Alliance Travel fund and by a Starting Independent Researcher's Grant (210007-TEMPUS_G) awarded by the European Research Council to the last author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abernethy B, 2007, J MOTOR BEHAV, V39, P353, DOI 10.3200/JMBR.39.5.353-368; Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Baker R, 2003, J BIOMECH, V36, P300, DOI 10.1016/S0021-9290(02)00336-6; BARCLAY CD, 1978, PERCEPT PSYCHOPHYS, V23, P145, DOI 10.3758/BF03208295; Bideau B, 2004, NEUROSCI LETT, V372, P119, DOI 10.1016/j.neulet.2004.09.023; Bideau B, 2010, IEEE COMPUT GRAPH, V30, P14, DOI 10.1109/MCG.2009.134; Brault S, 2010, HUM MOVEMENT SCI, V29, P412, DOI 10.1016/j.humov.2009.12.004; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Canal-Bruland R, 2010, HUM MOVEMENT SCI, V29, P94, DOI 10.1016/j.humov.2009.10.001; Craig CM, 2000, NATURE, V405, P295, DOI 10.1038/35012690; CUTTING JE, 1977, B PSYCHONOMIC SOC, V9, P353, DOI 10.3758/BF03337021; Dessing JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013161; Dittrich WH, 1996, PERCEPTION, V25, P727, DOI 10.1068/p250727; Gibson E. J., 1991, ODYSSEY LEARNING PER; Hill H, 2000, PSYCHOL SCI, V11, P223, DOI 10.1111/1467-9280.00245; Hill H, 2001, CURR BIOL, V11, P880, DOI 10.1016/S0960-9822(01)00243-3; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Jackson RC, 2006, ACTA PSYCHOL, V123, P355, DOI 10.1016/j.actpsy.2006.02.002; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Jokisch D, 2006, PERCEPTION, V35, P911, DOI 10.1068/p5540; KOZLOWSKI LT, 1977, PERCEPT PSYCHOPHYS, V21, P575, DOI 10.3758/BF03198740; Lange J, 2006, J VISION, V6, P836, DOI 10.1167/6.8.6; Lee DN, 1998, ECOL PSYCHOL, V10, P221, DOI 10.1207/s15326969eco103&4_4; LEE DN, 1981, NATURE, V293, P293, DOI 10.1038/293293a0; Lee DN, 2001, EXP BRAIN RES, V139, P151, DOI 10.1007/s002210100725; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; McLeod P, 1996, J EXP PSYCHOL HUMAN, V22, P531; Morris PH, 2010, J NONVERBAL BEHAV, V34, P1, DOI 10.1007/s10919-009-0075-0; Multon F, 2008, PRESENCE-VIRTUAL AUG, V17, P17, DOI 10.1162/pres.17.1.17; Palleroni A, 2005, NATURE, V434, P973, DOI 10.1038/434973b; Pollick FE, 2002, VISION RES, V42, P2345, DOI 10.1016/S0042-6989(02)00196-7; Pollick FE, 2001, COGNITION, V82, pB51, DOI 10.1016/S0010-0277(01)00147-0; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; RUNESON S, 1983, J EXP PSYCHOL GEN, V112, P585, DOI 10.1037/0096-3445.112.4.585; Schutz-Bosbach S, 2007, TRENDS COGN SCI, V11, P349, DOI 10.1016/j.tics.2007.06.005; Sebanz N, 2009, PSYCHON B REV, V16, P170, DOI 10.3758/PBR.16.1.170; Stevenage SV, 1999, APPL COGNITIVE PSYCH, V13, P513, DOI 10.1002/(SICI)1099-0720(199912)13:6<513::AID-ACP616>3.0.CO;2-8; Stuart-Fox D, 2005, TRENDS ECOL EVOL, V20, P521, DOI 10.1016/j.tree.2005.08.004; Szamado S, 2000, ANIM BEHAV, V59, P221, DOI 10.1006/anbe.1999.1293; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; Van der Kamp J, 2008, INT J SPORT PSYCHOL, V39, P100; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Zatsiorsky VM, 1990, CONT PROBLEMS BIOMEC, P272	44	80	80	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e37494	10.1371/journal.pone.0037494	http://dx.doi.org/10.1371/journal.pone.0037494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TU	22701569	gold, Green Submitted, Green Published			2022-12-25	WOS:000305337600009
J	Zhong, YM; Li, JM; Wang, JJ; Chen, C; Tran, JTA; Saadi, A; Yu, Q; Le, YZ; Mandal, MNA; Anderson, RE; Zhang, SX				Zhong, Yimin; Li, Jingming; Wang, Joshua J.; Chen, Chen; Tran, Julie-Thu A.; Saadi, Anisse; Yu, Qiang; Le, Yun-zheng; Mandal, Md Nawajes A.; Anderson, Robert E.; Zhang, Sarah X.			X-Box Binding Protein 1 Is Essential for the Anti-Oxidant Defense and Cell Survival in the Retinal Pigment Epithelium	PLOS ONE			English	Article							TRANSCRIPTION FACTOR XBP-1; ENDOPLASMIC-RETICULUM STRESS; MACULAR DEGENERATION; LIGHT DAMAGE; SOD1-DEFICIENT MICE; MOUSE MODEL; ER STRESS; EXPRESSION; DYSFUNCTION; ACTIVATION	Damage to the retinal pigment epithelium (RPE) is an early event in the pathogenesis of age-related macular degeneration (AMD). X-box binding protein 1 (XBP1) is a key transcription factor that regulates endoplasmic reticulum (ER) homeostasis and cell survival. This study aimed to delineate the role of endogenous XBP1 in the RPE. Our results show that in a rat model of light-induced retinal degeneration, XBP1 activation was suppressed in the RPE/choroid complex, accompanied by decreased anti-oxidant genes and increased oxidative stress. Knockdown of XBP1 by siRNA resulted in reduced expression of SOD1, SOD2, catalase, and glutathione synthase and sensitized RPE cells to oxidative damage. Using Cre/LoxP system, we generated a mouse line that lacks XBP1 only in RPE cells. Compared to wildtype littermates, RPE-XBP1 KO mice expressed less SOD1, SOD2, and catalase in the RPE, and had increased oxidative stress. At age 3 months and older, these mice exhibited apoptosis of RPE cells, decreased number of cone photoreceptors, shortened photoreceptor outer segment, reduced ONL thickness, and deficit in retinal function. Electron microscopy showed abnormal ultrastructure, Bruch's membrane thickening, and disrupted basal membrane infolding in XBP1-deficient RPE. These results indicate that XBP1 is an important gene involved in regulation of the anti-oxidant defense in the RPE, and that impaired activation of XBP1 may contribute to RPE dysfunction and cell death during retinal degeneration and AMD.	[Zhong, Yimin; Li, Jingming; Wang, Joshua J.; Chen, Chen; Le, Yun-zheng; Zhang, Sarah X.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Endocrinol & Diabet, Oklahoma City, OK 73190 USA; [Zhong, Yimin; Li, Jingming; Wang, Joshua J.; Chen, Chen; Le, Yun-zheng; Zhang, Sarah X.] Univ Oklahoma, Harold Hamm Diabet Ctr, Oklahoma City, OK USA; [Tran, Julie-Thu A.; Saadi, Anisse; Mandal, Md Nawajes A.; Anderson, Robert E.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK USA; [Tran, Julie-Thu A.; Saadi, Anisse; Mandal, Md Nawajes A.; Anderson, Robert E.] Dean A McGee Eye Inst, Oklahoma City, OK USA; [Le, Yun-zheng; Anderson, Robert E.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA; [Zhang, Sarah X.] Oklahoma Ctr Neurosci, Oklahoma City, OK USA; [Zhong, Yimin] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Sun Yat Sen University	Zhong, YM (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Endocrinol & Diabet, Oklahoma City, OK 73190 USA.	xin-zhang@ouhsc.edu	li, jingming/J-5760-2012	li, jingming/0000-0003-2300-8614; Chen, Chen/0000-0001-6741-7036	National Institutes of Health [EY019949, RR17703, RR024215]; American Diabetes Association [7-11-BS-182]; Oklahoma Center for the Advancement of Science and Technology [HR10-060]; American Health Assistance Foundation [M2010088]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703, P20RR024215] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Oklahoma Center for the Advancement of Science and Technology; American Health Assistance Foundation(BrightFocus Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grants EY019949, RR17703, and RR024215; Research Award 7-11-BS-182 from American Diabetes Association; Research Grant HR10-060 from Oklahoma Center for the Advancement of Science and Technology; and Research Grant M2010088 from American Health Assistance Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazan NG, 2006, ADV EXP MED BIOL, V572, P531; Chou CC, 2008, NANO LETT, V8, P437, DOI 10.1021/nl0723634; CLAUSS IM, 1993, DEV DYNAM, V197, P146, DOI 10.1002/aja.1001970207; Dong CJ, 2002, VISION RES, V42, P1081, DOI 10.1016/S0042-6989(02)00032-9; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Glimcher LH, 2010, ANN RHEUM DIS, V69, P67, DOI 10.1136/ard.2009.119388; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Hao WS, 2002, NAT GENET, V32, P254, DOI 10.1038/ng984; Hashizume K, 2008, AM J PATHOL, V172, P1325, DOI 10.2353/ajpath.2008.070730; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Jablonski MM, 2001, GLIA, V35, P14, DOI 10.1002/glia.1066; Justilien V, 2007, INVEST OPHTH VIS SCI, V48, P4407, DOI 10.1167/iovs.07-0432; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; KLEIN R, 1993, AM J EPIDEMIOL, V137, P190, DOI 10.1093/oxfordjournals.aje.a116659; Le YZ, 2008, INVEST OPHTH VIS SCI, V49, P1248, DOI 10.1167/iovs.07-1105; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Li JM, 2011, J BIOL CHEM, V286, P4912, DOI 10.1074/jbc.M110.199729; Li JM, 2010, DIABETES, V59, P1528, DOI 10.2337/db09-1057; LI LX, 1993, CURR EYE RES, V12, P841, DOI 10.3109/02713689309020389; LILES MR, 1991, ARCH OPHTHALMOL-CHIC, V109, P1285, DOI 10.1001/archopht.1991.01080090111033; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Liu Y, 2009, CELL DEATH DIFFER, V16, P847, DOI 10.1038/cdd.2009.14; Mandal MNA, 2009, FREE RADICAL BIO MED, V46, P672, DOI 10.1016/j.freeradbiomed.2008.12.006; Marc RE, 2008, MOL VIS, V14, P782; Naidoo N, 2008, J NEUROSCI, V28, P6539, DOI 10.1523/JNEUROSCI.5685-07.2008; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; Gavilan MP, 2009, AGING CELL, V8, P654, DOI 10.1111/j.1474-9726.2009.00519.x; Rattner A, 2008, J NEUROSCI, V28, P9880, DOI 10.1523/JNEUROSCI.2401-08.2008; Reimold AM, 1996, J EXP MED, V183, P393, DOI 10.1084/jem.183.2.393; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Sandbach JM, 2001, INVEST OPHTH VIS SCI, V42, P2173; TATE DJ, 1993, INVEST OPHTH VIS SCI, V34, P2348; Tirosh B, 2006, J BIOL CHEM, V281, P5852, DOI 10.1074/jbc.M509061200; Ueki Y, 2008, J NEUROCHEM, V105, P784, DOI 10.1111/j.1471-4159.2007.05180.x; Wang W, 2011, OPHTHALMOL EYE DIS, V3, DOI 10.4137/OED.S7797; Yang LP, 2008, J NEUROSCI RES, V86, P910, DOI 10.1002/jnr.21535; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P5191, DOI 10.1167/iovs.07-0512; Yoshida H, 2007, FEBS J, P274; Zeng LF, 2009, P NATL ACAD SCI USA, V106, P8326, DOI 10.1073/pnas.0903197106	46	45	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38616	10.1371/journal.pone.0038616	http://dx.doi.org/10.1371/journal.pone.0038616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715395	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336800037
J	Schmidt, PM; Sparrow, LG; Attwood, RM; Xiao, XW; Adams, TE; McKimm-Breschkin, JL				Schmidt, Peter M.; Sparrow, Lindsay G.; Attwood, Rebecca M.; Xiao, Xiaowen; Adams, Tim E.; McKimm-Breschkin, Jennifer L.			Taking down the FLAG! How Insect Cell Expression Challenges an Established Tag-System	PLOS ONE			English	Article							TYROSINE-O-SULFATE; MONOCLONAL-ANTIBODY; NEURAMINIDASE INHIBITORS; RECOMBINANT PROTEINS; MASS-SPECTROMETRY; PHAGE DISPLAY; PURIFICATION; IDENTIFICATION; SEQUENCES; PEPTIDES	In 1988 the preceding journal of Nature Biotechnology, Bio/Technology, reported a work by Hopp and co-workers about a new tag system for the identification and purification of recombinant proteins: the FLAG-tag. Beside the extensively used hexa-his tag system the FLAG-tag has gained broad popularity due to its small size, its high solubility, the presence of an internal Enterokinase cleavage site, and the commercial availability of high-affinity anti-FLAG antibodies. Surprisingly, considering the heavy use of FLAG in numerous laboratories world-wide, we identified in insect cells a post-translational modification (PTM) that abolishes the FLAG-anti-FLAG interaction rendering this tag system ineffectual for secreted proteins. The present publication shows that the tyrosine that is part of the crucial FLAG epitope DYK is highly susceptible to sulfation, a PTM catalysed by the enzyme family of Tyrosylprotein-Sulfo-transferases (TPSTs). We showed that this modification can result in less than 20% of secreted FLAG-tagged protein being accessible for purification questioning the universal applicability of this established tag system.	[Schmidt, Peter M.; Sparrow, Lindsay G.; Attwood, Rebecca M.; Xiao, Xiaowen; Adams, Tim E.; McKimm-Breschkin, Jennifer L.] CSIRO Mat Sci & Engn, Parkville, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Schmidt, PM (corresponding author), CSL Ltd, Res Dept, Parkville, Vic, Australia.	Peter.Schmidt@CSL.com.au	Adams, Timothy E/I-6231-2012; McKimm-Breschkin, Jennifer L/D-1880-2013; Schmidt, Peter/V-3882-2019	Adams, Timothy E/0000-0003-3436-0066; Schmidt, Peter/0000-0003-1340-9086; McKimm-Breschkin, Jennifer/0000-0002-2345-6786	National Institute of Allergy and Infectious Diseases (NIAID) [RO1A1062721]; Medical Research Grant from the National Health and Medical Research Council (NHMRC) [595625]; GlaxoSmithKline (GSK) U.K.; GlaxoSmithKline (GSK) Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062721] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Grant from the National Health and Medical Research Council (NHMRC); GlaxoSmithKline (GSK) U.K.; GlaxoSmithKline (GSK) Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grant RO1A1062721 from the National Institute of Allergy and Infectious Diseases (NIAID; http://www.niaid.nih.gov/), Medical Research Grant 595625 from the National Health and Medical Research Council (NHMRC; www.nhmrc.gov.au), and grants from GlaxoSmithKline (GSK) U.K. and Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Drake SK, 2010, INT J BIOCHEM CELL B, V42, P174, DOI 10.1016/j.biocel.2009.10.018; Einhauer A, 2001, J CHROMATOGR A, V921, P25, DOI 10.1016/S0021-9673(01)00831-7; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; EVANS MJ, 1995, J IMMUNOL METHODS, V184, P123, DOI 10.1016/0022-1759(95)00093-P; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Hoffhines AJ, 2006, J BIOL CHEM, V281, P37877, DOI 10.1074/jbc.M609398200; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; Hopp TP, 1996, MOL IMMUNOL, V33, P601, DOI 10.1016/0161-5890(96)00026-0; Johnson GD, 2005, ARCH BIOCHEM BIOPHYS, V444, P7, DOI 10.1016/j.abb.2005.09.011; Kehoe JW, 2006, MOL CELL PROTEOMICS, V5, P2350, DOI 10.1074/mcp.M600314-MCP200; Kehoe JW, 2000, CHEM BIOL, V7, pR57, DOI 10.1016/S1074-5521(00)00093-4; MCKIMMBRESCHKIN JL, 1990, J IMMUNOL METHODS, V135, P277, DOI 10.1016/0022-1759(90)90282-Z; McKimmBreschkin JL, 1996, ANTIMICROB AGENTS CH, V40, P40, DOI 10.1128/AAC.40.1.40; MICELI RM, 1994, J IMMUNOL METHODS, V167, P279, DOI 10.1016/0022-1759(94)90097-3; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Monigatti F, 2006, BBA-PROTEINS PROTEOM, V1764, P1904, DOI 10.1016/j.bbapap.2006.07.002; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Oakley AJ, 2010, J MED CHEM, V53, P6421, DOI 10.1021/jm100621s; PETERS J, 1995, J MOL BIOL, V245, P385, DOI 10.1006/jmbi.1994.0032; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; PRICKETT KS, 1989, BIOTECHNIQUES, V7, P580; Schmidt PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016284; Seibert C, 2008, BIOPOLYMERS, V90, P459, DOI 10.1002/bip.20821; Severs JC, 1999, RAPID COMMUN MASS SP, V13, P1016, DOI 10.1002/(SICI)1097-0231(19990615)13:11<1016::AID-RCM599>3.0.CO;2-5; Slootstra JW, 1997, MOL DIVERS, V2, P156, DOI 10.1007/BF01682203; STANKIEWICZ PJ, 1988, BIOCHEMISTRY-US, V27, P206, DOI 10.1021/bi00401a031; Stetefeld J, 2000, NAT STRUCT BIOL, V7, P772, DOI 10.1038/79006; Stone MJ, 2009, NEW BIOTECHNOL, V25, P299, DOI 10.1016/j.nbt.2009.03.011; SUIKO M, 1988, BIOCHEM BIOPH RES CO, V154, P1094, DOI 10.1016/0006-291X(88)90253-7; TRACEY AS, 1986, P NATL ACAD SCI USA, V83, P609, DOI 10.1073/pnas.83.3.609; Waugh DS, 2005, TRENDS BIOTECHNOL, V23, P316, DOI 10.1016/j.tibtech.2005.03.012; YAGAMI T, 1995, RAPID COMMUN MASS SP, V9, P1335, DOI 10.1002/rcm.1290091403; Yagami T, 2000, J PEPT RES, V56, P239, DOI 10.1034/j.1399-3011.2000.00746.x; Zhang Y, 2011, HUM GENE THER	34	20	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37779	10.1371/journal.pone.0037779	http://dx.doi.org/10.1371/journal.pone.0037779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701579	gold, Green Submitted, Green Published			2022-12-25	WOS:000305348400019
J	Kim, BJ; Yi, SY; Shim, TS; Do, SY; Yu, HK; Park, YG; Kook, YH; Kim, BJ				Kim, Byoung-Jun; Yi, Su-Yeon; Shim, Tae-Sun; Do, Seung Yeon; Yu, Hee-Kyung; Park, Young-Gil; Kook, Yoon-Hoh; Kim, Bum-Joon			Discovery of a Novel hsp65 Genotype within Mycobacterium massiliense Associated with the Rough Colony Morphology	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; COMPLETE GENOME SEQUENCE; NONTUBERCULOUS MYCOBACTERIA; CLINICAL-SIGNIFICANCE; SP NOV.; IDENTIFICATION; GENE; ABSCESSUS; DIFFERENTIATION; STRAINS	So far, genetic diversity among strains within Mycobacterium massiliense has rarely been studied. To investigate the genetic diversity among M. massiliense, we conducted phylogenetic analysis based on hsp65 (603-bp) and rpoB (711-bp) sequences from 65 M. massiliense Korean isolates. We found that hsp65 sequence analysis could clearly differentiate them into two distinct genotypes, Type I and Type II, which were isolated from 35 (53.8%) and 30 patients (46.2%), respectively. The rpoB sequence analysis revealed a total of four genotypes (R-I to R-IV) within M. massiliense strains, three of which (R-I, R-II and R-III) correlated with hsp65 Type I, and other (R-IV), which correlated with Type II. Interestingly, genotyping by the hsp65 method agreed well with colony morphology. Despite some exceptions, Type I and II correlated with smooth and rough colonies, respectively. Also, both types were completely different from one another in terms of MALDI-TOF mass spectrometry profiles of whole lipid. In addition, we developed PCR-restriction analysis (PRA) based on the Hinf I digestion of 644-bp hsp65 PCR amplicons, which enables the two genotypes within M. massiliense to be easily and reliably separated. In conclusion, two distinct hsp65 genotypes exist within M. massiliense strains, which differ from one another in terms of both morphology and lipid profile. Furthermore, our data indicates that Type II is a novel M. massiliense genotype being herein presented for the first time. The disparity in clinical traits between these two hsp65 genotypes needs to be exploited in the future study.	[Kim, Byoung-Jun; Yi, Su-Yeon; Do, Seung Yeon; Kook, Yoon-Hoh; Kim, Bum-Joon] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Canc Res Inst,Inst Endem Dis,SNUMRC, Seoul, South Korea; [Shim, Tae-Sun] Univ Ulsan, Coll Med, Asan Med Ctr, Div Pulm & Crit Care Med,Dept Internal Med, Seoul, South Korea; [Yu, Hee-Kyung; Park, Young-Gil] Korean Natl TB Assoc, Korean Inst TB, Chungcheongbuk Do, South Korea	Seoul National University (SNU); Seoul National University Hospital; University of Ulsan; Asan Medical Center	Kim, BJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Canc Res Inst,Inst Endem Dis,SNUMRC, Seoul, South Korea.	kbumjoon@snu.ac.kr	Kim, Bum Joon/J-2739-2012; Kim, Bum Joon/AGY-4274-2022; Kook, Yoon-Hoh/J-5378-2012	Kim, Bum Joon/0000-0003-0085-6709; 	Ministry for Health, Welfare & Family Affairs, Republic of Korea [A101205]	Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by grant A101205 from the Korean Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2006, INT J SYST EVOL MICR, V56, P133, DOI 10.1099/ijs.0.63969-0; Adekambi T, 2004, J CLIN MICROBIOL, V42, P5493, DOI 10.1128/JCM.42.12.5493-5501.2004; Adekambi T, 2003, J CLIN MICROBIOL, V41, P5699, DOI 10.1128/JCM.41.12.5699-5708.2003; Blauwendraat C, 2012, EUR J CLIN MICROBIOL; BUTLER WR, 1992, J CLIN MICROBIOL, V30, P2698, DOI 10.1128/JCM.30.10.2698-2704.1992; Catherinot E, 2007, INFECT IMMUN, V75, P1055, DOI 10.1128/IAI.00835-06; CDC, 1999, NAT PLAN EL SYPH US, P1; Cho AY, 2010, ANN DERMATOL, V22, P114, DOI 10.5021/ad.2010.22.1.114; Choi GE, 2011, J CLIN MICROBIOL, V49, P1107, DOI 10.1128/JCM.02318-10; Devallois A, 1997, J CLIN MICROBIOL, V35, P2969, DOI 10.1128/JCM.35.11.2969-2973.1997; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; FREGNAN GB, 1962, J BACTERIOL, V83, P819, DOI 10.1128/JB.83.4.819-827.1962; Go-eun Choi，, 2012, Journal of Bacteriology and Virology, V42, P17; Han XY, 2007, AM J CLIN PATHOL, V128, P612, DOI 10.1309/1KB2GKYT1BUEYLB5; Harris KA, 2012, J CLIN MICROBIOL, V50, P1758, DOI 10.1128/JCM.00155-12; Howard ST, 2006, MICROBIOL-SGM, V152, P1581, DOI 10.1099/mic.0.28625-0; Kent PT, 1985, GUIDE LEVEL 3 LAB; Kim B-J, 2012, J BACTERIOLOGY; Kim BJ, 1999, J CLIN MICROBIOL, V37, P1714, DOI 10.1128/JCM.37.6.1714-1720.1999; Kim BJ, 2011, INT J SYST EVOL MICR; Kim BJ, 2012, J BACTERIOL, V194, P2771, DOI 10.1128/JB.00365-12; Kim BJ, 2012, J BACTERIOL, V194, P2750, DOI 10.1128/JB.00295-12; Kim H, 2005, J MICROBIOL METH, V62, P199, DOI 10.1016/j.mimet.2005.02.010; Kim H, 2005, INT J SYST EVOL MICR, V55, P1649, DOI 10.1099/ijs.0.63553-0; Kim HY, 2008, J CLIN MICROBIOL, V46, P3384, DOI 10.1128/JCM.00319-08; Kim HY, 2007, J CLIN MICROBIOL, V45, P3127, DOI 10.1128/JCM.00608-07; Kim Hyejin, 2011, Journal of Bacteriology and Virology, V41, P237; Kim K, 2010, J CLIN MICROBIOL, V48, P3073, DOI 10.1128/JCM.00939-10; Koh WJ, 2006, CHEST, V129, P341, DOI 10.1378/chest.129.2.341; Koh WJ, 2011, AM J RESP CRIT CARE, V183, P405, DOI 10.1164/rccm.201003-0395OC; Koh WJ, 2009, J CLIN MICROBIOL, V47, P3362, DOI 10.1128/JCM.00592-09; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lee H, 2000, J CLIN MICROBIOL, V38, P2966, DOI 10.1128/JCM.38.8.2966-2971.2000; Lee HK, 2010, INT J SYST EVOL MICR, V60, P439, DOI 10.1099/ijs.0.012054-0; Lee H, 2010, MICROBIOL IMMUNOL, V54, P46, DOI 10.1111/j.1348-0421.2009.00184.x; MEIER A, 1994, ANTIMICROB AGENTS CH, V38, P381, DOI 10.1128/AAC.38.2.381; Nakanaga K, 2011, J CLIN MICROBIOL, V49, P613, DOI 10.1128/JCM.00817-10; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Perez E, 2004, J BIOL CHEM, V279, P42574, DOI 10.1074/jbc.M406246200; Petrini B, 2006, SCAND J INFECT DIS, V38, P246, DOI 10.1080/00365540500444652; Pulcini C, 2006, J CLIN MICROBIOL, V44, P3463, DOI 10.1128/JCM.02685-05; Rhoades ER, 2009, J IMMUNOL, V183, P1997, DOI 10.4049/jimmunol.0802181; Ripoll F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-114; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Simmon KE, 2007, J CLIN MICROBIOL, V45, P1978, DOI 10.1128/JCM.00563-07; Soini H, 1997, J CLIN MICROBIOL, V35, P769, DOI 10.1128/JCM.35.3.769-773.1997; TAKEWAKI S, 1994, INT J SYST BACTERIOL, V44, P159, DOI 10.1099/00207713-44-1-159; Tortoli E, 2008, EMERG INFECT DIS, V14, P984, DOI 10.3201/eid1406.080194; Zelazny AM, 2009, J CLIN MICROBIOL, V47, P1985, DOI 10.1128/JCM.01688-08	50	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38420	10.1371/journal.pone.0038420	http://dx.doi.org/10.1371/journal.pone.0038420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693637	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343900040
J	Jeon, J; Leibiger, I; Moede, T; Walter, B; Faul, C; Maiguel, D; Villarreal, R; Guzman, J; Berggren, PO; Mundel, P; Ricordi, C; Merscher-Gomez, S; Fornoni, A				Jeon, Jongmin; Leibiger, Ingo; Moede, Tilo; Walter, Britta; Faul, Christian; Maiguel, Dony; Villarreal, Rodrigo; Guzman, Johanna; Berggren, Per-Olof; Mundel, Peter; Ricordi, Camillo; Merscher-Gomez, Sandra; Fornoni, Alessia			Dynamin-mediated Nephrin Phosphorylation Regulates Glucose-stimulated Insulin Release in Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLIT DIAPHRAGM; TYROSINE PHOSPHORYLATION; ACTIN REORGANIZATION; PROTEIN; KINASE; SECRETION; ENDOCYTOSIS; RECRUITMENT; EXPRESSION; COMPONENT	We have previously demonstrated a role for Nephrin in glucose stimulated insulin release (GSIR). We now hypothesize that Nephrin phosphorylation is required for GSIR and that Dynamin influences Nephrin phosphorylation and function. MIN6-C3 Nephrin-deficient pancreatic beta cells and human islets were transfected with WT-Nephrin or with a mutant Nephrin in which the tyrosine residues responsible for SH2 domain binding were substituted with phenylalanine (3YF-Nephrin). GSIR and live images of Nephrin and vesicle trafficking were studied. Immunoprecipitation experiments and overexpression of WT-Dynamin or dominant negative Dynamin mutant (K44A-Dynamin) in WT-Nephrin, 3YF-Nephrin, or Nephrin siRNA-transfected cells were utilized to study Nephrin-Dynamin interaction. In contrast to WT-Nephrin or to single tyrosine mutants, 3YF-Nephrin did not positively affect GSIR and led to impaired cell-cell contacts and vesicle trafficking. K44A-Dynamin prevented the effect of Nephrin on GSIR in the absence of protein-protein interaction between Nephrin and Dynamin. Nephrin gene silencing abolished the positive effects of WT-Dynamin on GSIR. The effects of protamine sulfate and vanadate on Nephrin phosphorylation and GSIR were studied in MIN6 cells and human islets. WT-Nephrin phosphorylation after glucose occurred at Tyr-1176/1193 and resulted in improved GSIR. On the contrary, protamine sulfate-induced phosphorylation at Tyr-1176/1193/1217 was associated with Nephrin degradation and impaired GSIR. Vanadate, which prevented Nephrin dephosphorylation after glucose stimulation, improved GSIR in human islets and MIN6 cells. In conclusion, Dynamin-dependent Nephrin phosphorylation occurs in response to glucose and is necessary for Nephrin-mediated augmentation of GSIR. Pharmacological modulation of Nephrin phosphorylation may thus facilitate pancreatic beta cell function.	[Jeon, Jongmin; Maiguel, Dony; Villarreal, Rodrigo; Guzman, Johanna; Berggren, Per-Olof; Ricordi, Camillo; Fornoni, Alessia] Univ Miami, L Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA; [Jeon, Jongmin; Walter, Britta; Faul, Christian; Maiguel, Dony; Villarreal, Rodrigo; Guzman, Johanna; Merscher-Gomez, Sandra; Fornoni, Alessia] Univ Miami, L Miller Sch Med, Div Nephrol & Hypertens, Dept Med, Miami, FL 33136 USA; [Leibiger, Ingo; Moede, Tilo; Berggren, Per-Olof] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, SE-17177 Stockholm, Sweden; [Mundel, Peter] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Mundel, Peter] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	University of Miami; University of Miami; Karolinska Institutet; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Fornoni, A (corresponding author), Univ Miami, Miller Sch Med, Diabet Res Inst, 1450 NW 10th Ave, Miami, FL 33136 USA.	afornoni@med.miami.edu	Fornoni, Alessia/F-8350-2013; Faul, Christian/AFL-7858-2022; Faul, Christian/AAG-7800-2022; RICORDI, CAMILLO/AAA-4740-2019	Faul, Christian/0000-0002-7512-0977; Faul, Christian/0000-0002-7512-0977; Ricordi, Camillo/0000-0001-8092-7153; fornoni, Alessia/0000-0002-1313-7773; Berggren, Per-Olof/0000-0001-8991-413X; Moede, Tilo/0000-0002-2045-9244; Merscher, Sandra/0000-0002-4757-7494	National Institutes of Health [DK82636, DK70460, U42 RR016603]; American Diabetes Association [7-09-JF-23]; Forest County Potawatomi Community Foundation; Max and Yetta Karasik Family Foundation; Diabetes Research Institute Foundation; Swedish Research Council; Knut and Alice Wallenberg Foundation; Torsten and Ragnar Soderberg's Foundation; Swedish Diabetes Association; Family Erling-Persson Foundation; Peggy and Harold Katz Family Foundation; City of Hope, Duarte, CA; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR016603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057683, R01DK091218, K08DK082636, U01DK070460] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Forest County Potawatomi Community Foundation; Max and Yetta Karasik Family Foundation; Diabetes Research Institute Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Torsten and Ragnar Soderberg's Foundation; Swedish Diabetes Association; Family Erling-Persson Foundation; Peggy and Harold Katz Family Foundation; City of Hope, Duarte, CA; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK82636, DK70460, and U42 RR016603. This work was also supported by American Diabetes Association Grant 7-09-JF-23, the Forest County Potawatomi Community Foundation, the Max and Yetta Karasik Family Foundation, the Diabetes Research Institute Foundation, the Swedish Research Council, the Knut and Alice Wallenberg Foundation, Torsten and Ragnar Soderberg's Foundation, the Swedish Diabetes Association, the Family Erling-Persson Foundation, the Peggy and Harold Katz Family Foundation, and the City of Hope, Duarte, CA.	Aoudjit Lamine, 2011, J Signal Transduct, V2011, P376543, DOI 10.1155/2011/376543; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; Coward RJM, 2007, DIABETES, V56, P1127, DOI 10.2337/db06-0693; Fan QF, 2009, NEPHRON EXP NEPHROL, V111, pE92, DOI 10.1159/000209209; Fornoni A, 2008, DIABETOLOGIA, V51, P298, DOI 10.1007/s00125-007-0889-4; Fornoni A, 2010, DIABETES, V59, P190, DOI 10.2337/db09-0655; Gaffield MA, 2006, NAT PROTOC, V1, P2916, DOI 10.1038/nprot.2006.476; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; George B, 2012, J CLIN INVEST, V122, P674, DOI 10.1172/JCI60070; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; Heikkila E, 2011, BIOCHEM J, V435, P619, DOI 10.1042/BJ20101599; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; Jaques F, 2008, ENDOCRINOLOGY, V149, P2494, DOI 10.1210/en.2007-0974; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Khoshnoodi J, 2003, AM J PATHOL, V163, P2337, DOI 10.1016/S0002-9440(10)63590-0; Kim Y, 2006, MOL NEUROBIOL, V34, P129, DOI 10.1385/MN:34:2:129; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Lahdenpera J, 2003, KIDNEY INT, V64, P404, DOI 10.1046/j.1523-1755.2003.00097.x; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Lehtonen S, 2004, AM J PATHOL, V165, P923, DOI 10.1016/S0002-9440(10)63354-8; Li H, 2004, J AM SOC NEPHROL, V15, P3006, DOI 10.1097/01.ASN.0000146689.88078.80; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Liu XL, 2004, J AM SOC NEPHROL, V15, P1731, DOI 10.1097/01.ASN.0000129826.28932.FD; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Min L, 2007, J BIOL CHEM, V282, P33530, DOI 10.1074/jbc.M703402200; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Qin XS, 2009, J AM SOC NEPHROL, V20, P2534, DOI 10.1681/ASN.2009010011; Quack I, 2006, P NATL ACAD SCI USA, V103, P14110, DOI 10.1073/pnas.0602587103; Quack I, 2011, J BIOL CHEM, V286, P12959, DOI 10.1074/jbc.M110.204024; Ricordi C, 2004, NAT REV IMMUNOL, V4, P258, DOI 10.1038/nri1332; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Schafer DA, 2004, TRAFFIC, V5, P463, DOI 10.1111/j.1600-0854.2004.00199.x; Sever S, 2007, J CLIN INVEST, V117, P2095, DOI 10.1172/JCI32022; Simons M, 2001, AM J PATHOL, V159, P1069, DOI 10.1016/S0002-9440(10)61782-8; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Tryggvason K, 2006, CELL, V125, P221, DOI 10.1016/j.cell.2006.04.002; Tryggvason K, 1999, J AM SOC NEPHROL, V10, P2440; Uchida K, 2008, KIDNEY INT, V73, P926, DOI [10.1038/ki.2008.19, 10.1038/KI.2008.19]; Venkatareddy M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028710; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Wheeler MB, 1996, ENDOCRINOLOGY, V137, P1340, DOI 10.1210/en.137.4.1340; Wojtusciszyn A, 2008, DIABETOLOGIA, V51, P1843, DOI 10.1007/s00125-008-1103-z; Zhang ZY, 2011, MOL BIOL CELL, V22, P2235, DOI 10.1091/mbc.E10-12-0933; Zhu J, 2008, KIDNEY INT, V73, P556, DOI 10.1038/sj.ki.5002691	52	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28932	28942		10.1074/jbc.M112.389452	http://dx.doi.org/10.1074/jbc.M112.389452			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22718751	Green Published, hybrid			2022-12-25	WOS:000308074600062
J	Kim, HK; Kim, CW; Vo, MT; Lee, HH; Lee, JY; Yoon, NA; Lee, CY; Moon, CH; Min, YJ; Park, JW; Cho, WJ				Kim, Hong Kyeung; Kim, Chae Won; Vo, Mai-Tram; Lee, Hyun Hee; Lee, Ji Young; Yoon, Nal Ae; Lee, Chae Yeong; Moon, Chang Hoon; Min, Young Joo; Park, Jeong Woo; Cho, Wha Ja			Expression of Proviral Integration Site for Moloney Murine Leukemia Virus 1 (Pim-1) Is Post-transcriptionally Regulated by Tristetraprolin in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; MESSENGER-RNA; PROTEIN-KINASES; PROTOONCOGENE PIM-1; HEMATOPOIETIC-CELLS; BINDING-PROTEINS; C-MYC; STABILITY; PHOSPHORYLATION; SURVIVAL	The proviral integration site for Moloney murine leukemia virus 1 (Pim-1) is an oncogenic serine/threonine kinase that is up-regulated in several human cancers, facilitates cell cycle progression, and suppresses apoptosis. Previously, it has been reported that the Pim-1 3'-UTR plays important roles in the regulation of Pim-1 mRNA stability. However, the mechanisms explaining how Pim-1 mRNA stability is determined by its 3'-UTR are not well known. Here, we demonstrate that tristetraprolin (TTP) plays a critical role in the regulation of Pim-1 mRNA stability. Our results show that the level of Pim-1 expression is inversely correlated with TTP expression in human cancer cells. Pim-1 mRNA contains two AU-rich elements (ARE1 and ARE2) in the 3'-UTR. TTP bound to ARE2 and enhanced the decay of Pim-1 mRNA. Overexpression of TTP decreased Pim-1 expression and p21 and p27 phosphorylation and inhibited cell growth. Overexpression of Pim-1 cDNA without the 3'-UTR attenuated the inhibitory effects of TTP on p21 phosphorylation and cell growth. In addition, inhibition of p21 by siRNA attenuated the inhibitory effect of TTP on cell growth. Our results suggest that TTP post-transcriptionally down-regulates Pim-1 expression and that the overexpression of TTP may contribute to tumor suppression in part by down-regulating Pim-1 expression.	[Kim, Hong Kyeung; Kim, Chae Won; Vo, Mai-Tram; Lee, Hyun Hee; Lee, Ji Young; Yoon, Nal Ae; Lee, Chae Yeong; Park, Jeong Woo] Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea; [Moon, Chang Hoon; Min, Young Joo; Cho, Wha Ja] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Biomed Res Ctr, Ulsan 682060, South Korea; [Min, Young Joo] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Internal Med, Ulsan 682060, South Korea	University of Ulsan; University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital	Park, JW (corresponding author), Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea.	jwpark@ulsan.ac.kr; wjcho26@ulsan.ac.kr			Korean Research Foundation [NRF-2008-C00249, BRL-2009-0087350, 2009-0070260, 2010-0023905, 2011-0030746]; Korean Government (MOEHRD); Ministry of Health and Welfare, Korea [A101086]	Korean Research Foundation(National Research Foundation of Korea); Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Ministry of Health and Welfare, Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Korean Research Foundation Grants NRF-2008-C00249, BRL-2009-0087350, 2009-0070260, 2010-0023905, and 2011-0030746 funded by the Korean Government (MOEHRD) and Korean Health 21 R&D Project Grant A101086 from the Ministry of Health and Welfare, Korea.	Adam M, 2006, CANCER RES, V66, P3828, DOI 10.1158/0008-5472.CAN-05-2309; Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Blanco-Aparicio C, 2011, CANCER LETT, V300, P145, DOI 10.1016/j.canlet.2010.09.016; Brault L, 2010, HAEMATOL-HEMATOL J, V95, P1004, DOI 10.3324/haematol.2009.017079; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Cheney IW, 2007, BIOORG MED CHEM LETT, V17, P1679, DOI 10.1016/j.bmcl.2006.12.086; Chiang WF, 2006, INT J ORAL MAX SURG, V35, P740, DOI 10.1016/j.ijom.2006.01.027; Coleman ML, 2003, EMBO J, V22, P2036, DOI 10.1093/emboj/cdg189; CUYPERS HT, 1984, CELL, V37, P141; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; DOMEN J, 1987, ONCOGENE RES, V1, P103; Guo SJ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-161; Holder S, 2007, MOL CANCER THER, V6, P163, DOI 10.1158/1535-7163.MCT-06-0397; Hu XF, 2009, J CLIN INVEST, V119, P362, DOI 10.1172/JCI33216; Jascur T, 2005, MOL CELL, V17, P237, DOI 10.1016/j.molcel.2004.11.049; Kim KT, 2005, BLOOD, V105, P1759, DOI 10.1182/blood-2004-05-2006; Lee HH, 2010, J BIOL CHEM, V285, P17329, DOI 10.1074/jbc.M109.094235; Lee HH, 2010, INT J CANCER, V126, P1817, DOI 10.1002/ijc.24847; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Lilly M, 1997, CANCER RES, V57, P5348; Lin YW, 2010, BLOOD, V115, P824, DOI 10.1182/blood-2009-07-233445; MEEKER TC, 1987, J CELL BIOCHEM, V35, P105, DOI 10.1002/jcb.240350204; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; Scott MT, 2002, EMBO J, V21, P6771, DOI 10.1093/emboj/cdf684; SELTEN G, 1986, CELL, V46, P603, DOI 10.1016/0092-8674(86)90886-X; Shah N, 2008, EUR J CANCER, V44, P2144, DOI 10.1016/j.ejca.2008.06.044; Shyu AB, 2000, CELL, V102, P135, DOI 10.1016/S0092-8674(00)00018-0; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; Wang Z, 2001, J Vet Sci, V2, P167; Wang ZP, 2002, BBA-MOL CELL RES, V1593, P45, DOI 10.1016/S0167-4889(02)00347-6; Warnecke-Eberz U, 2009, ANTICANCER RES, V29, P4451; WINGETT D, 1991, J IMMUNOL, V147, P3653; Xu DP, 2011, CARCINOGENESIS, V32, P488, DOI 10.1093/carcin/bgr007; Young LE, 2009, GASTROENTEROLOGY, V136, P1669, DOI 10.1053/j.gastro.2009.01.010; Zhang Y, 2008, ONCOGENE, V27, P4809, DOI 10.1038/onc.2008.123; Zhang YD, 2007, MOL CANCER RES, V5, P909, DOI 10.1158/1541-7786.MCR-06-0388; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	43	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28770	28778		10.1074/jbc.M112.376483	http://dx.doi.org/10.1074/jbc.M112.376483			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22700982	Green Published, hybrid			2022-12-25	WOS:000308074600050
J	Bai, Y; Liu, SP; Li, JG; Lakshminarayanan, R; Sarawathi, P; Tang, C; Ho, DC; Verma, C; Beuerman, RW; Pervushin, K				Bai, Yang; Liu, Shouping; Li, Jianguo; Lakshminarayanan, Rajamani; Sarawathi, Padmanabhan; Tang, Charles; Ho, Duncun; Verma, Chandra; Beuerman, Roger W.; Pervushin, Konstantin			Progressive Structuring of a Branched Antimicrobial Peptide on the Path to the Inner Membrane Target	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-DEFENSE PEPTIDES; OUTER-MEMBRANE; PORE FORMATION; COMBINATORIAL DESIGN; MECHANISTIC-INSIGHTS; BILAYER STRUCTURE; LIPID-BILAYERS; NMR STRUCTURES; FORCE-FIELD; LIPOPOLYSACCHARIDE	In recent years, interest has grown in the antimicrobial properties of certain natural and non-natural peptides. The strategy of inserting a covalent branch point in a peptide can improve its antimicrobial properties while retaining host biocompatibility. However, little is known regarding possible structural transitions as the peptide moves on the access path to the presumed target, the inner membrane. Establishing the nature of the interactions with the complex bacterial outer and inner membranes is important for effective peptide design. Structure-activity relationships of an amphiphilic, branched antimicrobial peptide (B2088) are examined using environment-sensitive fluorescent probes, electron microscopy, molecular dynamics simulations, and high resolution NMR in solution and in condensed states. The peptide is reconstituted in bacterial outer membrane lipopolysaccharide extract as well as in a variety of lipid media mimicking the inner membrane of Gram-negative pathogens. Progressive structure accretion is observed for the peptide in water, LPS, and lipid environments. Despite inducing rapid aggregation of bacteria-derived lipopolysaccharides, the peptide remains highly mobile in the aggregated lattice. At the inner membranes, the peptide undergoes further structural compaction mediated by interactions with negatively charged lipids, probably causing redistribution of membrane lipids, which in turn results in increased membrane permeability and bacterial lysis. These findings suggest that peptides possessing both enhanced mobility in the bacterial outer membrane and spatial structure facilitating its interactions with the membrane-water interface may provide excellent structural motifs to develop new antimicrobials that can overcome antibiotic-resistant Gram-negative pathogens.	[Bai, Yang; Liu, Shouping; Lakshminarayanan, Rajamani; Sarawathi, Padmanabhan; Beuerman, Roger W.] Singapore Eye Res Inst, Singapore 168751, Singapore; [Bai, Yang; Ho, Duncun; Verma, Chandra; Pervushin, Konstantin] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Li, Jianguo; Verma, Chandra] Bioinformat Inst A STAR, Singapore 138671, Singapore; [Tang, Charles] Singapore Gen Hosp, Dept Pathol, Singapore 169608, Singapore; [Verma, Chandra] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Beuerman, Roger W.] Duke NUS, SRP Neurosci & Behav Disorders, Singapore 168751, Singapore	National University of Singapore; Singapore National Eye Center; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Singapore General Hospital; National University of Singapore; National University of Singapore	Beuerman, RW (corresponding author), Singapore Eye Res Inst, Singapore 168751, Singapore.	rwbeuerman@gmail.com; kpervushin@ntu.edu.sg	Rajamani, Lakshminarayanan/AAG-5541-2019; Pervushin, Konstantin/AAJ-6580-2020	Rajamani, Lakshminarayanan/0000-0001-8214-5315; Pervushin, Konstantin/0000-0002-6393-4340	Flagship (Exploit) funding [X031];  [NIG/NMRC/R753];  [NMRC/TCR/002-SER1/2088R618];  [BMRC-SCAMP-2/08/1/35/19/586R652,]	Flagship (Exploit) funding; ; ; 	This work was supported by NIG/NMRC/R753, NMRC/TCR/002-SER1/2088R618, BMRC-SCAMP-2/08/1/35/19/586R652, and Flagship (Exploit) funding X031. The authors also thank A* STAR Computational Resource Center for providing the computational facilities.	Andra J, 2004, ANTIMICROB AGENTS CH, V48, P1593, DOI 10.1128/AAC.48.5.1593-1599.2004; Bai Y, 2009, BIOCHEMISTRY-US, V48, P7229, DOI 10.1021/bi900670d; Bhattacharjya S, 2009, FEBS J, V276, P6465, DOI 10.1111/j.1742-4658.2009.07357.x; Bhunia A, 2011, J BIOL CHEM, V286, P24394, DOI 10.1074/jbc.M110.189662; Bland JM, 2001, MOL CELL BIOCHEM, V218, P105, DOI 10.1023/A:1007293816634; Bommineni YR, 2007, FEBS J, V274, P418, DOI 10.1111/j.1742-4658.2006.05589.x; Brandenburg K, 1997, BBA-BIOMEMBRANES, V1329, P183, DOI 10.1016/S0005-2736(97)00109-0; Campopiano DJ, 2004, J BIOL CHEM, V279, P48671, DOI 10.1074/jbc.M404690200; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; Dewan PC, 2009, BIOCHEMISTRY-US, V48, P5642, DOI 10.1021/bi900272r; Diebold Y, 2003, INVEST OPHTH VIS SCI, V44, P4263, DOI 10.1167/iovs.03-0560; Easton DM, 2009, TRENDS BIOTECHNOL, V27, P582, DOI 10.1016/j.tibtech.2009.07.004; Eckert R, 2011, FUTURE MICROBIOL, V6, P635, DOI [10.2217/fmb.11.27, 10.2217/FMB.11.27]; Epand RM, 2009, BBA-BIOMEMBRANES, V1788, P289, DOI 10.1016/j.bbamem.2008.08.023; Eun SY, 2006, MOL CELLS, V21, P229; Falciani C, 2007, CHEM BIOL DRUG DES, V69, P216, DOI 10.1111/j.1747-0285.2007.00487.x; Falla TJ, 1996, J BIOL CHEM, V271, P19298, DOI 10.1074/jbc.271.32.19298; Gazit E, 1996, J MOL BIOL, V258, P860, DOI 10.1006/jmbi.1996.0293; Giuliani A, 2011, CELL MOL LIFE SCI, V68, P2255, DOI 10.1007/s00018-011-0717-3; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hallock KJ, 2003, BIOPHYS J, V84, P3052, DOI 10.1016/S0006-3495(03)70031-9; Hamill P, 2008, CURR OPIN BIOTECH, V19, P628, DOI 10.1016/j.copbio.2008.10.006; Hancock R E, 1995, Adv Microb Physiol, V37, P135, DOI 10.1016/S0065-2911(08)60145-9; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Heller WT, 1998, BIOCHEMISTRY-US, V37, P17331, DOI 10.1021/bi981314q; Heller WT, 1997, BIOPHYS J, V73, P239, DOI 10.1016/S0006-3495(97)78064-0; Huang HW, 2000, BIOCHEMISTRY-US, V39, P8347, DOI 10.1021/bi000946l; HUANG HW, 1991, BIOPHYS J, V60, P1079, DOI 10.1016/S0006-3495(91)82144-0; Kaconis Y, 2011, BIOPHYS J, V100, P2652, DOI 10.1016/j.bpj.2011.04.041; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kolusheva S, 2008, PEPTIDES, V29, P1620, DOI 10.1016/j.peptides.2008.05.012; Leptihn S, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-22; Li JG, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3469790; Li P, 2004, J BIOL CHEM, V279, P50150, DOI 10.1074/jbc.M405606200; Li SH, 2010, J PHYS CHEM B, V114, P4063, DOI 10.1021/jp912283r; Liu SP, 2010, INT J PEPT RES THER, V16, P199, DOI 10.1007/s10989-010-9230-z; Liu SP, 2008, CHEMBIOCHEM, V9, P964, DOI 10.1002/cbic.200700560; Liu ZG, 2006, J MED CHEM, V49, P3436, DOI 10.1021/jm0601452; LOH B, 1984, ANTIMICROB AGENTS CH, V26, P546, DOI 10.1128/AAC.26.4.546; LUDTKE SJ, 1994, BBA-BIOMEMBRANES, V1190, P181, DOI 10.1016/0005-2736(94)90050-7; Mackerell AD, 2004, J COMPUT CHEM, V25, P1584, DOI 10.1002/jcc.20082; MacKerell Alexander D. Jr., 2000, Biopolymers, V56, P257, DOI 10.1002/1097-0282(2000)56:4<257::AID-BIP10029>3.0.CO;2-W; Mani R, 2006, BIOCHEMISTRY-US, V45, P8341, DOI 10.1021/bi060305b; Mani R, 2006, P NATL ACAD SCI USA, V103, P16242, DOI 10.1073/pnas.0605079103; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; MORRIS KF, 1992, J AM CHEM SOC, V114, P3139, DOI 10.1021/ja00034a071; Papo N, 2005, J BIOL CHEM, V280, P10378, DOI 10.1074/jbc.M412865200; Pieters RJ, 2007, MED RES REV, V27, P796, DOI 10.1002/med.20089; Pini A, 2007, J PEPT SCI, V13, P393, DOI 10.1002/psc.858; Pini A, 2010, FASEB J, V24, P1015, DOI 10.1096/fj.09-145474; Porcelli F, 2006, BIOCHEMISTRY-US, V45, P5793, DOI 10.1021/bi0601813; Raj PA, 2002, FEMS MICROBIOL LETT, V206, P9, DOI 10.1111/j.1574-6968.2002.tb10979.x; RAPAPORT D, 1991, J BIOL CHEM, V266, P23769; Rapaport D, 1996, BIOPHYS J, V70, P2502, DOI 10.1016/S0006-3495(96)79822-3; Rathinakumar R, 2008, J AM CHEM SOC, V130, P9849, DOI 10.1021/ja8017863; Rathinakumar R, 2009, J AM CHEM SOC, V131, P7609, DOI 10.1021/ja8093247; Rausch JM, 2007, BIOCHEMISTRY-US, V46, P12124, DOI 10.1021/bi700978h; Sass V, 2008, INT J MED MICROBIOL, V298, P619, DOI 10.1016/j.ijmm.2008.01.011; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Schuerholz T, 2012, CRIT CARE, V16, DOI 10.1186/cc11220; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Silvestro L, 1997, BIOCHEMISTRY-US, V36, P11452, DOI 10.1021/bi9630826; Snyder S, 1999, BIOCHEMISTRY-US, V38, P10758, DOI 10.1021/bi990867d; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Tam JP, 2002, EUR J BIOCHEM, V269, P923, DOI 10.1046/j.0014-2956.2001.02728.x; Tamba Y, 2005, BIOCHEMISTRY-US, V44, P15823, DOI 10.1021/bi051684w; Tamba Y, 2009, J PHYS CHEM B, V113, P4846, DOI 10.1021/jp8109622; Tencza SB, 1999, J ANTIMICROB CHEMOTH, V44, P33, DOI 10.1093/jac/44.1.33; Thomas CJ, 1999, J BIOL CHEM, V274, P29624, DOI 10.1074/jbc.274.42.29624; Tossi A, 2000, BIOPOLYMERS, V55, P4; Wang JF, 2004, BIOCHEM BIOPH RES CO, V324, P212, DOI 10.1016/j.bbrc.2004.09.039; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Wu MH, 1999, J BIOL CHEM, V274, P29, DOI 10.1074/jbc.274.1.29; Yesylevskyy SO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000810; Zhang LJ, 2001, J BIOL CHEM, V276, P35714, DOI 10.1074/jbc.M104925200; Zhang LJ, 1999, BIOCHEMISTRY-US, V38, P8102, DOI 10.1021/bi9904104; Zhou L, 2011, AMINO ACIDS, V40, P123, DOI 10.1007/s00726-010-0565-8	79	27	28	4	37	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26606	26617		10.1074/jbc.M112.363259	http://dx.doi.org/10.1074/jbc.M112.363259			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700968	Green Published, hybrid			2022-12-25	WOS:000307386000013
J	Holdsworth, G; Slocombe, P; Doyle, C; Sweeney, B; Veverka, V; Le Riche, K; Franklin, RJ; Compson, J; Brookings, D; Turner, J; Kennedy, J; Garlish, R; Shi, JY; Newnham, L; McMillan, D; Muzylak, M; Carr, MD; Henry, AJ; Ceska, T; Robinson, MK				Holdsworth, Gill; Slocombe, Patrick; Doyle, Carl; Sweeney, Bernadette; Veverka, Vaclav; Le Riche, Kelly; Franklin, Richard J.; Compson, Joanne; Brookings, Daniel; Turner, James; Kennedy, Jeffery; Garlish, Rachael; Shi, Jiye; Newnham, Laura; McMillan, David; Muzylak, Mariusz; Carr, Mark D.; Henry, Alistair J.; Ceska, Thomas; Robinson, Martyn K.			Characterization of the Interaction of Sclerostin with the Low Density Lipoprotein Receptor-related Protein (LRP) Family of Wnt Co-receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; BONE-FORMATION; CATENIN; CANCER; SOST; INHIBITION; MECHANISM; DISEASE; COMPLEX; DOMAIN	LRP5 and LRP6 are proteins predicted to contain four six-bladed beta-propeller domains and both bind the bone-specific Wnt signaling antagonist sclerostin. Here, we report the crystal structure of the amino-terminal region of LRP6 and using NMR show that the ability of sclerostin to bind to this molecule is mediated by the central core of sclerostin and does not involve the amino- and carboxyl-terminal flexible arm regions. We show that this structured core region interacts with LRP5 and LRP6 via an NXI motif (found in the sequence PNAIG) within a flexible loop region (loop 2) within the central core region. This sequence is related closely to a previously identified motif in laminin that mediates its interaction with the beta-propeller domain of nidogen. However, the NXI motif is not involved in the interaction of sclerostin with LRP4 (another beta-propeller containing protein in the LRP family). A peptide derived from the loop 2 region of sclerostin blocked the interaction of sclerostin with LRP5/6 and also inhibited Wnt1 but not Wnt3A or Wnt9B signaling. This suggests that these Wnts interact with LRP6 in different ways.	[Holdsworth, Gill; Slocombe, Patrick; Doyle, Carl; Sweeney, Bernadette; Le Riche, Kelly; Compson, Joanne; Kennedy, Jeffery; Newnham, Laura; McMillan, David; Muzylak, Mariusz; Henry, Alistair J.; Ceska, Thomas; Robinson, Martyn K.] UCB Pharma, Dept Biol, Slough SL1 4EN, Berks, England; [Franklin, Richard J.; Brookings, Daniel; Turner, James; Garlish, Rachael; Robinson, Martyn K.] UCB Pharma, Dept Chem, Slough SL1 4EN, Berks, England; [Shi, Jiye] UCB Pharma, Dept Informat, Slough SL1 4EN, Berks, England; [Veverka, Vaclav; Carr, Mark D.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England	UCB Pharma SA; UCB Pharma SA; UCB Pharma SA; University of Leicester	Robinson, MK (corresponding author), UCB Pharma, Dept Biol, 216 Bath Rd, Slough SL1 4EN, Berks, England.	martyn.robinson@ucb.com	Veverka, Vaclav/P-5251-2019; Veverka, Vaclav/G-9174-2014; Shi, Jiye/G-2745-2012	Veverka, Vaclav/0000-0003-3782-5279; Veverka, Vaclav/0000-0003-3782-5279; Carr, Mark/0000-0002-3939-0996; Shi, Jiye/0000-0002-9628-8680	UCB Pharma	UCB Pharma(UCB Pharma SA)	Supported by UCB Pharma.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; BEIGHTON P, 1988, J MED GENET, V25, P200, DOI 10.1136/jmg.25.3.200; Bourhis E, 2011, STRUCTURE, V19, P1433, DOI 10.1016/j.str.2011.07.005; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Chen JL, 2011, STRUCTURE, V19, P313, DOI 10.1016/j.str.2011.01.010; Chen S, 2011, DEV CELL, V21, P848, DOI 10.1016/j.devcel.2011.09.007; Cheng ZH, 2011, NAT STRUCT MOL BIOL, V18, P1204, DOI 10.1038/nsmb.2139; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Collins MN, 2011, STRUCTURE, V19, P324, DOI 10.1016/j.str.2010.11.017; Coombs GS, 2008, CURR DRUG TARGETS, V9, P513, DOI 10.2174/138945008784911796; Craig TA, 2010, BIOCHEM BIOPH RES CO, V392, P36, DOI 10.1016/j.bbrc.2009.12.143; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Hamersma H, 2003, CLIN GENET, V63, P192, DOI 10.1034/j.1399-0004.2003.00036.x; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Johnson ML, 2005, CRIT REV EUKAR GENE, V15, P229, DOI 10.1615/CritRevEukarGeneExpr.v15.i3.50; Kohler C, 2011, STRUCTURE, V19, P337, DOI 10.1016/j.str.2010.12.022; Krause C, 2010, J BIOL CHEM, V285, P41614, DOI 10.1074/jbc.M110.153890; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu WY, 2010, BIOCHEMISTRY-US, V49, P4635, DOI 10.1021/bi1001486; MacDonald BT, 2008, J BIOL CHEM, V283, P16115, DOI 10.1074/jbc.M800327200; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Pannone G, 2010, ONCOL REP, V24, P1035, DOI 10.3892/or_00000952; Paszty C, 2010, J BONE MINER RES, V25, P1897, DOI 10.1002/jbmr.161; Pendas-Franco N, 2008, ONCOGENE, V27, P4467, DOI 10.1038/onc.2008.88; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rosi MC, 2010, J NEUROCHEM, V112, P1539, DOI 10.1111/j.1471-4159.2009.06566.x; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; Takagi J, 2003, NATURE, V424, P969, DOI 10.1038/nature01873; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Veverka V, 2009, J BIOL CHEM, V284, P10890, DOI 10.1074/jbc.M807994200; Weidauer SE, 2009, BIOCHEM BIOPH RES CO, V380, P160, DOI 10.1016/j.bbrc.2009.01.062	46	64	68	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26464	26477		10.1074/jbc.M112.350108	http://dx.doi.org/10.1074/jbc.M112.350108			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22696217	Green Published, hybrid			2022-12-25	WOS:000307386000001
J	Kaniakova, M; Krausova, B; Vyklicky, V; Korinek, M; Lichnerova, K; Vyklicky, L; Horak, M				Kaniakova, Martina; Krausova, Barbora; Vyklicky, Vojtech; Korinek, Miloslav; Lichnerova, Katarina; Vyklicky, Ladislav; Horak, Martin			Key Amino Acid Residues within the Third Membrane Domains of NR1 and NR2 Subunits Contribute to the Regulation of the Surface Delivery of N-methyl-D-aspartate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL NMDA RECEPTORS; ER RETENTION SIGNAL; ENDOPLASMIC-RETICULUM; CELL-SURFACE; TERMINAL DOMAIN; LURCHER MUTATION; TRAFFICKING; EXPRESSION; CHANNELS; KAINATE	N-methyl-D-aspartate (NMDA) receptors are glutamate ionotropic receptors that play critical roles in synaptic transmission, plasticity, and excitotoxicity. The functional NMDA receptors, heterotetramers composed mainly of two NR1 and two NR2 subunits, likely pass endoplasmic reticulum quality control before they are released from the endoplasmic reticulum and trafficked to the cell surface. However, the mechanism underlying this process is not clear. Using truncated and mutated NMDA receptor subunits expressed in heterologous cells, we found that the M3 domains of both NR1 and NR2 subunits contain key amino acid residues that contribute to the regulation of the number of surface functional NMDA receptors. These key residues are critical neither for the interaction between the NR1 and NR2 subunits nor for the formation of the functional receptors, but rather they regulate the early trafficking of the receptors. We also found that the identified key amino acid residues within both NR1 and NR2 M3 domains contribute to the regulation of the surface expression of unassembled NR1 and NR2 subunits. Thus, our data identify the unique role of the membrane domains in the regulation of the number of surface NMDA receptors.	[Kaniakova, Martina; Krausova, Barbora; Vyklicky, Vojtech; Korinek, Miloslav; Lichnerova, Katarina; Vyklicky, Ladislav; Horak, Martin] Acad Sci Czech Republic, Inst Physiol, Vvi, CR-14220 Prague 4, Czech Republic; [Vyklicky, Vojtech] Charles Univ Prague, Fac Med 2, Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague	Horak, M (corresponding author), Acad Sci Czech Republic, Inst Physiol, Vvi, Videnska 1083, CR-14220 Prague 4, Czech Republic.	mhorak@biomed.cas.cz	Krausová, Barbora/AAL-9528-2021; Kaniakova, Martina/C-2593-2012; Horak, Martin/F-9819-2010; Vyklicky, Ladislav/C-1851-2012; Vyklicky, Vojtech/D-2022-2016; Korinek, Miloslav/C-5401-2012	Krausová, Barbora/0000-0001-5395-982X; Kaniakova, Martina/0000-0002-7956-3265; Horak, Martin/0000-0002-4359-051X; Vyklicky, Ladislav/0000-0002-0015-0098; Vyklicky, Vojtech/0000-0002-7763-850X; Korinek, Miloslav/0000-0001-5115-4489	Grant Agency of the Czech Republic [P303/11/0075, P304/12/G069, P303/12/1464]; Marie Curie International Reintegration Grant [PIRG-GA-2010-276827]; Research Project of the AS; Research Project of the CR [AV0Z50110509, RVO:67985823]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Marie Curie International Reintegration Grant(European Commission); Research Project of the AS; Research Project of the CR	This work was supported by the Grant Agency of the Czech Republic Grants P303/11/0075, P304/12/G069, and P303/12/1464); by Marie Curie International Reintegration Grant PIRG-GA-2010-276827; and by Research Projects of the AS CR AV0Z50110509 and RVO:67985823.	Atlason PT, 2007, J BIOL CHEM, V282, P25299, DOI 10.1074/jbc.M702778200; Cais O, 2008, NEUROSCIENCE, V151, P428, DOI 10.1016/j.neuroscience.2007.11.002; Cao JY, 2011, J BIOL CHEM, V286, P27698, DOI 10.1074/jbc.M111.235333; Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; Farina AN, 2011, J NEUROSCI, V31, P3565, DOI 10.1523/JNEUROSCI.6041-10.2011; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; Hansen KB, 2010, MOL PHARMACOL, V78, P535, DOI 10.1124/mol.110.067157; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; Horak M, 2004, J NEUROSCI, V24, P10318, DOI 10.1523/JNEUROSCI.2099-04.2004; Horak M, 2008, J NEUROSCI, V28, P3500, DOI 10.1523/JNEUROSCI.5239-07.2008; Horak M, 2009, J BIOL CHEM, V284, P9683, DOI 10.1074/jbc.M807050200; ISHII T, 1993, J BIOL CHEM, V268, P2836; Kenny AV, 2009, J BIOL CHEM, V284, P324, DOI 10.1074/jbc.M804023200; Klein RM, 2004, J NEUROSCI, V24, P4941, DOI 10.1523/JNEUROSCI.0660-04.2004; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Luo JH, 2002, NEUROPHARMACOLOGY, V42, P306, DOI 10.1016/S0028-3908(01)00188-5; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; Meddows E, 2001, J BIOL CHEM, V276, P18795, DOI 10.1074/jbc.M101382200; Okabe S, 1999, J NEUROSCI, V19, P7781; Papadakis M, 2004, J BIOL CHEM, V279, P14703, DOI 10.1074/jbc.M313446200; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Petralia RS, 2009, FRONT NEUROSCI, P149; Priel A, 2006, NEURON, V52, P1037, DOI 10.1016/j.neuron.2006.12.006; Qiu S, 2005, J BIOL CHEM, V280, P24923, DOI 10.1074/jbc.M413915200; Qiu S, 2009, J BIOL CHEM, V284, P20285, DOI 10.1074/jbc.M109.004960; Salussolia CL, 2011, J BIOL CHEM, V286, P40205, DOI 10.1074/jbc.M111.268839; Salussolia CL, 2011, J NEUROSCI, V31, P11295, DOI 10.1523/JNEUROSCI.5612-10.2011; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; Schuler T, 2008, J BIOL CHEM, V283, P37, DOI 10.1074/jbc.M703539200; Schwarz MK, 2001, EUR J NEUROSCI, V14, P861, DOI 10.1046/j.0953-816x.2001.01705.x; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Sobolevsky AI, 2002, NEURON, V33, P75, DOI 10.1016/S0896-6273(01)00560-8; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Stephenson FA, 2008, MOL MEMBR BIOL, V25, P311, DOI 10.1080/09687680801971367; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Vivithanaporn P, 2007, J NEUROSCI, V27, P10423, DOI 10.1523/JNEUROSCI.2674-07.2007; Wang JM, 2002, NAT NEUROSCI, V5, P963, DOI 10.1038/nn918	41	29	31	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26423	26434		10.1074/jbc.M112.339085	http://dx.doi.org/10.1074/jbc.M112.339085			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22711533	hybrid, Green Published			2022-12-25	WOS:000306916300067
J	Bertolini, G; Ramat, S; Bockisch, CJ; Marti, S; Straumann, D; Palla, A				Bertolini, Giovanni; Ramat, Stefano; Bockisch, Christopher J.; Marti, Sarah; Straumann, Dominik; Palla, Antonella			Is Vestibular Self-Motion Perception Controlled by the Velocity Storage? Insights from Patients with Chronic Degeneration of the Vestibulo-Cerebellum	PLOS ONE			English	Article							SPATIAL ORIENTATION; INERTIAL REPRESENTATION; TILT SUPPRESSION; RHESUS-MONKEYS; ANGULAR MOTION; OCULAR REFLEX; EYE-MOVEMENTS; ALERT MONKEY; NODULUS; NEURONS	Background: The rotational vestibulo-ocular reflex (rVOR) generates compensatory eye movements in response to rotational head accelerations. The velocity-storage mechanism (VSM), which is controlled by the vestibulo-cerebellar nodulus and uvula, determines the rVOR time constant. In healthy subjects, it has been suggested that self-motion perception in response to earth-vertical axis rotations depends on the VSM in a similar way as reflexive eye movements. We aimed at further investigating this hypothesis and speculated that if the rVOR and rotational self-motion perception share a common VSM, alteration in the latter, such as those occurring after a loss of the regulatory control by vestibulo-cerebellar structures, would result in similar reflexive and perceptual response changes. We therefore set out to explore both responses in patients with vestibulo-cerebellar degeneration. Methodology/Principal Findings: Reflexive eye movements and perceived rotational velocity were simultaneously recorded in 14 patients with chronic vestibulo-cerebellar degeneration (28-81yrs) and 12 age-matched healthy subjects (30-72yrs) after the sudden deceleration (90 degrees/s2) from constant-velocity (90 degrees/s) rotations about the earth-vertical yaw and pitch axes. rVOR and perceived rotational velocity data were analyzed using a two-exponential model with a direct pathway, representing semicircular canal activity, and an indirect pathway, implementing the VSM. We found that VSM time constants of rVOR and perceived rotational velocity co-varied in cerebellar patients and in healthy controls (Pearson correlation coefficient for yaw 0.95; for pitch 0.93, p<0.01). When constraining model parameters to use the same VSM time constant for rVOR and perceived rotational velocity, moreover, no significant deterioration of the quality of fit was found for both populations (variance-accounted-for >0.8). Conclusions/Significance: Our results confirm that self-motion perception in response to rotational velocity-steps may be controlled by the same velocity storage network that controls reflexive eye movements and that no additional, e. g. cortical, mechanisms are required to explain perceptual dynamics.	[Bertolini, Giovanni; Bockisch, Christopher J.; Marti, Sarah; Straumann, Dominik; Palla, Antonella] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Bertolini, Giovanni; Ramat, Stefano] Univ Pavia, Dept Comp Sci, I-27100 Pavia, Italy; [Bockisch, Christopher J.] Univ Zurich Hosp, Dept Otorhinolaryngol Head & Neck Surg, CH-8091 Zurich, Switzerland; [Bockisch, Christopher J.] Univ Zurich Hosp, Dept Ophthalmol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Pavia; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Bertolini, G (corresponding author), Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland.	bertoweb@gmail.com	Bertolini, Giovanni/H-3510-2016; Ramat, Stefano/E-6495-2011; Bertolini, Giovanni/W-4117-2019	Bertolini, Giovanni/0000-0003-2428-9454; Ramat, Stefano/0000-0001-5932-186X; Bertolini, Giovanni/0000-0003-2428-9454; Bockisch, Christopher/0000-0003-1054-2578	Swiss National Science Foundation [32323B_119376]; Betty and David Koetser Foundation for Brain Research; Baasch Medicus Foundation; Zurich Center for Integrative Human Physiology	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Betty and David Koetser Foundation for Brain Research; Baasch Medicus Foundation; Zurich Center for Integrative Human Physiology	This work was supported by the Swiss National Science Foundation #32323B_119376; the Betty and David Koetser Foundation for Brain Research; the Baasch Medicus Foundation and the Zurich Center for Integrative Human Physiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	ANGELAKI DE, 1995, J NEUROPHYSIOL, V73, P1729; ANGELAKI DE, 1994, J NEUROPHYSIOL, V71, P1222, DOI 10.1152/jn.1994.71.3.1222; ANGELAKI DE, 1995, J NEUROPHYSIOL, V73, P1716, DOI 10.1152/jn.1995.73.4.1716; Bertolini G, 2011, J NEUROPHYSIOL, V105, P209, DOI 10.1152/jn.00154.2010; BLANKS RHI, 1975, J NEUROPHYSIOL, V38, P1250, DOI 10.1152/jn.1975.38.5.1250; Bremmer F, 2011, J PHYSIOL-LONDON, V589, P815, DOI 10.1113/jphysiol.2010.195537; Bronstein AM, 2008, NEUROREPORT, V19, P691, DOI 10.1097/WNR.0b013e3282fbf9f6; BUTTNER U, 1981, EXP BRAIN RES, V41, P310; BUTTNER U, 1977, EXP BRAIN RES, V30, P435; Clement G, 2008, EXP BRAIN RES, V190, P307, DOI 10.1007/s00221-008-1471-0; Cohen B, 2003, ANN NY ACAD SCI, V1004, P359, DOI 10.1196/annals.1303.034; COHEN B, 1981, ANN NY ACAD SCI, V374, P421, DOI 10.1111/j.1749-6632.1981.tb30888.x; Cohen B, 2002, ANN NY ACAD SCI, V978, P28, DOI 10.1111/j.1749-6632.2002.tb07553.x; COHEN H, 1992, EXP BRAIN RES, V90, P526; CURTHOYS IS, 1977, ACTA OTO-LARYNGOL, V83, P258, DOI 10.3109/00016487709128843; Dai MJ, 1999, J VESTIBUL RES-EQUIL, V9, P293; Dai MJ, 2003, EXP BRAIN RES, V151, P173, DOI 10.1007/s00221-003-1479-4; Dickman JD, 2004, EXP BRAIN RES, V155, P91, DOI 10.1007/s00221-003-1692-1; FERNANDEZ C, 1971, J NEUROPHYSIOL, V34, P661, DOI 10.1152/jn.1971.34.4.661; GALIANA HL, 1995, ACTA OTO-LARYNGOL, V115, P585, DOI 10.3109/00016489509139372; Gizzi MS, 2003, CURR EYE RES, V26, P281, DOI 10.1076/ceyr.26.4.281.15426; Green AM, 2004, J NEUROPHYSIOL, V92, P905, DOI 10.1152/jn.01234.2003; Green AM, 2003, J NEUROSCI, V23, P9265; Guedry F. E., 1974, VESTIBULAR SYSTEM PA, VVI, P3; HAIN TC, 1988, ACTA OTO-LARYNGOL, V105, P13, DOI 10.3109/00016488809119440; Hastie T, 2001, SPRINGER SERIES STAT, P539; HAUSTEIN W, 1989, BIOL CYBERN, V60, P411, DOI 10.1007/BF00204696; Heide W, 1988, Adv Otorhinolaryngol, V41, P44; JAGER J, 1981, ANN NY ACAD SCI, V374, P330, DOI 10.1111/j.1749-6632.1981.tb30880.x; Jeong HS, 2007, NEUROLOGY, V68, P956, DOI 10.1212/01.wnl.0000257111.24769.d2; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; MAGNIN M, 1977, EXP BRAIN RES, V28, P293; Marlinski V, 2008, J NEUROPHYSIOL, V99, P2533, DOI 10.1152/jn.00761.2007; Meng H, 2007, J NEUROSCI, V27, P13590, DOI 10.1523/JNEUROSCI.3931-07.2007; Merfeld D M, 1993, J Vestib Res, V3, P123; Moon IS, 2009, STROKE, V40, P487, DOI 10.1161/STROKEAHA.108.527762; Okada T, 1999, BRAIN, V122, P1293, DOI 10.1093/brain/122.7.1293; OMAN CM, 1987, ACTA OTO-LARYNGOL, V103, P1, DOI 10.3109/00016488709134691; Ramat S, 2009, ANN NY ACAD SCI, V1164, P140, DOI 10.1111/j.1749-6632.2009.03855.x; RAPHAN T, 1979, EXP BRAIN RES, V35, P229; Raphan T, 1977, CONTROL GAZE BRAIN S, V1, P37; Robinson DA, 1977, CONTROL GAZE BRAIN S, V1, P49; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sheliga BM, 1999, ANN NY ACAD SCI, V871, P94, DOI 10.1111/j.1749-6632.1999.tb09178.x; Sinha N, 2008, PROG BRAIN RES, V171, P277, DOI 10.1016/S0079-6123(08)00639-0; SOLOMON D, 1994, EXP BRAIN RES, V102, P57; STRAUMANN D, 1995, VISION RES, V35, P3321, DOI 10.1016/0042-6989(95)00091-R; WAESPE W, 1985, SCIENCE, V228, P199, DOI 10.1126/science.3871968; Wearne S, 1996, ANN NY ACAD SCI, V781, P364, DOI 10.1111/j.1749-6632.1996.tb15713.x; Wearne S, 1998, J NEUROPHYSIOL, V79, P2690, DOI 10.1152/jn.1998.79.5.2690; Wiest G, 1999, NEUROLOGY, V52, P417, DOI 10.1212/WNL.52.2.417	52	46	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e36763	10.1371/journal.pone.0036763	http://dx.doi.org/10.1371/journal.pone.0036763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719833	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000305350000001
J	Thoma, EC; Wischmeyer, E; Offen, N; Maurus, K; Siren, AL; Schartl, M; Wagner, TU				Thoma, Eva C.; Wischmeyer, Erhard; Offen, Nils; Maurus, Katja; Siren, Anna-Leena; Schartl, Manfred; Wagner, Toni U.			Ectopic Expression of Neurogenin 2 Alone is Sufficient to Induce Differentiation of Embryonic Stem Cells into Mature Neurons	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; HELIX TRANSCRIPTION FACTORS; TRANSIENT EXPRESSION; DEVELOPING CNS; SELF-RENEWAL; NEURAL FATE; IN-VITRO; MOUSE; OLIG2; GENE	Recent studies show that combinations of defined key developmental transcription factors (TFs) can reprogram somatic cells to pluripotency or induce cell conversion of one somatic cell type to another. However, it is not clear if single genes can define a cells identity and if the cell fate defining potential of TFs is also operative in pluripotent stem cells in vitro. Here, we show that ectopic expression of the neural TF Neurogenin2 (Ngn2) is sufficient to induce rapid and efficient differentiation of embryonic stem cells (ESCs) into mature glutamatergic neurons. Ngn2-induced neuronal differentiation did not require any additional external or internal factors and occurred even under pluripotency-promoting conditions. Differentiated cells displayed neuron-specific morphology, protein expression, and functional features, most importantly the generation of action potentials and contacts with hippocampal neurons. Gene expression analyses revealed that Ngn2-induced in vitro differentiation partially resembled neurogenesis in vivo, as it included specific activation of Ngn2 target genes and interaction partners. These findings demonstrate that a single gene is sufficient to determine cell fate decisions of uncommitted stem cells thus giving insights into the role of key developmental genes during lineage commitment. Furthermore, we present a promising tool to improve directed differentiation strategies for applications in both stem cell research and regenerative medicine.	[Wischmeyer, Erhard] Univ Wurzburg, Inst Physiol, Wurzburg, Germany; [Offen, Nils; Siren, Anna-Leena] Univ Wurzburg, Dept Neurosurg, Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Thoma, EC (corresponding author), F Hoffmann La Roche & Cie AG, Stem Cell Platform, Basel, Switzerland.	e.thoma@biozentrum.uni-wuerzburg.de	Sirén, Anna-Leena/AAE-1374-2019	Sirén, Anna-Leena/0000-0002-2217-0081; Schartl, Manfred/0000-0001-9882-5948	EU through Plurigenes [018673]; Boehringer Ingelheim Fonds for basic research in medicine; German Research Foundation (DFG) [GRK1048]; University of Wuerzburg	EU through Plurigenes; Boehringer Ingelheim Fonds for basic research in medicine; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was funded by the EU through Plurigenes (http://www.plurigenes.org/, FP6 project 018673), the Boehringer Ingelheim Fonds (http://www.bifonds.de)for basic research in medicine, the German Research Foundation (DFG, GRK1048) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejar J, 2003, DEVELOPMENT, V130, P6545, DOI 10.1242/dev.00872; Blader P, 1997, DEVELOPMENT, V124, P4557; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chung S, 2002, EUR J NEUROSCI, V16, P1829, DOI 10.1046/j.1460-9568.2002.02255.x; Farah MH, 2000, DEVELOPMENT, V127, P693; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Kawakami K, 2004, GENETICS, V166, P895, DOI 10.1534/genetics.166.2.895; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Mattar P, 2008, MOL CELL BIOL, V28, P1456, DOI 10.1128/MCB.01510-07; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nishiguchi S, 1998, GENE DEV, V12, P776, DOI 10.1101/gad.12.6.776; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Peitz M, 2007, GENESIS, V45, P508, DOI 10.1002/dvg.20321; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Reyes JH, 2008, J NEUROSCI, V28, P12622, DOI 10.1523/JNEUROSCI.0563-08.2008; Scardigli R, 2003, DEVELOPMENT, V130, P3269, DOI 10.1242/dev.00539; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Suter DM, 2009, STEM CELLS, V27, P49, DOI 10.1634/stemcells.2008-0319; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Takebayashi K, 1997, EMBO J, V16, P384, DOI 10.1093/emboj/16.2.384; Thoma EC, 2012, CELL REPROGRAM, V14, P106, DOI 10.1089/cell.2011.0067; Thoma EC, 2011, STEM CELLS DEV, V20, P1425, DOI 10.1089/scd.2010.0290; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wagner TU, 2009, STEM CELLS DEV, V18, P151, DOI 10.1089/scd.2007.0262; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wiles MV, 1999, EXP CELL RES, V247, P241, DOI 10.1006/excr.1998.4353; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhao SL, 2004, MOL CELL NEUROSCI, V27, P332, DOI 10.1016/j.mcn.2004.08.002; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	51	52	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38651	10.1371/journal.pone.0038651	http://dx.doi.org/10.1371/journal.pone.0038651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719915	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341900041
J	Jumlongras, D; Lachke, SA; O'Connell, DJ; Aboukhalil, A; Li, X; Choe, SE; Ho, JWK; Turbe-Doan, A; Robertson, EA; Olsen, BR; Bulyk, ML; Amendt, BA; Maas, RL				Jumlongras, Dolrudee; Lachke, Salil A.; O'Connell, Daniel J.; Aboukhalil, Anton; Li, Xiao; Choe, Sung E.; Ho, Joshua W. K.; Turbe-Doan, Annick; Robertson, Erin A.; Olsen, Bjorn R.; Bulyk, Martha L.; Amendt, Brad A.; Maas, Richard L.			An Evolutionarily Conserved Enhancer Regulates Bmp4 Expression in Developing Incisor and Limb Bud	PLOS ONE			English	Article							MORPHOGENETIC PROTEIN-4 GENE; APICAL ECTODERMAL RIDGE; BINDING MICROARRAY DATA; TOOTH MORPHOGENESIS; TRANSCRIPTIONAL PROPERTIES; CRANIOFACIAL DEVELOPMENT; DNA INTERACTIONS; ONLINE DATABASE; RIEGER-SYNDROME; HAIR-FOLLICLES	To elucidate the transcriptional regulation of Bmp4 expression during organogenesis, we used phylogenetic footprinting and transgenic reporter analyses to identify Bmp4 cis-regulatory modules (CRMs). These analyses identified a regulatory region located similar to 46 kb upstream of the mouse Bmp4 transcription start site that had previously been shown to direct expression in lateral plate mesoderm. We refined this regulatory region to a 396-bp minimal enhancer, and show that it recapitulates features of endogenous Bmp4 expression in developing mandibular arch ectoderm and incisor epithelium during the initiation-stage of tooth development. In addition, this enhancer directs expression in the apical ectodermal ridge (AER) of the developing limb and in anterior and posterior limb mesenchyme. Transcript profiling of E11.5 mouse incisor dental lamina, together with protein binding microarray (PBM) analyses, allowed identification of a conserved DNA binding motif in the Bmp4 enhancer for Pitx homeoproteins, which are also expressed in the developing mandibular and incisor epithelium. In vitro electrophoretic mobility shift assays (EMSA) and in vivo transgenic reporter mutational analyses revealed that this site supports Pitx binding and that the site is necessary to recapitulate aspects of endogenous Bmp4 expression in developing craniofacial and limb tissues. Finally, Pitx2 chromatin immunoprecipitation (ChIP) demonstrated direct binding of Pitx2 to this Bmp4 enhancer site in a dental epithelial cell line. These results establish a direct molecular regulatory link between Pitx family members and Bmp4 gene expression in developing incisor epithelium.	[Jumlongras, Dolrudee; O'Connell, Daniel J.; Aboukhalil, Anton; Choe, Sung E.; Ho, Joshua W. K.; Turbe-Doan, Annick; Robertson, Erin A.; Bulyk, Martha L.; Maas, Richard L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet,Dept Med, Boston, MA 02115 USA; [Jumlongras, Dolrudee; Olsen, Bjorn R.] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Lachke, Salil A.] Univ Delaware, Dept Biol Sci, Ctr Bioinformat & Computat Biol, Newark, DE USA; [Aboukhalil, Anton] MIT, Dept Aeronaut & Astronaut, Cambridge, MA 02139 USA; [Li, Xiao; Amendt, Brad A.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Ho, Joshua W. K.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA USA; [Bulyk, Martha L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Bulyk, Martha L.] Harvard Univ, Sch Med, Harvard MIT Div Hlth Sci & Technol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard School of Dental Medicine; University of Delaware; Massachusetts Institute of Technology (MIT); Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Jumlongras, D (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet,Dept Med, Boston, MA 02115 USA.	maas@genetics.med.harvard.edu	Ho, Joshua W. K./AAK-7759-2020; Li, Xiao/X-3429-2019	Ho, Joshua W. K./0000-0003-2331-7011; Li, Xiao/0000-0001-8527-4438; Amendt, Brad A./0000-0001-6524-1006; Choe, Sung/0000-0001-9140-4198; Lachke, Salil/0000-0001-8845-010X	Harvard School of Dental Medicine Dean's Scholar Award; National Institutes of Health (NIH) MERIT Award [DE011697]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE011697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE011697] Funding Source: NIH RePORTER	Harvard School of Dental Medicine Dean's Scholar Award; National Institutes of Health (NIH) MERIT Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Harvard School of Dental Medicine Dean's Scholar Award to Dr. Jumlongras and National Institutes of Health (NIH) MERIT Award DE011697 to Dr. Maas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg T, 1997, AID AJA3 3 0 CO 2 C; Ahituv N, 2004, HUM MOL GENET, V13, pR261, DOI 10.1093/hmg/ddh229; Ahn K, 2001, DEVELOPMENT, V128, P4449; Amen M, 2007, MOL CELL BIOL, V27, P7560, DOI 10.1128/MCB.00315-07; Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Bejerano G, 2004, BIOINFORMATICS, V20, P40, DOI 10.1093/bioinformatics/bth946; Benazet JD, 2009, SCIENCE, V323, P1050, DOI 10.1126/science.1168755; Cao HJ, 2010, DEV BIOL, V347, P289, DOI 10.1016/j.ydbio.2010.08.031; Chandler KJ, 2009, DEV BIOL, V327, P590, DOI 10.1016/j.ydbio.2008.12.033; Chen YP, 1996, DEVELOPMENT, V122, P3035; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feng JQ, 2002, J DENT RES, V81, P6, DOI 10.1177/154405910208100103; FENG JQ, 1995, J BIOL CHEM, V270, P28364, DOI 10.1074/jbc.270.47.28364; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Green PD, 2001, GENE EXPRESSION, V9, P265, DOI 10.3727/000000001783992515; Gurnett CA, 2008, AM J HUM GENET, V83, P616, DOI 10.1016/j.ajhg.2008.10.004; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; JONES CM, 1991, DEVELOPMENT, V111, P531; Koop BF, 1996, P NATL ACAD SCI USA, V93, P1363, DOI 10.1073/pnas.93.4.1363; KURIHARA T, 1993, BIOCHEM BIOPH RES CO, V192, P1049, DOI 10.1006/bbrc.1993.1523; Lanctot C, 1999, DEVELOPMENT, V126, P1805; Lanctot C, 1997, DEVELOPMENT, V124, P2807; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Lenhard Boris, 2003, J Biol, V2, P13, DOI 10.1186/1475-4924-2-13; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Liu W, 2005, DEV BIOL, V283, P282, DOI 10.1016/j.ydbio.2005.04.019; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Liu W, 2003, DEVELOPMENT, V130, P6375, DOI 10.1242/dev.00849; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Marcil A, 2003, DEVELOPMENT, V130, P45, DOI 10.1242/dev.00192; Mitsiadis TA, 2008, DEV BIOL, V313, P887, DOI 10.1016/j.ydbio.2007.10.055; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nagy A., 2003, MANIPULATING MOUSE E; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; O'Connell DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002414; Ohazama A, 2005, J DENT RES, V84, P603, DOI 10.1177/154405910508400704; Pizette S, 2001, DEVELOPMENT, V128, P4463; Plikus MV, 2005, EVOL DEV, V7, P440, DOI 10.1111/j.1525-142X.2005.05048.x; Poulin G, 2000, MOL CELL BIOL, V20, P4826, DOI 10.1128/MCB.20.13.4826-4837.2000; Robasky K, 2011, NUCLEIC ACIDS RES, V39, pD124, DOI 10.1093/nar/gkq992; Robert B, 2007, DEV GROWTH DIFFER, V49, P455, DOI 10.1111/j.1440-169x.2007.00946.x; Santagati F, 2003, GENETICS, V165, P235; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Selever J, 2004, DEV BIOL, V276, P268, DOI 10.1016/j.ydbio.2004.08.024; SEMENZA GL, 1995, BIOCHEM BIOPH RES CO, V209, P257, DOI 10.1006/bbrc.1995.1497; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; St Amand TR, 2000, DEV BIOL, V217, P323, DOI 10.1006/dbio.1999.9547; Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484; THESLEFF, 2001, ADV DENT RES, V15, P14; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Tremblay JJ, 2000, NEUROENDOCRINOLOGY, V71, P277, DOI 10.1159/000054547; Van den Wijngaard A, 1999, J BONE MINER RES, V14, P1432, DOI 10.1359/jbmr.1999.14.8.1432; Venugopalan SR, 2011, J BIOL CHEM, V286, P21372, DOI 10.1074/jbc.M111.252031; Wang CKL, 2004, DEV BIOL, V269, P109, DOI 10.1016/j.ydbio.2004.01.016; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Zhang JH, 2002, BIOCHEM BIOPH RES CO, V293, P1412, DOI 10.1016/S0006-291X(02)00416-3; Zhang X, 2002, GENE DEV, V16, P2097, DOI 10.1101/gad.1007602; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167; Zhou YL, 2000, J BIOL CHEM, V275, P12273, DOI 10.1074/jbc.275.16.12273	65	16	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38568	10.1371/journal.pone.0038568	http://dx.doi.org/10.1371/journal.pone.0038568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701669	Green Published, gold			2022-12-25	WOS:000305340000033
J	Zamorano, S; Rojas-Rivera, D; Lisbona, F; Parra, V; Court, FA; Villegas, R; Cheng, EH; Korsmeyer, SJ; Lavandero, S; Hetz, C				Zamorano, Sebastian; Rojas-Rivera, Diego; Lisbona, Fernanda; Parra, Valentina; Court, Felipe A.; Villegas, Rosario; Cheng, Emily H.; Korsmeyer, Stanley J.; Lavandero, Sergio; Hetz, Claudio			A BAX/BAK and Cyclophilin D-Independent Intrinsic Apoptosis Pathway	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; UNFOLDED PROTEIN RESPONSE; BCL-2-RELATED OVARIAN KILLER; ENDOPLASMIC-RETICULUM STRESS; BCL-2 FAMILY-MEMBERS; CELL-DEATH; ER STRESS; CYTOCHROME-C; MEMBRANE PERMEABILIZATION; TRIGGERS APOPTOSIS	Most intrinsic death signals converge into the activation of pro-apoptotic BCL-2 family members BAX and BAK at the mitochondria, resulting in the release of cytochrome c and apoptosome activation. Chronic endoplasmic reticulum (ER) stress leads to apoptosis through the upregulation of a subset of pro-apoptotic BH3-only proteins, activating BAX and BAK at the mitochondria. Here we provide evidence indicating that the full resistance of BAX and BAK double deficient (DKO) cells to ER stress is reverted by stimulation in combination with mild serum withdrawal. Cell death under these conditions was characterized by the appearance of classical apoptosis markers, caspase-9 activation, release of cytochrome c, and was inhibited by knocking down caspase-9, but insensitive to BCL-XL overexpression. Similarly, the resistance of BIM and PUMA double deficient cells to ER stress was reverted by mild serum withdrawal. Surprisingly, BAX/BAK-independent cell death did not require Cyclophilin D (CypD) expression, an important regulator of the mitochondrial permeability transition pore. Our results suggest the existence of an alternative intrinsic apoptosis pathway emerging from a cross talk between the ER and the mitochondria.	[Zamorano, Sebastian; Rojas-Rivera, Diego; Lisbona, Fernanda; Hetz, Claudio] Univ Chile, Biomed Neurosci Inst, Fac Med, Santiago, Chile; [Zamorano, Sebastian; Rojas-Rivera, Diego; Lisbona, Fernanda; Parra, Valentina; Lavandero, Sergio; Hetz, Claudio] Univ Chile, Ctr Mol Studies Cell, Inst Biomed Sci, Santiago, Chile; [Parra, Valentina; Lavandero, Sergio] Univ Chile, Fac Chem & Pharmaceut Sci, Santiago, Chile; [Court, Felipe A.; Villegas, Rosario] P Catholic Univ Chile, Fac Biol, Santiago, Chile; [Cheng, Emily H.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Korsmeyer, Stanley J.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Korsmeyer, Stanley J.] Harvard Univ, Sch Med, Boston, MA USA; [Lavandero, Sergio] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA; [Hetz, Claudio] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Hetz, Claudio] Neurounion Biomed Fdn, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile; Pontificia Universidad Catolica de Chile; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard T.H. Chan School of Public Health	Zamorano, S (corresponding author), Univ Chile, Biomed Neurosci Inst, Fac Med, Santiago, Chile.	chetz@med.uchile.cl	Rojas Rivera, Diego/N-1870-2016; Parra, Valentina M/N-3972-2018; Hetz, Claudio/I-1900-2013; Lavandero, Sergio/B-6001-2013; Rojas-Riviera, Diego/AAN-5222-2020; Rivera, Diego Rojas/ABF-5865-2020; Hetz, Claudio/ABD-7514-2021; Court, Felipe/C-5911-2015	Rojas Rivera, Diego/0000-0002-8773-9830; Parra, Valentina M/0000-0002-0080-6472; Hetz, Claudio/0000-0001-7724-1767; Lavandero, Sergio/0000-0003-4258-1483; Rivera, Diego Rojas/0000-0002-8773-9830; Court, Felipe/0000-0002-9394-7601; Court, Felipe/0000-0002-1384-2552	FONDECYT [1100176, 1070377]; Millennium Institute [P09-015-F]; Michael J. Fox Foundation for Parkinson's Research; North American Spine Society; Muscular Dystrophy Association; ALS Therapy Allianze; FONDAP [15010006]; Millennium Nucleus [P-07-011-F]; National Institute of Health [R01CA125562]; American Cancer Society [RSG-10-030-01-CCG]; CONICYT; Alzheimer's Disease Foundation	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Institute(Takeda Pharmaceutical Company Ltd); Michael J. Fox Foundation for Parkinson's Research; North American Spine Society; Muscular Dystrophy Association(Muscular Dystrophy Association); ALS Therapy Allianze; FONDAP; Millennium Nucleus; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Alzheimer's Disease Foundation	This work was supported by FONDECYT no. 1100176, Millennium Institute no. P09-015-F, Michael J. Fox Foundation for Parkinson's Research, Alzheimer's Disease Foundation, North American Spine Society, Muscular Dystrophy Association, ALS Therapy Allianze (to CH), FONDAP grant no. 15010006 (to CH and SL), Supported by grants from FONDECYT no. 1070377 and Millennium Nucleus no. P-07-011-F (to FC), National Institute of Health R01CA125562 and American Cancer Society RSG-10-030-01-CCG (to EC), and PhD fellowships from CONICYT (to DRR, FL, and VP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Barrientos SA, 2011, J NEUROSCI, V31, P966, DOI 10.1523/JNEUROSCI.4065-10.2011; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Caro-Maldonado A, 2010, CELL DEATH DIFFER, V17, P1335, DOI 10.1038/cdd.2010.21; Chiara F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001852; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Heath-Engel HM, 2008, ONCOGENE, V27, P6419, DOI 10.1038/onc.2008.309; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hetz C, 2005, J BIOL CHEM, V280, P42960, DOI 10.1074/jbc.M505843200; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Hetz CA, 2007, ANTIOXID REDOX SIGN, V9, P2345, DOI 10.1089/ars.2007.1793; Hsu SY, 1997, P NATL ACAD SCI USA, V94, P12401, DOI 10.1073/pnas.94.23.12401; Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10; Kim AJ, 2005, J CELL SCI, V118, P89, DOI 10.1242/jcs.01562; Kim H, 2006, NAT CELL BIOL; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kim I, 2009, J BIOL CHEM, V284, P1593, DOI 10.1074/jbc.M807308200; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Lei XY, 2008, J BIOL CHEM, V283, P34819, DOI 10.1074/jbc.M807409200; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Leung AWC, 2008, BBA-BIOENERGETICS, V1777, P946, DOI 10.1016/j.bbabio.2008.03.009; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Llambi F, 2011, MOL CELL; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Merino D, 2009, J CELL BIOL, V186, P355, DOI 10.1083/jcb.200905153; Mizuta T, 2007, J BIOL CHEM, V282, P16623, DOI 10.1074/jbc.M611060200; Munoz JP, 2010, FREE RADICAL BIO MED, V48, P526, DOI 10.1016/j.freeradbiomed.2009.11.017; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Rodriguez D, 2012, EMBO J IN PRESS; Rodriguez JM, 2006, J BIOL CHEM, V281, P22729, DOI 10.1074/jbc.M604705200; Rojas-Rivera D, 2012, CELL DEATH DIFFER; Roy SS, 2009, MOL CELL, V33, P377, DOI 10.1016/j.molcel.2009.01.018; Scharstuhl A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006688; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Siskind LJ, 2005, J BIOENERG BIOMEMBR, V37, P143, DOI 10.1007/s10863-005-6567-7; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200; Song L, 2002, J BIOL CHEM, V277, P44701, DOI 10.1074/jbc.M206047200; Suominen JS, 2001, EUR J ENDOCRINOL, V145, P771, DOI 10.1530/eje.0.1450771; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhivotovsky B, 2009, CELL DEATH DIFFER, V16, P1419, DOI 10.1038/cdd.2009.118; Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084	61	33	35	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e37782	10.1371/journal.pone.0037782	http://dx.doi.org/10.1371/journal.pone.0037782			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719850	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340000005
J	Cerutti-Pereyra, F; Meekan, MG; Wei, NWV; O'Shea, O; Bradshaw, CJA; Austin, CM				Cerutti-Pereyra, Florencia; Meekan, Mark G.; Wei, Nu-Wei V.; O'Shea, Owen; Bradshaw, Corey J. A.; Austin, Chris M.			Identification of Rays through DNA Barcoding: An Application for Ecologists	PLOS ONE			English	Article							FRESH-WATER CRAYFISH; SPOTTED EAGLE RAY; POPULATION-STRUCTURE; EVOLUTIONARY RELATIONSHIPS; SHARKS; PHYLOGENY; TAXONOMY; UTILITY; HISTORY; DEEP	DNA barcoding potentially offers scientists who are not expert taxonomists a powerful tool to support the accuracy of field studies involving taxa that are diverse and difficult to identify. The taxonomy of rays has received reasonable attention in Australia, although the fauna in remote locations such as Ningaloo Reef, Western Australia is poorly studied and the identification of some species in the field is problematic. Here, we report an application of DNA-barcoding to the identification of 16 species (from 10 genera) of tropical rays as part of an ecological study. Analysis of the dataset combined across all samples grouped sequences into clearly defined operational taxonomic units, with two conspicuous exceptions: the Neotrygon kuhlii species complex and the Aetobatus species complex. In the field, the group that presented the most difficulties for identification was the spotted whiptail rays, referred to as the 'uarnak' complex. Two sets of problems limited the successful application of DNA barcoding: (1) the presence of cryptic species, species complexes with unresolved taxonomic status and intra-specific geographical variation, and (2) insufficient numbers of entries in online databases that have been verified taxonomically, and the presence of lodged sequences in databases with inconsistent names. Nevertheless, we demonstrate the potential of the DNA barcoding approach to confirm field identifications and to highlight species complexes where taxonomic uncertainty might confound ecological data.	[Cerutti-Pereyra, Florencia; Wei, Nu-Wei V.] Charles Darwin Univ, Res Inst Environm & Livelihood, Darwin, NT 0909, Australia; [O'Shea, Owen] Murdoch Univ, Murdoch, WA 6150, Australia; [Bradshaw, Corey J. A.] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Bradshaw, Corey J. A.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Austin, Chris M.] Monash Univ, Sch Sci, Petaling Jaya, Selangor, Malaysia	Charles Darwin University; Murdoch University; University of Adelaide; University of Adelaide; Monash University; Monash University Sunway	Cerutti-Pereyra, F (corresponding author), Charles Darwin Univ, Res Inst Environm & Livelihood, Darwin, NT 0909, Australia.	chris.austin@monash.edu	Austin, Christopher M/J-4527-2012; Bradshaw, Corey J.A./A-1311-2008; Austin, Christopher/L-7022-2017	Austin, Christopher M/0000-0003-1848-6267; Bradshaw, Corey J.A./0000-0002-5328-7741; Austin, Christopher/0000-0003-1848-6267; Meekan, Mark/0000-0002-3067-9427	Australian Institute of Marine Science; Charles Darwin University; CONACYT-Mexico	Australian Institute of Marine Science; Charles Darwin University; CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	We thank the Australian Institute of Marine Science and Charles Darwin University for financial support, and CONACYT-Mexico for an international grant to FCP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral AR, 2007, MAR FRESHWATER RES, V58, P505, DOI 10.1071/MF07050; Austin CM, 2002, INVERTEBR SYST, V16, P357, DOI 10.1071/IT01010; AVISE JC, 1992, OIKOS, V63, P62, DOI 10.2307/3545516; Bilgmann K, 2007, MAR MAMMAL SCI, V23, P218, DOI 10.1111/j.1748-7692.2006.00099.x; Bonfil R, 1997, ELASMOBRANCH BIODIVE, P15; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; BRANDER K, 1981, NATURE, V290, P48, DOI 10.1038/290048a0; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; Dewar H, 2008, MAR BIOL, V155, P121, DOI 10.1007/s00227-008-0988-x; Domingo-Roura X, 2006, BIOL CONSERV, V128, P425, DOI 10.1016/j.biocon.2005.08.013; Douady CJ, 2003, MOL PHYLOGENET EVOL, V26, P215, DOI 10.1016/S1055-7903(02)00333-0; Dulvy NK, 2000, CONSERV BIOL, V14, P283, DOI 10.1046/j.1523-1739.2000.98540.x; Ebach MC, 2005, BIOSCIENCE, V55, P822; Field IC, 2009, ADV MAR BIOL, V56, P275, DOI 10.1016/S0065-2881(09)56004-X; Frisk MG, 2010, CRC MAR BIOL SER, P283; Graham KJ, 2001, MAR FRESHWATER RES, V52, P549, DOI 10.1071/MF99174; Gray JE, 1851, LIST SPECIMENS FIS 1; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holmes BH, 2009, FISH RES, V95, P280, DOI 10.1016/j.fishres.2008.09.036; KEENAN CP, 1994, AUST J MAR FRESH RES, V45, P1123, DOI 10.1071/MF9941123; Keeney DB, 2003, MAR BIOL, V143, P1039, DOI 10.1007/s00227-003-1166-9; Khuroo AA, 2007, J NAT CONSERV, V15, P256, DOI 10.1016/j.jnc.2007.07.003; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2000, J MOL EVOL, V51, P544, DOI 10.1007/s002390010118; Last P.R., 1994, P1; Last PR, 2011, J FISH BIOL, V79, P1193, DOI 10.1111/j.1095-8649.2011.03095.x; LAST P R, 1987, Memoirs of the Museum of Victoria, V48, P57; Last P. R., 2010, DESCRIPTIONS NEW SHA; Last Peter R., 2010, Aqua, V16, P37; Last Peter R., 2006, Zootaxa, V1239, P19; Last PR, 2008, DESCRIPTIONS NEW AUS, P275; Last PR, 2010, DESCRIPTIONS NEW SHA, P115; Last PR, 2008, DESCRIPTIONS NEW AUS, P315; Last PR, 2008, DESCRIPTIONS NEW AUS, P303; Last PR, 2009, SHARKS RAYS AUSTR; LAWSON R, 1995, J ZOOL, V237, P101, DOI 10.1111/j.1469-7998.1995.tb02749.x; Leprovost Dames and Moore, 2000, NINGALOO MARINE PARK; Lovejoy NR, 1996, ZOOL J LINN SOC-LOND, V117, P207, DOI 10.1006/zjls.1996.0038; Manjaji-Matsumoto B. M., 2008, DESCRIPTIONS NEW AUS, V22, P293; Marshall Andrea D., 2009, Zootaxa, V2301, P1; McEachran JD, 2004, CRC MAR BIOL SER, P79; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Moura T, 2008, MAR FRESHWATER RES, V59, P214, DOI 10.1071/MF07192; Munasinghe DHN, 2003, J CRUSTACEAN BIOL, V23, P402, DOI 10.1651/0278-0372(2003)023[0402:UOMDSF]2.0.CO;2; Ovenden JR, 2010, MAR FRESHWATER RES, V61, P253, DOI 10.1071/MF09151; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rawlings LH, 2004, AUST J ZOOL, V52, P215, DOI 10.1071/ZO03030; Richards VP, 2009, J HERED, V100, P273, DOI 10.1093/jhered/esp005; Rocco L, 2007, GENE, V389, P80, DOI 10.1016/j.gene.2006.09.024; Ronquist F, 2005, MRBAYES 3 1 MANUAL F; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; Sandoval-Castillo J, 2004, MAR BIOL, V145, P983, DOI 10.1007/s00227-004-1378-7; Sandoval-Castillo J, 2011, J HERED, V102, P269, DOI 10.1093/jhered/esr004; Schluessel V, 2010, J ZOOL, V281, P46, DOI 10.1111/j.1469-7998.2009.00680.x; Schrey AW, 2003, CAN J FISH AQUAT SCI, V60, P670, DOI 10.1139/F03-064; Sezaki K, 1999, FISHERIES SCI, V65, P563, DOI 10.2331/fishsci.65.563; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Taylor J. G., 1999, Journal of the Royal Society of Western Australia, V82, P57; Toffoli D, 2008, GENET MOL BIOL, V31, P324, DOI 10.1590/S1415-47572008000200028; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Valiere N, 2003, ANIM CONSERV, V6, P83, DOI 10.1017/S1367943003003111; Vecchione M, 2000, ICES J MAR SCI, V57, P677, DOI 10.1006/jmsc.2000.0707; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; Ward Robert D., 2007, CSIRO Marine and Atmospheric Research Paper, V014, P117; White WT, 2007, J FISH BIOL, V70, P1809, DOI 10.1111/j.1095-8649.2007.01458.x; White W.T., 2006, EC IMPORTANT SHARKS; White WT, 2010, DESCRIPTIONS NEW SHA, P141; Winchell CJ, 2004, MOL PHYLOGENET EVOL, V31, P214, DOI 10.1016/j.ympev.2003.07.010; Wynen L, 2009, MAR FRESHWATER RES, V60, P554, DOI 10.1071/MF08201; Zemlak TS, 2009, MOL ECOL RESOUR, V9, P237, DOI 10.1111/j.1755-0998.2009.02649.x	80	49	49	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e36479	10.1371/journal.pone.0036479	http://dx.doi.org/10.1371/journal.pone.0036479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701556	Green Published, gold			2022-12-25	WOS:000305337600003
J	Fang, XL; Han, LR; Cao, XQ; Zhu, MX; Zhang, X; Wang, YH				Fang, Xiang-Ling; Han, Li-Rong; Cao, Xue-Qiang; Zhu, Ming-Xuan; Zhang, Xing; Wang, Yong-Hong			Statistical Optimization of Process Variables for Antibiotic Activity of Xenorhabdus bovienii	PLOS ONE			English	Article							RESPONSE-SURFACE METHODOLOGY; PHOTORHABDUS-LUMINESCENS; METABOLITES; BACTERIA; NEMATOPHILUS; NEMATODES; ENTEROBACTERIACEAE; IDENTIFICATION; DERIVATIVES; FAMILY	The production of secondary metabolites with antibiotic properties is a common characteristic to entomopathogenic bacteria Xenorhabdus spp. These metabolites not only have diverse chemical structures but also have a wide range of bioactivities of medicinal and agricultural interests. Culture variables are critical to the production of secondary metabolites of microorganisms. Manipulating culture process variables can promote secondary metabolite biosynthesis and thus facilitate the discovery of novel natural products. This work was conducted to evaluate the effects of five process variables (initial pH, medium volume, rotary speed, temperature, and inoculation volume) on the antibiotic production of Xenorhabdus bovienii YL002 using response surface methodology. A 2(5-1) factorial central composite design was chosen to determine the combined effects of the five variables, and to design a minimum number of experiments. The experimental and predicted antibiotic activity of X. bovienii YL002 was in close agreement. Statistical analysis of the results showed that initial pH, medium volume, rotary speed and temperature had a significant effect (P<0.05) on the antibiotic production of X. bovienii YL002 at their individual level; medium volume and rotary speed showed a significant effect at a combined level and was most significant at an individual level. The maximum antibiotic activity (287.5 U/mL) was achieved at the initial pH of 8.24, medium volume of 54 mL in 250 mL flask, rotary speed of 208 rpm, temperature of 32.0 degrees C and inoculation volume of 13.8%. After optimization, the antibiotic activity was improved by 23.02% as compared with that of unoptimized conditions.	[Fang, Xiang-Ling; Han, Li-Rong; Cao, Xue-Qiang; Zhu, Ming-Xuan; Zhang, Xing; Wang, Yong-Hong] NW A&F Univ, Res & Dev Ctr Biorat Pesticides, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Wang, YH (corresponding author), NW A&F Univ, Res & Dev Ctr Biorat Pesticides, Yangling, Shaanxi, Peoples R China.	ylagri@126.com; yhwang@nwsuaf.edu.cn	Fang, Xiangling/G-1075-2012		Natural Science Foundation of China [31171910]; National Department Public Benefit Research Foundation of China [200903052]; Northwest A F University [52211241]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Department Public Benefit Research Foundation of China; Northwest A F University	This work was supported by the Natural Science Foundation of China (no. 31171910), National Department Public Benefit Research Foundation of China (no. 200903052) and Young People Science Program of Northwest A & F University (no. 52211241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKHURST RJ, 1982, J GEN MICROBIOL, V128, P3061; Bode HB, 2002, CHEMBIOCHEM, V3, P619, DOI 10.1002/1439-7633(20020703)3:7<619::AID-CBIC619>3.0.CO;2-9; Chaston JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027909; Chen G, 1996, NEMATOLOGICA, V42, P124, DOI 10.1163/187529296X00139; CHEN G, 1994, BIOL CONTROL, V4, P157, DOI 10.1006/bcon.1994.1025; Chen G., 1996, THESIS S FRASER U BR; Chen XC, 2009, BIORESOURCE TECHNOL, V100, P919, DOI 10.1016/j.biortech.2008.07.062; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Fang XL, 2011, J APPL MICROBIOL, V111, P145, DOI 10.1111/j.1365-2672.2011.05033.x; Fang XL, 2008, J NW A F U, V36, P200; Gualtieri M, 2009, J ANTIBIOT, V62, P295, DOI 10.1038/ja.2009.31; Herbert EE, 2007, APPL ENVIRON MICROB, V73, P7826, DOI 10.1128/AEM.01586-07; Ji D, 2004, FEMS MICROBIOL LETT, V239, P241, DOI 10.1016/j.femsle.2004.08.041; Kaushik R, 2006, J MOL CATAL B-ENZYM, V40, P121, DOI 10.1016/j.molcatb.2006.02.019; Kontnik R, 2010, ACS CHEM BIOL, V5, P659, DOI 10.1021/cb100117k; Lai LST, 2005, ENZYME MICROB TECH, V36, P737, DOI 10.1016/j.enzmictec.2004.12.021; Lang G, 2008, J NAT PROD, V71, P1074, DOI 10.1021/np800053n; Lengyel K, 2005, SYST APPL MICROBIOL, V28, P115, DOI 10.1016/j.syapm.2004.10.004; LI JX, 1995, J NAT PRODUCTS, V58, P1081, DOI 10.1021/np50121a016; Li JX, 1997, CAN J MICROBIOL, V43, P770, DOI 10.1139/m97-110; Li Y, 2007, ENZYME MICROB TECH, V40, P1381, DOI 10.1016/j.enzmictec.2006.10.015; MAXWELL PW, 1994, APPL ENVIRON MICROB, V60, P715, DOI 10.1128/AEM.60.2.715-721.1994; MCINERNEY BV, 1991, J NAT PROD, V54, P785, DOI 10.1021/np50075a006; MCINERNEY BV, 1991, J NAT PROD, V54, P774, DOI 10.1021/np50075a005; Mudgetti R.E., 1986, MANUAL IND BIOTECHNO, P66; Ng KK, 1997, CAN J PLANT PATHOL, V19, P125, DOI 10.1080/07060669709500540; PAUL VJ, 1981, J CHEM ECOL, V7, P589, DOI 10.1007/BF00987707; Scherlach K, 2009, ORG BIOMOL CHEM, V7, P1753, DOI 10.1039/b821578b; Shapiro-Ilan David I., 2009, Archives of Phytopathology and Plant Protection, V42, P715, DOI 10.1080/03235400701390539; Wang YH, 2011, J BIOMED BIOTECHNOL, V100, P919; Wang YH, 2010, BIORESOURCE TECHNOL, V101, P7529, DOI 10.1016/j.biortech.2010.04.070; [王永宏 WANG Yonghong], 2006, [西北农林科技大学学报. 自然科学版, Journal of northwest sci-tech university of agriculture and forestry], V34, P174; Wolfe AJ, 2008, J BACTERIOL, V190, P2314, DOI 10.1128/JB.01906-07; YANG XF, 2001, CHIN MICROBIOL, V28, P12; Yang XiuFen, 2006, Chinese Journal of Biological Control, V22, P58; Zhang CH, 2009, BIORESOURCE TECHNOL, V100, P4284, DOI 10.1016/j.biortech.2009.03.022	36	10	13	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38421	10.1371/journal.pone.0038421	http://dx.doi.org/10.1371/journal.pone.0038421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701637	Green Published, Green Submitted, gold			2022-12-25	WOS:000305348400054
J	Nordstrom, I; Eriksson, K				Nordstrom, Inger; Eriksson, Kristina			HHV-6B Induces IFN-Lambda1 Responses in Cord Plasmacytoid Dendritic Cells through TLR9	PLOS ONE			English	Article							IFN-LAMBDA-S; INTERLEUKIN (IL)-28; III IFN; EXPRESSION; RECOGNITION; ALPHA; OLIGODEOXYNUCLEOTIDES; INFECTIONS; MODULATION; ACTIVATION	Human herpesvirus type 6B (HHV-6B) is a strong inducer of IFN-alpha and has the capacity to promote Th1 responses and block Th2 responses in vitro. In this study we addressed whether inactivated HHV-6B can also induce IFN lambda responses and to what extent interferons alpha and lambda affect Th1/Th2 polarization. We show that inactivated HHV-6B induced IFN-lambda1 (IL-29) but not IFN-lambda2 (IL-28A) responses in plasmacytoid DC and that this induction was mediated through TLR9. We have previously shown that HHV-6B promotes Th1 responses and blocks Th2 responses in both humans and mice. We now show that neutralization of IFN-alpha but not IFN-lambda1 blocked the HHV-6B-induced enhancement of Th1 responses in MLR, but did not affect the HHV-6-induced dampening of Th2 responses. Similarly, blockage of TLR9 counteracted HHV-6Bs effects on the Th1/Th2 balance. In addition, IFN-alpha but not IFN-lambda1 promoted IFN-gamma production and blocked IL-5 and IL-13 production in purified CD4+ T-cells. The lack of effect of IFN-lambda1 correlated with the absence of the IFN-lambda receptor IL-28Ralfa chain on the cell surface of both resting and activated CD4+ T-cells. We conclude that inactivated HHV-6B is a strong inducer of IFN-lambda1 in plasmacytoid DC and that this induction is TLR9-dependent. However, human CD4+ T-cells do not express the IFN-lambda receptor and are refractory to IFN-lambda1 treatment. The HHV-6B-induced alterations in the Th1/Th2 balance are instead mediated mainly through TLR9 and IFN-alpha.	[Nordstrom, Inger; Eriksson, Kristina] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Nordstrom, I (corresponding author), Univ Gothenburg, Dept Rheumatol & Inflammat Res, Sahlgrenska Acad, Gothenburg, Sweden.	kristina.eriksson@microbio.gu.se			Swedish Science Council; Cancer och Allergifonden; Petrus och Augusta Hedlunds Stiftelse; IngaBritt och Arne Lundbergs Forskningsstiftelse; Vastra Gotalandsregionen through the ALF	Swedish Science Council; Cancer och Allergifonden; Petrus och Augusta Hedlunds Stiftelse; IngaBritt och Arne Lundbergs Forskningsstiftelse; Vastra Gotalandsregionen through the ALF	These studies were supported by the Swedish Science Council, Cancer och Allergifonden, Petrus och Augusta Hedlunds Stiftelse, IngaBritt och Arne Lundbergs Forskningsstiftelse, and Vastra Gotalandsregionen through the ALF agreement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Arasteh J, 2010, IMMUNOPHARM IMMUNOT, V32, P339, DOI 10.3109/08923970903317445; Dai JH, 2009, BLOOD, V113, P5829, DOI 10.1182/blood-2008-09-179507; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; Farkas L, 2004, J ALLERGY CLIN IMMUN, V114, P436, DOI 10.1016/j.jaci.2004.04.035; Fiola S, 2010, J IMMUNOL, V185, P3620, DOI 10.4049/jimmunol.0903736; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Jordan WJ, 2007, GENES IMMUN, V8, P254, DOI 10.1038/sj.gene.6364382; Jordan WJ, 2007, GENES IMMUN, V8, P13, DOI 10.1038/sj.gene.6364348; Koltsida O, 2011, EMBO MOL MED, V3, P348, DOI 10.1002/emmm.201100142; Kotenko SV, 2011, CURR OPIN IMMUNOL, V23, P583, DOI 10.1016/j.coi.2011.07.007; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Lin SC, 2012, EUR J CLIN INVEST, V42, P61, DOI 10.1111/j.1365-2362.2011.02557.x; Liu BS, 2011, BLOOD, V117, P2385, DOI 10.1182/blood-2010-07-298976; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Megjugorac NJ, 2009, J LEUKOCYTE BIOL, V86, P1359, DOI 10.1189/jlb.0509347; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Nordstrom I, 2010, CLIN EXP ALLERGY, V40, P882, DOI 10.1111/j.1365-2222.2010.03491.x; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Peter M, 2008, IMMUNOLOGY, V123, P118, DOI 10.1111/j.1365-2567.2007.02718.x; Pien GC, 2002, J IMMUNOL, V169, P5827, DOI 10.4049/jimmunol.169.10.5827; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Srinivas S, 2008, IMMUNOLOGY, V125, P492, DOI 10.1111/j.1365-2567.2008.02862.x; Svensson A, 2011, SCAND J IMM IN PRESS; SVENSSON A, 2010, J ALLERGY THERAPY, V1, P101; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yu HR, 2011, CELL MOL IMMUNOL, V8, P181, DOI 10.1038/cmi.2010.84	29	10	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38683	10.1371/journal.pone.0038683	http://dx.doi.org/10.1371/journal.pone.0038683			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701693	gold, Green Published, Green Submitted			2022-12-25	WOS:000305348400085
J	Padilla-Gamino, JL; Pochon, X; Bird, C; Concepcion, GT; Gates, RD				Padilla-Gamino, Jacqueline L.; Pochon, Xavier; Bird, Christopher; Concepcion, Gregory T.; Gates, Ruth D.			From Parent to Gamete: Vertical Transmission of Symbiodinium (Dinophyceae) ITS2 Sequence Assemblages in the Reef Building Coral Montipora capitata	PLOS ONE			English	Article							ALGAL SYMBIOSIS; ACROPORA CORALS; PLANULA LARVAE; DIVERSITY; SPECIFICITY; ZOOXANTHELLAE; PATTERNS; ACQUISITION; CARBON; ASSOCIATIONS	Parental effects are ubiquitous in nature and in many organisms play a particularly critical role in the transfer of symbionts across generations; however, their influence and relative importance in the marine environment has rarely been considered. Coral reefs are biologically diverse and productive marine ecosystems, whose success is framed by symbiosis between reef-building corals and unicellular dinoflagellates in the genus Symbiodinium. Many corals produce aposymbiotic larvae that are infected by Symbiodinium from the environment (horizontal transmission), which allows for the acquisition of new endosymbionts (different from their parents) each generation. In the remaining species, Symbiodinium are transmitted directly from parent to offspring via eggs (vertical transmission), a mechanism that perpetuates the relationship between some or all of the Symbiodinium diversity found in the parent through multiple generations. Here we examine vertical transmission in the Hawaiian coral Montipora capitata by comparing the Symbiodinium ITS2 sequence assemblages in parent colonies and the eggs they produce. Parental effects on sequence assemblages in eggs are explored in the context of the coral genotype, colony morphology, and the environment of parent colonies. Our results indicate that ITS2 sequence assemblages in eggs are generally similar to their parents, and patterns in parental assemblages are different, and reflect environmental conditions, but not colony morphology or coral genotype. We conclude that eggs released by parent colonies during mass spawning events are seeded with different ITS2 sequence assemblages, which encompass phylogenetic variability that may have profound implications for the development, settlement and survival of coral offspring.	[Padilla-Gamino, Jacqueline L.; Pochon, Xavier; Bird, Christopher; Concepcion, Gregory T.; Gates, Ruth D.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Padilla-Gamino, Jacqueline L.] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; [Padilla-Gamino, Jacqueline L.] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; [Pochon, Xavier] Cawthron Inst, Aquaculture & Biotechnol Div, Nelson, New Zealand; [Concepcion, Gregory T.] Univ Maryland, College Pk, MD 20742 USA	University of Hawaii System; University of Hawaii System; University of Hawaii Manoa; University of California System; University of California Santa Barbara; Cawthron Institute; University System of Maryland; University of Maryland College Park	Padilla-Gamino, JL (corresponding author), Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA.	jacqueline.padilla.gamino@lifesci.ucsb.edu	Pochon, Xavier/K-5844-2019	Pochon, Xavier/0000-0001-9510-0407	Mexican National Council for Science and Technology (CONACyT); World Bank Coral Reef Targeted Research Project; Center for Microbial Oceanography Research and Education (C-MORE); National Science Foundation [OCE-0752604, OIA-0554657]; Swiss National Science Foundation [PGBEA-115118]; Edwin Pauley Foundation; Directorate For Geosciences [0752604] Funding Source: National Science Foundation	Mexican National Council for Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); World Bank Coral Reef Targeted Research Project; Center for Microbial Oceanography Research and Education (C-MORE); National Science Foundation(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Edwin Pauley Foundation; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	LPG was supported by the Mexican National Council for Science and Technology (CONACyT), the World Bank Coral Reef Targeted Research Project (www.gefcoral.org) and the Center for Microbial Oceanography Research and Education (C-MORE). The research was funded by the National Science Foundation (OCE-0752604 to RDG and OIA-0554657 administered by the University of Hawai'i), the Swiss National Science Foundation (PGBEA-115118 to XP), and the Edwin Pauley Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Abrego D, 2009, MOL ECOL, V18, P3532, DOI 10.1111/j.1365-294X.2009.04276.x; Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Badyaev AV, 2009, PHILOS T R SOC B, V364, P1169, DOI 10.1098/rstb.2008.0302; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Barneah O, 2004, MAR ECOL PROG SER, V275, P89, DOI 10.3354/meps275089; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; Concepcion GT, 2006, MOL ECOL NOTES, V6, P1208, DOI 10.1111/j.1471-8286.2006.01493.x; Correa AMS, 2009, CORAL REEFS, V28, P81, DOI 10.1007/s00338-008-0456-6; Cox EF, 2007, CORAL REEFS, V26, P721, DOI 10.1007/s00338-007-0251-9; Csaszar NBM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009751; Donelson JM, 2009, BIOL LETTERS, V5, P262, DOI 10.1098/rsbl.2008.0642; Donohue K, 2009, PHILOS T R SOC B, V364, P1059, DOI 10.1098/rstb.2008.0291; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Garren M, 2006, CORAL REEFS, V25, P503, DOI 10.1007/s00338-006-0146-1; Ginzburg LR, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P42; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; Heyward A.J., 1986, Hawaii Institute of Marine Biology Technical Report, P170; Hirose M, 2008, CORAL REEFS, V27, P247, DOI 10.1007/s00338-007-0330-y; Hirose M, 2001, CORAL REEFS, V20, P273; Hunter CL, 1988, P 6 INT COR REEF S, V2, P727; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Jokiel PL, 2004, GLOBAL CHANGE BIOL, V10, P1627, DOI 10.1111/j.1365-2486.2004.00836.x; JOKIEL PL, 1983, B MAR SCI, V33, P181; Kaniewska P, 2008, MAR BIOL, V155, P649, DOI 10.1007/s00227-008-1061-5; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P1158, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2004, CORAL REEFS, V23, P596, DOI 10.1007/s00338-004-0428-4; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Marshall DJ, 2008, OCEANOGR MAR BIOL, V46, P203, DOI 10.1201/9781420065756.ch5; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; MUSCATINE L, 1984, PROC R SOC SER B-BIO, V222, P181, DOI 10.1098/rspb.1984.0058; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Oliver TA, 2009, MAR ECOL PROG SER, V378, P93, DOI 10.3354/meps07871; Padilla-Gamino JL, 2011, CORAL REEFS, V30, P371, DOI 10.1007/s00338-010-0700-8; Padilla-Gamino JL, 2012, MAR ECOL PROG SER, V449, P145, DOI 10.3354/meps09530; Pochon X, 2006, MOL PHYLOGENET EVOL, V38, P20, DOI 10.1016/j.ympev.2005.04.028; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Pochon X, 2010, J PHYCOL, V46, P53, DOI 10.1111/j.1529-8817.2009.00797.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Santos Scott R., 2009, Galaxea - Tokyo, V11, P139; Smith DC, 1987, BIOL SYMBIOSIS; Stat M, 2008, CORAL REEFS, V27, P763, DOI 10.1007/s00338-008-0412-5; Stat M, 2008, P NATL ACAD SCI USA, V105, P9256, DOI 10.1073/pnas.0801328105; Stat Michael, 2011, Journal of Marine Biology, V2011, P1; Stat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015854; Stat M, 2009, MAR ECOL PROG SER, V386, P83, DOI 10.3354/meps08080; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Thompson JN, 1994, COEVOLUTIONARY PROCE; Thornhill DJ, 2006, CORAL REEFS, V25, P515, DOI 10.1007/s00338-006-0157-y; Ulstrup KE, 2003, MOL ECOL, V12, P3477, DOI 10.1046/j.1365-294X.2003.01988.x; van Oppen M, 2001, CORAL REEFS, V20, P200, DOI 10.1007/s003380100167; Van Oppen MJH, 2006, MOL ECOL, V15, P3863, DOI 10.1111/j.1365-294X.2006.03026.x; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733; Vautrin E, 2009, TRENDS MICROBIOL, V17, P95, DOI 10.1016/j.tim.2008.12.002; Wade MJ, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P5; Weis VM, 2001, CORAL REEFS, V20, P301, DOI 10.1007/s003380100179; WOLDA H, 1981, OECOLOGIA, V50, P296, DOI 10.1007/BF00344966; WULFF RD, 1986, J ECOL, V74, P99, DOI 10.2307/2260351	70	54	55	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38440	10.1371/journal.pone.0038440	http://dx.doi.org/10.1371/journal.pone.0038440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701642	Green Published, gold, Green Submitted			2022-12-25	WOS:000305348400058
J	Sellebjerg, F; Krakauer, M; Limborg, S; Hesse, D; Lund, H; Langkilde, A; Sondergaard, HB; Sorensen, PS				Sellebjerg, Finn; Krakauer, Martin; Limborg, Signe; Hesse, Dan; Lund, Henrik; Langkilde, Annika; Sondergaard, Helle Bach; Sorensen, Per Soelberg			Endogenous and Recombinant Type I Interferons and Disease Activity in Multiple Sclerosis	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; T-CELL-ACTIVATION; BETA TREATMENT; PERIPHERAL-BLOOD; DOUBLE-BLIND; IFN-BETA; CORRELATE; THERAPY; MS; PROLIFERATION	Although treatment of multiple sclerosis (MS) with the type I interferon (IFN) IFN-beta lowers disease activity, the role of endogenous type I IFN in MS remains controversial. We studied CD4+ T cells and CD4+ T cell subsets, monocytes and dendritic cells by flow cytometry and analysed the relationship with endogenous type I IFN-like activity, the effect of IFN-beta therapy, and clinical and magnetic resonance imaging (MRI) disease activity in MS patients. Endogenous type I IFN activity was associated with decreased expression of the integrin subunit CD49d (VLA-4) on CD4+ CD26(high) T cells (Th1 helper cells), and this effect was associated with less MRI disease activity. IFN-beta therapy reduced CD49d expression on CD4+ CD26(high) T cells, and the percentage of CD4+ CD26(high) T cells that were CD49d(high) correlated with clinical and MRI disease activity in patients treated with IFN-beta. Treatment with IFN-beta also increased the percentage of CD4+ T cells expressing CD71 and HLA-DR (activated T cells), and this was associated with an increased risk of clinical disease activity. In contrast, induction of CD71 and HLA-DR was not observed in untreated MS patients with evidence of endogenous type IFN I activity. In conclusion, the effects of IFN-beta treatment and endogenous type I IFN activity on VLA-4 expression are similar and associated with control of disease activity. However, immune-activating effects of treatment with IFN-beta may counteract the beneficial effects of treatment and cause an insufficient response to therapy.	[Sellebjerg, Finn; Krakauer, Martin; Limborg, Signe; Hesse, Dan; Sondergaard, Helle Bach; Sorensen, Per Soelberg] Copenhagen Univ Hosp, Rigshosp, Dept Neurol, Danish Multiple Sclerosis Ctr, Copenhagen, Denmark; [Lund, Henrik] Univ Copenhagen, Hvidovre Hosp, Danish Res Ctr Magnet Resonance, DK-2650 Hvidovre, Denmark; [Langkilde, Annika] Copenhagen Univ Hosp, Rigshosp, Dept Radiol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Sellebjerg, F (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Neurol, Danish Multiple Sclerosis Ctr, Copenhagen, Denmark.	sellebjerg@dadlnet.dk	Krakauer, Martin/M-4657-2019	Krakauer, Martin/0000-0002-2191-1861; Sorensen, Per Soelberg/0000-0002-2818-3780; Sellebjerg, Finn/0000-0002-1333-9623; Sondergaard, Helle Bach/0000-0001-9435-0658; Hesse, Dan/0000-0002-9670-6037	Danish Multiple Sclerosis Society; Warwara Larsen Foundation; Johnsen Foundation; Danish Council for Independent Research [271-06-0246]; Danish Council for Strategic Research [2142-08-0039]; Biogen Idec; Merck-Serono; Novartis; Sanofi-Aventis; Teva; Genmab; GSK; Bayer Schering; Baxter; BioMS; Bayer; RoFAR; Roche; Genzyme; Danish Medical Research Council; European Union Sixth Framework Programme: Life sciences, Genomics and Biotechnology for health	Danish Multiple Sclerosis Society; Warwara Larsen Foundation; Johnsen Foundation; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Biogen Idec(Biogen); Merck-Serono(Merck & Company); Novartis(Novartis); Sanofi-Aventis(Sanofi-Aventis); Teva(Teva Pharmaceutical Industries); Genmab(Genmab); GSK(GlaxoSmithKline); Bayer Schering(Bayer AG); Baxter; BioMS; Bayer(Bayer AG); RoFAR; Roche(Roche Holding); Genzyme(Sanofi-AventisGenzyme Corporation); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union Sixth Framework Programme: Life sciences, Genomics and Biotechnology for health	This study was supported by grants from the Danish Multiple Sclerosis Society, the Warwara Larsen Foundation, the Johnsen Foundation, the Danish Council for Independent Research [grant 271-06-0246] and the Danish Council for Strategic Research [grant 2142-08-0039]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Finn Sellebjerg has served on scientific advisory boards for and received funding for travel from Biogen Idec, Merck-Serono, Novartis, Sanofi-Aventis and Teva; served as a consultant for Biogen Idec and Novo Nordisk; received speaker honoraria from Bayer-Schering, Biogen Idec, Merck-Serono, Novartis, Sanofi-Aventis and Schering-Ploug; has received research support from Biogen Idec, Merck-Serono, Novartis and Sanofi-Aventis; and serves as section editor on Multiple Sclerosis and Related Disorders. Dan Hesse has received funding for travel from Biogen Idec, Merck-Serono, and Sanofi-Aventis; and received speaker honoraria from Sanofi-Aventis and Biogen Idec. Signe Limborg reports no disclosures. Helle Bach Sondergaard reports no disclosures. Martin Krakauer reports no disclosures. Per Soelberg Sorensen has served on scientific advisory boards Biogen Idec, Merck Serono, Novartis, Genmab, TEVA, Elan, GSK, has been on steering committees or independent data monitoring boards in clinical trials sponsored by Merck Serono, Genmab, TEVA, GSK, Bayer Schering, and has received funding of travel for these activities; has served as Editor-in-Chief of the European Journal of Neurology, and is editorial board member for Therapeutic Advances in Neurological Disorders and Multiple Sclerosis; has received speaker honoraria from Biogen Idec, Merck Serono, TEVA, Bayer Schering, Sanofi-aventis, and Novartis; and has received research support from Biogen Idec, Bayer Schering, Merck Serono, TEVA, Baxter, Sanofi-Aventis, BioMS, Novartis, Bayer, RoFAR, Roche, Genzyme, from the Danish Multiple Sclerosis Society, the Danish Medical Research Council, and the European Union Sixth Framework Programme: Life sciences, Genomics and Biotechnology for health. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials.	Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Barrau MA, 2000, J NEUROIMMUNOL, V111, P215, DOI 10.1016/S0165-5728(00)00357-X; Buttmann M, 2007, J NEUROIMMUNOL, V190, P170, DOI 10.1016/j.jneuroim.2007.08.009; Calabresi PA, 1997, NEUROLOGY, V49, P1111, DOI 10.1212/WNL.49.4.1111; Comabella M, 2009, BRAIN, V132, P3353, DOI 10.1093/brain/awp228; Dhib-Jalbut S, 2010, NEUROLOGY, V74, pS17, DOI 10.1212/WNL.0b013e3181c97d99; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; HAFLER DA, 1985, NEW ENGL J MED, V312, P1405, DOI 10.1056/NEJM198505303122201; Havenar-Daughton C, 2006, J IMMUNOL, V176, P3315, DOI 10.4049/jimmunol.176.6.3315; Hesse D, 2011, EUR J NEUROL, V18, P266, DOI 10.1111/j.1468-1331.2010.03116.x; Hesse D, 2010, NEUROLOGY, V74, P1455, DOI 10.1212/WNL.0b013e3181dc1a94; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Jensen J, 2006, J NEUROIMMUNOL, V179, P163, DOI 10.1016/j.jneuroim.2006.06.024; Jensen J, 2005, CYTOKINE, V29, P24, DOI 10.1016/j.cyto.2004.09.005; Jensen J, 2004, J NEUROIMMUNOL, V149, P202, DOI 10.1016/j.jneuroim.2003.12.019; Khoury SJ, 2000, ARCH NEUROL-CHICAGO, V57, P1183, DOI 10.1001/archneur.57.8.1183; Krakauer M, 2006, J NEUROIMMUNOL, V181, P157, DOI 10.1016/j.jneuroim.2006.09.006; Krakauer M, 2006, SCAND J IMMUNOL, V64, P155, DOI 10.1111/j.1365-3083.2006.01788.x; Krug A, 2003, J EXP MED, V197, P899, DOI 10.1084/jem.20021091; Lombardi G, 2000, J IMMUNOL, V165, P3782, DOI 10.4049/jimmunol.165.7.3782; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Michel L, 2008, J CLIN INVEST, V118, P3411, DOI 10.1172/JCI35365; Ossege LM, 2001, INT IMMUNOPHARMACOL, V1, P1085, DOI 10.1016/S1567-5769(01)00039-X; Ravnborg M, 2010, LANCET NEUROL, V9, P672, DOI 10.1016/S1474-4422(10)70132-0; Sellebjerg F, 2008, MULT SCLER J, V14, P615, DOI 10.1177/1352458507085976; Sellebjerg F, 2005, MULT SCLER J, V11, P641, DOI 10.1191/1352458505ms1217oa; Sellebjerg F, 2009, EUR J NEUROL, V16, P1291, DOI 10.1111/j.1468-1331.2009.02716.x; Sorensen PS, 2009, LANCET NEUROL, V8, P519, DOI 10.1016/S1474-4422(09)70085-7; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; van Baarsen LGM, 2006, GENES IMMUN, V7, P522, DOI 10.1038/sj.gene.6364324; van der Voort LF, 2010, NEUROLOGY, V75, P1228, DOI 10.1212/WNL.0b013e3181f6c556; Weinberg Andrew D., 2005, Current Drug Targets - Inflammation and Allergy, V4, P195, DOI 10.2174/1568010053586345; Weinstock-Guttman B, 2003, J IMMUNOL, V171, P2694, DOI 10.4049/jimmunol.171.5.2694; Weinstock-Guttman B, 2008, J NEUROIMMUNOL, V205, P113, DOI 10.1016/j.jneuroim.2008.09.004; Wiesemann E, 2008, MULT SCLER J, V14, P166, DOI 10.1177/1352458507081342; Yamaguchi KD, 2008, J NEUROIMMUNOL, V195, P116, DOI 10.1016/j.jneuroim.2007.12.007	38	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e35927	10.1371/journal.pone.0035927	http://dx.doi.org/10.1371/journal.pone.0035927			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701554	Green Published, gold, Green Submitted			2022-12-25	WOS:000305348400004
J	Garcia, I; Crowther, AJ; Gama, V; Miller, CR; Deshmukh, M; Gershon, TR				Garcia, I.; Crowther, A. J.; Gama, V.; Miller, C. Ryan; Deshmukh, M.; Gershon, T. R.			Bax deficiency prolongs cerebellar neurogenesis, accelerates medulloblastoma formation and paradoxically increases both malignancy and differentiation	ONCOGENE			English	Article						Bax; CGNPs; cerebellar neurogenesis; medulloblastoma; SmoA1 transgenic mouse	PROGRAMMED CELL-DEATH; KNOCK-OUT MICE; SONIC HEDGEHOG; NERVOUS-SYSTEM; POSTNATAL-DEVELOPMENT; TUMOR SUPPRESSORS; GRANULE CELLS; BCL-2 FAMILY; MOUSE MODEL; DAP-KINASE	Neurogenesis requires negative regulation through differentiation of progenitors or their programmed cell death (PCD). Growth regulation is particularly important in the postnatal cerebellum, where excessive progenitor proliferation promotes medulloblastoma, the most common malignant brain tumor in children. We present evidence that PCD operates alongside differentiation to regulate cerebellar granule neuron progenitors (CGNPs) and to prevent medulloblastoma. Here, we show that genetic deletion of pro-apoptotic Bax disrupts regulation of cerebellar neurogenesis and promotes medulloblastoma formation. In Bax(-/-) mice, the period of neurogenesis was extended into the third week of postnatal life, and ectopic neurons and progenitors collected in the molecular layer of the cerebellum and adjacent tectum. Importantly, genetic deletion of Bax in medulloblastoma-prone ND2:SmoA1 transgenic mice greatly accelerated tumorigenesis. Bax-deficient medulloblastomas exhibited strikingly distinct pathology, with reduced apoptosis, increased neural differentiation and tectal migration. Comparing Bax(-/-) and Bax(-/-) medulloblastomas, we were able to identify upregulation of Bcl-2 and nuclear exclusion of p27 as tumorigenic changes that are required to mitigate the tumor suppressive effect of Bax. Studies on human tumors confirmed the importance of modulating Bax in medulloblastoma pathogenesis. Our results demonstrate that Bax-dependent apoptosis regulates postnatal cerebellar neurogenesis, suppresses medulloblastoma formation and imposes selective pressure on tumors that form. Functional resistance to Bax-mediated apoptosis, required for medulloblastoma tumorigenesis, may be a tumor-specific vulnerability to be exploited for therapeutic benefit.	[Garcia, I.; Crowther, A. J.; Miller, C. Ryan; Gershon, T. R.] Univ N Carolina, Sch Med, Dept Neurol, Chapel Hill, NC 27599 USA; [Gama, V.; Deshmukh, M.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Miller, C. Ryan] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Div Neuropathol, Chapel Hill, NC 27599 USA; [Miller, C. Ryan; Deshmukh, M.; Gershon, T. R.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Miller, C. Ryan; Deshmukh, M.; Gershon, T. R.] Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Gershon, TR (corresponding author), Univ N Carolina, Sch Med, Dept Neurol, 170 Manning Dr CB7025, Chapel Hill, NC 27599 USA.	gershont@neurology.unc.edu	, Pathology Services Core/CEZ-2246-2022; Gershon, Timothy/H-5398-2019; Miller, Ryan/B-9365-2008	Gershon, Timothy/0000-0001-7034-6400; Miller, Ryan/0000-0002-0096-8762; Crowther, Andrew/0000-0001-9269-6188; Gama, Vivian/0000-0002-1201-1394	National Cancer Institute [3P30CA016086]; National Institute of Environmental Health Sciences [3P30ES010126]; Department of Defense [W81XWH-09-2-0042]; UNC University Cancer Research Fund (UCRF); Clinical Investigator award from the Damon Runyon Cancer Research Foundation [CI-45-09]; St Baldrick's Foundation; Morgan Adams Foundation; Matthew Larson Brain Tumor Foundation; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS077978] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Department of Defense(United States Department of Defense); UNC University Cancer Research Fund (UCRF); Clinical Investigator award from the Damon Runyon Cancer Research Foundation; St Baldrick's Foundation; Morgan Adams Foundation; Matthew Larson Brain Tumor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank James Olson, Fred Hutchinson Cancer Research Center for generously sharing ND2:SmoA1 mice; and Mervi Eeva, Jackie Kylander and Stephanie Cohen in the UNC Translational Pathology Laboratory (TPL) for expert technical assistance. The UNC TPL is supported, in part, by grants from the National Cancer Institute (3P30CA016086), National Institute of Environmental Health Sciences (3P30ES010126), Department of Defense (W81XWH-09-2-0042), and the UNC University Cancer Research Fund (UCRF). CRM is supported in part by a Clinical Investigator award from the Damon Runyon Cancer Research Foundation (CI-45-09). TRG is supported by a Scholar Award from the St Baldrick's Foundation. Major portions of this work were supported by the Morgan Adams Foundation and the Matthew Larson Brain Tumor Foundation.	Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Ayrault O, 2009, MOL CANCER RES, V7, P33, DOI 10.1158/1541-7786.MCR-08-0369; Bhatia B, 2010, CELL CYCLE, V9, P4307, DOI 10.4161/cc.9.21.13441; Bolduc ME, 2011, DEV MED CHILD NEUROL, V53, P409, DOI 10.1111/j.1469-8749.2011.03929.x; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Di Marcotullio L, 2004, P NATL ACAD SCI USA, V101, P10833, DOI 10.1073/pnas.0400690101; Dicou E, 2009, INT J DEV NEUROSCI, V27, P299, DOI 10.1016/j.ijdevneu.2009.02.005; Fan HB, 2001, J COMP NEUROL, V436, P82; Gershon TR, 2006, CURR NEUROL NEUROSCI, V6, P200, DOI 10.1007/s11910-006-0006-y; Gershon TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007491; Guenebeaud C, 2010, MOL CELL, V40, P863, DOI 10.1016/j.molcel.2010.11.021; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Heine VM, 2009, J CLIN INVEST, V119, P267, DOI 10.1172/JCI36376; Jung AR, 2008, J NEUROSCI, V28, P2941, DOI 10.1523/JNEUROSCI.3897-07.2008; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Kessler JD, 2009, GENE DEV, V23, P157, DOI 10.1101/gad.1759909; Kim WR, 2007, J NEUROSCI, V27, P14392, DOI 10.1523/JNEUROSCI.3903-07.2007; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Lindsten T, 2005, NEUROSCIENTIST, V11, P10, DOI 10.1177/1073858404269267; Lindsten T, 2003, J NEUROSCI, V23, P11112; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Llambi F, 2005, EMBO J, V24, P1192, DOI 10.1038/sj.emboj.7600584; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Noguchi KK, 2008, CELL DEATH DIFFER, V15, P1582, DOI 10.1038/cdd.2008.97; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Packer RJ, 2008, J CHILD NEUROL, V23, P1122, DOI 10.1177/0883073808320758; Parathath SR, 2010, CELL CYCLE, V9, P4013, DOI 10.4161/cc.9.19.13325; Pfaff E, 2010, J CLIN ONCOL, V28, P5188, DOI 10.1200/JCO.2010.31.1670; Preusser M, 2011, ANN NEUROL, V70, P9, DOI 10.1002/ana.22425; Sato T, 2008, MOL CELL NEUROSCI, V39, P569, DOI 10.1016/j.mcn.2008.08.003; Tanaka S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005922; Uziel T, 2005, GENE DEV, V19, P2656, DOI 10.1101/gad.1368605; Valerie AW, 1999, CURR BIOL, V9, P445; Wang H, 2008, BIOCHEM BIOPH RES CO, V370, P594, DOI 10.1016/j.bbrc.2008.03.152; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0	39	20	20	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2013	32	18					2304	2314		10.1038/onc.2012.248	http://dx.doi.org/10.1038/onc.2012.248			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	140VF	22710714	Green Submitted, Green Accepted			2022-12-25	WOS:000318683600007
J	Calhabeu, F; Hayashi, S; Morgan, JE; Relaix, F; Zammit, PS				Calhabeu, F.; Hayashi, S.; Morgan, J. E.; Relaix, F.; Zammit, P. S.			Alveolar rhabdomyosarcoma-associated proteins PAX3/FOXO1A and PAX7/FOXO1A suppress the transcriptional activity of MyoD-target genes in muscle stem cells	ONCOGENE			English	Article						alveolar rhabdomyosarcoma; PAX3/FOXO1A; PAX7/FOXO1A; MyoD; myogenin; satellite cell	PAX3-FKHR FUSION PROTEIN; SKELETAL-MUSCLE; SATELLITE CELLS; PROGENITOR CELLS; MYOGENIC DIFFERENTIATION; TERMINAL DIFFERENTIATION; FAMILY-MEMBERS; IN-VIVO; PAX3; EXPRESSION	Rhabdomyosarcoma (RMS) is the commonest soft-tissue sarcoma in childhood and is characterized by expression of myogenic proteins, including the transcription factors MyoD and myogenin. There are two main subgroups, embryonal RMS and alveolar RMS (ARMS). Most ARMS are associated with chromosomal translocations that have breakpoints in introns of either PAX3 or PAX7, and FOXO1A. These translocations create chimeric transcription factors termed PAX3/FOXO1A and PAX7/FOXO1A respectively. Upon ectopic PAX3/FOXO1A expression, together with other genetic manipulation in mice, both differentiating myoblasts and satellite cells (the resident stem cells of postnatal muscle) can give rise to tumours with ARMS characteristics. As PAX3 and PAX7 are part of transcriptional networks that regulate muscle stem cell function in utero and during early postnatal life, PAX3/FOXO1A and PAX7/FOXO1A may subvert normal PAX3 and PAX7 functions. Here we examined how PAX3/FOXO1A and PAX7/FOXO1A affect myogenesis in satellite cells. PAX3/FOXO1A or PAX7/FOXO1A inhibited myogenin expression and prevented terminal differentiation in nnurine satellite cells: the same effect as dominant-negative (DN) Pax3 or Pax7 constructs. The transcription of MyoD-target genes myogenin and muscle creatine kinase were suppressed by PAX3/FOXO1A or PAX7/FOXO1A in C2C12 myogenic cells again as seen with Pax3/7DN. PAX3/FOXO1A or PAX7/FOXO1A did not inhibit the transcriptional activity of MyoD by perturbing MyoD expression, localization, phosphorylation or interaction with E-proteins. Chromatin immunoprecipitation on the myogenin promoter showed that PAX3/FOXO1A or PAX7/FOXO1A did not prevent MyoD from binding. However, PAX3/FOXO1A or PAX7/FOXO1A reduced occupation of the myogenin promoter by RNA polynnerase II and decreased acetylation of histone H4, but did not directly bind to the myogenin promoter. Together, these observations reveal that PAX3/FOXO1A and PAX7/FOXO1A act to prevent myogenic differentiation via suppression of the transcriptional activation of MyoD-target genes. Oncogene (2013) 32, 651-662; doi:10.1038/onc.2012.73; published online 18 June 2012	[Calhabeu, F.; Zammit, P. S.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Hayashi, S.; Relaix, F.] Univ Paris 06, INSERM, UMR S 787,Fac Med Pitie Salpetriere, Myol Grp,Avenir Team Mouse Mol Genet, Paris, France; [Morgan, J. E.] UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England	University of London; King's College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London	Zammit, PS (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, New Hunts House,Guys Campus, London SE1 1UL, England.	peter.zammit@kcl.ac.uk	Zammit, peter/GXV-7746-2022	Hayashi, Shinichiro/0000-0001-5553-7698; zammit, peter/0000-0001-9562-3072; Relaix, Frederic/0000-0003-1270-1472	Association of International Cancer Research [07-0151]; Wellcome Trust [085137/Z/08/Z]; Medical Research Council; OPTISTEM European Commission [223098]; Wellcome Trust; INSERM Avenir Program; AFM; INCa; LNCC; ARC; FP7 ENDOSTEM [241440]	Association of International Cancer Research; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); OPTISTEM European Commission; Wellcome Trust(Wellcome Trust); INSERM Avenir Program(Institut National de la Sante et de la Recherche Medicale (Inserm)); AFM(Association Francaise contre les Myopathies); INCa(Institut National du Cancer (INCA) France); LNCC; ARC(Australian Research Council); FP7 ENDOSTEM	We thank Frederic Barr for PAX3-FOXO1A and PAX7-FOXO1A, and Stephen Tapscott for pcIBabe-MyoD similar to E12 and pC52-MCK-luciferase. We acknowledge colleagues who shared antibodies through the Developmental Studies Hybridoma Bank maintained by the University of Iowa. FC was funded by the Association of International Cancer Research (07-0151). The laboratory of PSZ is also supported by The Wellcome Trust (085137/Z/08/Z), The Medical Research Council and OPTISTEM (Grant 223098) from the European Commission FP7. JEM is supported by a Wellcome Trust University Award. The laboratory of FR is supported by the INSERM Avenir Program, AFM, INCa, LNCC, ARC and FP7 ENDOSTEM (Grant 241440).	Arndt CAS, 1999, NEW ENGL J MED, V341, P342, DOI 10.1056/NEJM199907293410507; Bajard L, 2006, GENE DEV, V20, P2450, DOI 10.1101/gad.382806; Barr FG, 2001, ONCOGENE, V20, P5736, DOI 10.1038/sj.onc.1204599; Begum S, 2005, ONCOGENE, V24, P1860, DOI 10.1038/sj.onc.1208315; Bennicelli JL, 1999, ONCOGENE, V18, P4348, DOI 10.1038/sj.onc.1202812; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Cao LA, 2010, CANCER RES, V70, P6497, DOI 10.1158/0008-5472.CAN-10-0582; Collins CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004475; Cui S, 1999, PATHOL INT, V49, P62, DOI 10.1046/j.1440-1827.1999.00825.x; Davicioni E, 2006, CANCER RES, V66, P6936, DOI 10.1158/0008-5472.CAN-05-4578; del Peso L, 1999, ONCOGENE, V18, P7328, DOI 10.1038/sj.onc.1203159; Dilworth FJ, 2004, P NATL ACAD SCI USA, V101, P11593, DOI 10.1073/pnas.0404192101; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Epstein JA, 1998, MOL CELL BIOL, V18, P4118, DOI 10.1128/MCB.18.7.4118; EPSTEIN JA, 1995, J BIOL CHEM, V270, P11719, DOI 10.1074/jbc.270.20.11719; Finckenstein FG, 2008, ONCOGENE, V27, P2004, DOI 10.1038/sj.onc.1210835; FREDERICKS WJ, 1995, MOL CELL BIOL, V15, P1522; Gnocchi VF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005205; GUO K, 1995, MOL CELL BIOL, V15, P3823; Gurney JG, 1999, CANC INCIDENCE SURVI, P111; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Hettmer S, 2010, NAT MED, V16, P171, DOI 10.1038/nm0210-171; Horst D, 2006, INT J DEV BIOL, V50, P47, DOI 10.1387/ijdb.052111dh; Keller C, 2004, GENE DEV, V18, P2608, DOI 10.1101/gad.1243904; Kelly KM, 1997, J CLIN ONCOL, V15, P1831, DOI 10.1200/JCO.1997.15.5.1831; Khan J, 1999, P NATL ACAD SCI USA, V96, P13264, DOI 10.1073/pnas.96.23.13264; L'honore A, 2007, MOL BIOL CELL, V18, P1992, DOI 10.1091/mbc.E06-09-0867; Lagha M, 2008, GENE DEV, V22, P1828, DOI 10.1101/gad.477908; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Maroto M, 1997, CELL, V89, P139, DOI 10.1016/S0092-8674(00)80190-7; Miller PJ, 2007, BBA-GEN SUBJECTS, V1770, P1450, DOI 10.1016/j.bbagen.2007.06.016; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Nishijo K, 2009, FASEB J, V23, P2681, DOI 10.1096/fj.08-128116; Ono Y, 2010, DEV BIOL, V337, P29, DOI 10.1016/j.ydbio.2009.10.005; Ornatsky OI, 1997, J BIOL CHEM, V272, P33271, DOI 10.1074/jbc.272.52.33271; Otten AD, 1997, CELL GROWTH DIFFER, V8, P1151; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; Relaix F, 2003, GENE DEV, V17, P2950, DOI 10.1101/gad.281203; Russo S, 1998, J CELL SCI, V111, P691; Saccone V, 2010, ORGANOGENESIS, V6, P48, DOI 10.4161/org.6.1.11293; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Scuoppo C, 2007, EXP CELL RES, V313, P2308, DOI 10.1016/j.yexcr.2007.02.037; Song A, 1998, MOL CELL BIOL, V18, P4994, DOI 10.1128/MCB.18.9.4994; Spitz F, 1998, P NATL ACAD SCI USA, V95, P14220, DOI 10.1073/pnas.95.24.14220; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; TAPSCOTT SJ, 1993, SCIENCE, V259, P1450, DOI 10.1126/science.8383879; Wei Q, 2001, FEBS LETT, V490, P171, DOI 10.1016/S0014-5793(01)02120-2; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Weintraub M, 1997, Sarcoma, V1, P135, DOI 10.1080/13577149778218; Yang ZH, 2009, GENE DEV, V23, P694, DOI 10.1101/gad.1765109; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zhang L, 2007, ONCOGENE, V26, P1595, DOI 10.1038/sj.onc.1209958	58	45	47	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN 31	2013	32	5					651	662		10.1038/onc.2012.73	http://dx.doi.org/10.1038/onc.2012.73			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	106SJ	22710712				2022-12-25	WOS:000316164700012
J	Lecat, A; Di Valentin, E; Somja, J; Jourdan, S; Fillet, M; Kufer, TA; Habraken, Y; Sadzot, C; Louis, E; Delvenne, P; Piette, J; Legrand-Poels, S				Lecat, Aurore; Di Valentin, Emmanuel; Somja, Joan; Jourdan, Samuel; Fillet, Marianne; Kufer, Thomas A.; Habraken, Yvette; Sadzot, Catherine; Louis, Edouard; Delvenne, Philippe; Piette, Jacques; Legrand-Poels, Sylvie			The c-Jun N-terminal Kinase (JNK)-binding Protein (JNKBP1) Acts as a Negative Regulator of NOD2 Protein Signaling by Inhibiting Its Oligomerization Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURAMYL DIPEPTIDE RECOGNITION; INTESTINAL EPITHELIAL-CELLS; KAPPA-B ACTIVATION; CROHNS-DISEASE; PANETH CELLS; EXPRESSION; INNATE; GENE; SUSCEPTIBILITY; RECRUITMENT	NOD2 is one of the best characterized members of the cytosolic NOD-like receptor family. NOD2 is able to sense muramyl dipeptide, a specific bacterial cell wall component, and to subsequently induce various signaling pathways leading to NF-kappa B activation and autophagy, both events contributing to an efficient innate and adaptive immune response. Interestingly, loss-of-function NOD2 variants were associated with a higher susceptibility for Crohn disease, which highlights the physiological importance of proper regulation of NOD2 activity. We performed a biochemical screen to search for new NOD2 regulators. We identified a new NOD2 partner, c-Jun N-terminal kinase-binding protein 1 (JNKBP1), a scaffold protein characterized by an N-terminal WD-40 domain. JNKBP1, through its WD-40 domain, binds to NOD2 following muramyl dipeptide activation. This interaction attenuates NOD2-mediated NF-kappa B activation and IL-8 secretion as well as NOD2 antibacterial activity. JNKBP1 exerts its repressor effect by disturbing NOD2 oligomerization and RIP2 tyrosine phosphorylation, both steps required for downstream NOD2 signaling. We furthermore showed that JNKBP1 and NOD2 are co-expressed in the human intestinal epithelium and in immune cells recruited in the lamina propria, which suggests that JNKBP1 contributes to maintain NOD2-mediated intestinal immune homeostasis.	[Lecat, Aurore; Di Valentin, Emmanuel; Habraken, Yvette; Sadzot, Catherine; Piette, Jacques; Legrand-Poels, Sylvie] Univ Liege, GIGA R, Lab Virol & Immunol, B-4000 Liege, Belgium; [Somja, Joan; Delvenne, Philippe] Univ Liege, Dept Anat & Pathol Cytol, B-4000 Liege, Belgium; [Jourdan, Samuel] Univ Liege, Inst Chim B6a, Ctr Prot Engn, B-4000 Liege, Belgium; [Fillet, Marianne] Univ Liege, Dept Pharmaceut Analyt Chem, B-4000 Liege, Belgium; [Louis, Edouard] Univ Liege, Dept Gastroenterol, B-4000 Liege, Belgium; [Kufer, Thomas A.] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50935 Cologne, Germany	University of Liege; University of Liege; University of Liege; University of Liege; University of Liege; University of Cologne	Legrand-Poels, S (corresponding author), Univ Liege, GIGA R, Lab Virol & Immunol, B-4000 Liege, Belgium.	S.Legrand@ulg.ac.be	Kufer, Thomas A/I-5146-2015	Kufer, Thomas A/0000-0003-4563-0412; Di Valentin, Emmanuel/0000-0002-5287-7950; Jourdan, Samuel/0000-0001-8270-3620; Fillet, Marianne/0000-0002-1453-6282	"Fonds Speciaux de l'Universite de Liege" (Credit d'Impulsion); "Fonds pour la Recherche dans l'Industrie et l'Agriculture" (FRIA, Brussels, Belgium); "Fonds National pour la Recherche Scientifique" (FNRS, Brussels, Belgium); Leon Fredericq Foundation (University of Liege, Belgium); Inter-University Attraction Poles (Brussels, Belgium) [IAP6/18]; Deutsche Forschungsgemeinschaft [SFB670-N01]	"Fonds Speciaux de l'Universite de Liege" (Credit d'Impulsion); "Fonds pour la Recherche dans l'Industrie et l'Agriculture" (FRIA, Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS); "Fonds National pour la Recherche Scientifique" (FNRS, Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS); Leon Fredericq Foundation (University of Liege, Belgium)(University of Liege); Inter-University Attraction Poles (Brussels, Belgium)(Belgian Federal Science Policy Office); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the "Fonds Speciaux de l'Universite de Liege" (Credit d'Impulsion), by the "Fonds pour la Recherche dans l'Industrie et l'Agriculture" (FRIA, Brussels, Belgium), by the "Fonds National pour la Recherche Scientifique" (FNRS, Brussels, Belgium), by the Leon Fredericq Foundation (University of Liege, Belgium), and by the Inter-University Attraction Poles (IAP6/18) (Brussels, Belgium).; Supported by Deutsche Forschungsgemeinschaft Grant SFB670-N01.	Anand PK, 2011, J BIOL CHEM, V286, P42981, DOI 10.1074/jbc.M111.310599; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Bielig H, 2009, MOL IMMUNOL, V46, P2647, DOI 10.1016/j.molimm.2009.04.022; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kim JY, 2008, J BIOL CHEM, V283, P137, DOI 10.1074/jbc.M704746200; Kim YG, 2011, IMMUNITY, V34, P769, DOI 10.1016/j.immuni.2011.04.013; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Koyano S, 1999, FEBS LETT, V457, P385, DOI 10.1016/S0014-5793(99)01084-4; Kufer TA, 2008, CELL MICROBIOL, V10, P477, DOI 10.1111/j.1462-5822.2007.01062.x; Lala S, 2003, GASTROENTEROLOGY, V125, P47, DOI 10.1016/S0016-5085(03)00661-9; Lecat A, 2010, BIOCHEM PHARMACOL, V80, P2021, DOI 10.1016/j.bcp.2010.07.016; Lipinski S, 2009, J CELL SCI, V122, P3522, DOI 10.1242/jcs.050690; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Perez LH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010915; Rosenstiel P, 2003, GASTROENTEROLOGY, V124, P1001, DOI 10.1053/gast.2003.50157; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Tattoli I, 2007, SEMIN IMMUNOPATHOL, V29, P289, DOI 10.1007/s00281-007-0083-2; Tigno-Aranjuez JT, 2010, GENE DEV, V24, P2666, DOI 10.1101/gad.1964410; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Werts C, 2007, EUR J IMMUNOL, V37, P2499, DOI 10.1002/eji.200737069; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704; Yamaguchi T, 2009, CELL BIOL INT, V33, P364, DOI 10.1016/j.cellbi.2009.01.003	36	19	21	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29213	29226		10.1074/jbc.M112.355545	http://dx.doi.org/10.1074/jbc.M112.355545			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22700971	Green Published, hybrid			2022-12-25	WOS:000308286900001
J	Corradi, V; Singh, G; Tieleman, DP				Corradi, Valentina; Singh, Gurpreet; Tieleman, D. Peter			The Human Transporter Associated with Antigen Processing MOLECULAR MODELS TO DESCRIBE PEPTIDE BINDING COMPETENT STATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN DOCKING; OUTWARD FACING STATE; HUMAN P-GLYCOPROTEIN; MHC CLASS-I; ABC-TRANSPORTER; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; CASSETTE TRANSPORTERS; STRUCTURE VALIDATION; AUTOMATED DOCKING	The human transporter associated with antigen processing (TAP) is a member of the ATP binding cassette (ABC) transporter superfamily. TAP plays an essential role in the antigen presentation pathway by translocating cytosolic peptides derived from proteasomal degradation into the endoplasmic reticulum lumen. Here, the peptides are loaded into major histocompatibility class I molecules to be in turn exposed at the cell surface for recognition by T-cells. TAP is a heterodimer formed by the association of two half-transporters, TAP1 and TAP2, with a typical ABC transporter core that consists of two nucleotide binding domains and two transmembrane domains. Despite the availability of biological data, a full understanding of the mechanism of action of TAP is limited by the absence of experimental structures of the full-length transporter. Here, we present homology models of TAP built on the crystal structures of P-glycoprotein, ABCB10, and Sav1866. The models represent the transporter in inward-and outward-facing conformations that could represent initial and final states of the transport cycle, respectively. We described conserved regions in the endoplasmic reticulum-facing loops with a role in the opening and closing of the cavity. We also identified conserved pi-stacking interactions in the cytosolic part of the transmembrane domains that could explain the experimental data available for TAP1-Phe265. Electrostatic potential calculations gave structural insights into the role of residues involved in peptide binding, such as TAP1-Val-288, TAP2-Cys-213, TAP2-Met-218. Moreover, these calculations identified additional residues potentially involved in peptide binding, in turn verified with replica exchange simulations performed on a peptide bound to the inward-facing models.	[Tieleman, D. Peter] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; Univ Calgary, Inst Biocomplex & Informat, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	Tieleman, DP (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	tieleman@ucalgary.ca	Tieleman, D. Peter/A-4790-2011; Corradi, Valentina/N-9312-2019; Singh, Gurpreet/S-7265-2019; Corradi, Valentina/G-3937-2017	Tieleman, D. Peter/0000-0001-5507-0688; Singh, Gurpreet/0000-0002-6091-6411; 	Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes for Health Research.	Aisenbrey C, 2006, J BIOL CHEM, V281, P30365, DOI 10.1074/jbc.M603000200; Alexander C, 2009, BIOCHEMISTRY-US, V48, P10078, DOI 10.1021/bi901314c; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDROLEWICZ MJ, 1994, IMMUNITY, V1, P7, DOI 10.1016/1074-7613(94)90004-3; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Armandola EA, 1996, EUR J IMMUNOL, V26, P1748, DOI 10.1002/eji.1830260813; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baldauf C, 2010, P NATL ACAD SCI USA, V107, P9135, DOI 10.1073/pnas.1001308107; Beinert D, 1997, BIOCHEMISTRY-US, V36, P4694, DOI 10.1021/bi962940v; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bessadok A, 2011, J BIOL CHEM, V286, P3552, DOI 10.1074/jbc.M110.155200; Borst P, 2000, BBA-MOL CELL BIOL L, V1486, P128, DOI 10.1016/S1388-1981(00)00053-6; Campbell JD, 2003, EMBO REP, V4, P1038, DOI 10.1038/sj.embor.7400003; Chen R, 2002, PROTEINS, V47, P281, DOI 10.1002/prot.10092; Chen R, 2011, J PHYS CHEM B, V115, P1038, DOI 10.1021/jp110002q; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2005, METHOD ENZYMOL, V400, P409, DOI 10.1016/S0076-6879(05)00024-8; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; DeGorter MK, 2008, BIOCHEM BIOPH RES CO, V365, P29, DOI 10.1016/j.bbrc.2007.10.141; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Denschlag R, 2009, CHEM PHYS LETT, V473, P193, DOI 10.1016/j.cplett.2009.03.053; Deverson EV, 1998, J IMMUNOL, V160, P2767; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eckford PDW, 2010, BIOCHEM J, V429, P195, DOI 10.1042/BJ20100144; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Galocha B, 1997, J EXP MED, V185, P1565, DOI 10.1084/jem.185.9.1565; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+; Gaudet R, 2001, TECHNOL REV, V104, P20; Globisch C, 2008, CHEMMEDCHEM, V3, P280, DOI 10.1002/cmdc.200700249; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Gromme M, 1997, EUR J IMMUNOL, V27, P898, DOI 10.1002/eji.1830270415; Haffke M, 2010, ACTA CRYSTALLOGR D, V66, P979, DOI 10.1107/S0907444910028593; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Herget M, 2007, J BIOL CHEM, V282, P3871, DOI 10.1074/jbc.M608480200; Herget M, 2011, P NATL ACAD SCI USA, V108, P1349, DOI 10.1073/pnas.1012355108; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Koch J, 2005, FEBS LETT, V579, P4413, DOI 10.1016/j.febslet.2005.07.006; Koch J, 2004, J BIOL CHEM, V279, P10142, DOI 10.1074/jbc.M312816200; Koopmann JO, 1996, EUR J IMMUNOL, V26, P1720, DOI 10.1002/eji.1830260809; Lankat-Buttgereit B, 2002, PHYSIOL REV, V82, P187, DOI 10.1152/physrev.00025.2001; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Leonhardt RM, 2005, J IMMUNOL, V175, P5104, DOI 10.4049/jimmunol.175.8.5104; LI SC, 1992, FEBS LETT, V311, P217, DOI 10.1016/0014-5793(92)81106-V; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; Momburg F, 1996, J IMMUNOL, V156, P1756; Moody JE, 2005, J BIOENERG BIOMEMBR, V37, P475, DOI 10.1007/s10863-005-9494-8; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Neumann L, 1997, J MOL BIOL, V272, P484, DOI 10.1006/jmbi.1997.1282; Neves-Petersen MT, 2003, BIOTECHNOL ANN REV, V9, P315, DOI 10.1016/S1387-2656(03)09010-0; Nijenhuis M, 1996, J IMMUNOL, V157, P5467; Norel R, 2001, PROTEIN SCI, V10, P2147, DOI 10.1110/ps.12901; O'Mara ML, 2007, FEBS LETT, V581, P4217, DOI 10.1016/j.febslet.2007.07.069; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfander R, 1999, BIOCHEMISTRY-US, V38, P13692, DOI 10.1021/bi9909647; Pleban K, 2005, MOL PHARMACOL, V67, P365, DOI 10.1124/mol.104.006973; Procko E, 2005, IMMUNOL CELL BIOL, V83, P475, DOI 10.1111/j.1440-1711.2005.01354.x; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; Qian F, 2006, BIOCHEMISTRY-MOSCOW+, V71, pS18, DOI 10.1134/S0006297906130037; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; RAVIV Y, 1990, J BIOL CHEM, V265, P3975; Ravna AW, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-33; Ravna AW, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-20; Ravna AW, 2008, BIOORG MED CHEM LETT, V18, P3481, DOI 10.1016/j.bmcl.2008.05.047; Ravna AW, 2008, EUR J MED CHEM, V43, P2557, DOI 10.1016/j.ejmech.2008.01.015; Ritz U, 2003, J IMMUNOL, V170, P941, DOI 10.4049/jimmunol.170.2.941; Rosenberg MF, 2010, STRUCTURE, V18, P482, DOI 10.1016/j.str.2010.01.017; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Schmitt L, 2003, J MOL BIOL, V330, P333, DOI 10.1016/S0022-2836(03)00592-8; SCHREIBER G, 1993, BIOCHEMISTRY-US, V32, P5145, DOI 10.1021/bi00070a025; Schrodt S, 2006, J BIOL CHEM, V281, P6455, DOI 10.1074/jbc.M509784200; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; Shirts MR, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2978177; Smriti, 2009, J BIOL CHEM, V284, P13904, DOI 10.1074/jbc.M900837200; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsai CJ, 1996, CRIT REV BIOCHEM MOL, V31, P127, DOI 10.3109/10409239609106582; Uebel S, 1997, P NATL ACAD SCI USA, V94, P8976, DOI 10.1073/pnas.94.17.8976; UEBEL S, 1995, J BIOL CHEM, V270, P18512, DOI 10.1074/jbc.270.31.18512; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VANENDERT PM, 1995, J EXP MED, V182, P1883, DOI 10.1084/jem.182.6.1883; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; Vasiliou Vasilis, 2009, Human Genomics, V3, P281; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Veiga MI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020212; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507	108	22	23	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28099	28111		10.1074/jbc.M112.381251	http://dx.doi.org/10.1074/jbc.M112.381251			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22700967	Green Published, hybrid			2022-12-25	WOS:000307840700083
J	Leyn, SA; Gao, F; Yang, C; Rodionov, DA				Leyn, Semen A.; Gao, Fang; Yang, Chen; Rodionov, Dmitry A.			N-Acetylgalactosamine Utilization Pathway and Regulon in Proteobacteria GENOMIC RECONSTRUCTION AND EXPERIMENTAL CHARACTERIZATION IN SHEWANELLA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; GENES; GALACTOSAMINE; METABOLISM; ACID	We used a comparative genomics approach to reconstruct the N-acetyl-D-galactosamine (GalNAc) and galactosamine (GalN) utilization pathways and transcriptional regulons in Proteobacteria. The reconstructed GalNAc/GalN utilization pathways include multiple novel genes with specific functional roles. Most of the pathway variations were attributed to the amino sugar transport, phosphorylation, and deacetylation steps, whereas the downstream catabolic enzymes in the pathway were largely conserved. The predicted GalNAc kinase AgaK, the novel variant of GalNAc-6-phosphate deacetylase AgaA(II) and the GalN-6-phosphate deaminase AgaS from Shewanella sp. ANA-3 were validated in vitro using individual enzymatic assays and reconstitution of the three-step pathway. By using genetic techniques, we confirmed that AgaS but not AgaI functions as the main GalN-6-P deaminase in the GalNAc/GalN utilization pathway in Escherichia coli. Regulons controlled by AgaR repressors were reconstructed by bioinformatics in most proteobacterial genomes encoding GalNAc pathways. Candidate AgaR-binding motifs share a common sequence with consensus CTTTC that was found in multiple copies and arrangements in regulatory regions of aga genes. This study provides comprehensive insights into the common and distinctive features of the GalNAc/GalN catabolism and its regulation in diverse Proteobacteria.	[Gao, Fang; Yang, Chen] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China; [Leyn, Semen A.; Rodionov, Dmitry A.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Leyn, Semen A.; Rodionov, Dmitry A.] Russian Acad Sci, Inst Informat Transmiss Problems, Moscow 127994, Russia	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Sanford Burnham Prebys Medical Discovery Institute; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences	Yang, C (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China.	chenyang@sibs.ac.cn; rodionov@burnham.org	Leyn, Semen A/J-1069-2019; Rodionov, Dmitry/V-2688-2018	Leyn, Semen A/0000-0002-9886-9120; Rodionov, Dmitry/0000-0002-0939-390X	National Institutes of Health through the NIGMS [R01GM077402]; Genomic Science Program (GSP), Office of Biological and Environmental Research (OBER), U.S. Dept. of Energy (DOE) [DE-SC0004999]; Sanford-Burnham Medical Research Institute (SBMRI); National Science Foundation of China [30970035, 31070033]; Russian Foundation for Basic Research [10-04-01768]; Chinese Academy of Sciences [KSCX2-EW-G-5]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077402] Funding Source: NIH RePORTER	National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Genomic Science Program (GSP), Office of Biological and Environmental Research (OBER), U.S. Dept. of Energy (DOE)(United States Department of Energy (DOE)); Sanford-Burnham Medical Research Institute (SBMRI); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM077402 through the NIGMS. This work was also supported by the Genomic Science Program (GSP), Office of Biological and Environmental Research (OBER), U.S. Dept. of Energy (DOE) under Contract DE-SC0004999 with the Sanford-Burnham Medical Research Institute (SBMRI) and as a contribution of the Pacific Northwest National Laboratory (PNNL) Foundational Scientific Focus Area, and by the National Science Foundation of China Grants 30970035 and 31070033), the Russian Foundation for Basic Research Grant 10-04-01768, and the Knowledge Innovation Program of the Chinese Academy of Sciences Grant KSCX2-EW-G-5.	Abu-Qarn M, 2008, CURR OPIN STRUC BIOL, V18, P544, DOI 10.1016/j.sbi.2008.06.010; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BARR J, 1980, BIOCHEM J, V192, P569, DOI 10.1042/bj1920569; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bernatchez S, 2005, J BIOL CHEM, V280, P4792, DOI 10.1074/jbc.M407767200; Brinkkotter A, 2000, MOL MICROBIOL, V37, P125, DOI 10.1046/j.1365-2958.2000.01969.x; Brinkkotter A, 2002, ARCH MICROBIOL, V177, P410, DOI 10.1007/s00203-002-0406-6; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CARRAWAY K L, 1991, Glycobiology, V1, P131, DOI 10.1093/glycob/1.2.131; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIS CG, 1986, J BIOL CHEM, V261, P2828; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Freymond PP, 2006, MICROBIOL-SGM, V152, P1709, DOI 10.1099/mic.0.28814-0; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Liu QYP, 2007, NAT BIOTECHNOL, V25, P454, DOI 10.1038/nbt1298; Mukherjee A, 2008, J BACTERIOL, V190, P1710, DOI 10.1128/JB.01737-07; Nobelmann B, 1996, J BACTERIOL, V178, P6790, DOI 10.1128/jb.178.23.6790-6795.1996; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pW299, DOI 10.1093/nar/gkq531; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pD111, DOI 10.1093/nar/gkp894; Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pinchuk GE, 2008, APPL ENVIRON MICROB, V74, P1198, DOI 10.1128/AEM.02026-07; Qin ZHS, 2003, NAT BIOTECHNOL, V21, P435, DOI 10.1038/nbt802; Ray WK, 2004, MOL MICROBIOL, V51, P813, DOI 10.1046/j.1365-2958.2003.03868.x; REISSIG JL, 1956, J BIOL CHEM, V219, P753; Reizer J, 1996, MICROBIOL-SGM, V142, P231, DOI 10.1099/13500872-142-2-231; Rodionov DA, 2007, CHEM REV, V107, P3467, DOI 10.1021/cr068309+; Rodionov DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-494; ROSEY EL, 1991, J BACTERIOL, V173, P5992, DOI 10.1128/jb.173.19.5992-5998.1991; SADLER JE, 1979, J BIOL CHEM, V254, P2112; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sambrook J., 2001, MOL CLONING LAB MANU; Yang C, 2008, J BACTERIOL, V190, P1773, DOI 10.1128/JB.01469-07	37	26	28	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28047	28056		10.1074/jbc.M112.382333	http://dx.doi.org/10.1074/jbc.M112.382333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22711537	Green Published, hybrid			2022-12-25	WOS:000307840700078
J	Townson, SA; Martinez-Hackert, E; Greppi, C; Lowden, P; Sako, D; Liu, J; Ucran, JA; Liharska, K; Underwood, KW; Seehra, J; Kumar, R; Grinberg, AV				Townson, Sharon A.; Martinez-Hackert, Erik; Greppi, Chloe; Lowden, Patricia; Sako, Dianne; Liu, June; Ucran, Jeffrey A.; Liharska, Katia; Underwood, Kathryn W.; Seehra, Jasbir; Kumar, Ravindra; Grinberg, Asya V.			Specificity and Structure of a High Affinity Activin Receptor-like Kinase 1 (ALK1) Signaling Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; BONE MORPHOGENETIC PROTEINS; SUPPRESSES TUMOR-GROWTH; CRYSTAL-STRUCTURE; ENDOTHELIAL-CELLS; ANGIOGENESIS; ACTIVATION; EXPRESSION; BMP9; MECHANISM	Activin receptor-like kinase 1 (ALK1), an endothelial cell-specific type I receptor of the TGF-beta superfamily, is an important regulator of normal blood vessel development as well as pathological tumor angiogenesis. As such, ALK1 is an important therapeutic target. Thus, several ALK1-directed agents are currently in clinical trials as anti-angiogenic cancer therapeutics. Given the biological and clinical importance of the ALK1 signaling pathway, we sought to elucidate the biophysical and structural basis underlying ALK1 signaling. The TGF-beta family ligands BMP9 and BMP10 as well as the three type II TGF-beta family receptors ActRIIA, ActRIIB, and BMPRII have been implicated in ALK1 signaling. Here, we provide a kinetic and thermodynamic analysis of BMP9 and BMP10 interactions with ALK1 and type II receptors. Our data show that BMP9 displays a significant discrimination in type II receptor binding, whereas BMP10 does not. We also report the crystal structure of a fully assembled ternary complex of BMP9 with the extracellular domains of ALK1 and ActRIIB. The structure reveals that the high specificity of ALK1 for BMP9/10 is determined by a novel orientation of ALK1 with respect to BMP9, which leads to a unique set of receptor-ligand interactions. In addition, the structure explains how BMP9 discriminates between low and high affinity type II receptors. Taken together, our findings provide structural and mechanistic insights into ALK1 signaling that could serve as a basis for novel anti-angiogenic therapies.	[Townson, Sharon A.; Martinez-Hackert, Erik; Greppi, Chloe; Lowden, Patricia; Sako, Dianne; Liu, June; Ucran, Jeffrey A.; Liharska, Katia; Underwood, Kathryn W.; Seehra, Jasbir; Kumar, Ravindra; Grinberg, Asya V.] Acceleron Pharma, Cambridge, MA 02139 USA	Acceleron Pharma	Grinberg, AV (corresponding author), 129 Sidney St, Cambridge, MA 02139 USA.	agrinberg@acceleronpharma.com		Martinez-Hackert, Erik/0000-0002-6182-7023				Abdalla SA, 2006, J MED GENET, V43, P97, DOI 10.1136/jmg.2005.030833; Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Attisano L, 1996, MOL CELL BIOL, V16, P1066; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cunha SI, 2011, BLOOD, V117, P6999, DOI 10.1182/blood-2011-01-330142; Cunha SI, 2010, J EXP MED, V207, P85, DOI 10.1084/jem.20091309; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Lopez A, 2007, HUM MOL GENET, V16, P1515, DOI 10.1093/hmg/ddm069; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Hu-Lowe DD, 2011, CANCER RES, V71, P1362, DOI 10.1158/0008-5472.CAN-10-1451; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; KOENIG BB, 1994, MOL CELL BIOL, V14, P5961, DOI 10.1128/MCB.14.9.5961; Kotzsch A, 2009, EMBO J, V28, P937, DOI 10.1038/emboj.2009.37; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Ricard N, 2010, BLOOD, V116, P1604, DOI 10.1182/blood-2010-03-276881; Sako D, 2010, J BIOL CHEM, V285, P21037, DOI 10.1074/jbc.M110.114959; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Scotti C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026431; Sebald W, 2004, BIOL CHEM, V385, P697, DOI 10.1515/BC.2004.086; Seki T, 2003, CIRC RES, V93, P682, DOI 10.1161/01.RES.0000095246.40391.3B; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0	34	121	131	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27313	27325		10.1074/jbc.M112.377960	http://dx.doi.org/10.1074/jbc.M112.377960			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718755	Green Published, hybrid			2022-12-25	WOS:000307840700004
J	Ortega, B; Mason, AK; Welling, PA				Ortega, Bernardo; Mason, Amanda K.; Welling, Paul A.			A Tandem Di-hydrophobic Motif Mediates Clathrin-dependent Endocytosis via Direct Binding to the AP-2 alpha sigma 2 Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL EXPLANATION; POTASSIUM CHANNELS; ADAPTER COMPLEX; SIGNALS; MEMBRANE; CELLS; PHOSPHORYLATION; INTERNALIZATION; RECOGNITION; ENDOSOMES	Select plasma membrane proteins can be marked as cargo for inclusion into clathrin-coated pits by common internalization signals (e. g. Y Chi Chi Phi, dileucine motifs, NPXY) that serve as universal recognition sites for the AP-2 adaptor complex or other clathrin-associated sorting proteins. However, some surface proteins, such as the Kir2.3 potassium channel, lack canonical signals but are still targeted for clathrin-dependent endocytosis. Here, we explore the mechanism. We found an unusual endocytic signal in Kir2.3 that is based on two consecutive pairs of hydrophobic residues. Characterized by the sequence Phi Phi Chi Phi Phi (a tandem di-hydrophobic (TDH) motif, where Phi is a hydrophobic amino acid), the signal shows no resemblance to other endocytic motifs, yet it directly interacts with AP-2 to target the Kir2.3 potassium channel into the endocytic pathway. We found that the tandem di-hydrophobic motif directly binds to the alpha sigma 2 subunits of AP-2, interacting within a large hydrophobic cleft that encompasses part of the docking site for di-Leu signals, but includes additional structures. These observations expand the repertoire of clathrin-dependent internalization signals and the ways in which AP-2 can coordinate endocytosis of cargo proteins.	[Ortega, Bernardo; Mason, Amanda K.; Welling, Paul A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Welling, PA (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	pwelling@umaryland.edu			National Institutes of Health [DK63049, DK54231]; National Kidney Foundation of Maryland; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063049, R01DK054231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation of Maryland; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK63049 and DK54231. This work was also supported the National Kidney Foundation of Maryland.	Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Blagoveshchenskaya AD, 1999, MOL BIOL CELL, V10, P3979, DOI 10.1091/mbc.10.11.3979; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Doray B, 2008, TRAFFIC, V9, P1551, DOI 10.1111/j.1600-0854.2008.00786.x; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Fang L, 2009, J CLIN INVEST, V119, P3278, DOI 10.1172/JCI37950; ISRAELACHVILI J, 1982, NATURE, V300, P341, DOI 10.1038/300341a0; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Karschin C, 1996, J NEUROSCI, V16, P3559; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Leser GP, 1999, VIROLOGY, V262, P79, DOI 10.1006/viro.1999.9890; Mankouri J, 2006, EMBO J, V25, P4142, DOI 10.1038/sj.emboj.7601275; Mason AK, 2008, J BIOL CHEM, V283, P5973, DOI 10.1074/jbc.M709756200; Melnyk P, 2002, AM J PHYSIOL-HEART C, V283, pH1123, DOI 10.1152/ajpheart.00934.2001; Millar ID, 2006, J MEMBRANE BIOL, V211, P173, DOI 10.1007/s00232-006-0036-z; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Pitcher C, 1999, MOL BIOL CELL, V10, P677, DOI 10.1091/mbc.10.3.677; Sandoval IV, 2000, J BIOL CHEM, V275, P39874, DOI 10.1074/jbc.M006261200; Stauber T, 2010, J BIOL CHEM, V285, P34537, DOI 10.1074/jbc.M110.162545; Tanemoto M, 2005, J AM SOC NEPHROL, V16, P2608, DOI 10.1681/ASN.2005030266; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Welling PA, 1997, AM J PHYSIOL-RENAL, V273, pF825, DOI 10.1152/ajprenal.1997.273.5.F825; Welling PA, 2010, PHYSIOLOGY, V25, P280, DOI 10.1152/physiol.00022.2010; YOKODE M, 1992, J CELL BIOL, V117, P39, DOI 10.1083/jcb.117.1.39; Zeng WZ, 2002, AM J PHYSIOL-RENAL, V283, pF630, DOI 10.1152/ajprenal.00378.2001; Zhao M, 2003, MOL CELL BIOL, V23, P8982, DOI 10.1128/MCB.23.24.8982-8991.2003; Zhao ZF, 2007, J BIOL CHEM, V282, P29022, DOI 10.1074/jbc.M703506200	32	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26867	26875		10.1074/jbc.M112.341990	http://dx.doi.org/10.1074/jbc.M112.341990			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22711530	hybrid, Green Published			2022-12-25	WOS:000307386000035
J	Tomalova, I; Iachia, C; Mulet, K; Castagnone-Sereno, P				Tomalova, Iva; Iachia, Cathy; Mulet, Karine; Castagnone-Sereno, Philippe			The map-1 Gene Family in Root-Knot Nematodes, Meloidogyne spp.: A Set of Taxonomically Restricted Genes Specific to Clonal Species	PLOS ONE			English	Article							ACCELERATED EVOLUTION; MODULAR EVOLUTION; SEQUENCE; DOMAIN; PARASITISM; DIVERSITY; RDNA; IDENTIFICATION; DUPLICATION; COMPARTMENT	Taxonomically restricted genes (TRGs), i.e., genes that are restricted to a limited subset of phylogenetically related organisms, may be important in adaptation. In parasitic organisms, TRG-encoded proteins are possible determinants of the specificity of host-parasite interactions. In the root-knot nematode (RKN) Meloidogyne incognita, the map-1 gene family encodes expansin-like proteins that are secreted into plant tissues during parasitism, thought to act as effectors to promote successful root infection. MAP-1 proteins exhibit a modular architecture, with variable number and arrangement of 58 and 13-aa domains in their central part. Here, we address the evolutionary origins of this gene family using a combination of bioinformatics and molecular biology approaches. Map-1 genes were solely identified in one single member of the phylum Nematoda, i.e., the genus Meloidogyne, and not detected in any other nematode, thus indicating that the map-1 gene family is indeed a TRG family. A phylogenetic analysis of the distribution of map-1 genes in RKNs further showed that these genes are specifically present in species that reproduce by mitotic parthenogenesis, with the exception of M. floridensis, and could not be detected in RKNs reproducing by either meiotic parthenogenesis or amphimixis. These results highlight the divergence between mitotic and meiotic RKN species as a critical transition in the evolutionary history of these parasites. Analysis of the sequence conservation and organization of repeated domains in map-1 genes suggests that gene duplication(s) together with domain loss/duplication have contributed to the evolution of the map-1 family, and that some strong selection mechanism may be acting upon these genes to maintain their functional role(s) in the specificity of the plant-RKN interactions.	[Tomalova, Iva; Iachia, Cathy; Mulet, Karine; Castagnone-Sereno, Philippe] French Natl Inst Agr Res INRA, Inst Sophia Agrobiotech, Sophia Antipolis, France; [Tomalova, Iva; Iachia, Cathy; Mulet, Karine; Castagnone-Sereno, Philippe] Univ Nice Sophia Antipolis, UMR Inst Sophia Agrobiotech, Sophia Antipolis, France; [Tomalova, Iva; Iachia, Cathy; Mulet, Karine; Castagnone-Sereno, Philippe] CNRS, Inst Sophia Agrobiotech, Sophia Antipolis, France	INRAE; UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Tomalova, I (corresponding author), Masaryk Univ, Fac Sci, Dept Chem, CS-61137 Brno, Czech Republic.	philippe.castagnone@sophia.inra.fr	Benešová, Iva/AAM-9142-2021		INRA (Institut National de la Recherche Agronomique); EU grant from the ERASMUS Mobility Programme	INRA (Institut National de la Recherche Agronomique); EU grant from the ERASMUS Mobility Programme	Iva Tomalova was the recipient of and EU grant from the ERASMUS Mobility Programme. This work has been financially supported by INRA (Institut National de la Recherche Agronomique). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2003, MOL PLANT PATHOL, V4, P217, DOI [10.1046/j.1364-3703.2003.00170.x, 10.1046/J.1364-3703.2003.00170.X]; Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Adam MAM, 2009, NEMATOLOGY, V11, P253, DOI 10.1163/156854109X429583; Apic Gordana, 2003, Journal of Structural and Functional Genomics, V4, P67, DOI 10.1023/A:1026113408773; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Blaxter ML, 2003, ADV PARASIT, V54, P101, DOI 10.1016/S0065-308X(03)54003-9; Blok VC, 2008, BIOESSAYS, V30, P249, DOI 10.1002/bies.20717; Carneiro RMDG, 2000, NEMATOLOGY, V2, P645, DOI 10.1163/156854100509510; Casewell NR, 2011, MOL BIOL EVOL, V28, P2637, DOI 10.1093/molbev/msr091; Castagnone-Sereno P, 2006, HEREDITY, V96, P282, DOI 10.1038/sj.hdy.6800794; Castagnone-Sereno P, 2009, MOL GENET GENOMICS, V282, P547, DOI 10.1007/s00438-009-0487-x; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; De Ley P, 2004, NEMATOL MONOGR PERSP, V2, P633; Denver DR, 2011, MOL PHYLOGENET EVOL, V61, P584, DOI 10.1016/j.ympev.2011.07.007; Domazet-Loso T, 2007, TRENDS GENET, V23, P533, DOI 10.1016/j.tig.2007.08.014; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fargette M, 2010, INFECT GENET EVOL, V10, P807, DOI 10.1016/j.meegid.2009.04.013; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garb JE, 2005, P NATL ACAD SCI USA, V102, P11379, DOI 10.1073/pnas.0502473102; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Haegeman A, 2011, MOL PLANT MICROBE IN, V24, P879, DOI 10.1094/MPMI-03-11-0055; Holterman M, 2009, PHYTOPATHOLOGY, V99, P227, DOI 10.1094/PHYTO-99-3-0227; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Hunt DJ, 2010, ROOT-KNOT NEMATODES, P55; Johnson BR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-164; Katju V, 2006, MOL BIOL EVOL, V23, P1056, DOI 10.1093/molbev/msj114; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Lipinski KJ, 2011, CURR BIOL, V21, P306, DOI 10.1016/j.cub.2011.01.026; Lunt DH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-194; Martin J, 2009, NUCLEIC ACIDS RES, V37, pD571, DOI 10.1093/nar/gkn744; Moens M, 2010, ROOT-KNOT NEMATODES, P1; Moore AD, 2008, TRENDS BIOCHEM SCI, V33, P444, DOI 10.1016/j.tibs.2008.05.008; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Podlaha O, 2006, MOL BIOL EVOL, V23, P1828, DOI 10.1093/molbev/msl066; Qin L, 2004, NATURE, V427, P30, DOI 10.1038/427030a; Randig O, 2002, GENOME, V45, P862, DOI 10.1139/G02-054; Rasteiro R, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-140; Rosso MN, 2011, PLANT SIGNAL BEHAV, V6, P1232, DOI 10.4161/psb.6.8.16290; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Semblat JP, 2001, MOL PLANT MICROBE IN, V14, P72, DOI 10.1094/MPMI.2001.14.1.72; Siddiqi M. R., 2000, TYLENCHIDA PARASITES; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tadepally HD, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-176; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Tigano M, 2010, PLANT PATHOL, V59, P1054, DOI 10.1111/j.1365-3059.2010.02350.x; Tigano MS, 2005, NEMATOLOGY, V7, P851, DOI 10.1163/156854105776186325; Triantaphyllou A.C., 1985, ADV TREATISE MELOIDO, VI, P113; Trudgill DL, 2001, ANNU REV PHYTOPATHOL, V39, P53, DOI 10.1146/annurev.phyto.39.1.53; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; Vieira P, 2011, J EXP BOT, V62, P1241, DOI 10.1093/jxb/erq352; Wilson GA, 2005, MICROBIOL-SGM, V151, P2499, DOI 10.1099/mic.0.28146-0; Wu YC, 2012, MOL BIOL EVOL, V29, P689, DOI 10.1093/molbev/msr222; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zijlstra C, 2000, NEMATOLOGY, V2, P847, DOI 10.1163/156854100750112798; Zijlstra C, 2000, EUR J PLANT PATHOL, V106, P283, DOI 10.1023/A:1008765303364	55	25	25	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38656	10.1371/journal.pone.0038656	http://dx.doi.org/10.1371/journal.pone.0038656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719916	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300039
J	Yang, F; He, JF; Zhong, HJ; Ke, CW; Zhang, X; Hong, T; Ni, HZ; Lin, JY				Yang, Fen; He, Jianfeng; Zhong, Haojie; Ke, Changwen; Zhang, Xin; Hong, Teng; Ni, Hanzhong; Lin, Jinyan			Temporal Trends of Influenza A (H1N1) Virus Seroprevalence following 2009 Pandemic Wave in Guangdong, China: Three Cross-Sectional Serology Surveys	PLOS ONE			English	Article							HEMAGGLUTINATION INHIBITION; ANTIBODY-RESPONSES	Background: To evaluate the temporal trends of seroprevalence to pH1N1 among the Guangdong population following 2009 H1N1 pandemic wave, we conducted three cross-sectional serology surveys in 2010. Methodology/Principal Findings: Three surveys were carried out consecutively in 2010 from January 8 to January 24, from March 15 to April 10 and from August 23 to September 4. Sample populations comprising of 4725, 4727, and 4721 subjects respectively were randomly selected for study in these three surveys. The level of antibodies against pH1N1 was evaluated by hemagglutination inhibition assay. In survey 1, the seroprevalence of pH1N1 among all the subjects is 25.1%, declining to 18.4% in survey 2 and increasing to 21.4% in survey 3. Among vaccinated subjects, the seroprevalence was 49.0%, 53.0%, and 49.4% in the three consecutive surveys, showing no significant differences. In contrast, among non-vaccinated subjects, the seroprevalence declined significantly from 22.8% (survey 1) to 14.3% (survey 2) and subsequently increased to 18.1% (survey 3). The multivariate logistic regression analysis revealed that seroprevalence to pH1N1 in non-vaccinated individuals correlated with the investigated order of the surveys, age, and region (all P<0.05). However, it was not correlated with gender (P = 0.650), seasonal influenza vaccination history (P = 0.402) and symptoms (P = 0.074). Conclusions/Significance: In Guangdong, the seroprevalance to pH1N1 decreased initially and then rebounded modestly during the first 9 months following the 2009 pandemic wave. Our results suggest that the prevalence of pH1N1 is still correlated with age and population density during the post-pandemic period. An early end to the free pH1N1 vaccination program might be another important reason for the slight rebound in seroprevalance. Our study findings can help the Guangdong authorities to make evidence-based decisions about a long-term vaccination strategy and boost immunity in specific population groups (such as children and people living in the capital-city) to prevent further transmission in the future.	[Yang, Fen; He, Jianfeng; Zhong, Haojie; Ke, Changwen; Zhang, Xin; Hong, Teng; Ni, Hanzhong; Lin, Jinyan] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China	Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention	Yang, F (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.	hjf@vip.sina.com			Field Epidemiology and Medical Scientific Research Foundation of Guangdong Province [A2010067]	Field Epidemiology and Medical Scientific Research Foundation of Guangdong Province	This study was supported by the key medical specialty program-Field Epidemiology and Medical Scientific Research Foundation of Guangdong Province Grant A2010067 (Research on patterns of transmission and intensity of epidemic of Pandemic Influenza H1N1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allwinn R, 2010, MED MICROBIOL IMMUN, V199, P117, DOI 10.1007/s00430-010-0143-4; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868; Cohen J, 2009, SCIENCE, V324, P1496, DOI 10.1126/science.324_1496; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Deng AP, 2008, MED, V34, P14; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Grund S, 2011, J VIROL METHODS, V171, P369, DOI 10.1016/j.jviromet.2010.11.024; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Jianfeng H, 2010, S CHINA J PREV MED, V36, P4; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Lohr Sharon L., 2002, SAMPLING DESIGN ANAL, P12; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; ROSS T, 2010, PLOS CURR INFLUENZA; Sun YZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014270; Wang M, 2011, PLOS ONE, V6, P1, DOI DOI 10.1371/J0URNAL.P0NE.0016809; *WHO, 2010, FOC H1N1 NOW POSTP P; *WHO, 2010, DIR GEN STAT FOLL 7; World Health Organization, 2009, CURR WHO PHAS PAND; World Health Organization (WHO), 2009, INFL LIK ILLN US MEX; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Xu CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020899	25	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38768	10.1371/journal.pone.0038768	http://dx.doi.org/10.1371/journal.pone.0038768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719938	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300047
J	Liu, XY; Fang, H; Chen, HC; Jiang, XL; Fang, DR; Wang, Y; Zhu, DX				Liu, Xiaoyan; Fang, Hong; Chen, Hongchao; Jiang, Xiaoling; Fang, Deren; Wang, Yan; Zhu, Dingxian			An Artificial miRNA against HPSE Suppresses Melanoma Invasion Properties, Correlating with a Down-Regulation of Chemokines and MAPK Phosphorylation	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; HEPARAN-SULFATE PROTEOGLYCANS; ENDOTHELIAL GROWTH-FACTOR; RNA INTERFERENCE; TUMOR PROGRESSION; IN-VITRO; FACTOR EXPRESSION; MAMMALIAN-CELLS; GENE-EXPRESSION; TRANSGENIC MICE	Ribonucleic acid interference (RNAi) based on microRNA (miRNA) context may provide an efficient and safe therapeutic knockdown effect and can be driven by ribonucleic acid polymerase II (RNAP II). In this study, we designed and synthesized miR155-based artificial miRNAs against heparanase (HPSE) constructed with BLOCK-iT (TM) Pol II miR RNAi Expression Vector Kit. The expression levels of HPSE declined significantly in both the mRNA and protein levels in HPSE-miRNA transfected melanoma cells that exhibited reduction of adhesion, migration, and invasion ability in vitro and in vivo. We also observed that HPSE miRNA could inhibit the expressions of chemokines of interleukin-8 (IL8) and chemokine (C-X-C motif) ligand 1 (CXCL1), at both the transcriptional and translational levels. Further study on its probable mechanism declared that down-regulation of IL8 and CXCL1 by HPSE-miRNA may be correlated with reduced growth-factor simulated mitogen-activated kinase (MAPK) phosphorylation including p38 MAPK, c-Jun N-terminal kinase (JNK) and extracellular-signal-regulated kinase (ERK) 1 and 2, which could be rescued by miRNA incompatible mutated HPSE cDNA. In conclusion, we demonstrated that artificial miRNAs against HPSE might serve as an alterative mean of therapy to low HPSE expression and to block the adhesion, invasion, and metastasis of melanoma cells. Furthermore, miRNA-based RNAi was also a powerful tool for gene function study.	[Liu, Xiaoyan; Fang, Hong; Chen, Hongchao; Jiang, Xiaoling; Fang, Deren; Wang, Yan; Zhu, Dingxian] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Dermatol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Liu, XY (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Dermatol, Hangzhou 310003, Zhejiang, Peoples R China.	Fanghongzy@sina.com		Fang, Hong/0000-0002-5917-2283	National Natural Science Foundation of China [30771944]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by National Natural Science Foundation of China Grants (No. 30771944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2007, J CLIN INVEST, V117, P3623, DOI 10.1172/JCI33494; Anderson Emily, 2008, V442, P45, DOI 10.1007/978-1-59745-191-8_4; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bauer M, 2009, GENE THER, V16, P142, DOI 10.1038/gt.2008.123; Bhatia S, 2009, ONCOLOGY-NY, V23, P488; Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Casu B, 2010, MATRIX BIOL, V29, P442, DOI 10.1016/j.matbio.2010.04.003; Cohen-Kaplan V, 2008, CANCER RES, V68, P10077, DOI 10.1158/0008-5472.CAN-08-2910; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Edovitsky E, 2004, JNCI-J NATL CANCER I, V96, P1219, DOI 10.1093/jnci/djh230; Fontijn D, 2009, CELL ONCOL, V31, P179, DOI 10.3233/CLO-2009-0477; Gohji K, 2001, INT J CANCER, V95, P295, DOI 10.1002/1097-0215(20010920)95:5<295::AID-IJC1051>3.0.CO;2-A; Huh SJ, 2010, CANCER RES, V70, P6071, DOI 10.1158/0008-5472.CAN-09-4442; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Khasraw M, 2010, ANN ONCOL, V21, P1302, DOI 10.1093/annonc/mdp524; Koliopanos A, 2001, CANCER RES, V61, P4655; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kudchadkar R, 2008, EXPERT OPIN INV DRUG, V17, P1769, DOI 10.1517/13543784.17.11.1769 ; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Leung RKM, 2005, PHARMACOL THERAPEUT, V107, P222, DOI 10.1016/j.pharmthera.2005.03.004; Levy-Adam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002319; Liu XY, 2008, INT J DERMATOL, V47, P448, DOI 10.1111/j.1365-4632.2008.03627.x; Liu YP, 2011, BBA-GENE REGUL MECH, V1809, P732, DOI 10.1016/j.bbagrm.2011.05.014; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Neuder LE, 2009, VET IMMUNOL IMMUNOP, V129, P192, DOI 10.1016/j.vetimm.2008.11.006; Ohtawa Y, 2006, HUM PATHOL, V37, P1145, DOI 10.1016/j.humpath.2006.04.005; Parish CR, 1999, CANCER RES, V59, P3433; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; Rasmussen MK, 2008, INFLAMM RES, V57, P329, DOI 10.1007/s00011-007-7220-1; Regina S, 2009, CLIN CHEM, V55, P1834, DOI 10.1373/clinchem.2009.123695; Roy M, 2009, J CELL BIOCHEM, V106, P200, DOI 10.1002/jcb.22005; Sanderson RD, 2001, SEMIN CELL DEV BIOL, V12, P89, DOI 10.1006/scdb.2000.0241; Sato T, 2004, J SURG ONCOL, V87, P174, DOI 10.1002/jso.20097; Scherr M, 2007, CELL CYCLE, V6, P444, DOI 10.4161/cc.6.4.3807; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Shinyo Y, 2003, ANN ONCOL, V14, P1505, DOI 10.1093/annonc/mdg407; Simizu S, 2003, CANCER LETT, V193, P83, DOI 10.1016/S0304-3835(02)00719-X; Singh S, 2009, BRIT J CANCER, V100, P1638, DOI 10.1038/sj.bjc.6605055; Singh S, 2009, CLIN CANCER RES, V15, P2380, DOI 10.1158/1078-0432.CCR-08-2387; Snyder LL, 2008, ANTIVIR RES, V80, P36, DOI 10.1016/j.antiviral.2008.04.001; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Sun BS, 2008, HEPATOLOGY, V48, P1834, DOI 10.1002/hep.22531; Takaoka M, 2003, LAB INVEST, V83, P613, DOI 10.1097/01.LAB.0000067482.84946.BD; Tan FL, 2004, CELL RES, V14, P460, DOI 10.1038/sj.cr.7290248; Timar J, 2002, SEMIN CANCER BIOL, V12, P173, DOI 10.1016/S1044-579X(02)00021-4; Watanabe M, 2003, GYNECOL OBSTET INVES, V56, P77, DOI 10.1159/000072821; Wurm S, 2008, CYTOKINE, V44, P185, DOI 10.1016/j.cyto.2008.08.003; Yuan J, 2006, MOL BIOL REP, V33, P43, DOI 10.1007/s11033-005-3965-1; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zetser A, 2003, CANCER RES, V63, P7733; Zhang LX, 2011, CANCER RES, V71, P645, DOI 10.1158/0008-5472.CAN-10-1910; Zhang YL, 2007, BIOCHEM BIOPH RES CO, V358, P124, DOI 10.1016/j.bbrc.2007.04.068; Zhao F, 2009, CLIN CANCER RES, V15, P4382, DOI 10.1158/1078-0432.CCR-09-0399; Zheng LD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-33	58	44	49	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38659	10.1371/journal.pone.0038659	http://dx.doi.org/10.1371/journal.pone.0038659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719918	gold, Green Submitted, Green Published			2022-12-25	WOS:000305350000020
J	Simmons, SC; McKenzie, EA; Harris, LK; Aplin, JD; Brenchley, PE; Velasco-Garcia, MN; Missailidis, S				Simmons, Suzanne C.; McKenzie, Edward A.; Harris, Lynda K.; Aplin, John D.; Brenchley, Paul E.; Velasco-Garcia, Maria N.; Missailidis, Sotiris			Development of Novel Single-Stranded Nucleic Acid Aptamers against the Pro-Angiogenic and Metastatic Enzyme Heparanase (HPSE1)	PLOS ONE			English	Article							GROWTH-FACTOR; MAMMALIAN HEPARANASE; EXPRESSION; HEPARIN; BINDING; INHIBITION; RAS; INVASION; CELLS; SPECIFICITY	Heparanase is an enzyme involved in extracellular matrix remodelling and heparan sulphate proteoglycan catabolism. It is secreted by metastatic tumour cells, allowing them to penetrate the endothelial cell layer and basement membrane to invade target organs. The release of growth factors at the site of cleaved heparan sulphate chains further enhance the potential of the tumour by encouraging the process of angiogenesis. This leads to increased survival and further proliferation of the tumour. Aptamers are single or double stranded oligonucleotides that recognise specific small molecules, peptides, proteins, or even cells or tissues and have shown great potential over the years as diagnostic and therapeutic agents in anticancer treatment. For the first time, single stranded DNA aptamers were successfully generated against the active heterodimer form of heparanase using a modified SELEX protocol, and eluted based on increasing affinity for the target. Sandwich ELISA assays showed recognition of heparanase by the aptamers at a site distinct from that of a polyclonal HPSE1 antibody. The binding affinities of aptamer to immobilised enzyme were high (7x10(7) to 8x10(7) M-1) as measured by fluorescence spectroscopy. Immunohistochemistry and immunofluorescence studies demonstrated that the aptamers were able to recognise heparanase with staining comparable or in some cases superior to that of the HPSE1 antibody control. Finally, matrigel assay demonstrated that aptamers were able to inhibit heparanase. This study provides clear proof of principle concept that nucleic acid aptamers can be generated against heparanase. These reagents may serve as useful tools to explore the functional role of the enzyme and in the future development of diagnostic assays or therapeutic reagents.	[Simmons, Suzanne C.; Velasco-Garcia, Maria N.; Missailidis, Sotiris] Open Univ, Dept Life Hlth & Chem Sci, Milton Keynes MK7 6AA, Bucks, England; [McKenzie, Edward A.] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester, Greater Manches, England; [Harris, Lynda K.; Aplin, John D.] Univ Manchester, Maternal & Fetal Hlth Res Ctr, Manchester, Greater Manches, England; [Brenchley, Paul E.] Univ Manchester, Renal Res Grp, Manchester, Greater Manches, England	Open University - UK; University of Manchester; University of Manchester; University of Manchester	Simmons, SC (corresponding author), Open Univ, Dept Life Hlth & Chem Sci, Milton Keynes MK7 6AA, Bucks, England.	s.missailidis@open.ac.uk	Harris, Lynda K/I-2628-2019; Aplin, John/AET-4363-2022	Harris, Lynda K/0000-0001-7709-5202; Brenchley, Paul/0000-0003-1290-9919; Aplin, John/0000-0001-8777-9261	Open University	Open University	This project was funded by The Open University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud-Jarrous G, 2005, J BIOL CHEM, V280, P13568, DOI 10.1074/jbc.M413370200; ADAMS DH, 1994, LANCET, V343, P831, DOI 10.1016/S0140-6736(94)92029-X; BARNER M, 1987, BLOOD, V70, P551; Berezovski M, 2006, J AM CHEM SOC, V128, P1410, DOI 10.1021/ja056943j; BLOTNICK S, 1994, P NATL ACAD SCI USA, V91, P2890, DOI 10.1073/pnas.91.8.2890; Cao ZH, 2009, ANGEW CHEM INT EDIT, V48, P6494, DOI 10.1002/anie.200901452; CHUANG E, 1994, MOL CELL BIOL, V14, P5318, DOI 10.1128/MCB.14.8.5318; Chuang WL, 2000, BIOCHEMISTRY-US, V39, P3542, DOI 10.1021/bi9926025; Courtney SM, 2005, BIOORG MED CHEM LETT, V15, P2295, DOI 10.1016/j.bmcl.2005.03.014; Da Pieve C, BIOCONJUG CHEM, V21, P169; ELDOR A, 1987, SEMIN THROMB HEMOST, V13, P475, DOI 10.1055/s-2007-1003524; Famulok M, 1999, CURR TOP MICROBIOL, V243, P123; Ferreira CSM, 2006, TUMOR BIOL, V27, P289, DOI 10.1159/000096085; Floege J, 1999, AM J PATHOL, V154, P169, DOI 10.1016/S0002-9440(10)65263-7; Friedmann Y, 2000, AM J PATHOL, V157, P1167, DOI 10.1016/S0002-9440(10)64632-9; GILAT D, 1995, J EXP MED, V181, P1929, DOI 10.1084/jem.181.5.1929; Gohji K, 2001, INT J CANCER, V95, P295, DOI 10.1002/1097-0215(20010920)95:5<295::AID-IJC1051>3.0.CO;2-A; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; He XT, 2004, CANCER RES, V64, P3928, DOI 10.1158/0008-5472.CAN-03-2718; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Hicke BJ, 2006, J NUCL MED, V47, P668; Hicke BJ, 2001, J BIOL CHEM, V276, P48644, DOI 10.1074/jbc.M104651200; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Ikuta M, 2001, ORAL ONCOL, V37, P177, DOI 10.1016/S1368-8375(00)00077-4; Ishida K, 2004, MOL CANCER THER, V3, P1069; JELLINEK D, 1995, BIOCHEMISTRY-US, V34, P11363, DOI 10.1021/bi00036a009; Kimoto M, 2002, EUR J BIOCHEM, V269, P697, DOI 10.1046/j.0014-2956.2001.02703.x; Koliopanos A, 2001, CANCER RES, V61, P4655; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; Li JP, 2009, THROMB HAEMOSTASIS, V102, P823, DOI 10.1160/TH09-02-0091; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Liss M, 2002, ANAL CHEM, V74, P4488, DOI 10.1021/ac011294p; Marchetti D, 2001, ADV ENZYME REGUL, V41, P343, DOI 10.1016/S0065-2571(00)00016-9; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Maxhimer JB, 2002, SURGERY, V132, P326, DOI 10.1067/msy.2002.125719; McKenzie E, 2003, BIOCHEM J, V373, P423, DOI 10.1042/BJ20030318; Mikami S, 2001, JPN J CANCER RES, V92, P1062, DOI 10.1111/j.1349-7006.2001.tb01061.x; Missailidis S, 2005, J IMMUNOL METHODS, V296, P45, DOI 10.1016/j.jim.2004.10.011; Missailidis Sotiris, 2004, Methods Mol Biol, V248, P547; Missailidis Sotiris, 2004, Methods Mol Biol, V248, P431; Osborne SE, 1997, CURR OPIN CHEM BIOL, V1, P5, DOI 10.1016/S1367-5931(97)80102-0; Parish CR, 1999, CANCER RES, V59, P3433; Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770; Rose Mark J., 2004, Current Drug Targets - Inflammation and Allergy, V3, P221, DOI 10.2174/1568010043343589; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Tang WH, 2002, MODERN PATHOL, V15, P593, DOI 10.1038/modpathol.3880571; VLODAVSKY I, 1992, INVAS METAST, V12, P112; Vlodavsky I, 2002, SEMIN CANCER BIOL, V12, P121, DOI 10.1006/scbi.2001.0420; Vlodavsky I., 2011, CANC MICROENVIRON; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; White R, 2001, MOL THER, V4, P567, DOI 10.1006/mthe.2001.0495; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zuker M., 1999, RNA BIOCH BIOTECHNOL	56	22	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e37938	10.1371/journal.pone.0037938	http://dx.doi.org/10.1371/journal.pone.0037938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719856	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350000009
J	Kawaguchi, T; Sumida, Y; Umemura, A; Matsuo, K; Takahashi, M; Takamura, T; Yasui, K; Saibara, T; Hashimoto, E; Kawanaka, M; Watanabe, S; Kawata, S; Imai, Y; Kokubo, M; Shima, T; Park, H; Tanaka, H; Tajima, K; Yamada, R; Matsuda, F; Okanoue, T				Kawaguchi, Takahisa; Sumida, Yoshio; Umemura, Atsushi; Matsuo, Keitaro; Takahashi, Meiko; Takamura, Toshinari; Yasui, Kohichiroh; Saibara, Toshiji; Hashimoto, Etsuko; Kawanaka, Miwa; Watanabe, Sumio; Kawata, Sumio; Imai, Yasuharu; Kokubo, Miki; Shima, Toshihide; Park, Hyohun; Tanaka, Hideo; Tajima, Kazuo; Yamada, Ryo; Matsuda, Fumihiko; Okanoue, Takeshi		JSG-NAFLD	Genetic Polymorphisms of the Human PNPLA3 Gene Are Strongly Associated with Severity of Non-Alcoholic Fatty Liver Disease in Japanese	PLOS ONE			English	Article							STEATOHEPATITIS; SUSCEPTIBILITY; VARIANT; I148M	Background: Nonalcoholic fatty liver disease (NAFLD) includes a broad range of liver pathologies from simple steatosis to cirrhosis and fibrosis, in which a subtype accompanying hepatocyte degeneration and fibrosis is classified as nonalcoholic steatohepatitis (NASH). NASH accounts for approximately 10-30% of NAFLD and causes a higher frequency of liver-related death, and its progression of NASH has been considered to be complex involving multiple genetic factors interacting with the environment and lifestyle. Principal Findings: To identify genetic factors related to NAFLD in the Japanese, we performed a genome-wide association study recruiting 529 histologically diagnosed NAFLD patients and 932 population controls. A significant association was observed for a cluster of SNPs in PNPLA3 on chromosome 22q13 with the strongest p-value of 1.4x10(-10) (OR = 1.66, 95%CI: 1.43-1.94) for rs738409. Rs738409 also showed the strongest association (p = 3.6x10(-6)) with the histological classifications proposed by Matteoni and colleagues based on the degree of inflammation, ballooning degeneration, fibrosis and Mallory-Denk body. In addition, there were marked differences in rs738409 genotype distributions between type4 subgroup corresponding to NASH and the other three subgroups (p = 4.8x10(-6), OR = 1.96, 95%CI: 1.47-2.62). Moreover, a subgroup analysis of NAFLD patients against controls showed a significant association of rs738409 with type4 (p = 1.7x10(-16), OR = 2.18, 95%CI: 1.81-2.63) whereas no association was obtained for type1 to type3 (p = 0.41). Rs738409 also showed strong associations with three clinical traits related to the prognosis of NAFLD, namely, levels of hyaluronic acid (p = 4.6x10(-4)), HbA1c (p = 0.0011) and iron deposition in the liver (p = 5.6x10(-4)). Conclusions: With these results we clearly demonstrated that Matteoni type4 NAFLD is both a genetically and clinically different subset from the other spectrums of the disease and that the PNPLA3 gene is strongly associated with the progression of NASH in Japanese population.	[Kawaguchi, Takahisa; Takahashi, Meiko; Kokubo, Miki; Yamada, Ryo; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Kawaguchi, Takahisa; Watanabe, Sumio; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, INSERM, U852, Kyoto, Japan; [Sumida, Yoshio] Nara City Hosp, Ctr Digest & Liver Dis, Nara, Japan; [Umemura, Atsushi; Shima, Toshihide; Park, Hyohun; Okanoue, Takeshi] Saiseikai Suita Hosp, Ctr Gastroenterol & Hepatol, Suita, Osaka, Japan; [Matsuo, Keitaro; Tanaka, Hideo; Tajima, Kazuo] Aichi Canc Ctr, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Takamura, Toshinari] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan; [Yasui, Kohichiroh] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Gastroenterol & Hepatol, Kyoto, Japan; [Shima, Toshihide] Kochi Med Sch, Dept Gastroenterol & Hepatol, Kochi, Japan; [Hashimoto, Etsuko] Tokyo Womens Med Univ, Dept Internal Med & Gastroenterol, Tokyo, Japan; [Kawanaka, Miwa] Kawasaki Med Sch, Kawasaki Hosp, Ctr Liver Dis, Okayama, Japan; [Kawata, Sumio] Juntendo Univ, Sch Med, Dept Gastroenterol, Tokyo 113, Japan; [Kawata, Sumio] Yamagata Univ, Sch Med, Dept Gastroenterol, Yamagata 99023, Japan; [Imai, Yasuharu] Ikeda Municipal Hosp, Dept Internal Med, Ikeda, Osaka, Japan	Kyoto University; Institut National de la Sante et de la Recherche Medicale (Inserm); Kyoto University; Aichi Cancer Center; Kanazawa University; Kyoto Prefectural University of Medicine; Kochi University; Tokyo Women's Medical University; Kawasaki Medical School; Juntendo University; Yamagata University	Kawaguchi, T (corresponding author), Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan.	fumi@genome.med.kyoto-u.ac.jp	Shima, Toshihide/AAW-9215-2020; Sumida, Yoshio/AAL-6723-2020; Matsuo, Keitaro/H-6758-2019	Shima, Toshihide/0000-0002-4120-9121; Matsuo, Keitaro/0000-0003-1761-6314; Takahashi, Meiko/0000-0002-8344-5472; Umemura, Atsushi/0000-0002-7433-8501; Yamada, Ryo/0000-0002-1587-630X	Ministry of Labor and Welfare Japan, Core Research of Evolutional Science & Technology (CREST) [H20-Hepatitis-general-008]; Grants-in-Aid for Scientific Research [23591301] Funding Source: KAKEN	Ministry of Labor and Welfare Japan, Core Research of Evolutional Science & Technology (CREST); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the grant from Ministry of Labor and Welfare Japan [T.O., H20-Hepatitis-general-008], Core Research of Evolutional Science & Technology (CREST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berson A, 1998, GASTROENTEROLOGY, V114, P764, DOI 10.1016/S0016-5085(98)70590-6; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Day CP, 2006, GASTROENTEROLOGY, V130, P207, DOI 10.1053/j.gastro.2005.11.017; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Hotta K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-172; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Okanoue Takeshi, 2011, Nihon Shokakibyo Gakkai Zasshi, V108, P1161; Okanoue T, 2011, J GASTROEN HEPATOL, V26, P153, DOI 10.1111/j.1440-1746.2010.06547.x; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Sookoian S, 2009, J LIPID RES, V50, P2111, DOI 10.1194/jlr.P900013-JLR200; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Suzuki T, 2008, CANCER EPIDEM BIOMAR, V17, P2742, DOI 10.1158/1055-9965.EPI-08-0470; Terao C, 2011, HUM MOL GENET, V20, P2680, DOI 10.1093/hmg/ddr161; UENO T, 1993, GASTROENTEROLOGY, V105, P475, DOI 10.1016/0016-5085(93)90722-O; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Yamada R, 2009, GENET EPIDEMIOL, V33, P114, DOI 10.1002/gepi.20362; Yasui K, 2011, CLIN GASTROENTEROL H, V9, P428, DOI 10.1016/j.cgh.2011.01.023	26	191	195	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38322	10.1371/journal.pone.0038322	http://dx.doi.org/10.1371/journal.pone.0038322			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719876	gold, Green Submitted, Green Published			2022-12-25	WOS:000305347800005
J	Raudies, F; Mingolla, E; Neumann, H				Raudies, Florian; Mingolla, Ennio; Neumann, Heiko			Active Gaze Control Improves Optic Flow-Based Segmentation and Steering	PLOS ONE			English	Article							SELF-MOTION; OBSTACLE AVOIDANCE; 3-DIMENSIONAL MOTION; MST NEURONS; PERCEPTION; STATISTICS; MODEL; MECHANISMS; FIXATION; PATTERNS	An observer traversing an environment actively relocates gaze to fixate objects. Evidence suggests that gaze is frequently directed toward the center of an object considered as target but more likely toward the edges of an object that appears as an obstacle. We suggest that this difference in gaze might be motivated by specific patterns of optic flow that are generated by either fixating the center or edge of an object. To support our suggestion we derive an analytical model that shows: Tangentially fixating the outer surface of an obstacle leads to strong flow discontinuities that can be used for flow-based segmentation. Fixation of the target center while gaze and heading are locked without head-, body-, or eye-rotations gives rise to a symmetric expansion flow with its center at the point being approached, which facilitates steering toward a target. We conclude that gaze control incorporates ecological constraints to improve the robustness of steering and collision avoidance by actively generating flows appropriate to solve the task.	[Raudies, Florian; Mingolla, Ennio; Neumann, Heiko] Boston Univ, CELEST, Boston, MA 02215 USA; [Raudies, Florian; Mingolla, Ennio] Boston Univ, Ctr Computat Neurosci & Neural Technol CompNet, Boston, MA 02215 USA; [Neumann, Heiko] Univ Ulm, Inst Neural Informat Proc, Ulm, Germany	Boston University; Boston University; Ulm University	Raudies, F (corresponding author), Boston Univ, CELEST, Boston, MA 02215 USA.	fraudies@bu.edu		Mingolla, Ennio/0000-0003-2623-3438	CELEST, a National Science Foundation Science of Learning Center [NSF OMA-0835976]; Office of Naval Research [ONR N00014-11-1-0535]; Transregional Collaborative Research Centre [SFB/TRR 62]; German Research Foundation (DFG)	CELEST, a National Science Foundation Science of Learning Center(National Science Foundation (NSF)NSF - Office of the Director (OD)); Office of Naval Research(Office of Naval Research); Transregional Collaborative Research Centre; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by CELEST, a National Science Foundation Science of Learning Center (NSF OMA-0835976), Office of Naval Research (ONR N00014-11-1-0535), and Transregional Collaborative Research Centre SFB/TRR 62 "Companion-Technology for Cognitive Technical Systems" funded by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADIV G, 1985, IEEE T PATTERN ANAL, V7, P384, DOI 10.1109/TPAMI.1985.4767678; ALOIMONOS J, 1987, INT J COMPUT VISION, V1, P333; BAJCSY R, 1988, P IEEE, V76, P996, DOI 10.1109/5.5968; Baker S, 2011, INT J COMPUT VISION, V92, P1, DOI 10.1007/s11263-010-0390-2; Baluchi F, 2011, TRENDS NEUROSCI, V34, P210, DOI 10.1016/j.tins.2011.02.003; Banks MS, 1996, VISION RES, V36, P431, DOI 10.1016/0042-6989(95)00122-0; Black MJ, 2012, FLOWER GARDEN VIDEO; BLOOMBERG JJ, 1992, ANN NY ACAD SCI, V656, P699; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; BRADDICK O, 1993, TRENDS NEUROSCI, V16, P263, DOI 10.1016/0166-2236(93)90179-P; Calow D, 2007, NETWORK-COMP NEURAL, V18, P343, DOI 10.1080/09548980701642277; Cavalleri P, 2003, VISION RES, V43, P1473, DOI 10.1016/S0042-6989(03)00139-1; Dakin SC, 2005, J VISION, V5, P878, DOI 10.1167/5.10.9; Daniilidis K, 1997, COMPUT VIS IMAGE UND, V68, P158, DOI 10.1006/cviu.1997.0535; Domke J, 2007, LECT NOTES COMPUT SC, V4358, P232; DUFFY CJ, 1995, J NEUROSCI, V15, P5192; Elder DM, 2009, J EXP PSYCHOL HUMAN, V35, P1501, DOI 10.1037/a0016459; Fajen BR, 2003, J EXP PSYCHOL HUMAN, V29, P343, DOI 10.1037/0096-1523.29.2.343; FERMULLER C, 1995, INT J COMPUT VISION, V15, P7, DOI 10.1007/BF01450848; FERMULLER C, 1993, INT J COMPUT VISION, V11, P165, DOI 10.1007/BF01469227; Fermuller C, 2001, COMPUT VIS IMAGE UND, V82, P1, DOI 10.1006/cviu.2000.0900; FERMULLER C, 1995, SCIENCE, V270, P1973, DOI 10.1126/science.270.5244.1973; field, 2021, OIL GAS STUDIES, P25, DOI [DOI 10.1007/978-3-540-24673-2, 10.31660/0445-0108-2021-3-25-36, DOI 10.31660/0445-0108-2021-3-25-36]; Gibson JJ, 1979, ECOLOGICAL APPROACH; Gibson JJ, 1950, PERCEPTION VISUAL WO; Goldstein H., 2001, CLASSICAL MECH; GORDON DA, 1965, J OPT SOC AM, V55, P1296, DOI 10.1364/JOSA.55.001296; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; Hayhoe M, 2000, VIS COGN, V7, P43, DOI 10.1080/135062800394676; HORN BKP, 1988, INT J COMPUT VISION, V2, P51, DOI 10.1007/BF00836281; HORN BKP, 1987, INT J COMPUT VISION, V1, P259, DOI 10.1007/BF00127824; KOENDERINK JJ, 1976, BIOL CYBERN, V24, P51, DOI 10.1007/BF00365595; KOENDERINK JJ, 1976, J OPT SOC AM, V66, P717, DOI 10.1364/JOSA.66.000717; Koenderink JJ, 1985, P NATO ADV STUD I BR, P31; Kohlberger T, 2003, LECT NOTES COMPUT SC, V2695, P432; Land M, 1999, PERCEPTION, V28, P1311, DOI 10.1068/p2935; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; LAPPE M, 1993, NEURAL COMPUT, V5, P374, DOI 10.1162/neco.1993.5.3.374; LONGUETHIGGINS HC, 1980, PROC R SOC SER B-BIO, V208, P385, DOI 10.1098/rspb.1980.0057; MacLean W. J., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P753, DOI 10.1109/ICCV.1999.790297; McCarthy C, 2012, IEEE T PATTERN ANAL, V34, P1024, DOI 10.1109/TPAMI.2012.27; NAKAYAMA K, 1974, PERCEPTION, V3, P63, DOI 10.1068/p030063; NELSON RC, 1989, IEEE T PATTERN ANAL, V11, P1102, DOI 10.1109/34.42840; Nestares O, 2000, PROC CVPR IEEE, P523, DOI 10.1109/CVPR.2000.855864; Otte M., 1994, Computer Vision - ECCV'94. Third European Conference on Computer Vision. Proceedings. Vol.I, P51; PERRONE JA, 1994, VISION RES, V34, P2917, DOI 10.1016/0042-6989(94)90060-4; PERRONE JA, 1992, J OPT SOC AM A, V9, P177, DOI 10.1364/JOSAA.9.000177; Persistence of Vision Pty. Ltd, 2004, PERS VIS TM RAYTR; Raudies F, 2009, FRONTIERS SYSTEMS NE; RIEGER JH, 1985, J OPT SOC AM A, V2, P354, DOI 10.1364/JOSAA.2.000354; Roth S, 2007, INT J COMPUT VISION, V74, P33, DOI 10.1007/s11263-006-0016-x; Rothkopf CA, 2009, VISUAL NEUROSCI, V26, P81, DOI 10.1017/S0952523808080978; Royden CS, 1997, J OPT SOC AM A, V14, P2128, DOI 10.1364/JOSAA.14.002128; ROYDEN CS, 1992, NATURE, V360, P583, DOI 10.1038/360583a0; SCHWARTZ EL, 1980, VISION RES, V20, P645, DOI 10.1016/0042-6989(80)90090-5; SCHWARTZ EL, 1977, BIOL CYBERN, V25, P181, DOI 10.1007/BF01885636; VANDENBERG AV, 1992, VISION RES, V32, P1285, DOI 10.1016/0042-6989(92)90223-6; von Helmholtz H., 1925, TREATISE PHYSL OPTIC, V3; WAGNER R, 2004, THESIS BOSTON U; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; WARREN WH, 1988, J EXP PSYCHOL HUMAN, V14, P646, DOI 10.1037/0096-1523.14.4.646; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; WAXMAN AM, 1986, IEEE T PATTERN ANAL, V8, P715, DOI 10.1109/TPAMI.1986.4767853; Xiao DK, 1997, CEREB CORTEX, V7, P662, DOI 10.1093/cercor/7.7.662	64	8	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38446	10.1371/journal.pone.0038446	http://dx.doi.org/10.1371/journal.pone.0038446			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WG	22719889	Green Published, Green Submitted, gold			2022-12-25	WOS:000305347800007
J	Bauwens, M; De Saint-Hubert, M; Cleynhens, J; Brams, L; Devos, E; Mottaghy, FM; Verbruggen, A				Bauwens, Matthias; De Saint-Hubert, Marijke; Cleynhens, Jan; Brams, Laura; Devos, Ellen; Mottaghy, Felix M.; Verbruggen, Alfons			Radioiodinated Phenylalkyl Malonic Acid Derivatives as pH-Sensitive SPECT Tracers	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; EXTRACELLULAR PH; CANCER-CELLS; TUMOR PH; APOPTOSIS; THERAPY; DEATH; MICE	Introduction: In vivo pH imaging has been a field of interest for molecular imaging for many years. This is especially important for determining tumor acidity, an important driving force of tumor invasion and metastasis formation, but also in the process of apoptosis. Methods: 2-(4-[I-123] iodophenethyl)-2-methylmalonic acid (IPMM), 2-(4-[I-123] iodophenethyl)-malonic acid (IPM), 2-(4-[I-123] iodobenzyl)-malonic acid (IBMM) and 4-[I-123] iodophthalic acid (IP) were radiolabeled via the Cu+ isotopic nucleophilic exchange method. All tracers were tested in vitro in buffer systems to assess pH driven cell uptake. In vivo biodistribution of [I-123] IPMM and [I-123] IPM was determined in healthy mice and the pH targeting efficacy in vivo of [I-123] IPM was evaluated in an anti-Fas monoclonal antibody (mAb) apoptosis model. In addition a mouse RIF-1 tumor model was explored in which tumor pH was decreased from 7.0 to 6.5 by means of induction of hyperglycemia in combination with administration of meta-iodobenzylguanidine. Results: Radiosynthesis resulted in 15-20% for iodo-bromo exchange and 50-60% yield for iodo-iodo exchange while in vitro experiments showed a pH-sensitive uptake for all tracers. Shelf-life stability and in vivo stability was excellent for all tracers. [I-123] IPMM and [I-123] IPM showed a moderately fast predominantly biliary clearance while a high retention was observed in blood. The biodistribution profile of [I-123] IPM was found to be most favorable in view of pH-specific imaging. [I-123] IPM showed a clear pH-related uptake pattern in the RIF-1 tumor model. Conclusion: Iodine-123 labeled malonic acid derivates such as [I-123] IPM show a clearly pH dependent uptake in tumor cells both in vitro and in vivo which allows to visualize regional acidosis. However, these compounds are not suitable for detection of apoptosis due to a poor acidosis effect.	[Bauwens, Matthias; Cleynhens, Jan; Brams, Laura; Verbruggen, Alfons] Katholieke Univ Leuven, Lab Radiopharm, Fac Pharmaceut Sci, Louvain, Belgium; [De Saint-Hubert, Marijke; Devos, Ellen; Mottaghy, Felix M.] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Louvain, Belgium; [Mottaghy, Felix M.] Rhein Westfal TH Aachen, D-52062 Aachen, Germany; [Mottaghy, Felix M.] MUMC, Maastricht, Netherlands	KU Leuven; KU Leuven; University Hospital Leuven; RWTH Aachen University; Maastricht University	Bauwens, M (corresponding author), Katholieke Univ Leuven, Lab Radiopharm, Fac Pharmaceut Sci, Louvain, Belgium.	Matthias.bauwens@mumc.nl	Mottaghy, Felix/AAU-2673-2020	Mottaghy, Felix/0000-0002-7212-6521; De Saint-Hubert, Marijke/0000-0003-2374-3280	European Union [Euregional PACT II]; Interreg IV programof Grensregio Vlaanderen-Nederland (IVA-VLANED-1.20)	European Union(European Commission); Interreg IV programof Grensregio Vlaanderen-Nederland (IVA-VLANED-1.20)	This work was financially supported by the European Union through the grant Euregional PACT II by the Interreg IV programof Grensregio Vlaanderen-Nederland (IVA-VLANED-1.20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloya R, 2006, APOPTOSIS, V11, P2089, DOI 10.1007/s10495-006-0282-7; Bauwens M, 2006, NUCL MED BIOL, V33, P735, DOI 10.1016/j.nucmedbio.2006.05.004; Bauwens M, 2011, NUCL MED BIOL, V38, P381, DOI 10.1016/j.nucmedbio.2010.09.008; Bhujwalla ZM, 1998, BRIT J CANCER, V78, P606, DOI 10.1038/bjc.1998.548; Bhujwalla ZM, 2002, NMR BIOMED, V15, P114, DOI 10.1002/nbm.743; Blanckaert P, 2005, APPL RADIAT ISOTOPES, V62, P737, DOI 10.1016/j.apradiso.2004.10.008; Blankenberg FG, 1998, P NATL ACAD SCI USA, V95, P6349, DOI 10.1073/pnas.95.11.6349; Cohen A, 2009, CELL RES, V19, P625, DOI 10.1038/cr.2009.17; Gallagher FA, 2008, NAT MED, V43, P940; Garcia-Martin ML, 2006, MAGN RESON MED, V55, P309, DOI 10.1002/mrm.20773; Garcia-Martin ML, 2001, CANCER RES, V61, P6524; Gillies RJ, 2004, IEEE ENG MED BIOL, V23, P57, DOI 10.1109/MEMB.2004.1360409; GRIFFITHS JR, 1991, BRIT J CANCER, V64, P425, DOI 10.1038/bjc.1991.326; Grunwald F, 2010, SEMIN NUCL MED, V40, P153, DOI 10.1053/j.semnuclmed.2009.11.004; Hill R P, 2001, Novartis Found Symp, V240, P154; HOOLEY JLW, 1984, RADIOTHER ONCOL, V2, P343; JAHDE E, 1992, CANCER RES, V52, P6209; Kersemans V, 2006, EUR J NUCL MED MOL I, V33, P919, DOI 10.1007/s00259-005-0043-9; KLINE RC, 1981, J NUCL MED, V22, P129; McCarthy JR, 2010, MOL ONCOL, V4, P511, DOI 10.1016/j.molonc.2010.08.003; MERTENS J, 1987, EUR J NUCL MED, V13, P380, DOI 10.1007/BF00253000; Nishimura Y, 1997, INT IMMUNOL, V9, P307, DOI 10.1093/intimm/9.2.307; Raghunand N, 1999, BIOCHEM PHARMACOL, V57, P1047, DOI 10.1016/S0006-2952(99)00021-0; Raghunand N, 2001, NEOPLASIA, V3, P227, DOI 10.1038/sj.neo.7900151; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; ROTTENBERG DA, 1985, ANN NEUROL, V17, P70, DOI 10.1002/ana.410170116; Rottenberg DA, 1984, ANN NEUROL S, V15, P98; SYROTA A, 1985, J CEREBR BLOOD F MET, V5, P358, DOI 10.1038/jcbfm.1985.50; Vavere AL, 2009, CANCER RES, V69, P4510, DOI 10.1158/0008-5472.CAN-08-3781; VAUPEL P, 1989, CANCER RES, V49, P6449; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Waybright SM, 2001, J AM CHEM SOC, V123, P1828, DOI 10.1021/ja000950k; Zhang X, 2010, J NUCL MED, V51, P4	33	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38428	10.1371/journal.pone.0038428	http://dx.doi.org/10.1371/journal.pone.0038428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719886	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341900027
J	Makin, ADJ; Poliakoff, E; Ackerley, R; El-Deredy, W				Makin, Alexis D. J.; Poliakoff, Ellen; Ackerley, Rochelle; El-Deredy, Wael			Covert Tracking: A Combined ERP and Fixational Eye Movement Study	PLOS ONE			English	Article							SMOOTH-PURSUIT; SPATIAL ATTENTION; TARGET BLANKING; EXTRAPOLATION; MICROSACCADES; MODULATION; ACTIVATION; MECHANISMS; OBJECTS; CORTEX	Attention can be directed to particular spatial locations, or to objects that appear at anticipated points in time. While most work has focused on spatial or temporal attention in isolation, we investigated covert tracking of smoothly moving objects, which requires continuous coordination of both. We tested two propositions about the neural and cognitive basis of this operation: first that covert tracking is a right hemisphere function, and second that pre-motor components of the oculomotor system are responsible for driving covert spatial attention during tracking. We simultaneously recorded event related potentials (ERPs) and eye position while participants covertly tracked dots that moved leftward or rightward at 12 or 20 degrees/s. ERPs were sensitive to the direction of target motion. Topographic development in the leftward motion was a mirror image of the rightward motion, suggesting that both hemispheres contribute equally to covert tracking. Small shifts in eye position were also lateralized according to the direction of target motion, implying covert activation of the oculomotor system. The data addresses two outstanding questions about the nature of visuospatial tracking. First, covert tracking is reliant upon a symmetrical frontoparietal attentional system, rather than being right lateralized. Second, this same system controls both pursuit eye movements and covert tracking.	[Makin, Alexis D. J.; Poliakoff, Ellen; El-Deredy, Wael] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Makin, Alexis D. J.] Univ Liverpool, Dept Expt Psychol, Liverpool L69 3BX, Merseyside, England; [Ackerley, Rochelle] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Ackerley, Rochelle] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden	University of Manchester; University of Liverpool; University of Manchester; University of Gothenburg	Makin, ADJ (corresponding author), Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England.	Ellen.Poliakoff@manchester.ac.uk	El-deredy, Wael/H-6521-2015; Ackerley, Rochelle/Q-5719-2017; Poliakoff, Ellen/N-9910-2015; Makin, Alexis/I-9828-2019	El-deredy, Wael/0000-0002-9822-1092; Ackerley, Rochelle/0000-0003-4621-7929; Poliakoff, Ellen/0000-0003-4975-7787; Makin, Alexis/0000-0002-4490-7400	The Economic and Social Sciences Research Council (ESRC); Medical Research Council (MRC)	The Economic and Social Sciences Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Economic and Social Sciences Research Council (ESRC) sponsored Dr. Makin, while the Medical Research Council (MRC) sponsored Dr. Ackerley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes GR, 2008, BRAIN COGNITION, V68, P309, DOI 10.1016/j.bandc.2008.08.020; Benguigui N, 2004, NEUROSCI LETT, V369, P197, DOI 10.1016/j.neulet.2004.07.051; Bennett SJ, 2006, EXP BRAIN RES, V168, P313, DOI 10.1007/s00221-005-0101-3; Bhattacharya J, 2001, NEUROSCI LETT, V311, P29, DOI 10.1016/S0304-3940(01)02133-4; Bongers RM, 2008, J EXP PSYCHOL HUMAN, V34, P1515, DOI 10.1037/a0011974; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; de'Sperati C, 2006, VISION RES, V46, P2593, DOI 10.1016/j.visres.2005.12.019; DeLucia PR, 1998, J EXP PSYCHOL HUMAN, V24, P901, DOI 10.1037/0096-1523.24.3.901; Dimigen O, 2009, J NEUROSCI, V29, P12321, DOI 10.1523/JNEUROSCI.0911-09.2009; Ding JH, 2009, HUM BRAIN MAPP, V30, P3541, DOI 10.1002/hbm.20777; Doherty JR, 2005, J NEUROSCI, V25, P8259, DOI 10.1523/JNEUROSCI.1821-05.2005; Eimer M, 2001, NEUROSCI BIOBEHAV R, V25, P497, DOI 10.1016/S0149-7634(01)00029-X; Eimer M, 2007, BRAIN RES, V1135, P154, DOI 10.1016/j.brainres.2006.12.007; Engbert R, 2004, PSYCHOL SCI, V15, P431, DOI 10.1111/j.0956-7976.2004.00697.x; Gowen E, 2007, BRAIN RES, V1141, P154, DOI 10.1016/j.brainres.2007.01.047; Heilman K. M., 2002, COGNITIVE NEURAL BAS, P3; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Horswill MS, 2005, OPTOMETRY VISION SCI, V82, P740, DOI 10.1097/01.opx.0000175563.21423.50; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kerzel D, 2002, VISION RES, V42, P159, DOI 10.1016/S0042-6989(01)00274-7; Kimmig H, 2008, NEUROPSYCHOLOGIA, V46, P2203, DOI 10.1016/j.neuropsychologia.2008.02.021; Kowler E, 2011, VISION RES, V51, P1457, DOI 10.1016/j.visres.2010.12.014; Lencer R, 2004, EUR J NEUROSCI, V19, P1430, DOI 10.1111/j.1460-9568.2004.03229.x; Lovejoy LP, 2009, VISION RES, V49, P1275, DOI 10.1016/j.visres.2009.01.011; Luck S.J., 2005, INTRO EVENT RELATED; LYON DR, 1995, ACTA PSYCHOL, V89, P239, DOI 10.1016/0001-6918(95)98945-Z; Makin ADJ, 2008, VISION RES, V48, P1884, DOI 10.1016/j.visres.2008.05.023; Makin ADJ, 2011, Q J EXP PSYCHOL, V64, P1327, DOI 10.1080/17470218.2010.548562; Makin ADJ, 2009, NEUROPSYCHOLOGIA, V47, P1128, DOI 10.1016/j.neuropsychologia.2009.01.010; Makin ADJ, 2009, EXP BRAIN RES, V193, P137, DOI 10.1007/s00221-008-1678-0; Martinez-Conde S, 2008, J VISION, V8, DOI [10.1167/8.14.i, 10.1167/8.14.28]; Mesulam M. M., 2002, COGNITIVE NEURAL BAS, P33, DOI DOI 10.1093/ACPROF:OSO/9780198508335.003.0002; Murray MM, 2004, NEUROIMAGE, V21, P125, DOI 10.1016/j.neuroimage.2003.09.035; Nagel M, 2006, NEUROIMAGE, V29, P1319, DOI 10.1016/j.neuroimage.2005.08.050; Ohlendorf S, 2007, EUR J NEUROSCI, V26, P2096, DOI 10.1111/j.1460-9568.2007.05824.x; Olson IR, 2004, NEUROPSYCHOLOGIA, V42, P95, DOI 10.1016/S0028-3932(03)00151-9; Pastukhov A, 2010, VISION RES, V50, P1173, DOI 10.1016/j.visres.2010.04.007; Petit L, 1999, J NEUROPHYSIOL, V82, P463, DOI 10.1152/jn.1999.82.1.463; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Praamstra P, 2005, J NEUROPHYSIOL, V94, P764, DOI 10.1152/jn.01052.2004; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; RIZZOLATTI G, 1994, ATTENTION PERFORM, V15, P231; Rohenkohl G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014620; Schutz A. C., 2011, J VISION, V11; Thier P, 2005, CURR OPIN NEUROBIOL, V15, P645, DOI 10.1016/j.conb.2005.10.013	46	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38479	10.1371/journal.pone.0038479	http://dx.doi.org/10.1371/journal.pone.0038479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719893	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341900031
J	Mei, SY				Mei, Suyu			Multi-Label Multi-Kernel Transfer Learning for Human Protein Subcellular Localization	PLOS ONE			English	Article							GENE ONTOLOGY TERMS; ENSEMBLE CLASSIFIER; LOCATION PREDICTION; MPLOC; PLOC; DATABASE; ENHANCE; FUSION; GO	Recent years have witnessed much progress in computational modelling for protein subcellular localization. However, the existing sequence-based predictive models demonstrate moderate or unsatisfactory performance, and the gene ontology (GO) based models may take the risk of performance overestimation for novel proteins. Furthermore, many human proteins have multiple subcellular locations, which renders the computational modelling more complicated. Up to the present, there are far few researches specialized for predicting the subcellular localization of human proteins that may reside in multiple cellular compartments. In this paper, we propose a multi-label multi-kernel transfer learning model for human protein subcellular localization (MLMK-TLM). MLMK-TLM proposes a multi-label confusion matrix, formally formulates three multi-labelling performance measures and adapts one-against-all multi-class probabilistic outputs to multi-label learning scenario, based on which to further extends our published work GO-TLM (gene ontology based transfer learning model for protein subcellular localization) and MK-TLM (multi-kernel transfer learning based on Chou's PseAAC formulation for protein submitochondria localization) for multiplex human protein subcellular localization. With the advantages of proper homolog knowledge transfer, comprehensive survey of model performance for novel protein and multi-labelling capability, MLMK-TLM will gain more practical applicability. The experiments on human protein benchmark dataset show that MLMK-TLM significantly outperforms the baseline model and demonstrates good multi-labelling ability for novel human proteins. Some findings (predictions) are validated by the latest Swiss-Prot database. The software can be freely downloaded at http://soft.synu.edu.cn/upload/msy.rar.	Shenyang Normal Univ, Software Coll, Shenyang, Peoples R China	Shenyang Normal University	Mei, SY (corresponding author), Shenyang Normal Univ, Software Coll, Shenyang, Peoples R China.	061021053@fudan.edu.cn						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Blum T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-274; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Chou KC, 2004, BIOCHEM BIOPH RES CO, V320, P1236, DOI 10.1016/j.bbrc.2004.06.073; Chou KC, 2003, BIOCHEM BIOPH RES CO, V311, P743, DOI 10.1016/j.bbrc.2003.10.062; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i; Chou KC, 2007, J CELL BIOCHEM, V100, P665, DOI 10.1002/jcb.21096; Chou KC, 2006, BIOCHEM BIOPH RES CO, V347, P150, DOI 10.1016/j.bbrc.2006.06.059; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Dai W., 2007, P 24 INT C MACH LEAR; Dai W, 2008, ADV NEURAL INFORM PR, V21; Garg A, 2005, J BIOL CHEM, V280, P14427, DOI 10.1074/jbc.M411789200; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Huang WL, 2009, BIOSYSTEMS, V98, P73, DOI 10.1016/j.biosystems.2009.06.007; Huang WL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-80; Lee K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn619; Mak MW, 2008, IEEE ACM T COMPUT BI, V5, P416, DOI 10.1109/TCBB.2007.70256; Mei SY, 2012, J THEOR BIOL, V293, P121, DOI 10.1016/j.jtbi.2011.10.015; Mei SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-44; Mei SY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S17; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Platt J., 1999, ADV LARGE MARGIN CLA; Rajendran L, 2010, NAT REV DRUG DISCOV, V9, P29, DOI 10.1038/nrd2897; Shen HB, 2007, AMINO ACIDS, V33, P57, DOI 10.1007/s00726-006-0478-8; Shen HB, 2010, J BIOMOLECULAR STRUC, V28, P0739; Shen HB, 2007, BIOCHEM BIOPH RES CO, V355, P1006, DOI 10.1016/j.bbrc.2007.02.071; Shen HB, 2010, J THEOR BIOL, V264, P326, DOI 10.1016/j.jtbi.2010.01.018; Shen HB, 2009, ANAL BIOCHEM, V394, P269, DOI 10.1016/j.ab.2009.07.046; Tu Y, 2002, P NATL ACAD SCI USA, V99, P14031, DOI 10.1073/pnas.222164199; Tung TQ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S43; van Dijk ADJ, 2008, BIOINFORMATICS, V24, P1779, DOI 10.1093/bioinformatics/btn309; Wu TF, 2004, J MACH LEARN RES, V5, P975; Xiao X, 2011, J THEOR BIOL, V284, P42, DOI 10.1016/j.jtbi.2011.06.005; Xiao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020592; Yang Q., 2009, P JOINT C 47 ANN M A, P1; Zhu L, 2009, PROTEIN J, V28, P384, DOI 10.1007/s10930-009-9205-0	41	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e37716	10.1371/journal.pone.0037716	http://dx.doi.org/10.1371/journal.pone.0037716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719847	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341900013
J	Swanson, EM; Holekamp, KE; Lundrigan, BL; Arsznov, BM; Sakai, ST				Swanson, Eli M.; Holekamp, Kay E.; Lundrigan, Barbara L.; Arsznov, Bradley M.; Sakai, Sharleen T.			Multiple Determinants of Whole and Regional Brain Volume among Terrestrial Carnivorans	PLOS ONE			English	Article							ANCESTRAL CHARACTER STATES; MAMMALIAN LIFE-HISTORY; FAST-SLOW CONTINUUM; BODY-SIZE; PHYLOGENETIC INFORMATION; FORELIMB DEXTERITY; ENDOCRANIAL VOLUME; MOTOR CORTEX; SOCIAL BRAIN; EVOLUTION	Mammalian brain volumes vary considerably, even after controlling for body size. Although several hypotheses have been proposed to explain this variation, most research in mammals on the evolution of encephalization has focused on primates, leaving the generality of these explanations uncertain. Furthermore, much research still addresses only one hypothesis at a time, despite the demonstrated importance of considering multiple factors simultaneously. We used phylogenetic comparative methods to investigate simultaneously the importance of several factors previously hypothesized to be important in neural evolution among mammalian carnivores, including social complexity, forelimb use, home range size, diet, life history, phylogeny, and recent evolutionary changes in body size. We also tested hypotheses suggesting roles for these variables in determining the relative volume of four brain regions measured using computed tomography. Our data suggest that, in contrast to brain size in primates, carnivoran brain size may lag behind body size over evolutionary time. Moreover, carnivore species that primarily consume vertebrates have the largest brains. Although we found no support for a role of social complexity in overall encephalization, relative cerebrum volume correlated positively with sociality. Finally, our results support negative relationships among different brain regions after accounting for overall endocranial volume, suggesting that increased size of one brain regions is often accompanied by reduced size in other regions rather than overall brain expansion.	[Swanson, Eli M.; Holekamp, Kay E.; Lundrigan, Barbara L.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Swanson, Eli M.; Holekamp, Kay E.; Lundrigan, Barbara L.] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; [Lundrigan, Barbara L.] Michigan State Univ, Michigan State Univ Museum, E Lansing, MI 48824 USA; [Sakai, Sharleen T.] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Arsznov, Bradley M.; Sakai, Sharleen T.] Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; Michigan State University	Swanson, EM (corresponding author), Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA.	eliswanson@gmail.com	Holekamp, Kay E/G-6054-2010; Swanson, Eli/A-1941-2009		National Science Foundation [IOB0618022, IOS1121479]; Michigan State University; National Science Foundation predoctoral fellowship; Direct For Biological Sciences [0819437, 1121474] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Michigan State University; National Science Foundation predoctoral fellowship(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by National Science Foundation grants IOB0618022 and IOS1121479 (Dr. Holekamp, Dr. Lundrigan) and an Intramural Research Grants Program (IRGP) grant from Michigan State University (Dr. Sakai, Dr. Holekamp, Dr. Lundrigan). Dr. Swanson was supported on an National Science Foundation predoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; ALLMAN J, 1993, P NATL ACAD SCI USA, V90, P118, DOI 10.1073/pnas.90.1.118; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; [Anonymous], 1997, MACHIAVELLIAN INTELL; Baker R. H., 1983, MICHIGAN MAMMALS; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Barton RA, 1998, P ROY SOC B-BIOL SCI, V265, P1933, DOI 10.1098/rspb.1998.0523; Bielby J, 2007, AM NAT, V169, P748, DOI 10.1086/516847; Bininda-Emonds ORP, 1999, BIOL REV, V74, P143, DOI 10.1017/S0006323199005307; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Byrne R., 1988, MACHIAVELLIAN INTELL; Byrne R.W., 1994, P223; Changizi MA, 2009, ENCY NEUROSCIENCE; CLUTTONBROCK TH, 1980, J ZOOL, V190, P309; CLUTTONBROCK TH, 1977, J ZOOL, V183, P1, DOI 10.1111/j.1469-7998.1977.tb04171.x; Corfield JR, 2008, BRAIN BEHAV EVOLUT, V71, P87, DOI 10.1159/000111456; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; DEACON TW, 1990, AM ZOOL, V30, P629; Deaner RO, 1999, P ROY SOC B-BIOL SCI, V266, P687, DOI 10.1098/rspb.1999.0690; Deaner RO, 2000, BRAIN BEHAV EVOLUT, V55, P44, DOI 10.1159/000006641; Dechmann DKN, 2009, BIOL REV, V84, P161, DOI 10.1111/j.1469-185X.2008.00067.x; Diaz-Uriarte R, 1998, SYST BIOL, V47, P654, DOI 10.1080/106351598260653; Dobson FS, 2007, ECOSCIENCE, V14, P292, DOI 10.2980/1195-6860(2007)14[292:FASLHO]2.0.CO;2; DONOGHUE JP, 1992, EXP BRAIN RES, V89, P1; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Dunbar RIM, 2007, PHILOS T R SOC B, V362, P649, DOI 10.1098/rstb.2006.2001; Dunbar RIM, 1998, ETHOLOGY, V104, P695, DOI 10.1111/j.1439-0310.1998.tb00103.x; Dunbar RIM, 2003, ANNU REV ANTHROPOL, V32, P163, DOI 10.1146/annurev.anthro.32.061002.093158; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; EISENBERG JF, 1978, EVOLUTION, V32, P740, DOI 10.1111/j.1558-5646.1978.tb04627.x; Emery NJ, 2007, PHILOS T R SOC B, V362, P489, DOI 10.1098/rstb.2006.1991; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Finarelli JA, 2006, J MAMMAL, V87, P1027, DOI 10.1644/05-MAMM-A-430R1.1; Finarelli JA, 2010, BIOL LETTERS, V6, P350, DOI 10.1098/rsbl.2009.0787; Finarelli JA, 2009, P NATL ACAD SCI USA, V106, P9345, DOI 10.1073/pnas.0901780106; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Finlay BL, 2001, BEHAV BRAIN SCI, V24, P263, DOI 10.1017/S0140525X01003958; Fish JL, 2003, AM J PHYS ANTHROPOL, V120, P171, DOI 10.1002/ajpa.10136; GAILLARD JM, 1989, OIKOS, V56, P59, DOI 10.2307/3566088; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; GITTLEMAN JL, 1992, ANNU REV ECOL SYST, V23, P383; GITTLEMAN JL, 1986, J MAMMAL, V67, P23, DOI 10.2307/1380998; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; GORSKA T, 1974, ACTA NEUROBIOL EXP, V34, P171; GOULD SJ, 1975, CONTRIB PRIMATOL, V5, P244; Gould SJ, 1991, BULLY BRONTOSAURUS, P109; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Harcourt AH., 1992, COALITIONS ALLIANCES; Harmon L, 2009, GEIGER ANAL EVOLUTIO; Harvey P.H., 1989, Oxford Surveys in Evolutionary Biology, V6, P13; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HARVEY PH, 1985, NATURE, V315, P319, DOI 10.1038/315319a0; HASSLER R, 1964, J Hirnforsch, V7, P377; HEALY SD, 1992, P ROY SOC B-BIOL SCI, V248, P241, DOI 10.1098/rspb.1992.0068; Holekamp KE, 2007, J MAMMAL, V88, P545, DOI 10.1644/06-MAMM-S-361R1.1; Holekamp KE, 2007, TRENDS COGN SCI, V11, P65, DOI 10.1016/j.tics.2006.11.003; Holekamp KE, 2010, ADV STUD BEHAV, V42, P189, DOI 10.1016/S0065-3454(10)42006-9; Humphrey N. K., 1976, GROWING POINTS ETHOL, P303; Isler K, 2009, J HUM EVOL, V57, P392, DOI 10.1016/j.jhevol.2009.04.009; Isler K, 2009, BIOL LETTERS, V5, P125, DOI 10.1098/rsbl.2008.0469; Iwaniuk AN, 1999, BRAIN BEHAV EVOLUT, V54, P167, DOI 10.1159/000006621; Iwaniuk AN, 2002, CAN J ZOOL, V80, P16, DOI 10.1139/Z01-204; Iwaniuk AN, 2000, CAN J ZOOL, V78, P1110, DOI 10.1139/cjz-78-7-1110; Iwaniuk AN, 2009, CAN J EXP PSYCHOL, V63, P150, DOI 10.1037/a0015678; JERISON HJ, 1985, PHILOS T ROY SOC B, V308, P21, DOI 10.1098/rstb.1985.0007; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Koepfli KP, 2006, MOL PHYLOGENET EVOL, V38, P603, DOI 10.1016/j.ympev.2005.10.017; LANDE R, 1979, EVOLUTION, V33, P234, DOI 10.1111/j.1558-5646.1979.tb04678.x; Lefebvre L, 2008, BRAIN BEHAV EVOLUT, V72, P135, DOI 10.1159/000151473; Losos JB, 1999, ANIM BEHAV, V58, P1319, DOI 10.1006/anbe.1999.1261; MADDISON WP, 2004, MESQUITE MODULAR SYS; Martin R.D., 1985, P147; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Mech LD., 1970, WOLF ECOLOGY BEHAV E; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Midford P. E., 2005, PDAP PACKAGE MESQUIT; Mills M. G. L., 1998, HYENAS STATUS SURVEY; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Nowak R. M., 2005, WALKERS CARNIVORES W; Oli MK, 2004, BASIC APPL ECOL, V5, P449, DOI 10.1016/j.baae.2004.06.002; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; PAGEL MD, 1992, J THEOR BIOL, V156, P431, DOI 10.1016/S0022-5193(05)80637-X; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2006; PARKER ST, 1977, J HUM EVOL, V6, P623, DOI 10.1016/S0047-2484(77)80135-8; Perez-Barberia FJ, 2007, EVOLUTION, V61, P2811, DOI 10.1111/j.1558-5646.2007.00229.x; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; RADINSKY LB, 1969, ANN NY ACAD SCI, V167, P277, DOI 10.1111/j.1749-6632.1969.tb20450.x; READ AF, 1989, J ZOOL, V219, P329, DOI 10.1111/j.1469-7998.1989.tb02584.x; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; Ricard AS, 2010, SURG RADIOL ANAT, V32, P989, DOI 10.1007/s00276-010-0650-4; RISKA B, 1985, SCIENCE, V229, P668, DOI 10.1126/science.229.4714.668; ROHRS M, 1986, Z ZOOL SYST EVOL, V24, P300; ROHRS M, 1989, Z ZOOL SYST EVOL, V27, P169; SACHER GA, 1974, AM NAT, V108, P593, DOI 10.1086/282938; Sakai ST, 2011, BRAIN BEHAV EVOLUT, V77, P91, DOI 10.1159/000323849; SAKAI ST, 1982, J COMP NEUROL, V204, P238, DOI 10.1002/cne.902040304; Shultz S, 2007, P ROY SOC B-BIOL SCI, V274, P2429, DOI 10.1098/rspb.2007.0693; Shultz S, 2010, BIOL J LINN SOC, V100, P111, DOI 10.1111/j.1095-8312.2010.01427.x; Sol D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009617; STEARNS SC, 1983, OIKOS, V41, P173, DOI 10.2307/3544261; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Sunquist ME, 2002, WILD CATS WORLD; Van Schaik CP, 2003, ANIMAL SOCIAL COMPLEXITY, P5; Watts HE, 2009, P ROY SOC B-BIOL SCI, V276, P2291, DOI 10.1098/rspb.2009.0268; Webster AJ, 2004, J EVOLUTION BIOL, V17, P396, DOI 10.1046/j.1420-9101.2003.00664.x; Weisbecker V, 2010, P NATL ACAD SCI USA, V107, P16216, DOI 10.1073/pnas.0906486107; WELKER WI, 1963, J COMP NEUROL, V120, P19, DOI 10.1002/cne.901200103; Weston EM, 2009, NATURE, V459, P85, DOI 10.1038/nature07922; Wilson DE, HDB MAMMALS WORLD; Young R.M., 1990, MIND BRAIN; YOUNG RW, 1959, AM J ANAT, V105, P383, DOI 10.1002/aja.1001050304; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	116	40	40	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38447	10.1371/journal.pone.0038447	http://dx.doi.org/10.1371/journal.pone.0038447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719890	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900028
J	Sampey, BP; Freemerman, AJ; Zhang, J; Kuan, PF; Galanko, JA; O'Connell, TM; Ilkayeva, OR; Muehlbauer, MJ; Stevens, RD; Newgard, CB; Brauer, HA; Troester, MA; Makowski, L				Sampey, Brante P.; Freemerman, Alex J.; Zhang, Jimmy; Kuan, Pei-Fen; Galanko, Joseph A.; O'Connell, Thomas M.; Ilkayeva, Olga R.; Muehlbauer, Michael J.; Stevens, Robert D.; Newgard, Christopher B.; Brauer, Heather A.; Troester, Melissa A.; Makowski, Liza			Metabolomic Profiling Reveals Mitochondrial-Derived Lipid Biomarkers That Drive Obesity-Associated Inflammation	PLOS ONE			English	Article							SERUM-CHOLESTEROL CONCENTRATIONS; CORONARY-ARTERY-DISEASE; SATURATED FATTY-ACIDS; ADIPOSE-TISSUE; PALMITOLEIC ACID; RAPID DIAGNOSIS; INNATE IMMUNITY; BLOOD SPOTS; PLASMA; RISK	Obesity has reached epidemic proportions worldwide. Several animal models of obesity exist, but studies are lacking that compare traditional lard-based high fat diets (HFD) to "Cafeteria diets" (CAF) consisting of nutrient poor human junk food. Our previous work demonstrated the rapid and severe obesogenic and inflammatory consequences of CAF compared to HFD including rapid weight gain, markers of Metabolic Syndrome, multi-tissue lipid accumulation, and dramatic inflammation. To identify potential mediators of CAF-induced obesity and Metabolic Syndrome, we used metabolomic analysis to profile serum, muscle, and white adipose from rats fed CAF, HFD, or standard control diets. Principle component analysis identified elevations in clusters of fatty acids and acylcarnitines. These increases in metabolites were associated with systemic mitochondrial dysfunction that paralleled weight gain, physiologic measures of Metabolic Syndrome, and tissue inflammation in CAF-fed rats. Spearman pairwise correlations between metabolites, physiologic, and histologic findings revealed strong correlations between elevated markers of inflammation in CAF-fed animals, measured as crown like structures in adipose, and specifically the pro-inflammatory saturated fatty acids and oxidation intermediates laurate and lauroyl carnitine. Treatment of bone marrow-derived macrophages with lauroyl carnitine polarized macrophages towards the M1 pro-inflammatory phenotype through downregulation of AMPK and secretion of pro-inflammatory cytokines. Results presented herein demonstrate that compared to a traditional HFD model, the CAF diet provides a robust model for diet-induced human obesity, which models Metabolic Syndrome-related mitochondrial dysfunction in serum, muscle, and adipose, along with pro-inflammatory metabolite alterations. These data also suggest that modifying the availability or metabolism of saturated fatty acids may limit the inflammation associated with obesity leading to Metabolic Syndrome.	[Sampey, Brante P.; Freemerman, Alex J.; Zhang, Jimmy; Makowski, Liza] Univ N Carolina, Sch Med, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Kuan, Pei-Fen] Univ N Carolina, Dept Biostat, Sch Med, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Brauer, Heather A.; Troester, Melissa A.] Univ N Carolina, Sch Med, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Galanko, Joseph A.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Kuan, Pei-Fen; Troester, Melissa A.; Makowski, Liza] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Ilkayeva, Olga R.; Muehlbauer, Michael J.; Stevens, Robert D.; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA; [Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [O'Connell, Thomas M.] LipoScience Inc, Raleigh, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; LipoScience, Inc	Sampey, BP (corresponding author), Metabolon Inc, Durham, NC USA.	liza.makowski@unc.edu	Kuan, Pei Fen/GRX-4622-2022	Sampey, Brante/0000-0001-7765-0667; Makowski, Liza/0000-0002-5337-8037; Brauer, Heather Ann/0000-0003-4394-1508	Lineberger Comprehensive Cancer Center University Cancer Research Funds; National Institutes of Health (NIH) [PO1DK58398]; Freedom to Discover Award from Bristol Meyers Squibb; NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [P30DK056350, P30DK034987]; Bristol Meyers Squibb;  [AA017376];  [ES019472]; NATIONAL CANCER INSTITUTE [P50CA058223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, P30DK056350, P01DK058398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019472, P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R00AA017376, K99AA017376] Funding Source: NIH RePORTER	Lineberger Comprehensive Cancer Center University Cancer Research Funds; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Freedom to Discover Award from Bristol Meyers Squibb; NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Bristol Meyers Squibb(Bristol-Myers Squibb); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The project was funded by AA017376 (http://www.niaaa.nih.gov/Pages/default.aspx), ES019472 (http://www.niehs.nih.gov/), and Lineberger Comprehensive Cancer Center University Cancer Research Funds (http://unclineberger.org/ucrf) to L. M. and National Institutes of Health (NIH) grant PO1DK58398 (http://www2.niddk.nih.gov/) and a Freedom to Discover Award from Bristol Meyers Squibb (http://www.bms.com/foundation/what_we_support/Pages/ftd_grants_awards.aspx) to C.B.N. This project is supported in part by NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grants (http://www2.niddk.nih.gov/) P30DK056350 to the UNC-CH Nutrition Obesity Research Center (L. M., J.A.G.) (http://www.sph.unc.edu/cnrc/) and P30DK034987 to the Center for Gastrointestinal Biology and Disease (L. M., J.A.G.) (https://cgibd.med.unc.edu/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare the following interests: The project was partially funded by A Freedom to Discover Award from Bristol Meyers Squibb (http://www.bms.com/foundation/what_we_support/Pages/ftd_grants_awards.aspx) to C.B.N. B. P. S. and T.M.O. were employed at UNC while analysis of this manuscript was completed, and currently are employed by Metabolon, Inc. and Liposcience, Inc., respectively. There are no declarations relating to employment, consultancy, patents or products in development or marketed products, etc. with regard to this work. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Babio N, 2009, NUTR METAB CARDIOVAS, V19, P563, DOI 10.1016/j.numecd.2008.10.007; Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Bradbury KE, 2010, AM J CLIN NUTR, V91, P398, DOI 10.3945/ajcn.2009.28159; Calder PC, 2008, P NUTR SOC, V67, P409, DOI 10.1017/S0029665108008690; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; CHACE DH, 1995, CLIN CHEM, V41, P62; CHACE DH, 1993, CLIN CHEM, V39, P66; Cocchi M, 1993, 3D QSAR DRUG DESIGN, V1; Crowe FL, 2006, AM J CLIN NUTR, V83, P887, DOI 10.1093/ajcn/83.4.887; Dasu MR, 2008, DIABETES, V57, P3090, DOI 10.2337/db08-0564; Davis JE, 2008, OBESITY, V16, P1248, DOI 10.1038/oby.2008.210; Deshmukh-Taskar PR, 2009, PUBLIC HEALTH NUTR, V12, P2493, DOI 10.1017/S1368980009991261; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Fernandez-Real JM, 2005, CLIN CHEM, V51, P603, DOI 10.1373/clinchem.2004.041350; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fogli-Cawley JJ, 2007, AM J CLIN NUTR, V86, P1193, DOI 10.1093/ajcn/86.4.1193; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502; Huffman KM, 2011, DIABETES CARE, V34, P174, DOI 10.2337/dc10-0709; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jensen MD, 2007, HORM METAB RES, V39, P722, DOI 10.1055/s-2007-990274; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Lee JY, 2004, J BIOL CHEM, V279, P16971, DOI 10.1074/jbc.M312990200; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Lee JY, 2003, J BIOL CHEM, V278, P37041, DOI 10.1074/jbc.M305213200; Lien LF, 2009, OMICS, V13, P21, DOI 10.1089/omi.2008.0035; Lum H, 2011, J GERONTOL A-BIOL, V66, P548, DOI 10.1093/gerona/glr006; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2009, NAT MED, V15, P846, DOI 10.1038/nm0809-846; Makowski L, 2004, J NUTR, V134, p2464S, DOI 10.1093/jn/134.9.2464S; Makowski L, 2009, FASEB J, V23, P586, DOI 10.1096/fj.08-119420; McGuinness OP, 2005, ANNU REV NUTR, V25, P9, DOI 10.1146/annurev.nutr.24.012003.132159; Millington DS, 2011, METHODS MOL BIOL, V708, P55, DOI 10.1007/978-1-61737-985-7_3; MILLINGTON DS, 1992, PROG CLIN BIOL RES, V375, P339; Mozaffarian D, 2010, ANN INTERN MED, V153, P790, DOI 10.7326/0003-4819-153-12-201012210-00005; Mozaffarian D, 2010, AM J CLIN NUTR, V92, P1350, DOI 10.3945/ajcn.110.003970; Newgard CB, 2012, CELL METAB IN PRESS; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nielsen S, 2004, J CLIN INVEST, V113, P1582, DOI [10.1172/JCI200421047, 10.1172/JCI21047]; Noland RC, 2009, J BIOL CHEM, V284, P22840, DOI 10.1074/jbc.M109.032888; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Riccardi G, 2000, BRIT J NUTR, V83, pS143; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sampey BP, 2011, OBESITY SILVER SPRIN; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; Saraswathi V, 2007, J NUTR, V137, P1776, DOI 10.1093/jn/137.7.1776; Schaffaler A, 2010, TRENDS IMMUNOL, V31, P228, DOI 10.1016/j.it.2010.03.001; Schwartz EA, 2010, ARTERIOSCL THROM VAS, V30, P802, DOI 10.1161/ATVBAHA.109.201681; Shah SH, 2012, DIABETOLOGIA, V55, P321, DOI 10.1007/s00125-011-2356-5; Shah SH, 2011, CELL METAB, V13, P491, DOI 10.1016/j.cmet.2011.04.003; Shah SH, 2010, AM HEART J, V160, P371, DOI 10.1016/j.ahj.2010.06.051; Shah SH, 2010, CIRC-CARDIOVASC GENE, V3, P207, DOI 10.1161/CIRCGENETICS.109.852814; Shah SH, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.11; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Suganami T, 2010, J LEUKOCYTE BIOL, V88, P33, DOI 10.1189/jlb.0210072; Tazoe H, 2008, J PHYSIOL PHARMACOL, V59, P251; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Turer AT, 2009, CIRCULATION, V119, P1736, DOI 10.1161/CIRCULATIONAHA.108.816116; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Weatherill AR, 2005, J IMMUNOL, V174, P5390, DOI 10.4049/jimmunol.174.9.5390; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu JY, 2004, J CLIN INVEST, V113, P434, DOI 10.1172/JCI200419574; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yerlikaya H, 2011, CLIN LIPIDOL, V6, P615, DOI 10.2217/CLP.11.48; Yusof HM, 2008, PROSTAG LEUKOTR ESS, V78, P219, DOI 10.1016/j.plefa.2008.02.002	77	91	93	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38812	10.1371/journal.pone.0038812	http://dx.doi.org/10.1371/journal.pone.0038812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701716	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340000048
J	Yu, L; Zhang, L; Sun, LN; Lu, J; Wu, W; Li, C; Zhang, QF; Zhang, FS; Jin, C; Wang, XJ; Bi, ZQ; Li, DX; Liang, MF				Yu, Li; Zhang, Li; Sun, Lina; Lu, Jing; Wu, Wei; Li, Chuan; Zhang, Quanfu; Zhang, Fushun; Jin, Cong; Wang, Xianjun; Bi, Zhenqiang; Li, Dexin; Liang, Mifang			Critical Epitopes in the Nucleocapsid Protein of SFTS Virus Recognized by a Panel of SFTS Patients Derived Human Monoclonal Antibodies	PLOS ONE			English	Article							THROMBOCYTOPENIA SYNDROME BUNYAVIRUS; HUMORAL RESPONSE; ENVELOPE PROTEIN; ANTIGENIC SITES; IGM ANTIBODIES; INDIRECT ELISA; SEVERE FEVER; N-PROTEIN; NUCLEOPROTEIN; IMMUNOASSAYS	Background: SFTS virus (SFTSV) is a newly discovered pathogen to cause severe fever with thrombocytopenia syndrome (SFTS) in human. Successful control of SFTSV epidemic requires better understanding of the antigen target in humoral immune responses to the new bunyavirus infection. Methodology/Principal Findings: We have generated a combinatorial Fab antibody phage library from two SFTS patients recovered from SFTSV infection. To date, 94 unique human antibodies have been generated and characterized from over 1200 Fab antibody clones obtained by screening the library with SFTS purified virions. All those monoclonal antibodies (MAbs) recognized the nucleocapsid (N) protein of SFTSV while none of them were reactive to the viral glycoproteins Gn or Gc. Furthermore, over screening 1000 mouse monoclonal antibody clones derived from SFTSV virions immunization, 462 clones reacted with N protein, while only 16 clones were reactive to glycoprotein. Furthermore, epitope mapping of SFTSV N protein was performed through molecular simulation, site mutation and competitive ELISA, and we found that at least 4 distinct antigenic epitopes within N protein were recognized by those human and mouse MAbs, in particular mutation of Glu10 to Ala10 abolished or significantly reduced the binding activity of nearly most SFTS patients derived MAbs. Conclusions/Significance: The large number of human recombinant MAbs derived from SFTS patients recognized the viral N protein indicated the important role of the N protein in humoral responses to SFTSV infection, and the critical epitopes we defined in this study provided molecular basis for detection and diagnosis of SFTSV infection.	[Yu, Li; Zhang, Li; Sun, Lina; Lu, Jing; Wu, Wei; Li, Chuan; Zhang, Quanfu; Zhang, Fushun; Jin, Cong; Li, Dexin; Liang, Mifang] China CDC, Lab Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Wang, Xianjun; Bi, Zhenqiang] Shandong Prov CDC, Shandong Key Lab Infect Dis Prevent & Control, Jinan, Shandong, Peoples R China	Chinese Center for Disease Control & Prevention	Yu, L (corresponding author), China CDC, Lab Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	mifangl@vip.sina.com			Ministry of Science and Technology [2011ZX10004-001]; Ministry of Health; Mount Tai Scholarship of Shandong Province; National Natural Science Foundation of China [81102171]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health; Mount Tai Scholarship of Shandong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was mainly supported by China Mega-Project for Infectious Diseases (2011ZX10004-001) from Ministry of Science and Technology and Ministry of Health, and Mount Tai Scholarship of Shandong Province (D. L.), the National Natural Science Foundation of China (81102171). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agostino M, 2009, MOL IMMUNOL, V47, P233, DOI 10.1016/j.molimm.2009.09.031; ARIKAWA J, 1989, J GEN VIROL, V70, P615, DOI 10.1099/0022-1317-70-3-615; ARIKAWA J, 1992, ARCH VIROL, V126, P271, DOI 10.1007/BF01309700; Barbas CF, 1996, TRENDS BIOTECHNOL, V14, P230, DOI 10.1016/0167-7799(96)10029-9; BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978; BESSELAAR TG, 1991, ARCH VIROL, V121, P111, DOI 10.1007/BF01316748; Boshra H, 2011, VACCINE, V29, P4469, DOI 10.1016/j.vaccine.2011.04.043; Boshra H, 2011, J VIROL, V85, P6098, DOI 10.1128/JVI.02641-10; Clark RL, 2006, BIOORGAN MED CHEM, V14, P2674, DOI 10.1016/j.bmc.2005.11.042; COOK GP, 1995, IMMUNOL TODAY, V16, P237, DOI 10.1016/0167-5699(95)80166-9; Fafetine JM, 2007, VET MICROBIOL, V121, P29, DOI 10.1016/j.vetmic.2006.11.008; Gai ZT, 2012, CLIN INFECT DIS, V54, P249, DOI 10.1093/cid/cir776; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Katz A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-187; Kaushik S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026251; Kearns-Jonker M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-3; Le May N, 2005, J VIROL, V79, P11974, DOI 10.1128/JVI.79.18.11974-11980.2005; Lu Jing, 2011, Chinese Journal of Virology, V27, P515; LUNDKVIST A, 1993, ARCH VIROL, V130, P121, DOI 10.1007/BF01319001; Magurano F, 1999, CLIN DIAGN LAB IMMUN, V6, P55, DOI 10.1128/CDLI.6.1.55-60.1999; Martin-Folgar R, 2010, MABS-AUSTIN, V2, P275, DOI 10.4161/mabs.2.3.11676; Mohl BP, 2009, RNA, V15, P391, DOI 10.1261/rna.1367209; NAKAMURA T, 1985, J INFECT DIS, V151, P691, DOI 10.1093/infdis/151.4.691; Raymond DD, 2010, P NATL ACAD SCI USA, V107, P11769, DOI 10.1073/pnas.1001760107; Schmaljohn C.S., 2007, FIELDS VIROLOGY, P1741; Stephenson I, 2003, J MED VIROL, V70, P391, DOI 10.1002/jmv.10408; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; van Vuren PJ, 2007, J VIROL METHODS, V140, P106, DOI 10.1016/j.jviromet.2006.11.005; van Vuren PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025027; YOSHIMATSU K, 1993, ARCH VIROL, V130, P365, DOI 10.1007/BF01309667; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095	31	28	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38291	10.1371/journal.pone.0038291	http://dx.doi.org/10.1371/journal.pone.0038291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719874	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340000017
J	Broach, WH; Egan, N; Wing, HJ; Payne, SM; Murphy, ER				Broach, William H.; Egan, Nicholas; Wing, Helen J.; Payne, Shelley M.; Murphy, Erin R.			VirF-Independent Regulation of Shigella virB Transcription is Mediated by the Small RNA RyhB	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEASE; III SECRETION SYSTEM; INVE GENE-EXPRESSION; H-NS; ESCHERICHIA-COLI; MESSENGER-RNA; INTRACELLULAR ENVIRONMENT; IRON-METABOLISM; VIBRIO-CHOLERAE; FLEXNERI	Infection of the human host by Shigella species requires the coordinated production of specific Shigella virulence factors, a process mediated largely by the VirF/VirB regulatory cascade. VirF promotes the transcription of virB, a gene encoding the transcriptional activator of several virulence-associated genes. This study reveals that transcription of virB is also regulated by the small RNA RyhB, and importantly, that this regulation is not achieved indirectly via modulation of VirF activity. These data are the first to demonstrate that the regulation of virB transcription can be uncoupled from the master regulator VirF. It is also established that efficient RyhB-dependent regulation of transcription is facilitated by specific nucleic acid sequences within virB. This study not only reveals RyhB-dependent regulation of virB transcription as a novel point of control in the central regulatory circuit modulating Shigella virulence, but also highlights the versatility of RyhB in controlling bacterial gene expression.	[Broach, William H.] Ohio Univ, Mol & Cellular Biol Program, Dept Biol Sci, Athens, OH 45701 USA; [Egan, Nicholas; Wing, Helen J.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Payne, Shelley M.] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Murphy, Erin R.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	University System of Ohio; Ohio University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Texas System; University of Texas Austin; University System of Ohio; Ohio University	Broach, WH (corresponding author), Ohio Univ, Mol & Cellular Biol Program, Dept Biol Sci, Athens, OH 45701 USA.	murphye@ohio.edu		Murphy, Erin/0000-0002-5716-4829; Wing, Helen J./0000-0003-0123-5568	Ruth L. Kirschstein National Research Service Award National Institutes of Health (NIH) [8-FGM069312A]; Ohio University Research Committee; Ohio University Heritage College of Osteopathic Medicine; NIH [AI-16935, 5P20RR016464-10]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI016935, R01AI016935] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio University Research Committee; Ohio University Heritage College of Osteopathic Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by Ruth L. Kirschstein National Research Service Award National Institutes of Health (NIH) 8-FGM069312A, a grant from the Ohio University Research Committee and by the Ohio University Heritage College of Osteopathic Medicine (to ERM), as well as by NIH grants AI-16935 (to SMP) and 5P20RR016464-10 (to HJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER B, 1989, MOL MICROBIOL, V3, P627, DOI 10.1111/j.1365-2958.1989.tb00210.x; Afonyushkin T, 2005, NUCLEIC ACIDS RES, V33, P1678, DOI 10.1093/nar/gki313; Africa LAA, 2011, INFECT IMMUN, V79, P4543, DOI 10.1128/IAI.05340-11; Castellanos MI, 2009, J BACTERIOL, V191, P4047, DOI 10.1128/JB.00313-09; CLERC P, 1988, CURR TOP MICROBIOL, V138, P3; Desnoyers G, 2009, EMBO J, V28, P1551, DOI 10.1038/emboj.2009.116; Dorman CJ, 1998, MOL MICROBIOL, V29, P677, DOI 10.1046/j.1365-2958.1998.00902.x; Falconi M, 1998, EMBO J, V17, P7033, DOI 10.1093/emboj/17.23.7033; Falconi M, 2001, MOL MICROBIOL, V42, P439, DOI 10.1046/j.1365-2958.2001.02646.x; FORMAL SB, 1958, J BACTERIOL, V75, P604, DOI 10.1128/JB.75.5.604-610.1958; GOLDBERG MB, 1994, INFECT IMMUN, V62, P5664, DOI 10.1128/IAI.62.12.5664-5668.1994; Gore AL, 2010, INFECT IMMUN, V78, P4674, DOI 10.1128/IAI.00589-10; Jennison AV, 2004, FEMS MICROBIOL REV, V28, P43, DOI 10.1016/j.femsre.2003.07.002; Le Gall T, 2005, MICROBIOL-SGM, V151, P951, DOI 10.1099/mic.0.27639-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LODGE J, 1992, FEMS MICROBIOL LETT, V95, P271; Lucchini S, 2005, INFECT IMMUN, V73, P88, DOI 10.1128/IAI.73.1.88-102.2005; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Mills M, 1997, INFECT IMMUN, V65, P5358, DOI 10.1128/IAI.65.12.5358-5363.1997; Mitobe J, 2005, J BACTERIOL, V187, P107, DOI 10.1128/JB.187.1.107-113.2005; Mitobe J, 2008, J BIOL CHEM, V283, P5738, DOI 10.1074/jbc.M710108200; Mitobe J, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-110; Murphy ER, 2007, INFECT IMMUN, V75, P3470, DOI 10.1128/IAI.00112-07; NAKAYAMA S, 1995, J BACTERIOL, V177, P5062, DOI 10.1128/jb.177.17.5062-5069.1995; OAKS EV, 1985, INFECT IMMUN, V48, P124, DOI 10.1128/IAI.48.1.124-129.1985; Oglesby AG, 2005, MOL MICROBIOL, V58, P1354, DOI 10.1111/j.1365-2958.2005.04920.x; Payne SM, 2006, BIOMETALS, V19, P173, DOI 10.1007/s10534-005-4577-x; PAYNE SM, 1977, INFECT IMMUN, V18, P94, DOI 10.1128/IAI.18.1.94-98.1977; Porter ME, 1997, MOL GEN GENET, V256, P93, DOI 10.1007/s004380050550; Porter ME, 1997, J BACTERIOL, V179, P6537, DOI 10.1128/jb.179.21.6537-6550.1997; Prevost K, 2007, MOL MICROBIOL, V64, P1260, DOI 10.1111/j.1365-2958.2007.05733.x; Prosseda G, 1998, RES MICROBIOL, V149, P15, DOI 10.1016/S0923-2508(97)83619-4; Runyen-Janecky LJ, 2002, INFECT IMMUN, V70, P4379, DOI 10.1128/IAI.70.8.4379-4388.2002; SAKAI T, 1988, MOL MICROBIOL, V2, P589, DOI 10.1111/j.1365-2958.1988.tb00067.x; Sambrook J, 2001, MOL CLONING LAB MANU; TOBE T, 1991, MOL MICROBIOL, V5, P887, DOI 10.1111/j.1365-2958.1991.tb00762.x; TOBE T, 1993, J BACTERIOL, V175, P6142, DOI 10.1128/JB.175.19.6142-6149.1993; Vecerek B, 2003, MOL MICROBIOL, V50, P897, DOI 10.1046/j.1365-2958.2003.03727.x; Wing HJ, 2004, J BACTERIOL, V186, P699, DOI 10.1128/JB.186.3.699-705.2004; Wyckoff EE, 2006, J BACTERIOL, V188, P6515, DOI 10.1128/JB.00626-06	42	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38592	10.1371/journal.pone.0038592	http://dx.doi.org/10.1371/journal.pone.0038592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701677	Green Submitted, Green Published, gold			2022-12-25	WOS:000305337600032
J	Edwards, LM; Tyler, DJ; Kemp, GJ; Dwyer, RM; Johnson, A; Holloway, CJ; Nevill, AM; Clarke, K				Edwards, Lindsay M.; Tyler, Damian J.; Kemp, Graham J.; Dwyer, Renee M.; Johnson, Andrew; Holloway, Cameron J.; Nevill, Alan M.; Clarke, Kieran			The Reproducibility of 31-Phosphorus MRS Measures of Muscle Energetics at 3 Tesla in Trained Men	PLOS ONE			English	Article							PHOSPHOCREATINE RECOVERY KINETICS; MAGNETIC-RESONANCE-SPECTROSCOPY; SKELETAL-MUSCLE; MITOCHONDRIAL-FUNCTION; ATP HYDROLYSIS; P-31 MRS; IN-VIVO; ASSESSING AGREEMENT; OXIDATIVE CAPACITY; EXERCISE	Objective: Magnetic resonance spectroscopy (MRS) provides an exceptional opportunity for the study of in vivo metabolism. MRS is widely used to measure phosphorus metabolites in trained muscle, although there are no published data regarding its reproducibility in this specialized cohort. Thus, the aim of this study was to assess the reproducibility of 31 P-MRS in trained skeletal muscle. Methods: We recruited fifteen trained men (VO(2)peak = 4.7 +/- 0.8 L min(-1)/58 +/- 8 mL kg(-1) min(-1)) and performed duplicate MR experiments during plantar flexion exercise, three weeks apart. Results: Measures of resting phosphorus metabolites were reproducible, with 1.7 mM the smallest detectable difference in phosphocreatine (PCr). Measures of metabolites during exercise were less reliable: exercising PCr had a coefficient of variation (CV) of 27% during exercise, compared with 8% at rest. Estimates of mitochondrial function were variable, but experimentally useful. The CV of PCr1/2t was 40%, yet much of this variance was inter-subject such that differences of <20% were detectable with n = 15, given a significance threshold of p < 0.05. Conclusions: 31-phosphorus MRS provides reproducible and experimentally useful measures of phosphorus metabolites and mitochondrial function in trained human skeletal muscle.	[Edwards, Lindsay M.; Tyler, Damian J.; Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Edwards, Lindsay M.; Tyler, Damian J.; Johnson, Andrew; Holloway, Cameron J.] John Radcliffe Hosp, Oxford Ctr Clin Magnet Resonance Res, Oxford OX3 9DU, England; [Kemp, Graham J.] Univ Liverpool, Dept Musculoskeletal Biol, Fac Hlth & Life Sci, Liverpool L69 3BX, Merseyside, England; [Dwyer, Renee M.] Univ Tasmania, Sch Med, Hobart, Tas, Australia; [Nevill, Alan M.] Wolverhampton Univ, Sch Sport Performing Arts & Leisure, Wolverhampton WV1 1DJ, W Midlands, England	University of Oxford; University of Oxford; University of Liverpool; University of Tasmania; University of Wolverhampton	Edwards, LM (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	ledwards@essex.ac.uk	Nevill, Alan/Q-1010-2019; Kemp, Graham J/A-7540-2008	Nevill, Alan/0000-0003-0506-3652; Kemp, Graham J/0000-0002-8324-9666; Tyler, Damian/0000-0002-0780-8905	British Heart Foundation [RG/07/004/22659]; British Heart Foundation [FS/10/002/28078, PS/02/002/14893] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was funded by a Programme Grant from the British Heart Foundation (www.bhf.org.uk, grant code: RG/07/004/22659). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker A, 2006, EUR J APPL PHYSIOL, V98, P556, DOI 10.1007/s00421-006-0302-x; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Bendahan D, 2002, BRIT J SPORT MED, V36, P282, DOI 10.1136/bjsm.36.4.282; Bingisser R, 1997, MED SCI SPORT EXER, V29, P1499, DOI 10.1097/00005768-199711000-00017; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Edwards LM, 2011, AM J PHYSIOL-REG I, V301, pR320, DOI 10.1152/ajpregu.00850.2010; Edwards LM, 2011, FASEB J, V25, P1088, DOI 10.1096/fj.10-171983; Edwards LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010681; Freyssenet D, 2007, J APPL PHYSIOL, V102, P529, DOI 10.1152/japplphysiol.01126.2005; Gerzevic M, 2011, J STRENGTH COND RES, V25, P2470, DOI 10.1519/JSC.0b013e3181fb4111; GOLDING EM, 1995, J EXP BIOL, V198, P1775; HEITKAMP HC, 1991, INT J SPORTS MED, V12, P363, DOI 10.1055/s-2007-1024695; Holloway Cameron, 2011, Front Biosci (Schol Ed), V3, P331, DOI 10.2741/s154; Jeneson JAL, 1997, MOL CELL BIOCHEM, V174, P17, DOI 10.1023/A:1006891420109; JENESON JAL, 1995, AM J PHYSIOL-CELL PH, V268, pC1474, DOI 10.1152/ajpcell.1995.268.6.C1474; Jeneson JAL, 1996, J BIOL CHEM, V271, P27995, DOI 10.1074/jbc.271.45.27995; Jubrias SA, 2001, J APPL PHYSIOL, V90, P1663, DOI 10.1152/jappl.2001.90.5.1663; Kemp GJ, 2004, MITOCHONDRION, V4, P629, DOI 10.1016/j.mito.2004.07.017; Kemp GJ, 2004, NEPHROL DIAL TRANSPL, V19, P1520, DOI 10.1093/ndt/gfh189; KEMP GJ, 1994, MAGN RESON QUART, V10, P43; Kemp GJ, 1996, HEART, V76, P35, DOI 10.1136/hrt.76.1.35; Kemp GJ, 2007, NMR BIOMED, V20, P555, DOI 10.1002/nbm.1192; Larson-Meyer DE, 2000, NMR BIOMED, V13, P14, DOI 10.1002/(SICI)1099-1492(200002)13:1<14::AID-NBM605>3.0.CO;2-0; Layec G, 2011, NMR BIOMED, V24, P425, DOI 10.1002/nbm.1607; Layec G, 2009, MAGN RESON MED, V62, P840, DOI 10.1002/mrm.22085; Layec G, 2009, EUR J APPL PHYSIOL, V106, P229, DOI 10.1007/s00421-009-1012-y; McCully Kevin K, 2009, Dyn Med, V8, P5, DOI 10.1186/1476-5918-8-5; McKeough ZJ, 2006, RESP MED, V2, P2; McPhee JS, 2009, EXP PHYSIOL, V94, P684, DOI 10.1113/expphysiol.2008.045658; MILLER RG, 1995, MUSCLE NERVE, V18, P60, DOI 10.1002/mus.880180109; MILLER RG, 1987, MUSCLE NERVE, V10, P810, DOI 10.1002/mus.880100906; Nakagawa Y, 2005, MED SCI SPORT EXER, V37, P937, DOI 10.1249/01.mss.0000166946.94871.9b; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; Nevill AM, 1997, BRIT J SPORT MED, V31, P314, DOI 10.1136/bjsm.31.4.314; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Rimbert V, 2004, FASEB J, V18, P737, DOI 10.1096/fj.03-1104fje; Rossiter HB, 2003, J APPL PHYSIOL, V95, P1105, DOI 10.1152/japplphysiol.00964.2002; Roussel M, 2000, BBA-BIOENERGETICS, V1457, P18, DOI 10.1016/S0005-2728(99)00111-5; Trenell MI, 2006, MUSCLE NERVE, V33, P524, DOI 10.1002/mus.20484; van den Broek NMA, 2007, AM J PHYSIOL-CELL PH, V293, pC228, DOI 10.1152/ajpcell.00023.2007; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Walter G, 1997, AM J PHYSIOL-CELL PH, V272, pC525, DOI 10.1152/ajpcell.1997.272.2.C525; WESTERHOFF HV, 1995, BIOPHYS CHEM, V54, P137, DOI 10.1016/0301-4622(94)00129-8	43	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e37237	10.1371/journal.pone.0037237	http://dx.doi.org/10.1371/journal.pone.0037237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701564	Green Published, gold			2022-12-25	WOS:000305337600006
J	Zhang, YZ; Liu, Z; Medrzycki, M; Cao, KX; Fan, YH				Zhang, Yunzhe; Liu, Zheng; Medrzycki, Magdalena; Cao, Kaixiang; Fan, Yuhong			Reduction of Hox Gene Expression by Histone H1 Depletion	PLOS ONE			English	Article							CHROMATIN-STRUCTURE; NUCLEAR REORGANIZATION; CELL FATE; DEVELOPMENTAL REGULATORS; MOUSE DEVELOPMENT; GLOBAL CONTROL; POLYCOMB; STEM; MURINE; PLURIPOTENT	The evolutionarily conserved homeotic (Hox) genes are organized in clusters and expressed collinearly to specify body patterning during embryonic development. Chromatin reorganization and decompaction are intimately connected with Hox gene activation. Linker histone H1 plays a key role in facilitating folding of higher order chromatin structure. Previous studies have shown that deletion of three somatic H1 subtypes together leads to embryonic lethality and that H1c/H1d/H1e triple knockout (TKO) embryonic stem cells (ESCs) display bulk chromatin decompaction. To investigate the potential role of H1 and higher order chromatin folding in the regulation of Hox gene expression, we systematically analyzed the expression of all 39 Hox genes in triple H1 null mouse embryos and ESCs by quantitative RT-PCR. Surprisingly, we find that H1 depletion causes significant reduction in the expression of a broad range of Hox genes in embryos and ESCs. To examine if any of the three H1 subtypes (H1c, H1d and H1e) is responsible for decreased expression of Hox gene in triple-H1 null ESCs, we derived and characterized H1c(-/-), H1d(-/-), and H1e(-/-) single-H1 null ESCs. We show that deletion of individual H1 subtypes results in down-regulation of specific Hox genes in ESCs. Finally we demonstrate that, in triple-H1- and single-H1- null ESCs, the levels of H3K4 trimethylation (H3K4me3) and H3K27 trimethylation (H3K27me3) were affected at specific Hox genes with decreased expression. Our data demonstrate that marked reduction in total H1 levels causes significant reduction in both expression and the level of active histone mark H3K4me3 at many Hox genes and that individual H1 subtypes may also contribute to the regulation of specific Hox gene expression. We suggest possible mechanisms for such an unexpected role of histone H1 in Hox gene regulation.	[Zhang, Yunzhe] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Zhang, YZ (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	Yuhong.fan@biology.gatech.edu	Liu, Zheng/GVU-3695-2022	Liu, Zheng/0000-0003-4158-6768; Cao, Kaixiang/0000-0001-9953-1503	Georgia Cancer Coalition Distinguished Scholar award; National Institutes of Health (United States) grant [GM085261]; Georgia Tech; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085261] Funding Source: NIH RePORTER	Georgia Cancer Coalition Distinguished Scholar award; National Institutes of Health (United States) grant; Georgia Tech; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by a Georgia Cancer Coalition Distinguished Scholar award (to YF), National Institutes of Health (United States) grant GM085261, and Georgia Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka T, 2001, DEVELOPMENT, V128, P1587; Alami R, 2003, P NATL ACAD SCI USA, V100, P5920, DOI 10.1073/pnas.0736105100; Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bai L, 2010, TRENDS GENET, V26, P476, DOI 10.1016/j.tig.2010.08.003; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chambeyron S, 2005, DEVELOPMENT, V132, P2215, DOI 10.1242/dev.01813; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Deschamps J, 2007, CURR OPIN GENET DEV, V17, P422, DOI 10.1016/j.gde.2007.07.008; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Erzurumlu RS, 2010, NAT REV NEUROSCI, V11, P252, DOI 10.1038/nrn2804; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2004, METHOD ENZYMOL, V377, P85; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Fan YH, 2001, MOL CELL BIOL, V21, P7933, DOI 10.1128/MCB.21.23.7933-7943.2001; Giambra V, 2008, MOL CELL BIOL, V28, P6123, DOI 10.1128/MCB.00233-08; Goodman FR, 2002, AM J MED GENET, V112, P256, DOI 10.1002/ajmg.10776; Gouti M, 2008, STEM CELLS, V26, P1985, DOI 10.1634/stemcells.2008-0182; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Gunjan A, 1999, NUCLEIC ACIDS RES, V27, P3355, DOI 10.1093/nar/27.16.3355; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Herrscher RF, 1995, GENE DEV, V9, P3067, DOI 10.1101/gad.9.24.3067; Huang TH, 1996, NUCLEIC ACIDS RES, V24, P1695, DOI 10.1093/nar/24.9.1695; IZAURRALDE E, 1989, J MOL BIOL, V210, P573, DOI 10.1016/0022-2836(89)90133-2; IZPISUABELMONTE JC, 1991, EMBO J, V10, P2279, DOI 10.1002/j.1460-2075.1991.tb07764.x; Jorgensen HF, 2006, CELL CYCLE, V5, P1411, DOI 10.4161/cc.5.13.2927; Kharchenko PV, 2008, GENOME RES, V18, P1554, DOI 10.1101/gr.075952.107; Kortschak RD, 2000, TRENDS BIOCHEM SCI, V25, P294, DOI 10.1016/S0968-0004(00)01597-8; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leucht P, 2008, DEVELOPMENT, V135, P2845, DOI 10.1242/dev.023788; MacLean JA, 2011, MOL CELL BIOL, V31, P1275, DOI 10.1128/MCB.00734-10; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; McIntyre DC, 2007, DEVELOPMENT, V134, P2981, DOI 10.1242/dev.007567; Medrzycki M, 2012, JOVE-J VIS EXP, DOI 10.3791/3577; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Morey C, 2007, DEVELOPMENT, V134, P909, DOI 10.1242/dev.02779; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Oury F, 2006, SCIENCE, V313, P1408, DOI 10.1126/science.1130042; PANYIM S, 1969, BIOCHEM BIOPH RES CO, V37, P1042, DOI 10.1016/0006-291X(69)90237-X; PEHRSON J, 1980, NATURE, V285, P43, DOI 10.1038/285043a0; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; RUDDLE FH, 1994, ANNU REV GENET, V28, P423, DOI 10.1146/annurev.ge.28.120194.002231; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; van Lohuizen M, 1998, CELL MOL LIFE SCI, V54, P71, DOI 10.1007/s000180050126; vanderLugt NMT, 1996, MECH DEVELOP, V58, P153, DOI 10.1016/S0925-4773(96)00570-9; Vinagre T, 2010, DEV CELL, V18, P655, DOI 10.1016/j.devcel.2010.02.011; Wagner GP, 2003, P NATL ACAD SCI USA, V100, P14603, DOI 10.1073/pnas.2536656100; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhang YZ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002691	70	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38829	10.1371/journal.pone.0038829	http://dx.doi.org/10.1371/journal.pone.0038829			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701719	gold, Green Published			2022-12-25	WOS:000305337600047
J	Komarov, I; D'Souza, RM; Tapia, JJ				Komarov, Ivan; D'Souza, Roshan M.; Tapia, Jose-Juan			Accelerating the Gillespie tau-Leaping Method Using Graphics Processing Units	PLOS ONE			English	Article							EXACT STOCHASTIC SIMULATION; SIZE SELECTION; SYSTEMS; ALGORITHM	The Gillespie tau-Leaping Method is an approximate algorithm that is faster than the exact Direct Method (DM) due to the progression of the simulation with larger time steps. However, the procedure to compute the time leap tau is quite expensive. In this paper, we explore the acceleration of the tau-Leaping Method using Graphics Processing Unit (GPUs) for ultra-large networks (>0.5e(6) reaction channels). We have developed data structures and algorithms that take advantage of the unique hardware architecture and available libraries. Our results show that we obtain a performance gain of over 60x when compared with the best conventional implementations.	[Komarov, Ivan; D'Souza, Roshan M.] Univ Wisconsin, Dept Mech Engn, Complex Syst Simulat Lab, Milwaukee, WI 53201 USA; [Tapia, Jose-Juan] Univ Pittsburgh, Dept Computat Biol, Pittsburgh, PA USA	University of Wisconsin System; University of Wisconsin Milwaukee; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Komarov, I (corresponding author), Univ Wisconsin, Dept Mech Engn, Complex Syst Simulat Lab, Milwaukee, WI 53201 USA.	dsouza@uwm.edu	Valiyaveettill, Suresh/D-4848-2009	Valiyaveettill, Suresh/0000-0001-6990-660X	National Science Foundation (NSF) [CNS 0968519, CCF 1013278]; Division Of Computer and Network Systems [0968519] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was funded by the grants CNS 0968519 and CCF 1013278 from the National Science Foundation (NSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell N, 2009, STUDENTS GUIDE TO THE MA TESOL, P1; Burrage K, 2006, PARALLEL COMPUTING B, P79; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Cao Y, 2004, J CHEM PHYS, V121, P4059, DOI 10.1063/1.1778376; Dittamo C, 2009, 2009 INTERNATIONAL CONFERENCE ON COMPUTER MODELING AND SIMULATION, PROCEEDINGS, P156, DOI 10.1109/ICCMS.2009.42; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gillespie DT, 2003, J CHEM PHYS, V119, P8229, DOI 10.1063/1.1613254; Hoberock Jared, 2010, THRUST PARALLEL TEMP; Howes L., 2007, GPU GEMS, P805; Kirk D, 2010, PROGRAMMING MASSIVEL; Li H, 2006, LOGARITHMIC DIRECT M, DOI 10.1.1.79.7703; Li H, 2010, INT J HIGH PERFORM C, V24, P107, DOI 10.1177/1094342009106066; Macchiarulo L, 2008, IEEE ENG MED BIO, P1343, DOI 10.1109/IEMBS.2008.4649413; MCCOLLUMA JM, 2005, J COMPUT BIOL CHEM, V30, P39; Nickolls John, 2008, ACM Queue, V6, DOI 10.1145/1365490.1365500; Owens JD, 2007, COMPUT GRAPH FORUM, V26, P80, DOI 10.1111/j.1467-8659.2007.01012.x; Rathinam M, 2003, J CHEM PHYS, V119, P12784, DOI 10.1063/1.1627296; Sanders J., 2010, CUDA EXAMPLE INTRO G; Sanft KR, 2011, BIOINFORMATICS, V27, P2457, DOI 10.1093/bioinformatics/btr401; Schulze TP, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036704; Stone JE, 2010, COMPUT SCI ENG, V12, P66, DOI 10.1109/MCSE.2010.69; Tian TH, 2004, J CHEM PHYS, V121, P10356, DOI 10.1063/1.1810475; Tian TH, 2005, Eighth International Conference on High-Performance Computing in Asia-Pacific Region, Proceedings, P621, DOI 10.1109/HPCASIA.2005.67; Turner TE, 2004, COMPUT BIOL CHEM, V28, P165, DOI 10.1016/j.compbiolchem.2004.05.001; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Vigelius M, 2011, BIOINFORMATICS, V27, P288, DOI 10.1093/bioinformatics/btq622	28	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e37370	10.1371/journal.pone.0037370	http://dx.doi.org/10.1371/journal.pone.0037370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715366	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000305336800007
J	Shwartz, A; Cosquer, A; Jaillon, A; Piron, A; Julliard, R; Raymond, R; Simon, L; Prevot-Julliard, AC				Shwartz, Assaf; Cosquer, Alix; Jaillon, Alexandre; Piron, Armony; Julliard, Romain; Raymond, Richard; Simon, Laurent; Prevot-Julliard, Anne-Caroline			Urban Biodiversity, City-Dwellers and Conservation: How Does an Outdoor Activity Day Affect the Human-Nature Relationship?	PLOS ONE			English	Article							ENVIRONMENTAL-EDUCATION; URBANIZATION; BELIEFS; PROGRAM; SCIENCE	Urban conservation education programs aim to increase knowledge and awareness towards biodiversity and to change attitudes and behaviour towards the environment. However, to date, few urban conservation education studies have evaluated to what extent these programs have managed to achieve their goals. In this study, we experimentally explored the influence of an urban conservation activity day on individual knowledge, awareness and actions towards biodiversity, in both the short and longer term. We organised three activity days in Paris (France), during which people were invited to participate in urban conservation efforts. Both quantitative (questionnaire) and qualitative (interviews) methods were employed to investigate the influence of this short urban nature experience on the relationships that city-dwellers develop with nearby biodiversity. We found a strong positive correlation between the levels of participation and an immediate interest towards local urban biodiversity. In the longer term, however, although participants claimed to have gained more knowledge, local awareness and interest for species in their daily environment, they did not seem to extend this interest to participating in other related activities. These results highlight the complexity of validating the effectiveness of this type of education program for achieving conservation goals. Although such a short activity may only have a limited environmental impact, it nevertheless seems to increase people's knowledge, awareness, interest and concern. We therefore believe that when repeated locally, these short conservation education programs could enhance people's experience with nature in cities and achieve conservation goals more fully.	[Shwartz, Assaf; Cosquer, Alix; Raymond, Richard; Simon, Laurent] Univ Paris Ouest Nanterre La Defense, Univ Paris 08, Univ Paris 01,Univ Paris 07,UMR CNRS 7533, Lab Dynam Sociales & Recomposit Espaces LADYSS, Paris, France; [Shwartz, Assaf; Cosquer, Alix; Jaillon, Alexandre; Piron, Armony; Julliard, Romain; Prevot-Julliard, Anne-Caroline] Museum Natl Hist Nat, UMR7204, CNRS MNHN UPMC, Lab Conservat Especes Restaurat & Suivi Populat C, F-75231 Paris, France; [Piron, Armony] Univ Liege, Inst Sci Humaines & Sociales, Lab Anthropol Sociale & Culturelle, Liege, Belgium; [Prevot-Julliard, Anne-Caroline] ISCC, Paris, France	heSam Universite; Universite Pantheon-Sorbonne; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Nanterre; Universite Paris-VIII; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Liege	Shwartz, A (corresponding author), Univ Paris Ouest Nanterre La Defense, Univ Paris 08, Univ Paris 01,Univ Paris 07,UMR CNRS 7533, Lab Dynam Sociales & Recomposit Espaces LADYSS, Paris, France.	shwar.a@mail.huji.ac.il		Alix, Cosquer/0000-0002-5894-1466	Ile-de-France Sustainable Development Research Network Reseau Francilien de Recherche sur le Developpement Soutenable - R2DS Ile-de-France)	Ile-de-France Sustainable Development Research Network Reseau Francilien de Recherche sur le Developpement Soutenable - R2DS Ile-de-France)	This work was supported by Ile-de-France Sustainable Development Research Network Reseau Francilien de Recherche sur le Developpement Soutenable - R2DS Ile-de-France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I., 1985, ACTION CONTROL COGNI, V1985, P11, DOI [10.1007/978-3-642-69746-3_2, DOI 10.1007/978-3-642-69746-3_2]; [Anonymous], 2003, PSYCHOL THEORIES ENV; [Anonymous], 2007, J ENVIRON EDUC, V38, P33, DOI DOI 10.3200/JOEE.38.3.33-42; Basile C., 2000, J ENVIRON EDUC, V32, P121, DOI [10.1080/00958960009598668, DOI 10.1080/00958960009598668]; Bogner F.X., 1998, J ENVIRON EDUC, V29, P17, DOI [10.1080/00958969809599124, DOI 10.1080/00958969809599124]; Bogner FX, 1997, J ENVIRON PSYCHOL, V17, P111, DOI 10.1006/jevp.1997.0046; Brewer C, 2006, CONSERV BIOL, V20, P689, DOI 10.1111/j.1523-1739.2006.00467.x; Burt RS, 2005, BROKERAGE CLOSURE IN; Chatzisarantis NLD, 2007, PERS SOC PSYCHOL B, V33, P663, DOI 10.1177/0146167206297401; Clayton S., 2009, CONSERVATION PSYCHOL; Corraliza JA, 2000, ENVIRON BEHAV, V32, P832, DOI 10.1177/00139160021972829; Courtenay-Hall P., 2002, ENVIRON EDUC RES, V8, P283, DOI DOI 10.1080/13504620220145438; Dearborn DC, 2010, CONSERV BIOL, V24, P432, DOI 10.1111/j.1523-1739.2009.01328.x; Evans C, 2005, CONSERV BIOL, V19, P589, DOI 10.1111/j.1523-1739.2005.00s01.x; Falk J., 2005, ENVIRON EDUC RES, V11, P265, DOI DOI 10.1080/13504620500081129; Fallis J, 1991, J EXPT ED, V14, P27; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Gass M.A., 2003, J EXPERIENTIAL ED, V26, P34, DOI [https://doi.org/10.1177/105382590302600106, DOI 10.1177/105382590302600106]; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Gregory J., 2000, SCI PUBLIC COMMUNICA; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hinchliffe S, 1996, GLOBAL ENVIRON CHANG, V6, P53, DOI 10.1016/0959-3780(95)00113-1; Hunter LM, 2004, SOC NATUR RESOUR, V17, P517, DOI 10.1080/08941920490452454; INSEE, 2010, PAR GAGN NOUV FAM; Jacobsen JB, 2009, ENVIRON RESOUR ECON, V43, P137, DOI 10.1007/s10640-008-9226-8; Jacobson S.K., 2006, CONSERVATION ED OUTR; Kobori H, 2009, BIOL CONSERV, V142, P1950, DOI 10.1016/j.biocon.2009.04.017; Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI [10.1080/1350462022014540, DOI 10.1080/1350462022014540, DOI 10.1080/13504620220145401, 10.1080/13504620220145401]; Kruse C.K., 2004, J ENVIRON EDUC, V35, P33, DOI DOI 10.3200/JOEE.35.4.33-45; Kuhar CW, 2010, AM J PRIMATOL, V72, P407, DOI 10.1002/ajp.20726; Leeming F.C., 2010, J ENVIRON EDUC, V24, P8, DOI DOI 10.1080/00958964.1993.9943504; Lindemann-Matthies P, 2005, INT J SCI EDUC, V27, P655, DOI 10.1080/09500690500038116; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Miller JR, 2006, BIOL CONSERV, V127, P356, DOI 10.1016/j.biocon.2005.07.021; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Norris K., 1998, J ENVIRON EDUC, V30, P38, DOI DOI 10.1080/00958969809601862; Palmberg I.E., 2000, J ENVIRON EDUC, V31, P32, DOI [DOI 10.1080/00958960009598649, 10.1080/00958960009598649]; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pooley JA, 2000, ENVIRON BEHAV, V32, P711, DOI 10.1177/0013916500325007; Prevot-Julliard AC, 2011, ENV MANAGEMENT; Rickinson M., 2001, ENVIRON EDUC RES, V7, P207, DOI [DOI 10.1080/13504620120065230, 10.1080/13504620120065230]; Rutherford C, 1998, INDIVIDUAL PARTICIPA; Storksdieck M, 2005, ENVIRON EDUC RES, V11, P353, DOI DOI 10.1080/13504620500081228; Sturgis P, 2004, PUBLIC UNDERST SCI, V13, P55, DOI 10.1177/0963662504042690; Turner WR, 2004, BIOSCIENCE, V54, P585, DOI 10.1641/0006-3568(2004)054[0585:GUATSO]2.0.CO;2; UNESCO, 1978, INT C ENV ED TBIL US; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249	48	26	28	4	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38642	10.1371/journal.pone.0038642	http://dx.doi.org/10.1371/journal.pone.0038642			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TQ	22715403	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336800045
J	Adhikari, RP; Karauzum, H; Sarwar, J; Abaandou, L; Mahmoudieh, M; Boroun, AR; Vu, H; Nguyen, T; Devi, VS; Shulenin, S; Warfield, KL; Aman, MJ				Adhikari, Rajan P.; Karauzum, Hatice; Sarwar, Jawad; Abaandou, Laura; Mahmoudieh, Mahta; Boroun, Atefeh R.; Hong Vu; Tam Nguyen; Devi, V. Sathya; Shulenin, Sergey; Warfield, Kelly L.; Aman, M. Javad			Novel Structurally Designed Vaccine for S. aureus alpha-Hemolysin: Protection against Bacteremia and Pneumonia	PLOS ONE			English	Article							COMMUNITY-ASSOCIATED MRSA; STAPHYLOCOCCUS-AUREUS; PASSIVE-IMMUNIZATION; VIRULENCE GENES; TOXIN; ANTIBODIES; MODEL; INFECTION	Staphylococcus aureus (S. aureus) is a human pathogen associated with skin and soft tissue infections (SSTI) and life threatening sepsis and pneumonia. Efforts to develop effective vaccines against S. aureus have been largely unsuccessful, in part due to the variety of virulence factors produced by this organism. S. aureus alpha-hemolysin (Hla) is a pore-forming toxin expressed by most S. aureus strains and reported to play a key role in the pathogenesis of SSTI and pneumonia. Here we report a novel recombinant subunit vaccine candidate for Hla, rationally designed based on the heptameric crystal structure. This vaccine candidate, denoted AT-62aa, was tested in pneumonia and bacteremia infection models using S. aureus strain Newman and the pandemic strain USA300 (LAC). Significant protection from lethal bacteremia/sepsis and pneumonia was observed upon vaccination with AT-62aa along with a Glucopyranosyl Lipid Adjuvant-Stable Emulsion (GLA-SE) that is currently in clinical trials. Passive transfer of rabbit immunoglobulin against AT-62aa (AT62-IgG) protected mice against intraperitoneal and intranasal challenge with USA300 and produced significant reduction in bacterial burden in blood, spleen, kidney, and lungs. Our Hla-based vaccine is the first to be reported to reduce bacterial dissemination and to provide protection in a sepsis model of S. aureus infection. AT62-IgG and sera from vaccinated mice effectively neutralized the toxin in vitro and AT62-IgG inhibited the formation of Hla heptamers, suggesting antibody-mediated neutralization as the primary mechanism of action. This remarkable efficacy makes this Hla-based vaccine a prime candidate for inclusion in future multivalent S. aureus vaccine. Furthermore, identification of protective epitopes within AT-62aa could lead to novel immunotherapy for S. aureus infection.	[Adhikari, Rajan P.; Karauzum, Hatice; Sarwar, Jawad; Abaandou, Laura; Mahmoudieh, Mahta; Boroun, Atefeh R.; Hong Vu; Tam Nguyen; Devi, V. Sathya; Shulenin, Sergey; Warfield, Kelly L.; Aman, M. Javad] Integrated Biotherapeut Inc, Gaithersburg, MD USA		Adhikari, RP (corresponding author), Integrated Biotherapeut Inc, Gaithersburg, MD USA.	javad@integratedbiotherapeutics.com	Venkatarmani, Sathyadevi/AAP-1068-2020; Adhikari, Rajan/J-7396-2019	Venkatarmani, Sathyadevi/0000-0003-1242-8162; 	Integrated Bio Therapeutics (IBT)	Integrated Bio Therapeutics (IBT)	The authors have the following interests to declare. All authors, except for Tam Nguyen, are employed by Integrated Bio Therapeutics (IBT), who funded this study. Tam Nguyen served as a consultant to IBT. M. Javad Aman and Kelly L. Warfield are shareholders of Integrated BioTherapeutics. There are no products in development or marketed products to declare. The authors declare a patent application related to the vaccine described in this manuscript (PCT/US2012/024031; Filed on Feb 8, 2012, Title: IMMUNOGENIC COMPOSITION COMPRISING ALPHA-HEMOLYSIN OLIGOPEPTIDES). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Aarestrup FM, 1999, APMIS, V107, P425, DOI 10.1111/j.1699-0463.1999.tb01576.x; Bassetti M, 2009, INT J ANTIMICROB AG, V34, pS15, DOI 10.1016/S0924-8579(09)70544-8; BHAKDI S, 1984, INFECT IMMUN, V46, P318, DOI 10.1128/IAI.46.2.318-323.1984; BHAKDI S, 1989, INFECT IMMUN, V57, P3512, DOI 10.1128/IAI.57.11.3512-3519.1989; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Bradley SF, 2005, SEMIN RESP CRIT CARE, V26, P643, DOI 10.1055/s-2005-925528; BROWN DR, 1980, INFECT IMMUN, V30, P36, DOI 10.1128/IAI.30.1.36-42.1980; Caiazza NC, 2003, J BACTERIOL, V185, P3214, DOI 10.1128/JB.185.10.3214-3217.2003; Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; Coffman JD, 2002, PROTEIN EXPRES PURIF, V24, P302, DOI 10.1006/prep.2001.1556; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Coler RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013677; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Fattom AI, 1996, INFECT IMMUN, V64, P1659, DOI 10.1128/IAI.64.5.1659-1665.1996; Foster TJ, 2004, J CLIN INVEST, V114, P1693, DOI 10.1172/JCI200423825; Husmann M, 2009, FEBS LETT, V583, P337, DOI 10.1016/j.febslet.2008.12.028; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Liang XD, 2009, INFECT IMMUN, V77, P977, DOI 10.1128/IAI.00920-08; Lin G, 2007, CURR HIV RES, V5, P514, DOI 10.2174/157016207782418489; McElroy MC, 1999, INFECT IMMUN, V67, P5541, DOI 10.1128/IAI.67.10.5541-5544.1999; Menzies BE, 1996, INFECT IMMUN, V64, P1839, DOI 10.1128/IAI.64.5.1839-1841.1996; Nara PL, 1998, VACCINE, V16, P1780, DOI 10.1016/S0264-410X(98)00168-6; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; PANCHAL RG, 1995, J BIOL CHEM, V270, P23072, DOI 10.1074/jbc.270.39.23072; Parker D, 2012, SEMIN IMMUNOPATHOL, V34, P281, DOI 10.1007/s00281-011-0291-7; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; Rose F, 2002, AM J PHYSIOL-LUNG C, V282, pL207, DOI 10.1152/ajplung.00156.2001; Shukla SK, 2010, J CLIN MICROBIOL, V48, P3582, DOI 10.1128/JCM.00657-10; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Tobin GJ, 2008, VACCINE, V26, P6189, DOI 10.1016/j.vaccine.2008.09.080; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107	33	75	88	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38567	10.1371/journal.pone.0038567	http://dx.doi.org/10.1371/journal.pone.0038567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701668	Green Published, gold, Green Submitted			2022-12-25	WOS:000305348400072
J	de Vere, N; Rich, TCG; Ford, CR; Trinder, SA; Long, C; Moore, CW; Satterthwaite, D; Davies, H; Allainguillaume, J; Ronca, S; Tatarinova, T; Garbett, H; Walker, K; Wilkinson, MJ				de Vere, Natasha; Rich, Tim C. G.; Ford, Col R.; Trinder, Sarah A.; Long, Charlotte; Moore, Chris W.; Satterthwaite, Danielle; Davies, Helena; Allainguillaume, Joel; Ronca, Sandra; Tatarinova, Tatiana; Garbett, Hannah; Walker, Kevin; Wilkinson, Mike J.			DNA Barcoding the Native Flowering Plants and Conifers of Wales	PLOS ONE			English	Article							HERBARIUM SPECIMENS; EXTRACTION; IDENTIFY; IDENTIFICATION; AMPLIFICATION; RESOLUTION; ALIGNMENT	We present the first national DNA barcode resource that covers the native flowering plants and conifers for the nation of Wales (1143 species). Using the plant DNA barcode markers rbcL and matK, we have assembled 97.7% coverage for rbcL, 90.2% for matK, and a dual-locus barcode for 89.7% of the native Welsh flora. We have sampled multiple individuals for each species, resulting in 3304 rbcL and 2419 matK sequences. The majority of our samples (85%) are from DNA extracted from herbarium specimens. Recoverability of DNA barcodes is lower using herbarium specimens, compared to freshly collected material, mostly due to lower amplification success, but this is balanced by the increased efficiency of sampling species that have already been collected, identified, and verified by taxonomic experts. The effectiveness of the DNA barcodes for identification (level of discrimination) is assessed using four approaches: the presence of a barcode gap ( using pairwise and multiple alignments), formation of monophyletic groups using Neighbour- Joining trees, and sequence similarity in BLASTn searches. These approaches yield similar results, providing relative discrimination levels of 69.4 to 74.9% of all species and 98.6 to 99.8% of genera using both markers. Species discrimination can be further improved using spatially explicit sampling. Mean species discrimination using barcode gap analysis (with a multiple alignment) is 81.6% within 10610 km squares and 93.3% for 262 km squares. Our database of DNA barcodes for Welsh native flowering plants and conifers represents the most complete coverage of any national flora, and offers a valuable platform for a wide range of applications that require accurate species identification.	[Rich, Tim C. G.] Natl Museum Wales, Dept Biodivers & Systemat Biol, Cardiff CF1 3NP, S Glam, Wales; [Allainguillaume, Joel] Univ W England, Dept Appl Sci, Bristol BS16 1QY, Avon, England; [Ronca, Sandra; Wilkinson, Mike J.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Tatarinova, Tatiana; Garbett, Hannah] Univ Glamorgan, Fac Adv Technol, Pontypridd CF37 1DL, M Glam, Wales; [Walker, Kevin] Bot Soc British Isles, Harrogate, N Yorkshire, England	University of West England; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); University of South Wales		natasha.devere@gardenofwales.org.uk	Tatarinova, Tatiana V./K-3445-2016; Tatarinova, Tatiana Valerievna/AAU-4719-2021; Tatarinova, Tatiana/AAH-1915-2020	Tatarinova, Tatiana V./0000-0003-1787-1112; Tatarinova, Tatiana/0000-0003-1787-1112; Trinder, Sarah/0000-0002-0767-9912; de Vere, Natasha/0000-0001-9593-6925; Davies, Helena Susan/0000-0003-2582-7197; Wilkinson, Michael/0000-0002-9881-6993	National Botanic Garden of Wales; National Museum Wales; Welsh Government; Countryside Council for Wales; people of Wales	National Botanic Garden of Wales; National Museum Wales; Welsh Government; Countryside Council for Wales; people of Wales	Funded by the National Botanic Garden of Wales (www.gardenofwales.org.uk), National Museum Wales (http://www.museumwales.ac.uk/), Welsh Government (wales.gov.uk), Countryside Council for Wales (http://www.ccw.gov.uk/), and sponsorship from the people of Wales. The National Botanic Garden of Wales and National Museum Wales are the employers of eight of the co-authors. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Asahina H, 2010, J NAT MED-TOKYO, V64, P133, DOI 10.1007/s11418-009-0379-8; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Bininda-Emonds ORP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-156; Blackstock T, 2010, HABITATS WALES COMPR; Bleeker W, 2008, BIOL CONSERV, V141, P692, DOI 10.1016/j.biocon.2007.12.015; Burgess KS, 2011, METHODS ECOL EVOL, V2, P333, DOI 10.1111/j.2041-210X.2011.00092.x; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Chater A, 2010, FLORA CARDIGANSHIRE; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cowan RS, 2006, TAXON, V55, P611, DOI 10.2307/25065638; de Groot GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016371; De Mattia F, 2011, FOOD RES INT, V44, P693, DOI 10.1016/j.foodres.2010.12.032; Dines T, 2008, VASCULAR PLANT RED D; Drabkova L, 2002, PLANT MOL BIOL REP, V20, P161, DOI 10.1007/BF02799431; Ebihara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015136; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erkens RHJ, 2008, BLUMEA, V53, P407, DOI 10.3767/000651908X608052; Gao T, 2010, J ETHNOPHARMACOL, V130, P116, DOI 10.1016/j.jep.2010.04.026; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Jaakola L, 2010, FOOD CHEM, V123, P494, DOI 10.1016/j.foodchem.2010.04.069; Kelly LJ, 2011, NEW PHYTOL, V191, P288, DOI 10.1111/j.1469-8137.2011.03677.x; Kesanakurti PR, 2011, MOL ECOL, V20, P1289, DOI 10.1111/j.1365-294X.2010.04989.x; Kress WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015409; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kumar S, 2011, FOOD CHEM, V127, P1335, DOI 10.1016/j.foodchem.2011.01.094; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Little DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020552; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Pang XH, 2011, CLADISTICS, V27, P165, DOI 10.1111/j.1096-0031.2010.00328.x; Preston C, 2002, NEW ATLAS BRIT IRISH; Preston CD, 2004, BOT J LINN SOC, V145, P257, DOI 10.1111/j.1095-8339.2004.00284.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Saunders GW, 2009, MOL ECOL RESOUR, V9, P140, DOI 10.1111/j.1755-0998.2009.02639.x; Schnell IB, 2010, ARTHROPOD-PLANT INTE, V4, P107, DOI 10.1007/s11829-010-9089-0; Sonstebo JH, 2010, MOL ECOL RESOUR, V10, P1009, DOI 10.1111/j.1755-0998.2010.02855.x; Stace C., 1997, New flora of the British Isles.; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; Stevens DP, 2010, GRASSLANDS WALES SUR; Stoeckle MY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00042; Van De Wiel CCM, 2009, MOL ECOL RESOUR, V9, P1086, DOI 10.1111/j.1755-0998.2009.02547.x; Wang WQ, 2010, BMC PLANT BIOL, V10, DOI [10.1186/1471-2229-10-205, 10.1186/1471-2229-10-14]; Xue CY, 2011, J SYST EVOL, V49, P267, DOI 10.1111/j.1759-6831.2011.00127.x	48	125	131	1	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37945	10.1371/journal.pone.0037945	http://dx.doi.org/10.1371/journal.pone.0037945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701588	Green Published, gold			2022-12-25	WOS:000305348400026
J	Zgaga, L; Theodoratou, E; Kyle, J; Farrington, SM; Agakov, F; Tenesa, A; Walker, M; McNeill, G; Wright, AF; Rudan, I; Dunlop, MG; Campbell, H				Zgaga, Lina; Theodoratou, Evropi; Kyle, Janet; Farrington, Susan M.; Agakov, Felix; Tenesa, Albert; Walker, Marion; McNeill, Geraldine; Wright, Alan F.; Rudan, Igor; Dunlop, Malcolm G.; Campbell, Harry			The Association of Dietary Intake of Purine-Rich Vegetables, Sugar-Sweetened Beverages and Dairy with Plasma Urate, in a Cross-Sectional Study	PLOS ONE			English	Article							FRUCTOSE-INDUCED HYPERURICAEMIA; URINARY URIC-ACID; SOFT DRINKS; GOUT; SERUM; DISEASE; PROTEIN; MEN; CONSUMPTION; RISK	Introduction: Hyperuricemia is a strong risk factor for gout. The incidence of gout and hyperuricemia has increased recently, which is thought to be, in part, due to changes in diet and lifestyle. Objective of this study was to investigate the association between plasma urate concentration and: a) food items: dairy, sugar-sweetened beverages (SSB) and purine-rich vegetables; b) related nutrients: lactose, calcium and fructose. Methods: A total of 2,076 healthy participants (44% female) from a population-based case-control study in Scotland (1999-2006) were included in this study. Dietary data was collected using a semi-quantitative food frequency questionnaire (FFQ). Nutrient intake was calculated using FFQ and composition of foods information. Urate concentration was measured in plasma. Results: Mean urate concentration was 283.8 +/- 72.1 mmol/dL (females: 260.1668.9 mmol/dL and males: 302.3 +/- 69.2 mmol/dL). Using multivariate regression analysis we found that dairy, calcium and lactose intakes were inversely associated with urate (p = 0.008, p = 0.003, p = 0.0007, respectively). Overall SSB consumption was positively associated with urate (p = 0.008), however, energy-adjusted fructose intake was not associated with urate (p = 0.66). The intake of purine-rich vegetables was not associated to plasma urate (p = 0.38). Conclusions: Our results suggest that limiting purine-rich vegetables intake for lowering plasma urate may be ineffectual, despite current recommendations. Although a positive association between plasma urate and SSB consumption was found, there was no association with fructose intake, suggesting that fructose is not the causal agent underlying the SSB-urate association. The abundant evidence supporting the inverse association between plasma urate concentration and dairy consumption should be reflected in dietary guidelines for hyperuricemic individuals and gout patients. Further research is needed to establish which nutrients and food products influence plasma urate concentration, to inform the development of evidence-based dietary guidelines.	[Zgaga, Lina; Agakov, Felix; Rudan, Igor; Campbell, Harry] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Zgaga, Lina] Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Zagreb 41001, Croatia; [Theodoratou, Evropi; Farrington, Susan M.; Tenesa, Albert; Walker, Marion; Dunlop, Malcolm G.; Campbell, Harry] Univ Edinburgh, Inst Genet & Mol Med, Colon Canc Genet Grp, Edinburgh, Midlothian, Scotland; [Theodoratou, Evropi; Farrington, Susan M.; Tenesa, Albert; Walker, Marion; Wright, Alan F.; Dunlop, Malcolm G.; Campbell, Harry] Western Gen Hosp, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Kyle, Janet; McNeill, Geraldine] Rowett Inst Nutr & Hlth, Publ Hlth Nutr Res Grp, Bucksburn, Aberdeen, Scotland; [Agakov, Felix] Pharmatics Ltd, Edinburgh, Midlothian, Scotland; [Wright, Alan F.] Western Gen Hosp, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh; University of Zagreb; University of Edinburgh; University of Edinburgh; University of Aberdeen; University of Edinburgh	Zgaga, L (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland.	lina.zgaga@ed.ac.uk; harry.campbell@ed.ac.uk	Farrington, Susan M/C-7319-2013; Theodoratou, Evropi/C-3430-2014; Farrington, Susan M/Q-2710-2019; Campbell, Harry/E-2959-2010; Dunlop, Malcolm G/F-1973-2011; Zgaga, Lina/Q-9415-2018; Rudan, Igor/I-1467-2012	Theodoratou, Evropi/0000-0001-5887-9132; Farrington, Susan M/0000-0001-5955-7389; Campbell, Harry/0000-0002-6169-6262; Dunlop, Malcolm G/0000-0002-3033-5851; Zgaga, Lina/0000-0003-4089-9703; Rudan, Igor/0000-0001-6993-6884; McNeill, Geraldine/0000-0003-0373-650X; Tenesa, Albert/0000-0003-4884-4475; Agakov, Felix/0000-0003-4280-9062	Cancer Research UK [C348/A3758, C348/A8896]; Scottish Government Chief Scientist Office [K/OPR/2/2/D333, CZB/4/94]; Medical Research Council [G0000657-53203]; Centre Grant from CORE as part of the Digestive Cancer Campaign; Cancer Research UK Fellowship [C31250/A10107]; Cancer Research UK [12076] Funding Source: researchfish; Medical Research Council [MC_PC_U127527198, MC_U127561128, MC_U127527198, MC_PC_U127561128, G0800604] Funding Source: researchfish; MRC [MC_U127561128, MC_PC_U127561128, MC_PC_U127527198, MC_U127527198, G0800604] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Scottish Government Chief Scientist Office; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Centre Grant from CORE as part of the Digestive Cancer Campaign; Cancer Research UK Fellowship(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from Cancer Research UK (C348/A3758, C348/A8896); Scottish Government Chief Scientist Office (K/OPR/2/2/D333, CZB/4/94); Medical Research Council (G0000657-53203); and Centre Grant from CORE as part of the Digestive Cancer Campaign (http://www.corecharity.org.uk). ET is funded by Cancer Research UK Fellowship C31250/A10107. There are no other financial disclosures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RD, 1996, STROKE, V27, P813, DOI 10.1161/01.STR.27.5.813; Annanmaki T, 2007, MOVEMENT DISORD, V22, P1133, DOI 10.1002/mds.21502; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2009, MCCANCE WIDDOWSONS C; Apovian CM, 2004, JAMA-J AM MED ASSOC, V292, P978, DOI 10.1001/jama.292.8.978; Bingham S, 2007, CANCER EPIDEM BIOMAR, V16, P1651, DOI 10.1158/1055-9965.EPI-06-1050; Bomback AS, 2010, KIDNEY INT, V77, P609, DOI 10.1038/ki.2009.500; BRESLAU NA, 1988, J CLIN ENDOCR METAB, V66, P140, DOI 10.1210/jcem-66-1-140; BRULE D, 1992, J AM COLL NUTR, V11, P353; Castenmiller JJM, 1999, J NUTR, V129, P2162, DOI 10.1093/jn/129.12.2162; Centres for Disease Control and Prevention, 1996, STAT HMNCFH; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; Choi HK, 2005, CURR OPIN RHEUMATOL, V17, P341; Choi HK, 2008, BMJ-BRIT MED J, V336, P309, DOI 10.1136/bmj.39449.819271.BE; Choi Hyon K., 2010, JAMA (Journal of the American Medical Association), V304, P2270, DOI 10.1001/jama.2010.1638; Choi JWJ, 2008, ARTHRIT RHEUM-ARTHR, V59, P109, DOI 10.1002/art.23245; CLIFFORD AJ, 1976, J NUTR, V106, P435, DOI 10.1093/jn/106.3.435; CLIFFORD AJ, 1976, J NUTR, V106, P428, DOI 10.1093/jn/106.3.428; Curhan GC, 2010, KIDNEY INT, V77, P569, DOI 10.1038/ki.2009.543; Dalbeth N, 2009, RHEUMATOLOGY, V48, P195, DOI 10.1093/rheumatology/ken416; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; EMMERSON BT, 1974, ANN RHEUM DIS, V33, P276, DOI 10.1136/ard.33.3.276; FOX IH, 1972, METABOLISM, V21, P713, DOI 10.1016/0026-0495(72)90120-5; GARREL DR, 1991, AM J CLIN NUTR, V53, P665; GHADIRIAN P, 1995, EUR J EPIDEMIOL, V11, P275, DOI 10.1007/BF01719431; GIBSON T, 1983, ANN RHEUM DIS, V42, P123, DOI 10.1136/ard.42.2.123; HALLFRISCH J, 1990, FASEB J, V4, P2652, DOI 10.1096/fasebj.4.9.2189777; HARRIS CM, 1995, J CLIN EPIDEMIOL, V48, P1153, DOI 10.1016/0895-4356(94)00244-K; Hata Y, 1996, AM J CLIN NUTR, V64, P767, DOI 10.1093/ajcn/64.5.767; Holland B., 1991, MCCANCE WIDDOWSONS C, V5; Indyk HE, 2004, J AOAC INT, V87, P116; Jeroncic I, 2010, CROAT MED J, V51, P40, DOI 10.3325/cmj.2010.51.40; Johnson RJ, 2010, J AM SOC NEPHROL, V21, P2036, DOI 10.1681/ASN.2010050506; Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033; Jordan KM, 2007, RHEUMATOLOGY, V46, P1372, DOI 10.1093/rheumatology/kem056a; Kerksick CM, 2006, J STRENGTH COND RES, V20, P643, DOI 10.1519/R-17695.1; Livesey G, 2009, J NUTR, V139, pS1246, DOI 10.3945/jn.108.097949; LOENEN HMJA, 1990, J CLIN EPIDEMIOL, V43, P1297, DOI 10.1016/0895-4356(90)90095-7; Masson LF, 2003, PUBLIC HEALTH NUTR, V6, P313, DOI 10.1079/PHN2002429; Pal B, 2000, CLIN RHEUMATOL, V19, P21, DOI 10.1007/s100670050005; PERHEENT.J, 1967, LANCET, V2, P528; RAIVIO KO, 1975, METABOLISM, V24, P861, DOI 10.1016/0026-0495(75)90133-X; Schlesinger N, 2005, CURR PHARM DESIGN, V11, P4133, DOI 10.2174/138161205774913273; Sigman-Grant M, 2003, AM J CLIN NUTR, V78, p815S, DOI 10.1093/ajcn/78.4.815S; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; STIRPE F, 1970, LANCET, V2, P1310; Sui XM, 2008, METABOLISM, V57, P845, DOI 10.1016/j.metabol.2008.01.030; Theodoratou E, 2007, CANCER EPIDEM BIOMAR, V16, P684, DOI 10.1158/1055-9965.EPI-06-0785; VERDI RJ, 1987, J DAIRY SCI, V70, P230, DOI 10.3168/jds.S0022-0302(87)80002-4; Wallace KL, 2004, J RHEUMATOL, V31, P1582; Yamakita J, 1998, ADV EXP MED BIOL, V431, P839; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269	52	77	84	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38123	10.1371/journal.pone.0038123	http://dx.doi.org/10.1371/journal.pone.0038123			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701608	Green Published, Green Submitted, gold			2022-12-25	WOS:000305348400037
J	Zhang, S; Cheng, JQ; Qin, YX				Zhang, Shu; Cheng, Jiqi; Qin, Yi-Xian			Mechanobiological Modulation of Cytoskeleton and Calcium Influx in Osteoblastic Cells by Short-Term Focused Acoustic Radiation Force	PLOS ONE			English	Article							LOW-INTENSITY ULTRASOUND; FLUID-FLOW; SHEAR-STRESS; INTRAMEDULLARY PRESSURE; PULSED ULTRASOUND; GENE-EXPRESSION; BONE-CELLS; IN-VITRO; GROWTH; OSCILLATIONS	Mechanotransduction has demonstrated potential for regulating tissue adaptation in vivo and cellular activities in vitro. It is well documented that ultrasound can produce a wide variety of biological effects in biological systems. For example, pulsed ultrasound can be used to noninvasively accelerate the rate of bone fracture healing. Although a wide range of studies has been performed, mechanism for this therapeutic effect on bone healing is currently unknown. To elucidate the mechanism of cellular response to mechanical stimuli induced by pulsed ultrasound radiation, we developed a method to apply focused acoustic radiation force (ARF) (duration, one minute) on osteoblastic MC3T3-E1 cells and observed cellular responses to ARF using a spinning disk confocal microscope. This study demonstrates that the focused ARF induced F-actin cytoskeletal rearrangement in MC3T3-E1 cells. In addition, these cells showed an increase in intracellular calcium concentration following the application of focused ARF. Furthermore, passive bending movement was noted in primary cilium that were treated with focused ARF. Cell viability was not affected. Application of pulsed ultrasound radiation generated only a minimal temperature rise of 0.1 degrees C, and induced a streaming resulting fluid shear stress of 0.186 dyne/cm(2), suggesting that hyperthermia and acoustic streaming might not be the main causes of the observed cell responses. In conclusion, these data provide more insight in the interactions between acoustic mechanical stress and osteoblastic cells. This experimental system could serve as basis for further exploration of the mechanosensing mechanism of osteoblasts triggered by ultrasound.	[Zhang, Shu; Cheng, Jiqi; Qin, Yi-Xian] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Zhang, Shu] Chinese Minist Educ, Key Lab Aerosp Med, Xian, Shaanxi, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Zhang, S (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.	Yi-Xian.Qin@sunysb.edu		Zhang, Shu/0000-0002-4380-1268	China Scholarship Council; National Institutes of Health [AR49286, AR52379]; National Space Biomedical Research Institute through NASA [NCC 9-58]; US Army Medical Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052379, R01AR061821, R01AR049286] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Space Biomedical Research Institute through NASA; US Army Medical Research(United States Department of DefenseUS Army Research Laboratory (ARL)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Dr. Shu Zhang thanks the China Scholarship Council for providing partial financial support for his staying in Stony Brook as a visiting scholar. The authors are grateful for the assistance from Dr. Chris Jacobs and Sara Temiyasathit for their help with the primary cilia immunostaining protocol and analysis.; This work was supported by National Institutes of Health grants (AR49286 and AR52379), National Space Biomedical Research Institute through NASA Cooperative Agreement NCC 9-58, and US Army Medical Research to Dr. Qin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293; Barnett SB, 1997, ULTRASOUND MED BIOL, V23, P805, DOI 10.1016/S0301-5629(97)00027-6; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bikle DD, 2008, OSTEOPOROSIS INT, V19, P1237, DOI 10.1007/s00198-008-0597-z; Bloomfield SA, 2001, INT J SPORT NUTR EXE, V11, pS128, DOI 10.1123/ijsnem.11.s1.s128; Chen NX, 2000, AM J PHYSIOL-CELL PH, V278, pC989, DOI 10.1152/ajpcell.2000.278.5.C989; Coakley WT, 2000, ULTRASONICS, V38, P638, DOI 10.1016/S0041-624X(99)00151-1; Cook SD, 1997, CLIN ORTHOP RELAT R, P198; CRUM LA, 1992, J ACOUST SOC AM, V91, P1113, DOI 10.1121/1.402638; Dalecki D, 2004, ANNU REV BIOMED ENG, V6, P229, DOI 10.1146/annurev.bioeng.6.040803.140126; Donahue SW, 2003, J BIOMECH, V36, P35, DOI 10.1016/S0021-9290(02)00318-4; Donahue SW, 2001, AM J PHYSIOL-CELL PH, V281, pC1635, DOI 10.1152/ajpcell.2001.281.5.C1635; DUARTE LR, 1983, ARCH ORTHOP TRAUM SU, V101, P153, DOI 10.1007/BF00436764; FOWLKES JB, 1988, J ACOUST SOC AM, V83, P2190, DOI 10.1121/1.396347; Frenkel V, 2008, ADV DRUG DELIVER REV, V60, P1193, DOI 10.1016/j.addr.2008.03.007; Frohlich M, 2010, TISSUE ENG PT A, V16, P179, DOI [10.1089/ten.tea.2009.0164, 10.1089/ten.TEA.2009.0164]; Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2; Hancock HA, 2009, ULTRASOUND MED BIOL, V35, P1722, DOI 10.1016/j.ultrasmedbio.2009.04.020; HECKMAN JD, 1994, J BONE JOINT SURG AM, V76A, P26, DOI 10.2106/00004623-199401000-00004; Hollman KW, 2007, EXP EYE RES, V85, P890, DOI 10.1016/j.exer.2007.09.006; Hsieh YL, 2005, ARCH PHYS MED REHAB, V86, P1311, DOI 10.1016/j.apmr.2004.12.035; Hultstrom J, 2007, ULTRASOUND MED BIOL, V33, P145, DOI 10.1016/j.ultrasmedbio.2006.07.024; HUNG CT, 1995, CLIN ORTHOP RELAT R, P256; INGBER DE, 1994, INT REV CYTOL, V150, P173; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6; Juffermans LJM, 2009, ULTRASOUND MED BIOL, V35, P1917, DOI 10.1016/j.ultrasmedbio.2009.06.1091; Kimmel Eitan, 2006, Critical Reviews in Biomedical Engineering, V34, P105, DOI 10.1615/CritRevBiomedEng.v34.i2.10; Korstjens CM, 2004, J ORTHOP RES, V22, P495, DOI 10.1016/j.orthres.2003.09.011; Lee J, 2005, J ACOUST SOC AM, V117, P3273, DOI 10.1121/1.1886387; Li DQ, 2009, TISSUE ENG PT A, V15, P2773, DOI [10.1089/ten.tea.2008.0540, 10.1089/ten.TEA.2008.0540]; Liu YY, 2006, ULTRASON SONOCHEM, V13, P232, DOI 10.1016/j.ultsonch.2005.03.005; Lyon R, 2003, J ORTHOPAED RES, V21, P865, DOI 10.1016/S0736-0266(03)00047-0; Maleke C, 2008, PHYS MED BIOL, V53, P1773, DOI 10.1088/0031-9155/53/6/018; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Malone AMD, 2007, AM J PHYSIOL-CELL PH, V292, pC1830, DOI 10.1152/ajpcell.00352.2005; Miller DL, 2007, PROG BIOPHYS MOL BIO, V93, P314, DOI 10.1016/j.pbiomolbio.2006.07.027; Milowska K, 2005, ULTRASOUND MED BIOL, V31, P1707, DOI 10.1016/j.ultrasmedbio.2005.07.018; Myers KA, 2007, BIOCHEM BIOPH RES CO, V364, P214, DOI 10.1016/j.bbrc.2007.09.109; Naruse K, 2003, J BONE MINER RES, V18, P360, DOI 10.1359/jbmr.2003.18.2.360; Nightingale K, 2002, ULTRASOUND MED BIOL, V28, P227, DOI 10.1016/S0301-5629(01)00499-9; Nolte PA, 2001, J TRAUMA, V51, P693, DOI 10.1097/00005373-200110000-00012; O'Neill BE, 2009, ULTRASOUND MED BIOL, V35, P416, DOI 10.1016/j.ultrasmedbio.2008.09.021; Papachroni KK, 2009, TRENDS MOL MED, V15, P208, DOI 10.1016/j.molmed.2009.03.001; Parvizi J, 1999, J ORTHOPAED RES, V17, P488, DOI 10.1002/jor.1100170405; Pickard JE, 2009, BIOPHYS J, V96, P4249, DOI 10.1016/j.bpj.2009.01.060; Qin YX, 2003, J BIOMECH, V36, P1427, DOI 10.1016/S0021-9290(03)00127-1; Qin YX, 2002, ANN BIOMED ENG, V30, P693, DOI 10.1114/1.1483863; Reher P, 1997, ULTRASOUND MED BIOL, V23, P1251, DOI 10.1016/S0301-5629(97)00031-8; Rubin C, 2001, J BONE JOINT SURG AM, V83A, P259, DOI 10.2106/00004623-200102000-00015; Scaglione S, 2008, J BIOMED MATER RES A, V86A, P411, DOI 10.1002/jbm.a.31607; Scott A, 2008, SPORTS MED, V38, P139, DOI 10.2165/00007256-200838020-00004; Sena K, 2005, ULTRASOUND MED BIOL, V31, P703, DOI 10.1016/j.ultrasmedbio.2005.01.013; Shou WD, 2006, ULTRASONICS, V44, pE17, DOI 10.1016/j.ultras.2006.06.034; Vaezy S, 2001, ULTRASOUND MED BIOL, V27, P33, DOI 10.1016/S0301-5629(00)00279-9; WANG SJ, 1994, J ORTHOP RES, V12, P40, DOI 10.1002/jor.1100120106; WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8; Worthington AE, 1997, ULTRASOUND MED BIOL, V23, P1095, DOI 10.1016/S0301-5629(97)00019-7; Yang KH, 1996, J ORTHOP RES, V14, P802, DOI 10.1002/jor.1100140518; You J, 2000, J BIOMECH ENG-T ASME, V122, P387, DOI 10.1115/1.1287161; Zhou YF, 2006, J ACOUST SOC AM, V120, P676, DOI 10.1121/1.2214131	61	39	41	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38343	10.1371/journal.pone.0038343	http://dx.doi.org/10.1371/journal.pone.0038343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701628	Green Submitted, gold, Green Published			2022-12-25	WOS:000305348400052
J	Ni, F; Gong, Y; Li, LL; Abdolmaleky, HM; Zhou, JR				Ni, Feng; Gong, Yi; Li, Linglin; Abdolmaleky, Hamid M.; Zhou, Jin-Rong			Flavonoid Ampelopsin Inhibits the Growth and Metastasis of Prostate Cancer In Vitro and in Mice	PLOS ONE			English	Article							BREAST-CANCER; CHEMOKINE RECEPTORS; TUMOR ANGIOGENESIS; ORTHOTOPIC GROWTH; APOPTOSIS; CELLS; CXCR4; BCL-2; EXPRESSION; RESISTANCE	The objective of this study was to evaluate the chemopreventive effect of a novel flavonoid, ampelopsin (AMP) on the growth and metastasis of prostate cancer cells. AMP showed the more potent activity in inhibiting the proliferation of androgen-sensitive LNCaP and, to less extent, androgen-independent PC-3 human prostate cancer cell lines in vitro, primarily by induction of apoptosis associated with down-regulation of bcl-2. On the other hand, AMP showed much less activity in inhibiting the proliferation of normal prostate epithelial cells than that of prostate cancer cell lines. AMP also inhibited the migration and invasion of PC-3 cells in vitro associated with down-regulation of CXCR4 expression. In the animal study using an orthotopic prostate tumor model, AMP (150 and 300 mg/kg body weight) inhibited the growth of PC-3 tumors and lymph node and lung metastases in a dose-dependent manner. Compared to the control mice, mice treated with AMP at 300 mg/kg BW had reduced final tumor weight by 49.2% (P<0.05), lymph node metastases by 54.5% (P = 0.3) and lung metastases by 93% (P<0.05), but had no apparent alteration on food intake or body weight. The in vivo anti-growth and anti-metastasis activities of AMP were associated with induction of apoptosis and inhibition of proliferation of prostate cancer cells, reduction of prostate tumor angiogenesis, and reduction of CXCR4 expression. Our results provide supporting evidence to warrant further investigation to develop AMP as a novel efficacious and safe candidate agent against progression and metastasis of prostate cancer.	[Ni, Feng] Fujian Hlth Coll, Dept Pharmaceut, Fuzhou, Fujian, Peoples R China; [Ni, Feng; Gong, Yi; Li, Linglin; Abdolmaleky, Hamid M.; Zhou, Jin-Rong] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Nutr Metab Lab,Dept Surg, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Ni, F (corresponding author), Fujian Hlth Coll, Dept Pharmaceut, Fuzhou, Fujian, Peoples R China.	jrzhou@bidmc.harvard.edu	Liu, Deyu/G-5665-2012	Mostafavi Abdolmaleky, Hamid/0000-0002-8872-5174	Foundation of Chinese Ministry of Health & United Fujian Provincial Health and Education [WKJ2008-2-60]; Foundation of Fujian Provincial Department of Science Technology [2011Y0015]; Scientific Research Foundation of Exploitation on Industrial Technology of Fujian Development and Reform Commission [2008-762]; Department of Defense [PC073988]; NCI/NIH [R21 CA133865]; NATIONAL CANCER INSTITUTE [R21CA133865] Funding Source: NIH RePORTER	Foundation of Chinese Ministry of Health & United Fujian Provincial Health and Education; Foundation of Fujian Provincial Department of Science Technology; Scientific Research Foundation of Exploitation on Industrial Technology of Fujian Development and Reform Commission; Department of Defense(United States Department of Defense); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Foundation of Chinese Ministry of Health & United Fujian Provincial Health and Education (WKJ2008-2-60), Foundation of Fujian Provincial Department of Science & Technology (2011Y0015) and Scientific Research Foundation of Exploitation on Industrial Technology of Fujian Development and Reform Commission (2008-762) to FN, and Department of Defense (PC073988) and NCI/NIH (R21 CA133865) to JRZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the menuscript.	Cao Y, 2010, EXP CELL RES, V316, P1304, DOI 10.1016/j.yexcr.2010.02.031; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Grande F, 2008, CURR PHARM DESIGN, V14, P385; Harvey JR, 2007, CLIN CANCER RES, V13, P1562, DOI 10.1158/1078-0432.CCR-06-1987; Hase K, 1997, BIOL PHARM BULL, V20, P381, DOI 10.1248/bpb.20.381; He Guixia, 2003, Zhong Yao Cai, V26, P338; Krajewska M, 1996, AM J PATHOL, V148, P1567; Liu D, 2001, Zhong Yao Cai, V24, P348; Liu De-yu, 2003, Zhongguo Zhongyao Zazhi, V28, P957; Liu DY, 2004, BIOMED ENVIRON SCI, V17, P153; Luo Gao-qin, 2006, Zhong Yao Cai, V29, P146; McConkey DJ, 1996, CANCER RES, V56, P5594; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murakami T, 2004, BIOFACTORS, V21, P175, DOI 10.1002/biof.552210136; Perez de Castro I, 2008, CURR OPIN PHARMACOL, V8, P375, DOI 10.1016/j.coph.2008.06.013; Pitts M., 2002, I ANIMAL CARE USE CO, V2; RAFFO AJ, 1995, CANCER RES, V55, P4438; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Salvucci O, 2006, BREAST CANCER RES TR, V97, P275, DOI 10.1007/s10549-005-9121-8; Scotton CJ, 2001, CANCER RES, V61, P4961; Scotton CJ, 2002, CANCER RES, V62, P5930; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh AV, 2006, CANCER RES, V66, P1851, DOI 10.1158/0008-5472.CAN-05-1332; Song R, 2010, PROSTATE, V70, P571, DOI 10.1002/pros.21091; Steel RGD, 1980, PRINCIPLES PROCEDURE; Yang LH, 2007, CANCER RES, V67, P651, DOI 10.1158/0008-5472.CAN-06-2762; Ye Jiantao, 2009, Zhongguo Zhong Yao Za Zhi, V34, P761; Zeng Sa, 2006, Zhong Yao Cai, V29, P260; Zeng Sa, 2004, Zhong Yao Cai, V27, P842; Zheng Hong-Qiang, 2003, Ai Zheng, V22, P363; Zhong Zheng-xian, 2002, Zhongguo Zhongyao Zazhi, V27, P687; Zhou JR, 1999, J NUTR, V129, P1628, DOI 10.1093/jn/129.9.1628; Zhou JR, 2004, INT J CANCER, V110, P800, DOI 10.1002/ijc.20206; Zhou JR, 2002, PROSTATE, V53, P143, DOI 10.1002/pros.10141; Zhou JR, 1998, CANCER RES, V58, P5231	35	50	58	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38802	10.1371/journal.pone.0038802	http://dx.doi.org/10.1371/journal.pone.0038802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693649	Green Submitted, Green Published, gold			2022-12-25	WOS:000305343900066
J	Kiware, SS; Chitnis, N; Moore, SJ; Devine, GJ; Majambere, S; Merrill, S; Killeen, GF				Kiware, Samson S.; Chitnis, Nakul; Moore, Sarah J.; Devine, Gregor J.; Majambere, Silas; Merrill, Stephen; Killeen, Gerry F.			Simplified Models of Vector Control Impact upon Malaria Transmission by Zoophagic Mosquitoes	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; ENTOMOLOGIC INOCULATION RATES; IMPREGNATED PLASTIC STRIPS; ANOPHELES-GAMBIAE COMPLEX; INSECTICIDE-TREATED NETS; AN.-QUADRIANNULATUS; SPATIAL REPELLENCY; HOST-PREFERENCE; BLOOD MEALS; BED NETS	Background: High coverage of personal protection measures that kill mosquitoes dramatically reduce malaria transmission where vector populations depend upon human blood. However, most primary malaria vectors outside of sub-Saharan Africa can be classified as "very zoophagic," meaning they feed occasionally (<10% of blood meals) upon humans, so personal protection interventions have negligible impact upon their survival. Methods and Findings: We extended a published malaria transmission model to examine the relationship between transmission, control, and the baseline proportion of bloodmeals obtained from humans (human blood index). The lower limit of the human blood index enables derivation of simplified models for zoophagic vectors that (1) Rely on only three field-measurable parameters. (2) Predict immediate and delayed (with and without assuming reduced human infectivity, respectively) impacts of personal protection measures upon transmission. (3) Illustrate how appreciable indirect communal-level protection for non-users can be accrued through direct personal protection of users. (4) Suggest the coverage and efficacy thresholds required to attain epidemiological impact. The findings suggest that immediate, indirect, community-wide protection of users and non-users alike may linearly relate to the efficacy of a user's direct personal protection, regardless of whether that is achieved by killing or repelling mosquitoes. High protective coverage and efficacy (>= 80%) are important to achieve epidemiologically meaningful impact. Non-users are indirectly protected because the two most common species of human malaria are strict anthroponoses. Therefore, the small proportion of mosquitoes that are killed or diverted while attacking humans can represent a large proportion of those actually transmitting malaria. Conclusions: Simplified models of malaria transmission by very zoophagic vectors may be used by control practitioners to predict intervention impact interventions using three field-measurable parameters; the proportion of human exposure to mosquitoes occurring when an intervention can be practically used, its protective efficacy when used, and the proportion of people using it.	[Kiware, Samson S.; Moore, Sarah J.; Devine, Gregor J.; Majambere, Silas; Killeen, Gerry F.] Ifakara Hlth Inst, Biomed & Environm Themat Grp, Ifakara, Tanzania; [Kiware, Samson S.; Merrill, Stephen] Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA; [Chitnis, Nakul] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Chitnis, Nakul] Univ Basel, Basel, Switzerland; [Moore, Sarah J.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Devine, Gregor J.; Majambere, Silas; Killeen, Gerry F.] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England	Ifakara Health Institute; Marquette University; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of London; London School of Hygiene & Tropical Medicine; Liverpool School of Tropical Medicine; University of Liverpool	Kiware, SS (corresponding author), Ifakara Hlth Inst, Biomed & Environm Themat Grp, Ifakara, Tanzania.	skiware@ihi.or.tz	Chitnis, Nakul/B-3105-2013; Smith, Thomas/B-5569-2015; Devine, Gregor J/H-1141-2014; Moore, Sarah J/HGE-7143-2022	Smith, Thomas/0000-0002-3650-9381; Devine, Gregor J/0000-0001-6312-0390; Moore, Sarah J/0000-0002-0938-6654; Chitnis, Nakul/0000-0002-1103-9141; Kiware, Samson/0000-0001-7252-520X	Bill & Melinda Gates Foundation [45114, 51431, 52644, 39777.01]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was funded in part by the Bill & Melinda Gates Foundation through award numbers 45114 (Malaria Transmission Consortium), 51431 (Replacing DDT: Rigorous Evaluation of Spatial Repellents for the Control of Vector Borne Diseases), 52644 (Control of Anophelines by the auto-dissemination of insecticides) and 39777.01 (A stochastic simulation platform for predicting the effects of different malaria intervention strategies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANDERSON R M, 1991; [Anonymous], 1987, SUPPLEMENT ANOPHELIN; [Anonymous], 2007, INS TREAT MOSQ NETS; Antonio-Nkondjio C, 2006, J MED ENTOMOL, V43, P1215, DOI 10.1603/0022-2585(2006)43[1215:COTMVS]2.0.CO;2; Balkew M, 2010, RES INSECTICIDE RESI; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Besansky NJ, 2004, TRENDS PARASITOL, V20, P249, DOI 10.1016/j.pt.2004.03.007; Bogh C, 2001, J MED ENTOMOL, V38, P822, DOI 10.1603/0022-2585-38.6.822; Bugoro H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-133; Chitnis N, 2010, AM J TROP MED HYG, V83, P230, DOI 10.4269/ajtmh.2010.09-0179; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; ELLIOTT R, 1968, B WORLD HEALTH ORGAN, V38, P239; Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241; GARRETTJONES C, 1969, B WORLD HEALTH ORGAN, V40, P531; GARRETTJONES C, 1980, B ENTOMOL RES, V70, P165, DOI 10.1017/S0007485300007422; Geissbuhler Y, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-126; Gerry K, 2011, PARASIT VECTORS, P4; Gillies M., 1960, B ENTOMOL RES, V51, P248, DOI DOI 10.1017/S0007485300057953; Gillies M, 1962, NEW SPECIES ANOPHELE, P81; GILLIES M. T., 1964, Bulletin of Entomological Research, V55, P1, DOI 10.1017/S0007485300049221; GITHEKO AK, 1994, ACTA TROP, V58, P307, DOI 10.1016/0001-706X(94)90024-8; Govella NJ, 2010, AM J TROP MED HYG, V82, P415, DOI 10.4269/ajtmh.2010.09-0579; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Hargreaves K, 2003, MED VET ENTOMOL, V17, P417, DOI 10.1111/j.1365-2915.2003.00460.x; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Hoffmann EJ, 2002, J MED ENTOMOL, V39, P935, DOI 10.1603/0022-2585-39.6.935; Kawada H, 2008, J AM MOSQUITO CONTR, V24, P404, DOI 10.2987/5743.1; Kawada H, 2005, J VECTOR ECOL, V30, P181; Kay B, 1979, MOSQ NEWS; Kent RJ, 2007, AM J TROP MED HYG, V76, P267, DOI 10.4269/ajtmh.2007.76.267; Killeen GF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-121; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Killeen GF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-161; Killeen GF, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-17; Killeen GF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-207; Killeen GF, 2001, T ROY SOC TROP MED H, V95, P469, DOI 10.1016/S0035-9203(01)90005-7; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Le Menach A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-10; Lengeler C, 2003, INDOOR RESIDUAL SPRA, P17; Lwetoijera DW, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-18; Lyimo IN, 2009, TRENDS PARASITOL, V25, P189, DOI 10.1016/j.pt.2009.01.005; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Ogoma SB, 2012, PARASIT VECTORS; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011573; Prior A, 2002, MED VET ENTOMOL, V16, P207, DOI 10.1046/j.1365-2915.2002.00367.x; Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184; Ross A, 2006, AM J TROP MED HYG, V75, P32, DOI 10.4269/ajtmh.2006.75.32; Russell T, 2010, MALARIA J, V9, P62; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Sama W, 2004, AM J TROP MED HYG, V70, P625, DOI 10.4269/ajtmh.2004.70.625; Saul A, 1996, PARASITOL TODAY, V12, P74, DOI 10.1016/0169-4758(96)80659-4; Saul A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-32; SHALABY AM, 1969, ANN ENTOMOL SOC AM, V62, P1270, DOI 10.1093/aesa/62.6.1270; Simpson JE, 2011, P R SOC B; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Smith DL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-87; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; Smith T, 2006, AM J TROP MED HYG, V75, P11, DOI 10.4269/ajtmh.2006.75.2_suppl.0750011; SOTA T, 1989, MED VET ENTOMOL, V3, P337, DOI 10.1111/j.1365-2915.1989.tb00240.x; Takken W, 1999, T ROY SOC TROP MED H, V93, P578, DOI 10.1016/S0035-9203(99)90054-8; TEMPELIS CH, 1975, J MED ENTOMOL, V11, P635, DOI 10.1093/jmedent/11.6.635; Torr S, 2008, MED VET ENTOMOL, V22, P93, DOI 10.1111/j.1365-2915.2008.00723.x; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2; WHITE GB, 1972, B ENTOMOL RES, V62, P295, DOI 10.1017/S0007485300047738; Yakob L, 2011, J R SOC INTERFACE, V8, P799, DOI 10.1098/rsif.2010.0537	70	39	39	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37661	10.1371/journal.pone.0037661	http://dx.doi.org/10.1371/journal.pone.0037661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701527	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500048
J	Simoes, RD; Howard, KE; Dean, GA				Simoes, Rita D.; Howard, Kristina E.; Dean, Gregg A.			In Vivo Assessment of Natural Killer Cell Responses during Chronic Feline Immunodeficiency Virus Infection	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES INFECTION; ACTIVE ANTIRETROVIRAL THERAPY; PATHOGEN-FREE CATS; DENDRITIC CELLS; T-LYMPHOCYTES; HIV-1 INFECTION; LYMPH-NODES; INTRACELLULAR BACTERIUM; MONOCLONAL-ANTIBODIES; CYTOKINE RESPONSE	Accumulating evidence suggests that natural killer (NK) cells may have an important role in HIV-1 disease pathogenesis; however, in vivo studies are lacking. Feline immunodeficiency virus (FIV) infection of cats provides a valuable model to study NK cell function in vivo. The immune response against Listeria monocytogenes (Lm) is well characterized, allowing its use as an innate immune probe. We have previously shown that locally delivered IL-15 can improve Lm clearance in FIV-infected animals, and this correlated with an increase in NK cell number. In the present study, chronically FIV-infected and SPF-control cats were challenged with Lm by unilateral subcutaneous injection next to the footpad and then treated with 5-bromo-2'-deoxyuridine (BrdU). The Lm draining and contralateral control lymph nodes were evaluated for NK, NKT, CD4(+) and CD8(+) T cell number, proliferation, apoptosis, and NK cell function. Listeria monocytogenes burden was also assessed in both control and Lm draining lymph nodes. NK, NKT, CD4(+) T and CD8(+) T cells in the Lm-challenged lymph node of FIV-infected cats did not increase in number. In addition, after Lm challenge, NK cells from FIV-infected cats did not increase their proliferation rate, apoptosis was elevated, and perforin expression was not upregulated when compared to SPF-control cats. The failure of the NK cell response against Lm challenge in the draining lymph node of FIV-infected cats correlates with the delayed control and clearance of this opportunistic bacterial pathogen.	[Simoes, Rita D.; Howard, Kristina E.; Dean, Gregg A.] N Carolina State Univ, Coll Vet Med, Ctr Comparat Med & Translat Res, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Simoes, RD (corresponding author), N Carolina State Univ, Coll Vet Med, Ctr Comparat Med & Translat Res, Raleigh, NC 27695 USA.	gregg.dean@colostate.edu	Dean, Gregg A/A-5623-2012	Dean, Gregg A/0000-0001-7025-9550	National Institutes of Health [R01-AI047707]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health [grant number R01-AI047707]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam C, 2005, BLOOD, V106, P338, DOI 10.1182/blood-2004-09-3775; Ahmad R, 2001, J MED VIROL, V65, P431, DOI 10.1002/jmv.2053.abs; Alter G, 2006, AIDS, V20, P1549, DOI 10.1097/01.aids.0000237371.31315.48; Andre P, 1999, EUR J IMMUNOL, V29, P1076, DOI 10.1002/(SICI)1521-4141(199904)29:04<1076::AID-IMMU1076>3.0.CO;2-Z; Assogba BD, 2007, J INFECT DIS, V195, P1184, DOI 10.1086/512861; BANCROFT GJ, 1987, J IMMUNOL, V139, P1104; BANCROFT GJ, 1993, CURR OPIN IMMUNOL, V5, P503, DOI 10.1016/0952-7915(93)90030-V; Becknell B, 2005, ADV IMMUNOL, V86, P209, DOI 10.1016/S0065-2776(04)86006-1; Biancotto A, 2007, BLOOD, V109, P4272, DOI 10.1182/blood-2006-11-055764; Burkhard MJ, 2003, CURR HIV RES, V1, P15, DOI 10.2174/1570162033352101; De Boer RJ, 2003, J IMMUNOL, V170, P2479, DOI 10.4049/jimmunol.170.5.2479; Dean GA, 2006, J INFECT DIS, V193, P1520, DOI 10.1086/503873; Dean GA, 1998, J VIROL, V72, P9436, DOI 10.1128/JVI.72.12.9436-9440.1998; Dean GA, 1998, VET IMMUNOL IMMUNOP, V65, P125, DOI 10.1016/S0165-2427(98)00148-2; DUNN PL, 1991, INFECT IMMUN, V59, P2892, DOI 10.1128/IAI.59.9.2892-2900.1991; Elder JH, 1998, AIDS RES HUM RETROV, V14, P797, DOI 10.1089/aid.1998.14.797; Elder JH, 2010, CURR HIV RES, V8, P73, DOI 10.2174/157016210790416389; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; Howard KE, 2005, J IMMUNOL METHODS, V302, P36, DOI 10.1016/j.jim.2005.04.019; Howard KE, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-2; KAGI D, 1994, EUR J IMMUNOL, V24, P3068, DOI 10.1002/eji.1830241223; Kang SJ, 2008, IMMUNITY, V29, P819, DOI 10.1016/j.immuni.2008.09.017; KAWASAKI A, 1990, INT IMMUNOL, V2, P677, DOI 10.1093/intimm/2.7.677; Kottilil S, 2003, J INFECT DIS, V187, P1038, DOI 10.1086/368222; Kottilil S, 2007, JAIDS-J ACQ IMM DEF, V46, P151, DOI 10.1097/QAI.0b013e3180dc9909; Kovacs JA, 2001, J EXP MED, V194, P1731, DOI 10.1084/jem.194.12.1731; Luteijn R, 2011, EUR J IMMUNOL, V41, P2729, DOI 10.1002/eji.201040886; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Mikkelsen SR, 2010, VIROLOGY, V403, P163, DOI 10.1016/j.virol.2010.04.016; Mocikat R, 2003, IMMUNITY, V19, P561, DOI 10.1016/S1074-7613(03)00264-4; Mohri H, 1998, SCIENCE, V279, P1223, DOI 10.1126/science.279.5354.1223; Moretta A, 2005, TRENDS IMMUNOL, V26, P668, DOI 10.1016/j.it.2005.09.008; Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956; Nishimura Y, 2004, J GEN VIROL, V85, P2585, DOI 10.1099/vir.0.80102-0; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Pedersen NC, 2001, VET IMMUNOL IMMUNOP, V79, P53, DOI 10.1016/S0165-2427(01)00252-5; Reeves RK, 2010, J VIROL, V84, P8959, DOI 10.1128/JVI.01126-10; Sachsenberg N, 1998, J EXP MED, V187, P1295, DOI 10.1084/jem.187.8.1295; Scott-Algara D, 2003, J IMMUNOL, V171, P5663, DOI 10.4049/jimmunol.171.11.5663; Shegarfi H, 2009, SCAND J IMMUNOL, V70, P238, DOI 10.1111/j.1365-3083.2009.02292.x; Stevens R, 2004, J VIROL, V78, P8210, DOI 10.1128/JVI.78.15.8210-8218.2004; TAKADA H, 1994, IMMUNOLOGY, V82, P106; TEIXEIRA HC, 1994, J IMMUNOL, V152, P1873; TOMPKINS MB, 1990, VET IMMUNOL IMMUNOP, V26, P305, DOI 10.1016/0165-2427(90)90115-9; ULLUM H, 1995, J EXP MED, V182, P789, DOI 10.1084/jem.182.3.789; Valentin A, 2002, P NATL ACAD SCI USA, V99, P7015, DOI 10.1073/pnas.102672999; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Voskoboinik I, 2010, IMMUNOL REV, V235, P35, DOI 10.1111/j.0105-2896.2010.00896.x; Vujanovic L, 2010, BLOOD, V116, P575, DOI 10.1182/blood-2009-08-240325; Yang JS, 1996, J VIROL, V70, P3011, DOI 10.1128/JVI.70.5.3011-3017.1996	54	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37606	10.1371/journal.pone.0037606	http://dx.doi.org/10.1371/journal.pone.0037606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701523	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500044
J	Chen, WH; Guo, WW; Huang, YX; Ma, ZQ				Chen, Wenhan; Guo, William W.; Huang, Yanxin; Ma, Zhiqiang			PepMapper: A Collaborative Web Tool for Mapping Epitopes from Affinity-Selected Peptides	PLOS ONE			English	Article							PHAGE-DISPLAY LIBRARIES; B-CELL EPITOPE; MIMOTOPE ANALYSIS; PREDICTION; PROTEINS; ALGORITHM; DATABASE	Epitope mapping from affinity-selected peptides has become popular in epitope prediction, and correspondingly many Web-based tools have been developed in recent years. However, the performance of these tools varies in different circumstances. To address this problem, we employed an ensemble approach to incorporate two popular Web tools, MimoPro and Pep-3D-Search, together for taking advantages offered by both methods so as to give users more options for their specific purposes of epitope-peptide mapping. The combined operation of Union finds as many associated peptides as possible from both methods, which increases sensitivity in finding potential epitopic regions on a given antigen surface. The combined operation of Intersection achieves to some extent the mutual verification by the two methods and hence increases the likelihood of locating the genuine epitopic region on a given antigen in relation to the interacting peptides. The Consistency between Intersection and Union is an indirect sufficient condition to assess the likelihood of successful peptide-epitope mapping. On average from 27 tests, the combined operations of PepMapper outperformed either MimoPro or Pep-3D-Search alone. Therefore, PepMapper is another multipurpose mapping tool for epitope prediction from affinity-selected peptides. The Web server can be freely accessed at: http://informatics.nenu.edu.cn/PepMapper/	[Chen, Wenhan; Ma, Zhiqiang] NE Normal Univ, Sch Comp Sci & Informat Technol, Changchun, Peoples R China; [Guo, William W.] Cent Queensland Univ, Sch Informat & Commun Technol, Rockhampton, Qld 4702, Australia; [Huang, Yanxin] NE Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun, Peoples R China; [Chen, Wenhan] NE Normal Univ, Jilin Univ, Key Lab Intelligent Informat Proc, Changchun, Peoples R China	Northeast Normal University - China; Central Queensland University; Northeast Normal University - China; Jilin University; Northeast Normal University - China	Chen, WH (corresponding author), NE Normal Univ, Sch Comp Sci & Informat Technol, Changchun, Peoples R China.	huangyx356@nenu.edu.cn; mazq@nenu.edu.cn			National Natural Science Foundation of China [61172183]; Natural Science Foundation of Jilin Province [20101503, 20101506]; Scientific and Technical Project of Administration of Traditional Chinese Medicine of Jilin Province [2010pt067, 2011-zd16]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin Province; Scientific and Technical Project of Administration of Traditional Chinese Medicine of Jilin Province	This work was supported by the National Natural Science Foundation of China (no. 61172183), the Natural Science Foundation of Jilin Province (no. 20101503 and no. 20101506), and the Scientific and Technical Project of Administration of Traditional Chinese Medicine of Jilin Province (nos. 2010pt067 and 2011-zd16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryson CJ, 2010, BIODRUGS, V24, P1, DOI 10.2165/11318560-000000000-00000; Bublil EM, 2007, PROTEINS, V68, P294, DOI 10.1002/prot.21387; Chen WH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-199; Enshell-Seijffers D, 2003, J MOL BIOL, V334, P87, DOI 10.1016/j.jmb.2003.09.002; GEYSEN HM, 1986, MOL IMMUNOL, V23, P709, DOI 10.1016/0161-5890(86)90081-7; Halperin I, 2003, PROTEIN SCI, V12, P1344, DOI 10.1110/ps.0237103; Huang J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-451; Huang J, 2012, NUCLEIC ACIDS RES, V40, pD271, DOI 10.1093/nar/gkr922; Huang J, 2011, MOLECULES, V16, P694, DOI 10.3390/molecules16010694; Huang YX, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-538; Irving MB, 2001, CURR OPIN CHEM BIOL, V5, P314, DOI 10.1016/S1367-5931(00)00208-8; Mayrose I, 2007, BIOINFORMATICS, V23, P3244, DOI 10.1093/bioinformatics/btm493; Mayrose I, 2007, NUCLEIC ACIDS RES, V35, P69, DOI 10.1093/nar/gkl975; Moreau V, 2006, BIOINFORMATICS, V22, P1088, DOI 10.1093/bioinformatics/btl012; Mumey BM, 2003, J COMPUT BIOL, V10, P555, DOI 10.1089/10665270360688183; Negi SS, 2009, BIOINFORM BIOL INSIG, V3, P71; Schreiber A, 2005, J COMPUT CHEM, V26, P879, DOI 10.1002/jcc.20229; Sun PP, 2011, MOLECULES, V16, P4971, DOI 10.3390/molecules16064971; Sussman JL, 1998, ACTA CRYSTALLOGR D, V54, P1078, DOI 10.1107/S0907444998009378; Tarnovitski N, 2006, J MOL BIOL, V359, P190, DOI 10.1016/j.jmb.2006.03.008	20	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37869	10.1371/journal.pone.0037869	http://dx.doi.org/10.1371/journal.pone.0037869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22701536	gold, Green Published, Green Submitted			2022-12-25	WOS:000305342300133
J	Larsen, LHG; Rasmussen, A; Giessing, AMB; Jogl, G; Kirpekar, F				Larsen, Line H. G.; Rasmussen, Anette; Giessing, Anders M. B.; Jogl, Gerwald; Kirpekar, Finn			Identification and Characterization of the Thermus thermophilus 5-Methylcytidine (m(5)C) Methyltransferase Modifying 23 S Ribosomal RNA (rRNA) Base C1942	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL NUCLEOLAR RNAS; ESCHERICHIA-COLI; PSEUDOURIDINE RESIDUES; SUBSTRATE SELECTIVITY; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; PRERIBOSOMAL RNA; METHYLATION; COMPLEX; CONTRIBUTES	Methylation of cytidines at carbon-5 is a common posttranscriptional RNA modification encountered across all domains of life. Here, we characterize the modifications of C1942 and C1962 in Thermus thermophilus 23 S rRNA as 5-methylcytidines (m(5)C) and identify the two associated methyltransferases. The methyltransferase modifying C1942, named RlmO, has not been characterized previously. RlmO modifies naked 23 S rRNA, but not the assembled 50 S subunit or 70 S ribosomes. The x-ray crystal structure of this enzyme in complex with the S-adenosyl-L-methionine cofactor at 1.7 angstrom resolution confirms that RlmO is structurally related to other m(5)C rRNA methyltransferases. Key residues in the active site are located similar to the further distant 5-methyluridine methyltransferase RlmD, suggestive of a similar enzymatic mechanism. RlmO homologues are primarily found in mesophilic bacteria related to T. thermophilus. In accordance, we find that growth of the T. thermophilus strain with an inactivated C1942 methyltransferase gene is not compromised at non-optimal temperatures.	[Jogl, Gerwald] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Larsen, Line H. G.; Rasmussen, Anette; Giessing, Anders M. B.; Kirpekar, Finn] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	Brown University; University of Southern Denmark	Jogl, G (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Box G-E129, Providence, RI 02912 USA.	Gerwald_Jogl@brown.edu; f.kir@bmb.sdu.dk	Jogl, Gerwald/AAJ-5783-2021; Larsen, Line H. G./ABF-5932-2020	Jogl, Gerwald/0000-0002-5465-5315; Kirpekar, Finn/0000-0003-1901-2266	National Institutes of Health [GM094157]; Danish National science Foundation; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094157] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish National science Foundation(Danmarks Grundforskningsfond); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM094157 (to G. J.) and by a grant from the Danish National science Foundation (to F. K.).; We thank John Schwanof and Randy Abramowitz for access to the X4A beamline at the National Synchrotron Light Source. Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-98CH10886.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alian A, 2008, P NATL ACAD SCI USA, V105, P6876, DOI 10.1073/pnas.0802247105; Andersen NM, 2006, J MOL BIOL, V359, P777, DOI 10.1016/j.jmb.2006.04.007; Andersen TE, 2004, RNA, V10, P907, DOI 10.1261/rna.5259404; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barneche F, 2001, J MOL BIOL, V311, P57, DOI 10.1006/jmbi.2001.4851; Baudin-Baillieu A, 2009, NUCLEIC ACIDS RES, V37, P7665, DOI 10.1093/nar/gkp816; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Cavaille J, 1996, NATURE, V383, P732, DOI 10.1038/383732a0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Del Lampo M, 2005, RNA, V11, P210, DOI 10.1261/rna.7209905; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Demirci H, 2010, RNA, V16, P1584, DOI 10.1261/rna.2088310; Douthwaite S, 2007, METHOD ENZYMOL, V425, P3, DOI 10.1016/S0076-6879(07)25001-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foster PG, 2003, STRUCTURE, V11, P1609, DOI 10.1016/j.str.2003.10.014; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Gaspin C, 2000, J MOL BIOL, V297, P895, DOI 10.1006/jmbi.2000.3593; Giessing AMB, 2011, J AM SOC MASS SPECTR, V22, P1242, DOI 10.1007/s13361-011-0126-8; Gustafsson C, 1998, J BACTERIOL, V180, P359, DOI 10.1128/JB.180.2.359-365.1998; Hallberg BM, 2006, J MOL BIOL, V360, P774, DOI 10.1016/j.jmb.2006.05.047; Hashimoto Y, 2001, FEBS LETT, V506, P231, DOI 10.1016/S0014-5793(01)02926-X; Havelund JF, 2011, J MOL BIOL, V411, P529, DOI 10.1016/j.jmb.2011.06.036; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Kimura S, 2012, NUCLEIC ACIDS RES, V40, P4071, DOI 10.1093/nar/gkr1287; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lee TT, 2005, CELL, V120, P599, DOI 10.1016/j.cell.2004.12.037; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Maden B E, 1990, Prog Nucleic Acid Res Mol Biol, V39, P241, DOI 10.1016/S0079-6603(08)60629-7; MADEN BEH, 1988, J MOL BIOL, V201, P289, DOI 10.1016/0022-2836(88)90139-8; Massenet S, 1999, FEBS LETT, V462, P94, DOI 10.1016/S0014-5793(99)01524-0; Mengel-Jorgensen J, 2006, J BIOL CHEM, V281, P22108, DOI 10.1074/jbc.M600377200; Motorin Y, 2010, NUCLEIC ACIDS RES, V38, P1415, DOI 10.1093/nar/gkp1117; O'Connor M, 2011, J BACTERIOL, V193, P154, DOI 10.1128/JB.00970-10; Ofengand J, 1997, J MOL BIOL, V266, P246, DOI 10.1006/jmbi.1996.0737; Omer AD, 2000, SCIENCE, V288, P517, DOI 10.1126/science.288.5465.517; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Perez-Arellano I, 2007, FEBS J, V274, P4972, DOI 10.1111/j.1742-4658.2007.06031.x; Pioszak AA, 2005, ACTA CRYSTALLOGR F, V61, P867, DOI 10.1107/S1744309105029842; Purta E, 2008, J MOL BIOL, V383, P641, DOI 10.1016/j.jmb.2008.08.061; RAUE HA, 1988, PROG BIOPHYS MOL BIO, V51, P77, DOI 10.1016/0079-6107(88)90011-9; SIRUMCONNOLLY K, 1995, BIOCHIMIE, V77, P30, DOI 10.1016/0300-9084(96)88101-6; Stanley RE, 2010, NAT STRUCT MOL BIOL, V17, P289, DOI 10.1038/nsmb.1755; Sun W, 2005, PROTEIN SCI, V14, P3121, DOI 10.1110/ps.051821805; Sunita S, 2008, J MOL BIOL, V383, P652, DOI 10.1016/j.jmb.2008.08.062; Toh SM, 2008, RNA, V14, P98, DOI 10.1261/rna.814408; Tycowski KT, 1996, P NATL ACAD SCI USA, V93, P14480, DOI 10.1073/pnas.93.25.14480; Vazquez-Laslop N, 2010, EMBO J, V29, P3108, DOI 10.1038/emboj.2010.180	50	5	5	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27593	27600		10.1074/jbc.M112.376160	http://dx.doi.org/10.1074/jbc.M112.376160			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22711535	Green Published, hybrid			2022-12-25	WOS:000307840700034
J	Baek, GH; Cheng, HL; Kim, I; Rao, H				Baek, Guem Hee; Cheng, Haili; Kim, Ikjin; Rao, Hai			The Cdc48 Protein and Its Cofactor Vms1 Are Involved in Cdc13 Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; UBIQUITIN LIGASE; COMPLEXES; YEAST; UFD2; TURNOVER; ATPASE; SYSTEM	Vms1 is a newly identified Cdc48-binding protein. The biological function of Vms1 remains obscure. Here, we show that both Cdc48 and Vms1, but not Cdc48 cofactors Ufd1 and Ufd2, are crucial for the degradation of Cdc13, a telomere regulator. Interestingly, both autophagy and the proteasome are involved in Cdc13 turnover. Toxicity associated with accumulation of large amounts of Cdc13 in vms1 Delta or autophagy mutants underscores the significance of the proteolytic regulation of Cdc13. Because few ubiquitylated yeast proteins are known to be degraded by autophagy under non-stress conditions, the identification of Cdc13 as a target of autophagy provides a valuable tool to unravel the mechanism of autophagy-mediated selective protein degradation.	[Baek, Guem Hee; Cheng, Haili; Kim, Ikjin; Rao, Hai] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA	University of Texas System; University of Texas Health San Antonio	Rao, H (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, 15355 Lambda Dr, San Antonio, TX 78245 USA.	raoh@uthscsa.edu	Cheng, Haili/AGG-8193-2022	Cheng, Haili/0000-0002-1860-3585; RAO, HAI/0000-0002-4235-2210	National Institutes of Health [GM078085, P30 CA054174]; United States Department of Defense [W911NF-11-10466]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM078085 and P30 CA054174 and United States Department of Defense Grant W911NF-11-10466 (to H. R.).	Badadani M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013183; Baek GH, 2011, P NATL ACAD SCI USA, V108, P13558, DOI 10.1073/pnas.1104051108; Buchberger A, 2010, SUBCELL BIOCHEM, V54, P17, DOI 10.1007/978-1-4419-6676-6_2; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; Kirkin V, 2011, CURR OPIN GENET DEV, V21, P21, DOI 10.1016/j.gde.2010.10.004; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Liu C, 2011, J BIOL CHEM, V286, P43660, DOI 10.1074/jbc.M111.286229; Liu C, 2010, J BIOL CHEM, V285, P10265, DOI 10.1074/jbc.M110.110551; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Nair U, 2011, AUTOPHAGY, V7, P1546, DOI 10.4161/auto.7.12.18424; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Pinto AR, 2011, FRONT BIOSCI-LANDMRK, V16, P187, DOI 10.2741/3683; Ramanathan HN, 2011, MOL CELL, V44, P3, DOI 10.1016/j.molcel.2011.09.006; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Tran JR, 2011, J BIOL CHEM, V286, P5744, DOI 10.1074/jbc.M110.179259; Tseng SF, 2009, NUCLEIC ACIDS RES, V37, P3602, DOI 10.1093/nar/gkp235; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814	24	14	15	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26788	26795		10.1074/jbc.M112.351825	http://dx.doi.org/10.1074/jbc.M112.351825			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22718752	Green Published, hybrid			2022-12-25	WOS:000307386000028
J	Caillet-Saguy, C; Piccioli, M; Turano, P; Lukat-Rodgers, G; Wolff, N; Rodgers, KR; Izadi-Pruneyre, N; Delepierre, M; Lecroisey, A				Caillet-Saguy, Celia; Piccioli, Mario; Turano, Paola; Lukat-Rodgers, Gudrun; Wolff, Nicolas; Rodgers, Kenton R.; Izadi-Pruneyre, Nadia; Delepierre, Muriel; Lecroisey, Anne			Role of the Iron Axial Ligands of Heme Carrier HasA in Heme Uptake and Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOPHORE HASA; SERRATIA-MARCESCENS; RESONANCE RAMAN; BINDING PROTEIN; OUTER-MEMBRANE; ACQUISITION-SYSTEM; ESCHERICHIA-COLI; NMR-SPECTROSCOPY; RECEPTOR HASR; CYTOCHROME-C	The hemophore protein HasA from Serratia marcescens cycles between two states as follows: the heme-bound holoprotein, which functions as a carrier of the metal cofactor toward the membrane receptor HasR, and the heme-free apoprotein fishing for new porphyrin to be taken up after the heme has been delivered to HasR. Holo- and apo-forms differ for the conformation of the two loops L1 and L2, which provide the axial ligands of the iron through His(32) and Tyr(75), respectively. In the apo-form, loop L1 protrudes toward the solvent far away from loop L2; in the holoprotein, closing of the loops on the heme occurs upon establishment of the two axial coordination bonds. We have established that the two variants obtained via single point mutations of either axial ligand (namely H32A and Y75A) are both in the closed conformation. The presence of the heme and one out of two axial ligands is sufficient to establish a link between L1 and L2, thanks to the presence of coordinating solvent molecules. The latter are stabilized in the iron coordination environment by H-bond interactions with surrounding protein residues. The presence of such a water molecule in both variants is revealed here through a set of different spectroscopic techniques. Previous studies had shown that heme release and uptake processes occur via intermediate states characterized by a Tyr(75)-iron-bound form with open conformation of loop L1. Here, we demonstrate that these states do not naturally occur in the free protein but can only be driven by the interaction with the partner proteins.	[Caillet-Saguy, Celia; Wolff, Nicolas; Izadi-Pruneyre, Nadia; Delepierre, Muriel; Lecroisey, Anne] Inst Pasteur, CNRS, URA 2185, Unite RMN Biomol, F-75015 Paris, France; [Piccioli, Mario; Turano, Paola] Univ Florence, Ctr Nucl Magnet Resonance, I-50019 Florence, Italy; [Piccioli, Mario; Turano, Paola] Univ Florence, Dept Chem, I-50019 Florence, Italy; [Lukat-Rodgers, Gudrun; Rodgers, Kenton R.] N Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58108 USA	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Florence; University of Florence; North Dakota State University Fargo	Caillet-Saguy, C (corresponding author), Inst Pasteur, CNRS, URA 2185, Unite RMN Biomol, 28 Rue Docteur Roux, F-75015 Paris, France.	ccaillet@pasteur.fr	Piccioli, Mario/M-1994-2015; Turano, Paola/F-9089-2011; Caillet-Saguy, Célia/AAC-1249-2022	Piccioli, Mario/0000-0001-9882-9754; Turano, Paola/0000-0002-7683-8614; Izadi-Pruneyre, Nadia/0000-0002-6864-2961	National Institutes of Health [GM094039, AI072719]; Pasteur Institute; Bio-NMR Project [261686]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI072719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM094039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pasteur Institute; Bio-NMR Project; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM094039 (to G. S. L. R.) and AI072719 (to K. R. R.).; Recipient of a Bourse Roux postdoctoral fellowship from Pasteur Institute.; We thank B. Guigliarelli for EPR data. Bio-NMR Project (Contract 261686) is acknowledged for providing access to NMR and NMRD instrumentations available at Center of Nuclear Magnetic Resonance.	Aime S, 1996, BIOPHYS J, V70, P482, DOI 10.1016/S0006-3495(96)79593-0; Arnoux P, 1999, NAT STRUCT BIOL, V6, P516; Arnoux P, 2000, PROTEINS, V41, P202, DOI 10.1002/1097-0134(20001101)41:2<202::AID-PROT50>3.0.CO;2-8; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Bertini I, 1999, J BIOL INORG CHEM, V4, P515, DOI 10.1007/s007750050337; Bertini I, 2003, CHEM-EUR J, V9, P2316, DOI 10.1002/chem.200204562; Bertini I., 2001, SOLUTION NMR PARAMAG; Bertini I, 2007, BIOL INORGANIC CHEM, P31; Bondon A, 1998, J MAGN RESON, V134, P154, DOI 10.1006/jmre.1998.1523; BRUSCHI M, 1992, BIOCHEMISTRY-US, V31, P3281, DOI 10.1021/bi00127a033; Caillet-Saguy C, 2006, J AM CHEM SOC, V128, P150, DOI 10.1021/ja054902h; Caillet-Saguy C, 2008, J BIOL CHEM, V283, P5960, DOI 10.1074/jbc.M703795200; Caillet-Saguy C, 2009, J AM CHEM SOC, V131, P1736, DOI 10.1021/ja804783x; CHAKRABARTI P, 1990, PROTEIN ENG, V4, P57, DOI 10.1093/protein/4.1.57; Dawson R., 1986, DATA BIOCH RES, P233; Deniau C, 2003, BIOCHEMISTRY-US, V42, P10627, DOI 10.1021/bi030015k; Deniau C, 2001, J BIOMOL NMR, V21, P189, DOI 10.1023/A:1012438610532; Eakanunkul S, 2005, BIOCHEMISTRY-US, V44, P13179, DOI 10.1021/bi050422r; EVANS DF, 1959, J CHEM SOC, P2003, DOI 10.1039/jr9590002003; Franzen S, 2001, BIOCHEMISTRY-US, V40, P5299, DOI 10.1021/bi0023403; Ghigo JM, 1997, J BACTERIOL, V179, P3572, DOI 10.1128/jb.179.11.3572-3579.1997; Gsponer J, 2006, P NATL ACAD SCI USA, V103, P99, DOI 10.1073/pnas.0508667102; Heering HA, 2001, BIOCHEMISTRY-US, V40, P10360, DOI 10.1021/bi0106033; HILDEBRAND DP, 1995, BIOCHEMISTRY-US, V34, P1997, DOI 10.1021/bi00006a021; HU SH, 1992, FEBS LETT, V314, P293, DOI 10.1016/0014-5793(92)81492-5; Hu SZ, 1996, J AM CHEM SOC, V118, P12638, DOI 10.1021/ja962239e; Idei A, 1999, J BACTERIOL, V181, P7545, DOI 10.1128/JB.181.24.7545-7551.1999; Ikezaki A, 2002, INORG CHEM, V41, P6225, DOI 10.1021/ic020378t; Izadi N, 1997, BIOCHEMISTRY-US, V36, P7050, DOI 10.1021/bi962577s; Izadi-Pruneyre N, 1999, EUR J BIOCHEM, V261, P562, DOI 10.1046/j.1432-1327.1999.00305.x; Izadi-Pruneyre N, 2006, J BIOL CHEM, V281, P25541, DOI 10.1074/jbc.M603698200; Jin YY, 2004, BIOCHEMISTRY-US, V43, P8517, DOI 10.1021/bi036170g; Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106; LETOFFE S, 1994, P NATL ACAD SCI USA, V91, P9876, DOI 10.1073/pnas.91.21.9876; Letoffe S, 1998, MOL MICROBIOL, V28, P1223, DOI 10.1046/j.1365-2958.1998.00885.x; Letoffe S, 2001, MOL MICROBIOL, V41, P439, DOI 10.1046/j.1365-2958.2001.02530.x; Lukat-Rodgers GS, 2008, BIOCHEMISTRY-US, V47, P2087, DOI 10.1021/bi7019518; MOTIE M, 1990, BIOCHEMISTRY-US, V29, P1932, DOI 10.1021/bi00459a038; Phillips W D, 1972, Methods Enzymol, V24, P304; Rossi MS, 2001, INFECT IMMUN, V69, P6707, DOI 10.1128/IAI.69.11.6707-6717.2001; Siebel JF, 2012, CHEMBIOCHEM, V13, P879, DOI 10.1002/cbic.201100808; Smulevich G, 1996, BIOSPECTROSCOPY, V2, P365, DOI 10.1002/(SICI)1520-6343(1996)2:6<365::AID-BSPY3>3.0.CO;2-2; Stevens JM, 2006, J BIOL CHEM, V281, P6144, DOI 10.1074/jbc.M508765200; Streit BR, 2010, J AM CHEM SOC, V132, P5711, DOI 10.1021/ja9082182; SUN J, 1994, BIOCHEMISTRY-US, V33, P13734, DOI 10.1021/bi00250a026; Wolff N, 2002, PROTEIN SCI, V11, P757, DOI 10.1110/ps.3630102; Wolff N, 2008, J MOL BIOL, V376, P517, DOI 10.1016/j.jmb.2007.11.072; Zeng YH, 2005, J AM CHEM SOC, V127, P9794, DOI 10.1021/ja0425987	48	31	32	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26932	26943		10.1074/jbc.M112.366385	http://dx.doi.org/10.1074/jbc.M112.366385			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700962	Green Published, hybrid			2022-12-25	WOS:000307386000041
J	Bos, MHA; Camire, RM				Bos, Mettine H. A.; Camire, Rodney M.			A Bipartite Autoinhibitory Region within the B-domain Suppresses Function in Factor V	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBIN-CATALYZED ACTIVATION; XA-BINDING-SITE; BOVINE FACTOR-V; VENOM FACTOR-V; BLOOD-COAGULATION; FACTOR-VIII; EXOSITE-I; ELECTRON-MICROSCOPY; COFACTOR FUNCTION; HEAVY-CHAIN	Activation of blood coagulation factor V (FV) is a key reaction of hemostasis. FV circulates in plasma as an inactive procofactor, and proteolytic removal of a large central B-domain converts it to an active cofactor (FVa) for factor Xa (FXa). Here we show that two short evolutionary conserved segments of the B-domain, together termed the procofactor regulatory region, serve an essential autoinhibitory function. This newly identified motif consists of a basic (963-1008) and an acidic (1493-1537) region and defines the minimal sequence requirements to maintain FV as a procofactor. Our data suggest that dismantling this autoinhibitory region via deletion or proteolysis is the driving force to unveil a high affinity binding site(s) for FXa. These findings document an unexpected sequence-specific role for the B-domain by negatively regulating FV function and preventing activity of the procofactor. These new mechanistic insights point to new ways in which the FV procofactor to cofactor transition could be modulated to alter hemostasis.	[Camire, Rodney M.] Childrens Hosp Philadelphia, Colket Translat Res Ctr 5018, Div Hematol, Philadelphia, PA 19104 USA; [Camire, Rodney M.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Camire, RM (corresponding author), Childrens Hosp Philadelphia, Colket Translat Res Ctr 5018, Div Hematol, 3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	rcamire@mail.med.upenn.edu	Bos, Mettine/S-5317-2016	Bos, Mettine/0000-0002-8164-817X	National Institutes of Health [R01 HL88010, P01 HL74124]; National Hemophilia Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088010, P01HL074124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Hemophilia Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL88010 and P01 HL74124, Project 2 (to R. M. C.). This work was also supported by the National Hemophilia Foundation (Judith Graham Pool Postdoctoral Research Fellowship; to M. H. A. B.).	Adams TE, 2004, P NATL ACAD SCI USA, V101, P8918, DOI 10.1073/pnas.0403072101; Corral-Rodriguez MA, 2011, BLOOD, V117, P7164, DOI 10.1182/blood-2010-10-315309; Baugh RJ, 1996, J BIOL CHEM, V271, P16126, DOI 10.1074/jbc.271.27.16126; Betz A, 1998, J BIOL CHEM, V273, P10709, DOI 10.1074/jbc.273.17.10709; Bevington PR., 2002, DATA REDUCTION ERROR; Bos MHA, 2010, TOXINS, V2, P1554, DOI 10.3390/toxins2061554; Bos MHA, 2009, BLOOD, V114, P686, DOI 10.1182/blood-2009-02-202663; Bradford HN, 2010, J BIOL CHEM, V285, P328, DOI 10.1074/jbc.M109.070334; Buddai SK, 2010, J BIOL CHEM, V285, P5212, DOI 10.1074/jbc.M109.049833; Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200; Camire RM, 2009, J THROMB HAEMOST, V7, P1951, DOI 10.1111/j.1538-7836.2009.03622.x; Camire RM, 2002, J BIOL CHEM, V277, P37863, DOI 10.1074/jbc.M203692200; Camire RM, 1998, BIOCHEMISTRY-US, V37, P11896, DOI 10.1021/bi980520v; CRIPE LD, 1992, BIOCHEMISTRY-US, V31, P3777, DOI 10.1021/bi00130a007; Davidson CJ, 2003, J THROMB HAEMOST, V1, P1487, DOI 10.1046/j.1538-7836.2003.00334.x; Dharmawardana KR, 1999, J BIOL CHEM, V274, P18635, DOI 10.1074/jbc.274.26.18635; Dharmawardana KR, 1998, BIOCHEMISTRY-US, V37, P13143, DOI 10.1021/bi9812165; Duckers C, 2009, BRIT J HAEMATOL, V146, P17, DOI 10.1111/j.1365-2141.2009.07708.x; ESMON CT, 1979, J BIOL CHEM, V254, P964; Esmon CT, 1996, J BIOL CHEM, V271, P13882, DOI 10.1074/jbc.271.23.13882; Fay PJ, 2006, INT J HEMATOL, V83, P103, DOI 10.1532/IJH97.05113; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; FOWLER WE, 1990, P NATL ACAD SCI USA, V87, P7648, DOI 10.1073/pnas.87.19.7648; Gale AJ, 2007, J BIOL CHEM, V282, P21848, DOI 10.1074/jbc.M702192200; Heeb MJ, 1996, PROTEIN SCI, V5, P1883, DOI 10.1002/pro.5560050914; HIGGINS DL, 1983, J BIOL CHEM, V258, P6503; HILLEUBANKS DC, 1989, P NATL ACAD SCI USA, V86, P6508, DOI 10.1073/pnas.86.17.6508; JENNY RJ, 1987, P NATL ACAD SCI USA, V84, P4846, DOI 10.1073/pnas.84.14.4846; Jiang Y, 2003, P NATL ACAD SCI USA, V100, P7527, DOI 10.1073/pnas.0932632100; Kalafatis M, 2003, J BIOL CHEM, V278, P33550, DOI 10.1074/jbc.M303153200; KANE WH, 1986, P NATL ACAD SCI USA, V83, P6800, DOI 10.1073/pnas.83.18.6800; KANE WH, 1990, BIOCHEMISTRY-US, V29, P6762, DOI 10.1021/bi00481a003; KANE WH, 1981, J BIOL CHEM, V256, P1002; KATZMANN JA, 1981, P NATL ACAD SCI-BIOL, V78, P162, DOI 10.1073/pnas.78.1.162; KELLER FG, 1995, BIOCHEMISTRY-US, V34, P4118, DOI 10.1021/bi00012a030; Khan AR, 1998, PROTEIN SCI, V7, P815; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; LAMPE PD, 1984, J BIOL CHEM, V259, P9959; LAUE TM, 1984, BIOCHEMISTRY-US, V23, P1339, DOI 10.1021/bi00302a001; Mann K G, 1976, Methods Enzymol, V45, P123; Mann KG, 2003, BLOOD, V101, P20, DOI 10.1182/blood-2002-01-0290; MANN KG, 1990, BLOOD, V76, P1; MOSESSON MW, 1985, BLOOD, V65, P1158; MOSESSON MW, 1990, J BIOL CHEM, V265, P8863; NESHEIM ME, 1979, J BIOL CHEM, V254, P508; NESHEIM ME, 1979, J BIOL CHEM, V254, P1326; NESHEIM ME, 1984, J BIOL CHEM, V259, P3187; Pierre LS, 2005, MOL BIOL EVOL, V22, P1853, DOI 10.1093/molbev/msi181; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; RAND MD, 1995, BLOOD, V86, P2616; Rao VS, 2003, BLOOD, V102, P1347, DOI 10.1182/blood-2002-12-3839; Segers K, 2007, J BIOL CHEM, V282, P33915, DOI 10.1074/jbc.M701123200; Segers K, 2006, PROTEINS, V64, P968, DOI 10.1002/prot.21051; Siigur J, 2001, HAEMOSTASIS, V31, P123; Steen M, 2002, J BIOL CHEM, V277, P50022, DOI 10.1074/jbc.M205609200; Steen M, 2002, J BIOL CHEM, V277, P38424, DOI 10.1074/jbc.M204972200; Steen M, 2008, J BIOL CHEM, V283, P20805, DOI 10.1074/jbc.M802703200; STRAUME M, 1992, METHOD ENZYMOL, V210, P87; SUZUKI K, 1982, J BIOL CHEM, V257, P6556; Thorelli E, 1997, EUR J BIOCHEM, V247, P12, DOI 10.1111/j.1432-1033.1997.00012.x; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; Vos H. L., 2009, J THROMB HAEMOST, V7, P368; Welton RE, 2005, TOXICON, V46, P328, DOI 10.1016/j.toxicon.2005.05.001; Zhang B, 2009, BRIT J HAEMATOL, V145, P15, DOI 10.1111/j.1365-2141.2008.07559.x; Zhu H, 2007, J BIOL CHEM, V282, P15033, DOI 10.1074/jbc.M701315200	65	45	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26342	26351		10.1074/jbc.M112.377168	http://dx.doi.org/10.1074/jbc.M112.377168			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22707727	Green Published, hybrid			2022-12-25	WOS:000306916300060
J	Kang, Y; Deng, R; Wang, C; Deng, T; Peng, PC; Cheng, XX; Wang, GQ; Qian, MP; Gao, HF; Han, B; Chen, YS; Hu, YH; Geng, R; Hu, CP; Zhang, W; Yang, JP; Wan, HY; Yu, Q; Wei, LP; Li, JS; Tian, GZ; Wang, QY; Hu, K; Wang, SQ; Wang, RQ; Du, J; He, B; Ma, JJ; Zhong, XN; Mu, L; Cai, SX; Zhu, XD; Xing, WL; Yu, J; Deng, MH; Gao, ZC				Kang, Yu; Deng, Rui; Wang, Can; Deng, Tao; Peng, Peichao; Cheng, Xiaoxing; Wang, Guoqing; Qian, Minping; Gao, Huafang; Han, Bei; Chen, Yusheng; Hu, Yinghui; Geng, Rong; Hu, Chengping; Zhang, Wei; Yang, Jingping; Wan, Huanying; Yu, Qin; Wei, Liping; Li, Jiashu; Tian, Guizhen; Wang, Qiuyue; Hu, Ke; Wang, Siqin; Wang, Ruiqin; Du, Juan; He, Bei; Ma, Jianjun; Zhong, Xiaoning; Mu, Lan; Cai, Shaoxi; Zhu, Xiangdong; Xing, Wanli; Yu, Jun; Deng, Minghua; Gao, Zhancheng			Etiologic Diagnosis of Lower Respiratory Tract Bacterial Infections Using Sputum Samples and Quantitative Loop-Mediated Isothermal Amplification	PLOS ONE			English	Article							PNEUMONIA; LAMP; PCR; COLONIZATION; VIRUS; TESTS; ASSAY; DNA	Etiologic diagnoses of lower respiratory tract infections (LRTI) have been relying primarily on bacterial cultures that often fail to return useful results in time. Although DNA-based assays are more sensitive than bacterial cultures in detecting pathogens, the molecular results are often inconsistent and challenged by doubts on false positives, such as those due to system- and environment-derived contaminations. Here we report a nationwide cohort study on 2986 suspected LRTI patients across P. R. China. We compared the performance of a DNA-based assay qLAMP (quantitative Loop-mediated isothermal AMPlification) with that of standard bacterial cultures in detecting a panel of eight common respiratory bacterial pathogens from sputum samples. Our qLAMP assay detects the panel of pathogens in 1047(69.28%) patients from 1533 qualified patients at the end. We found that the bacterial titer quantified based on qLAMP is a predictor of probability that the bacterium in the sample can be detected in culture assay. The relatedness of the two assays fits a logistic regression curve. We used a piecewise linear function to define breakpoints where latent pathogen abruptly change its competitive relationship with others in the panel. These breakpoints, where pathogens start to propagate abnormally, are used as cutoffs to eliminate the influence of contaminations from normal flora. With help of the cutoffs derived from statistical analysis, we are able to identify causative pathogens in 750 (48.92%) patients from qualified patients. In conclusion, qLAMP is a reliable method in quantifying bacterial titer. Despite the fact that there are always latent bacteria contaminated in sputum samples, we can identify causative pathogens based on cutoffs derived from statistical analysis of competitive relationship.	[Peng, Peichao; Cheng, Xiaoxing; Qian, Minping; Deng, Minghua] Peking Univ, Sch Math Sci, Beijing 100871, Peoples R China; [Peng, Peichao; Cheng, Xiaoxing; Qian, Minping; Deng, Minghua] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China; [Kang, Yu; Deng, Rui; Gao, Zhancheng] Peking Univ, Peoples Hosp, Dept Resp & Crit Care Med, Beijing 100871, Peoples R China; [Kang, Yu; Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Wang, Can; Deng, Tao] Tsinghua Univ, Sch Med, Dept Biomed Engn, Beijing 100084, Peoples R China; [Wang, Guoqing; Gao, Huafang; Han, Bei; Xing, Wanli] Capitalbio Corp, Dept Assay Dev, Beijing, Peoples R China; [Chen, Yusheng] Fujian Prov Hosp, Dept Resp Med, Fuzhou, Peoples R China; [Hu, Yinghui] Capital Med Univ, Beijing Childrens Hosp, Dept Resp Med, Beijing, Peoples R China; [Geng, Rong] Capital Med Univ, Beijing Childrens Hosp, Dept Emergency Med, Beijing, Peoples R China; [Hu, Chengping] Cent S Univ, Xiangya Hosp, Dept Resp Med, Changsha, Hunan, Peoples R China; [Zhang, Wei] Nanchang Univ, Affiliated Hosp 1, Dept Resp Med, Nanchang, Peoples R China; [Yang, Jingping] Inner Mongolia Med Coll, Affiliated Hosp 3, Dept Resp & Crit Care Med, Baotou, Peoples R China; [Wan, Huanying] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Resp Med, Shanghai 200030, Peoples R China; [Yu, Qin] Lanzhou Univ, Hosp 1, Dept Resp Med, Lanzhou 730000, Peoples R China; [Wei, Liping] Guangzhou Med Univ, Affiliated Hosp 3, Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Li, Jiashu] Xuzhou Med Coll, Lianyungang Peoples Hosp 1, Dept Resp Med, Lianyungang, Peoples R China; [Tian, Guizhen] Mil Gen Hosp Beijing, Clin Sect 263, Dept Resp Med, Beijing, Peoples R China; [Wang, Qiuyue] China Med Univ, Affiliated Hosp 1, Inst Resp Dis, Shenyang, Peoples R China; [Hu, Ke] Wuhan Univ, Renmin Hosp, Dept Resp Med, Wuhan 430072, Peoples R China; [Wang, Siqin] Henan Prov People Hosp, Dept Resp Med, Zhengzhou, Peoples R China; [Wang, Ruiqin] Tsinghua Univ, Affiliated Hosp 1, Dept Resp Med, Beijing 100084, Peoples R China; [Du, Juan] GuiYang Med Coll, Affiliated Hosp, Dept Resp Med, Guiyang, Peoples R China; [He, Bei] Peking Univ, Hosp 3, Dept Resp Med, Beijing 100871, Peoples R China; [Ma, Jianjun] Lanzhou Pulm Hosp, Dept Resp Med, Lanzhou, Peoples R China; [Zhong, Xiaoning] Guangxi Med Univ, Affiliated Hosp 1, Dept Resp Med, Nanning, Peoples R China; [Mu, Lan] Peking Univ, Space Cent Hosp, Dept Resp Med, Beijing 100871, Peoples R China; [Cai, Shaoxi] So Med Univ, Nanfang Hosp, Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Zhu, Xiangdong] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med MC 6076, Chicago, IL 60637 USA	Peking University; Peking University; Peking University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Tsinghua University; Fujian Provincial Hospital; Capital Medical University; Capital Medical University; Central South University; Nanchang University; Inner Mongolia Medical University; Shanghai Jiao Tong University; Lanzhou University; Guangzhou Medical University; Xuzhou Medical University; China Medical University; Wuhan University; Tsinghua University; Guizhou Medical University; Peking University; Guangxi Medical University; Peking University; Southern Medical University - China; University of Chicago	Deng, MH (corresponding author), Peking Univ, Sch Math Sci, Beijing 100871, Peoples R China.	dengmh@pku.edu.cn; zcgao@bjmu.edu.cn	黎, 伟/GXM-4040-2022; wei, li/GSD-3630-2022; Deng, Minghua/B-5430-2012; Deng, Minghua/B-1316-2012; Wang, Can/J-4222-2013	Deng, Minghua/0000-0002-9143-1898; yang, jingping/0000-0002-5598-1016; zhu, xiangdong/0000-0002-5627-8082; Wang, Can/0000-0001-6115-0377	Chinese Ministry of Science and Technology; Chinese government	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese government	This study is completely funded by the Chinese Ministry of Science and Technology, and no external funding was received for this study, including Capitalbio Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; In the manuscript, three authors are staffs of Beijing Capitalbio Corporation, which is also named as "National Engineering Research Center for Beijing Biochip Technology'', fully owned by the Chinese government. As a basic research, this study is completely funded by the Chinese government. National Engineering Research Center for Beijing Biochip Technology (Capitalbio Corporation) was one of the 23 cooperating institutes for this project. Based on this study, Capitalbio Corporation may develop products in the future. But currently there is no relevant patent or any product under development and in the market. This does not alter the authors'adherence to all the PLoS ONE policies on sharing data and materials.	Alonzo TA, 1999, STAT MED, V18, P2987, DOI 10.1002/(SICI)1097-0258(19991130)18:22<2987::AID-SIM205>3.3.CO;2-2; Anevlavis S, 2010, EXPERT OPIN PHARMACO, V11, P361, DOI 10.1517/14656560903508770; Aoi Y, 2006, J BIOTECHNOL, V125, P484, DOI 10.1016/j.jbiotec.2006.04.007; Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmico1523, 10.1038/nrmicro1523]; Bouchara JP, 2009, J CLIN MICROBIOL, V47, P142, DOI 10.1128/JCM.01668-08; Cai ZJ, 2011, J CLIN VIROL, V52, P288, DOI 10.1016/j.jcv.2011.08.013; Charlson ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015216; Chinese Ministry of Health, 2010, CHIN HLTH STAT DIG 2; Chuang JS, 2009, SCIENCE, V323, P272, DOI 10.1126/science.1166739; Ding CM, 2004, J BIOCHEM MOL BIOL, V37, P1; Fang XE, 2010, ANAL CHEM, V82, P3002, DOI 10.1021/ac1000652; Geojith G, 2011, J MICROBIOL METH, V84, P71, DOI 10.1016/j.mimet.2010.10.015; Ieven M, 2007, J CLIN VIROL, V40, P259, DOI 10.1016/j.jcv.2007.08.012; Jensen L, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-140; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Liu You-ning, 2006, Zhonghua Jiehe He Huxi Zazhi, V29, P3; MacLean R, 2008, HEREDITY, V100, P471, DOI 10.1038/sj.hdy.6801073x; Monte SV, 2008, AM J MANAG CARE, V14, P190; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Parida MM, 2007, J CLIN MICROBIOL, V45, P351, DOI 10.1128/JCM.01734-06; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Poon LLM, 2006, CLIN CHEM, V52, P303; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sibley CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022702; Smith J, 2010, SCIENCE, V328, P1700, DOI 10.1126/science.1189675; SUNG RYT, 1993, CLIN INFECT DIS, V17, P894, DOI 10.1093/clinids/17.5.894; Wang Ying-Jian, 2010, Zhongguo Dang Dai Er Ke Za Zhi, V12, P184; Weinreich UM, 2008, CLIN RESPIR J, V2, P116, DOI 10.1111/j.1752-699X.2008.00048.x; Yang S, 2005, J CLIN MICROBIOL, V43, P3221, DOI 10.1128/JCM.43.7.3221-3226.2005; Zaki MES, 2009, AM J CLIN PATHOL, V131, P74, DOI 10.1309/AJCP34YZGEHERWRX	32	21	28	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38743	10.1371/journal.pone.0038743	http://dx.doi.org/10.1371/journal.pone.0038743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719933	Green Published, gold, Green Submitted			2022-12-25	WOS:000305347800015
J	Azzopardi, D; Strohm, B; Linsell, L; Hobson, A; Juszczak, E; Kurinczuk, JJ; Brocklehurst, P; Edwards, AD				Azzopardi, Denis; Strohm, Brenda; Linsell, Louise; Hobson, Anna; Juszczak, Edmund; Kurinczuk, Jennifer J.; Brocklehurst, Peter; Edwards, A. David		UK TOBY Cooling Register	Implementation and Conduct of Therapeutic Hypothermia for Perinatal Asphyxial Encephalopathy in the UK - Analysis of National Data	PLOS ONE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; AMPLITUDE-INTEGRATED ELECTROENCEPHALOGRAM; WHOLE-BODY HYPOTHERMIA; NEONATAL ENCEPHALOPATHY; SYSTEMIC HYPOTHERMIA; MODERATE HYPOTHERMIA; CEREBRAL-PALSY; PROGNOSTIC VALUE; NEWBORN-INFANTS; TRIAL	Background: Delay in implementing new treatments into clinical practice results in considerable health and economic opportunity costs. Data from the UK TOBY Cooling Register provides the opportunity to examine how one new effective therapy for newborn infants suspected of suffering asphyxial encephalopathy - therapeutic hypothermia-was implemented in the UK. Methodology/Principal Findings: We analysed returned data forms from inception of the Register in December 2006 to the end of July 2011. Data forms were received for 1384 (67%) of the 2069 infants registered. The monthly rate of notifications increased from median {IQR} 18 {15-31} to 33 {30-39} after the announcement of the results of the recent TOBY trial, and to 50 {36-55} after their publication. This rate further increased to 70 {64-83} following official endorsement of the therapy, and is now close to the expected numbers of eligible infants. Cooling was started at 3.3 {1.5-5.5} hours after birth and the time taken to achieve the target 33-34 degrees C rectal temperature was 1 {0-3} hours. The rectal temperature was in the target range in 83% of measurements. From 2006 to 2011 there was evidence of extension of treatment to slightly less severely affected infants. 278 of 1362 (20%) infants died at 2.9 {1.4-4.1} days of age. The rates of death fell slightly over the period of the Register and, at two years of age cerebral palsy was diagnosed in 22% of infants; half of these were spastic bilateral. Factors independently associated with adverse outcome were clinical seizures prior to cooling (p<0.001) and severely abnormal amplitude integrated EEG (p<0.001). Conclusions/Significance: Therapeutic hypothermia was implemented appropriately within the UK, with significant benefit to patients and the health economy. This may be due in part to participation by neonatal units in clinical trials, the establishment of the national Register, and its endorsement by advisory bodies.	[Azzopardi, Denis; Edwards, A. David] Univ London Imperial Coll Sci Technol & Med, Ctr Developing Brain, London, England; [Strohm, Brenda; Linsell, Louise; Hobson, Anna; Juszczak, Edmund; Kurinczuk, Jennifer J.] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England; [Brocklehurst, Peter] UCL, Inst Womens Hlth, London, England	Imperial College London; University of Oxford; University of London; University College London	Azzopardi, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Developing Brain, London, England.	d.azzopardi@imperial.ac.uk	Edwards, Anthony/HCI-9626-2022	Edwards, Anthony David/0000-0003-4801-7066	Medical Research Council [G0200270, MC_U120081323, G0100126] Funding Source: Medline; MRC [MC_U120081323, G0200270, G0100126] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AZZOPARDI D, 1989, PEDIATR RES, V25, P445, DOI 10.1203/00006450-198905000-00004; Azzopardi D, 2009, ARCH DIS CHILD-FETAL, V94, pF260, DOI 10.1136/adc.2008.146977; Azzopardi D, 2000, PEDIATRICS, V106, P684, DOI 10.1542/peds.106.4.684; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Blackmon LR, 2006, PEDIATRICS, V117, P942, DOI 10.1542/peds.2005-2950; British Association of Perinatal Medicine, 2010, POS STAT THER COD NE; Cooksey D., 2006, REV UK HLTH RES FUND; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Djulbegovic B, 2011, JAMA-J AM MED ASSOC, V305, P2005, DOI 10.1001/jama.2011.650; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Eliasson AC, 2006, DEV MED CHILD NEUROL, V48, P549, DOI 10.1017/S0012162206001162; Evans K, 2001, J Obstet Gynaecol, V21, P114, DOI 10.1080/01443610020025967; GLASZIOU PP, 1995, BMJ-BRIT MED J, V311, P1356, DOI 10.1136/bmj.311.7016.1356; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Grosse SD, 2009, MED CARE, V47, pS94, DOI 10.1097/MLR.0b013e31819c9571; Gunn AJ, 2005, J PERINAT MED, V33, P340, DOI 10.1515/JPM.2005.061; Gunn AJ, 1997, J CLIN INVEST, V99, P248, DOI 10.1172/JCI119153; Gunn AJ, 1998, PEDIATRICS, V102, P885, DOI 10.1542/peds.102.4.885; Gunn AJ, 2008, J PEDIATR-US, V152, P55, DOI 10.1016/j.jpeds.2007.06.003; Hallberg B, 2010, ACTA PAEDIATR, V99, P531, DOI 10.1111/j.1651-2227.2009.01653.x; Iwata O, 2007, BRAIN RES, V1154, P173, DOI 10.1016/j.brainres.2007.03.083; Jacobs SE, 2011, ARCH PEDIAT ADOLESC; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Kruse M, 2009, DEV MED CHILD NEUROL, V51, P622, DOI 10.1111/j.1469-8749.2008.03190.x; Li Tongchuan, 2009, Hosp Pract (1995), V37, P147, DOI 10.3810/hp.2009.12.269; National Institute for Health and Clinical Excellence, 2010, THER HYP INTR TEMP M; Office for national statistics UK, 2011, UK 13 7 2011 BIRTHS; Palisano RJ, 2000, PHYS THER, V80, P974, DOI 10.1093/ptj/80.10.974; Regier DA, 2010, VALUE HEALTH, V13, P695, DOI 10.1111/j.1524-4733.2010.00731.x; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shankaran S, 2011, PEDIATRICS, V128, pE112, DOI 10.1542/peds.2010-2036; Simbruner G, 2010, PEDIATRICS, V126, pE771, DOI 10.1542/peds.2009-2441; Smith J, 2000, BRIT J OBSTET GYNAEC, V107, P461, DOI 10.1111/j.1471-0528.2000.tb13262.x; Strohm B, 2011, PEDIATRICS, V128, pE450, DOI 10.1542/peds.2010-3508; Thompson CM, 1997, ACTA PAEDIATR, V86, P757, DOI 10.1111/j.1651-2227.1997.tb08581.x; THORESEN M, 1995, PEDIATR RES, V37, P667, DOI 10.1203/00006450-199505000-00019; Thoresen M, 2010, PEDIATRICS, V126, pE131, DOI 10.1542/peds.2009-2938; Zhou WH, 2010, J PEDIATR-US, V157, P367, DOI 10.1016/j.jpeds.2010.03.030	38	93	98	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38504	10.1371/journal.pone.0038504	http://dx.doi.org/10.1371/journal.pone.0038504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719897	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341900033
J	Nasman, A; Romanitan, M; Nordfors, C; Grun, N; Johansson, H; Hammarstedt, L; Marklund, L; Munck-Wikland, E; Dalianis, T; Ramqvist, T				Nasman, Anders; Romanitan, Mircea; Nordfors, Cecilia; Grun, Nathalie; Johansson, Hemming; Hammarstedt, Lalle; Marklund, Linda; Munck-Wikland, Eva; Dalianis, Tina; Ramqvist, Torbjorn			Tumor Infiltrating CD8(+) and Foxp3(+) Lymphocytes Correlate to Clinical Outcome and Human Papillomavirus (HPV) Status in Tonsillar Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; REGULATORY T-CELLS; NECK-CANCER; CERVICAL-CANCER; TONGUE CANCER; HEAD; SURVIVAL; RISK; RELAPSE; EXPRESSION	Background: Human papillomavirus (HPV) is a causative factor for tonsillar squamous cell carcinoma (TSCC) and patients with HPV positive (HPV+) TSCC have a better clinical outcome than those with HPV negative (HPV 2) TSCC. However, since not all patients with HPV+TSCC respond to treatment, additional biomarkers are needed together with HPV status to better predict response to therapy and to individualize treatment. For this purpose, we examined whether the number of tumor infiltrating cytotoxic and regulatory T-cells in TSCC correlated to HPV status and to clinical outcome. Methods: Formalin fixed paraffin embedded TSCC, previously analysed for HPV DNA, derived from 83 patients, were divided into four groups depending on the HPV status of the tumor and clinical outcome. Tumors were stained by immunohistochemistry and evaluated for the number of infiltrating cytotoxic (CD8(+)) and regulatory (Foxp3(+)) T-cells. Results: A high CD8(+) T-cell infiltration was significantly positively correlated to a good clinical outcome in both patients with HPV+ and HPV- TSCC patients. Similarly, a high CD8(+)/Foxp3(+) TIL ratio was correlated to a 3-year disease free survival. Furthermore, HPV+ TSCC had in comparison to HPV 2 TSCC, higher numbers of infiltratin(g) CD8(+) and Foxp3(+) T-cells. Conclusions: In conclusion, a positive correlation between a high number of infiltrating CD8(+) cells and clinical outcome indicates that CD8(+) cells may contribute to a beneficial clinical outcome in TSCC patients, and may potentially serve as a biomarker. Likewise, the CD8(+)/Foxp3(+) cell ratio can potentially be used for the same purpose.	[Nasman, Anders; Romanitan, Mircea; Nordfors, Cecilia; Grun, Nathalie; Johansson, Hemming; Dalianis, Tina; Ramqvist, Torbjorn] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Hammarstedt, Lalle; Marklund, Linda; Munck-Wikland, Eva] Karolinska Inst, Karolinska Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Nasman, A (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	torbjorn.ramqvist@ki.se	Marklunf, Linda/L-1913-2015	Nasman, Anders/0000-0003-4602-4297; Hammarstedt-Nordenvall, Lalle/0000-0003-1660-9737; Dalianis, Tina/0000-0001-7022-2424	Swedish Cancer Society [100258]; Swedish Medical Research Council [K2011-56X-15282-07-6]; Stockholm Cancer Society [101081]; Henning and Ida Perssons Foundation; Karolinska Institutet; Stockholm City Council [2010067]	Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Stockholm Cancer Society; Henning and Ida Perssons Foundation; Karolinska Institutet(Karolinska Institutet); Stockholm City Council	This work was supported by the Swedish Cancer Society (TD, 100258), the Swedish Medical Research Council (TD, TR, K2011-56X-15282-07-6), the Stockholm Cancer Society (TD, 101081), the Henning and Ida Perssons Foundation (TD), the Karolinska Institutet (TD, TR) and the Stockholm City Council (TD, TR, EMW, 2010067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attner P, 2011, INT J CANC; Attner P, 2011, INT J CANCER, V128, P2892, DOI 10.1002/ijc.25625; Attner P, 2010, INT J CANCER, V126, P2879, DOI 10.1002/ijc.24994; Babu JM, 2011, BBA-REV CANCER, V1816, P67, DOI 10.1016/j.bbcan.2011.04.003; Badoual C, 2006, CLIN CANCER RES, V12, P465, DOI 10.1158/1078-0432.CCR-05-1886; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Bontkes HJ, 2000, INT J CANCER, V88, P92, DOI 10.1002/1097-0215(20001001)88:1&lt;92::AID-IJC15&gt;3.0.CO;2-E; Carreras J, 2006, BLOOD, V108, P2957, DOI 10.1182/blood-2006-04-018218; Chaturvedi AK, 2011, J CLIN ONCOL; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Ferreira MBA, 2011, CURR OPIN ONCOL, V23, P259, DOI 10.1097/CCO.0b013e328344f53a; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Hammarstedt L, 2006, INT J CANCER, V119, P2620, DOI 10.1002/ijc.22177; Heusinkveld M, 2011, INT J CANC; HILDERS CGJM, 1994, INT J CANCER, V57, P805, DOI 10.1002/ijc.2910570608; Ichihara F, 2003, CLIN CANCER RES, V9, P4404; Lallemant B, 2010, HEAD NECK-J SCI SPEC, V32, P1712, DOI 10.1002/hed.21491; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lindquist D, 2007, MOL ONCOL, V1, P350, DOI 10.1016/j.molonc.2007.08.005; Mellin H, 2000, INT J CANCER, V89, P300, DOI 10.1002/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G; Mougiakakos D, 2010, ADV CANCER RES, V107, P57, DOI 10.1016/S0065-230X(10)07003-X; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; Nedergaard BS, 2007, BRIT J CANCER, V97, P1135, DOI 10.1038/sj.bjc.6604001; Ogino T, 2006, CANCER RES, V66, P9281, DOI 10.1158/0008-5472.CAN-06-0488; Piersma SJ, 2007, CANCER RES, V67, P354, DOI 10.1158/0008-5472.CAN-06-3388; Ramqvist T, 2010, EMERG INFECT DIS, V16, P1671, DOI 10.3201/eid1611.100452; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shah W, 2011, CELL MOL IMMUNOL, V8, P59, DOI 10.1038/cmi.2010.56; Smeets SJ, 2007, INT J CANCER, V121, P2465, DOI 10.1002/ijc.22980; Spanos WC, 2009, ARCH OTOLARYNGOL, V135, P1137, DOI 10.1001/archoto.2009.159; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Talmadge JE, 2007, CANCER METAST REV, V26, P373, DOI 10.1007/s10555-007-9072-0; Welters MJP, 2006, INT J CANCER, V118, P950, DOI 10.1002/ijc.21459; Zackrisson B, 2011, RADIOTHER ONCOL, V100, P41, DOI 10.1016/j.radonc.2010.12.010	35	137	143	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38711	10.1371/journal.pone.0038711	http://dx.doi.org/10.1371/journal.pone.0038711			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701698	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340000040
J	Tulp, I; Schekkerman, H; de Leeuw, J				Tulp, Ingrid; Schekkerman, Hans; de Leeuw, Joep			Eggs in the Freezer: Energetic Consequences of Nest Site and Nest Design in Arctic Breeding Shorebirds	PLOS ONE			English	Article							MATING SYSTEM; HEAT-LOSS; INCUBATION; PREDATION; EXPENDITURE; INSULATION; SANDPIPERS; SELECTION; CLUTCH; TUNDRA	Birds construct nests for several reasons. For species that breed in the Arctic, the insulative properties of nests are very important. Incubation is costly there and due to an increasing surface to volume ratio, more so in smaller species. Small species are therefore more likely to place their nests in thermally favourable microhabitats and/or to invest more in nest insulation than large species. To test this hypothesis, we examined characteristics of nests of six Arctic breeding shorebird species. All species chose thermally favourable nesting sites in a higher proportion than expected on the basis of habitat availability. Site choice did not differ between species. Depth to frozen ground, measured near the nests, decreased in the course of the season at similar non-species-specific speeds, but this depth increased with species size. Nest cup depth and nest scrape depth (nest cup without the lining) were unrelated to body mass (we applied an exponent of 0.73, to account for metabolic activity of the differently sized species). Cup depth divided by diameter 2 was used as a measure of nest cup shape. Small species had narrow and deep nests, while large species had wide shallow nests. The thickness of nest lining varied between 0.1 cm and 7.6 cm, and decreased significantly with body mass. We reconstruct the combined effect of different nest properties on the egg cooling coefficient using previously published quantitative relationships. The predicted effect of nest cup depth and lining depth on heat loss to the frozen ground did not correlate with body mass, but the sheltering effect of nest cup diameter against wind and the effects of lining material on the cooling coefficient increased with body mass. Our results suggest that small arctic shorebirds invest more in the insulation of their nests than large species.	[Tulp, Ingrid] Inst Marine Resources & Ecosyst Studies, Ijmuiden, Netherlands; [Schekkerman, Hans] Sovon Dutch Ctr Field Ornithol, Nijmegen, Netherlands; [de Leeuw, Joep] Swedish Univ Agr Sci, Inst Freshwater Res, Drottningholm, Sweden	Wageningen University & Research; Swedish University of Agricultural Sciences	Tulp, I (corresponding author), Inst Marine Resources & Ecosyst Studies, Ijmuiden, Netherlands.	ingrid.tulp@wur.nl		Schekkerman, Hans/0000-0003-3127-4832				Ar A, 2002, OX ORN SER, V13, P143; Aschoff J, 1970, J. Orn., Berl., V111, P38, DOI 10.1007/BF01668180; BIEBACH H, 1986, PHYSIOL ZOOL, V59, P69, DOI 10.1086/physzool.59.1.30156092; BUTTEMER WA, 1987, AUK, V104, P531, DOI 10.2307/4087558; BYRKJEDAL I, 1980, ORNIS SCAND, V11, P249, DOI 10.2307/3676131; CHERNOV YUI, 1985, LIVING TUNDRA; Cramp S., 1983, BIRDS W PALEARCTIC, VIII; Cresswell W, 2003, BEHAV ECOL, V14, P97, DOI 10.1093/beheco/14.1.97; Cresswell W, 2004, BEHAV ECOL, V15, P498, DOI 10.1093/beheco/arh042; De Heij ME., 2006, THESIS U GRONINGEN G; Drent R., 1975, AVIAN BIOL, P333; Grubbauer P, 1996, ECOSCIENCE, V3, P274, DOI 10.1080/11956860.1996.11682342; Hansell M.H., 2000, BIRD NESTS CONSTRUCT, DOI [10.1017/CBO9781139106788, DOI 10.1017/CBO9781139106788]; Hansell MH, 2002, OX ORN SER, V13, P8; Heenan CB, 2011, P ROY SOC B-BIOL SCI, V278, P2924, DOI 10.1098/rspb.2010.2798; Hilden O., 1978, Anser Supplement, P96; Hilton GM, 2004, AUK, V121, P777, DOI 10.1642/0004-8038(2004)121[0777:UANTTI]2.0.CO;2; Lamprecht I, 2004, THERMOCHIM ACTA, V415, P141, DOI 10.1016/j.tca.2003.08.029; Liebezeit JR, 2007, CONDOR, V109, P32, DOI 10.1650/0010-5422(2007)109[32:ATDOSE]2.0.CO;2; Lombardo MP, 1995, AUK, V112, P973, DOI 10.2307/4089028; McCracken KG, 1997, AUK, V114, P610, DOI 10.2307/4089280; McGowan A, 2004, FUNCT ECOL, V18, P578, DOI 10.1111/j.0269-8463.2004.00883.x; MOLLER AP, 1987, OIKOS, V50, P91, DOI 10.2307/3565404; NORTON DW, 1972, CONDOR, V74, P164, DOI 10.2307/1366280; Piersma T, 2003, FUNCT ECOL, V17, P356, DOI 10.1046/j.1365-2435.2003.00741.x; Piersma T., 1996, HDB BIRDS WORLD, P384; Pinowski J, 2006, J THERM BIOL, V31, P573, DOI 10.1016/j.jtherbio.2006.05.007; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reid JM, 2002, FUNCT ECOL, V16, P305, DOI 10.1046/j.1365-2435.2002.00632.x; Reneerkens J, 2007, THESIS U GRONINGEN G; Reneerkens J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016834; REYNOLDS JD, 1987, IBIS, V129, P225, DOI 10.1111/j.1474-919X.1987.tb03203.x; Sanchez-Lafuente AM, 1998, J FIELD ORNITHOL, V69, P563; Schekkerman H, 2004, STUDIES BREEDING SHO, P922; Szentirmai I, 2005, ACTA ZOOL ACAD SCI H, V51, P59; Szentirmai I, 2002, BEHAVIOUR, V139, P847, DOI 10.1163/156853902320262844; Tinbergen JM, 2002, OX ORN SER, V13, P299; TOIEN O, 1993, J COMP PHYSIOL B, V163, P182; Tomkovich P.S., 2006, International Wader Studies, V19, P19; Tulp I, 2006, J AVIAN BIOL, V37, P207, DOI 10.1111/j.2006.0908-8857.03519.x; Tulp I, 2007, ARCTIC PULSE TIMING; Tulp I, 2008, ARCTIC, V61, P48; Tulp I, 2009, AUK, V126, P155, DOI 10.1525/auk.2009.07181; Turner JS, 2002, OX ORN SER, V13, P119; VLECK CM, 1981, CONDOR, V83, P229, DOI 10.2307/1367313; Whitfield DP, 1996, BIOL J LINN SOC, V57, P277, DOI 10.1111/j.1095-8312.1996.tb00313.x; Whittingham MJ, 2002, J AVIAN BIOL, V33, P184, DOI 10.1034/j.1600-048X.2002.330210.x; Williams Joseph B., 1996, P375	48	19	19	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38041	10.1371/journal.pone.0038041	http://dx.doi.org/10.1371/journal.pone.0038041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701596	Green Published, Green Accepted, gold			2022-12-25	WOS:000305340000009
J	Jordan, KW; Craver, KL; Magwire, MM; Cubilla, CE; Mackay, TFC; Anholt, RRH				Jordan, Katherine W.; Craver, Kyle L.; Magwire, Michael M.; Cubilla, Carmen E.; Mackay, Trudy F. C.; Anholt, Robert R. H.			Genome-Wide Association for Sensitivity to Chronic Oxidative Stress in Drosophila melanogaster	PLOS ONE			English	Article							LIFE-SPAN; SUPEROXIDE-DISMUTASE; LOCOMOTOR BEHAVIOR; SUBSTANTIA-NIGRA; RESISTANCE; GENE; EXPRESSION; OVEREXPRESSION; MECHANISMS; EXTENSION	Reactive oxygen species (ROS) are a common byproduct of mitochondrial energy metabolism, and can also be induced by exogenous sources, including UV light, radiation, and environmental toxins. ROS generation is essential for maintaining homeostasis by triggering cellular signaling pathways and host defense mechanisms. However, an imbalance of ROS induces oxidative stress and cellular death and is associated with human disease, including age-related locomotor impairment. To identify genes affecting sensitivity and resistance to ROS-induced locomotor decline, we assessed locomotion of aged flies of the sequenced, wild-derived lines from the Drosophila melanogaster Genetics Reference Panel on standard medium and following chronic exposure to medium supplemented with 3 mM menadione sodium bisulfite (MSB). We found substantial genetic variation in sensitivity to oxidative stress with respect to locomotor phenotypes. We performed genome-wide association analyses to identify candidate genes associated with variation in sensitivity to ROS-induced decline in locomotor performance, and confirmed the effects for 13 of 16 mutations tested in these candidate genes. Candidate genes associated with variation in sensitivity to MSB-induced oxidative stress form networks of genes involved in neural development, immunity, and signal transduction. Many of these genes have human orthologs, highlighting the utility of genome-wide association in Drosophila for studying complex human disease.	[Jordan, Katherine W.; Magwire, Michael M.; Cubilla, Carmen E.; Mackay, Trudy F. C.; Anholt, Robert R. H.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Jordan, Katherine W.; Magwire, Michael M.; Mackay, Trudy F. C.; Anholt, Robert R. H.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Craver, Kyle L.; Anholt, Robert R. H.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Jordan, KW (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	anholt@ncsu.edu	Anholt, Robert/S-5977-2019		National Institutes of Health [GM 45146, ES18255]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC1ES018255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM 45146 and ES18255. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonov A.V., 2010, NUCLEIC ACIDS RES, V38, pW118; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Chaudhuri A, 2007, J NEUROSCI, V27, P2457, DOI 10.1523/JNEUROSCI.4239-06.2007; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; Davey KM, 2006, J MED GENET, V43, P385, DOI 10.1136/jmg.2005.036657; Falconer D. S, 1996, INTRO QUANTITATIVE G; FALCONER DS, 1990, GENET RES, V56, P57, DOI 10.1017/S0016672300028883; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Finkel T, 2005, NAT REV MOL CELL BIO, V6, P971, DOI 10.1038/nrm1763; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Ortega-Arellano HF, 2011, NEUROCHEM RES, V36, P1073, DOI 10.1007/s11064-011-0451-0; Ghersi E, 2004, J ALZHEIMERS DIS, V6, P67; Ginsberg SD, 2012, NEUROBIOL DIS, V45, P99, DOI 10.1016/j.nbd.2011.07.013; Girardot F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-74; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jordan KW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r172; Jordan KW, 2006, GENETICS, V174, P271, DOI 10.1534/genetics.106.058099; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Lavara-Culebras E, 2010, GENE, V462, P26, DOI 10.1016/j.gene.2010.04.009; Lee WS, 2011, ARCH BIOCHEM BIOPHYS, V514, P57, DOI 10.1016/j.abb.2011.07.014; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Loor G, 2010, FREE RADICAL BIO MED, V49, P1925, DOI 10.1016/j.freeradbiomed.2010.09.021; Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Madamanchi NR, 2005, J THROMB HAEMOST, V3, P254, DOI 10.1111/j.1538-7836.2004.01085.x; Magwere T, 2006, MECH AGEING DEV, V127, P356, DOI 10.1016/j.mad.2005.12.009; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; Nishioka K, 2010, PARKINSONISM RELAT D, V16, P686, DOI 10.1016/j.parkreldis.2010.09.007; ORR EC, 1990, NUCLEIC ACIDS RES, V18, P3663, DOI 10.1093/nar/18.12.3663; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Park J, 2005, GENE, V361, P133, DOI 10.1016/j.gene.2005.06.040; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; SETO NOL, 1987, NUCLEIC ACIDS RES, V15, P10601, DOI 10.1093/nar/15.24.10601; SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B; Sun JT, 1999, MOL CELL BIOL, V19, P216; Venkateshappa C, 2012, NEUROCHEM RES, V37, P358, DOI 10.1007/s11064-011-0619-7; Weber AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034745; Yoshida T, 2011, J NEUROSCI, V31, P13485, DOI 10.1523/JNEUROSCI.2136-11.2011; Zhao HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011701	46	59	59	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38722	10.1371/journal.pone.0038722	http://dx.doi.org/10.1371/journal.pone.0038722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715409	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336800051
J	Keats, E; Khan, ZA				Keats, Emily; Khan, Zia A.			Unique Responses of Stem Cell-Derived Vascular Endothelial and Mesenchymal Cells to High Levels of Glucose	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; NETWORKS IN-VIVO; PROGENITOR CELLS; ADIPOCYTE DIFFERENTIATION; COMPLICATIONS; NEOVASCULARIZATION; BINDING; ADULT; PROLIFERATION	Diabetes leads to complications in selected organ systems, and vascular endothelial cell (EC) dysfunction and loss is the key initiating and perpetuating step in the development of these complications. Experimental and clinical studies have shown that hyperglycemia leads to EC dysfunction in diabetes. Vascular stem cells that give rise to endothelial progenitor cells (EPCs) and mesenchymal progenitor cells (MPCs) represent an attractive target for cell therapy for diabetic patients. Whether these vascular stem/progenitor cells succumb to the adverse effects of high glucose remains unknown. We sought to determine whether adult vascular stem/progenitor cells display cellular activation and dysfunction upon exposure to high levels of glucose as seen in diabetic complications. Mononuclear cell fraction was prepared from adult blood and bone marrow. EPCs and MPCs were derived, characterized, and exposed to either normal glucose (5 mmol/L) or high glucose levels (25 mmol/L). We then assayed for cell activity and molecular changes following both acute and chronic exposure to high glucose. Our results show that high levels of glucose do not alter the derivation of either EPCs or MPCs. The adult blood-derived EPCs were also resistant to the effects of glucose in terms of growth. Acute exposure to high glucose levels increased caspase-3 activity in EPCs (1.4x increase) and mature ECs (2.3x increase). Interestingly, MPCs showed a transient reduction in growth upon glucose challenge. Our results also show that glucose skews the differentiation of MPCs towards the adipocyte lineage while suppressing other mesenchymal lineages. In summary, our studies show that EPCs are resistant to the effects of high levels of glucose, even following chronic exposure. The findings further show that hyperglycemia may have detrimental effects on the MPCs, causing reduced growth and altering the differentiation potential.	[Keats, Emily; Khan, Zia A.] Univ Western Ontario, Dept Pathol, London, ON, Canada; [Khan, Zia A.] Lawson Hlth Res Inst, Metab & Diabet Program, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Keats, E (corresponding author), Univ Western Ontario, Dept Pathol, London, ON, Canada.	zia.khan@schulich.uwo.ca	Khan, Zia A./G-8348-2011	Khan, Zia A./0000-0003-1682-5720	Canadian Diabetes Association; Lawson Health Research Institute; New Investigator Award from the Heart and Stroke Foundation of Canada	Canadian Diabetes Association; Lawson Health Research Institute; New Investigator Award from the Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	The authors would like to acknowledge support from the Canadian Diabetes Association (Z.K.) and the Lawson Health Research Institute (Z.K. and E.K.). Z.K. is a recipient of a New Investigator Award from the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers JW, 2010, DIABETES CARE, V33, P1090, DOI 10.2337/dc09-1941; Aronson D, 2008, ADV CARDIOL, V45, P1, DOI 10.1159/000115118; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; CAGLIERO E, 1988, J CLIN INVEST, V82, P735, DOI 10.1172/JCI113655; Capla JM, 2007, PLAST RECONSTR SURG, V119, P59, DOI 10.1097/01.prs.0000244830.16906.3f; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chung SS, 2012, OBESITY, V20, P482, DOI 10.1038/oby.2011.212; ENGERMAN R, 1977, DIABETES, V26, P760, DOI 10.2337/diabetes.26.8.760; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Ferreira LS, 2007, CIRC RES, V101, P286, DOI 10.1161/CIRCRESAHA.107.150201; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; JACKSON CJ, 1990, J CELL SCI, V96, P257; Khan ZA, 2004, INVEST OPHTH VIS SCI, V45, P287, DOI 10.1167/iovs.03-0540; Khan ZA, 2003, CAN J PHYSIOL PHARM, V81, P622, DOI 10.1139/Y03-053; Khan Zia A., 2006, Current Vascular Pharmacology, V4, P45, DOI 10.2174/157016106775203081; Khan ZA, 2006, BLOOD, V108, P915, DOI 10.1182/blood-2006-03-006478; Khan ZA, 2006, EXP BIOL MED, V231, P1022; Khan Zia A, 2006, Recent Pat Cardiovasc Drug Discov, V1, P167, DOI 10.2174/157489006777442531; Kusuyama T, 2006, J PHARMACOL SCI, V102, P96, DOI 10.1254/jphs.FP0060256; Leung VYL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002356; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Lopez-Holgado N, 2007, CYTOTHERAPY, V9, P14, DOI 10.1080/14653240601047726; MacArthur BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003086; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Ratner R E, 2001, Clin Cornerstone, V4, P24, DOI 10.1016/S1098-3597(01)90027-4; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Walter DH, 2002, HERZ, V27, P579, DOI 10.1007/s00059-002-2427-y; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yang K, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-66; Yue WS, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-113	38	45	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38752	10.1371/journal.pone.0038752	http://dx.doi.org/10.1371/journal.pone.0038752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701703	gold, Green Submitted, Green Published			2022-12-25	WOS:000305348400092
J	Nishimune, H; Numata, T; Chen, J; Aoki, Y; Wang, YH; Starr, MP; Mori, Y; Stanford, JA				Nishimune, Hiroshi; Numata, Tomohiro; Chen, Jie; Aoki, Yudai; Wang, Yonghong; Starr, Miranda P.; Mori, Yasuo; Stanford, John A.			Active Zone Protein Bassoon Co-Localizes with Presynaptic Calcium Channel, Modifies Channel Function, and Recovers from Aging Related Loss by Exercise	PLOS ONE			English	Article							CA2+ CHANNEL; NEUROTRANSMITTER RELEASE; NEUROMUSCULAR-JUNCTIONS; TRANSMITTER RELEASE; MICE LACKING; MUSCLE; LOCALIZATION; AGE; TRANSMISSION; MICRODOMAINS	The P/Q-type voltage-dependent calcium channels (VDCCs) are essential for synaptic transmission at adult mammalian neuromuscular junctions (NMJs); however, the subsynaptic location of VDCCs relative to active zones in rodent NMJs, and the functional modification of VDCCs by the interaction with active zone protein Bassoon remain unknown. Here, we show that P/Q-type VDCCs distribute in a punctate pattern within the NMJ presynaptic terminals and align in three dimensions with Bassoon. This distribution pattern of P/Q-type VDCCs and Bassoon in NMJs is consistent with our previous study demonstrating the binding of VDCCs and Bassoon. In addition, we now show that the interaction between P/Q-type VDCCs and Bassoon significantly suppressed the inactivation property of P/Q-type VDCCs, suggesting that the Ca2+ influx may be augmented by Bassoon for efficient synaptic transmission at NMJs. However, presynaptic Bassoon level was significantly attenuated in aged rat NMJs, which suggests an attenuation of VDCC function due to a lack of this interaction between VDCC and Bassoon. Importantly, the decreased Bassoon level in aged NMJs was ameliorated by isometric strength training of muscles for two months. The training increased Bassoon immunoreactivity in NMJs without affecting synapse size. These results demonstrated that the P/Q-type VDCCs preferentially accumulate at NMJ active zones and play essential role in synaptic transmission in conjunction with the active zone protein Bassoon. This molecular mechanism becomes impaired by aging, which suggests altered synaptic function in aged NMJs. However, Bassoon level in aged NMJs can be improved by muscle exercise.	[Nishimune, Hiroshi; Chen, Jie] Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Wang, Yonghong; Starr, Miranda P.; Stanford, John A.] Univ Kansas, Sch Med, Dept Mol & Integrat Physiol, Kansas City, KS USA; [Numata, Tomohiro; Aoki, Yudai; Mori, Yasuo] Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Kyoto, Japan	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Kyoto University	Nishimune, H (corresponding author), Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS 66103 USA.	hnishimune@kumc.edu; mori@sbchem.kyoto-u.ac.jp; JSTANFORD@kumc.edu	Nishimune, Hiroshi/B-7226-2013; Numata, Tomohiro/AAW-2453-2020; Numata, Tomohiro/AAC-2330-2021	Numata, Tomohiro/0000-0002-5719-4884; Numata, Tomohiro/0000-0002-5719-4884; Stanford, John/0000-0002-4667-4057	Whitehall foundation; Japan Society for the Promotion of Science; National Institutes of Health (NIH) [AG023549, AG026491, HD02528]; NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG026491, R01AG023549] Funding Source: NIH RePORTER	Whitehall foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Whitehall foundation to HN; the Japan Society for the Promotion of Science to YM; National Institutes of Health (NIH) AG023549, AG026491 to JAS; and NIH HD02528. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank B. Yoo and D. Warn for technical assistance on image analysis. The monoclonal SV2 antibody developed by K. M. Buckley was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA 52242.	BaliceGordon RJ, 1997, MUSCLE NERVE, pS83; BANKER BQ, 1983, J PHYSIOL-LONDON, V339, P355, DOI 10.1113/jphysiol.1983.sp014721; Billings SE, 2012, NEUROREPORT, V23, P49, DOI 10.1097/WNR.0b013e32834e7deb; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Carlson SS, 2010, J NEUROCHEM, V115, P654, DOI 10.1111/j.1471-4159.2010.06965.x; Chakkalakal JV, 2010, DEVELOPMENT, V137, P3489, DOI 10.1242/dev.053348; Chen J, 2012, J COMP NEUROL, V520, P434, DOI 10.1002/cne.22764; Chen J, 2011, J NEUROSCI, V31, P512, DOI 10.1523/JNEUROSCI.3771-10.2011; Cote MP, 2011, J NEUROTRAUM, V28, P299, DOI 10.1089/neu.2010.1594; Day NC, 1997, J NEUROSCI, V17, P6226; De Laet A, 2002, NEUROGASTROENT MOTIL, V14, P173, DOI 10.1046/j.1365-2982.2002.00320.x; Dupont-Versteegden EE, 2004, MUSCLE NERVE, V29, P73, DOI 10.1002/mus.10511; Fahim MA, 1997, J APPL PHYSIOL, V83, P59, DOI 10.1152/jappl.1997.83.1.59; FAHIM MA, 1982, J NEUROCYTOL, V11, P641, DOI 10.1007/BF01262429; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; Fregosi RF, 1997, RESP PHYSIOL, V110, P295, DOI 10.1016/S0034-5687(97)00095-9; Guggenmos DJ, 2009, BEHAV BRAIN RES, V201, P229, DOI 10.1016/j.bbr.2009.02.020; GUTMANN E, 1971, J PHYSIOL-LONDON, V216, P331, DOI 10.1113/jphysiol.1971.sp009528; Hallermann S, 2010, NEURON, V68, P710, DOI 10.1016/j.neuron.2010.10.026; HAYDON PG, 1994, NEURON, V13, P1275, DOI 10.1016/0896-6273(94)90414-6; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; Hodges SH, 2004, ANN OTO RHINOL LARYN, V113, P175, DOI 10.1177/000348940411300301; Hubert MF, 2000, TOXICOL SCI, V58, P195, DOI 10.1093/toxsci/58.1.195; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; Knight D, 2003, J PHYSIOL-LONDON, V546, P789, DOI 10.1113/jphysiol.2002.030924; Liu KSY, 2011, SCIENCE, V334, P1565, DOI 10.1126/science.1212991; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Maselli RA, 2009, J MED GENET, V46, P203, DOI 10.1136/jmg.2008.063693; McCullough MJ, 2011, NEUROSCIENCE, V174, P234, DOI 10.1016/j.neuroscience.2010.11.016; Muller CS, 2010, P NATL ACAD SCI USA, V107, P14950, DOI 10.1073/pnas.1005940107; Mukherjee K, 2010, P NATL ACAD SCI USA, V107, P6504, DOI 10.1073/pnas.1002307107; NARUSAWA M, 1987, J CELL BIOL, V104, P447, DOI 10.1083/jcb.104.3.447; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Prakash YS, 1996, J NEUROCYTOL, V25, P88, DOI 10.1007/BF02284788; PUMPLIN DW, 1981, P NATL ACAD SCI-BIOL, V78, P7210, DOI 10.1073/pnas.78.11.7210; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; Rowley KL, 2007, J NEUROPHYSIOL, V98, P478, DOI 10.1152/jn.00251.2006; Salemme S, 2007, CELL PHYSIOL BIOCHEM, V20, P55, DOI 10.1159/000104153; Santafe MM, 2005, ANN NEUROL, V57, P396, DOI 10.1002/ana.20403; Schaser AJ, 2012, BEHAV BRAIN RES, V226, P235, DOI 10.1016/j.bbr.2011.09.027; Shibasaki T, 2004, DIABETES, V53, pS59, DOI 10.2337/diabetes.53.suppl_3.S59; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Siri MDR, 1999, J PHYSIOL-LONDON, V514, P533, DOI 10.1111/j.1469-7793.1999.533ae.x; SMITH DO, 1984, J PHYSIOL-LONDON, V347, P161, DOI 10.1113/jphysiol.1984.sp015059; Smittkamp SE, 2010, BEHAV BRAIN RES, V211, P48, DOI 10.1016/j.bbr.2010.03.007; UCHITEL OD, 1992, P NATL ACAD SCI USA, V89, P3330, DOI 10.1073/pnas.89.8.3330; Udina E, 2011, MUSCLE NERVE, V43, P500, DOI 10.1002/mus.21912; Urbano FJ, 2003, P NATL ACAD SCI USA, V100, P3491, DOI 10.1073/pnas.0437991100; Uriu Y, 2010, J BIOL CHEM, V285, P21750, DOI 10.1074/jbc.M110.101311; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; Westenbroek RE, 1998, J NEUROSCI, V18, P6319	55	39	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38029	10.1371/journal.pone.0038029	http://dx.doi.org/10.1371/journal.pone.0038029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701595	gold, Green Published, Green Submitted			2022-12-25	WOS:000305348400030
J	Shah, S; Lowery, E; Braun, RK; Martin, A; Huang, N; Medina, M; Sethupathi, P; Seki, Y; Takami, M; Byrne, K; Wigfield, C; Love, RB; Iwashima, M				Shah, Shivanee; Lowery, Erin; Braun, Rudolf K.; Martin, Alicia; Huang, Nick; Medina, Melissa; Sethupathi, Periannan; Seki, Yoichi; Takami, Mariko; Byrne, Kathryn; Wigfield, Christopher; Love, Robert B.; Iwashima, Makio			Cellular Basis of Tissue Regeneration by Omentum	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; GASTROOMENTAL FREE-FLAP; BONE-MARROW; STROMAL CELLS; SUPPRESSOR-CELLS; GREATER OMENTUM; DIFFERENTIATION; INFLAMMATION; RAT; BRAIN	The omentum is a sheet-like tissue attached to the greater curvature of the stomach and contains secondary lymphoid organs called milky spots. The omentum has been used for its healing potential for over 100 years by transposing the omental pedicle to injured organs (omental transposition), but the mechanism by which omentum helps the healing process of damaged tissues is not well understood. Omental transposition promotes expansion of pancreatic islets, hepatocytes, embryonic kidney, and neurons. Omental cells (OCs) can be activated by foreign bodies in vivo. Once activated, they become a rich source for growth factors and express pluripotent stem cell markers. Moreover, OCs become engrafted in injured tissues suggesting that they might function as stem cells. Omentum consists of a variety of phenotypically and functionally distinctive cells. To understand the mechanism of tissue repair support by the omentum in more detail, we analyzed the cell subsets derived from the omentum on immune and inflammatory responses. Our data demonstrate that the omentum contains at least two groups of cells that support tissue repair, immunomodulatory myeloid derived suppressor cells and omnipotent stem cells that are indistinguishable from mesenchymal stem cells. Based on these data, we propose that the omentum is a designated organ for tissue repair and healing in response to foreign invasion and tissue damage.	[Shah, Shivanee; Huang, Nick; Seki, Yoichi; Takami, Mariko; Iwashima, Makio] Loyola Univ, Dept Microbiol & Immunol, Stritch Sch Med, Chicago, IL 60611 USA; [Lowery, Erin] Loyola Univ, Dept Med, Stritch Sch Med, Chicago, IL 60611 USA; [Braun, Rudolf K.; Martin, Alicia; Medina, Melissa; Sethupathi, Periannan; Byrne, Kathryn; Wigfield, Christopher; Love, Robert B.] Loyola Univ, Dept Thorac & Cardiovasc Surg, Stritch Sch Med, Chicago, IL 60611 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago	Shah, S (corresponding author), Loyola Univ, Dept Microbiol & Immunol, Stritch Sch Med, Chicago, IL 60611 USA.	miwashima@lumc.edu		Braun, Rudolf/0000-0002-1778-9613	NIH [R01 AI055022]; Van Kampen cardiovascular research fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055022] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Van Kampen cardiovascular research fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH R01 AI055022 (MI) and Van Kampen cardiovascular research fund (RBL). Funders provided financial support for supplies and personnel involved in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai S, 2004, ANN PLAS SURG, V52, P144, DOI 10.1097/01.sap.0000100898.68014.6f; Athanassiadi Kalliopi, 2007, Asian Cardiovasc Thorac Ann, V15, P200; Augello A, 2010, EUR CELLS MATER, V20, P121; Avouac J, ARTHRITIS RHEUM, V63, P800; Bayles SW, 2008, ARCH FACIAL PLAST S, V10, P255, DOI 10.1001/archfaci.10.4.255; Braun RK, 2008, INFLAMMATION, V31, P167, DOI 10.1007/s10753-008-9062-6; Bronte V, 2009, EUR J IMMUNOL, V39, P2670, DOI 10.1002/eji.200939892; Burlingham WJ, 2007, J CLIN INVEST, V117, P3498, DOI 10.1172/JCI28031; CANNADAY JE, 1948, AM J SURG, V76, P502, DOI 10.1016/S0002-9610(48)90236-0; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Christensen LH, 2008, DERMATOL SURG, V34, pS68, DOI 10.1111/j.1524-4725.2008.34246.x; Collins D, 2009, J GASTROINTEST SURG, V13, P1138, DOI 10.1007/s11605-009-0855-1; Crabtree JH, 1999, SURG LAPARO ENDO PER, V9, P228, DOI 10.1097/00019509-199906000-00018; DELATORRE JC, 1994, BRAIN RES BULL, V35, P413, DOI 10.1016/0361-9230(94)90153-8; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Falagas Matthew E, 2006, J Infect, V52, pe151, DOI 10.1016/j.jinf.2005.08.007; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Garcia-Gomez I, 2005, NEUROL RES, V27, P807, DOI 10.1179/016164105X63674; GIN H, 1990, BIOMATER ARTIF CELL, V18, P25, DOI 10.3109/10731199009117287; GOLDSMITH HS, 1994, NEUROL RES, V16, P159; GOLDSMITH HS, 1973, ARCH SURG-CHICAGO, V106, P695; GOLDSMITH HS, 1992, BRAIN RES, V589, P217, DOI 10.1016/0006-8993(92)91280-R; Hammerman MR, 2004, J AM SOC NEPHROL, V15, P1126, DOI 10.1097/01.ASN.0000106020.64930.64; Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009; Kin T, 2003, AM J TRANSPLANT, V3, P281, DOI 10.1034/j.1600-6143.2003.00049.x; KRIST LFG, 1995, ANAT REC, V241, P163, DOI 10.1002/ar.1092410204; Lee HM, 2003, TISSUE ENG, V9, P1227, DOI 10.1089/10763270360728134; Liebermann-Meffert D, 2000, SURG CLIN N AM, V80, P275, DOI 10.1016/S0039-6109(05)70406-0; Litbarg NO, 2007, CELL TISSUE RES, V328, P487, DOI 10.1007/s00441-006-0356-4; Liu TJ, 2011, J IMMUNOL, V187, P450, DOI 10.4049/jimmunol.1000964; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Maloney CT, 2003, PLAST RECONSTR SURG, V111, P1899, DOI 10.1097/01.PRS.0000056874.31920.7D; Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689; Mohammadi R, MUSCLE NERVE, V43, P157; Moreschi Alexandre Heitor, 2008, J. bras. pneumol., V34, P654, DOI 10.1590/S1806-37132008000900004; Moriscot C, 2005, STEM CELLS, V23, P594, DOI 10.1634/stemcells.2004-0123; Morison R, 1906, Br Med J, V1, P76; Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102; NAKASHIMA JM, 1986, AM J PATHOL, V124, P528; Oh K, 2011, J EXP MED, V208, P1707, DOI 10.1084/jem.20101457; Oh SH, 2004, LAB INVEST, V84, P607, DOI 10.1038/labinvest.3700074; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Pancholi N, 2010, TRANSL RES, V156, P358, DOI 10.1016/j.trsl.2010.09.002; Patel RS, 2009, CURR OPIN OTOLARYNGO, V17, P258, DOI 10.1097/MOO.0b013e32832cba42; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Pond CM, 2003, TRENDS IMMUNOL, V24, P13, DOI 10.1016/S1471-4906(02)00004-2; Rajesh RV, COMP BIOCH PHYSL D, V5, P234; Ray P, 2011, IMMUNOL RES, V50, P153, DOI 10.1007/s12026-011-8230-1; Rippon HJ, 2006, STEM CELLS, V24, P1389, DOI 10.1634/stemcells.2005-0465; Rogers SA, 2004, AM J PHYSIOL-ENDOC M, V286, pE502, DOI 10.1152/ajpendo.00445.2003; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Sigrist S, 2003, J VASC RES, V40, P359, DOI 10.1159/000072700; Singh AK, 2008, CELL TISSUE RES, V332, P81, DOI 10.1007/s00441-007-0560-x; Singh AK, 2009, WORLD J GASTROENTERO, V15, P1057, DOI 10.3748/wjg.15.1057; Singh N, 2010, J IMMUNOL, V184, P94, DOI 10.4049/jimmunol.0900753; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; Sueblinvong V, 2008, AM J RESP CRIT CARE, V177, P701, DOI 10.1164/rccm.200706-859OC; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Ugel S, 2009, CURR OPIN PHARMACOL, V9, P470, DOI 10.1016/j.coph.2009.06.014; Vatansev C, 2003, EUR SURG RES, V35, P388, DOI 10.1159/000070612; Vernik J, 2007, INT J ARTIF ORGANS, V30, P95, DOI 10.1177/039139880703000203; VINEBERG AM, 1966, AM HEART J, V72, P79, DOI 10.1016/0002-8703(66)90630-2; Wang GS, 2005, P NATL ACAD SCI USA, V102, P186, DOI 10.1073/pnas.0406266102; Wang WJ, 2009, BIOMATERIALS, V30, P2705, DOI 10.1016/j.biomaterials.2009.01.030; Weiss Daniel J, 2006, Proc Am Thorac Soc, V3, P193, DOI 10.1513/pats.200601-013MS; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	71	55	60	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38368	10.1371/journal.pone.0038368	http://dx.doi.org/10.1371/journal.pone.0038368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701632	Green Published, Green Submitted, gold			2022-12-25	WOS:000305348400053
J	Chegou, NN; Essone, PN; Loxton, AG; Stanley, K; Black, GF; van der Spuy, GD; van Helden, PD; Franken, KL; Parida, SK; Klein, MR; Kaufmann, SHE; Ottenhoff, THM; Walzl, G				Chegou, Novel N.; Essone, Paulin N.; Loxton, Andre G.; Stanley, Kim; Black, Gillian F.; van der Spuy, Gian D.; van Helden, Paul D.; Franken, Kees L.; Parida, Shreemanta K.; Klein, Michel R.; Kaufmann, Stefan H. E.; Ottenhoff, Tom H. M.; Walzl, Gerhard			Potential of Host Markers Produced by Infection Phase-Dependent Antigen-Stimulated Cells for the Diagnosis of Tuberculosis in a Highly Endemic Area	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; HUMORAL IMMUNE-RESPONSES; LATERAL FLOW ASSAY; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; WHOLE-BLOOD; T-CELLS; DISEASE; BURDEN; HIV	Background: Recent interferon gamma (IFN-gamma)-based studies have identified novel Mycobacterium tuberculosis (M.tb) infection phase-dependent antigens as diagnostic candidates. In this study, the levels of 11 host markers other than IFN-gamma, were evaluated in whole blood culture supernatants after stimulation with M.tb infection phase-dependent antigens, for the diagnosis of TB disease. Methodology and Principal Findings: Five M.tb infection phase-dependent antigens, comprising of three DosR-regulon-encoded proteins (Rv2032, Rv0081, Rv1737c), and two resucitation promoting factors (Rv0867c and Rv2389c), were evaluated in a case-control study with 15 pulmonary TB patients and 15 household contacts that were recruited from a high TB incidence setting in Cape Town, South Africa. After a 7-day whole blood culture, supernatants were harvested and the levels of the host markers evaluated using the Luminex platform. Multiple antigen-specific host markers were identified with promising diagnostic potential. Rv0081-specific levels of IL-12(p40), IP-10, IL-10 and TNF-alpha were the most promising diagnostic candidates, each ascertaining TB disease with an accuracy of 100%, 95% confidence interval for the area under the receiver operating characteristics plots, (1.0 to 1.0). Conclusions: Multiple cytokines other than IFN-gamma in whole blood culture supernatants after stimulation with M.tb infection phase-dependent antigens show promise as diagnostic markers for active TB. These preliminary findings should be verified in well-designed diagnostic studies employing short-term culture assays.	[Chegou, Novel N.; Essone, Paulin N.; Loxton, Andre G.; Stanley, Kim; Black, Gillian F.; van der Spuy, Gian D.; van Helden, Paul D.; Walzl, Gerhard] Univ Stellenbosch, Fac Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, ZA-7505 Tygerberg, South Africa; [Chegou, Novel N.; Essone, Paulin N.; Loxton, Andre G.; Stanley, Kim; Black, Gillian F.; van der Spuy, Gian D.; van Helden, Paul D.; Walzl, Gerhard] Univ Stellenbosch, Fac Hlth Sci, MRC Ctr Mol & Cellular Biol, Div Mol Biol & Human Genet,Dept Biomed Sci, ZA-7505 Tygerberg, South Africa; [Franken, Kees L.; Klein, Michel R.; Ottenhoff, Tom H. M.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Parida, Shreemanta K.; Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany	National Research Foundation - South Africa; Stellenbosch University; Stellenbosch University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Max Planck Society	Chegou, NN (corresponding author), Univ Stellenbosch, Fac Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, ZA-7505 Tygerberg, South Africa.	novel@sun.ac.za	Franken, Kees/ABA-7095-2021; van der Spuy, Gian/AAY-7701-2020; Walzl, Gerhard/N-6371-2016; Kaufmann, Stefan HE/I-5454-2014	Franken, Kees/0000-0002-4747-6060; van der Spuy, Gian/0000-0002-9067-5903; Walzl, Gerhard/0000-0003-2487-125X; Kaufmann, Stefan HE/0000-0001-9866-8268; Parida, Shreemanta K/0000-0003-2129-6691; Black, Gillian/0000-0002-5081-274X; Chegou, Novel N/0000-0002-8690-1699; Loxton, Andre/0000-0003-0659-9803	Bill & Melinda Gates Foundation through Grand Challenge 6 (BMGFGC6) [37772]; Claude Leon Foundation; South African Medical Research Council	Bill & Melinda Gates Foundation through Grand Challenge 6 (BMGFGC6); Claude Leon Foundation; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Bill & Melinda Gates Foundation through Grand Challenge 6 (BMGFGC6, grant no 37772). Dr. Chegou received financial support from the Claude Leon Foundation and the South African Medical Research Council during the writing up of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09; Chaisson RE, 2008, NEW ENGL J MED, V358, P1089, DOI 10.1056/NEJMp0800809; Chegou NN, 2008, RESPIRATION, V76, P131, DOI 10.1159/000128575; Chegou NN, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-10; Chegou NN, 2011, EXPERT REV ANTI-INFE, V9, P457, DOI [10.1586/eri.11.23, 10.1586/ERI.11.23]; Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21; Chiacchio T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027539; Commandeur S, 2011, EUR J IMMUNOL, V41, P2925, DOI 10.1002/eji.201141602; Commandeur S, 2011, CLIN VACCINE IMMUNOL, V18, P676, DOI 10.1128/CVI.00492-10; Connell TG, 2007, CLIN VACCINE IMMUNOL, V14, P847, DOI 10.1128/CVI.00041-07; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corstjens PLAM, 2008, CLIN BIOCHEM, V41, P440, DOI 10.1016/j.clinbiochem.2007.12.015; Corstjens PLAM, 2008, J CLIN MICROBIOL, V46, P171, DOI 10.1128/JCM.00877-07; Corstjens PLAM, 2007, ANN NY ACAD SCI, V1098, P437, DOI 10.1196/annals.1384.016; Corstjens PLAM, 2011, CLIN BIOCHEM, V44, P1241, DOI 10.1016/j.clinbiochem.2011.06.983; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Feske M, 2008, CLIN VACCINE IMMUNOL, V15, P1616, DOI 10.1128/CVI.00185-08; Frahm M, 2011, TUBERCULOSIS, V91, P250, DOI 10.1016/j.tube.2011.02.006; Franken KLMC, 2000, PROTEIN EXPRES PURIF, V18, P95, DOI 10.1006/prep.1999.1162; Geluk A, 2010, CLIN VACCINE IMMUNOL, V17, P993, DOI 10.1128/CVI.00046-10; GOIN JE, 1982, PATTERN RECOGN, V15, P263, DOI 10.1016/0031-3203(82)90077-2; Goletti D, 2010, EUR RESPIR J, V36, P135, DOI 10.1183/09031936.00140009; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hesseling AC, 2009, THORAX, V64, P840, DOI 10.1136/thx.2007.085340; Honaker RW, 2008, INFECT IMMUN, V76, P2587, DOI 10.1128/IAI.01235-07; Jones GJ, 2010, CLIN VACCINE IMMUNOL, V17, P1946, DOI 10.1128/CVI.00377-10; Kellar KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026545; Kritzinger FE, 2009, TROP MED INT HEALTH, V14, P136, DOI 10.1111/j.1365-3156.2008.02213.x; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Lighter-Fisher J, 2010, INT J TUBERC LUNG D, V14, P1548; Lin MY, 2007, INFECT IMMUN, V75, P3523, DOI 10.1128/IAI.01999-06; Lu CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024290; Mandalakas AM, 2008, INT J TUBERC LUNG D, V12, P417; Munk ME, 2001, J INFECT DIS, V183, P175, DOI 10.1086/317663; Palma C, 2008, VACCINE, V26, P4237, DOI 10.1016/j.vaccine.2008.05.050; Raja A, 2004, INDIAN J MED RES, V120, P213; Roy RB, 2012, CURR OPIN INFECT DIS, V25, P250, DOI 10.1097/QCO.0b013e3283529af9; Rubbo PA, 2012, J CLIN MICROBIOL, V50, P1711, DOI 10.1128/JCM.00117-12; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Ruhwald M, 2007, MICROBES INFECT, V9, P806, DOI 10.1016/j.micinf.2007.02.021; Ruhwald M, 2012, EXPERT REV MOL DIAGN, V12, P175, DOI [10.1586/ERM.11.97, 10.1586/erm.11.97]; Ruhwald M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002858; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Schuck SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005590; Su WL, 2010, CLIN VACCINE IMMUNOL, V17, P771, DOI 10.1128/CVI.00526-09; Sutherland JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012365; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Tanaka T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-71; Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392; Ulrichs T, 2004, TUBERCULOSIS, P251	51	54	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38501	10.1371/journal.pone.0038501	http://dx.doi.org/10.1371/journal.pone.0038501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693640	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343900050
J	Roy, S; Brownell, WE; Spector, AA				Roy, Sitikantha; Brownell, William E.; Spector, Alexander A.			Modeling Electrically Active Viscoelastic Membranes	PLOS ONE			English	Article							OUTER HAIR CELL; LIVING CELLS; ELECTROMECHANICAL PROPERTIES; FORCE GENERATION; PRESTIN; VOLTAGE; MOTOR; PIEZOELECTRICITY; ELECTROMOTILITY; DEPENDENCE	The membrane protein prestin is native to the cochlear outer hair cell that is crucial to the ear's amplification and frequency selectivity throughout the whole acoustic frequency range. The outer hair cell exhibits interrelated dimensional changes, force generation, and electric charge transfer. Cells transfected with prestin acquire unique active properties similar to those in the native cell that have also been useful in understanding the process. Here we propose a model describing the major electromechanical features of such active membranes. The model derived from thermodynamic principles is in the form of integral relationships between the history of voltage and membrane resultants as independent variables and the charge density and strains as dependent variables. The proposed model is applied to the analysis of an active force produced by the outer hair cell in response to a harmonic electric field. Our analysis reveals the mechanism of the outer hair cell active (isometric) force having an almost constant amplitude and phase up to 80 kHz. We found that the frequency-invariance of the force is a result of interplay between the electrical filtering associated with prestin and power law viscoelasticity of the surrounding membrane. Paradoxically, the membrane viscoelasticity boosts the force balancing the electrical filtering effect. We also consider various modes of electromechanical coupling in membrane with prestin associated with mechanical perturbations in the cell. We consider pressure or strains applied step-wise or at a constant rate and compute the time course of the resulting electric charge. The results obtained here are important for the analysis of electromechanical properties of membranes, cells, and biological materials as well as for a better understanding of the mechanism of hearing and the role of the protein prestin in this mechanism.	[Roy, Sitikantha; Spector, Alexander A.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Brownell, William E.] Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA	Johns Hopkins University; Baylor College of Medicine	Roy, S (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	aspector@jhu.edu	Spector, Alexander/A-3330-2010; ROY, SITIKANTHA/AAT-2836-2021		National Institute on Deafness and Other Communication Disorders, National Institutes of Health [R01 DC 002775, R01 DC 000354]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000354, R01DC002775] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work is supported by research grants R01 DC 002775 and R01 DC 000354 from National Institute on Deafness and Other Communication Disorders, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashmore J, 2010, HEARING RES, V266, P1, DOI 10.1016/j.heares.2010.05.001; Bett GCL, 2000, J MEMBRANE BIOL, V173, P237, DOI 10.1007/s002320001023; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Brownell WE, 2001, ANNU REV BIOMED ENG, V3, P169, DOI 10.1146/annurev.bioeng.3.1.169; Cady WG., 1964, PIEZOELECTRICITY, V1; Chakrapani S, 2010, P NATL ACAD SCI USA, V107, P5435, DOI 10.1073/pnas.0914109107; Christensen R.M., 1982, THEORY VISCOELASTICI; DALLOS P, 1993, J NEUROPHYSIOL, V70, P299, DOI 10.1152/jn.1993.70.1.299; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Deng LH, 2006, NAT MATER, V5, P636, DOI 10.1038/nmat1685; Deo N, 2004, BIOPHYS J, V86, P3519, DOI 10.1529/biophysj.103.026658; Dong XX, 2004, BIOPHYS J, V86, P1201, DOI 10.1016/S0006-3495(04)74194-6; Dong XX, 2002, BIOPHYS J, V82, P1254, DOI 10.1016/S0006-3495(02)75481-7; Fabry B, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041914; Frank G, 1999, P NATL ACAD SCI USA, V96, P4420, DOI 10.1073/pnas.96.8.4420; GALE JE, 1994, P ROY SOC B-BIOL SCI, V255, P243, DOI 10.1098/rspb.1994.0035; Haddad YM, 1995, VISCOELASTICIY ENG M; HALLWORTH R, 1993, J NEUROPHYSIOL, V70, P549, DOI 10.1152/jn.1993.70.2.549; Hoffman BD, 2006, P NATL ACAD SCI USA, V103, P10259, DOI 10.1073/pnas.0510348103; Iwasa KH, 1997, BIOPHYS J, V73, P546, DOI 10.1016/S0006-3495(97)78092-5; KAKEHATA S, 1995, BIOPHYS J, V68, P2190, DOI 10.1016/S0006-3495(95)80401-7; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; Kim KS, 1998, BIOPHYS J, V75, P2274, DOI 10.1016/S0006-3495(98)77672-6; Lai WM, 2002, BIORHEOLOGY, V39, P39; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Liu YW, 2009, J ACOUST SOC AM, V126, P751, DOI 10.1121/1.3158919; Luckey M., 2008, MEMBRANE STRUCTURAL; Ludwig J, 2001, P NATL ACAD SCI USA, V98, P4178, DOI 10.1073/pnas.071613498; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; Mountain DC, 1994, J ACOUST SOC AM, V97, P3006; Nobili R, 1996, J ACOUST SOC AM, V99, P2244, DOI 10.1121/1.415412; Petrov A.G., 1999, LYOTROPIC STATE MATT; Rabbitt RD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000444; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Sachs F, 1998, REV PHYSIOL BIOCH P, V132, P1, DOI 10.1007/BFb0004985; SALZSTEIN RA, 1987, J BIOMECH, V20, P271, DOI 10.1016/0021-9290(87)90294-6; Spector AA, 2003, J ACOUST SOC AM, V113, P453, DOI 10.1121/1.1526493; Spector AA, 2001, INT J SOLIDS STRUCT, V38, P2115, DOI 10.1016/S0020-7683(00)00156-6; Spector AA, 1998, J ACOUST SOC AM, V103, P1007, DOI 10.1121/1.421217; Stamenovic D, 2007, BIOPHYS J, V93, pL39, DOI 10.1529/biophysj.107.116582; Sun DD, 2004, J BIOMECH ENG-T ASME, V126, P6, DOI 10.1115/1.1644562; Sun SX, 2009, J THEOR BIOL, V260, P137, DOI 10.1016/j.jtbi.2009.05.019; Tolomeo JA, 1995, J ACOUST SOC AM, V95, P350; Villalba-Galea CA, 2009, BIOPHYS J, V96, pL19, DOI 10.1016/j.bpj.2008.11.003; Weitzel EK, 2003, J ACOUST SOC AM, V114, P1462, DOI 10.1121/1.1596172; Yamada S, 2000, BIOPHYS J, V78, P1736, DOI 10.1016/S0006-3495(00)76725-7; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zimmerberg J, 2006, CURR BIOL, V16, pR272, DOI 10.1016/j.cub.2006.03.050	48	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37667	10.1371/journal.pone.0037667	http://dx.doi.org/10.1371/journal.pone.0037667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701528	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500049
J	Zhu, Y; Zhao, T; Itasaka, S; Zeng, L; Yeom, CJ; Hirota, K; Suzuki, K; Morinibu, A; Shinomiya, K; Ou, G; Yoshimura, M; Hiraoka, M; Harada, H				Zhu, Y.; Zhao, T.; Itasaka, S.; Zeng, L.; Yeom, C. J.; Hirota, K.; Suzuki, K.; Morinibu, A.; Shinomiya, K.; Ou, G.; Yoshimura, M.; Hiraoka, M.; Harada, H.			Involvement of decreased hypoxia-inducible factor 1 activity and resultant G(1)-S cell cycle transition in radioresistance of perinecrotic tumor cells	ONCOGENE			English	Article						radiation therapy; radioresistance; tumor microenvironments; hypoxia; hypoxia-inducible factor 1 (HIF-1)	DOUBLE-STRAND BREAKS; SOLID TUMORS; DNA-DAMAGE; FACTOR-I; IONIZING-RADIATION; MAMMALIAN-CELLS; STRESS-RESPONSE; CANCER-THERAPY; HISTONE H2AX; EXPRESSION	Cancer patients often suffer from local tumor recurrence after radiation therapy. Some intracellular and extracellular factors, such as activity of hypoxia-inducible factor 1 (HIF-1), cell cycle status and oxygen availability, have been suggested to affect DNA damage responses and eventual radioresistant characteristics of cancer cells. But when, where, and how these factors affect one another and induce cellular radioresistance is largely unknown. Here, we analyzed mechanistic and spatio-temporal relationships among them in highly heterogeneous tumor microenvironments. Experiments in vitro demonstrated that a decrease in the glucose concentration reduced the transcriptional activity of HIF-1 and expression of a downstream gene for the cell cycle regulator p27(Kip1) even under hypoxic conditions. Then, the proportion of cells in the radioresistant S phase increased, whereas that radiosensitive G(1) phase decreased, significantly. Immunohistochemical analyses showed that cancer cells in perinecrotic hypoxic regions, which should be under low-glucose conditions, expressed little HIF-1 alpha, and therefore, were mainly in S phase and less damaged by radiation treatment. Continuous administration of glucagon, which increases the blood glucose concentration and so improves glucose availability in perinecrotic hypoxic regions, induced HIF-1 alpha expression and increased radiation-induced DNA damage. Taken all together, these results indicate that cancer cells in perinecrotic regions, which would be under low-glucose and hypoxic conditions, obtain radioresistance by decreasing the level of both HIF-1 activity and p27(Kip1) expression, and adjusting their cell cycle to the radioresistant S phase. Oncogene (2013) 32, 2058-2068; doi:10.1038/onc.2012.223; published online 18 June 2012	[Zhu, Y.; Zhao, T.; Zeng, L.; Yeom, C. J.; Morinibu, A.; Shinomiya, K.; Harada, H.] Kyoto Univ, Grp Radiat & Tumor Biol, Career Path Promot Unit Young Life Scientists, Kyoto, Japan; [Zhu, Y.; Zhao, T.; Itasaka, S.; Zeng, L.; Ou, G.; Yoshimura, M.; Hiraoka, M.] Kyoto Univ, Dept Radiat Oncol & Image Appl Therapy, Grad Sch Med, Kyoto, Japan; [Zhu, Y.] Chongqing Med Univ, Affiliated Hosp 1, Dept Oncol, Chongqing, Peoples R China; [Zhao, T.; Itasaka, S.] Fourth Mil Med Univ, Dept Radiat Med, Xian, Shaanxi, Peoples R China; [Hirota, K.] Kyoto Univ, Kyoto Univ Hosp, Dept Anesthesia, Kyoto, Japan; [Suzuki, K.] Nagasaki Univ, Grad Sch Biomed Sci, Div Radiat Biol, Dept Radiol & Radiat Biol, Nagasaki 852, Japan	Kyoto University; Kyoto University; Chongqing Medical University; Air Force Military Medical University; Kyoto University; Nagasaki University	Harada, H (corresponding author), Kyoto Univ, Grp Radiat & Tumor Biol, Career Path Promot Unit Young Life Scientists, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan.	hharada@kuhp.kyoto-u.ac.jp	; Hirota, Kiichi/E-9181-2010	Yuxi, Zhu/0000-0001-7563-505X; Hirota, Kiichi/0000-0003-1110-0827	Funding Program for NEXT Generation World-Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS), Japan [LS071]; Program for Promotion of Fundamental Studies in Health Science from the National Institute of Biomedical Innovation (NIBIO), Japan [09-25]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [21791184, 22791190]; Sagawa Foundation for the Promotion of Cancer Research; International Science and Technology Cooperation Project of China and Japan [2010DFA31900]; Grants-in-Aid for Scientific Research [24659695] Funding Source: KAKEN	Funding Program for NEXT Generation World-Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS), Japan; Program for Promotion of Fundamental Studies in Health Science from the National Institute of Biomedical Innovation (NIBIO), Japan; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sagawa Foundation for the Promotion of Cancer Research; International Science and Technology Cooperation Project of China and Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr Masahiro Inoue for discussions and Dr GL Semenza for the plasmid pcDNA3-HIF-1 alpha-CA, which expresses the constitutively active mutant form of HIF-1 alpha (HIF-1 alpha-CA). This study was supported by the Funding Program for NEXT Generation World-Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS), Japan to HH (No. LS071), by the Program for Promotion of Fundamental Studies in Health Science from the National Institute of Biomedical Innovation (NIBIO), Japan to HH (No. 09-25), by Grants-in-aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan to HH (No. 21791184). and SI (No. 22791190), by the Sagawa Foundation for the Promotion of Cancer Research to HH, and by the International Science and Technology Cooperation Project of China and Japan to ZL and HH (No. 2010DFA31900).	Aebersold DM, 2001, CANCER RES, V61, P2911; Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Berra E, 2001, EMBO REP, V2, P615, DOI 10.1093/embo-reports/kve130; Box AH, 2004, CARCINOGENESIS, V25, P2325, DOI 10.1093/carcin/bgh274; BROWN JM, 1993, BRIT J CANCER, V67, P1163, DOI 10.1038/bjc.1993.220; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Brown JM, 1998, CANCER RES, V58, P1408; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DESCHNER EE, 1959, RADIAT RES, V11, P115, DOI 10.2307/3570739; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Gorski DH, 1999, CANCER RES, V59, P3374; GRAY LH, 1953, BRIT J RADIOL, V26, P638, DOI 10.1259/0007-1285-26-312-638; Harada H, 2009, BRIT J CANCER, V100, P747, DOI 10.1038/sj.bjc.6604939; Harada H, 2007, BIOCHEM BIOPH RES CO, V360, P791, DOI 10.1016/j.bbrc.2007.06.149; Harada H, 2005, MOL IMAGING, V4, P182; Harada H, 2006, FEBS LETT, V580, P5718, DOI 10.1016/j.febslet.2006.09.025; Harada H, 2009, J BIOL CHEM, V284, P5332, DOI 10.1074/jbc.M806653200; Irie Nobuyuki, 2004, Brain Tumor Pathol, V21, P1, DOI 10.1007/BF02482169; Ishikawa H, 2004, INT J RADIAT ONCOL, V60, P513, DOI 10.1016/j.ijrobp.2004.03.025; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kizaka-Kondoh S, 2003, CANCER SCI, V94, P1021, DOI 10.1111/j.1349-7006.2003.tb01395.x; Kizaka-Kondoh S, 2009, CANCER SCI, V100, P1366, DOI 10.1111/j.1349-7006.2009.01195.x; Kizaka-Kondoh S, 2009, ADV DRUG DELIVER REV, V61, P623, DOI 10.1016/j.addr.2009.01.006; Li XC, 2008, CLIN SCI, V114, P591, DOI 10.1042/CS20070257; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Moeller BJ, 2004, CELL CYCLE, V3, P1107; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; PALCIC B, 1984, RADIAT RES, V100, P328, DOI 10.2307/3576354; Pryde F, 2005, J CELL SCI, V118, P2043, DOI 10.1242/jcs.02336; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2011, AM J PHYSIOL-CELL PH, V301, pC550, DOI 10.1152/ajpcell.00176.2011; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; SINCLAIR WK, 1968, RADIAT RES, V33, P620, DOI 10.2307/3572419; Sobhanifar S, 2005, CANCER RES, V65, P7259, DOI 10.1158/0008-5472.CAN-04-4480; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; TERASIMA T, 1963, BIOPHYS J, V3, P11, DOI 10.1016/S0006-3495(63)86801-0; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; Tomida A, 1999, ANTI-CANCER DRUG DES, V14, P169; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; VAUPEL P, 1989, CANCER RES, V49, P6449; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Webb GC, 2002, DIABETES, V51, P398, DOI 10.2337/diabetes.51.2.398; Zeng LH, 2008, CANCER SCI, V99, P2327, DOI 10.1111/j.1349-7006.2008.00943.x	51	21	22	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR 18	2013	32	16					2058	2068		10.1038/onc.2012.223	http://dx.doi.org/10.1038/onc.2012.223			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	130LY	22710721	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000317919900007
J	Liu, Z; Zanata, SM; Kim, J; Peterson, MA; Di Vizio, D; Chirieac, LR; Pyne, S; Agostini, M; Freeman, MR; Loda, M				Liu, Z.; Zanata, S. M.; Kim, J.; Peterson, M. A.; Di Vizio, D.; Chirieac, L. R.; Pyne, S.; Agostini, M.; Freeman, M. R.; Loda, M.			The ubiquitin-specific protease USP2a prevents endocytosis-mediated EGFR degradation	ONCOGENE			English	Article						USP2a; DUB; EGFR; endocytosis	EPIDERMAL-GROWTH-FACTOR; DEUBIQUITINATING ENZYME USP2A; RECEPTOR TYROSINE KINASES; CLATHRIN-COATED PITS; DOWN-REGULATION; PROSTATE-CANCER; MEMBRANE-PROTEIN; PLASMA-MEMBRANE; LUNG-CANCER; CELL-GROWTH	Ubiquitination of epidermal growth factor receptor (EGFR) is required for downregulation of the receptor by endocytosis. Impairment of this pathway results in constitutively active EGFR, which is associated with carcinogenesis, particularly in lung cancer. We previously demonstrated that the deubiquitinating enzyme ubiquitin-specific protease 2a (USP2a) has oncogenic properties. Here, we show a new role for USP2a as a regulator of EGFR endocytosis. USP2a localizes to early endosomes and associates with EGFR, stabilizing the receptor, which retains active downstream signaling. HeLa cells transiently expressing catalytically active, but not mutant (MUT), USP2a show increased plasma membrane-localized EGFR, as well as decreased internalized and ubiquitinated EGFR. Conversely, USP2a silencing reverses this phenotype. Importantly, USP2a prevents the degradation of MUT in addition to wild-type EGFR. Finally, we observed that USP2a and EGFR proteins are coordinately overexpressed in non-small cell lung cancers. Taken together, our data indicate that USP2a antagonizes EGFR endocytosis and thus amplifies signaling activity from the receptor. Our findings suggest that regulation of deubiquitination could be exploited therapeutically in cancers overexpressing EGFR. Oncogene (2013) 32, 1660-1669; doi:10.1038/onc.2012.188; published online 18 June 2012	[Liu, Z.; Zanata, S. M.; Peterson, M. A.; Chirieac, L. R.; Pyne, S.; Agostini, M.; Loda, M.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Liu, Z.; Zanata, S. M.; Peterson, M. A.; Chirieac, L. R.; Pyne, S.; Agostini, M.; Loda, M.] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02215 USA; [Liu, Z.; Loda, M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Zanata, S. M.] Univ Fed Parana, Dept Basic Pathol, BR-80060000 Curitiba, Parana, Brazil; [Zanata, S. M.] Univ Fed Parana, Dept Cell Biol, BR-80060000 Curitiba, Parana, Brazil; [Kim, J.; Di Vizio, D.; Freeman, M. R.] Childrens Hosp, Urol Dis Res Ctr, Boston, MA 02115 USA; [Kim, J.; Di Vizio, D.; Freeman, M. R.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Freeman, M. R.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Loda, M.] Kings Coll London, Div Canc Studies, London WC2R 2LS, England	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Universidade Federal do Parana; Universidade Federal do Parana; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of London; King's College London	Loda, M (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, DA1536,450 Brookline Ave, Boston, MA 02215 USA.	Massimo_loda@dfci.harvard.edu	Chirieac, Lucian R./AAD-2030-2019; Agostini, Michelle/AAD-6610-2022; Zanata, Silvio/AAC-9670-2021; Agostini, Michelle/I-1275-2012	Agostini, Michelle/0000-0002-3648-337X; Zanata, Silvio/0000-0003-2818-6954; 	National Cancer Institute [RO1CA131945, PO1CA89021, P50 CA90381]; Prostate Cancer Foundation; CAPES, Brazil [3665/10-0]; NATIONAL CANCER INSTITUTE [P50CA090381, R01CA131945, P01CA089021, R00CA131472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087806] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prostate Cancer Foundation; CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Tomas Kirchhausen for AMSH constructs, Mihee Ji and Erik McCauley for technical assistance, Jane Hayward for help with preparation of the figures, Giulio Draetta and Richard J Flavin for critical reading of the manuscript. This work was supported by the National Cancer Institute (RO1CA131945, PO1CA89021, P50 CA90381 and the Prostate Cancer Foundation). SMZ was supported by CAPES (no. 3665/10-0), Brazil.	Abella JV, 2005, MOL CELL BIOL, V25, P9632, DOI 10.1128/MCB.25.21.9632-9645.2005; Agromayor M, 2006, J BIOL CHEM, V281, P23083, DOI 10.1074/jbc.M513803200; Allende-Vega N, 2010, ONCOGENE, V29, P432, DOI 10.1038/onc.2009.330; Alwan HAJ, 2007, J BIOL CHEM, V282, P1658, DOI 10.1074/jbc.M604711200; Amit I, 2004, GENE DEV, V18, P1737, DOI 10.1101/gad.294904; Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; Benassi B, 2012, CANCER DISCOV, V2, P236, DOI 10.1158/2159-8290.CD-11-0219; Bowers K, 2006, J BIOL CHEM, V281, P5094, DOI 10.1074/jbc.M508632200; Bunn PA, 2002, SEMIN ONCOL, V29, P38, DOI 10.1053/sonc.2002.35646; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; CERNY T, 1986, BRIT J CANCER, V54, P265, DOI 10.1038/bjc.1986.172; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; de Araujo Mariana Eca Guimaraes, 2008, V424, P317, DOI 10.1007/978-1-60327-064-9_25; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Gousseva N, 2003, GENE EXPRESSION, V11, P163, DOI 10.3727/000000003108749053; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Grovdal LM, 2004, EXP CELL RES, V300, P388, DOI 10.1016/j.yexcr.2004.07.003; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hammond DE, 2001, ONCOGENE, V20, P2761, DOI 10.1038/sj.onc.1204475; Haslekas C, 2005, MOL BIOL CELL, V16, P5832, DOI 10.1091/mbc.E05-05-0456; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Katz M, 2002, TRAFFIC, V3, P740, DOI 10.1034/j.1600-0854.2002.31006.x; Komada Masayuki, 2008, Curr Drug Discov Technol, V5, P78, DOI 10.2174/157016308783769469; Lenferink AEG, 1997, BIOCHEM J, V327, P859; Lenferink AEG, 1998, EMBO J, V17, P3385, DOI 10.1093/emboj/17.12.3385; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lin HJ, 2000, MOL CELL BIOL, V20, P6568, DOI 10.1128/MCB.20.17.6568-6578.2000; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; Ma YM, 2007, J BIOL CHEM, V282, P9805, DOI 10.1074/jbc.M611635200; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Metzig M, 2011, INT J CANCER, V129, P607, DOI 10.1002/ijc.26124; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Mizuno E, 2006, TRAFFIC, V7, P1017, DOI 10.1111/j.1600-0854.2006.00452.x; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Polo S, 2004, CURR OPIN CELL BIOL, V16, P156, DOI 10.1016/j.ceb.2004.02.003; Priolo C, 2006, CANCER RES, V66, P8625, DOI 10.1158/0008-5472.CAN-06-1374; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Sakurada A, 2006, CLIN LUNG CANCER, V7, pS138, DOI 10.3816/CLC.2006.s.005; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Shi Y, 2011, J BIOL CHEM, V286, P38960, DOI 10.1074/jbc.M111.231498; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Stuffers S, 2009, EXP CELL RES, V315, P1619, DOI 10.1016/j.yexcr.2008.10.013; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Urbe S, 2006, BIOCHEM SOC T, V34, P754, DOI 10.1042/BST0340754; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6	61	47	48	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 28	2013	32	13					1660	1669		10.1038/onc.2012.188	http://dx.doi.org/10.1038/onc.2012.188			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	116AY	22710717	Green Accepted			2022-12-25	WOS:000316855800006
J	Wang, DH; Prakash, J; Nguyen, P; Davis-Dusenbery, BN; Hill, NS; Layne, MD; Hata, A; Lagna, G				Wang, Dahai; Prakash, Jamunabai; Nguyen, Peter; Davis-Dusenbery, Brandi N.; Hill, Nicholas S.; Layne, Matthew D.; Hata, Akiko; Lagna, Giorgio			Bone Morphogenetic Protein Signaling in Vascular Disease ANTI-INFLAMMATORY ACTION THROUGH MYOCARDIN-RELATED TRANSCRIPTION FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY-ARTERIAL-HYPERTENSION; MUSCLE-CELL PROLIFERATION; FACTOR-KAPPA-B; GROWTH-FACTOR-BETA; SMOOTH-MUSCLE; EXPRESSION; RECEPTOR; INTERLEUKIN-6; FAMILY; SMAD	Pulmonary artery hypertension (PAH) patients exhibit elevated levels of inflammatory cytokines and infiltration of inflammatory cells in the lung. Concurrently, mutations of bmpr2, the gene encoding the type II receptor of bone morphogenetic proteins (BMP), are found in similar to 75% of patients with familial PAH, but a possible nexus between increased inflammation and diminished BMP signaling has hitherto remained elusive. We previously showed that BMP4 triggers nuclear localization of the Myocardin-related transcription factor A (MRTF-A) in human pulmonary artery smooth muscle cells (PASMC), resulting in the induction of contractile proteins. Here we report the BMPR2-dependent repression of a set of inflammatory mediators in response to BMP4 stimulation of PASMC. Forced expression of MRTF-A precisely emulates the anti-inflammatory effect of BMP4, while MRTF-A depletion precludes BMP4-mediated cytokine inhibition. BMP4 and MRTF-A block signaling through NF-kappa B, the keystone of most pathways leading to inflammatory responses, at the level of chromatin recruitment and promoter activation. Moreover, MRTF-A physically interacts with RelA/p65, the NF-kappa B subunit endowed with a transcription activation domain. Interestingly, the MRTF-A-NF-kappa B interaction is mutually antagonistic: stimulation of NF-kappa B signaling by TNF alpha, as well as p65 overexpression, hinders MRTF-A activity and the expression of contractile genes. Thus, a molecular inhibitory pathway linking BMP4 signaling, activation of MRTF-A, and inhibition of NF-kappa B provides insights into the etiology of PAH and a potential focus of therapeutic intervention.	[Wang, Dahai; Prakash, Jamunabai; Nguyen, Peter; Davis-Dusenbery, Brandi N.; Hata, Akiko; Lagna, Giorgio] Tufts Univ, Sch Med, Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; [Hill, Nicholas S.] Tufts Univ, Sch Med, Tufts Med Ctr, Pulm Crit Care & Sleep Div, Boston, MA 02111 USA; [Hata, Akiko] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; [Layne, Matthew D.] Boston Univ, Dept Biochem, Boston, MA 02118 USA	Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University; Tufts University; Boston University	Lagna, G (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, MC 3118,555 Mission Bay Blvd S,Room 252V, San Francisco, CA 94158 USA.	giorgio.lagna@ucsf.edu	Davis-Dusenbery, Brandi/N-2798-2013	Davis-Dusenbery, Brandi/0000-0001-7811-8613; Layne, Matthew/0000-0003-0007-4870	National Institutes of Health [HL086572, HL082854, HL093154, HL078869]; American Heart Association; Molecular Cardiology Research Institute at Tufts University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093154, R01HL078869, R21HL086572, R01HL082854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Molecular Cardiology Research Institute at Tufts University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL086572 (to G. L.), HL082854 (to A. H. and G. L.), HL093154 (to A. H.), and HL078869 (to M. D. L.). Further support was provided by the American Heart Association and the Molecular Cardiology Research Institute at Tufts University.	Agrawal A, 2003, IMMUNOLOGY, V108, P539, DOI 10.1046/j.1365-2567.2003.01608.x; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; Burton DGA, 2010, EXP GERONTOL, V45, P819, DOI 10.1016/j.exger.2010.07.005; Chan MC, 2010, EMBO J, V29, P559, DOI 10.1038/emboj.2009.370; Daley E, 2008, J EXP MED, V205, P361, DOI 10.1084/jem.20071008; Davis-Dusenbery BN, 2011, J BIOL CHEM, V286, P28097, DOI 10.1074/jbc.M111.236950; Dendooven A, 2011, AM J PATHOL, V178, P1069, DOI 10.1016/j.ajpath.2010.12.005; Eickelberg O, 2007, TRENDS CARDIOVAS MED, V17, P263, DOI 10.1016/j.tcm.2007.09.003; Fartoukh M, 1998, CHEST, V114, p50S, DOI 10.1378/chest.114.1_Supplement.50S; Fujita M, 2002, J APPL PHYSIOL, V93, P2162, DOI 10.1152/japplphysiol.00083.2002; Gupta V, 2007, CANCER RES, V67, P2747, DOI 10.1158/0008-5472.CAN-06-2312; Hagen M, 2007, AM J PHYSIOL-LUNG C, V292, pL1473, DOI 10.1152/ajplung.00197.2006; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; HUMBERT M, 1995, AM J RESP CRIT CARE, V151, P1628, DOI 10.1164/ajrccm.151.5.7735624; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; Luchsinger LL, 2011, J BIOL CHEM, V286, P44116, DOI 10.1074/jbc.M111.276931; Machado RD, 2009, J AM COLL CARDIOL, V54, pS32, DOI 10.1016/j.jacc.2009.04.015; Machado RD, 2006, HUM MUTAT, V27, P121, DOI 10.1002/humu.20285; Nicolls MR, 2005, EUR RESPIR J, V26, P1110, DOI 10.1183/09031936.05.00045705; Preston IR, 2006, AM J PHYSIOL-LUNG C, V290, pL367, DOI 10.1152/ajplung.00114.2005; Pullamsetti SS, 2011, CLIN MICROBIOL INFEC, V17, P7, DOI 10.1111/j.1469-0691.2010.03285.x; Sanchez O, 2007, AM J RESP CRIT CARE, V176, P1041, DOI 10.1164/rccm.200610-1559OC; Sawada H, 2007, CHEST, V132, P1265, DOI 10.1378/chest.06-2243; Simic P, 2005, CYTOKINE GROWTH F R, V16, P299, DOI 10.1016/j.cytogfr.2005.02.010; Song YL, 2008, AM J PHYSIOL-HEART C, V295, pH677, DOI 10.1152/ajpheart.91519.2007; Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Tang RH, 2008, P NATL ACAD SCI USA, V105, P3362, DOI 10.1073/pnas.0705842105; Taraseviciene-Stewart L, 2007, AM J RESP CRIT CARE, V175, P1280, DOI 10.1164/rccm.200608-1189OC; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Toshner M, 2010, BRIT MED BULL, V94, P21, DOI 10.1093/bmb/ldq012; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; West J, 2010, ADV EXP MED BIOL, V661, P265, DOI 10.1007/978-1-60761-500-2_17; Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68; Yao YC, 2010, CIRC RES, V107, P485, DOI 10.1161/CIRCRESAHA.110.219071; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200; Yu Y, 2003, AM J PHYSIOL-CELL PH, V284, pC316, DOI 10.1152/ajpcell.00125.2002; Yu Y, 2009, CIRCULATION, V119, P2313, DOI 10.1161/CIRCULATIONAHA.108.782458; ZABEL U, 1993, EMBO J, V12, P201, DOI 10.1002/j.1460-2075.1993.tb05646.x; Zhang Y, 2008, J IMMUNOL, V181, P503, DOI 10.4049/jimmunol.181.1.503	44	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28067	28077		10.1074/jbc.M112.379487	http://dx.doi.org/10.1074/jbc.M112.379487			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718766	Green Published, hybrid			2022-12-25	WOS:000307840700080
J	Rapoport, BI; Kedzierski, JT; Sarpeshkar, R				Rapoport, Benjamin I.; Kedzierski, Jakub T.; Sarpeshkar, Rahul			A Glucose Fuel Cell for Implantable Brain-Machine Interfaces	PLOS ONE			English	Article							BIOFUEL CELLS; ELECTRICITY-GENERATION; ELECTRODES; OXIDATION; SILICON; DESIGN	We have developed an implantable fuel cell that generates power through glucose oxidation, producing 3.4 mu W cm(-2) steady-state power and up to 180 mu W cm(-2) peak power. The fuel cell is manufactured using a novel approach, employing semiconductor fabrication techniques, and is therefore well suited for manufacture together with integrated circuits on a single silicon wafer. Thus, it can help enable implantable microelectronic systems with long-lifetime power sources that harvest energy from their surrounds. The fuel reactions are mediated by robust, solid state catalysts. Glucose is oxidized at the nanostructured surface of an activated platinum anode. Oxygen is reduced to water at the surface of a self-assembled network of single-walled carbon nanotubes, embedded in a Nafion film that forms the cathode and is exposed to the biological environment. The catalytic electrodes are separated by a Nafion membrane. The availability of fuel cell reactants, oxygen and glucose, only as a mixture in the physiologic environment, has traditionally posed a design challenge: Net current production requires oxidation and reduction to occur separately and selectively at the anode and cathode, respectively, to prevent electrochemical short circuits. Our fuel cell is configured in a half-open geometry that shields the anode while exposing the cathode, resulting in an oxygen gradient that strongly favors oxygen reduction at the cathode. Glucose reaches the shielded anode by diffusing through the nanotube mesh, which does not catalyze glucose oxidation, and the Nafion layers, which are permeable to small neutral and cationic species. We demonstrate computationally that the natural recirculation of cerebrospinal fluid around the human brain theoretically permits glucose energy harvesting at a rate on the order of at least 1 mW with no adverse physiologic effects. Low-power brain-machine interfaces can thus potentially benefit from having their implanted units powered or recharged by glucose fuel cells.	[Rapoport, Benjamin I.; Sarpeshkar, Rahul] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Rapoport, Benjamin I.; Kedzierski, Jakub T.] MIT, Lincoln Lab, Adv Silicon Technol Grp, Lexington, MA 02173 USA; [Rapoport, Benjamin I.] Harvard Univ, Sch Med, MD PhD Program, Boston, MA USA	Massachusetts Institute of Technology (MIT); Lincoln Laboratory; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Rapoport, BI (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	rahuls@mit.edu	Rapoport, Benjamin/ABF-2332-2021		National Institutes of Health [NS-056140]; Office of Naval Research [N00014-09-1-1015]; DARPA Research Assistantship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); DARPA Research Assistantship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded in part by the National Institutes of Health under grant NS-056140, by the Office of Naval Research under grant N00014-09-1-1015, and by a DARPA Research Assistantship to MIT Lincoln Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2008, BRAIN RES, V1218, P77, DOI 10.1016/j.brainres.2008.04.007; [Anonymous], 2010, LT3108 ULTR VOLT STE; Attard GS, 1997, SCIENCE, V278, P838, DOI 10.1126/science.278.5339.838; Attard GS, 1997, ANGEW CHEM INT EDIT, V36, P1315, DOI 10.1002/anie.199713151; Baker MW, 2007, IEEE T BIOMED CIRC S, V1, P28, DOI 10.1109/TBCAS.2007.893180; Bard A. J., 2001, ELECTROCHEMICAL METH; Barrett Kim E, 2010, GANONGS REV MEDICAL; Bullen RA, 2006, BIOSENS BIOELECTRON, V21, P2015, DOI 10.1016/j.bios.2006.01.030; Burke A, 2000, J POWER SOURCES, V91, P37, DOI 10.1016/S0378-7753(00)00485-7; Chaudhry HJ, 2004, FUNDAMENTALS CLIN ME; Davis F, 2007, BIOSENS BIOELECTRON, V22, P1224, DOI 10.1016/j.bios.2006.04.029; Davson H., 1996, PHYSL CSF BLOOD BRAI; Denny M. W., 1993, AIR WATER BIOL PHYS; DRAKE RF, 1970, T AM SOC ART INT ORG, V16, P199; Dudney NJ, 1999, CURR OPIN SOLID ST M, V4, P479, DOI 10.1016/S1359-0286(99)00052-2; Ellenbogen KA, 2000, CLIN CARDIAC PACING; GEBHARDT U, 1976, J APPL ELECTROCHEM, V6, P127, DOI 10.1007/BF00615377; Gold S, 2004, J POWER SOURCES, V135, P198, DOI 10.1016/j jpowsour.2004.03.084; Greenberg M.S, 2010, HDB NEUROSURGERY; Heller A, 2004, PHYS CHEM CHEM PHYS, V6, P209, DOI 10.1039/b313149a; Heller A, 2008, U.S. Patent, Patent No. [7,368,190, 7368190]; Ilic B, 1999, ELECTROCHEM SOLID ST, V2, P86, DOI 10.1149/1.1390743; Jayalakshmi M, 2008, INT J ELECTROCHEM SC, V3, P1196; Kerzenmacher S, 2008, J POWER SOURCES, V182, P66, DOI 10.1016/j.jpowsour.2008.03.049; Kerzenmacher S, 2008, J POWER SOURCES, V182, P1, DOI 10.1016/j.jpowsour.2008.03.031; Kerzenmacher S, 2010, J POWER SOURCES, V195, P6516, DOI 10.1016/j.jpowsour.2010.04.039; Kerzenmacher S, 2010, J POWER SOURCES, V195, P6524, DOI 10.1016/j.jpowsour.2010.04.049; Kim G, 2009, J BIOMAT SCI-POLYM E, V20, P1687, DOI 10.1163/156856208X386273; Kumar K, 2005, ROBBINS COTRANS PATH, V7, P213; Kurs A, 2007, SCIENCE, V317, P83, DOI 10.1126/science.1143254; Lee YJ, 2008, IEEE SENS J, V8, P1922, DOI 10.1109/JSEN.2008.2006697; Leonov V, 2007, IEEE SENS J, V7, P650, DOI 10.1109/JSEN.2007.894917; Logan B.E., 2008, MICROBIAL FUEL CELLS; Lu K, 2004, AM J PHYSIOL-HEART C, V286, pH584, DOI 10.1152/ajpheart.00594.2003; MacKay David J.C., 2009, SUSTAINABLE ENERGY H; Maclay J, 1989, U.S. Patent, Patent No. [4,795,543, 4795543]; Mandal S, 2007, IEEE T CIRCUITS-I, V54, P1177, DOI 10.1109/TCSI.2007.895229; Mitcheson PD, 2008, P IEEE, V96, P1457, DOI 10.1109/JPROC.2008.927494; Newman J., 2004, ELECTROCHEMICAL SYST; Niessen J, 2004, ELECTROCHEM COMMUN, V6, P955, DOI 10.1016/j.elecom.2004.07.010; Osman MH, 2010, BIOSENS BIOELECTRON, V26, P953, DOI 10.1016/j.bios.2010.08.057; Panasonic Industry, 2022, ULTRA LOW POWER BIOE, DOI 10.1017/CBO9780511841446; Prilutsky S, 2010, ELECTROCHIM ACTA, V55, P3694, DOI 10.1016/j.electacta.2010.02.005; Rabaey J, 2009, INTEGR CIRCUIT SYST, P1, DOI 10.1007/978-0-387-71713-5; Rabaey K, 2003, BIOTECHNOL LETT, V25, P1531, DOI 10.1023/A:1025484009367; Rabaey K, 2004, APPL ENVIRON MICROB, V70, P5373, DOI 10.1128/AEM.70.9.5373-5382.2004; Rao R, 1975, U.S. Patent, Patent No. [3861397, 3,861,397]; Rapoport B, 2011, SYSTEM CIRCUIT DESIG, P216; Rapoport BI, 2009, P 31 ANN INT C IEEE; RISHPON J, 1994, ELECTROANAL, V6, P17, DOI 10.1002/elan.1140060105; Ropper A.H. a.B., 2005, ADAMS VICTORS PRINCI; ROSENBERG GA, 1990, BRAIN FLUIDS METABOL; Sarpeshkar R, 2005, IEEE T BIO-MED ENG, V52, P711, DOI 10.1109/TBME.2005.844043; Sarpeshkar R, 2008, IEEE T BIOMED CIRC S, V2, P173, DOI 10.1109/TBCAS.2008.2003198; Sharma T, 2011, LAB CHIP, V11, P2460, DOI 10.1039/c1lc20119k; von Stetten F, 2006, HLTH AIMS DISS DAY P, pWP5b; von Sturm F, 1976, U.S. Patent, Patent No. [3,941,135, 3941135]; Wattanapanitch W, 2007, IEEE T BIOMED CIRC S, V1, P136, DOI 10.1109/TBCAS.2007.907868; Weidlich E, 1976, BIOMATERIALS MED DEV, V3-4, P227; Wu G, 2007, J POWER SOURCES, V174, P148, DOI 10.1016/j.jpowsour.2007.08.024; Zaharchuk G, 2005, MAGNET RESON MED, V54, P113, DOI 10.1002/mrm.20546	62	154	160	3	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38436	10.1371/journal.pone.0038436	http://dx.doi.org/10.1371/journal.pone.0038436			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719888	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340000023
J	Cady, NC; McKean, KA; Behnke, J; Kubec, R; Mosier, AP; Kasper, SH; Burz, DS; Musah, RA				Cady, Nathaniel C.; McKean, Kurt A.; Behnke, Jason; Kubec, Roman; Mosier, Aaron P.; Kasper, Stephen H.; Burz, David S.; Musah, Rabi A.			Inhibition of Biofilm Formation, Quorum Sensing and Infection in Pseudomonas aeruginosa by Natural Products-Inspired Organosulfur Compounds	PLOS ONE			English	Article							PETIVERIA-ALLIACEA; BACTERIAL BIOFILMS; MICROBIAL BIOFILMS; IN-VITRO; SULFOXIDE; CYSTEINE; GENES; EXPRESSION; MODEL; DERIVATIVES	Using a microplate-based screening assay, the effects on Pseudomonas aeruginosa PAO1 biofilm formation of several S-substituted cysteine sulfoxides and their corresponding disulfide derivatives were evaluated. From our library of compounds, S-phenyl-L-cysteine sulfoxide and its breakdown product, diphenyl disulfide, significantly reduced the amount of biofilm formation by P. aeruginosa at levels equivalent to the active concentration of 4-nitropyridine-N-oxide (NPO) (1 mM). Unlike NPO, which is an established inhibitor of bacterial biofilms, our active compounds did not reduce planktonic cell growth and only affected biofilm formation. When used in a Drosophila-based infection model, both S-phenyl-L-cysteine sulfoxide and diphenyl disulfide significantly reduced the P. aeruginosa recovered 18 h post infection (relative to the control), and were non-lethal to the fly hosts. The possibility that the observed biofilm inhibitory effects were related to quorum sensing inhibition (QSI) was investigated using Escherichia coli-based reporters expressing P. aeruginosa lasR or rhIR response proteins, as well as an endogenous P. aeruginosa reporter from the lasI/lasR QS system. Inhibition of quorum sensing by S-phenyl-L-cysteine sulfoxide was observed in all of the reporter systems tested, whereas diphenyl disulfide did not exhibit QSI in either of the E. coli reporters, and showed very limited inhibition in the P. aeruginosa reporter. Since both compounds inhibit biofilm formation but do not show similar QSI activity, it is concluded that they may be functioning by different pathways. The hypothesis that biofilm inhibition by the two active compounds discovered in this work occurs through QSI is discussed.	[Cady, Nathaniel C.; Behnke, Jason; Mosier, Aaron P.; Kasper, Stephen H.] SUNY Albany, Coll Nanoscale Sci & Engn, Albany, NY 12222 USA; [McKean, Kurt A.] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA; [Kubec, Roman] Univ S Bohemia, Dept Appl Chem, Bohemia, Czech Republic; [Burz, David S.; Musah, Rabi A.] SUNY Albany, Dept Chem, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; SUNY Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of South Bohemia Ceske Budejovice; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Cady, NC (corresponding author), SUNY Albany, Coll Nanoscale Sci & Engn, Albany, NY 12222 USA.	musah@albany.edu	Kubec, Roman/P-7507-2019	Kubec, Roman/0000-0002-2934-4443	National Science Foundation [0239755]; Div Of Biological Infrastructure [1062963] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work reported here was supported by a grant to RAM from the National Science Foundation under award number 0239755. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apidianakis Y, 2009, NAT PROTOC, V4, P1285, DOI 10.1038/nprot.2009.124; Bjarnsholt T, 2005, MICROBIOL-SGM, V151, P3873, DOI 10.1099/mic.0.27955-0; Block E, 2010, J AGR FOOD CHEM, V58, P4617, DOI 10.1021/jf1000106; Brackman G, 2011, ANTIMICROB AGENTS CH, V55, P2655, DOI 10.1128/AAC.00045-11; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Christensen LD, 2012, J ANTIMICROB CHEMOTH, V67, P1198, DOI 10.1093/jac/dks002; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Dasgupta MK, 1996, J AM SOC NEPHROL, V7, P877; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; De Kievit TR, 2001, APPL ENVIRON MICROB, V67, P1865, DOI 10.1128/AEM.67.4.1865-1873.2001; Estin ML, 2010, ADV EXP MED BIOL, V660, P183, DOI 10.1007/978-1-60761-350-3_17; Harjai K, 2010, FEMS IMMUNOL MED MIC, V58, P161, DOI 10.1111/j.1574-695X.2009.00614.x; Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87; Heydorn A, 2002, APPL ENVIRON MICROB, V68, P2008, DOI 10.1128/AEM.68.4.2008-2017.2002; Jakobsen TH, 2012, ANTIMICROB AGENTS CH, V56, P2314, DOI 10.1128/AAC.05919-11; JENSEN ET, 1993, MICROB PATHOGENESIS, V15, P377, DOI 10.1006/mpat.1993.1087; Junker LM, 2007, ANTIMICROB AGENTS CH, V51, P3582, DOI 10.1128/AAC.00506-07; Kaufmann GF, 2008, EXPERT OPIN BIOL TH, V8, P719, DOI 10.1517/14712598.8.6.719 ; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Kovaleva J, 2010, J HOSP INFECT, V76, P345, DOI 10.1016/j.jhin.2010.07.008; Krom BP, 2007, J MICROBIOL METH, V68, P421, DOI 10.1016/j.mimet.2006.08.003; Kubec R, 2002, J NAT PROD, V65, P960, DOI 10.1021/np020064i; Kubec R, 2002, PHYTOCHEMISTRY, V60, P21, DOI 10.1016/S0031-9422(02)00065-1; Kubec R, 2002, PHYTOCHEMISTRY, V61, P675, DOI 10.1016/S0031-9422(02)00328-X; Kubec R, 2001, PHYTOCHEMISTRY, V58, P981, DOI 10.1016/S0031-9422(01)00304-1; MELULENI GJ, 1995, J IMMUNOL, V155, P2029; Miyamoto CM, 1996, MOL MICROBIOL, V19, P767, DOI 10.1046/j.1365-2958.1996.417948.x; Montazerozohori M, 2007, MOLECULES, V12, P694, DOI 10.3390/12030694; Muh U, 2006, ANTIMICROB AGENTS CH, V50, P3674, DOI 10.1128/AAC.00665-06; Mulcahy H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002299; Musah RA, 2009, PLANT PHYSIOL, V151, P1304, DOI 10.1104/pp.109.142430; NOMURA J, 1963, J BIOL CHEM, V238, P1441; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Persson T, 2005, ORG BIOMOL CHEM, V3, P253, DOI 10.1039/b415761c; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Purevdorj B, 2002, APPL ENVIRON MICROB, V68, P4457, DOI 10.1128/AEM.68.9.4457-4464.2002; Reen FJ, FEMS MICROBIOL ECOL, V77, P413; Rogers FP, 1994, FEMS IMMUNOL MED MIC, V9, P109; Sakuragi Y, 2007, J BACTERIOL, V189, P5383, DOI 10.1128/JB.00137-07; Schaber JA, 2007, J MED MICROBIOL, V56, P738, DOI 10.1099/jmm.0.47031-0; Smyth AR, 2010, PEDIATR PULM, V45, P356, DOI 10.1002/ppul.21193; Vanoyan N, 2010, LANGMUIR, V26, P12089, DOI 10.1021/la101319e; Walencka Elzbieta, 2005, Polish Journal of Microbiology, V54, P191	47	135	144	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38492	10.1371/journal.pone.0038492	http://dx.doi.org/10.1371/journal.pone.0038492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715388	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336800030
J	Liu, ZJ; Li, Y; Tan, YR; Xiao, M; Zhang, JL; Radtke, F; Velazquez, OC				Liu, Zhao-Jun; Li, Yan; Tan, Yurong; Xiao, Min; Zhang, Jialin; Radtke, Freddy; Velazquez, Omaida C.			Inhibition of Fibroblast Growth by Notch1 Signaling Is Mediated by Induction of Wnt11-Dependent WISP-1	PLOS ONE			English	Article							MELANOMA PROGRESSION; EXTRACELLULAR-MATRIX; STROMAL FIBROBLASTS; WNT/BETA-CATENIN; DOWN-REGULATION; CANCER; CELLS; TUMOR; ACTIVATION; WNT11	Fibroblasts are an integral component of stroma and important source of growth factors and extracellular matrix (ECM). They play a prominent role in maintaining tissue homeostasis and in wound healing and tumor growth. Notch signaling regulates biological function in a variety of cells. To elucidate the physiological function of Notch signaling in fibroblasts, we ablated Notch1 in mouse (Notch1(Flox/Flox)) embryonic fibroblasts (MEFs). Notch1-deficient (Notch1(-/-)) MEFs displayed faster growth and motility rate compared to Notch1(Flox/Flox) MEFs. Such phenotypic changes, however, were reversible by reconstitution of Notch1 activation via overexpression of the intracellular domain of Notch1 (NICD1) in Notch1-deficient MEFs. In contrast, constitutive activation of Notch1 signaling by introducing NICD1 into primary human dermal fibroblasts (FF2441), which caused pan-Notch activation, inhibited cell growth and motility, whereas cellular inhibition was relievable when the Notch activation was countered with dominant-negative mutant of Master-mind like 1 (DN-MAML-1). Functionally, "Notch-activated" stromal fibroblasts could inhibit tumor cell growth/invasion. Moreover, Notch activation induced expression of Wnt-induced secreted proteins-1 (WISP-1/CCN4) in FF2441 cells while deletion of Notch1 in MEFs resulted in an opposite effect. Notably, WISP-1 suppressed fibroblast proliferation, and was responsible for mediating Notch1's inhibitory effect since siRNA-mediated blockade of WISP-1 expression could relieve cell growth inhibition. Notch1-induced WISP-1 expression appeared to be Wnt11-dependent, but Wnt1-independent. Blockade of Wnt11 expression resulted in decreased WISP-1 expression and liberated Notch-induced cell growth inhibition. These findings indicated that inhibition of fibroblast proliferation by Notch pathway activation is mediated, at least in part, through regulating Wnt1-independent, but Wnt11-dependent WISP-1 expression.	[Liu, Zhao-Jun; Li, Yan; Tan, Yurong; Zhang, Jialin; Velazquez, Omaida C.] Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA; [Liu, Zhao-Jun; Velazquez, Omaida C.] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA; [Xiao, Min] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Radtke, Freddy] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, CH-1015 Lausanne, Switzerland	University of Miami; University of Miami; The Wistar Institute; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Liu, ZJ (corresponding author), Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA.	ovelazquez@med.miami.edu	Radtke, Freddy/Q-3198-2017	Radtke, Freddy/0000-0003-4315-4045	National Institutes of Health [R01DK-071084, R01GM081570]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (R01DK-071084 and R01GM081570). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Becker V, 1998, CLIN EXP NEPHROL, V2, P295; Desnoyers L, 2001, J BIOL CHEM, V276, P47599, DOI 10.1074/jbc.M108339200; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Fukunaga-Kalabis M, 2008, ONCOGENE, V27, P2552, DOI 10.1038/sj.onc.1210896; Fukunaga-Kalabis M, 2006, J CELL BIOL, V175, P563, DOI 10.1083/jcb.200602132; Hogan B., 1994, MANIPULATING MOUSE E; Hsu MY, 1998, AM J PATHOL, V153, P1435, DOI 10.1016/S0002-9440(10)65730-6; Ingber DE, 2002, DIFFERENTIATION, V70, P547, DOI 10.1046/j.1432-0436.2002.700908.x; Ishii G, 2003, BIOCHEM BIOPH RES CO, V309, P232, DOI 10.1016/S0006-291X(03)01544-4; Ishikawa Y, 2008, ONCOGENE, V27, P6164, DOI 10.1038/onc.2008.216; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kirikoshi H, 2001, INT J MOL MED, V8, P651; Lin ZH, 2007, CANCER RES, V67, P5017, DOI 10.1158/0008-5472.CAN-06-3696; Liu ZJ, 2006, FASEB J, V20, P1009, DOI 10.1096/fj.05-4880fje; Lynch CC, 2002, DIFFERENTIATION, V70, P561, DOI 10.1046/j.1432-0436.2002.700909.x; Maillard I, 2003, CANCER CELL, V3, P203, DOI 10.1016/S1535-6108(03)00052-7; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Meier F, 2000, AM J PATHOL, V156, P193, DOI 10.1016/S0002-9440(10)64719-0; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Ouko L, 2004, J BIOL CHEM, V279, P26707, DOI 10.1074/jbc.M402877200; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Railo A, 2008, EXP CELL RES, V314, P2389, DOI 10.1016/j.yexcr.2008.04.010; Ross DA, 2004, EXP CELL RES, V296, P173, DOI 10.1016/j.yexcr.2004.02.003; Sakamoto K, 2002, J BIOL CHEM, V277, P29399, DOI 10.1074/jbc.M203727200; SAPPINO AP, 1988, INT J CANCER, V41, P707, DOI 10.1002/ijc.2910410512; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Shao H, 2011, ONCOGENE, V30, P4316, DOI 10.1038/onc.2011.142; Tanaka S, 2001, ONCOGENE, V20, P5525, DOI 10.1038/sj.onc.1204723; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Urs S, 2008, AM J PATHOL, V173, P865, DOI 10.2353/ajpath.2008.080006; Venkatachalam K, 2009, J BIOL CHEM, V284, P14414, DOI 10.1074/jbc.M809757200; Xu LF, 2000, GENE DEV, V14, P585; Zhou WL, 2007, NAT GENET, V39, P1225, DOI 10.1038/ng2112; Zhu HN, 2004, CANCER RES, V64, P7918, DOI 10.1158/0008-5472.CAN-04-2704	41	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38811	10.1371/journal.pone.0038811	http://dx.doi.org/10.1371/journal.pone.0038811			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715413	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336800055
J	Tozzi, A; de Iure, A; Marsili, V; Romano, R; Tantucci, M; Di Filippo, M; Costa, C; Napolitano, F; Mercuri, NB; Borsini, F; Giampa, C; Fusco, FR; Picconi, B; Usiello, A; Calabresi, P				Tozzi, Alessandro; de Iure, Antonio; Marsili, Valentina; Romano, Rosaria; Tantucci, Michela; Di Filippo, Massimiliano; Costa, Cinzia; Napolitano, Francesco; Mercuri, Nicola Biagio; Borsini, Franco; Giampa, Carmen; Fusco, Francesca Romana; Picconi, Barbara; Usiello, Alessandro; Calabresi, Paolo			A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation	PLOS ONE			English	Article							DOPAMINE D2 RECEPTORS; LONG-TERM DEPRESSION; MEDIUM SPINY NEURONS; CHOLINERGIC INTERNEURONS; BASAL GANGLIA; ENDOCANNABINOID RELEASE; NUCLEUS-ACCUMBENS; GENE-EXPRESSION; NEURAL BASIS; STRIATUM	Background: Cocaine increases the level of endogenous dopamine (DA) in the striatum by blocking the DA transporter. Endogenous DA modulates glutamatergic inputs to striatal neurons and this modulation influences motor activity. Since D2 DA and A2A-adenosine receptors (A2A-Rs) have antagonistic effects on striatal neurons, drugs targeting adenosine receptors such as caffeine-like compounds, could enhance psychomotor stimulant effects of cocaine. In this study, we analyzed the electrophysiological effects of cocaine and A2A-Rs antagonists in striatal slices and the motor effects produced by this pharmacological modulation in rodents. Principal Findings: Concomitant administration of cocaine and A2A-Rs antagonists reduced glutamatergic synaptic transmission in striatal spiny neurons while these drugs failed to produce this effect when given in isolation. This inhibitory effect was dependent on the activation of D2-like receptors and the release of endocannabinoids since it was prevented by L-sulpiride and reduced by a CB1 receptor antagonist. Combined application of cocaine and A2A-R antagonists also reduced the firing frequency of striatal cholinergic interneurons suggesting that changes in cholinergic tone might contribute to this synaptic modulation. Finally, A2A-Rs antagonists, in the presence of a sub-threshold dose of cocaine, enhanced locomotion and, in line with the electrophysiological experiments, this enhanced activity required activation of D2-like and CB1 receptors. Conclusions: The present study provides a possible synaptic mechanism explaining how caffeine-like compounds could enhance psychomotor stimulant effects of cocaine.	[Tozzi, Alessandro; de Iure, Antonio; Tantucci, Michela; Di Filippo, Massimiliano; Costa, Cinzia; Calabresi, Paolo] Univ Perugia, Neurol Clin, Osped S Maria della Misericordia, I-06100 Perugia, Italy; [Tozzi, Alessandro; de Iure, Antonio; Tantucci, Michela; Mercuri, Nicola Biagio; Giampa, Carmen; Fusco, Francesca Romana; Picconi, Barbara; Calabresi, Paolo] Fdn Santa Lucia IRCCS, Rome, Italy; [Marsili, Valentina; Romano, Rosaria; Napolitano, Francesco; Usiello, Alessandro] CEINGE Biotecnol Avanzate, Naples, Italy; [Borsini, Franco] Sigma Tau Ind Riunite, Pomezia, Italy; [Usiello, Alessandro] SUN, Naples, Italy	Hospital Santa Maria della Misericordia; University of Perugia; IRCCS Santa Lucia; CEINGE Biotecnologie Avanzate	Tozzi, A (corresponding author), Univ Perugia, Neurol Clin, Osped S Maria della Misericordia, I-06100 Perugia, Italy.	calabre@unipg.it	usiello, alessandro/B-2368-2012; Fusco, Francesca R/K-1080-2018; Costa, Cinzia/K-8485-2016; Picconi, Barbara/G-8299-2011; Tozzi, Alessandro/AAB-8707-2022; Calabresi, Paolo/G-8496-2011; Tozzi, Alessandro/G-7254-2011; Napolitano, Francesco/F-8691-2012; Mercuri, Nicola Biagio/K-5348-2016; de iure, Antonio/B-1084-2019	Fusco, Francesca R/0000-0003-2226-523X; Costa, Cinzia/0000-0002-4862-4221; Picconi, Barbara/0000-0001-6020-1021; Calabresi, Paolo/0000-0003-0326-5509; Mercuri, Nicola Biagio/0000-0001-6700-7491; Napolitano, Francesco/0000-0003-0884-1851; de iure, Antonio/0000-0002-7672-7068; Usiello, Alessandro/0000-0001-9203-853X; , Giampa/0000-0002-1763-5665; Tozzi, Alessandro/0000-0003-3153-2424	European Community (EC) [222918 (REPLACES)]; Italian Ministery of Health "Progetto Strategico 2007"; Italian Ministery of Health "Progetti Finalizzati 2006-2008"; Fondazione Cassa di Risparmio di Perugia; Progetti Finalizzati Multicentrici Programma Neuroscienze Compagnia di San Paolo; Bayer Schering; Biogen; Boehringer Ingelheim; Eisai; Novartis; Lundbeck; Sanofi-Aventis; Sigma-Tau; UCB Pharma; Ricerca Corrente IRCCS; Ricerca Finalizzata IRCCS; European Community [SYNSCAFF, REPLACES]; Italian Minister of Health and AIFA (Agenzia Italiana del Farmaco)	European Community (EC)(European CommissionEuropean Commission Joint Research Centre); Italian Ministery of Health "Progetto Strategico 2007"; Italian Ministery of Health "Progetti Finalizzati 2006-2008"; Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia); Progetti Finalizzati Multicentrici Programma Neuroscienze Compagnia di San Paolo(Compagnia di San Paolo); Bayer Schering(Bayer AG); Biogen(Biogen); Boehringer Ingelheim(Boehringer Ingelheim); Eisai(Eisai Co Ltd); Novartis(Novartis); Lundbeck(Lundbeck Corporation); Sanofi-Aventis(Sanofi-Aventis); Sigma-Tau; UCB Pharma(UCB Pharma SA); Ricerca Corrente IRCCS(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC)); Ricerca Finalizzata IRCCS(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); European Community(European Commission); Italian Minister of Health and AIFA (Agenzia Italiana del Farmaco)	This work was supported by grants from: European Community (EC) contract number 222918 (REPLACES) FP7 - Thematic priority HEALTH (PC), Italian Ministery of Health "Progetto Strategico 2007" (PC, BP), Italian Ministery of Health "Progetti Finalizzati 2006-2008" (PC, BP), Fondazione Cassa di Risparmio di Perugia (PC) and Progetti Finalizzati Multicentrici Programma Neuroscienze Compagnia di San Paolo (PC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Calabresi serves as an editorial board member of Lancet Neurology, the Journal of Neuroscience, Movement Disorders and Synapse; receives research support from Bayer Schering, Biogen, Boehringer Ingelheim, Eisai, Novartis, Lundbeck, Sanofi-Aventis, Sigma-Tau, and UCB Pharma; and from Ricerca Corrente IRCCS, Ricerca Finalizzata IRCCS [European Community Grants SYNSCAFF and REPLACES], the Italian Minister of Health and AIFA (Agenzia Italiana del Farmaco). Dr. Franco Borsini is employed by Sigma-tau Industrie Riunite, Pomezia, Italy. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. All other authors reported no biomedical financial interests or potential conflicts of interest.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Alcantara AA, 2003, BRAIN RES, V986, P22, DOI 10.1016/S0006-8993(03)03165-2; Aliane V, 2011, BRAIN, V134, P110, DOI 10.1093/brain/awq285; Aliane V, 2009, EUR J NEUROSCI, V30, P1269, DOI 10.1111/j.1460-9568.2009.06907.x; AMALRIC M, 1993, PROG BRAIN RES, V99, P209; Bagetta V, 2011, J NEUROSCI IN PRESS, V31; BECKSTEAD RM, 1985, J COMP NEUROL, V232, P481, DOI 10.1002/cne.902320406; Bennett BD, 1998, J NEUROSCI, V18, P8539; Bennett BD, 1999, J NEUROSCI, V19, P5586; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bhide PG, 2009, SEMIN CELL DEV BIOL, V20, P395, DOI 10.1016/j.semcdb.2009.01.006; Bradberry CW, 2008, REV NEUROSCIENCE, V19, P113; Calabresi P, 1998, ANN NEUROL, V43, P586, DOI 10.1002/ana.410430506; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Carey RJ, 2008, PROG BRAIN RES, V172, P347, DOI 10.1016/S0079-6123(08)00917-5; Centonze D, 2004, NEUROPSYCHOPHARMACOL, V29, P1488, DOI 10.1038/sj.npp.1300458; Cheer JF, 2007, J NEUROSCI, V27, P791, DOI 10.1523/JNEUROSCI.4152-06.2007; Costa C, 2008, J NEUROSCI, V28, P8040, DOI 10.1523/JNEUROSCI.1947-08.2008; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Deng YP, 2006, J CHEM NEUROANAT, V32, P101, DOI 10.1016/j.jchemneu.2006.07.001; Ferre S, 1997, PSYCHOPHARMACOLOGY, V133, P107, DOI 10.1007/s002130050380; Ferre S, 2010, J ALZHEIMERS DIS, V20, pS35, DOI 10.3233/JAD-2010-1400; Ferre S, 2010, BRIT J PHARMACOL, V160, P443, DOI 10.1111/j.1476-5381.2010.00723.x; Ferre S, 2009, NEUROPHARMACOLOGY, V56, P226, DOI 10.1016/j.neuropharm.2008.06.076; Fisone G, 2004, CELL MOL LIFE SCI, V61, P857, DOI 10.1007/s00018-003-3269-3; Fuxe K., 2003, Neurology, V61, pS19; Fuxe K, 2007, PHYSIOL BEHAV, V92, P210, DOI 10.1016/j.physbeh.2007.05.034; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Higley MJ, 2009, NAT NEUROSCI, V12, P1121, DOI 10.1038/nn.2368; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kalivas PW, 1998, J PSYCHOPHARMACOL, V12, P49, DOI 10.1177/026988119801200107; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; Kelley AE, 2002, J NEUROSCI, V22, P3306; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Lerner TN, 2010, J NEUROSCI, V30, P2160, DOI 10.1523/JNEUROSCI.5844-09.2010; Letchworth SR, 2001, J NEUROSCI, V21, P2799, DOI 10.1523/JNEUROSCI.21-08-02799.2001; Nader MA, 2006, NAT NEUROSCI, V9, P1050, DOI 10.1038/nn1737; Napolitano F, 2010, J NEUROSCI, V30, P11043, DOI 10.1523/JNEUROSCI.1682-10.2010; Penberthy Jennifer K, 2010, Curr Drug Abuse Rev, V3, P49; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Porrino LJ, 2007, PROG NEURO-PSYCHOPH, V31, P1593, DOI 10.1016/j.pnpbp.2007.08.040; Riegel AC, 2004, J NEUROSCI, V24, P11070, DOI 10.1523/JNEUROSCI.3695-04.2004; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; RITZ MC, 1990, LIFE SCI, V46, P635, DOI 10.1016/0024-3205(90)90132-B; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Roitman MF, 2008, NAT NEUROSCI, V11, P1376, DOI 10.1038/nn.2219; Schiffmann SN, 2007, PROG NEUROBIOL, V83, P277, DOI 10.1016/j.pneurobio.2007.05.001; Schwarzschild MA, 2006, TRENDS NEUROSCI, V29, P647, DOI 10.1016/j.tins.2006.09.004; Shen HY, 2008, J NEUROSCI, V28, P2970, DOI 10.1523/JNEUROSCI.5255-07.2008; Singla S, 2007, J NEUROSCI, V27, P5260, DOI 10.1523/JNEUROSCI.0018-07.2007; Song WJ, 2000, J NEUROPHYSIOL, V83, P322, DOI 10.1152/jn.2000.83.1.322; Svenningsson P, 2005, AAPS J, V7, DOI 10.1208/aapsj070235; Tozzi A, 2007, NEUROPHARMACOLOGY, V53, P783, DOI 10.1016/j.neuropharm.2007.08.006; Tozzi A, 2011, J NEUROSCI, V31, P1850, DOI 10.1523/JNEUROSCI.4082-10.2011; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Yin HH, 2006, P NATL ACAD SCI USA, V103, P8251, DOI 10.1073/pnas.0510797103; Zhang Y, 2001, ANN NY ACAD SCI, V937, P93	60	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38312	10.1371/journal.pone.0038312	http://dx.doi.org/10.1371/journal.pone.0038312			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715379	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336800020
J	Arora, PK; Jain, RK				Arora, Pankaj Kumar; Jain, Rakesh Kumar			Metabolism of 2-Chloro-4-Nitrophenol in a Gram Negative Bacterium, Burkholderia sp RKJ 800	PLOS ONE			English	Article							CHLORINATED NITROAROMATIC COMPOUNDS; REDUCTIVE DECHLORINATION; DEGRADATION; PATHWAY; 4-CHLORO-2-NITROPHENOL; BIODEGRADATION; 4-CHLORONITROBENZENE; INVOLVEMENT	A 2-Chloro-4-nitrophenol (2C4NP) degrading bacterial strain designated as RKJ 800 was isolated from a pesticide contaminated site of India by enrichment method and utilized 2C4NP as sole source of carbon and energy. The stoichiometric amounts of nitrite and chloride ions were detected during the degradation of 2C4NP. On the basis of thin layer chromatography, high performance liquid chromatography and gas chromatography-mass spectrometry, chlorohydroquinone (CHQ) and hydroquinone (HQ) were identified as major metabolites of the degradation pathway of 2C4NP. Manganese dependent HQ dioxygenase activity was observed in the crude extract of 2C4NP induced cells of the strain RKJ 800 that suggested the cleavage of the HQ to gamma-hydroxymuconic semialdehyde. On the basis of the 16S rRNA gene sequencing, strain RKJ 800 was identified as a member of genus Burkholderia. Our studies clearly showed that Burkholderia sp. RKJ 800 degraded 2-chloro-4-nitrophenol via hydroquinone pathway. The pathway identified in a gram negative bacterium, Burkholderia sp. strain RKJ 800 was differed from previously reported 2C4NP degradation pathway in another gram-negative Burkholderia sp. SJ98. This is the first report of the formation of CHQ and HQ in the degradation of 2C4NP by any gram-negative bacteria. Laboratory-scale soil microcosm studies showed that strain RKJ 800 is a suitable candidate for bioremediation of 2C4NP contaminated sites.	[Arora, Pankaj Kumar; Jain, Rakesh Kumar] Inst Microbial Technol CSIR, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Arora, PK (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Plant Sci, PO Cent Univ, Hyderabad 500134, Andhra Pradesh, India.	arora484@gmail.com	ARORA, PANKAJ K/F-9418-2014	ARORA, PANKAJ K/0000-0002-4106-8859				Arora PK, 2013, 3 BIOTECH, V3, P29, DOI 10.1007/s13205-012-0066-4; Arora PK, 2012, BIODEGRADATION, V23, P325, DOI 10.1007/s10532-011-9512-y; Arora PK, 2012, APPL MICROBIOL BIOT, V93, P2265, DOI 10.1007/s00253-012-3927-1; Arora PK, 2011, CURR MICROBIOL, V63, P568, DOI 10.1007/s00284-011-0022-2; Arora PK, 2011, INT J SYST EVOL MICR, V61, P1859, DOI 10.1099/ijs.0.023184-0; Arora PK, 2010, J BIOREMED BIODEGRAD, V1, P110; BEUNINK J, 1990, APPL MICROBIOL BIOT, V34, P108, DOI 10.1007/BF00170933; BRUHN C, 1988, ARCH MICROBIOL, V150, P171, DOI 10.1007/BF00425158; Ghosh A, 2010, ENVIRON SCI TECHNOL, V44, P1069, DOI 10.1021/es9034123; Hayatsu M, 2000, APPL ENVIRON MICROB, V66, P1737, DOI 10.1128/AEM.66.4.1737-1740.2000; Ju KS, 2010, MICROBIOL MOL BIOL R, V74, P250, DOI 10.1128/MMBR.00006-10; Katsivela E, 1999, APPL ENVIRON MICROB, V65, P1405; Kolvenbach BA, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-8; Li BZ, 2010, J ZHEJIANG UNIV-SC B, V11, P177, DOI 10.1631/jzus.B0900291; Miyauchi K, 1998, J BACTERIOL, V180, P1354, DOI 10.1128/JB.180.6.1354-1359.1998; Ohtsubo Y, 1999, FEBS LETT, V459, P395, DOI 10.1016/S0014-5793(99)01305-8; Pandey J, 2011, APPL MICROBIOL BIOT, V92, P597, DOI 10.1007/s00253-011-3254-y; Prakash D, 2011, APPL ENVIRON MICROB, V77, P6606, DOI 10.1128/AEM.00685-11; Reddy GVB, 1998, J BACTERIOL, V180, P5159, DOI 10.1128/JB.180.19.5159-5164.1998; Schenzle A, 1999, APPL ENVIRON MICROB, V65, P2317; SPAIN JC, 1991, APPL ENVIRON MICROB, V57, P812, DOI 10.1128/AEM.57.3.812-819.1991; Wu HZ, 2009, J ENVIRON SCI-CHINA, V21, P89, DOI 10.1016/S1001-0742(09)60016-4; Wu JF, 2006, APPL ENVIRON MICROB, V72, P1759, DOI 10.1128/AEM.72.3.1759-1765.2006; Zhen D, 2006, APPL MICROBIOL BIOT, V72, P797, DOI 10.1007/s00253-006-0345-2	24	38	38	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38676	10.1371/journal.pone.0038676	http://dx.doi.org/10.1371/journal.pone.0038676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701692	Green Submitted, gold, Green Published			2022-12-25	WOS:000305348400084
J	Reamon-Buettner, SM; Borlak, J				Reamon-Buettner, Stella Marie; Borlak, Juergen			Dissecting Epigenetic Silencing Complexity in the Mouse Lung Cancer Suppressor Gene Cadm1	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; NUCLEOSOME-FREE REGIONS; HISTONE VARIANT H2A.Z; DNA METHYLATION; ADHESION MOLECULE; EUKARYOTIC GENOME; HUMAN-DISEASE; IN-VIVO; CHROMATIN; MARKS	Disease-oriented functional analysis of epigenetic factors and their regulatory mechanisms in aberrant silencing is a prerequisite for better diagnostics and therapy. Yet, the precise mechanisms are still unclear and complex, involving the interplay of several effectors including nucleosome positioning, DNA methylation, histone variants and histone modifications. We investigated the epigenetic silencing complexity in the tumor suppressor gene Cadm1 in mouse lung cancer progenitor cell lines, exhibiting promoter hypermethylation associated with transcriptional repression, but mostly unresponsive to demethylating drug treatments. After predicting nucleosome positions and transcription factor binding sites along the Cadm1 promoter, we carried out single-molecule mapping with DNA methyltransferase M. SssI, which revealed in silent promoters high nucleosome occupancy and occlusion of transcription factor binding sites. Furthermore, M. SssI maps of promoters varied within and among the different lung cancer cell lines. Chromatin analysis with micrococcal nuclease also indicated variations in nucleosome positioning to have implications in the binding of transcription factors near nucleosome borders. Chromatin immunoprecipitation showed that histone variants (H2A.Z and H3.3), and opposing histone modification marks (H3K4me3 and H3K27me3) all colocalized in the same nucleosome positions that is reminiscent of epigenetic plasticity in embryonic stem cells. Altogether, epigenetic silencing complexity in the promoter region of Cadm1 is not only defined by DNA hypermethylation, but high nucleosome occupancy, altered nucleosome positioning, and 'bivalent' histone modifications, also likely contributed in the transcriptional repression of this gene in the lung cancer cells. Our results will help define therapeutic intervention strategies using epigenetic drugs in lung cancer.	[Reamon-Buettner, Stella Marie; Borlak, Juergen] Fraunhofer Inst Toxicol & Expt Med, Hannover, Germany	Fraunhofer Gesellschaft	Reamon-Buettner, SM (corresponding author), Fraunhofer Inst Toxicol & Expt Med, Hannover, Germany.	reamon-buettner@item.fraunhofer.de			Ministry of Science and Culture, Lower Saxony, Germany [25A 5-7251-99/00]	Ministry of Science and Culture, Lower Saxony, Germany	This work was supported by the Ministry of Science and Culture, Lower Saxony, Germany 25A 5-7251-99/00. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of manuscript.	Andrews AJ, 2011, ANNU REV BIOPHYS, V40, P99, DOI 10.1146/annurev-biophys-042910-155329; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Arya G, 2010, J BIOMOL STRUCT DYN, V27, P803, DOI 10.1080/07391102.2010.10508585; Bai L, 2010, TRENDS GENET, V26, P476, DOI 10.1016/j.tig.2010.08.003; Bapat SA, 2010, EPIGENETICS-US, V5, P716, DOI 10.4161/epi.5.8.13014; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Carey Michael, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4890; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Choy JS, 2010, J AM CHEM SOC, V132, P1782, DOI 10.1021/ja910264z; Clark DJ, 2010, J BIOMOL STRUCT DYN, V27, P781, DOI 10.1080/073911010010524945; Conerly ML, 2010, GENOME RES, V20, P1383, DOI 10.1101/gr.106542.110; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Draker R, 2009, BIOCHEM CELL BIOL, V87, P19, DOI 10.1139/O08-117; Fatemi M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni180; Felle M, 2011, NUCLEIC ACIDS RES, V39, P8355, DOI 10.1093/nar/gkr528; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Fullgrabe J, 2011, ONCOGENE, V30, P3391, DOI 10.1038/onc.2011.121; Gal-Yam EN, 2006, PLOS GENET, V2, P1451, DOI 10.1371/journal.pgen.0020160; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gevry N, 2009, GENE DEV, V23, P1522, DOI 10.1101/gad.1787109; Gomperts BN, 2011, SEMIN RESP CRIT CARE, V32, P32, DOI 10.1055/s-0031-1272867; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Henikoff S, 2009, NAT GENET, V41, P865, DOI 10.1038/ng0809-865; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kaplan N, 2010, NAT STRUCT MOL BIOL, V17, P918, DOI 10.1038/nsmb0810-918; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kelly TK, 2010, MOL CELL, V39, P901, DOI 10.1016/j.molcel.2010.08.026; Kerkhoff E, 2000, CELL GROWTH DIFFER, V11, P185; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Liang QL, 2011, CANCER INVEST, V29, P107, DOI 10.3109/07357907.2010.543211; Lin JC, 2007, CANCER CELL, V12, P432, DOI 10.1016/j.ccr.2007.10.014; Marques M, 2010, EPIGENETICS-US, V5, P267, DOI 10.4161/epi.5.4.11520; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Murakami Y, 2005, CANCER SCI, V96, P543, DOI 10.1111/j.1349-7006.2005.00089.x; Muratovska A, 2003, ONCOGENE, V22, P7989, DOI 10.1038/sj.onc.1206766; Niehof M, 2005, MOL PHARMACOL, V67, P604, DOI 10.1124/mol.104.008672; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pondugula S, 2008, J CELL BIOCHEM, V105, P330, DOI 10.1002/jcb.21849; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Reamon-Buettner SM, 2008, CANCER RES, V68, P7587, DOI 10.1158/0008-5472.CAN-08-0967; Reka AK, 2011, LUNG CANCER, V72, P154, DOI 10.1016/j.lungcan.2011.01.019; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rodriguez J, 2008, P NATL ACAD SCI USA, V105, P19809, DOI 10.1073/pnas.0810133105; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Sharma S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001286; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Sikes ML, 2009, J IMMUNOL METHODS, V344, P58, DOI 10.1016/j.jim.2009.03.007; Steward Nicolas, 2004, Methods Mol Biol, V287, P65; Stolz RC, 2010, NUCLEIC ACIDS RES, V38, pW254, DOI 10.1093/nar/gkq496; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Svotelis A, 2009, BIOCHEM CELL BIOL, V87, P179, DOI 10.1139/O08-138; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Thakar A, 2010, BIOCHEMISTRY-US, V49, P4018, DOI 10.1021/bi1001618; Thakar A, 2009, BIOCHEMISTRY-US, V48, P10852, DOI 10.1021/bi901129e; Weber CM, 2010, NAT STRUCT MOL BIOL, V17, P1500, DOI 10.1038/nsmb.1926; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Xi LQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-346; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324; Zlatanova J, 2008, STRUCTURE, V16, P166, DOI 10.1016/j.str.2007.12.008	77	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38531	10.1371/journal.pone.0038531	http://dx.doi.org/10.1371/journal.pone.0038531			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701659	Green Published, gold, Green Submitted			2022-12-25	WOS:000305348400069
J	McBerry, C; Gonzalez, RMS; Shryock, N; Dias, A; Aliberti, J				McBerry, Cortez; Gonzalez, Rosa Maria Salazar; Shryock, Nathaniel; Dias, Alexandra; Aliberti, Julio			SOCS2-Induced Proteasome-Dependent TRAF6 Degradation: A Common Anti-Inflammatory Pathway for Control of Innate Immune Responses	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; LIPOXIN A(4); INDOLEAMINE 2,3-DIOXYGENASE; TOXOPLASMA-GONDII; MYCOBACTERIUM-TUBERCULOSIS; IL-12 PRODUCTION; DIOXIN RECEPTOR; EXPRESSION; INFECTION; INFLAMMATION	Pattern recognition receptors and receptors for pro-inflammatory cytokines provide critical signals to drive the development of protective immunity to infection. Therefore, counter-regulatory pathways are required to ensure that overwhelming inflammation harm host tissues. Previously, we showed that lipoxins modulate immune response during infection, restraining inflammation during infectious diseases in an Aryl hydrocarbon receptor (AhR)/suppressors of cytokine signaling (SOCS)2-dependent-manner. Recently, Indoleamine-pyrrole 2,3-dioxygenase (IDO)-derived tryptophan metabolites, including L-kynurenine, were also shown to be involved in several counter-regulatory mechanisms. Herein, we addressed whether the intracellular molecular events induced by lipoxins mediating control of innate immune signaling are part of a common regulatory pathway also shared by L-kynurenine exposure. We demonstrate that Tumor necrosis factor receptor-associated factor (TRAF)6 - member of a family of adapter molecules that couple the TNF receptor and interleukin-1 receptor/Toll-like receptor families to intracellular signaling events essential for the development of immune responses - is targeted by both lipoxins and L-kynurenine via an AhR/SOCS2-dependent pathway. Furthermore, we show that LXA(4)- and L-kynurenine-induced AhR activation, its subsequent nuclear translocation, leading SOCS2 expression and TRAF6 Lys47-linked poly-ubiquitination and proteosome-mediated degradation of the adapter proteins. The in vitro consequences of such molecular interactions included inhibition of TLR- and cytokine receptor-driven signal transduction and cytokine production. Subsequently, in vivo proteosome inhibition led to unresponsiveness to lipoxins, as well as to uncontrolled pro-inflammatory reactions and elevated mortality during toxoplasmosis. In summary, our results establish proteasome degradation of TRAF6 as a key molecular target for the anti-inflammatory pathway triggered by lipoxins and L-kynurenine, critical counter-regulatory mediators in the innate and adaptive immune systems.	[McBerry, Cortez] Cincinnati Childrens Hosp Med Ctr, Div Mol Immunol, Cincinnati, OH USA; Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	McBerry, C (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Mol Immunol, Cincinnati, OH USA.	julio.aliberti@cchmc.org	Aliberti, Julio/I-7354-2013; Aliberti, Julio/G-4565-2012	Aliberti, Julio/0000-0003-3420-8478; 	National Institutes of Health (NIH) [AI075038, AI078969]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078969, R01AI075038] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research results presented here were funded by National Institutes of Health (NIH) grants AI075038 and AI078969 and by a supplement for C.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti J, 2002, NAT IMMUNOL, V3, P76, DOI 10.1038/ni745; Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Aliberti J, 2005, NAT REV IMMUNOL, V5, P162, DOI 10.1038/nri1547; Aliberti J, 2002, J EXP MED, V196, P1253, DOI 10.1084/jem.20021183; Anbanandam A, 2008, J MOL BIOL, V384, P219, DOI 10.1016/j.jmb.2008.09.021; Bafica A, 2005, J CLIN INVEST, V115, P1601, DOI 10.1172/JCI23949; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bergander L, 2003, DRUG METAB DISPOS, V31, P233, DOI 10.1124/dmd.31.2.233; BERGHARD A, 1993, MOL CELL BIOL, V13, P677, DOI 10.1128/MCB.13.1.677; Boasso A, 2007, BLOOD, V109, P3351, DOI 10.1182/blood-2006-07-034785; Celik GE, 2007, CLIN EXP ALLERGY, V37, P1494, DOI 10.1111/j.1365-2222.2007.02806.x; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DENIS M, 1988, BIOCHEM BIOPH RES CO, V155, P801, DOI 10.1016/S0006-291X(88)80566-7; Divanovic S, 2012, J INFECT DIS, V205, P152, DOI 10.1093/infdis/jir621; DURRIN LK, 1987, J CELL BIOCHEM, V35, P153, DOI 10.1002/jcb.240350208; Floto RA, 2006, SCIENCE, V314, P454, DOI 10.1126/science.1133515; Golding H, 2003, BLOOD, V102, P3280, DOI 10.1182/blood-2003-04-1096; Karp CL, 2004, NAT IMMUNOL, V5, P388, DOI 10.1038/ni1056; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Kieran NE, 2004, KIDNEY INT, V65, P1145, DOI 10.1111/j.1523-1755.2004.00487.x; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Mandi Y, 2012, J NEURAL TRANSM, V119, P197, DOI 10.1007/s00702-011-0681-y; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mezrich JD, J IMMUNOL, V185, P3190; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Nguyen NT, P NATL ACAD SCI US, V107, P19961; Odemuyiwa SO, 2009, ALLERGY, V64, P488, DOI 10.1111/j.1398-9995.2008.01809.x; SAMUELSSON B, 1991, Z RHEUMATOL, V50, P3; Schaldach CM, 1999, BIOCHEMISTRY-US, V38, P7594, DOI 10.1021/bi982861e; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Van Dyke TE, 2003, J DENT RES, V82, P82, DOI 10.1177/154405910308200202; Wei YD, 1998, CHEM-BIOL INTERACT, V110, P39, DOI 10.1016/S0009-2797(97)00111-7; Willey JJ, 1998, TOXICOL APPL PHARM, V151, P33, DOI 10.1006/taap.1998.8444; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	35	33	35	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38384	10.1371/journal.pone.0038384	http://dx.doi.org/10.1371/journal.pone.0038384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693634	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343900034
J	Unmack, PJ; Bagley, JC; Adams, M; Hammer, MP; Johnson, JB				Unmack, Peter J.; Bagley, Justin C.; Adams, Mark; Hammer, Michael P.; Johnson, Jerald B.			Molecular Phylogeny and Phylogeography of the Australian Freshwater Fish Genus Galaxiella, with an Emphasis on Dwarf Galaxias (G. pusilla)	PLOS ONE			English	Article							TELEOSTEI PERCICHTHYIDAE; MAXIMUM-LIKELIHOOD; STATISTICAL-METHOD; PISCES GALAXIIDAE; BASS BASIN; BIOGEOGRAPHY; VICARIANCE; EVOLUTION; RECONSTRUCTION; BIODIVERSITY	The freshwater fauna of Southern Australia is primarily restricted to the southwestern and southeastern corners of the continent, and is separated by a large, arid region that is inhospitable to this biota. This geographic phenomenon has attracted considerable interest from biogeographers looking to explain evolutionary diversification in this region. Here, we employed phylogenetic and phylogeographic approaches to evaluate the effect of this barrier on a group of four galaxiid fish species (Galaxiella) endemic to temperate Southern Australia. We also tested if continental shelf width has influenced connectivity among populations during low sea levels when rivers, now isolated, could have been connected. We addressed these questions by sampling each species across its range using multiple molecular markers (mitochondrial cytochrome b sequences, nuclear S7 intron sequences, and 49 allozyme loci). These data also allowed us to assess species boundaries, to refine phylogenetic affinities, and to estimate species ages. Interestingly, we found compelling evidence for cryptic species in G. pusilla, manifesting as allopatric eastern and western taxa. Our combined phylogeny and dating analysis point to an origin for the genus dating to the early Cenozoic, with three of the four species originating during the Oligocene-Miocene. Each Galaxiella species showed high levels of genetic divergences between all but the most proximate populations. Despite extensive drainage connections during recent low sea levels in southeastern Australia, populations of both species within G. pusilla maintained high levels of genetic structure. All populations experienced Late Pleistocene-Holocene population growth, possibly in response to the relaxation of arid conditions after the last glacial maximum. High levels of genetic divergence and the discovery of new cryptic species have important implications for the conservation of this already threatened group of freshwater species.	[Unmack, Peter J.] Natl Evolutionary Synth Ctr, Durham, NC USA; [Unmack, Peter J.; Bagley, Justin C.; Johnson, Jerald B.] Brigham Young Univ, Dept Biol, Evolutionary Ecol Labs, Provo, UT 84602 USA; [Adams, Mark; Hammer, Michael P.] S Australian Museum, Evolutionary Biol Unit, Adelaide, SA 5000, Australia; [Adams, Mark] Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Evolutionary Biol & Biodivers, Adelaide, SA, Australia; [Hammer, Michael P.] Museum & Art Gallery No Terr, Darwin, NT, Australia; [Johnson, Jerald B.] Brigham Young Univ, Monte L Bean Life Sci Museum, Provo, UT 84602 USA	The National Evolutionary Synthesis Center; Brigham Young University; University of Adelaide; Northern Territory Government; Brigham Young University	Unmack, PJ (corresponding author), Natl Evolutionary Synth Ctr, Durham, NC USA.	peter.pub@unmack.net	Unmack, Peter J./AAU-3023-2020; Bagley, Justin C./N-9654-2019; Bagley, Justin/D-3982-2011; Johnson, Jerald/AAN-5574-2020	Unmack, Peter J./0000-0003-1175-1152; Bagley, Justin C./0000-0001-6737-8380; Bagley, Justin/0000-0001-6737-8380; Hammer, Michael/0000-0002-0981-4647	National Evolutionary Synthesis Center (NESCent); NSF [EF-0905606]; Brigham Young University's Department of Biology	National Evolutionary Synthesis Center (NESCent)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NSF(National Science Foundation (NSF)); Brigham Young University's Department of Biology	We thank the many people who helped with field work and other aspects relative to obtaining specimens, in particular C. Burridge, D. Galeotti, G. Knowles, T. Raadik, R. Remington. We also thank R. Arriagades, S. Beatty, D. Galeotti, E. Habit, J. Jackson, D. Morgan, D. Neely, T. Raadik and P. Victoriano for supplying collection records and/or specimens from their local jurisdictions. We thank E. White for help collecting sequence data, J. Heled for enabling us to complete our *BEAST analysis, C. Burridge for discussion of our dating results and other help, and R. Coleman for carefully reading our final draft. PJU was supported by the National Evolutionary Synthesis Center (NESCent) and NSF #EF-0905606; JCB received stipend support from Brigham Young University's Department of Biology.	Allen G.R., 2002, FIELD GUIDE FRESHWAT; ASFB, 2011, AUSTR SOC FISH BIOL, V41, P94; Backhouse G.N., 1978, Victorian Naturalist (Blackburn), V95, P128; Bagley JC, 2011, BIOL J LINN SOC, V104, P346, DOI 10.1111/j.1095-8312.2011.01720.x; BECK R G, 1985, South Australian Naturalist, V60, P12; Benbow M.C., 1995, GEOLOGY S AUSTR, V2, P208; BERRA T M, 1989, Records of the Western Australian Museum, V14, P293; BLOM WM, 1988, SEDIMENT GEOL, V60, P269, DOI 10.1016/0037-0738(88)90124-8; BLOM WM, 1988, SEARCH, V19, P94; Brown B, 2006, PALAEOGEOGR PALAEOCL, V231, P158, DOI 10.1016/j.palaeo.2005.07.033; Burns EL, 2006, MOL PHYLOGENET EVOL, V39, P573, DOI 10.1016/j.ympev.2005.11.017; Burridge CP, 2008, MOL BIOL EVOL, V25, P624, DOI 10.1093/molbev/msm271; Burridge CP, 2012, J BIOGEOGR, V39, P306, DOI 10.1111/j.1365-2699.2011.02600.x; Cadwallader PL, 1983, GUIDE FRESHWATER FIS; Chow S, 1998, FISHERIES SCI, V64, P397, DOI 10.2331/fishsci.64.397; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coleman RA, 2010, CONSERV GENET, V11, P1911, DOI 10.1007/s10592-010-0082-z; CRANDALL KA, 1994, SYST BIOL, V43, P222, DOI 10.2307/2413463; Crisp MD, 2007, MOL PHYLOGENET EVOL, V43, P1106, DOI 10.1016/j.ympev.2007.02.030; Currey D.T., 1964, P R SOC VIC, V77, P377; DEGLIESPOSTI M, 1993, BIOCHIM BIOPHYS ACTA, V1143, P243, DOI 10.1016/0005-2728(93)90197-N; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EIGENMANN CARL H., 1928, MEM NATION ACAD SCI U S A, V22, P1; ESRI, 1993, DIG CHART WORLD 1 1; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frankham R., 2002, INTRO CONSERVATION G; Fu YX, 1997, GENETICS, V147, P915; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Galeotti D. M., 2010, Journal of the Royal Society of Western Australia, V93, P13; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hammer MP, 2007, MAR FRESHWATER RES, V58, P327, DOI 10.1071/MF05258; Hammer MP, 2010, CONSERV GENET, V11, P213, DOI 10.1007/s10592-009-0024-9; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; HUMPHRIES P, 1986, Proceedings of the Royal Society of Victoria, V98, P133; IUCN, 2011, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2021-3.RLTS.T168474749A169378348.en, DOI 10.2305/IUCN.UK.2021-3.RLTS.T168474749A169378348.EN]; Jennings WB, 2003, SYST BIOL, V52, P757, DOI 10.1080/10635150390250974; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh Kazutaka, 2010, Bioinformatics, V26, P1899, DOI 10.1093/bioinformatics/btq224; Knowles LL, 2002, MOL ECOL, V11, P2623, DOI 10.1046/j.1365-294X.2002.01637.x; Kumazawa Y, 1999, BIOL BIODIVERSITY, P35; Lawver LA, 2003, PALAEOGEOGR PALAEOCL, V198, P11, DOI 10.1016/S0031-0182(03)00392-4; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Littlejohn MJ, 1967, AUSTR INLAND WATERS, P150; Mack G., 1936, Memoirs of the National Museum Melbourne, V9, P98; Martin Helene A., 1998, Proceedings of the Linnean Society of New South Wales, V119, P115; MCDOWALL R M, 1973, Journal of the Royal Society of New Zealand, V3, P193; McDowall R.M., 1981, Records of the Australian Museum, V33, P443; MCDOWALL RM, 1978, J ROY SOC NEW ZEAL, V8, P115, DOI 10.1080/03036758.1978.10419420; McDowall RM, 2004, J ROY SOC NEW ZEAL, V34, P23, DOI 10.1080/03014223.2004.9517762; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Morgan D.L., 1998, RECORDS W AUSTR MU S, V56, P1; Morgan MJ, 2007, MOL PHYLOGENET EVOL, V44, P371, DOI 10.1016/j.ympev.2006.12.009; Munasinghe DHN, 2004, BIOL J LINN SOC, V81, P553, DOI 10.1111/j.1095-8312.2003.00299.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NEI M, 1974, GENETICS, V76, P379; PEN LJ, 1991, J FISH BIOL, V39, P717, DOI 10.1111/j.1095-8649.1991.tb04401.x; PEN LJ, 1993, J FISH BIOL, V43, P847, DOI 10.1111/j.1095-8649.1993.tb01160.x; Phillips N, 2007, EVOLUTIONARY S UNPUB; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PUSEY BJ, 1990, AUST J MAR FRESH RES, V41, P721; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richardson BJ, 1990, ALLOZYME ELECTROPHOR; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Saddlier S, 2010, NATL RECOVERY PLAN D; Schultz MB, 2008, MOL ECOL, V17, P5291, DOI 10.1111/j.1365-294X.2008.03996.x; Scott E. O. G., 1942, Records of the Queen Victoria Museum, V1, P51; SHIPWAY BRUCE, 1953, WEST AUSTRALIAN NAT, V3, P173; Smith Kimberly D., 2002, Records of the Western Australian Museum, V21, P285; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thacker CE, 2008, BIOL J LINN SOC, V95, P175, DOI 10.1111/j.1095-8312.2008.01000.x; Unmack PJ, 2011, SYST BIOL, V60, P797, DOI 10.1093/sysbio/syr042; Unmack PJ, 2001, J BIOGEOGR, V28, P1053, DOI 10.1046/j.1365-2699.2001.00615.x; Wallman JF, 2001, J FORENSIC SCI, V46, P681; Waters JM, 2000, SYST BIOL, V49, P777, DOI 10.1080/106351500750049824; Waters JM, 1999, MOL PHYLOGENET EVOL, V11, P1, DOI 10.1006/mpev.1998.0554; Waters JM, 2011, MOL ECOL, V20, P4388, DOI 10.1111/j.1365-294X.2011.05286.x; White S, 2003, GEOLOGY VICTORIA, P563	86	35	35	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38433	10.1371/journal.pone.0038433	http://dx.doi.org/10.1371/journal.pone.0038433			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693638	Green Submitted, gold, Green Published			2022-12-25	WOS:000305343900043
J	Choi, NM; Boss, JM				Choi, Nancy M.; Boss, Jeremy M.			Multiple Histone Methyl and Acetyltransferase Complex Components Bind the HLA-DRA Gene	PLOS ONE			English	Article							CLASS-II TRANSACTIVATOR; COOPERATIVE BINDING; COACTIVATORS P300; X-BOX; ACETYLATION; CIITA; TRANSCRIPTION; EXPRESSION; PROMOTERS; CREB	Major histocompatibility complex class II (MHC-II) genes are fundamental components that contribute to adaptive immune responses. While characterization of the chromatin features at the core promoter region of these genes has been studied, the scope of histone modifications and the modifying factors responsible for activation of these genes are less well defined. Using the MHC-II gene HLA-DRA as a model, the extent and distribution of major histone modifications associated with active expression were defined in interferon-c induced epithelial cells, B cells, and B-cell mutants for MHC-II expression. With active transcription, nucleosome density around the proximal regulatory region was diminished and histone acetylation and methylation modifications were distributed throughout the gene in distinct patterns that were dependent on the modification examined. Irrespective of the location, the majority of these modifications were dependent on the binding of either the X-box binding factor RFX or the class II transactivator (CIITA) to the proximal regulatory region. Importantly, once established, the modifications were stable through multiple cell divisions after the activating stimulus was removed, suggesting that activation of this system resulted in an epigenetic state. A dual crosslinking chromatin immunoprecipitation method was used to detect histone modifying protein components that interacted across the gene. Components of the MLL methyltransferase and GCN5 acetyltransferase complexes were identified. Some MLL complex components were found to be CIITA independent, including MLL1, ASH2L and RbBP5. Likewise, GCN5 containing acetyltransferase complex components belonging to the ATAC and STAGA complexes were also identified. These results suggest that multiple complexes are either used or are assembled as the gene is activated for expression. Together the results define and illustrate a complex network of histone modifying proteins and multisubunit complexes participating in MHC-II transcription.	[Choi, Nancy M.; Boss, Jeremy M.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University	Choi, NM (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	jmboss@emory.edu			National Institutes of Health [GM47310, AI43000]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health, GM47310 and AI43000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACCOLLA RS, 1983, J EXP MED, V157, P1053, DOI 10.1084/jem.157.3.1053; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BAXTERLOWE LA, 1989, J CLIN INVEST, V84, P613, DOI 10.1172/JCI114206; Beresford GW, 2001, NAT IMMUNOL, V2, P652, DOI 10.1038/89810; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Brown JA, 1998, NUCLEIC ACIDS RES, V26, P4128, DOI 10.1093/nar/26.18.4128; BROWNELL JE, 1995, P NATL ACAD SCI USA, V92, P6364, DOI 10.1073/pnas.92.14.6364; CASPER JT, 1990, J PEDIATR-US, V116, P262, DOI 10.1016/S0022-3476(05)82885-9; Choi NM, 2010, CURRENT OPINION IMMU; Chou SD, 2008, MOL IMMUNOL, V45, P971, DOI 10.1016/j.molimm.2007.07.039; COLLINS T, 1984, P NATL ACAD SCI-BIOL, V81, P4917, DOI 10.1073/pnas.81.15.4917; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; EPSTEIN MA, 1965, J NATL CANCER I, V34, P231, DOI 10.1093/jnci/34.2.231; Fontes JD, 1999, MOL CELL BIOL, V19, P941; Fossati A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017220; Gamper AM, 2009, MOL CELL BIOL, V29, P266, DOI 10.1128/MCB.00315-08; Gialitakis M, 2006, NUCLEIC ACIDS RES, V34, P765, DOI 10.1093/nar/gkj462; Gialitakis M, 2010, MOL CELL BIOL, V30, P2046, DOI 10.1128/MCB.00906-09; Gobin SJP, 1998, IMMUNITY, V9, P531, DOI 10.1016/S1074-7613(00)80636-6; Gomez JA, 2005, J IMMUNOL, V175, P1030, DOI 10.4049/jimmunol.175.2.1030; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Guelman S, 2009, MOL CELL BIOL, V29, P1176, DOI 10.1128/MCB.01599-08; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; JACKSON V, 1978, CELL, V15, P945, DOI 10.1016/0092-8674(78)90278-7; Jin Q, 2010, EMBO J; Johnsson A, 2009, EMBO REP, V10, P1009, DOI 10.1038/embor.2009.127; KARA CJ, 1991, SCIENCE, V252, P709, DOI 10.1126/science.1902592; Kasper LH, 2010, EMBO J, V29, P3660, DOI 10.1038/emboj.2010.235; Koues OI, 2008, MOL CELL BIOL, V28, P5837, DOI 10.1128/MCB.00535-08; Koues OI, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-5; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krebs AR, 2011, MOL CELL, V44, P410, DOI 10.1016/j.molcel.2011.08.037; Kretsovali A, 1998, MOL CELL BIOL, V18, P6777, DOI 10.1128/MCB.18.11.6777; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Leimgruber E, 2009, NUCLEIC ACIDS RES, V37, P2514, DOI 10.1093/nar/gkp116; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lochamy J, 2007, MOL IMMUNOL, V44, P837, DOI 10.1016/j.molimm.2006.04.004; Masternak K, 2000, GENE DEV, V14, P1156; Masternak K, 2003, NAT IMMUNOL, V4, P132, DOI 10.1038/ni883; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Moreno CS, 1999, IMMUNITY, V10, P143, DOI 10.1016/S1074-7613(00)80015-1; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; NOCERA A, 1993, HUM IMMUNOL, V38, P231, DOI 10.1016/0198-8859(93)90547-E; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Patel A, 2011, J BIOL CHEM, V286, P3359, DOI 10.1074/jbc.M110.174524; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; REITH W, 1994, J BIOL CHEM, V269, P20020; REITH W, 1994, P NATL ACAD SCI USA, V91, P554, DOI 10.1073/pnas.91.2.554; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; ROSENTHA.AS, 1973, J EXP MED, V138, P1194, DOI 10.1084/jem.138.5.1194; Rybtsova N, 2007, NUCLEIC ACIDS RES, V35, P3431, DOI 10.1093/nar/gkm214; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Sisk TJ, 2000, J IMMUNOL, V165, P2511, DOI 10.4049/jimmunol.165.5.2511; Spilianakis C, 2003, EMBO J, V22, P5125, DOI 10.1093/emboj/cdg496; Spilianakis C, 2000, MOL CELL BIOL, V20, P8489; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; Villard J, 1999, INT IMMUNOL, V11, P461, DOI 10.1093/intimm/11.3.461; WANG Y, 1987, J EXP MED, V166, P625, DOI 10.1084/jem.166.3.625; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Xu WT, 1998, MOL CELL BIOL, V18, P5659, DOI 10.1128/MCB.18.10.5659; Zika E, 2005, P NATL ACAD SCI USA, V102, P16321, DOI 10.1073/pnas.0505045102; Zsindely N, 2009, NUCLEIC ACIDS RES, V37, P6665, DOI 10.1093/nar/gkp722	69	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37554	10.1371/journal.pone.0037554	http://dx.doi.org/10.1371/journal.pone.0037554			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701520	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500042
J	Vidal-Petiot, E; Cheval, L; Faugeroux, J; Malard, T; Doucet, A; Jeunemaitre, X; Hadchouel, J				Vidal-Petiot, Emmanuelle; Cheval, Lydie; Faugeroux, Julie; Malard, Thierry; Doucet, Alain; Jeunemaitre, Xavier; Hadchouel, Juliette			A New Methodology for Quantification of Alternatively Spliced Exons Reveals a Highly Tissue-Specific Expression Pattern of WNK1 Isoforms	PLOS ONE			English	Article							PROTEIN-KINASE; GENE-EXPRESSION; BLOOD-PRESSURE; HUMAN BREAST; MUTATIONS; KIDNEY; HYPERTENSION; SCREEN; PCR	Mutations in the WNK1 gene, encoding a serine-threonine kinase of the WNK (With No lysine (K)) family, have been implicated in two rare human diseases, Familial Hyperkalemic Hypertension (FHHt) and Hereditary Sensory and Autonomic Neuropathy type 2 (HSAN2). Alternative promoters give rise to a ubiquitous isoform, L-WNK1, and a kidney-specific isoform, KS-WNK1. Several other isoforms are generated through alternative splicing of exons 9, 11 and 12 but their precise tissue distribution is not known. Two additional exons, 8b and HSN2, involved in HSAN2, are thought to be specifically expressed in the nervous system. The purpose of this study was to establish an exhaustive description of all WNK1 isoforms and to quantify their relative level of expression in a panel of human and mouse tissues and in mouse nephron segments. For the latter purpose, we developed a new methodology allowing the determination of the proportions of the different isoforms generated by alternative splicing. Our results evidenced a striking tissue-specific distribution of the different isoforms and the unexpected presence of exon HSN2 in many tissues other than the nervous system. We also found exon 26 to be alternatively spliced in human and identified two new exons, 26a and 26b, within intron 26, specifically expressed in nervous tissues both in humans and mice. WNK1 should therefore no longer be designated as a 28-but as a 32-exon gene, with 8 of them - 8b, HSN2, 9, 11, 12, 26, 26a and 26b - alternatively spliced in a tissue-specific manner. These tissue-specific isoforms must be considered when studying the different roles of this ubiquitous kinase.	[Vidal-Petiot, Emmanuelle; Faugeroux, Julie; Jeunemaitre, Xavier; Hadchouel, Juliette] INSERM UMR970 Paris Cardiovasc Res Ctr Paris, Paris, France; [Vidal-Petiot, Emmanuelle; Cheval, Lydie; Faugeroux, Julie; Doucet, Alain; Jeunemaitre, Xavier; Hadchouel, Juliette] Univ Paris 05, Fac Med, Paris, France; [Cheval, Lydie; Doucet, Alain] Univ Paris 06, F-75252 Paris 05, France; [Cheval, Lydie; Doucet, Alain] INSERM UMRS 872, Paris, France; [Cheval, Lydie; Doucet, Alain] CNRS ERL726 Cordeliers Res Ctr Paris, Paris, France; [Malard, Thierry] CNRS, LCTS, UMR5801, Pessac, France; [Jeunemaitre, Xavier] Hop Europeen Georges Pompidou, AP HP, Dept Genet, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Vidal-Petiot, E (corresponding author), INSERM UMR970 Paris Cardiovasc Res Ctr Paris, Paris, France.	juliette.hadchouel@inserm.fr	JEUNEMAITRE, Xavier/AAQ-4853-2021; Hadchouel, Juliette/K-4593-2016	JEUNEMAITRE, Xavier/0000-0001-5925-381X; CHEVAL, LYDIE/0000-0003-2957-6487; Vidal-Petiot, Emmanuelle/0000-0001-9356-7302	INSERM the European Community [HEALTH-F2-2007-201590]; Fondation Leducq Transatlantic Network on Hypertension; Agence Nationale pour la Recherche [ANR-05-MRAR-010-01]	INSERM the European Community; Fondation Leducq Transatlantic Network on Hypertension(Leducq Foundation); Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by INSERM the European Community's 7th Framework Program (HEALTH-F2-2007-201590, EUNEFRON program), the Fondation Leducq Transatlantic Network on Hypertension, and the Agence Nationale pour la Recherche (ANR-05-MRAR-010-01). E.V-P. was a recipient of a "Poste d'accueil Inserm". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergaya S, 2011, HYPERTENSION; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Cheval L, 2011, PHYSIOL GENOMICS, V43, P161, DOI 10.1152/physiolgenomics.00093.2010; Choate KA, 2003, P NATL ACAD SCI USA, V100, P663, DOI 10.1073/pnas.242728499; Cruz-Rangel S, 2011, AM J PHYSIOL-CELL PH, V301, pC601, DOI 10.1152/ajpcell.00070.2011; Delaloy C, 2003, MOL CELL BIOL, V23, P9208, DOI 10.1128/MCB.23.24.9208-9221.2003; Delaloy C, 2006, AM J PATHOL, V169, P105, DOI 10.2353/ajpath.2006.051290; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; FRIEDMAN PA, 1995, KIDNEY INT, V48, P1427, DOI 10.1038/ki.1995.432; Glover M, 2009, J AM SOC NEPHROL, V20, P1314, DOI 10.1681/ASN.2008050542; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; Min XS, 2004, STRUCTURE, V12, P1303, DOI 10.1016/j.str.2004.04.014; Morla L, 2008, J BIOL CHEM, V283, P28020, DOI 10.1074/jbc.M804399200; Nissant A, 2004, AM J PHYSIOL-RENAL, V287, pF1233, DOI 10.1152/ajprenal.00155.2004; O'Reilly M, 2003, J AM SOC NEPHROL, V14, P2447, DOI 10.1097/01.ASN.0000089830.97681.3B; Picard N, 2008, J BIOL CHEM, V283, P4602, DOI 10.1074/jbc.M705664200; Shekarabi M, 2008, J CLIN INVEST, V118, P2496, DOI 10.1172/JCI34088; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Sun XT, 2006, J NEUROCHEM, V99, P1114, DOI 10.1111/j.1471-4159.2006.04159.x; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Xie J, 2009, AM J PATHOL; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100	29	50	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37751	10.1371/journal.pone.0037751	http://dx.doi.org/10.1371/journal.pone.0037751			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701532	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500053
J	Wang, SP; Dorsey, TH; Terunuma, A; Kittles, RA; Ambs, S; Kwabi-Addo, B				Wang, Songping; Dorsey, Tiffany H.; Terunuma, Atsushi; Kittles, Rick A.; Ambs, Stefan; Kwabi-Addo, Bernard			Relationship between Tumor DNA Methylation Status and Patient Characteristics in African-American and European-American Women with Breast Cancer	PLOS ONE			English	Article							RACIAL DISPARITIES; SURVIVAL; CARCINOMA; SUBTYPES; HYPERMETHYLATION; BIOLOGY; RACE; PROGNOSIS; PATTERNS; CAROLINA	Aberrant DNA methylation is critical for development and progression of breast cancer. We investigated the association of CpG island methylation in candidate genes and clinicopathological features in 65 African-American (AA) and European-American (EA) breast cancer patients. Quantitative methylation analysis was carried out on bisulfite modified genomic DNA and sequencing (pyrosequencing) for promoter CpG islands of p16, ESR1, RASSF1A, RAR beta 2, CDH13, HIN1, SFRP1 genes and the LINE1 repetitive element using matched paired non-cancerous and breast tumor specimen (32 AA and 33 EA women). Five of the genes, all known tumor suppressor genes (RASSF1A, RAR beta 2, CDH13, HIN1 and SFRP1), were found to be frequently hypermethylated in breast tumor tissues but not in the adjacent non-cancerous tissues. Significant differences in the CDH13 methylation status were observed by comparing DNA methylation between AA and EA patients, with more obvious CDH13 methylation differences between the two patient groups in the ER-disease and among young patients (age<50). In addition, we observed associations between CDH13, SFRP1, and RASSF1A methylation and breast cancer subtypes and between SFRP1 methylation and patient's age. Furthermore, tumors that received neoadjuvant therapy tended to have reduced RASSF1A methylation when compared with chemotherapy naive tumors. Finally, Kaplan Meier survival analysis showed a significant association between methylation at 3 loci (RASSF1A, RAR beta 2 and CDH13) and reduced overall disease survival. In conclusion, the DNA methylation status of breast tumors was found to be significantly associated with clinicopathological features and race/ethnicity of the patients.	[Wang, Songping; Kwabi-Addo, Bernard] Howard Univ, Dept Biochem & Mol Biol, Washington, DC 20059 USA; [Dorsey, Tiffany H.; Terunuma, Atsushi; Ambs, Stefan] NCI, Human Carcinogenesis Lab, Ctr Canc Res & Epidemiol, NIH, Bethesda, MD 20892 USA; [Dorsey, Tiffany H.; Terunuma, Atsushi; Ambs, Stefan] NCI, Genet Res Program, NIH, Bethesda, MD 20892 USA; [Kittles, Rick A.] Univ Illinois, Dept Med, Chicago, IL USA	Howard University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wang, SP (corresponding author), Howard Univ, Dept Biochem & Mol Biol, Washington, DC 20059 USA.	bkwabi-addo@howard.edu	; Kwabi-Addo, Bernard/A-6993-2016	Ambs, Stefan/0000-0001-7651-9309; Kwabi-Addo, Bernard/0000-0003-3692-6350	Department of Defense Program Idea Award [PC073828]; NATIONAL CANCER INSTITUTE [ZIABC010887] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003048] Funding Source: NIH RePORTER	Department of Defense Program Idea Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grant PC073828 from the Department of Defense Program Idea Award to BKA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amend K, 2006, CANCER RES, V66, P8327, DOI 10.1158/0008-5472.CAN-06-1927; American Cancer Society, 2009, BREAST CANC SOURCEBO; Bae YK, 2004, CLIN CANCER RES, V10, P5998, DOI 10.1158/1078-0432.CCR-04-0667; Bowen RL, 2006, PHARMACOGENOMICS, V7, P935, DOI 10.2217/14622416.7.6.935; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Celebiler A, 2009, CANCER SCI, V100, P2341, DOI 10.1111/j.1349-7006.2009.01333.x; Chan TA, 2008, PLOS MED, V5, P823, DOI 10.1371/journal.pmed.0050114; CHEN VW, 1994, CANCER EPIDEM BIOMAR, V3, P127; Chlebowski RT, 2005, JNCI-J NATL CANCER I, V97, P439, DOI 10.1093/jnci/dji064; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; Cunningham JE, 2004, BREAST CANCER RES TR, V88, P161, DOI 10.1007/s10549-004-0592-9; Demicheli R, 2007, CANCER-AM CANCER SOC, V110, P1880, DOI 10.1002/cncr.22998; Fackler MJ, 2003, INT J CANCER, V107, P970, DOI 10.1002/ijc.11508; Feng W, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1762; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glynn SA, 2010, J CLIN INVEST, V120, P3843, DOI 10.1172/JCI42059; Issa JP, 2002, J NUTR, V132, p2388S, DOI 10.1093/jn/132.8.2388S; Joe AK, 2001, ANTICANCER RES, V21, P3535; Konishi K, 2007, GASTROENTEROLOGY, V132, P1254, DOI 10.1053/j.gastro.2007.01.035; Kwabi-Addo B, 2007, CLIN CANCER RES, V13, P3796, DOI 10.1158/1078-0432.CCR-07-0085; Kwabi-Addo B, 2010, CLIN CANCER RES, V16, P3539, DOI 10.1158/1078-0432.CCR-09-3342; Lehmann U, 2002, CANCER RES, V62, P6634; Li CI, 2003, ARCH INTERN MED, V163, P49, DOI 10.1001/archinte.163.1.49; Loo LWM, 2011, BREAST CANCER RES TR, V127, P297, DOI 10.1007/s10549-010-1297-x; Lund MJ, 2009, BREAST CANCER RES TR, V113, P357, DOI 10.1007/s10549-008-9926-3; Malone KE, 2006, CANCER RES, V66, P8297, DOI 10.1158/0008-5472.CAN-06-0503; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; Mehrotra J, 2004, CLIN CANCER RES, V10, P2052, DOI 10.1158/1078-0432.CCR-03-0514; Nimmrich I, 2008, BREAST CANCER RES TR, V111, P429, DOI 10.1007/s10549-007-9800-8; O'Malley CD, 2003, CANCER, V97, P1303, DOI 10.1002/cncr.11160; Olopade Olufunmilayo I., 2003, Cancer, V97, P236, DOI 10.1002/cncr.11019; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ries L, 2011, SEER CANC STAT REV 1; Rose DP, 2001, CANCER DETECT PREV, V25, P16; Selhub J, 2002, J Nutr Health Aging, V6, P39; Shu JM, 2006, CANCER RES, V66, P5077, DOI 10.1158/0008-5472.CAN-05-2629; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tisserand P, 2003, CANCER BIOL THER, V2, P559, DOI 10.4161/cbt.2.5.511; Wendt MK, 2008, ONCOGENE, V27, P1461, DOI 10.1038/sj.onc.1210751; Weston A, 1997, ENVIRON HEALTH PERSP, V105, P919, DOI 10.2307/3433304; Yu K, 2004, CLIN CANCER RES, V10, P5508, DOI 10.1158/1078-0432.CCR-04-0085	42	43	46	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37928	10.1371/journal.pone.0037928	http://dx.doi.org/10.1371/journal.pone.0037928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701537	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500067
J	Karaskova, M; Gunisova, S; Herrmannova, A; Wagner, S; Munzarova, V; Valasek, LS				Karaskova, Martina; Gunisova, Stanislava; Herrmannova, Anna; Wagner, Susan; Munzarova, Vanda; Valasek, Leos Shivaya			Functional Characterization of the Role of the N-terminal Domain of the c/Nip1 Subunit of Eukaryotic Initiation Factor 3 (eIF3) in AUG Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							START CODON SELECTION; 40S RIBOSOMAL-SUBUNIT; TRANSLATION INITIATION; MESSENGER-RNA; PREINITIATION COMPLEX; MULTIFACTOR COMPLEX; BINDING; GCN4; YEAST; REINITIATION	In eukaryotes, for a protein to be synthesized, the 40 S subunit has to first scan the 5'-UTR of the mRNA until it has encountered the AUG start codon. Several initiation factors that ensure high fidelity of AUG recognition were identified previously, including eIF1A, eIF1, eIF2, and eIF5. In addition, eIF3 was proposed to coordinate their functions in this process as well as to promote their initial binding to 40 S subunits. Here we subjected several previously identified segments of the N-terminal domain (NTD) of the eIF3c/Nip1 subunit, which mediates eIF3 binding to eIF1 and eIF5, to semirandom mutagenesis to investigate the molecular mechanism of eIF3 involvement in these reactions. Three major classes of mutant substitutions or internal deletions were isolated that affect either the assembly of preinitiation complexes (PICs), scanning for AUG, or both. We show that eIF5 binds to the extreme c/Nip1-NTD (residues 1-45) and that impairing this interaction predominantly affects the PIC formation. eIF1 interacts with the region (60-137) that immediately follows, and altering this contact deregulates AUG recognition. Together, our data indicate that binding of eIF1 to the c/Nip1-NTD is equally important for its initial recruitment to PICs and for its proper functioning in selecting the translational start site.	[Karaskova, Martina; Gunisova, Stanislava; Herrmannova, Anna; Wagner, Susan; Munzarova, Vanda; Valasek, Leos Shivaya] Acad Sci Czech Republ, Inst Microbiol, Lab Regulat Gene Express, CR-14220 Prague 4, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Valasek, LS (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Lab Regulat Gene Express, Videnska 1083, CR-14220 Prague 4, Czech Republic.	valasekl@biomed.cas.cz	Valášek, Leoš Shivaya/I-5743-2014; Wagner, Susan/K-8240-2014; Herrmannová, Anna/I-1745-2014; Gunišová, Stanislava/I-1765-2014; Wagner, Susan/ABA-1307-2021	Valášek, Leoš Shivaya/0000-0001-8123-8667; Herrmannová, Anna/0000-0003-3500-3212; Wagner, Susan/0000-0002-7492-7541	Wellcome Trust [076456/Z/05/Z, 090812/B/09/Z]; Czech Science Foundation [305/10/0335]	Wellcome Trust(Wellcome TrustEuropean Commission); Czech Science Foundation(Grant Agency of the Czech Republic)	This research was supported by The Wellcome Trust Grants 076456/Z/05/Z and 090812/B/09/Z and Czech Science Foundation Grant 305/10/0335.	Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Chiu WL, 2010, MOL CELL BIOL, V30, P4415, DOI 10.1128/MCB.00280-10; CIGAN AM, 1988, MOL CELL BIOL, V8, P2964, DOI 10.1128/MCB.8.7.2964; Cuchalova L, 2010, MOL CELL BIOL, V30, P4671, DOI 10.1128/MCB.00430-10; Donahue TF, 2000, COLD SPRING HARBOR M, V39, P487; ElAntak L, 2010, J MOL BIOL, V396, P1097, DOI 10.1016/j.jmb.2009.12.047; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GRANT CM, 1994, MOL CELL BIOL, V14, P606, DOI 10.1128/MCB.14.1.606; Herrmannova A, 2012, NUCLEIC ACIDS RES, V40, P2294, DOI 10.1093/nar/gkr765; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Jennings MD, 2010, NATURE, V465, P378, DOI 10.1038/nature09003; Jivotovskaya AV, 2006, MOL CELL BIOL, V26, P1355, DOI 10.1128/MCB.26.4.1355-1372.2006; Kouba T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040464; Kouba T, 2012, NUCLEIC ACIDS RES, V40, P2683, DOI 10.1093/nar/gkr1083; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Maag D, 2006, J MOL BIOL, V356, P724, DOI 10.1016/j.jmb.2005.11.083; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Mitchell SF, 2010, MOL CELL, V39, P950, DOI 10.1016/j.molcel.2010.08.021; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; Munzarova V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002137; Nanda JS, 2009, J MOL BIOL, V394, P268, DOI 10.1016/j.jmb.2009.09.017; Nielsen KH, 2006, MOL CELL BIOL, V26, P2984, DOI 10.1128/MCB.26.8.2984-2998.2006; Nielsen KH, 2004, EMBO J, V23, P1166, DOI 10.1038/sj.emboj.7600116; Nielsen KH, 2007, METHOD ENZYMOL, V431, P15, DOI 10.1016/S0076-6879(07)31002-1; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Phan L, 1998, MOL CELL BIOL, V18, P4935, DOI 10.1128/MCB.18.8.4935; Phan L, 2001, EMBO J, V20, P2954, DOI 10.1093/emboj/20.11.2954; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Pisarev AV, 2007, CELL, V131, P286, DOI 10.1016/j.cell.2007.08.041; Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Reibarkh M, 2008, J BIOL CHEM, V283, P1094, DOI 10.1074/jbc.M708155200; Saini AK, 2010, GENE DEV, V24, P97, DOI 10.1101/gad.1871910; Shin BS, 2011, NAT STRUCT MOL BIOL, V18, P1227, DOI 10.1038/nsmb.2133; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Szamecz B, 2008, GENE DEV, V22, P2414, DOI 10.1101/gad.480508; Valasek L, 1998, J BIOL CHEM, V273, P21253, DOI 10.1074/jbc.273.33.21253; Valasek L, 2004, MOL CELL BIOL, V24, P9437, DOI 10.1128/MCB.24.21.9437-9455.2004; Valasek L, 2003, GENE DEV, V17, P786, DOI 10.1101/gad.1065403; Valasek L, 2002, EMBO J, V21, P5886, DOI 10.1093/emboj/cdf563; Valasek LS, 2012, CURR PROTEIN PEPT SC, V13, P305; Yamamoto Y, 2005, P NATL ACAD SCI USA, V102, P16164, DOI 10.1073/pnas.0507960102	46	28	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28420	28434		10.1074/jbc.M112.386656	http://dx.doi.org/10.1074/jbc.M112.386656			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22718758	Green Published, hybrid			2022-12-25	WOS:000308074600018
J	Bullock, HD; Hower, S; Fields, KA				Bullock, Holly D.; Hower, Suzanne; Fields, Kenneth A.			Domain Analyses Reveal That Chlamydia trachomatis CT694 Protein Belongs to the Membrane-localized Family of Type III Effector Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA; HOST-CELLS; PLASMA-MEMBRANE; YERSINIA-YOPE; SECRETION; ENTRY; EXOS; CYTOTOXIN; CYCLE; APPARATUS	The Chlamydia trachomatis type three-secreted effector protein CT694 is expressed during late-cycle development yet is secreted by infectious particles during the invasion process. We have previously described the presence of at least two functional domains within CT694. CT694 was found to interact with the human protein Ahnak through a C-terminal domain and affect formation of host-cell actin stress fibers. Immunolocalization analyses of ectopically expressed pEGFP-CT694 also revealed plasma membrane localization for CT694 that was independent of Ahnak binding. Here we provide evidence that CT694 contains multiple functional domains. Plasma membrane localization and CT694-induced alterations in host cell morphology are dependent on an N-terminal domain. We demonstrate that membrane association of CT694 is dependent on a domain resembling a membrane localization domain (MLD) found in anti-host proteins from Yersinia, Pseudomonas, and Salmonella spp. This domain is necessary and sufficient for localization and morphology changes but is not required for Ahnak binding. Further, the CT694 MLD is able to complement ExoS Delta MLD when ectopically expressed. Taken together, our data indicate that CT694 is a multidomain protein with the potential to modulate multiple host cell processes.	[Bullock, Holly D.; Hower, Suzanne; Fields, Kenneth A.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA	University of Miami	Fields, KA (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, 1600 NW 10th Ave, Miami, FL 33136 USA.	kfields@med.miami.edu			Public Health Service from NIAID, National Institutes of Health [AI065530]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065530] Funding Source: NIH RePORTER	Public Health Service from NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service Grant AI065530 from NIAID, National Institutes of Health (to K.A.F.).	Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Benaud C, 2004, J CELL BIOL, V164, P133, DOI 10.1083/jcb.200307098; Betts-Hampikian HJ, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00114; Black DS, 2000, MOL MICROBIOL, V37, P515, DOI 10.1046/j.1365-2958.2000.02021.x; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Burton M. J., 2009, TRAVEL MED INFECT, V3, pe460; Cain RJ, 2004, MOL MICROBIOL, V54, P887, DOI 10.1111/j.1365-2958.2004.04336.x; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Carabeo RA, 2004, TRAFFIC, V5, P418, DOI 10.1111/j.1398-9219.2004.00184.x; Carabeo RA, 2002, INFECT IMMUN, V70, P3793, DOI 10.1128/IAI.70.7.3793-3803.2002; Chellas-Gery B, 2011, INFECT IMMUN, V79, P3036, DOI 10.1128/IAI.00159-11; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; Deng Q, 2007, TRAFFIC, V8, P1331, DOI 10.1111/j.1600-0854.2007.00626.x; Evdokimov AG, 2002, PROTEIN SCI, V11, P401, DOI 10.1110/ps.34102; Fields KA, 2005, J BACTERIOL, V187, P6466, DOI 10.1128/JB.187.18.6466-6478.2005; Fields KA, 2003, MOL MICROBIOL, V48, P671, DOI 10.1046/j.1365-2958.2003.03462.x; FrithzLindsten E, 1997, MOL MICROBIOL, V25, P1125, DOI 10.1046/j.1365-2958.1997.5411905.x; Fu YX, 1998, MOL MICROBIOL, V27, P359, DOI 10.1046/j.1365-2958.1998.00684.x; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Hakansson S, 1996, MOL MICROBIOL, V20, P593, DOI 10.1046/j.1365-2958.1996.5251051.x; Hoffman K., 2011, J BIOL CHEM, P374; Hower S, 2009, MOL MICROBIOL, V72, P1423, DOI 10.1111/j.1365-2958.2009.06732.x; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Isaksson EL, 2009, INFECT IMMUN, V77, P4740, DOI 10.1128/IAI.00333-09; Jewett TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000997; Krall R, 2004, J BIOL CHEM, V279, P2747, DOI 10.1074/jbc.M301963200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee IH, 2004, J BIOL CHEM, V279, P26645, DOI 10.1074/jbc.M311525200; Maniatis T., 1982, MOL CLONING LAB MANU; Marcus SL, 2002, CELL MICROBIOL, V4, P435, DOI 10.1046/j.1462-5822.2002.00202.x; McGuffie EM, 1999, INFECT IMMUN, V67, P3494, DOI 10.1128/IAI.67.7.3494-3503.1999; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Mounier J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000271; Pederson KJ, 2002, MOL MICROBIOL, V46, P1381, DOI 10.1046/j.1365-2958.2002.03256.x; ROSQVIST R, 1991, INFECT IMMUN, V59, P4562, DOI 10.1128/IAI.59.12.4562-4569.1991; U.S. Department of Health and Human Services CfDCaP Division of STD Prevention, 2010, SEX TRANSM DIS SURV; Wolf K, 2006, MOL MICROBIOL, V61, P1543, DOI 10.1111/j.1365-2958.2006.05347.x; Zhang Y, 2005, INFECT IMMUN, V73, P7938, DOI 10.1128/IAI.73.12.7938-7945.2005; Zhang Y, 2007, CELL MICROBIOL, V9, P2192, DOI 10.1111/j.1462-5822.2007.00949.x; Zhou DG, 2001, MICROBES INFECT, V3, P1293, DOI 10.1016/S1286-4579(01)01489-7	42	21	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28078	28086		10.1074/jbc.M112.386904	http://dx.doi.org/10.1074/jbc.M112.386904			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22711538	hybrid, Green Published			2022-12-25	WOS:000307840700081
J	Flemmig, J; Zschaler, J; Remmler, J; Arnhold, J				Flemmig, Joerg; Zschaler, Josefin; Remmler, Johannes; Arnhold, Juegen			The Fluorescein-derived Dye Aminophenyl Fluorescein Is a Suitable Tool to Detect Hypobromous Acid (HOBr)-producing Activity in Eosinophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN HEME PEROXIDASES; HYPOCHLOROUS ACID; HUMAN MYELOPEROXIDASE; CHLORINATING ACTIVITY; SPECTRAL PROPERTIES; HYDROGEN-PEROXIDE; ELECTRON-TRANSFER; RATIONAL DESIGN; NITRIC-OXIDE; COMPOUND-I	The specific detection of peroxidase activity in human granulocytes is essential to elucidate their role in innate immune responses, immune regulation, and inflammatory diseases. The halogenating activity of myeloperoxidase in neutrophils can be determined by the novel fluorescent probe aminophenyl fluorescein (APF). Thereby non-fluorescent APF is oxidized by HOCl to form fluorescein. We successfully verified that APF equally detects the hypobromous acid (HOBr)-producing activity of eosinophil granulocytes. This was revealed by three different approaches. First, we investigated the conversion of non-fluorescent APF into fluorescein by HOCl and HOBr by means of fluorescence and mass spectrometry approaches. Thereby comparable chemical mechanisms were observed for both acids. Furthermore in vitro kinetic studies were used to detect the halogenating activity of myeloperoxidase and eosinophil peroxidase by using APF. Here the dye well reflected the different substrate specificities of myeloperoxidase and eosinophil peroxidase regarding chloride and bromide. Finally, peroxidase activities were successfully detected in phorbol ester-stimulated neutrophils and eosinophils using flow cytometry. Thereby inhibitory studies confirmed the peroxidase-dependent oxidation of APF. To sum up, APF is a promising tool for further evaluation of the halogenating activity of peroxidases in both neutrophils and eosinophils.	[Flemmig, Joerg; Zschaler, Josefin; Remmler, Johannes; Arnhold, Juegen] Univ Leipzig, Fac Med, Inst Med Phys & Biophys, D-04107 Leipzig, Germany; [Flemmig, Joerg; Zschaler, Josefin] Univ Leipzig, Translat Ctr Regenerat Med Leipzig, D-04103 Leipzig, Germany	Leipzig University; Leipzig University	Flemmig, J (corresponding author), Univ Leipzig, Fac Med, Inst Med Phys & Biophys, Hartelstr 16-18, D-04107 Leipzig, Germany.	joerg.flemmig@medizin.uni-leipzig.de		Flemmig, Jorg/0000-0001-5872-3373; Remmler, Johannes/0000-0003-2598-3616	German Federal Ministry of Education and Research (BMBF, PtJ-Bio) [0315883]	German Federal Ministry of Education and Research (BMBF, PtJ-Bio)(Federal Ministry of Education & Research (BMBF))	This work was made possible by funding from the German Federal Ministry of Education and Research (BMBF, PtJ-Bio, 0315883).	Arnhold J, 2003, REDOX REP, V8, P179, DOI 10.1179/135100003225002664; Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436; Arnhold J, 2010, ARCH BIOCHEM BIOPHYS, V500, P92, DOI 10.1016/j.abb.2010.04.008; Azadniv M, 2001, INHAL TOXICOL, V13, P485, DOI 10.1080/08958370151131855; BEERS RF, 1952, J BIOL CHEM, V195, P133; Chapman ALP, 2009, BIOCHEM J, V417, P773, DOI 10.1042/BJ20071563; Chen X, 2011, CHEM COMMUN, V47, P4373, DOI 10.1039/c1cc10589b; Chen XQ, 2008, CHEM-EUR J, V14, P4719, DOI 10.1002/chem.200701677; CHIHARA J, 1995, ALLERGY, V50, P11, DOI 10.1111/j.1398-9995.1995.tb02477.x; Davies MJ, 2011, J CLIN BIOCHEM NUTR, V48, P8, DOI 10.3164/jcbn.11-006FR; Doughty MJ, 2010, OPHTHAL PHYSL OPT, V30, P167, DOI 10.1111/j.1475-1313.2009.00703.x; Fierro IM, 1999, J LEUKOCYTE BIOL, V65, P508, DOI 10.1002/jlb.65.4.508; Flemmig J, 2008, CELL PHYSIOL BIOCHEM, V21, P287, DOI 10.1159/000129387; Franck T, 2009, VET IMMUNOL IMMUNOP, V130, P243, DOI 10.1016/j.vetimm.2009.02.015; Furtmuller PG, 2000, BIOCHEMISTRY-US, V39, P15578, DOI 10.1021/bi0020271; Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772; Galijasevic S, 2006, BIOCHEMISTRY-US, V45, P1255, DOI 10.1021/bi051438k; Ge FY, 2008, J FLUORESC, V18, P741, DOI 10.1007/s10895-007-0305-y; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Grant DC, 2007, RAPID COMMUN MASS SP, V21, P837, DOI 10.1002/rcm.2899; HANSEL TT, 1989, J IMMUNOL METHODS, V122, P97, DOI 10.1016/0022-1759(89)90339-6; HURST JK, 1984, J BIOL CHEM, V259, P4812; Ilmarinen P, 2009, PULM PHARMACOL THER, V22, P167, DOI 10.1016/j.pupt.2008.11.012; Ilmarinen-Salo P, 2010, PULM PHARMACOL THER, V23, P365, DOI 10.1016/j.pupt.2010.04.001; Izumi S, 2009, J AM CHEM SOC, V131, P10189, DOI 10.1021/ja902511p; Kankaanranta H, 2000, J ALLERGY CLIN IMMUN, V106, P77; Kankaanranta Hannu, 2005, Current Drug Targets - Inflammation and Allergy, V4, P433, DOI 10.2174/1568010054526395; Kenmoku S, 2007, J AM CHEM SOC, V129, P7313, DOI 10.1021/ja068740g; Kettle AJ, 1997, BIOCHEM J, V321, P503, DOI 10.1042/bj3210503; Kirchner T, 2010, ARCH BIOCHEM BIOPHYS, V495, P21, DOI 10.1016/j.abb.2009.12.013; Kooter IM, 1999, J BIOL CHEM, V274, P26794, DOI 10.1074/jbc.274.38.26794; KOPPENOL WH, 1987, BIOELECTROCH BIOENER, V18, P3, DOI 10.1016/0302-4598(87)85002-X; Koppenol WH, 1998, CHEM RES TOXICOL, V11, P87, DOI 10.1021/tx970200x; KUMAR K, 1987, INORG CHEM, V26, P2706, DOI 10.1021/ic00263a030; Leszyk John D, 2010, J Biomol Tech, V21, P81; Lou XD, 2011, CHEM COMMUN, V47, P3189, DOI 10.1039/c0cc04911e; Loughran NB, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-101; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Martinez VM, 2008, J AM CHEM SOC, V130, P13192, DOI 10.1021/ja804606m; Merenyi G, 1997, CHEM RES TOXICOL, V10, P1216, DOI 10.1021/tx970101j; Miura T, 2003, J AM CHEM SOC, V125, P8666, DOI 10.1021/ja035282s; MORRIS JC, 1966, J PHYS CHEM-US, V70, P3798, DOI 10.1021/j100884a007; Nagano T, 2010, P JPN ACAD B-PHYS, V86, P837, DOI 10.2183/pjab.86.837; Nagano T, 2009, J CLIN BIOCHEM NUTR, V45, P111, DOI 10.3164/jcbn.R09-66; Nagy P, 2006, BIOCHEMISTRY-US, V45, P12610, DOI 10.1021/bi061015y; Nakajima Y, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-4; Nakazato T, 2007, CLIN CANCER RES, V13, P5436, DOI 10.1158/1078-0432.CCR-07-0481; OFLaherty JT, 1996, J IMMUNOL, V157, P336; Pattison DI, 2006, CURR MED CHEM, V13, P3271, DOI 10.2174/092986706778773095; Persike M, 2010, ANAL CHEM, V82, P922, DOI 10.1021/ac902130h; ROMANCHUK KG, 1982, SURV OPHTHALMOL, V26, P269, DOI 10.1016/0039-6257(82)90163-1; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; SCHAUENSTEIN K, 1978, J HISTOCHEM CYTOCHEM, V26, P277, DOI 10.1177/26.4.77868; Senthilmohan R, 2006, ARCH BIOCHEM BIOPHYS, V445, P235, DOI 10.1016/j.abb.2005.07.005; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Shepherd J, 2007, CHEM BIOL, V14, P1221, DOI 10.1016/j.chembiol.2007.10.005; SJOBACK R, 1995, SPECTROCHIM ACTA A, V51, pL7, DOI 10.1016/0584-8539(95)01421-P; Someya A, 1997, ARCH BIOCHEM BIOPHYS, V345, P207, DOI 10.1006/abbi.1997.0252; Spalteholz H, 2006, ARCH BIOCHEM BIOPHYS, V445, P225, DOI 10.1016/j.abb.2005.06.025; Spalteholz H, 2008, BIOCHEM BIOPH RES CO, V371, P810, DOI 10.1016/j.bbrc.2008.04.139; Sun ZN, 2008, ORG LETT, V10, P2171, DOI 10.1021/ol800507m; Tanaka K, 2001, J AM CHEM SOC, V123, P2530, DOI 10.1021/ja0035708; Ueno T, 2004, J AM CHEM SOC, V126, P14079, DOI 10.1021/ja048241k; Urano Y, 2005, J AM CHEM SOC, V127, P4888, DOI 10.1021/ja043919h; vanDalen CJ, 1997, BIOCHEM J, V327, P487; WEISS SJ, 1986, SCIENCE, V234, P200, DOI 10.1126/science.3018933; WEVER R, 1981, FEBS LETT, V123, P327, DOI 10.1016/0014-5793(81)80320-1; Yang YK, 2009, ORG LETT, V11, P859, DOI 10.1021/ol802822t; Zhang XF, 2010, PHOTOCHEM PHOTOBIOL, V86, P492, DOI 10.1111/j.1751-1097.2010.00706.x; Zhu XD, 1998, J IMMUNOL, V161, P2574	70	30	30	1	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27913	27923		10.1074/jbc.M112.364299	http://dx.doi.org/10.1074/jbc.M112.364299			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718769	hybrid, Green Published			2022-12-25	WOS:000307840700065
J	Stengel, KR; Zheng, Y				Stengel, Kristy R.; Zheng, Yi			Essential Role of Cdc42 in Ras-Induced Transformation Revealed by Gene Targeting	PLOS ONE			English	Article							CELL-POLARITY; RHO-GTPASES; ACTIVATION; KINASE; PHOSPHORYLATION; INVOLVEMENT; PROGRESSION; GROWTH	The ras proto-oncogene is one of the most frequently mutated genes in human cancer. However, given the prevalence of activating mutations in Ras and its association with aggressive forms of cancer, attempts to therapeutically target aberrant Ras signaling have been largely disappointing. This lack of progress highlights the deficiency in our understanding of cellular pathways required for Ras-mediated tumorigenesis and suggests the importance of identifying new molecular pathways associated with Ras-driven malignancies. Cdc42 is a Ras-related small GTPase that is known to play roles in oncogenic processes such as cell growth, survival, invasion, and migration. A pan-dominant negative mutant overexpression approach to suppress Cdc42 and related pathways has previously shown a requirement for Cdc42 in Ras-induced anchorage-independent cell growth, however the lack of specificity of such approaches make it difficult to determine if effects are directly related to changes in Cdc42 activity or other Rho family members. Therefore, in order to directly and unambiguously address the role of Cdc42 in Ras-mediated transformation, tumor formation and maintenance, we have developed a model of conditional cdc42 gene in Ras-transformed cells. Loss of Cdc42 drastically alters the cell morphology and inhibits proliferation, cell cycle progression and tumorigenicity of Ras-transformed cells, while non-transformed cells or c-Myc transformed cells are largely unaffected. The loss of Cdc42 in Ras-transformed cells results in reduced Akt signaling, restoration of which could partially rescues the proliferation defects associated with Cdc42 loss. Moreover, disruption of Cdc42 function in established tumors inhibited continued tumor growth. These studies implicate Cdc42 in Ras-driven tumor growth and suggest that targeting Cdc42 is beneficial in Ras-mediated malignancies.	[Stengel, Kristy R.] Univ Cincinnati, Div Expt Hematol & Canc Biol, Childrens Res Fdn, Cincinnati, OH 45221 USA; Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Stengel, KR (corresponding author), Univ Cincinnati, Div Expt Hematol & Canc Biol, Childrens Res Fdn, Cincinnati, OH 45221 USA.	yi.zheng@cchmc.org	Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074; Stengel, Kristy/0000-0002-8330-5744	National Institutes of Health [R01CA150547, T32CA117846]; NATIONAL CANCER INSTITUTE [T32CA117846, R01CA150547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work is supported by National Institutes of Health grants R01CA150547 and T32CA117846. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Appledorn DM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-13; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Beeser A, 2005, J BIOL CHEM, V280, P36609, DOI 10.1074/jbc.M502306200; Bosco EE, 2010, BLOOD, V115, P3320, DOI 10.1182/blood-2009-02-202440; Cerione RA, 2004, TRENDS CELL BIOL, V14, P127, DOI 10.1016/j.tcb.2004.01.008; Chen L, 2006, P NATL ACAD SCI USA, V103, P16520, DOI 10.1073/pnas.0603533103; Cheng CM, 2011, MOL CELL BIOL, V31, P983, DOI 10.1128/MCB.00137-10; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Cox Adrienne D, 2010, Small GTPases, V1, P2; Del Pulgar TG, 2008, INT J ONCOL, V33, P185; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Fehrenbacher N, 2009, MOL ONCOL, V3, P297, DOI 10.1016/j.molonc.2009.06.004; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Li WQ, 2001, J BIOL CHEM, V276, P34728, DOI 10.1074/jbc.M103496200; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; McCormick F, 2011, J SURG ONCOL, V103, P464, DOI 10.1002/jso.21749; Melendez J, 2011, J BIOL CHEM, V286, P2375, DOI 10.1074/jbc.R110.200329; METZ T, 1995, CELL, V82, P29, DOI 10.1016/0092-8674(95)90049-7; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Qiu RG, 1997, MOL CELL BIOL, V17, P3449, DOI 10.1128/MCB.17.6.3449; Saxena N, 2008, CANCER INVEST, V26, P948, DOI 10.1080/07357900802087275; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Stengel K, 2011, CELL SIGNAL, V23, P1415, DOI 10.1016/j.cellsig.2011.04.001; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; Tucci MG, 2007, BRIT J DERMATOL, V157, P1212, DOI 10.1111/j.1365-2133.2007.08246.x; Wang RW, 2006, CELL SIGNAL, V18, P1722, DOI 10.1016/j.cellsig.2006.01.020; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; ZHENG Y, 1994, J BIOL CHEM, V269, P18727; Zheng YH, 2009, MOL CELL, V35, P11, DOI 10.1016/j.molcel.2009.06.013	41	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37317	10.1371/journal.pone.0037317	http://dx.doi.org/10.1371/journal.pone.0037317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719838	gold, Green Submitted, Green Published			2022-12-25	WOS:000305583300006
J	Nandadasa, S; Tao, QH; Shoemaker, A; Cha, SW; Wylie, C				Nandadasa, Sumeda; Tao, Qinghua; Shoemaker, Amanda; Cha, Sang-wook; Wylie, Christopher			Regulation of Classical Cadherin Membrane Expression and F-Actin Assembly by Alpha-Catenins, during Xenopus Embryogenesis	PLOS ONE			English	Article							CELL-CELL-ADHESION; N-CATENIN; JUNCTIONAL COMPLEX; MOLECULES; EMBRYOS; POLYMERIZATION; IDENTIFICATION; MORPHOGENESIS; LOCALIZATION; ACCUMULATION	Alpha (alpha)-E-catenin is a component of the cadherin complex, and has long been thought to provide a link between cell surface cadherins and the actin skeleton. More recently, it has also been implicated in mechano-sensing, and in the control of tissue size. Here we use the early Xenopus embryos to explore functional differences between two alpha-catenin family members, alpha-E- and alpha-N-catenin, and their interactions with the different classical cadherins that appear as tissues of the embryo become segregated from each other. We show that they play both cadherin-specific and context-specific roles in the emerging tissues of the embryo. alpha-E-catenin interacts with both C- and E-cadherin. It is specifically required for junctional localization of C-cadherin, but not of E-cadherin or N-cadherin at the neurula stage. alpha-N-cadherin interacts only with, and is specifically required for junctional localization of, N-cadherin. In addition, alpha-E-catenin is essential for normal tissue size control in the non-neural ectoderm, but not in the neural ectoderm or the blastula. We also show context specificity in cadherin/alpha-catenin interactions. E-cadherin requires alpha-E-catenin for junctional localization in some tissues, but not in others, during early development. These specific functional cadherin/alpha-catenin interactions may explain the basis of cadherin specificity of actin assembly and morphogenetic movements seen previously in the neural and non-neural ectoderm.	[Nandadasa, Sumeda; Tao, Qinghua; Shoemaker, Amanda; Cha, Sang-wook; Wylie, Christopher] Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH USA; [Nandadasa, Sumeda] Cincinnati Childrens Hosp Res Fdn, Grad Program Mol & Dev Biol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Nandadasa, S (corresponding author), Cleveland Clin Fdn, Dept Biomed Engn, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	Christopher.Wylie@cchmc.org	Cha, Sang-Wook/D-3523-2016	Nandadasa, Sumeda/0000-0002-4954-6376	NIH [R01HD044764-07]; Albert J. Ryan Foundation; University of Cincinnati Distinguished Dissertation Completion Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044764] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert J. Ryan Foundation; University of Cincinnati Distinguished Dissertation Completion Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by NIH R01HD044764-07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the NIH for support of this work. SN was also suppported by the Albert J. Ryan Foundation and the University of Cincinnati Distinguished Dissertation Completion Fellowship. We would like to thank Dr. Masatoshi Takeichi for the ECCD2, and NCAT2 antibodies. We would also like to thank Dr. Cara Gottardi, and Rebecca Daugherty (Northwestern University) for the human alpha-E-catenin construct. We would also like to thank Dr. Matt Koforn for his assistance with confocal microscopy.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Cha SW, 2010, METHODS, V51, P52, DOI 10.1016/j.ymeth.2010.01.029; Cha SW, 2009, CURR BIOL, V19, P1573, DOI 10.1016/j.cub.2009.07.062; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; HEASMAN J, 1994, DEVELOPMENT, V120, P49; Helwani FM, 2004, J CELL BIOL, V164, P899, DOI 10.1083/jcb.200309034; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; HIRANO S, 1987, J CELL BIOL, V105, P2501, DOI 10.1083/jcb.105.6.2501; HIRANO S, 1994, INT J DEV BIOL, V38, P379; HOLWILL S, 1987, DEVELOPMENT, V100, P735; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Jhingory S, 2010, DEV BIOL, V344, P896, DOI 10.1016/j.ydbio.2010.06.006; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kofron M, 1997, DEVELOPMENT, V124, P1553; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Lien WH, 2008, J CELL BIOL, V183, P989, DOI 10.1083/jcb.200805041; Lloyd B, 2005, DEVELOPMENT, V132, P805, DOI 10.1242/dev.01618; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Maiden SL, 2011, J CELL BIOL, V195, P543, DOI 10.1083/jcb.201103106; Morita H, 2010, DEVELOPMENT, V137, P1315, DOI 10.1242/dev.043190; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; Nandadasa S, 2009, DEVELOPMENT, V136, P1327, DOI 10.1242/dev.031203; Nieset JE, 1997, J CELL SCI, V110, P1013; Nieuwkoop P D, 1967, Acta Biotheor, V17, P178, DOI 10.1007/BF01601987; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; SCHNEIDER S, 1993, DEVELOPMENT, V118, P629; Scott JA, 2006, MOL BIOL CELL, V17, P1085, DOI 10.1091/mbc.e05-07-0644; Silvis MR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001823; TAKEICHI M, 1988, CELL DIFFER DEV, V25, P91, DOI 10.1016/0922-3371(88)90104-9; Tao QH, 2005, DEVELOPMENT, V132, P2825, DOI 10.1242/dev.01866; Tao QH, 2007, DEVELOPMENT, V134, P2651, DOI 10.1242/dev.002824; UCHIDA N, 1994, DEV BIOL, V163, P75, DOI 10.1006/dbio.1994.1124; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020	42	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38756	10.1371/journal.pone.0038756	http://dx.doi.org/10.1371/journal.pone.0038756			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719936	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900047
J	Beacher, FDCC; Radulescu, E; Minati, L; Baron-Cohen, S; Lombardo, MV; Lai, MC; Walker, A; Howard, D; Gray, MA; Harrison, NA; Critchley, HD				Beacher, Felix D. C. C.; Radulescu, Eugenia; Minati, Ludovico; Baron-Cohen, Simon; Lombardo, Michael V.; Lai, Meng-Chuan; Walker, Anne; Howard, Dawn; Gray, Marcus A.; Harrison, Neil A.; Critchley, Hugo D.			Sex Differences and Autism: Brain Function during Verbal Fluency and Mental Rotation	PLOS ONE			English	Article							SPECTRUM QUOTIENT AQ; ACTIVATION PATTERN; ASPERGER-SYNDROME; VISUAL-SEARCH; FMRI; DISORDERS; INTELLIGENCE; PERFORMANCE; EMPATHY; CORTEX	Autism spectrum conditions (ASC) affect more males than females. This suggests that the neurobiology of autism: 1) may overlap with mechanisms underlying typical sex-differentiation or 2) alternately reflect sex-specificity in how autism is expressed in males and females. Here we used functional magnetic resonance imaging (fMRI) to test these alternate hypotheses. Fifteen men and fourteen women with Asperger syndrome (AS), and sixteen typically developing men and sixteen typically developing women underwent fMRI during performance of mental rotation and verbal fluency tasks. All groups performed the tasks equally well. On the verbal fluency task, despite equivalent task-performance, both males and females with AS showed enhanced activation of left occipitoparietal and inferior prefrontal activity compared to controls. During mental rotation, there was a significant diagnosis-by-sex interaction across occipital, temporal, parietal, middle frontal regions, with greater activation in AS males and typical females compared to AS females and typical males. These findings suggest a complex relationship between autism and sex that is differentially expressed in verbal and visuospatial domains.	[Beacher, Felix D. C. C.; Radulescu, Eugenia; Minati, Ludovico; Gray, Marcus A.; Harrison, Neil A.; Critchley, Hugo D.] Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Radulescu, Eugenia; Gray, Marcus A.; Harrison, Neil A.; Critchley, Hugo D.] Univ Sussex, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England; [Beacher, Felix D. C. C.] SUNY Stony Brook, Sch Med, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Minati, Ludovico] Fdn IRCCS Ist Neurol Carlo Besta, Dept Sci, Milan, Italy; [Minati, Ludovico] Fdn IRCCS Ist Neurol Carlo Besta, Neuroradiol Unit, Milan, Italy; [Baron-Cohen, Simon; Lombardo, Michael V.; Lai, Meng-Chuan] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England; [Walker, Anne; Howard, Dawn; Harrison, Neil A.; Critchley, Hugo D.] Sussex Partnership NHS Fdn Trust, Neurobehav Clin, Sussex Educ Ctr, Hove, England; [Gray, Marcus A.] Monash Univ, Expt Neuropsychol Res Unit, Sch Psychol, Psychiat Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia	University of Brighton; University of Sussex; University of Sussex; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; IRCCS Istituto Neurologico Besta; Italfarmaco; IRCCS Istituto Neurologico Besta; University of Cambridge; Monash University	Beacher, FDCC (corresponding author), Brighton & Sussex Med Sch, Brighton, E Sussex, England.	e.radulescu@bsms.ac.uk	Gray, Marcus/F-6521-2013; Minati, Ludovico/R-1076-2017; Lai, Meng-Chuan/K-7407-2016; critchley, hugo d/G-9267-2011; Lombardo, Michael V/J-1773-2012	Gray, Marcus/0000-0001-8671-6939; Minati, Ludovico/0000-0002-2532-1674; Lai, Meng-Chuan/0000-0002-9593-5508; critchley, hugo d/0000-0002-2445-9284; Lombardo, Michael V/0000-0001-6780-8619; beacher, felix/0000-0002-4130-4073; Baron-Cohen, Simon/0000-0001-9217-2544; Harrison, Neil/0000-0002-9584-3769	Dr. Mortimer and Theresa Sackler Foundation; Wellcome Trust Programme Grant; Medical Research Council [G0600977] Funding Source: researchfish; MRC [G0600977] Funding Source: UKRI	Dr. Mortimer and Theresa Sackler Foundation; Wellcome Trust Programme Grant(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	ER and partly HDC were supported by the Dr. Mortimer and Theresa Sackler Foundation. HDC was supported by a Wellcome Trust Programme Grant and LM was supported by the Shirley Foundation during the acquisition of these data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Astur RS, 2004, BEHAV BRAIN RES, V151, P103, DOI 10.1016/j.bbr.2003.08.024; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Baker SC, 1997, PSYCHOL MED, V27, P565, DOI 10.1017/S0033291797004856; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; Baron-Cohen S, 2009, ANN NY ACAD SCI, V1156, P68, DOI 10.1111/j.1749-6632.2009.04467.x; Beacher FD, 2012, AM J NEURORADIOL, V33, P83, DOI 10.3174/ajnr.A2880; Bejerot S, 2012, BRIT J PSYCHIAT, V201, P116, DOI 10.1192/bjp.bp.111.097899; Brosnan M, 2010, J AUTISM DEV DISORD, V40, P1, DOI 10.1007/s10803-009-0815-3; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Clements-Stephens AM, 2009, NEUROSCI LETT, V449, P155, DOI 10.1016/j.neulet.2008.10.094; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Critchley HD, 2005, NEUROIMAGE, V24, P751, DOI 10.1016/j.neuroimage.2004.10.013; Crucian GP, 1998, BRAIN COGNITION, V36, P377, DOI 10.1006/brcg.1998.0999; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Decety J, 2011, ANN NY ACAD SCI, V1231, P35, DOI 10.1111/j.1749-6632.2011.06027.x; Dehaene S, 2002, NEUROREPORT, V13, P321, DOI 10.1097/00001756-200203040-00015; Deichmann R, 2002, NEUROIMAGE, V15, P120, DOI 10.1006/nimg.2001.0985; Filipek PA, 1999, J AUTISM DEV DISORD, V29, P439, DOI 10.1023/A:1021943802493; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; Gauthier CT, 2009, CORTEX, V45, P164, DOI 10.1016/j.cortex.2007.09.006; Golestani N, 2006, NEUROPSYCHOLOGIA, V44, P1029, DOI 10.1016/j.neuropsychologia.2005.11.009; Halari R, 2006, EXP BRAIN RES, V169, P1, DOI 10.1007/s00221-005-0118-7; Harris GJ, 2006, BRAIN COGNITION, V61, P54, DOI 10.1016/j.bandc.2005.12.015; Hugdahl K, 2006, NEUROPSYCHOLOGIA, V44, P1575, DOI 10.1016/j.neuropsychologia.2006.01.026; Jordan K, 2002, NEUROPSYCHOLOGIA, V40, P2397, DOI 10.1016/S0028-3932(02)00076-3; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; Kaiser A, 2009, BRAIN RES REV, V61, P49, DOI 10.1016/j.brainresrev.2009.03.005; Keehn B, 2008, J INT NEUROPSYCH SOC, V14, P990, DOI 10.1017/S1355617708081356; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Kozaki T, 2009, INT J NEUROSCI, V119, P59, DOI 10.1080/00207450802480101; Lai G, 2012, BRAIN, V135, P961, DOI 10.1093/brain/awr335; Lai MC, 2011, THESIS U CAMBRIDGE; Lai MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020835; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Leekam SR, 2002, J CHILD PSYCHOL PSYC, V43, P327, DOI 10.1111/1469-7610.00024; Liederman J, 2012, ARCH SEXUAL BEH 0321; Lissek S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002023; Manjaly ZM, 2007, NEUROIMAGE, V35, P283, DOI 10.1016/j.neuroimage.2006.11.036; Materna S, 2008, NEUROPSYCHOLOGIA, V46, P2759, DOI 10.1016/j.neuropsychologia.2008.05.016; Mayes SD, 2001, AUTISM, V5, P81, DOI 10.1177/1362361301005001008; Mechelli A, 2007, HUM BRAIN MAPP, V28, P205, DOI 10.1002/hbm.20272; Minshew NJ, 2007, ARCH NEUROL-CHICAGO, V64, P945, DOI 10.1001/archneur.64.7.945; Murty VP, 2011, NEUROIMAGE, V57, P1264, DOI 10.1016/j.neuroimage.2011.05.006; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; Parsons LM, 2003, TRENDS COGN SCI, V7, P515, DOI 10.1016/j.tics.2003.10.002; Parsons TD, 2004, NEUROPSYCHOLOGIA, V42, P555, DOI 10.1016/j.neuropsychologia.2003.08.014; Perani D, 2001, NEUROIMAGE, V14, P749, DOI 10.1006/nimg.2001.0872; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Radulescu E, 2012, PHARMACOGENOMIC 0214; Schwarz E, 2011, MOL PSYCHIATR, V16, P1213, DOI 10.1038/mp.2010.102; Scott-Van Zeeland AA, 2010, BIOL PSYCHIAT, V68, P345, DOI 10.1016/j.biopsych.2010.01.011; Silk TJ, 2006, AM J PSYCHIAT, V163, P1440, DOI 10.1176/appi.ajp.163.8.1440; Simon SR, 2002, J NEUROPHYSIOL, V88, P2047, DOI 10.1152/jn.2002.88.4.2047; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Soulieres I, 2009, HUM BRAIN MAPP, V30, P4082, DOI 10.1002/hbm.20831; Steinmetz KRM, 2010, PSYCHOL AGING, V25, P239, DOI 10.1037/a0018297; Tang J, 2006, J COGNITIVE NEUROSCI, V18, P2049, DOI 10.1162/jocn.2006.18.12.2049; Tesink CMJY, 2011, NEUROPSYCHOLOGIA, V49, P1095, DOI 10.1016/j.neuropsychologia.2011.01.018; Thomsen T, 2000, Med Sci Monit, V6, P1186; Turner MA, 1999, J CHILD PSYCHOL PSYC, V40, P189, DOI 10.1111/1469-7610.00432; Volkmar FR, 2000, KAPLAN SADOCKS COMPR; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Wakabayashi A, 2006, J AUTISM DEV DISORD, V36, P263, DOI 10.1007/s10803-005-0061-2; Wallace GL, 2010, BRAIN, V133, P3745, DOI 10.1093/brain/awq279; Weiss E, 2003, NEUROSCI LETT, V344, P169, DOI 10.1016/S0304-3940(03)00406-3; Weiss EM, 2003, NEUROSCI LETT, V352, P191, DOI 10.1016/j.neulet.2003.08.071; Wing L, 2011, RES DEV DISABIL 0103; Zacks JM, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI 10.1162/jocn.2008.20013	75	54	56	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38355	10.1371/journal.pone.0038355	http://dx.doi.org/10.1371/journal.pone.0038355			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UJ	22701630	gold, Green Accepted, Green Published			2022-12-25	WOS:000305340000018
J	Sutrave, S; Scoglio, C; Isard, SA; Hutchinson, JMS; Garrett, KA				Sutrave, Sweta; Scoglio, Caterina; Isard, Scott A.; Hutchinson, J. M. Shawn; Garrett, Karen A.			Identifying Highly Connected Counties Compensates for Resource Limitations when Evaluating National Spread of an Invasive Pathogen	PLOS ONE			English	Article							SOYBEAN RUST; PHAKOPSORA-PACHYRHIZI; CLIMATE-CHANGE; PLANT-DISEASE; CROP PEST; NETWORKS; MANAGEMENT; INFECTION; DYNAMICS; RISK	Surveying invasive species can be highly resource intensive, yet near-real-time evaluations of invasion progress are important resources for management planning. In the case of the soybean rust invasion of the United States, a linked monitoring, prediction, and communication network saved U. S. soybean growers approximately $200 M/yr. Modeling of future movement of the pathogen (Phakopsora pachyrhizi) was based on data about current disease locations from an extensive network of sentinel plots. We developed a dynamic network model for U. S. soybean rust epidemics, with counties as nodes and link weights a function of host hectarage and wind speed and direction. We used the network model to compare four strategies for selecting an optimal subset of sentinel plots, listed here in order of increasing performance: random selection, zonal selection (based on more heavily weighting regions nearer the south, where the pathogen overwinters), frequency-based selection (based on how frequently the county had been infected in the past), and frequency-based selection weighted by the node strength of the sentinel plot in the network model. When dynamic network properties such as node strength are characterized for invasive species, this information can be used to reduce the resources necessary to survey and predict invasion progress.	[Sutrave, Sweta; Garrett, Karen A.] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Sutrave, Sweta; Scoglio, Caterina] Kansas State Univ, Dept Elect & Comp Engn, Manhattan, KS 66506 USA; [Isard, Scott A.] Penn State Univ, Dept Plant Pathol, University Pk, PA 16802 USA; [Isard, Scott A.] Penn State Univ, Dept Meteorol, University Pk, PA 16802 USA; [Hutchinson, J. M. Shawn] Kansas State Univ, Dept Geog, Manhattan, KS 66506 USA	Kansas State University; Kansas State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Kansas State University	Sutrave, S (corresponding author), Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA.	kgarrett@ksu.edu		Scoglio, Caterina/0000-0003-4486-9229; Hutchinson, J.M. Shawn/0000-0002-7667-8446	United States Department of Agriculture North Central Regional Integrated Pest Management Grant [2010-34103-20964]; United States Department of Agriculture Animal and Plant Health Inspection Service Grant [11-8453-1483-CA]; United States Department of Agriculture Animal and Plant Health Inspection Service Grant for spatial modeling; National Science Foundation, joint National Science Foundation-National Institute of Health Ecology of Infectious Disease program [EF-0525712]; National Science Foundation [DEB-0516046, SBE-0244984]; Kansas Agricultural Experiment Station [12-197-J]	United States Department of Agriculture North Central Regional Integrated Pest Management Grant; United States Department of Agriculture Animal and Plant Health Inspection Service Grant; United States Department of Agriculture Animal and Plant Health Inspection Service Grant for spatial modeling; National Science Foundation, joint National Science Foundation-National Institute of Health Ecology of Infectious Disease program; National Science Foundation(National Science Foundation (NSF)); Kansas Agricultural Experiment Station	The authors appreciate support of this work by United States Department of Agriculture North Central Regional Integrated Pest Management Grant 2010-34103-20964, United States Department of Agriculture Animal and Plant Health Inspection Service Grant 11-8453-1483-CA, a United States Department of Agriculture Animal and Plant Health Inspection Service Grant for spatial modeling, National Science Foundation Grant EF-0525712 as part of the joint National Science Foundation-National Institute of Health Ecology of Infectious Disease program, National Science Foundation Grant DEB-0516046, National Science Foundation Grant SBE-0244984 (R. A. Dyer, PI), and the Kansas Agricultural Experiment Station (Contribution No. 12-197-J). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Anderson CB, 2010, REV CHIL HIST NAT, V83, P1; [Anonymous], 2006, VALUE PLANT DIS EARL; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Bonde MR, 2008, PLANT DIS, V92, P30, DOI 10.1094/PDIS-92-1-0030; Borer ET, 2010, ECOL LETT, V13, P810, DOI 10.1111/j.1461-0248.2010.01475.x; Brooks CP, 2008, AM NAT, V172, P149, DOI 10.1086/589451; Chades I, 2011, P NATL ACAD SCI USA, V108, P8323, DOI 10.1073/pnas.1016846108; Cheatham MR, 2009, PHYTOPATHOLOGY, V99, P1228, DOI 10.1094/PHYTO-99-11-1228; Chen YP, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.058701; Claffy KC, 1993, SIGCOMM C P COMM ARC; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Cox CM, 2004, PHYTOPATHOLOGY, V94, P961, DOI 10.1094/PHYTO.2004.94.9.961; Crowl TA, 2008, FRONT ECOL ENVIRON, V6, P238, DOI 10.1890/070151; Demon I, 2011, PHYTOPATHOLOGY, V101, P725, DOI 10.1094/PHYTO-05-09-0120; Dorrance A. E., 2007, USING FOLIAR FUNGICI; Ellis AM, 2010, OIKOS, V119, P485, DOI 10.1111/j.1600-0706.2009.17918.x; Epanchin-Niell RS, 2010, FRONT ECOL ENVIRON, V8, P210, DOI 10.1890/090029; Epanchin-Niell RS, 2010, ECOL LETT, V13, P528, DOI 10.1111/j.1461-0248.2010.01440.x; Fabiszewski AM, 2010, ECOL APPL, V20, P582, DOI 10.1890/08-0820.1; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; FITT BDL, 1987, J PHYTOPATHOL, V118, P227, DOI 10.1111/j.1439-0434.1987.tb00452.x; Floerl O, 2009, J APPL ECOL, V46, P37, DOI 10.1111/j.1365-2664.2008.01540.x; Florance D, 2011, P ROY SOC B-BIOL SCI, V278, P2900, DOI 10.1098/rspb.2011.0032; Forster GA, 2007, P NATL ACAD SCI USA, V104, P4984, DOI 10.1073/pnas.0607900104; Gallos LK, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045104; Garrett KA, 2013, AGR FOREST METEOROL, V170, P216, DOI 10.1016/j.agrformet.2012.04.018; Garrett KA, 2012, EUR J PLANT PATHOL, V133, P75, DOI 10.1007/s10658-012-9963-y; Garrett KA, 2011, PLANT PATHOL, V60, P15, DOI 10.1111/j.1365-3059.2010.02409.x; Garrett KA, 2009, ECOL APPL, V19, P1868, DOI 10.1890/08-0942.1; Gent DH, 2011, PHYTOPATHOLOGY, V101, P640, DOI 10.1094/PHYTO-04-10-0124; Giesler L. J., 2007, 2 NAT SBR S AM PHYT; Gilbert M, 2010, ECOGRAPHY, V33, P809, DOI 10.1111/j.1600-0587.2009.06018.x; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Harwood TD, 2009, ECOL MODEL, V220, P3353, DOI 10.1016/j.ecolmodel.2009.08.014; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Irwin ME, 1999, AGR FOREST METEOROL, V97, P235, DOI 10.1016/S0168-1923(99)00069-6; Isard SA, 2006, PLANT DIS, V90, P941, DOI 10.1094/PD-90-0941; Isard SA, 2011, PLANT DIS, V95, P1346, DOI 10.1094/PDIS-01-11-0034; Isard SA, 2005, BIOSCIENCE, V55, P851, DOI 10.1641/0006-3568(2005)055[0851:POTAPF]2.0.CO;2; Isard SA, 2007, AEROBIOLOGIA, V23, P271, DOI 10.1007/s10453-007-9073-z; Jeger MJ, 2007, NEW PHYTOL, V174, P279, DOI 10.1111/j.1469-8137.2007.02028.x; Jeger MJ, 1999, AGR FOREST METEOROL, V97, P331, DOI 10.1016/S0168-1923(99)00076-3; Kampe TU, 2010, J APPL REMOTE SENS, V4, DOI 10.1117/1.3361375; Keller M, 2008, FRONT ECOL ENVIRON, V6, P282, DOI 10.1890/1540-9295(2008)6[282:ACSFTN]2.0.CO;2; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; KO CW, 1995, OPER RES, V43, P684, DOI 10.1287/opre.43.4.684; KOCHMAN JK, 1979, AUST J AGR RES, V30, P273, DOI 10.1071/AR9790273; Lamour A, 2007, FEMS MICROBIOL ECOL, V62, P222, DOI 10.1111/j.1574-6941.2007.00358.x; Legendre P, 2002, ECOGRAPHY, V25, P601, DOI 10.1034/j.1600-0587.2002.250508.x; Li X, 2010, PLANT DIS, V94, P796, DOI 10.1094/PDIS-94-7-0796; Lowman M, 2009, SCIENCE, V323, P1172, DOI 10.1126/science.1166945; Madar N, 2004, EUR PHYS J B, V38, P269, DOI 10.1140/epjb/e2004-00119-8; Malmstrom CM, 2006, J ECOL, V94, P264, DOI 10.1111/j.1365-2745.2006.01101.x; MARCHETTI MA, 1976, PHYTOPATHOLOGY, V66, P461, DOI 10.1094/Phyto-66-461; Margosian ML, 2009, BIOSCIENCE, V59, P141, DOI 10.1525/bio.2009.59.2.7; Marshall JD, 2008, FRONT ECOL ENVIRON, V6, P273, DOI 10.1890/070165; Masuda N, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036108; McRoberts N, 2011, PHYTOPATHOLOGY, V101, P654, DOI 10.1094/PHYTO-04-10-0126; Minor ES, 2011, ECOL APPL, V21, P739, DOI 10.1890/10-0321.1; Moslonka-Lefebvre M, 2011, PHYTOPATHOLOGY, V101, P392, DOI 10.1094/PHYTO-07-10-0192; Muirhead JR, 2005, J APPL ECOL, V42, P80, DOI 10.1111/j.1365-2664.2004.00988.x; Mundt CC, 2009, AM NAT, V173, P456, DOI 10.1086/597220; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.035108; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pautasso M, 2008, ECOL COMPLEX, V5, P1, DOI 10.1016/j.ecocom.2007.07.001; Pfender WF, 2011, PHYTOPATHOLOGY, V101, P644, DOI 10.1094/PHYTO-05-10-0131; Reynolds AM, 2011, PHYTOPATHOLOGY, V101, P1465, DOI 10.1094/PHYTO-01-11-0001; Richardson AD, 2009, ECOL APPL, V19, P1417, DOI 10.1890/08-2022.1; Rothlisberger JD, 2011, CONSERV BIOL, V25, P64, DOI 10.1111/j.1523-1739.2010.01589.x; Saleh AA, 2010, MOL ECOL, V19, P79, DOI 10.1111/j.1365-294X.2009.04433.x; Schneider CM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061911; Schneider RW, 2005, PLANT DIS, V89, P774, DOI 10.1094/PD-89-0774A; Schumm P, 2007, P IEEE ACM BION; Shaw MW, 2011, PLANT PATHOL, V60, P31, DOI 10.1111/j.1365-3059.2010.02407.x; Singh RP, 2011, ANNU REV PHYTOPATHOL, V49, P465, DOI 10.1146/annurev-phyto-072910-095423; Skelsey P, 2005, PHYTOPATHOLOGY, V95, P328, DOI 10.1094/PHYTO-95-0328; Sparks AH, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00128.1; Urban DL, 2009, ECOL LETT, V12, P260, DOI 10.1111/j.1461-0248.2008.01271.x; Van Mieghem P, 2009, IEEE ACM T NETWORK, V17, P1, DOI 10.1109/TNET.2008.925623; Wang Y, 2003, SYM REL DIST SYST, P25; WHITTLE P, 1955, BIOMETRIKA, V42, P116, DOI 10.2307/2333427; With KA, 2002, CONSERV BIOL, V16, P1192, DOI 10.1046/j.1523-1739.2002.01064.x; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341; Xu XM, 2009, ECOGRAPHY, V32, P504, DOI 10.1111/j.1600-0587.2008.05597.x; YANG XB, 1992, J PHYTOPATHOL, V136, P46, DOI 10.1111/j.1439-0434.1992.tb01280.x; YANG XB, 1991, J PHYTOPATHOL, V133, P187, DOI 10.1111/j.1439-0434.1991.tb00153.x; Yorinori JT, 2005, PLANT DIS, V89, P675, DOI 10.1094/PD-89-0675; Youssef M, 2011, J COMPUT SCI-NETH, V2, P286, DOI 10.1016/j.jocs.2011.03.001; Zacharias S, 2011, VADOSE ZONE J, V10, P955, DOI 10.2136/vzj2010.0139	91	35	35	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e37793	10.1371/journal.pone.0037793	http://dx.doi.org/10.1371/journal.pone.0037793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701580	Green Published, gold			2022-12-25	WOS:000305340000006
J	Felline, S; Caricato, R; Cutignano, A; Gorbi, S; Lionetto, MG; Mollo, E; Regoli, F; Terlizzi, A				Felline, Serena; Caricato, Roberto; Cutignano, Adele; Gorbi, Stefania; Lionetto, Maria Giulia; Mollo, Ernesto; Regoli, Francesco; Terlizzi, Antonio			Subtle Effects of Biological Invasions: Cellular and Physiological Responses of Fish Eating the Exotic Pest Caulerpa racemosa	PLOS ONE			English	Article							VAR. CYLINDRACEA; MYTILUS-GALLOPROVINCIALIS; REPRODUCTIVE-BIOLOGY; DIPLODUS-SARGUS; MEDITERRANEAN SEA; OXIDATIVE STRESS; BROWN BULLHEADS; TRACE-METALS; ASSEMBLAGES; BIOMARKERS	The green alga Caulerpa racemosa var. cylindracea has invaded Mediterranean seabed including marine reserves, modifying the structure of habitats and altering the distributional patterns of associated organisms. However, the understanding of how such invasion can potentially affect functional properties of Mediterranean subtidal systems is yet to be determined. In this study, we show that C. racemosa changes foraging habit of the native white seabream, Diplodus sargus. In invaded areas, we found a high frequency of occurrence of C. racemosa in the stomach contents of this omnivorous fish (72.7 and 85.7%), while the alga was not detected in fish from a control area. We also found a significant accumulation of caulerpin, one of the main secondary metabolites of C. racemosa, in fish tissues. The level of caulerpin in fish tissues was used here as an indicator of the trophic exposure to the invasive pest and related with observed cellular and physiological alterations. Such effects included activation of some enzymatic pathways (catalase, glutathione peroxidases, glutathione S-transferases, total glutathione and the total oxyradical scavenging capacity, 7-ethoxy resorufin O-deethylase), the inhibition of others (acetylcholinesterase and acylCoA oxidase), an increase of hepatosomatic index and decrease of gonadosomatic index. The observed alterations might lead to a detrimental health status and altered behaviours, potentially preventing the reproductive success of fish populations. Results of this study revealed that the entering of alien species in subtidal systems can alter trophic webs and can represent an important, indirect mechanism which might contribute to influence fluctuations of fish stocks and, also, the effectiveness of protection regimes.	[Felline, Serena; Caricato, Roberto; Lionetto, Maria Giulia; Terlizzi, Antonio] Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali, CoNISMa, Lecce, Italy; [Cutignano, Adele; Mollo, Ernesto] CNR, Ist Chim Biomol, I-80125 Naples, Italy; [Gorbi, Stefania; Regoli, Francesco] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy	CoNISMa; University of Salento; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); Marche Polytechnic University	Felline, S (corresponding author), Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali, CoNISMa, Lecce, Italy.	antonio.terlizzi@unisalento.it	Terlizzi, Antonio/B-6131-2015; Gorbi, Stefania/K-5662-2016; Lionetto, Maria Giulia/H-1356-2011; Regoli, Francesco/K-2719-2018; Cutignano, Adele/C-3343-2012; Mollo, Ernesto/F-7842-2013	Terlizzi, Antonio/0000-0001-5968-4548; Gorbi, Stefania/0000-0002-4232-2652; Lionetto, Maria Giulia/0000-0003-3752-0192; Regoli, Francesco/0000-0001-6084-6188; Cutignano, Adele/0000-0003-3035-9252; Mollo, Ernesto/0000-0001-7379-1788; Felline, Serena/0000-0003-1221-7306; caricato, roberto/0000-0002-7928-4573	MIUR (The Ministry of Education, Universities and Research) (PRIN, CAUDIP project); EU FP7 PERSEUS Project	MIUR (The Ministry of Education, Universities and Research) (PRIN, CAUDIP project)(Ministry of Education, Universities and Research (MIUR)); EU FP7 PERSEUS Project	Financial support provided by MIUR (The Ministry of Education, Universities and Research) (PRIN 2009, CAUDIP project), and by the EU FP7 PERSEUS Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS SM, 1985, J FISH BIOL, V26, P111, DOI 10.1111/j.1095-8649.1985.tb04248.x; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Benedetti M, 2007, AQUAT TOXICOL, V85, P167, DOI 10.1016/j.aquatox.2007.08.009; Bocchetti R, 2006, CHEMOSPHERE, V65, P913, DOI 10.1016/j.chemosphere.2006.03.049; Bocquene Gilles, 1998, ICES Techniques in Marine Environmental Sciences, V22, P1; Box A, 2009, J EXP MAR BIOL ECOL, V380, P11, DOI 10.1016/j.jembe.2009.08.010; Brunelli M, 2000, PROG NEURO-PSYCHOPH, V24, P939, DOI 10.1016/S0278-5846(00)00112-3; Bulleri F, 2009, OIKOS, V118, P269, DOI 10.1111/j.1600-0706.2008.16955.x; Bulleri F, 2011, MAR ECOL PROG SER, V431, P55, DOI 10.3354/meps09137; Bulleri F, 2010, ECOLOGY, V91, P2205, DOI 10.1890/09-1857.1; Byrnes JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000295; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Cnubben NHP, 2001, ENVIRON TOXICOL PHAR, V10, P141, DOI 10.1016/S1382-6689(01)00077-1; DIGIULIO RT, 1995, MAR ENVIRON RES, V39, P175, DOI 10.1016/0141-1136(94)00021-G; DOTY MS, 1970, PAC SCI, V24, P351; EVERAARTS JM, 1993, MAR ENVIRON RES, V35, P101, DOI 10.1016/0141-1136(93)90021-Q; FABACHER DL, 1985, ENVIRON TOXICOL CHEM, V4, P703, DOI 10.1897/1552-8618(1985)4[703:ELAHMM]2.0.CO;2; Fraschetti S, 2005, MAR ENVIRON RES, V59, P309, DOI 10.1016/j.marenvres.2004.05.007; Frasco MF, 2005, BIOMARKERS, V10, P360, DOI 10.1080/13547500500264660; GALLAGHER EP, 1989, ENVIRON POLLUT, V62, P113, DOI 10.1016/0269-7491(89)90182-6; Grigorakis K, 2007, AQUACULTURE, V272, P55, DOI 10.1016/j.aquaculture.2007.04.062; Guilhermino L, 1998, BIOMARKERS, V3, P157, DOI 10.1080/135475098231318; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; HAYSE JW, 1990, FISH B-NOAA, V88, P67; Hoey AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025824; Kopecka-Pilarczyk J, 2011, B ENVIRON CONTAM TOX, V86, P379, DOI 10.1007/s00128-011-0234-y; KRUSKAL J.B., 1978, MULTIDIMENSIONAL SCA; KURELEC B, 1993, MAR ENVIRON RES, V35, P341, DOI 10.1016/0141-1136(93)90101-5; Lionetto MG, 2003, MAR POLLUT BULL, V46, P324, DOI 10.1016/S0025-326X(02)00403-4; Lionetto MG, 2001, AQUAT CONSERV, V11, P305, DOI 10.1002/aqc.458; Longepierre S, 2005, BIODIVERS CONSERV, V14, P365, DOI [10.1007/s10531-004-5356-7, 10.1007/s10531-004-5056-7]; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mann BQ, 1998, CYBIUM, V22, P31; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Medina MH, 2007, CHEMOSPHERE, V67, P2105, DOI 10.1016/j.chemosphere.2006.12.024; MICALE V, 1994, J FISH BIOL, V45, P661, DOI 10.1006/jfbi.1994.1165; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Morato T, 2003, J FISH BIOL, V63, P59, DOI 10.1046/j.1095-8649.2003.00129.x; Mouine N, 2007, SCI MAR, V71, P461, DOI 10.3989/scimar.2007.71n3461; Mozzachiodi R, 2001, NEUROSCIENCE, V107, P519, DOI 10.1016/S0306-4522(01)00365-7; Parvez M, 2000, Acta Crystallogr C, V56, pE96; Piazzi L, 2005, ESTUAR COAST SHELF S, V64, P467, DOI 10.1016/j.ecss.2005.03.010; Piazzi L, 2008, MAR ENVIRON RES, V65, P50, DOI 10.1016/j.marenvres.2007.07.002; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Piva F, 2011, CHEMOSPHERE, V83, P475, DOI 10.1016/j.chemosphere.2010.12.064; Raniello R, 2007, BIOL INVASIONS, V9, P361, DOI 10.1007/s10530-006-9044-2; Regoli F, 2005, ENVIRON TOXICOL CHEM, V24, P1475, DOI 10.1897/04-514R.1; Regoli F, 2002, MAR ENVIRON RES, V54, P419, DOI 10.1016/S0141-1136(02)00146-0; Regoli F, 2011, AQUAT TOXICOL, V105, P56, DOI 10.1016/j.aquatox.2011.06.014; Rocha FD, 2007, PHYTOTHER RES, V21, P170, DOI 10.1002/ptr.2038; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Santos MA, 2004, ENVIRON INT, V30, P301, DOI 10.1016/S0160-4120(03)00178-8; Schroder HC, 1998, ENVIRON TOXICOL PHAR, V5, P119, DOI 10.1016/S1382-6689(97)10067-9; Sibley P. K., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P117, DOI 10.1023/A:1009967213300; SLOOFF W, 1983, AQUAT TOXICOL, V4, P1, DOI 10.1016/0166-445X(83)90057-7; Stefania G, 2009, ENVIRON POLLUT, V157, P3166, DOI 10.1016/j.envpol.2009.05.021; Sureda A, 2006, COMP BIOCHEM PHYS C, V144, P191, DOI 10.1016/j.cbpc.2006.08.001; Terlizzi A, 2004, MAR POLLUT BULL, V48, P188, DOI 10.1016/j.marpolbul.2003.10.019; Terlizzi A, 2002, MAR POLLUT BULL, V44, P544, DOI 10.1016/S0025-326X(01)00282-X; Terlizzi A, 2011, AQUAT BIOL, V12, P109, DOI 10.3354/ab00330; Uchimura M, 1999, ENVIRON SCI TECHNOL, V33, P1671, DOI 10.1021/es980444j; UEDA T, 1992, WATER SCI TECHNOL, V25, P235, DOI 10.2166/wst.1992.0297; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; Vazquez-Luis M, 2008, MAR ENVIRON RES, V65, P416, DOI 10.1016/j.marenvres.2008.01.006; Vazquez-Luis M, 2009, HELGOLAND MAR RES, V63, P107, DOI 10.1007/s10152-008-0129-4; Vazquez-Luis M, 2010, HYDROBIOLOGIA, V654, P147, DOI 10.1007/s10750-010-0378-5; Vazquez-Luis M, 2009, ESTUAR COAST SHELF S, V84, P161, DOI 10.1016/j.ecss.2009.04.016; VIDAL JP, 1984, BOT MAR, V27, P533, DOI 10.1515/botm.1984.27.12.533; Wallentinus I, 2007, MAR POLLUT BULL, V55, P323, DOI 10.1016/j.marpolbul.2006.11.010; WEST G, 1990, AUST J MAR FRESH RES, V41, P199, DOI 10.1071/MF9900199; Zenetos A, 2010, MEDITERR MAR SCI, V11, P381, DOI 10.12681/mms.87; Zhan ZJ, 2010, BIOORG MED CHEM LETT, V20, P6185, DOI 10.1016/j.bmcl.2010.08.123	77	35	37	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38763	10.1371/journal.pone.0038763	http://dx.doi.org/10.1371/journal.pone.0038763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701707	gold, Green Submitted, Green Published			2022-12-25	WOS:000305337600040
J	Han, Y; Zhang, W; Tang, Y; Bai, WL; Yang, F; Xie, LP; Li, XZ; Zhou, SM; Pan, SY; Chen, Q; Ferro, A; Ji, Y				Han, Yi; Zhang, Wen; Tang, Yan; Bai, Wenli; Yang, Fan; Xie, Liping; Li, Xiaozhen; Zhou, Suming; Pan, Shiyang; Chen, Qi; Ferro, Albert; Ji, Yong			l-Tetrahydropalmatine, an Active Component of Corydalis yanhusuo W.T. Wang, Protects against Myocardial Ischaemia-Reperfusion Injury in Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; CARDIOVASCULAR-DISEASE; SEPTIC SHOCK; CYTOCHROME-C; TNF-ALPHA; PEROXYNITRITE; ACTIVATION; EXPRESSION; APOPTOSIS	l-Tetrahydropalmatine (l-THP) is an active ingredients of Corydalis yanhusuo W.T. Wang, which protects against acute global cerebral ischaemia-reperfusion injury. In this study, we show that l-THP is cardioprotective in myocardial ischaemia-reperfusion injury and examined the mechanism. Rats were treated with l-THP (0, 10, 20, 40 mg/kg b.w.) for 20 min before occlusion of the left anterior descending coronary artery and subjected to myocardial ischaemia-reperfusion (30 min/6 h). Compared with vehicle-treated animals, the infarct area/risk area (IA/RA) of l-THP (20, 40 mg/kg b.w.) treated rats was reduced, whilst l-THP (10 mg/kg b.w.) had no significant effect. Cardiac function was improved in l-THP-treated rats whilst plasma creatine kinase activity declined. Following treatment with l-THP (20 mg/kg b.w.), subunit of phosphatidylinositol 3-kinase p85, serine(473) phosphorylation of Akt and serine(1177) phosphorylation of endothelial NO synthase (eNOS) increased in myocardium, whilst expression of inducible NO synthase (iNOS) decreased. However, the expression of HIF-1 alpha and VEGF were increased in I30 minR6 (h), but decreased to normal level in I30 minR24 (h), while treatment with l-THP (20 mg/kg b.w.) enhanced the levels of these two genes in I30 minR24 h. Production of NO in myocardium and plasma, activity of myeloperoxidase (MPO) in plasma and the expression of tumour necrosis factor-alpha (TNF-alpha) in myocardium were decreased by l-THP. TUNEL assay revealed that l-THP (20 mg/kg b.w.) reduced apoptosis in myocardium. Thus, we show that l-THP activates the PI3K/Akt/eNOS/NO pathway and increases expression of HIF-1 alpha and VEGF, whilst depressing iNOS-derived NO production in myocardium. This effect may decrease the accumulation of inflammatory factors, including TNF-alpha and MPO, and lessen the extent of apoptosis, therefore contributing to the cardioprotective effects of l-THP in myocardial ischaemia-reperfusion injury.	[Han, Yi; Zhou, Suming] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing, Jiangsu, Peoples R China; [Zhang, Wen; Tang, Yan; Bai, Wenli; Yang, Fan; Xie, Liping; Li, Xiaozhen; Chen, Qi; Ji, Yong] Nanjing Med Univ, Key Lab Cardiovasc Dis & Mol Intervent, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Pan, Shiyang] Nanjing Med Univ, Affiliated Hosp 1, Dept Lab Med, Nanjing, Jiangsu, Peoples R China; [Ferro, Albert] Kings Coll London, Sch Med, Dept Clin Pharmacol, Div Cardiovasc, London WC2R 2LS, England	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; University of London; King's College London	Ji, Y (corresponding author), Nanjing Med Univ, Key Lab Cardiovasc Dis & Mol Intervent, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	yongji@njmu.edu.cn		Ferro, Albert/0000-0002-5486-9145	National Basic Research Program (973) [2010CB535010, 2011CB503903, 2012CB517503]; National Natural Science Foundation of China [30971256, 81170083]; PAPD; Universities Natural Science Research Project of Jiangsu Province [10KJA310033]	National Basic Research Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PAPD; Universities Natural Science Research Project of Jiangsu Province	This work was supported by grants from National Basic Research Program (973) (Nos. 2010CB535010, 2011CB503903 and 2012CB517503), the National Natural Science Foundation of China (Nos. 30971256 and 81170083), PAPD and Universities Natural Science Research Project of Jiangsu Province (No. 10KJA310033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arstall MA, 1999, CIRC RES, V85, P829, DOI 10.1161/01.RES.85.9.829; BJORKMAN JA, 1991, BASIC RES CARDIOL, V86, P236, DOI 10.1007/BF02190603; Borutaite V, 1999, BBA-MOL BASIS DIS, V1453, P41, DOI 10.1016/S0925-4439(98)00082-9; Brown GC, 2007, CARDIOVASC RES, V75, P283, DOI 10.1016/j.cardiores.2007.03.022; Chu HY, 2008, CELL MOL NEUROBIOL, V28, P491, DOI 10.1007/s10571-007-9179-4; Davidson SM, 2006, CARDIOVASC RES, V71, P10, DOI 10.1016/j.cardiores.2006.01.019; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; DINERMAN JL, 1993, CIRC RES, V73, P217, DOI 10.1161/01.RES.73.2.217; Freeman BD, 2000, EXPERT OPIN INV DRUG, V9, P1651, DOI 10.1517/13543784.9.7.1651; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; Gao F, 2002, CARDIOVASC RES, V53, P414, DOI 10.1016/S0008-6363(01)00488-6; Griendling KK, 1997, CIRCULATION, V96, P3264; Hong ZY, 2006, BIOPHARM DRUG DISPOS, V27, P111, DOI 10.1002/bdd.489; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Jurgensen JS, 2004, FASEB J, V18, P1415, DOI 10.1096/fj.04-1605fje; Kaminski A, 2004, AM J PATHOL, V164, P2241, DOI 10.1016/S0002-9440(10)63780-7; Kido M, 2005, J AM COLL CARDIOL, V46, P2116, DOI 10.1016/j.jacc.2005.08.045; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Li CF, 2001, AM J PHYSIOL-HEART C, V280, pH1264, DOI 10.1152/ajpheart.2001.280.3.H1264; Li J, 2008, CRIT CARE MED, V36, P1551, DOI 10.1097/CCM.0b013e3181782335; Li JR, 2005, P NATL ACAD SCI USA, V102, P9936, DOI 10.1073/pnas.0502552102; Liang F, 2004, CARDIOVASC RES, V62, P568, DOI 10.1016/j.cardiores.2004.01.025; Liang J, 1999, CHINESE PHARMACOL B, V15, P167; Liu Bin, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P445; Lu MJ, 2005, J FORMOS MED ASSOC, V104, P707; Ma HD, 2009, J PHARMACEUT BIOMED, V49, P440, DOI 10.1016/j.jpba.2008.11.019; MA XL, 1993, CIRC RES, V72, P403, DOI 10.1161/01.RES.72.2.403; Matsuhisa S, 2008, AM J PHYSIOL-HEART C, V294, pH2473, DOI 10.1152/ajpheart.91533.2007; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; Merla R, 2007, AM HEART J, V154, P391, DOI 10.1016/j.ahj.2007.04.029; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Otani H, 2009, ANTIOXID REDOX SIGN, V11, P1913, DOI [10.1089/ars.2009.2453, 10.1089/ARS.2009.2453]; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; PARK E, 1995, J IMMUNOL, V154, P4778; RADI R, 1993, BIOCHEM J, V290, P51, DOI 10.1042/bj2900051; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; Sheeba MS, 2009, J ETHNOPHARMACOL, V124, P39, DOI 10.1016/j.jep.2009.04.020; Shiva S, 2005, FREE RADICAL BIO MED, V38, P297, DOI 10.1016/j.freeradbiomed.2004.10.037; Titheradge MA, 1999, BBA-BIOENERGETICS, V1411, P437, DOI 10.1016/S0005-2728(99)00031-6; Uchiyama T, 2002, J MOL CELL CARDIOL, V34, P1049, DOI 10.1006/jmcc.2002.2045; Wang T., 2003, CHINA REHAB, V18, P135; Wang XL, 2007, APOPTOSIS, V12, P1209, DOI 10.1007/s10495-007-0055-y; Wu LM, 2007, J PHARM PHARMACOL, V59, P695, DOI 10.1211/jpp.59.5.0010; Yang G, 2000, J Tongji Med Univ, V20, P106; Ye YM, 2008, AM J PHYSIOL-HEART C, V295, pH2436, DOI 10.1152/ajpheart.00690.2008; ZHU XZ, 1991, MEM I OSWALDO CRUZ, V86, P173, DOI 10.1590/S0074-02761991000600039; Zingarelli B, 2002, FASEB J, V16, DOI 10.1096/fj.01-0533com	49	45	51	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38627	10.1371/journal.pone.0038627	http://dx.doi.org/10.1371/journal.pone.0038627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715398	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336800040
J	Lasry, A; Sansom, SL; Hicks, KA; Uzunangelov, V				Lasry, Arielle; Sansom, Stephanie L.; Hicks, Katherine A.; Uzunangelov, Vladislav			Allocating HIV Prevention Funds in the United States: Recommendations from an Optimization Model	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; COST-EFFECTIVENESS; AFRICAN-AMERICAN; PERSONS AWARE; RISK BEHAVIOR; INTERVENTION; TRANSMISSION; VIRUS; WOMEN; CARE	The Centers for Disease Control and Prevention (CDC) had an annual budget of approximately $327 million to fund health departments and community-based organizations for core HIV testing and prevention programs domestically between 2001 and 2006. Annual HIV incidence has been relatively stable since the year 2000 [1] and was estimated at 48,600 cases in 2006 and 48,100 in 2009 [2]. Using estimates on HIV incidence, prevalence, prevention program costs and benefits, and current spending, we created an HIV resource allocation model that can generate a mathematically optimal allocation of the Division of HIV/AIDS Prevention's extramural budget for HIV testing, and counseling and education programs. The model's data inputs and methods were reviewed by subject matter experts internal and external to the CDC via an extensive validation process. The model projects the HIV epidemic for the United States under different allocation strategies under a fixed budget. Our objective is to support national HIV prevention planning efforts and inform the decision-making process for HIV resource allocation. Model results can be summarized into three main recommendations. First, more funds should be allocated to testing and these should further target men who have sex with men and injecting drug users. Second, counseling and education interventions ought to provide a greater focus on HIV positive persons who are aware of their status. And lastly, interventions should target those at high risk for transmitting or acquiring HIV, rather than lower-risk members of the general population. The main conclusions of the HIV resource allocation model have played a role in the introduction of new programs and provide valuable guidance to target resources and improve the impact of HIV prevention efforts in the United States.	[Lasry, Arielle; Sansom, Stephanie L.] Centers Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30329 USA; [Hicks, Katherine A.; Uzunangelov, Vladislav] RTI Int, Res Triangle Pk, NC USA	Centers for Disease Control & Prevention - USA; Research Triangle Institute	Lasry, A (corresponding author), Centers Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30329 USA.	alasry@cdc.gov		Hicks, Katherine/0000-0002-1058-3401				Anderson John E, 2006, Adv Data, P1; [Anonymous], 2010, NAT HIV AIDS STRAT U; Brady JE, 2008, J URBAN HEALTH, V85, P323, DOI 10.1007/s11524-007-9248-5; Brandeau ML, 2009, HEALTH CARE MANAG SC, V12, P27, DOI 10.1007/s10729-008-9074-7; Campsmith ML, 2010, JAIDS-J ACQ IMM DEF, V53, P619, DOI 10.1097/QAI.0b013e3181bf1c45; CAPASSO V, 1978, MATH BIOSCI, V42, P43, DOI 10.1016/0025-5564(78)90006-8; Centers for Disease Control and Prevention, 2008, HIV SURV REP 2006, V18; Centers for Disease Control and Prevention (Database accessed May 2008), HIV COUNS TEST SYST, P2002; Chesson HW, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-24; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cooper HL, 2007, 2007 ANN M AM PUBL H; Crosby R, 2009, AM J PUBLIC HEALTH, V99, pS96, DOI 10.2105/AJPH.2007.123893; Farnham PG, 2008, PUBLIC HEALTH REP, V123, P51, DOI 10.1177/00333549081230S307; Fisher JD, 2006, JAIDS-J ACQ IMM DEF, V41, P44, DOI 10.1097/01.qai.0000192000.15777.5c; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Guinness Lorna, 2007, Cost Eff Resour Alloc, V5, P13, DOI 10.1186/1478-7547-5-13; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hall HI, 2006, AM J EPIDEMIOL, V164, P391, DOI 10.1093/aje/kwj216; Hutchinson AB, 2012, JAIDS-J ACQ IMM DEF, V59, P281, DOI 10.1097/QAI.0b013e31823e5bee; Jemmott LS, 2007, AM J PUBLIC HEALTH, V97, P1034, DOI 10.2105/AJPH.2003.020271; Kalichman SC, 2001, AM J PREV MED, V21, P84, DOI 10.1016/S0749-3797(01)00324-5; Lasry A, 2011, HEALTH CARE MANAG SC, V14, P115, DOI 10.1007/s10729-010-9147-2; Lasry A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S8; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Marks G, 2009, AIDS BEHAV, V13, P682, DOI 10.1007/s10461-008-9380-6; Morin SF, 2007, JAIDS-J ACQ IMM DEF, V44, P213, DOI 10.1097/QAI.0b013e31802c0cae; NASTAD and the Kaiser Family Foundation, 2009, NAT HIV PREV INV STA; National Compensation Survey, 2006, NAT COMP SURV; Prejean J., 2008, Morbidity and Mortality Weekly Report, V57, P985; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Rotheram-Borus MJ, 2004, JAIDS-J ACQ IMM DEF, V37, pS68, DOI 10.1097/01.qai.0000140604.57478.67; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Scholes D, 2003, AIDS, V17, P1547, DOI 10.1097/00002030-200307040-00016; Shrestha RK, 2008, PUBLIC HEALTH REP, V123, P94, DOI 10.1177/00333549081230S312; Shrestha RK, 2012, J PUBLIC HEALTH MAN, V18, P259, DOI 10.1097/PHH.0b013e31822b2077; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Silva A, 2007, ANN EMERG MED, V49, P564, DOI 10.1016/j.annemergmed.2006.09.028; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Sweat M, 2001, AIDS, V15, P781, DOI 10.1097/00002030-200104130-00014; Weinhardt LS, 1999, AM J PUBLIC HEALTH, V89, P1397, DOI 10.2105/AJPH.89.9.1397; Wingood GM, 2004, JAIDS-J ACQ IMM DEF, V37, pS58, DOI 10.1097/01.qai.0000140603.57478.a9; YORKE JA, 1978, SEX TRANSM DIS, V5, P51, DOI 10.1097/00007435-197804000-00003	43	24	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37545	10.1371/journal.pone.0037545	http://dx.doi.org/10.1371/journal.pone.0037545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WK	22701571	Green Published, Green Submitted, gold			2022-12-25	WOS:000305348400013
J	Balzer, EM; Tong, ZQ; Paul, CD; Hung, WC; Stroka, KM; Boggs, AE; Martin, SS; Konstantopoulos, K				Balzer, Eric M.; Tong, Ziqiu; Paul, Colin D.; Hung, Wei-Chien; Stroka, Kimberly M.; Boggs, Amanda E.; Martin, Stuart S.; Konstantopoulos, Konstantinos			Physical confinement alters tumor cell adhesion and migration phenotypes	FASEB JOURNAL			English	Article						mesenchymal; microtubules; actin; cytoskeleton	MATRIX ADHESIONS; DYNAMICS; ACTIN; MICROTENTACLES; ORGANIZATION; MECHANISM; STIFFNESS; PHOSPHORYLATION; CONTRACTILITY; MICROTUBULES	Cell migration on planar surfaces is driven by cycles of actin protrusion, integrin-mediated adhesion, and myosin-mediated contraction; however, this mechanism may not accurately describe movement in 3-dimensional (3D) space. By subjecting cells to restrictive 3D environments, we demonstrate that physical confinement constitutes a biophysical stimulus that alters cell morphology and suppresses mesenchymal motility in human breast carcinoma (MDA-MB-231). Dorsoventral polarity, stress fibers, and focal adhesions are markedly attenuated by confinement. Inhibitors of myosin, Rho/ROCK, or beta 1-integrins do not impair migration through 3-mu m-wide channels (confinement), even though these treatments repress motility in 50-mu m-wide channels (unconfined migration) by >= 50%. Strikingly, confined migration persists even when F-actin is disrupted, but depends largely on microtubule (MT) dynamics. Interfering with MT polymerization/depolymerization causes confined cells to undergo frequent directional changes, thereby reducing the average net displacement by >= 80% relative to vehicle controls. Live-cell EB1-GFP imaging reveals that confinement redirects MT polymerization toward the leading edge, where MTs continuously impact during advancement of the cell front. These results demonstrate that physical confinement can induce cytoskeletal alterations that reduce the dependence of migrating cells on adhesion-contraction force coupling. This mechanism may explain why integrins can exhibit reduced or altered function during migration in 3D environments.-Balzer, E. M., Tong, Z., Paul, C. D., Hung, W.-C., Stroka, K. M., Boggs, A. E., Martin, S. S., Konstantopoulos, K. Physical confinement alters tumor cell adhesion and migration phenotypes. FASEB J. 26, 4045-4056 (2012). www.fasebj.org	[Balzer, Eric M.; Tong, Ziqiu; Paul, Colin D.; Hung, Wei-Chien; Stroka, Kimberly M.; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Balzer, Eric M.; Tong, Ziqiu; Paul, Colin D.; Stroka, Kimberly M.; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Inst NanoBioTechnol, Baltimore, MD 21218 USA; [Balzer, Eric M.; Tong, Ziqiu; Stroka, Kimberly M.; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol, Baltimore, MD 21218 USA; [Boggs, Amanda E.; Martin, Stuart S.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore	Konstantopoulos, K (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	konstant@jhu.edu	Konstantopoulos, Konstantinos/A-7045-2011; Tong, Ziqiu/AAR-6182-2020	Tong, Ziqiu/0000-0003-4183-1858	U.S. National Cancer Institute [T32-CA130840, U54-CA143868, RO1-CA101135]; Kleberg Foundation; NATIONAL CANCER INSTITUTE [R01CA101135, U54CA143868, P30CA134274, T32CA130840] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kleberg Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the U.S. National Cancer Institute (awards T32-CA130840, U54-CA143868, and RO1-CA101135) and the Kleberg Foundation.	Balzer EM, 2010, ONCOGENE, V29, P6402, DOI 10.1038/onc.2010.360; Balzer EM, 2010, BREAST CANCER RES TR, V121, P65, DOI 10.1007/s10549-009-0457-3; Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102; Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Ehrbar M, 2011, BIOPHYS J, V100, P284, DOI 10.1016/j.bpj.2010.11.082; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Friedl P, 1998, EUR J IMMUNOL, V28, P2331, DOI 10.1002/(SICI)1521-4141(199808)28:08<2331::AID-IMMU2331>3.0.CO;2-C; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; GODDETTE DW, 1986, J BIOL CHEM, V261, P5974; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hawkins RJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058103; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Ilina O, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015010; Irimia D, 2009, INTEGR BIOL, V1, P506, DOI 10.1039/b908595e; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Katoh K, 2001, AM J PHYSIOL-CELL PH, V280, pC1669, DOI 10.1152/ajpcell.2001.280.6.C1669; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lakshman N, 2007, CELL MOTIL CYTOSKEL, V64, P434, DOI 10.1002/cm.20194; Liu R, 2012, ANN SURG ONCOL, V19, P199, DOI 10.1245/s10434-011-1871-4; Malawista SE, 1997, P NATL ACAD SCI USA, V94, P11577, DOI 10.1073/pnas.94.21.11577; Matrone MA, 2010, ONCOGENE, V29, P3217, DOI 10.1038/onc.2010.68; Matrone MA, 2010, CANCER RES, V70, P7737, DOI 10.1158/0008-5472.CAN-10-1569; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Renkawitz J, 2009, NAT CELL BIOL, V11, P1438, DOI 10.1038/ncb1992; Rolli CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008726; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Stroka KM, 2011, BLOOD, V118, P1632, DOI 10.1182/blood-2010-11-321125; Stroka KM, 2009, CELL MOTIL CYTOSKEL, V66, P328, DOI 10.1002/cm.20363; Tong ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029211; WatermanStorer CM, 1997, CURR BIOL, V7, pR369, DOI 10.1016/S0960-9822(06)00177-1; Whipple RA, 2008, CANCER RES, V68, P5678, DOI 10.1158/0008-5472.CAN-07-6589; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607	48	171	174	2	91	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2012	26	10					4045	4056		10.1096/fj.12-211441	http://dx.doi.org/10.1096/fj.12-211441			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22707566	Green Published			2022-12-25	WOS:000309704000012
J	Fauvet, B; Fares, MB; Samuel, F; Dikiy, I; Tandon, A; Eliezer, D; Lashuel, HA				Fauvet, Bruno; Fares, Mohamed-Bilal; Samuel, Filsy; Dikiy, Igor; Tandon, Anurag; Eliezer, David; Lashuel, Hilal A.			Characterization of Semisynthetic and Naturally N-alpha-Acetylated alpha-Synuclein in Vitro and in Intact Cells IMPLICATIONS FOR AGGREGATION AND CELLULAR PROPERTIES OF alpha-SYNUCLEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; TERMINAL ACETYLTRANSFERASE; POSTTRANSLATIONAL MODIFICATIONS; PROTEIN; PHOSPHORYLATION; IDENTIFICATION; MUTATION; YEAST; PATHOGENESIS; BINDING	N-terminal acetylation is a very common post-translational modification, although its role in regulating protein physical properties and function remains poorly understood. alpha-Synuclein (alpha-syn), a protein that has been linked to the pathogenesis of Parkinson disease, is constitutively N-alpha-acetylated in vivo. Nevertheless, most of the biochemical and biophysical studies on the structure, aggregation, and function of alpha-syn in vitro utilize recombinant alpha-syn from Escherichia coli, which is not N-terminally acetylated. To elucidate the effect of N-alpha-acetylation on the biophysical and biological properties of alpha-syn, we produced N-alpha-acetylated alpha-syn first using a semisynthetic methodology based on expressed protein ligation (Berrade, L., and Camarero, J. A. (2009) Cell. Mol. Life Sci. 66, 3909-3922) and then a recombinant expression strategy, to compare its properties to unacetylated alpha-syn. We demonstrate that both WT and N-alpha-acetylated alpha-syn share a similar secondary structure and oligomeric state using both purified protein preparations and in-cell NMR on E. coli overexpressing N-alpha-acetylated alpha-syn. The two proteins have very close aggregation propensities as shown by thioflavin T binding and sedimentation assays. Furthermore, both N-alpha-acetylated and WT alpha-syn exhibited similar ability to bind synaptosomal membranes in vitro and in HeLa cells, where both internalized proteins exhibited prominent cytosolic subcellular distribution. We then determined the effect of attenuating N-alpha-acetylation in living cells, first by using a nonacetylable mutant and then by silencing the enzyme responsible for alpha-syn N-alpha-acetylation. Both approaches revealed similar subcellular distribution and membrane binding for both the nonacetylable mutant and WT alpha-syn, suggesting that N-terminal acetylation does not significantly affect its structure in vitro and in intact cells.	[Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Lab Mol & Chem Biol Neurodegenerat, Stn 19, CH-1015 Lausanne, Switzerland; [Samuel, Filsy; Tandon, Anurag] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; [Dikiy, Igor; Eliezer, David] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Dikiy, Igor; Eliezer, David] Weill Cornell Med Coll, Program Struct Biol, New York, NY 10065 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Toronto; Cornell University; Cornell University	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne, Lab Mol & Chem Biol Neurodegenerat, Stn 19, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	Lashuel, Hilal/M-3500-2017; Dikiy, Igor/M-1031-2019	Dikiy, Igor/0000-0002-8155-7788	National Institutes of Health [AG019391]; Swiss Federal Institute of Technology, Lausanne; European Research Council [243182]; NATIONAL INSTITUTE ON AGING [R37AG019391, R01AG019391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss Federal Institute of Technology, Lausanne; European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG019391 (to D. E.). This work was also supported by the Swiss Federal Institute of Technology, Lausanne (to H. A. L.), and European Research Council Starting Grant 243182 (to H. A. L. and B. F.).	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Arnesen T, 2005, BIOCHEM J, V386, P433, DOI 10.1042/BJ20041071; Arnesen T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001074; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Berrade L, 2009, CELL MOL LIFE SCI, V66, P3909, DOI 10.1007/s00018-009-0122-3; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Blanco-Canosa JB, 2008, ANGEW CHEM INT EDIT, V47, P6851, DOI 10.1002/anie.200705471; Brown DR, 2007, FEBS J, V274, P3766, DOI 10.1111/j.1742-4658.2007.05917.x; BROWN JL, 1979, J BIOL CHEM, V254, P1447; BROWN JL, 1976, J BIOL CHEM, V251, P1009; Bussell R, 2004, BIOCHEMISTRY-US, V43, P4810, DOI 10.1021/bi036135+; Caesar R, 2006, EUKARYOT CELL, V5, P368, DOI 10.1128/EC.5.2.368-378.2006; Caesar R, 2004, J BIOL CHEM, V279, P38532, DOI 10.1074/jbc.M402939200; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; Cookson MR, 2008, EXP NEUROL, V209, P5, DOI 10.1016/j.expneurol.2007.05.022; COTMAN C, 1969, BIOCHEMISTRY-US, V8, P4606, DOI 10.1021/bi00839a056; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Goetze S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000236; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hejjaoui M, 2012, J AM CHEM SOC, V134, P5196, DOI 10.1021/ja210866j; Hejjaoui M, 2011, ANGEW CHEM INT EDIT, V50, P405, DOI 10.1002/anie.201005546; HOL WGJ, 1985, PROG BIOPHYS MOL BIO, V45, P149, DOI 10.1016/0079-6107(85)90001-X; Huang H, 1999, J PEPT RES, V53, P548, DOI 10.1034/j.1399-3011.1999.00059.x; Ito Y, 2010, CURR OPIN STRUC BIOL, V20, P640, DOI 10.1016/j.sbi.2010.07.006; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson ECB, 2006, J AM CHEM SOC, V128, P6640, DOI 10.1021/ja058344i; Johnson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015801; Kang LJ, 2012, PROTEIN SCI, V21, P911, DOI 10.1002/pro.2088; Kikuchi J, 2010, PROTEOMICS, V10, P2769, DOI 10.1002/pmic.200900283; Kim HJ, 2011, P NATL ACAD SCI USA, V108, P2010, DOI 10.1073/pnas.1018974108; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; LEE FJS, 1989, FEBS LETT, V256, P139, DOI 10.1016/0014-5793(89)81734-X; Li CG, 2008, J AM CHEM SOC, V130, P6310, DOI 10.1021/ja801020z; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; Maldonado AY, 2011, PROG NUCL MAG RES SP, V59, P197, DOI 10.1016/j.pnmrs.2010.11.002; Manning LR, 2001, BIOCHEMISTRY-US, V40, P1635, DOI 10.1021/bi002157+; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Martinez M, 1998, J NEUROCHEM, V71, P2528; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; Nonaka T, 2005, BIOCHEMISTRY-US, V44, P361, DOI 10.1021/bi0485528; Ohrfelt A, 2011, NEUROCHEM RES, V36, P2029, DOI 10.1007/s11064-011-0527-x; Oueslati A, 2010, PROG BRAIN RES, V183, P115, DOI 10.1016/S0079-6123(10)83007-9; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Paleologou KE, 2010, J NEUROSCI, V30, P3184, DOI 10.1523/JNEUROSCI.5922-09.2010; PERSSON B, 1985, EUR J BIOCHEM, V152, P523, DOI 10.1111/j.1432-1033.1985.tb09227.x; Polevoda B, 2003, J BIOL CHEM, V278, P30686, DOI 10.1074/jbc.M304690200; Polevoda B, 2001, J BIOL CHEM, V276, P20154, DOI 10.1074/jbc.M011440200; Polevoda B, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-5-reviews0006; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Soppa J., 2010, ARCHAEA; Starheim KK, 2008, BIOCHEM J, V415, P325, DOI 10.1042/BJ20080658; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; Starheim KK, 2009, MOL CELL BIOL, V29, P3569, DOI 10.1128/MCB.01909-08; Sung YH, 2007, J MOL BIOL, V372, P689, DOI 10.1016/j.jmb.2007.07.008; TERCERO JC, 1992, J BIOL CHEM, V267, P20277; Trexler AJ, 2012, PROTEIN SCI, V21, P601, DOI 10.1002/pro.2056; URBANCIKOVA M, 1994, J BIOL CHEM, V269, P24310; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Vamvaca K, 2009, J MOL BIOL, V389, P413, DOI 10.1016/j.jmb.2009.03.021; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wislet-Gendebien S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-92; Zabrocki P, 2008, BBA-MOL CELL RES, V1783, P1767, DOI 10.1016/j.bbamcr.2008.06.010; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhou WB, 2010, BBA-MOL BASIS DIS, V1802, P322, DOI 10.1016/j.bbadis.2009.12.004	75	120	120	0	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28243	28262		10.1074/jbc.M112.383711	http://dx.doi.org/10.1074/jbc.M112.383711			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22718772	hybrid, Green Published			2022-12-25	WOS:000308074600004
J	Kim, JH; Wang, AB; Conti, MA; Adelstein, RS				Kim, Jong Hyun; Wang, Aibing; Conti, Mary Anne; Adelstein, Robert S.			Nonmuscle Myosin II Is Required for Internalization of the Epidermal Growth Factor Receptor and Modulation of Downstream Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; KINASE; ACTIVATION; ISOFORM; CELLS; IDENTIFICATION; ENDOCYTOSIS; DOMAIN; PROLIFERATION; TRAFFICKING	Ligand-induced internalization of the epidermal growth factor receptor (EGFR) is an important process for regulating signal transduction, cellular dynamics, and cell-cell communication. Here, we demonstrate that nonmuscle myosin II (NM II) is required for the internalization of the EGFR and to trigger the EGFR-dependent activation of ERK and AKT. The EGFR was identified as a protein that interacts with with NM II by co-immunoprecipitation and mass spectrometry analysis. This interaction requires both the regulatory light chain 20 (RLC20) of NM II and the kinase domain of the EGFR. Two paralogs of NM II, NM II-A, and NM II-B can act to internalize the EGFR, depending on the cell type and paralog content of the cell line. Loss (siRNA) or inhibition (25 mu M blebbistatin) of NM II attenuates the internalization of the EGFR and impairs EGFR-dependent activation of ERK and AKT. Both internalization of the EGFR and downstream signaling to ERK and AKT can be partially restored in siRNA-treated cells by introduction of wild type (WT) GFP-NM II, but cannot be restored by motor mutant NM II. Taken together, these results suggest that NM II plays a role in the internalization of the EGFR and EGFR-mediated signaling pathways.	[Kim, Jong Hyun; Wang, Aibing; Conti, Mary Anne; Adelstein, Robert S.] NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kim, JH (corresponding author), Seoul Natl Univ, Med Bioconvergence Res Ctr, Seoul 151742, South Korea.	nr.kimjohn@gmail.com; adelster@mail.nih.gov		Adelstein, Robert/0000-0002-8683-2144	Division of Intramural Research, NHLBI, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004216, ZIAHL004230, ZIAHL004218, ZICHL006019] Funding Source: NIH RePORTER	Division of Intramural Research, NHLBI, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Division of Intramural Research, NHLBI, National Institutes of Health.	Andzelm MM, 2007, J EXP MED, V204, P2285, DOI 10.1084/jem.20071143; Bajaj G, 2009, J BIOL CHEM, V284, P1252, DOI 10.1074/jbc.M801861200; Bao JJ, 2005, J BIOL CHEM, V280, P19594, DOI 10.1074/jbc.M501573200; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Eden ER, 2009, BIOCHEM SOC T, V37, P173, DOI 10.1042/BST0370173; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; FAZIOLI F, 1993, MOL CELL BIOL, V13, P5814, DOI 10.1128/MCB.13.9.5814; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Haugh JM, 1999, J BIOL CHEM, V274, P34350, DOI 10.1074/jbc.274.48.34350; Heath KE, 2001, AM J HUM GENET, V69, P1033, DOI 10.1086/324267; Hosaka K, 2009, KIDNEY INT, V75, P1308, DOI 10.1038/ki.2009.85; Hours MC, 2010, J CELL SCI, V123, P1449, DOI 10.1242/jcs.057687; Hu AH, 2002, J BIOL CHEM, V277, P46512, DOI 10.1074/jbc.M208506200; Jiang GQ, 1999, CURR BIOL, V9, pR568, DOI 10.1016/S0960-9822(99)80357-1; KAGEYAMA R, 1989, CELL, V59, P815, DOI 10.1016/0092-8674(89)90605-3; Kim JH, 2002, BIOCHEMISTRY-US, V41, P3414, DOI 10.1021/bi015700a; Kim JH, 2005, MOL CELL BIOL, V25, P3194, DOI 10.1128/MCB.25.8.3194-3208.2005; Kim KY, 2008, BIOCHEM BIOPH RES CO, V369, P124, DOI 10.1016/j.bbrc.2007.11.108; Lambert S, 2008, J CELL PHYSIOL, V217, P834, DOI 10.1002/jcp.21563; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Leal A, 2003, GENE, V312, P165, DOI 10.1016/S0378-1119(03)00613-9; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Ma XF, 2007, MOL BIOL CELL, V18, P2305, DOI 10.1091/mbc.E07-01-0073; Ma XF, 2010, MOL BIOL CELL, V21, P3952, DOI 10.1091/mbc.E10-04-0293; Marqueze-Pouey B, 2008, TRAFFIC, V9, P1088, DOI 10.1111/j.1600-0854.2008.00743.x; MAUPIN P, 1994, J CELL SCI, V107, P3077; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Moulder SL, 2001, CANCER RES, V61, P8887; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Pennock S, 2003, MOL CELL BIOL, V23, P5803, DOI 10.1128/MCB.23.16.5803-5815.2003; PHILLIPS CL, 1995, J MUSCLE RES CELL M, V16, P379, DOI 10.1007/BF00114503; Rey M, 2007, J CELL SCI, V120, P1126, DOI 10.1242/jcs.03415; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SchmidtUllrich RK, 1997, ONCOGENE, V15, P1191, DOI 10.1038/sj.onc.1201275; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; Togo T, 2004, MOL BIOL CELL, V15, P688, DOI 10.1091/mbc.E03-06-0430; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Walker F, 1998, MOL CELL BIOL, V18, P7192, DOI 10.1128/MCB.18.12.7192; Wan YS, 2001, CELL SIGNAL, V13, P139, DOI 10.1016/S0898-6568(00)00146-7; Wang AB, 2010, P NATL ACAD SCI USA, V107, P14645, DOI 10.1073/pnas.1004023107; Wang Y., 2002, SCI STKE, V161, pl17; WILEY HS, 1982, J BIOL CHEM, V257, P4222	50	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27345	27358		10.1074/jbc.M111.304824	http://dx.doi.org/10.1074/jbc.M111.304824			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718763	Green Published, hybrid			2022-12-25	WOS:000307840700007
J	Wu, LS; Cheng, WC; Shen, CKJ				Wu, Lien-Szu; Cheng, Wei-Cheng; Shen, C. -K. James			Targeted Depletion of TDP-43 Expression in the Spinal Cord Motor Neurons Leads to the Development of Amyotrophic Lateral Sclerosis-like Phenotypes in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; TRANSGENIC MICE; SUPEROXIDE-DISMUTASE; FAMILIAL ALS; GENE-EXPRESSION; FTLD-U; DISEASE; PROTEIN; NEURODEGENERATION; INCLUSIONS	ALS, or amyotrophic lateral sclerosis, is a progressive and fatal motor neuron disease with no effective medicine. Importantly, the majority of the ALS cases are with TDP-43 proteinopathies characterized with TDP-43-positive, ubiquitin-positive inclusions (UBIs) in the cytosol. However, the role of the mismetabolism of TDP-43 in the pathogenesis of ALS with TDP-43 proteinopathies is unclear. Using the conditional mouse gene targeting approach, we show that mice with inactivation of the Tardbp gene in the spinal cord motor neurons (HB9:Cre-Tardbp(1x/-)) exhibit progressive and male-dominant development of ALS-related phenotypes including kyphosis, motor dysfunctions, muscle weakness/atrophy, motor neuron loss, and astrocytosis in the spinal cord. Significantly, ubiquitinated proteins accumulate in the TDP-43-depleted motor neurons of the spinal cords of HB9:Cre-Tardbp(1x/-) mice with the ALS phenotypes. This study not only establishes an important role of TDP-43 in the long term survival and functioning of the mammalian spinal cord motor neurons, but also establishes that loss of TDP-43 function could be one major cause for neurodegeneration in ALS with TDP-43 proteinopathies.	[Wu, Lien-Szu; Cheng, Wei-Cheng; Shen, C. -K. James] Acad Sinica, Inst Mol Biol, Taipei 11574, Taiwan; [Wu, Lien-Szu; Shen, C. -K. James] Natl Taiwan Univ, Inst Mol Med, Coll Med, Taipei 10002, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Shen, CKJ (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan.	ckshen@imb.sinica.edu.tw	shen, Che-Kun James/L-1343-2015; wu, Lien szu/N-8942-2014	wu, Lien szu/0000-0003-0216-882X	National Science Council; Academia Sinica (AS), Taipei Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica (AS), Taipei Taiwan(Academia Sinica - Taiwan)	This work was supported by a Frontiers of Science Award from the National Science Council and the Academia Sinica (AS), Taipei Taiwan.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Azzouz M, 1997, MUSCLE NERVE, V20, P45, DOI 10.1002/(SICI)1097-4598(199701)20:1<45::AID-MUS6>3.0.CO;2-H; Bose JK, 2011, J BIOL CHEM, V286, P44441, DOI 10.1074/jbc.M111.237115; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Buratti E, 2009, ADV GENET, V66, P1, DOI 10.1016/S0065-2660(09)66001-6; BURKE RE, 1977, J NEUROPHYSIOL, V40, P667, DOI 10.1152/jn.1977.40.3.667; Cheever TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017768; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Forman MS, 2007, CURR OPIN NEUROBIOL, V17, P548, DOI 10.1016/j.conb.2007.08.005; Friese A, 2009, P NATL ACAD SCI USA, V106, P13588, DOI 10.1073/pnas.0906809106; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Gurney ME, 1996, PATHOL BIOL, V44, P51; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hess DM, 2007, J COMP NEUROL, V501, P465, DOI 10.1002/cne.21163; HUDSON AJ, 1993, BRAIN RES BULL, V30, P359, DOI 10.1016/0361-9230(93)90265-D; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Johnston CA, 2006, J NEUROL, V253, P1642, DOI 10.1007/s00415-006-0195-y; Kato S, 2005, ACTA NEUROPATHOL, V110, P101, DOI 10.1007/s00401-005-1019-3; Kato S, 2008, ACTA NEUROPATHOL, V115, P97, DOI 10.1007/s00401-007-0308-4; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Li XM, 2008, NAT NEUROSCI, V11, P262, DOI 10.1038/nn2053; Lin MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020371; Luria V, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-13; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Manjaly ZR, 2010, AMYOTROPH LATERAL SC, V11, P439, DOI 10.3109/17482961003610853; Mulder D W, 1982, Adv Neurol, V36, P15; Neumann M, 2007, ARCH NEUROL-CHICAGO, V64, P1388, DOI 10.1001/archneur.64.10.1388; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, INT J MOL SCI, V10, P232, DOI 10.3390/ijms10010232; NEWMAN DS, 1995, J NEUROL SCI, V129, P38, DOI 10.1016/0022-510X(95)00058-A; Nguyen MD, 2000, P NATL ACAD SCI USA, V97, P12306, DOI 10.1073/pnas.97.22.12306; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pesiridis GS, 2011, J BIOL CHEM, V286, P18845, DOI 10.1074/jbc.M111.231118; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Shan X, 2010, P NATL ACAD SCI USA, V107, P16325, DOI 10.1073/pnas.1003459107; Shaw PJ, 2005, J NEUROL NEUROSUR PS, V76, P1046, DOI 10.1136/jnnp.2004.048652; Shneider NA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-42; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stallings NR, 2010, NEUROBIOL DIS, V40, P404, DOI 10.1016/j.nbd.2010.06.017; Tsai KJ, 2010, J EXP MED, V207, P1661, DOI 10.1084/jem.20092164; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Wang IF, 2008, TRENDS MOL MED, V14, P479, DOI 10.1016/j.molmed.2008.09.001; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Yang CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015878; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Zhou C, 2007, AMYOTROPH LATERAL SC, V8, P366, DOI 10.1080/17482960701538759; Zhou HX, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000887	58	113	115	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27335	27344		10.1074/jbc.M112.359000	http://dx.doi.org/10.1074/jbc.M112.359000			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718760	hybrid, Green Published			2022-12-25	WOS:000307840700006
J	Nibourg, GAA; Chamuleau, RAFM; van der Hoeven, TV; Maas, MAW; Ruiter, AFC; Lamers, WH; Elferink, RPJO; van Gulik, TM; Hoekstra, R				Nibourg, Geert A. A.; Chamuleau, Robert A. F. M.; van der Hoeven, Tessa V.; Maas, Martinus A. W.; Ruiter, An F. C.; Lamers, Wouter H.; Elferink, Ronald P. J. Oude; van Gulik, Thomas M.; Hoekstra, Ruurdtje			Liver Progenitor Cell Line HepaRG Differentiated in a Bioartificial Liver Effectively Supplies Liver Support to Rats with Acute Liver Failure	PLOS ONE			English	Article							ERYTHROID DIFFERENTIATION; HEPATOCYTES; EXPRESSION; OVEREXPRESSION; IMPROVEMENT; INDUCTION; DEVICES; CULTURE; VIRUS	A major roadblock to the application of bioartificial livers is the need for a human liver cell line that displays a high and broad level of hepatic functionality. The human bipotent liver progenitor cell line HepaRG is a promising candidate in this respect, for its potential to differentiate into hepatocytes and bile duct cells. Metabolism and synthesis of HepaRG monolayer cultures is relatively high and their drug metabolism can be enhanced upon treatment with 2% dimethyl sulfoxide (DMSO). However, their potential for bioartificial liver application has not been assessed so far. Therefore, HepaRG cells were cultured in the Academic Medical Center bioartificial liver (AMC-BAL) with and without DMSO and assessed for their hepatic functionality in vitro and in a rat model of acute liver failure. HepaRG-AMC-BALs cultured without DMSO eliminated ammonia and lactate, and produced apolipoprotein A-1 at rates comparable to freshly isolated hepatocytes. Cytochrome P450 3A4 transcript levels and activity were high with 88% and 37%, respectively, of the level of hepatocytes. DMSO treatment of HepaRG-AMC-BALs reduced the cell population and the abovementioned functions drastically. Therefore, solely HepaRG-AMC-BALs cultured without DMSO were tested for efficacy in rats with acute liver failure (n = 6). HepaRG-AMC-BAL treatment increased survival time of acute liver failure rats similar to 50% compared to acellular-BAL treatment. Moreover, HepaRG-AMC-BAL treatment decreased the progression of hepatic encephalopathy, kidney failure, and ammonia accumulation. These results demonstrate that the HepaRG-AMC-BAL is a promising bioartificial liver for clinical application.	[Nibourg, Geert A. A.; Chamuleau, Robert A. F. M.; van der Hoeven, Tessa V.; Lamers, Wouter H.; Elferink, Ronald P. J. Oude; Hoekstra, Ruurdtje] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Nibourg, Geert A. A.; van der Hoeven, Tessa V.; Maas, Martinus A. W.; van Gulik, Thomas M.; Hoekstra, Ruurdtje] Univ Amsterdam, Acad Med Ctr, Dept Surg, Surg Lab, NL-1105 AZ Amsterdam, Netherlands; [Ruiter, An F. C.] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Endocrinol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Nibourg, GAA (corresponding author), Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	r.hoekstra@amc.uva.nl	Lamers, Wouter H./D-2965-2012; Sharma, Ashwani/AAK-3879-2020	Sharma, Ashwani/0000-0001-9835-1973	AMC; Hep-Art Medical Devices BV, The Netherlands	AMC; Hep-Art Medical Devices BV, The Netherlands	This study was partly funded by the Subsidy Regulation Knowledge Exploitation (SKE-fund) of the AMC, and by Hep-Art Medical Devices BV, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759; Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; Bjerring PN, 2010, J HEPATOL, V53, P1054, DOI 10.1016/j.jhep.2010.05.032; Brusilow SW, 2010, NEUROTHERAPEUTICS, V7, P452, DOI 10.1016/j.nurt.2010.05.015; Butterworth RF, 2003, LIVER INT, V23, P5, DOI 10.1034/j.1478-3231.23.s.3.1.x; Carpentier B, 2009, GUT, V58, P1690, DOI 10.1136/gut.2008.175380; Cerec V, 2007, HEPATOLOGY, V45, P957, DOI 10.1002/hep.21536; Chan AC, 2009, HEPATOL INT, V3, P571, DOI 10.1007/s12072-009-9148-8; Deurholt T, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-89; Flendrig LM, 1997, J HEPATOL, V26, P1379, DOI 10.1016/S0168-8278(97)80475-8; Flendrig LM, 1999, J HEPATOL, V30, P311, DOI 10.1016/S0168-8278(99)80078-6; Fruhauf JH, 2009, LIVER INT, V29, P1553, DOI 10.1111/j.1478-3231.2009.02087.x; Greuet J, 1997, HEPATOLOGY, V25, P1166, DOI 10.1002/hep.510250520; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Hart SN, 2010, DRUG METAB DISPOS, V38, P988, DOI 10.1124/dmd.109.031831; Hoekstra R, 2011, INT J BIOCHEM CELL B, V43, P1483, DOI 10.1016/j.biocel.2011.06.011; Kim WR, 2006, HEPATOLOGY, V43, P345, DOI 10.1002/hep.21025; LEVY J, 1975, P NATL ACAD SCI USA, V72, P28, DOI 10.1073/pnas.72.1.28; Li Y, 2008, EUR J PHARMACOL, V590, P417, DOI 10.1016/j.ejphar.2008.06.047; Liou IW, 2008, SEMIN LIVER DIS, V28, P201, DOI 10.1055/s-2008-1073119; Nibourg GAA, 2010, LIVER TRANSPLANT, V16, P1075, DOI 10.1002/lt.22110; NYBERG SL, 1994, ANN SURG, V220, P59; Poyck PPC, 2008, ARTIF ORGANS, V32, P116, DOI 10.1111/j.1525-1594.2007.00500.x; Poyck PPC, 2007, TISSUE ENG, V13, P1235, DOI 10.1089/ten.2006.0343; Sen S, 2002, LIVER, V22, P5, DOI 10.1034/j.1600-0676.2002.00001.x; Suh KS, 1999, J SURG RES, V85, P243, DOI 10.1006/jsre.1999.5669; Sumida K, 2011, HUM EXP TOXICOL, V30, P1701, DOI 10.1177/0960327111399325; TERADA M, 1978, CANCER RES, V38, P835; van de Kerkhove MP, 2005, INT J ARTIF ORGANS, V28, P617, DOI 10.1177/039139880502800611	29	44	47	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38778	10.1371/journal.pone.0038778	http://dx.doi.org/10.1371/journal.pone.0038778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719943	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300048
J	Fang, W; Price, MS; Toffaletti, DL; Tenor, J; Betancourt-Quiroz, M; Price, JL; Pan, WH; Liao, WQ; Perfect, JR				Fang, Wei; Price, Michael S.; Toffaletti, Dena L.; Tenor, Jennifer; Betancourt-Quiroz, Marisol; Price, Jennifer L.; Pan, Wei-hua; Liao, Wan-qing; Perfect, John R.			Pleiotropic Effects of Deubiquitinating Enzyme Ubp5 on Growth and Pathogenesis of Cryptococcus neoformans	PLOS ONE			English	Article							PHOSPHOLIPASE-ACTIVITY; 2-COMPONENT SYSTEM; POLYUBIQUITIN GENE; VIRULENCE FACTOR; UBIQUITIN; YEAST; DEGRADATION; EXPRESSION; PATHWAY; PROMOTES	Ubiquitination is a reversible protein modification that influences various cellular processes in eukaryotic cells. Deubiquitinating enzymes remove ubiquitin, maintain ubiquitin homeostasis and regulate protein degradation via the ubiquitination pathway. Cryptococcus neoformans is an important basidiomycete pathogen that causes life-threatening meningoencephalitis primarily in the immunocompromised population. In order to understand the possible influence deubiquitinases have on growth and virulence of the model pathogenic yeast Cryptococcus neoformans, we generated deletion mutants of seven putative deubiquitinase genes. Compared to other deubiquitinating enzyme mutants, a ubp5 Delta mutant exhibited severely attenuated virulence and many distinct phenotypes, including decreased capsule formation, hypomelanization, defective sporulation, and elevated sensitivity to several external stressors (such as high temperature, oxidative and nitrosative stresses, high salts, and antifungal agents). Ubp5 is likely the major deubiquitinating enzyme for stress responses in C. neoformans, which further delineates the evolutionary divergence of Cryptococcus from the model yeast S. cerevisiae, and provides an important paradigm for understanding the potential role of deubiquitination in virulence by other pathogenic fungi. Other putative deubiquitinase mutants (doa4 Delta and ubp13 Delta) share some phenotypes with the ubp5 Delta mutant, illustrating functional overlap among deubiquitinating enzymes in C. neoformans. Therefore, deubiquitinating enzymes (especially Ubp5) are essential for the virulence composite of C. neoformans and provide an additional yeast survival and propagation advantage in the host.	[Fang, Wei; Pan, Wei-hua; Liao, Wan-qing] Second Mil Med Univ, Changzheng Hosp, PLA Key Lab Mycosis Inst Dermatol & Mycosis, Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China; [Fang, Wei; Price, Michael S.; Toffaletti, Dena L.; Tenor, Jennifer; Betancourt-Quiroz, Marisol; Price, Jennifer L.; Perfect, John R.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Naval Medical University; Duke University	Fang, W (corresponding author), Second Mil Med Univ, Changzheng Hosp, PLA Key Lab Mycosis Inst Dermatol & Mycosis, Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China.	liaowanqing@sohu.com; perfe001@mc.duke.edu		Price, Michael/0000-0001-6022-328X; Betancourt Quiroz, Marisol/0000-0002-6920-9182	National Institutes of Health PHS [AI73896, AI28388]; Shanghai Science and Technology Committee [10dz2220100]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI028388, R01AI028388, R01AI073896] Funding Source: NIH RePORTER	National Institutes of Health PHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health PHS grants AI73896 and AI28388 (JRP), and also supported by Shanghai Science and Technology Committee grant 10dz2220100 (W-QL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamgir Md, 2010, BMC Chemical Biology, V10, P6, DOI 10.1186/1472-6769-10-6; Alspaugh JA, 2000, MOL MICROBIOL, V36, P352, DOI 10.1046/j.1365-2958.2000.01852.x; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Auesukaree C, 2009, J APPL GENET, V50, P301, DOI 10.1007/BF03195688; Bahn YS, 2006, MOL BIOL CELL, V17, P3122, DOI 10.1091/mbc.E06-02-0113; Bahn YS, 2008, EUKARYOT CELL, V7, P2017, DOI 10.1128/EC.00323-08; Ballou ER, 2010, MOL MICROBIOL, V75, P763, DOI 10.1111/j.1365-2958.2009.07019.x; Boase NA, 2003, GENETICS, V164, P95; Bozza WP, 2011, BIOCHEMISTRY-US, V50, P6423, DOI 10.1021/bi200529z; Brady GF, 2010, MOL CELL BIOL, V30, P1923, DOI 10.1128/MCB.00900-09; Brown AJP, 2009, CURR OPIN MICROBIOL, V12, P384, DOI 10.1016/j.mib.2009.06.007; Brown SM, 2007, CURR OPIN MICROBIOL, V10, P320, DOI 10.1016/j.mib.2007.05.014; Cappell SD, 2010, MOL CELL, V38, P746, DOI 10.1016/j.molcel.2010.05.026; CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Chen SCA, 1997, J INFECT DIS, V175, P414, DOI 10.1093/infdis/175.2.414; Chen SCA, 1997, INFECT IMMUN, V65, P405, DOI 10.1128/IAI.65.2.405-411.1997; CHENG L, 1994, MOL GEN GENET, V243, P358, DOI 10.1007/BF00301072; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Cox GM, 2001, MOL MICROBIOL, V39, P166, DOI 10.1046/j.1365-2958.2001.02236.x; Davidson RC, 2003, MOL MICROBIOL, V49, P469, DOI 10.1046/j.1365-2958.2003.03563.x; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; de Jesus-Berrios M, 2003, CURR BIOL, V13, P1963, DOI 10.1016/j.cub.2003.10.029; Ding F, 2011, CURR TOP MED CHEM; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Eisele F, 2006, BIOCHEM BIOPH RES CO, V350, P329, DOI 10.1016/j.bbrc.2006.09.041; ELLIS DH, 1990, LANCET, V336, P923, DOI 10.1016/0140-6736(90)92283-N; Enyenihi AH, 2003, GENETICS, V163, P47; Esch RK, 2002, P NATL ACAD SCI USA, V99, P9160, DOI 10.1073/pnas.142034399; Feldmesser M, 2000, INFECT IMMUN, V68, P4225, DOI 10.1128/IAI.68.7.4225-4237.2000; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Finley Daniel, 2004, Cell, VS116, pS29, DOI 10.1016/S0092-8674(03)00971-1; Gancedo C, 2004, FEMS YEAST RES, V4, P351, DOI 10.1016/S1567-1356(03)00222-8; Goranov AI, 2009, GENE DEV, V23, P1408, DOI 10.1101/gad.1777309; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HUFFNAGLE GB, 1995, J IMMUNOL, V155, P3507; Hull CM, 2002, ANNU REV GENET, V36, P557, DOI 10.1146/annurev.genet.36.052402.152652; Idnurm A, 2005, NAT REV MICROBIOL, V3, P753, DOI 10.1038/nrmicro1245; Jiang N, 2009, FEMS MICROBIOL LETT, V296, P84, DOI 10.1111/j.1574-6968.2009.01619.x; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Kahana A, 2001, BIOCHEM BIOPH RES CO, V282, P916, DOI 10.1006/bbrc.2001.4669; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kim KS, 2008, NAT REV MICROBIOL, V6, P625, DOI 10.1038/nrmicro1952; Kishi T, 2007, P NATL ACAD SCI USA, V104, P17418, DOI 10.1073/pnas.0704951104; Ko YJ, 2009, EUKARYOT CELL, V8, P1197, DOI 10.1128/EC.00120-09; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kouranti I, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000471; Kozubowski L, 2009, CELL MICROBIOL, V11, P370, DOI 10.1111/j.1462-5822.2008.01273.x; Kozubowski L, 2010, MOL MICROBIOL, V75, P658, DOI 10.1111/j.1365-2958.2009.06983.x; Laney JD, 2003, GENE DEV, V17, P2259, DOI 10.1101/gad.1115703; Lee A, 2010, INFECT IMMUN, V78, P4213, DOI 10.1128/IAI.00551-10; Lin XR, 2009, INFECT GENET EVOL, V9, P401, DOI 10.1016/j.meegid.2009.01.013; Liu JX, 2007, TRAFFIC, V8, P1375, DOI 10.1111/j.1600-0854.2007.00616.x; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Liu TB, 2011, EUKARYOT CELL, V10, P791, DOI 10.1128/EC.00004-11; McClelland EE, 2006, INFECT IMMUN, V74, P1500, DOI 10.1128/IAI.74.3.1500-1504.2006; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Narasipura SD, 2005, MOL MICROBIOL, V55, P1782, DOI 10.1111/j.1365-2958.2005.04503.x; Nichols CB, 2007, MOL MICROBIOL, V63, P1118, DOI 10.1111/j.1365-2958.2006.05566.x; Nicholson Benjamin, 2007, Future Oncol, V3, P191, DOI 10.2217/14796694.3.2.191; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; O'Meara TR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000776; Olszewski MA, 2004, AM J PATHOL, V164, P1761, DOI 10.1016/S0002-9440(10)63734-0; Osterholzer JJ, 2009, AM J PATHOL, V174, P932, DOI 10.2353/ajpath.2009.080673; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Perfect JR, 2006, FEMS YEAST RES, V6, P463, DOI 10.1111/j.1567-1364.2006.00051.x; Petzold EW, 2006, INFECT IMMUN, V74, P5877, DOI 10.1128/IAI.00624-06; Price MS, 2008, INFECT IMMUN, V76, P5729, DOI 10.1128/IAI.00896-08; Price MS, 2011, MBIO, V2, DOI 10.1128/mBio.00103-11; Pukkila-Worley R, 2005, EUKARYOT CELL, V4, P190, DOI 10.1128/EC.4.1.190-201.2005; Reese AJ, 2003, MOL MICROBIOL, V50, P1401, DOI 10.1046/j.1365-2958.2003.03780.x; Reese AJ, 2007, MOL MICROBIOL, V63, P1385, DOI 10.1111/j.1365-2958.2006.05551.x; RHODES JC, 1982, INFECT IMMUN, V36, P1175, DOI 10.1128/IAI.36.3.1175-1184.1982; Rodrigues ML, 2008, EUKARYOT CELL, V7, P602, DOI 10.1128/EC.00307-07; Sato N, 2003, MOL CELL BIOL, V23, P6662, DOI 10.1128/MCB.23.18.6662-6671.2003; Semighini CP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002364; Shen WC, 2002, EUKARYOT CELL, V1, P366, DOI 10.1128/EC.1.3.366-377.2002; SPITZER ED, 1995, GENE, V161, P113, DOI 10.1016/0378-1119(95)00231-T; Steenbergen JN, 2001, P NATL ACAD SCI USA, V98, P15245, DOI 10.1073/pnas.261418798; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; TREGER JM, 1988, MOL CELL BIOL, V8, P1132, DOI 10.1128/MCB.8.3.1132; Vandenbroucke K, 2008, MOL BIOL EVOL, V25, P507, DOI 10.1093/molbev/msm276; Varma A, 1999, GENE, V232, P155, DOI 10.1016/S0378-1119(99)00132-8; Velagapudi R, 2009, INFECT IMMUN, V77, P4345, DOI 10.1128/IAI.00542-09; Walton FJ, 2005, MOL MICROBIOL, V57, P1381, DOI 10.1111/j.1365-2958.2005.04779.x; Wang P, 1999, CURR OPIN MICROBIOL, V2, P358, DOI 10.1016/S1369-5274(99)80063-0; WANG YL, 1995, INFECT IMMUN, V63, P3131, DOI 10.1128/IAI.63.8.3131-3136.1995; Weiss P, 2008, EUKARYOT CELL, V7, P1888, DOI 10.1128/EC.00194-08; Wilkinson KD, 2004, CELL, V119, P741, DOI 10.1016/S0092-8674(04)01154-7; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Yoneda A, 2006, MOL BIOL CELL, V17, P5131, DOI 10.1091/mbc.E06-08-0701; Yoshikawa K, 2011, YEAST, V28, P349, DOI 10.1002/yea.1843; Zhang J, 2002, CURR BIOL, V12, P1992, DOI 10.1016/S0960-9822(02)01305-2; Zhu XD, 2004, FEMS YEAST RES, V5, P1, DOI 10.1016/j.femsyr.2004.04.004	99	17	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38326	10.1371/journal.pone.0038326	http://dx.doi.org/10.1371/journal.pone.0038326			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719877	Green Submitted, Green Published, gold			2022-12-25	WOS:000305347800006
J	Li, H; Qian, WW; Weng, XS; Wu, ZH; Li, HH; Zhuang, QY; Feng, B; Bian, YY				Li, Hui; Qian, Wenwei; Weng, Xisheng; Wu, Zhihong; Li, Huihua; Zhuang, Qianyu; Feng, Bin; Bian, Yanyan			Glucocorticoid Receptor and Sequential P53 Activation by Dexamethasone Mediates Apoptosis and Cell Cycle Arrest of Osteoblastic MC3T3-E1 Cells	PLOS ONE			English	Article							DNA-BINDING COOPERATIVITY; TUMOR-SUPPRESSOR PROTEIN; LEUCINE-ZIPPER GILZ; MULTIPLE-MYELOMA; GRANZYME-A; MECHANISMS; BONE; IDENTIFICATION; INHIBITION; EXPRESSION	Glucocorticoids play a pivotal role in the proliferation of osteoblasts, but the underlying mechanism has not been successfully elucidated. In this report, we have investigated the molecular mechanism which elucidates the inhibitory effects of dexamethasone on murine osteoblastic MC3T3-E1 cells. It was found that the inhibitory effects were largely attributed to apoptosis and G1 phase arrest. Both the cell cycle arrest and apoptosis were dependent on glucocorticoid receptor (GR), as they were abolished by GR blocker RU486 pre-treatment and GR interference. G1 phase arrest and apoptosis were accompanied with a p53-dependent up-regulation of p21 and pro-apoptotic genes NOXA and PUMA. We also proved that dexamethasone can't induce apoptosis and cell cycle arrest when p53 was inhibited by p53 RNA interference. These data demonstrate that proliferation of MC3T3-E1 cell was significantly and directly inhibited by dexamethasone treatment via aberrant GR activation and subsequently P53 activation.	[Li, Hui] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Orthopaed Surg, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, H (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Orthopaed Surg, Beijing 100730, Peoples R China.	xshweng@medmail.com.cn	wu, zhi/GXH-3041-2022	Weng, Xisheng/0000-0002-6021-1462	National Natural Science Foundation of P.R. China [30973042]	National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of P.R. China (Grant Number: 30973042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Civitelli R, 2008, J Endocrinol Invest, V31, P2; Crochemore C, 2002, FASEB J, V16, DOI 10.1096/fj.01-0577com; de Late PL, 2010, J BIOL CHEM, V285, P5594, DOI 10.1074/jbc.M109.068346; Espina B, 2008, J CELL PHYSIOL, V215, P488, DOI 10.1002/jcp.21335; Fukushima W, 2010, CLIN ORTHOP RELAT R, V468, P2715, DOI 10.1007/s11999-010-1292-x; Grugan KD, 2008, J STEROID BIOCHEM, V110, P244, DOI 10.1016/j.jsbmb.2007.11.003; Lowenberg M, 2008, STEROIDS, V73, P1025, DOI 10.1016/j.steroids.2007.12.002; Lu NZ, 2007, MOL CELL BIOL, V27, P7143, DOI 10.1128/MCB.00253-07; Murphy SH, 2011, P NATL ACAD SCI USA, V108, P17117, DOI 10.1073/pnas.1114420108; Myoumoto A, 2007, J HUM GENET, V52, P328, DOI 10.1007/s10038-007-0119-4; O'Brien CA, 2004, ENDOCRINOLOGY, V145, P1835, DOI 10.1210/en.2003-0990; Ruike Y, 2007, J HUM GENET, V52, P172, DOI 10.1007/s10038-006-0099-9; Sasson R, 2002, BIOCHEM BIOPH RES CO, V294, P51, DOI 10.1016/S0006-291X(02)00431-X; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schlereth K, 2010, CELL CYCLE, V9, P4068, DOI 10.4161/cc.9.20.13595; Schlereth K, 2010, MOL CELL, V38, P356, DOI 10.1016/j.molcel.2010.02.037; Sengupta S, 2001, GENE DEV, V15, P2367, DOI 10.1101/gad.202201; Sengupta S, 2000, EMBO J, V19, P6051, DOI 10.1093/emboj/19.22.6051; Shen L, 2004, LEUKEMIA, V18, P1850; Smith E, 2000, J BIOL CHEM, V275, P19992, DOI 10.1074/jbc.M001758200; Smith E, 2002, J BIOL CHEM, V277, P18191, DOI 10.1074/jbc.M109708200; Soundararajan R, 2010, J BIOL CHEM, V285, P39905, DOI 10.1074/jbc.M110.161133; Urban G, 2003, J BIOL CHEM, V278, P9747, DOI 10.1074/jbc.M210993200; Wang DP, 2006, J IMMUNOL, V176, P1695, DOI 10.4049/jimmunol.176.3.1695; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Wu W, 2005, J BIOL CHEM, V280, P4117, DOI 10.1074/jbc.M411200200; Xie H, 2010, AMINO ACIDS, V38, P1145, DOI 10.1007/s00726-009-0325-9; Yan HJ, 2006, CANCER RES, V66, P2305, DOI 10.1158/0008-5472.CAN-05-2447; Yun SI, 2009, J BONE MINER METAB, V27, P140, DOI 10.1007/s00774-008-0019-5	30	70	78	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e37030	10.1371/journal.pone.0037030	http://dx.doi.org/10.1371/journal.pone.0037030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719835	Green Submitted, Green Published, gold			2022-12-25	WOS:000305347800002
J	Manuelpillai, U; Lourensz, D; Vaghjiani, V; Tchongue, J; Lacey, D; Tee, JY; Murthi, P; Chan, J; Hodge, A; Sievert, W				Manuelpillai, Ursula; Lourensz, Dinushka; Vaghjiani, Vijesh; Tchongue, Jorge; Lacey, Derek; Tee, Jing-Yang; Murthi, Padma; Chan, James; Hodge, Alexander; Sievert, William			Human Amniotic Epithelial Cell Transplantation Induces Markers of Alternative Macrophage Activation and Reduces Established Hepatic Fibrosis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HUMAN FETAL MEMBRANES; LIVER FIBROSIS; AUTOLOGOUS INFUSION; INFLAMMATION; DIFFERENTIATION; REGENERATION; CIRRHOSIS; PLACENTA; THERAPY	Chronic hepatic inflammation from multiple etiologies leads to a fibrogenic response that can progress to cirrhosis and liver failure. Transplantation of human amniotic epithelial cells (hAEC) from term delivered placenta has been shown to decrease mild to moderate hepatic fibrosis in a murine model. To model advanced human liver disease and assess the efficacy of hAEC therapy, we transplanted hAEC in mice with advanced hepatic fibrosis. Immunocompetent C57BL/6 mice were administered carbon tetrachloride (CCl4) twice weekly resulting in bridging fibrosis by 12 weeks. hAEC (2610 6) were infused via the tail vein at week 8 or weeks 8 and 10 (single and double dose, respectively). Human cells were detected in mouse liver four weeks after transplantation showing hAEC engraftment. CCl4 treated mice receiving single or double hAEC doses showed a significant but similar decrease in liver fibrosis area associated with decreased activation of collagen-producing hepatic stellate cells and decreased hepatic protein levels of the pro-fibrogenic cytokine, transforming growth factor-beta1. CCl4 administration caused hepatic T cell infiltration that decreased significantly following hAEC transplantation. Hepatic macrophages play a crucial role in both fibrogenesis and fibrosis resolution. Mice exposed to CCl4 demonstrated increased numbers of hepatic macrophages compared to normal mice; the number of macrophages decreased significantly in CCl4 treated mice given hAEC. These mice had significantly lower hepatic protein levels of the chemokine monocyte chemoattractant protein-1 than mice given CCl4 alone. Alternatively activated M2 macrophages are associated with fibrosis resolution. CCl4 treated mice given hAEC showed increased expression of genes associated with M2 macrophages including YM-1, IL-10 and CD206. We provide novel data showing that hAEC transplantation induces a wound healing M2 macrophage phenotype associated with reduction of established hepatic fibrosis that justifies further investigation of this potential cell-based therapy for advanced hepatic fibrosis.	[Manuelpillai, Ursula; Vaghjiani, Vijesh; Tee, Jing-Yang] Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Melbourne, Vic 3004, Australia; [Lourensz, Dinushka; Tchongue, Jorge; Chan, James; Hodge, Alexander; Sievert, William] Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic 3004, Australia; [Lacey, Derek] Univ Melbourne, Royal Melbourne Hosp, Arthrit & Inflammat Res Ctr, Melbourne, Vic 3050, Australia; [Murthi, Padma] Univ Melbourne, Dept Obstet & Gynecol, Melbourne, Vic, Australia; [Lourensz, Dinushka; Tchongue, Jorge; Hodge, Alexander; Sievert, William] So Hlth, Gastroenterol & Hepatol Unit, Melbourne, Vic, Australia; [Murthi, Padma] Royal Womens Hosp, Pregnancy Res Ctr, Dept Perinatal Med, Melbourne, Vic, Australia	Monash University; Monash University; Royal Melbourne Hospital; University of Melbourne; University of Melbourne	Manuelpillai, U (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Melbourne, Vic 3004, Australia.	william.sievert@monash.edu	Murthi, Padma/AAY-5395-2021; Tee, Jing Yang/F-2821-2013; Hodge, Alexander/GRJ-5820-2022	Tee, Jing Yang/0000-0003-1605-4938; Vaghjiani, Vijesh/0000-0001-8004-3876	Australian National Health & Medical Research Council [606473, 509140, 436634]; Victorian Government's Operational Infrastructure Support Program	Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	Australian National Health & Medical Research Council (www.nhmrc.gov.au) project grants #606473 to UM and WS and #509140 to PM and JC by program grant #436634 with support from the Victorian Government's Operational Infrastructure Support Program (http://www.business.vic.gov.au/BUSVIC/STANDARD/PC_60698.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 2010, HEPATOLOGY, V52, P1390, DOI 10.1002/hep.23795; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Busch SA, 2011, J NEUROSCI, V31, P944, DOI 10.1523/JNEUROSCI.3566-10.2011; Cargnoni A, 2009, CELL TRANSPLANT, V18, P405, DOI 10.3727/096368909788809857; Couto BG, 2011, LIVER INT, V31, P391, DOI 10.1111/j.1478-3231.2010.02424.x; Dayan V, 2011, BASIC RES CARDIOL, V106, P1299, DOI 10.1007/s00395-011-0221-9; Fang BJ, 2004, TRANSPLANTATION, V78, P83, DOI 10.1097/01.TP.0000128326.95294.14; Friedman Lawrence S, 2010, Trans Am Clin Climatol Assoc, V121, P192; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gilchrist ES, 2010, LIVER TRANSPLANT, V16, P118, DOI 10.1002/lt.21965; Hanje J, 2007, NAT CLIN PRACT GASTR, V4, P266, DOI 10.1038/ncpgasthep0794; Heymann Felix, 2009, Inflammation & Allergy Drug Targets, V8, P307; Ilancheran S, 2009, PLACENTA, V30, P2, DOI 10.1016/j.placenta.2008.09.009; Ilancheran S, 2007, BIOL REPROD, V77, P577, DOI 10.1095/biolreprod.106.055244; Karlmark KR, 2010, HEPATOLOGY, V52, P1769, DOI 10.1002/hep.23894; Karlmark Karlin Raja, 2008, Expert Rev Gastroenterol Hepatol, V2, P233, DOI 10.1586/17474124.2.2.233; Kharaziha P, 2009, EUR J GASTROEN HEPAT, V21, P1199, DOI 10.1097/MEG.0b013e32832a1f6c; Kisseleva T, 2007, J GASTROEN HEPATOL, V22, pS73, DOI 10.1111/j.1440-1746.2006.04658.x; Kolios G, 2006, WORLD J GASTROENTERO, V12, P7413, DOI 10.3748/wjg.v12.i46.7413; Leviar N, 2008, CELL PROLIFERAT, V41, P115, DOI 10.1111/j.1365-2184.2008.00491.x; Liu TJ, 2008, SHOCK, V29, P603, DOI 10.1097/SHK.0b013e318157e845; Madala SK, 2010, J IMMUNOL, V184, P3955, DOI 10.4049/jimmunol.0903008; Manuelpillai U, 2011, PLACENTA, V32, pS320, DOI 10.1016/j.placenta.2011.04.010; Manuelpillai U, 2010, CELL TRANSPLANT, V19, P1157, DOI 10.3727/096368910X504496; Miki Toshio, 2010, Curr Protoc Stem Cell Biol, VChapter 1, DOI [10.1002/9780470151808.sc01e03s3, 10.1002/9780470151808.sc01e03s12]; Moodley Y, 2010, AM J RESP CRIT CARE, V182, P643, DOI 10.1164/rccm.201001-0014OC; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Pai M, 2008, AM J GASTROENTEROL, V103, P1952, DOI 10.1111/j.1572-0241.2008.01993.x; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Patella S, 2006, AM J PHYSIOL-GASTR L, V290, pG137, DOI 10.1152/ajpgi.00080.2005; Pratama G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026136; Ramachandran P, 2009, ANN HEPATOL, V8, P283, DOI 10.1016/S1665-2681(19)31740-5; Sakaida I, 2004, HEPATOLOGY, V40, P1304, DOI 10.1002/hep.20452; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Stutchfield BM, 2010, LIVER TRANSPLANT, V16, P827, DOI 10.1002/lt.22083; Takashima S, 2004, CELL STRUCT FUNCT, V29, P73, DOI 10.1247/csf.29.73; Thomas JA, 2011, HEPATOLOGY, V53, P2003, DOI 10.1002/hep.24315; Tsai PC, 2009, LIVER TRANSPLANT, V15, P484, DOI 10.1002/lt.21715; Wasmuth HE, 2010, SEMIN LIVER DIS, V30, P215, DOI 10.1055/s-0030-1255351; Wolbank S, 2007, TISSUE ENG, V13, P1173, DOI 10.1089/ten.2006.0313; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yang XX, 2010, NEUROL RES, V32, P1054, DOI 10.1179/016164110X12681290831207	42	84	92	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38631	10.1371/journal.pone.0038631	http://dx.doi.org/10.1371/journal.pone.0038631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719909	Green Published, gold			2022-12-25	WOS:000305347800011
J	Bilal, E; Vassallo, K; Toppmeyer, D; Barnard, N; Rye, IH; Almendro, V; Russnes, H; Borresen-Dale, AL; Levine, AJ; Bhanot, G; Ganesan, S				Bilal, Erhan; Vassallo, Kristen; Toppmeyer, Deborah; Barnard, Nicola; Rye, Inga H.; Almendro, Vanessa; Russnes, Hege; Borresen-Dale, Anne-Lise; Levine, Arnold J.; Bhanot, Gyan; Ganesan, Shridar			Amplified Loci on Chromosomes 8 and 17 Predict Early Relapse in ER-Positive Breast Cancers	PLOS ONE			English	Article							ENDOCRINE THERAPY RESISTANCE; ESTROGEN-RECEPTOR; MOLECULAR SUBTYPES; GROWTH-FACTOR; BONE-MARROW; CYCLIN D1; EXPRESSION; TAMOXIFEN; AMPLIFICATION; GENES	Adjuvant hormonal therapy is administered to all early stage ER+ breast cancers, and has led to significantly improved survival. Unfortunately, a subset of ER+ breast cancers suffer early relapse despite hormonal therapy. To identify molecular markers associated with early relapse in ER+ breast cancer, an outlier analysis method was applied to a published gene expression dataset of 268 ER+ early-stage breast cancers treated with tamoxifen alone. Increased expression of sets of genes that clustered in chromosomal locations consistent with the presence of amplicons at 8q24.3, 8p11.2, 17q12 (HER2 locus) and 17q21.33-q25.1 were each found to be independent markers for early disease recurrence. Distant metastasis free survival (DMFS) after 10 years for cases with any amplicon (DMFS = 56.1%, 95% CI = 48.3-63.9%) was significantly lower (P = 0.0016) than cases without any of the amplicons (DMFS = 87%, 95% CI = 76.3% -97.7%). The association between presence of chromosomal amplifications in these regions and poor outcome in ER+ breast cancers was independent of histologic grade and was confirmed in independent clinical datasets. A separate validation using a FISH-based assay to detect the amplicons at 8q24.3, 8p11.2, and 17q21.33-q25.1 in a set of 36 early stage ER+/HER2- breast cancers treated with tamoxifen suggests that the presence of these amplicons are indeed predictive of early recurrence. We conclude that these amplicons may serve as prognostic markers of early relapse in ER+ breast cancer, and may identify novel therapeutic targets for poor prognosis ER+ breast cancers.	[Bilal, Erhan; Bhanot, Gyan] State Univ New Jersey, Piscataway, NJ USA; [Toppmeyer, Deborah; Levine, Arnold J.; Bhanot, Gyan; Ganesan, Shridar] Canc Inst New Jersey, New Brunswick, NJ USA; [Vassallo, Kristen; Barnard, Nicola] Robert Wood Johnson Univ Hosp, New Brunswick, NJ USA; [Russnes, Hege; Borresen-Dale, Anne-Lise] Norwegian Radium Hosp, Inst Canc Res, Oslo, Norway; [Almendro, Vanessa; Russnes, Hege] Harvard Univ, Dana Farber Canc Inst, Boston, MA 02115 USA; [Rye, Inga H.; Borresen-Dale, Anne-Lise] Univ Oslo, Inst Clin Med, Oslo, Norway; [Almendro, Vanessa] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain; [Levine, Arnold J.; Bhanot, Gyan] Inst Adv Study, Princeton, NJ 08540 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Oslo; Harvard University; Dana-Farber Cancer Institute; University of Oslo; University of Barcelona; Hospital Clinic de Barcelona; Institute for Advanced Study - USA	Bilal, E (corresponding author), State Univ New Jersey, Piscataway, NJ USA.	gyanbhanot@gmail.com; ganesash@umdnj.edu	Russnes, Hege Elisabeth Giercksky/N-6170-2015	Russnes, Hege Elisabeth Giercksky/0000-0001-8724-1891	New Jersey Commission on Cancer Research; National Institutes of Health; Norwegian Cancer Association; The Norwegian Research Council; Raagholdt Foundation; Thorsteds Foundation; Radiumhospitalets legater; Cellex Foundation	New Jersey Commission on Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norwegian Cancer Association; The Norwegian Research Council(Research Council of Norway); Raagholdt Foundation; Thorsteds Foundation; Radiumhospitalets legater; Cellex Foundation(Foundation CELLEX)	EB was supported in part by a grant from the New Jersey Commission on Cancer Research. SG has received support from the National Institutes of Health, and the New Jersey Commission on Cancer Research. HR is funded by the Norwegian Cancer Association, The Norwegian Research Council, Raagholdt Foundation, Thorsteds Foundation and Radiumhospitalets legater. VA is funded by Cellex Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Alexe G, 2006, CANCER INFORM, V2, P243; Alexe G, 2007, CANCER RES, V67, P10669, DOI 10.1158/0008-5472.CAN-07-0539; Argani P, 2003, ONCOGENE, V22, P5374, DOI 10.1038/sj.onc.1206686; Arpino G, 2004, CLIN CANCER RES, V10, P5670, DOI 10.1158/1078-0432.CCR-04-0110; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Bautista S, 1998, GENE CHROMOSOME CANC, V22, P268, DOI 10.1002/(SICI)1098-2264(199808)22:4<268::AID-GCC2>3.0.CO;2-T; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergamaschi A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2913; Bernard-Pierrot I, 2008, CANCER RES, V68, P7165, DOI 10.1158/0008-5472.CAN-08-1360; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; BORG A, 1994, CANCER LETT, V81, P137, DOI 10.1016/0304-3835(94)90194-5; Butt AJ, 2005, ENDOCR-RELAT CANCER, V12, pS47, DOI 10.1677/erc.1.00993; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Cingoz S, 2003, CANCER GENET CYTOGEN, V145, P108, DOI 10.1016/S0165-4608(03)00094-3; Clarke M, 1998, LANCET, V351, P1451; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dalgin GS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-291; De Paepe P, 2003, BLOOD, V102, P2638, DOI 10.1182/blood-2003-04-1050; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Frasor J, 2006, CANCER RES, V66, P7334, DOI 10.1158/0008-5472.CAN-05-4269; Gelsi-Boyer W, 2005, MOL CANCER RES, V3, P655, DOI 10.1158/1541-7786.MCR-05-0128; Gnant M, 2009, CLIN BREAST CANCER, V9, pS18, DOI 10.3816/CBC.2009.s.002; Gyorffy B, 2009, BREAST CANCER RES TR, V118, P433, DOI 10.1007/s10549-008-0242-8; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; He B, 2008, MOL ENDOCRINOL, V22, P344, DOI 10.1210/me.2007-0400; Hurvitz SA, 2008, CANCER-AM CANCER SOC, V113, P2385, DOI 10.1002/cncr.23875; Ishii Y, 2008, CANCER RES, V68, P852, DOI 10.1158/0008-5472.CAN-07-2879; Jonsson G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2596; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; Karlsson E, 2009, CANCER RES, V69, P5166, DOI [10.1158/0008-5472.SABCS-09-5166, DOI 10.1158/0008-5472.SABCS-09-5166]; Kwek SS, 2009, ONCOGENE, V28, P1892, DOI 10.1038/onc.2009.34; Lockwood WW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000315; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Ma CX, 2009, ONCOLOGY-NY, V23, P133; Naume B, 2007, MOL ONCOL, V1, P160, DOI 10.1016/j.molonc.2007.03.004; Naylor TL, 2005, BREAST CANCER RES, V7, pR1186, DOI 10.1186/bcr1356; Orsetti B, 1999, ONCOGENE, V18, P6262, DOI 10.1038/sj.onc.1203006; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Parssinen J, 2007, BRIT J CANCER, V96, P1258, DOI 10.1038/sj.bjc.6603692; Patel AS, 2007, CANCER GENET CYTOGEN, V176, P107, DOI 10.1016/j.cancergencyto.2007.04.004; Rastelli F, 2008, TUMORI J, V94, P370; SINGH L, 1988, BRIT J CANCER, V57, P612, DOI 10.1038/bjc.1988.139; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stec I, 2001, GENOMICS, V76, P5, DOI 10.1006/geno.2001.6581; Streicher KL, 2007, ONCOGENE, V26, P2104, DOI 10.1038/sj.onc.1210002; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wiedswang G, 2003, J CLIN ONCOL, V21, P3469, DOI 10.1200/JCO.2003.02.009	55	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38575	10.1371/journal.pone.0038575	http://dx.doi.org/10.1371/journal.pone.0038575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719901	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341900035
J	Zhang, TY; DeSimone, RA; Jiao, XM; Rohlf, FJ; Zhu, W; Gong, QQ; Hunt, SR; Dassopoulos, T; Newberry, RD; Sodergren, E; Weinstock, G; Robertson, CE; Frank, DN; Li, E				Zhang, Tianyi; DeSimone, Robert A.; Jiao, Xiangmin; Rohlf, F. James; Zhu, Wei; Gong, Qing Qing; Hunt, Steven R.; Dassopoulos, Themistocles; Newberry, Rodney D.; Sodergren, Erica; Weinstock, George; Robertson, Charles E.; Frank, Daniel N.; Li, Ellen			Host Genes Related to Paneth Cells and Xenobiotic Metabolism Are Associated with Shifts in Human Ileum-Associated Microbial Composition	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ILEAL CROHNS-DISEASE; CLOSTRIDIUM-DIFFICILE; DEFENSIN EXPRESSION; ULCERATIVE-COLITIS; NOD2; ATG16L1; PATHOGENESIS; IMBALANCES; PHENOTYPE	The aim of this study was to integrate human clinical, genotype, mRNA microarray and 16 S rRNA sequence data collected on 84 subjects with ileal Crohn's disease, ulcerative colitis or control patients without inflammatory bowel diseases in order to interrogate how host-microbial interactions are perturbed in inflammatory bowel diseases (IBD). Ex-vivo ileal mucosal biopsies were collected from the disease unaffected proximal margin of the ileum resected from patients who were undergoing initial intestinal surgery. Both RNA and DNA were extracted from the mucosal biopsy samples. Patients were genotyped for the three major NOD2 variants (Leufs1007, R702W, and G908R) and the ATG16L1T300A variant. Whole human genome mRNA expression profiles were generated using Agilent microarrays. Microbial composition profiles were determined by 454 pyrosequencing of the V3-V5 hypervariable region of the bacterial 16 S rRNA gene. The results of permutation based multivariate analysis of variance and covariance (MANCOVA) support the hypothesis that host mucosal Paneth cell and xenobiotic metabolism genes play an important role in host microbial interactions.	[Zhang, Tianyi; Jiao, Xiangmin; Zhu, Wei] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Zhang, Tianyi; DeSimone, Robert A.; Li, Ellen] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Rohlf, F. James] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Gong, Qing Qing; Dassopoulos, Themistocles; Newberry, Rodney D.; Li, Ellen] Washington Univ, Dept Med, St Louis Sch Med, St Louis, MO USA; [Hunt, Steven R.] Washington Univ, St Louis Sch Med, Dept Surg, St Louis, MO USA; [Sodergren, Erica; Weinstock, George] Washington Univ, St Louis Sch Med, Genome Inst, St Louis, MO USA; [Robertson, Charles E.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Frank, Daniel N.] Univ Colorado, Dept Med, Aurora, CO 80309 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus	Zhang, TY (corresponding author), SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA.	Ellen.Li@stonybrook.edu	Rohlf, F./AAR-6717-2021; Weinstock, George M/C-6314-2013	Rohlf, F./0000-0003-0522-3679; Weinstock, George M/0000-0002-2997-4592; ROBERTSON, CHARLES/0000-0002-4136-4121; DeSimone, Robert/0000-0002-3484-790X; Jiao, Xiangmin/0000-0002-7111-9813; Newberry, Rodney/0000-0002-4152-5191	National Institutes of Health (NIH) [UH2DK083994]; Crohn's and Colitis Foundation of America; Simons Foundation; Leona M. and Harry B. Helmsley charitable trust through the Sinai-Helmsley Alliance for Research Excellence (SHARE) Network; NIH [R21HG005964]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG005964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, UH2DK083994] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Simons Foundation; Leona M. and Harry B. Helmsley charitable trust through the Sinai-Helmsley Alliance for Research Excellence (SHARE) Network; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported partially by National Institutes of Health (NIH) UH2DK083994, the Crohn's and Colitis Foundation of America, the Simons Foundation and by the Leona M. and Harry B. Helmsley charitable trust through the Sinai-Helmsley Alliance for Research Excellence (SHARE) Network and NIH R21HG005964. The authors acknowledge use of the Washington University Digestive Diseases Research Core Center Tissue Procurement Facility (P30 DK52574). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Aitchison J, 2003, STAT ANAL COMPOSITIO; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bevins CL, 2009, GUT, V58, P882; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Chen HY, 2011, DIS COLON RECTUM, V54, P1020, DOI 10.1007/DCR.0b013e31821b94b3; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dieckgraefe BK, 2000, PHYSIOL GENOMICS, V4, P1; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2011, TRENDS MICROBIOL, V19, P427, DOI 10.1016/j.tim.2011.06.005; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamm CM, 2010, INFLAMM BOWEL DIS, V16, P1649, DOI 10.1002/ibd.21208; Hancock L, 2008, INFLAMM BOWEL DIS, V14, P1667, DOI 10.1002/ibd.20517; Hartupee JC, 2001, BBA-GENE STRUCT EXPR, V1518, P287, DOI 10.1016/S0167-4781(00)00284-0; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Issa M, 2007, CLIN GASTROENTEROL H, V5, P345, DOI 10.1016/j.cgh.2006.12.028; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Langmann T, 2004, GASTROENTEROLOGY, V127, P26, DOI 10.1053/j.gastro.2004.04.019; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Li E, 2011, PLOS ONE IN PRESS; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nelson RL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001181.pub3; Ng SC, 2012, INFLAMM BOWEL DIS, V18, P725, DOI 10.1002/ibd.21747; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Ott RL, 2001, INTRO STAT METHODS D; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Prescott NJ, 2007, GASTROENTEROLOGY, V132, P1665, DOI 10.1053/j.gastro.2007.03.034; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rodemann JF, 2007, CLIN GASTROENTEROL H, V5, P339, DOI 10.1016/j.cgh.2006.12.027; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Simms LA, 2008, GUT, V57, P903, DOI 10.1136/gut.2007.142588; Singh W., 2008, THESIS U ICELAND; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sokol H, 2008, INFLAMM BOWEL DIS, V14, P858, DOI 10.1002/ibd.20392; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sun JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011351; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vaughan IP, 2005, J APPL ECOL, V42, P487, DOI 10.1111/j.1365-2664.2005.01038.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WARD RF, 1963, SCIENCE, V140, P978, DOI 10.1126/science.140.3570.978; Waterman M, 2011, INFLAMM BOWEL DIS, V17, P1936, DOI 10.1002/ibd.21579; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wu F, 2007, INFLAMM BOWEL DIS, V13, P807, DOI 10.1002/ibd.20110; Yoo SM, 2005, VIROLOGY, V343, P47, DOI 10.1016/j.virol.2005.08.018	58	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e30044	10.1371/journal.pone.0030044	http://dx.doi.org/10.1371/journal.pone.0030044			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719822	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341900005
J	Stratton, P; Cheung, A; Wiles, J; Kiyatkin, E; Sah, P; Windels, F				Stratton, Peter; Cheung, Allen; Wiles, Janet; Kiyatkin, Eugene; Sah, Pankaj; Windels, Francois			Action Potential Waveform Variability Limits Multi-Unit Separation in Freely Behaving Rats	PLOS ONE			English	Article							SUBSTANTIA-NIGRA; DOPAMINERGIC-NEURONS; UNRESTRAINED RATS; CORTICAL-NEURONS; BASAL GANGLIA; TOTAL NUMBER; IN-VIVO; RECORDINGS; CORTEX; CAT	Extracellular multi-unit recording is a widely used technique to study spontaneous and evoked neuronal activity in awake behaving animals. These recordings are done using either single-wire or mulitwire electrodes such as tetrodes. In this study we have tested the ability of single-wire electrodes to discriminate activity from multiple neurons under conditions of varying noise and neuronal cell density. Using extracellular single-unit recording, coupled with iontophoresis to drive cell activity across a wide dynamic range, we studied spike waveform variability, and explored systematic differences in single-unit spike waveform within and between brain regions as well as the influence of signal-to-noise ratio (SNR) on the similarity of spike waveforms. We also modelled spike misclassification for a range of cell densities based on neuronal recordings obtained at different SNRs. Modelling predictions were confirmed by classifying spike waveforms from multiple cells with various SNRs using a leading commercial spike-sorting system. Our results show that for single-wire recordings, multiple units can only be reliably distinguished under conditions of high recording SNR (>= 4) and low neuronal density (approximate to 20,000/mm(3)). Physiological and behavioural changes, as well as technical limitations typical of awake animal preparations, reduce the accuracy of single-channel spike classification, resulting in serious classification errors. For SNR <4, the probability of misclassifying spikes approaches 100% in many cases. Our results suggest that in studies where the SNR is low or neuronal density is high, separation of distinct units needs to be evaluated with great caution.	[Stratton, Peter; Cheung, Allen; Sah, Pankaj; Windels, Francois] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Stratton, Peter; Wiles, Janet] Univ Queensland, Sch Informat Technol & Elect Engn, Brisbane, Qld, Australia; [Kiyatkin, Eugene] NIA, Behav Neurosci Branch, Intramural Res Program, NIH,DHHS, Baltimore, MD 21224 USA	University of Queensland; University of Queensland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Stratton, P (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	f.windels@uq.edu.au	Windels, Francois/G-5432-2010; Cheung, Allen/C-8305-2009; Sah, Pankaj/C-8175-2009; Wiles, Janet/C-1989-2008	Cheung, Allen/0000-0001-9770-217X; Stratton, Peter/0000-0002-3312-7505; Wiles, Janet/0000-0002-4051-4116; Windels, Francois/0000-0001-5341-2197; Kiyatkin, Eugene A./0000-0002-3744-0873; Sah, Pankaj/0000-0001-5063-1589	National Health and Medical Research Council (NHMRC); thinking system ARC grant	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); thinking system ARC grant	This work was funded by the National Health and Medical Research Council (NHMRC) (http://www.nhmrc.gov.au/) and a thinking system ARC grant (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOURQUE CW, 1985, J PHYSIOL-LONDON, V363, P429, DOI 10.1113/jphysiol.1985.sp015720; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Cromwell HC, 2005, BRAIN RES, V1043, P12, DOI 10.1016/j.brainres.2005.01.106; CUCCHIARO JB, 1991, NEUROSCIENCE, V41, P213, DOI 10.1016/0306-4522(91)90211-6; de Polavieja GG, 2005, J NEUROSCI, V25, P5657, DOI 10.1523/JNEUROSCI.0242-05.2005; Fee MS, 1996, J NEUROPHYSIOL, V76, P3823, DOI 10.1152/jn.1996.76.6.3823; Gentet LJ, 2007, J NEUROSCI, V27, P1892, DOI 10.1523/JNEUROSCI.5234-06.2007; Girardin CC, 2009, NEUROSCIENCE, V164, P777, DOI 10.1016/j.neuroscience.2009.07.064; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; GROFOVA I, 1982, J COMP NEUROL, V208, P352, DOI 10.1002/cne.902080406; Guatteo E, 2005, J NEUROPHYSIOL, V94, P3069, DOI 10.1152/jn.00066.2005; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Humphrey DR, 1990, NEUROPHYSIOLOGICAL T, P1, DOI [10.1385/0-89603-185-3:1, DOI 10.1385/0-89603-185-3:1]; Karlsen AS, 2011, CEREB CORTEX, V21, P2519, DOI 10.1093/cercor/bhr033; Kiyatkin EA, 2010, FRONT BIOSCI-LANDMRK, V15, P73, DOI 10.2741/3608; Kress GJ, 2009, NEUROSCIENCE, V158, P211, DOI 10.1016/j.neuroscience.2008.03.021; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Mechler F, 2012, J COMPUT NEUROSCI, V32, P73, DOI 10.1007/s10827-011-0341-0; Nair-Roberts RG, 2008, NEUROSCIENCE, V152, P1024, DOI 10.1016/j.neuroscience.2008.01.046; Oorschot DE, 1996, J COMP NEUROL, V366, P580, DOI 10.1002/(SICI)1096-9861(19960318)366:4<580::AID-CNE3>3.0.CO;2-0; OTTERSEN OP, 1984, ANAT EMBRYOL, V170, P197, DOI 10.1007/BF00319005; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Quirk MC, 1999, J NEUROSCI METH, V94, P41, DOI 10.1016/S0165-0270(99)00124-7; RALL WILFRID, 1962, BIOPHYS JOUR, V2, P145; REBEC GV, 1993, J NEUROSCI METH, V47, P53, DOI 10.1016/0165-0270(93)90021-I; Takekawa T, 2010, EUR J NEUROSCI, V31, P263, DOI 10.1111/j.1460-9568.2009.07068.x; TERZUOLO CA, 1961, ANN NY ACAD SCI, V94, P547, DOI 10.1111/j.1749-6632.1961.tb35558.x; THOMPSON SM, 1985, J NEUROSCI, V5, P817; TOWE AL, 1970, EXP NEUROL, V29, P366, DOI 10.1016/0014-4886(70)90065-8; Tye KM, 2007, J NEUROSCI, V27, P3937, DOI 10.1523/JNEUROSCI.5281-06.2007; Windels F, 2003, EUR J NEUROSCI, V17, P613, DOI 10.1046/j.1460-9568.2003.02492.x; Windels F, 2004, J NEUROSCI, V24, P6751, DOI 10.1523/JNEUROSCI.1528-04.2004; Windels F, 2006, BRAIN RES, V1086, P104, DOI 10.1016/j.brainres.2006.02.064; YEDLIN M, 1974, EXP NEUROL, V43, P555, DOI 10.1016/0014-4886(74)90195-2; Zhang R, 2006, J ANAT, V208, P577, DOI 10.1111/j.1469-7580.2006.00573.x	39	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38482	10.1371/journal.pone.0038482	http://dx.doi.org/10.1371/journal.pone.0038482			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719894	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340000024
J	van Bochove, K; van Schalkwijk, DB; Parnell, LD; Lai, CQ; Ordovas, JM; de Graaf, AA; van Ommen, B; Arnett, DK				van Bochove, Kees; van Schalkwijk, Daniel B.; Parnell, Laurence D.; Lai, Chao-Qiang; Ordovas, Jose M.; de Graaf, Albert A.; van Ommen, Ben; Arnett, Donna K.			Clustering by Plasma Lipoprotein Profile Reveals Two Distinct Subgroups with Positive Lipid Response to Fenofibrate Therapy	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; HDL-CHOLESTEROL; CARDIOVASCULAR EVENTS; INSULIN-RESISTANCE; ARTERY-DISEASE; RISK; MEN; LDL; TRIGLYCERIDE; GEMFIBROZIL	Fibrates lower triglycerides and raise HDL cholesterol in dyslipidemic patients, but show heterogeneous treatment response. We used k-means clustering to identify three representative NMR lipoprotein profiles for 775 subjects from the GOLDN population, and study the response to fenofibrate in corresponding subgroups. The subjects in each subgroup showed differences in conventional lipid characteristics and in presence/absence of cardiovascular risk factors at baseline; there were subgroups with a low, medium and high degree of dyslipidemia. Modeling analysis suggests that the difference between the subgroups with low and medium dyslipidemia is influenced mainly by hepatic uptake dysfunction, while the difference between subgroups with medium and high dyslipidemia is influenced mainly by extrahepatic lipolysis disfunction. The medium and high dyslipidemia subgroups showed a positive, yet distinct lipid response to fenofibrate treatment. When comparing our subgroups to known subgrouping methods, we identified an additional 33% of the population with favorable lipid response to fenofibrate compared to a standard baseline triglyceride cutoff method. Compared to a standard HDL cholesterol cutoff method, the addition was 18%. In conclusion, by using constructing subgroups based on representative lipoprotein profiles, we have identified two subgroups of subjects with positive lipid response to fenofibrate therapy and with different underlying disturbances in lipoprotein metabolism. The total subgroup with positive lipid response to fenofibrate is larger than subgroups identified with baseline triglyceride and HDL cholesterol cutoffs.	[van Bochove, Kees; van Schalkwijk, Daniel B.; de Graaf, Albert A.; van Ommen, Ben] TNO, Dept Microbiol & Syst Biol, NL-3700 AJ Zeist, Netherlands; [van Bochove, Kees; van Schalkwijk, Daniel B.; de Graaf, Albert A.; van Ommen, Ben] TNO, Dept Microbiol & Syst Biol, Leiden, Netherlands; [van Schalkwijk, Daniel B.] Leiden Amsterdam Ctr Drug Res, Analyt Sci Div, Leiden, Netherlands; [van Schalkwijk, Daniel B.] Netherlands Bioinformat Ctr NBIC, Nijmegen, Netherlands; [Parnell, Laurence D.; Lai, Chao-Qiang; Ordovas, Jose M.] Tufts Univ, Nutr & Genom Lab, JM USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Arnett, Donna K.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA	Netherlands Organization Applied Science Research; Netherlands Organization Applied Science Research; Leiden University; Leiden University - Excl LUMC; Tufts University; United States Department of Agriculture (USDA); University of Alabama System; University of Alabama Birmingham	van Bochove, K (corresponding author), TNO, Dept Microbiol & Syst Biol, NL-3700 AJ Zeist, Netherlands.	daan.vanschalkwijk@tno.nl	; Ordovas, Jose/B-8727-2013	Lai, Chao-Qiang/0000-0003-1107-8375; van Bochove, Kees/0000-0002-8589-0609; de Graaf, Albert/0000-0002-1067-3570; Ordovas, Jose/0000-0002-7581-5680	NIH Heart, Lung and Blood Institute [U01HL72524]; European Nutrigenomics Organisation [DS08-008]; Netherlands Bioinformatics Centre, Biorange project [SP3.3.1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072524] Funding Source: NIH RePORTER	NIH Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); European Nutrigenomics Organisation; Netherlands Bioinformatics Centre, Biorange project; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH Heart, Lung and Blood Institute grant U01HL72524, Genetic and Environmental Determinants of Triglycerides. KvB was supported by the European Nutrigenomics Organisation exchange grant DS08-008. DBvS was supported by The Netherlands Bioinformatics Centre, Biorange project SP3.3.1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360; AUSTIN MA, 1990, CIRCULATION, V82, P495, DOI 10.1161/01.CIR.82.2.495; Bruckert E, 2011, J CARDIOVASC PHARM, V57, P267, DOI 10.1097/FJC.0b013e318202709f; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Despres JP, 2000, ATHEROSCLEROSIS, V153, P263, DOI 10.1016/S0021-9150(00)00603-1; El Harchaoui K, 2007, J AM COLL CARDIOL, V49, P547, DOI 10.1016/j.jacc.2006.09.043; Elam M, 2011, CURR OPIN LIPIDOL, V22, P55, DOI 10.1097/MOL.0b013e328341a5a8; Freedman DS, 2004, CLIN CHEM, V50, P1189, DOI 10.1373/clinchem.2004.032763; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Ginsberg HN, 2007, AM J CARDIOL, V99, p56I, DOI 10.1016/j.amjcard.2007.03.024; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jeyarajah EJ, 2006, CLIN LAB MED, V26, P847, DOI 10.1016/j.cll.2006.07.006; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Lai CQ, 2007, ARTERIOSCL THROM VAS, V27, P1417, DOI 10.1161/ATVBAHA.107.140103; MANNINEN V, 1992, CIRCULATION, V85, P37, DOI 10.1161/01.CIR.85.1.37; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meade T, 2002, BRIT MED J, V325, P1139, DOI 10.1136/bmj.325.7373.1139; OLIVER M F, 1978, British Heart Journal, V40, P1069, DOI 10.1136/hrt.40.10.1069; Otvos James D, 2002, Clin Lab, V48, P171; OTVOS JD, 1992, CLIN CHEM, V38, P1632; Otvos JD, 2002, AM J CARDIOL, V90, p22I; Packard CJ, 2000, J LIPID RES, V41, P305; Robins SJ, 2003, DIABETES CARE, V26, P1513, DOI 10.2337/diacare.26.5.1513; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21; Schoonjans K, 1996, BBA-LIPID LIPID MET, V1302, P93, DOI 10.1016/0005-2760(96)00066-5; Scott R, 2007, CIRCULATION, V116, P838; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; Steiner G, 2001, LANCET, V357, P905; Usui S, 2002, J LIPID RES, V43, P805; van Schalkwijk Daniel B, 2011, J Clin Bioinforma, V1, P29, DOI 10.1186/2043-9113-1-29; van Schalkwijk DB, 2010, BRIEF BIOINFORM, V11, P403, DOI 10.1093/bib/bbp071; van Schalkwijk DB, 2009, J LIPID RES, V50, P2398, DOI 10.1194/jlr.M800354-JLR200; Wierzbicki AS, 2010, CURR OPIN LIPIDOL, V21, P352, DOI 10.1097/MOL.0b013e32833c1e74; Wierzbicki AS, 2006, INT J CLIN PRACT, V60, P442, DOI 10.1111/j.1368-5031.2006.00882.x; Zeljkovic A, 2008, CLIN EXP MED, V8, P109, DOI 10.1007/s10238-008-0165-z	38	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38072	10.1371/journal.pone.0038072	http://dx.doi.org/10.1371/journal.pone.0038072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719863	Green Submitted, gold, Green Published			2022-12-25	WOS:000305340000010
J	Seeger-Nukpezah, T; Liebau, MC; Hopker, K; Lamkemeyer, T; Benzing, T; Golemis, EA; Schermer, B				Seeger-Nukpezah, Tamina; Liebau, Max C.; Hoepker, Katja; Lamkemeyer, Tobias; Benzing, Thomas; Golemis, Erica A.; Schermer, Bernhard			The Centrosomal Kinase Plk1 Localizes to the Transition Zone of Primary Cilia and Induces Phosphorylation of Nephrocystin-1	PLOS ONE			English	Article							POLO-LIKE KINASES; AURORA-A; PROTEIN; DISEASE; CILIOGENESIS; ACTIVATION; REVEALS; MECHANISMS; MUTATIONS; P130(CAS)	Polo-like kinase (Plk1) plays a central role in regulating the cell cycle. Plk1-mediated phosphorylation is essential for centrosome maturation, and for numerous mitotic events. Although Plk1 localizes to multiple subcellular sites, a major site of action is the centrosomes, which supports mitotic functions in control of bipolar spindle formation. In G0 or G1 untransformed cells, the centriolar core of the centrosome differentiates into the basal body of the primary cilium. Primary cilia are antenna-like sensory organelles dynamically regulated during the cell cycle. Whether Plk1 has a role in ciliary biology has never been studied. Nephrocystin-1 (NPHP1) is a ciliary protein; loss of NPHP1 in humans causes nephronophthisis (NPH), an autosomal-recessive cystic kidney disease. We here demonstrate that Plk1 colocalizes with nephrocystin-1 to the transition zone of primary cilia in epithelial cells. Plk1 co-immunoprecipitates with NPHP1, suggesting it is part of the nephrocystin protein complex. We identified a candidate Plk1 phosphorylation motif (D/E-X-S/T-phi-X-D/E) in nephrocystin-1, and demonstrated in vitro that Plk1 phosphorylates the nephrocystin N-terminus, which includes the specific PLK1 phosphorylation motif. Further, induced disassembly of primary cilia rapidly evoked Plk1 kinase activity, while small molecule inhibition of Plk1 activity or RNAi-mediated downregulation of Plk1 limited the first and second phase of ciliary disassembly. These data identify Plk1 as a novel transition zone signaling protein, suggest a function of Plk1 in cilia dynamics, and link Plk1 to the pathogenesis of NPH and potentially other cystic kidney diseases.	[Seeger-Nukpezah, Tamina; Golemis, Erica A.] Fox Chase Canc Ctr, Dept Dev Therapeut, Philadelphia, PA 19111 USA; [Seeger-Nukpezah, Tamina; Liebau, Max C.; Hoepker, Katja; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Dept Internal Med 2, D-50931 Cologne, Germany; [Seeger-Nukpezah, Tamina; Liebau, Max C.; Hoepker, Katja; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Liebau, Max C.] Univ Cologne, Dept Pediat, D-50931 Cologne, Germany	Fox Chase Cancer Center; University of Cologne; University of Cologne; University of Cologne	Seeger-Nukpezah, T (corresponding author), Fox Chase Canc Ctr, Dept Dev Therapeut, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	bernhard.schermer@uk-koeln.de	Liebau, Max Christoph/K-3470-2019; Benzing, Thomas/X-5476-2019; Schermer, Bernhard/E-9972-2014	Liebau, Max Christoph/0000-0003-0494-9080; Schermer, Bernhard/0000-0002-5194-9000; Golemis, Erica/0000-0003-3618-3673	German Research foundation (DFG) grants [SCHE1562, SFB832, SFB829]; National Institutes of Health core grant [CA-06927]; Pew Charitable Fund;  [R01s CA63366];  [CA113342]; NATIONAL CANCER INSTITUTE [R01CA113342, P30CA006927, R01CA063366] Funding Source: NIH RePORTER	German Research foundation (DFG) grants(German Research Foundation (DFG)); National Institutes of Health core grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Fund; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the German Research foundation (DFG) grants SCHE1562 and SFB832 to BS and SFB829 to TB. EAG was supported by R01s CA63366 and CA113342, and National Institutes of Health core grant CA-06927, and the Pew Charitable Fund (to Fox Chase Cancer Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Astier A, 1997, J BIOL CHEM, V272, P19719, DOI 10.1074/jbc.272.32.19719; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; Benzing T, 2011, NAT GENET, V43, P723, DOI 10.1038/ng.896; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Cao MQ, 2009, METHOD CELL BIOL, V94, P333, DOI 10.1016/S0091-679X(08)94017-6; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Dafinger C, 2011, J CLIN INVEST, V121, P2662, DOI 10.1172/JCI43639; De Luca M, 2006, CELL CYCLE, V5, P296; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fliegauf M, 2006, J AM SOC NEPHROL, V17, P2424, DOI 10.1681/ASN.2005121351; Grosstessner-Hain K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008540; Habbig S, 2011, J CELL BIOL, V193, P633, DOI 10.1083/jcb.201009069; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hildebrandt F, 2009, J AM SOC NEPHROL, V20, P23, DOI 10.1681/ASN.2008050456; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Jauregui AR, 2008, J CELL BIOL, V180, P973, DOI 10.1083/jcb.200707090; Jiang ST, 2009, HUM MOL GENET, V18, P1566, DOI 10.1093/hmg/ddp068; Johmura Y, 2011, P NATL ACAD SCI USA, V108, P11446, DOI 10.1073/pnas.1106223108; Kim S, 2011, CELL CYCLE, V10, P2683, DOI 10.4161/cc.10.16.17009; Kishi K, 2009, MOL CELL BIOL, V29, P3134, DOI 10.1128/MCB.01663-08; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Li J, 2011, CELL CYCLE, V10, P2946, DOI 10.4161/cc.10.17.15922; Liebau MC, 2011, J BIOL CHEM, V286, P14237, DOI 10.1074/jbc.M110.165464; Liu XS, 2010, PROTEIN CELL, V1, P999, DOI 10.1007/s13238-010-0131-x; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Manie SN, 1997, J BIOL CHEM, V272, P4230, DOI 10.1074/jbc.272.7.4230; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Pan JM, 2011, J PROTEOME RES, V10, P3830, DOI 10.1021/pr200428n; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Plotnikova OV, 2008, CANCER RES, V68, P2058, DOI 10.1158/0008-5472.CAN-07-5838; Plotnikova OV, 2011, J CELL BIOL, V193, P1021, DOI 10.1083/jcb.201012061; Plotnikova OV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1061; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; Santos N, 2008, DEV DYNAM, V237, P1972, DOI 10.1002/dvdy.21540; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Schermer B, 2005, EMBO J, V24, P4415, DOI 10.1038/sj.emboj.7600885; Schermer B, 2006, J CELL BIOL, V175, P547, DOI 10.1083/jcb.200605092; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Soung NK, 2009, DEV CELL, V16, P539, DOI 10.1016/j.devcel.2009.02.004; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; van Leuken R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005282; Vazquez-Martin A, 2011, CELL CYCLE, V10, P1295, DOI 10.4161/cc.10.8.15342; Wheatley DN, 1996, CELL BIOL INT, V20, P73, DOI 10.1006/cbir.1996.0011; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116; Yuan K, 2011, CELL SIGNAL, V23, P1, DOI 10.1016/j.cellsig.2010.07.003	55	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38838	10.1371/journal.pone.0038838	http://dx.doi.org/10.1371/journal.pone.0038838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701722	Green Submitted, Green Published, gold			2022-12-25	WOS:000305337600049
J	Sabatel, H; Di Valentin, E; Gloire, G; Dequiedt, F; Piette, J; Habraken, Y				Sabatel, Helene; Di Valentin, Emmanuel; Gloire, Geoffrey; Dequiedt, Franck; Piette, Jacques; Habraken, Yvette			Phosphorylation of p65(RelA) on Ser(547) by ATM Represses NF-kappa B-Dependent Transcription of Specific Genes after Genotoxic Stress	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; DOUBLE-STRAND BREAKS; POSTTRANSLATIONAL MODIFICATIONS; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; OXIDATIVE STRESS; IKK ACTIVATION; KINASE; ALPHA; P65	The NF-kappa B pathway is involved in immune and inflammation responses, proliferation, differentiation and cell death or survival. It is activated by many external stimuli including genotoxic stress. DNA double-strand breaks activate NF-kappa B in an ATM-dependent manner. In this manuscript, a direct interaction between p65(RelA) and the N-terminal extremity of ATM is reported. We also report that only one of the five potential ATM-(S/T)Q target sites present in p65, namely Ser(547), is specifically phosphorylated by ATM in vitro. A comparative transcriptomic analysis performed in HEK-293 cells expressing either wild-type HA-p65 or a non-phosphorylatable mutant HA-p65(S547A) identified several differentially transcribed genes after an etoposide treatment (e.g. IL8, A20, SELE). The transcription of these genes is increased in cells expressing the mutant. Substitution of Ser(547) to alanine does not affect p65 binding abilities on the kappa B site of the IL8 promoter but reduces p65 interaction with HDAC1. Cells expressing p65(S547A) have a higher level of histone H3 acetylated on Lys(9) at the IL8 promoter, which is in agreement with the higher gene induction observed. These results indicate that ATM regulates a subset of NF-kappa B dependent genes after a genotoxic stress by direct phosphorylation of p65.	[Sabatel, Helene; Di Valentin, Emmanuel; Gloire, Geoffrey; Piette, Jacques; Habraken, Yvette] Univ Liege, Lab Virol & Immunol, GIGA R, Signal Transduct Unit, Liege, Belgium; [Gloire, Geoffrey] Interface Entreprises Univ Liege Sci Pk, Angleur, Belgium; [Dequiedt, Franck] Univ Liege, Lab Signalisat & Prot Interact, GIGA R, Signal Transduct Unit, Liege, Belgium	University of Liege; University of Liege; University of Liege	Sabatel, H (corresponding author), Univ Liege, Lab Virol & Immunol, GIGA R, Signal Transduct Unit, Liege, Belgium.	yvette.habraken@ulg.ac.be		Dequiedt, Franck/0000-0003-1234-7477	Belgian "Fonds National de la Recherche Scientifique" (FNRS) [1.A227.08]; TELEVIE [7.4514.10]; Interuniversity Attraction Poles (IAP) [6/18]; Belgian FNRS [3.4543.08]; University of Liege; Federal Scientific Policy [IAP6/18]; "Centre anticancereux aupres de l'ULg";  [CR.CH.08.09.1.5.023.09]	Belgian "Fonds National de la Recherche Scientifique" (FNRS)(Fonds de la Recherche Scientifique - FNRS); TELEVIE; Interuniversity Attraction Poles (IAP)(Belgian Federal Science Policy Office); Belgian FNRS(Fonds de la Recherche Scientifique - FNRS); University of Liege(University of Liege); Federal Scientific Policy; "Centre anticancereux aupres de l'ULg"; 	HS was supported by research fellow grants from the Belgian "Fonds National de la Recherche Scientifique" (FNRS) [grant number 1.A227.08] and the TELEVIE [grant number 7.4514.10]. EDV, a research scientist, is paid by the Interuniversity Attraction Poles (IAP) [grant number 6/18]. FD, YH and JP are a research scientist, a senior research scientist and a research director respectively from the Belgian FNRS. Financial support was provided by the Belgian FNRS [grant number 3.4543.08] and the associate fund [grant number CR.CH.08.09.1.5.023.09], the University of Liege, the Federal Scientific Policy IAP6/18, and the "Centre anticancereux aupres de l'ULg". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barre B, 2010, CELL CYCLE, V9, P4795, DOI 10.4161/cc.9.24.14245; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Campbell KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-101; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Choudhary S, 2011, J BIOL CHEM, V286, P37187, DOI 10.1074/jbc.M111.224923; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; DEJARDIN E, 1995, ONCOGENE, V11, P1835; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; EMI N, 1991, J VIROL, V65, P1202, DOI 10.1128/JVI.65.3.1202-1207.1991; Fernandes N, 2005, J BIOL CHEM, V280, P15158, DOI 10.1074/jbc.M412065200; Frank AK, 2011, MOL CELL BIOL, V31, P1201, DOI 10.1128/MCB.01136-10; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Habraken Y, 2006, BIOCHEM PHARMACOL, V72, P1132, DOI 10.1016/j.bcp.2006.07.015; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hinz M, 2010, MOL CELL, V40, P63, DOI 10.1016/j.molcel.2010.09.008; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Horion J, 2007, J BIOL CHEM, V282, P15383, DOI 10.1074/jbc.M609166200; Hu J, 2005, MOL CANCER RES, V3, P100, DOI 10.1158/1541-7786.MCR-04-0070; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Li NX, 2001, J BIOL CHEM, V276, P8898, DOI 10.1074/jbc.M009809200; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Miyamoto S, 2011, CELL RES, V21, P116, DOI 10.1038/cr.2010.179; O'Shea JM, 2008, BIOCHEM SOC T, V36, P603, DOI 10.1042/BST0360603; O'Shea JM, 2010, BIOCHEM J, V426, P345, DOI 10.1042/BJ20091630; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Owen HR, 2005, J PROTEOME RES, V4, P1381, DOI 10.1021/pr0500713; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Piret B, 1999, ONCOGENE, V18, P2261, DOI 10.1038/sj.onc.1202541; Place RF, 2005, BIOCHEM PHARMACOL, V70, P394, DOI 10.1016/j.bcp.2005.04.030; Rocha S, 2003, MOL CELL, V12, P15, DOI 10.1016/S1097-2765(03)00223-5; Sabatel H, 2011, BIOCHEM PHARMACOL, V82, P1371, DOI 10.1016/j.bcp.2011.07.105; Schneider G, 2010, ONCOGENE, V29, P2795, DOI 10.1038/onc.2010.46; Schoonbroodt S, 2000, J IMMUNOL, V164, P4292, DOI 10.4049/jimmunol.164.8.4292; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wu ZH, 2010, MOL CELL, V40, P75, DOI 10.1016/j.molcel.2010.09.010; WUERZBERGERDAVI.SM, 2007, DNADAMAGE ONCOGENE, V26, P641; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	49	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38246	10.1371/journal.pone.0038246	http://dx.doi.org/10.1371/journal.pone.0038246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715377	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336800018
J	Bjorkgren, I; Saastamoinen, L; Krutskikh, A; Huhtaniemi, I; Poutanen, M; Sipila, P				Bjorkgren, Ida; Saastamoinen, Lauri; Krutskikh, Anton; Huhtaniemi, Ilpo; Poutanen, Matti; Sipila, Petra			Dicer1 Ablation in the Mouse Epididymis Causes Dedifferentiation of the Epithelium and Imbalance in Sex Steroid Signaling	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; FIBROBLAST-GROWTH-FACTOR; MALE REPRODUCTIVE-TRACT; WILD-TYPE MICE; POSTNATAL-DEVELOPMENT; KNOCKOUT MICE; RAT EPIDIDYMIS; MESSENGER-RNA; MICRORNA EXPRESSION; INITIAL SEGMENT	Background: The postnatal development of the epididymis is a complex process that results in a highly differentiated epithelium, divided into several segments. Recent studies indicate a role for RNA interference (RNAi) in the development of the epididymis, however, the actual requirement for RNAi has remained elusive. Here, we present the first evidence of a direct need for RNAi in the differentiation of the epididymal epithelium. Methodology/Principal Findings: By utilizing the Cre-LoxP system we have generated a conditional knock-out of Dicer1 in the two most proximal segments of the mouse epididymis. Recombination of Dicer1, catalyzed by Defb41(iCre/wt), took place before puberty, starting from 12 days postpartum. Shortly thereafter, downregulation of the expression of two genes specific for the most proximal epididymis (lipocalin 8 and cystatin 8) was observed. Following this, segment development continued until week 5 at which age the epithelium started to regress back to an undifferentiated state. The dedifferentiated epithelium also showed an increase in estrogen receptor 1 expression while the expression of androgen receptor and its target genes; glutathione peroxidase 5, lipocalin 5 and cysteine-rich secretory protein 1 was downregulated, indicating imbalanced sex steroid signaling. Conclusions/Significance: At the time of the final epididymal development, Dicer1 acts as a regulator of signaling pathways essential for maintaining epithelial cell differentiation.	[Bjorkgren, Ida; Saastamoinen, Lauri; Poutanen, Matti; Sipila, Petra] Univ Turku, Dept Physiol, Inst Biomed, Turku, Finland; [Bjorkgren, Ida] Turku Grad Sch Biomed Sci, Turku, Finland; [Krutskikh, Anton; Huhtaniemi, Ilpo] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Poutanen, Matti; Sipila, Petra] Univ Turku, Turku Ctr Dis Modeling, TCDM, Turku, Finland	University of Turku; University of Turku; Imperial College London; University of Turku	Bjorkgren, I (corresponding author), Univ Turku, Dept Physiol, Inst Biomed, Turku, Finland.	petra.sipila@utu.fi	Sipilä, Petra/GYE-3323-2022; Poutanen, Matti/I-1700-2018	Poutanen, Matti/0000-0002-8953-1734; Bjorkgren, Ida/0000-0001-6678-2672; Sipila, Petra/0000-0001-8187-7143	Academy of Finland [138561]; Sigrid Juselius Foundation; Turku Doctoral Programme of Biomedical Sciences	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku Doctoral Programme of Biomedical Sciences	This work was supported by research grants from The Academy of Finland (project number 138561, http://www.aka.fi), and Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation). IB is supported by the Turku Doctoral Programme of Biomedical Sciences (http://www.tubs.utu.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Elmaksoud A, 2009, J MOL HISTOL, V40, P407, DOI 10.1007/s10735-010-9254-x; Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Alkafafy M, 2011, ACTA HISTOCHEM, V113, P96, DOI 10.1016/j.acthis.2009.08.004; Avram CE, 2004, CELL TISSUE RES, V317, P23, DOI 10.1007/s00441-004-0892-8; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Carreau S, 1999, INT J ANDROL, V22, P211, DOI 10.1046/j.1365-2605.1999.00172.x; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Clulow J, 1998, J REPROD FERTIL, P1; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; Cotton LM, 2008, ENDOCR REV, V29, P193, DOI 10.1210/er.2007-0028; Crocoll A, 1998, MECH DEVELOP, V72, P175, DOI 10.1016/S0925-4773(98)00007-0; Delic D, 2010, STEROIDS, V75, P998, DOI 10.1016/j.steroids.2010.06.010; Egger GF, 2009, ACTA VET BRNO, V78, P3, DOI 10.2754/avb200978010003; Fibbi B, 2009, J SEX MED, V6, P2173, DOI 10.1111/j.1743-6109.2009.01282.x; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; HERMO L, 1992, ANAT RECORD, V233, P205, DOI 10.1002/ar.1092330205; Hess RA, 2000, J ANDROL, V21, P107; Hoshii T, 2007, BIOL REPROD, V76, P303, DOI 10.1095/biolreprod.106.054619; Huang Y, 2011, J PHYSIOL BIOCHEM, V67, P129, DOI 10.1007/s13105-010-0050-6; Joseph A, 2010, BIOL REPROD, V82, P948, DOI 10.1095/biolreprod.109.079889; Joseph A, 2010, BIOL REPROD, V82, P958, DOI 10.1095/biolreprod.109.080366; Joseph A, 2009, DEV BIOL, V325, P6, DOI 10.1016/j.ydbio.2008.10.012; Keilhack H, 2001, J CELL BIOL, V152, P325, DOI 10.1083/jcb.152.2.325; Kirby JL, 2003, BIOL REPROD, V68, P2314, DOI 10.1095/biolreprod.102.011270; Kirchhoff C, 1999, INT REV CYTOL, V188, P133; Krutskikh A, 2011, ENDOCRINOLOGY, V152, P689, DOI 10.1210/en.2010-0768; Lan ZJ, 1998, BIOL REPROD, V58, P197, DOI 10.1095/biolreprod58.1.197; Lareyre JJ, 2001, ENDOCRINOLOGY, V142, P1296, DOI 10.1210/en.142.3.1296; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; McKinnell C, 2001, J ANDROL, V22, P323; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Morani A, 2008, J INTERN MED, V264, P128, DOI 10.1111/j.1365-2796.2008.01976.x; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Murashima A, 2011, ENDOCRINOLOGY, V152, P1640, DOI 10.1210/en.2010-1121; Narayanan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013637; O'Hara L, 2011, ENDOCRINOLOGY, V152, P718, DOI 10.1210/en.2010-0928; Pandey DP, 2010, CURR OPIN PHARMACOL, V10, P637, DOI 10.1016/j.coph.2010.08.009; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Robaire B, 2000, E SCHERING RES FDN W, P229; Rosenfeld CS, 1998, ENDOCRINOLOGY, V139, P2982, DOI 10.1210/en.139.6.2982; Sekine S, 2009, J PATHOL, V219, P365, DOI 10.1002/path.2606; Shayu D, 2006, MOL CELL ENDOCRINOL, V249, P40, DOI 10.1016/j.mce.2006.01.016; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Shum WW, 2011, J ANDROL; Simanainen U, 2008, ENDOCRINOLOGY, V149, P3330, DOI 10.1210/en.2007-1805; Sipila P, 2002, MOL ENDOCRINOL, V16, P2603, DOI 10.1210/me.2002-0100; SonnenbergRiethmacher E, 1996, GENE DEV, V10, P1184, DOI 10.1101/gad.10.10.1184; Soukup GA, 2009, DEV BIOL, V328, P328, DOI 10.1016/j.ydbio.2009.01.037; SUN EL, 1979, AM J ANAT, V154, P27, DOI 10.1002/aja.1001540104; Takagi-Morishita Y, 2002, ENDOCR J, V49, P75, DOI 10.1507/endocrj.49.75; Tomaszewski J, 2007, P NATL ACAD SCI USA, V104, P11322, DOI 10.1073/pnas.0703445104; Wang JF, 2010, BIOCHEM BIOPH RES CO, V402, P222, DOI 10.1016/j.bbrc.2010.10.002; Welsh M, 2007, ENDOCRINOLOGY, V148, P3185, DOI 10.1210/en.2007-0028; Williams K, 2001, HUM REPROD UPDATE, V7, P236, DOI 10.1093/humupd/7.3.236; Yeung CH, 1999, BIOL REPROD, V61, P1062, DOI 10.1095/biolreprod61.4.1062; Yuan Q, 2007, ASIAN J ANDROL, V9, P305, DOI 10.1111/j.1745-7262.2007.00260.x; Zhang JS, 2010, ACTA BIOCH BIOPH SIN, V42, P145, DOI 10.1093/abbs/gmp116; Zhou Q, 2002, J ANDROL, V23, P870	61	53	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38457	10.1371/journal.pone.0038457	http://dx.doi.org/10.1371/journal.pone.0038457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701646	Green Published, Green Submitted, gold			2022-12-25	WOS:000305348400061
J	Garcia-Santisteban, I; Zorroza, K; Rodriguez, JA				Garcia-Santisteban, Iraia; Zorroza, Kerman; Antonio Rodriguez, Jose			Two Nuclear Localization Signals in USP1 Mediate Nuclear Import of the USP1/UAF1 Complex	PLOS ONE			English	Article							FANCONI-ANEMIA PATHWAY; UBIQUITIN SYSTEM; PROTEIN; EXPORT; CANCER; REPAIR; DEUBIQUITINATION; IDENTIFICATION; SEQUENCE; REVERSE	The human deubiquitinase USP1 plays important roles in cancer-related processes, such as the DNA damage response, and the maintenance of the undifferentiated state of osteosarcoma cells. USP1 deubiquitinase activity is critically regulated by its interaction with the WD40 repeat-containing protein UAF1. Inhibiting the function of the USP1/UAF1 complex sensitizes cancer cells to chemotherapy, suggesting that this complex is a relevant anticancer target. Intriguingly, whereas UAF1 has been reported to locate in the cytoplasm, USP1 is a nuclear protein, although the sequence motifs that mediate its nuclear import have not been functionally characterized. Here, we identify two nuclear localization signals (NLSs) in USP1 and show that these NLSs mediate the nuclear import of the USP1/UAF1 complex. Using a cellular relocation assay based on these results, we map the UAF1-binding site to a highly conserved 100 amino acid motif in USP1. Our data support a model in which USP1 and UAF1 form a complex in the cytoplasm that subsequently translocates to the nucleus through import mediated by USP1 NLSs. Importantly, our findings have practical implications for the development of USP1-directed therapies. First, the UAF1-interacting region of USP1 identified here might be targeted to disrupt the USP1/UAF1 interaction with therapeutic purposes. On the other hand, we describe a cellular relocation assay that can be easily implemented in a high throughput setting to search for drugs that may dissociate the USP1/UAF1 complex.	[Garcia-Santisteban, Iraia; Antonio Rodriguez, Jose] Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain; [Zorroza, Kerman] Basque Fdn Hlth Innovat & Res, BioEF, Bilbao, Spain	University of Basque Country	Garcia-Santisteban, I (corresponding author), Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain.	josean.rodriguez@ehu.es	Garcia-Santisteban, Iraia/AAS-1463-2020; Rodriguez, Jose Antonio/AAA-1125-2019	Rodriguez, Jose Antonio/0000-0002-2823-3733; GARCIA SANTISTEBAN, IRAIA/0000-0002-7912-385X	Basque Country Government Department of Industry [ETORTEK BioGUNE2010]; Spanish Government MICINN (Ministerio de Ciencia e Innovacion) [BFU2009-13245]; University of the Basque Country [UFI11/20]; Department of Education of the Basque Country Government	Basque Country Government Department of Industry; Spanish Government MICINN (Ministerio de Ciencia e Innovacion); University of the Basque Country; Department of Education of the Basque Country Government	This work was supported by the Basque Country Government Department of Industry (grant number ETORTEK BioGUNE2010 to JAR), the Spanish Government MICINN (Ministerio de Ciencia e Innovacion) (grant number BFU2009-13245 to JAR), the University of the Basque Country (UFI11/20), and a fellowship from the Department of Education of the Basque Country Government (to IG-S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Chen JJ, 2011, CHEM BIOL, V18, P1390, DOI 10.1016/j.chembiol.2011.08.014; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Cote-Martin A, 2008, J VIROL, V82, P1271, DOI 10.1128/JVI.01405-07; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Garcia-Santisteban I, 2012, BIOCHEM J, V441, P209, DOI 10.1042/BJ20111300; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Joo HY, 2011, J BIOL CHEM, V286, P7190, DOI 10.1074/jbc.M110.158311; Kim JM, 2009, DEV CELL, V16, P314, DOI 10.1016/j.devcel.2009.01.001; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Murai J, 2011, MOL CELL BIOL, V31, P2462, DOI 10.1128/MCB.05058-11; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Park J, 2002, IMMUNITY, V17, P221, DOI 10.1016/S1074-7613(02)00368-0; Ramakrishna S, 2011, CELL MOL LIFE SCI, V68, P15, DOI 10.1007/s00018-010-0504-6; Rodriguez JA, 2000, J BIOL CHEM, V275, P38589, DOI 10.1074/jbc.M003851200; Song L, 2008, CURR OPIN CELL BIOL, V20, P156, DOI 10.1016/j.ceb.2008.01.012; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Williams SA, 2011, CELL, V146, P917, DOI 10.1016/j.cell.2011.07.040	30	28	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38570	10.1371/journal.pone.0038570	http://dx.doi.org/10.1371/journal.pone.0038570			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701671	Green Published, Green Submitted, gold			2022-12-25	WOS:000305348400074
J	Wajnberg, E; Coquillard, P; Vet, LEM; Hoffmeister, T				Wajnberg, Eric; Coquillard, Patrick; Vet, Louise E. M.; Hoffmeister, Thomas			Optimal Resource Allocation to Survival and Reproduction in Parasitic Wasps Foraging in Fragmented Habitats	PLOS ONE			English	Article							PATCH-LEAVING STRATEGIES; RANDOM ARRIVAL TIMES; EGG LIMITATION; LIFE-HISTORY; GENETIC ALGORITHMS; EVOLUTIONARY ARGUMENT; LANDSCAPE STRUCTURE; BEHAVIORAL ECOLOGY; OVIPOSITION; CONSEQUENCES	Expansion and intensification of human land use represents the major cause of habitat fragmentation. Such fragmentation can have dramatic consequences on species richness and trophic interactions within food webs. Although the associated ecological consequences have been studied by several authors, the evolutionary effects on interacting species have received little research attention. Using a genetic algorithm, we quantified how habitat fragmentation and environmental variability affect the optimal reproductive strategies of parasitic wasps foraging for hosts. As observed in real animal species, the model is based on the existence of a negative trade-off between survival and reproduction resulting from competitive allocation of resources to either somatic maintenance or egg production. We also asked to what degree plasticity along this trade-off would be optimal, when plasticity is costly. We found that habitat fragmentation can indeed have strong effects on the reproductive strategies adopted by parasitoids. With increasing habitat fragmentation animals should invest in greater longevity with lower fecundity; yet, especially in unpredictable environments, some level of phenotypic plasticity should be selected for. Other consequences in terms of learning ability of foraging animals were also observed. The evolutionary consequences of these results are discussed.	[Wajnberg, Eric; Coquillard, Patrick] INRA, Sophia Antipolis, France; [Vet, Louise E. M.] Netherlands Inst Ecol NIOO KNAW, Wageningen, Netherlands; [Hoffmeister, Thomas] Univ Bremen, Inst Ecol, D-28359 Bremen, Germany	INRAE; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of Bremen	Wajnberg, E (corresponding author), INRA, Sophia Antipolis, France.	wajnberg@sophia.inra.fr	Vet, Louise E.M./B-1342-2009; Wajnberg, Eric/A-4862-2009; Hoffmeister, Thomas S/E-2804-2013; Hoffmeister, Thomas S./AAH-7796-2020; KNAW, NIOO-KNAW/A-4320-2012	Vet, Louise E.M./0000-0002-2287-1128; Wajnberg, Eric/0000-0002-6700-7114; Hoffmeister, Thomas S/0000-0003-2840-7278; Hoffmeister, Thomas S./0000-0003-2840-7278; KNAW, NIOO-KNAW/0000-0002-3835-159X				Barta Z, 1997, P ROY SOC B-BIOL SCI, V264, P1233, DOI 10.1098/rspb.1997.0170; Bernstein Carlos, 2008, P129, DOI 10.1002/9780470696200.ch7; Blumstein DT, 1996, OIKOS, V77, P569, DOI 10.2307/3545948; Bonsall MB, 2004, SCIENCE, V306, P111, DOI 10.1126/science.1100680; Burger JMS, 2004, OIKOS, V106, P117, DOI 10.1111/j.0030-1299.2004.12908.x; Casas J, 2000, J ANIM ECOL, V69, P185, DOI 10.1046/j.1365-2656.2000.00376.x; Casas J, 2009, ECOLOGY, V90, P537, DOI 10.1890/08-0507.1; CHARNOV EL, 1995, P NATL ACAD SCI USA, V92, P1446, DOI 10.1073/pnas.92.5.1446; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; DEJONG G, 1992, AM NAT, V139, P749, DOI 10.1086/285356; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Ellers J, 2000, AM NAT, V156, P650, DOI 10.1086/316990; Ellers J, 1997, J EVOLUTION BIOL, V10, P771, DOI 10.1007/s000360050053; Ellers J, 2000, NETH J ZOOL, V50, P29, DOI 10.1163/156854200505784; Evans EW, 2011, BIOCONTROL, V56, P395, DOI 10.1007/s10526-011-9375-5; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fischer B, 2011, OIKOS, V120, P258, DOI 10.1111/j.1600-0706.2010.18642.x; FORREST S, 1993, SCIENCE, V261, P872, DOI 10.1126/science.8346439; Green DM, 2009, POPUL ECOL, V51, P253, DOI 10.1007/s10144-008-0131-3; Hamelin F, 2007, ANN INT SOC DYN GAME, V9, P327, DOI 10.1007/978-0-8176-4553-3_16; Hamelin F, 2007, ANN INT SOC DYN GAME, V9, P349, DOI 10.1007/978-0-8176-4553-3_17; Harvey JA, 2008, EVOL ECOL, V22, P153, DOI 10.1007/s10682-007-9164-x; HASSELL MP, 1978, ANNU REV ECOL SYST, V9, P75, DOI 10.1146/annurev.es.09.110178.000451; Heimpel GE, 1996, ECOLOGY, V77, P2410, DOI 10.2307/2265742; Heimpel GE, 1998, AM NAT, V152, P273, DOI 10.1086/286167; Heimpel GE, 1998, BIOL CONTROL, V11, P160, DOI 10.1006/bcon.1997.0587; Hoffmeister Thomas S., 2008, P384, DOI 10.1002/9780470696200.ch17; Hoffmeister TS, 2005, ECOSYSTEMS, V8, P657, DOI 10.1007/s10021-003-0138-8; Hoffmeister TS, 1998, ECOSCIENCE, V5, P312, DOI 10.1080/11956860.1998.11682470; Hovestadt T, 2011, J ANIM ECOL, V80, P1070, DOI 10.1111/j.1365-2656.2011.01848.x; Hunt J, 2004, BEHAV ECOL SOCIOBIOL, V55, P302, DOI 10.1007/s00265-003-0705-1; Hunter MD, 2002, AGR FOREST ENTOMOL, V4, P159, DOI 10.1046/j.1461-9563.2002.00152.x; Huse G, 1999, EVOL ECOL, V13, P469, DOI 10.1023/A:1006746727151; Jervis MA, 2004, OIKOS, V107, P449, DOI 10.1111/j.0030-1299.2004.13453.x; Jervis MA, 2008, ANNU REV ENTOMOL, V53, P361, DOI 10.1146/annurev.ento.53.103106.093433; Krivan V, 1997, THEOR POPUL BIOL, V51, P201, DOI 10.1006/tpbi.1997.1300; KRUESS A, 1994, SCIENCE, V264, P1581, DOI 10.1126/science.264.5165.1581; MCNAMARA JM, 1987, J THEOR BIOL, V125, P385, DOI 10.1016/S0022-5193(87)80209-6; MINKENBERG OPJM, 1992, OIKOS, V65, P134, DOI 10.2307/3544896; MURDOCH WW, 1994, ECOLOGY, V75, P271, DOI 10.2307/1939533; Nonacs P, 2001, BEHAV ECOL, V12, P71, DOI 10.1093/oxfordjournals.beheco.a000381; OLLASON JG, 1980, THEOR POPUL BIOL, V18, P44, DOI 10.1016/0040-5809(80)90039-8; Papaj DR, 2000, ANNU REV ENTOMOL, V45, P423, DOI 10.1146/annurev.ento.45.1.423; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Richard R, 2009, ECOL MONOGR, V79, P465, DOI 10.1890/08-1566.1; Rivero A, 1999, RES POPUL ECOL, V41, P39, DOI 10.1007/PL00011981; RiveroLynch AP, 1997, FUNCT ECOL, V11, P184, DOI 10.1046/j.1365-2435.1997.00076.x; Roff DA, 2007, J EVOLUTION BIOL, V20, P433, DOI 10.1111/j.1420-9101.2006.01255.x; Roff Derek A., 1992; Rosenheim JA, 1999, EVOL ECOL, V13, P141, DOI 10.1023/A:1006612519265; Rosenheim JA, 2000, P ROY SOC B-BIOL SCI, V267, P1565, DOI 10.1098/rspb.2000.1179; Rosenheim JA, 1996, EVOLUTION, V50, P2089, DOI 10.1111/j.1558-5646.1996.tb03595.x; Rosenheim JA, 1999, EVOLUTION, V53, P376, DOI 10.1111/j.1558-5646.1999.tb03773.x; Rosenheim JA, 2008, AM NAT, V172, P486, DOI 10.1086/591677; Rosenheim JA, 2011, EVOLUTION, V65, P2300, DOI 10.1111/j.1558-5646.2011.01305.x; Russell RE, 2003, OIKOS, V103, P142, DOI 10.1034/j.1600-0706.2003.12418.x; Ruxton GD, 2008, J THEOR BIOL, V250, P435, DOI 10.1016/j.jtbi.2007.10.022; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Sevenster JG, 1998, EVOLUTION, V52, P1241, DOI [10.2307/2411256, 10.1111/j.1558-5646.1998.tb01853.x]; Shea K, 1996, J ANIM ECOL, V65, P743, DOI 10.2307/5673; Stephens D.W., 1986, pi; Strand E, 2002, AM NAT, V159, P624, DOI 10.1086/339997; SUMIDA BH, 1990, J THEOR BIOL, V147, P59, DOI 10.1016/S0022-5193(05)80252-8; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; TATAR M, 1993, EVOLUTION, V47, P1302, DOI [10.1111/j.1558-5646.1993.tb02156.x, 10.2307/2410149]; Thies C, 1999, SCIENCE, V285, P893, DOI 10.1126/science.285.5429.893; Toquenaga Y, 1996, TRENDS ECOL EVOL, V11, P478, DOI 10.1016/0169-5347(96)20075-8; Tully T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003207; Valone TJ, 2006, OIKOS, V112, P252; Van Buskirk J, 2009, J EVOLUTION BIOL, V22, P852, DOI 10.1111/j.1420-9101.2009.01685.x; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; van Nouhuys S, 2005, ANN ZOOL FENN, V42, P433; Vet Louise E.M., 1995, P65; Wajnberg E, 2006, BEHAV ECOL SOCIOBIOL, V60, P1, DOI 10.1007/s00265-005-0131-7; Wajnberg E, 2004, J ANIM ECOL, V73, P1179, DOI 10.1111/j.0021-8790.2004.00892.x; Wajnberg E, 2006, BEHAV ECOL SOCIOBIOL, V60, P589, DOI 10.1007/s00265-006-0198-9; WHITLEY D, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P116	79	16	17	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38227	10.1371/journal.pone.0038227	http://dx.doi.org/10.1371/journal.pone.0038227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701614	Green Published, gold			2022-12-25	WOS:000305348400041
J	Bagrow, JP; Lin, YR				Bagrow, James P.; Lin, Yu-Ru			Mesoscopic Structure and Social Aspects of Human Mobility	PLOS ONE			English	Article							PREDICTABILITY; NETWORKS; DEMAND; TRAVEL	The individual movements of large numbers of people are important in many contexts, from urban planning to disease spreading. Datasets that capture human mobility are now available and many interesting features have been discovered, including the ultra-slow spatial growth of individual mobility. However, the detailed substructures and spatiotemporal flows of mobility - the sets and sequences of visited locations - have not been well studied. We show that individual mobility is dominated by small groups of frequently visited, dynamically close locations, forming primary "habitats" capturing typical daily activity, along with subsidiary habitats representing additional travel. These habitats do not correspond to typical contexts such as home or work. The temporal evolution of mobility within habitats, which constitutes most motion, is universal across habitats and exhibits scaling patterns both distinct from all previous observations and unpredicted by current models. The delay to enter subsidiary habitats is a primary factor in the spatiotemporal growth of human travel. Interestingly, habitats correlate with non-mobility dynamics such as communication activity, implying that habitats may influence processes such as information spreading and revealing new connections between human mobility and social networks.	[Bagrow, James P.] Northwestern Univ, Evanston, IL 60208 USA; [Bagrow, James P.] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA; [Lin, Yu-Ru] Northeastern Univ, Coll Comp & Informat Sci, Boston, MA 02115 USA; [Lin, Yu-Ru] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA	Northwestern University; Northeastern University; Northeastern University; Harvard University	Bagrow, JP (corresponding author), Northwestern Univ, Evanston, IL 60208 USA.	james.bagrow@northwestern.edu	Bagrow, James/E-1701-2016	Bagrow, James/0000-0002-4614-0792	Center for Complex Network Research; James S. McDonnell Foundation; National Science Foundation [DMR-0426737, IIS-0513650]; Defense Threat Reduction Agency [HDTRA1-08-1-0027, HDTRA1-10-1-0100]; Network Science Collaborative Technology Alliance by the United States Army Research Laboratory [W911NF-09-2-0053]; U.S. Office of Naval Research [N000141010968]; MURI [G00003585]	Center for Complex Network Research; James S. McDonnell Foundation; National Science Foundation(National Science Foundation (NSF)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Network Science Collaborative Technology Alliance by the United States Army Research Laboratory; U.S. Office of Naval Research(Office of Naval Research); MURI(MURI)	This work was supported by the Center for Complex Network Research supported by the James S. McDonnell Foundation 21st Century Initiative in Studying Complex Systems (http://www.jsmf.org/programs/cs/index.htm), the National Science Foundation within the Information Technology Research (DMR-0426737) and IIS-0513650 programs (http://www.nsf.gov/funding/pgm_summ.jsp?pims_id = 5524&from = fund), the Defense Threat Reduction Agency award HDTRA1-08-1-0027 and HDTRA1-10-1-0100 (http://www.dtrasubmission.net/portal/), the Network Science Collaborative Technology Alliance sponsored by the United States Army Research Laboratory under agreement number W911NF-09-2-0053 (http://www.arl.army.mil/www/default.cfm?page = 391), and the U.S. Office of Naval Research Award (N000141010968) (http://www.onr.navy.mil/Contracts-Grants.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank F. Simini, J. Menche, J.-P. Onnela, S. Lehmann, W.-T. Chung, D. Brockmann, B. Uzzi, and D. Lazer for many useful discussions and A.-L. Barabasi, D. Lazer, B. Uzzi and D. Brockmann for support. We gratefully acknowledge the hospitality of the LazerLab at Northeastern University, supported by MURI grant #G00003585. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the funding source.	Backstrom L., 2011, P 5 INT C WEBL SOC M; Bagrow James P., 2009, 2009 International Conference on Computational Science and Engineering (CSE), P944, DOI 10.1109/CSE.2009.283; Bagrow JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017680; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Brons M, 2002, J AIR TRANSP MANAG, V8, P165, DOI 10.1016/S0969-6997(01)00050-3; Calabrese F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020814; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Crandall DJ, 2010, P NATL ACAD SCI USA, V107, P22436, DOI 10.1073/pnas.1006155107; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Expert P, 2011, P NATL ACAD SCI USA, V108, P7663, DOI 10.1073/pnas.1018962108; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Horner MW., 2001, J TRANSP GEOGR, V9, P255, DOI DOI 10.1016/S0966-6923(01)00019-9; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Hui P, 2005, P 2005 ACM SIGCOMM W, P244, DOI DOI 10.1145/1080139.1080142; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kitamura R, 2000, TRANSPORTATION, V27, P25, DOI 10.1023/A:1005259324588; Kleinberg JM, 2000, NATURE, V406, P845, DOI 10.1038/35022643; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Onnela JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016939; Park J, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/11/P11021; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Ratti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014248; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Song C., 2010, NATURE PHYS; Song CM, 2010, SCIENCE, V327, P1018, DOI 10.1126/science.1177170; Stouffer SA, 1940, AM SOCIOL REV, V5, P845, DOI 10.2307/2084520; Thiemann C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015422; Wang D., 2011, P 17 ACM SIGKDD INT, P1100, DOI DOI 10.1145/2020408.2020581	30	72	72	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37676	10.1371/journal.pone.0037676	http://dx.doi.org/10.1371/journal.pone.0037676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701529	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000305338500050
J	Perez-Benavente, B; Garcia, JL; Rodriguez, MS; Pineda-Lucena, A; Piechaczyk, M; de Mora, JF; Farras, R				Perez-Benavente, B.; Garcia, J. L.; Rodriguez, M. S.; Pineda-Lucena, A.; Piechaczyk, M.; Font de Mora, J.; Farras, R.			GSK3-SCFFBXW7 targets JunB for degradation in G2 to preserve chromatid cohesion before anaphase	ONCOGENE			English	Article						JunB; G2 phase; ubiquitin-proteasome; NPM-ALK; GSK3; DDX11	LARGE-CELL-LYMPHOMA; CHRONIC MYELOID-LEUKEMIA; C-JUN; PROFILING REVEALS; TUMOR-SUPPRESSOR; HODGKIN-LYMPHOMA; EXPRESSION; TRANSCRIPTION; KINASE; ALK	JunB, an activator protein-1 (AP-1) transcription factor component, acts either as a tumor suppressor or as an oncogene depending on the cell context. In particular, JunB is strongly upregulated in anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL) where it enhances cell proliferation. Although its overexpression is linked to lymphomagenesis, the mechanisms whereby JunB promotes neoplastic growth are still largely obscure. Here, we show that JunB undergoes coordinated phosphorylation-dependent ubiquitylation during the G2 phase of the cell cycle. We characterized a critical consensus phosphodegron that controls JunB turnover and identified GSK3 and SCFFBXW7 as, respectively, the kinase and the E3 ubiquitin ligase responsible for its degradation in G2. Pharmacological or genetic inactivation of the GSK3-FBXW7-JunB axis induced accumulation of JunB in G2/M and entailed transcriptional repression of the DNA helicase DDX11, leading to premature sister chromatid separation. This abnormal phenotype due to dysregulation of the GSK3 beta/JunB/DDX11 pathway is phenocopied in ALK-positive ALCL. Thus, our results reveal a novel mechanism by which mitosis progression and chromatid cohesion are regulated through GSK3/SCFFBXW7-mediated proteolysis of JunB, and suggest that JunB proteolysis in G2 is an essential step in maintaining genetic fidelity during mitosis. Oncogene (2013) 32, 2189-2199; doi:10.1038/onc.2012.235; published online 18 June 2012	[Perez-Benavente, B.; Farras, R.] Ctr Invest Principe Felipe, Cytom Lab, Valencia 46012, Spain; [Garcia, J. L.] Univ Salamanca, Ctr Invest Canc, Hosp Univ Salamanca, Unidad Invest,IECSCYL,CSIC, E-37008 Salamanca, Spain; [Rodriguez, M. S.] CIC BioGUNE, Prote Unit, Bizkaia, Spain; [Pineda-Lucena, A.] Ctr Invest Principe Felipe, Struct Biochem Lab, Valencia 46012, Spain; [Piechaczyk, M.] Univ Montpellier I, Univ Montpellier 2, CNRS, UMR 5535,Inst Genet Mol Montpellier, Montpellier 2, France; [Font de Mora, J.] Ctr Invest Principe Felipe, Cellular & Mol Biol Lab, Valencia 46012, Spain	Prince Felipe Research Center; Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca; CIC bioGUNE; Prince Felipe Research Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Prince Felipe Research Center	Farras, R (corresponding author), Ctr Invest Principe Felipe, Cytom Lab, C EP Autopista del Saler 16, Valencia 46012, Spain.	rfarras@cipf.es	RODRIGUEZ, Manuel S./D-5439-2018; PIECHACZYK, Marc/E-7896-2013; Pineda-Lucena, Antonio/B-1320-2014; Farràs, Rosa/B-5180-2014; de Mora, Jaime Font/AAK-7591-2021; de Mora, Jaime Font/H-6304-2015	PIECHACZYK, Marc/0000-0003-1367-2597; Pineda-Lucena, Antonio/0000-0002-3532-8781; Farràs, Rosa/0000-0003-4931-1494; de Mora, Jaime Font/0000-0002-6816-2095; de Mora, Jaime Font/0000-0002-6816-2095; Perez-Benavente, Beatriz/0000-0001-9977-058X	Fondo de Investigaciones Sanitarias [PI08/1127]; Valencia's Regional Ministry of Health [AP007/11]; Spanish Ministry of Science and Innovation [SAF2009-08334]; Institute of Health Carlos III; Regional Ministry of Health; program 'Equipe Labellisee' of the French Ligue against Cancer	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Valencia's Regional Ministry of Health; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Institute of Health Carlos III(Instituto de Salud Carlos III); Regional Ministry of Health; program 'Equipe Labellisee' of the French Ligue against Cancer	We thank Sandra Gallach and Pablo Mateos for their excellent technical support and A Ferrando, TM Thomson, G Bossis and O Coux for fruitful discussions and critical reading of the manuscript. This research was supported by grants from the Fondo de Investigaciones Sanitarias (PI08/1127) and from Valencia's Regional Ministry of Health (AP007/11) to RF, from the Spanish Ministry of Science and Innovation (SAF2009-08334) to JFM. RF is supported by the Institute of Health Carlos III and by the Regional Ministry of Health. MP was supported by the program 'Equipe Labellisee' of the French Ligue against Cancer. We are grateful to B Vogelstein for providing DLD1 and DLD1<SUP>FBXW7-/-</SUP> cells, M Pagano for Flag-tagged SKP2, CDH1 and CDC20 constructs, O Sangfield for Flag-tagged FBXW7 alpha and FBXW7 gamma constructs, C Bonne-Andrea for Flag-tagged FBXW7 alpha(R465A), PK Vogt (Scripps Research Institute) for activated AKT and E Noguchi for DDX11.	Amin HM, 2007, BLOOD, V110, P2259, DOI 10.1182/blood-2007-04-060715; Andrecht S, 2002, J BIOL CHEM, V277, P35961, DOI 10.1074/jbc.M202847200; Aoki M, 1998, P NATL ACAD SCI USA, V95, P14950, DOI 10.1073/pnas.95.25.14950; Babaei-Jadidi R, 2011, J EXP MED, V208, P295, DOI 10.1084/jem.20100830; Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Bossis G, 2003, MOL CELL BIOL, V23, P7425, DOI 10.1128/MCB.23.20.7425-7436.2003; BOSSYWETZEL E, 1992, GENE DEV, V6, P2340, DOI 10.1101/gad.6.12a.2340; Bruchova H, 2002, LEUKEMIA LYMPHOMA, V43, P1289, DOI 10.1080/10428190290026358; Crusio KM, 2010, ONCOGENE, V29, P4865, DOI 10.1038/onc.2010.222; Dorsam ST, 2004, BLOOD, V103, P1676, DOI 10.1182/blood-2003-07-2202; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fadlelmola FM, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-2; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Farina A, 2008, J BIOL CHEM, V283, P20925, DOI 10.1074/jbc.M802696200; Farras R, 2008, MOL CELL BIOL, V28, P4173, DOI 10.1128/MCB.01620-07; Fuchs SY, 1997, J BIOL CHEM, V272, P32163, DOI 10.1074/jbc.272.51.32163; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Inoue A, 2007, CELL CYCLE, V6, P1646, DOI 10.4161/cc.6.13.4411; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; KOVARY K, 1991, MOL CELL BIOL, V11, P4466, DOI 10.1128/MCB.11.9.4466; Lallemand D, 1997, ONCOGENE, V14, P819, DOI 10.1038/sj.onc.1200901; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Mao X, 2003, BLOOD, V101, P1513, DOI 10.1182/blood-2002-08-2434; Mathas S, 2002, EMBO J, V21, P4104, DOI 10.1093/emboj/cdf389; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Mussolin L, 2010, PEDIATR BLOOD CANCER, V55, P446, DOI 10.1002/pbc.22550; Nagel S, 2008, LEUKEMIA, V22, P387, DOI 10.1038/sj.leu.2405028; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Parish JL, 2006, J CELL SCI, V119, P4857, DOI 10.1242/jcs.03262; Passegue E, 2001, CELL, V104, P21, DOI 10.1016/S0092-8674(01)00188-X; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Passegue E, 2002, NAT GENET, V30, P158, DOI 10.1038/ng790; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Piccaluga PP, 2010, ADV HEMATOL, DOI DOI 10.1155/2010/345053; Piechaczyk M, 2008, BIOCHEM SOC T, V36, P864, DOI 10.1042/BST0360864; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Rassidakis GZ, 2005, MODERN PATHOL, V18, P1365, DOI 10.1038/modpathol.3800419; Salaverria I, 2008, BRIT J HAEMATOL, V140, P516, DOI 10.1111/j.1365-2141.2007.06924.x; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Singh RR, 2009, CANCER RES, V69, P2550, DOI 10.1158/0008-5472.CAN-08-1808; Staber PB, 2007, BLOOD, V110, P3374, DOI 10.1182/blood-2007-02-071258; van der Lelij P, 2010, AM J HUM GENET, V86, P262, DOI 10.1016/j.ajhg.2010.01.008; Watanabe M, 2005, CANCER RES, V65, P7628, DOI 10.1158/0008-5472.CAN-05-0925; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Zettl A, 2004, AM J PATHOL, V164, P1837, DOI 10.1016/S0002-9440(10)63742-X	53	35	35	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2013	32	17					2189	2199		10.1038/onc.2012.235	http://dx.doi.org/10.1038/onc.2012.235			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	132JD	22710716				2022-12-25	WOS:000318062800008
J	Buey, RM; Sen, I; Kortt, O; Mohan, R; Gfeller, D; Veprintsev, D; Kretzschmar, I; Scheuermann, J; Neri, D; Zoete, V; Michielin, O; de Pereda, JM; Akhmanova, A; Volkmer, R; Steinmetz, MO				Buey, Ruben M.; Sen, Indrani; Kortt, Oliver; Mohan, Renu; Gfeller, David; Veprintsev, Dmitry; Kretzschmar, Ines; Scheuermann, Joerg; Neri, Dario; Zoete, Vincent; Michielin, Olivier; Maria de Pereda, Jose; Akhmanova, Anna; Volkmer, Rudolf; Steinmetz, Michel O.			Sequence Determinants of a Microtubule Tip Localization Signal (MtLS)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END-TRACKING PROTEINS; EUKARYOTIC LINEAR MOTIFS; PLUS-END; MEMBRANE SUPPORTS; PEPTIDE ARRAYS; SPOT SYNTHESIS; IN-VITRO; EB1; DYNAMICS; BINDING	Microtubule plus-end-tracking proteins (+TIPs) specifically localize to the growing plus-ends of microtubules to regulate microtubule dynamics and functions. A large group of +TIPs contain a short linear motif, SXIP, which is essential for them to bind to end-binding proteins (EBs) and target microtubule ends. The SXIP sequence site thus acts as a widespread microtubule tip localization signal (MtLS). Here we have analyzed the sequence-function relationship of a canonical MtLS. Using synthetic peptide arrays on membrane supports, we identified the residue preferences at each amino acid position of the SXIP motif and its surrounding sequence with respect to EB binding. We further developed an assay based on fluorescence polarization to assess the mechanism of the EB-SXIP interaction and to correlate EB binding and microtubule tip tracking of MtLS sequences from different +TIPs. Finally, we investigated the role of phosphorylation in regulating the EB-SXIP interaction. Together, our results define the sequence determinants of a canonical MtLS and provide the experimental data for bioinformatics approaches to carry out genome-wide predictions of novel +TIPs in multiple organisms.	[Buey, Ruben M.; Sen, Indrani; Veprintsev, Dmitry; Steinmetz, Michel O.] Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Kortt, Oliver; Kretzschmar, Ines; Volkmer, Rudolf] Charite, Inst Med Immunol, D-10117 Berlin, Germany; [Mohan, Renu; Akhmanova, Anna] Univ Utrecht, Fac Sci, Div Cell Biol, NL-3508 TC Utrecht, Netherlands; [Gfeller, David; Zoete, Vincent; Michielin, Olivier] Swiss Inst Bioinformat, Mol Modeling Grp, CH-1015 Lausanne, Switzerland; [Scheuermann, Joerg; Neri, Dario] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Dept Chem & Appl Biosci, CH-8092 Zurich, Switzerland; [Buey, Ruben M.; Maria de Pereda, Jose] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Salamanca 37007, Spain	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Utrecht University; Swiss Institute of Bioinformatics; Swiss Federal Institutes of Technology Domain; ETH Zurich; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Buey, RM (corresponding author), Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Salamanca 37007, Spain.	ruben.martinez@usal.es; michel.steinmetz@psi.ch	Steinmetz, Michel O/AAA-3349-2022; de Pereda, Jose M/F-1733-2010; Akhmanova, Anna S/B-8896-2011; Martinez-Buey, Ruben/K-4296-2014; Michielin, Olivier/ABE-7924-2020; gfeller, david/D-3395-2009; Veprintsev, Dmitry B/H-2228-2012; Scheuermann, Joerg/N-8693-2016; Neri, Dario/P-4368-2016; de Pereda, Jose M/AAE-5226-2022; Gfeller, David/A-6493-2019	Steinmetz, Michel O/0000-0001-6157-3687; de Pereda, Jose M/0000-0002-8912-6739; Akhmanova, Anna S/0000-0002-9048-8614; Martinez-Buey, Ruben/0000-0003-1263-0221; gfeller, david/0000-0002-3952-0930; Veprintsev, Dmitry B/0000-0002-3583-5409; Scheuermann, Joerg/0000-0001-7746-4717; Neri, Dario/0000-0001-5234-7370; de Pereda, Jose M/0000-0002-8912-6739; Gfeller, David/0000-0002-3952-0930; Volkmer, Rudolf/0000-0003-4710-1143	Federation of European Biochemical Societies (FEBS); Juan de la Cierva program; Marie Curie Career Integration grant (EB-SxIP) [293831]; Marie Curie IIF grant (MT-TIP Inhibitors) [253818]; EMBO grant; Swiss National Science Foundation [31003A_122545, 310030B_138659]	Federation of European Biochemical Societies (FEBS); Juan de la Cierva program; Marie Curie Career Integration grant (EB-SxIP); Marie Curie IIF grant (MT-TIP Inhibitors); EMBO grant(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a Federation of European Biochemical Societies (FEBS) postdoctoral fellowship and a contract from the Juan de la Cierva program and a Marie Curie Career Integration grant (EB-SxIP; 293831) (to R. M. B.), by a Marie Curie IIF grant (MT-TIP Inhibitors; 253818) (to R. M.), by an EMBO grant (to D. G.), and by Swiss National Science Foundation Grants 31003A_122545 and 310030B_138659 (to M. O. S.).	Abiatari I, 2009, INT J ONCOL, V35, P1111, DOI 10.3892/ijo_00000426; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Akhmanova A, 2010, J CELL SCI, V123, P3415, DOI 10.1242/jcs.062414; Applewhite DA, 2010, MOL BIOL CELL, V21, P1714, DOI 10.1091/mbc.E10-01-0011; Askham JM, 2000, ONCOGENE, V19, P1950, DOI 10.1038/sj.onc.1203498; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beinhauer JD, 1997, J CELL BIOL, V139, P717, DOI 10.1083/jcb.139.3.717; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Buey RM, 2011, MOL BIOL CELL, V22, P2912, DOI 10.1091/mbc.E11-01-0017; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; De Groot CO, 2010, J BIOL CHEM, V285, P5802, DOI 10.1074/jbc.M109.068130; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dong X, 2010, J PATHOL, V220, P361, DOI 10.1002/path.2662; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Gouveia SM, 2010, CURR BIOL, V20, P1717, DOI 10.1016/j.cub.2010.08.020; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Heald R, 2002, J CELL SCI, V115, P3; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Hsieh PC, 2007, ONCOGENE, V26, P4928, DOI 10.1038/sj.onc.1210304; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Jiang K, 2009, EMBO REP, V10, P857, DOI 10.1038/embor.2009.94; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Kumar P, 2012, J BIOL CHEM, V287, P17050, DOI 10.1074/jbc.M111.316661; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; Lee T, 2008, ONCOGENE, V27, P2494, DOI 10.1038/sj.onc.1210867; Li WJ, 2011, J CELL BIOL, V193, P973, DOI 10.1083/jcb.201101108; Liu M, 2009, MOL CARCINOGEN, V48, P212, DOI 10.1002/mc.20471; Lu Q, 2005, TRENDS BIOTECHNOL, V23, P199, DOI 10.1016/j.tibtech.2005.02.008; Martinez-Lopez MJ, 2005, MOL CELL NEUROSCI, V28, P599, DOI 10.1016/j.mcn.2004.09.016; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Olieric N, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-56; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Slep KC, 2010, CURR OPIN CELL BIOL, V22, P88, DOI 10.1016/j.ceb.2009.10.009; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; van der Spoel D, 2012, BIOINFORMATICS, V28, P752, DOI 10.1093/bioinformatics/bts020; van der Vaart B, 2011, J CELL BIOL, V193, P1083, DOI 10.1083/jcb.201012179; Volkmer R, 2009, CHEMBIOCHEM, V10, P1431, DOI 10.1002/cbic.200900078; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weiser AA, 2005, ANAL BIOCHEM, V342, P300, DOI 10.1016/j.ab.2005.04.033; Wenschuh H, 2000, BIOPOLYMERS, V55, P188, DOI 10.1002/1097-0282(2000)55:3<188::AID-BIP20>3.0.CO;2-T; Wu XS, 2005, J CELL BIOL, V171, P201, DOI 10.1083/jcb.200503028; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zimniak T, 2012, CURR BIOL, V22, P787, DOI 10.1016/j.cub.2012.03.007; Zimniak T, 2009, J CELL BIOL, V186, P379, DOI 10.1083/jcb.200901036; Zoete V, 2007, PROTEINS, V67, P1026, DOI 10.1002/prot.21395	55	34	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28227	28242		10.1074/jbc.M112.373928	http://dx.doi.org/10.1074/jbc.M112.373928			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22696216	hybrid, Green Published			2022-12-25	WOS:000308074600003
J	Boura, E; Ivanov, V; Carlson, LA; Mizuuchi, K; Hurley, JH				Boura, Evzen; Ivanov, Vassili; Carlson, Lars-Anders; Mizuuchi, Kiyoshi; Hurley, James H.			Endosomal Sorting Complex Required for Transport (ESCRT) Complexes Induce Phase-separated Microdomains in Supported Lipid Bilayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; UBIQUITIN RECOGNITION; MOLECULAR-MECHANISM; STRUCTURAL BASIS; PLASMA-MEMBRANE; III PROTEIN; CHOLESTEROL; CURVATURE; VESICLES; DOMAINS	The endosomal sorting complex required for transport (ESCRT) system traffics ubiquitinated cargo to lysosomes via an unusual membrane budding reaction that is directed away from the cytosol. Here, we show that human ESCRT-II self-assembles into clusters of 10-100 molecules on supported lipid bilayers. The ESCRT-II clusters are functional in that they bind to ubiquitin and the ESCRT-III subunit VPS20 at nanomolar concentrations on membranes with the same stoichiometries observed in solution and in crystals. The clusters only form when cholesterol is included in the lipid mixture at >10 mol %. The clusters induce the formation of ordered membrane domains that exclude the dye 1,1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbo-cyanine perchlorate. These results show that ESCRT complexes are capable of inducing lateral lipid phase separation under conditions where the lipids themselves do not spontaneously phase-separate. This property could facilitate ESCRT-mediated membrane budding.	[Boura, Evzen; Ivanov, Vassili; Carlson, Lars-Anders; Mizuuchi, Kiyoshi; Hurley, James H.] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hurley, JH (corresponding author), NIDDK, Mol Biol Lab, NIH, Bldg 50,Rm 4517, Bethesda, MD 20892 USA.	james.hurley@nih.gov	Boura, Evzen/G-5275-2014	Carlson, Lars-Anders/0000-0003-2342-6488; Boura, Evzen/0000-0002-9652-4065	National Institutes of Health Intramural Program, NIDDK; Intramural AIDS Targeted Anti-viral Program of the Office of the Director; Intramural AIDS Research Fellowship; Human Frontier Science Program postdoctoral fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036123] Funding Source: NIH RePORTER	National Institutes of Health Intramural Program, NIDDK; Intramural AIDS Targeted Anti-viral Program of the Office of the Director; Intramural AIDS Research Fellowship; Human Frontier Science Program postdoctoral fellowship(Human Frontier Science Program); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Program, NIDDK (to K. M. and J. H. H.), and the Intramural AIDS Targeted Anti-viral Program of the Office of the Director (to J. H. H.).; Supported by an Intramural AIDS Research Fellowship. Present address: Institute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic, Flemingovo nam. 2., 166 10 Praha 6, Czech Republic.; Supported by a Human Frontier Science Program postdoctoral fellowship.	Alam SL, 2006, NAT STRUCT MOL BIOL, V13, P1029, DOI 10.1038/nsmb1160; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Boura E, 2012, STRUCTURE, V20, P874, DOI 10.1016/j.str.2012.03.008; Boura E, 2011, P NATL ACAD SCI USA, V108, P9437, DOI 10.1073/pnas.1101763108; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Du XM, 2012, CELL REP, V1, P29, DOI 10.1016/j.celrep.2011.10.004; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Fyfe I, 2011, J BIOL CHEM, V286, P34262, DOI 10.1074/jbc.M111.266411; Gokhale NA, 2005, J BIOL CHEM, V280, P42831, DOI 10.1074/jbc.M508129200; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hanson PI, 2009, CURR OPIN CELL BIOL, V21, P568, DOI 10.1016/j.ceb.2009.06.002; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P1031, DOI 10.1038/nsmb1163; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Hurley JH, 2011, ANNU REV BIOPHYS, V40, P119, DOI 10.1146/annurev-biophys-042910-155404; Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030; Im YJ, 2008, DEV CELL, V14, P902, DOI 10.1016/j.devcel.2008.04.004; Im YJ, 2009, DEV CELL, V17, P234, DOI 10.1016/j.devcel.2009.07.008; Ivanov V, 2010, P NATL ACAD SCI USA, V107, P8071, DOI 10.1073/pnas.0911036107; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; LIPOWSKY R, 1992, J PHYS II, V2, P1825, DOI 10.1051/jp2:1992238; MacDonald C, 2012, EMBO REP, V13, P331, DOI 10.1038/embor.2012.18; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Mayers Jonathan R, 2012, Commun Integr Biol, V5, P50; McDonald B, 2009, J CELL SCI, V122, P2167, DOI 10.1242/jcs.028308; Mobius W, 2003, TRAFFIC, V4, P222; Murray DH, 2011, BIOCHEMISTRY-US, V50, P9014, DOI 10.1021/bi201307u; Murray DH, 2009, BIOCHEMISTRY-US, V48, P4617, DOI 10.1021/bi9003217; Nabhan JF, 2012, P NATL ACAD SCI USA, V109, P4146, DOI 10.1073/pnas.1200448109; Peck JW, 2004, BIOCHEM J, V377, P693, DOI 10.1042/bj20031347; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Sens P, 2008, CURR OPIN CELL BIOL, V20, P476, DOI 10.1016/j.ceb.2008.04.004; Shields SB, 2011, TRAFFIC, V12, P1306, DOI 10.1111/j.1600-0854.2011.01242.x; Teis D, 2010, EMBO J, V29, P871, DOI 10.1038/emboj.2009.408; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Tong J, 2008, BIOPHYS J, V94, P125, DOI 10.1529/biophysj.107.110536; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Veatch SL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.148101; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yorikawa C, 2005, BIOCHEM J, V387, P17, DOI 10.1042/BJ20041227	47	46	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28144	28151		10.1074/jbc.M112.378646	http://dx.doi.org/10.1074/jbc.M112.378646			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718754	Green Published, hybrid			2022-12-25	WOS:000307840700087
J	Little, SC; Biesiadecki, BJ; Kilic, A; Higgins, RSD; Janssen, PML; Davis, JP				Little, Sean C.; Biesiadecki, Brandon J.; Kilic, Ahmet; Higgins, Robert S. D.; Janssen, Paul M. L.; Davis, Jonathan P.			The Rates of Ca2+ Dissociation and Cross-bridge Detachment from Ventricular Myofibrils as Reported by a Fluorescent Cardiac Troponin C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-SENSITIZING MUTATIONS; LOAD-DEPENDENT KINETICS; SKELETAL-MUSCLE FIBERS; RATE-LIMITING STEP; RELAXATION KINETICS; PHOSPHATE RELEASE; FORCE DEVELOPMENT; STRIATED-MUSCLE; REGULATED ACTIN; HEART-FAILURE	The rate-limiting step of cardiac muscle relaxation has been proposed to reside in the myofilament. Both the rates of cross-bridge detachment and Ca2+ dissociation from troponin C (TnC) have been hypothesized to rate-limit myofilament inactivation. In this study we used a fluorescent TnC to measure both the rate of Ca2+ dissociation from TnC and the rate of cross-bridge detachment from several different species of ventricular myofibrils. The fluorescently labeled TnC was sensitive to both Ca2+ dissociation and cross-bridge detachment at low Ca2+ (presence of EGTA), allowing for a direct comparison between the two proposed rates of myofilament inactivation. Unlike Ca2+ dissociation from TnC, cross-bridge detachment varied in myofibrils from different species and was rate-limited by ADP release. At subphysiological temperatures (<20 degrees C), the rate of Ca2+ dissociation from TnC was faster than the rate of cross-bridge detachment in the presence of ADP. These results support the hypothesis that cross-bridge detachment rate-limits relaxation. However, Ca2+ dissociation from TnC was not as temperature-sensitive as cross-bridge detachment. At a near physiological temperature (35 degrees C) and ADP, the rate of cross-bridge detachment may actually be faster than the rate of Ca2+ dissociation. This provides evidence that there may not be a simple, single rate-limiting step of myofilament inactivation.	[Little, Sean C.; Biesiadecki, Brandon J.; Janssen, Paul M. L.; Davis, Jonathan P.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Kilic, Ahmet; Higgins, Robert S. D.] Ohio State Univ, Coll Med, Div Cardiac Surg, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Davis, JP (corresponding author), Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, 1645 Neil Ave, Columbus, OH 43210 USA.	davis.812@osu.edu	Higgins, Robert/AGZ-7064-2022; Janssen, Paul ML/E-3307-2011	Janssen, Paul/0000-0002-9682-3014	National Center for Research Resources Award [TL1RR025753, HL091986, HL091056, RC1 HL099538]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000090] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025753] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL091056, R00HL091056, RC1HL099538, R56HL091986, R01HL091986] Funding Source: NIH RePORTER	National Center for Research Resources Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Center for Research Resources Award TL1RR025753 and Grants HL091986 (to J.P.D., HL091056 (to B.J.B.), and RC1 HL099538 (to P.M.L.J.).	ALLEN DG, 1988, J PHYSIOL-LONDON, V407, P489, DOI 10.1113/jphysiol.1988.sp017427; BACKX PH, 1995, J GEN PHYSIOL, V105, P1, DOI 10.1085/jgp.105.1.1; Belus A, 2003, J MUSCLE RES CELL M, V24, P261; Belus A, 2008, J PHYSIOL-LONDON, V586, P3639, DOI 10.1113/jphysiol.2008.155952; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bloemink MJ, 2011, SEMIN CELL DEV BIOL, V22, P961, DOI 10.1016/j.semcdb.2011.09.015; Borrego-Diaz E, 2010, BIOPHYS J, V98, P2601, DOI 10.1016/j.bpj.2010.02.030; BRENNER B, 1995, BIOPHYS J, V68, pS106; Candau R, 2011, J MUSCLE RES CELL M, V32, P315, DOI 10.1007/s10974-011-9264-7; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; Davis JP, 2004, J BIOL CHEM, V279, P17348, DOI 10.1074/jbc.M314095200; de Tombe PP, 2007, J PHYSIOL-LONDON, V584, P591, DOI 10.1113/jphysiol.2007.138693; Dong WJ, 1996, J BIOL CHEM, V271, P688, DOI 10.1074/jbc.271.2.688; EISENBERG E, 1985, SCIENCE, V227, P999, DOI 10.1126/science.3156404; Fitzsimons DP, 1998, J PHYSIOL-LONDON, V513, P171, DOI 10.1111/j.1469-7793.1998.171by.x; Gillis TE, 2007, J PHYSIOL-LONDON, V580, P561, DOI 10.1113/jphysiol.2007.128975; Gordon AM, 2001, NEWS PHYSIOL SCI, V16, P49; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Greenberg MJ, 2010, P NATL ACAD SCI USA, V107, P17403, DOI 10.1073/pnas.1009619107; GROSSMAN W, 1990, EUR HEART J, V11, P2, DOI 10.1093/eurheartj/11.suppl_C.2; HAMILTON N, 1991, MOL CELL BIOCHEM, V106, P133; Han YS, 2011, CYTOSKELETON, V68, P18, DOI 10.1002/cm.20491; HANNON JD, 1992, CIRC RES, V71, P984, DOI 10.1161/01.RES.71.4.984; Hazard AL, 1998, PROTEIN SCI, V7, P2451, DOI 10.1002/pro.5560071123; HIBBERD MG, 1985, SCIENCE, V228, P1317, DOI 10.1126/science.3159090; HOUSMANS PR, 1983, SCIENCE, V221, P159, DOI 10.1126/science.6857274; Ingwall J. S., 2002, ATP HEART, P21; James J, 2010, J MOL CELL CARDIOL, V48, P999, DOI 10.1016/j.yjmcc.2009.10.013; Janssen PML, 2007, J MOL CELL CARDIOL, V43, P523, DOI 10.1016/j.yjmcc.2007.08.012; Janssen PML, 2002, AM J PHYSIOL-HEART C, V282, pH499, DOI 10.1152/ajpheart.00595.2001; Kad NM, 2003, J CELL BIOL, V162, P481, DOI 10.1083/jcb.200304023; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; Kreutziger KL, 2011, J MOL CELL CARDIOL, V50, P165, DOI 10.1016/j.yjmcc.2010.10.025; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Lee RS, 2010, AM J PHYSIOL-CELL PH, V299, pC1091, DOI 10.1152/ajpcell.00491.2009; Liang B, 2008, PHYSIOL GENOMICS, V33, P257, DOI 10.1152/physiolgenomics.00154.2007; Lionne C, 2003, J MUSCLE RES CELL M, V24, P139, DOI 10.1023/A:1026045328949; Lionne C, 2002, BIOCHEMISTRY-US, V41, P13297, DOI 10.1021/bi0260278; Liu JX, 2009, EXP PHYSIOL, V94, P117, DOI 10.1113/expphysiol.2008.043877; MARTIN H, 1994, BIOPHYS J, V66, P1115, DOI 10.1016/S0006-3495(94)80892-6; Martyn DA, 1999, BIOPHYS J, V76, P1480, DOI 10.1016/S0006-3495(99)77308-X; Maughan D, 1998, ADV EXP MED BIOL, V453, P471; McCurdy DT, 2001, AM J PHYSIOL-HEART C, V281, pH1390, DOI 10.1152/ajpheart.2001.281.3.H1390; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; Palmiter KA, 1999, J PHYSIOL-LONDON, V519, P669, DOI 10.1111/j.1469-7793.1999.0669n.x; Poggesi C, 2005, PFLUG ARCH EUR J PHY, V449, P505, DOI 10.1007/s00424-004-1363-5; Putkey JA, 1997, BIOCHEMISTRY-US, V36, P970, DOI 10.1021/bi9617466; SIEMANKOWSKI RF, 1984, J BIOL CHEM, V259, P5045; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; Simnett SJ, 1998, AM J PHYSIOL-HEART C, V275, pH951, DOI 10.1152/ajpheart.1998.275.3.H951; Solzin J, 2007, BIOPHYS J, V93, P3917, DOI 10.1529/biophysj.107.111146; Stehle R, 2009, PFLUG ARCH EUR J PHY, V458, P337, DOI 10.1007/s00424-008-0630-2; Sun YB, 2009, J PHYSIOL-LONDON, V587, P155, DOI 10.1113/jphysiol.2008.164707; Suzuki T, 2009, CIRC-HEART FAIL, V2, P334, DOI 10.1161/CIRCHEARTFAILURE.108.802298; Swartz DR, 1999, AM J PHYSIOL-HEART C, V276, pH1460, DOI 10.1152/ajpheart.1999.276.5.H1460; Tesi C, 2002, BIOPHYS J, V83, P2142, DOI 10.1016/S0006-3495(02)73974-X; Tikunova SB, 2004, J BIOL CHEM, V279, P35341, DOI 10.1074/jbc.M405413200; Tikunova SB, 2010, BIOCHEMISTRY-US, V49, P1975, DOI 10.1021/bi901867s; TRYBUS KM, 1980, P NATL ACAD SCI-BIOL, V77, P7209, DOI 10.1073/pnas.77.12.7209; VANBUREN P, 1995, CIRC RES, V77, P439, DOI 10.1161/01.RES.77.2.439; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; YATES LD, 1983, J MOL BIOL, V168, P123, DOI 10.1016/S0022-2836(83)80326-X; ZOT AS, 1989, BIOCHEMISTRY-US, V28, P6751, DOI 10.1021/bi00442a031	64	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27930	27940		10.1074/jbc.M111.337295	http://dx.doi.org/10.1074/jbc.M111.337295			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718768	hybrid, Green Published			2022-12-25	WOS:000307840700067
J	Lu, HL; Efremov, AK; Bookwalter, CS; Krementsova, EB; Driver, JW; Trybus, KM; Diehl, MR				Lu, Hailong; Efremov, Artem K.; Bookwalter, Carol S.; Krementsova, Elena B.; Driver, Jonathan W.; Trybus, Kathleen M.; Diehl, Michael R.			Collective Dynamics of Elastically Coupled Myosin V Motors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE KINESIN MOLECULES; HAND-OVER-HAND; IN-VITRO; INTRACELLULAR-TRANSPORT; CARGO TRANSPORT; COORDINATION; MICROTUBULES; MOVEMENT; PROCESSIVITY; PROTEINS	Characterization of the collective behaviors of different classes of processive motor proteins has become increasingly important to understand various intracellular trafficking and transport processes. This work examines the dynamics of structurally-defined motor complexes containing two myosin Va (myoVa) motors that are linked together via a molecular scaffold formed from a single duplex of DNA. Dynamic changes in the filament-bound configuration of these complexes due to motor binding, stepping, and detachment were monitored by tracking the positions of different color quantum dots that report the position of one head of each myoVa motor on actin. As in studies of multiple kinesins, the run lengths produced by two myosins are only slightly larger than those of single motor molecules. This suggests that internal strain within the complexes, due to asynchronous motor stepping and the resultant stretching of motor linkages, yields net negative cooperative behaviors. In contrast to multiple kinesins, multiple myosin complexes move with appreciably lower velocities than a single-myosin molecule. Although similar trends are predicted by a discrete state stochastic model of collective motor dynamics, these analyses also suggest that multiple myosin velocities and run lengths depend on both the compliance and the effective size of their cargo. Moreover, it is proposed that this unique collective behavior occurs because the large step size and relatively small stalling force of myoVa leads to a high sensitivity of motor stepping rates to strain.	[Trybus, Kathleen M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Efremov, Artem K.; Driver, Jonathan W.; Diehl, Michael R.] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Efremov, Artem K.; Diehl, Michael R.] Rice Univ, Dept Chem, Houston, TX 77005 USA	University of Vermont; Rice University; Rice University	Trybus, KM (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.	kathleen.trybus@uvm.edu; diehl@rice.edu	lu, hailong/C-7754-2009	Efremov, Artem/0000-0002-1603-610X	National Institutes of Health [GM078097, 1R01GM094489-01]; National Science Foundation [MCB-0643832]; Welch Foundation [C-1625]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078097, R01GM094489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM078097 (to K. M. T.) and 1R01GM094489-01 (to M. R. D.). This work was also supported by the National Science Foundation (MCB-0643832), and the Welch Foundation (C-1625 to M. R. D.).	Ali MY, 2008, P NATL ACAD SCI USA, V105, P4691, DOI 10.1073/pnas.0711531105; Ali MY, 2011, P NATL ACAD SCI USA, V108, pE535, DOI 10.1073/pnas.1104298108; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; Diehl MR, 2006, SCIENCE, V311, P1468, DOI 10.1126/science.1122125; Driver JW, 2011, BIOPHYS J, V101, P386, DOI 10.1016/j.bpj.2011.05.067; Driver JW, 2010, PHYS CHEM CHEM PHYS, V12, P10398, DOI 10.1039/c0cp00117a; Fisher ME, 2001, P NATL ACAD SCI USA, V98, P7748, DOI 10.1073/pnas.141080498; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Jamison DK, 2012, J BIOL CHEM, V287, P3357, DOI 10.1074/jbc.M111.296582; Jamison DK, 2010, BIOPHYS J, V99, P2967, DOI 10.1016/j.bpj.2010.08.025; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Klumpp S, 2005, P NATL ACAD SCI USA, V102, P17284, DOI 10.1073/pnas.0507363102; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Laib JA, 2009, P NATL ACAD SCI USA, V106, P3190, DOI 10.1073/pnas.0809849106; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Purcell TJ, 2005, P NATL ACAD SCI USA, V102, P13873, DOI 10.1073/pnas.0506441102; Rogers AR, 2009, PHYS CHEM CHEM PHYS, V11, P4882, DOI 10.1039/b900964g; Rogers SL, 1997, P NATL ACAD SCI USA, V94, P3720, DOI 10.1073/pnas.94.8.3720; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Rovner AS, 2006, BIOCHEMISTRY-US, V45, P5280, DOI 10.1021/bi060154c; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Schweller RM, 2008, BIOCONJUGATE CHEM, V19, P2304, DOI 10.1021/bc8003606; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; Uemura S, 2004, NAT STRUCT MOL BIOL, V11, P877, DOI 10.1038/nsmb806; Warshaw DM, 2005, BIOPHYS J, V88, pL30, DOI 10.1529/biophysj.105.061903; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	31	42	42	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27753	27761		10.1074/jbc.M112.371393	http://dx.doi.org/10.1074/jbc.M112.371393			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718762	Green Published, hybrid			2022-12-25	WOS:000307840700049
J	Daee, DL; Ferrari, E; Longerich, S; Zheng, XF; Xue, XY; Branzei, D; Sung, P; Myung, K				Daee, Danielle L.; Ferrari, Elisa; Longerich, Simonne; Zheng, Xiao-feng; Xue, Xiaoyu; Branzei, Dana; Sung, Patrick; Myung, Kyungjae			Rad5-dependent DNA Repair Functions of the Saccharomyces cerevisiae FANCM Protein Homolog Mph1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERSTRAND CROSS-LINKS; CELL NUCLEAR ANTIGEN; FREE POSTREPLICATION REPAIR; STALLED REPLICATION FORKS; STRAND BREAK REPAIR; GROSS CHROMOSOMAL REARRANGEMENTS; NUCLEOTIDE EXCISION-REPAIR; UBIQUITIN LIGASE; RAD6 PATHWAY; ERROR-PRONE	Interstrand cross-links (ICLs) covalently link complementary DNA strands, block DNA replication, and transcription and must be removed to allow cell survival. Several pathways, including the Fanconi anemia (FA) pathway, can faithfully repair ICLs and maintain genomic integrity; however, the precise mechanisms of most ICL repair processes remain enigmatic. In this study we genetically characterized a conserved yeast ICL repair pathway composed of the yeast homologs (Mph1, Chl1, Mhf1, Mhf2) of four FA proteins (FANCM, FANCJ, MHF1, MHF2). This pathway is epistatic with Rad5-mediated DNA damage bypass and distinct from the ICL repair pathways mediated by Rad18 and Pso2. In addition, consistent with the FANCM role in stabilizing ICL-stalled replication forks, we present evidence that Mph1 prevents ICL-stalled replication forks from collapsing into double-strand breaks. This unique repair function of Mph1 is specific for ICL damage and does not extend to other types of damage. These studies reveal the functional conservation of the FA pathway and validate the yeast model for future studies to further elucidate the mechanism of the FA pathway.	[Daee, Danielle L.; Myung, Kyungjae] NHGRI, Genome Instabil Sect, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; [Ferrari, Elisa; Branzei, Dana] Fdn IFOM, Ist FIRC Oncol Mol, I-20139 Milan, Italy; [Longerich, Simonne; Zheng, Xiao-feng; Xue, Xiaoyu; Sung, Patrick] Yale Univ, Dept Mol Biophys & Biochem, Sch Med, New Haven, CT 06520 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); IFOM - FIRC Institute of Molecular Oncology; Yale University	Myung, K (corresponding author), NHGRI, Genome Instabil Sect, Genet & Mol Biol Branch, NIH, 49 Convent Dr, Bethesda, MD 20892 USA.	kmyung@mail.nih.gov	Branzei, Dana/GOG-9093-2022; xue, xiaoyu/G-9574-2012; Branzei, Dana/A-2806-2015	Branzei, Dana/0000-0002-0544-4888; Branzei, Dana/0000-0002-0544-4888; Zheng, Xiao-Feng/0000-0001-8769-4604	National Institutes of Health Grant [HG012003-09]; European Research Council Grant [REPSUBREP 242928]; Associazione Italiana per la Ricerca sul Cancuro Grant [IG 10637]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG012003, Z01HG012003] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council Grant(European Research Council (ERC)); Associazione Italiana per la Ricerca sul Cancuro Grant(Fondazione AIRC per la ricerca sul cancro); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by National Institutes of Health Grant HG012003-09 (National Human Genome Research Institute; to K. M.). This work was also supported by European Research Council Grant REPSUBREP 242928 and Associazione Italiana per la Ricerca sul Cancuro Grant IG 10637 (to D. B.).	Atkinson J, 2009, NUCLEIC ACIDS RES, V37, P3475, DOI 10.1093/nar/gkp244; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Ball LG, 2009, MOL MICROBIOL, V73, P89, DOI 10.1111/j.1365-2958.2009.06748.x; Banerjee S, 2008, J CELL BIOL, V181, P1083, DOI 10.1083/jcb.200711146; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; Branzei D, 2008, NATURE, V456, P915, DOI 10.1038/nature07587; Broomfield S, 2002, NUCLEIC ACIDS RES, V30, P732, DOI 10.1093/nar/30.3.732; Chavez A, 2010, J BIOL CHEM, V285, P11922, DOI 10.1074/jbc.M109.041277; Chen CC, 2007, J MOL MED, V85, P497, DOI 10.1007/s00109-006-0153-2; Chen S, 2005, NUCLEIC ACIDS RES, V33, P5878, DOI 10.1093/nar/gki902; Chen YH, 2009, P NATL ACAD SCI USA, V106, P21252, DOI 10.1073/pnas.0908258106; Choi KY, 2010, MOL BIOL CELL, V21, P2306, DOI 10.1091/mbc.E10-01-0050; Daigaku Y, 2010, NATURE, V465, P951, DOI 10.1038/nature09097; Das-Bradoo S, 2010, NAT CELL BIOL, V12, P74, DOI 10.1038/ncb2007; Donahue SL, 2003, J BIOL CHEM, V278, P29487, DOI 10.1074/jbc.M213251200; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; Evdokimova VN, 2005, AM J MED GENET A, V135A, P59, DOI 10.1002/ajmg.a.30687; Gari K, 2008, MOL CELL, V29, P141, DOI 10.1016/j.molcel.2007.11.032; GEIDUSCH.E, 1961, P NATL ACAD SCI USA, V47, P950, DOI 10.1073/pnas.47.7.950; GERRING SL, 1990, EMBO J, V9, P4347, DOI 10.1002/j.1460-2075.1990.tb07884.x; Grossmann KF, 2001, MUTAT RES-DNA REPAIR, V487, P73, DOI 10.1016/S0921-8777(01)00106-9; Hazlehurst LA, 2003, CANCER RES, V63, P7900; Helleday T, 1998, CARCINOGENESIS, V19, P973, DOI 10.1093/carcin/19.6.973; Hinz JM, 2010, ENVIRON MOL MUTAGEN, V51, P582, DOI 10.1002/em.20577; Hlavin EM, 2010, ENVIRON MOL MUTAGEN, V51, P604, DOI 10.1002/em.20559; Ho V, 2010, ENVIRON MOL MUTAGEN, V51, P552, DOI 10.1002/em.20573; HUANG H, 1993, J AM CHEM SOC, V115, P9402, DOI 10.1021/ja00074a005; Hwang JY, 2008, DNA REPAIR, V7, P1426, DOI 10.1016/j.dnarep.2008.05.006; Kao WH, 2011, J INVEST DERMATOL, V131, P2139, DOI 10.1038/jid.2011.181; Karras GI, 2010, CELL, V141, P255, DOI 10.1016/j.cell.2010.02.028; Kats ES, 2009, MOL CELL BIOL, V29, P5226, DOI 10.1128/MCB.00894-09; Kitao H, 2011, INT J HEMATOL, V93, P417, DOI 10.1007/s12185-011-0777-z; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krijger PHL, 2011, DNA REPAIR, V10, P438, DOI 10.1016/j.dnarep.2010.12.008; Lage C, 2003, MUTAT RES-REV MUTAT, V544, P143, DOI 10.1016/j.mrrev.2003.06.003; Laha S, 2006, NUCLEIC ACIDS RES, V34, P5880, DOI 10.1093/nar/gkl749; Lawley PD, 1996, MUTAT RES-FUND MOL M, V355, P13, DOI 10.1016/0027-5107(96)00020-6; Legerski RJ, 2010, ENVIRON MOL MUTAGEN, V51, P540, DOI 10.1002/em.20566; Liefshitz B, 1998, MUTAT RES-DNA REPAIR, V407, P135, DOI 10.1016/S0921-8777(97)00070-0; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mace-Aime G, 2010, ENVIRON MOL MUTAGEN, V51, P508, DOI 10.1002/em.20548; MAGANASCHWENCKE N, 1982, P NATL ACAD SCI-BIOL, V79, P1722, DOI 10.1073/pnas.79.6.1722; Malagon F, 1996, CURR GENET, V30, P101, DOI 10.1007/s002940050107; McHugh PJ, 2001, LANCET ONCOL, V2, P483, DOI 10.1016/S1470-2045(01)00454-5; McHugh PJ, 2000, MOL CELL BIOL, V20, P3425, DOI 10.1128/MCB.20.10.3425-3433.2000; Mcvey M, 2010, ENVIRON MOL MUTAGEN, V51, P646, DOI 10.1002/em.20551; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Minca EC, 2010, MOL CELL, V38, P649, DOI 10.1016/j.molcel.2010.03.020; Moertl S, 2008, DNA REPAIR, V7, P1893, DOI 10.1016/j.dnarep.2008.07.016; Motegi A, 2006, MOL CELL BIOL, V26, P1424, DOI 10.1128/MCB.26.4.1424-1433.2006; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Motegi A, 2006, J CELL BIOL, V175, P703, DOI 10.1083/jcb.200606145; Muniandy PA, 2010, CRIT REV BIOCHEM MOL, V45, P23, DOI 10.3109/10409230903501819; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Myung K, 2003, DNA REPAIR, V2, P243, DOI 10.1016/S1568-7864(02)00216-1; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; OCONNOR PM, 1990, CANCER COMMUN, V2, P387, DOI 10.3727/095535490820873949; Ohashi A, 2005, J BIOL CHEM, V280, P14877, DOI 10.1074/jbc.M414669200; Panico ER, 2010, YEAST, V27, P11, DOI 10.1002/yea.1727; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Rahn JJ, 2010, ENVIRON MOL MUTAGEN, V51, P567, DOI 10.1002/em.20583; ROBERTS JJ, 1982, CHEM-BIOL INTERACT, V39, P181, DOI 10.1016/0009-2797(82)90120-X; SALATREPAT M, 1993, MUTAT RES, V289, P115, DOI 10.1016/0027-5107(93)90137-5; Sarkar S, 2006, EMBO J, V25, P1285, DOI 10.1038/sj.emboj.7600993; Schmidt KH, 2010, EUKARYOT CELL, V9, P315, DOI 10.1128/EC.00260-09; Schurer KA, 2004, GENETICS, V166, P1673, DOI 10.1534/genetics.166.4.1673; Shen X, 2010, ENVIRON MOL MUTAGEN, V51, P493, DOI 10.1002/em.20558; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Sun W, 2008, MOL CELL, V32, P118, DOI 10.1016/j.molcel.2008.08.024; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Thyagarajan B, 1997, J BIOL CHEM, V272, P23328, DOI 10.1074/jbc.272.37.23328; Ulrich HD, 2003, J BIOL CHEM, V278, P7051, DOI 10.1074/jbc.M212195200; Ulrich HD, 2001, NUCLEIC ACIDS RES, V29, P3487, DOI 10.1093/nar/29.17.3487; Unk I, 2008, P NATL ACAD SCI USA, V105, P3768, DOI 10.1073/pnas.0800563105; Unk I, 2006, P NATL ACAD SCI USA, V103, P18107, DOI 10.1073/pnas.0608595103; Vanoli F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001205; Vasquez KM, 2010, ENVIRON MOL MUTAGEN, V51, P527, DOI 10.1002/em.20557; WILBORN F, 1989, CURR GENET, V16, P331, DOI 10.1007/BF00340711; Wood RD, 2010, ENVIRON MOL MUTAGEN, V51, P520, DOI 10.1002/em.20569; Wu HI, 2004, CANCER RES, V64, P3940, DOI 10.1158/0008-5472.CAN-03-3113; Wu Y, 2009, CELL MOL LIFE SCI, V66, P1209, DOI 10.1007/s00018-008-8580-6; Xiao W, 2000, GENETICS, V155, P1633; Yamamoto K, 2005, MOL CELL BIOL, V25, P34, DOI 10.1128/MCB.25.1.34-43.2005; Yamamoto K, 2003, MOL CELL BIOL, V23, P5421, DOI 10.1128/MCB.23.15.5421-5430.2003; Yan ZJ, 2010, MOL CELL, V37, P865, DOI 10.1016/j.molcel.2010.01.039; Yuan FH, 2010, FRONT BIOSCI-LANDMRK, V15, P1131, DOI 10.2741/3666; Zheng XF, 2011, DNA REPAIR, V10, P1034, DOI 10.1016/j.dnarep.2011.08.002	90	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26563	26575		10.1074/jbc.M112.369918	http://dx.doi.org/10.1074/jbc.M112.369918			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22696213	Green Published, hybrid			2022-12-25	WOS:000307386000009
J	Fonollosa, J; Gutierrez-Galvez, A; Marco, S				Fonollosa, Jordi; Gutierrez-Galvez, Agustin; Marco, Santiago			Quality Coding by Neural Populations in the Early Olfactory Pathway: Analysis Using Information Theory and Lessons for Artificial Olfactory Systems	PLOS ONE			English	Article							ODORANT RECEPTORS; GLOMERULAR LAYER; RESPONSES; CELLS; NEURONS; ARRAYS; CODES; MAP	In this article, we analyze the ability of the early olfactory system to detect and discriminate different odors by means of information theory measurements applied to olfactory bulb activity images. We have studied the role that the diversity and number of receptor neuron types play in encoding chemical information. Our results show that the olfactory receptors of the biological system are low correlated and present good coverage of the input space. The coding capacity of ensembles of olfactory receptors with the same receptive range is maximized when the receptors cover half of the odor input space -a configuration that corresponds to receptors that are not particularly selective. However, the ensemble's performance slightly increases when mixing uncorrelated receptors of different receptive ranges. Our results confirm that the low correlation between sensors could be more significant than the sensor selectivity for general purpose chemo-sensory systems, whether these are biological or biomimetic.	[Fonollosa, Jordi; Gutierrez-Galvez, Agustin; Marco, Santiago] Univ Barcelona, Dept Elect, Barcelona, Spain; [Fonollosa, Jordi; Gutierrez-Galvez, Agustin; Marco, Santiago] Inst Bioengn Catalonia, Artificial Olfact Grp, Barcelona, Spain	University of Barcelona; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya	Fonollosa, J (corresponding author), Univ Barcelona, Dept Elect, Barcelona, Spain.	smarco@ibecbarcelona.eu	Fonollosa, Jordi/L-2303-2014; marco, santiago/A-6111-2009; Fonollosa, Jordi/AAF-5152-2019; marco, santiago/H-3203-2019	Fonollosa, Jordi/0000-0001-8854-8588; marco, santiago/0000-0003-2663-2965; Fonollosa, Jordi/0000-0001-8854-8588; marco, santiago/0000-0003-2663-2965	European Project NEUROCHEM [FP7-216916]; Spanish project SMART-IMS [TEC2011-26143]; Spanish project BIOENCODE [TEC2011-26988]; Generalitat de Catalunya [2009SGR-0753]	European Project NEUROCHEM; Spanish project SMART-IMS; Spanish project BIOENCODE; Generalitat de Catalunya(Generalitat de Catalunya)	The authors are members of a consolidated research group by the Generalitat de Catalunya (2009SGR-0753). This work has been partially funded by European Project NEUROCHEM: Biologically Inspired Computation for Chemical Sensing (FP7-216916), and Spanish projects SMART-IMS (TEC2011-26143) and BIOENCODE (TEC2011-26988). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkasab TK, 2002, CHEM SENSES, V27, P261, DOI 10.1093/chemse/27.3.261; Alkasab TK, 1999, TRENDS NEUROSCI, V22, P102, DOI 10.1016/S0166-2236(98)01351-4; Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Araneda RC, 2004, J PHYSIOL-LONDON, V555, P743, DOI 10.1113/jphysiol.2003.058040; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Baud O, 2011, BIOCHEMISTRY-US, V50, P843, DOI 10.1021/bi1017396; Beccherelli R, 2010, SENSOR ACTUAT B-CHEM, V146, P446, DOI 10.1016/j.snb.2009.11.031; Berna AZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006406; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Cleland TA, 2007, P NATL ACAD SCI USA, V104, P1953, DOI 10.1073/pnas.0608564104; Di Natale C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003139; Duchamp-Viret P, 1999, SCIENCE, V284, P2171, DOI 10.1126/science.284.5423.2171; Fonollosa J, 2011, PROCEDIA COMPUT SCI, V7, P226, DOI 10.1016/j.procs.2011.09.066; GARDNER JW, 1994, SENSOR ACTUAT B-CHEM, V18, P211; Grosmaitre X, 2009, J NEUROSCI, V29, P14545, DOI 10.1523/JNEUROSCI.2752-09.2009; Haddad R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040018; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hamana H, 2003, CHEM SENSES, V28, P87, DOI 10.1093/chemse/28.2.87; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Johnson BA, 1999, J COMP NEUROL, V409, P529; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Johnson BA, 2007, J COMP NEUROL, V503, P1, DOI 10.1002/cne.21396; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Kostal L, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000053; Kraskov A, 2004, PHYS REV E, V69; Leon M, 2003, BRAIN RES REV, V42, P23, DOI 10.1016/S0165-0173(03)00142-5; Leon M, 2009, CELL MOL LIFE SCI, V66, P2135, DOI 10.1007/s00018-009-0011-9; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Moddemeijer R, 1999, SIGNAL PROCESS, V75, P51, DOI 10.1016/S0165-1684(98)00224-2; Mori K, 2003, BIOCHEM SOC T, V31, P134, DOI 10.1042/bst0310134; Nara K, 2011, J NEUROSCI, V31, P9179, DOI 10.1523/JNEUROSCI.1282-11.2011; Raman B, 2010, J NEUROSCI, V30, P1994, DOI 10.1523/JNEUROSCI.5639-09.2010; Reisert J, 2009, CHEM SENSES, V34, P535, DOI 10.1093/chemse/bjp028; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Ruderman DL, 1998, J OPT SOC AM A, V15, P2036, DOI 10.1364/JOSAA.15.002036; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sanchez-Montanes MA, 2002, BIOSYSTEMS, V67, P229, DOI 10.1016/S0303-2647(02)00081-3; SICARD G, 1984, BRAIN RES, V292, P283, DOI 10.1016/0006-8993(84)90764-9; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Ulmer H, 2000, SENSOR ACTUAT B-CHEM, V65, P79, DOI 10.1016/S0925-4005(99)00330-5; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; ZEKI S, 1983, NEUROSCIENCE, V9, P741, DOI 10.1016/0306-4522(83)90265-8; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	45	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37809	10.1371/journal.pone.0037809	http://dx.doi.org/10.1371/journal.pone.0037809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719851	gold, Green Published			2022-12-25	WOS:000305583300013
J	Morrey, JD; Siddharthan, V; Wang, H; Hall, JO				Morrey, John D.; Siddharthan, Venkatraman; Wang, Hong; Hall, Jeffery O.			Respiratory Insufficiency Correlated Strongly with Mortality of Rodents Infected with West Nile Virus	PLOS ONE			English	Article							HUMANIZED MONOCLONAL-ANTIBODY; EASTERN EQUINE ENCEPHALITIS; ACUTE FLACCID PARALYSIS; HAMSTER MODEL; UNITED-STATES; BRAIN; MICE; OUTCOMES; PERMEABILITY; NEURONS	West Nile virus (WNV) disease can be fatal for high-risk patients. Since WNV or its antigens have been identified in multiple anatomical locations of the central nervous system of persons or rodent models, one cannot know where to investigate the actual mechanism of mortality without careful studies in animal models. In this study, depressed respiratory functions measured by plethysmography correlated strongly with mortality. This respiratory distress, as well as reduced oxygen saturation, occurred beginning as early as 4 days before mortality. Affected medullary respiratory control cells may have contributed to the animals' respiratory insufficiency, because WNV antigen staining was present in neurons located in the ventrolateral medulla. Starvation or dehydration would be irrelevant in people, but could cause death in rodents due to lethargy or loss of appetite. Animal experiments were performed to exclude this possibility. Plasma ketones were increased in moribund infected hamsters, but late-stage starvation markers were not apparent. Moreover, daily subcutaneous administration of 5% dextrose in physiological saline solution did not improve survival or other disease signs. Therefore, infected hamsters did not die from starvation or dehydration. No cerebral edema was apparent in WNV- or sham-infected hamsters as determined by comparing wet-to-total weight ratios of brains, or by evaluating blood-brain-barrier permeability using Evans blue dye penetration into brains. Limited vasculitis was present in the right atrium of the heart of infected hamsters, but abnormal electrocardiograms for several days leading up to mortality did not occur. Since respiratory insufficiency was strongly correlated with mortality more than any other pathological parameter, it is the likely cause of death in rodents. These animal data and a poor prognosis for persons with respiratory insufficiency support the hypothesis that neurological lesions affecting respiratory function may be the primary cause of human WNV-induced death.	[Morrey, John D.; Siddharthan, Venkatraman; Wang, Hong; Hall, Jeffery O.] Utah State Univ, Dept Anim Dairy & Vet Sci, Inst Antiviral Res, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Morrey, JD (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, Inst Antiviral Res, Logan, UT 84322 USA.	john.morrey@usu.edu			Rocky Mountain Regional Centers of Excellence, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) [U54 AI-065357]; Virology Branch, NIAID, NIH [HHSN272201000039I]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357] Funding Source: NIH RePORTER	Rocky Mountain Regional Centers of Excellence, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); Virology Branch, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U54 AI-065357 Rocky Mountain Regional Centers of Excellence, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) by supplying labor, supplies, and instrumentation, and HHSN272201000039I Virology Branch, NIAID, NIH by supplying essential instrumentation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agamanolis DP, 2003, ANN NEUROL, V54, P547, DOI 10.1002/ana.10731; Bagic A, 2007, EPILEPTIC DISORD, V9, P98; Bates J, 2004, AM J RESP CELL MOL, V31, P373, DOI 10.1165/ajrcmb.31.3.1; Berdanier, 2000, ADV NUTR MACRONUTRIE; Bode AV, 2006, CLIN INFECT DIS, V42, P1234, DOI 10.1086/503038; Carson PJ, 2006, CLIN INFECT DIS, V43, P723, DOI 10.1086/506939; Doron SI, 2003, CLIN INFECT DIS, V37, pE74, DOI 10.1086/377177; Fratkin JD, 2004, ARCH PATHOL LAB MED, V128, P533; Gardner CL, 2011, P NATL ACAD SCI USA, V108, P16026, DOI 10.1073/pnas.1110617108; Getts DR, 2007, J NEUROCHEM, V103, P1019, DOI 10.1111/j.1471-4159.2007.04798.x; Gowen BB, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-240; Groeben H, 2003, BRIT J ANAESTH, V91, P541, DOI 10.1093/bja/aeg222; Hoffer LJ, 2006, MODERN NUTR HLTH DIS, P730; Hunsperger EA, 2006, J NEUROVIROL, V12, P129, DOI 10.1080/13550280600758341; Lanciotti RS, 2001, J CLIN MICROBIOL, V39, P4506, DOI 10.1128/JCM.39.12.4506-4513.2001; Lanciotti RS, 2002, VIROLOGY, V298, P96, DOI 10.1006/viro.2002.1449; Leis A Arturo, 2005, Curr Treat Options Neurol, V7, P15, DOI 10.1007/s11940-005-0002-6; Lindsey Nicole P., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mandel DA, 2006, J PHYSIOL-LONDON, V572, P881, DOI 10.1113/jphysiol.2005.103622; Mongue-Din H, 2009, AM J PHYSIOL-REG I, V296, pR610, DOI 10.1152/ajpregu.90376.2008; Morrey JD, 2004, ANTIVIR RES, V63, P41, DOI 10.1016/j.antiviral.2004.02.005; Morrey JD, 2008, J NEUROVIROL, V14, P152, DOI 10.1080/13550280801958930; Morrey JD, 2008, J GEN VIROL, V89, P467, DOI 10.1099/vir.0.83345-0; Morrey JD, 2007, ANTIMICROB AGENTS CH, V51, P2396, DOI 10.1128/AAC.00147-07; Morrey JD, 2006, J INFECT DIS, V194, P1300, DOI 10.1086/508293; Morrey JD, 2010, J NEUROVIROL, V16, P318, DOI 10.3109/13550284.2010.501847; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Paessler S, 2004, J INFECT DIS, V189, P2072, DOI 10.1086/383246; Saad M, 2005, J INFECTION, V51, P120, DOI 10.1016/j.jinf.2004.10.005; Sampson BA, 2000, HUM PATHOL, V31, P527, DOI 10.1053/hp.2000.8047; Sejvar JJ, 2007, CLIN INFECT DIS, V44, P1617, DOI 10.1086/518281; Sejvar JJ, 2008, J NEUROPSYCHOL, V2, P477, DOI 10.1348/174866407X218312; Sejvar JJ, 2006, EMERG INFECT DIS, V12, P514, DOI 10.3201/eid1203.050643; Sgoifo A, 1996, PHYSIOL BEHAV, V60, P1397, DOI 10.1016/S0031-9384(96)00228-4; Shpall AI, 2003, UROLOGY, V61, DOI 10.1016/S0090-4295(03)00119-5; Siddharthan V, 2009, J VIROL, V83, P4251, DOI 10.1128/JVI.00017-09; SIDWELL RW, 1992, ANTIMICROB AGENTS CH, V36, P473, DOI 10.1128/AAC.36.2.473; Smee DF, 2010, ANTIVIR RES, V88, P38, DOI 10.1016/j.antiviral.2010.07.003; Smeraski CA, 2011, ANTIVIR RES, V91, P43, DOI 10.1016/j.antiviral.2011.04.011; Wang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019575; Wang H, 2009, J NEUROVIROL, V15, P293, DOI 10.1080/13550280902973978; Weiss D, 2001, EMERG INFECT DIS, V7, P654, DOI 10.3201/eid0704.010409; Xiao SY, 2001, EMERG INFECT DIS, V7, P714; Yudkoff M, 2001, J NEUROSCI RES, V66, P272, DOI 10.1002/jnr.1221	44	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38672	10.1371/journal.pone.0038672	http://dx.doi.org/10.1371/journal.pone.0038672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719920	gold, Green Published			2022-12-25	WOS:000305347800012
J	Callens, M; Tops, W; Brysbaert, M				Callens, Maaike; Tops, Wim; Brysbaert, Marc			Cognitive Profile of Students Who Enter Higher Education with an Indication of Dyslexia	PLOS ONE			English	Article							POSTSECONDARY STUDENTS; DEVELOPMENTAL DYSLEXIA; CHILDREN; ADULTS; SKILLS; DISABILITIES; METAANALYSIS; ACQUISITION; PREVALENCE; DIAGNOSES	For languages other than English there is a lack of empirical evidence about the cognitive profile of students entering higher education with a diagnosis of dyslexia. To obtain such evidence, we compared a group of 100 Dutch-speaking students diagnosed with dyslexia with a control group of 100 students without learning disabilities. Our study showed selective deficits in reading and writing (effect sizes for accuracy between d = 1 and d = 2), arithmetic (d approximate to 1), and phonological processing (d>0.7). Except for spelling, these deficits were larger for speed related measures than for accuracy related measures. Students with dyslexia also performed slightly inferior on the KAIT tests of crystallized intelligence, due to the retrieval of verbal information from long-term memory. No significant differences were observed in the KAIT tests of fluid intelligence. The profile we obtained agrees with a recent meta-analysis of English findings suggesting that it generalizes to all alphabetic languages. Implications for special arrangements for students with dyslexia in higher education are outlined.	[Callens, Maaike; Tops, Wim; Brysbaert, Marc] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium	Ghent University	Callens, M (corresponding author), Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium.	maaike.callens@ugent.be	Brysbaert, Marc/A-3910-2011	Brysbaert, Marc/0000-0002-3645-3189; Tops, Wim/0000-0002-7889-8610				Borgwaldt S, 2004, AUST J PSYCHOL, V56, P106; Brus B, 1991, MINUUT TEST VORM A B; Bruyer R, 2011, PSYCHOL BELG, V51, P5, DOI 10.5334/pb-51-1-5; Brysbaert M., 2011, BASIC STAT PSYCHOL; Campbell JID, 2002, BEHAV RES METH INS C, V34, P332, DOI 10.3758/BF03195460; Carroll J. B., 1993, HUMAN COGNITIVE ABIL, DOI DOI 1017/CBO9780511571312; Cotton SM, 2005, DYSLEXIA, V11, P186, DOI 10.1002/dys.298; Cumming G, 2001, EDUC PSYCHOL MEAS, V61, P532, DOI 10.1177/00131640121971374; De Pessemier P, 2009, TEST GEVORDERD LEZEN; De Smedt B, 2010, NEUROPSYCHOLOGIA, V48, P3973, DOI 10.1016/j.neuropsychologia.2010.10.018; De Vos T., 1992, TEMPO TEST REKENEN; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dekker PH, 2007, ONTWIKKELING VIJF NI; Dekker R, 2004, KAUFMAN ADOLESCENT A; Dekker R, 2003, DVMH DIFFERENTIELE V; Desoete A, 2002, LEARN DISABILITY Q, V25, P123, DOI 10.2307/1511279; Everatt J, 1997, PERCEPTION, V26, P1330; Farmer M, 2002, DYSLEXIA INCLUSION A; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FELTON RH, 1990, BRAIN LANG, V39, P485, DOI 10.1016/0093-934X(90)90157-C; Field A., 2009, DISCOVERING STAT USI; Gauderis K, 2004, THESIS U COLL ARTEVE; Ghesquiere P, 1998, THESIS U LEUVEN LEUV; Gobel SM, 2010, Q J EXP PSYCHOL, V63, P1361, DOI 10.1080/17470210903359206; Haager D., 2007, EVIDENCE BASED READI; Hadjikakou K, 2008, HIGH EDUC, V55, P103, DOI 10.1007/s10734-007-9070-8; Hanley JR, 2004, Q J EXP PSYCHOL-A, V57, P1393, DOI 10.1080/02724980343000819; Hatcher J, 2002, BRIT J EDUC PSYCHOL, V72, P119, DOI 10.1348/000709902158801; Henneman K, 2004, PROTOCOL DYSLEXIE VO; Keuleers E, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00174; Kleijen R, 2008, TOETSEN INTERVENTIES; Kleijnen R., 2006, PROTOCOL DYSLEXIE HO; Landerl K, 1997, COGNITION, V63, P315, DOI 10.1016/S0010-0277(97)00005-X; Landerl K, 2010, J CHILD PSYCHOL PSYC, V51, P287, DOI 10.1111/j.1469-7610.2009.02164.x; LEFLY DL, 1991, ANN DYSLEXIA, V41, P143, DOI 10.1007/BF02648083; LINDGREN SD, 1985, CHILD DEV, V56, P1404, DOI 10.1111/j.1467-8624.1985.tb00206.x; Lovett BJ, 2010, J PSYCHOEDUC ASSESS, V28, P91, DOI 10.1177/0734282909341019; Madriaga M, 2010, STUD HIGH EDUC, V35, P647, DOI 10.1080/03075070903222633; Pieters S, 2012, CHILD CARE HLTH DEV, V38, P139, DOI 10.1111/j.1365-2214.2011.01225.x; Ransby MJ, 2003, J LEARN DISABIL-US, V36, P538, DOI 10.1177/00222194030360060501; Reid AA, 2007, DYSLEXIA, V13, P1, DOI 10.1002/dys.321; Seymour PHK, 2003, BRIT J PSYCHOL, V94, P143, DOI 10.1348/000712603321661859; Share DL, 2008, PSYCHOL BULL, V134, P584, DOI 10.1037/0033-2909.134.4.584; Sharpe D, 1997, CLIN PSYCHOL REV, V17, P881, DOI 10.1016/S0272-7358(97)00056-1; Snowling M., 2000, DYSLEXIA; Sparks RL, 2009, J LEARN DISABIL-US, V42, P494, DOI 10.1177/0022219409338746; Sparks RL, 2009, J LEARN DISABIL-US, V42, P230, DOI 10.1177/0022219408331040; Stichting Dyslexie Nederland, 2008, DIAGN DYSL BROCH STI; Stone GO, 1997, J MEM LANG, V36, P337, DOI 10.1006/jmla.1996.2487; Swanson HL, 2009, REV EDUC RES, V79, P1362, DOI 10.3102/0034654309350931; Szenkovits G, 2005, DYSLEXIA, V11, P253, DOI 10.1002/dys.308; Tops W, 2012, ANN DYSLEXI IN PRESS; Trainin G, 2005, LEARN DISABILITY Q, V28, P261, DOI 10.2307/4126965; van den Bos K, 1999, KLEPEL VORM A B TEST; Van den Bosch A., 1994, J QUANT LINGUIST, V1, P178, DOI [10.1080/09296179408590015, DOI 10.1080/09296179408590015]; Van der Leij A, 2012, INTERACTIEV IN PRESS; Vanderswalmen R, 2010, TRENDS AND PROSPECTS IN METACOGNITION RESEARCH, P367, DOI 10.1007/978-1-4419-6546-2_17; Vaughn S., 2003, LEARNING DISABILITIE, V18, P137, DOI [10.1111/1540-5826.00070, DOI 10.1111/1540-5826.00070]; Wechsler D, 2001, WAIS 3 NEDERLANDSTAL; Wilkinson G.S, 1993, WIDE RANGE ACHIEVEME; Wolf LE, 2008, NEUROPSYCHOLOGISTS H; Wolff U, 2009, INT J DISABIL DEV ED, V56, P73, DOI 10.1080/10349120802682083; Yoshimasu K, 2010, PEDIATRICS, V126, pE788, DOI 10.1542/peds.2010-1187; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3	64	69	69	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38081	10.1371/journal.pone.0038081	http://dx.doi.org/10.1371/journal.pone.0038081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UV	22719864	gold, Green Published			2022-12-25	WOS:000305341900018
J	Rajaei, K; Khaligh-Razavi, SM; Ghodrati, M; Ebrahimpour, R; Abadi, MESA				Rajaei, Karim; Khaligh-Razavi, Seyed-Mahdi; Ghodrati, Masoud; Ebrahimpour, Reza; Abadi, Mohammad Ebrahim Shiri Ahmad			A Stable Biologically Motivated Learning Mechanism for Visual Feature Extraction to Handle Facial Categorization	PLOS ONE			English	Article							RECEPTIVE-FIELDS; FUNCTIONAL ARCHITECTURE; RECOGNITION; CORTEX; NEOCOGNITRON; FEEDBACK; CLASSIFICATION; CIRCUITS; BRAIN; MODEL	The brain mechanism of extracting visual features for recognizing various objects has consistently been a controversial issue in computational models of object recognition. To extract visual features, we introduce a new, biologically motivated model for facial categorization, which is an extension of the Hubel and Wiesel simple-to-complex cell hierarchy. To address the synaptic stability versus plasticity dilemma, we apply the Adaptive Resonance Theory (ART) for extracting informative intermediate level visual features during the learning process, which also makes this model stable against the destruction of previously learned information while learning new information. Such a mechanism has been suggested to be embedded within known laminar microcircuits of the cerebral cortex. To reveal the strength of the proposed visual feature learning mechanism, we show that when we use this mechanism in the training process of a well-known biologically motivated object recognition model (the HMAX model), it performs better than the HMAX model in face/non-face classification tasks. Furthermore, we demonstrate that our proposed mechanism is capable of following similar trends in performance as humans in a psychophysical experiment using a face versus non-face rapid categorization task.	[Rajaei, Karim; Abadi, Mohammad Ebrahim Shiri Ahmad] Amirkabir Univ Technol, Dept Math & Comp Sci, Tehran, Iran; [Rajaei, Karim; Khaligh-Razavi, Seyed-Mahdi; Ghodrati, Masoud; Ebrahimpour, Reza] Inst Res Fundamental Sci IPM, SCS, Tehran, Iran; [Khaligh-Razavi, Seyed-Mahdi] Univ Tehran, Dept Math Stat & Comp Sci, Tehran, Iran; [Khaligh-Razavi, Seyed-Mahdi] Univ Cambridge, MRC Cognit & Brain Sci Unit, Cambridge, England; [Ghodrati, Masoud] Shahed Univ, Fac Engn, Dept Biomed Engn, Tehran, Iran; [Ebrahimpour, Reza] Shahid Rajaee Teacher Training Univ, Dept Elect & Comp Engn, Brain & Intelligent Syst Res Lab BISLab, Tehran, Iran	Amirkabir University of Technology; University of Tehran; University of Cambridge; Shahed University; Shahid Rajaee Teacher Training University (SRTTU)	Rajaei, K (corresponding author), Amirkabir Univ Technol, Dept Math & Comp Sci, Tehran, Iran.	ebrahimpour@ipm.ir	Ebrahimpour, Reza/A-9721-2009; Ebrahimpour, Reza/AAH-8531-2019	Ebrahimpour, Reza/0000-0002-7013-8078; Ghodrati, Masoud/0000-0002-4006-2578; Khaligh-Razavi, Seyed-Mahdi/0000-0002-5700-1704	MRC [MC_U105597120] Funding Source: UKRI; Medical Research Council [MC_U105597120] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Akhbardeh A, 2005, 2005 IEEE INTERNATIONAL WORKSHOP ON INTELLIGENT SIGNAL PROCESSING (WISP), P149; Angelucci A, 2003, J PHYSIOL-PARIS, V97, P141, DOI 10.1016/j.jphysparis.2003.09.001; Anton-Rodriguez M, 2009, NEUROCOMPUTING, V72, P3713, DOI 10.1016/j.neucom.2009.06.007; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bullier J, 2001, PROG BRAIN RES, V134, P193; Carpenter G. A., 2004, Proceedings. 33rd Applied Imagery Pattern Recognition Workshop, P61; Carpenter G. A., 1991, PATTERN RECOGNITION; CARPENTER GA, 1992, IEEE T NEURAL NETWOR, V3, P698, DOI 10.1109/72.159059; CARPENTER GA, 1987, COMPUT VISION GRAPH, V37, P54, DOI 10.1016/S0734-189X(87)80014-2; Fergus R, 2003, PROC CVPR IEEE, P264; FERSTER D, 1983, J PHYSIOL-LONDON, V342, P181, DOI 10.1113/jphysiol.1983.sp014846; FUKUSHIMA K, 1988, NEURAL NETWORKS, V1, P119, DOI 10.1016/0893-6080(88)90014-7; Fukushima K, 2003, NEUROCOMPUTING, V51, P161, DOI 10.1016/S0925-2312(02)00614-8; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; Ghodrati M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032357; Grossberg S, 1997, TRENDS NEUROSCI, V20, P106, DOI 10.1016/S0166-2236(96)01002-8; Grossberg S, 1999, SPATIAL VISION, V12, P163, DOI 10.1163/156856899X00102; GROSSBERG S, 1986, PSYCHOL REV, V93, P46, DOI 10.1037/0033-295X.93.1.46; GROSSBERG S, 1995, AM SCI, V83, P438; GROSSBERG S, 1976, BIOL CYBERN, V23, P187; GROSSBERG S, 1980, PSYCHOL REV, V87, P1, DOI 10.1037/0033-295X.87.1.1; Grossberg S, 2008, BRAIN RES, V1218, P278, DOI 10.1016/j.brainres.2008.04.024; Grossberg Stephen, 2003, Behav Cogn Neurosci Rev, V2, P47, DOI 10.1177/1534582303002001003; Grossberg S, 2007, PROG BRAIN RES, V165, P79, DOI 10.1016/S0079-6123(06)65006-1; Huang Y, 2011, IEEE T SYSTEMS MAN B; Hubel D. H., 1965, J NEUROPHYSIOLOGY; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; Kadiran S., 1993, Proceedings 1993 The First New Zealand International Two-Stream Conference on Artificial Neural Networks and Expert Systems, P341, DOI 10.1109/ANNES.1993.323007; Kleiner M, 2007, PERCEPTION, V36, P14; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Kusiak A, 1991, GT ART USING NEURAL; LeCun Y., 2003, CONVOLUTIONAL NETWOR, P276; Li FF, 2007, COMPUT VIS IMAGE UND, V106, P59, DOI 10.1016/j.cviu.2005.09.012; Liao IE, 2008, INT SYST DES APPL 20, V1, P318; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Masquelier T, 2007, PLOS COMPUT BIOL, V3, P247, DOI 10.1371/journal.pcbi.0030031; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Mutch J, 2008, INT J COMPUT VISION, V80, P45, DOI 10.1007/s11263-007-0118-0; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PERRETT DI, 1993, IMAGE VISION COMPUT, V11, P317, DOI 10.1016/0262-8856(93)90011-5; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Serre T, 2005, PROC CVPR IEEE, P994; Serre T., 2005, THEORY OBJECT RECOGN; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Uysal M, 2006, IEEE IMAGE PROC, P2913, DOI 10.1109/ICIP.2006.313128; Weber M, 2000, LECT NOTES COMPUT SC, V1842, P18; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Woodbeck Kris, 2008, 2008 IEEE Computer Society Conference on Computer Vision and Pattern Recognition Workshops (CVPR Workshops), P1, DOI 10.1109/CVPRW.2008.4563091; Zikan K., 1991, IJCNN-91-Seattle: International Joint Conference on Neural Networks (Cat. No.91CH3049-4), DOI 10.1109/IJCNN.1991.155600	54	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38478	10.1371/journal.pone.0038478	http://dx.doi.org/10.1371/journal.pone.0038478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719892	Green Published, gold			2022-12-25	WOS:000305341900030
J	Summers, EL; Meindl, K; Uson, I; Mitra, AK; Radjainia, M; Colangeli, R; Alland, D; Arcus, VL				Summers, Emma L.; Meindl, Kathrin; Uson, Isabel; Mitra, Alok K.; Radjainia, Mazdak; Colangeli, Roberto; Alland, David; Arcus, Vickery L.			The Structure of the Oligomerization Domain of Lsr2 from Mycobacterium tuberculosis Reveals a Mechanism for Chromosome Organization and Protection	PLOS ONE			English	Article							HISTONE-LIKE PROTEIN; NUCLEOID-ASSOCIATED PROTEINS; DNA; SMEGMATIS; LEPRAE; RESPONSES; SOFTWARE; GENOMES; GENE	Lsr2 is a small DNA-binding protein present in mycobacteria and related actinobacteria that regulates gene expression and influences the organization of bacterial chromatin. Lsr2 is a dimer that binds to AT-rich regions of chromosomal DNA and physically protects DNA from damage by reactive oxygen intermediates (ROI). A recent structure of the C-terminal DNA-binding domain of Lsr2 provides a rationale for its interaction with the minor groove of DNA, its preference for AT-rich tracts, and its similarity to other bacterial nucleoid-associated DNA-binding domains. In contrast, the details of Lsr2 dimerization (and oligomerization) via its N-terminal domain, and the mechanism of Lsr2-mediated chromosomal cross-linking and protection is unknown. We have solved the structure of the N-terminal domain of Lsr2 (N-Lsr2) at 1.73 angstrom resolution using crystallographic ab initio approaches. The structure shows an intimate dimer of two beta-beta-a motifs with no close homologues in the structural databases. The organization of individual N-Lsr2 dimers in the crystal also reveals a mechanism for oligomerization. Proteolytic removal of three N-terminal residues from Lsr2 results in the formation of an anti-parallel beta-sheet between neighboring molecules and the formation of linear chains of N-Lsr2. Oligomerization can be artificially induced using low concentrations of trypsin and the arrangement of N-Lsr2 into long chains is observed in both monoclinic and hexagonal crystallographic space groups. In solution, oligomerization of N-Lsr2 is also observed following treatment with trypsin. A change in chromosomal topology after the addition of trypsin to full-length Lsr2-DNA complexes and protection of DNA towards DNAse digestion can be observed using electron microscopy and electrophoresis. These results suggest a mechanism for oligomerization of Lsr2 via protease-activation leading to chromosome compaction and protection, and concomitant down-regulation of large numbers of genes. This mechanism is likely to be relevant under conditions of stress where cellular proteases are known to be upregulated.	[Summers, Emma L.; Arcus, Vickery L.] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand; [Meindl, Kathrin] Inst Biol Mol Barcelona, Barcelona, Spain; [Uson, Isabel] Inst Biol Mol Barcelona, Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Mitra, Alok K.; Radjainia, Mazdak] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Colangeli, Roberto; Alland, David] Univ Med & Dent New Jersey, New Jersey Med Sch, Div Infect Dis, Dept Med, Newark, NJ 07103 USA; [Colangeli, Roberto; Alland, David] Univ Med & Dent New Jersey, New Jersey Med Sch, Ctr Emerging Pathogens, Dept Med, Newark, NJ 07103 USA	University of Waikato; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); ICREA; University of Auckland; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Summers, EL (corresponding author), Univ Waikato, Dept Biol Sci, Private Bag 3105, Hamilton, New Zealand.	varcus@waikato.ac.nz	Meindl, Kathrin/O-9343-2015; Mitra, Alok/P-7800-2016	Meindl, Kathrin/0000-0001-6626-0428; ROBERTO, COLANGELI/0000-0003-3263-7404; Mitra, Alok/0000-0003-0891-5697	Biomedical Strategic Initiative at the University of Waikato; University of Waikato Doctoral Scholarship Award; Spanish Ministerio de Ciencia e Innovacion (MICINN); Generalitat de Catalunya [BIO2009-10576, IDC-20101173, 2009SGR-1036]; Deutsche Forschungsgemeinschaft [ME 3679/1-1]; "Juan de la Cierva" MICINN (MICINN-JDC) Program; ICREA Funding Source: Custom	Biomedical Strategic Initiative at the University of Waikato; University of Waikato Doctoral Scholarship Award; Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); "Juan de la Cierva" MICINN (MICINN-JDC) Program; ICREA(ICREA)	This work was supported by the Biomedical Strategic Initiative at the University of Waikato. ELS was supported by a University of Waikato Doctoral Scholarship Award. IU is thankful to the Spanish Ministerio de Ciencia e Innovacion (MICINN) and Generalitat de Catalunya for financial support (Grant BIO2009-10576; IDC-20101173; 2009SGR-1036). KM thanks the Deutsche Forschungsgemeinschaft (ME 3679/1-1) and "Juan de la Cierva" MICINN (MICINN-JDC) Program for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Arold ST, 2010, P NATL ACAD SCI USA, V107, P15728, DOI 10.1073/pnas.1006966107; Arora K, 2008, J BACTERIOL, V190, P4291, DOI 10.1128/JB.00023-08; Becker NA, 2007, NUCLEIC ACIDS RES, V35, P3988, DOI 10.1093/nar/gkm419; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Browning DF, 2010, CURR OPIN MICROBIOL, V13, P773, DOI 10.1016/j.mib.2010.09.013; Chen JM, 2008, NUCLEIC ACIDS RES, V36, P2123, DOI 10.1093/nar/gkm1162; Chen JM, 2006, J BACTERIOL, V188, P633, DOI 10.1128/JB.188.2.633-641.2006; Colangeli R, 2009, P NATL ACAD SCI USA, V106, P4414, DOI 10.1073/pnas.0810126106; Colangeli R, 2007, PLOS PATHOG, V3, P780, DOI 10.1371/journal.ppat.0030087; Dame RT, 2005, MOL MICROBIOL, V56, P858, DOI 10.1111/j.1365-2958.2005.04598.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gordon BRG, 2008, J BACTERIOL, V190, P7052, DOI 10.1128/JB.00733-08; Gordon BRG, 2011, P NATL ACAD SCI USA, V108, P10690, DOI 10.1073/pnas.1102544108; Gordon BRG, 2010, P NATL ACAD SCI USA, V107, P18741, DOI 10.1073/pnas.1014494107; Gordon BRG, 2010, P NATL ACAD SCI USA, V107, P5154, DOI 10.1073/pnas.0913551107; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; LAAL S, 1991, P NATL ACAD SCI USA, V88, P1054, DOI 10.1073/pnas.88.3.1054; Lee BH, 1998, MOL GEN GENET, V260, P475, DOI 10.1007/s004380050919; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Maurer S, 2009, J MOL BIOL, V387, P1261, DOI 10.1016/j.jmb.2009.02.050; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Oftung F, 2000, FEMS IMMUNOL MED MIC, V27, P87, DOI 10.1111/j.1574-695X.2000.tb01416.x; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Ribeiro-Guimaraes ML, 2007, MICROB PATHOGENESIS, V43, P173, DOI 10.1016/j.micpath.2007.05.010; Rodriguez D, 2012, ACTA CRYSTALLOGR D, V68, P336, DOI 10.1107/S0907444911056071; Rodriguez DD, 2009, NAT METHODS, V6, P651, DOI [10.1038/NMETH.1365, 10.1038/nmeth.1365]; Sharadamma N, 2010, NUCLEIC ACIDS RES, V38, P3555, DOI 10.1093/nar/gkq064; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; SINGH S, 1994, INFECT IMMUN, V62, P5702, DOI 10.1128/IAI.62.12.5702-5705.1994; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	34	25	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38542	10.1371/journal.pone.0038542	http://dx.doi.org/10.1371/journal.pone.0038542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719899	Green Published, gold			2022-12-25	WOS:000305341900034
J	Ciriello, G; Mina, M; Guzzi, PH; Cannataro, M; Guerra, C				Ciriello, Giovanni; Mina, Marco; Guzzi, Pietro H.; Cannataro, Mario; Guerra, Concettina			AlignNemo: A Local Network Alignment Method to Integrate Homology and Topology	PLOS ONE			English	Article							PROTEIN-INTERACTION MAP; YEAST; DATABASE; SIMILARITY; BIOLOGY	Local network alignment is an important component of the analysis of protein-protein interaction networks that may lead to the identification of evolutionary related complexes. We present AlignNemo, a new algorithm that, given the networks of two organisms, uncovers subnetworks of proteins that relate in biological function and topology of interactions. The discovered conserved subnetworks have a general topology and need not to correspond to specific interaction patterns, so that they more closely fit the models of functional complexes proposed in the literature. The algorithm is able to handle sparse interaction data with an expansion process that at each step explores the local topology of the networks beyond the proteins directly interacting with the current solution. To assess the performance of AlignNemo, we ran a series of benchmarks using statistical measures as well as biological knowledge. Based on reference datasets of protein complexes, AlignNemo shows better performance than other methods in terms of both precision and recall. We show our solutions to be biologically sound using the concept of semantic similarity applied to Gene Ontology vocabularies. The binaries of AlignNemo and supplementary details about the algorithms and the experiments are available at: sourceforge.net/p/alignnemo.	[Ciriello, Giovanni; Mina, Marco; Guerra, Concettina] Univ Padua, Dept Informat Engn, Padua, Italy; [Guzzi, Pietro H.; Cannataro, Mario] Magna Graecia Univ Catanzaro, Dept Surg & Med Sci, Germaneto, Italy; [Guerra, Concettina] Georgia Inst Technol, Coll Comp, Atlanta, GA 30332 USA	University of Padua; Magna Graecia University of Catanzaro; University System of Georgia; Georgia Institute of Technology	Ciriello, G (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Dept, 1275 York Ave, New York, NY 10021 USA.	ciriello@cbio.mskcc.org; guerra@dei.unipd.it	Cannataro, Mario/B-1503-2012; Guzzi, Pietro Hiram/AAF-4094-2020	Cannataro, Mario/0000-0003-1502-2387; Ciriello, Giovanni/0000-0003-2021-8683; Mina, Marco/0000-0002-4186-8995	CARIPARO project "Systems Biology approaches to infer gene and protein time-series expression data"	CARIPARO project "Systems Biology approaches to infer gene and protein time-series expression data"	This work was funded in part by the CARIPARO project "Systems Biology approaches to infer gene and protein time-series expression data". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ORTH RES GERST LAB; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Cootes AP, 2007, J MOL BIOL, V369, P1126, DOI 10.1016/j.jmb.2007.03.013; de Silva E, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-39; Deng Minghua, 2003, Pac Symp Biocomput, P140; Engel SR, 2010, NUCLEIC ACIDS RES, V38, pD433, DOI 10.1093/nar/gkp917; Faria D, 2007, U LISBON TECHNICAL R; Flannick J, 2006, GENOME RES, V16, P1169, DOI 10.1101/gr.5235706; Flannick J, 2009, J COMPUT BIOL, V16, P1001, DOI 10.1089/cmb.2009.0099; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Guzzi PH, 2012, BRIEF BIOINFORM, V13, P569, DOI 10.1093/bib/bbr066; Hakes L, 2008, NAT BIOTECHNOL, V26, P69, DOI 10.1038/nbt0108-69; Kalaev M, 2008, LECT N BIOINFORMAT, V4955, P246; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kelley BP, 2003, P NATL ACAD SCI USA, V100, P11394, DOI 10.1073/pnas.1534710100; Kiemer Lars, 2007, Trends Biotechnol, V25, P448, DOI 10.1016/j.tibtech.2007.08.002; Koyuturk M, 2006, J COMPUT BIOL, V13, P182, DOI 10.1089/cmb.2006.13.182; Kuchaiev O, 2011, BIOINFORMATICS, V27, P1390, DOI 10.1093/bioinformatics/btr127; Kuchaiev O, 2010, J R SOC INTERFACE, V7, P1341, DOI 10.1098/rsif.2010.0063; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Milenkovic T, 2010, CANCER INFORM, V9, P121, DOI 10.4137/CIN.S4744; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Pache RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031220; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Singh Rohit, 2008, Pac Symp Biocomput, P303; Singh R, 2007, LECT NOTES COMPUT SC, V4453, P16; Tian WH, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P99; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Veltman DM, 2010, MOL BIOL CELL, V21, P2880, DOI 10.1091/mbc.E10-04-0372; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	35	74	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38107	10.1371/journal.pone.0038107	http://dx.doi.org/10.1371/journal.pone.0038107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719866	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340000012
J	Sepulveda, D; Cardenas, C; Carmona, M; Marshall, SH				Sepulveda, Dagoberto; Cardenas, Constanza; Carmona, Marisela; Marshall, Sergio H.			Novel Strategy to Evaluate Infectious Salmon Anemia Virus Variants by High Resolution Melting	PLOS ONE			English	Article							ORTHOMYXO-LIKE VIRUS; INFLUENZA-A VIRUS; ATLANTIC SALMON; HEMAGGLUTININ GENE; ISAV; IDENTIFICATION; SEQUENCE; VIRULENCE; SALAR; PATHOGENICITY	Genetic variability is a key problem in the prevention and therapy of RNA-based virus infections. Infectious Salmon Anemia virus (ISAv) is an RNA virus which aggressively attacks salmon producing farms worldwide and in particular in Chile. Just as with most of the Orthomyxovirus, ISAv displays high variability in its genome which is reflected by a wider infection potential, thus hampering management and prevention of the disease. Although a number of widely validated detection procedures exist, in this case there is a need of a more complex approach to the characterization of virus variability. We have adapted a procedure of High Resolution Melting (HRM) as a fine-tuning technique to fully differentiate viral variants detected in Chile and projected to other infective variants reported elsewhere. Out of the eight viral coding segments, the technique was adapted using natural Chilean variants for two of them, namely segments 5 and 6, recognized as virulence-associated factors. Our work demonstrates the versatility of the technique as well as its superior resolution capacity compared with standard techniques currently in use as key diagnostic tools.	[Sepulveda, Dagoberto; Carmona, Marisela; Marshall, Sergio H.] Pontificia Univ Catolica Valparaiso, Lab Patogenos Acuicolas, Nucleo Biotecnol Curauma, Valparaiso, Chile; [Sepulveda, Dagoberto; Carmona, Marisela; Marshall, Sergio H.] Pontificia Univ Catolica Valparaiso, Lab Genet & Inmunol Mol, Inst Biol, Fac Ciencias, Valparaiso, Chile	Pontificia Universidad Catolica de Valparaiso; Pontificia Universidad Catolica de Valparaiso	Sepulveda, D (corresponding author), Pontificia Univ Catolica Valparaiso, Lab Patogenos Acuicolas, Nucleo Biotecnol Curauma, Campus Curauma, Valparaiso, Chile.	smarshal@ucv.cl	Cárdenas, Constanza/ABA-6477-2021	Cardenas Carvajal, Constanza/0000-0002-3673-9320; marshall, sergio/0000-0003-0438-8252; Sepulveda, Dagoberto/0000-0001-8553-5861	Chilean Government Grant CORFO-Innova Chile [09MCSS-6725]	Chilean Government Grant CORFO-Innova Chile	This work was funded by the Chilean Government Grant CORFO-Innova Chile 09MCSS-6725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Aspehaug V, 2005, J VIROL, V79, P12544, DOI 10.1128/JVI.79.19.12544-12553.2005; BALDINO F, 1989, METHOD ENZYMOL, V168, P761; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bouchard D, 1999, DIS AQUAT ORGAN, V35, P131, DOI 10.3354/dao035131; Bouchard DA, 2001, BULL EUR ASSN FISH P, V21, P86; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Brown EG, 2000, BIOMED PHARMACOTHER, V54, P196, DOI 10.1016/S0753-3322(00)89026-5; Cheng JC, 2006, CLIN CHEM, V52, P1997, DOI 10.1373/clinchem.2006.069286; Christiansen DH, 2011, J GEN VIROL, V92, P909, DOI 10.1099/vir.0.027094-0; Coleman JR, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-9; Cunningham CO, 2000, DIS AQUAT ORGAN, V41, P1, DOI 10.3354/dao041001; Devold M, 2006, J GEN VIROL, V87, P2031, DOI 10.1099/vir.0.81687-0; Devold M, 2001, DIS AQUAT ORGAN, V47, P119, DOI 10.3354/dao047119; Erali M, 2008, EXP MOL PATHOL, V85, P50, DOI 10.1016/j.yexmp.2008.03.012; Erali M, 2010, METHODS, V50, P250, DOI 10.1016/j.ymeth.2010.01.013; Falk K, 2004, J VIROL, V78, P3063, DOI 10.1128/JVI.78.6.3063-3071.2004; Falk K, 1997, J VIROL, V71, P9016, DOI 10.1128/JVI.71.12.9016-9023.1997; Fortini D, 2007, CLIN CHEM, V53, P1377, DOI 10.1373/clinchem.2007.085993; Ghorashi SA, 2011, J VIROL METHODS, V171, P264, DOI 10.1016/j.jviromet.2010.11.013; Godoy MG, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-28; Goto H, 2001, J VIROL, V75, P9297, DOI 10.1128/JVI.75.19.9297-9301.2001; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Kawaoka Y., 2005, 8 INT COMM TAX VIR, P681; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kibenge FSB, 2007, J GEN VIROL, V88, P3100, DOI 10.1099/vir.0.83097-0; Kibenge FSB, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-88; Kibenge FSB, 2001, J GEN VIROL, V82, P2869, DOI 10.1099/0022-1317-82-12-2869; Kibenge FSB, 2001, DIS AQUAT ORGAN, V45, P9, DOI 10.3354/dao045009; Krossoy B, 2001, J GEN VIROL, V82, P1757, DOI 10.1099/0022-1317-82-7-1757; Krossoy B, 1999, J VIROL, V73, P2136; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; Lin JH, 2008, J CLIN MICROBIOL, V46, P1090, DOI 10.1128/JCM.02015-07; Lovely JE, 1999, DIS AQUAT ORGAN, V35, P145, DOI 10.3354/dao035145; Markussen T, 2008, VIROLOGY, V374, P515, DOI 10.1016/j.virol.2008.01.019; McBeath AJA, 2009, DIS AQUAT ORGAN, V87, P161, DOI 10.3354/dao02128; Mjaaland S, 1997, J VIROL, V71, P7681, DOI 10.1128/JVI.71.10.7681-7686.1997; Mjaaland S, 2002, VIROLOGY, V304, P379, DOI 10.1006/viro.2002.1658; Mullins J.E., 1998, Bulletin of the European Association of Fish Pathologists, V18, P110; Naze F, 2010, J CLIN MICROBIOL, V48, P3146, DOI 10.1128/JCM.00402-10; Neron B, 2009, BIOINFORMATICS, V25, P3005, DOI 10.1093/bioinformatics/btp493; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rimstad E, 2001, J VIROL, V75, P5352, DOI 10.1128/JVI.75.11.5352-5356.2001; Rodger H.D., 1998, Bulletin of the European Association of Fish Pathologists, V18, P115; Rozen S, 2000, Methods Mol Biol, V132, P365; Rumschlag-Booms E, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-76; Snow M, 2006, DEV BIOLOGICALS, V126, P133; Tajiri-Utagawa E, 2009, J CLIN MICROBIOL, V47, P435, DOI 10.1128/JCM.01247-08; Taylor CF, 2009, BIOCHEM SOC T, V37, P433, DOI 10.1042/BST0370433; Thorud K., 1988, Bulletin of the European Association of Fish Pathologists, V8, P109; Ugo V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008893; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853	57	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e37265	10.1371/journal.pone.0037265	http://dx.doi.org/10.1371/journal.pone.0037265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719837	Green Submitted, Green Published, gold			2022-12-25	WOS:000305340000002
J	Soekmadji, C; Angkawidjaja, C; Kelly, LE				Soekmadji, Carolina; Angkawidjaja, Clement; Kelly, Leonard E.			Ca2+ Regulates the Drosophila Stoned-A and Stoned-B Proteins Interaction with the C2B Domain of Synaptotagmin-1	PLOS ONE			English	Article							NEUROTRANSMITTER RELEASE; IN-VIVO; NEUROMUSCULAR-JUNCTIONS; SYNAPTIC TRANSMISSION; PHOSPHOLIPID-BINDING; MOLECULAR-DYNAMICS; AP-2 BINDING; MUTANTS; LOCUS; MOTIF	The dicistronic Drosophila stoned gene is involved in exocytosis and/or endocytosis of synaptic vesicles. Mutations in either stonedA or stonedB cause a severe disruption of neurotransmission in fruit flies. Previous studies have shown that the coiled-coil domain of the Stoned-A and the mu-homology domain of the Stoned-B protein can interact with the C2B domain of Synaptotagmin-1. However, very little is known about the mechanism of interaction between the Stoned proteins and the C2B domain of Synaptotagmin-1. Here we report that these interactions are increased in the presence of Ca2+. The Ca2+-dependent interaction between the m-homology domain of Stoned-B and C2B domain of Synaptotagmin-1 is affected by phospholipids. The C-terminal region of the C2B domain, including the tryptophan-containing motif, and the Ca2+-binding loop region that modulate the Ca2+-dependent oligomerization, regulates the binding of the Stoned-A and Stoned-B proteins to the C2B domain. Stoned-B, but not Stoned-A, interacts with the Ca2+-binding loop region of C2B domain. The results indicate that Ca2+-induced self-association of the C2B domain regulates the binding of both Stoned-A and Stoned-B proteins to Synaptotagmin-1. The Stoned proteins may regulate sustainable neurotransmission in vivo by binding to Ca-(2+)bound Synaptotagmin-1 associated synaptic vesicles.	[Soekmadji, Carolina; Kelly, Leonard E.] Univ Melbourne, Dept Genet, Parkville, Vic 3052, Australia; [Angkawidjaja, Clement] Osaka Univ, Dept Mat & Life Sci, Suita, Osaka, Japan	University of Melbourne; Osaka University	Soekmadji, C (corresponding author), Univ Melbourne, Dept Genet, Parkville, Vic 3052, Australia.	carolina.soekmadji@qut.edu.au	Soekmadji, Carolina/M-2757-2016	Soekmadji, Carolina/0000-0002-6920-6627; Angkawidjaja, Clement/0000-0002-5019-2536				Andrews J, 1996, GENETICS, V143, P1699; Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; Cheng Y, 2004, PROTEIN SCI, V13, P2665, DOI 10.1110/ps.04832604; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; Estes PS, 2003, GENETICS, V165, P185; FABIATO A, 1981, J GEN PHYSIOL, V78, P457, DOI 10.1085/jgp.78.5.457; Fergestad T, 2001, J NEUROSCI, V21, P1218; Fergestad T, 1999, J NEUROSCI, V19, P5847, DOI 10.1523/JNEUROSCI.19-14-05847.1999; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Grass I, 2004, J BIOL CHEM, V279, P54872, DOI 10.1074/jbc.M409995200; Haucke V, 2000, EMBO J, V19, P6011, DOI 10.1093/emboj/19.22.6011; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jarousse N, 2003, TRAFFIC, V4, P468, DOI 10.1034/j.1600-0854.2003.00101.x; Jarousse N, 2001, CURR OPIN CELL BIOL, V13, P461, DOI 10.1016/S0955-0674(00)00237-4; Jung N, 2007, J CELL BIOL, V179, P1497, DOI 10.1083/jcb.200708107; Kelly LE, 2005, BIOCHEM J, V388, P195, DOI 10.1042/BJ20041797; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Loewen CA, 2006, MOL BIOL CELL, V17, P5211, DOI 10.1091/mbc.E06-07-0622; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Mackler JM, 2001, J COMP NEUROL, V436, P4, DOI 10.1002/cne.1049; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Martina JA, 2001, J CELL BIOL, V153, P1111, DOI 10.1083/jcb.153.5.1111; Mohrmann R, 2008, NEUROSCIENCE, V153, P1048, DOI 10.1016/j.neuroscience.2008.02.060; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; PETROVICH TZ, 1993, GENETICS, V133, P955; Phillips AM, 2010, TRAFFIC, V11, P16, DOI 10.1111/j.1600-0854.2009.00999.x; Phillips AM, 2000, J NEUROSCI, V20, P8254, DOI 10.1523/JNEUROSCI.20-22-08254.2000; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poskanzer KE, 2006, NEURON, V50, P49, DOI 10.1016/j.neuron.2006.02.021; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Stimson DT, 2001, J NEUROSCI, V21, P3034, DOI 10.1523/JNEUROSCI.21-09-03034.2001; Stimson DT, 1998, J NEUROSCI, V18, P9638; Tamura T, 2007, J NEUROPHYSIOL, V97, P540, DOI 10.1152/jn.00905.2006; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c; Vrljic M, 2011, BIOCHEMISTRY-US, V50, P9998, DOI 10.1021/bi200998y; Wu Y, 2003, P NATL ACAD SCI USA, V100, P2082, DOI 10.1073/pnas.0435872100; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1; Zhang XY, 1998, BIOCHEMISTRY-US, V37, P12395, DOI 10.1021/bi9807512	50	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38822	10.1371/journal.pone.0038822	http://dx.doi.org/10.1371/journal.pone.0038822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701718	Green Published, gold			2022-12-25	WOS:000305340000049
J	Hu, ZZ; Du, J; Yang, L; Zhu, YC; Yang, Y; Zheng, DT; Someya, A; Gu, L; Lu, X				Hu, ZhenZhen; Du, Jun; Yang, Ling; Zhu, YiChao; Yang, Yu; Zheng, DaTong; Someya, Akimasa; Gu, Luo; Lu, Xiang			GEP100/Arf6 Is Required for Epidermal Growth Factor-Induced ERK/Rac1 Signaling and Cell Migration in Human Hepatoma HepG2 Cells	PLOS ONE			English	Article							RIBOSYLATION FACTOR 6; INHIBITOR ZD1839 IRESSA; BREAST-CANCER INVASION; ADP-RIBOSYLATION; ARF6 ACTIVATION; FACTOR RECEPTOR; DOWNSTREAM ACTIVATION; DEPENDENT MECHANISM; ACTIN CYTOSKELETON; PLASMA-MEMBRANE	Background: Epidermal growth factor (EGF) signaling is implicated in the invasion and metastasis of hepatoma cells. However, the signaling pathways for EGF-induced motility of hepatoma cells remain undefined. Methodology/Principal Findings: We found that EGF dose-dependently stimulated the migration of human hepatoma cells HepG2, with the maximal effect at 10 ng/mL. Additionally, EGF increased Arf6 activity, and ectopic expression of Arf6 T27N, a dominant negative Arf6 mutant, largely abolish EGF-induced cell migration. Blocking GEP100 with GEP100 siRNA or GEP100-Delta PH, a pleckstrin homology (PH) domain deletion mutant of GEP100, blocked EGF-induced Arf6 activity and cell migration. EGF also increased ERK and Rac1 activity. Ectopic expression GEP100 siRNA, GEP100-Delta PH, or Arf6-T27N suppressed EGF-induced ERK and Rac1 activity. Furthermore, blocking ERK signaling with its inhibitor U0126 remarkably inhibited both EGF-induced Rac1 activation as well as cell migration, and ectopic expression of inactive mutant form of Rac1 (Rac1-T17N) also largely abolished EGF-induced cell migration. Conclusions/Significance: Taken together, this study highlights the function of the PH domain of GEP100 and its regulated Arf6/ERK/Rac1 signaling cascade in EGF-induced hepatoma cell migration. These findings could provide a rationale for designing new therapy based on inhibition of hepatoma metastasis.	[Hu, ZhenZhen; Zhu, YiChao; Yang, Yu] Nanjing Med Univ, Dept Physiol, Nanjing, Jiangsu, Peoples R China; [Hu, ZhenZhen; Zheng, DaTong] Nanjing Med Univ, Affiliated Hosp 2, Dept Pediat, Nanjing, Jiangsu, Peoples R China; [Du, Jun] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Yang, Ling] Suzhou Univ, Affiliated Hosp 3, Dept Cardiol, Suzhou 215006, Peoples R China; [Someya, Akimasa] Juntendo Univ, Sch Med, Dept Host Def & Biochem Res, Tokyo 113, Japan; [Gu, Luo] Nanjing Med Univ, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [Lu, Xiang] Nanjing Med Univ, Affiliated Hosp 2, Dept Geriatr, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Soochow University - China; Juntendo University; Nanjing Medical University; Nanjing Medical University	Hu, ZZ (corresponding author), Nanjing Med Univ, Dept Physiol, Nanjing, Jiangsu, Peoples R China.	lgu@njmu.edu.cn; Luxiang66@njmu.edu.cn		Hu, Zhenzhen/0000-0002-9892-6068	National Natural Science Foundation of China [30872926, 81172002]; Postdoctoral Science Foundation of Jiangsu Province; Postdoctoral Science Foundation of China [2011M501254]; Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University; State Key Laboratory of Reproductive Medicine, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of Jiangsu Province(China Postdoctoral Science Foundation); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University; State Key Laboratory of Reproductive Medicine, China	This work was supported by grants from the National Natural Science Foundation of China (No. 30872926, 81172002) to Dr. Luo Gu, the Postdoctoral Science Foundation of Jiangsu Province and the Postdoctoral Science Foundation of China (2011M501254) to Dr. Jun Du. This work was also partially supported by the research grants from Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, and State Key Laboratory of Reproductive Medicine, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Barnes CJ, 2003, MOL CANCER THER, V2, P345; Beier I, 2008, ATHEROSCLEROSIS, V196, P92, DOI 10.1016/j.atherosclerosis.2007.02.003; BORNANCIN F, 1993, J BIOL CHEM, V268, P17026; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; Criss AK, 2001, J CELL SCI, V114, P1331; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Du J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025213, 10.1371/journal.pone.0026204]; Du J, 2010, CELL PHYSIOL BIOCHEM, V25, P501, DOI 10.1159/000303055; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; GRAY A, 1983, NATURE, V303, P722, DOI 10.1038/303722a0; Hakoshima T, 2003, J BIOCHEM, V134, P327, DOI 10.1093/jb/mvg149; Hashimoto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023359; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; Hiroi T, 2006, P NATL ACAD SCI USA, V103, P10672, DOI 10.1073/pnas.0604091103; Hu B, 2009, CANCER RES, V69, P794, DOI 10.1158/0008-5472.CAN-08-2110; Ikeda S, 2005, CIRC RES, V96, P467, DOI 10.1161/01.RES.0000158286.51045.16; Jing J, 2009, EUR J CELL BIOL, V88, P325, DOI 10.1016/j.ejcb.2009.02.186; LaMarca HL, 2008, HUM REPROD, V23, P1733, DOI 10.1093/humrep/den178; Lee EJ, 2007, ANN NY ACAD SCI, V1095, P113, DOI 10.1196/annals.1397.015; Li M, 2009, CANCER-AM CANCER SOC, V115, P4959, DOI 10.1002/cncr.24550; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Muralidharan-Chari V, 2009, CANCER RES, V69, P2201, DOI 10.1158/0008-5472.CAN-08-1301; Palacios F, 2003, J BIOL CHEM, V278, P17395, DOI 10.1074/jbc.M300998200; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Price JT, 1999, CANCER RES, V59, P5475; Rathinam R, 2011, FRONT BIOSCI, V17, P2561; Ray RM, 2007, CELL MOTIL CYTOSKEL, V64, P143, DOI 10.1002/cm.20172; Sabe H, 2003, J BIOCHEM, V134, P485, DOI 10.1093/jb/mvg181; Sabe H, 2008, CELL ADHES MIGR, V2, P71, DOI 10.4161/cam.2.2.6191; Sabe H, 2009, TRAFFIC, V10, P982, DOI 10.1111/j.1600-0854.2009.00917.x; Saif MW, 2010, EXPERT OPIN INV DRUG, V19, P357, DOI 10.1517/13543781003593962; Sakurai A, 2011, J BIOL CHEM, V286, P34335, DOI 10.1074/jbc.M111.259499; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Tague SE, 2004, P NATL ACAD SCI USA, V101, P9671, DOI 10.1073/pnas.0403531101; Turbov JM, 2002, J SURG ONCOL, V79, P17, DOI 10.1002/jso.10033; Tushir JS, 2007, EMBO J, V26, P1806, DOI 10.1038/sj.emboj.7601644; Valderrama F, 2008, NAT CELL BIOL, V10, P16, DOI 10.1038/ncb0108-16; Venkateswarlu K, 2007, J CELL SCI, V120, P792, DOI 10.1242/jcs.03373; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Wang R., 2011, LUNG CANC; Woo CH, 2002, BIOCHEM BIOPH RES CO, V298, P392, DOI 10.1016/S0006-291X(02)02432-4; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Zhang Q, 1999, MOL CELL BIOL, V19, P8158	49	20	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38777	10.1371/journal.pone.0038777	http://dx.doi.org/10.1371/journal.pone.0038777			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701712	Green Published, Green Submitted, gold			2022-12-25	WOS:000305337600044
J	Pope, PB; Mackenzie, AK; Gregor, I; Smith, W; Sundset, MA; McHardy, AC; Morrison, M; Eijsink, VGH				Pope, Phillip B.; Mackenzie, Alasdair K.; Gregor, Ivan; Smith, Wendy; Sundset, Monica A.; McHardy, Alice C.; Morrison, Mark; Eijsink, Vincent G. H.			Metagenomics of the Svalbard Reindeer Rumen Microbiome Reveals Abundance of Polysaccharide Utilization Loci	PLOS ONE			English	Article							DATABASE; BACTERIAL; PROTEINS; GENES	Lignocellulosic biomass remains a largely untapped source of renewable energy predominantly due to its recalcitrance and an incomplete understanding of how this is overcome in nature. We present here a compositional and comparative analysis of metagenomic data pertaining to a natural biomass-converting ecosystem adapted to austere arctic nutritional conditions, namely the rumen microbiome of Svalbard reindeer (Rangifer tarandus platyrhynchus). Community analysis showed that deeply-branched cellulolytic lineages affiliated to the Bacteroidetes and Firmicutes are dominant, whilst sequence binning methods facilitated the assemblage of metagenomic sequence for a dominant and novel Bacteroidales clade (SRM-1). Analysis of unassembled metagenomic sequence as well as metabolic reconstruction of SRM-1 revealed the presence of multiple polysaccharide utilization loci-like systems (PULs) as well as members of more than 20 glycoside hydrolase and other carbohydrate-active enzyme families targeting various polysaccharides including cellulose, xylan and pectin. Functional screening of cloned metagenome fragments revealed high cellulolytic activity and an abundance of PULs that are rich in endoglucanases (GH5) but devoid of other common enzymes thought to be involved in cellulose degradation. Combining these results with known and partly re-evaluated metagenomic data strongly indicates that much like the human distal gut, the digestive system of herbivores harbours high numbers of deeply branched and as-yet uncultured members of the Bacteroidetes that depend on PUL-like systems for plant biomass degradation.	[Pope, Phillip B.; Mackenzie, Alasdair K.; Eijsink, Vincent G. H.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Gregor, Ivan; McHardy, Alice C.] Max Planck Inst Informat, Max Planck Res Grp Computat Genom & Epidemiol, Saarbrucken, Germany; [Gregor, Ivan; McHardy, Alice C.] Univ Dusseldorf, Dept Algorithm Bioinformat, D-40225 Dusseldorf, Germany; [Smith, Wendy; Morrison, Mark] CSIRO Livestock Ind, Queensland Biosci Precinct, St Lucia, Qld, Australia; [Sundset, Monica A.] Univ Tromso, Dept Arct & Marine Biol, Tromso, Norway	Norwegian University of Life Sciences; Max Planck Society; Heinrich Heine University Dusseldorf; Commonwealth Scientific & Industrial Research Organisation (CSIRO); UiT The Arctic University of Tromso	Pope, PB (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway.	phil.pope@umb.no	McHardy, Alice C/K-9377-2018; Morrison, Mark/C-9707-2013; McHardy, Alice/ABF-2322-2020; Pope, Phillip/AAQ-2251-2021	McHardy, Alice C/0000-0003-2370-3430; Morrison, Mark/0000-0001-9257-9133; McHardy, Alice/0000-0003-2370-3430; Pope, Phillip/0000-0002-2067-4059; Sundset, Monica Alterskjaer/0000-0002-4850-262X	Research Council of Norway's Bilateralt forskningssamarbeid - prosjektetablering (BILAT) program; European Commission [PIIF-GA-2010-274303]; Norwegian Research Council [190965/S60]; CSIRO's Livestock Industries, Queensland Bioscience Precinct Office of the Chief Executive (OCE); Max-Planck society; Heinrich-Heine University Dusseldorf	Research Council of Norway's Bilateralt forskningssamarbeid - prosjektetablering (BILAT) program(Research Council of Norway); European Commission(European CommissionEuropean Commission Joint Research Centre); Norwegian Research Council(Research Council of NorwayEuropean Commission); CSIRO's Livestock Industries, Queensland Bioscience Precinct Office of the Chief Executive (OCE); Max-Planck society(Max Planck SocietyFoundation CELLEX); Heinrich-Heine University Dusseldorf	The Svalbard reindeer project is partially supported by The Research Council of Norway's Bilateralt forskningssamarbeid - prosjektetablering (BILAT) program (awarded to VE) and the European Commission Marie Curie International Incoming Fellowship (awarded to PBP; PIIF-GA-2010-274303). AM is supported by a grant from the Norwegian Research Council (190965/S60). This work was performed in part under the auspices of the CSIRO's Livestock Industries, Queensland Bioscience Precinct Office of the Chief Executive (OCE) Science Leader program (awarded to MM). ACM and IG gratefully acknowledge support from the Max-Planck society and Heinrich-Heine University Dusseldorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bayer EA, 2008, CHEM REC, V8, P364, DOI 10.1002/tcr.20160; Borodovsky Mark, 2003, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0405s01; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Ding SY, 2001, J BACTERIOL, V183, P1945, DOI 10.1128/JB.183.6.1945-1953.2001; Dodd D, 2010, J BIOL CHEM, V285, P30261, DOI 10.1074/jbc.M110.141788; Duan CJ, 2009, J APPL MICROBIOL, V107, P245, DOI 10.1111/j.1365-2672.2009.04202.x; Duan CJ, 2010, BIOTECHNOL LETT, V32, P1765, DOI 10.1007/s10529-010-0356-z; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Mello LV, 2010, FEBS LETT, V584, P2421, DOI 10.1016/j.febslet.2010.04.045; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; ORPIN CG, 1985, APPL ENVIRON MICROB, V50, P144, DOI 10.1128/AEM.50.1.144-151.1985; Patil KR, 2011, NAT METHODS, V8, P191, DOI 10.1038/nmeth0311-191; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Popper ZA, 2003, ANN BOT-LONDON, V91, P1, DOI 10.1093/aob/mcg013; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rosewarne CP, 2011, MICROB ECOL, V61, P448, DOI 10.1007/s00248-010-9745-z; Sekelja M, 2011, ISME J, V5, P519, DOI 10.1038/ismej.2010.129; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000; Sormo W, 1999, J ZOOL, V247, P247, DOI 10.1017/S0952836999002125; Suen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018814; Sundset MA, 2007, MICROB ECOL, V54, P424, DOI 10.1007/s00248-007-9254-x; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269	40	127	142	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38571	10.1371/journal.pone.0038571	http://dx.doi.org/10.1371/journal.pone.0038571			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701672	Green Published, Green Submitted, gold			2022-12-25	WOS:000305348400075
J	Takayama, Y; Clore, GM				Takayama, Yuki; Clore, G. Marius			Impact of Protein/Protein Interactions on Global Intermolecular Translocation Rates of the Transcription Factors Sox2 and Oct1 between DNA Cognate Sites Analyzed by z-Exchange NMR Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARAMAGNETIC RELAXATION ENHANCEMENT; CHEMICAL-EXCHANGE; HETERONUCLEAR CORRELATION; CRYSTAL-STRUCTURE; POU DOMAIN; BINDING; COMPLEXES; ACTIVATION; HOMEODOMAIN; PROTEINS	Oct1 and Sox2 synergistically regulate developmental genes by binding to adjacent sites within promoters. We have investigated the kinetics of global intermolecular translocation of Sox2 and Oct1 between cognate sites located on different DNA molecules by z-exchange NMR spectroscopy. In the Hoxb1 promoter, the Sox2 and Oct1 sites are immediately adjacent to one another, and the intermolecular translocation rates are too slow to be measured by z-exchange spectroscopy. By introducing a 3-bp insertion between the Sox2 and Oct1 sites to mimic the spacing in the FGF4 enhancer, the interprotein contact surface is reduced, and the translocation rates are increased. Interaction between Sox2 and the POU-specific domain (POUS) of Oct1 does not affect the translocation mechanism but modulates the rates. Translocation involves only jumping (dissociation and reassociation) for Sox2, but both jumping and direct intersegment transfer (no dissociation into free solution) for Oct1. The dissociation (k(off) similar to 1.5 s(-1)) and association (k(on) similar to 5.1 x 10(9) M(-1)s(-1)) rate constants for Sox2 are reduced 4-fold and increased 5-fold, respectively, in the presence of Oct1. k(off) (similar to 3.5 s(-1)) for Oct1 is unaffected by Sox2, whereas k(on) (similar to 1.3 x 10(9) M(-1)s(-1)) is increased similar to 13-fold. The direct intermolecular translocation rate (k(inter) similar to 1.8 x 10(4)M(-1)s(-1)) for the POUS domain of Oct1 is reduced 2-fold by Sox2, whereas that for the POU homeodomain (POUHD) of Oct1 (k(inter) similar to 1.7 x 10(4) M(-1)s(-1)) remains unaltered, consistent with the absence of contacts between Sox2 and POUHD. The data suggest a model for the sequence of binding events involved in synergistic gene regulation by Sox2 and Oct1.	[Takayama, Yuki; Clore, G. Marius] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Clore, GM (corresponding author), NIDDK, Chem Phys Lab, NIH, Bldg 5, Bethesda, MD 20892 USA.	mariusc@intra.niddk.nih.gov	Clore, G Marius/L-2546-2018; Clore, G. Marius/A-3511-2008	Clore, G Marius/0000-0003-3809-1027; Clore, G. Marius/0000-0003-3809-1027	NIDDK, National Institutes of Health; AIDS Targeted Antiviral Program of the Office of the Director of the National Institutes of Health; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029023] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AIDS Targeted Antiviral Program of the Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the intramural program of NIDDK, National Institutes of Health and by the AIDS Targeted Antiviral Program of the Office of the Director of the National Institutes of Health (to G. M. C.).; Recipient of a Japan Society for the Promotion of Science Research Fellowship for Japanese Biomedical and Behavioral Researchers at the National Institutes of Health.	Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; Clore GM, 2011, J BIOMOL NMR, V51, P209, DOI 10.1007/s10858-011-9555-8; Clore GM, 2011, PROTEIN SCI, V20, P229, DOI 10.1002/pro.576; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Dailey L, 2001, J CELL PHYSIOL, V186, P315, DOI 10.1002/1097-4652(2001)9999:9999<000::AID-JCP1046>3.0.CO;2-Y; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Rocco G, 2001, J BIOL CHEM, V276, P20506, DOI 10.1074/jbc.M011175200; Doucleff M, 2008, P NATL ACAD SCI USA, V105, P13871, DOI 10.1073/pnas.0805050105; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Iwahara J, 2006, J AM CHEM SOC, V128, P404, DOI 10.1021/ja056786o; Iwahara J, 2004, J AM CHEM SOC, V126, P12800, DOI 10.1021/ja046246b; Iwahara J, 2003, J AM CHEM SOC, V125, P6634, DOI 10.1021/ja034488q; Iwahara J, 2006, P NATL ACAD SCI USA, V103, P15062, DOI 10.1073/pnas.0605868103; Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kang JS, 2009, TRENDS BIOCHEM SCI, V34, P491, DOI 10.1016/j.tibs.2009.06.003; KLEMM JD, 1994, CELL, V77, P21, DOI 10.1016/0092-8674(94)90231-3; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; MONTELIONE GT, 1989, J AM CHEM SOC, V111, P3096, DOI 10.1021/ja00190a072; Murphy EC, 2001, J MOL BIOL, V312, P481, DOI 10.1006/jmbi.2001.4977; PERRIN CL, 1990, CHEM REV, V90, P935, DOI 10.1021/cr00104a002; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Remenyi A, 2001, MOL CELL, V8, P569, DOI 10.1016/S1097-2765(01)00336-7; Sahu D, 2007, J AM CHEM SOC, V129, P13232, DOI 10.1021/ja074604f; Takayama Y, 2012, J BIOL CHEM, V287, P14349, DOI 10.1074/jbc.M112.352864; Takayama Y, 2011, P NATL ACAD SCI USA, V108, pE169, DOI 10.1073/pnas.1100050108; Vijayakumar M, 1998, J MOL BIOL, V278, P1015, DOI 10.1006/jmbi.1998.1747; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; Wolberger C, 1999, ANNU REV BIOPH BIOM, V28, P29, DOI 10.1146/annurev.biophys.28.1.29; Zhang J, 2012, HUM PATHOL, V43, P1405, DOI 10.1016/j.humpath.2011.10.016	36	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26962	26970		10.1074/jbc.M112.382960	http://dx.doi.org/10.1074/jbc.M112.382960			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22718759	Green Published, hybrid			2022-12-25	WOS:000307386000044
J	Wojtaszek, J; Liu, JX; D'Souza, S; Wang, S; Xue, YH; Walker, GC; Zhou, P				Wojtaszek, Jessica; Liu, Jiangxin; D'Souza, Sanjay; Wang, Su; Xue, Yaohua; Walker, Graham C.; Zhou, Pei			Multifaceted Recognition of Vertebrate Rev1 by Translesion Polymerases zeta and kappa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY DNA-POLYMERASES; SACCHAROMYCES-CEREVISIAE; PCNA UBIQUITINATION; C-TERMINUS; PROTEIN; REPAIR; MECHANISMS; TOLERANCE; COMPLEX; HREV1	Translesion synthesis is a fundamental biological process that enables DNA replication across lesion sites to ensure timely duplication of genetic information at the cost of replication fidelity, and it is implicated in development of cancer drug resistance after chemotherapy. The eukaryotic Y-family polymerase Rev1 is an essential scaffolding protein in translesion synthesis. Its C-terminal domain (CTD), which interacts with translesion polymerase zeta through the Rev7 subunit and with polymerases kappa, iota, and eta in vertebrates through the Rev1-interacting region (RIR), is absolutely required for function. We report the first solution structures of the mouse Rev1 CTD and its complex with the Pol kappa RIR, revealing an atypical four-helix bundle. Using yeast two-hybrid assays, we have identified a Rev7-binding surface centered at the alpha 2-alpha 3 loop and N-terminal half of alpha 3 of the Rev1 CTD. Binding of the mouse Pol kappa RIR to the Rev1 CTD induces folding of the disordered RIR peptide into a three-turn alpha-helix, with the helix stabilized by an N-terminal cap. RIR binding also induces folding of a disordered N-terminal loop of the Rev1 CTD into a beta-hairpin that projects over the shallow alpha 1-alpha 2 surface and creates a deep hydrophobic cavity to interact with the essential FF residues juxtaposed on the same side of the RIR helix. Our combined structural and biochemical studies reveal two distinct surfaces of the Rev1 CTD that separately mediate the assembly of extension and insertion translesion polymerase complexes and provide a molecular framework for developing novel cancer therapeutics to inhibit translesion synthesis.	[Wojtaszek, Jessica; Liu, Jiangxin; Wang, Su; Zhou, Pei] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [D'Souza, Sanjay; Walker, Graham C.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Xue, Yaohua] Duke Univ, Trinity Coll Arts & Sci, Durham, NC 27708 USA	Duke University; Massachusetts Institute of Technology (MIT); Duke University	Zhou, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	peizhou@biochem.duke.edu	Zhou, Pei/O-6704-2019	Zhou, Pei/0000-0002-7823-3416; Wojtaszek, Jessica/0000-0002-9108-2886; /0000-0001-7243-8261; Xue, Jenny/0000-0003-1192-1836	National Institutes of Health; NIGMS [GM-079376]; Stewart Trust Foundation; NIEHS [ES-015818]; American Cancer Society Research professorship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES015818, R01ES015818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stewart Trust Foundation; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Cancer Society Research professorship(American Cancer Society); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health, NIGMS GM-079376 and Stewart Trust Foundation (to P. Z.) and National Institutes of Health, NIEHS ES-015818 and an American Cancer Society Research professorship (to G. C. W.).	Acharya N, 2006, MOL CELL BIOL, V26, P9555, DOI 10.1128/MCB.01671-06; Akagi JI, 2009, DNA REPAIR, V8, P585, DOI 10.1016/j.dnarep.2008.12.006; Avkin S, 2006, MOL CELL, V22, P407, DOI 10.1016/j.molcel.2006.03.022; Baynton K, 1998, MOL CELL BIOL, V18, P960, DOI 10.1128/MCB.18.2.960; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Coggins BE, 2008, J BIOMOL NMR, V42, P225, DOI 10.1007/s10858-008-9275-x; D'Souza S, 2008, DNA REPAIR, V7, P1455, DOI 10.1016/j.dnarep.2008.05.009; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doles J, 2010, P NATL ACAD SCI USA, V107, P20786, DOI 10.1073/pnas.1011409107; Dumstorf CA, 2009, MOL CANCER RES, V7, P247, DOI 10.1158/1541-7786.MCR-08-0399; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Goddard T. D., 2008, SPARKY 3; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Hara K, 2010, J BIOL CHEM, V285, P12299, DOI 10.1074/jbc.M109.092403; Hendel A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002262; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; James P, 1996, GENETICS, V144, P1425; Kim H, 2012, NAT STRUCT MOL BIOL, V19, P164, DOI 10.1038/nsmb.2222; Kosarek JN, 2008, DNA REPAIR, V7, P439, DOI 10.1016/j.dnarep.2007.11.016; Krijger PHL, 2011, DNA REPAIR, V10, P1051, DOI 10.1016/j.dnarep.2011.08.005; Lawrence CW, 2004, ADV PROTEIN CHEM, V69, P167; LAWRENCE CW, 1985, MOL GEN GENET, V200, P80, DOI 10.1007/BF00383316; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; LEMONTT JF, 1971, GENETICS, V68, P21; Lin XJ, 2006, MOL CANCER THER, V5, P1239, DOI 10.1158/1535-7163.MCT-05-0491; Lin XJ, 2006, MOL PHARMACOL, V69, P1748, DOI 10.1124/mol.105.020446; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Livneh Z, 2010, CELL CYCLE, V9, P729, DOI 10.4161/cc.9.4.10727; LYU PC, 1993, BIOCHEMISTRY-US, V32, P421, DOI 10.1021/bi00053a006; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; Nelson JR, 2000, MOL MICROBIOL, V37, P549, DOI 10.1046/j.1365-2958.2000.01997.x; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Ogi T, 2002, P NATL ACAD SCI USA, V99, P15548, DOI 10.1073/pnas.222377899; Ohashi E, 2004, GENES CELLS, V9, P523, DOI 10.1111/j.1356-9597.2004.00747.x; Ohashi E, 2009, GENES CELLS, V14, P101, DOI 10.1111/j.1365-2443.2008.01255.x; Okuda T, 2005, MOL PHARMACOL, V67, P1852, DOI 10.1124/mol.104.010579; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Ross AL, 2005, NUCLEIC ACIDS RES, V33, P1280, DOI 10.1093/nar/gki279; Sabbioneda S, 2008, MOL BIOL CELL, V19, P5193, DOI 10.1091/mbc.E08-07-0724; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Stallons LJ, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/643857; Tissier A, 2004, DNA REPAIR, V3, P1503, DOI 10.1016/j.dnarep.2004.06.015; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Xie K, 2010, P NATL ACAD SCI USA, V107, P20792, DOI 10.1073/pnas.1011412107	52	67	67	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26400	26408		10.1074/jbc.M112.380998	http://dx.doi.org/10.1074/jbc.M112.380998			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22700975	hybrid, Green Published			2022-12-25	WOS:000306916300065
J	Shi, SP; Qiu, JD; Sun, XY; Suo, SB; Huang, SY; Liang, RP				Shi, Shao-Ping; Qiu, Jian-Ding; Sun, Xing-Yu; Suo, Sheng-Bao; Huang, Shu-Yun; Liang, Ru-Ping			PMeS: Prediction of Methylation Sites Based on Enhanced Feature Encoding Scheme	PLOS ONE			English	Article							PROTEIN ARGININE METHYLATION; POSTTRANSLATIONAL MODIFICATIONS; HISTONE; IDENTIFICATION; ACCESSIBILITY; SPECIFICITY; EXPRESSION; SULFATION; SEQUENCE; MODELS	Protein methylation is predominantly found on lysine and arginine residues, and carries many important biological functions, including gene regulation and signal transduction. Given their important involvement in gene expression, protein methylation and their regulatory enzymes are implicated in a variety of human disease states such as cancer, coronary heart disease and neurodegenerative disorders. Thus, identification of methylation sites can be very helpful for the drug designs of various related diseases. In this study, we developed a method called PMeS to improve the prediction of protein methylation sites based on an enhanced feature encoding scheme and support vector machine. The enhanced feature encoding scheme was composed of the sparse property coding, normalized van der Waals volume, position weight amino acid composition and accessible surface area. The PMeS achieved a promising performance with a sensitivity of 92.45%, a specificity of 93.18%, an accuracy of 92.82% and a Matthew's correlation coefficient of 85.69% for arginine as well as a sensitivity of 84.38%, a specificity of 93.94%, an accuracy of 89.16% and a Matthew's correlation coefficient of 78.68% for lysine in 10-fold cross validation. Compared with other existing methods, the PMeS provides better predictive performance and greater robustness. It can be anticipated that the PMeS might be useful to guide future experiments needed to identify potential methylation sites in proteins of interest. The online service is available at http://bioinfo.ncu.edu.cn/inquiries_PMeS.aspx.	[Shi, Shao-Ping; Qiu, Jian-Ding; Sun, Xing-Yu; Suo, Sheng-Bao; Huang, Shu-Yun; Liang, Ru-Ping] Nanchang Univ, Dept Chem, Nanchang, Peoples R China; [Shi, Shao-Ping] Nanchang Univ, Dept Math, Nanchang, Peoples R China	Nanchang University; Nanchang University	Shi, SP (corresponding author), Nanchang Univ, Dept Chem, Nanchang, Peoples R China.	jdqiu@ncu.edu.cn	Qiu, Jianding/A-2259-2012; Shi, Shaoping/AAV-9122-2020	Qiu, Jianding/0000-0002-6793-9499; Shi, Shaoping/0000-0003-0045-868X	National Natural Science Foundation of China [21175064, 21163014, 21065006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (21175064, 21163014 and 21065006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Ahmad S, 2003, PROTEINS, V50, P629, DOI 10.1002/prot.10328; Aleta JM, 1998, TRENDS BIOCHEM SCI, V23, P89, DOI 10.1016/S0968-0004(98)01185-2; Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen H, 2006, NUCLEIC ACIDS RES, V34, pW249, DOI 10.1093/nar/gkl233; Chen X, 2006, BASIC RES CARDIOL, V101, P346, DOI 10.1007/s00395-006-0592-5; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Couture JF, 2007, NAT STRUCT MOL BIOL, V14, P689, DOI 10.1038/nsmb1273; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Daily KM, 2005, PROCEEDINGS OF THE 2005 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P475; Dolzhanskaya N, 2006, J CELL SCI, V119, P1933, DOI 10.1242/jcs.02882; Dong LH, 2006, J BIOMOL STRUCT DYN, V24, P239; FAUCHERE JL, 1988, INT J PEPT PROT RES, V32, P269; Gao JJ, 2010, MOL CELL PROTEOMICS, V9, P2586, DOI 10.1074/mcp.M110.001388; Hu LL, 2011, BIOPOLYMERS, V95, P763, DOI 10.1002/bip.21645; Johnson DS, 2008, GENOME RES, V18, P393, DOI 10.1101/gr.7080508; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Lapko VN, 2005, PROTEIN SCI, V14, P45, DOI 10.1110/ps.04738505; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Mastronardi FG, 2006, J NEUROSCI, V26, P11387, DOI 10.1523/JNEUROSCI.3349-06.2006; Nanni L, 2011, EXPERT SYST APPL, V38, P3185, DOI 10.1016/j.eswa.2010.09.005; Niu S, 2010, J PROTEOME RES, V9, P6490, DOI 10.1021/pr1007152; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; PAIK WK, 1967, BIOCHEM BIOPH RES CO, V29, P14, DOI 10.1016/0006-291X(67)90533-5; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; Pang CNI, 2007, J PROTEOME RES, V6, P1833, DOI 10.1021/pr060674u; Pang CNI, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-92; Plewczynski D, 2005, BIOINFORMATICS, V21, P2525, DOI 10.1093/bioinformatics/bti333; Predel R, 1999, EUR J BIOCHEM, V263, P552, DOI 10.1046/j.1432-1327.1999.00532.x; Rognvaldsson T, 2007, EXPERT REV MOL DIAGN, V7, P435, DOI 10.1586/14737159.7.4.435; Rognvaldsson T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-149; Rudbeck ME, 2012, J PHYS CHEM B, V116, P2751, DOI 10.1021/jp206414d; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Shao JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004920; Shien DM, 2009, J COMPUT CHEM, V30, P1532, DOI 10.1002/jcc.21232; Shukla A, 2009, CELL MOL LIFE SCI, V66, P1419, DOI 10.1007/s00018-008-8605-1; Snijders APL, 2010, J AM SOC MASS SPECTR, V21, P88, DOI 10.1016/j.jasms.2009.09.010; Stallcup MR, 2001, ONCOGENE, V20, P3014, DOI 10.1038/sj.onc.1204325; Suzuki A, 2007, ANN NY ACAD SCI, V1108, P323, DOI 10.1196/annals.1422.034; Teyssier C, 2010, TRENDS ENDOCRIN MET, V21, P181, DOI 10.1016/j.tem.2009.11.002; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Wooderchak WL, 2008, BIOCHEMISTRY-US, V47, P9456, DOI 10.1021/bi800984s; Xiao B, 2003, CURR OPIN STRUC BIOL, V13, P699, DOI 10.1016/j.sbi.2003.10.003; Xu JL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-8; Zhang ZH, 2006, FEBS LETT, V580, P6169, DOI 10.1016/j.febslet.2006.10.017	49	69	70	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38772	10.1371/journal.pone.0038772	http://dx.doi.org/10.1371/journal.pone.0038772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719939	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350000023
J	Cantarel, BL; Lombard, V; Henrissat, B				Cantarel, Brandi L.; Lombard, Vincent; Henrissat, Bernard			Complex Carbohydrate Utilization by the Healthy Human Microbiome	PLOS ONE			English	Article							GUT MICROBIOME; CLASSIFICATION; METAGENOMICS; CELLULOSOMES; DEGRADATION; BACTERIA; GENOMES	The various ecological habitats in the human body provide microbes a wide array of nutrient sources and survival challenges. Advances in technology such as DNA sequencing have allowed a deeper perspective into the molecular function of the human microbiota than has been achievable in the past. Here we aimed to examine the enzymes that cleave complex carbohydrates (CAZymes) in the human microbiome in order to determine (i) whether the CAZyme profiles of bacterial genomes are more similar within body sites or bacterial families and (ii) the sugar degradation and utilization capabilities of microbial communities inhabiting various human habitats. Upon examination of 493 bacterial references genomes from 12 human habitats, we found that sugar degradation capabilities of taxa are more similar to others in the same bacterial family than to those inhabiting the same habitat. Yet, the analysis of 520 metagenomic samples from five major body sites show that even when the community composition varies the CAZyme profiles are very similar within a body site, suggesting that the observed functional profile and microbial habitation have adapted to the local carbohydrate composition. When broad sugar utilization was compared within the five major body sites, the gastrointestinal track contained the highest potential for total sugar degradation, while dextran and peptidoglycan degradation were highest in oral and vaginal sites respectively. Our analysis suggests that the carbohydrate composition of each body site has a profound influence and probably constitutes one of the major driving forces that shapes the community composition and therefore the CAZyme profile of the local microbial communities, which in turn reflects the microbiome fitness to a body site.	[Cantarel, Brandi L.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Lombard, Vincent; Henrissat, Bernard] Aix Marseille Univ, Ctr Natl Rech Sci, Marseille, France	University System of Maryland; University of Maryland Baltimore; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Cantarel, BL (corresponding author), Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA.	bcantarel@som.umaryland.edu	Henrissat, Bernard/J-2475-2012; Cantarel, Brandi/ABF-5756-2020	Henrissat, Bernard/0000-0002-3434-8588; Cantarel, Brandi/0000-0003-4126-4478; Lombard, Vincent/0000-0002-9684-7067	National Institutes of Health [1U01HG004866-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004866] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The data analysis was funded by National Institutes of Health grant number 1U01HG004866-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubucker S, 2011, PLOS COMP B IN PRESS; [Anonymous], 1957, KONGELIGE DANSKE VID; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carpita NC, 1996, ANNU REV PLANT PHYS, V47, P445, DOI 10.1146/annurev.arplant.47.1.445; Consortium HMP, 2011, NATURE UNPUB; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Gorshkova TA, 1996, PLANT PHYSIOL, V110, P721, DOI 10.1104/pp.110.3.721; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1985, BIO-TECHNOL, V3, P722, DOI 10.1038/nbt0885-722; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hu YN, 2002, CHEM BIOL, V9, P1287, DOI 10.1016/S1074-5521(02)00295-8; Jones BV, 2007, NAT METHODS, V4, P55, DOI 10.1038/NMETH964; LAINE RA, 1994, GLYCOBIOLOGY, V4, P759, DOI 10.1093/glycob/4.6.759; Lozupone CA, 2008, P NATL ACAD SCI USA, V105, P15076, DOI 10.1073/pnas.0807339105; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (NC-IUBMB), 1999, EUROPEAN J BIOCH, V264, P610; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Roberts AP, 2008, PLASMID, V60, P167, DOI 10.1016/j.plasmid.2008.08.001; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Tamames J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-136; Tasse L, 2010, GENOME RES, V20, P1605, DOI 10.1101/gr.108332.110; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Turnbaugh PJ, 2010, ACTA CRYSTALLOGR F, V66, P1261, DOI 10.1107/S1744309110029088; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Varki A, 2009, HIST BACKGROUND OVER; Varki Ajit, 1999; WANG TCV, 1991, BIOCHIMIE, V73, P335, DOI 10.1016/0300-9084(91)90221-L; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	42	214	225	5	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e28742	10.1371/journal.pone.0028742	http://dx.doi.org/10.1371/journal.pone.0028742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719820	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900003
J	Catarino, R; Coelho, A; Araujo, A; Gomes, M; Nogueira, A; Lopes, C; Medeiros, R				Catarino, Raquel; Coelho, Ana; Araujo, Antonio; Gomes, Monica; Nogueira, Augusto; Lopes, Carlos; Medeiros, Rui			Circulating DNA: Diagnostic Tool and Predictive Marker for Overall Survival of NSCLC Patients	PLOS ONE			English	Article							CELL LUNG-CANCER; MESSENGER-RNA EXPRESSION; PLASMA DNA; NUCLEIC-ACIDS; TUMOR DNA; QUANTITATIVE-ANALYSIS; PROGNOSTIC VALUE; FOLLOW-UP; QUANTIFICATION; SERUM	Purpose: The purpose of our study was to determine whether the amounts of circulating DNA (cDNA) could discriminate between NSCLC patients and healthy individuals and assess its value as a prognostic marker of this disease. Methods: We conducted a study of 309 individuals and the cDNA levels were assessed through real-time PCR methodology. Results: We found increased cDNA levels in NSCLC patients compared to control individuals. We also found a decreased overall survival time in patients presenting high cDNA levels, when compared to lower cDNA concentrations. Conclusions: Quantification of cDNA may be a good tool for NSCLC detection with potential for clinical applicability.	[Catarino, Raquel; Coelho, Ana; Gomes, Monica; Nogueira, Augusto; Lopes, Carlos; Medeiros, Rui] Portuguese Inst Oncol, Mol Oncol Grp Invest Ctr, Oporto, Portugal; [Araujo, Antonio] Portuguese Inst Oncol, Dept Med Oncol, Oporto, Portugal; [Lopes, Carlos; Medeiros, Rui] Abel Salazar Inst Biomed Sci, Oporto, Portugal; [Medeiros, Rui] Portuguese League Canc N, Res Dept, Oporto, Portugal; [Medeiros, Rui] Fernando Pessoa Univ, CEBIMED, Fac Hlth Sci, Oporto, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade do Porto; Universidade Fernando Pessoa	Catarino, R (corresponding author), Portuguese Inst Oncol, Mol Oncol Grp Invest Ctr, Oporto, Portugal.	raquelcatarino@yahoo.com	Medeiros, Rui/C-7938-2009; Araújo, António/B-5047-2008	Medeiros, Rui/0000-0003-3010-8373; Araújo, António/0000-0002-7267-3584; Lopes, Carlos/0000-0003-3209-8447; Catarino, Raquel/0000-0001-6320-0788; Gomes, Monica/0000-0001-9947-5775	Ministry of Health of Portugal; Ministery of Science, Technology and Superior Education-FCT (Fundacao para a Ciencia e Tecnologia) [SFRH/BPD/72932/2010]	Ministry of Health of Portugal; Ministery of Science, Technology and Superior Education-FCT (Fundacao para a Ciencia e Tecnologia)	The authors acknowledge funding of this work by the Ministry of Health of Portugal. The authors also gratefully acknowledge the financial support of an individual post-doctoral grant of the first author from the Ministery of Science, Technology and Superior Education-FCT (Fundacao para a Ciencia e Tecnologia: SFRH/BPD/72932/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker P, 1999, CANCER METAST REV, V18, P65, DOI 10.1023/A:1006260319913; Beau-Faller M, 2003, INT J CANCER, V105, P361, DOI 10.1002/ijc.11079; Bremnes RM, 2005, LUNG CANCER, V49, P1, DOI 10.1016/j.lungcan.2004.12.008; Brundage MD, 2002, CHEST, V122, P1037, DOI 10.1378/chest.122.3.1037; Bunn PA, 2003, J CLIN ONCOL, V21, P3891, DOI 10.1200/JCO.2003.07.976; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Catarino R, 2008, BIOCHEM BIOPH RES CO, V370, P118, DOI 10.1016/j.bbrc.2008.03.039; Catarino R, 2007, EJC SUPPL, V5, P184; de Geus-Oei LF, 2007, CANCER-AM CANCER SOC, V110, P1654, DOI 10.1002/cncr.22979; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Esteller M, 1999, CANCER RES, V59, P67; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Frattini M, 2005, J CLIN ONCOL, V23, P3163, DOI 10.1200/JCO.2005.05.430; Gal S, 2004, BRIT J CANCER, V90, P1211, DOI 10.1038/sj.bjc.6601609; Gautschi O, 2004, J CLIN ONCOL, V22, P4157, DOI 10.1200/JCO.2004.11.123; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Herrera LJ, 2005, CLIN CHEM, V51, P113, DOI 10.1373/clinchem.2004.039263; Huang ZH, 2006, CANCER LETT, V243, P64, DOI 10.1016/j.canlet.2005.11.027; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; Johnson PJ, 2002, CLIN CHEM, V48, P1186; Laktionov PP, 2004, NUCLEOS NUCLEOT NUCL, V23, P879, DOI 10.1081/NCN-200026035; LEON SA, 1977, CANCER RES, V37, P646; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; MAO L, 1994, CANCER RES, V54, P1634; Metzger R, 2009, ANTICANCER RES, V29, P1157; Paci M, 2009, LUNG CANCER, V64, P92, DOI 10.1016/j.lungcan.2008.07.012; Pathak AK, 2006, CLIN CHEM, V52, P1833, DOI 10.1373/clinchem.2005.062893; Sethi T, 2002, THORAX, V57, P992, DOI 10.1136/thorax.57.11.992; Silva JM, 2002, CLIN CANCER RES, V8, P3761; Silva JM, 2002, GUT, V50, P530, DOI 10.1136/gut.50.4.530; Skvortsova TE, 2006, BRIT J CANCER, V94, P1492, DOI 10.1038/sj.bjc.6603117; Sozzi G, 2005, J NATL CANCER I, V97, P1848, DOI 10.1093/jnci/dji432; Sozzi G, 2003, J CLIN ONCOL, V21, P3902, DOI 10.1200/JCO.2003.02.006; Sozzi G, 2001, CANCER RES, V61, P4675; Sozzi G, 2009, AM J RESP CRIT CARE, V179, P69, DOI 10.1164/rccm.200807-1068OC; Van den Berg RM, 2010, INT J ONCOL, V37, P455, DOI 10.3892/ijo_00000694; van der Drift MA, 2010, LUNG CANCER, V68, P283, DOI 10.1016/j.lungcan.2009.06.021; Wakelee HA, 2006, CANCER-AM CANCER SOC, V106, P2208, DOI 10.1002/cncr.21869; Xie GS, 2004, CHINESE MED J-PEKING, V117, P1485; Zhang RF, 2010, LUNG CANCER, V69, P225, DOI 10.1016/j.lungcan.2009.11.009; Ziegler A, 2002, CANCER TREAT REV, V28, P255, DOI 10.1016/S0305-7372(02)00077-4	42	53	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38559	10.1371/journal.pone.0038559	http://dx.doi.org/10.1371/journal.pone.0038559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701665	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340000032
J	Menzaghi, C; Salvemini, L; Fini, G; Thompson, R; Mangiacotti, D; Di Paola, R; Morini, E; Giorelli, M; De Bonis, C; De Cosmo, S; Doria, A; Trischitta, V				Menzaghi, Claudia; Salvemini, Lucia; Fini, Grazia; Thompson, Ryan; Mangiacotti, Davide; Di Paola, Rosa; Morini, Eleonora; Giorelli, Maddalena; De Bonis, Concetta; De Cosmo, Salvatore; Doria, Alessandro; Trischitta, Vincenzo			Serum Resistin and Kidney Function: A Family-Based Study in Non-Diabetic, Untreated Individuals	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; INSULIN-RESISTANCE; RENAL-FUNCTION; CARDIOVASCULAR-DISEASE; CIRCULATING RESISTIN; ADIPONECTIN; ASSOCIATION; CAUCASIANS; INFLAMMATION; LEPTIN	Background: High serum resistin levels have been associated with kidney dysfunction. Most of these studies have been carried out in individuals with severe kidney impairment, diabetes, cardiovascular disease and related treatments. Thus, the observed association might have been influenced by these confounders. Our aim was to study the relationship between serum resistin, urinary albumin/creatinine ratio (ACR) and glomerular filtration rate (GFR) in a family-based sample, the Gargano Family Study (GFS) of 635 non diabetic, untreated Whites. Methods: A linear mixed effects model and bivariate analyses were used to evaluate the phenotypic and genetic relations between serum resistin and both ACR and eGFR. All analyses were adjusted for sex, age, age squared, BMI, systolic blood pressure, smoking habits and physical exercise. Results: After adjustments, resistin levels were slightly positively associated with ACR (beta +/- SE = 0.049 +/- 0.023, p = 0.035) and inversely related to eGFR (beta +/- SE = 21.43 +/- 0.61, p = 0.018) levels. These associations remained significant when either eGFR or ACR were, reciprocally, added as covariates. A genetic correlation (rho g = -0.31 +/- 0.12; adjusted p = 0.013) was observed between resistin and eGFR (but not ACR) levels. Conclusion: Serum resistin levels are independently associated with ACR and eGFR in untreated non-diabetic individuals. Serum resistin and eGFR share also some common genetic background. Our data strongly suggest that resistin plays a role in modulating kidney function.	[Menzaghi, Claudia; Salvemini, Lucia; Fini, Grazia; Mangiacotti, Davide; Di Paola, Rosa; Morini, Eleonora; Giorelli, Maddalena; De Bonis, Concetta; Trischitta, Vincenzo] IRCCS Casa Sollievo Sofferenza San Giovanni Roton, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy; [Thompson, Ryan; Doria, Alessandro] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [De Cosmo, Salvatore] IRCCS Casa Sollievo Sofferenza, Unit Endocrinol, San Giovanni Rotondo, Italy; [Doria, Alessandro] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Trischitta, Vincenzo] IRCSS Casa Sollievo Sofferenza,Rome, Mendel Lab, Rome, Italy; [Trischitta, Vincenzo] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	IRCCS Casa Sollievo Della Sofferenza; Harvard University; Joslin Diabetes Center, Inc.; IRCCS Casa Sollievo Della Sofferenza; Harvard University; Harvard Medical School; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Sapienza University Rome	Menzaghi, C (corresponding author), IRCCS Casa Sollievo Sofferenza San Giovanni Roton, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy.	c.menzaghi@operapadrepio.it; v.trischitta@operapadrepio.it	Salvemini, Lucia/K-2121-2016; De Cosmo, Salvatore/J-7420-2016; Trischitta, Vincenzo/K-1487-2016; mangiacotti, davide/AAM-8142-2020; fini, grazia/AAM-3320-2020; DE BONIS, CONCETTA/AAM-8146-2020; Menzaghi, Claudia/J-7210-2016; Di Paola, Rosa/G-7813-2011; Doria, Alessandro/H-9157-2018	Salvemini, Lucia/0000-0001-8776-9477; De Cosmo, Salvatore/0000-0001-8787-8286; Trischitta, Vincenzo/0000-0003-1174-127X; Menzaghi, Claudia/0000-0002-7438-8955; Di Paola, Rosa/0000-0001-5837-9111; Doria, Alessandro/0000-0002-3830-4304	Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PST; Italian Ministry of Health [RC2011]; EFSD/Pfizer; National Institutes of Health [HL073168]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073168] Funding Source: NIH RePORTER	Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PST; Italian Ministry of Health(Ministry of Health, Italy); EFSD/Pfizer(Pfizer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PST 2006, an Italian Ministry of Health grant (RC2011), a EFSD/Pfizer grant (C. M.) and National Institutes of Health grant HL073168 (A. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Almasy L., 2010, COLD SPRING HARB PRO; Axelsson J, 2006, KIDNEY INT, V69, P596, DOI 10.1038/sj.ki.5000089; Chen CY, 2010, AM J PHYSIOL-HEART C, V299, pH193, DOI 10.1152/ajpheart.00431.2009; COMUZZIE AG, 1994, INT J OBESITY, V18, P413; De Cosmo S, 2006, DIABETES CARE, V29, P432, DOI 10.2337/diacare.29.02.06.dc05-1841; Diez JJ, 2005, CLIN ENDOCRINOL, V62, P242, DOI 10.1111/j.1365-2265.2005.02207.x; Ellington AA, 2007, HYPERTENSION, V50, P708, DOI 10.1161/HYPERTENSIONAHA.107.095257; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Kawamura R, 2010, NEPHROL DIAL TRANSPL, V25, P3236, DOI 10.1093/ndt/gfq155; Koh KK, 2010, INT J CARDIOL, V140, P73, DOI 10.1016/j.ijcard.2008.11.017; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Ma XW, 2002, J CLIN ENDOCR METAB, V87, P4407, DOI 10.1210/jc.2002-020109; Menzaghi C, 2010, J INTERN MED, V267, P287, DOI 10.1111/j.1365-2796.2009.02141.x; Menzaghi C, 2010, DIABETOLOGIA, V53, P226, DOI 10.1007/s00125-009-1589-z; Menzaghi C, 2011, DIABETOLOGIA; Menzaghi C, 2006, J CLIN ENDOCR METAB, V91, P2792, DOI 10.1210/jc.2005-2715; Nusken KD, 2006, NEPHROL DIAL TRANSPL, V21, P107, DOI 10.1093/ndt/gfi084; Osawa H, 2004, AM J HUM GENET, V75, P678, DOI 10.1086/424761; Ott J, 2011, NAT REV GENET, V12, P465, DOI 10.1038/nrg2989; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Risch L, 2007, CLIN CHIM ACTA, V376, P108, DOI 10.1016/j.cca.2006.07.026; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x; Tsioufis C, 2010, AM J HYPERTENS, V23, P681, DOI 10.1038/ajh.2010.34; von Eynatten M, 2005, DIABETES CARE, V28, P754, DOI 10.2337/diacare.28.3.754; Yilmaz MI, 2007, CLIN NEPHROL, V68, P1; Zoccali C, 2008, NEPHROL DIAL TRANSPL, V23, P783, DOI 10.1093/ndt/gfm924; Zoccali C, 2008, NEPHROL DIAL TRANSPL, V23, P3767, DOI 10.1093/ndt/gfn517	30	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38414	10.1371/journal.pone.0038414	http://dx.doi.org/10.1371/journal.pone.0038414			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701635	Green Submitted, gold, Green Published			2022-12-25	WOS:000305340000021
J	Elling, L; Schupp, H; Bayer, J; Brockelmann, AK; Steinberg, C; Dobel, C; Junghofer, M				Elling, Ludger; Schupp, Harald; Bayer, Janine; Broeckelmann, Ann-Kathrin; Steinberg, Christian; Dobel, Christian; Junghofer, Markus			The Impact of Acute Psychosocial Stress on Magnetoencephalographic Correlates of Emotional Attention and Exogenous Visual Attention	PLOS ONE			English	Article							SALIVARY ALPHA-AMYLASE; SELF-REPORTED STRESS; BLOOD-BRAIN-BARRIER; SEX-DIFFERENCES; WORKING-MEMORY; COGNITIVE FLEXIBILITY; PSYCHOLOGICAL STRESS; PREFRONTAL CORTEX; NEURAL MECHANISMS; SPATIAL ATTENTION	Stress-induced acute activation of the cerebral catecholaminergic systems has often been found in rodents. However, little is known regarding the consequences of this activation on higher cognitive functions in humans. Theoretical inferences would suggest increased distractibility in the sense of increased exogenous attention and emotional attention. The present study investigated the influence of acute stress responses on magnetoencephalographic (MEG) correlates of visual attention. Healthy male subjects were presented emotional and neutral pictures in three subsequent MEG recording sessions after being exposed to a TSST-like social stressor, intended to trigger a HPA-response. The subjects anticipation of another follow-up stressor was designed to sustain the short-lived central catecholaminergic stress reactions throughout the ongoing MEG recordings. The heart rate indicates a stable level of anticipatory stress during this time span, subsequent cortisol concentrations and self-report measures of stress were increased. With regard to the MEG correlates of attentional functions, we found that the N1m amplitude remained constantly elevated during stressor anticipation. The magnetic early posterior negativity (EPNm) was present but, surprisingly, was not at all modulated during stressor anticipation. This suggests that a general increase of the influence of exogenous attention but no specific effect regarding emotional attention in this time interval. Regarding the time course of the effects, an influence of the HPA on these MEG correlates of attention seems less likely. An influence of cerebral catecholaminergic systems is plausible, but not definite.	[Elling, Ludger; Broeckelmann, Ann-Kathrin; Steinberg, Christian; Dobel, Christian; Junghofer, Markus] Univ Hosp Muenster, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Schupp, Harald] Univ Konstanz, Dept Psychol, Constance, Germany; [Bayer, Janine] Univ Hosp Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany	University of Munster; University of Konstanz; University of Hamburg; University Medical Center Hamburg-Eppendorf	Elling, L (corresponding author), Univ Hosp Muenster, Inst Biomagnetism & Biosignalanal, Munster, Germany.	ellingl@uni-muenster.de	Bayer, Janine/AAS-1939-2021; Junghoefer, Markus/AAA-2892-2021	Bayer, Janine/0000-0003-4681-4571; Junghoefer, Markus/0000-0002-8532-2986	Deutsche Forschungsgemeinschaft [DFG-FOR 751-JU445/4.2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was funded by the Deutsche Forschungsgemeinschaft (DFG-FOR 751-JU445/4.2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams RA, 2006, PERCEPT PSYCHOPHYS, V68, P114, DOI 10.3758/BF03193661; Al'Absi M, 2002, PSYCHOPHYSIOLOGY, V39, P95, DOI 10.1017/S0048577202001543; Alexander JK, 2007, J COGNITIVE NEUROSCI, V19, P468, DOI 10.1162/jocn.2007.19.3.468; Arnsten AFT, 1998, SCIENCE, V280, P1711, DOI 10.1126/science.280.5370.1711; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; BANKS WA, 1995, PEPTIDES, V16, P1157, DOI 10.1016/0196-9781(95)00043-J; Benarroch EE, 2009, NEUROLOGY, V73, P1699, DOI 10.1212/WNL.0b013e3181c2937c; Bradley MM, 2007, PSYCHOPHYSIOLOGY, V44, P364, DOI 10.1111/j.1469-8986.2007.00520.x; Braunstein-Bercovitz H, 2003, ANXIETY STRESS COPIN, V16, P345, DOI 10.1080/10615800310000112560; Bublatzky F, SOC COGN AF IN PRESS; Calvo MG, 2007, J EXP PSYCHOL GEN, V136, P347, DOI 10.1037/0096-3445.136.3.347; Carretie L, 2003, PSYCHOPHYSIOLOGY, V40, P381, DOI 10.1111/1469-8986.00041; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cousijn H, 2010, P NATL ACAD SCI USA, V107, P9867, DOI 10.1073/pnas.1003514107; COX T, 1985, BRIT J PSYCHOL, V76, P183, DOI 10.1111/j.2044-8295.1985.tb01941.x; de Kloet ER, 2008, FRONT NEUROENDOCRIN, V29, P268, DOI 10.1016/j.yfrne.2007.10.002; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Dedovic K, 2005, J PSYCHIATR NEUROSCI, V30, P319; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Doallo S, 2007, NEUROSCI LETT, V418, P111, DOI 10.1016/j.neulet.2007.03.009; Ellenbogen MA, 2009, BEHAV RES THER, V47, P128, DOI 10.1016/j.brat.2008.10.021; Elling L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018009; Goldstein JM, 2005, J NEUROSCI, V25, P9309, DOI 10.1523/JNEUROSCI.2239-05.2005; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hauk O, 2004, NEUROIMAGE, V21, P1612, DOI 10.1016/j.neuroimage.2003.12.018; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Hoffman R, 2004, ARCH CLIN NEUROPSYCH, V19, P497, DOI 10.1016/j.acn.2003.07.005; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Junghofer M, 2006, PROG BRAIN RES, V156, P123, DOI 10.1016/S0079-6123(06)56007-8; Junghofer M, 2000, PSYCHOPHYSIOLOGY, V37, P523, DOI 10.1111/1469-8986.3740523; Junghofer M, 2001, PSYCHOPHYSIOLOGY, V38, P175, DOI 10.1017/S0048577201000762; Keil A, 2001, CLIN NEUROPHYSIOL, V112, P2057, DOI 10.1016/S1388-2457(01)00654-X; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; KIRSCHBAUM C, 1992, PSYCHOSOM MED, V54, P648, DOI 10.1097/00006842-199211000-00004; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; KIRSCHBAUM C, 1989, NEUROPSYCHOBIOLOGY, V22, P150, DOI 10.1159/000118611; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004; Lang P. J., 2005, A6 U FLOR, DOI DOI 10.1027/0269-8803/A000147; Lang P. J., 1997, NIMH CTR STUDY EMOTI, P39; LAVIE N, 1994, PERCEPT PSYCHOPHYS, V56, P183, DOI 10.3758/BF03213897; Lithari C, 2010, BRAIN TOPOGR, V23, P27, DOI 10.1007/s10548-009-0130-5; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; MACKAY C, 1978, BRIT J SOC CLIN PSYC, V17, P283, DOI 10.1111/j.2044-8260.1978.tb00280.x; Martins JM, 1996, NEUROENDOCRINOLOGY, V63, P338; Muller MM, 2008, CEREB CORTEX, V18, P1892, DOI 10.1093/cercor/bhm215; Natale E, 2006, EUR J NEUROSCI, V23, P2511, DOI 10.1111/j.1460-9568.2006.04756.x; Nater UM, 2005, INT J PSYCHOPHYSIOL, V55, P333, DOI 10.1016/j.ijpsycho.2004.09.009; Oei NYL, 2006, STRESS, V9, P133, DOI 10.1080/10253890600965773; Oei NYL, 2011, SOCIAL COGNITIVE AFF; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; PARDRIDGE WM, 1983, ANNU REV PHYSIOL, V45, P73, DOI 10.1146/annurev.ph.45.030183.000445; Pessoa L, 2002, COGNITIVE BRAIN RES, V15, P31, DOI 10.1016/S0926-6410(02)00214-8; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Pessoa L, 2003, J NEUROSCI, V23, P3990; Peyk P, 2008, BRAIN TOPOGR, V20, P205, DOI 10.1007/s10548-008-0052-7; Peyk P, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/861705; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Plessow F, 2011, J COGNITIVE NEUROSCI, V23, P3218, DOI 10.1162/jocn_a_00024; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; REMINGTON RW, 1992, PERCEPT PSYCHOPHYS, V51, P279, DOI 10.3758/BF03212254; Rohleder N, 2006, PSYCHOPHYSIOLOGY, V43, P645, DOI 10.1111/j.1469-8986.2006.00457.x; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schimmack U, 1998, DIAGNOSTICA, V44, P166; Schoofs D, 2008, PSYCHONEUROENDOCRINO, V33, P643, DOI 10.1016/j.psyneuen.2008.02.004; Schupp HT, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-16; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Schupp HT, 2007, J NEUROSCI, V27, P1082, DOI 10.1523/JNEUROSCI.3223-06.2007; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Schupp HT, 2003, NEUROREPORT, V14, P1107, DOI 10.1097/00001756-200306110-00002; Schupp HT, 2003, PSYCHOL SCI, V14, P7, DOI 10.1111/1467-9280.01411; Shackman AJ, 2011, J NEUROSCI, V31, P1156, DOI 10.1523/JNEUROSCI.3384-10.2011; Simoens VL, 2007, PSYCHOPHYSIOLOGY, V44, P30, DOI 10.1111/j.1469-8986.2006.00476.x; Skosnik PD, 2000, INT J PSYCHOPHYSIOL, V36, P59, DOI 10.1016/S0167-8760(99)00100-2; Southwick SM, 1999, BIOL PSYCHIAT, V46, P1192, DOI 10.1016/S0006-3223(99)00219-X; Stark R, 2006, NEUROIMAGE, V32, P1290, DOI 10.1016/j.neuroimage.2006.05.046; Steyer, 1997, MEHRDIMENSIONALE BEF; Strawn JR, 2008, DEPRESS ANXIETY, V25, P260, DOI 10.1002/da.20292; Taylor VA, 2011, BIOL PSYCHOL, V86, P17, DOI 10.1016/j.biopsycho.2010.10.001; Valentino RJ, 2008, EUR J PHARMACOL, V583, P194, DOI 10.1016/j.ejphar.2007.11.062; van Marle HJF, 2009, BIOL PSYCHIAT, V66, P649, DOI 10.1016/j.biopsych.2009.05.014; Veer IM, 2011, NEUROIMAGE, V57, P1534, DOI 10.1016/j.neuroimage.2011.05.074; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2009, CURR DIR PSYCHOL SCI, V18, P148, DOI 10.1111/j.1467-8721.2009.01626.x; WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.4770130405; Wittchen H.-U., 1997, SKID STRUKTURIERTES; ZLOKOVIC BV, 1990, BIOCHIM BIOPHYS ACTA, V1025, P191, DOI 10.1016/0005-2736(90)90097-8	94	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e35767	10.1371/journal.pone.0035767	http://dx.doi.org/10.1371/journal.pone.0035767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701552	Green Published, Green Submitted, gold			2022-12-25	WOS:000305337600002
J	Singh, VP; Lakshmi, BJ; Singh, S; Shah, V; Goel, S; Sarathi, DP; Kumar, S				Singh, Vijay Pratap; Lakshmi, B. Jyothi; Singh, Shalu; Shah, Vanya; Goel, Sandeep; Sarathi, D. Partha; Kumar, Satish			Lack of Wdr13 Gene in Mice Leads to Enhanced Pancreatic Beta Cell Proliferation, Hyperinsulinemia and Mild Obesity	PLOS ONE			English	Article							WD-REPEAT; GLUCOSE-INTOLERANCE; INSULIN-SECRETION; ADIPOSE-TISSUE; DIABETIC-RATS; GROWTH-FACTOR; CYCLE ARREST; MASS; PROTEINS; REPLICATION	WD-repeat proteins are very diverse, yet these are structurally related proteins that participate in a wide range of cellular functions. WDR13, a member of this family, is conserved from fishes to humans and localizes into the nucleus. To understand the in vivo function(s) of Wdr13 gene, we have created and characterized a mutant mouse strain lacking this gene. The mutant mice had higher serum insulin levels and increased pancreatic islet mass as a result of enhanced beta cell proliferation. While a known cell cycle inhibitor, p21, was downregulated in the mutant islets, over expression of WDR13 in the pancreatic beta cell line (MIN6) resulted in upregulation of p21, accompanied by retardation of cell proliferation. We suggest that WDR13 is a novel negative regulator of the pancreatic beta cell proliferation. Given the higher insulin levels and better glucose clearance in Wdr13 gene deficient mice, we propose that this protein may be a potential candidate drug target for ameliorating impaired glucose metabolism in diabetes.	[Singh, Vijay Pratap; Lakshmi, B. Jyothi; Singh, Shalu; Shah, Vanya; Goel, Sandeep; Sarathi, D. Partha; Kumar, Satish] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Singh, VP (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	satishk@ccmb.res.in	Singh, Vijay/AAH-9906-2020; singh, shalu/GYD-6110-2022; Goel, Sandeep/C-5985-2009	Singh, Vijay/0000-0002-6803-7585; Goel, Sandeep/0000-0001-7485-5392; Singh, Shalu/0000-0002-5884-4850	Council of Scientific and Industrial Research, New Delhi; Department of Science and Technology, Government of India, New Delhi; Department of Biotechnology, Government of India, New Delhi	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India, New Delhi(Department of Science & Technology (India)); Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India)	The first author was supported by a fellowship from the Council of Scientific and Industrial Research, New Delhi. This manuscript is an outcome of the research funds provided by the Council of Scientific and Industrial Research, New Delhi, Department of Science and Technology, Government of India, New Delhi and Department of Biotechnology, Government of India, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyama Y, 2007, OBESITY, V15, P1647, DOI 10.1038/oby.2007.197; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bonner-Weir S, 2000, ENDOCRINOLOGY, V141, P1926, DOI 10.1210/en.141.6.1926; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Cinti S, 1998, DIABETOLOGIA, V41, P171, DOI 10.1007/s001250050886; Cozar-Castellano I, 2006, DIABETES, V55, P70, DOI 10.2337/diabetes.55.01.06.db05-0632; Cozar-Castellano I, 2006, DIABETES, V55, P3271, DOI 10.2337/db06-0627; D'Agata V, 2003, GENES BRAIN BEHAV, V2, P231, DOI 10.1034/j.1601-183X.2003.00029.x; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; El-Hattab A, 2010, CLIN GENET; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Gerich JE, 1998, ENDOCR REV, V19, P491, DOI 10.1210/er.19.4.491; GIRARD J, 1994, FASEB J, V8, P36, DOI 10.1096/fasebj.8.1.7905448; Gupta RK, 2007, GENE DEV, V21, P756, DOI 10.1101/gad.1535507; Hanley SC, 2010, ENDOCRINOLOGY, V151, P1462, DOI 10.1210/en.2009-1277; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Honore B, 2002, ONCOGENE, V21, P1123, DOI 10.1038/sj.onc.1205186; Lee YC, 2009, MOL CELL ENDOCRINOL, V297, P18, DOI 10.1016/j.mce.2008.08.033; Loftus TM, 1998, P NATL ACAD SCI USA, V95, P14168, DOI 10.1073/pnas.95.24.14168; Lustig RH, 2004, INT J OBESITY, V28, P1344, DOI 10.1038/sj.ijo.0802753; Mauvais-Jarvis F, 2011, TRENDS ENDOCRIN MET, V22, P24, DOI 10.1016/j.tem.2010.10.002; Meng ZX, 2009, DIABETOLOGIA, V52, P125, DOI 10.1007/s00125-008-1174-x; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nielsen JH, 2001, DIABETES, V50, pS25, DOI 10.2337/diabetes.50.2007.S25; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Podcheko A, 2007, MOL CELL BIOL, V27, P6484, DOI 10.1128/MCB.02409-06; Price M, 2003, MOL BRAIN RES, V117, P58, DOI 10.1016/S0169-328X(03)00285-7; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Ritzel RA, 2006, DIABETES CARE, V29, P717, DOI 10.2337/diacare.29.03.06.dc05-1538; ROHNERJEANRENAUD F, 1985, ENDOCRINOLOGY, V116, P830, DOI 10.1210/endo-116-2-830; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; SIMON J, 1985, AM J PHYSIOL, V249, pR393, DOI 10.1152/ajpregu.1985.249.4.R393; Singh BN, 2003, GENOMICS, V81, P315, DOI 10.1016/S0888-7543(02)00036-8; Smith Temple F., 2008, V48, P20, DOI 10.1007/978-0-387-09595-0_3; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Suarez-Pinzon WL, 2005, DIABETES, V54, P2596, DOI 10.2337/diabetes.54.9.2596; Suresh A, 2005, MOL REPROD DEV, V72, P299, DOI 10.1002/mrd.20362; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Wen T, 2009, MOL ENDOCRINOL, V23, P671, DOI 10.1210/me.2008-0345; Whibley AC, 2010, AM J HUM GENET, V87, P173, DOI 10.1016/j.ajhg.2010.06.017; WILLING AE, 1990, PHYSIOL BEHAV, V48, P893, DOI 10.1016/0031-9384(90)90245-Y; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270	48	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38685	10.1371/journal.pone.0038685	http://dx.doi.org/10.1371/journal.pone.0038685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715406	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336800048
J	He, H; Sui, J; Yu, QB; Turner, JA; Ho, BC; Sponheim, SR; Manoach, DS; Clark, VP; Calhoun, VD				He, Hao; Sui, Jing; Yu, Qingbao; Turner, Jessica A.; Ho, Beng-Choon; Sponheim, Scott R.; Manoach, Dara S.; Clark, Vincent P.; Calhoun, Vince D.			Altered Small-World Brain Networks in Schizophrenia Patients during Working Memory Performance	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; INDEPENDENT COMPONENT ANALYSIS; FUNCTIONAL CONNECTIVITY; COGNITIVE CONTROL; MOTION CORRECTION; LOW-FREQUENCY; DYSFUNCTION; ACTIVATION; INEFFICIENCY; COEFFICIENT	Impairment of working memory (WM) performance in schizophrenia patients (SZ) is well-established. Compared to healthy controls (HC), SZ patients show aberrant blood oxygen level dependent (BOLD) activations and disrupted functional connectivity during WM performance. In this study, we examined the small-world network metrics computed from functional magnetic resonance imaging (fMRI) data collected as 35 HC and 35 SZ performed a Sternberg Item Recognition Paradigm (SIRP) at three WM load levels. Functional connectivity networks were built by calculating the partial correlation on preprocessed time courses of BOLD signal between task-related brain regions of interest (ROIs) defined by group independent component analysis (ICA). The networks were then thresholded within the small-world regime, resulting in undirected binarized small-world networks at different working memory loads. Our results showed: 1) at the medium WM load level, the networks in SZ showed a lower clustering coefficient and less local efficiency compared with HC; 2) in SZ, most network measures altered significantly as the WM load level increased from low to medium and from medium to high, while the network metrics were relatively stable in HC at different WM loads; and 3) the altered structure at medium WM load in SZ was related to their performance during the task, with longer reaction time related to lower clustering coefficient and lower local efficiency. These findings suggest brain connectivity in patients with SZ was more diffuse and less strongly linked locally in functional network at intermediate level of WM when compared to HC. SZ show distinctly inefficient and variable network structures in response to WM load increase, comparing to stable highly clustered network topologies in HC.	[He, Hao; Sui, Jing; Yu, Qingbao; Turner, Jessica A.; Clark, Vincent P.; Calhoun, Vince D.] Mind Res Network, Albuquerque, NM USA; [He, Hao; Calhoun, Vince D.] Univ New Mexico, Dept Elect & Comp Engn, Albuquerque, NM 87131 USA; [Ho, Beng-Choon] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Sponheim, Scott R.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Sponheim, Scott R.] Univ Minnesota, Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; [Manoach, Dara S.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA; [Clark, Vincent P.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Calhoun, Vince D.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Calhoun, Vince D.] Yale Univ, Dept Neurobiol, New Haven, CT USA; [Calhoun, Vince D.] Olin Neuropsychiat Res Ctr, Hartford, CT USA	Lovelace Respiratory Research Institute; University of New Mexico; University of Iowa; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Harvard University; Massachusetts General Hospital; University of New Mexico; Yale University; Yale University	He, H (corresponding author), Mind Res Network, Albuquerque, NM USA.	vcalhoun@unm.edu	Sponheim, Scott/J-3857-2017; Clark, Vincent P/B-3343-2010; Yu, Qingbao/I-2244-2013; Turner, Jessica A/H-7282-2015; Ho, Beng-Choon/D-6959-2011; Sui, Jing/B-3455-2018; He, Hao/H-9618-2014; Calhoun, Vince D./ACN-9399-2022; Turner, Jessica A/N-2228-2017	Sponheim, Scott/0000-0002-2782-0856; Clark, Vincent P/0000-0002-9151-2102; Yu, Qingbao/0000-0003-4166-3102; Turner, Jessica A/0000-0003-0076-8434; Ho, Beng-Choon/0000-0003-3976-1555; Sui, Jing/0000-0001-6837-5966; He, Hao/0000-0002-9382-998X; Calhoun, Vince D./0000-0001-9058-0747; Turner, Jessica A/0000-0003-0076-8434	Department of Energy [DE-FG02-99ER62764]; National Institutes of Health [R01 EB000840, 5P20RR021938]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000840] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The data collection was funded by the Department of Energy, grant DE-FG02-99ER62764. This work was supported by the National Institutes of Health grants R01 EB000840 (PI: VDC) and 5P20RR021938 (PI: VDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Andreasen N., 1984, SCALE ASSESSMENT POS; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Brown GG, 2009, SCHIZOPHRENIA BULL, V35, P32, DOI 10.1093/schbul/sbn149; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Camchong J, 2011, SCHIZOPHRENIA BULL, V37, P640, DOI 10.1093/schbul/sbp131; Cohen JD, 1996, PHILOS T R SOC B, V351, P1515, DOI 10.1098/rstb.1996.0138; Ehrlich S, 2012, PSYCHOL MED, V42, P267, DOI 10.1017/S003329171100119X; Ehrlich S, 2012, SCHIZOPHRENIA BULL, V38, P1050, DOI 10.1093/schbul/sbr018; First M. B., 2014, SCID 5 105 STRUCTURE; Fisher RA, 1914, BIOMETRIKA, V10, P507; Fornito A, 2011, BIOL PSYCHIAT, V70, P64, DOI 10.1016/j.biopsych.2011.02.019; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Freire L, 2002, IEEE T MED IMAGING, V21, P470, DOI 10.1109/TMI.2002.1009383; Freire L, 2001, NEUROIMAGE, V14, P709, DOI 10.1006/nimg.2001.0869; Ginestet CE, 2011, NEUROIMAGE, V55, P688, DOI 10.1016/j.neuroimage.2010.11.030; GOLDMANRAKIC PS, 1994, J NEUROPSYCH CLIN N, V6, P348; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2009, NEUROSCIENTIST, V15, P333, DOI 10.1177/1073858409334423; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kaiser M, 2004, NEUROCOMPUTING, V58, P297, DOI 10.1016/j.neucom.2004.01.059; Kang SS, 2011, NEUROPSYCHOLOGIA, V49, P2836, DOI 10.1016/j.neuropsychologia.2011.06.009; Karlsgodt KH, 2007, SCHIZOPHR RES, V89, P191, DOI 10.1016/j.schres.2006.08.016; Kim DI, 2010, NEUROINFORMATICS, V8, P213, DOI 10.1007/s12021-010-9077-7; Kim DI, 2009, HUM BRAIN MAPP, V30, P3795, DOI 10.1002/hbm.20807; Kim MA, 2010, SCHIZOPHR RES, V117, P42, DOI 10.1016/j.schres.2009.12.014; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Lauritzen SL, 1996, GRAPHICAL MODELS, Vx; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Manoach DS, 1999, BIOL PSYCHIAT, V45, P1128, DOI 10.1016/S0006-3223(98)00318-7; Manoach DS, 2000, BIOL PSYCHIAT, V48, P99, DOI 10.1016/S0006-3223(00)00227-4; Manoach DS, 2003, SCHIZOPHR RES, V60, P285, DOI 10.1016/S0920-9964(02)00294-3; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; MCCARTHY G, 1994, P NATL ACAD SCI USA, V91, P8690, DOI 10.1073/pnas.91.18.8690; Michael AM, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00071; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Moussa MN, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00083; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pachou E, 2008, BRAIN TOPOGR, V21, P128, DOI 10.1007/s10548-008-0062-5; Palva S, 2010, NEUROIMAGE, V49, P3257, DOI 10.1016/j.neuroimage.2009.11.031; PARK S, 1992, ARCH GEN PSYCHIAT, V49, P975; Perlstein WM, 2001, AM J PSYCHIAT, V158, P1105, DOI 10.1176/appi.ajp.158.7.1105; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P19, DOI 10.1093/schbul/sbn162; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Roffman JL, 2008, P NATL ACAD SCI USA, V105, P17573, DOI 10.1073/pnas.0803727105; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; SAYKIN AJ, 1991, ARCH GEN PSYCHIAT, V48, P618; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Sui J, 2010, NEUROIMAGE, V51, P123, DOI 10.1016/j.neuroimage.2010.01.069; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wang H, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021924; Wang LA, 2010, J NEUROSCI, V30, P13171, DOI 10.1523/JNEUROSCI.3514-10.2010; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; White T, 2011, CEREB CORTEX, V21, P510, DOI 10.1093/cercor/bhq114; Whittaker J, 1990, GRAPHICAL MODELS APP, Vxiv; Yu QB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025423; Yu QB, 2011, FRONT SYST NEUROSCI, V5, DOI [10.3389/fnsys.2011.00007, 10.3389/fnsys.2011.00103]; Zhao QB, 2008, PHYSICA A, V387, P5952, DOI 10.1016/j.physa.2008.07.002	89	57	57	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38195	10.1371/journal.pone.0038195	http://dx.doi.org/10.1371/journal.pone.0038195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701611	Green Submitted, Green Published, gold			2022-12-25	WOS:000305348400039
J	Owens, GC; Walcott, EC				Owens, Geoffrey C.; Walcott, Elisabeth C.			Extensive Fusion of Mitochondria in Spinal Cord Motor Neurons	PLOS ONE			English	Article							AXONAL MITOCHONDRIA; TRANSPORT; MECHANISMS; DENDRITES; TURNOVER; DYNAMICS; DATABASE; DOCKING; CULTURE; GTPASE	The relative roles played by trafficking, fission and fusion in the dynamics of mitochondria in neurons have not been fully elucidated. In the present study, a slow widespread redistribution of mitochondria within cultured spinal cord motor neurons was observed as a result of extensive organelle fusion. Mitochondria were labeled with a photoconvertible fluorescent protein (mitoKaede) that is red-shifted following brief irradiation with blue light. The behavior of these selectively labeled mitochondria was followed by live fluorescence imaging. Marking mitochondria within the cell soma revealed a complete mixing, within 18 hours, of these organelles with mitochondria coming from the surrounding neurites. Fusion of juxtaposed mitochondria was directly observed in neuritic processes at least 200 microns from the cell body. Within 24 hours, photoconverted mitoKaede was dispersed to all of the mitochondria in the portion of neurite under observation. When time lapse imaging over minutes was combined with long-term observation of marked mitochondria, moving organelles that traversed the field of view did not initially contain photoconverted protein, but after several hours organelles in motion contained both fluorescent proteins, coincident with widespread fusion of all of the mitochondria within the length of neurite under observation. These observations suggest that there is a widespread exchange of mitochondrial components throughout a neuron as a result of organelle fusion.	[Owens, Geoffrey C.; Walcott, Elisabeth C.] Inst Neurosci, San Diego, CA USA		Owens, GC (corresponding author), Inst Neurosci, San Diego, CA USA.	owens@nsi.edu			Neurosciences Research Foundation; G. Harold & Leila Y. Mathers Foundation	Neurosciences Research Foundation; G. Harold & Leila Y. Mathers Foundation	Funded by The Neurosciences Research Foundation and The G. Harold & Leila Y. Mathers Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Amiri M, 2008, DEV NEUROBIOL, V68, P1348, DOI 10.1002/dneu.20668; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Andreoli C, 2004, NUCLEIC ACIDS RES, V32, pD459, DOI 10.1093/nar/gkh137; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; BEATTIE DS, 1967, J BIOL CHEM, V242, P4584; Cai Q, 2009, EXP NEUROL, V218, P257, DOI 10.1016/j.expneurol.2009.03.024; Carriedo SG, 1996, J NEUROSCI, V16, P4069; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen S, 2007, MOL CELL NEUROSCI, V36, P472, DOI 10.1016/j.mcn.2007.08.004; Cotter D, 2004, NUCLEIC ACIDS RES, V32, pD463, DOI 10.1093/nar/gkh048; CUZNER ML, 1966, BIOCHEM J, V101, P618, DOI 10.1042/bj1010618; Desai NS, 2006, J NEUROSCI, V26, P2215, DOI 10.1523/JNEUROSCI.4310-05.2006; Edelman DB, 2011, JOVE-J VIS EXP, DOI 10.3791/2599; EVANS MJ, 1989, J BIOL CHEM, V264, P14361; Feissner RF, 2009, FRONT BIOSCI-LANDMRK, V14, P1197, DOI 10.2741/3303; Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x; Gumy LF, 2010, EXP NEUROL, V223, P28, DOI 10.1016/j.expneurol.2009.06.004; Haastert K, 2005, J NEUROSCI METH, V142, P275, DOI 10.1016/j.jneumeth.2004.09.003; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Magrane J, 2012, J NEUROSCI, V32, P229, DOI 10.1523/JNEUROSCI.1233-11.2012; Mattenberger Y, 2003, FEBS LETT, V538, P53, DOI 10.1016/S0014-5793(03)00124-8; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Overly CC, 1996, J CELL SCI, V109, P971; Pathak D, 2010, J NEUROSCI, V30, P8984, DOI 10.1523/JNEUROSCI.1621-10.2010; Popov V, 2005, J COMP NEUROL, V492, P50, DOI 10.1002/cne.20682; Quintero OA, 2009, CURR BIOL, V19, P2008, DOI 10.1016/j.cub.2009.10.026; RANSOM BR, 1977, J NEUROPHYSIOL, V40, P1132, DOI 10.1152/jn.1977.40.5.1132; Reis K, 2009, FEBS LETT, V583, P1391, DOI 10.1016/j.febslet.2009.04.015; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; SALAMANCA MC, 1987, DEV NEUROSCI-BASEL, V9, P174, DOI 10.1159/000111620; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wagner OI, 2003, J NEUROSCI, V23, P9046; Walcott EC, 2011, J NEUROSCI, V31, P13097, DOI 10.1523/JNEUROSCI.1341-11.2011; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; WESTBURY DR, 1982, J PHYSIOL-LONDON, V325, P79, DOI 10.1113/jphysiol.1982.sp014137; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	48	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38435	10.1371/journal.pone.0038435	http://dx.doi.org/10.1371/journal.pone.0038435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701641	gold, Green Published, Green Submitted			2022-12-25	WOS:000305348400057
J	Vandecandelaere, I; Matthijs, N; Van Nieuwerburgh, F; Deforce, D; Vosters, P; De Bus, L; Nelis, HJ; Depuydt, P; Coenye, T				Vandecandelaere, Ilse; Matthijs, Nele; Van Nieuwerburgh, Filip; Deforce, Dieter; Vosters, Peter; De Bus, Liesbet; Nelis, Hans J.; Depuydt, Pieter; Coenye, Tom			Assessment of Microbial Diversity in Biofilms Recovered from Endotracheal Tubes Using Culture Dependent and Independent Approaches	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; SURVEILLANCE CULTURES; NOSOCOMIAL PNEUMONIA; ORAL CAVITY; BACTERIA; IMPACT; INFECTION; RISK	Ventilator-associated pneumonia (VAP) is a common nosocomial infection in mechanically ventilated patients. Biofilm formation is one of the mechanisms through which the endotracheal tube (ET) facilitates bacterial contamination of the lower airways. In the present study, we analyzed the composition of the ET biofilm flora by means of culture dependent and culture independent (16 S rRNA gene clone libraries and pyrosequencing) approaches. Overall, the microbial diversity was high and members of different phylogenetic lineages were detected (Actinobacteria, beta-Proteobacteria, Candida spp., Clostridia, epsilon-Proteobacteria, Firmicutes, Fusobacteria and gamma-Proteobacteria). Culture dependent analysis, based on the use of selective growth media and conventional microbiological tests, resulted in the identification of typical aerobic nosocomial pathogens which are known to play a role in the development of VAP, e. g. Staphylococcus aureus and Pseudomonas aeruginosa. Other opportunistic pathogens were also identified, including Staphylococcus epidermidis and Kocuria varians. In general, there was little correlation between the results obtained by sequencing 16 S rRNA gene clone libraries and by cultivation. Pyrosequencing of PCR amplified 16 S rRNA genes of four selected samples resulted in the identification of a much wider variety of bacteria. The results from the pyrosequencing analysis suggest that these four samples were dominated by members of the normal oral flora such as Prevotella spp., Peptostreptococcus spp. and lactic acid bacteria. A combination of methods is recommended to obtain a complete picture of the microbial diversity of the ET biofilm.	[Vandecandelaere, Ilse; Matthijs, Nele; Nelis, Hans J.; Coenye, Tom] Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium; [Van Nieuwerburgh, Filip; Deforce, Dieter] Univ Ghent, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium; [Vosters, Peter; De Bus, Liesbet; Depuydt, Pieter] Ghent Univ Hosp, Dept Intens Care, Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University Hospital	Vandecandelaere, I (corresponding author), Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium.	Ilse.Vandecandelaere@UGent.be	Deforce, Dieter LD/J-4725-2013; Van Nieuwerburgh, Filip/H-9697-2015; Coenye, Tom/Z-1928-2019; Coenye, Tom/A-6291-2014	Deforce, Dieter LD/0000-0002-0635-661X; Van Nieuwerburgh, Filip/0000-0001-8815-5485; Coenye, Tom/0000-0002-6407-0601; Coenye, Tom/0000-0002-6407-0601	'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen' (FWO-Vlaanderen) [3G001211]	'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen' (FWO-Vlaanderen)(FWO)	This work was funded by 'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen' (FWO-Vlaanderen; project number: 3G001211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott S.L., 2011, MANUAL CLIN MICROBIO; Adair CG, 1999, INTENS CARE MED, V25, P1072, DOI 10.1007/s001340051014; ALBERTSON D, 1978, ARCH INTERN MED, V138, P487, DOI 10.1001/archinte.138.3.487; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Argimon S, 2011, J CLIN MICROBIOL, V49, P984, DOI 10.1128/JCM.01993-10; Augustyn B, 2007, CRIT CARE NURSE, V27, P32; Bahrani-Mougeot FK, 2007, J CLIN MICROBIOL, V45, P1588, DOI 10.1128/JCM.01963-06; Baron EJ, 2011, MANUAL CLIN MICROBIO; Bauer T T, 2002, Monaldi Arch Chest Dis, V57, P84; Becker K., 2011, MANUAL CLIN MICROBIO; Blot S, 2008, CLIN INFECT DIS, V46, P481, DOI 10.1086/526349; Blot S, 2008, INTENS CARE MED, V34, P2130, DOI 10.1007/s00134-008-1249-7; Bouza E, 2009, CURR OPIN INFECT DIS, V22, P345, DOI 10.1097/QCO.0b013e32832d8910; Cairns S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014759; Carbon C, 2000, CLIN MICROBIOL INFEC, V6, P17, DOI 10.1046/j.1469-0691.2000.00005.x; Chang EP, 2009, J MICROBIOL IMMUNOL, V42, P329; Coenye T, 1999, INT J SYST BACTERIOL, V49, P405, DOI 10.1099/00207713-49-2-405; Conville PS, 2011, MANUAL CLIN MICROBIO; Costerton JW, 2011, FEMS IMMUNOL MED MIC, V61, P133, DOI 10.1111/j.1574-695X.2010.00766.x; Czosnowski QA, 2011, PHARMACOTHERAPY, V31, P338, DOI 10.1592/phco.31.4.338; Decraene V, 2008, J GEN APPL MICROBIOL, V54, P195, DOI 10.2323/jgam.54.195; Decre D, 2011, J CLIN MICROBIOL, V49, P3012, DOI 10.1128/JCM.00676-11; Depuydt P, 2008, INTENS CARE MED, V34, P675, DOI 10.1007/s00134-007-0953-z; Depuydt P, 2006, CURR OPIN PULM MED, V12, P192; Depuydt P, 2006, INTENS CARE MED, V32, P1773, DOI 10.1007/s00134-006-0354-8; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Edwards C, 2000, MOL BIOTECHNOL, V15, P211, DOI 10.1385/MB:15:3:211; Esteban J, 2010, ACTA ORTHOP, V81, P674, DOI 10.3109/17453674.2010.537810; Funke G, 1997, CLIN MICROBIOL REV, V10, P125, DOI 10.1128/CMR.10.1.125; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Heo SM, 2008, CLIN INFECT DIS, V47, P1562, DOI 10.1086/593193; INGLIS TJJ, 1989, J CLIN MICROBIOL, V27, P2014, DOI 10.1128/JCM.27.9.2014-2018.1989; Joly E, 1996, METHOD MOL BIOL, V58, P256; Joseph NM, 2010, EUR J INTERN MED, V21, P360, DOI 10.1016/j.ejim.2010.07.006; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Luna CM, 2009, EUR RESPIR J, V33, P182, DOI 10.1183/09031936.00046308; Mahenthiralingam E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-251; Mancini F, 2009, EMERG INFECT DIS, V15, P1874, DOI 10.3201/eid1511.090126; Narayan SA, 2009, INFECT CONT HOSP EP, V30, P797, DOI 10.1086/598240; Nseir S, 2007, INTENS CARE MED, V33, P137, DOI 10.1007/s00134-006-0422-0; Oudiz RJ, 2004, CHEST, V126, P90, DOI 10.1378/chest.126.1.90; Palatinszky M, 2011, J MICROBIOL METH, V85, P131, DOI 10.1016/j.mimet.2011.02.007; Park David R, 2005, Respir Care, V50, P742; Pereira EM, 2010, MICROBIOL RES, V165, P243, DOI 10.1016/j.micres.2009.03.003; Perkins SD, 2010, INT J MED MICROBIOL, V300, P503, DOI 10.1016/j.ijmm.2010.02.005; Ruoff KL, 2011, MANUAL CLIN MICROBIO; Ryan MP, 2010, J HOSP INFECT, V75, P153, DOI 10.1016/j.jhin.2010.03.007; Savini V, 2010, J MED MICROBIOL, V59, P1395, DOI 10.1099/jmm.0.021709-0; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Song EH, 2010, DIAGN MICR INFEC DIS, V66, P436, DOI 10.1016/j.diagmicrobio.2009.11.007; Sookkhee S, 2001, J APPL MICROBIOL, V90, P172, DOI 10.1046/j.1365-2672.2001.01229.x; SOTTILE FD, 1986, CRIT CARE MED, V14, P265, DOI 10.1097/00003246-198604000-00001; Takeshita T, 2010, J AM GERIATR SOC, V58, P1050, DOI 10.1111/j.1532-5415.2010.02867.x; Toyoshima Mikio, 2010, Respirology, V15, P867, DOI 10.1111/j.1440-1843.2010.01780.x; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Vaneechoutte ML, 2011, MANUAL CLIN MICROBIO; WATANABE T, 1986, J CLIN MICROBIOL, V23, P1034, DOI 10.1128/JCM.23.6.1034-1038.1986; Zemanick ET, 2011, CURR OPIN PEDIATR, V23, P319, DOI 10.1097/MOP.0b013e32834604f2; Zhao JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033127; Ziebuhr W, 2006, INT J ANTIMICROB AG, V28, pS14, DOI 10.1016/j.ijantimicag.2006.05.012	64	50	50	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38401	10.1371/journal.pone.0038401	http://dx.doi.org/10.1371/journal.pone.0038401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693635	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343900035
J	Athavale, SS; Petrov, AS; Hsiao, C; Watkins, D; Prickett, CD; Gossett, JJ; Lie, L; Bowman, JC; O'Neill, E; Bernier, CR; Hud, NV; Wartell, RM; Harvey, SC; Williams, LD				Athavale, Shreyas S.; Petrov, Anton S.; Hsiao, Chiaolong; Watkins, Derrick; Prickett, Caitlin D.; Gossett, J. Jared; Lie, Lively; Bowman, Jessica C.; O'Neill, Eric; Bernier, Chad R.; Hud, Nicholas V.; Wartell, Roger M.; Harvey, Stephen C.; Williams, Loren Dean			RNA Folding and Catalysis Mediated by Iron (II)	PLOS ONE			English	Article							ENERGY DECOMPOSITION ANALYSIS; MOLECULAR-INTERACTIONS; TERTIARY STRUCTURE; METAL-IONS; BINDING; MAGNESIUM; MANGANESE; RIBOZYME; MINERALOGY; FRAMEWORK	Mg2+ shares a distinctive relationship with RNA, playing important and specific roles in the folding and function of essentially all large RNAs. Here we use theory and experiment to evaluate Fe2+ in the absence of free oxygen as a replacement for Mg2+ in RNA folding and catalysis. We describe both quantum mechanical calculations and experiments that suggest that the roles of Mg2+ in RNA folding and function can indeed be served by Fe2+. The results of quantum mechanical calculations show that the geometry of coordination of Fe2+ by RNA phosphates is similar to that of Mg2+. Chemical footprinting experiments suggest that the conformation of the Tetrahymena thermophila Group I intron P4-P6 domain RNA is conserved between complexes with Fe2+ or Mg2+. The catalytic activities of both the L1 ribozyme ligase, obtained previously by in vitro selection in the presence of Mg2+, and the hammerhead ribozyme are enhanced in the presence of Fe2+ compared to Mg2+. All chemical footprinting and ribozyme assays in the presence of Fe2+ were performed under anaerobic conditions. The primary motivation of this work is to understand RNA in plausible early earth conditions. Life originated during the early Archean Eon, characterized by a non-oxidative atmosphere and abundant soluble Fe2+. The combined biochemical and paleogeological data are consistent with a role for Fe2+ in an RNA World. RNA and Fe2+ could, in principle, support an array of RNA structures and catalytic functions more diverse than RNA with Mg2+ alone.	[Athavale, Shreyas S.; Petrov, Anton S.; Gossett, J. Jared; Lie, Lively; Wartell, Roger M.; Harvey, Stephen C.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Hsiao, Chiaolong; Watkins, Derrick; Prickett, Caitlin D.; Bowman, Jessica C.; O'Neill, Eric; Bernier, Chad R.; Hud, Nicholas V.; Wartell, Roger M.; Harvey, Stephen C.; Williams, Loren Dean] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Athavale, Shreyas S.; Petrov, Anton S.; Hsiao, Chiaolong; Watkins, Derrick; Prickett, Caitlin D.; Gossett, J. Jared; Lie, Lively; Bowman, Jessica C.; O'Neill, Eric; Bernier, Chad R.; Hud, Nicholas V.; Harvey, Stephen C.; Williams, Loren Dean] Georgia Inst Technol, NAI Ctr Ribosomal Origins & Evolut, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Athavale, SS (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	loren.williams@chemistry.gatech.edu	Hud, Nicholas V/T-7017-2017	Bowman, Jessica/0000-0002-6219-2680; Hud, Nicholas/0000-0001-7711-6472	NASA Astrobiology Institute [NNA09DA78A]	NASA Astrobiology Institute	Funding provided by NASA Astrobiology Institute Grant number: NNA09DA78A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; Anbar AD, 2008, SCIENCE, V322, P1481, DOI 10.1126/science.1163100; Athavale SS, 2012, RNA, V18, P752, DOI 10.1261/rna.030692.111; Atkins J. F., 2011, RNA WORLDS LIFES ORI; Auffinger P, 2011, METAL IONS LIFE SCI, V9, P1, DOI 10.1039/978184973251200001; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bock CW, 2006, THEOR CHEM ACC, V115, P100, DOI 10.1007/s00214-005-0056-2; BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561; Brion P, 1997, ANNU REV BIOPH BIOM, V26, P113, DOI 10.1146/annurev.biophys.26.1.113; BROWN ID, 1992, ACTA CRYSTALLOGR B, V48, P553, DOI 10.1107/S0108768192002453; Butcher SE, 2011, METAL IONS LIFE SCI, V9, P235, DOI 10.1039/978184973251200235; Cate JH, 1997, NAT STRUCT BIOL, V4, P553, DOI 10.1038/nsb0797-553; Chiancone E, 2004, BIOMETALS, V17, P197, DOI 10.1023/B:BIOM.0000027692.24395.76; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Condie KC, 2007, EARTHS OLDEST ROCKS; Condie KC, 2008, GEOL SOC AM SPEC PAP, V440, P281, DOI 10.1130/2008.2440(14); DAVIES GF, 1992, GEOLOGY, V20, P963, DOI 10.1130/0091-7613(1992)020<0963:OTEOPT>2.3.CO;2; Draper DE, 2008, BIOPHYS J, V95, P5489, DOI 10.1529/biophysj.108.131813; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Glendening ED, 1996, J AM CHEM SOC, V118, P2473, DOI 10.1021/ja951834y; GLENDENING ED, 1994, J CHEM PHYS, V100, P2900, DOI 10.1063/1.466432; Gordon MS, 2005, THEORY AND APPLICATIONS OF COMPUTATIONAL CHEMISTRY: THE FIRST FORTY YEARS, P1167, DOI 10.1016/B978-044451719-7/50084-6; Goss DJ, 2011, ACCOUNTS CHEM RES, V44, P1320, DOI 10.1021/ar2001149; Hanson S, 2005, RNA, V11, P503, DOI 10.1261/rna.7251305; Hazen RM, 2008, AM MINERAL, V93, P1693, DOI 10.2138/am.2008.2955; Hazen RM, 2010, ELEMENTS, V6, P9, DOI 10.2113/gselements.6.1.9; Holland H.D., 1984, CHEM EVOLUTION ATMOS; Hsiao CL, 2009, NUCLEIC ACIDS RES, V37, P3134, DOI 10.1093/nar/gkp119; Hsiao Chiaolong, 2009, P1; Johnson CM, 2008, ANNU REV EARTH PL SC, V36, P457, DOI 10.1146/annurev.earth.36.031207.124139; Johnson-Buck AE, 2011, METAL IONS LIFE SCI, V9, P175, DOI 10.1039/978184973251200175; Kell DB, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-2; Klein C, 2005, AM MINERAL, V90, P1473, DOI 10.2138/am.2005.1871; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LINDAHL T, 1966, P NATL ACAD SCI USA, V55, P941, DOI 10.1073/pnas.55.4.941; LYNCH DC, 1974, BIOCHEMISTRY-US, V13, P1841, DOI 10.1021/bi00706a012; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Misra VK, 2001, P NATL ACAD SCI USA, V98, P12456, DOI 10.1073/pnas.221234598; Moore J.K., 2007, BIOGEOSCIENCES, V4, P1241, DOI [10.5194/bgd-4-1241-2007, DOI 10.5194/BGD-4-1241-2007, DOI 10.5194/bgd-4-1241-2007]; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; Mortimer SA, 2008, J AM CHEM SOC, V130, P16178, DOI 10.1021/ja8061216; Peers G, 2004, LIMNOL OCEANOGR, V49, P1774, DOI 10.4319/lo.2004.49.5.1774; Petrov AS, 2011, RNA, V17, P291, DOI 10.1261/rna.2390311; RASHIN AA, 1985, J PHYS CHEM-US, V89, P5588, DOI 10.1021/j100272a006; Robertson MP, 2007, SCIENCE, V315, P1549, DOI 10.1126/science.1136231; Rosing MT, 2010, NATURE, V464, P744, DOI 10.1038/nature08955; Schenter GK, 1996, J PHYS CHEM-US, V100, P17152, DOI 10.1021/jp9612994; Scott WG, 2007, CURR OPIN STRUC BIOL, V17, P280, DOI 10.1016/j.sbi.2007.05.003; Seehafer C, 2011, RNA, V17, P21, DOI 10.1261/rna.2429911; SNOW JE, 1995, GEOCHIM COSMOCHIM AC, V59, P4219, DOI 10.1016/0016-7037(95)00239-V; Som SM, 2012, NATURE, V484, P359, DOI 10.1038/nature10890; Stage-Zimmermann TK, 2001, NAT STRUCT BIOL, V8, P863, DOI 10.1038/nsb1001-863; STEIN A, 1976, BIOCHEMISTRY-US, V15, P160, DOI 10.1021/bi00646a025; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; TAJIKA E, 1992, EARTH PLANET SC LETT, V113, P251, DOI 10.1016/0012-821X(92)90223-I; Takamoto K, 2004, J MOL BIOL, V343, P1195, DOI 10.1016/j.jmb.2004.08.080; Theil EC, 2009, CHEM REV, V109, P4568, DOI 10.1021/cr900052g; Tomasi J, 1999, J MOL STRUC-THEOCHEM, V464, P211, DOI 10.1016/S0166-1280(98)00553-3; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Van duijneveldt-Van de Rijdt JGCM, 1997, WILEY THEOR CHEM, P13; VARY CPH, 1984, P NATL ACAD SCI-BIOL, V81, P6978, DOI 10.1073/pnas.81.22.6978; Vicens Q, 2007, RNA, V13, P536, DOI 10.1261/rna.400207; WANG JF, 1992, SCIENCE, V256, P526, DOI 10.1126/science.1315076; Ward WL, 2012, RNA, V18, P16, DOI 10.1261/rna.030239.111; Whitfield M, 2001, ADV MAR BIOL, V41, P1, DOI 10.1016/S0065-2881(01)41002-9; Wilkinson KA, 2005, J AM CHEM SOC, V127, P4659, DOI 10.1021/ja0436749; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Wolfe-Simon F, 2006, PLANT PHYSIOL, V142, P1701, DOI 10.1104/pp.106.088963	69	63	66	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38024	10.1371/journal.pone.0038024	http://dx.doi.org/10.1371/journal.pone.0038024			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701543	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500074
J	Liu, JS; Sudom, A; Min, XS; Cao, ZD; Gao, X; Ayres, M; Lee, F; Cao, P; Johnstone, S; Plotnikova, O; Walker, N; Chen, GQ; Wang, ZL				Liu, Jinsong; Sudom, Athena; Min, Xiaoshan; Cao, Zhaodan; Gao, Xiong; Ayres, Merrill; Lee, Fei; Cao, Ping; Johnstone, Sheree; Plotnikova, Olga; Walker, Nigel; Chen, Guoqing; Wang, Zhulun			Structure of the Nuclear Factor kappa B-inducing Kinase (NIK) Kinase Domain Reveals a Constitutively Active Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PROTEIN-KINASES; ACTIVATION PATHWAYS; IKK-ALPHA; INSIGHTS	NF-kappa B-inducing kinase (NIK) is a central component in the non-canonical NF-kappa B signaling pathway. Excessive NIK activity is implicated in various disorders, such as autoimmune conditions and cancers. Here, we report the first crystal structure of truncated human NIK in complex with adenosine 5'-O-(thiotriphosphate) at a resolution of 2.5 angstrom. This truncated protein is a catalytically active construct, including an N-terminal extension of 60 residues prior to the kinase domain, the kinase domain, and 20 residues afterward. The structure reveals that the NIK kinase domain assumes an active conformation in the absence of any phosphorylation. Analysis of the structure uncovers a unique role for the N-terminal extension sequence, which stabilizes helix alpha C in the active orientation and keeps the kinase domain in the catalytically competent conformation. Our findings shed light on the long-standing debate over whether NIK is a constitutively active kinase. They also provide a molecular basis for the recent observation of gain-of-function activity for an N-terminal deletion mutant (Delta N324) of NIK, leading to constitutive non-canonical NF-kappa B signaling with enhanced B-cell adhesion and apoptosis resistance.	[Liu, Jinsong; Sudom, Athena; Min, Xiaoshan; Cao, Zhaodan; Gao, Xiong; Ayres, Merrill; Lee, Fei; Cao, Ping; Johnstone, Sheree; Plotnikova, Olga; Walker, Nigel; Chen, Guoqing; Wang, Zhulun] Amgen Inc, San Francisco, CA 94080 USA	Amgen	Wang, ZL (corresponding author), Amgen Inc, San Francisco, CA 94080 USA.	zwang@amgen.com			United States Department of Energy [DE-AC03-76SF00098]	United States Department of Energy(United States Department of Energy (DOE))	We thank David Goeddel for valuable guidance and advice. The Advanced Light Source at the Lawrence Berkeley National Laboratory is supported by United States Department of Energy Contract DE-AC03-76SF00098.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Aya K, 2005, J CLIN INVEST, V115, P1848, DOI 10.1172/JCI23763; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Demchenko YN, 2010, BLOOD, V115, P3541, DOI 10.1182/blood-2009-09-243535; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garceau N, 2000, J EXP MED, V191, P381, DOI 10.1084/jem.191.2.381; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HU SH, 1994, NATURE, V369, P581, DOI 10.1038/369581a0; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LESLIE AGW, 1992, JOINT CCP4 ESF EACMB, V26; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Lin X, 1998, MOL CELL BIOL, V18, P5899, DOI 10.1128/MCB.18.10.5899; Lowe ED, 1997, EMBO J, V16, P6646, DOI 10.1093/emboj/16.22.6646; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; Razani B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000778; Rosebeck S, 2011, SCIENCE, V331, P468, DOI 10.1126/science.1198946; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Saitoh Y, 2008, BLOOD, V111, P5118, DOI 10.1182/blood-2007-09-110635; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Smith C, 2001, J IMMUNOL, V167, P5895, DOI 10.4049/jimmunol.167.10.5895; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Sun SC, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3123pe18; TAYLOR SS, 1995, FASEB J, V9, P1255, DOI 10.1096/fasebj.9.13.7557015; Thu YM, 2010, CYTOKINE GROWTH F R, V21, P213, DOI 10.1016/j.cytogfr.2010.06.002; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xiao GT, 2000, J BIOL CHEM, V275, P21081, DOI 10.1074/jbc.M002552200; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	46	36	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27326	27334		10.1074/jbc.M112.366658	http://dx.doi.org/10.1074/jbc.M112.366658			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718757	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000307840700005
J	Grewer, C; Zhang, Z; Mwaura, J; Albers, T; Schwartz, A; Gameiro, A				Grewer, Christof; Zhang, Zhou; Mwaura, Juddy; Albers, Thomas; Schwartz, Alexander; Gameiro, Armanda			Charge Compensation Mechanism of a Na+-coupled, Secondary Active Glutamate Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTROLS CATION INTERACTIONS; EXTRACELLULAR GATE; CONFORMATIONAL-CHANGES; RAT-BRAIN; BINDING; SUBSTRATE; EAAC1; RESIDUE; ASPARTATE; KINETICS	Forward glutamate transport by the excitatory amino acid carrier EAAC1 is coupled to the inward movement of three Na+ and one proton and the subsequent outward movement of one K+ in a separate step. Based on indirect evidence, it was speculated that the cation binding sites bear a negative charge. However, little is known about the electrostatics of the transport process. Valences calculated using the Poisson-Boltzmann equation indicate that negative charge is transferred across the membrane when only one cation is bound. Consistently, transient currents were observed in response to voltage jumps when K+ was the only cation on both sides of the membrane. Furthermore, rapid extracellular K+ application to EAAC1 under single turnover conditions (K+ inside) resulted in outward transient current. We propose a charge compensation mechanism, in which the C-terminal transport domain bears an overall negative charge of -1.23. Charge compensation, together with distribution of charge movement over many steps in the transport cycle, as well as defocusing of the membrane electric field, may be combined strategies used by Na+-coupled transporters to avoid prohibitive activation barriers for charge translocation.	[Grewer, Christof; Mwaura, Juddy; Albers, Thomas; Schwartz, Alexander; Gameiro, Armanda] SUNY Binghamton, Dept Chem, Binghamton, NY 13902 USA; [Zhang, Zhou] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai 200234, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Shanghai Normal University	Grewer, C (corresponding author), SUNY Binghamton, Dept Chem, 4400 Vestal Pkwy E, Binghamton, NY 13902 USA.	cgrewer@binghamton.edu			National Institutes of Health [2R01NS049335-06A1]; Binational Science Foundation [2007051]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01NS049335-06A1 (to C. G.). This work was also supported by Binational Science Foundation Grant 2007051 (to C. G. and B. I. Kanner).	Auger C, 2000, NEURON, V28, P547, DOI 10.1016/S0896-6273(00)00132-X; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARBOUR B, 1991, J PHYSIOL-LONDON, V436, P169, DOI 10.1113/jphysiol.1991.sp018545; Bergles DE, 2002, J NEUROSCI, V22, P10153; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Callenberg KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012722; Choudhary OP, 2010, J MOL BIOL, V396, P580, DOI 10.1016/j.jmb.2009.12.006; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Diez-Sampedro A, 2004, BIOCHEMISTRY-US, V43, P13175, DOI 10.1021/bi048652d; Erreger K, 2008, J NEUROSCI, V28, P976, DOI 10.1523/JNEUROSCI.2796-07.2008; Forster IC, 2002, PROG BIOPHYS MOL BIO, V80, P69, DOI 10.1016/S0079-6107(02)00015-9; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Grewer C, 2003, J BIOL CHEM, V278, P2585, DOI 10.1074/jbc.M207956200; Holley DC, 2009, PHILOS T R SOC B, V364, P155, DOI 10.1098/rstb.2008.0246; Huang ZJ, 2008, BIOPHYS J, V95, P2292, DOI 10.1529/biophysj.108.133421; Huang ZJ, 2010, BIOPHYS J, V99, P1416, DOI 10.1016/j.bpj.2010.06.052; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jiang J, 2011, P NATL ACAD SCI USA, V108, P15141, DOI 10.1073/pnas.1112216108; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Larsson HP, 2004, P NATL ACAD SCI USA, V101, P3951, DOI 10.1073/pnas.0306737101; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Mim C, 2007, BIOCHEMISTRY-US, V46, P9007, DOI 10.1021/bi7005465; Otis TS, 2000, J NEUROSCI, V20, P2749; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Rosental N, 2011, J BIOL CHEM, V286, P41381, DOI 10.1074/jbc.M111.291021; Roux B, 1997, BIOPHYS J, V73, P2980, DOI 10.1016/S0006-3495(97)78327-9; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Shrivastava IH, 2008, J BIOL CHEM, V283, P28680, DOI 10.1074/jbc.M800889200; Silva JR, 2009, P NATL ACAD SCI USA, V106, P11102, DOI 10.1073/pnas.0904505106; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Teichman S, 2009, P NATL ACAD SCI USA, V106, P14297, DOI 10.1073/pnas.0904625106; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wadiche JI, 1998, J NEUROSCI, V18, P7650; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P18025, DOI 10.1073/pnas.0704570104	41	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26921	26931		10.1074/jbc.M112.364059	http://dx.doi.org/10.1074/jbc.M112.364059			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707712	hybrid, Green Published			2022-12-25	WOS:000307386000040
J	Pavlenok, M; Derrington, IM; Gundlach, JH; Niederweis, M				Pavlenok, Mikhail; Derrington, Ian M.; Gundlach, Jens H.; Niederweis, Michael			MspA Nanopores from Subunit Dimers	PLOS ONE			English	Article							SINGLE-CHAIN ANTIBODY; MYCOBACTERIUM-SMEGMATIS; ESCHERICHIA-COLI; OUTER-MEMBRANE; PORIN MSPA; BETA-BARREL; LINKER PEPTIDES; MOLECULAR-BASIS; ANTHRAX TOXIN; CELL-WALL	Mycobacterium smegmatis porin A (MspA) forms an octameric channel and represents the founding member of a new family of pore proteins. Control of subunit stoichiometry is important to tailor MspA for nanotechnological applications. In this study, two MspA monomers were connected by linkers ranging from 17 to 62 amino acids in length. The oligomeric pore proteins were purified from M. smegmatis and were shown to form functional channels in lipid bilayer experiments. These results indicated that the peptide linkers did not prohibit correct folding and localization of MspA. However, expression levels were reduced by 10-fold compared to wild-type MspA. MspA is ideal for nanopore sequencing due to its unique pore geometry and its robustness. To assess the usefulness of MspA made from dimeric subunits for DNA sequencing, we linked two M1-MspA monomers, whose constriction zones were modified to enable DNA translocation. Lipid bilayer experiments demonstrated that this construct also formed functional channels. Voltage gating of MspA pores made from M1 monomers and M1-M1 dimers was identical indicating similar structural and dynamic channel properties. Glucose uptake in M. smegmatis cells lacking porins was restored by expressing the dimeric mspA M1 gene indicating correct folding and localization of M1-M1 pores in their native membrane. Single-stranded DNA hairpins produced identical ionic current blockades in pores made from monomers and subunit dimers demonstrating that M1-M1 pores are suitable for DNA sequencing. This study provides the proof of principle that production of single-chain MspA pores in M. smegmatis is feasible and paves the way for generating MspA pores with altered stoichiometries. Subunit dimers enable better control of the chemical and physical properties of the constriction zone of MspA. This approach will be valuable both in understanding transport across the outer membrane in mycobacteria and in tailoring MspA for nanopore sequencing of DNA.	[Pavlenok, Mikhail; Niederweis, Michael] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Derrington, Ian M.; Gundlach, Jens H.] Univ Washington, Dept Phys, Seattle, WA 98195 USA	University of Alabama System; University of Alabama Birmingham; University of Washington; University of Washington Seattle	Pavlenok, M (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	mnieder@uab.edu		Niederweis, Michael/0000-0003-4068-8092; Gundlach, Jens Horst/0000-0002-0773-8038	United States National Institutes of Health, National Human Genome Research Institute [R21HG004145, R01HG005115]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004145, R01HG005115] Funding Source: NIH RePORTER	United States National Institutes of Health, National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the United States National Institutes of Health, National Human Genome Research Institute $1000 Genome Program Grants R21HG004145 and R01HG005115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFTHAN K, 1995, PROTEIN ENG, V8, P725, DOI 10.1093/protein/8.7.725; Bainbridge G, 1998, FEBS LETT, V431, P305, DOI 10.1016/S0014-5793(98)00761-3; Bayley H, 2001, NATURE, V413, P226, DOI 10.1038/35093038; Bi WL, 1997, NUCLEIC ACIDS RES, V25, P2949, DOI 10.1093/nar/25.14.2949; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106; DELAVEGA AL, 1995, EMBO J, V14, P6058, DOI 10.1002/j.1460-2075.1995.tb00294.x; Derrington IM, 2010, P NATL ACAD SCI USA, V107, P16060, DOI 10.1073/pnas.1001831107; Duret G, 2007, CHANNELS, V1, P70, DOI 10.4161/chan.3983; Economou A, 1999, TRENDS MICROBIOL, V7, P315, DOI 10.1016/S0966-842X(99)01555-3; Engelhardt H, 2002, J BIOL CHEM, V277, P37567, DOI 10.1074/jbc.M206983200; Faller M, 2004, SCIENCE, V303, P1189, DOI 10.1126/science.1094114; Gouaux E, 1998, J STRUCT BIOL, V121, P110, DOI 10.1006/jsbi.1998.3959; Guo XV, 2007, J BACTERIOL, V189, P4614, DOI 10.1128/JB.00216-07; Hammerstein AF, 2011, J BIOL CHEM, V286, P14324, DOI 10.1074/jbc.M111.218164; Heinz C, 2000, ANAL BIOCHEM, V285, P113, DOI 10.1006/abio.2000.4728; Heinz C, 2003, J CHROMATOGR B, V790, P337, DOI 10.1016/S1570-0232(03)00130-2; Heinz Christian, 2003, Methods Mol Biol, V228, P139, DOI 10.1385/1-59259-400-X:139; Huff J, 2009, J BIOL CHEM, V284, P10223, DOI 10.1074/jbc.M808599200; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Iacovache I, 2010, CURR OPIN STRUC BIOL, V20, P241, DOI 10.1016/j.sbi.2010.01.013; Iyer R, 1997, J BIOL CHEM, V272, P18595, DOI 10.1074/jbc.272.30.18595; Kavoosi M, 2007, BIOTECHNOL BIOENG, V98, P599, DOI 10.1002/bit.21396; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Liu NZ, 1998, PROTEIN ENG, V11, P797, DOI 10.1093/protein/11.9.797; Mahfoud M, 2006, J BIOL CHEM, V281, P5908, DOI 10.1074/jbc.M511642200; Mailaender C, 2004, MICROBIOL-SGM, V150, P853, DOI 10.1099/mic.0.26902-0; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359; Nassi S, 2002, BIOCHEMISTRY-US, V41, P1445, DOI 10.1021/bi0119518; Niederweis M, 1999, MOL MICROBIOL, V33, P933, DOI 10.1046/j.1365-2958.1999.01472.x; Niederweis M, 2003, MOL MICROBIOL, V49, P1167, DOI 10.1046/j.1365-2958.2003.03662.x; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Robertson KM, 2002, BIOCHEM CELL BIOL, V80, P517, DOI 10.1139/O02-145; Rotem D, 2012, J AM CHEM SOC, V134, P2781, DOI 10.1021/ja2105653; Stahl C, 2001, MOL MICROBIOL, V40, P451, DOI 10.1046/j.1365-2958.2001.02394.x; Stephan J, 2005, MOL MICROBIOL, V58, P714, DOI 10.1111/j.1365-2958.2005.04878.x; Tang Y, 1996, J BIOL CHEM, V271, P15682, DOI 10.1074/jbc.271.26.15682; Worner M, 2007, SMALL, V3, P1084, DOI 10.1002/smll.200600559	40	11	27	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38726	10.1371/journal.pone.0038726	http://dx.doi.org/10.1371/journal.pone.0038726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719928	Green Submitted, Green Published, gold			2022-12-25	WOS:000305583300043
J	Garcia-Amado, M; Prensa, L				Garcia-Amado, Maria; Prensa, Lucia			Stereological Analysis of Neuron, Glial and Endothelial Cell Numbers in the Human Amygdaloid Complex	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; 5 SUBCORTICAL REGIONS; TISSUE SHRINKAGE; IMMUNOREACTIVE CELLS; ALZHEIMERS-DISEASE; LATERAL VENTRICLE; CHEMICAL ANATOMY; BIPOLAR DISORDER; THALAMIC NUCLEUS; HUMAN-BRAIN	Cell number alterations in the amygdaloid complex (AC) might coincide with neurological and psychiatric pathologies with anxiety imbalances as well as with changes in brain functionality during aging. This stereological study focused on estimating, in samples from 7 control individuals aged 20 to 75 years old, the number and density of neurons, glia and endothelial cells in the entire AC and in its 5 nuclear groups (including the basolateral (BL), corticomedial and central groups), 5 nuclei and 13 nuclear subdivisions. The volume and total cell number in these territories were determined on Nissl-stained sections with the Cavalieri principle and the optical fractionator. The AC mean volume was 956 mm(3) and mean cell numbers (x10(6)) were: 15.3 neurons, 60 glial cells and 16.8 endothelial cells. The numbers of endothelial cells and neurons were similar in each AC region and were one fourth the number of glial cells. Analysis of the influence of the individuals' age at death on volume, cell number and density in each of these 24 AC regions suggested that aging does not affect regional size or the amount of glial cells, but that neuron and endothelial cell numbers respectively tended to decrease and increase in territories such as AC or BL. These accurate stereological measures of volume and total cell numbers and densities in the AC of control individuals could serve as appropriate reference values to evaluate subtle alterations in this structure in pathological conditions.	[Garcia-Amado, Maria; Prensa, Lucia] Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain	Autonomous University of Madrid	Garcia-Amado, M (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain.	lucia.prensa@uam.es	; Garcia-Amado Sancho, Maria/K-2705-2014	Prensa Sepulveda, Lucia/0000-0003-2217-3271; Garcia-Amado Sancho, Maria/0000-0001-6778-5680	Spanish Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III [PI070199]; Fundacion Eugenio Rodriguez Pascual; Universidad Autonoma de Madrid [FPI2009]	Spanish Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III; Fundacion Eugenio Rodriguez Pascual; Universidad Autonoma de Madrid	The project was supported by Grants from the Spanish Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III (PI070199)(http://www.isciii.es/) and the Fundacion Eugenio Rodriguez Pascual (http://www. fundacioneugeniorodriguezpascual.es/), and a predoctoral fellowship from the Universidad Autonoma de Madrid (FPI2009) (www.uam.es) to Maria Garcia-Amado. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen BB, 1999, J MICROSC-OXFORD, V196, P69; Asllani I, 2009, HUM BRAIN MAPP, V30, P2927, DOI 10.1002/hbm.20719; BEACH TG, 1989, GLIA, V2, P420, DOI 10.1002/glia.440020605; Bermejo PE, 2003, J COMP NEUROL, V463, P419, DOI 10.1002/cne.10747; Berretta S, 2007, BIOL PSYCHIAT, V62, P884, DOI 10.1016/j.biopsych.2007.04.023; Bezchlibnyk YB, 2007, J PSYCHIATR NEUROSCI, V32, P203; BOONSTRA H, 1983, VIRCHOWS ARCH A, V402, P195, DOI 10.1007/BF00695061; Bowley MP, 2002, BIOL PSYCHIAT, V52, P404, DOI 10.1016/S0006-3223(02)01404-X; Boyce RW, 2010, TOXICOL PATHOL, V38, P1011, DOI 10.1177/0192623310385140; Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041; Carlo CN, 2010, J COMP NEUROL, V518, P1176, DOI 10.1002/cne.22264; Chance SA, 2002, BRIT J PSYCHIAT, V180, P331, DOI 10.1192/bjp.180.4.331; deCampo DM, 2012, NEUROSCI BIOBEHAV R, V36, P520, DOI 10.1016/j.neubiorev.2011.08.007; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Dorph-Petersen KA, 2009, ACTA NEUROPATHOL, V117, P369, DOI 10.1007/s00401-008-0410-2; Gallyas F, 1979, Neurol Res, V1, P203; Gardella D, 2003, J NEUROSCI METH, V124, P45, DOI 10.1016/S0165-0270(02)00363-1; Grieve SM, 2011, NEUROIMAGE, V55, P868, DOI 10.1016/j.neuroimage.2010.12.087; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hajek T, 2009, J AFFECT DISORDERS, V115, P395, DOI 10.1016/j.jad.2008.10.007; Hamidi M, 2004, BIOL PSYCHIAT, V55, P563, DOI 10.1016/j.biopsych.2003.11.006; Hatton WJ, 1999, J COMP NEUROL, V409, P169; HAUG H, 1984, J HIRNFORSCH, V25, P353; HECKERS S, 1990, ARCH GEN PSYCHIAT, V47, P1016; Hof PR, 2001, TRENDS NEUROSCI, V24, P377, DOI 10.1016/S0166-2236(00)01834-8; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Kaye JA, 1997, NEUROLOGY, V48, P1297, DOI 10.1212/WNL.48.5.1297; Konopaske GT, 2007, NEUROPSYCHOPHARMACOL, V32, P1216, DOI 10.1038/sj.npp.1301233; Kreczmanski P, 2007, BRAIN, V130, P678, DOI 10.1093/brain/awl386; Kreczmanski P, 2009, ACTA NEUROPATHOL, V117, P409, DOI 10.1007/s00401-009-0482-7; KUSHNER PD, 1991, J NEUROPATH EXP NEUR, V50, P263, DOI 10.1097/00005072-199105000-00008; LaManna JC, 2004, J EXP BIOL, V207, P3163, DOI 10.1242/jeb.00976; LEHERICY S, 1994, AM J NEURORADIOL, V15, P929; Mai JK, 2004, ATLAS HUMAN BRAIN; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Mu QW, 1999, AM J NEURORADIOL, V20, P207; Muramori F, 1998, PSYCHIAT CLIN NEUROS, V52, P593, DOI 10.1111/j.1440-1819.1998.tb02706.x; Nissl F, 1913, ARCH PSYCHIAT NERVEN, V52, P867, DOI 10.1007/BF02160485; PAKKENBERG B, 1990, ARCH GEN PSYCHIAT, V47, P1023; Pakkenberg B, 1997, J COMP NEUROL, V384, P312, DOI 10.1002/(SICI)1096-9861(19970728)384:2<312::AID-CNE10>3.0.CO;2-K; Prensa L, 2003, J COMP NEUROL, V460, P345, DOI 10.1002/cne.10627; Price JL, 2003, ANN NY ACAD SCI, V985, P50; Rubinow MJ, 2009, NEUROBIOL AGING, V30, P137, DOI 10.1016/j.neurobiolaging.2007.05.006; Rubinow MJ, 2009, BEHAV BRAIN RES, V198, P263, DOI 10.1016/j.bbr.2008.11.024; Rubinow MJ, 2009, J COMP NEUROL, V512, P717, DOI 10.1002/cne.21924; Schumann CM, 2005, J COMP NEUROL, V491, P320, DOI 10.1002/cne.20704; Schumann CM, 2006, J NEUROSCI, V26, P7674, DOI 10.1523/JNEUROSCI.1285-06.2006; Sherwood CC, 2006, P NATL ACAD SCI USA, V103, P13606, DOI 10.1073/pnas.0605843103; SIMS KS, 1990, NEUROSCIENCE, V36, P449, DOI 10.1016/0306-4522(90)90440-F; SORVARI H, 1995, J COMP NEUROL, V360, P185, DOI 10.1002/cne.903600202; St Jacques P, 2009, NEUROBIOL AGING, V31, P315; Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Uroz V, 2004, SYNAPSE, V51, P173, DOI 10.1002/syn.10298; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; Yachnis AT, 2000, J NEUROPATH EXP NEUR, V59, P113, DOI 10.1093/jnen/59.2.113; Zhang XM, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.017.2009	58	42	42	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38692	10.1371/journal.pone.0038692	http://dx.doi.org/10.1371/journal.pone.0038692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719923	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341900042
J	de Oliveira, AS; Melo, FL; Inoue-Nagata, AK; Nagata, T; Kitajima, EW; Resende, RO				de Oliveira, Athos Silva; Melo, Fernando Lucas; Inoue-Nagata, Alice Kazuko; Nagata, Tatsuya; Kitajima, Elliot Watanabe; Resende, Renato Oliveira			Characterization of Bean Necrotic Mosaic Virus: A Member of a Novel Evolutionary Lineage within the Genus Tospovirus	PLOS ONE			English	Article							SPOTTED WILT VIRUS; INSECT VECTOR; S-RNA; NUCLEOTIDE-SEQUENCE; IDENTIFICATION; PROTEIN; THYSANOPTERA; PHYLOGENY; THRIPIDAE; SEGMENT	Background: Tospoviruses (Genus Tospovirus, Family Bunyaviridae) are phytopathogens responsible for significant worldwide crop losses. They have a tripartite negative and ambisense RNA genome segments, termed S (Small), M (Medium) and L (Large) RNA. The vector-transmission is mediated by thrips in a circulative-propagative manner. For new tospovirus species acceptance, several analyses are needed, e. g., the determination of the viral protein sequences for enlightenment of their evolutionary history. Methodology/Principal Findings: Biological (host range and symptomatology), serological, and molecular (S and M RNA sequencing and evolutionary studies) experiments were performed to characterize and differentiate a new tospovirus species, Bean necrotic mosaic virus (BeNMV), which naturally infects common beans in Brazil. Based upon the results, BeNMV can be classified as a novel species and, together with Soybean vein necrosis-associated virus (SVNaV), they represent members of a new evolutionary lineage within the genus Tospovirus. Conclusion/Significances: Taken together, these evidences suggest that two divergent lineages of tospoviruses are circulating in the American continent and, based on the main clades diversity (American and Eurasian lineages), new tospovirus species related to the BeNMV-SVNaV clade remain to be discovered. This possible greater diversity of tospoviruses may be reflected in a higher number of crops as natural hosts, increasing the economic impact on agriculture. This idea also is supported since BeNMV and SVNaV were discovered naturally infecting atypical hosts (common bean and soybean, respectively), indicating, in this case, a preference for leguminous species. Further studies, for instance a survey focusing on crops, specifically of leguminous plants, may reveal a greater tospovirus diversity not only in the Americas (where both viruses were reported), but throughout the world.	[de Oliveira, Athos Silva; Melo, Fernando Lucas; Nagata, Tatsuya; Resende, Renato Oliveira] Univ Brasilia, Dept Cell Biol, Brasilia, DF, Brazil; [Inoue-Nagata, Alice Kazuko] Embrapa Vegetables, Brasilia, DF, Brazil; [Kitajima, Elliot Watanabe] Univ Sao Paulo, Sao Paulo, Brazil	Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo	de Oliveira, AS (corresponding author), Univ Brasilia, Dept Cell Biol, Brasilia, DF, Brazil.	rresende@unb.br	Citros, Inct/I-2442-2013; de Oliveira, Athos S./AAC-4106-2019; Nagata, Tatsuya/I-4031-2013; Inoue-Nagata, Alice/H-3775-2012; Melo, Fernando Lucas/U-6535-2017	de Oliveira, Athos S./0000-0003-2715-8898; Nagata, Tatsuya/0000-0002-7114-017X; Inoue-Nagata, Alice/0000-0002-8355-9269; Melo, Fernando Lucas/0000-0002-9591-0239; Resende, Renato/0000-0003-3852-1576	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); Capes (Conselho de Aperfeicoamento de Pessoal de Nivel Superior); FAP-DF (Fundacao de Apoio a Pesquisa do Distrito Federal)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Capes (Conselho de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAP-DF (Fundacao de Apoio a Pesquisa do Distrito Federal)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), Capes (Conselho de Aperfeicoamento de Pessoal de Nivel Superior) and FAP-DF (Fundacao de Apoio a Pesquisa do Distrito Federal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Bezerra IC, 1999, PHYTOPATHOLOGY, V89, P823, DOI 10.1094/PHYTO.1999.89.9.823; Chen CC, 1995, ACTA HORTIC, P57; Chu FH, 2001, PHYTOPATHOLOGY, V91, P856, DOI 10.1094/PHYTO.2001.91.9.856; Cortez I, 2001, ARCH VIROL, V146, P265, DOI 10.1007/s007050170174; de Oliveira AS, 2011, VIRUS GENES, V43, P385, DOI 10.1007/s11262-011-0639-z; DEAVILA AC, 1993, J GEN VIROL, V74, P153, DOI 10.1099/0022-1317-74-2-153; DEAVILA AC, 1993, ARCH VIROL, V128, P211, DOI 10.1007/BF01309435; DEHAAN P, 1990, J GEN VIROL, V71, P1001, DOI 10.1099/0022-1317-71-5-1001; DEHAAN P, 1991, J GEN VIROL, V72, P2207, DOI 10.1099/0022-1317-72-9-2207; Dong JH, 2008, ARCH VIROL, V153, P855, DOI 10.1007/s00705-008-0054-5; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Hassani-Mehraban A, 2010, ARCH VIROL, V155, P423, DOI 10.1007/s00705-010-0590-7; Inoue T, 2007, APPL ENTOMOL ZOOL, V42, P71, DOI 10.1303/aez.2007.71; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; King AM, 2012, 9 REPORT INT COMMITT, P770; Knierim D, 2006, ARCH VIROL, V151, P1761, DOI 10.1007/s00705-006-0749-4; KORMELINK R, 1992, J GEN VIROL, V73, P2795, DOI 10.1099/0022-1317-73-11-2795; Kosakovsky Pond SL, 2011, MOL BIOL EVOL; Lopez C, 2011, J GEN VIROL, V92, P210, DOI 10.1099/vir.0.026708-0; Medeiros RB, 2004, J VIROL, V78, P4976, DOI 10.1128/JVI.78.10.4976-4982.2004; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Mound L. A, 2002, THRIPS TOSPOVIRUSES, P379; Nakahara S, 1999, P ENTOMOL SOC WASH, V101, P290; Nakahara S, 1997, ANNOTATED LIST FRANK; Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Ribeiro D, 2008, J GEN VIROL, V89, P1811, DOI 10.1099/vir.0.2008/001164-0; Riley DG, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10020; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Satyanarayana T, 1998, ARCH VIROL, V143, P353, DOI 10.1007/s007050050291; Seepiban C, 2011, ARCH VIROL, V156, P263, DOI 10.1007/s00705-010-0856-0; Snippe M, 2007, VIROLOGY, V363, P272, DOI 10.1016/j.virol.2006.12.038; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Storms MMH, 1998, PLANT J, V13, P131, DOI 10.1046/j.1365-313X.1998.00007.x; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; ULLMAN DE, 1993, PHYTOPATHOLOGY, V83, P456, DOI 10.1094/Phyto-83-456; Whitfield AE, 2005, ANNU REV PHYTOPATHOL, V43, P459, DOI 10.1146/annurev.phyto.43.040204.140017; WIJKAMP I, 1993, J GEN VIROL, V74, P341, DOI 10.1099/0022-1317-74-3-341; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; Zhou J, 2011, VIRUS GENES, V43, P289, DOI 10.1007/s11262-011-0621-9	47	41	42	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38634	10.1371/journal.pone.0038634	http://dx.doi.org/10.1371/journal.pone.0038634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715400	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336800042
J	Peura, S; Eiler, A; Hiltunen, M; Nykanen, H; Tiirola, M; Jones, RI				Peura, Sari; Eiler, Alexander; Hiltunen, Minna; Nykanen, Hannu; Tiirola, Marja; Jones, Roger I.			Bacterial and Phytoplankton Responses to Nutrient Amendments in a Boreal Lake Differ According to Season and to Taxonomic Resolution	PLOS ONE			English	Article							FRESH-WATER; COMMUNITY COMPOSITION; HUMIC LAKE; TOP-DOWN; LIMITATION; BACTERIOPLANKTON; NITROGEN; PHOSPHORUS; GROWTH; DIVERSITY	Nutrient limitation and resource competition in bacterial and phytoplankton communities may appear different when considering different levels of taxonomic resolution. Nutrient amendment experiments conducted in a boreal lake on three occasions during one open water season revealed complex responses in overall bacterioplankton and phytoplankton abundance and biovolume. In general, bacteria were dominant in spring, while phytoplankton was clearly the predominant group in autumn. Seasonal differences in the community composition of bacteria and phytoplankton were mainly related to changes in observed taxa, while the differences across nutrient treatments within an experiment were due to changes in relative contributions of certain higher-and lower-level phylogenetic groups. Of the main bacterioplankton phyla, only Actinobacteria had a treatment response that was visible even at the phylum level throughout the season. With increasing resolution (from 75 to 99% sequence similarity) major responses to nutrient amendments appeared using 454 pyrosequencing data of 16S rRNA amplicons. This further revealed that OTUs (defined by 97% sequence similarity) annotated to the same highly resolved freshwater groups appeared to occur during different seasons and were showing treatment-dependent differentiation, indicating that OTUs within these groups were not ecologically coherent. Similarly, phytoplankton species from the same genera responded differently to nutrient amendments even though biovolumes of the majority of taxa increased when both nitrogen and phosphorus were added simultaneously. The bacterioplankton and phytoplankton community compositions showed concurrent trajectories that could be seen in synchronous succession patterns over the season. Overall, our data revealed that the response of both communities to nutrient changes was highly dependent on season and that contradictory results may be obtained when using different taxonomic resolutions.	[Peura, Sari; Nykanen, Hannu; Tiirola, Marja; Jones, Roger I.] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Eiler, Alexander] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden; [Hiltunen, Minna] Univ Eastern Finland, Dept Biol, Joensuu, Finland	University of Jyvaskyla; Uppsala University; University of Eastern Finland	Peura, S (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.	sari.peura@jyu.fi	Eiler, Alexander/V-9220-2017; Jones, Roger I/C-7703-2011	Eiler, Alexander/0000-0001-9916-9567; Jones, Roger I/0000-0002-0835-8264; Peura, Sari/0000-0003-3892-8157; Hiltunen, Minna/0000-0002-0003-3000; Tiirola, Marja/0000-0001-5589-3748	Academy of Finland [114604]; University of Jyvaskyla; Swedish foundation of strategic research; Nordic Environmental NUcleotide Network (NENUN)	Academy of Finland(Academy of Finland); University of Jyvaskyla; Swedish foundation of strategic research(Swedish Foundation for Strategic Research); Nordic Environmental NUcleotide Network (NENUN)	This work was supported by Academy of Finland grant 114604 to RIJ. SP was also partly funded by a Rectors grant from the University of Jyvaskyla. AE was partly funded by the Swedish foundation of strategic research. Nordic Environmental NUcleotide Network (NENUN) is acknowledged for travel grant to SP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2007, ENVIRON MICROBIOL, V9, P2728, DOI 10.1111/j.1462-2920.2007.01385.x; Anderson M. J., 2001, AUSTRAL ECOL, V26, P2; Anderson MJ, 2004, ECOL LETT, V6, P683; ARVOLA L, 1986, HYDROBIOLOGIA, V137, P125, DOI 10.1007/BF00004208; Barlett MA, 2010, CAN J MICROBIOL, V56, P32, DOI [10.1139/W09-099, 10.1139/w09-099]; Bergstrom AK, 2008, AQUAT BIOL, V4, P55, DOI 10.3354/ab00099; Brett Michael T., 1999, Aquatic Ecology, V33, P135, DOI 10.1023/A:1009998915078; Burkert U, 2003, APPL ENVIRON MICROB, V69, P6550, DOI 10.1128/AEM.69.11.6550-6559.2003; CHAO A, 1984, SCAND J STAT, V11, P265; COLE JJ, 1982, ANNU REV ECOL SYST, V13, P291, DOI 10.1146/annurev.es.13.110182.001451; Danger M, 2008, OIKOS, V117, P1741, DOI 10.1111/j.1600-0706.2008.16793.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Eiler A, 2012, ISME J, V6, P330, DOI 10.1038/ismej.2011.113; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Grossart HP, 2008, ENVIRON MICROBIOL, V10, P635, DOI 10.1111/j.1462-2920.2007.01487.x; Grossart HP, 2007, AQUAT MICROB ECOL, V47, P163, DOI 10.3354/ame047163; Haukka K, 2006, MICROB ECOL, V51, P137, DOI 10.1007/s00248-005-0049-7; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Hessen DO, 1994, ENVIRON INT, V20, P7; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; HOWARTH RW, 1988, ANNU REV ECOL SYST, V19, P89, DOI 10.1146/annurev.es.19.110188.000513; Hutalle-Schmelzer KML, 2010, FEMS MICROBIOL ECOL, V72, P58, DOI 10.1111/j.1574-6941.2009.00831.x; ILMAVIRTA V, 1982, HYDROBIOLOGIA, V86, P11, DOI 10.1007/BF00005782; Jansson M, 1996, LIMNOL OCEANOGR, V41, P1552, DOI 10.4319/lo.1996.41.7.1552; Jansson M, 2007, TRENDS ECOL EVOL, V22, P316, DOI 10.1016/j.tree.2007.02.015; Jezbera J, 2006, ENVIRON MICROBIOL, V8, P1330, DOI 10.1111/j.1462-2920.2006.01026.x; Jezbera J, 2011, ENVIRON MICROBIOL, V13, P922, DOI 10.1111/j.1462-2920.2010.02396.x; Johnson John L., 1994, P655; Kankaala P, 2010, FUND APPL LIMNOL, V177, P161, DOI 10.1127/1863-9135/2010/0177-0161; Kent AD, 2007, ISME J, V1, P38, DOI 10.1038/ismej.2007.6; Kent AD, 2006, ENVIRON MICROBIOL, V8, P1448, DOI 10.1111/j.1462-2920.2006.01039.x; Keskitalo Jorma, 1998, Boreal Environment Research, V3, P251; Krebs C. J., 1999, ECOLOGICAL METHODOLO; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lewitus AJ, 1998, LIMNOL OCEANOGR, V43, P636, DOI 10.4319/lo.1998.43.4.0636; Maberly SC, 2002, FRESHWATER BIOL, V47, P2136, DOI 10.1046/j.1365-2427.2002.00962.x; Massana R, 2009, ISME J, V3, P588, DOI 10.1038/ismej.2008.130; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Mills DK, 2003, J MICROBIOL METH, V54, P57, DOI 10.1016/S0167-7012(03)00007-1; NEEFS JM, 1990, NUCLEIC ACIDS RES, V18, P2237, DOI 10.1093/nar/18.suppl.2237; Newton RJ, 2011, ENVIRON MICROBIOL, V13, P887, DOI 10.1111/j.1462-2920.2010.02387.x; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Peura S, 2012, ISME J, V6, P1640, DOI 10.1038/ismej.2012.21; PIELOU EC, 1966, AM NAT, V100, P463, DOI 10.1086/282439; Ptacnik R, 2010, ECOSYSTEMS, V13, P1201, DOI 10.1007/s10021-010-9380-z; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REDFIELD AC, 1958, AM SCI, V46, P205; SCHANZ F, 1983, HYDROBIOLOGIA, V102, P187, DOI 10.1007/BF00006346; Schauer M, 2005, APPL ENVIRON MICROB, V71, P5900, DOI 10.1128/AEM.71.10.5900-5907.2005; Selinummi J, 2005, BIOTECHNIQUES, V39, P859, DOI 10.2144/000112018; Shade A, 2007, LIMNOL OCEANOGR, V52, P487, DOI 10.4319/lo.2007.52.2.0487; Simek K, 2005, APPL ENVIRON MICROB, V71, P2381, DOI 10.1128/AEM.71.5.2381-2390.2005; Simek K, 2006, ENVIRON MICROBIOL, V8, P1613, DOI 10.1111/j.1462-2920.2006.01053.x; Suzuki M, 1998, APPL ENVIRON MICROB, V64, P4522; Taipale S, 2009, AQUAT MICROB ECOL, V55, P1, DOI 10.3354/ame01277; Tessier JT, 2003, J APPL ECOL, V40, P523, DOI 10.1046/j.1365-2664.2003.00820.x; Thomsen TR, 2007, FEMS MICROBIOL ECOL, V60, P370, DOI 10.1111/j.1574-6941.2007.00309.x; Tiirola MA, 2002, APPL ENVIRON MICROB, V68, P173, DOI 10.1128/AEM.68.1.173-180.2002; van der Ploeg RR, 1999, SOIL SCI SOC AM J, V63, P1055, DOI 10.2136/sssaj1999.6351055x; van Hannen EJ, 1999, APPL ENVIRON MICROB, V65, P795; VANNI MJ, 1990, LIMNOL OCEANOGR, V35, P697, DOI 10.4319/lo.1990.35.3.0697; Vrede K, 1999, LIMNOL OCEANOGR, V44, P1616, DOI 10.4319/lo.1999.44.7.1616; Vrede K, 2005, MICROB ECOL, V49, P245, DOI 10.1007/s00248-004-0259-4; WOLDA H, 1981, OECOLOGIA, V50, P296, DOI 10.1007/BF00344966; Wu LQ, 2009, MICROB ECOL, V57, P58, DOI 10.1007/s00248-008-9403-x	70	23	23	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38552	10.1371/journal.pone.0038552	http://dx.doi.org/10.1371/journal.pone.0038552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715392	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336800034
J	Theodoratou, E; Palmer, T; Zgaga, L; Farrington, SM; McKeigue, P; Din, FVN; Tenesa, A; Davey-Smith, G; Dunlop, MG; Campbell, H				Theodoratou, Evropi; Palmer, Tom; Zgaga, Lina; Farrington, Susan M.; McKeigue, Paul; Din, Farhat V. N.; Tenesa, Albert; Davey-Smith, George; Dunlop, Malcolm G.; Campbell, Harry			Instrumental Variable Estimation of the Causal Effect of Plasma 25-Hydroxy-Vitamin D on Colorectal Cancer Risk: A Mendelian Randomization Analysis	PLOS ONE			English	Article							VITAMIN-D INTAKE; 25-HYDROXYVITAMIN D; D SUPPLEMENTATION; D DEFICIENCY; CALCIUM; ASSOCIATION; HEALTH; METAANALYSIS; PREVENTION; ASPIRIN	Vitamin D deficiency has been associated with several common diseases, including cancer and is being investigated as a possible risk factor for these conditions. We reported the striking prevalence of vitamin D deficiency in Scotland. Previous epidemiological studies have reported an association between low dietary vitamin D and colorectal cancer (CRC). Using a case-control study design, we tested the association between plasma 25-hydroxy-vitamin D (25-OHD) and CRC (2,001 cases, 2,237 controls). To determine whether plasma 25-OHD levels are causally linked to CRC risk, we applied the control function instrumental variable (IV) method of the Mendelian randomization (MR) approach using four single nucleotide polymorphisms (rs2282679, rs12785878, rs10741657, rs6013897) previously shown to be associated with plasma 25-OHD. Low plasma 25-OHD levels were associated with CRC risk in the crude model (odds ratio (OR): 0.76, 95% Confidence Interval (CI): 0.71, 0.81, p: 1.4x10(-14)) and after adjusting for age, sex and other confounding factors. Using an allele score that combined all four SNPs as the IV, the estimated causal effect was OR 1.16 (95% CI 0.60, 2.23), whilst it was 0.94 (95% CI 0.46, 1.91) and 0.93 (0.53, 1.63) when using an upstream (rs12785878, rs10741657) and a downstream allele score (rs2282679, rs6013897), respectively. 25-OHD levels were inversely associated with CRC risk, in agreement with recent meta-analyses. The fact that this finding was not replicated when the MR approach was employed might be due to weak instruments, giving low power to demonstrate an effect (<0.35). The prevalence and degree of vitamin D deficiency amongst individuals living in northerly latitudes is of considerable importance because of its relationship to disease. To elucidate the effect of vitamin D on CRC cancer risk, additional large studies of vitamin D and CRC risk are required and/or the application of alternative methods that are less sensitive to weak instrument restrictions.	[Theodoratou, Evropi; Zgaga, Lina; McKeigue, Paul; Campbell, Harry] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Theodoratou, Evropi; Zgaga, Lina; Farrington, Susan M.; Din, Farhat V. N.; Tenesa, Albert; Dunlop, Malcolm G.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit,Colon Canc Grp & Acad Colopr, Edinburgh EH8 9YL, Midlothian, Scotland; [Palmer, Tom; Davey-Smith, George] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Zgaga, Lina] Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Zagreb 41000, Croatia; [Tenesa, Albert] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Bristol; University of Zagreb; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Theodoratou, E (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland.	E.Theodoratou@ed.ac.uk	Campbell, Harry/E-2959-2010; Dunlop, Malcolm G/F-1973-2011; Palmer, Tom Michael/X-6807-2019; Farrington, Susan M/C-7319-2013; Din, Farhat/A-1944-2015; Davey Smith, George/A-7407-2013; Zgaga, Lina/Q-9415-2018; Farrington, Susan M/Q-2710-2019; Theodoratou, Evropi/C-3430-2014	Campbell, Harry/0000-0002-6169-6262; Dunlop, Malcolm G/0000-0002-3033-5851; Palmer, Tom Michael/0000-0003-4655-4511; Davey Smith, George/0000-0002-1407-8314; Zgaga, Lina/0000-0003-4089-9703; Farrington, Susan M/0000-0001-5955-7389; Theodoratou, Evropi/0000-0001-5887-9132; Tenesa, Albert/0000-0003-4884-4475; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768	Cancer Research UK Programme grant [C348/A12076]; Medical Research Council [G0000657-53203]; Scottish Executive Chief Scientist's Office [CZH/4/529, CZB/4/449]; Centre Grant from CORE, Digestive Cancer Campaign; Cancer Research UK Fellowship [C31250/A10107]; MRC centre grant [G0600705]; United States National Institute for Health-National Cancer Institute U19 programme grant, CORECT consortium [1U19CA148107-01]; Cancer Research UK [12076, 11378] Funding Source: researchfish; Medical Research Council [MC_PC_U127527198, G0600705, MC_U127527198, G0800604] Funding Source: researchfish; Chief Scientist Office [CZB/4/449, CZH/4/529] Funding Source: researchfish; MRC [G0600705, MC_U127527198, G0800604, MC_PC_U127527198] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [U19CA148107] Funding Source: NIH RePORTER	Cancer Research UK Programme grant(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Executive Chief Scientist's Office; Centre Grant from CORE, Digestive Cancer Campaign; Cancer Research UK Fellowship(Cancer Research UK); MRC centre grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United States National Institute for Health-National Cancer Institute U19 programme grant, CORECT consortium; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the following grants: Cancer Research UK Programme grant (C348/A12076), Medical Research Council (G0000657-53203) and Scottish Executive Chief Scientist's Office (CZH/4/529, CZB/4/449), and a Centre Grant from CORE as part of the Digestive Cancer Campaign. Dr. Theodoratou is funded by Cancer Research UK Fellowship C31250/A10107. Dr. Palmer is funded by MRC centre grant G0600705. Dr. Zgaga is supported by the United States National Institute for Health-National Cancer Institute U19 programme grant (1U19CA148107-01) as part of the CORECT consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benn M, 2011, JNCI-J NATL CANCER I, V103, P508, DOI 10.1093/jnci/djr008; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Breitling LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022318; Burleigh E, 2006, SCOT MED J, V51, P27; *COMA, 1991, DIET REF VAL FOOD EN; Dahl M, 2011, THORAX, V66, P197, DOI 10.1136/thx.2009.131193; De Silva NMG, 2011, DIABETES, V60, P1008, DOI 10.2337/db10-1317; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; Din FVN, 2010, GUT, V59, P1670, DOI 10.1136/gut.2009.203000; Ding EL, 2008, INT J CANCER, V122, P1690, DOI 10.1002/ijc.23311; Gross MD, 2005, J NUTR, V135, P326, DOI 10.1093/jn/135.2.326; Jimenez-Lara AM, 2007, INT J BIOCHEM CELL B, V39, P672, DOI 10.1016/j.biocel.2006.10.024; Kivimaki M, 2011, INT J EPIDEMIOL, V40, P470, DOI 10.1093/ije/dyq205; Kivimaki M, 2011, AM J EPIDEMIOL, V173, P421, DOI 10.1093/aje/kwq444; Knox S, 2009, ANN CLIN BIOCHEM, V46, P226, DOI 10.1258/acb.2009.008206; Lawlor DA, 2007, STAT MED; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lawlor DA, 2011, J INTERN MED, V269, P525, DOI 10.1111/j.1365-2796.2011.02343.x; Lee JE, 2011, CANCER PREV RES, V4, P735, DOI 10.1158/1940-6207.CAPR-10-0289; Lewis SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021689; McKeigue PM, 2010, INT J EPIDEMIOL, V39, P907, DOI 10.1093/ije/dyp397; Mumby HS, 2011, J OBES, V2011, DOI 10.1155/2011/180729; Ng K, 2011, J CLIN ONCOL, V29, P1599, DOI 10.1200/JCO.2010.31.7255; Palmer TM, 2011, AM J EPIDEMIOL, V173, P1392, DOI 10.1093/aje/kwr026; Park SY, 2007, AM J EPIDEMIOL, V165, P784, DOI 10.1093/aje/kwk069; Pearce SHS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5664; Pfister R, 2011, DIABETOLOGIA, V54, P2561, DOI 10.1007/s00125-011-2235-0; Pierce BL, 2011, INT J EPIDEMIOL, V40, P740, DOI 10.1093/ije/dyq151; Sivakumaran S, 2011, AM J HUM GE IN PRESS; Slattery ML, 2004, CANCER EPIDEM BIOMAR, V13, P538; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2007, PLOS MED, V4, P1985, DOI 10.1371/journal.pmed.0040352; Theodoratou E, 2008, INT J CANCER, V123, P2170, DOI 10.1002/ijc.23769; Theodoratou E, 2007, CANCER EPIDEM BIOMAR, V16, P684, DOI 10.1158/1055-9965.EPI-06-0785; Touvier M, 2011, CANCER EPIDEM BIOMAR, V20, P1003, DOI 10.1158/1055-9965.EPI-10-1141; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Vieth R, 2007, AM J CLIN NUTR, V85, P649, DOI 10.1093/ajcn/85.3.649; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Wagner CL, 2008, PEDIATRICS, V122, P1142, DOI 10.1542/peds.2008-1862; Wallace AM, 2010, STEROIDS, V75, P477, DOI 10.1016/j.steroids.2010.02.012; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Yin L, 2011, PREV MED, V53, P10, DOI 10.1016/j.ypmed.2011.05.013; Zgaga L, 2011, J NUTR	45	42	42	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37662	10.1371/journal.pone.0037662	http://dx.doi.org/10.1371/journal.pone.0037662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701574	gold, Green Published, Green Submitted			2022-12-25	WOS:000305348400015
J	Nagel, M; Sprenger, A; Steinlechner, S; Binkofski, F; Lencer, R				Nagel, Matthias; Sprenger, Andreas; Steinlechner, Susanne; Binkofski, Ferdinand; Lencer, Rebekka			Altered Velocity Processing in Schizophrenia during Pursuit Eye Tracking	PLOS ONE			English	Article							ARCUATE FRONTAL-CORTEX; SMOOTH-PURSUIT; MOTION PERCEPTION; CORTICAL MECHANISMS; OCULOMOTOR SYSTEM; VISUAL-PERCEPTION; CEREBELLAR UVULA; TARGET BLANKING; MOVEMENTS; DEFICITS	Smooth pursuit eye movements (SPEM) are needed to keep the retinal image of slowly moving objects within the fovea. Depending on the task, about 50%-80% of patients with schizophrenia have difficulties in maintaining SPEM. We designed a study that comprised different target velocities as well as testing for internal (extraretinal) guidance of SPEM in the absence of a visual target. We applied event-related fMRI by presenting four velocities (5, 10, 15, 20 degrees/s) both with and without intervals of target blanking. 17 patients and 16 healthy participants were included. Eye movements were registered during scanning sessions. Statistical analysis included mixed ANOVAs and regression analyses of the target velocity on the Blood Oxygen Level Dependency (BOLD) signal. The main effect group and the interaction of velocityxgroup revealed reduced activation in V5 and putamen but increased activation of cerebellar regions in patients. Regression analysis showed that activation in supplementary eye field, putamen, and cerebellum was not correlated to target velocity in patients in contrast to controls. Furthermore, activation in V5 and in intraparietal sulcus (putative LIP) bilaterally was less strongly correlated to target velocity in patients than controls. Altered correlation of target velocity and neural activation in the cortical network supporting SPEM (V5, SEF, LIP, putamen) implies impaired transformation of the visual motion signal into an adequate motor command in patients. Cerebellar regions seem to be involved in compensatory mechanisms although cerebellar activity in patients was not related to target velocity.	[Nagel, Matthias; Steinlechner, Susanne; Lencer, Rebekka] Univ Lubeck, Dept Psychiat & Psychotherapy, Lubeck, Germany; [Sprenger, Andreas] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Nagel, Matthias] Univ Clin Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Nagel, Matthias] Clin Psychiat & Psychotherapy, Asklepios Klin Nord Wandsbek, Hamburg, Germany; [Lencer, Rebekka] Univ Munster, Dept Psychiat & Psychotherapy, Munster, Germany; [Binkofski, Ferdinand] Rhein Westfal TH Aachen, Div Cognit Neurol, Dept Neurol, Aachen, Germany	University of Lubeck; University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; RWTH Aachen University	Nagel, M (corresponding author), Univ Lubeck, Dept Psychiat & Psychotherapy, Lubeck, Germany.	ma.nagel@asklepios.com	Sprenger, Andreas/C-7612-2009; Lencer, Rebekka/A-4994-2009; Binkofski, Ferdinand/S-6997-2017	Sprenger, Andreas/0000-0001-9255-7911; Lencer, Rebekka/0000-0003-4032-7297; Binkofski, Ferdinand/0000-0002-6750-943X	DFG (Deutsche Forschungsgemeinschaft/German Research Foundation) [NA 614/3-1]	DFG (Deutsche Forschungsgemeinschaft/German Research Foundation)(German Research Foundation (DFG))	This work was granted by the DFG (Deutsche Forschungsgemeinschaft/German Research Foundation, grant: NA 614/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen NC, 2008, BIOL PSYCHIAT, V64, P81, DOI 10.1016/j.biopsych.2008.01.003; BECKER W, 1985, EXP BRAIN RES, V57, P562; Burke MR, 2008, CEREB CORTEX, V18, P126, DOI 10.1093/cercor/bhm038; Butler PD, 2008, BIOL PSYCHIAT, V64, P40, DOI 10.1016/j.biopsych.2008.03.023; Butler PD, 2005, CURR OPIN PSYCHIATR, V18, P151, DOI 10.1097/00001504-200503000-00008; Chen Y, 2004, BIOL PSYCHIAT, V55, P834, DOI 10.1016/j.biopsych.2003.12.024; Chen Y, 1999, ARCH GEN PSYCHIAT, V56, P149, DOI 10.1001/archpsyc.56.2.149; Chen Y, 1999, ARCH GEN PSYCHIAT, V56, P155, DOI 10.1001/archpsyc.56.2.155; Chen Y, 2003, SCHIZOPHR RES, V61, P215, DOI 10.1016/S0920-9964(02)00222-0; Dash S, 2012, CEREB CORTEX, V22, P877, DOI 10.1093/cercor/bhr153; Dieterich M, 2009, ANN NY ACAD SCI, V1164, P282, DOI 10.1111/j.1749-6632.2008.03718.x; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Fukushima J, 2004, J NEUROPHYSIOL, V91, P2809, DOI 10.1152/jn.01128.2003; Heinen SJ, 1996, EXP BRAIN RES, V110, P1; HEINEN SJ, 1992, ANN NY ACAD SCI, V656, P775, DOI 10.1111/j.1749-6632.1992.tb25256.x; HOLZMAN PS, 1974, ARCH GEN PSYCHIAT, V31, P143; Hong LE, 2008, BIOL PSYCHIAT, V63, P458, DOI 10.1016/j.biopsych.2007.06.004; Hong LE, 2009, BIOL PSYCHIAT, V65, P1079, DOI 10.1016/j.biopsych.2008.10.021; Hong LE, 2005, BIOL PSYCHIAT, V57, P726, DOI 10.1016/j.biopsych.2004.12.015; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; Lencer R, 2000, BIOL PSYCHIAT, V47, P391, DOI 10.1016/S0006-3223(99)00249-8; Lencer R, 2004, EUR J NEUROSCI, V19, P1430, DOI 10.1111/j.1460-9568.2004.03229.x; Lencer R, 2005, NEUROIMAGE, V24, P1256, DOI 10.1016/j.neuroimage.2004.11.013; Lencer R, 2011, PSYCHIAT RES-NEUROIM, V194, P30, DOI 10.1016/j.pscychresns.2011.06.011; Lencer R, 2010, BIOL PSYCHIAT, V67, P217, DOI 10.1016/j.biopsych.2009.08.005; Lynch JC, 2006, PROG BRAIN RES, V151, P461, DOI 10.1016/S0079-6123(05)51015-X; Nagel M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-89; Nagel M, 2006, NEUROIMAGE, V29, P1319, DOI 10.1016/j.neuroimage.2005.08.050; Nagel M, 2008, NEUROIMAGE, V41, P483, DOI 10.1016/j.neuroimage.2008.02.058; Nagel M, 2007, NEUROIMAGE, V34, P300, DOI 10.1016/j.neuroimage.2006.08.025; Neggers SFW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029517; Nkam I, 2010, BIOL PSYCHIAT, V67, P992, DOI 10.1016/j.biopsych.2009.11.029; ODonnell BF, 1996, AM J PSYCHIAT, V153, P687; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; Robinson FR, 2001, ANNU REV NEUROSCI, V24, P981, DOI 10.1146/annurev.neuro.24.1.981; Schmid A, 2001, NEUROREPORT, V12, P1409, DOI 10.1097/00001756-200105250-00023; Schraa-Tam CKL, 2008, EXP BRAIN RES, V185, P535, DOI 10.1007/s00221-007-1176-9; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shichinohe N, 2009, NEURON, V62, P717, DOI 10.1016/j.neuron.2009.05.010; Slaghuis WL, 2007, EXP BRAIN RES, V182, P415, DOI 10.1007/s00221-007-1003-3; Slaghuis WL, 2004, EXP BRAIN RES, V156, P196, DOI 10.1007/s00221-003-1771-3; Takagi M, 2000, J NEUROPHYSIOL, V83, P2047, DOI 10.1152/jn.2000.83.4.2047; Tanaka M, 2002, J NEUROPHYSIOL, V87, P2700, DOI 10.1152/jn.2002.87.6.2700; Tanaka M, 2002, J NEUROPHYSIOL, V87, P2684, DOI 10.1152/jn.2002.87.6.2684; Thaker GK, 1998, ARCH GEN PSYCHIAT, V55, P830, DOI 10.1001/archpsyc.55.9.830; Thaker GK, 1999, PSYCHIAT RES, V88, P209, DOI 10.1016/S0165-1781(99)00084-0; Thaker GK, 2008, SCHIZOPHRENIA BULL, V34, P760, DOI 10.1093/schbul/sbn049; Thier P, 2005, CURR OPIN NEUROBIOL, V15, P645, DOI 10.1016/j.conb.2005.10.013; Voogd J, 2012, CEREBELLUM, V11, P392, DOI 10.1007/s12311-010-0204-7	53	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38494	10.1371/journal.pone.0038494	http://dx.doi.org/10.1371/journal.pone.0038494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693639	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343900049
J	Wendt, MK; Schiemann, BJ; Parvani, JG; Lee, YH; Kang, Y; Schiemann, WP				Wendt, M. K.; Schiemann, B. J.; Parvani, J. G.; Lee, Y-H; Kang, Y.; Schiemann, W. P.			TGF-beta stimulates Pyk2 expression as part of an epithelial-mesenchymal transition program required for metastatic outgrowth of breast cancer	ONCOGENE			English	Article						EMT; FAK; metastasis; Pyk2; signal transduction; TGF-beta	FOCAL ADHESION KINASE; GROWTH-FACTOR-BETA; PROTEIN-TYROSINE KINASE; CELL-PROLIFERATION; SIGNALING EVENTS; BONE METASTASIS; UP-REGULATION; SRC; FAK; INHIBITION	Epithelial-mesenchymal transition (EMT) programs are essential in promoting breast cancer invasion, systemic dissemination and in arousing proliferative programs in breast cancer micrometastases, a reaction that is partially dependent on focal adhesion kinase (FAK). Many functions of FAK are shared by its homolog, protein tyrosine kinase 2 (Pyk2), raising the question as to whether Pyk2 also participates in driving the metastatic outgrowth of disseminated breast cancer cells. In addressing this question, we observed Pyk2 expression to be (i) significantly upregulated in recurrent human breast cancers; (ii) differentially expressed across clonal isolates of human MDA-MB-231 breast cancer cells in a manner predictive for metastatic outgrowth, but not for invasiveness; and (iii) dramatically elevated in ex vivo cultures of breast cancer cells isolated from metastatic lesions as compared with cells that produced the primary tumor. We further show that metastatic human and murine breast cancer cells robustly upregulate their expression of Pyk2 during EMT programs stimulated by transforming growth factor-beta (TGF-beta). Genetic and pharmacological inhibition of Pyk2 demonstrated that the activity of this protein tyrosine kinase was dispensable for the ability of breast cancer cells to undergo invasion in response to TGF-beta, and to form orthotopic mammary tumors in mice. In stark contrast, Pyk2-deficiency prevented TGF-beta from stimulating the growth of breast cancer cells in 3D-organotypic cultures that recapitulated pulmonary microenvironments, as well as inhibited the metastatic outgrowth of disseminated breast cancer cells in the lungs of mice. Mechanistically, Pyk2 expression was inversely related to that of E-cadherin, such that elevated Pyk2 levels stabilized beta 1 integrin expression necessary to initiate the metastatic outgrowth of breast cancer cells. Thus, we have delineated novel functions for Pyk2 in mediating distinct elements of the EMT program and metastatic cascade regulated by TGF-beta, particularly the initiation of secondary tumor outgrowth by disseminated cells. Oncogene (2013) 32, 2005-2015; doi:10.1038/onc.2012.230; published online 18 June 2012	[Wendt, M. K.; Schiemann, B. J.; Parvani, J. G.; Lee, Y-H; Schiemann, W. P.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Kang, Y.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Case Western Reserve University; Princeton University	Schiemann, WP (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44106 USA.	william.schiemann@case.edu		Kang, Yibin/0000-0002-1626-6730; Wendt, Mike/0000-0002-3665-7413	National Institutes of Health [CA129359]; Susan G Komen for the Cure Foundation [BCTR0706967]; Department of Defense [BC084561]; Case Comprehensive Cancer Center [P30 CA043703]; American Cancer Society [PF-09-120-01]; NATIONAL CANCER INSTITUTE [R01CA129359, P30CA043703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); Department of Defense(United States Department of Defense); Case Comprehensive Cancer Center; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Pfizer for generously providing the small molecule inhibitors against FAK and Pyk2. Members of the Schiemann Laboratory are thanked for critical reading of the manuscript. WPS was supported in part by grants from the National Institutes of Health (CA129359), the Susan G Komen for the Cure Foundation (BCTR0706967), the Department of Defense (BC084561), and pilot funding from the Case Comprehensive Cancer Center (P30 CA043703), while MKW was supported by a fellowship from the American Cancer Society (PF-09-120-01).	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Behmoaram E, 2008, AM J PATHOL, V173, P1540, DOI 10.2353/ajpath.2008.080292; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Burdick AD, 2006, CARCINOGENESIS, V27, P2331, DOI 10.1093/carcin/bgl083; Carelli S, 2006, LUNG CANCER, V53, P263, DOI 10.1016/j.lungcan.2006.06.001; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dahl U, 1996, DEVELOPMENT, V122, P2895; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Fan HP, 2011, J BIOL CHEM, V286, P18573, DOI 10.1074/jbc.M110.200717; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Galliher Amy J, 2006, Future Oncol, V2, P743, DOI 10.2217/14796694.2.6.743; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Galliher-Beckley AJ, 2008, CARCINOGENESIS, V29, P244, DOI 10.1093/carcin/bgm245; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; ILLC D, 1995, NATURE, V377, P539; Judson PL, 1999, CANCER, V86, P1551, DOI 10.1002/(SICI)1097-0142(19991015)86:6<1551::AID-CNCR23>3.0.CO;2-P; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kim SJ, 2004, J KOREAN MED SCI, V19, P710, DOI 10.3346/jkms.2004.19.5.710; Korpal M, 2009, NAT MED; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Lightfoot HM, 2004, BREAST CANCER RES TR, V88, P109, DOI 10.1007/s10549-004-1022-8; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lim ST, 2010, J BIOL CHEM, V285, P1743, DOI 10.1074/jbc.M109.064212; Lipinski CA, 2010, EXPERT OPIN THER TAR, V14, P95, DOI 10.1517/14728220903473194; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Nakamura K, 2001, ONCOGENE, V20, P2626, DOI 10.1038/sj.onc.1204359; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Parvani JG, 2011, J MAMMARY GLAND BIOL, V16, P127, DOI 10.1007/s10911-011-9207-3; Roberts WG, 2008, CANCER RES, V68, P1935, DOI 10.1158/0008-5472.CAN-07-5155; Schaller MD, 1997, J BIOL CHEM, V272, P25319, DOI 10.1074/jbc.272.40.25319; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Sun CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018878; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Taylor MA, 2010, J MAMMARY GLAND BIOL, V15, P169, DOI 10.1007/s10911-010-9181-1; Ungefroren H, 2011, CURR CANCER DRUG TAR, V11, P524, DOI 10.2174/156800911795538075; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038; Wendt MK, 2010, ONCOGENE, V29, P6485, DOI 10.1038/onc.2010.377; Wendt MK, 2011, JOVE-J VIS EXP, DOI 10.3791/3245; Wendt MK, 2011, MOL BIOL CELL, V22, P2423, DOI 10.1091/mbc.E11-04-0306; Wendt MK, 2009, J BIOL CHEM, V284, P34145, DOI 10.1074/jbc.M109.023614; Wendt MK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2360; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zrihan-Licht S, 2000, ONCOGENE, V19, P1318, DOI 10.1038/sj.onc.1203422	58	51	54	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 18	2013	32	16					2005	2015		10.1038/onc.2012.230	http://dx.doi.org/10.1038/onc.2012.230			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	130LY	22710711	Green Accepted			2022-12-25	WOS:000317919900002
J	Thuault, S; Hayashi, S; Lagirand-Cantaloube, J; Plutoni, C; Comunale, F; Delattre, O; Relaix, F; Gauthier-Rouviere, C				Thuault, S.; Hayashi, S.; Lagirand-Cantaloube, J.; Plutoni, C.; Comunale, F.; Delattre, O.; Relaix, F.; Gauthier-Rouviere, C.			P-cadherin is a direct PAX3-FOXO1A target involved in alveolar rhabdomyosarcoma aggressiveness	ONCOGENE			English	Article						P-cadherin; rhabdomyosarcoma; PAX3-FOXO1A; invasion; cadherin switch	TRANSCRIPTIONAL ACTIVATOR; SKELETAL MYOGENESIS; CELL-MIGRATION; GENE FUSIONS; PAX GENES; EXPRESSION; PAX3-FKHR; IDENTIFICATION; FAMILY; TRANSFORMATION	Alveolar rhabdomyosarcoma (ARMS) is an aggressive childhood cancer of striated muscle characterized by the presence of the PAX3-FOXO1A or PAX7-FOXO1A chimeric oncogenic transcription factor. Identification of their targets is essential for understanding ARMS pathogenesis. To this aim, we analyzed transcriptomic data from rhabdomyosarcoma samples and found that P-cadherin expression is correlated with PAX3/7-FOXO1A presence. We then show that expression of a PAX3 dominant negative variant inhibits P-cadherin expression in ARMS cells. Using mouse models carrying modified Pax3 alleles, we demonstrate that P-cadherin is expressed in the dermomyotome and lies genetically downstream from the myogenic factor Pax3. Moreover, in vitro gel shift analysis and chromatin immunoprecipitation indicate that the P-cadherin gene is a direct transcriptional target for PAX3/7-FOXO1A. Finally, P-cadherin expression in normal myoblasts inhibits myogenesis and induces myoblast transformation, migration and invasion. Conversely, P-cadherin downregulation by small hairpin RNA decreases the transformation, migration and invasive potential of ARMS cells. P-cadherin also favors cadherin switching, which is a hallmark of metastatic progression, by controlling N- and M-cadherin expression and/or localization. Our findings demonstrate that P-cadherin is a direct PAX3-FOXO1A transcriptional target involved in ARMS aggressiveness. Therefore, P-cadherin emerges as a new and attractive target for therapeutic intervention in ARMS. Oncogene (2013) 32, 1876-1887; doi:10.1038/onc.2012.217; published online 18 June 2012	[Thuault, S.; Lagirand-Cantaloube, J.; Plutoni, C.; Comunale, F.; Gauthier-Rouviere, C.] Univ Montpellier 2, CRBM, CNRS, UMR 5237, F-34293 Montpellier, France; [Thuault, S.; Lagirand-Cantaloube, J.; Plutoni, C.; Comunale, F.; Gauthier-Rouviere, C.] Univ Montpellier I, CRBM, CNRS, UMR 5237, F-34293 Montpellier, France; [Hayashi, S.; Relaix, F.] INSERM UPMC AIM, UMRS787, Paris, France; [Delattre, O.] Inst Curie, INSERM Unite 830, Unite Genet Somat, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite	Gauthier-Rouviere, C (corresponding author), Univ Montpellier 2, CRBM, CNRS, UMR 5237, 1919 Route Mende, F-34293 Montpellier, France.	cecile.gauthier@crbm.cnrs.fr		GAUTHIER-ROUVIERE, Cecile/0000-0002-8364-3882; THUAULT, Sylvie/0000-0003-0133-3803; Hayashi, Shinichiro/0000-0001-5553-7698; Comunale, Franck/0000-0001-8838-2151; Relaix, Frederic/0000-0003-1270-1472; delattre, olivier/0000-0002-8730-2276	"Cartes d'Identite des Tumeurs" program of the Ligue Nationale contre le Cancer; Ligue Nationale contre le Cancer (LNCC) ("Equipe labellisee"); Institut National du Cancer (INCa); INSERM; INCa; Association pour la Recherche contre le Cancer (ARC); INSERM Avenir Program; Association Francaise Contre les Myopathies; LNCC; ARC; Fondation pour la Recherche Medicale; European Union, project ENDOSTEM [241440]	"Cartes d'Identite des Tumeurs" program of the Ligue Nationale contre le Cancer; Ligue Nationale contre le Cancer (LNCC) ("Equipe labellisee"); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INCa(Institut National du Cancer (INCA) France); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); INSERM Avenir Program(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); LNCC; ARC(Australian Research Council); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Union, project ENDOSTEM	We thank Vincent Mouly for the LHCN-M2 myoblasts, Setsuo Hirohashi and Keith Johnson for the P-cadherin cDNA, Mickael Rudnicki for the pBRIT plasmid, Pete Zammit for the pMSCV-Pax3-En-IRES-eGFP plasmids. We thank the Montpellier Imaging Facility (http://www.mri.cnrs.fr/) and Lionel Larue, Sophie Charrasse and Stephane Bodin for discussion. This work was supported by the "Cartes d'Identite des Tumeurs" program (http://cit.ligue-cancer.net/) of the Ligue Nationale contre le Cancer, the Ligue Nationale contre le Cancer (LNCC) ("Equipe labellisee") and the Institut National du Cancer (INCa). CGR was supported by INSERM, ST by INCa and JLC by the Association pour la Recherche contre le Cancer (ARC). FR's team is supported by the INSERM Avenir Program, Association Francaise Contre les Myopathies, LNCC, ARC, Fondation pour la Recherche Medicale, INCa and from the European Union Seventh Framework Programme, project ENDOSTEM (number 241440).	Bach AS, 2010, MOL BIOL CELL, V21, P2412, DOI 10.1091/mbc.E09-12-1063; Bajard L, 2006, GENE DEV, V20, P2450, DOI 10.1101/gad.382806; Barr FG, 2001, ONCOGENE, V20, P5736, DOI 10.1038/sj.onc.1204599; Ben-Yair R, 2005, DEVELOPMENT, V132, P689, DOI 10.1242/dev.01617; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Cao LA, 2010, CANCER RES, V70, P6497, DOI 10.1158/0008-5472.CAN-10-0582; Cavallaro U, 2002, CANCER LETT, V176, P123, DOI 10.1016/S0304-3835(01)00759-5; Charrasse S, 2004, ONCOGENE, V23, P2420, DOI 10.1038/sj.onc.1207382; Charrasse S, 2002, J CELL BIOL, V158, P953, DOI 10.1083/jcb.200202034; Cheung LWT, 2010, ONCOGENE, V29, P2427, DOI 10.1038/onc.2009.523; Christofori G, 2003, EMBO J, V22, P2318, DOI 10.1093/emboj/cdg228; Collins CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004475; Davicioni E, 2006, CANCER RES, V66, P6936, DOI 10.1158/0008-5472.CAN-05-4578; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; Fortier M, 2008, CELL DEATH DIFFER, V15, P1221, DOI 10.1038/cdd.2008.34; FREDERICKS WJ, 1995, MOL CELL BIOL, V15, P1522; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Grass B, 2009, HISTOPATHOLOGY, V54, P873, DOI 10.1111/j.1365-2559.2009.03303.x; Hayashi S, 2011, MOL BIOL EVOL, V28, P2787, DOI 10.1093/molbev/msr114; Imai K, 2008, CLIN CANCER RES, V14, P6487, DOI 10.1158/1078-0432.CCR-08-1086; Keller C, 2004, GENE DEV, V18, P2614, DOI 10.1101/gad.1244004; Kjaer KW, 2005, J MED GENET, V42, P292, DOI 10.1136/jmg.2004.027821; Kucharczak J, 2008, CANCER RES, V68, P6559, DOI 10.1158/0008-5472.CAN-08-0196; Lae M, 2007, J PATHOL, V212, P143, DOI 10.1002/path.2170; Manceau M, 2008, GENE DEV, V22, P668, DOI 10.1101/gad.454408; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Meriane M, 2000, MOL BIOL CELL, V11, P2513, DOI 10.1091/mbc.11.8.2513; Merlino G, 1999, ONCOGENE, V18, P5340, DOI 10.1038/sj.onc.1203038; NOSE A, 1987, EMBO J, V6, P3655, DOI 10.1002/j.1460-2075.1987.tb02698.x; Paredes J, 2005, CLIN CANCER RES, V11, P5869, DOI 10.1158/1078-0432.CCR-05-0059; Park J, 2011, INVEST NEW DRUGS, V11, P9710; Puskulluoglu M, 2010, FOLIA HISTOCHEM CYTO, V48, P671, DOI 10.2478/v10042-010-0046-7; RAO SS, 1995, J BIOL CHEM, V270, P4093, DOI 10.1074/jbc.270.8.4093; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Relaix F, 2003, GENE DEV, V17, P2950, DOI 10.1101/gad.281203; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; Sorensen PHB, 2002, J CLIN ONCOL, V20, P2672, DOI 10.1200/JCO.2002.03.137; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Tarnowski M, 2010, MOL CANCER RES, V8, P1, DOI 10.1158/1541-7786.MCR-09-0259; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wachtel M, 2006, J CLIN ONCOL, V24, P816, DOI 10.1200/JCO.2005.03.4934; Wachtel M, 2004, CANCER RES, V64, P5539, DOI 10.1158/0008-5472.CAN-04-0844; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wiercinska E, 2011, BREAST CANCER RES TR, V128, P657, DOI 10.1007/s10549-010-1147-x; Williamson D, 2010, J CLIN ONCOL, V28, P2151, DOI 10.1200/JCO.2009.26.3814; Zhang CC, 2010, CLIN CANCER RES, V16, P5177, DOI 10.1158/1078-0432.CCR-10-1343	46	23	23	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 11	2013	32	15					1876	1887		10.1038/onc.2012.217	http://dx.doi.org/10.1038/onc.2012.217			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	126GB	22710718				2022-12-25	WOS:000317599900002
J	Mu, YX; Prochnow, C; Pham, P; Chen, XS; Goodman, MF				Mu, Yunxiang; Prochnow, Courtney; Phuong Pham; Chen, Xiaojiang S.; Goodman, Myron F.			A Structural Basis for the Biochemical Behavior of Activation-induced Deoxycytidine Deaminase Class-switch Recombination-defective Hyper-IgM-2 Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CYTIDINE DEAMINASE; SINGLE-STRANDED-DNA; HYPER-IGM SYNDROME; APOBEC3G CATALYTIC DOMAIN; SOMATIC HYPERMUTATION; FUNCTIONAL IMPLICATIONS; CRYSTAL-STRUCTURE; GENE CONVERSION; WILD-TYPE; AID	Hyper-IgM syndrome type 2 stems from mutations in activation-induced deoxycytidine deaminase (AID) that abolish immunoglobulin class-switch recombination, causing an accumulation of IgM and absence of IgG, IgA, and IgE isotypes. Although hyper-IgM syndrome type 2 is rare, the 23 missense mutations identified in humans span almost the entire gene for AID resulting in a recessive phenotype. Using high resolution x-ray structures for Apo3G-CD2 as a surrogate for AID, we identify three classes of missense mutants as follows: catalysis (class I), substrate interaction (class II), and structural integrity (class III). Each mutant was expressed and purified from insect cells and compared biochemically to wild type (WT) AID. Four point mutants retained catalytic activity at 1/3rd to 1/200th the level of WTAID. These "active" point mutants mimic the behavior of WTAID for motif recognition specificity, deamination spectra, and high deamination processivity. We constructed a series of C-terminal deletion mutants (class IV) that retain catalytic activity and processivity for deletions <= 18 amino acids, with Delta C-10 and Delta C-15 having 2-3-fold higher specific activities than WT AID. Deleting 19 C-terminal amino acids inactivates AID. WT AID and active and inactive point mutants bind cooperatively to single-stranded DNA (Hill coefficients similar to 1.7-3.2) with microscopic dissociation constant values (K-A) ranging between 10 and 250 nM. Active C-terminal deletion mutants bind single-stranded DNA noncooperatively with K-A values similar to wild type AID. A structural analysis is presented that shows how localized defects in different regions of AID can contribute to loss of catalytic function.	[Goodman, Myron F.] Univ So Calif, Mol & Computat Biol Sect, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ So Calif, Mol & Computat Biol Sect, Dept Chem, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Goodman, MF (corresponding author), Univ So Calif, Mol & Computat Biol Sect, Dept Biol Sci, Los Angeles, CA 90089 USA.	mgoodman@usc.edu	Mu, Yunxiang/H-3538-2015	Mu, Yunxiang/0000-0001-9754-2129	National Institutes of Health [GM21422, ES013192, GM087986]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES013192, R01ES013192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021422, R37GM021422, R01GM087986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM21422 and ES013192 (to M. F. G.) and GM087986 (to X.S.C.).	Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Bates PA, 2001, PROTEINS, P39; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Carpenter MA, 2010, DNA REPAIR, V9, P579, DOI 10.1016/j.dnarep.2010.02.010; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chelico L, 2009, J BIOL CHEM, V284, P27761, DOI 10.1074/jbc.R109.052449; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chen KM, 2007, FEBS LETT, V581, P4761, DOI 10.1016/j.febslet.2007.08.076; Demorest ZL, 2011, J BIOL CHEM, V286, P26568, DOI 10.1074/jbc.M111.235721; Durandy A, 2006, HUM MUTAT, V27, P1185, DOI 10.1002/humu.20414; Durandy A, 2009, PHILOS T R SOC B, V364, P577, DOI 10.1098/rstb.2008.0210; Furukawa A, 2009, EMBO J, V28, P440, DOI 10.1038/emboj.2008.290; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Imai K, 2005, CLIN IMMUNOL, V115, P277, DOI 10.1016/j.clim.2005.02.003; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; Kracker S, 2011, IMMUNOL LETT, V138, P97, DOI 10.1016/j.imlet.2011.02.004; Minegishi Y, 2000, CLIN IMMUNOL, V97, P203, DOI 10.1006/clim.2000.4956; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pham P, 2008, J BIOL CHEM, V283, P17428, DOI 10.1074/jbc.M802121200; Pham P, 2011, J BIOL CHEM, V286, P24931, DOI 10.1074/jbc.M111.241208; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Prochnow C, 2009, SCI CHINA SER C, V52, P893, DOI 10.1007/s11427-009-0133-1; RAJEWSKY K, 1987, SCIENCE, V238, P1088, DOI 10.1126/science.3317826; Ranjit S, 2011, J IMMUNOL, V187, P2464, DOI 10.4049/jimmunol.1101406; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Shapiro GS, 2002, J IMMUNOL, V168, P2302, DOI 10.4049/jimmunol.168.5.2302; Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Wu XS, 2005, J IMMUNOL, V174, P934, DOI 10.4049/jimmunol.174.2.934; WYSOCKI LJ, 1989, ANNU REV BIOCHEM, V58, P509; Xu ZM, 2010, NAT STRUCT MOL BIOL, V17, P1124, DOI 10.1038/nsmb.1884; Zhu Yi, 2003, Journal of Medical and Dental Sciences, V50, P41	40	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28007	28016		10.1074/jbc.M112.370189	http://dx.doi.org/10.1074/jbc.M112.370189			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22715099	hybrid, Green Published			2022-12-25	WOS:000307840700074
J	Kruth, KA; Rubenstein, PA				Kruth, Karina A.; Rubenstein, Peter A.			Two Deafness-causing (DFNA20/26) Actin Mutations Affect Arp2/3-dependent Actin Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REFLECTION FLUORESCENCE MICROSCOPY; YEAST ARP2/3 COMPLEX; IN-VITRO; HEARING IMPAIRMENT; ACTG1 MUTATIONS; FILAMENT; POLYMERIZATION; GENE; NUCLEATION; DYNAMICS	Hearing requires proper function of the auditory hair cell, which is critically dependent upon its actin-based cytoskeletal structure. Currently, ten point mutations in nonmuscle gamma-actin have been identified as causing progressive autosomal dominant nonsyndromic hearing loss (DFNA20/26), highlighting these ten residues as functionally important to actin structure and/or regulation. Two of the mutations, K118M and K118N, are located near the putative binding site for the ubiquitously expressed Arp2/3 complex. We therefore hypothesized that these mutations may affect Arp2/3-dependent regulation of the actin cytoskeleton. Using in vitro bulk polymerization assays, we show that the Lys-118 mutations notably reduce actin + Arp2/3 polymerization rates compared with WT. Further in vitro analysis of the K118M mutant using TIRF microscopy indicates the actual number of branches formed per filament is reduced compared with WT and, surprisingly, branch location is altered such that the majority of K118M branches form near the pointed end of the filament. These results highlight a previously unknown role for the Lys-118 residue in the actin-Arp2/3 interaction and also further suggest that Lys-118 may play a more significant role in intra-and intermonomer interactions than was initially hypothesized.	[Kruth, Karina A.; Rubenstein, Peter A.] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Rubenstein, PA (corresponding author), Univ Iowa, Carver Coll Med, Dept Biochem, 51 Newton Rd, Iowa City, IA 52242 USA.	peter-rubenstein@uiowa.edu		Kruth, Karina/0000-0003-2494-0745; Rubenstein, Peter/0000-0003-1225-4414	National Institutes of Health from NIDCD [DC008803]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008803, R55DC008803] Funding Source: NIH RePORTER	National Institutes of Health from NIDCD; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant DC008803 from the NIDCD (to P. A. R.).	Abramoff M. D., 2004, J BIOPHOTONICS INT, V11, P36; Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; BREMER A, 1991, J CELL BIOL, V115, P689, DOI 10.1083/jcb.115.3.689; BREMER A, 1992, Current Opinion in Cell Biology, V4, P20, DOI 10.1016/0955-0674(92)90054-G; Bryan KE, 2006, J BIOL CHEM, V281, P20129, DOI 10.1074/jbc.M601514200; COOK RK, 1992, J BIOL CHEM, V267, P9430; DRUBIN DG, 1990, CELL MOTIL CYTOSKEL, V15, P7, DOI 10.1002/cm.970150103; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Goley ED, 2010, P NATL ACAD SCI USA, V107, P8159, DOI 10.1073/pnas.0911668107; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Karpova TS, 1998, J CELL BIOL, V142, P1501, DOI 10.1083/jcb.142.6.1501; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; MILLONIG R, 1988, J CELL BIOL, V106, P785, DOI 10.1083/jcb.106.3.785; Morin M, 2009, HUM MOL GENET, V18, P3075, DOI 10.1093/hmg/ddp249; Mullins RD, 1997, J CELL BIOL, V136, P331, DOI 10.1083/jcb.136.2.331; Neidt EM, 2009, J BIOL CHEM, V284, P673, DOI 10.1074/jbc.M804201200; NG R, 1980, P NATL ACAD SCI-BIOL, V77, P3912, DOI 10.1073/pnas.77.7.3912; Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837; Oda T, 2010, STRUCTURE, V18, P761, DOI 10.1016/j.str.2010.05.009; Orlova A, 2004, P NATL ACAD SCI USA, V101, P17664, DOI 10.1073/pnas.0407525102; Pfaendtner J, 2012, J MOL BIOL, V416, P148, DOI 10.1016/j.jmb.2011.12.025; Pollard TD, 2002, CURR OPIN STRUC BIOL, V12, P768, DOI 10.1016/S0959-440X(02)00396-2; Rendtorff ND, 2006, EUR J HUM GENET, V14, P1097, DOI 10.1038/sj.ejhg.5201670; Stapley BJ, 1997, J MOL BIOL, V272, P465, DOI 10.1006/jmbi.1997.1262; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Wen KK, 2005, J BIOL CHEM, V280, P24168, DOI 10.1074/jbc.M502024200; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286	34	13	13	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27217	27226		10.1074/jbc.M112.377283	http://dx.doi.org/10.1074/jbc.M112.377283			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22718764	Green Published, hybrid			2022-12-25	WOS:000307386000073
J	Wen, Y; Kim, IH; Son, JS; Lee, BH; Kim, KS				Wen, Yancheng; Kim, In Hwang; Son, Jee-Soo; Lee, Byeong-Ha; Kim, Kun-Soo			Iron and Quorum Sensing Coordinately Regulate the Expression of Vulnibactin Biosynthesis in Vibrio vulnificus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; VIRULENCE; CHOLERAE; SIDEROPHORE; FUR; HARVEYI; PROTEIN; SMCR; GENE; IDENTIFICATION	Vibrio vulnificus is a halophilic marine pathogen associated with human diseases such as septicemia and serious wound infections. Genes vvsA and vvsB, which are co-transcribed and encode a member of the nonribosomal peptide synthase family, are required for vulnibactin biosynthesis in V. vulnificus. In this study, we found that quorum sensing represses the transcription of a vvsAB-lux reporter fusion. Gel shift assay and DNaseI foot-printing experiments show that the main regulator of quorum sensing, SmcR, binds to a 22-bp region located between -40 and -19 with respect to the vvsA transcription start site. Mutation of the SmcR binding site abolishes the repression of vvsA::luxAB by SmcR. Fur represses vvsAB transcription in the presence of iron by binding to a 47-bp region located between -45 and +2 with respect to the vvsA transcription start site. A competition gel shift assay and footprinting experiment using Fur and SmcR showed that Fur binds to the vvsA promoter region with higher affinity than SmcR. Studies with the vvsAB:: luxAB transcriptional fusion demonstrate that in the presence of iron, Fur is the key repressor of vvsAB transcription, whereas in iron-limited conditions, SmcR is the key regulator repressing vvsAB transcription. This study demonstrates that the Fe-Fur complex and quorum sensing cooperate to repress the transcription of vvsAB in response to iron conditions, suggesting that fine tuning of the intracellular iron level is important for the survival and pathogenicity of V. vulnificus.	[Wen, Yancheng; Kim, In Hwang; Son, Jee-Soo; Lee, Byeong-Ha; Kim, Kun-Soo] Sogang Univ, Dept Life Sci, Seoul 121742, South Korea; [Kim, Kun-Soo] Sogang Univ, Interdisciplinary Program Integrated Biotechnol, Seoul 121742, South Korea	Sogang University; Sogang University	Kim, KS (corresponding author), Sogang Univ, Dept Life Sci, Seoul 121742, South Korea.	kskim@sogang.ac.kr	Lee, Byeong-ha/B-8478-2009	Lee, Byeong-ha/0000-0001-7633-3264; KIM, KUN-SOO/0000-0002-5433-4175	National Research Foundation of Korea Grant [2011-0018115]; Korean Ministry of Education, Science, and Technology (MEST); 21C Frontier Microbial Genomics and Applications Center Program, MEST, Republic of Korea	National Research Foundation of Korea Grant(National Research Foundation of Korea); Korean Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); 21C Frontier Microbial Genomics and Applications Center Program, MEST, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Research Foundation of Korea Grant 2011-0018115 funded by the Korean Ministry of Education, Science, and Technology (MEST) and by the 21C Frontier Microbial Genomics and Applications Center Program, MEST, Republic of Korea.	Braun V, 1999, TRENDS BIOCHEM SCI, V24, P104, DOI 10.1016/S0968-0004(99)01359-6; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; GREENBERG EP, 1979, ARCH MICROBIOL, V120, P87, DOI 10.1007/BF00409093; Jeong HS, 2001, J BIOL CHEM, V276, P13875, DOI 10.1074/jbc.M010567200; Keating TA, 2000, BIOCHEMISTRY-US, V39, P15522, DOI 10.1021/bi0016523; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kim IH, 2008, J MICROBIOL BIOTECHN, V18, P35; Kim SY, 2003, MOL MICROBIOL, V48, P1647, DOI 10.1046/j.1365-2958.2003.03536.x; Lee DH, 2008, J BIOL CHEM, V283, P23610, DOI 10.1074/jbc.M801480200; Lee HJ, 2003, J BACTERIOL, V185, P5891, DOI 10.1128/JB.185.19.5891-5896.2003; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Lewenza S, 1999, J BACTERIOL, V181, P748, DOI 10.1128/JB.181.3.748-756.1999; Lilley BN, 2000, MOL MICROBIOL, V36, P940, DOI 10.1046/j.1365-2958.2000.01913.x; LITWIN CM, 1993, J BACTERIOL, V175, P706, DOI 10.1128/JB.175.3.706-715.1993; Litwin CM, 1996, INFECT IMMUN, V64, P2834, DOI 10.1128/IAI.64.7.2834-2838.1996; McDougald D, 2001, J BACTERIOL, V183, P758, DOI 10.1128/JB.183.2.758-762.2001; Mey AR, 2005, INFECT IMMUN, V73, P5706, DOI 10.1128/IAI.73.9.5706-5719.2005; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; MORRIS JG, 1987, FEMS MICROBIOL LETT, V40, P55; PAYNE SM, 1994, METHOD ENZYMOL, V235, P329; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Ren DC, 2005, APPL MICROBIOL BIOT, V66, P689, DOI 10.1007/s00253-004-1691-6; Roh JB, 2006, J BIOL CHEM, V281, P34775, DOI 10.1074/jbc.M607844200; SAITO T, 1991, EUR J BIOCHEM, V197, P43, DOI 10.1111/j.1432-1033.1991.tb15880.x; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; SIMPSON LM, 1983, INFECT IMMUN, V41, P644, DOI 10.1128/IAI.41.2.644-649.1983; Sousa F, 2007, ENZYME MICROB TECH, V40, P1772, DOI 10.1016/j.enzmictec.2006.12.017; Watnick PI, 1997, J BACTERIOL, V179, P243, DOI 10.1128/jb.179.1.243-247.1997; WRIGHT AC, 1981, INFECT IMMUN, V34, P503, DOI 10.1128/IAI.34.2.503-507.1981; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	33	27	27	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26727	26739		10.1074/jbc.M112.374165	http://dx.doi.org/10.1074/jbc.M112.374165			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22696215	Green Published, hybrid			2022-12-25	WOS:000307386000023
J	Bhat, AA; Sharma, A; Pope, J; Krishnan, M; Washington, MK; Singh, AB; Dhawan, P				Bhat, Ajaz A.; Sharma, Ashok; Pope, Jillian; Krishnan, Moorthy; Washington, Mary K.; Singh, Amar B.; Dhawan, Punita			Caudal Homeobox Protein Cdx-2 Cooperates with Wnt Pathway to Regulate Claudin-1 Expression in Colon Cancer Cells	PLOS ONE			English	Article							TIGHT JUNCTION STRANDS; CARBONIC-ANHYDRASE 1; GENE-EXPRESSION; INTESTINAL DIFFERENTIATION; TRANSCRIPTION FACTORS; HOMEODOMAIN PROTEINS; EPITHELIAL-CELLS; PROMOTER; OCCLUDIN; PROLIFERATION	Dysregulation of tight junctions (TJs) is often associated with human diseases including carcinogenesis and recent studies support role of TJ integral proteins in the regulation of Epithelial-to-Mesenchymal Transition (EMT). In this regard, expression of claudin-1, a key constituent of TJs, is highly increased in colon cancer and is causally associated with the tumor growth and progression. However, mechanism/s underlying regulation of claudin-1 expression in intestinal epithelial cells remains poorly understood. In our studies, we have identified putative binding sites for intestinal transcription factors Cdx1, -2 and GATA4 in the 5'-flanking region of the claudin-1 gene. Our further studies using full length and/or deletion mutant constructs in two different human colon cancer cell lines, SW480 and HCT116, showed key role of Cdx1, Cdx2 and GATA4 in the regulation of claudin-1 mRNA expression. However, overexpression of Cdx2 had the most potent effect upon claudin-1 mRNA expression and promoter activity. Also, in colon cancer patient samples, we observed a significant and parallel correlation between claudin-1 and Cdx2 expressions. Chromatin immunoprecipitation (ChIP) assay confirmed the Cdx2 binding with claudin-1 promoter in vivo. Using Cdx2 deletion mutant constructs, we further mapped the Cdx2 C-terminus domain to be important in the regulation of claudin-1 promoter activity. Interestingly, co-expression of activated beta-catenin further induced the Cdx2-dependent upregulation of claudin-1 promoter activity while expression of the dominant negative (dn)-TCF-4 abrogated this activation. Taken together, we conclude that homeodomain transcription factors Cdx1, Cdx2 and GATA4 regulate claudin-1 gene expression in human colon cancer cells. Moreover, a functional crosstalk between Wnt-signaling and transcriptional activation related to caudal-related homeobox (Cdx) proteins and GATA-proteins is demonstrated in the regulation of claudin-1 promoter-activation.	[Bhat, Ajaz A.; Sharma, Ashok; Pope, Jillian; Krishnan, Moorthy; Singh, Amar B.; Dhawan, Punita] Vanderbilt Univ, Sch Med, Dept Surg, Nashville, TN 37212 USA; [Pope, Jillian; Dhawan, Punita] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Washington, Mary K.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA; [Singh, Amar B.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Bhat, AA (corresponding author), Vanderbilt Univ, Sch Med, Dept Surg, Nashville, TN 37212 USA.	punita.dhawan@vanderbilt.edu2	Sharma, Ashok/AAE-5439-2019; Bhat, Ajaz/V-3642-2019	Sharma, Ashok/0000-0001-7505-6023; Bhat, Ajaz/0000-0003-3640-6275	National Institutes of Health (NIH) [CA124977, DK088902]; NATIONAL CANCER INSTITUTE [R01CA124977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant CA124977 (P. Dhawan) and DK088902 (A.B. Singh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2003, NAT GENET, V35, P323, DOI 10.1038/ng1265; Bonhomme C, 2003, GUT, V52, P1465, DOI 10.1136/gut.52.10.1465; Boudreau F, 2002, J BIOL CHEM, V277, P31909, DOI 10.1074/jbc.M204622200; Charite J, 1998, DEVELOPMENT, V125, P4349; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Chun SY, 2007, ONCOGENE, V26, P4725, DOI 10.1038/sj.onc.1210258; Dang LH, 2006, ONCOGENE, V25, P2264, DOI 10.1038/sj.onc.1209247; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Dhawan P, 2011, ONCOGENE, V30, P3234, DOI 10.1038/onc.2011.43; Drummond F, 1996, EUR J BIOCHEM, V236, P670, DOI 10.1111/j.1432-1033.1996.t01-1-00670.x; Drummond FJ, 1998, FEBS LETT, V423, P218, DOI 10.1016/S0014-5793(98)00103-3; DUPREY P, 1988, GENE DEV, V2, P1647, DOI 10.1101/gad.2.12a.1647; Escaffit F, 2005, J CELL PHYSIOL, V203, P15, DOI 10.1002/jcp.20189; Fang RX, 2000, GASTROENTEROLOGY, V118, P115, DOI 10.1016/S0016-5085(00)70420-3; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Guo RJ, 2010, CARCINOGENESIS, V31, P159, DOI 10.1093/carcin/bgp213; Hellebrekers DMEI, 2009, CLIN CANCER RES, V15, P3990, DOI 10.1158/1078-0432.CCR-09-0055; JAMES R, 1991, J BIOL CHEM, V266, P3246; JAMES R, 1994, J BIOL CHEM, V269, P15229; Kahler RA, 2003, J BIOL CHEM, V278, P11937, DOI 10.1074/jbc.M211443200; Kaimaktchiev V, 2004, MODERN PATHOL, V17, P1392, DOI 10.1038/modpathol.3800205; Krishnan M, 2010, ONCOGENE, V29, P305, DOI 10.1038/onc.2009.324; Lambert M, 1996, EUR J BIOCHEM, V236, P778, DOI 10.1111/j.1432-1033.1996.00778.x; Lickert H, 2000, DEVELOPMENT, V127, P3805; Lynch J, 2000, J BIOL CHEM, V275, P4499, DOI 10.1074/jbc.275.6.4499; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Miller CT, 2003, CLIN CANCER RES, V9, P4819; Mitchelmore C, 2000, BIOCHEM J, V346, P529, DOI 10.1042/0264-6021:3460529; Miwa N, 2001, ONCOL RES, V12, P469, DOI 10.3727/096504001108747477; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Moskaluk CA, 2003, MODERN PATHOL, V16, P913, DOI 10.1097/01.MP.0000086073.92773.55; Sakaguchi T, 2002, J BIOL CHEM, V277, P21361, DOI 10.1074/jbc.M110261200; Satake S, 2008, PATHOL INT, V58, P156, DOI 10.1111/j.1440-1827.2007.02204.x; Shiou SR, 2007, CANCER RES, V67, P1571, DOI 10.1158/0008-5472.CAN-06-1680; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; Singh AB, 2011, GASTROENTEROLOGY, V141, P2140, DOI 10.1053/j.gastro.2011.08.038; Soubeyran P, 1999, GASTROENTEROLOGY, V117, P1326, DOI 10.1016/S0016-5085(99)70283-0; Suh E, 1996, MOL CELL BIOL, V16, P619; SUH E, 1994, MOL CELL BIOL, V14, P7340, DOI 10.1128/MCB.14.11.7340; Tamai Y, 1999, CANCER RES, V59, P2965; Troelsen JT, 1997, BIOCHEM J, V322, P833, DOI 10.1042/bj3220833; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 2000, J CELL BIOL, V149, P13, DOI 10.1083/jcb.149.1.13; Verzi MP, 2010, P NATL ACAD SCI USA, V107, P15157, DOI 10.1073/pnas.1003822107; Vietor I, 2001, EMBO REP, V2, P306, DOI 10.1093/embo-reports/kve066; Wong V, 1997, J CELL BIOL, V136, P399, DOI 10.1083/jcb.136.2.399	46	52	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e37174	10.1371/journal.pone.0037174	http://dx.doi.org/10.1371/journal.pone.0037174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719836	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350000004
J	Miura, S; Kiya, Y; Hanzawa, H; Nakao, N; Fujino, M; Imaizumi, S; Matsuo, Y; Yanagisawa, H; Koike, H; Komuro, I; Karnik, SS; Saku, K				Miura, Shin-ichiro; Kiya, Yoshihiro; Hanzawa, Hiroyuki; Nakao, Naoki; Fujino, Masahiro; Imaizumi, Satoshi; Matsuo, Yoshino; Yanagisawa, Hiroaki; Koike, Hiroyuki; Komuro, Issei; Karnik, Sadashiva S.; Saku, Keijiro			Small Molecules with Similar Structures Exhibit Agonist, Neutral Antagonist or Inverse Agonist Activity toward Angiotensin II Type 1 Receptor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; ALPHA(1B)-ADRENERGIC RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; BETA(1)-ADRENERGIC RECEPTOR; AT(1) RECEPTOR; ACTIVATION; STATE; ADRENOCEPTOR; MECHANISM	Small differences in the chemical structures of ligands can be responsible for agonism, neutral antagonism or inverse agonism toward a G-protein-coupled receptor (GPCR). Although each ligand may stabilize the receptor conformation in a different way, little is known about the precise conformational differences. We synthesized the angiotensin II type 1 receptor blocker (ARB) olmesartan, R239470 and R794847, which induced inverse agonism, antagonism and agonism, respectively, and then investigated the ligand-specific changes in the receptor conformation with respect to stabilization around transmembrane (TM)3. The results of substituted cysteine accessibility mapping studies support the novel concept that ligand-induced changes in the conformation of TM3 play a role in stabilizing GPCR. Although the agonist-, neutral antagonist and inverse agonist-binding sites in the AT(1) receptor are similar, each ligand induced specific conformational changes in TM3. In addition, all of the experimental data were obtained with functional receptors in a native membrane environment (in situ).	[Miura, Shin-ichiro; Kiya, Yoshihiro; Fujino, Masahiro; Imaizumi, Satoshi; Matsuo, Yoshino; Saku, Keijiro] Fukuoka Univ, Sch Med, Dept Cardiol, Fukuoka 81401, Japan; [Miura, Shin-ichiro; Karnik, Sadashiva S.] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH USA; [Hanzawa, Hiroyuki; Nakao, Naoki; Yanagisawa, Hiroaki; Koike, Hiroyuki] Daiichi Sankyo Co Ltd, Div Res & Dev, Tokyo, Japan; [Komuro, Issei] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan	Fukuoka University; Cleveland Clinic Foundation; Daiichi Sankyo Company Limited; Osaka University	Miura, S (corresponding author), Fukuoka Univ, Sch Med, Dept Cardiol, Fukuoka 81401, Japan.	miuras@cis.fukuoka-u.ac.jp	Imaizumi, Satoshi/AHB-5318-2022; Saku, Keijiro/HGB-6168-2022; Karnik, Sadashiva/Y-2477-2019	Karnik, Sadashiva/0000-0003-0746-2753	Ministry of Education, Culture, Sports, Science and Technology, Japan [21591065]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057470] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a Grant-in-Aid for Scientific Research (21591065) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Chen SH, 2002, BIOCHEMISTRY-US, V41, P588, DOI 10.1021/bi011868k; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Feng YH, 1998, BIOCHEMISTRY-US, V37, P15791, DOI 10.1021/bi980863t; Jongejan A, 2005, NAT CHEM BIOL, V1, P98, DOI 10.1038/nchembio714; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; Martin SS, 2004, J BIOL CHEM, V279, P51415, DOI 10.1074/jbc.M407965200; Miura S, 1999, J BIOL CHEM, V274, P7103, DOI 10.1074/jbc.274.11.7103; Miura S, 2003, J BIOL CHEM, V278, P3720, DOI 10.1074/jbc.M211338200; Miura SI, 2008, MOL ENDOCRINOL, V22, P139, DOI 10.1210/me.2007-0312; Miura S, 2006, J BIOL CHEM, V281, P19288, DOI 10.1074/jbc.M602144200; Moukhametzianov R, 2011, P NATL ACAD SCI USA, V108, P8228, DOI 10.1073/pnas.1100185108; Noda K, 1996, BIOCHEMISTRY-US, V35, P16435, DOI 10.1021/bi961593m; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Parnot C, 2002, TRENDS ENDOCRIN MET, V13, P336, DOI 10.1016/S1043-2760(02)00628-8; Perez DM, 2005, PHARMACOL REV, V57, P147, DOI 10.1124/pr.57.2.2; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rossier O, 1999, MOL PHARMACOL, V56, P858, DOI 10.1124/mol.56.5.858; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schneider EH, 2010, J PHARMACOL EXP THER, V334, P513, DOI 10.1124/jpet.110.165977; Schneider G, 2005, NAT REV DRUG DISCOV, V4, P649, DOI 10.1038/nrd1799; Soudijn W, 2005, MED RES REV, V25, P398, DOI 10.1002/med.20031; Wang RX, 2000, J MOL MODEL, V6, P498, DOI 10.1007/s0089400060498; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Yasuda N, 2008, EMBO REP, V9, P179, DOI 10.1038/sj.embor.7401157	29	17	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e37974	10.1371/journal.pone.0037974	http://dx.doi.org/10.1371/journal.pone.0037974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719858	Green Published, gold, Green Submitted			2022-12-25	WOS:000305347800003
J	Ehlgen, F; Pham, JS; de Koning-Ward, T; Cowman, AF; Ralph, SA				Ehlgen, Florian; Pham, James S.; de Koning-Ward, Tania; Cowman, Alan F.; Ralph, Stuart A.			Investigation of the Plasmodium falciparum Food Vacuole through Inducible Expression of the Chloroquine Resistance Transporter (PfCRT)	PLOS ONE			English	Article							TRANSMEMBRANE PROTEIN PFCRT; DYNAMIN-LIKE PROTEIN; MALARIA PARASITE; DIGESTIVE-VACUOLE; ENDOPLASMIC-RETICULUM; GUANINE-NUCLEOTIDE; HEMOGLOBIN UPTAKE; DRUG-RESISTANCE; MAURERS CLEFTS; BREFELDIN-A	Haemoglobin degradation during the erythrocytic life stages is the major function of the food vacuole (FV) of Plasmodium falciparum and the target of several anti-malarial drugs that interfere with this metabolic pathway, killing the parasite. Two multi-spanning food vacuole membrane proteins are known, the multidrug resistance protein 1 (PfMDR1) and Chloroquine Resistance Transporter (PfCRT). Both modulate resistance to drugs that act in the food vacuole. To investigate the formation and behaviour of the food vacuole membrane we have generated inducible GFP fusions of chloroquine sensitive and resistant forms of the PfCRT protein. The inducible expression system allowed us to follow newly-induced fusion proteins, and corroborated a previous report of a direct trafficking route from the ER/Golgi to the food vacuole membrane. These parasites also allowed the definition of a food vacuole compartment in ring stage parasites well before haemozoin crystals were apparent, as well as the elucidation of secondary PfCRT-labelled compartments adjacent to the food vacuole in late stage parasites. We demonstrated that in addition to previously demonstrated Brefeldin A sensitivity, the trafficking of PfCRT is disrupted by Dynasore, a non competitive inhibitor of dynamin-mediated vesicle formation. Chloroquine sensitivity was not altered in parasites over-expressing chloroquine resistant or sensitive forms of the PfCRT fused to GFP, suggesting that the PfCRT does not mediate chloroquine transport as a GFP fusion protein.	[Ehlgen, Florian; Pham, James S.; Ralph, Stuart A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [de Koning-Ward, Tania] Deakin Univ, Sch Med, Waurn Ponds, Vic, Australia; [Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Div Infect & Immun, Parkville, Vic, Australia	University of Melbourne; Deakin University; Walter & Eliza Hall Institute	Ehlgen, F (corresponding author), Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia.	saralph@unimelb.edu.au	Cowman, Alan F/C-7642-2013; de Koning-Ward, Tania F/N-3572-2017; Ralph, Stuart/C-8590-2014	Cowman, Alan F/0000-0001-5145-9004; de Koning-Ward, Tania F/0000-0001-5810-8063; Ralph, Stuart/0000-0003-0114-7808	Australian Research Council; University of Melbourne postgraduate scholarship; Australian Postgraduate Award; Australian Research Council Future fellowship [FT0990350]; National Health and Medical Research Council	Australian Research Council(Australian Research Council); University of Melbourne postgraduate scholarship; Australian Postgraduate Award(Australian Government); Australian Research Council Future fellowship(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by research from the National Health and Medical Research Council, Australia (http://www.nhmrc.gov.au/), and the Australian Research Council (http://www.arc.gov.au/). FE was supported by a University of Melbourne postgraduate scholarship, JSP is supported by an Australian Postgraduate Award. SAR is supported by an Australian Research Council Future fellowship FT0990350. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Bakar N, 2010, J CELL SCI, V123, P441, DOI 10.1242/jcs.061499; Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bennett TN, 2004, MOL BIOCHEM PARASIT, V133, P99, DOI 10.1016/j.molbiopara.2003.09.008; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brandizzi F, 2002, PLANT CELL, V14, P1077, DOI 10.1105/tpc.000620; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Cao H, 2005, NAT CELL BIOL, V7, P483, DOI 10.1038/ncb1246; Charneau S, 2007, MICROBES INFECT, V9, P797, DOI 10.1016/j.micinf.2007.02.020; Cooper RA, 2002, MOL PHARMACOL, V61, P35, DOI 10.1124/mol.61.1.35; Cooper RA, 2007, MOL MICROBIOL, V63, P270, DOI 10.1111/j.1365-2958.2006.05511.x; COWMAN AF, 1991, J CELL BIOL, V113, P1033, DOI 10.1083/jcb.113.5.1033; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Egan TJ, 2008, J INORG BIOCHEM, V102, P1288, DOI 10.1016/j.jinorgbio.2007.12.004; Elliott DA, 2008, P NATL ACAD SCI USA, V105, P2463, DOI 10.1073/pnas.0711067105; Famin O, 2003, PARASITE, V10, P39, DOI 10.1051/parasite/2003101p39; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Fitch CD, 1999, BBA-MOL BASIS DIS, V1454, P31, DOI 10.1016/S0925-4439(99)00017-4; FITCH CD, 1986, PARASITOL TODAY, V2, P330, DOI 10.1016/0169-4758(86)90051-7; FITCH CD, 1969, P NATL ACAD SCI USA, V64, P1181, DOI 10.1073/pnas.64.4.1181; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Gilson PR, 2008, MOL MICROBIOL, V68, P124, DOI 10.1111/j.1365-2958.2008.06140.x; Goodman CD, 2007, MOL BIOCHEM PARASIT, V152, P181, DOI 10.1016/j.molbiopara.2007.01.005; Haase S, 2009, MOL MICROBIOL, V71, P1003, DOI 10.1111/j.1365-2958.2008.06582.x; Hanssen E, 2012, J STRUCT BIOL, V177, P224, DOI 10.1016/j.jsb.2011.09.003; Hanssen E, 2011, J STRUCT BIOL, V173, P161, DOI 10.1016/j.jsb.2010.08.013; Hayward R, 2006, J CELL SCI, V119, P1016, DOI 10.1242/jcs.02795; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Jackson KE, 2012, INT J PARASITOL, V42, P177, DOI 10.1016/j.ijpara.2011.11.008; Jackson KE, 2004, MOL MICROBIOL, V54, P109, DOI 10.1111/j.1365-2958.2004.04284.x; Jiang HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002484; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Klemba M, 2004, J CELL BIOL, V164, P47, DOI 10.1083/jcb200307147; Kolakovich KA, 1997, MOL BIOCHEM PARASIT, V87, P123, DOI 10.1016/S0166-6851(97)00062-5; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KROGSTAD DJ, 1987, SCIENCE, V238, P1283, DOI 10.1126/science.3317830; Kuhn Y, 2010, TRAFFIC, V11, P236, DOI 10.1111/j.1600-0854.2009.01018.x; Lakshmanan V, 2005, EMBO J, V24, P2294, DOI 10.1038/sj.emboj.7600681; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lazarus MD, 2008, J CELL SCI, V121, P1937, DOI 10.1242/jcs.023150; Lehane AM, 2008, J CELL SCI, V121, P1624, DOI 10.1242/jcs.016758; Li HL, 2004, BIOCHEM BIOPH RES CO, V320, P664, DOI 10.1016/j.bbrc.2004.06.010; Loria P, 1999, BIOCHEM J, V339, P363, DOI 10.1042/0264-6021:3390363; MACHAMER CE, 1993, MOL BIOL CELL, V4, P695, DOI 10.1091/mbc.4.7.695; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MACOMBER PB, 1966, SCIENCE, V152, P1374, DOI 10.1126/science.152.3727.1374; Martin RE, 2004, MOL BIOL EVOL, V21, P1938, DOI 10.1093/molbev/msh205; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; Meissner M, 2005, P NATL ACAD SCI USA, V102, P2980, DOI 10.1073/pnas.0500112102; Mu JB, 2003, MOL MICROBIOL, V49, P977, DOI 10.1046/j.1365-2958.2003.03627.x; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; Muriel MP, 2009, J NEUROCHEM, V110, P1607, DOI 10.1111/j.1471-4159.2009.06258.x; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Naude B, 2005, J BIOL CHEM, V280, P25596, DOI 10.1074/jbc.M503227200; Przyborski JM, 2005, EMBO J, V24, P2306, DOI 10.1038/sj.emboj.7600720; Rayner JC, 1997, EMBO J, V16, P1832, DOI 10.1093/emboj/16.8.1832; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; RUDZINSKA MA, 1965, J PROTOZOOL, V12, P563, DOI 10.1111/j.1550-7408.1965.tb03256.x; Saliba KJ, 1998, BIOCHEM PHARMACOL, V56, P313, DOI 10.1016/S0006-2952(98)00140-3; Sanchez CP, 2007, MOL MICROBIOL, V64, P407, DOI 10.1111/j.1365-2958.2007.05664.x; Sanchez CP, 2005, BIOCHEMISTRY-US, V44, P9862, DOI 10.1021/bi050061f; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; SLATER AFG, 1991, P NATL ACAD SCI USA, V88, P325, DOI 10.1073/pnas.88.2.325; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Stack CM, 2007, J BIOL CHEM, V282, P2069, DOI 10.1074/jbc.M609251200; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; SWIFT AM, 1991, J CELL BIOL, V115, P19, DOI 10.1083/jcb.115.1.19; Tawk L, 2010, EUKARYOT CELL, V9, P1519, DOI 10.1128/EC.00124-10; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wong RPM, 2012, ANTIMICROB AGENTS CH, V56, P2814, DOI 10.1128/AAC.05076-11; Wong RPM, 2011, ANTIMICROB AGENTS CH, V55, P1194, DOI 10.1128/AAC.01312-10; Yoon Y, 1998, J CELL BIOL, V140, P779, DOI 10.1083/jcb.140.4.779; Zhou HC, 2009, CHINESE MED J-PEKING, V122, P1686, DOI 10.3760/cma.j.issn.0366-6999.2009.14.015	83	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38781	10.1371/journal.pone.0038781	http://dx.doi.org/10.1371/journal.pone.0038781			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719945	Green Published, gold			2022-12-25	WOS:000305341900051
J	Neto, JM; Arroyo, JL; Bargain, B; Monros, JS; Matrai, N; Prochazka, P; Zehtindjiev, P				Neto, Julio M.; Arroyo, Jose L.; Bargain, Bruno; Monros, Juan S.; Matrai, Norbert; Prochazka, Petr; Zehtindjiev, Pavel			Phylogeography of a Habitat Specialist with High Dispersal Capability: The Savi's Warbler Locustella luscinioides	PLOS ONE			English	Article							CROSS-SPECIES AMPLIFICATION; EXTRA-PAIR PATERNITY; POPULATION-STRUCTURE; GENETIC DIFFERENTIATION; MICROSATELLITE LOCI; SOFTWARE; MITOCHONDRIAL; DIVERSIFICATION; REFUGIA; COLONIZATION	In order to describe the influence of Pleistocene glaciations on the genetic structure and demography of a highly mobile, but specialized, passerine, the Savi's Warbler (Locustella luscinioides), mitochondrial DNA sequences (ND2) and microsatellites were analysed in c. 330 individuals of 17 breeding and two wintering populations. Phylogenetic, population genetics and coalescent methods were used to describe the genetic structure, determine the timing of the major splits and model the demography of populations. Savi's Warblers split from its sister species c. 8 million years ago and have two major haplotype groups that diverged in the early/middle Pleistocene. One of these clades originated in the Balkans and is currently widespread, showing strong evidence for population expansion; whereas the other is restricted to Iberia and remained stable. Microsatellites agreed with a genetic break around the Pyrenees, but showed considerable introgression and a weaker genetic structure. Both genetic markers showed an isolation-by-distance pattern associated with the population expansion of the eastern clade. Breeding populations seem to be segregated at the wintering sites, but results on migratory connectivity are preliminary. Savi's Warbler is the only known migratory bird species in which Iberian birds did not expand beyond the Pyrenees after the last glaciation. Despite the long period of independent evolution of western and eastern populations, complete introgression occurred when these groups met in Iberia. Mitochondrial sequences indicated the existence of refugia-within-refugia in the Iberian Peninsula during the last glacial period, which is surprising given the high dispersal capacity of this species. Plumage differences of eastern subspecies seemed to have evolved recently through natural selection, in agreement with the glacial expansion hypothesis. This study supports the great importance of the Iberian Peninsula and its role for the conservation of genetic variation.	[Neto, Julio M.] Lund Univ, Dept Biol, Lund, Sweden; [Neto, Julio M.] Univ Porto, CIBIO UP Ctr Invest Biodiversidade & Recursos Gen, Vairao, Portugal; [Arroyo, Jose L.] Fuentes Nava, Grp Iber Anillamiento, Palencia, Spain; [Bargain, Bruno] Bretagne Vivante, Village De Trunvel, Treogat, France; [Monros, Juan S.] Univ Valencia, Inst Cavanilles Biodivers & Evolutionary Biol, Valencia, Spain; [Matrai, Norbert] Szent Istvan Univ, Dept Zool & Anim Ecol, Godollo, Hungary; [Prochazka, Petr] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic; [Zehtindjiev, Pavel] Bulgarian Acad Sci, Inst Biodivers & Ecosyst Res, Sofia, Bulgaria	Lund University; Universidade do Porto; University of Valencia; Hungarian University of Agriculture & Life Sciences; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; Bulgarian Academy of Sciences	Neto, JM (corresponding author), Lund Univ, Dept Biol, Ecol Bldg, Lund, Sweden.	julio.m.neto@gmail.com	Neto, Júlio Manuel/D-1853-2009; Zehtidiev, Pavel/K-3236-2012; Monros, Juan/AAA-3726-2020; Monros, Juan S/L-9750-2014; Matos, José Luis Arroyo/H-7074-2019; Prochazka, Petr/A-9727-2008	Neto, Júlio Manuel/0000-0002-4855-3988; Zehtidiev, Pavel/0000-0002-9786-3974; Monros, Juan/0000-0002-0952-2089; Monros, Juan S/0000-0002-0952-2089; Matos, José Luis Arroyo/0000-0002-7605-5599; Prochazka, Petr/0000-0001-9385-4547	Portuguese Foundation for Science and Technology [SFRH/BPD/40667/2007, PTDC/BIA-BDE/64285/2006]; Fundo Social Europeu (FSE) under the Programa Operacional Potencial Humano (POPH) from QREN (Quadro de Referencia Estrategico Nacional)	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Fundo Social Europeu (FSE) under the Programa Operacional Potencial Humano (POPH) from QREN (Quadro de Referencia Estrategico Nacional)	JMN was supported financially by the Portuguese Foundation for Science and Technology (grant SFRH/BPD/40667/2007), co-financed by Fundo Social Europeu (FSE) under the Programa Operacional Potencial Humano (POPH) from QREN (Quadro de Referencia Estrategico Nacional). This study was partially financed by the same institution through the project PTDC/BIA-BDE/64285/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstrom P, 2011, MOL PHYLOGENET EVOL, V58, P513, DOI 10.1016/j.ympev.2010.12.012; Arbogast BS, 2006, EVOLUTION, V60, P370, DOI 10.1111/j.0014-3820.2006.tb01113.x; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Bensch S, 2009, MOL ECOL, V18, P3087, DOI 10.1111/j.1365-294X.2009.04210.x; Brito PH, 2007, MOL ECOL, V16, P3423, DOI 10.1111/j.1365-294X.2007.03401.x; Cabral M.J., 2005, LIVRO VERMELHO VERTE; Centeno-Cuadros A, 2009, MOL ECOL, V18, P3652, DOI 10.1111/j.1365-294X.2009.04297.x; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Double MC, 1997, MOL ECOL, V6, P691, DOI 10.1046/j.1365-294X.1997.00228.x; Drovetski SV, 2004, J AVIAN BIOL, V35, P105; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2010, GENEIOUS 5 1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Earl DA, 2009, STRUCTURE HARVESTER; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ferrero ME, 2011, MOL ECOL, V20, P2628, DOI 10.1111/j.1365-294X.2011.05111.x; Frentiu FD, 2003, MOL ECOL NOTES, V3, P462, DOI 10.1046/j.1471-8286.2003.00484.x; Garcia JT, 2008, MOL PHYLOGENET EVOL, V46, P237, DOI 10.1016/j.ympev.2007.06.022; Gibbs HL, 1999, MOL ECOL, V8, P1551; Goossens B, 1998, MOL ECOL, V7, P1237, DOI 10.1046/j.1365-294x.1998.00407.x; Griffith SC, 1999, BIOL J LINN SOC, V68, P303, DOI 10.1111/j.1095-8312.1999.tb01171.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hackett SJ, 1996, MOL PHYLOGENET EVOL, V5, P368, DOI 10.1006/mpev.1996.0032; Hansson B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002794; Helbig AJ, 1996, IBIS, V138, P650, DOI 10.1111/j.1474-919X.1996.tb04767.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Johnson KP, 1998, MOL PHYLOGENET EVOL, V10, P82, DOI 10.1006/mpev.1997.0481; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kennerley P, 2010, REED BUSH WARBLERS; Kvist L, 2011, J ORNITHOL, V152, P681, DOI 10.1007/s10336-011-0646-9; Lerner HRL, 2011, CURR BIOL, V21, P1838, DOI 10.1016/j.cub.2011.09.039; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lovette IJ, 2005, TRENDS ECOL EVOL, V20, P57, DOI 10.1016/j.tree.2004.11.011; Madrono A., 2004, LIBRO ROJO AVES ESPA; Manthey JD, 2011, MOL PHYLOGENET EVOL, V58, P502, DOI 10.1016/j.ympev.2010.12.003; Martinez JG, 1999, EVOLUTION, V53, P269, DOI 10.1111/j.1558-5646.1999.tb05352.x; Mila B, 2007, P R SOC B, V274, P2653, DOI 10.1098/rspb.2007.0852; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Neto JM, 2006, IBIS, V148, P39, DOI 10.1111/j.1474-919X.2006.00477.x; Neto JM, 2006, BIRD STUDY, V53, P171, DOI 10.1080/00063650609461430; Neto JM, 2010, BEHAVIOUR, V147, P1413, DOI 10.1163/000579510X517217; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petren K, 1998, MOL ECOL, V7, P1782, DOI 10.1046/j.1365-294x.1998.00518.x; Pons JM, 2011, J BIOGEOGR, V38, P311, DOI 10.1111/j.1365-2699.2010.02401.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Prochazka P, 2011, J AVIAN BIOL, V42, P103, DOI 10.1111/j.1600-048X.2010.05161.x; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Richardson DS, 2000, MOL ECOL, V9, P2226; Saetre GP, 2001, IBIS, V143, P494, DOI 10.1111/j.1474-919X.2001.tb04951.x; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; TEMPLETON AR, 1992, GENETICS, V132, P619; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Weiss S, 2007, PHYLOGEOGRAPHY SO EU; Zink RM, 2004, P ROY SOC B-BIOL SCI, V271, P561, DOI 10.1098/rspb.2003.2617; Zink RM, 2010, J AVIAN BIOL, V41, P1, DOI 10.1111/j.1600-048X.2009.04903.x	64	18	20	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38497	10.1371/journal.pone.0038497	http://dx.doi.org/10.1371/journal.pone.0038497			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701653	gold, Green Published			2022-12-25	WOS:000305337600027
J	Manjerovic, MB; Waterman, JM				Manjerovic, Mary Beth; Waterman, Jane M.			Immunological Sex Differences in Socially Promiscuous African Ground Squirrels	PLOS ONE			English	Article							IMMUNE FUNCTION; BODY CONDITION; MASS; ORGANIZATION; MAMMALS; HOST; AGE	Differences in how males and females respond to foreign antigens are common across taxa. Such sexual differences in the immune system are predicted to be greater in species with high promiscuity and sociality as these factors increase the likelihood of disease transmission. Intense sperm competition is thought to further this sexual dichotomy as increased investment in spermatogenesis likely incurs additional immunological costs. Xerus inauris, a ground squirrel found throughout southern Africa, is extremely social and promiscuous with one of the highest male reproductive investments among rodents. These life-history attributes suggest males and females should demonstrate a large dichotomy in immunity. Contrary to our prediction, we found no difference in spleen mass between the sexes. However, we did find significant biases in leukocyte types and red blood cell counts, possibly reflecting responses to parasite types. Among males, we predicted greater investments in spermatogenesis would result in reduced immunological investments. We found a negative association between testes and spleen size and a positive relationship between testes and number of lice suggesting trade-offs in reproductive investment possibly due to the costs associated with spermatogenesis and immunity. We suggest when measuring sexual differences in immunity it is important to consider the effects of reproductive pressures, parasite types, and life history costs.	[Manjerovic, Mary Beth] Univ Illinois, Dept Anim Sci, Illinois Nat Hist Survey, Urbana, IL 61801 USA; [Waterman, Jane M.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada	Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; University of Manitoba	Manjerovic, MB (corresponding author), Univ Illinois, Dept Anim Sci, Illinois Nat Hist Survey, 328 Mumford Hall, Urbana, IL 61801 USA.	Jane.Waterman@ad.umanitoba.ca			National Science Foundation [0130600]; Natural Sciences and Engineering Research Council of Canada	National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	National Science Foundation grant (#0130600) (http://www.nsf.gov/) and a Natural Sciences and Engineering Research Council of Canada Discovery grant (http://www.nserc-crsng.gc.ca/) to JMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; BEARDSELL PL, 1984, Z PARASITENKD, V70, P337, DOI 10.1007/BF00927820; Bordes F, 2011, OECOLOGIA, V165, P7, DOI 10.1007/s00442-010-1743-9; Christe P, 2002, J AVIAN BIOL, V33, P321, DOI 10.1034/j.1600-048X.2002.330317.x; Corbin E, 2008, MAMMAL REV, V38, P108, DOI 10.1111/j.1365-2907.2007.00112.x; Deerenberg C, 1997, P ROY SOC B-BIOL SCI, V264, P1021, DOI 10.1098/rspb.1997.0141; Ezenwa VO, FUNCTIONAL ECOLOGY, V26, P123; Falcone FH, 2001, TRENDS PARASITOL, V17, P126, DOI 10.1016/S1471-4922(00)01846-8; Fernandez-Llario P, EUROPEAN J WILDLIFE, V50, P13; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Fuxjager MJ, FUNCTIONAL ECOLOGY, V25, P132; GERACI JR, 1975, J FISH RES BOARD CAN, V32, P2559, DOI 10.1139/f75-302; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hawlena H, 2008, COMP BIOCHEM PHYS A, V150, P66, DOI 10.1016/j.cbpa.2008.03.004; Hillegass MA, BEHAV ECOLOGY, V21, P696; Hillegass MA, BEHAV ECOLOGY, V19, P1006; Hosken DJ, 2001, ETHOL ECOL EVOL, V13, P173; Klein SL, 2000, BEHAV PROCESS, V51, P149, DOI 10.1016/S0376-6357(00)00125-X; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Manjerovic MB, J ZOOLOGY, V275, P375; Moller AP, AM NATURALISTTURALIS, V152, P605; Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196; Nunn CL, 2000, SCIENCE, V290, P1168, DOI 10.1126/science.290.5494.1168; Nunn CL, PHILOS T ROYAL SOC B, V364, P61; Owen JP, TRENDS PARASITOLOGY, V26, P530; Owens IPF, TRENDS ECOLOGY EVOLU, V14, P170; Pettitt BA, J ZOOLOGY, V276, P291; Post J, 2003, POULTRY SCI, V82, P591, DOI 10.1093/ps/82.4.591; Restif O, P ROYAL SOC B, V277, P2247; Roberts ML, ANIMAL BEHAV, V68, P227; Rolff J, P ROYAL SOC B, V269, P867; Scantlebury M, 2010, J ZOOL, V282, P246, DOI 10.1111/j.1469-7998.2010.00734.x; Scantlebury M, PHYSL BEHAV, V94, P359; Schalk G, 1997, OIKOS, V78, P67, DOI 10.2307/3545801; Schmid-Hempel P, P ROYAL SOC B, V270, P357; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Simmons LW, 2005, SCIENCE, V309, P2031, DOI 10.1126/science.1114500; Sokal RR, 1995, BIOMETRY; Stoehr AM, BEHAV ECOLOGY, V17, P751; Thrall PH, 2000, P ROY SOC B-BIOL SCI, V267, P1555, DOI 10.1098/rspb.2000.1178; Waterman JM, 1996, J MAMMAL, V77, P134, DOI 10.2307/1382715; WATERMAN JM, 1995, ETHOLOGY, V101, P130, DOI 10.1111/j.1439-0310.1995.tb00352.x; Waterman JM, ANIMAL BEHAV, V56, P459; Zuk M, 1996, ECOLOGY, V77, P1037, DOI 10.2307/2265574; Zuk M, INT J PARASITOLOGY, V26, P1009; Zuk M, PARASITOLOGY TODAY, V6, P231	47	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38524	10.1371/journal.pone.0038524	http://dx.doi.org/10.1371/journal.pone.0038524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715391	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336800033
J	Gremillet, D; Prudor, A; le Maho, Y; Weimerskirch, H				Gremillet, David; Prudor, Aurelien; le Maho, Yvon; Weimerskirch, Henri			Vultures of the Seas: Hyperacidic Stomachs in Wandering Albatrosses as an Adaptation to Dispersed Food Resources, including Fishery Wastes	PLOS ONE			English	Article							DIOMEDEA-EXULANS; SEABIRDS; PREY; PHYSIOLOGY; PENGUINS; ECOLOGY; WIND	Animals are primarily limited by their capacity to acquire food, yet digestive performance also conditions energy acquisition, and ultimately fitness. Optimal foraging theory predicts that organisms feeding on patchy resources should maximize their food loads within each patch, and should digest these loads quickly to minimize travelling costs between food patches. We tested the prediction of high digestive performance in wandering albatrosses, which can ingest prey of up to 3 kg, and feed on highly dispersed food resources across the southern ocean. GPS-tracking of 40 wandering albatrosses from the Crozet archipelago during the incubation phase confirmed foraging movements of between 475-4705 km, which give birds access to a variety of prey, including fishery wastes. Moreover, using miniaturized, autonomous data recorders placed in the stomach of three birds, we performed the first-ever measurements of gastric pH and temperature in procellariformes. These revealed surprisingly low pH levels (average 1.50 +/- 0.13), markedly lower than in other seabirds, and comparable to those of vultures feeding on carrion. Such low stomach pH gives wandering albatrosses a strategic advantage since it allows them a rapid chemical breakdown of ingested food and therefore a rapid digestion. This is useful for feeding on patchy, natural prey, but also on fishery wastes, which might be an important additional food resource for wandering albatrosses.	[Gremillet, David] CEFE CNRS, UMR5175, Montpellier, France; [Gremillet, David] Univ Cape Town, Percy FitzPatrick Inst, ZA-7700 Rondebosch, South Africa; [Gremillet, David] Univ Cape Town, DST NRF Ctr Excellence, ZA-7700 Rondebosch, South Africa; [Prudor, Aurelien; Weimerskirch, Henri] CEBC CNRS, UPR1934, Villiers En Bois, France; [le Maho, Yvon] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [le Maho, Yvon] CNRS, UMR7178, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Montpellier; University of Cape Town; National Research Foundation - South Africa; University of Cape Town; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Gremillet, D (corresponding author), CEFE CNRS, UMR5175, Montpellier, France.	david.gremillet@cefe.cnrs.fr	Weimerskirch, Henri/K-7306-2019; Weimerskirch, Henri/F-5562-2013; Gremillet, David/W-1946-2018	Weimerskirch, Henri/0000-0002-0457-586X; Gremillet, David/0000-0002-7711-9398	Centre National de la Recherche Scientifique; French Polar Institute Paul-Emile Victor [109]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); French Polar Institute Paul-Emile Victor	This study was funded by Centre National de la Recherche Scientifique and by the French Polar Institute Paul-Emile Victor (programme 109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbraud C, 2012, J ORNITHOL, V153, P375, DOI 10.1007/s10336-011-0752-8; Bost CA, 1997, MAR ECOL PROG SER, V150, P21, DOI 10.3354/meps150021; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bugoni L, 2010, J EXP MAR BIOL ECOL, V391, P190, DOI 10.1016/j.jembe.2010.06.027; Cherel Y, 1999, MAR ECOL PROG SER, V188, P93, DOI 10.3354/meps188093; CROXALL JP, 1988, POLAR BIOL, V9, P9, DOI 10.1007/BF00441760; DIAMOND JM, 1986, NATURE, V320, P62, DOI 10.1038/320062a0; Duke GE, 1997, P NUTR SOC, V56, P1049, DOI 10.1079/PNS19970109; Ford S, 2010, J EXOT PET MED, V19, P140, DOI 10.1053/j.jepm.2010.05.004; Garthe S, 1996, MAR ECOL PROG SER, V136, P1, DOI 10.3354/meps136001; Gremillet D, 2000, CAN J ZOOL, V78, P1567, DOI 10.1139/cjz-78-9-1567; Gremillet D, 2008, P R SOC B, V275, P1149, DOI 10.1098/rspb.2007.1763; Hammond KA, 1997, NATURE, V386, P457, DOI 10.1038/386457a0; HERPOL C, 1967, Z VERGL PHYSIOL, V57, P209, DOI 10.1007/BF00302996; Hilton GM, 2000, EVOL ECOL RES, V2, P207; HOUSTON D C, 1975, Journal of Wildlife Diseases, V11, P306; IMBER MJ, 1992, J ROY SOC NEW ZEAL, V22, P243, DOI 10.1080/03036758.1992.10420819; JACKSON S, 1992, PHYSIOL ZOOL, V65, P674, DOI 10.1086/physzool.65.3.30157976; KARASOV WH, 1985, SCIENCE, V228, P202, DOI 10.1126/science.3975638; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; Peters G, 1997, THESIS KIEL U; Shaffer SA, 2001, J ANIM ECOL, V70, P864, DOI 10.1046/j.0021-8790.2001.00548.x; Speakman JR, 2010, J ANIM ECOL, V79, P726, DOI 10.1111/j.1365-2656.2010.01689.x; Stephens D.W., 1986, pi; Thouzeau C, 2004, J EXP BIOL, V207, P2715, DOI 10.1242/jeb.01074; Weimerskirch H, 2005, ECOLOGY, V86, P2611, DOI 10.1890/04-1866; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; WEIMERSKIRCH H, 1992, MAR ECOL PROG SER, V86, P297, DOI 10.3354/meps086297; WEIMERSKIRCH H, 1995, OECOLOGIA, V102, P37, DOI 10.1007/BF00333308; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; Whelan CJ, 2005, OIKOS, V110, P481, DOI 10.1111/j.0030-1299.2005.13387.x; WILSON RP, 1992, J EXP BIOL, V167, P267; WILSON RP, 1989, COMP BIOCHEM PHYS A, V94, P461, DOI 10.1016/0300-9629(89)90121-7; WILSON RP, 1984, J FIELD ORNITHOL, V55, P109; Xavier JC, 2004, FISH OCEANOGR, V13, P324, DOI 10.1111/j.1365-2419.2004.00298.x	36	14	14	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37834	10.1371/journal.pone.0037834	http://dx.doi.org/10.1371/journal.pone.0037834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701581	Green Published, Green Submitted, gold			2022-12-25	WOS:000305348400020
J	Oda, M; Hashimoto, M; Takahashi, M; Ohmae, Y; Seike, S; Kato, R; Fujita, A; Tsuge, H; Nagahama, M; Ochi, S; Sasahara, T; Hayashi, S; Hirai, Y; Sakurai, J				Oda, Masataka; Hashimoto, Manabu; Takahashi, Masaya; Ohmae, Yuka; Seike, Soshi; Kato, Ryoko; Fujita, Aoi; Tsuge, Hideaki; Nagahama, Masahiro; Ochi, Sadayuki; Sasahara, Teppei; Hayashi, Shunji; Hirai, Yoshikazu; Sakurai, Jun			Role of Sphingomyelinase in Infectious Diseases Caused by Bacillus cereus	PLOS ONE			English	Article							PERFRINGENS ALPHA-TOXIN; STAPHYLOCOCCUS-AUREUS; CLOSTRIDIUM-PERFRINGENS; NEUTRAL SPHINGOMYELINASE; SHEEP ERYTHROCYTES; VIRULENCE FACTOR; PHOSPHOLIPASE-C; HEMOLYSIN BL; CERAMIDE; STRAINS	Bacillus cereus (B. cereus) is a pathogen in opportunistic infections. Here we show that Bacillus cereus sphingomyelinase (Bc-SMase) is a virulence factor for septicemia. Clinical isolates produced large amounts of Bc-SMase, grew in vivo, and caused death among mice, but ATCC strains isolated from soil did not. A transformant of the ATCC strain carrying a recombinant plasmid containing the Bc-SMase gene grew in vivo, but that with the gene for E53A, which has little enzymatic activity, did not. Administration of an anti-Bc-SMase antibody and immunization against Bc-SMase prevented death caused by the clinical isolates, showing that Bc-SMase plays an important role in the diseases caused by B. cereus. Treatment of mouse macrophages with Bc-SMase resulted in a reduction in the generation of H2O2 and phagocytosis of macrophages induced by peptidoglycan (PGN), but no effect on the release of TNF-alpha and little release of LDH under our experimental conditions. Confocal laser microscopy showed that the treatment of mouse macrophages with Bc-SMase resulted in the formation of ceramide-rich domains. A photobleaching analysis suggested that the cells treated with Bc-SMase exhibited a reduction in membrane fluidity. The results suggest that Bc-SMase is essential for the hydrolysis of SM in membranes, leading to a reduction in phagocytosis.	[Oda, Masataka; Hashimoto, Manabu; Takahashi, Masaya; Ohmae, Yuka; Seike, Soshi; Kato, Ryoko; Fujita, Aoi; Nagahama, Masahiro; Sakurai, Jun] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Yamashiro, Tokushima 770, Japan; [Tsuge, Hideaki] Tokushima Bunri Univ, Inst Hlth Sci, Yamashiro, Tokushima, Japan; [Tsuge, Hideaki] Kyoto Sangyo Univ, Fac Life Sci, Kamigamo Motoyama Kita Ku, Kyoto 603, Japan; [Ochi, Sadayuki] Fujita Hlth Univ, Sch Med, Toyoake, Aichi 47011, Japan; [Sasahara, Teppei; Hayashi, Shunji; Hirai, Yoshikazu] Jichi Med Univ, Sch Med, Shimono City, Tochigi, Japan	Tokushima Bunri University; Tokushima Bunri University; Kyoto Sangyo University; Fujita Health University; Jichi Medical University	Oda, M (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Yamashiro, Tokushima 770, Japan.	sakurai@ph.bunri-u.ac.jp	Tsuge, Hideaki/ABF-6424-2021; Oda, Masataka/ABG-6047-2020	Seike, Soshi/0000-0001-9029-0715; Tsuge, Hideaki/0000-0003-0166-9163	Ministry of Education, Culture, Sports, Science and Technology, Japan. SENRYAKU Fund; Mutual Aid Corporation for Private Schools of Japan; Sumitomo Foundation for Promotion of Science; Tokushima Bunri University	Ministry of Education, Culture, Sports, Science and Technology, Japan. SENRYAKU Fund; Mutual Aid Corporation for Private Schools of Japan; Sumitomo Foundation for Promotion of Science; Tokushima Bunri University	This research was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. SENRYAKU Fund (2009-2011) for Promotion of Science, the Mutual Aid Corporation for Private Schools of Japan, and the Sumitomo Foundation for Promotion of Science, and funding from Tokushima Bunri University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago H, 2006, J BIOL CHEM, V281, P16157, DOI 10.1074/jbc.M601089200; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Bryant AE, 2000, J INFECT DIS, V182, P799, DOI 10.1086/315756; Cadot C, 2010, J CLIN MICROBIOL, V48, P1358, DOI 10.1128/JCM.02123-09; Callegan MC, 1999, INFECT IMMUN, V67, P3357, DOI 10.1128/IAI.67.7.3357-3366.1999; Callegan MC, 2003, INFECT IMMUN, V71, P3116, DOI 10.1128/IAI.71.6.3116-3124.2003; Callegan MC, 2002, INFECT IMMUN, V70, P5381, DOI 10.1128/IAI.70.10.5381-5389.2002; Collins J, 2008, J CLIN MICROBIOL, V46, P2112, DOI 10.1128/JCM.00156-08; Dohmae S, 2008, J HOSP INFECT, V69, P361, DOI 10.1016/j.jhin.2008.04.014; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; Drobnik W, 2003, J LIPID RES, V44, P754, DOI 10.1194/jlr.M200401-JLR200; Duport C, 2004, ARCH MICROBIOL, V182, P90, DOI 10.1007/s00203-004-0688-y; Fagerlund A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-43; Gaur AH, 2001, PEDIATR INFECT DIS J, V20, P533, DOI 10.1097/00006454-200105000-00013; GIANNELLA RA, 1979, J INFECT DIS, V139, P366, DOI 10.1093/infdis/139.3.366; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Goni FM, 2009, BBA-BIOMEMBRANES, V1788, P169, DOI 10.1016/j.bbamem.2008.09.002; Gonzalez-Zorn B, 1999, MOL MICROBIOL, V33, P510, DOI 10.1046/j.1365-2958.1999.01486.x; Guillemet E, 2010, J BACTERIOL, V192, P286, DOI 10.1128/JB.00264-09; Guinebretiere MH, 2002, J CLIN MICROBIOL, V40, P3053, DOI 10.1128/JCM.40.8.3053-3056.2002; Gulbins E, 2004, J MOL MED, V82, P357, DOI 10.1007/s00109-004-0539-y; Heffernan BJ, 2006, INFECT IMMUN, V74, P3756, DOI 10.1128/IAI.00307-06; Huseby M, 2007, J BACTERIOL, V189, P8719, DOI 10.1128/JB.00741-07; IKEZAWA H, 1978, BIOCHIM BIOPHYS ACTA, V528, P247; Klein C, 2003, BRAIN RES PROTOC, V11, P46, DOI 10.1016/S1385-299X(03)00016-3; Lereclus D, 1996, J BACTERIOL, V178, P2749, DOI 10.1128/jb.178.10.2749-2756.1996; Lo CW, 2011, J INVEST DERMATOL, V131, P401, DOI 10.1038/jid.2010.319; MARQUES MB, 1989, J CLIN MICROBIOL, V27, P2451, DOI 10.1128/JCM.27.11.2451-2454.1989; Montes LR, 2008, BIOCHEMISTRY-US, V47, P11222, DOI 10.1021/bi801139z; Nakabo Y, 1997, IMMUNOLOGY, V90, P477, DOI 10.1046/j.1365-2567.1997.d01-2189.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Obama T, 2003, J BIOCHEM, V133, P279, DOI 10.1093/jb/mvg038; Ochi S, 2004, J BIOL CHEM, V279, P12181, DOI 10.1074/jbc.M307046200; Oda M, 2008, J LIPID RES, V49, P1039, DOI 10.1194/jlr.M700587-JLR200; Oda M, 2010, BBA-BIOMEMBRANES, V1798, P1073, DOI 10.1016/j.bbamem.2010.03.004; Openshaw AEA, 2005, J BIOL CHEM, V280, P35011, DOI 10.1074/jbc.M506800200; Ramarao N, 2005, CELL MICROBIOL, V7, P1357, DOI 10.1111/j.1462-5822.2005.00562.x; Sasahara T, 2011, EUR J CLIN MICROBIOL, V30, P219, DOI 10.1007/s10096-010-1072-2; Schwan WR, 2003, FEMS IMMUNOL MED MIC, V38, P23, DOI 10.1016/S0928-8244(03)00098-1; TAYLOR AJ, 1975, J MED MICROBIOL, V8, P543, DOI 10.1099/00222615-8-4-543; Tran SL, 2011, CELL MICROBIOL, V13, P92, DOI 10.1111/j.1462-5822.2010.01522.x; Tseng HJ, 2004, BIOCHEM BIOPH RES CO, V314, P513, DOI 10.1016/j.bbrc.2003.12.125; Van der Zwet WC, 2000, J CLIN MICROBIOL, V38, P4131, DOI 10.1128/JCM.38.11.4131-4136.2000	44	43	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38054	10.1371/journal.pone.0038054	http://dx.doi.org/10.1371/journal.pone.0038054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701599	gold, Green Published, Green Submitted			2022-12-25	WOS:000305348400033
J	Stahl, F				Stahl, Frank			Defining and Detecting Crossover-Interference Mutants in Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CROSSING-OVER; MISMATCH REPAIR; GENE CONVERSION; MUTS HOMOLOG; MEIOSIS; RECOMBINATION; ASSURANCE; PATHWAYS	The analysis of crossover interference in many creatures is complicated by the presence of two kinds of crossovers, interfering and noninterfering. In such creatures, the values of the traditional indicators of interference are subject not only to the strength of interference but also to the relative frequencies of crossing over contributed by the two kinds. We formalize the relationship among these variables and illustrate the possibilities and limitations of classical interference analysis with meiotic tetrad data from wild-type Saccharomyces cerevisiae and from mlh1 and ndj1 mutants.	Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Oregon	Stahl, F (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	fstahl@uoregon.edu						Abdullah MFF, 2004, CYTOGENET GENOME RES, V107, P180, DOI 10.1159/000080596; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Cole F, 2012, NAT CELL BIOL, V14, P424, DOI 10.1038/ncb2451; Falque M, 2009, PLANT CELL, V21, P3915, DOI 10.1105/tpc.109.071514; FOSS E, 1993, GENETICS, V133, P681; Gauthier F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-27; Getz TJ, 2008, GENETICS, V178, P1251, DOI 10.1534/genetics.106.067603; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Housworth EA, 2003, AM J HUM GENET, V73, P188, DOI 10.1086/376610; Malkova A, 2004, GENETICS, V168, P49, DOI 10.1534/genetics.104.027961; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Muller HJ, 1916, AM NAT, V50, P194; PAPAZIAN HP, 1952, GENETICS, V37, P175; PERKINS DD, 1949, GENETICS, V34, P607; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Rosu S, 2011, SCIENCE, V334, P1286, DOI 10.1126/science.1212424; Shinohara M, 2008, NAT GENET, V40, P299, DOI 10.1038/ng.83; Stahl F, 2008, GENETICS, V180, P1, DOI 10.1534/genetics.104.95596; Stahl FW, 2008, GENETICS, V179, P701, DOI 10.1534/genetics.108.086918; Stahl FW, 2010, GENETICS, V186, P515, DOI 10.1534/genetics.110.121194; Stahl FW, 2009, METHODS MOL BIOL, V557, P35, DOI 10.1007/978-1-59745-527-5_4; Stahl FW, 2004, GENETICS, V168, P35, DOI 10.1534/genetics.104.027789; Sturtevant A. H., 1915, Zs indukt Abstamm Berlin, V13, DOI 10.1007/BF01792906; Viswanath L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-297; Wanat JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000188	25	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38476	10.1371/journal.pone.0038476	http://dx.doi.org/10.1371/journal.pone.0038476			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701650	Green Published, Green Submitted, gold			2022-12-25	WOS:000305348400064
J	Zhang, M; Zhang, HW; Zhang, T; Ji, YX; Jiao, YM; Wu, H				Zhang, Mei; Zhang, Hongwei; Zhang, Tong; Ji, Yunxia; Jiao, Yanmei; Wu, Hao			Longitudinal Changes of Peripheral Blood DC Subsets and Regulatory T Cells in Chinese Chronic HIV-1-Infected Patients during Antiretroviral Therapy	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELL; INTERFERON-PRODUCING CELLS; HIV-INFECTION; IMMUNE ACTIVATION; INNATE; RECONSTITUTION; FREQUENCY; DECREASE; NUMBERS; TYPE-1	It has been emphasized that chronic generalized immune dysfunction is the leading event in the pathogenesis of HIV infection, in which the contribution of dendritic cells (DCs) and regulatory T cells (Tregs) should not be underestimated. In current study, we assessed the longitudinal changes of peripheral blood DC subsets and Tregs in chronically asymptomatic treatment-naive HIV-1-infected patients during 60 weeks of antiretroviral therapy (ART), and compared with those in healthy controls and long term non-progressors (LTNPs). Blood samples were collected at week 0, 4, 12, 24, 48 and 60 of treatment to measure the counts of DC subsets and Tregs by flow cytometry and IFN-a plasma levels by ELISA. The counts of myeloid dendritic cells (mDCs) increased during ART, reaching similar levels to healthy controls at week 60 post ART but still lower than those of LTNPs. In HIV-1-infected patients, the mDCs counts were directly correlated with CD4 counts during ART. Changes in mDCs at week 8 were positively correlated with the changes in CD4 counts at week 60 post ART. However, the counts and function of plasmacytoid dendritic cells (pDCs) remained relatively stable during ART, and similar to those in healthy controls and LTNPs. The percentage of Tregs increased before ART and normalized after ART. Importantly, we found pDCs counts were associated with percentage of Tregs during ART, which may help in understanding of the role of these cells in HIV infection.	[Zhang, Mei; Zhang, Hongwei; Zhang, Tong; Ji, Yunxia; Jiao, Yanmei; Wu, Hao] Capital Med Univ, Beijing Youan Hosp, Ctr Infect Dis, Beijing, Peoples R China	Capital Medical University	Zhang, M (corresponding author), Capital Med Univ, Beijing Youan Hosp, Ctr Infect Dis, Beijing, Peoples R China.	jiaoyanmei@sina.com; wuhd2002@yahoo.com.cn	Zhang, Tong/HGC-1090-2022		Key Project of the National Twelfth-Five Year Research Program of China [2012ZX10001-003, 2012ZX10001-006, 2012ZX10001-008]; Beijing Municipal Science and Technology Commission [D09050703590901]; Beijing Key Laboratory [BZ0089]	Key Project of the National Twelfth-Five Year Research Program of China; Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Beijing Key Laboratory	This work was supported by grants from Key Project of the National Twelfth-Five Year Research Program of China (2012ZX10001-003,2012ZX10001-006, 2012ZX10001-008), Project of Beijing Municipal Science and Technology Commission (D09050703590901) and Beijing Key Laboratory (BZ0089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzoni L, 2007, AIDS, V21, P293, DOI 10.1097/QAD.0b013e328012b85f; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barratt-Boyes SM, 2011, J MED PRIMATOL, V40, P206, DOI 10.1111/j.1600-0684.2011.00484.x; Barron MA, 2003, J INFECT DIS, V187, P26, DOI 10.1086/345957; Bi X, 2009, EUR J IMMUNOL, V39, P301, DOI 10.1002/eji.200838667; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Chatila TA, 2005, J ALLERGY CLIN IMMUN, V116, P949, DOI 10.1016/j.jaci.2005.08.047; Chehimi J, 2002, J IMMUNOL, V168, P4796, DOI 10.4049/jimmunol.168.9.4796; Chehimi J, 2007, J IMMUNOL, V179, P2642, DOI 10.4049/jimmunol.179.4.2642; Donaghy H, 2001, BLOOD, V98, P2574, DOI 10.1182/blood.V98.8.2574; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Fazekas de St Groth B, 2008, AIDS, V22, P671, DOI 10.1097/QAD.0b013e3282f466da; Finke JS, 2004, J CLIN IMMUNOL, V24, P647, DOI 10.1007/s10875-004-6250-5; Fitzgerald-Bocarsly P, 2010, J LEUKOCYTE BIOL, V87, P609, DOI 10.1189/jlb.0909635; Fontaine J, 2009, J INFECT DIS, V199, P1007, DOI 10.1086/597278; Ford ES, 2009, CURR OPIN HIV AIDS, V4, P206, DOI 10.1097/COH.0b013e328329c68c; Gaardbo JC, 2008, CLIN EXP IMMUNOL, V154, P80, DOI 10.1111/j.1365-2249.2008.03725.x; Geng WQ, 2011, J CLIN IMMUNOL, V31, P882, DOI 10.1007/s10875-011-9556-0; Hubert P, 2007, J LEUKOCYTE BIOL, V82, P781, DOI 10.1189/jlb.1106694; Hunt PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015924; Jiao YM, 2009, IMMUNOLOGY, V128, pe366, DOI 10.1111/j.1365-2567.2008.02978.x; Killian MS, 2006, AIDS, V20, P1247, DOI 10.1097/01.aids.0000232231.34253.bd; Krathwohl MD, 2006, J INFECT DIS, V193, P494, DOI 10.1086/499597; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lore K, 2003, APMIS, V111, P776, DOI 10.1034/j.1600-0463.2003.11107809.x; Mahnke K, 2007, CELL IMMUNOL, V250, P1, DOI 10.1016/j.cellimm.2008.01.004; Manches O, 2008, J CLIN INVEST, V118, P3431, DOI 10.1172/JCI34823; Ndhlovu LC, 2008, J LEUKOCYTE BIOL, V83, P254, DOI 10.1189/jlb.0507281; Pacanowski J, 2001, BLOOD, V98, P3016, DOI 10.1182/blood.V98.10.3016; Presicce P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028118; Robertson SJ, 2006, SPRINGER SEMIN IMMUN, V28, P51, DOI 10.1007/s00281-006-0019-2; Sabado RL, 2010, BLOOD, V116, P3839, DOI 10.1182/blood-2010-03-273763; Sachdeva N, 2008, J IMMUNOL, V181, P2887, DOI 10.4049/jimmunol.181.4.2887; Schmidt B, 2006, J CLIN IMMUNOL, V26, P55, DOI 10.1007/s10875-006-8401-3; Smed-Sorensen A, 2011, CURR OPIN HIV AIDS, V6, P405, DOI 10.1097/COH.0b013e328349b06b; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Weiss L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011659; Wijewardana V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001235; Yonezawa A, 2003, J VIROL, V77, P3777, DOI 10.1128/JVI.77.6.3777-3784.2003; Zhang ZN, 2008, JPN J INFECT DIS, V61, P391	40	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37966	10.1371/journal.pone.0037966	http://dx.doi.org/10.1371/journal.pone.0037966			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701538	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338500068
J	Pittet, F; Coignard, M; Houdelier, C; Richard-Yris, MA; Lumineau, S				Pittet, Florent; Coignard, Maud; Houdelier, Cecilia; Richard-Yris, Marie-Annick; Lumineau, Sophie			Age Affects the Expression of Maternal Care and Subsequent Behavioural Development of Offspring in a Precocial Bird	PLOS ONE			English	Article							LONG-LIVED BIRD; JAPANESE-QUAIL; REPRODUCTIVE EFFORT; EMOTIONAL REACTIVITY; TERMINAL INVESTMENT; PARENTAL EXPERIENCE; COTURNIX-JAPONICA; GENE-EXPRESSION; CALIFORNIA GULL; MOTHERS	Variations of breeding success with age have been studied largely in iteroparous species and particularly in birds: survival of offspring increases with parental age until senescence. Nevertheless, these results are from observations of free-living individuals and therefore, it remains impossible to determine whether these variations result from parental investment or efficiency or both, and whether these variations occur during the prenatal or the postnatal stage or during both. Our study aimed first, to determine whether age had an impact on the expression of maternal breeding care by comparing inexperienced female birds of two different ages, and second, to define how these potential differences impact chicks' growth and behavioural development. We made 22 2-month-old and 22 8-month-old female Japanese quail foster 1-day-old chicks. We observed their maternal behaviour until the chicks were 11 days old and then tested these chicks after separation from their mothers. Several behavioural tests estimated their fearfulness and their sociality. We observed first that a longer induction was required for young females to express maternal behaviour. Subsequently as many young females as elder females expressed maternal behaviour, but young females warmed chicks less, expressed less covering postures and rejected their chicks more. Chicks brooded by elder females presented higher growth rates and more fearfulness and sociality. Our results reveal that maternal investment increased with age independently of maternal experience, suggesting modification of hormone levels implied in maternal behaviour. Isolated effects of maternal experience should now be assessed in females of the same age. In addition, our results show, for first time in birds, that variations in maternal care directly induce important differences in the behavioural development of chicks. Finally, our results confirm that Japanese quail remains a great laboratory model of avian maternal behaviour and that the way we sample maternal behaviour is highly productive.	[Pittet, Florent; Coignard, Maud; Houdelier, Cecilia; Richard-Yris, Marie-Annick; Lumineau, Sophie] Univ Rennes 1, UMR Ethol Anim & Humaine 6552, CNRS, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Pittet, F (corresponding author), Univ Rennes 1, UMR Ethol Anim & Humaine 6552, CNRS, Rennes, France.	florent.pittet@univ-rennes1.fr	Pittet, Florent/Q-2100-2015	Lumineau, Sophie/0000-0002-2076-9947	CNRS, the French Ministry of Research	CNRS, the French Ministry of Research(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the CNRS, the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER G, 1993, AUST J EXP AGR, V33, P721, DOI 10.1071/EA9930721; Angelier F, 2007, BEHAV ECOL SOCIOBIOL, V61, P611, DOI 10.1007/s00265-006-0290-1; Angelier F, 2006, GEN COMP ENDOCR, V149, P1, DOI 10.1016/j.ygcen.2006.04.006; Archer J, 1976, PERSPECTIVES ETHOLOG, P231; Avery ML, 1996, ANIM BEHAV, V51, P1279, DOI 10.1006/anbe.1996.0132; Beamonte-Barrientos R, 2010, AM NAT, V175, P469, DOI 10.1086/650726; Bertin A, 2005, J EXP ZOOL PART A, V303A, P792, DOI 10.1002/jez.a.202; Bertin A, 2004, APPL ANIM BEHAV SCI, V89, P215, DOI 10.1016/j.applanim.2004.06.004; Boguszewski P, 2002, BEHAV BRAIN RES, V133, P323, DOI 10.1016/S0166-4328(02)00018-9; Boos M, 2007, BEHAV PROCESS, V76, P206, DOI 10.1016/j.beproc.2007.05.003; Cameron EZ, 2000, BEHAV ECOL SOCIOBIOL, V47, P243, DOI 10.1007/s002650050661; Cameron NM, 2005, NEUROSCI BIOBEHAV R, V29, P843, DOI 10.1016/j.neubiorev.2005.03.022; Chiu SF, 1996, J GERONTOL A-BIOL, V51, pB220, DOI 10.1093/gerona/51A.3.B220; Clarke JA, 2010, ANIM BEHAV, V79, P25, DOI 10.1016/j.anbehav.2009.09.021; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Cote SD, 2001, ANIM BEHAV, V62, P173, DOI 10.1006/anbe.2001.1719; CURIO E, 1983, IBIS, V125, P400, DOI 10.1111/j.1474-919X.1983.tb03130.x; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Formanek L, 2008, ETHOLOGY, V114, P817, DOI 10.1111/j.1439-0310.2008.01536.x; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Green WCH, 1990, BEHAV ECOL, V1, P148, DOI 10.1093/beheco/1.2.148; Guibert F, 2012, PHYSIOL BEHAV, V105, P242, DOI 10.1016/j.physbeh.2011.08.009; Hoffman CL, 2010, BEHAV ECOL, V21, P972, DOI 10.1093/beheco/arq098; Holmes WG, 1998, ANIM BEHAV, V55, P1555, DOI 10.1006/anbe.1997.0700; JONES RB, 1986, WORLD POULTRY SCI J, V42, P82, DOI 10.1079/WPS19860008; JONES RB, 1983, BEHAV PROCESS, V8, P243; Krijgsveld KL, 2003, PHYSIOL BEHAV, V79, P311, DOI 10.1016/S0031-9384(03)00117-3; Krpan KM, 2005, HORM BEHAV, V47, P112, DOI 10.1016/j.yhbeh.2004.08.006; LEVINE L, 1985, PEDIATRICS, V75, P23; Mauck RA, 2004, EVOLUTION, V58, P880, DOI 10.1554/03-147; Meaney MJ, 2001, NEUROSCIENCE, V24; MILLS A D, 1990, Medical Science Research, V18, P179; Mills AD, 1997, NEUROSCI BIOBEHAV R, V21, P261, DOI 10.1016/S0149-7634(96)00028-0; Moretti M, 2011, PHYSIOL BEHAV, V102, P115, DOI 10.1016/j.physbeh.2010.09.019; ORCUTT FS, 1976, AUK, V93, P135; Pflanz T, 2002, ANIM BEHAV, V63, P613, DOI 10.1006/anbe.2001.1930; PIANKA ER, 1975, AM NAT, V109, P453, DOI 10.1086/283013; PUGESEK BH, 1995, ANIM BEHAV, V49, P641; PUGESEK BH, 1983, BEHAV ECOL SOCIOBIOL, V13, P161, DOI 10.1007/BF00299919; Richard-Yris M. A., 1994, COMPORTEMENT ADAPTAT, P61; Richard-Yris MA, 2005, DEV PSYCHOBIOL, V46, P1, DOI 10.1002/dev.20040; RICHARDYRIS MA, 1988, BEHAVIOUR, V104, P126, DOI 10.1163/156853988X00638; Ruscio MG, 2004, HORM BEHAV, V46, P19, DOI 10.1016/j.yhbeh.2004.02.002; Salchner P, 2004, BEHAV BRAIN RES, V151, P1, DOI 10.1016/j.bbr.2003.07.002; Schino G, 2001, DEV PSYCHOBIOL, V38, P186, DOI 10.1002/dev.1012; Simpson MJA, 1985, PRIMATES, V26, P57; TENCATE C, 1989, ETHOLOGY, V82, P287; THORNHILL R, 1989, ETHOLOGY, V83, P31, DOI 10.1111/j.1439-0310.1989.tb00517.x; Wauters AM, 2002, DEV PSYCHOBIOL, V41, P25, DOI 10.1002/dev.10042; Wyss JM, 2000, NEUROBIOL AGING, V21, P671, DOI 10.1016/S0197-4580(00)00132-9	50	23	23	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36835	10.1371/journal.pone.0036835	http://dx.doi.org/10.1371/journal.pone.0036835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22701515	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338200048
J	Zhang, LJ; Vogel, WK; Liu, X; Topark-Ngarm, A; Arbogast, BL; Maier, CS; Filtz, TM; Leid, M				Zhang, Ling-juan; Vogel, Walter K.; Liu, Xiao; Topark-Ngarm, Acharawan; Arbogast, Brian L.; Maier, Claudia S.; Filtz, Theresa M.; Leid, Mark			Coordinated Regulation of Transcription Factor Bcl11b Activity in Thymocytes by the Mitogen-activated Protein Kinase (MAPK) Pathways and Protein Sumoylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINEAGE COMMITMENT; POSITIVE SELECTION; STATISTICAL-MODEL; NURD COMPLEX; TCR SIGNALS; DUAL ROLE; SUMO; DIFFERENTIATION; EXPRESSION; GENE	The transcriptional regulatory protein Bcl11b is essential for T-cell development. We have discovered a dynamic, MAPK-regulated pathway involving sequential, linked, and reversible post-translational modifications of Bcl11b in thymocytes. MAPK-mediated phosphorylation of Bcl11b was coupled to its rapid desumoylation, which was followed by a subsequent cycle of dephosphorylation and resumoylation. Additionally and notably, we report the first instance of direct identification by mass spectrometry of a site of small ubiquitin-like modifier (SUMO) adduction, Lys-679 of Bcl11b, in a protein isolated from a native, mammalian cell. Sumoylation of Bcl11b resulted in recruitment of the transcriptional co-activator p300 to a Bcl11b-repressed promoter with subsequent induction of transcription. Prolonged treatment of native thymocytes with phorbol 12,13-dibutyrate together with the calcium ionophore A23187 also promoted ubiquitination and proteasomal degradation of Bcl11b, providing a mechanism for signal termination. A Bcl11b phospho-deSUMO switch was identified, the basis of which was phosphorylation-dependent recruitment of the SUMO hydrolase SENP1 to phospho-Bcl11b, coupled to hydrolysis of SUMO-Bcl11b. These results define a regulatory pathway in thymocytes that includes the MAPK pathways and upstream signaling components, Bcl11b and the associated nucleosome remodeling and deacetylation (NuRD) complex, SENP proteins, the Bcl11b protein phosphatase 6, the sumoylation machinery, the histone acetyltransferase p300, and downstream transcriptional machinery. This pathway appears to facilitate derepression of repressed Bcl11b target genes as immature thymocytes initiate differentiation programs, biochemically linking MAPK signaling with the latter stages of T-cell development.	[Filtz, Theresa M.; Leid, Mark] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Arbogast, Brian L.; Maier, Claudia S.] Oregon State Univ, Dept Chem, Corvallis, OR 97331 USA; [Arbogast, Brian L.; Maier, Claudia S.] Oregon State Univ, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University	Filtz, TM (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	Theresa.Filtz@oregonstate.edu; Mark.Leid@oregonstate.edu	Zhang, Ling-juan/V-6141-2019; Zhang, Lingjuan/K-3080-2017	Zhang, Ling-juan/0000-0001-6937-4578; Zhang, Lingjuan/0000-0001-6937-4578; Filtz, Theresa/0000-0002-5348-1114; Maier, Claudia S./0000-0003-0743-8956; Vogel, Walter/0000-0002-5663-6660	National Institutes of Health [GM096243]; Medical Research Foundation of Oregon; Oregon State University College of Pharmacy; Environmental Health Sciences Center; NIEHS, National Institutes of Health Center [ES000210]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM096243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Foundation of Oregon; Oregon State University College of Pharmacy; Environmental Health Sciences Center; NIEHS, National Institutes of Health Center; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM096243 (to T. M. F.). This work was also supported by an award from the Medical Research Foundation of Oregon (to M. L.) and funds provided by the Oregon State University College of Pharmacy.; Partially supported by the Environmental Health Sciences Center during the early phases of this work involving mass spectrometry.; We thank David Brautigan for generously providing expression vectors encoding HA-PP6 subunits and anti-PP6 antibodies, Grace Gill for sharing mammalian expression vector encoding FLAG-SENP protein and bacterial expression vectors for GST-SUMO1 and -SUMO2, and Mark Zabriskie for encouragement and continuous support of this project. The Mass Spectrometry Facility at Oregon State University is supported by NIEHS, National Institutes of Health Center Grant ES000210 to the Environmental Health Sciences Center at Oregon State University.	AlberolaIla J, 1997, ANNU REV IMMUNOL, V15, P125, DOI 10.1146/annurev.immunol.15.1.125; Albu DI, 2007, J EXP MED, V204, P3003, DOI 10.1084/jem.20070863; Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Arlotta P, 2008, J NEUROSCI, V28, P622, DOI 10.1523/JNEUROSCI.2986-07.2008; Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; Bommhardt U, 1999, J IMMUNOL, V163, P715; Cismasiu VB, 2005, ONCOGENE, V24, P6753, DOI 10.1038/sj.onc.1208904; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Crompton T, 1996, CELL, V86, P243, DOI 10.1016/S0092-8674(00)80096-3; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Dowell P, 1997, J BIOL CHEM, V272, P33435, DOI 10.1074/jbc.272.52.33435; Drag M, 2008, IUBMB LIFE, V60, P734, DOI 10.1002/iub.113; Enomoto T, 2011, J NEUROSCI, V31, P10159, DOI 10.1523/JNEUROSCI.1245-11.2011; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Garaude J, 2008, J IMMUNOL, V180, P5983, DOI 10.4049/jimmunol.180.9.5983; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Golonzhka O, 2007, GENE EXPR PATTERNS, V7, P754, DOI 10.1016/j.modgep.2007.06.002; Golonzhka O, 2009, J INVEST DERMATOL, V129, P1459, DOI 10.1038/jid.2008.392; Golonzhka O, 2009, P NATL ACAD SCI USA, V106, P4278, DOI 10.1073/pnas.0900568106; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hsiao HH, 2009, MOL CELL PROTEOMICS, V8, P2664, DOI 10.1074/mcp.M900087-MCP200; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Huang X, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-44; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Kamimura K, 2007, ONCOGENE, V26, P5840, DOI 10.1038/sj.onc.1210388; Kang Jungseog, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-5; Kastner P, 2010, EUR J IMMUNOL, V40, P2143, DOI 10.1002/eji.200940258; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kuo HY, 2005, P NATL ACAD SCI USA, V102, P16973, DOI 10.1073/pnas.0504460102; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Leid M, 2004, GENE EXPR PATTERNS, V4, P733, DOI 10.1016/j.modgep.2004.03.009; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Li X, 2007, J BIOL CHEM, V282, P36177, DOI 10.1074/jbc.M706912200; Li YJ, 2010, ONCOGENE, V29, P3509, DOI 10.1038/onc.2010.108; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Motohashi H, 2006, MOL CELL BIOL, V26, P4652, DOI 10.1128/MCB.02193-05; Narayanan A, 2009, CURR OPIN STRUC BIOL, V19, P156, DOI 10.1016/j.sbi.2009.02.007; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Ohoka Y, 1996, INT IMMUNOL, V8, P297, DOI 10.1093/intimm/8.3.297; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Priatel JJ, 2002, IMMUNITY, V17, P617, DOI 10.1016/S1074-7613(02)00451-X; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Przybylski GK, 2005, LEUKEMIA, V19, P201, DOI 10.1038/sj.leu.2403619; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Senawong T, 2003, J BIOL CHEM, V278, P43041, DOI 10.1074/jbc.M307477200; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; Takahama Y, 1996, J IMMUNOL, V157, P1508; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tempe D, 2008, BIOCHEM SOC T, V36, P874, DOI 10.1042/BST0360874; Terui Y, 2004, J BIOL CHEM, V279, P28257, DOI 10.1074/jbc.M403153200; Topark-Ngarm A, 2006, J BIOL CHEM, V281, P32272, DOI 10.1074/jbc.M602776200; Tremblay AM, 2008, MOL ENDOCRINOL, V22, P570, DOI 10.1210/me.2007-0357; Valin A, 2007, BIOCHEM SOC T, V35, P1393, DOI 10.1042/BST0351393; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Witty J, 2010, BIOCHEM J, V428, P247, DOI 10.1042/BJ20091948; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Yang Y, 2011, ONCOGENE, V30, P2207, DOI 10.1038/onc.2010.600; Zhang LJ, 2009, J BIOL CHEM, V284, P6156, DOI 10.1074/jbc.M807713200	70	43	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26971	26988		10.1074/jbc.M112.344176	http://dx.doi.org/10.1074/jbc.M112.344176			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700985	hybrid, Green Published			2022-12-25	WOS:000307386000045
J	Bouvier, T; Venail, P; Pommier, T; Bouvier, C; Barbera, C; Mouquet, N				Bouvier, Thierry; Venail, Patrick; Pommier, Thomas; Bouvier, Corinne; Barbera, Claire; Mouquet, Nicolas			Contrasted Effects of Diversity and Immigration on Ecological Insurance in Marine Bacterioplankton Communities	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; 16S RIBOSOMAL-RNA; BACTERIAL COMMUNITIES; FRESH-WATER; BIODIVERSITY; STABILITY; METACOMMUNITIES; DISPERSAL; PREDICTABILITY; PRODUCTIVITY	The ecological insurance hypothesis predicts a positive effect of species richness on ecosystem functioning in a variable environment. This effect stems from temporal and spatial complementarity among species within metacommunities coupled with optimal levels of dispersal. Despite its importance in the context of global change by human activities, empirical evidence for ecological insurance remains scarce and controversial. Here we use natural aquatic bacterial communities to explore some of the predictions of the spatial and temporal aspects of the ecological insurance hypothesis. Addressing ecological insurance with bacterioplankton is of strong relevance given their central role in fundamental ecosystem processes. Our experimental set up consisted of water and bacterioplankton communities from two contrasting coastal lagoons. In order to mimic environmental fluctuations, the bacterioplankton community from one lagoon was successively transferred between tanks containing water from each of the two lagoons. We manipulated initial bacterial diversity for experimental communities and immigration during the experiment. We found that the abundance and production of bacterioplankton communities was higher and more stable (lower temporal variance) for treatments with high initial bacterial diversity. Immigration was only marginally beneficial to bacterial communities, probably because microbial communities operate at different time scales compared to the frequency of perturbation selected in this study, and of their intrinsic high physiologic plasticity. Such local "physiological insurance" may have a strong significance for the maintenance of bacterial abundance and production in the face of environmental perturbations.	[Bouvier, Thierry; Pommier, Thomas; Bouvier, Corinne] Univ Montpellier 2, Lab Ecol Syst Marins Cotiers ECOSYM, CNRS IRD IFREMER, UMR5119, Montpellier, France; [Venail, Patrick; Barbera, Claire; Mouquet, Nicolas] Univ Montpellier 2, Inst Sci Evolut ISEM, CNRS, UMR 5554, Montpellier, France; [Venail, Patrick] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Pommier, Thomas] Univ Lyon 1, UMR Ecol Microbienne CNRS 5557, USC INRA 1193, F-69622 Villeurbanne, France	Ifremer; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Michigan System; University of Michigan; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Bouvier, T (corresponding author), Univ Montpellier 2, Lab Ecol Syst Marins Cotiers ECOSYM, CNRS IRD IFREMER, UMR5119, Pl E Bataillon, Montpellier, France.	thierry.bouvier@univ-montp2.fr	Venail, Patrick/D-2968-2018; Pommier, Thomas/AAR-1115-2021; Bouvier, Thierry/A-1895-2013; MOUQUET, Nicolas/AAL-1440-2021	Venail, Patrick/0000-0003-1126-280X; Pommier, Thomas/0000-0003-2986-5326; Mouquet, Nicolas/0000-0003-1840-6984; bouvier, thierry/0000-0002-7151-5680	French grant ANR [BACH-09-JCJC-0110-01]; fellowship within the postdoctoral program of the French National Center for Scientific Research (CNRS)	French grant ANR(French National Research Agency (ANR)); fellowship within the postdoctoral program of the French National Center for Scientific Research (CNRS)	Research funding was provided by the French grant ANR # BACH-09-JCJC-0110-01 (to NM and TB). TP was supported by a fellowship within the postdoctoral program of the French National Center for Scientific Research (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann R, 2008, NAT REV MICROBIOL, V6, P339, DOI 10.1038/nrmicro1888; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bec B, 2011, AQUAT MICROB ECOL, V63, P29, DOI 10.3354/ame01480; Becking L.G.M.B, 1934, GEOBIOLOGIE INLEIDIN; Bernhard AE, 2005, FEMS MICROBIOL ECOL, V52, P115, DOI 10.1016/j.femsec.2004.10.016; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Bostrom KH, 2004, LIMNOL OCEANOGR-METH, V2, P365, DOI 10.4319/lom.2004.2.365; Bowen JL, 2011, ISME J, V5, P1540, DOI 10.1038/ismej.2011.22; Campbell V, 2011, OIKOS, V120, P399, DOI 10.1111/j.1600-0706.2010.18768.x; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2011, NATURE, V472, P86, DOI 10.1038/nature09904; Cissoko M, 2008, FRESHWATER BIOL, V53, P1154, DOI 10.1111/j.1365-2427.2007.01930.x; Cottingham KL, 2001, ECOL LETT, V4, P72, DOI 10.1046/j.1461-0248.2001.00189.x; Covert JS, 2001, AQUAT MICROB ECOL, V25, P127, DOI 10.3354/ame025127; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; Forrest J, 2007, ECOSCIENCE, V14, P137, DOI 10.2980/1195-6860(2007)14[137:VAPIAZ]2.0.CO;2; France KE, 2006, NATURE, V441, P1139, DOI 10.1038/nature04729; Gasol JM, 2002, LIMNOL OCEANOGR, V47, P62, DOI 10.4319/lo.2002.47.1.0062; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; Girvan MS, 2005, ENVIRON MICROBIOL, V7, P301, DOI 10.1111/j.1462-2920.2005.00695.x; Hector A, 2010, ECOLOGY, V91, P2213, DOI 10.1890/09-1162.1; Howeth JG, 2010, ECOLOGY, V91, P2727, DOI 10.1890/09-1004.1; Jiang L, 2009, AM NAT, V174, P651, DOI 10.1086/605961; Kaiser E, 1997, APPL ENVIRON MICROB, V63, P4026, DOI 10.1128/AEM.63.10.4026-4031.1997; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Kirchman D.L., 2008, MICROBIAL ECOLOGY OC, Vsecond; Langenheder S, 2005, LIMNOL OCEANOGR, V50, P957, DOI 10.4319/lo.2005.50.3.0957; Langenheder S, 2007, ECOLOGY, V88, P2154, DOI 10.1890/06-2098.1; Lavik G, 2009, NATURE, V457, P581, DOI 10.1038/nature07588; Leary DJ, 2009, J ANIM ECOL, V78, P1143, DOI 10.1111/j.1365-2656.2009.01586.x; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Leibold MA, 2004, LIMNOL OCEANOGR, V49, P1278, DOI 10.4319/lo.2004.49.4_part_2.1278; Lindstrom ES, 2011, PLOS ONE, DOI [10.1371/journal.-pone.0025883, DOI 10.1371/JOURNAL.-PONE.0025883]; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; Logue Jurg Brendan, 2008, Freshwater Reviews, V1, P99, DOI 10.1608/FRJ-1.1.9; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; MORITA RY, 1982, ADV MICROB ECOL, V6, P171; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Ovreas L, 1997, APPL ENVIRON MICROB, V63, P3367; PAINCHAUD J, 1995, APPL ENVIRON MICROB, V61, P205, DOI 10.1128/AEM.61.1.205-208.1995; Peter H, 2011, ISME J, V5, P351, DOI 10.1038/ismej.2010.119; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Reche I, 2005, ECOLOGY, V86, P1715, DOI 10.1890/04-1587; Reed HE, 2007, FEMS MICROBIOL ECOL, V62, P161, DOI 10.1111/j.1574-6941.2007.00386.x; Reinthaler T, 2005, APPL ENVIRON MICROB, V71, P2260, DOI 10.1128/AEM.71.5.2260-2266.2005; Shade A, 2011, ENVIRON MICROBIOL, V13, P2752, DOI 10.1111/j.1462-2920.2011.02546.x; Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Steiner CF, 2011, AM NAT, V178, P159, DOI 10.1086/660835; VASCONCELOS GJ, 1976, APPL ENVIRON MICROB, V31, P913, DOI 10.1128/AEM.31.6.913-920.1976; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; YENTSCH CS, 1963, DEEP-SEA RES, V10, P221, DOI 10.1016/0011-7471(63)90358-9	56	12	12	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e37620	10.1371/journal.pone.0037620	http://dx.doi.org/10.1371/journal.pone.0037620			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701572	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340000004
J	Tomlinson, DC; Baxter, EW; Loadman, PM; Hull, MA; Knowles, MA				Tomlinson, Darren C.; Baxter, Euan W.; Loadman, Paul M.; Hull, Mark A.; Knowles, Margaret A.			FGFR1-Induced Epithelial to Mesenchymal Transition through MAPK/PLC gamma/COX-2-Mediated Mechanisms	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PHOSPHOLIPASE-C-GAMMA; RAT BLADDER-CARCINOMA; CELL CARCINOMA; URINARY-BLADDER; CYCLOOXYGENASE-2 EXPRESSION; TUMOR PROGRESSION; DEPENDENT MECHANISM; CANCER CELLS; PPAR-GAMMA	Tumour invasion and metastasis is the most common cause of death from cancer. For epithelial cells to invade surrounding tissues and metastasise, an epithelial-mesenchymal transition (EMT) is required. We have demonstrated that FGFR1 expression is increased in bladder cancer and that activation of FGFR1 induces an EMT in urothelial carcinoma (UC) cell lines. Here, we created an in vitro FGFR1-inducible model of EMT, and used this model to identify regulators of urothelial EMT. FGFR1 activation promoted EMT over a period of 72 hours. Initially a rapid increase in actin stress fibres occurred, followed by an increase in cell size, altered morphology and increased migration and invasion. By using site-directed mutagenesis and small molecule inhibitors we demonstrated that combined activation of the mitogen activated protein kinase (MAPK) and phospholipase C gamma (PLC gamma) pathways regulated this EMT. Actin stress fibre formation was regulated by PLC gamma activation, and was also important for the increase in cell size, migration and altered morphology. MAPK activation regulated migration and E-cadherin expression, indicating that combined activation of PLC gamma and MAPK is required for a full EMT. We used expression microarrays to assess changes in gene expression downstream of these signalling cascades. COX-2 was transcriptionally upregulated by FGFR1 and caused increased intracellular prostaglandin E-2 levels, which promoted migration. In conclusion, we have demonstrated that FGFR1 activation in UC cells lines promotes EMT via coordinated activation of multiple signalling pathways and by promoting activation of prostaglandin synthesis.	[Tomlinson, Darren C.; Baxter, Euan W.; Knowles, Margaret A.] St James Univ Hosp, Sect Expt Oncol, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Loadman, Paul M.] Univ Bradford, Inst Canc Therapeut, Bradford BD7 1DP, W Yorkshire, England; [Hull, Mark A.] St James Univ Hosp, Sect Mol Gastroenterol, Leeds Inst Mol Med, Leeds, W Yorkshire, England	Saint James's University Hospital; University of Leeds; University of Bradford; Saint James's University Hospital; University of Leeds	Tomlinson, DC (corresponding author), St James Univ Hosp, Sect Expt Oncol, Leeds Inst Mol Med, Leeds, W Yorkshire, England.	m.a.knowles@leeds.ac.uk		Tomlinson, Darren/0000-0003-4134-7484; Loadman, Paul/0000-0002-4259-8616; Knowles, Margaret/0000-0002-9363-8657	Yorkshire Cancer Research [L346]; Cancer Research UK [C6228/A5437]; Medical Research Council [G116/146] Funding Source: researchfish; MRC [G116/146] Funding Source: UKRI	Yorkshire Cancer Research; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from Yorkshire Cancer Research (L346) and Cancer Research UK (C6228/A5437). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; ARTEAGA CL, 1991, P NATL ACAD SCI USA, V88, P10435, DOI 10.1073/pnas.88.23.10435; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bakin AV, 2002, J CELL SCI, V115, P3193; Bernard-Pierrot I, 2006, CARCINOGENESIS, V27, P740, DOI 10.1093/carcin/bgi290; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; BOYER B, 1993, J CELL BIOL, V120, P767, DOI 10.1083/jcb.120.3.767; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Carpenter G, 1999, EXP CELL RES, V253, P15, DOI 10.1006/excr.1999.4671; Chapman EJ, 2006, ONCOGENE, V25, P5037, DOI 10.1038/sj.onc.1209513; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; CLYMAN RI, 1994, CELL ADHES COMMUN, V1, P333, DOI 10.3109/15419069409097264; di Martino E, 2009, ONCOGENE, V28, P4306, DOI 10.1038/onc.2009.280; Ellenrieder V, 2001, CANCER RES, V61, P4222; Gotzmann J, 2004, MUTAT RES-REV MUTAT, V566, P9, DOI 10.1016/S1383-5742(03)00033-4; Gotzmann J, 2002, J CELL SCI, V115, P1189; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Inoue H, 2000, J BIOL CHEM, V275, P28028; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Jang TJ, 2010, VIRCHOWS ARCH, V457, P319, DOI 10.1007/s00428-010-0943-3; Jouanneau J, 1999, ONCOGENE, V18, P327, DOI 10.1038/sj.onc.1202285; Knowles MA, 2006, CARCINOGENESIS, V27, P361, DOI 10.1093/carcin/bgi310; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Komhoff M, 2000, AM J PATHOL, V157, P29, DOI 10.1016/S0002-9440(10)64513-0; Mbonye UR, 2009, BMB REP, V42, P552, DOI 10.5483/BMBRep.2009.42.9.552; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; MOHAMMADI M, 1992, NATURE, V358, P681, DOI 10.1038/358681a0; Munro NP, 2003, J UROLOGY, V169, P675, DOI 10.1016/S0022-5347(05)63991-2; NOMOTO K, 1995, MOL CARCINOGEN, V12, P146, DOI 10.1002/mc.2940120306; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; OTOOLE C, 1978, BRIT J CANCER, V38, P64, DOI 10.1038/bjc.1978.164; Piek E, 1999, J CELL SCI, V112, P4557; Price JT, 1999, CANCER RES, V59, P5475; Qing J, 2009, J CLIN INVEST, V119, P1216, DOI 10.1172/JCI38017; Ristimaki A, 2001, AM J PATHOL, V158, P849, DOI 10.1016/S0002-9440(10)64033-3; Sarkar S, 2000, CANCER RES, V60, P3862; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; Shirahama T, 2001, CANCER, V92, P188, DOI 10.1002/1097-0142(20010701)92:1<188::AID-CNCR1308>3.0.CO;2-W; Shirahama T, 2000, CLIN CANCER RES, V6, P2424; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thiery JP, 1999, CANCER METAST REV, V18, P31, DOI 10.1023/A:1006256219004; Thomas SM, 2003, CANCER RES, V63, P5629; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; Tomlinson DC, 2010, AM J PATHOL, V177, P2379, DOI 10.2353/ajpath.2010.100354; Tomlinson DC, 2009, CANCER RES, V69, P4613, DOI 10.1158/0008-5472.CAN-08-2816; Turner T, 1996, CLIN EXP METASTAS, V14, P409, DOI 10.1007/BF00123400; Varley CL, 2004, J CELL SCI, V117, P2029, DOI 10.1242/jcs.01042; Wild PJ, 2005, INT J ONCOL, V27, P385; WILLIAMS RD, 1980, INVEST UROL, V17, P359; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Xian W, 2005, J CELL BIOL, V171, P663, DOI 10.1083/jcb.200505098; Yang WL, 2001, CARCINOGENESIS, V22, P1379, DOI 10.1093/carcin/22.9.1379; Yang YN, 2006, CANCER RES, V66, P8617, DOI 10.1158/0008-5472.CAN-06-1308; Yeager TR, 1998, GENE DEV, V12, P163, DOI 10.1101/gad.12.2.163; Zuo W, 2009, MOL BIOL CELL, V20, P1020, DOI 10.1091/mbc.E08-09-0898	58	63	69	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38972	10.1371/journal.pone.0038972	http://dx.doi.org/10.1371/journal.pone.0038972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701738	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340000058
J	Yue, GH; Xia, JH; Liu, F; Lin, GC				Yue, Gen Hua; Xia, Jun Hong; Liu, Feng; Lin, Grace			Evidence for Female-Biased Dispersal in the Protandrous Hermaphroditic Asian Seabass, Lates calcarifer	PLOS ONE			English	Article							EARLY LIFE-HISTORY; INBREEDING AVOIDANCE; POPULATION-STRUCTURE; GENETIC-STRUCTURE; NATAL DISPERSAL; BARRAMUNDI; BLOCH; EVOLUTION; DIFFERENTIATION; MIGRATION	Movement of individuals influences individual reproductive success, fitness, genetic diversity and relationships among individuals within populations and gene exchange among populations. Competition between males or females for mating opportunities and/or local resources predicts a female bias in taxa with monogamous mating systems and a male-biased dispersal in polygynous species. In birds and mammals, the patterns of dispersal between sexes are well explored, while dispersal patterns in protandrous hermaphroditic fish species have not been studied. We collected 549 adult individuals of Asian seabass (Lates calcarifer) from four locations in the South China Sea. To assess the difference in patterns of dispersal between sexes, we genotyped all individuals with 18 microsatellites. Significant genetic differentiation was detected among and within sampling locations. The parameters of population structure (F-ST), relatedness (r) and the mean assignment index (mAIC), in combination with data on tagging-recapture, supplied strong evidences for female-biased dispersal in the Asian seabass. This result contradicts our initial hypothesis of no sex difference in dispersal. We suggest that inbreeding avoidance of females, female mate choice under the condition of low mate competition among males, and male resource competition create a female-biased dispersal. The bigger body size of females may be a cause of the female-biased movement. Studies of dispersal using data from DNA markers and tagging-recapture in hermaphroditic fish species could enhance our understanding of patterns of dispersal in fish.	[Yue, Gen Hua; Xia, Jun Hong; Liu, Feng; Lin, Grace] Natl Univ Singapore, Mol Populat Genet Grp, Temasek Life Sci Lab, Singapore 117548, Singapore	National University of Singapore	Yue, GH (corresponding author), Natl Univ Singapore, Mol Populat Genet Grp, Temasek Life Sci Lab, Singapore 117548, Singapore.	genhua@tll.org.sg	Yue, GH/F-4801-2015	Yue, GH/0000-0002-3537-2248	National Research Foundation of Singapore	National Research Foundation of Singapore(National Research Foundation, Singapore)	This research is funded by the National Research Foundation of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews AH, 1999, CAN J FISH AQUAT SCI, V56, P1339, DOI 10.1139/cjfas-56-8-1339; Austin JD, 2003, MOL ECOL, V12, P3165, DOI 10.1046/j.1365-294X.2003.01948.x; Avise JC, 2009, SEX DEV, V3, P152, DOI 10.1159/000223079; Avise J.C., 2004, MOL MARKERS NATURAL; Berg EC, 2009, MOL ECOL, V18, P3486, DOI 10.1111/j.1365-294X.2009.04284.x; Bird C, 1992, TRIAL BARRAMUNDI TRA; Blaber SJM, 2009, DEV EARTH ENV SCI, V9, P411, DOI 10.1016/S1571-9197(08)00411-4; Cano JM, 2008, MOL ECOL, V17, P3234, DOI 10.1111/j.1365-294X.2008.03837.x; CHARNOV E L, 1982; Chenoweth SF, 1998, HEREDITY, V80, P187, DOI 10.1046/j.1365-2540.1998.00292.x; Chopelet J, 2009, FISH FISH, V10, P329, DOI 10.1111/j.1467-2979.2009.00329.x; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; Costello CM, 2008, MOL ECOL, V17, P4713, DOI 10.1111/j.1365-294X.2008.03930.x; Croft DP, 2003, OECOLOGIA, V137, P62, DOI 10.1007/s00442-003-1268-6; DAVIS TLO, 1986, FISH RES, V4, P243, DOI 10.1016/0165-7836(86)90006-8; DAVIS TLO, 1982, AUST J MAR FRESH RES, V33, P529; De Meester N, 2010, BEHAV ECOL, V21, P992, DOI 10.1093/beheco/arq088; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127, DOI 10.1098/rspb.1997.0019; Fishbase, 2011, FISHBASE GLOB INF SY; GARCIA LMB, 1992, J FISH BIOL, V40, P359, DOI 10.1111/j.1095-8649.1992.tb02583.x; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hutchings JA, 2002, P ROY SOC B-BIOL SCI, V269, P2487, DOI 10.1098/rspb.2002.2176; Itaya K, 2006, HOKKAIDO FISHERIES S, V70, P89; Ito M, 2008, MARINE FISHERIES STO, P774; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Johns R, 2010, OECOLOGIA, V163, P935, DOI 10.1007/s00442-010-1632-2; JOHNSON ML, 1990, ANNU REV ECOL SYST, V21, P449, DOI 10.1146/annurev.ecolsys.21.1.449; JONSSON B, 1993, REV FISH BIOL FISHER, V3, P348, DOI 10.1007/BF00043384; KEENAN CP, 1994, AUST J MAR FRESH RES, V45, P1123, DOI 10.1071/MF9941123; KLIMLEY AP, 1987, ENVIRON BIOL FISH, V18, P27, DOI 10.1007/BF00002325; Knight ME, 1999, MOL ECOL, V8, P1521, DOI 10.1046/j.1365-294x.1999.00740.x; Koizumi I, 2006, J FISH BIOL, V68, P1513, DOI 10.1111/j.0022-1112.2006.001038.x; Lebigre C, 2010, MOL ECOL, V19, P1929, DOI 10.1111/j.1365-294X.2010.04614.x; Lewis P, 2000, GENETIC DATA ANAL GD; Long ES, 2008, BEHAV ECOL, V19, P1235, DOI 10.1093/beheco/arn082; Mank JE, 2009, SEX DEV, V3, P60, DOI 10.1159/000223071; Mc Dougall A, 2004, FISH RES, V67, P129, DOI 10.1016/j.fishres.2003.09.044; McCulloch M, 2005, MAR FRESHWATER RES, V56, P637, DOI 10.1071/MF04184; Milton DA, 2005, MAR ECOL PROG SER, V301, P279, DOI 10.3354/meps301279; MOORE R, 1982, AUST J MAR FRESH RES, V33, P647; MOORE R, 1979, AUST J MAR FRESH RES, V30, P803, DOI 10.1071/MF9790803; MOORE R, 1982, AUST J MAR FRESH RES, V33, P671, DOI 10.1071/MF9820671; Morita SH, 2012, ENVIRON BIOL FISH, V94, P505, DOI 10.1007/s10641-010-9613-1; Perrin N, 1999, AM NAT, V154, P282, DOI 10.1086/303236; Perrin N, 2000, AM NAT, V155, P116, DOI 10.1086/303296; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, STRUCTURE 2 3 3; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Randall DA, 2007, BEHAV ECOL, V18, P579, DOI 10.1093/beheco/arm010; Roff Derek, 2002, pi; ROSS RM, 1990, ENVIRON BIOL FISH, V29, P81, DOI 10.1007/BF00005025; RUSSELL DJ, 1988, AUST J MAR FRESH RES, V39, P117; RUSSELL DJ, 1985, AUST J MAR FRESH RES, V36, P191, DOI 10.1071/MF9850191; SALINI J, 1988, AUST J MAR FRESH RES, V39, P317, DOI 10.1071/MF9880317; SHAKLEE JB, 1993, T AM FISH SOC, V122, P685, DOI 10.1577/1548-8659(1993)122&lt;0685:ECOMGS&gt;2.3.CO;2; SHAPIRO DY, 1987, BIOSCIENCE, V37, P490, DOI 10.2307/1310421; Stiver KA, 2007, MOL ECOL, V16, P2974, DOI 10.1111/j.1365-294X.2007.03350.x; Tamate T, 2004, ECOL FRESHW FISH, V13, P96, DOI 10.1111/j.1600-0633.2004.00043.x; Ulrich Y, 2009, MOL ECOL, V18, P1791, DOI 10.1111/j.1365-294X.2009.04154.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Wang CM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-174; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; WARNER RR, 1988, ENVIRON BIOL FISH, V22, P81, DOI 10.1007/BF00001539; WAUTERS L, 1994, BEHAV ECOL SOCIOBIOL, V34, P197, DOI 10.1007/s002650050033; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Williams DA, 2007, ETHOLOGY, V113, P534, DOI 10.1111/j.1439-0310.2007.01353.x; Yue GH, 2005, ELECTROPHORESIS, V26, P3081, DOI 10.1002/elps.200410411; Yue GH, 2002, MAR BIOTECHNOL, V4, P503, DOI 10.1007/s10126-002-0037-6; Zhu ZY, 2010, ANIM GENET, V41, P208, DOI 10.1111/j.1365-2052.2009.01973.x	80	14	14	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e37976	10.1371/journal.pone.0037976	http://dx.doi.org/10.1371/journal.pone.0037976			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701591	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340000007
J	Svensson, L; Stanley, P; Willenbrock, F; Hogg, N				Svensson, Lena; Stanley, Paula; Willenbrock, Frances; Hogg, Nancy			The G alpha q/11 Proteins Contribute to T Lymphocyte Migration by Promoting Turnover of Integrin LFA-1 through Recycling	PLOS ONE			English	Article							PLASMA-MEMBRANE; RAP1-INDUCED ADHESION; ALPHA-SUBUNITS; UP-REGULATION; CELL; ACTIVATION; RAPL; STIMULATION; TRAFFICKING; NEUTROPHILS	The role of G alpha i proteins coupled to chemokine receptors in directed migration of immune cells is well understood. In this study we show that the separate class of G alpha q/11 proteins is required for the underlying ability of T cells to migrate both randomly and in a directed chemokine-dependent manner. Interfering with G alpha q or G alpha 11 using dominant negative cDNA constructs or siRNA for G alpha q causes accumulation of LFA-1 adhesions and stalled migration. G alpha q/11 has an impact on LFA-1 expression at plasma membrane level and also on its internalization. Additionally G alpha q co-localizes with LFA-1- and EEA1-expressing intracellular vesicles and partially with Rap1- but not Rab11-expressing vesicles. However the influence of G alpha q is not confined to the vesicles that express it, as its reduction alters intracellular trafficking of other vesicles involved in recycling. In summary vesicle-associated G alpha q/11 is required for the turnover of LFA-1 adhesion that is necessary for migration. These G proteins participate directly in the initial phase of recycling and this has an impact on later stages of the endo-exocytic pathway.	[Svensson, Lena; Stanley, Paula; Willenbrock, Frances; Hogg, Nancy] Canc Res UK London Res Inst, Leukocyte Adhes Lab, London, England	Cancer Research UK	Svensson, L (corresponding author), Lund Univ, Immunol Sect, Dept Expt Med Sci, Lund, Sweden.	nancy.hogg@cancer.org.uk			Cancer Research UK; EC Marie Curie Fellowship; Career Re-entry Fellowship from the Wellcome Trust	Cancer Research UK(Cancer Research UK); EC Marie Curie Fellowship(European CommissionEuropean Commission Joint Research Centre); Career Re-entry Fellowship from the Wellcome Trust	This work was supported by Cancer Research UK; LS was partially supported by an individual EC Marie Curie Fellowship; FW was supported by a Career Re-entry Fellowship from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon R, 2010, CELL ADHES MIGR, V4, P211, DOI 10.4161/cam.4.2.11133; Bivona TG, 2004, J CELL BIOL, V164, P461, DOI 10.1083/jcb.200311093; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; DRANSFIELD I, 1989, EMBO J, V8, P3759, DOI 10.1002/j.1460-2075.1989.tb08552.x; Ebisuno Y, 2010, BLOOD, V115, P804, DOI 10.1182/blood-2009-03-211979; Evans R, 2011, BLOOD, V117, P3331, DOI 10.1182/blood-2010-06-289140; Fabbri M, 2005, MOL BIOL CELL, V16, P5793, DOI 10.1091/mbc.E05-05-0413; Fabbri M, 1999, EMBO J, V18, P4915, DOI 10.1093/emboj/18.18.4915; Herroeder S, 2009, IMMUNITY, V30, P708, DOI 10.1016/j.immuni.2009.02.010; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Hwang IY, 2007, J IMMUNOL, V179, P439, DOI 10.4049/jimmunol.179.1.439; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kumar A, 2011, J IMMUNOL, V186, P951, DOI 10.4049/jimmunol.1002019; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; Mellado M, 2001, ANNU REV IMMUNOL, V19, P397, DOI 10.1146/annurev.immunol.19.1.397; Mor A, 2009, MOL CELL BIOL, V29, P3297, DOI 10.1128/MCB.00366-09; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Ngai J, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-27; Pierini LM, 2000, BLOOD, V95, P2471; Raab M, 2010, IMMUNITY, V32, P541, DOI 10.1016/j.immuni.2010.03.007; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; Shi GX, 2007, J EXP MED, V204, P2705, DOI 10.1084/jem.20071267; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Soede RDM, 2001, J IMMUNOL, V166, P4293, DOI 10.4049/jimmunol.166.7.4293; Soede RDM, 2000, BLOOD, V96, P691; Stanley P, 2008, EMBO J, V27, P62, DOI 10.1038/sj.emboj.7601959; Svensson L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015090; Tohyama Y, 2003, MOL BIOL CELL, V14, P2570, DOI 10.1091/mbc.E02-09-0615; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; WINITZ S, 1994, J BIOL CHEM, V269, P1889; WRIGHT DD, 1994, MOL CELL BIOL, V14, P2429, DOI 10.1128/MCB.14.4.2429; Yu B, 2000, J BIOL CHEM, V275, P71, DOI 10.1074/jbc.275.1.71; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	38	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38517	10.1371/journal.pone.0038517	http://dx.doi.org/10.1371/journal.pone.0038517			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701657	Green Submitted, gold, Green Published			2022-12-25	WOS:000305337600028
J	Tanic, M; Yanowsky, K; Rodriguez-Antona, C; Andres, R; Marquez-Rodas, I; Osorio, A; Benitez, J; Martinez-Delgado, B				Tanic, Miljana; Yanowsky, Kira; Rodriguez-Antona, Cristina; Andres, Raquel; Marquez-Rodas, Ivan; Osorio, Ana; Benitez, Javier; Martinez-Delgado, Beatriz			Deregulated miRNAs in Hereditary Breast Cancer Revealed a Role for miR-30c in Regulating KRAS Oncogene	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAY; MALIGNANT-TRANSFORMATION; RAS ACTIVATION; GENE; TUMORS; RESISTANCE; MICRORNAS; GROWTH	Aberrant miRNA expression has been previously established in breast cancer and has clinical relevance. However, no studies so far have defined miRNAs deregulated in hereditary breast tumors. In this study we investigated the role of miRNAs in hereditary breast tumors comparing with normal breast tissue. Global miRNA expression profiling using Exiqon microarrays was performed on 22 hereditary breast tumors and 15 non-tumoral breast tissues. We identified 19 miRNAs differentially expressed, most of them down-regulated in tumors. An important proportion of deregulated miRNAs in hereditary tumors were previously identified commonly deregulated in sporadic breast tumors. Under-expression of these miRNAs was validated by qRT-PCR in additional 18 sporadic breast tumors and their normal breast tissue counterparts. Pathway enrichment analysis revealed that deregulated miRNAs collectively targeted a number of genes belonging to signaling pathways such as MAPK, ErbB, mTOR, and those regulating cell motility or adhesion. In silico prediction detected KRAS oncogene as target of several deregulated miRNAs. In particular, we experimentally validated KRAS as a miR-30c target. Luciferase assays confirmed that miR-30c binds the 39UTR of KRAS transcripts and expression of pre-miR-30c down-regulated KRAS mRNA and protein. Furthermore, miR-30c overexpression inhibited proliferation of breast cancer cells. Our results identify miRNAs associated to hereditary breast cancer, as well as miRNAs commonly miss-expressed in hereditary and sporadic tumors, suggesting common underlying mechanisms of tumor progression. In addition, we provide evidence that KRAS is a target of miR-30c, and that this miRNA suppresses breast cancer cell growth potentially through inhibition of KRAS signaling.	[Tanic, Miljana; Yanowsky, Kira; Osorio, Ana; Benitez, Javier; Martinez-Delgado, Beatriz] Spanish Natl Canc Res Ctr CNIO, Human Genet Grp, Madrid, Spain; [Yanowsky, Kira; Osorio, Ana; Benitez, Javier; Martinez-Delgado, Beatriz] CIBERER, Madrid, Spain; [Rodriguez-Antona, Cristina] CNIO, Hereditary Endocrine Canc Grp, Madrid, Spain; [Andres, Raquel] Univ Lozano Blesa, Hosp Clin, Med Oncol Serv, Zaragoza, Spain; [Marquez-Rodas, Ivan] Hosp Gregorio Maranon, Med Oncol Serv, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Centro Nacional de Investigaciones Oncologicas (CNIO); Lozano Blesa University Clinical Hospital; General University Gregorio Maranon Hospital	Tanic, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, Human Genet Grp, Madrid, Spain.	bmartinez@cnio.es	Tanic, Miljana/M-6650-2019; Tanic, Miljana/A-5458-2014; Osorio, Ana/I-4324-2014; Martinez-Delgado, Beatriz/B-6833-2013; Rodriguez-Antona, Cristina/E-1073-2011; Marquez-Rodas, Ivan/ABD-5532-2021	Tanic, Miljana/0000-0003-3102-776X; Tanic, Miljana/0000-0003-3102-776X; Osorio, Ana/0000-0001-8124-3984; Martinez-Delgado, Beatriz/0000-0001-6834-350X; Rodriguez-Antona, Cristina/0000-0001-8750-7338; Marquez-Rodas, Ivan/0000-0002-2476-668X	Asociacion Espanola contra el cancer (AECC); Fundacion La Caixa	Asociacion Espanola contra el cancer (AECC); Fundacion La Caixa(La Caixa Foundation)	This study was supported by grants from the Asociacion Espanola contra el cancer (AECC). MT has financial support from Fundacion La Caixa. The CIBER de Enfermedades Raras is an initiative of the ISCIII, Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNANTIS NJ, 1994, ANTICANCER RES, V14, P2135; Atanaskova N, 2002, ONCOGENE, V21, P4000, DOI 10.1038/sj.onc.1205506; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Bradbury AR, 2007, REV ENDOCR METAB DIS, V8, P255, DOI 10.1007/s11154-007-9038-0; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; CLARK GJ, 1995, BREAST CANCER RES TR, V35, P133, DOI 10.1007/BF00694753; Dunn KL, 2005, BIOCHEM CELL BIOL, V83, P1, DOI 10.1139/O04-121; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Haagenson KK, 2010, CANCER METAST REV, V29, P143, DOI 10.1007/s10555-010-9208-5; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; KOFFA M, 1994, INT J ONCOL, V4, P573; Lee CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007314; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Lo HW, 2006, BREAST CANCER RES TR, V95, P211, DOI 10.1007/s10549-005-9011-0; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Morrissey ER, 2009, NUCLEIC ACIDS RES, V37, pW581, DOI 10.1093/nar/gkp366; Palacios J, 2008, PATHOBIOLOGY, V75, P85, DOI 10.1159/000123846; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rodriguez-Gonzalez FG, 2011, BREAST CANCER RES TR, V127, P43, DOI 10.1007/s10549-010-0940-x; Salh B, 1999, ANTICANCER RES, V19, P731; SPANDIDOS DA, 1987, ANTICANCER RES, V7, P991; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; von Lintig FC, 2000, BREAST CANCER RES TR, V62, P51, DOI 10.1023/A:1006491619920; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167; Yu SN, 2010, CANCER RES, V70, P6015, DOI 10.1158/0008-5472.CAN-09-4531; Zajac M, 2008, MOL CANCER THER, V7, P2358, DOI 10.1158/1535-7163.MCT-08-0327	37	70	75	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38847	10.1371/journal.pone.0038847	http://dx.doi.org/10.1371/journal.pone.0038847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701724	Green Submitted, gold, Green Published			2022-12-25	WOS:000305337600051
J	Waduthantri, S; Yong, SS; Tan, CH; Shen, L; Lee, MX; Nagarajan, S; Hla, MH; Tong, L				Waduthantri, Samanthila; Yong, Siew Sian; Tan, Chien Hua; Shen, Liang; Lee, Man Xin; Nagarajan, Sangeetha; Hla, Mynt Htoon; Tong, Louis			Cost of Dry Eye Treatment in an Asian Clinic Setting	PLOS ONE			English	Article							POPULATION; SYMPTOMS; EFFICACY; IMPACT	Objectives: To estimate the cost and patterns of expenditure of dry eye treatment. Methodology: We retrieved data on the type and cost of dry eye treatment in Singapore National Eye Centre from pharmacy and clinic inventory databases over a 2 year period (2008-2009) retrospectively. According to the type of treatment, data were sorted into 7 groups; meibomien gland disease (MGD) treatment, preservative free lubricant eye drops, preserved lubricant eye drops, lubricant ointments and gels, cyclosporine eye drops, oral supplements and non-pharmacological treatments/procedures. Each recorded entry was considered as one patient episode (PE). Comparisons in each group between two years were carried out using Pearson Chi-Square test. Significance level was set at alpha = 0.05. Results: Cost data from 54,052 patients were available for analysis. Total number of recorded PEs was 132,758. Total annual expenditure on dry eye treatment for year 2008 and 2009 were US$1,509,372.20 and US$1,520,797.80 respectively. Total expenditure per PE in year 2008 and 2009 were US$22.11 and US$23.59 respectively. From 2008 to 2009, there was a 0.8% increase in total annual expenditure and 6.69% increase in expenditure per PE. Pharmacological treatment attributes to 99.2% of the total expenditure with lubricants accounting for 79.3% of the total pharmacological treatment expenditure. Total number of units purchased in preservative free lubricants, cyclosporine eye drops and MGD therapy have increased significantly (p < 0.001) whereas number of units purchased in preserved lubricants and ointments/gels have reduced significantly (p < 0.001) from 2008 to 2009. Conclusion: Dry Eye imposes a significant direct burden to health care expenditure even without considering indirect costs. Health care planners should be aware that these direct costs appear to increase over the time and more so for particular types of medications. Given the limitations of socio-economic data, true societal costs of Dry eye syndrome are likely to be much higher than estimated.	[Waduthantri, Samanthila; Yong, Siew Sian; Tan, Chien Hua; Lee, Man Xin; Nagarajan, Sangeetha; Hla, Mynt Htoon; Tong, Louis] Singapore Eye Res Inst, Singapore, Singapore; [Waduthantri, Samanthila; Tong, Louis] Singapore Natl Eye Ctr, Singapore, Singapore; [Shen, Liang] Natl Univ Singapore, Singapore 117548, Singapore; [Tong, Louis] Duke NUS Grad Med Sch, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; National University of Singapore	Waduthantri, S (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.	samanthila@hotmail.com		Tong, Louis/0000-0002-3986-6552	National Medical Research Council (NMRC) [NMRC/1206/2009, NMRC/0808/2003, NMRC/CPG/002/2003, NMRC/0982/2005]	National Medical Research Council (NMRC)(National Medical Research Council, Singapore)	This work received grant support NMRC/1206/2009, NMRC/0808/2003, NMRC/CPG/002/2003, NMRC/0982/2005 and NMRC/1206/2009 from National Medical Research Council (NMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASBELL PA, 2007, DRY EYE DIS CLIN GUI; Balaram M, 2001, AM J OPHTHALMOL, V131, P30, DOI 10.1016/S0002-9394(00)00620-6; Brown MM, 2009, ARCH OPHTHALMOL-CHIC, V127, P146, DOI 10.1001/archophthalmol.2008.608; Clegg JP, 2006, OPHTHAL EPIDEMIOL, V13, P263, DOI 10.1080/09286580600801044; Ellwein LB, 2002, ARCH OPHTHALMOL-CHIC, V120, P804; Hirsch JD, 2007, SURV OPHTHALMOL, V52, P618, DOI 10.1016/j.survophthal.2007.08.017; Hirsch Jan D, 2003, Manag Care, V12, P33; Kozma CM, 2000, INVEST OPHTH VIS SCI, V41, pS928; Lemp Michael A, 2008, Am J Manag Care, V14, pS88; Pflugfelder Stephen C, 2008, Am J Manag Care, V14, pS102; Rand AL, 2011, CURR OPIN OPHTHALMOL, V22, P279, DOI 10.1097/ICU.0b013e3283477d23; Reddy P, 2004, CORNEA, V23, P751, DOI 10.1097/01.ico.0000134183.47687.75; Shimmura S, 1999, CORNEA, V18, P408, DOI 10.1097/00003226-199907000-00003; Smeeding JE, 2001, VALUE HEALTH, V4, P117; Tai MC, 2002, CORNEA, V21, P135, DOI 10.1097/00003226-200203000-00001; Tong L, 2010, EYE, V24, P1486, DOI 10.1038/eye.2010.67; Yu JH, 2011, CORNEA, V30, P379, DOI 10.1097/ICO.0b013e3181f7f363	17	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e37711	10.1371/journal.pone.0037711	http://dx.doi.org/10.1371/journal.pone.0037711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701577	Green Published, gold, Green Submitted			2022-12-25	WOS:000305337600010
J	Young, AMH; Campbell, EC; Lynch, S; Dunn, MH; Powis, SJ; Suckling, J				Young, Adam M. H.; Campbell, Elaine C.; Lynch, Sarah; Dunn, Malcolm H.; Powis, Simon J.; Suckling, John			Regional Susceptibility to TNF-alpha Induction of Murine Brain Inflammation via Classical IKK/NF-kappa B Signalling	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; IN-VITRO; AUTISM; ACTIVATION; MICROGLIA; PATHWAY; MOUSE	It is becoming clear that inflammation plays a significant role in a number of neurological and psychiatric conditions. Post mortem brain samples in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, schizophrenia and most recently autism spectrum condition, all exhibit neuroglial activation and inflammatory markers within the CSF. Many questions remain about the underlying molecular mechanisms. By adding the pro-inflammatory cytokine, TNF-alpha, to mouse brain tissue we demonstrated that the frontal lobes and temporal region, areas involved in higher functions such as memory and learning, are most susceptible to cytokine-induced inflammation via the NF-kappa B signalling pathway. We observed direct correlations between the volumetric increase and molecular expression indicating that therapeutic targets in these lobes may require different approaches when treating conditions with a central neuroinflammatory component.	[Young, Adam M. H.; Campbell, Elaine C.; Lynch, Sarah; Powis, Simon J.] Univ St Andrews, Sch Med, St Andrews KY16 9AJ, Fife, Scotland; [Young, Adam M. H.; Suckling, John] Univ Cambridge, Sch Clin Med, Cambridge, England; [Dunn, Malcolm H.] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9AJ, Fife, Scotland; [Suckling, John] Univ Cambridge, Dept Psychiat, Cambridge, England	University of St Andrews; University of Cambridge; University of St Andrews; University of Cambridge	Young, AMH (corresponding author), Univ St Andrews, Sch Med, St Andrews KY16 9AJ, Fife, Scotland.	js369@cam.ac.uk	Suckling, John/ABD-7246-2021	Suckling, John/0000-0002-5098-1527; Powis, Simon/0000-0003-4218-2984; Williams, Sarah/0000-0003-1574-3328	University of St Andrews & Archimedes Pharmaceuticals	University of St Andrews & Archimedes Pharmaceuticals	This study received financial support from the University of St Andrews & Archimedes Pharmaceuticals (www.archimedespharma.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA H, 1994, TOHOKU J EXP MED, V174, P295, DOI 10.1620/tjem.174.295; Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Cruz-Machado SD, 2010, J PINEAL RES, V49, P183, DOI 10.1111/j.1600-079X.2010.00785.x; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hagihara Hideo, 2009, J Vis Exp, DOI 10.3791/1543; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Herbert MR, 2008, ALTERN THER HEALTH M, V14, P28; Hollander E, 2009, PSYCHIAT RES, V170, P43, DOI 10.1016/j.psychres.2008.07.014; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Konradi C, 2012, NEUROBIOL DIS, V45, P37, DOI 10.1016/j.nbd.2011.01.025; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Meyer U, 2011, PEDIATR RES, V69, p26R, DOI 10.1203/PDR.0b013e318212c196; Oldreive CE, 2010, J MOL NEUROSCI, V42, P44, DOI 10.1007/s12031-010-9370-9; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pardo CA, 2006, INT REV PSYCHIATR, V17, P485, DOI 10.1080/02646830500381930; Perkins ND, 2004, TRENDS CELL BIOL, V14, P64, DOI 10.1016/j.tcb.2003.12.004; SCHMIDT EL, 1965, APPL MICROBIOL, V13, P673, DOI 10.1128/AEM.13.5.673-679.1965; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Terada T, 2011, J NEUROL SCI, V309, P136, DOI 10.1016/j.jns.2011.06.049; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Viel TA, 2011, CURR ALZHEIMER RES, V8, P59; Widera D, 2006, EUR CELLS MATER, V11, P76, DOI 10.22203/eCM.v011a08; WING L, 1979, J AUTISM DEV DISORD, V9, P11, DOI 10.1007/BF01531288; Young Adam M H, 2011, Front Psychiatry, V2, P27, DOI 10.3389/fpsyt.2011.00027; Zilbovicius M, 2000, AM J PSYCHIAT, V157, P1988, DOI 10.1176/appi.ajp.157.12.1988; Zimmerman AW, 2005, PEDIATR NEUROL, V33, P195, DOI 10.1016/j.pediatrneurol.2005.03.014; Zindler E, 2010, BEST PRACT RES-CLIN, V24, P551, DOI 10.1016/j.bpa.2010.11.001	32	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e39049	10.1371/journal.pone.0039049	http://dx.doi.org/10.1371/journal.pone.0039049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701747	Green Accepted, gold, Green Published			2022-12-25	WOS:000305337600067
J	Sidhaye, VK; Chau, E; Srivastava, V; Sirimalle, S; Balabhadrapatruni, C; Aggarwal, NR; D'Alessio, FR; Robinson, DN; King, LS				Sidhaye, Venkataramana K.; Chau, Eric; Srivastava, Vasudha; Sirimalle, Srinivas; Balabhadrapatruni, Chinmayee; Aggarwal, Neil R.; D'Alessio, Franco R.; Robinson, Douglas N.; King, Landon S.			A Novel Role for Aquaporin-5 in Enhancing Microtubule Organization and Stability	PLOS ONE			English	Article							EPITHELIAL BARRIER FUNCTION; CELL-MIGRATION; WATER PERMEABILITY; EXPRESSION; AQP5; INVOLVEMENT; TUBULIN; PROTEIN; MICE; PROLIFERATION	Aquaporin-5 (AQP5) is a water-specific channel located on the apical surface of airway epithelial cells. In addition to regulating transcellular water permeability, AQP5 can regulate paracellular permeability, though the mechanisms by which this occurs have not been determined. Microtubules also regulate paracellular permeability. Here, we report that AQP5 promotes microtubule assembly and helps maintain the assembled microtubule steady state levels with slower turnover dynamics in cells. Specifically, reduced levels of AQP5 correlated with lower levels of assembled microtubules and decreased paracellular permeability. In contrast, overexpression of AQP5 increased assembly of microtubules, with evidence of increased MT stability, and promoted the formation of long straight microtubules in the apical domain of the epithelial cells. These findings indicate that AQP5-mediated regulation of microtubule dynamics modulates airway epithelial barrier properties and epithelial function.	[Sidhaye, Venkataramana K.; Chau, Eric; Sirimalle, Srinivas; Balabhadrapatruni, Chinmayee; Aggarwal, Neil R.; D'Alessio, Franco R.; King, Landon S.] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA; [Srivastava, Vasudha; Robinson, Douglas N.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD USA; [King, Landon S.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Sidhaye, VK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA.	vsidhay1@jhmi.edu	Sidhaye, Venkataramana/AAC-3930-2019	Sidhaye, Venkataramana/0000-0002-4506-8549; , Neil/0000-0002-0922-8824; Srivastava, Vasudha/0000-0001-8845-9518; Robinson, Douglas/0000-0003-1236-4891	FAMRI (Flight Attendants Medical Research Institute); Johns Hopkins Bayview Scholars Program; NIH [GM66817];  [K08HL085763]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL085763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066817] Funding Source: NIH RePORTER	FAMRI (Flight Attendants Medical Research Institute); Johns Hopkins Bayview Scholars Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the FAMRI (Flight Attendants Medical Research Institute) (FAMRI Young Investigator Award) Young Investigator Award and K08HL085763 (VKS), the Johns Hopkins Bayview Scholars Program (LSK), and an NIH grant GM66817 (DNR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belmadani S, 2004, MOL CELL BIOCHEM, V258, P35, DOI 10.1023/B:MCBI.0000012834.43990.b6; Birukova AA, 2005, J CELL PHYSIOL, V204, P934, DOI 10.1002/jcp.20359; Birukova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL75, DOI 10.1152/ajplung.00447.2004; BLACK MM, 1984, BRAIN RES, V295, P255, DOI 10.1016/0006-8993(84)90974-0; Blagosklonny MV, 2002, MOL CANCER THER, V1, P937; Chae YK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002162; Chae YK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002594; Dobbs LG, 1998, P NATL ACAD SCI USA, V95, P2991, DOI 10.1073/pnas.95.6.2991; GUMBINER B, 1987, AM J PHYSIOL, V253, pC749, DOI 10.1152/ajpcell.1987.253.6.C749; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; Herrlich A, 2004, P NATL ACAD SCI USA, V101, P15799, DOI 10.1073/pnas.0406853101; Hoffert JD, 2000, J BIOL CHEM, V275, P9070, DOI 10.1074/jbc.275.12.9070; Horsefield R, 2008, P NATL ACAD SCI USA, V105, P13327, DOI 10.1073/pnas.0801466105; Hwang SM, 2002, EXP MOL MED, V34, P69, DOI 10.1038/emm.2002.10; Ivanov AI, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-12; Ivanov AI, 2010, AM J PATHOL, V177, P512, DOI 10.2353/ajpath.2010.100168; Jiao GY, 2002, CHINESE MED J-PEKING, V115, P963; Kannarkat GT, 2006, J HEPATOL, V44, P963, DOI 10.1016/j.jhep.2005.07.007; Kawedia JD, 2007, P NATL ACAD SCI USA, V104, P3621, DOI 10.1073/pnas.0608384104; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kozono D, 2002, J CLIN INVEST, V109, P1395, DOI 10.1172/JCI200215851; Krane CM, 2001, J BIOL CHEM, V276, P23413, DOI 10.1074/jbc.M008760200; Kumari SS, 2009, BIOCHEM BIOPH RES CO, V390, P1034, DOI 10.1016/j.bbrc.2009.10.103; Levin MH, 2006, INVEST OPHTH VIS SCI, V47, P4365, DOI 10.1167/iovs.06-0335; Liu JL, 2011, J CELL SCI, V124, P198, DOI 10.1242/jcs.072652; Liu XB, 2006, J BIOL CHEM, V281, P15485, DOI 10.1074/jbc.M600549200; Lorenowicz MJ, 2007, AM J PHYSIOL-LUNG C, V293, pL1321, DOI 10.1152/ajplung.00443.2006; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; Milewski MI, 2005, FEBS LETT, V579, P483, DOI 10.1016/j.febslet.2004.11.106; Nicchia GP, 2005, FASEB J, V19, P1674, DOI 10.1096/fj.04-3281fje; Ochoa CD, 2011, AM J PHYSIOL-LUNG C, V300, pL132, DOI 10.1152/ajplung.00185.2010; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Petrache I, 2003, AM J RESP CELL MOL, V28, P574, DOI 10.1165/rcmb.2002-0075OC; Poruchynsky MS, 2004, BIOCHEMISTRY-US, V43, P13944, DOI 10.1021/bi049300+; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Saadoun S, 2009, NEUROSCIENCE, V161, P764, DOI 10.1016/j.neuroscience.2009.03.069; Schneider A, 2011, GASTROENTEROLOGY, V140, P162, DOI 10.1053/j.gastro.2010.10.045; Shankardas J, 2010, MOL VIS, V16, P1538; Shen Y, 2010, RESP PHYSIOL NEUROBI, V171, P212, DOI 10.1016/j.resp.2010.03.021; Sidhaye V, 2005, J BIOL CHEM, V280, P3590, DOI 10.1074/jbc.M411038200; Sidhaye VK, 2008, P NATL ACAD SCI USA, V105, P3345, DOI 10.1073/pnas.0712287105; Sidhaye VK, 2011, AM J RESP CELL MOL, V45, P120, DOI 10.1165/rcmb.2010-0235OC; Sidhaye VK, 2006, P NATL ACAD SCI USA, V103, P4747, DOI 10.1073/pnas.0511211103; Sidhaye VK, 2011, AM J RESP CELL MOL B; Steinfeld S, 2001, LAB INVEST, V81, P143, DOI 10.1038/labinvest.3780221; TASHIRO T, 1991, J NEUROSCI RES, V30, P192, DOI 10.1002/jnr.490300120; Towne JE, 2001, J BIOL CHEM, V276, P18657, DOI 10.1074/jbc.M100322200; Varadaraj K, 2010, EXP EYE RES, V91, P393, DOI 10.1016/j.exer.2010.06.013; Wang Z, 2011, INVEST OPHTH VIS SCI, V52, P5079, DOI 10.1167/iovs.10-6998; Woo J, 2008, BIOCHEM BIOPH RES CO, V366, P321, DOI 10.1016/j.bbrc.2007.11.078; Yan Xia, 2007, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V19, P214; Yang F, 2003, J BIOL CHEM, V278, P32173, DOI 10.1074/jbc.M305149200; Yu XS, 2005, J BIOL CHEM, V280, P22081, DOI 10.1074/jbc.M414377200; Zhang H, 2008, J MOL BIOL, V382, P1136, DOI 10.1016/j.jmb.2008.07.089; Zhang ZQ, 2010, J PATHOL, V221, P210, DOI 10.1002/path.2702	60	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38717	10.1371/journal.pone.0038717	http://dx.doi.org/10.1371/journal.pone.0038717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715407	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336800049
J	Buchwald, ZS; Kiesel, JR; DiPaolo, R; Pagadala, MS; Aurora, R				Buchwald, Zachary S.; Kiesel, Jennifer R.; DiPaolo, Richard; Pagadala, Meghana S.; Aurora, Rajeev			Osteoclast Activated FoxP3(+) CD8(+) T-Cells Suppress Bone Resorption in vitro	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; HEMATOPOIETIC STEM-CELL; TGF-BETA; AUTOIMMUNE-DISEASE; OSTEOBLASTIC CELLS; RECEPTOR ACTIVATOR; INTERFERON-GAMMA; IMMUNE-RESPONSE; CD4(+) CD25(+); CUTTING EDGE	Background: Osteoclasts are the body's sole bone resorbing cells. Cytokines produced by pro-inflammatory effector T-cells (T-EFF) increase bone resorption by osteoclasts. Prolonged exposure to the T-EFF produced cytokines leads to bone erosion diseases such as osteoporosis and rheumatoid arthritis. The crosstalk between T-cells and osteoclasts has been termed osteoimmunology. We have previously shown that under non-inflammatory conditions, murine osteoclasts can recruit naive CD8 T-cells and activate these T-cells to induce CD25 and FoxP3 (Tc-REG). The activation of CD8 T-cells by osteoclasts also induced the cytokines IL-2, IL-6, IL-10 and IFN-gamma. Individually, these cytokines can activate or suppress osteoclast resorption. Principal Findings: To determine the net effect of Tc-REG on osteoclast activity we used a number of in vitro assays. We found that Tc-REG can potently and directly suppress bone resorption by osteoclasts. Tc-REG could suppress osteoclast differentiation and resorption by mature osteoclasts, but did not affect their survival. Additionally, we showed that Tc-REG suppress cytoskeletal reorganization in mature osteoclasts. Whereas induction of Tc-REG by osteoclasts is antigen-dependent, suppression of osteoclasts by Tc-REG does not require antigen or re-stimulation. We demonstrated that antibody blockade of IL-6, IL-10 or IFN-gamma relieved suppression. The suppression did not require direct contact between the Tc-REG and osteoclasts. Significance: We have determined that osteoclast-induced Tc-REG can suppress osteoclast activity, forming a negative feedback system. As the CD8 T-cells are activated in the absence of inflammatory signals, these observations suggest that this regulatory loop may play a role in regulating skeletal homeostasis. Our results provide the first documentation of suppression of osteoclast activity by CD8 regulatory T-cells and thus, extend the purview of osteoimmunology.	[Buchwald, Zachary S.; Kiesel, Jennifer R.; DiPaolo, Richard; Pagadala, Meghana S.; Aurora, Rajeev] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA	Saint Louis University	Buchwald, ZS (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA.	aurorar@slu.edu		Aurora, Rajeev/0000-0002-6609-6055	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235] Funding Source: NIH RePORTER; NIAMS NIH HHS [P30 AR057235] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aandahl EM, 2008, HUM IMMUNOL, V69, P696, DOI 10.1016/j.humimm.2008.08.291; Ablamunits V, 2008, HUM IMMUNOL, V69, P732, DOI 10.1016/j.humimm.2008.08.290; Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Allez M, 2002, GASTROENTEROLOGY, V123, P1516, DOI 10.1053/gast.2002.36588; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Arai F, 2005, INT J HEMATOL, V82, P371, DOI 10.1532/IJH97.05100; Arron JR, 2000, NATURE, V408, P535, DOI 10.1038/35046196; Asseman C, 2003, J IMMUNOL, V171, P971, DOI 10.4049/jimmunol.171.2.971; Axmann R, 2008, ANN RHEUM DIS, V67, P1603, DOI 10.1136/ard.2007.080713; Badillo AT, 2006, STEM CELL REV, V2, P241, DOI 10.1007/s12015-006-0052-5; Banham AH, 2006, EUR J IMMUNOL, V36, P2832, DOI 10.1002/eji.200636459; Bonewald LF, 1997, ENDOCRINOLOGY, V138, P657, DOI 10.1210/en.138.2.657; Brimnes J, 2005, J IMMUNOL, V174, P5814, DOI 10.4049/jimmunol.174.9.5814; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Caetano-Lopes J, 2009, AUTOIMMUN REV, V8, P250, DOI 10.1016/j.autrev.2008.07.038; CENTRELLA M, 1989, CONNECT TISSUE RES, V20, P267, DOI 10.3109/03008208909023896; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cheung J, 2003, J ENDOCRINOL, V177, P423, DOI 10.1677/joe.0.1770423; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Colovai AI, 2003, HUM IMMUNOL, V64, P31, DOI 10.1016/S0198-8859(02)00742-5; Correale J, 2010, ANN NEUROL, V67, P625, DOI 10.1002/ana.21944; Corthay A, 2009, SCAND J IMMUNOL, V70, P326, DOI 10.1111/j.1365-3083.2009.02308.x; Dallas SL, 2002, J BIOL CHEM, V277, P21352, DOI 10.1074/jbc.M111663200; DASCH JR, 1989, J IMMUNOL, V142, P1536; David JP, 2007, ADV IMMUNOL, V95, P149, DOI 10.1016/S0065-2776(07)95005-1; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Filgueira L, 2004, J HISTOCHEM CYTOCHEM, V52, P411, DOI 10.1177/002215540405200312; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fox SW, 2000, BIOCHEM BIOPH RES CO, V276, P868, DOI 10.1006/bbrc.2000.3577; Fuller K, 2000, J CELL SCI, V113, P2445; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Haylock DN, 2005, CELL CYCLE, V4, P1353, DOI 10.4161/cc.4.10.2056; Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang X, 2011, J DENT RES, V90, P981, DOI 10.1177/0022034511408613; Huter EN, 2008, EUR J IMMUNOL, V38, P1814, DOI 10.1002/eji.200838346; Jiang H, 2008, HUM IMMUNOL, V69, P721, DOI 10.1016/j.humimm.2008.08.279; Kared H, 2006, IMMUNITY, V25, P823, DOI 10.1016/j.immuni.2006.09.008; Kezuka T, 2000, INVEST OPHTH VIS SCI, V41, P1803; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kiesel J, 2007, DEV DYNAM, V236, P2181, DOI 10.1002/dvdy.21206; Kiesel JR, 2009, J IMMUNOL, V182, P5477, DOI 10.4049/jimmunol.0803897; Kiniwa Y, 2007, CLIN CANCER RES, V13, P6947, DOI 10.1158/1078-0432.CCR-07-0842; Kohara H, 2011, IMMUNOL LETT, V137, P53, DOI 10.1016/j.imlet.2011.02.017; Kollet O, 2007, ANNU REV IMMUNOL, V25, P51, DOI 10.1146/annurev.immunol.25.022106.141631; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Konya C, 2009, EXPERT OPIN BIOL TH, V9, P951, DOI 10.1517/14712590903020759; Krause CD, 2000, J BIOL CHEM, V275, P22995, DOI 10.1074/jbc.M909607199; Li HY, 2010, BLOOD, V116, P210, DOI 10.1182/blood-2009-11-255026; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lorenzo J, 2005, IMMUNOL REV, V208, P5, DOI 10.1111/j.0105-2896.2005.00340.x; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; Martin TJ, 2008, BEST PRACT RES CL EN, V22, P701, DOI 10.1016/j.beem.2008.07.006; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Mayer CT, 2011, EUR J IMMUNOL, V41, P716, DOI 10.1002/eji.201040913; Meloni F, 2006, HUM IMMUNOL, V67, P1, DOI 10.1016/j.humimm.2005.11.005; Mossetti G, 2005, BONE, V36, P549, DOI 10.1016/j.bone.2004.11.004; Nagahama K, 2004, BONE, V35, P1059, DOI 10.1016/j.bone.2004.06.018; Niederkorn JY, 2008, CURR OPIN IMMUNOL, V20, P327, DOI 10.1016/j.coi.2008.02.003; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Novack DV, 2011, AGEING RES REV, V10, P54, DOI 10.1016/j.arr.2009.09.005; OURSLER MJ, 1994, J BONE MINER RES, V9, P443; Pacifici R, 2008, CELL IMMUNOL, V252, P68, DOI 10.1016/j.cellimm.2007.06.008; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Paterson AM, 2010, NAT IMMUNOL, V11, P109, DOI 10.1038/ni0210-109; Pillai MR, 2011, J IMMUNOL, V187, P4987, DOI 10.4049/jimmunol.1102173; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Sato Kojiro, 2008, Allergol Int, V57, P109, DOI 10.2332/allergolint.R-07-158; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Sharabi A, 2008, J IMMUNOL, V181, P3243, DOI 10.4049/jimmunol.181.5.3243; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; Singh RP, 2007, J IMMUNOL, V178, P7649, DOI 10.4049/jimmunol.178.12.7649; Soysa Niroshani Surangika, 2009, Journal of Medical and Dental Sciences, V56, P107; Stephens GL, 2007, J IMMUNOL, V178, P6901, DOI 10.4049/jimmunol.178.11.6901; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Suzuki M, 2008, HUM IMMUNOL, V69, P781, DOI 10.1016/j.humimm.2008.08.283; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Takami M, 1999, CELL TISSUE RES, V298, P327, DOI 10.1007/s004419900092; Takayanagi Hiroshi, 2005, Mod Rheumatol, V15, P225; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Takayanagi H, 2002, ARTHRITIS RES THER, V4, pS227, DOI 10.1186/ar581; Taubman MA, 2005, J PERIODONTOL, V76, P2033, DOI 10.1902/jop.2005.76.11-S.2033; Teng YTA, 2006, J DENT RES, V85, P209, DOI 10.1177/154405910608500302; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Tomimori Y, 2009, J BONE MINER RES, V24, P1194, DOI [10.1359/JBMR.090217, 10.1359/jbmr.090217]; Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015; Udagawa N, 1999, BONE, V25, P517, DOI 10.1016/S8756-3282(99)00210-0; van der Vliet HJJ, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/89017; VantHof RJ, 1997, J BONE MINER RES, V12, P1797, DOI 10.1359/jbmr.1997.12.11.1797; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Waschbisch A, 2010, J NEUROIMMUNOL, V225, P137, DOI 10.1016/j.jneuroim.2010.03.013; Zaiss MM, 2007, ARTHRITIS RHEUM, V56, P4104, DOI 10.1002/art.23138; Zhang HJ, 2011, AM J PHYSIOL-RENAL, V301, pF171, DOI 10.1152/ajprenal.00339.2010; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213	101	55	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38199	10.1371/journal.pone.0038199	http://dx.doi.org/10.1371/journal.pone.0038199			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701612	Green Published, Green Submitted, gold			2022-12-25	WOS:000305348400040
J	Rosa, R; Pimentel, MS; Boavida-Portugal, J; Teixeira, T; Trubenbach, K; Diniz, M				Rosa, Rui; Pimentel, Marta S.; Boavida-Portugal, Joana; Teixeira, Tatiana; Truebenbach, Katja; Diniz, Mario			Ocean Warming Enhances Malformations, Premature Hatching, Metabolic Suppression and Oxidative Stress in the Early Life Stages of a Keystone Squid	PLOS ONE			English	Article							THERMAL TOLERANCE; LOLIGO-VULGARIS; CLIMATE-CHANGE; EMBRYONIC-DEVELOPMENT; ELEVATED-TEMPERATURE; FOOD AVAILABILITY; MARINE; GROWTH; FISH; HISTORY	Background: The knowledge about the capacity of organisms' early life stages to adapt to elevated temperatures is very limited but crucial to understand how marine biota will respond to global warming. Here we provide a comprehensive and integrated view of biological responses to future warming during the early ontogeny of a keystone invertebrate, the squid Loligo vulgaris. Methodology/Principal Findings: Recently-spawned egg masses were collected and reared until hatching at present day and projected near future (+2 degrees C)temperatures, to investigate the ability of early stages to undergo thermal acclimation, namely phenotypic altering of morphological, behavioural, biochemical and physiological features. Our findings showed that under the projected near-future warming, the abiotic conditions inside the eggs promoted metabolic suppression, which was followed by premature hatching. Concomitantly, the less developed newborns showed greater incidence of malformations. After hatching, the metabolic burst associated with the transition from an encapsulated embryo to a planktonic stage increased linearly with temperature. However, the greater exposure to environmental stress by the hatchlings seemed to be compensated by physiological mechanisms that reduce the negative effects on fitness. Heat shock proteins (HSP70/HSC70) and antioxidant enzymes activities constituted an integrated stress response to ocean warming in hatchlings (but not in embryos). Conclusions/Significance: The stressful abiotic conditions inside eggs are expected to be aggravated under the projected near-future ocean warming, with deleterious effects on embryo survival and growth. Greater feeding challenges and the lower thermal tolerance limits of the hatchlings are strictly connected to high metabolic demands associated with the planktonic life strategy. Yet, we found some evidence that, in the future, the early stages might support higher energy demands by adjusting some cellular functional properties to increase their thermal tolerance windows.	[Rosa, Rui; Pimentel, Marta S.; Boavida-Portugal, Joana; Teixeira, Tatiana; Truebenbach, Katja] Univ Lisbon, Fac Ciencias, Lab Maritimo Guia, Ctr Oceanog, Cascais, Portugal; [Diniz, Mario] Univ Nova Lisboa, REQUIMTE, Dept Quim, Ctr Quim Fina & Biotecnol,Fac Ciencias & Tecnol, Caparica, Portugal	Universidade de Lisboa; Universidade Nova de Lisboa	Rosa, R (corresponding author), Univ Lisbon, Fac Ciencias, Lab Maritimo Guia, Ctr Oceanog, Cascais, Portugal.	rrosa@fc.ul.pt	Rosa, Rui/A-4580-2009; Pimentel, Marta S/H-3229-2014; Pimentel, Marta S./I-4844-2012; Diniz, Mário/C-7849-2013; REQUIMTE, C4O/M-5599-2013; Boavida-Portugal, Joana/I-4525-2012; Trubenbach, Katja/I-4841-2012	Rosa, Rui/0000-0003-2801-5178; Pimentel, Marta S/0000-0003-3248-4479; Diniz, Mário/0000-0003-1571-0366; Boavida-Portugal, Joana/0000-0001-5101-227X; Trubenbach, Katja/0000-0002-1824-608X	Portuguese Foundation for Science and Technology (FCT) [PTDC/BIA-BEC/103266/2008, PTDC/MAR/0908066/2008]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	The Portuguese Foundation for Science and Technology (FCT) supported this study through project grants PTDC/BIA-BEC/103266/2008 and PTDC/MAR/0908066/2008 to RR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartol IK, 2009, J EXP BIOL, V212, P1506, DOI 10.1242/jeb.026948; Boavida-Portugal J, 2010, FISH RES, V106, P193, DOI 10.1016/j.fishres.2010.06.002; Boyle P, 2005, CEPHALOPODS: ECOLOGY AND FISHERIES, P1, DOI 10.1002/9780470995310; Burt JM, 2011, REV FISH BIOL FISHER, V21, P377, DOI 10.1007/s11160-010-9179-1; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Cooper RU, 2002, J EXP MAR BIOL ECOL, V279, P1, DOI 10.1016/S0022-0981(02)00329-5; Cronin ER, 2000, MAR BIOL, V136, P863, DOI 10.1007/s002270000274; de Oliveira UO, 2005, COMP BIOCHEM PHYS B, V140, P51, DOI 10.1016/j.cbpc.2004.09.026; Donelson JM, 2010, MAR ECOL PROG SER, V401, P233, DOI 10.3354/meps08366; Donelson JM, 2011, GLOBAL CHANGE BIOL, V17, P1712, DOI 10.1111/j.1365-2486.2010.02339.x; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Grieshaber M K, 1994, Rev Physiol Biochem Pharmacol, V125, P43, DOI 10.1007/BFb0030909; Gutowska MA, 2009, MAR BIOL, V156, P515, DOI 10.1007/s00227-008-1096-7; Helmuth B, 2006, ANNU REV ECOL EVOL S, V37, P373, DOI 10.1146/annurev.ecolsys.37.091305.110149; Hu MY, 2011, AM J PHYSIOL-REG I, V301, pR1700, DOI 10.1152/ajpregu.00107.2011; Hu MY, 2010, CELL TISSUE RES, V339, P571, DOI 10.1007/s00441-009-0921-8; Jordaan A, 2003, BIG FISH BANG, P45; Kamler E, 2008, REV FISH BIOL FISHER, V18, P143, DOI 10.1007/s11160-007-9070-x; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Levitus S, 2005, GEOPHYS RES LETT, V32; Mackenzie BR, 2007, GLOBAL CHANGE BIOL, V13, P1335, DOI 10.1111/j.1365-2486.2007.01360.x; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Moreno A, 2009, J PLANKTON RES, V31, P73, DOI 10.1093/plankt/fbn103; Munday PL, 2008, CORAL REEFS, V27, P927, DOI 10.1007/s00338-008-0393-4; Munday PL, 2009, MAR ECOL PROG SER, V388, P235, DOI 10.3354/meps08137; Naef A, 1928, MONOGRAPHIA, V35, P194; Njemini R, 2005, J IMMUNOL METHODS, V306, P176, DOI 10.1016/j.jim.2005.08.012; Oosthuizen A, 2002, S AFR J MARINE SCI, V24, P379, DOI 10.2989/025776102784528367; Oyarzun FX, 2011, INTEGR COMP BIOL, V51, P81, DOI 10.1093/icb/icr009; Pechenik J.A., 1987, P551; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2004, RESP PHYSIOL NEUROBI, V141, P243, DOI 10.1016/j.resp.2004.03.011; Prosser CL, 1994, ENV METABOLIC ANIMAL; Przeslawski Rachel, 2004, Molluscan Research, V24, P43, DOI 10.1071/MR04001; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosa R, 2010, PROG OCEANOGR, V86, P72, DOI 10.1016/j.pocean.2010.04.004; Rosa R, 2009, PHYSIOL BIOCHEM ZOOL, V82, P419, DOI 10.1086/591950; Rosa R, 2008, ECOLOGY, V89, P3449, DOI 10.1890/08-0638.1; Santos F. D., 2002, CLIMATE CHANGE PORTU; Sokolova IM, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P263; Stillman JH, 2000, PHYSIOL BIOCHEM ZOOL, V73, P200, DOI 10.1086/316738; STRATHMANN RR, 1985, ANNU REV ECOL SYST, V16, P339, DOI 10.1146/annurev.es.16.110185.002011; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Vidal EAG, 2002, B MAR SCI, V71, P915; Villanueva R, 2000, MAR BIOL, V136, P449, DOI 10.1007/s002270050704; Villanueva R, 2003, MAR ECOL PROG SER, V253, P197, DOI 10.3354/meps253197; Villanueva R, 2007, REV FISH BIOL FISHER, V17, P101, DOI 10.1007/s11160-006-9022-x	50	68	69	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38282	10.1371/journal.pone.0038282	http://dx.doi.org/10.1371/journal.pone.0038282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701620	Green Submitted, Green Published, gold			2022-12-25	WOS:000305348400045
J	Wang, N; Leung, HT; Mazalouskas, MD; Watkins, GR; Gomez, RJ; Wadzinski, BE				Wang, Ning; Leung, Hung-Tat; Mazalouskas, Matthew D.; Watkins, Guy R.; Gomez, Rey J.; Wadzinski, Brian E.			Essential Roles of the Tap42-Regulated Protein Phosphatase 2A (PP2A) Family in Wing Imaginal Disc Development of Drosophila melanogaster	PLOS ONE			English	Article							ALPHA4 PROTEIN; SIGNALING PATHWAY; PERIPODIAL CELLS; THORAX CLOSURE; JNK PATHWAY; GAL4 SYSTEM; TAP42; DORSAL; PHOSPHORYLATION; MORPHOGENESIS	Protein ser/thr phosphatase 2A family members (PP2A, PP4, and PP6) are implicated in the control of numerous biological processes, but our understanding of the in vivo function and regulation of these enzymes is limited. In this study, we investigated the role of Tap42, a common regulatory subunit for all three PP2A family members, in the development of Drosophila melanogaster wing imaginal discs. RNAi-mediated silencing of Tap42 using the binary Gal4/UAS system and two disc drivers, pnr- and ap-Gal4, not only decreased survival rates but also hampered the development of wing discs, resulting in a remarkable thorax cleft and defective wings in adults. Silencing of Tap42 also altered multiple signaling pathways (HH, JNK and DPP) and triggered apoptosis in wing imaginal discs. The Tap42(RNAi)-induced defects were the direct result of loss of regulation of Drosophila PP2A family members (MTS, PP4, and PPV), as enforced expression of wild type Tap42, but not a phosphatase binding defective Tap42 mutant, rescued fly survivorship and defects. The experimental platform described herein identifies crucial roles for Tap42 center dot phosphatase complexes in governing imaginal disc and fly development.	[Wang, Ning; Mazalouskas, Matthew D.; Watkins, Guy R.; Gomez, Rey J.; Wadzinski, Brian E.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Leung, Hung-Tat] Grambling State Univ, Dept Biol Sci, Grambling, LA USA	Vanderbilt University; University of Louisiana System; Grambling State University	Wang, N (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA.	brian.wadzinski@vanderbilt.edu			National Institutes of Health [GM051366, DK070787]; Minority Biomedical Research Support-Research Initiative for Scientific Enhancement (MBRS-RISE) Program [5R25GM066714-07]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM051366, R25GM066714, R01GM051366] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minority Biomedical Research Support-Research Initiative for Scientific Enhancement (MBRS-RISE) Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM051366 and DK070787 (to B. E. W.) and 5R25GM066714-07, Minority Biomedical Research Support-Research Initiative for Scientific Enhancement (MBRS-RISE) Program to Grambling State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Agnes F, 1999, CR ACAD SCI III-VIE, V322, P5, DOI 10.1016/S0764-4469(99)80012-2; Agnes F, 1999, DEVELOPMENT, V126, P5453; Alcedo J, 2000, MOL CELL, V6, P457, DOI 10.1016/S1097-2765(00)00044-7; BATE M, 1991, DEVELOPMENT, V112, P755; Bielinski VA, 2007, EXP CELL RES, V313, P3117, DOI 10.1016/j.yexcr.2007.05.008; Calleja M, 2000, DEVELOPMENT, V127, P3971; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Chen LP, 2011, ONCOGENE, V30, P2943, DOI 10.1038/onc.2011.20; Cygnar KD, 2005, GENETICS, V170, P733, DOI 10.1534/genetics.104.039909; DIAZBENJUMEA FJ, 1993, CELL, V75, P741, DOI 10.1016/0092-8674(93)90494-B; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Elliott David A., 2008, V420, P79, DOI 10.1007/978-1-59745-583-1_5; Gibson MC, 2000, CELL, V103, P343, DOI 10.1016/S0092-8674(00)00125-2; Gibson MC, 2002, DEV CELL, V3, P451, DOI 10.1016/S1534-5807(02)00264-2; Gibson MC, 2001, BIOESSAYS, V23, P691, DOI 10.1002/bies.1098; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; Harlow E., 1999, USING ANTIBODIES LAB; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jia H, 2009, DEVELOPMENT, V136, P307, DOI 10.1242/dev.030015; Kloeker S, 2003, PROTEIN EXPRES PURIF, V31, P19, DOI 10.1016/S1046-5928(03)00141-4; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Kong M, 2007, J BIOL CHEM, V282, P29712, DOI 10.1074/jbc.M703159200; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; LeNoue-Newton M, 2011, J BIOL CHEM, V286, P17665, DOI 10.1074/jbc.M111.222414; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; Maeda K, 1999, EUR J BIOCHEM, V264, P702, DOI 10.1046/j.1432-1327.1999.00571.x; Martin-Blanco E, 2000, P NATL ACAD SCI USA, V97, P7888, DOI 10.1073/pnas.97.14.7888; MartinBlanco E, 1997, CURR OPIN GENET DEV, V7, P666, DOI 10.1016/S0959-437X(97)80015-9; McConnell JL, 2010, BIOCHEMISTRY-US, V49, P1713, DOI 10.1021/bi901837h; Nanahoshi M, 1998, BIOCHEM BIOPH RES CO, V251, P520, DOI 10.1006/bbrc.1998.9493; Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682; Pallavi SK, 2003, DEVELOPMENT, V130, P4931, DOI 10.1242/dev.00719; Pallavi SK, 2005, J CELL SCI, V118, P3363, DOI 10.1242/jcs.02464; Sato M, 1999, DEVELOPMENT, V126, P1457; Su Y, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001747; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Tripura C, 2011, INT J DEV BIOL, V55, P583, DOI 10.1387/ijdb.103275ct; Umemori M, 2009, GENE REGUL SYST BIO, V3, P11; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Wang HM, 2003, MOL CELL BIOL, V23, P3116, DOI 10.1128/MCB.23.9.3116-3125.2003; Wang N, 2008, J NEUROSCI, V28, P1444, DOI 10.1523/JNEUROSCI.5134-07.2008; Yamashita T, 2006, BRAIN RES, V1082, P1, DOI 10.1016/j.brainres.2006.01.101; Yang J, 2007, BIOCHEMISTRY-US, V46, P8807, DOI 10.1021/bi7007118; Zeitlinger J, 1999, DEVELOPMENT, V126, P3947; Zolnierowicz S, 2000, BIOCHEM PHARMACOL, V60, P1225, DOI 10.1016/S0006-2952(00)00424-X	49	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38569	10.1371/journal.pone.0038569	http://dx.doi.org/10.1371/journal.pone.0038569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701670	Green Published, Green Submitted, gold			2022-12-25	WOS:000305348400073
J	Xu, E; Zhang, J; Chen, X				Xu, E.; Zhang, J.; Chen, X.			MDM2 expression is repressed by the RNA-binding protein RNPC1 via mRNA stability	ONCOGENE			English	Article						RNA-binding proteins; RNPC1; MDM2; mRNA stability	ONCOPROTEIN MDM2; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; UBIQUITIN LIGASE; P53 FAMILY; DEGRADATION; TARGET; INHIBITION; DOMAIN; HUR	The RNA-binding protein (RBP) RNPC1 is a target of the p53 family and forms a feedback regulatory loop with the p53 family proteins. The murine double minute-2 (MDM2) oncogene, a key negative regulator of p53, has a critical role in a variety of fundamental cellular processes. MDM2 expression is found to be regulated via gene amplification, transcription, protein translation and protein stability. In the current study, we reported a novel regulation of MDM2 by RNPC1 via mRNA stability. Specifically, we found that overexpression of RNPC1 decreases, whereas knockdown or knockout of RNPC1 increases, the level of MDM2 transcript and protein independent of p53. To uncover the underlying mechanism, we found that RNPC1 is able to destabilize the MDM2 transcript via binding to multiple AU-/U-rich elements in MDM2 3'untranslated region (3'UTR). Consistent with this, we showed that RNPC1 inhibits expression of exogenous MDM2 from an expression vector as long as the vector contains an AU-/U-rich element from MDM2 3'UTR. Finally, we showed that the RNA-binding activity of RNPC1 is required for binding to MDM2 transcript and consequently, for inhibiting MDM2 expression. Together, we uncover a novel regulation of MDM2 by the RBP RNPC1 via mRNA stability. Oncogene (2013) 32, 2169-2178; doi:10.1038/onc.2012.238; published online 18 June 2012	[Xu, E.; Zhang, J.; Chen, X.] Univ Calif Davis, Dept Surg & Radiol Sci, Comparat Oncol Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Zhang, J (corresponding author), Univ Calif Davis, Dept Surg & Radiol Sci, Comparat Oncol Lab, 2128 Tupper Hall, Davis, CA 95616 USA.	jinzhang@ucdavis.edu; xbchen@ucdavis.edu			NIH [R01 CA076069, R01 CA102188]; NATIONAL CANCER INSTITUTE [R01CA076069, R01CA102188] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by NIH grants R01 CA076069 and R01 CA102188.	BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bartel F, 2002, CANCER CELL, V2, P9, DOI 10.1016/S1535-6108(02)00091-0; Bouska A, 2009, TRENDS BIOCHEM SCI, V34, P279, DOI 10.1016/j.tibs.2009.02.006; CAHILLYSNYDER L, 1987, SOMAT CELL MOLEC GEN, V13, P235, DOI 10.1007/BF01535205; Cho SJ, 2010, NUCLEIC ACIDS RES, V38, P2256, DOI 10.1093/nar/gkp1229; Cho SJ, 2012, J BIOL CHEM, V287, P14535, DOI 10.1074/jbc.M111.326827; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; FAKHARZADEH SS, 1991, EMBO J, V10, P1565, DOI 10.1002/j.1460-2075.1991.tb07676.x; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Ganguli G, 2003, MOL CANCER RES, V1, P1027; Ghosh M, 2009, J CLIN INVEST, V119, P3530, DOI 10.1172/JCI38263; Giles KM, 2003, J BIOL CHEM, V278, P2937, DOI 10.1074/jbc.M208439200; Harms KL, 2007, CANCER RES, V67, P3145, DOI 10.1158/0008-5472.CAN-06-4397; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Jung YS, 2012, DNA REPAIR, V11, P177, DOI 10.1016/j.dnarep.2011.10.017; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Leveille N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1519; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Lukas J, 2001, CANCER RES, V61, P3212; LUNA RMD, 1995, NATURE, V378, P203; Miyamoto S, 2009, GENES CELLS, V14, P1241, DOI 10.1111/j.1365-2443.2009.01347.x; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Moumen A, 2007, DEVELOPMENT, V134, P1443, DOI 10.1242/dev.02820; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Shu LM, 2006, GENE DEV, V20, P2961, DOI 10.1101/gad.1463306; Sigalas I, 1996, NAT MED, V2, P912, DOI 10.1038/nm0896-912; Trotta R, 2003, CANCER CELL, V3, P145, DOI 10.1016/S1535-6108(03)00020-5; Xiao JN, 2011, EMBO J, V30, P5021, DOI 10.1038/emboj.2011.463; Xiong L, 2007, J CELL BIOL, V178, P995, DOI 10.1083/jcb.200703044; Xiong X, 2011, ONCOGENE, V30, P1798, DOI 10.1038/onc.2010.569; Yan W, MOL CELL BIOL; ZAUBERMAN A, 1995, NUCLEIC ACIDS RES, V23, P2584, DOI 10.1093/nar/23.14.2584; Zhang J, 2013, ONCOGENE, V32, P61, DOI 10.1038/onc.2012.28; Zhang J, 2011, GENE DEV, V25, P1528, DOI 10.1101/gad.2069311; Zhang J, 2010, P NATL ACAD SCI USA, V107, P9614, DOI 10.1073/pnas.0912594107; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	46	38	40	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2013	32	17					2169	2178		10.1038/onc.2012.238	http://dx.doi.org/10.1038/onc.2012.238			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	132JD	22710720	Green Accepted			2022-12-25	WOS:000318062800006
J	Aratake, Y; Okuno, T; Matsunobu, T; Saeki, K; Takayanagi, R; Furuya, S; Yokomizo, T				Aratake, Yoshifusa; Okuno, Toshiaki; Matsunobu, Takehiko; Saeki, Kazuko; Takayanagi, Ryoichi; Furuya, Sonoko; Yokomizo, Takehiko			Helix 8 of leukotriene B-4 receptor 1 inhibits ligand-induced internalization	FASEB JOURNAL			English	Article						GPCR; BLT1; endocytosis; phosphorylation	PROTEIN-COUPLED RECEPTOR; AGONIST-INDUCED INTERNALIZATION; ACTIVATING-FACTOR RECEPTOR; CRYSTAL-STRUCTURE; CIRCULAR-DICHROISM; C-TERMINUS; PHOSPHORYLATION; TRAFFICKING; NMR; ENDOCYTOSIS	Recent crystallographic studies revealed that G-protein-coupled receptors (GPCRs) possess a putative cytoplasmic helical domain, termed helix 8, at the proximal region of the C-terminal tail. However, the significance of helix 8 in GPCR functions and signaling is not fully understood. Helix 8 mutants of leukotriene B-4 receptor type 1 (BLT1) exhibit prolonged activation after ligand stimulation, suggesting some regulatory roles of helix 8 in GPCR signaling. Here, we report the inhibitory role of BLT1 helix 8 on ligand-dependent internalization using BLT1 and platelet- activating factor receptor as model GPCRs. Mutating the dileucine motif in helix 8 of BLT1 to alanines (BLT1 LLAA) enhanced LTB4-dependent internalization of BLT1, whereas wild-type (WT) BLT1 exhibited minimal internalization. Mutational studies revealed that phosphorylation of 5 serine/threonine residues between amino acids 308 and 319 of BLT1 was responsible for enhanced ligand-dependent internalization of BLT1 LLAA. BLT1 LLAA showed enhanced basal and ligand-dependent phosphorylation compared to WT BLT1. Taken together, helix 8 of BLT1 inhibits receptor internalization by suppressing the excessive phosphorylation of the C-terminal tail.-Aratake, Y., Okuno, T., Matsunobu, T., Saeki, K., Takayanagi, R., Furuya, S., Yokomizo, T. Helix 8 of leukotriene B4 receptor 1 inhibits ligand-induced internalization. FASEB J. 26, 4068-4078 (2012). www.fasebj.org	[Yokomizo, Takehiko] Kyushu Univ, Grad Sch Med Sci, Dept Med Biochem, Higashi Ku, Fukuoka 8128582, Japan; [Aratake, Yoshifusa; Takayanagi, Ryoichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 8128582, Japan; [Furuya, Sonoko] Natl Inst Physiol Sci, Support Ctr Brain Res, Sect Brain Struct Informat, Aichi, Japan	Kyushu University; Kyushu University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Yokomizo, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Med Biochem, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	yokomizo-tky@umin.ac.jp	Yokomizo, Takehiko/P-5673-2016	Yokomizo, Takehiko/0000-0002-5219-1553	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21390083, 22116001, 22116002, 22790296, 24102522]; Mochida Memorial Foundation; Takeda Science Foundation; Senshin Medial Research Foundation; Kowa Life Science Foundation; Inamori Foundation; Japan Society for the Promotion of Science (Global COE program)	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Senshin Medial Research Foundation; Kowa Life Science Foundation; Inamori Foundation; Japan Society for the Promotion of Science (Global COE program)	The authors thank the Support Center for Education and Research, Graduate School of Medical Sciences, Kyushu University for technical support; F. Sasaki, M. Minami, K. Moroishi, and N. Onohara for technical assistance; and all of their laboratory members for valuable advice and discussions. This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (21390083, 22116001, and 22116002 to T. Y.; 22790296 and 24102522 to T.O.), and grants from the Mochida Memorial Foundation, the Takeda Science Foundation, the Senshin Medial Research Foundation, the Kowa Life Science Foundation, and the Inamori Foundation (to T.O.), and Japan Society for the Promotion of Science (Global COE program; to T.Y.).	Ahn KH, 2010, BIOCHEMISTRY-US, V49, P502, DOI 10.1021/bi901619r; Anavi-Goffer S, 2007, J BIOL CHEM, V282, P25100, DOI 10.1074/jbc.M703388200; Awwad HO, 2010, EUR J PHARMACOL, V635, P9, DOI 10.1016/j.ejphar.2010.02.033; Back M, 2011, PHARMACOL REV, V63, P539, DOI 10.1124/pr.110.004184; Chen ZG, 2004, MOL PHARMACOL, V66, P377; Chen ZG, 2002, J BIOL CHEM, V277, P7356, DOI 10.1074/jbc.M110058200; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Choi G, 2005, BBA-BIOMEMBRANES, V1668, P1, DOI 10.1016/j.bbamem.2004.10.011; Choi G, 2002, J PEPT RES, V60, P169, DOI 10.1034/j.1399-3011.2002.21012.x; D'Amelio N, 2003, BIOPOLYMERS, V70, P134, DOI 10.1002/bip.10426; Delos Santos NM, 2006, J BIOL CHEM, V281, P12896, DOI 10.1074/jbc.M508500200; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Ferrari SL, 1999, J BIOL CHEM, V274, P29968, DOI 10.1074/jbc.274.42.29968; Fukunaga K, 2001, J BIOL CHEM, V276, P43025, DOI 10.1074/jbc.M108288200; Gaudreau R, 2004, J BIOL CHEM, V279, P10338, DOI 10.1074/jbc.M309207200; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Iizuka Y, 2010, FASEB J, V24, P4678, DOI 10.1096/fj.10-165050; Jala VR, 2005, J BIOL CHEM, V280, P4880, DOI 10.1074/jbc.M409821200; Katragadda M, 2004, BBA-BIOMEMBRANES, V1663, P74, DOI 10.1016/j.bbamem.2004.01.012; Kuramasu A, 2011, CELL SIGNAL, V23, P1843, DOI 10.1016/j.cellsig.2011.06.021; Kuwasako K, 2011, PEPTIDES, V32, P144, DOI 10.1016/j.peptides.2010.10.005; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; Moskowitz HS, 2003, MOL BIOL CELL, V14, P4437, DOI 10.1091/mbc.e03-04-0230; Mukhopadhyay S, 1999, BIOCHEMISTRY-US, V38, P3447, DOI 10.1021/bi981767v; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nakamura M, 2011, CHEM REV, V111, P6231, DOI 10.1021/cr100392s; Okuno T, 2005, J BIOL CHEM, V280, P32049, DOI 10.1074/jbc.R500007200; Okuno T, 2003, J BIOL CHEM, V278, P41500, DOI 10.1074/jbc.M307335200; Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parhamifar L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014439; Piserchio A, 2005, BIOPOLYMERS, V80, P367, DOI 10.1002/bip.20220; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Reid HM, 2010, J BIOL CHEM, V285, P18709, DOI 10.1074/jbc.M110.106476; Serezani CH, 2009, BLOOD, V114, P3316, DOI 10.1182/blood-2009-01-199919; Suvorova ES, 2008, BBA-MOL CELL RES, V1783, P1261, DOI 10.1016/j.bbamcr.2008.02.004; Suvorova ES, 2009, BBA-MOL CELL RES, V1793, P406, DOI 10.1016/j.bbamcr.2008.09.011; Swift S, 2006, J BIOL CHEM, V281, P4109, DOI 10.1074/jbc.M509525200; von Zastrow M, 2003, LIFE SCI, V74, P217, DOI 10.1016/j.lfs.2003.09.008; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Yasuda D, 2009, FASEB J, V23, P1470, DOI 10.1096/fj.08-125385; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	48	17	17	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2012	26	10					4068	4078		10.1096/fj.12-212050	http://dx.doi.org/10.1096/fj.12-212050			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22707565	Green Accepted			2022-12-25	WOS:000309704000014
J	Oberoi-Khanuja, TK; Karreman, C; Larisch, S; Rapp, UR; Rajalingam, K				Oberoi-Khanuja, Tripat Kaur; Karreman, Christiaan; Larisch, Sarit; Rapp, Ulf R.; Rajalingam, Krishnaraj			Role of Melanoma Inhibitor of Apoptosis (ML-IAP) Protein, a Member of the Baculoviral IAP Repeat (BIR) Domain Family, in the Regulation of C-RAF Kinase and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SILENCING LIVIN GENE; NF-KAPPA-B; LUNG-CANCER; TRANSCRIPTIONAL REGULATOR; PROGNOSTIC-SIGNIFICANCE; EXPRESSION; DEGRADATION; RESISTANCE; PATHWAY; IDENTIFICATION	Inhibitor of apoptosis (IAPs) proteins are characterized by the presence of evolutionarily conserved baculoviral inhibitor of apoptosis repeat (BIR) domains, predominantly known for their role in inhibiting caspases and, thereby, apoptosis. We have shown previously that multi-BIR domain-containing IAPs, cellular IAPs, and X-linked IAP can control tumor cell migration by directly regulating the protein stability of C-RAF kinase. Here, we extend our observations to a single BIR domain containing IAP family member melanoma- IAP (ML-IAP). We show that ML-IAP can directly bind to C-RAF and that ML-IAP depletion leads to an increase in C-RAF protein levels, MAPK activation, and cell migration in melanoma cells. Thus, our results unveil a thus far unknown role for ML-IAP in controlling C-RAF stability and cell migration.	[Oberoi-Khanuja, Tripat Kaur; Rajalingam, Krishnaraj] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, DFG,Emmy Noether Grp, D-60590 Frankfurt, Germany; [Karreman, Christiaan] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Larisch, Sarit] Univ Haifa, Fac Nat Sci, Dept Biol, Cell Death Res Lab, IL-31905 Haifa, Israel; [Rapp, Ulf R.] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany	German Research Foundation (DFG); Goethe University Frankfurt; University of Konstanz; University of Haifa; Max Planck Society	Rajalingam, K (corresponding author), Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, DFG,Emmy Noether Grp, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	krishna@biochem2.de		Oberoi, Tripat Kaur/0000-0001-9299-9496	Emmy Noether Program from the Deutsche Forschungs Gemeinschaft [RA1739/1-1]	Emmy Noether Program from the Deutsche Forschungs Gemeinschaft(German Research Foundation (DFG))	This work was supported by Emmy Noether Program Grant RA1739/1-1 from the Deutsche Forschungs Gemeinschaft (to K. R.).	Augello C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-125; Blankenship JW, 2008, BIOCHEM J, V417, P1; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Crnkovic-Mertens I, 2007, CELL MOL LIFE SCI, V64, P1137, DOI 10.1007/s00018-007-6510-7; Dasgupta A, 2009, ONCOL REP, V22, P831, DOI 10.3892/or_00000506; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Didelot C, 2008, CELL DEATH DIFFER, V15, P859, DOI 10.1038/sj.cdd.4402320; Dogan T, 2008, NAT CELL BIOL, V10, P1447, DOI 10.1038/ncb1804; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dueber EC, 2011, SCIENCE, V334, P376, DOI 10.1126/science.1207862; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Dynek JN, 2008, CANCER RES, V68, P3124, DOI 10.1158/0008-5472.CAN-07-6622; Gazzaniga P, 2003, ANN ONCOL, V14, P85, DOI 10.1093/annonc/mdg002; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Kempkensteffen C, 2007, TUMOR BIOL, V28, P132, DOI 10.1159/000103008; Kim DK, 2005, PEDIATR DEVEL PATHOL, V8, P621, DOI 10.1007/s10024-005-4108-3; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; Kyriakis JM, 2007, BBA-MOL CELL RES, V1773, P1238, DOI 10.1016/j.bbamcr.2006.11.003; Light Y, 2002, MOL CELL BIOL, V22, P4984, DOI 10.1128/MCB.22.14.4984-4996.2002; Ma L, 2006, CELL DEATH DIFFER, V13, P2079, DOI 10.1038/sj.cdd.4401959; Noble C, 2008, MOL CELL, V31, P862, DOI 10.1016/j.molcel.2008.08.026; Oberoi TK, 2012, EMBO J, V31, P14, DOI 10.1038/emboj.2011.423; Rajalingam K, 2006, PLOS PATHOG, V2, P1013, DOI 10.1371/journal.ppat.0020114; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Shin H, 2003, BIOCHEM J, V373, P965, DOI 10.1042/BJ20030583; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Sun JG, 2011, CANCER BIOTHER RADIO, V26, P585, DOI 10.1089/cbr.2011.0962; Tanabe H, 2004, LUNG CANCER, V46, P299, DOI 10.1016/j.lungcan.2004.05.002; Vaux DL, 2005, CELL DEATH DIFFER, V12, P1205, DOI 10.1038/sj.cdd.4401696; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; von Kriegsheim A, 2006, NAT CELL BIOL, V8, P1011, DOI 10.1038/ncb1465; Vucic D, 2000, CURR BIOL, V10, P1359, DOI 10.1016/S0960-9822(00)00781-8; Vucic D, 2005, BIOCHEM J, V385, P11, DOI 10.1042/BJ20041108; Vucic D, 2002, J BIOL CHEM, V277, P12275, DOI 10.1074/jbc.M112045200; Wang H, 2007, ACTA PHARMACOL SIN, V28, P1968, DOI 10.1111/j.1745-7254.2007.00724.x; Wang R, 2008, CANCER GENE THER, V15, P402, DOI 10.1038/cgt.2008.16; Wang XD, 2010, CLIN BIOCHEM, V43, P655, DOI 10.1016/j.clinbiochem.2010.02.004; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wu HH, 2010, CLIN CANCER RES, V16, P5200, DOI 10.1158/1078-0432.CCR-10-0020; Yuan BQ, 2012, J NEURO-ONCOL, V107, P81, DOI 10.1007/s11060-011-0728-9; Yuan D, 2007, MOL CELL BIOCHEM, V306, P171, DOI 10.1007/s11010-007-9567-6; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang QP, 2004, CANCER RES, V64, P7579, DOI 10.1158/0008-5472.CAN-04-0641	46	23	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28445	28455		10.1074/jbc.M112.341297	http://dx.doi.org/10.1074/jbc.M112.341297			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22711539	Green Published, hybrid			2022-12-25	WOS:000308074600020
J	Oksayan, S; Wiltzer, L; Rowe, CL; Blondel, D; Jans, DA; Moseley, GW				Oksayan, Sibil; Wiltzer, Linda; Rowe, Caitlin L.; Blondel, Danielle; Jans, David A.; Moseley, Gregory W.			A Novel Nuclear Trafficking Module Regulates the Nucleocytoplasmic Localization of the Rabies Virus Interferon Antagonist, P Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNEIN LIGHT-CHAIN; VESICULAR STOMATITIS-VIRUS; NIPAH-VIRUS; PHOSPHOPROTEIN-P; IMPORTIN-ALPHA; MATRIX PROTEIN; PREVENTING STAT1; EXPORT SIGNALS; MESSENGER-RNA; HENDRA-VIRUS	Regulated nucleocytoplasmic transport of proteins is central to cellular function and dysfunction during processes such as viral infection. Active protein trafficking into and out of the nucleus is dependent on the presence within cargo proteins of intrinsic specific modular signals for nuclear import (nuclear localization signals, NLSs) and export (nuclear export signals, NESs). Rabies virus (RabV) phospho (P) protein, which is largely responsible for antagonising the host anti-viral response, is expressed as five isoforms (P1-P5). The subcellular trafficking of these isoforms is thought to depend on a balance between the activities of a dominant N-terminal NES (N-NES) and a distinct C-terminal NLS (C-NLS). Specifically, the N-NES-containing isoforms P1 and P2 are cytoplasmic, whereas the shorter P3-P5 isoforms, which lack the N-NES, are believed to be nuclear through the activity of the C-NLS. Here, we show for the first time that RabV P contains an additional strong NLS in the N-terminal region (N-NLS), which, intriguingly, overlaps with the N-NES. This arrangement represents a novel nuclear trafficking module where the N-NLS is inactive in P1 but becomes activated in P3, concomitant with truncation of the N-NES, to become the principal targeting signal conferring nuclear accumulation. Understanding this unique switch arrangement of overlapping, co-regulated NES/NLS sequences is vital to delineating the critical role of RabV P protein in viral infection.	[Oksayan, Sibil; Wiltzer, Linda; Rowe, Caitlin L.; Moseley, Gregory W.] Monash Univ, Viral Immune Evas & Pathogen Lab, Clayton, Vic 3800, Australia; [Oksayan, Sibil; Wiltzer, Linda; Rowe, Caitlin L.; Jans, David A.] Monash Univ, Nucl Signaling Lab, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Blondel, Danielle] CNRS, Lab Virol Mol & Struct, Ctr Rech Gif, F-91198 Gif Sur Yvette, France	Monash University; Monash University; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite Paris Saclay	Moseley, GW (corresponding author), Monash Univ, Viral Immune Evas & Pathogen Lab, Clayton, Vic 3800, Australia.	greg.moseley@monash.edu	Wiltzer-Bach, Linda/D-8064-2015	Rowe, Caitlin/0000-0003-0829-1220; Jans, David/0000-0001-5115-4745; Moseley, Gregory/0000-0003-4516-3906	National Health and Medical Research Council, Australia [1003244, 1002486]; Australian Research Council [DP110101749]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by National Health and Medical Research Council, Australia, Project Grant 1003244 (to G. W. M.), and Senior Principal Research Fellowship 1002486 (to D.A.J.), and by Australian Research Council Discovery Project DP110101749 (to G. W. M. and D.A.J.).	Ahmed M, 2003, J VIROL, V77, P4646, DOI 10.1128/JVI.77.8.4646-4657.2003; Baliga BC, 2003, J BIOL CHEM, V278, P4899, DOI 10.1074/jbc.M211512200; Blondel D, 2002, ONCOGENE, V21, P7957, DOI 10.1038/sj.onc.1205931; Bouttier M, 2008, VIROLOGIE, V12, P159, DOI [10.1684/vir.2008.0173, 10.1684/12-3.2011.11041]; Brzozka K, 2006, J VIROL, V80, P2675, DOI 10.1128/JVI.80.6.2675-2683.2006; Chelbi-Alix MK, 2006, J INTERF CYTOK RES, V26, P271, DOI 10.1089/jir.2006.26.271; CHENIK M, 1995, J VIROL, V69, P707, DOI 10.1128/JVI.69.2.707-712.1995; Chenik M, 1998, J VIROL, V72, P1925, DOI 10.1128/JVI.72.3.1925-1930.1998; CHENIK M, 1994, J GEN VIROL, V75, P2889, DOI 10.1099/0022-1317-75-11-2889; Chumakov SP, 2010, MOL BIOL+, V44, P186, DOI 10.1134/S0026893310020020; Claudiani P, 2005, EXP CELL RES, V309, P358, DOI 10.1016/j.yexcr.2005.06.009; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Deonarain R, 2002, CURR PHARM DESIGN, V8, P2131, DOI 10.2174/1381612023393288; FAGIOLI M, 1992, ONCOGENE, V7, P1083; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Forwood JK, 1999, BIOCHEM BIOPH RES CO, V257, P731, DOI 10.1006/bbrc.1999.0370; Forwood JK, 2001, J BIOL CHEM, V276, P46575, DOI 10.1074/jbc.M101668200; Fulcher AJ, 2011, BBA-MOL CELL RES, V1813, P2176, DOI 10.1016/j.bbamcr.2011.03.019; Fulcher AJ, 2010, J BIOL CHEM, V285, P17744, DOI 10.1074/jbc.M109.055491; Gale M, 2009, J INTERF CYTOK RES, V29, P475, DOI 10.1089/jir.2009.0078; Gerard FCA, 2009, J MOL BIOL, V388, P978, DOI 10.1016/j.jmb.2009.03.061; Ghildyal R, 2005, BIOCHEMISTRY-US, V44, P12887, DOI 10.1021/bi050701e; Giesecke A, 2010, J BIOL CHEM, V285, P17628, DOI 10.1074/jbc.M110.102343; Harcourt BH, 2000, VIROLOGY, V271, P334, DOI 10.1006/viro.2000.0340; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Ito N, 2010, J VIROL, V84, P6699, DOI 10.1128/JVI.00011-10; Ivanov I, 2010, J VIROL, V84, P3707, DOI 10.1128/JVI.02557-09; Jayakar HR, 2002, J VIROL, V76, P8011, DOI 10.1128/JVI.76.16.8011-8018.2002; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kaur G, 2011, FASEB J, V25, P665, DOI 10.1096/fj.10-173351; Kaur G, 2010, BIOCHEM J, V430, P39, DOI 10.1042/BJ20091758; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lahaye X, 2009, J VIROL, V83, P7948, DOI 10.1128/JVI.00554-09; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lange A, 2010, TRAFFIC, V11, P311, DOI 10.1111/j.1600-0854.2009.01028.x; Marschalek A, 2012, EUR J CELL BIOL, V91, P17, DOI 10.1016/j.ejcb.2011.01.009; Moseley GW, 2007, BIOCHEMISTRY-US, V46, P12053, DOI 10.1021/bi700521m; Moseley GW, 2007, MOL BIOL CELL, V18, P3204, DOI 10.1091/mbc.E07-01-0030; Moseley GW, 2010, J BIOTECHNOL, V145, P222, DOI 10.1016/j.jbiotec.2009.11.015; Moseley GW, 2009, J CELL SCI, V122, P3652, DOI 10.1242/jcs.045542; Oksayan Sibil, 2012, Infectious Disorders - Drug Targets, V12, P38; Pasdeloup D, 2005, VIROLOGY, V334, P284, DOI 10.1016/j.virol.2005.02.005; Poisson N, 2001, J GEN VIROL, V82, P2691, DOI 10.1099/0022-1317-82-11-2691; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Raux H, 2000, J VIROL, V74, P10212, DOI 10.1128/JVI.74.21.10212-10216.2000; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Rodriguez E, 2009, CELL RES, V19, P1041, DOI 10.1038/cr.2009.103; Rodriguez JJ, 2004, VIRAL IMMUNOL, V17, P210, DOI 10.1089/0882824041310568; Rodriguez JJ, 2003, J VIROL, V77, P11842, DOI 10.1128/JVI.77.21.11842-11845.2003; Rodriguez JJ, 2002, J VIROL, V76, P11476, DOI 10.1128/JVI.76.22.11476-11483.2002; Roth DM, 2007, TRAFFIC, V8, P673, DOI 10.1111/j.1600-0854.2007.00564.x; Roth DM, 2011, J BIOL CHEM, V286, P14335, DOI 10.1074/jbc.M110.210302; Schnell MJ, 2010, NAT REV MICROBIOL, V8, P51, DOI 10.1038/nrmicro2260; Shaw ML, 2005, J VIROL, V79, P6078, DOI 10.1128/JVI.79.10.6078-6088.2005; Shaw ML, 2004, J VIROL, V78, P5633, DOI 10.1128/JVI.78.11.5633-5641.2004; Shimizu K, 2007, VIRUS RES, V123, P154, DOI 10.1016/j.virusres.2006.08.011; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strom AC, 2001, GENOME BIOL, V2; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Uversky VN, 2011, J MOL RECOGNIT, V24, P647, DOI 10.1002/jmr.1093; Vidy A, 2005, J VIROL, V79, P14411, DOI 10.1128/JVI.79.22.14411-14420.2005; Vidy A, 2007, J VIROL, V81, P4255, DOI 10.1128/JVI.01930-06; Wagstaff KM, 2006, ANAL BIOCHEM, V348, P49, DOI 10.1016/j.ab.2005.10.029; Wagstaff KM, 2005, J FLUORESC, V15, P469, DOI 10.1007/s10895-005-2819-5; Xue B, 2010, PROTEIN PEPTIDE LETT, V17, P932, DOI 10.2174/092986610791498984	68	31	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28112	28121		10.1074/jbc.M112.374694	http://dx.doi.org/10.1074/jbc.M112.374694			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22700958	Green Published, hybrid			2022-12-25	WOS:000307840700084
J	Liu, LW; Wang, LM; Zhang, Z; Wang, S; Chen, HG				Liu, Liangwei; Wang, Linmin; Zhang, Zhang; Wang, Suya; Chen, Hongge			Effect of Codon Message on Xylanase Thermal Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-COMPOSITION; LATERAL GENE-TRANSFER; USAGE; TEMPERATURE; EXPRESSION; PROTEINS; THERMOSTABILITY; TRANSLATION; ADAPTATION; SEQUENCE	Because the genetic codon is known for degeneracy, its effect on enzyme thermal property is seldom investigated. A dataset was constructed for GH10 xylanase coding sequences and optimal temperatures for activity (T-opt). Codon contents and relative synonymous codon usages were calculated and respectively correlated with the enzyme T-opt values, which were used to describe the xylanase thermophilic tendencies without dividing them into two thermophilic and mesophilic groups. After analyses of codon content and relative synonymous codon usages were checked by the Bonferroni correction, we found five codons, with three (AUA, AGA, and AGG) correlating positively and two (CGU and AGC) correlating negatively with the T-opt value. The three positive codons are purine-rich codons, and the two negative codons have A-ends. The two negative codons are pyridine-rich codons, and one has a C-end. Comparable with the codon C- and A-ending features, C- and A-content within mRNA correlated negatively and positively with the T-opt value, respectively. Thereby, codons have effects on enzyme thermal property. When the issue is analyzed at the residual level, the effect of codon message is lost. The codons relating to enzyme thermal property are selected by thermophilic force at nucleotide level.	[Liu, Liangwei] Henan Agr Univ, Life Sci Coll, Zhengzhou 450002, Henan, Peoples R China; [Wang, Linmin; Zhang, Zhang; Chen, Hongge] Henan Agr Univ, Minist Agr, Key Lab Enzyme Engn Agr Microbiol, Zhengzhou 450002, Henan, Peoples R China; [Wang, Suya] Nanjing Univ Econ, Dept Food Sci & Engn, Nanjing 210003, Peoples R China	Henan Agricultural University; Henan Agricultural University; Ministry of Agriculture & Rural Affairs; Nanjing University of Finance & Economics	Liu, LW (corresponding author), Henan Agr Univ, Life Sci Coll, 95 Wenhua Rd, Zhengzhou 450002, Henan, Peoples R China.	LLW321@yahoo.com.cn		liu, liangwei/0000-0002-1896-8437	Natural Science Foundation of China [30972123]; Henan Science and Technology Fund of China [092102110102]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Henan Science and Technology Fund of China	This work was supported by Natural Science Foundation of China (Grant 30972123) and Grant 092102110102 from the Henan Science and Technology Fund of China.	Adzhubei AA, 1996, FEBS LETT, V399, P78, DOI 10.1016/S0014-5793(96)01287-2; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bae E, 2004, J BIOL CHEM, V279, P28202, DOI 10.1074/jbc.M401865200; Basak S, 2005, BIOCHEM BIOPH RES CO, V330, P629, DOI 10.1016/j.bbrc.2005.02.134; Benjamini Y, 2001, ANN STAT, V29, P1165; Bernado P, 2010, NATURE, V468, P1046, DOI 10.1038/4681046a; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Dalboge H, 1997, FEMS MICROBIOL REV, V21, P29, DOI 10.1016/S0168-6445(97)00005-3; Dehouck Y, 2008, PROTEIN ENG DES SEL, V21, P275, DOI 10.1093/protein/gzn001; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Facchiano AM, 1998, PROTEIN ENG, V11, P753, DOI 10.1093/protein/11.9.753; Farias Savio T, 2003, Genet Mol Res, V2, P383; Fasman KH, 1998, N COMP BIOC, V32, P29; Gaucher EA, 2008, NATURE, V451, P704, DOI 10.1038/nature06510; Gomes J, 2000, EXTREMOPHILES, V4, P227, DOI 10.1007/s007920070024; Gubitz GM, 1997, APPL MICROBIOL BIOT, V47, P658, DOI 10.1007/s002530050991; Gupta SK, 2000, BIOCHEM BIOPH RES CO, V269, P692, DOI 10.1006/bbrc.2000.2351; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kidane D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000630; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Kreil DP, 2001, NUCLEIC ACIDS RES, V29, P1608, DOI 10.1093/nar/29.7.1608; Kumar PR, 2000, J MOL BIOL, V295, P581, DOI 10.1006/jmbi.1999.3348; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Liu LW, 2011, J BIOL CHEM, V286, P44710, DOI 10.1074/jbc.M111.269753; Liu LW, 2008, J BIOTECHNOL, V136, pS201, DOI 10.1016/j.jbiotec.2008.07.423; Liu LW, 2006, PROCESS BIOCHEM, V41, P305, DOI 10.1016/j.procbio.2005.06.027; Liu LW, 2005, PROCESS BIOCHEM, V40, P1389, DOI 10.1016/j.procbio.2004.06.003; Lo Leggio L, 1999, PROTEINS, V36, P295; Lobry JR, 2003, J APPL GENET, V44, P235; Lynn DJ, 2002, NUCLEIC ACIDS RES, V30, P4272, DOI 10.1093/nar/gkf546; Malkov SN, 2009, PROTEIN J, V28, P74, DOI 10.1007/s10930-009-9166-3; Mendez R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000767; Mozo-Villiarias A, 2006, CURR BIOINFORM, V1, P25, DOI 10.2174/157489306775330561; Musto H, 2004, FEBS LETT, V573, P73, DOI 10.1016/j.febslet.2004.07.056; Musto H, 1999, J MOL EVOL, V49, P27, DOI 10.1007/PL00006531; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Pasamontes A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-257; Paz A, 2004, P NATL ACAD SCI USA, V101, P2951, DOI 10.1073/pnas.0308594100; Puigbo P, 2008, TRENDS GENET, V24, P10, DOI 10.1016/j.tig.2007.10.005; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; Rodin SN, 2008, HEREDITY, V100, P341, DOI 10.1038/sj.hdy.6801086; Rogers MB, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-89; Saunders R, 2010, NUCLEIC ACIDS RES, V38, P6719, DOI 10.1093/nar/gkq495; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Singer A, 2009, J IND MICROBIOL BIOT, V36, P521, DOI 10.1007/s10295-008-0522-7; Singer GAC, 2003, GENE, V317, P39, DOI 10.1016/S0378-1119(03)00660-7; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Tekaia F, 2002, GENE, V297, P51, DOI 10.1016/S0378-1119(02)00871-5; Thanaraj TA, 1996, PROTEIN SCI, V5, P1973, DOI 10.1002/pro.5560051003; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; THOMAS LK, 1988, P NATL ACAD SCI USA, V85, P4242, DOI 10.1073/pnas.85.12.4242; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; Waller RF, 2006, MOL BIOL EVOL, V23, P1437, DOI 10.1093/molbev/msl008; Wang HC, 2006, BIOCHEM BIOPH RES CO, V342, P681, DOI 10.1016/j.bbrc.2006.02.037; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Xie T, 1998, FEBS LETT, V434, P93; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554	61	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27183	27188		10.1074/jbc.M111.327577	http://dx.doi.org/10.1074/jbc.M111.327577			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707716	hybrid, Green Published			2022-12-25	WOS:000307386000070
J	dos Santos, VA; Chatkin, JM; Bau, CHD; Paixao-Cortes, VR; Sun, Y; Zamel, N; Siminovitch, K				dos Santos, Vanessa Argondizo; Chatkin, Jose Miguel; Dotto Bau, Claiton Henrique; Paixao-Cortes, Vanessa Rodrigues; Sun, Ye; Zamel, Noe; Siminovitch, Katherine			Glutamate and Synaptic Plasticity Systems and Smoking Behavior: Results from a Genetic Association Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NICOTINE DEPENDENCE; LOCI; TRANSMISSION; METAANALYSIS; POPULATIONS; INITIATION; ADDICTION; RECEPTORS; CESSATION	Smoking behavior is a multifactorial phenotype with significant heritability. Identifying the specific loci that influence smoking behavior could provide important etiological insights and facilitate the development of treatments to further reduce smoking related mortality. Although several studies pointed to different candidate genes for smoking, there is still a need for replication especially in samples from different countries. In the present study, we investigated whether 21 positive signals for smoking behavior from these studies are replicated in a sample of 531 blood donors from the Brazilian population. The polymorphisms were chosen based on their representativeness of different candidate biologic systems, strength of previous evidence, location and allele frequencies. By genotyping with the Sequenom MassARRAY iPLEX platform and subsequent statistical analysis using Plink software, we show that two of the SNPs studied, in the SLC1A2 (rs1083658) and ACTN1 (rs2268983) genes, were associated with smoking behavior in our study population. These genes are involved in crucial aspects of nicotine dependence, glutamate system and synaptic plasticity, and as such, are biologically plausible candidates that merit further molecular analyses so as to clarify their potential role in smoking behavior.	[dos Santos, Vanessa Argondizo; Chatkin, Jose Miguel] Pontificia Univ Catolica Rio Grande Sul PUCRS, Sch Med, Porto Alegre, RS, Brazil; [Dotto Bau, Claiton Henrique; Paixao-Cortes, Vanessa Rodrigues] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil; [Sun, Ye; Zamel, Noe; Siminovitch, Katherine] Univ Toronto, Dept Med, Toronto, ON, Canada; [Sun, Ye; Siminovitch, Katherine] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Sun, Ye; Siminovitch, Katherine] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Sun, Ye; Siminovitch, Katherine] Samuel Lunenfeld & Toronto Gen Hosp Res Inst, Toronto, ON, Canada	Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal do Rio Grande do Sul; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	dos Santos, VA (corresponding author), Pontificia Univ Catolica Rio Grande Sul PUCRS, Sch Med, Porto Alegre, RS, Brazil.	jmchatkin@pucrs.br	Paixão-Côrtes, Vanessa R/H-3564-2011; Chatkin, Jose M/Q-3925-2016; Sun, Ye/B-9814-2017; Siminovitch, Katherine/K-1475-2013; Bau, Claiton Henrique Dotto/C-9980-2013	Paixão-Côrtes, Vanessa R/0000-0003-2677-0903; Chatkin, Jose M/0000-0002-4343-025X; Bau, Claiton Henrique Dotto/0000-0001-5644-3845	Ontario Research Excellence Fund [ORF RE-01-061]; Canada Research Chair; Conselho Nacional de Pesquisa (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES); Fundacao de Auxilio a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Programa de Apoio a Nucleos de Excelencia (PRONEX)	Ontario Research Excellence Fund; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Auxilio a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Programa de Apoio a Nucleos de Excelencia (PRONEX)	This study was supported by an Ontario Research Excellence Fund grant (ORF RE-01-061) to KAS. KAS holds the Sherman Family Chair in Genomic Medicine and is also supported by a Canada Research Chair. The Brazilian authors (VAS, JMC, CHDB) received funding from the agencies Conselho Nacional de Pesquisa (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES); Fundacao de Auxilio a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) and Programa de Apoio a Nucleos de Excelencia (PRONEX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2010, NAT GENET, V42, P366, DOI 10.1038/ng0510-366; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Beuten J, 2006, NEUROPSYCHOPHARMACOL, V31, P675, DOI 10.1038/sj.npp.1300997; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Caporaso N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004653; Centers for Disease Control and Prevention, 1994, MMWR-MORBID MORTAL W, V43, P342; Ducci F, 2011, BIOL PSYCHIAT, V69, P650, DOI 10.1016/j.biopsych.2010.09.055; Flatscher-Bader T, 2008, HUM MOL GENET, V17, P38, DOI 10.1093/hmg/ddm283; Gelernter J, 2006, HUM MOL GENET, V15, P3498, DOI 10.1093/hmg/ddl426; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; HERRMANN BG, 1987, METHOD ENZYMOL, V152, P180; Jackson A, 2009, NEUROPSYCHOPHARMACOL, V34, P257, DOI 10.1038/npp.2008.50; Lang UE, 2007, PSYCHOPHARMACOLOGY, V190, P433, DOI 10.1007/s00213-006-0647-1; Levin ED, 2006, PSYCHOPHARMACOLOGY, V184, P523, DOI 10.1007/s00213-005-0164-7; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Li MD, 2008, HUM GENET, V123, P119, DOI 10.1007/s00439-008-0473-0; Liechti ME, 2008, CNS DRUGS, V22, P705, DOI 10.2165/00023210-200822090-00001; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Liu QR, 2005, P NATL ACAD SCI USA, V102, P11864, DOI 10.1073/pnas.0500329102; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; Nesic J, 2011, PSYCHOPHARMACOLOGY, V216, P29, DOI 10.1007/s00213-011-2189-4; Novak G, 2010, ANN HUM GENET, V74, P291, DOI 10.1111/j.1469-1809.2010.00578.x; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Takahashi M, 1997, J EXP BIOL, V200, P401; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P683, DOI 10.1001/archpsyc.65.6.683; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Vink J, 2005, BEHAV GENET, V35, P397, DOI 10.1007/s10519-004-1327-8; Vink JM, 2009, AM J HUM GENET, V84, P367, DOI 10.1016/j.ajhg.2009.02.001; Vink JM, 2004, PHARMACOGENOMICS J, V4, P274, DOI 10.1038/sj.tpj.6500255; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Watkins S S, 2000, Nicotine Tob Res, V2, P19; Wipfli H, 2009, CLIN PHARMACOL THER, V86, P263, DOI 10.1038/clpt.2009.93	38	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38666	10.1371/journal.pone.0038666	http://dx.doi.org/10.1371/journal.pone.0038666			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719919	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300040
J	Kim, HS; Woo, JS; Joo, HJ; Moon, WK				Kim, Hoe Suk; Woo, Ji Soo; Joo, Hyun Jung; Moon, Woo Kyung			Cardiac Transcription Factor Nkx2.5 Is Downregulated under Excessive O-GlcNAcylation Condition	PLOS ONE			English	Article							LINKED N-ACETYLGLUCOSAMINE; CELL-DEATH; HEART; PROTEINS; PHOSPHORYLATION; GLYCOSYLATION; CSX/NKX2.5; NUCLEAR; P53	Post-translational modification of proteins with O-linked N-acetylglucosamine (O-GlcNAc) is linked the development of diabetic cardiomyopathy. We investigated whether Nkx2.5 protein, a cardiac transcription factor, is regulated by O-GlcNAc. Recombinant Nkx2.5 (myc-Nkx2.5) proteins were reduced by treatment with the O-GlcNAcase inhibitors STZ and O-(2-acetamido-2-deoxy-D-glucopyroanosylidene)-amino-N-phenylcarbamate; PUGNAC) as well as the overexpression of recombinant O-GlcNAc transferase (OGT-flag). Co-immunoprecipitation analysis revealed that myc-Nkx2.5 and OGT-flag proteins interacted and myc-Nkx2.5 proteins were modified by O-GlcNAc. In addition, Nkx2.5 proteins were reduced in the heart tissue of streptozotocin (STZ)-induced diabetic mice and O-GlcNAc modification of Nkx2.5 protein increased in diabetic heart tissue compared with non-diabetic heart. Thus, excessive O-GlcNAcylation causes downregulation of Nkx2.5, which may be an underlying contributing factor for the development of diabetic cardiomyopathy.	[Kim, Hoe Suk; Woo, Ji Soo; Moon, Woo Kyung] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Kim, Hoe Suk; Woo, Ji Soo; Joo, Hyun Jung; Moon, Woo Kyung] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Joo, Hyun Jung; Moon, Woo Kyung] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kim, HS (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.	moonwk@snu.ac.kr	Moon, Woo Kyung/J-2755-2012		National Research Foundation of Korea Grant; Korean Government [KRF-2006-311-C00399]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0003657, 2011-0004322]	National Research Foundation of Korea Grant(National Research Foundation of Korea); Korean Government(Korean Government); Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Research Foundation of Korea Grant funded by the Korean Government (KRF-2006-311-C00399) and supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0003657, 2011-0004322). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2005, PHARMACOL THERAPEUT, V107, P252, DOI 10.1016/j.pharmthera.2005.03.005; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Fiordaliso F, 2001, DIABETES, V50, P2363, DOI 10.2337/diabetes.50.10.2363; Guinez C, 2008, FASEB J, V22, P2901, DOI 10.1096/fj.07-102509; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 1996, GLYCOBIOLOGY, V6, P711, DOI 10.1093/glycob/6.7.711; Hidaka K, 2003, FASEB J, V17, P740, DOI 10.1096/fj.02-0104fje; Hu Y, 2005, CIRC RES, V96, P1006, DOI 10.1161/01.RES.0000165478.06813.58; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Kasahara H, 1999, MOL CELL BIOL, V19, P526; Kasahara H, 2000, J CLIN INVEST, V106, P299, DOI 10.1172/JCI9860; Kim HS, 2009, FEBS LETT, V583, P2474, DOI 10.1016/j.febslet.2009.06.052; Kim HS, 2006, FEBS LETT, V580, P2311, DOI 10.1016/j.febslet.2006.03.043; Kohda Y, 2009, J PHARMACOL SCI, V111, P446, DOI 10.1254/jphs.09236SC; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; LINTS TJ, 1993, DEVELOPMENT, V119, P419; McNulty PH, 2007, AM J PHYSIOL-CELL PH, V292, pC1243, DOI 10.1152/ajpcell.00521.2006; Ramirez-Correa GA, 2008, CIRC RES, V103, P1354, DOI 10.1161/CIRCRESAHA.108.184978; Toko H, 2002, J BIOL CHEM, V277, P24735, DOI 10.1074/jbc.M107669200; Wang J, 2008, J BIOL CHEM, V283, P23235, DOI 10.1074/jbc.M709748200; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7	23	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38053	10.1371/journal.pone.0038053	http://dx.doi.org/10.1371/journal.pone.0038053			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719862	Green Submitted, Green Published, gold			2022-12-25	WOS:000305350000011
J	Yen, ML; Hsu, PN; Liao, HJ; Lee, BH; Tsai, HF				Yen, Men-Luh; Hsu, Ping-Ning; Liao, Hsiu-Jung; Lee, Be-Hang; Tsai, Hwei-Fang			TRAF-6 Dependent Signaling Pathway Is Essential for TNF-Related Apoptosis-Inducing Ligand (TRAIL) Induces Osteoclast Differentiation	PLOS ONE			English	Article							LYMPH-NODE ORGANOGENESIS; ACTIVATED PROTEIN-KINASE; LINEAGE PRECURSOR CELLS; NF-KAPPA-B; DEFECTIVE INTERLEUKIN-1; RANKL; RECEPTOR; BONE; AXIS; OSTEOPROTEGERIN	Human osteoclast formation from mononuclear phagocyte precursors involves interactions between tumor necrosis factor (TNF) ligand superfamily members and their receptors. Recent evidence indicates that in addition to triggering apoptosis, the TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation. To understand TRAIL-mediated signal transduction mechanism in osteoclastogenesis, we demonstrated that TRAIL induces osteoclast differentiation via a Tumor necrosis factor receptor-associated factor 6 (TRAF-6)-dependent signaling pathway. TRAIL-induced osteoclast differentiation was significantly inhibited by treatment with TRAF-6 siRNA and TRAF6 decoy peptides in both human monocytes and murine RAW264.7 macrophage cell lines, as evaluated in terms of tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cells and bone resorption activity. Moreover, TRAIL-induced osteoclast differentiation was also abolished in TRAF6 knockout bone marrow macrophages. In addition to induction of NFATc1, treatment of TRAIL also induced ubiquitination of TRAF6 in osteoclast differentiation. Thus, our data demonstrate that TRAIL induces osteoclastic differentiation via a TRAF-6 dependent signaling pathway. This study suggests TRAF6-dependent signaling may be a central pathway in osteoclast differentiation, and that TNF superfamily molecules other than RANKL may modify RANK signaling by interaction with TRAF6-associated signaling.	[Yen, Men-Luh] Natl Taiwan Univ, Coll Med, Dept Gen Med, Taipei 10764, Taiwan; [Yen, Men-Luh] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Hsu, Ping-Ning; Liao, Hsiu-Jung; Lee, Be-Hang] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan; [Hsu, Ping-Ning] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Tsai, Hwei-Fang] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Taipei, Taiwan; [Tsai, Hwei-Fang] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University	Yen, ML (corresponding author), Natl Taiwan Univ, Coll Med, Dept Gen Med, Taipei 10764, Taiwan.	hftsai8635@yahoo.com.tw		HSU, PING-NING/0000-0003-4479-3391; YEN, MEN-LUH/0000-0003-3800-3664	National Science Council, Taiwan [NSC096-2811-B-002-043, NSC98-3112-B-002-047, NSC98-2320-B-002-049-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council, Taiwan (NSC096-2811-B-002-043, NSC98-3112-B-002-047, and NSC98-2320-B-002-049-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bai S, 2008, J BIOL CHEM, V283, P30861, DOI 10.1074/jbc.M802525200; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cheng X, 2003, IMMUNOL RES, V27, P287, DOI 10.1385/IR:27:2-3:287; Chou AH, 2005, J IMMUNOL, V174, P2160, DOI 10.4049/jimmunol.174.4.2160; Clowes JA, 2005, IMMUNOL REV, V208, P207, DOI 10.1111/j.0105-2896.2005.00334.x; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Jin W, 2008, J CLIN INVEST, V118, P1858, DOI 10.1172/JCI34257; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; Kitaura H, 2005, J CLIN INVEST, V115, P3418, DOI 10.1172/JCI26132; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lamothe B, 2007, BIOCHEM BIOPH RES CO, V359, P1044, DOI 10.1016/j.bbrc.2007.06.017; Lamothe B, 2008, J BIOL CHEM, V283, P24871, DOI 10.1074/jbc.M802749200; Li XT, 2003, ENDOCRINOLOGY, V144, P4999, DOI 10.1210/en.2003-0166; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Massey HM, 1999, BRIT J HAEMATOL, V106, P167; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Park H, 2005, J IMMUNOL, V175, P7193, DOI 10.4049/jimmunol.175.11.7193; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2005, J MOL MED, V83, P170, DOI 10.1007/s00109-004-0612-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Walsh MC, 2003, CYTOKINE GROWTH F R, V14, P251, DOI 10.1016/S1359-6101(03)00027-3; Walsh NC, 2005, IMMUNOL REV, V208, P228, DOI 10.1111/j.0105-2896.2005.00338.x; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Yang CR, 2004, CELL DEATH DIFFER, V11, pS97, DOI 10.1038/sj.cdd.4401403; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yen ML, 2008, MOL IMMUNOL, V45, P2205, DOI 10.1016/j.molimm.2007.12.003	36	39	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38048	10.1371/journal.pone.0038048	http://dx.doi.org/10.1371/journal.pone.0038048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719861	Green Submitted, gold, Green Published			2022-12-25	WOS:000305347800004
J	Hass, J; Blaschke, S; Herrmann, JM				Hass, Joachim; Blaschke, Stefan; Herrmann, J. Michael			Cross-Modal Distortion of Time Perception: Demerging the Effects of Observed and Performed Motion	PLOS ONE			English	Article							PURSUIT TRACKING; INTEGRATION; MOVEMENT; DISCRIMINATION; INFORMATION; MECHANISMS; INTERVALS; MODEL; LAW	Temporal information is often contained in multi-sensory stimuli, but it is currently unknown how the brain combines e. g. visual and auditory cues into a coherent percept of time. The existing studies of cross-modal time perception mainly support the "modality appropriateness hypothesis", i.e. the domination of auditory temporal cues over visual ones because of the higher precision of audition for time perception. However, these studies suffer from methodical problems and conflicting results. We introduce a novel experimental paradigm to examine cross-modal time perception by combining an auditory time perception task with a visually guided motor task, requiring participants to follow an elliptic movement on a screen with a robotic manipulandum. We find that subjective duration is distorted according to the speed of visually observed movement: The faster the visual motion, the longer the perceived duration. In contrast, the actual execution of the arm movement does not contribute to this effect, but impairs discrimination performance by dual-task interference. We also show that additional training of the motor task attenuates the interference, but does not affect the distortion of subjective duration. The study demonstrates direct influence of visual motion on auditory temporal representations, which is independent of attentional modulation. At the same time, it provides causal support for the notion that time perception and continuous motor timing rely on separate mechanisms, a proposal that was formerly supported by correlational evidence only. The results constitute a counterexample to the modality appropriateness hypothesis and are best explained by Bayesian integration of modality-specific temporal information into a centralized "temporal hub".	[Hass, Joachim] Heidelberg Univ, Res Grp Computat Neurosci, Cent Inst Mental Hlth, Med Fac Mannheim, D-6800 Mannheim, Germany; [Hass, Joachim] Bernstein Ctr Computat Neurosci Heidelberg Mannhe, Mannheim, Germany; [Blaschke, Stefan] FH Arnstadt Balingen, Balingen, Germany; [Herrmann, J. Michael] Univ Edinburgh, Inst Percept Act & Behav, Sch Informat, Edinburgh, Midlothian, Scotland; [Herrmann, J. Michael] Bernstein Ctr Gottingen, Gottingen, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Edinburgh	Hass, J (corresponding author), Heidelberg Univ, Res Grp Computat Neurosci, Cent Inst Mental Hlth, Med Fac Mannheim, D-6800 Mannheim, Germany.	joachim.hass@zi-mannheim.de		Hass, Joachim/0000-0001-6802-7718	German Bundesministerium fur Bildung und Forschung (BMBF) in the framework of the Bernstein Center for Computational Neuroscience Gottingen project C3 [01GQ0432, 01GQ1005B]	German Bundesministerium fur Bildung und Forschung (BMBF) in the framework of the Bernstein Center for Computational Neuroscience Gottingen project C3(Federal Ministry of Education & Research (BMBF))	This work was funded by the German Bundesministerium fur Bildung und Forschung (BMBF) in the framework of the Bernstein Center for Computational Neuroscience Gottingen project C3, grant numbers 01GQ0432 and 01GQ1005B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biess A, 2007, J NEUROSCI, V27, P13045, DOI 10.1523/JNEUROSCI.4334-06.2007; Brown JF, 1931, PSYCHOL FORSCH, V14, P233, DOI 10.1007/BF00403874; Brown SW, 2008, PSYCHOLOGY OF TIME, P111, DOI 10.1016/B978-0-08046-977-5.00004-1; Brown SW, 1997, PERCEPT PSYCHOPHYS, V59, P1118, DOI 10.3758/BF03205526; BROWN SW, 1995, PERCEPT PSYCHOPHYS, V57, P105, DOI 10.3758/BF03211853; Brown SW, 2002, PSYCHOL RES-PSYCH FO, V66, P80, DOI 10.1007/s004260100076; Buonomano DV, 2010, TRENDS COGN SCI, V14, P520, DOI 10.1016/j.tics.2010.09.002; Burr D, 2009, EXP BRAIN RES, V198, P49, DOI 10.1007/s00221-009-1933-z; Chen KM, 2009, ACTA PSYCHOL, V130, P225, DOI 10.1016/j.actpsy.2008.12.008; CREELMAN CD, 1962, J ACOUST SOC AM, V34, P582, DOI 10.1121/1.1918172; Deneve S, 2004, J PHYSIOLOGY-PARIS, V98, P249, DOI 10.1016/j.jphysparis.2004.03.011; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; Fraisse P, 1963, PSYCHOL TIME; Gamache PL, 2010, EUR J NEUROSCI, V31, P1908, DOI 10.1111/j.1460-9568.2010.07197.x; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Grondin S, 2001, PSYCHOL BULL, V127, P22, DOI 10.1037//0033-2909.127.1.22; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Guttman SE, 2005, PSYCHOL SCI, V16, P228, DOI 10.1111/j.0956-7976.2005.00808.x; Hass J, 2008, J COMPUT NEUROSCI, V25, P449, DOI 10.1007/s10827-008-0088-4; Hass J, 2012, NEURAL COMPUT, V24, P1519, DOI 10.1162/NECO_a_00280; Hass J, 2009, PROG NEURAL PROCESS, V18, P167, DOI 10.1142/9789812834232_0014; IVRY RB, 1995, J EXP PSYCHOL HUMAN, V21, P3, DOI 10.1037/0096-1523.21.1.3; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Jazayeri M, 2010, NAT NEUROSCI, V13, P1020, DOI 10.1038/nn.2590; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; KAERNBACH C, 1991, PERCEPT PSYCHOPHYS, V49, P227, DOI 10.3758/BF03214307; Kanai R, 2006, J VISION, V6, P1421, DOI 10.1167/16.12.8; KEELE SW, 1985, ACTA PSYCHOL, V60, P173, DOI 10.1016/0001-6918(85)90054-X; Klink PC, 2011, ATTEN PERCEPT PSYCHO, V73, P219, DOI 10.3758/s13414-010-0010-9; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Ley I, 2009, J EXP PSYCHOL HUMAN, V35, P1005, DOI 10.1037/a0015021; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; Pariyadath V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001264; Rammsayer T, 2005, ACTA PSYCHOL, V120, P141, DOI 10.1016/j.actpsy.2005.03.005; RAMMSAYER TH, 1991, PERCEPT PSYCHOPHYS, V50, P565, DOI 10.3758/BF03207541; Recanzone GH, 2003, J NEUROPHYSIOL, V89, P1078, DOI 10.1152/jn.00706.2002; Recanzone GH, 2009, HEARING RES, V258, P89, DOI 10.1016/j.heares.2009.04.009; Robertson SD, 1999, J EXP PSYCHOL HUMAN, V25, P1316, DOI 10.1037/0096-1523.25.5.1316; van Wassenhove V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001437; VIVIANI P, 1990, J MOTOR BEHAV, V22, P407; VIVIANI P, 1987, J EXP PSYCHOL HUMAN, V13, P62, DOI 10.1037/0096-1523.13.1.62; VIVIANI P, 1995, J EXP PSYCHOL HUMAN, V21, P32, DOI 10.1037/0096-1523.21.1.32; Wada Y, 2003, INT J PSYCHOPHYSIOL, V50, P117, DOI 10.1016/S0167-8760(03)00128-4; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Wuerger S, 2010, INFORM FUSION, V11, P45, DOI 10.1016/j.inffus.2009.04.005; Zakay D, 1997, CURR DIR PSYCHOL SCI, V6, P12, DOI 10.1111/1467-8721.ep11512604; Zelaznik HN, 2002, J EXP PSYCHOL HUMAN, V28, P575, DOI 10.1037//0096-1523.28.3.575; Zelaznik HN, 2008, PSYCHOLOGY OF TIME, P233, DOI 10.1016/B978-0-08046-977-5.00007-7	48	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38092	10.1371/journal.pone.0038092	http://dx.doi.org/10.1371/journal.pone.0038092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UJ	22701603	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340000011
J	Kascakova, S; Maigre, L; Chevalier, J; Refregiers, M; Pages, JM				Kascakova, Slavka; Maigre, Laure; Chevalier, Jacqueline; Refregiers, Matthieu; Pages, Jean-Marie			Antibiotic Transport in Resistant Bacteria: Synchrotron UV Fluorescence Microscopy to Determine Antibiotic Accumulation with Single Cell Resolution	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; EFFLUX PUMP; ANTIMICROBIAL RESISTANCE; DRUG-RESISTANCE; ACTIVE EFFLUX; CIPROFLOXACIN; NORFLOXACIN; SERUM; PORIN	A molecular definition of the mechanism conferring bacterial multidrug resistance is clinically crucial and today methods for quantitative determination of the uptake of antimicrobial agents with single cell resolution are missing. Using the naturally occurring fluorescence of antibacterial agents after deep ultraviolet (DUV) excitation, we developed a method to non-invasively monitor the quinolones uptake in single bacteria. Our approach is based on a DUV fluorescence microscope coupled to a synchrotron beamline providing tuneable excitation from 200 to 600 nm. A full spectrum was acquired at each pixel of the image, to study the DUV excited fluorescence emitted from quinolones within single bacteria. Measuring spectra allowed us to separate the antibiotic fluorescence from the autofluorescence contribution. By performing spectroscopic analysis, the quantification of the antibiotic signal was possible. To our knowledge, this is the first time that the intracellular accumulation of a clinical antibitiotic could be determined and discussed in relation with the level of drug susceptibility for a multiresistant strain. This method is especially important to follow the behavior of quinolone molecules at individual cell level, to quantify the intracellular concentration of the antibiotic and develop new strategies to combat the dissemination of MDR-bacteria. In addition, this original approach also indicates the heterogeneity of bacterial population when the same strain is under environmental stress like antibiotic attack.	[Kascakova, Slavka; Refregiers, Matthieu] Synchrotron Soleil, DISCO Beamline, St Aubin, France; [Maigre, Laure; Chevalier, Jacqueline; Pages, Jean-Marie] Aix Marseille Univ, UMR MD1, IRBA, Fac Med & Pharm, Marseille, France	SOLEIL Synchrotron; UDICE-French Research Universities; Aix-Marseille Universite	Kascakova, S (corresponding author), Synchrotron Soleil, DISCO Beamline, St Aubin, France.	Jean-Marie.PAGES@univ-amu.fr	Réfrégiers, Matthieu/A-4249-2011; Kascakova, Slavka/V-1844-2018; Réfrégiers, Matthieu/AAE-2075-2022; PAGES, jean-marie/F-2555-2013	Réfrégiers, Matthieu/0000-0002-3281-2308; PAGES, jean-marie/0000-0001-7092-7977	Aix-Marseille Universite, Service de Sante des Armees; SOLEIL [N0 9909 0101, N0 2010 0674, N0 2010 0054]; ANR METABACT [ANR2010 BLAN 725]	Aix-Marseille Universite, Service de Sante des Armees; SOLEIL; ANR METABACT(French National Research Agency (ANR))	The authors are grateful to the SOLEIL for general facilities placed at the authors' disposure. This research was supported by Aix-Marseille Universite, Service de Sante des Armees, the SOLEIL (program N0 9909 0101; N0 2010 0674; N0 2010 0054) and by the ANR METABACT (ANR2010 BLAN 725). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral Leonard, 2011, Adv Enzymol Relat Areas Mol Biol, V77, P61; Ankomah P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002487; Batard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019440; BEDARD J, 1987, ANTIMICROB AGENTS CH, V31, P1348, DOI 10.1128/AAC.31.9.1348; Blot S, 2007, CURR OPIN INFECT DIS, V20, P391, DOI 10.1097/QCO.0b013e32818be6f7; Bornet C, 2003, BIOCHEM BIOPH RES CO, V301, P985, DOI 10.1016/S0006-291X(03)00074-3; CHAPMAN JS, 1988, ANTIMICROB AGENTS CH, V32, P438, DOI 10.1128/AAC.32.4.438; CHAPMAN JS, 1989, ANTIMICROB AGENTS CH, V33, P27, DOI 10.1128/AAC.33.1.27; Davin-Regli A, 2008, CURR DRUG TARGETS, V9, P750, DOI 10.2174/138945008785747824; de Kraker MEA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001104; Dorr T, 2010, PLOS BIOL, DOI [10.1371/journal.-pbio.1000317, DOI 10.1371/JOURNAL.-PBIO.1000317]; Dupont M, 2007, ANTIMICROB AGENTS CH, V51, P3190, DOI 10.1128/AAC.01481-06; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Falagas ME, 2007, INT J ANTIMICROB AG, V29, P630, DOI 10.1016/j.ijantimicag.2006.12.012; Gandhi TN, 2010, CRIT CARE MED, V38, pS315, DOI 10.1097/CCM.0b013e3181e6a2a4; Giuliani A, 2009, J SYNCHROTRON RADIAT, V16, P835, DOI 10.1107/S0909049509034049; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; HIRAI K, 1987, ANTIMICROB AGENTS CH, V31, P582, DOI 10.1128/AAC.31.4.582; HIRAI K, 1986, ANTIMICROB AGENTS CH, V29, P535, DOI 10.1128/AAC.29.3.535; Jamme F, 2010, MICROSC MICROANAL, V16, P507, DOI 10.1017/S1431927610093852; JOOS B, 1985, ANTIMICROB AGENTS CH, V27, P353, DOI 10.1128/AAC.27.3.353; Kirkpatrick ND, 2005, PHOTOCHEM PHOTOBIOL, V81, P125, DOI 10.1562/2004-08-09-RA-267.1; Kouyos RD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001334; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; Lidstrom ME, 2010, NAT CHEM BIOL, V6, P705, DOI [10.1038/NCHEMBIO.436, 10.1038/nchembio.436]; Long T, 2009, PLOS BIOL, V7, P640, DOI 10.1371/journal.pbio.1000068; Mallea M, 1998, MICROBIOL-UK, V144, P3003, DOI 10.1099/00221287-144-11-3003; MORTON SJ, 1986, ANTIMICROB AGENTS CH, V30, P325, DOI 10.1128/AAC.30.2.325; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Nikaido Hiroshi, 2011, Adv Enzymol Relat Areas Mol Biol, V77, P1; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Pages JM, 2011, CURR MED CHEM, V18, P2969, DOI 10.2174/092986711796150469; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Piddock LJV, 2000, J ANTIMICROB CHEMOTH, V45, P159, DOI 10.1093/jac/45.2.159; Poole K, 2007, ANN MED, V39, P162, DOI 10.1080/07853890701195262; Pradel E, 2002, ANTIMICROB AGENTS CH, V46, P2640, DOI 10.1128/AAC.46.8.2640-2643.2002; Ricci V, 2000, ANTIMICROB AGENTS CH, V44, P2361, DOI 10.1128/AAC.44.9.2361-2366.2000; Rice Louis B, 2007, Cleve Clin J Med, V74 Suppl 4, pS12; Wagnieres GA, 1998, PHOTOCHEM PHOTOBIOL, V68, P603; Wernli D, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001022; Zeller V, 1997, ANTIMICROB AGENTS CH, V41, P1973, DOI 10.1128/AAC.41.9.1973; ZENILMAN JM, 1986, ANTIMICROB AGENTS CH, V30, P877, DOI 10.1128/AAC.30.6.877	45	46	48	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38624	10.1371/journal.pone.0038624	http://dx.doi.org/10.1371/journal.pone.0038624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719907	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340000037
J	Zhang, YW; Staal, B; Dykema, KJ; Furge, KA; Vande Woude, GF				Zhang, Yu-Wen; Staal, Ben; Dykema, Karl J.; Furge, Kyle A.; Vande Woude, George F.			Cancer-Type Regulation of MIG-6 Expression by Inhibitors of Methylation and Histone Deacetylation	PLOS ONE			English	Article							MITOGEN-INDUCIBLE GENE-6; NEGATIVE REGULATOR; EGF RECEPTOR; APOPTOSIS; DELETION; BINDING; PROTEIN; DRUGS	Epigenetic silencing is one of the mechanisms leading to inactivation of a tumor suppressor gene, either by DNA methylation or histone modification in a promoter regulatory region. Mitogen inducible gene 6 (MIG-6), mainly known as a negative feedback inhibitor of the epidermal growth factor receptor (EGFR) family, is a tumor suppressor gene that is associated with many human cancers. To determine if MIG-6 is inactivated by epigenetic alteration, we identified a group of human lung cancer and melanoma cell lines in which its expression is either low or undetectable and studied the effects of methylation and of histone deacetylation on its expression. The DNA methyltransferase (DNMT) inhibitor 5-aza-2'-deoxycytidine (5-aza-dC) induced MIG-6 expression in melanoma cell lines but little in lung cancer lines. By contrast, the histone deacetylase (HDAC) inhibitor trichostatin A (TSA) induced MIG-6 expression in lung cancer lines but had little effect in melanoma lines. However, the MIG-6 promoter itself did not appear to be directly affected by either methylation or histone deacetylation, indicating an indirect regulatory mechanism. Luciferase reporter assays revealed that a short segment of exon 1 in the MIG-6 gene is responsible for TSA response in the lung cancer cells; thus, the MIG-6 gene can be epigenetically silenced through an indirect mechanism without having a physical alteration in its promoter. Furthermore, our data also suggest that MIG-6 gene expression is differentially regulated in lung cancer and melanoma.	[Zhang, Yu-Wen; Staal, Ben; Vande Woude, George F.] Van Andel Res Inst, Mol Oncol Lab, Grand Rapids, MI USA; [Dykema, Karl J.; Furge, Kyle A.] Van Andel Res Inst, Lab Computat Biol, Grand Rapids, MI USA	Van Andel Institute; Van Andel Institute	Zhang, YW (corresponding author), Van Andel Res Inst, Mol Oncol Lab, Grand Rapids, MI USA.	YuWen.Zhang@vai.org; George.VandeWoude@vai.org			Van Andel Foundation	Van Andel Foundation	This work was supported by funding from the Van Andel Foundation. The funders had no role in study design, data collection and manuscript.	Amatschek S, 2004, CANCER RES, V64, P844, DOI 10.1158/0008-5472.CAN-03-2361; Anastasi S, 2005, ONCOGENE, V24, P4540, DOI 10.1038/sj.onc.1208658; Anastasi S, 2003, ONCOGENE, V22, P4221, DOI 10.1038/sj.onc.1206516; Caren H, 2007, BRIT J CANCER, V97, P1416, DOI 10.1038/sj.bjc.6604032; Duncan CG, 2010, ONCOTARGET, V1, P265, DOI 10.18632/oncotarget.137; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; Frosi Y, 2010, J CELL BIOL, V189, P557, DOI 10.1083/jcb.201002032; Girard L, 2000, CANCER RES, V60, P4894; Hackel PO, 2001, BIOL CHEM, V382, P1649, DOI 10.1515/BC.2001.200; Hilger-Eversheim K, 2000, GENE, V260, P1, DOI 10.1016/S0378-1119(00)00454-6; Jeong JW, 2009, P NATL ACAD SCI USA, V106, P8677, DOI 10.1073/pnas.0903632106; Jin N, 2009, DEVELOPMENT, V136, P3347, DOI 10.1242/dev.032979; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Li Z, 2011, MOL CARCINOG; Lin CI, 2011, J CLIN ENDOCR METAB, V96, pE554, DOI 10.1210/jc.2010-1800; Mai A, 2009, INT J BIOCHEM CELL B, V41, P199, DOI 10.1016/j.biocel.2008.08.020; Makkinje A, 2000, J BIOL CHEM, V275, P17838, DOI 10.1074/jbc.M909735199; Nomoto S, 2000, GENE CHROMOSOME CANC, V28, P342, DOI 10.1002/1098-2264(200007)28:3<342::AID-GCC13>3.0.CO;2-A; Orso F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-355; Pante G, 2005, J CELL BIOL, V171, P337, DOI 10.1083/jcb.200502013; Poetsch M, 1999, VIRCHOWS ARCH, V435, P105, DOI 10.1007/s004280050406; Reschke M, 2010, HEPATOLOGY, V51, P1383, DOI 10.1002/hep.23428; Ruan DT, 2008, SURGERY, V144, P908, DOI 10.1016/j.surg.2008.07.028; Schmelz K, 2005, LEUKEMIA, V19, P103, DOI 10.1038/sj.leu.2403552; Sigalotti L, 2007, J CELL PHYSIOL, V212, P330, DOI 10.1002/jcp.21066; Taddei A, 2005, EMBO REP, V6, P520, DOI 10.1038/sj.embor.7400441; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Tseng RC, 2005, INT J CANCER, V117, P241, DOI 10.1002/ijc.21178; VanBrocklin MW, 2009, CANCER RES, V69, P1985, DOI 10.1158/0008-5472.CAN-08-3934; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zhang YW, 2007, ONCOGENE, V26, P269, DOI 10.1038/sj.onc.1209790; Zhang YW, 2007, CELL CYCLE, V6, P507, DOI 10.4161/cc.6.5.3928; Zhang YW, 2005, P NATL ACAD SCI USA, V102, P11740, DOI 10.1073/pnas.0505171102	34	41	43	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38955	10.1371/journal.pone.0038955	http://dx.doi.org/10.1371/journal.pone.0038955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701735	Green Submitted, Green Published, gold			2022-12-25	WOS:000305340000056
J	Ruan, GX; Gamble, KL; Risner, ML; Young, LA; McMahon, DG				Ruan, Guo-Xiang; Gamble, Karen L.; Risner, Michael L.; Young, Laurel A.; McMahon, Douglas G.			Divergent Roles of Clock Genes in Retinal and Suprachiasmatic Nucleus Circadian Oscillators	PLOS ONE			English	Article							MAMMALIAN RETINA; MOUSE RETINA; DOPAMINE; PHOTORECEPTOR; RHYTHMS; POLYMORPHISM; SYSTEM; PER3	The retina is both a sensory organ and a self-sustained circadian clock. Gene targeting studies have revealed that mammalian circadian clocks generate molecular circadian rhythms through coupled transcription/translation feedback loops which involve 6 core clock genes, namely Period (Per) 1 and 2, Cryptochrome (Cry) 1 and 2, Clock, and Bmal1 and that the roles of individual clock genes in rhythms generation are tissue-specific. However, the mechanisms of molecular circadian rhythms in the mammalian retina are incompletely understood and the extent to which retinal neural clocks share mechanisms with the suprachiasmatic nucleus (SCN), the central neural clock, is unclear. In the present study, we examined the rhythmic amplitude and period of real-time bioluminescence rhythms in explants of retina from Per1-, Per2-, Per3-, Cry1-, Cry2-, and Clock-deficient mice that carried transgenic PERIOD2:: LUCIFERASE (PER2::LUC) or Period1::luciferase (Per1::luc) circadian reporters. Per1-, Cry1- and Clock-deficient retinal and SCN explants showed weakened or disrupted rhythms, with stronger effects in retina compared to SCN. Per2, Per3, and Cry2 were individually dispensable for sustained rhythms in both tissues. Retinal and SCN explants from double knockouts of Cry1 and Cry2 were arrhythmic. Gene effects on period were divergent with reduction in the number of Per1 alleles shortening circadian period in retina, but lengthening it in SCN, and knockout of Per3 substantially shortening retinal clock period, but leaving SCN unaffected. Thus, the retinal neural clock has a unique pattern of clock gene dependence at the tissue level that it is similar in pattern, but more severe in degree, than the SCN neural clock, with divergent clock gene regulation of rhythmic period.	[Ruan, Guo-Xiang; Gamble, Karen L.; Risner, Michael L.; Young, Laurel A.; McMahon, Douglas G.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA	Vanderbilt University	Ruan, GX (corresponding author), Harvard Univ, Schepens Eye Res Inst, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA 02114 USA.	douglas.g.mcmahon@vanderbilt.edu	Risner, Michael L. L/L-6751-2018	Risner, Michael L. L/0000-0002-8399-5036; Gamble, Karen/0000-0003-3813-8577	National Eye Institute [R01 EY15815]; NATIONAL EYE INSTITUTE [R01EY015815] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was funded by the National Eye Institute (R01 EY15815), www.nei.nih.gov/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SN, 2003, SLEEP, V26, P413, DOI 10.1093/sleep/26.4.413; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Cameron MA, 2008, J BIOL RHYTHM, V23, P489, DOI 10.1177/0748730408325874; DeBruyne JP, 2007, CURR BIOL, V17, pR538, DOI 10.1016/j.cub.2007.05.067; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Dmitriev AV, 2001, J NEUROSCI, V21, P2897, DOI 10.1523/JNEUROSCI.21-08-02897.2001; Doyle SE, 2002, VISUAL NEUROSCI, V19, P593, DOI 10.1017/S0952523802195058; Doyle SE, 2002, J NEUROCHEM, V83, P211, DOI 10.1046/j.1471-4159.2002.01149.x; Ebisawa T, 2001, EMBO REP, V2, P342, DOI 10.1093/embo-reports/kve070; Granados-Fuentes D, 2006, J NEUROSCI, V26, P12219, DOI 10.1523/JNEUROSCI.3445-06.2006; Green CB, 2004, J BIOL RHYTHM, V19, P91, DOI 10.1177/0748730404263002; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; IUVONE PM, 1991, INVEST OPHTH VIS SCI, V32, P1674; Jaliffa CO, 2001, BRAIN RES, V912, P195, DOI 10.1016/S0006-8993(01)02736-6; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Nir I, 2000, BRAIN RES, V870, P118, DOI 10.1016/S0006-8993(00)02409-4; Ogilvie JM, 2002, NEUROBIOL DIS, V10, P33, DOI 10.1006/nbdi.2002.0489; Organisciak DT, 2000, INVEST OPHTH VIS SCI, V41, P3694; Pendergast JS, 2009, J NEUROSCI, V29, P14681, DOI 10.1523/JNEUROSCI.3261-09.2009; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ribelayga C, 2008, NEURON, V59, P790, DOI 10.1016/j.neuron.2008.07.017; Ruan GX, 2006, P NATL ACAD SCI USA, V103, P9703, DOI 10.1073/pnas.0601940103; Ruan GX, 2008, PLOS BIOL, V6, P2248, DOI 10.1371/journal.pbio.0060249; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Styles CJ, 2007, CLIN EXP OPHTHALMOL, V35, P18, DOI 10.1111/j.1442-9071.2007.01416.x; Tanoue S, 2004, CURR BIOL, V14, P638, DOI 10.1016/j.cub.2004.04.009; TEIRSTEIN PS, 1980, INVEST OPHTH VIS SCI, V19, P1268; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Tosini G, 1998, BRAIN RES, V789, P221, DOI 10.1016/S0006-8993(97)01446-7; Tosini G, 2007, FASEB J, V21, P3866, DOI 10.1096/fj.07-8371com; Tosini G, 2007, BRAIN RES, V1159, P134, DOI 10.1016/j.brainres.2007.05.023; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; van der Veen DR, 2010, J BIOL RHYTHM, V25, P3, DOI 10.1177/0748730409356680; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Von Schantz M, 2008, J GENET, V87, P513, DOI 10.1007/s12041-008-0074-7; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	39	40	42	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38985	10.1371/journal.pone.0038985	http://dx.doi.org/10.1371/journal.pone.0038985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701739	Green Submitted, gold, Green Published			2022-12-25	WOS:000305337600063
J	Gordts, PLSM; Bartelt, A; Nilsson, SK; Annaert, W; Christoffersen, C; Nielsen, LB; Heeren, J; Roebroek, AJM				Gordts, Philip L. S. M.; Bartelt, Alexander; Nilsson, Stefan K.; Annaert, Wim; Christoffersen, Christina; Nielsen, Lars Bo; Heeren, Joerg; Roebroek, Anton J. M.			Impaired LDL Receptor-Related Protein 1 Translocation Correlates with Improved Dyslipidemia and Atherosclerosis in apoE-Deficient Mice	PLOS ONE			English	Article							TRIGLYCERIDE-RICH LIPOPROTEINS; HEPARAN-SULFATE PROTEOGLYCANS; APOLIPOPROTEIN-E; CHYLOMICRON REMNANTS; LRP1 EXPRESSION; APOPROTEIN-E; IN-VITRO; CLEARANCE; BINDING; DYSBETALIPOPROTEINEMIA	Objective: Determination of the in vivo significance of LDL receptor-related protein 1 (LRP1) dysfunction on lipid metabolism and atherosclerosis development in absence of its main ligand apoE. Methods and Results: LRP1 knock-in mice carrying an inactivating mutation in the NPxYxxL motif were crossed with apoE-deficient mice. In the absence of apoE, relative to LRP1 wild-type animals, LRP1 mutated mice showed an increased clearance of postprandial lipids despite a compromised LRP1 endocytosis rate and inefficient insulin-mediated translocation of the receptor to the plasma membrane, likely due to inefficient slow recycling of the mutated receptor. Postprandial lipoprotein improvement was explained by increased hepatic clearance of triglyceride-rich remnant lipoproteins and accompanied by a compensatory 1.6-fold upregulation of LDLR expression in hepatocytes. One year-old apoE-deficient mice having the dysfunctional LRP1 revealed a 3-fold decrease in spontaneous atherosclerosis development and a 2-fold reduction in LDL-cholesterol levels. Conclusion: These findings demonstrate that the NPxYxxL motif in LRP1 is important for insulin-mediated translocation and slow perinuclear endosomal recycling. These LRP1 impairments correlated with reduced atherogenesis and cholesterol levels in apoE-deficient mice, likely via compensatory LDLR upregulation.	[Gordts, Philip L. S. M.; Roebroek, Anton J. M.] Katholieke Univ Leuven, Lab Expt Mouse Genet, Ctr Human Genet, Louvain, Belgium; [Bartelt, Alexander; Heeren, Joerg] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Hamburg, Germany; [Bartelt, Alexander] Univ Med Ctr Hamburg Eppendorf, Dept Orthoped, Hamburg, Germany; [Nilsson, Stefan K.] Umea Univ, Dept Med Biosci Physiol Chem, Umea, Sweden; [Annaert, Wim] VIB, Lab Membrane Trafficking, Dept Mol & Dev Genet, Louvain, Belgium; [Annaert, Wim] Katholieke Univ Leuven, Lab Membrane Trafficking, Ctr Human Genet, Louvain, Belgium; [Christoffersen, Christina; Nielsen, Lars Bo] Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Nielsen, Lars Bo] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark	KU Leuven; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Umea University; Flanders Institute for Biotechnology (VIB); KU Leuven; Rigshospitalet; University of Copenhagen; University of Copenhagen	Gordts, PLSM (corresponding author), Katholieke Univ Leuven, Lab Expt Mouse Genet, Ctr Human Genet, Louvain, Belgium.	heeren@uke.uni-hamburg.de; anton.roebroek@med.kuleuven.be	Nilsson, Stefan/K-5555-2012; Bartelt, Alexander/ABC-2525-2020	Christoffersen, Christina/0000-0003-3751-5203; Gordts, Philip/0000-0001-7224-4328	"Fonds voor Wetenschappelijk Onderzoek Vlaanderen" (FWO-Vlaanderen) [G.0529.08, G.0689.10]; KU Leuven [GOA/12/016]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); European Atherosclerosis Society; BMBF ANCYLOSS project;  [GRK1459]	"Fonds voor Wetenschappelijk Onderzoek Vlaanderen" (FWO-Vlaanderen)(FWO); KU Leuven(KU Leuven); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); European Atherosclerosis Society; BMBF ANCYLOSS project(Federal Ministry of Education & Research (BMBF)); 	This work was supported by grants from the "Fonds voor Wetenschappelijk Onderzoek Vlaanderen" (FWO-Vlaanderen G.0529.08 and G.0689.10) and from the KU Leuven (GOA/12/016) to Anton Roebroek. The research was also funded by a PhD grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) to Philip Gordts. Alexander Bartelt is supported by a Postdoctoral Fellowship Award from the European Atherosclerosis Society and the BMBF ANCYLOSS project. Joerg Heeren is supported by the GRK1459. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Basford JE, 2011, J BIOL CHEM, V286, P13079, DOI 10.1074/jbc.M111.229369; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; Boucher P, 2011, BIOCHEM PHARMACOL, V81, P1, DOI 10.1016/j.bcp.2010.09.018; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Dedieu S, 2008, MOL CELL BIOL, V28, P2980, DOI 10.1128/MCB.02238-07; Donoso M, 2009, MOL BIOL CELL, V20, P481, DOI 10.1091/mbc.E08-08-0805; ERICSSON S, 1991, J CLIN INVEST, V87, P591, DOI 10.1172/JCI115034; Field PA, 2000, METABOLISM, V49, P492, DOI 10.1016/S0026-0495(00)80014-1; Gordts PLSM, 2009, ARTERIOSCL THROM VAS, V29, P1258, DOI 10.1161/ATVBAHA.109.192211; Heeren J, 2002, J MOL MED-JMM, V80, P576, DOI 10.1007/s00109-002-0351-5; HERZ J, 1991, J BIOL CHEM, V266, P21232; Hui DY, 2005, NEUROBIOL AGING, V26, P317, DOI 10.1016/j.neurobiolaging.2004.02.030; Johnson AO, 1998, J BIOL CHEM, V273, P17968, DOI 10.1074/jbc.273.28.17968; Knisely Jane M., 2008, V457, P319, DOI 10.1007/978-1-59745-261-8_24; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; Laatsch A, 2009, ATHEROSCLEROSIS, V204, P105, DOI 10.1016/j.atherosclerosis.2008.07.046; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Llorente-Cortes V, 2007, CARDIOVASC RES, V74, P526, DOI 10.1016/j.cardiores.2007.02.020; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Mahley RW, 2007, J CLIN INVEST, V117, P94, DOI 10.1172/JCI30889; Mahley RW, 1999, J LIPID RES, V40, P1933; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mahley RW, 1999, J LIPID RES, V40, P1; Melman L, 2002, MOL BIOL CELL, V13, P3325, DOI 10.1091/mbc.E02-03-0152; MEREDITH MJ, 1988, CELL BIOL TOXICOL, V4, P405, DOI 10.1007/BF00117769; Merkel M, 2005, J BIOL CHEM, V280, P21553, DOI 10.1074/jbc.M411412200; Moon JH, 2011, METABOLISM, V60, P930, DOI 10.1016/j.metabol.2010.08.013; Niemeier A, 2005, J BONE MINER RES, V20, P283, DOI 10.1359/JBMR.041102; Niemeier A, 1996, J LIPID RES, V37, P1733; Nilsson SK, 2007, BIOCHEMISTRY-US, V46, P3896, DOI 10.1021/bi7000533; OTWAY S, 1967, J PHYSIOL-LONDON, V190, P321, DOI 10.1113/jphysiol.1967.sp008211; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Reekmans SM, 2010, CELL MOL LIFE SCI, V67, P135, DOI 10.1007/s00018-009-0171-7; Roebroek AJM, 2006, MOL CELL BIOL, V26, P605, DOI 10.1128/MCB.26.2.605-616.2006; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Schaefer JR, 2009, EUR J HUM GENET, V17, P541, DOI 10.1038/ejhg.2008.222; Schapiro FB, 2004, MOL BIOL CELL, V15, P2884, DOI 10.1091/mbc.E03-09-0653; SCHNEIDER WJ, 1981, J CLIN INVEST, V68, P1075, DOI 10.1172/JCI110330; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tuma P L, 2001, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0302s02; Willnow TE, 1996, BIOCHEM J, V313, P71, DOI 10.1042/bj3130071; Yancey PG, 2011, CIRCULATION, V124, P454, DOI 10.1161/CIRCULATIONAHA.111.032268; Yancey PG, 2010, ARTERIOSCL THROM VAS, V30, P787, DOI 10.1161/ATVBAHA.109.202051; Zhou L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006853	49	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38330	10.1371/journal.pone.0038330	http://dx.doi.org/10.1371/journal.pone.0038330			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701627	Green Published, Green Submitted, gold			2022-12-25	WOS:000305348400051
J	Wucherer, MF; Michiels, NK				Wucherer, Matthias F.; Michiels, Nico K.			A Fluorescent Chromatophore Changes the Level of Fluorescence in a Reef Fish	PLOS ONE			English	Article							MELANOPHORES; PATTERNS; PIGMENT; COLOR; COMMUNICATION; TRANSPORT; EVOLUTION; SYSTEMS	Body coloration plays a major role in fish ecology and is predominantly generated using two principles: a) absorbance combined with reflection of the incoming light in pigment colors and b) scatter, refraction, diffraction and interference in structural colors. Poikilotherms, and especially fishes possess several cell types, so-called chromatophores, which employ either of these principles. Together, they generate the dynamic, multi-color patterns used in communication and camouflage. Several chromatophore types possess motile organelles, which enable rapid changes in coloration. Recently, we described red fluorescence in a number of marine fish and argued that it may be used for private communication in an environment devoid of red. Here, we describe the discovery of a chromatophore in fishes that regulates the distribution of fluorescent pigments in parts of the skin. These cells have a dendritic shape and contain motile fluorescent particles. We show experimentally that the fluorescent particles can be aggregated or dispersed through hormonal and nervous control. This is the first description of a stable and natural cytoskeleton-related fluorescence control mechanism in vertebrate cells. Its nervous control supports suggestions that fluorescence could act as a context-dependent signal in some marine fish species and encourages further research in this field. The fluorescent substance is stable under different chemical conditions and shows no discernible bleaching under strong, constant illumination.	[Wucherer, Matthias F.; Michiels, Nico K.] Univ Tubingen, Tubingen, Germany	Eberhard Karls University of Tubingen	Wucherer, MF (corresponding author), Univ Tubingen, Tubingen, Germany.	matthias.wucherer@uni-tuebingen.de	Michiels, Nico K/A-2045-2009	Michiels, Nico K/0000-0001-9873-3111	German Science Foundation (DFG) [Mi 482/13-1]; Hanns-Seidel-Foundation, Munich, Germany	German Science Foundation (DFG)(German Research Foundation (DFG)); Hanns-Seidel-Foundation, Munich, Germany	This study was part of the "Koselleck Grant Mi 482/13-1" funded by the German Science Foundation (DFG, http://www.dfg.de). The main author was supported by a stipend from the Hanns-Seidel-Foundation, Munich, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott F, 1973, INTEGR COMP BIOL, V13, P885; Aspengren S, 2003, PIGM CELL RES, V16, P59, DOI 10.1034/j.1600-0749.2003.00003.x; Aspengren S, 2009, DIFFERENT STRATEGIES; Aspengren S, 2007, J NEUROSCI RES, V85, P2591, DOI 10.1002/jnr.21132; Bagnara JT, 2007, PIGM CELL RES, V20, P14, DOI 10.1111/j.1600-0749.2006.00360.x; Bagnara JT., 2006, PIGMENTARY SYSTEM PH, P11, DOI [10.1002/9780470987100.ch2, DOI 10.1002/9780470987100.CH2]; Burton D, 2000, J FISH BIOL; Cheney KL, 2008, P R SOC B, V275, P117, DOI 10.1098/rspb.2007.0966; Cott H.B., 1940, ADAPTIVE COLORATION; Endler J, 2008, BIOL J LINN SOC, V41, P315; ENDLER JA, 1993, PHILOS T R SOC B, V340, P215, DOI 10.1098/rstb.1993.0060; ENDLER JA, 1999, ANIMAL SIGNALS SIGNA, P11; Fujii R, 2000, PIGM CELL RES, V13, P300, DOI 10.1034/j.1600-0749.2000.130502.x; Fujishige A, 2000, COMP BIOCHEM PHYS A, V127, P167, DOI 10.1016/S1095-6433(00)00252-X; Goda M, 1995, ZOOL SCI, V12, P811, DOI 10.2108/zsj.12.811; HAROSI FI, 1983, SCIENCE, V222, P1021, DOI 10.1126/science.6648514; KASUKAWA H, 1987, PIGM CELL RES, V1, P152, DOI 10.1111/j.1600-0749.1987.tb00406.x; Kawauchi H, 2004, PEPTIDES, V25, P1577, DOI 10.1016/j.peptides.2004.03.025; Kelsh RN, 2004, PIGM CELL RES, V17, P326, DOI 10.1111/j.1600-0749.2004.00174.x; Leclercq E, 2010, FISH FISH, V11, P159, DOI 10.1111/j.1467-2979.2009.00346.x; Loew E.R., 1990, P1; Losey GS, 1999, J FISH BIOL, V54, P921, DOI 10.1111/j.1095-8649.1999.tb00848.x; Lythgoe J.N., 1979, ECOLOGY VISION; Marshall NJ, 2003, COPEIA, P455, DOI 10.1643/01-055; Marshall NJ, 2000, PHILOS T ROY SOC B, V355, P1243, DOI 10.1098/rstb.2000.0676; Marshall NJ, 2010, COLOUR DESIGN CREATI, V5, P1; Michiels Nico K., 2008, BMC Ecology, V8, P16, DOI 10.1186/1472-6785-8-16; Miyata S, 2005, J EXPT ZOOLOGY, V241, P31; Nakajima M, 1999, ZOOLOGICAL SCI; Price AC, 2008, ZEBRAFISH, V5, P297, DOI 10.1089/zeb.2008.0551; Quigley AK, 2004, DEVELOPMENT, V131, P6053, DOI 10.1242/dev.01526; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Siebeck UE, 2010, CURR BIOL, V20, P407, DOI 10.1016/j.cub.2009.12.047; Sugimoto M, 2002, MICROSCOPY RES TECHN; Turner JR, 2009, DEEP-SEA RES PT I, V56, P1003, DOI 10.1016/j.dsr.2009.01.007; Zhang C, 2010, P NATL ACAD SCI US	36	20	20	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37913	10.1371/journal.pone.0037913	http://dx.doi.org/10.1371/journal.pone.0037913			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701587	gold, Green Submitted, Green Published			2022-12-25	WOS:000305348400025
J	Cao, DS; Zhong, LL; Hsieh, TH; Abooj, M; Bishnoi, M; Hughes, L; Premkumar, LS				Cao, De-Shou; Zhong, Linlin; Hsieh, Tsung-han; Abooj, Mruvil; Bishnoi, Mahendra; Hughes, Lauren; Premkumar, Louis S.			Expression of Transient Receptor Potential Ankyrin 1 (TRPA1) and Its Role in Insulin Release from Rat Pancreatic Beta Cells	PLOS ONE			English	Article							SENSITIVE K+ CHANNELS; SENSORY NEURONS; DIABETIC COMPLICATIONS; COVALENT MODIFICATION; COLD HYPERALGESIA; CATION CHANNELS; CA2+ RELEASE; ION CHANNELS; LINE RIN-5F; ADP-RIBOSE	Objective: Several transient receptor potential (TRP) channels are expressed in pancreatic beta cells and have been proposed to be involved in insulin secretion. However, the endogenous ligands for these channels are far from clear. Here, we demonstrate the expression of the transient receptor potential ankyrin 1 (TRPA1) ion channel in the pancreatic beta cells and its role in insulin release. TRPA1 is an attractive candidate for inducing insulin release because it is calcium permeable and is activated by molecules that are produced during oxidative glycolysis. Methods: Immunohistochemistry, RT-PCR, and Western blot techniques were used to determine the expression of TRPA1 channel. Ca2+ fluorescence imaging and electrophysiology (voltage-and current-clamp) techniques were used to study the channel properties. TRPA1-mediated insulin release was determined using ELISA. Results: TRPA1 is abundantly expressed in a rat pancreatic beta cell line and freshly isolated rat pancreatic beta cells, but not in pancreatic alpha cells. Activation of TRPA1 by allyl isothiocyanate (AITC), hydrogen peroxide (H2O2), 4-hydroxynonenal (4-HNE), and cyclopentenone prostaglandins (PGJ(2)) and a novel agonist methylglyoxal (MG) induces membrane current, depolarization, and Ca2+ influx leading to generation of action potentials in a pancreatic beta cell line and primary cultured pancreatic beta cells. Activation of TRPA1 by agonists stimulates insulin release in pancreatic beta cells that can be inhibited by TRPA1 antagonists such as HC030031 or AP-18 and by RNA interference. TRPA1-mediated insulin release is also observed in conditions of voltage-gated Na+ and Ca2+ channel blockade as well as ATP sensitive potassium (K-ATP) channel activation. Conclusions: We propose that endogenous and exogenous ligands of TRPA1 cause Ca2+ influx and induce basal insulin release and that TRPA1-mediated depolarization acts synergistically with K-ATP channel blockade to facilitate insulin release.	[Cao, De-Shou; Zhong, Linlin; Hsieh, Tsung-han; Abooj, Mruvil; Bishnoi, Mahendra; Hughes, Lauren; Premkumar, Louis S.] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA	Southern Illinois University System; Southern Illinois University	Cao, DS (corresponding author), So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA.	dcao@ucsd.edu; lpremkumar@siumed.edu	Bishnoi, Mahendra/CAG-3229-2022; Cao, Deshou/G-8697-2014	Bishnoi, Mahendra/0000-0002-7785-1204	National Institutes of Health [NS042296, DK065742, DA028017]; Southern Illinois University School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK065742, R01DK065742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Southern Illinois University School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from National Institutes of Health (NS042296 and DK065742 and DA028017) and an Excellence in Academic Medicine (EAM) award from Southern Illinois University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba Y, 2004, BIOCHEM BIOPH RES CO, V321, P219, DOI 10.1016/j.bbrc.2004.06.149; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Barbasa M, 2008, ETHNICITY DIS S1, V18, P62; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; BRITSCH S, 1995, BIOCHEM BIOPH RES CO, V207, P33, DOI 10.1006/bbrc.1995.1149; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Casas S, 2008, DIABETOLOGIA, V51, P2252, DOI 10.1007/s00125-008-1111-z; Ceppa E, 2010, AM J PHYSIOL-GASTR L, V299, pG556, DOI 10.1152/ajpgi.00433.2009; Cheng H, 2007, CELL CALCIUM, V41, P51, DOI 10.1016/j.ceca.2006.04.032; Colsoul B, 2010, P NATL ACAD SCI USA, V107, P5208, DOI 10.1073/pnas.0913107107; Cook LJ, 1998, BIOCHEM PHARMACOL, V55, P1361, DOI 10.1016/S0006-2952(97)00619-9; Drews G, 2010, ADV EXP MED BIOL, V654, P115, DOI 10.1007/978-90-481-3271-3_7; Gram DX, 2007, EUR J NEUROSCI, V25, P213, DOI 10.1111/j.1460-9568.2006.05261.x; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hisanaga E, 2009, DIABETES, V58, P174, DOI 10.2337/db08-0862; Ishii M, 2006, J PHARMACOL SCI, V101, P174, DOI 10.1254/jphs.SCJ06001X; Ishii M, 2006, CELL CALCIUM, V39, P487, DOI 10.1016/j.ceca.2006.01.013; Islam MS, 2011, ADV EXP MED BIOL, V704, P811, DOI 10.1007/978-94-007-0265-3_42; Jacobson D. A., 2007, V179, P409; Jan CR, 2005, CELL SIGNAL, V17, P847, DOI 10.1016/j.cellsig.2004.11.007; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Katsura H, 2006, EXP NEUROL, V200, P112, DOI 10.1016/j.expneurol.2006.01.031; Kerstein PC, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-19; Komatsu M, 2001, ENDOCR J, V48, P275, DOI 10.1507/endocrj.48.275; Krippeit-Drews P, 1999, J PHYSIOL-LONDON, V514, P471, DOI 10.1111/j.1469-7793.1999.471ae.x; KRIPPEITDREWS P, 1994, PFLUG ARCH EUR J PHY, V426, P552, DOI 10.1007/BF00378534; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Leech CA, 1997, J BIOL CHEM, V272, P17987, DOI 10.1074/jbc.272.29.17987; Li F, 2009, WORLD J GASTROENTERO, V15, P3046, DOI 10.3748/wjg.15.3046; MacDonald MJ, 2006, ARCH BIOCHEM BIOPHYS, V447, P118, DOI 10.1016/j.abb.2006.01.019; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Miura Y, 2003, AM J PHYSIOL-ENDOC M, V285, pE1001, DOI 10.1152/ajpendo.00005.2003; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; NAKAZAKI M, 1995, DIABETES, V44, P878, DOI 10.2337/diabetes.44.8.878; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Numazawa S, 2012, BIOL PHARM BULL, V35, P346, DOI 10.1248/bpb.35.346; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Qian F, 2002, DIABETES, V51, pS183, DOI 10.2337/diabetes.51.2007.S183; Ravier MA, 2010, DIABETOLOGIA, V53, P1947, DOI 10.1007/s00125-010-1775-z; Razavi R, 2006, CELL, V127, P1123, DOI 10.1016/j.cell.2006.10.038; Roe MW, 1998, J BIOL CHEM, V273, P10402, DOI 10.1074/jbc.273.17.10402; Sakura H, 1997, DIABETOLOGIA, V40, P528, DOI 10.1007/s001250050711; Sato Y, 1999, ENDOCRINOLOGY, V140, P2252, DOI 10.1210/en.140.5.2252; Sawada Y, 2008, EUR J NEUROSCI, V27, P1131, DOI 10.1111/j.1460-9568.2008.06093.x; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Straub SG, 1998, DIABETES, V47, P758, DOI 10.2337/diabetes.47.5.758; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Uchida K, 2011, DIABETES, V60, P119, DOI 10.2337/db10-0276; Vennekens R, 2007, NAT IMMUNOL, V8, P312, DOI 10.1038/ni1441; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Wang H, 2007, CLIN BIOCHEM, V40, P1232, DOI 10.1016/j.clinbiochem.2007.07.016	60	84	90	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38005	10.1371/journal.pone.0038005	http://dx.doi.org/10.1371/journal.pone.0038005			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701540	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338500071
J	Fior, J				Fior, Jonathan			An Initial In Vitro Investigation into the Potential Therapeutic Use of SupT1 Cells to Prevent AIDS in HIV-Seropositive Individuals	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELLS; SOLUBLE CD4; MULTIPLE-SCLEROSIS; LINES; VIF; DNA; REPLICATION; VACCINATION; INHIBITION	HIV infection usually leads to a progressive decline in number and functionality of CD4+ T lymphocytes, resulting in AIDS development. In this study, I investigated the strategy of using inoculated SupT1 cells to move infection from HIV-1 X4 strains toward the inoculated cells, which should theoretically prevent infection and depletion of normal CD4+ T cells, preventing the development of AIDS-related pathologies. Interestingly, the persistent in vitro replication in SupT1 cells renders the virus less cytopathic and more sensitive to antibody-mediated neutralization, suggesting that replication of the virus in the inoculated SupT1 cells may have a vaccination effect in the long run. In order to mimic the scenario of a therapy in which SupT1 cells are inoculated in an HIV-seropositive patient, I used infected SupT1/PBMC cocultures and a series of control experiments. Infections were done with equal amounts of the wild type HIV-1 LAI virus. The SupT1 CD4+ CD8+ T cell population was distinguished from the PBMC CD4+ CD8-T cell population by FACS analysis. The results of this study show that the virus-mediated killing of primary CD4+ T cells in the SupT1/PBMC cocultures was significantly delayed, suggesting that the preferential infection of SupT1 cells can induce the virus to spare primary CD4+ T cells from infection and depletion. The preferential infection of SupT1 cells can be explained by the higher viral tropism for the SupT1 cell line. In conclusion, this study demonstrates that it's possible in an in vitro system to use SupT1 cells to prevent HIV infection of primary CD4+ T cells, suggesting that further exploration of the SupT1 cell line as a cell-based therapy against HIV-1 may prove worthwhile.	Univ Milan, Sect Infect Dis & Immunopathol, Dept Clin Sci, Luigi Sacco Hosp, Milan, Italy	University of Milan; Luigi Sacco Hospital	Fior, J (corresponding author), Univ Milan, Sect Infect Dis & Immunopathol, Dept Clin Sci, Luigi Sacco Hosp, Milan, Italy.	jonathan.fior82@gmail.com		Fior, Jonathan/0000-0002-5283-407X	University of Mila	University of Mila	This study was supported by the University of Mila. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUERSPERG N, 1964, J NATL CANCER I, V32, P135; Badley AD, 2000, BLOOD, V96, P2951, DOI 10.1182/blood.V96.9.2951.h8002951_2951_2964; Brenner MK, 2010, CURR OPIN IMMUNOL, V22, P251, DOI 10.1016/j.coi.2010.01.020; Chinnaiyan AM, 1997, NAT MED, V3, P333, DOI 10.1038/nm0397-333; DAAR ES, 1990, P NATL ACAD SCI USA, V87, P6574, DOI 10.1073/pnas.87.17.6574; Das AT, 1999, VIROLOGY, V263, P55, DOI 10.1006/viro.1999.9898; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Glynn JM, 1996, J IMMUNOL, V157, P2754; Jeeninga RE, 2005, CANCER RES, V65, P3347, DOI 10.1158/0008-5472.CAN-04-4280; MOORE JP, 1993, AIDS RES HUM RETROV, V9, P529, DOI 10.1089/aid.1993.9.529; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; SMITH SD, 1984, CANCER RES, V44, P5657; Thielen BK, 2007, PLOS PATHOG, V3, P1320, DOI 10.1371/journal.ppat.0030135; TURNER S, 1992, P NATL ACAD SCI USA, V89, P1335, DOI 10.1073/pnas.89.4.1335; Van der AA A, 2003, CLIN EXP IMMUNOL, V131, P155, DOI 10.1046/j.1365-2249.2003.02019.x; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; Xin KQ, 1999, VACCINE, V17, P858, DOI 10.1016/S0264-410X(98)00271-0; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang JZ, 2002, J NEUROL, V249, P212, DOI 10.1007/PL00007867	20	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2012	7	5							e37511	10.1371/journal.pone.0037511	http://dx.doi.org/10.1371/journal.pone.0037511			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TH	22701517	gold, Green Published, Green Submitted			2022-12-25	WOS:000305335800050
J	Tian, XY; Tian, YF; Sarich, N; Wu, TH; Birukova, AA				Tian, Xinyong; Tian, Yufeng; Sarich, Nicolene; Wu, Tinghuai; Birukova, Anna A.			Novel role of stathmin in microtubule-dependent control of endothelial permeability	FASEB JOURNAL			English	Article						dynamics; cytoskeleton; lung; Rho GTPase; GEF-H1	BARRIER ENHANCEMENT; PROTEIN-KINASE; RHO-KINASE; IN-VITRO; GEF-H1; DYNAMICS; MYOSIN; PHOSPHORYLATION; PHOSPHATASE	Microtubule (MT) dynamics in vascular endothelium are modulated by vasoactive mediators and are critically involved in the control of endothelial cell (EC) permeability via Rho GTPase-dependent crosstalk with the actin cytoskeleton. However, the role of regulators in MT stability in these mechanisms remains unclear. This study investigated the involvement of the MT-associated protein stathmin in the mediation of agonist-induced permeability in EC cultures and vascular leak in vivo. Thrombin treatment of human pulmonary ECs induced rapid dephosphorylation and activation of stathmin. Inhibition of stathmin activity by small interfering RNA-based knockdown or cAMP-mediated phosphorylation abrogated thrombin-induced F-actin remodeling and Rho-dependent EC hyperpermeability, while expression of a phosphorylation-deficient stathmin mutant exacerbated thrombin-induced EC barrier disruption. Stathmin suppression preserved the MT network against thrombin-induced MT disassembly and release of Rho-specific guanine nucleotide exchange factor, GEF-H1. The protective effects of stathmin knockdown were observed in vivo in the mouse 2-hit model of ventilator-induced lung injury and were linked to MT stabilization and down-regulation of Rho signaling in the lung. These results demonstrate the mechanism of stathmin-dependent control of MT dynamics, Rho signaling, and permeability and suggest novel potential pharmacological interventions in the prevention of increased vascular leak via modulation of stathmin activity.-Tian, X., Tian, Y., Sarich, N., Wu, T., Birukova, A. A. Novel role of stathmin in microtubule-dependent control of endothelial permeability. FASEB J. 26, 3862-3874 (2012). www.fasebj.org	[Birukova, Anna A.] Univ Chicago, Dept Med, Lung Injury Ctr, Sect Pulm & Crit Med,Off N 611, Chicago, IL 60637 USA	University of Chicago	Birukova, AA (corresponding author), Univ Chicago, Dept Med, Lung Injury Ctr, Sect Pulm & Crit Med,Off N 611, 5841 S Maryland Ave, Chicago, IL 60637 USA.	abirukov@medicine.bsd.uchicago.edu			U.S. National Heart, Lung, and Blood Institute [HL-089257, HL-107920]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089257, R01HL107920] Funding Source: NIH RePORTER	U.S. National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are grateful to Katherine Higginbotham for invaluable assistance with editing and proofreading the manuscript. This work was aupported by U.S. National Heart, Lung, and Blood Institute grants HL-089257 and HL-107920	Amano M, 2003, J NEUROCHEM, V87, P780, DOI 10.1046/j.1471-4159.2003.02054.x; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2005, J CELL PHYSIOL, V204, P934, DOI 10.1002/jcp.20359; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Birukova AA, 2007, EXP CELL RES, V313, P2504, DOI 10.1016/j.yexcr.2007.03.036; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V299, pL652, DOI 10.1152/ajplung.00202.2009; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009; Birukova AA, 2010, TRANSL RES, V155, P44, DOI 10.1016/j.trsl.2009.09.002; Birukova AA, 2010, MICROVASC RES, V79, P128, DOI 10.1016/j.mvr.2009.11.007; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Chen PW, 2010, J BIOL CHEM, V285, P10053, DOI 10.1074/jbc.M109.044420; CURMI PA, 1994, BIOCHEM J, V300, P331, DOI 10.1042/bj3000331; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Essler M, 1998, J BIOL CHEM, V273, P21867, DOI 10.1074/jbc.273.34.21867; Giampietro C, 2005, ENDOCRINOLOGY, V146, P1825, DOI 10.1210/en.2004-0972; Gradin HM, 1998, J CELL BIOL, V140, P131, DOI 10.1083/jcb.140.1.131; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Jin KL, 2004, FASEB J, V18, P287, DOI 10.1096/fj.03-0973com; Kakiashvili E, 2009, J BIOL CHEM, V284, P11454, DOI 10.1074/jbc.M805933200; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Manna T, 2009, J BIOL CHEM, V284, P15640, DOI 10.1074/jbc.M900343200; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Petrache I, 2003, AM J RESP CELL MOL, V28, P574, DOI 10.1165/rcmb.2002-0075OC; Singleton PA, 2009, CIRC RES, V104, P978, DOI 10.1161/CIRCRESAHA.108.193367; Thomas M, 2005, P NATL ACAD SCI USA, V102, P5679, DOI 10.1073/pnas.0502067102; Thomas M, 2005, PHARM RES-DORDR, V22, P373, DOI 10.1007/s11095-004-1874-y; Verin AD, 1998, AM J PHYSIOL-LUNG C, V275, pL788, DOI 10.1152/ajplung.1998.275.4.L788; Waterman-Storer CM, 1999, CURR OPIN CELL BIOL, V11, P61, DOI 10.1016/S0955-0674(99)80008-8; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Xing JJ, 2010, MICROVASC RES, V79, P56, DOI 10.1016/j.mvr.2009.11.006	35	23	24	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2012	26	9					3862	3874		10.1096/fj.12-207746	http://dx.doi.org/10.1096/fj.12-207746			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22700873	Green Published			2022-12-25	WOS:000308391600026
J	Bom, APDA; Rangel, LP; Costa, DCF; de Oliveira, GAP; Sanches, D; Braga, CA; Gava, LM; Ramos, CHI; Cepeda, AOT; Stumbo, AC; Gallo, CVD; Cordeiro, Y; Silva, JL				Bom, Ana P. D. Ano; Rangel, Luciana P.; Costa, Danielly C. F.; de Oliveira, Guilherme A. P.; Sanches, Daniel; Braga, Carolina A.; Gava, Lisandra M.; Ramos, Carlos H. I.; Cepeda, Ana O. T.; Stumbo, Ana C.; De Moura Gallo, Claudia V.; Cordeiro, Yraima; Silva, Jerson L.			Mutant p53 Aggregates into Prion-like Amyloid Oligomers and Fibrils IMPLICATIONS FOR CANCER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR P53; TETRAMERIZATION DOMAIN; COMMON MECHANISM; MOLTEN GLOBULE; PROTEIN; NEUROBLASTOMA; ACCUMULATION; ANTIBODIES; HYDRATION; BIOLOGY	Over 50% of all human cancers lose p53 function. To evaluate the role of aggregation in cancer, we asked whether wild-type (WT) p53 and the hot-spot mutant R248Q could aggregate as amyloids under physiological conditions and whether the mutant could seed aggregation of the wild-type form. The central domains (p53C) of both constructs aggregated into a mixture of oligomers and fibrils. R248Q had a greater tendency to aggregate than WT p53. Full-length p53 aggregated into amyloid-like species that bound thioflavin T. The amyloid nature of the aggregates was demonstrated using x-ray diffraction, electron microscopy, FTIR, dynamic light scattering, cell viabilility assay, and anti-amyloid immunoassay. The x-ray diffraction pattern of the fibrillar aggregates was consistent with the typical conformation of cross beta-sheet amyloid fibers with reflexions of 4.7 angstrom and 10 angstrom. A seed of R248Q p53C amyloid oligomers and fibrils accelerated the aggregation of WTp 53C, a behavior typical of a prion. The R248Q mutant co-localized with amyloid-like species in a breast cancer sample, which further supported its prion-like effect. A tumor cell line containing mutant p53 also revealed massive aggregation of p53 in the nucleus. We conclude that aggregation of p53 into a mixture of oligomers and fibrils sequestrates the native protein into an inactive conformation that is typical of a prionoid. This prion-like behavior of oncogenic p53 mutants provides an explanation for the negative dominance effect and may serve as a potential target for cancer therapy.	[Braga, Carolina A.; Silva, Jerson L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil; [Bom, Ana P. D. Ano; Rangel, Luciana P.; Costa, Danielly C. F.; de Oliveira, Guilherme A. P.; Sanches, Daniel; Braga, Carolina A.; Gava, Lisandra M.; Ramos, Carlos H. I.; De Moura Gallo, Claudia V.; Cordeiro, Yraima; Silva, Jerson L.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, BR-21941590 Rio De Janeiro, Brazil; [Cordeiro, Yraima] Univ Fed Rio de Janeiro, Fac Farm, BR-21941590 Rio De Janeiro, Brazil; Univ Estadual Campinas, Inst Biol, Inst Quim, BR-13084862 Campinas, SP, Brazil; [De Moura Gallo, Claudia V.] Univ Estado Rio de Janeiro, Dept Genet, IBRAG, BR-20550013 Rio De Janeiro, Brazil; [Stumbo, Ana C.] Univ Estado Rio de Janeiro, Dept Histol & Embriol, IBRAG, BR-20550013 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Estadual de Campinas; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Bloco E Sala 10,Cidade Univ, BR-21941590 Rio De Janeiro, Brazil.	jerson@bioqmed.ufrj.br	Ramos, CH/C-1571-2012; Braga, Carolina/E-3471-2013; Cordeiro, Yraima/J-7619-2012; de Oliveira, Guilherme A. P./O-1192-2013; SILVA, JERSON Lima/GRF-1442-2022; Silva, Jerson/J-8984-2014; Rangel, Luciana/E-7861-2018	Ramos, CH/0000-0002-7246-9081; Cordeiro, Yraima/0000-0003-4278-212X; de Oliveira, Guilherme A. P./0000-0002-0063-5888; SILVA, JERSON Lima/0000-0001-9523-9441; Silva, Jerson/0000-0001-9523-9441; /0000-0002-6154-0815; Stumbo, Ana/0000-0001-8848-7850	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) of Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) of Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB), and the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) of Brazil.	Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Bom APDA, 2010, J BIOL CHEM, V285, P2857, DOI 10.1074/jbc.M109.075861; Antony H, 2012, CANCER METAST REV, V31, P1, DOI 10.1007/s10555-011-9325-9; Butler JS, 2003, BIOCHEMISTRY-US, V42, P2396, DOI 10.1021/bi026635n; Caughey B, 2006, ACCOUNTS CHEM RES, V39, P646, DOI 10.1021/ar050068p; Chen LH, 1999, MOL MED, V5, P21, DOI 10.1007/BF03402136; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Cordeiro Y, 2005, BIOPHYS J, V89, P2667, DOI 10.1529/biophysj.105.067603; Cordeiro Y, 2004, J BIOL CHEM, V279, P32354, DOI 10.1074/jbc.M404295200; ELLEDGE RM, 1994, CANCER RES, V54, P3752; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Galea C, 2005, PROTEIN SCI, V14, P2993, DOI 10.1110/ps.051622005; Gerweck LE, 1998, SEMIN RADIAT ONCOL, V8, P176, DOI 10.1016/S1053-4296(98)80043-X; Glabe CG, 2004, TRENDS BIOCHEM SCI, V29, P542, DOI 10.1016/j.tibs.2004.08.009; Goh AM, 2011, J PATHOL, V223, P116, DOI 10.1002/path.2784; Gomes MPB, 2008, J BIOL CHEM, V283, P19616, DOI 10.1074/jbc.M802102200; Gomes MPB, 2008, PRION, V2, P64, DOI 10.4161/pri.2.2.6988; Gottifredi V, 2001, SCIENCE, V292, P1851, DOI 10.1126/science.1062238; Higashimoto Y, 2006, BIOCHEMISTRY-US, V45, P1608, DOI 10.1021/bi051192j; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Howie AJ, 2008, LAB INVEST, V88, P232, DOI 10.1038/labinvest.3700714; Ishimaru D, 2004, BIOPHYS J, V87, P2691, DOI 10.1529/biophysj.104.044685; Ishimaru D, 2003, BIOCHEMISTRY-US, V42, P9022, DOI 10.1021/bi034218k; Ishimaru D, 2009, BIOCHEMISTRY-US, V48, P6126, DOI 10.1021/bi9003028; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Joerger AC, 2009, P NATL ACAD SCI USA, V106, P17705, DOI 10.1073/pnas.0905867106; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kocisko DA, 2006, ANTIMICROB AGENTS CH, V50, P1034, DOI 10.1128/AAC.50.3.1034-1044.2006; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Levy CB, 2011, INT J BIOCHEM CELL B, V43, P60, DOI 10.1016/j.biocel.2010.10.017; Moll UM, 1997, INT J GYNECOL PATHOL, V16, P156, DOI 10.1097/00004347-199704000-00012; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; Nicholls CD, 2002, J BIOL CHEM, V277, P12937, DOI 10.1074/jbc.M108815200; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Ostermeyer AG, 1996, P NATL ACAD SCI USA, V93, P15190, DOI 10.1073/pnas.93.26.15190; Park SJ, 2011, NAT STRUCT MOL BIOL, V18, P537, DOI 10.1038/nsmb.2045; Pastore A, 2012, CURR OPIN STRUC BIOL, V22, P30, DOI 10.1016/j.sbi.2011.11.007; Rigacci S, 2008, BIOPHYS J, V94, P3635, DOI 10.1529/biophysj.107.122283; Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x; Vieira TCRG, 2011, J AM CHEM SOC, V133, P334, DOI 10.1021/ja106725p; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546	48	181	184	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28152	28162		10.1074/jbc.M112.340638	http://dx.doi.org/10.1074/jbc.M112.340638			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22715097	Green Published, hybrid			2022-12-25	WOS:000307840700088
J	Grande, L; Bretones, G; Rosa-Garrido, M; Garrido-Martin, EM; Hernandez, T; Fraile, S; Botella, L; de Alava, E; Vidal, A; del Muro, XG; Villanueva, A; Delgado, MD; Fernandez-Luna, JL				Grande, Lara; Bretones, Gabriel; Rosa-Garrido, Manuel; Garrido-Martin, Eva M.; Hernandez, Teresa; Fraile, Susana; Botella, Luisa; de Alava, Enrique; Vidal, August; Garcia del Muro, Xavier; Villanueva, Alberto; Dolores Delgado, M.; Fernandez-Luna, Jose L.			Transcription Factors Sp1 and p73 Control the Expression of the Proapoptotic Protein NOXA in the Response of Testicular Embryonal Carcinoma Cells to Cisplatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; UP-REGULATION; FAMILY PROTEINS; BCL-2 FAMILY; CANCER; P53; RESISTANCE; TUMORS; ACTIVATION; DEATH	Testicular germ cell tumors (TGCTs) are highly responsive to and curable by cisplatin-based chemotherapy even in advanced stages. We have studied the molecular mechanisms involved in the induction of apoptosis in response to cisplatin, and found that proapoptotic Noxa is transcriptionally up-regulated following cisplatin exposure, even in the absence of p53, in NTERA2 cisplatin-sensitive cells but not in 1411HP-resistant cells. Blockade of Noxa reduced the apoptotic response of embryonal carcinoma (EC) NTERA2 cells to cisplatin. A detailed analysis of the Noxa promoter revealed that p73 and Sp1-like factors, Sp1 and KLF6, played key roles in the transcriptional control of this gene. Overexpression of TAp73 induced Noxa whereas the dominant negative isoform Delta Np73, reduced the levels of Noxa after cisplatin exposure in NTERA2 and 2102EP. Interestingly, down-regulation of Sp1 increased Noxa expression in response to cisplatin. However, blockade of KLF6 decreased cisplatin-induced up-regulation of Noxa in EC cell lines. In addition, tissue microarray analyses of TGCTs revealed that expression of Noxa correlates with good clinical prognosis in patients with embryonal carcinoma. Thus, our data show the transcriptional network that regulates Noxa in EC cells, which is key for their apoptotic response to cisplatin-based chemotherapy, and propose Noxa as a predictive factor of therapeutic response.	[Grande, Lara; Fernandez-Luna, Jose L.] Hosp Valdecilla, Mol Genet Unit, Santander 39011, Spain; [Grande, Lara; Fernandez-Luna, Jose L.] Inst Formac & Invest Marques Valdecilla IFIMAV, Santander 39011, Spain; [Bretones, Gabriel; Rosa-Garrido, Manuel; Dolores Delgado, M.] Univ Cantabria, Dept Mol Biol, Spanish Natl Res Council CSIC, Santander 39011, Spain; [Bretones, Gabriel; Rosa-Garrido, Manuel; Dolores Delgado, M.] Univ Cantabria, Inst Biomed & Biotecnol Cantabria IBBTEC, Spanish Natl Res Council CSIC, Santander 39011, Spain; [Garrido-Martin, Eva M.; Botella, Luisa] CSIC, Ctr Biol Res CIB, Dept Cellular & Mol Med, E-28040 Madrid, Spain; [de Alava, Enrique] CSIC, Canc Res Ctr CIC, Salamanca 37007, Spain; [Hernandez, Teresa; Fraile, Susana; de Alava, Enrique] Hosp Univ Salamanca IBSAL, Dept Pathol, Salamanca 37007, Spain; [Vidal, August] Bellvitge Univ Hosp, Serv Anat Pathol, Barcelona 08907, Spain; [Garcia del Muro, Xavier; Villanueva, Alberto] Catalan Inst Oncol ICO, Barcelona 08907, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Catalan Institute of Oncology	Fernandez-Luna, JL (corresponding author), Hosp Valdecilla, Mol Genet Unit, Av Cardenal Herrera Oria S-N, Santander 39011, Spain.	fluna@humv.es	Bretones, Gabriel/AAB-4637-2021; Martín, Susana Fraile/AAC-2028-2021; Martin, Eva Maria Garrido/A-9497-2017; IBIS, SARCOMAS/O-1893-2015; Botella, Luisa M/L-1392-2014; Vidal, August/N-4662-2016; Garrido Martín, Eva María/HHM-3287-2022; Rosa-Garrido, Manuel/AAE-4188-2019; de Alava, Enrique/GOH-0368-2022; Delgado, M. Dolores/K-9056-2014	Bretones, Gabriel/0000-0002-1521-5544; Martín, Susana Fraile/0000-0001-6761-3950; Martin, Eva Maria Garrido/0000-0002-8094-2668; Vidal, August/0000-0001-5727-2099; Garrido Martín, Eva María/0000-0002-8094-2668; Rosa-Garrido, Manuel/0000-0002-2169-3972; de Alava, Enrique/0000-0001-8400-046X; Delgado, M. Dolores/0000-0003-4682-4040	Instituto de Salud Carlos III Grants [RD06/0020/0074, RD06/0020/0059, RD06/0020/0017PI11/00397, PI081491]; Instituto de Formacion e Investigacion Marques de Valdecilla (IFIMAV) [API2011-04]	Instituto de Salud Carlos III Grants(Instituto de Salud Carlos III); Instituto de Formacion e Investigacion Marques de Valdecilla (IFIMAV)	This work was supported by Instituto de Salud Carlos III Grants RD06/0020/0074 (to J. L. F.-L.), RD06/0020/0059 (to E. A.), RD06/0020/0017 (to M. D. D.) (Red Tematica de Investigacion Cooperativa en Cancer), PI11/00397 (to M. D. D.), and PI081491 (to X. G.); and a grant from Instituto de Formacion e Investigacion Marques de Valdecilla (IFIMAV), API2011-04 (to J. L. F.-L.).	Al-Bahlani S, 2011, ONCOGENE, V30, P4219, DOI 10.1038/onc.2011.134; Amin ARMR, 2013, ONCOGENE, V32, P920, DOI 10.1038/onc.2012.96; [Anonymous], 2011, CANCER-AM CANCER SOC, V117, P4337, DOI 10.1002/cncr.26546; Armstrong JL, 2007, APOPTOSIS, V12, P613, DOI 10.1007/s10495-006-0020-1; Bahrami AR, 2005, MECH DEVELOP, V122, P1034, DOI 10.1016/j.mod.2005.04.011; Botella LM, 2009, BIOCHEM J, V419, P485, DOI 10.1042/BJ20081434; Burger H, 1999, INT J CANCER, V81, P620, DOI 10.1002/(SICI)1097-0215(19990517)81:4<620::AID-IJC19>3.3.CO;2-J; Chirakkal H, 2006, ONCOGENE, V25, P7192, DOI 10.1038/sj.onc.1209702; Davidoff AM, 2009, CURR OPIN PEDIATR, V21, P357, DOI 10.1097/MOP.0b013e32832b323a; de Wit R, 2006, J CLIN ONCOL, V24, P5482, DOI 10.1200/JCO.2006.07.9434; Difeo A, 2009, CANCER RES, V69, P4733, DOI 10.1158/0008-5472.CAN-08-4282; Feldman DR, 2008, JAMA-J AM MED ASSOC, V299, P672, DOI 10.1001/jama.299.6.672; Fernandez-Garcia B, 2007, CELL DEATH DIFFER, V14, P254, DOI 10.1038/sj.cdd.4401945; Fernandez-Luna JL, 2008, CELL SIGNAL, V20, P1921, DOI 10.1016/j.cellsig.2008.04.015; Garcia-Velasco A, 2012, CLIN TRANSL ONCOL, V14, P452, DOI 10.1007/s12094-012-0823-1; Guminski AD, 2002, LANCET ONCOL, V3, P312, DOI 10.1016/S1470-2045(02)00733-7; Gutekunst M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019198; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Horita M, 2000, J EXP MED, V191, P977, DOI 10.1084/jem.191.6.977; Huh SJ, 2010, JNCI-J NATL CANCER I, V102, P1131, DOI 10.1093/jnci/djq218; Hussain SA, 2008, EXPERT REV ANTICANC, V8, P1659, DOI 10.1586/14737140.8.10.1659; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kersemaekers AMF, 2002, J CLIN ONCOL, V20, P1551, DOI 10.1200/JCO.20.6.1551; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Koster R, 2010, J CLIN INVEST, V120, P3594, DOI 10.1172/JCI41939; Malaguarnera R, 2007, ENDOCR-RELAT CANCER, V14, P43, DOI 10.1677/erc.1.01223; Mathai JP, 2002, ONCOGENE, V21, P2534, DOI 10.1038/sj.onc.1205340; Mayer F, 2003, CLIN CANCER RES, V9, P767; Mazumdar M, 2003, J CLIN ONCOL, V21, P2679, DOI 10.1200/JCO.2003.03.136; Ming LH, 2008, CARCINOGENESIS, V29, P1878, DOI 10.1093/carcin/bgn150; Mora J, 2012, PEDIATR BLOOD CANCER, V58, P532, DOI 10.1002/pbc.23348; Mueller T, 2003, CANCER RES, V63, P513; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Narla G, 2005, CANCER RES, V65, P5761, DOI 10.1158/0008-5472.CAN-05-0217; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Ploner C, 2008, ONCOGENE, V27, pS84, DOI 10.1038/onc.2009.46; Qin JZ, 2004, MOL CANCER THER, V3, P895; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Schellong G, 1999, J CLIN ONCOL, V17, P3736, DOI 10.1200/JCO.1999.17.12.3736; Schmoll HJ, 2004, ANN ONCOL, V15, P1377, DOI 10.1093/annonc/mdh301; Schweyer S, 2004, BRIT J CANCER, V91, P589, DOI 10.1038/sj.bjc.6601919; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sheridan C, 2010, ONCOGENE, V29, P6428, DOI 10.1038/onc.2010.380; Sudhakar C, 2008, FEBS J, V275, P2200, DOI 10.1111/j.1742-4658.2008.06373.x; Voortman J, 2007, MOL CANCER THER, V6, P1046, DOI 10.1158/1535-7163.MCT-06-0577; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang J, 2011, J BIOL CHEM, V286, P22384, DOI 10.1074/jbc.M111.239566; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307	50	40	43	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26495	26505		10.1074/jbc.M112.376319	http://dx.doi.org/10.1074/jbc.M112.376319			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22718761	Green Published, hybrid			2022-12-25	WOS:000307386000003
J	Loo, TW; Bartlett, MC; Detty, MR; Clarke, DM				Loo, Tip W.; Bartlett, M. Claire; Detty, Michael R.; Clarke, David M.			The ATPase Activity of the P-glycoprotein Drug Pump Is Highly Activated When the N-terminal and Central Regions of the Nucleotide-binding Domains Are Linked Closely Together	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE CROSS-LINKING; TRANSMEMBRANE SEGMENTS; CONFORMATIONAL-CHANGES; MULTIDRUG TRANSPORTER; CATALYTIC CYCLE; COVALENT MODIFICATION; MOLECULAR RULERS; RESISTANCE; SITES; HYDROLYSIS	The P-glycoprotein (P-gp, ABCB1) drug pump protects us from toxic compounds and confers multidrug resistance. Each of the homologous halves of P-gp is composed of a transmembrane domain (TMD) with 6 TM segments followed by a nucleotide-binding domain (NBD). The predicted drug-and ATP-binding sites reside at the interface between the TMDs and NBDs, respectively. Crystal structures and EM projection images suggest that the two halves of P-gp are separated by a central cavity that closes upon binding of nucleotide. Binding of drug substrates may induce further structural rearrangements because they stimulate ATPase activity. Here, we used disulfide cross-linking with short (8 angstrom) or long (22 angstrom) cross-linkers to identify domain-domain interactions that activate ATPase activity. It was found that cross-linking of cysteines that lie close to the LSGGQ (P517C) and Walker A (I1050C) sites of NBD1 and NBD2, respectively, as well as the cytoplasmic extensions of TM segments 3 (D177C or L175C) and 9 (N820C) with a short cross-linker activated ATPase activity over 10-fold. A pyrylium compound that inhibits ATPase activity blocked cross-linking at these sites. Cross-linking between the NBDs was not inhibited by tariquidar, a drug transport inhibitor that stimulates P-gp ATPase activity but is not transported. Cross-linking between extracellular cysteines (T333C/L975C) predicted to lock P-gp into a conformation that prevents close NBD association inhibited ATPase activity. The results suggest that trapping P-gp in a conformation in which the NBDs are closely associated likely mimics the structural rearrangements caused by binding of drug substrates that stimulate ATPase activity.	[Loo, Tip W.; Bartlett, M. Claire; Clarke, David M.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Loo, Tip W.; Bartlett, M. Claire; Clarke, David M.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Detty, Michael R.] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA	University of Toronto; University of Toronto; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Clarke, DM (corresponding author), Univ Toronto, Dept Med, 1 Kings Coll Circle,Rm 7342,Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	david.clarke@utoronto.ca	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188	National Institutes of Health [GM-94367]; Canadian Cancer Society [19074]; Canadian Institutes of Health Research [25043]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-94367 (to M. R. D.) and by grants from the Canadian Cancer Society (19074) (to D. M. C.), the Canadian Institutes of Health Research (25043) (to D. M. C.).	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Bikadi Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025815; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Delannoy S, 2005, BIOCHEMISTRY-US, V44, P14010, DOI 10.1021/bi0512445; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Ebert SP, 2012, J MED CHEM, V55, P4683, DOI 10.1021/jm3004398; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; Fox E, 2007, EXPERT REV ANTICANC, V7, P447, DOI 10.1586/14737140.7.4.447; Ghosh P, 2006, ARCH BIOCHEM BIOPHYS, V450, P100, DOI 10.1016/j.abb.2006.02.025; Globisch C, 2008, CHEMMEDCHEM, V3, P280, DOI 10.1002/cmdc.200700249; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; Hrycyna CA, 1999, BIOCHEMISTRY-US, V38, P13887, DOI 10.1021/bi991115m; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kannan P, 2011, ACS CHEM NEUROSCI, V2, P82, DOI 10.1021/cn100078a; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Loo TW, 2007, J BIOL CHEM, V282, P32043, DOI 10.1074/jbc.M706175200; Loo TW, 2007, BIOCHEMISTRY-US, V46, P9328, DOI 10.1021/bi700837y; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; Loo TW, 2009, J BIOL CHEM, V284, P24074, DOI 10.1074/jbc.M109.023267; Loo TW, 2003, J BIOL CHEM, V278, P39706, DOI 10.1074/jbc.M308559200; Loo TW, 2003, J BIOL CHEM, V278, P1575, DOI 10.1074/jbc.M211307200; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Loo TW, 2004, J BIOL CHEM, V279, P18232, DOI 10.1074/jbc.M400229200; Loo TW, 1999, FASEB J, V13, P1724, DOI 10.1096/fasebj.13.13.1724; Loo TW, 2003, J BIOL CHEM, V278, P20449, DOI 10.1074/jbc.C300154200; Loo TW, 1997, J BIOL CHEM, V272, P20986, DOI 10.1074/jbc.272.34.20986; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Loo TW, 2002, J BIOL CHEM, V277, P41303, DOI 10.1074/jbc.C200484200; Loo TW, 2002, P NATL ACAD SCI USA, V99, P3511, DOI 10.1073/pnas.022049799; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Loo TW, 2001, J BIOL CHEM, V276, P31800, DOI 10.1074/jbc.M103498200; Loo TW, 2001, J BIOL CHEM, V276, P14972, DOI 10.1074/jbc.M100407200; LOO TW, 1995, J BIOL CHEM, V270, P21839, DOI 10.1074/jbc.270.37.21839; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P643, DOI 10.1021/bi0485326; Mandal D, 2012, BIOCHEMISTRY-US, V51, P2852, DOI 10.1021/bi201479k; Martin C, 2000, BIOCHEMISTRY-US, V39, P11901, DOI 10.1021/bi000559b; Martin C, 1999, BRIT J PHARMACOL, V128, P403, DOI 10.1038/sj.bjp.0702807; Omote H, 2002, J BIOL CHEM, V277, P45688, DOI 10.1074/jbc.M206479200; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Ritchie TK, 2011, J BIOL CHEM, V286, P39489, DOI 10.1074/jbc.M111.284554; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Samanta S, 2003, J BIOL CHEM, V278, P35265, DOI 10.1074/jbc.M301171200; Sauna ZE, 2001, J BIOL CHEM, V276, P11653, DOI 10.1074/jbc.M011294200; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Shapiro AB, 1997, EUR J BIOCHEM, V250, P130, DOI 10.1111/j.1432-1033.1997.00130.x; Sharom FJ, 2006, BIOCHEM CELL BIOL, V84, P979, DOI 10.1139/O06-199; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; TANGWAI DF, 1995, BIOCHEMISTRY-US, V34, P32, DOI 10.1021/bi00001a005; Tombline G, 2004, J BIOL CHEM, V279, P46518, DOI 10.1074/jbc.M408052200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Urbatsch IL, 2001, J BIOL CHEM, V276, P26980, DOI 10.1074/jbc.M010829200; Verhalen B, 2012, J BIOL CHEM, V287, P1112, DOI 10.1074/jbc.M111.301192; Verhalen B, 2011, J BIOL CHEM, V286, P10476, DOI 10.1074/jbc.M110.193151; Vigano C, 2002, J BIOL CHEM, V277, P5008, DOI 10.1074/jbc.M107928200; Zhou YG, 2008, P NATL ACAD SCI USA, V105, P3774, DOI 10.1073/pnas.0800825105	66	43	43	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26806	26816		10.1074/jbc.M112.376202	http://dx.doi.org/10.1074/jbc.M112.376202			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700974	hybrid, Green Published			2022-12-25	WOS:000307386000030
J	Zong, XG; Krause, S; Chen, CC; Kruger, J; Gruner, C; Cao-Ehlker, X; Fenske, S; Wahl-Schott, C; Biel, M				Zong, Xiangang; Krause, Stefanie; Chen, Cheng-Chang; Krueger, Jens; Gruner, Christian; Cao-Ehlker, Xiaochun; Fenske, Stefanie; Wahl-Schott, Christian; Biel, Martin			Regulation of Hyperpolarization-activated Cyclic Nucleotide-gated (HCN) Channel Activity by cCMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTIDINE 3',5'-MONOPHOSPHATE CCMP; LOTI K1 CHANNEL; PACEMAKER CHANNELS; CATION CHANNELS; STRUCTURAL BASIS; BINDING DOMAIN; RAT-TISSUES; PATCH-CLAMP; MODULATION; CAMP	Activation of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels is facilitated in vivo by direct binding of the second messenger cAMP. This process plays a fundamental role in the fine-tuning of HCN channel activity and is critical for the modulation of cardiac and neuronal rhythmicity. Here, we identify the pyrimidine cyclic nucleotide cCMP as another regulator of HCN channels. We demonstrate that cCMP shifts the activation curves of two members of the HCN channel family, HCN2 and HCN4, to more depolarized voltages. Moreover, cCMP speeds up activation and slows down deactivation kinetics of these channels. The two other members of the HCN channel family, HCN1 and HCN3, are not sensitive to cCMP. The modulatory effect of cCMP is reversible and requires the presence of a functional cyclic nucleotide-binding domain. We determined an EC50 value of similar to 30 mu M for cCMP compared with 1 mu M for cAMP. Notably, cCMP is a partial agonist of HCN channels, displaying an efficacy of similar to 0.6. cCMP increases the frequency of pacemaker potentials from isolated sinoatrial pacemaker cells in the presence of endogenous cAMP concentrations. Electrophysiological recordings indicated that this increase is caused by a depolarizing shift in the activation curve of the native HCN current, which in turn leads to an enhancement of the slope of the diastolic depolarization of sinoatrial node cells. In conclusion, our findings establish cCMP as a gating regulator of HCN channels and indicate that this cyclic nucleotide has to be considered in HCN channel-regulated processes.	[Zong, Xiangang; Krause, Stefanie; Chen, Cheng-Chang; Gruner, Christian; Cao-Ehlker, Xiaochun; Fenske, Stefanie; Wahl-Schott, Christian; Biel, Martin] Univ Munich, Dept Pharm, Zentrum Pharmaforsch, D-80539 Munich, Germany; [Zong, Xiangang; Krause, Stefanie; Chen, Cheng-Chang; Gruner, Christian; Cao-Ehlker, Xiaochun; Fenske, Stefanie; Wahl-Schott, Christian; Biel, Martin] Univ Munich, Dept Pharm, Ctr Integrated Prot Sci CIPSM, D-80539 Munich, Germany; [Krueger, Jens] Univ Tubingen, Wilhelm Schickard Inst Comp Sci, Appl Bioinformat Grp, D-72076 Tubingen, Germany	University of Munich; University of Munich; Eberhard Karls University of Tubingen	Biel, M (corresponding author), Univ Munich, Dept Pharm, Butenandtstr 5-13, D-81377 Munich, Germany.	martin.biel@cup.uni-muenchen.de	Wahl-Schott, Christian A/J-2623-2015; Biel, Martin/G-1175-2014	Biel, Martin/0000-0002-9974-3052; Fenske, Stefanie/0000-0002-6994-8401; Kruger, Jens/0000-0002-2636-3163	Deutsche Forschungsgemeinschaft; Graduate School Life Science Munich (LSM); Bayerische Forschungsstiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduate School Life Science Munich (LSM); Bayerische Forschungsstiftung	This work was supported by grants from the Deutsche Forschungsgemeinschaft, the Graduate School Life Science Munich (LSM), and a fellowship from the Bayerische Forschungsstiftung (to C.-C.C.).	ANDERSON TR, 1982, MOL CELL ENDOCRINOL, V28, P373, DOI 10.1016/0303-7207(82)90134-4; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Beste KY, 2012, BIOCHEMISTRY-US, V51, P194, DOI 10.1021/bi201259y; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; BROWN H, 1980, J PHYSIOL-LONDON, V308, P331, DOI 10.1113/jphysiol.1980.sp013474; BROWN HF, 1979, NATURE, V280, P235, DOI 10.1038/280235a0; Bruggemann A, 2006, SMALL, V2, P840, DOI [10.1002/smll.200600083, 10.1002/50111.200600083]; Bucchi A, 2007, J MOL CELL CARDIOL, V43, P39, DOI 10.1016/j.yjmcc.2007.04.017; Burhenne H, 2011, N-S ARCH PHARMACOL, V383, P33; CECH SY, 1977, SCIENCE, V198, P1063, DOI 10.1126/science.22127; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Desch M, 2010, FEBS LETT, V584, P3979, DOI 10.1016/j.febslet.2010.07.059; DIFRANCESCO D, 1989, SCIENCE, V243, P669, DOI 10.1126/science.2916119; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DiFrancesco D, 2010, CIRC RES, V106, P434, DOI 10.1161/CIRCRESAHA.109.208041; Frere SGA, 2004, MOL NEUROBIOL, V30, P279, DOI 10.1385/MN:30:3:279; GAION RM, 1979, BIOCHEM BIOPH RES CO, V86, P105, DOI 10.1016/0006-291X(79)90387-5; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Herrmann S, 2007, EMBO J, V26, P4423, DOI 10.1038/sj.emboj.7601868; Liang J, 1998, PROTEINS, V33, P18, DOI 10.1002/(SICI)1097-0134(19981001)33:1<18::AID-PROT2>3.3.CO;2-X; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; NEWTON RP, 1984, BIOCHEM J, V221, P665, DOI 10.1042/bj2210665; NEWTON RP, 1986, BIOCHEM J, V236, P431, DOI 10.1042/bj2360431; Pian P, 2007, PFLUG ARCH EUR J PHY, V455, P125, DOI 10.1007/s00424-007-0295-2; Pian P, 2006, J GEN PHYSIOL, V128, P593, DOI 10.1085/jgp.200609648; Rozas I, 1997, J PHYS CHEM A, V101, P9457, DOI 10.1021/jp971893t; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Schunke S, 2011, P NATL ACAD SCI USA, V108, P6121, DOI 10.1073/pnas.1015890108; Schunke S, 2009, EMBO REP, V10, P729, DOI 10.1038/embor.2009.68; Shaikh AG, 2005, HEARING RES, V201, P70, DOI 10.1016/j.heares.2004.10.005; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; Wolter S, 2011, BIOCHEM BIOPH RES CO, V415, P563, DOI 10.1016/j.bbrc.2011.10.093; Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005; Zong XG, 2005, J BIOL CHEM, V280, P34224, DOI 10.1074/jbc.M506544200	41	46	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26506	26512		10.1074/jbc.M112.357129	http://dx.doi.org/10.1074/jbc.M112.357129			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22715094	hybrid, Green Published			2022-12-25	WOS:000307386000004
J	Canepa, GE; Mesias, AC; Yu, H; Chen, X; Buscaglia, CA				Canepa, Gaspar E.; Mesias, Andrea C.; Yu, Hai; Chen, Xi; Buscaglia, Carlos A.			Structural Features Affecting Trafficking, Processing, and Secretion of Trypanosoma cruzi Mucins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHOR; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; EXPRESSION VECTOR; MAMMALIAN-CELLS; TRANS-SIALIDASE; SURFACE MUCINS; FAMILY; BRUCEI	Trypanosoma cruzi is wrapped by a dense coat of mucin-type molecules encoded by complex gene families termed TcSMUG and TcMUC, which are expressed in the insect-and mammal-dwelling forms of the parasite, respectively. Here, we dissect the contribution of distinct post-translational modifications on the trafficking of these glycoconjugates. In vivo tracing and characterization of tagged-variants expressed by transfected epimastigotes indicate that although the N-terminal signal peptide is responsible for targeting TcSMUG products to the endoplasmic reticulum (ER), the glycosyl phosphatidylinositol (GPI)-anchor likely functions as a forward transport signal for their timely progression along the secretory pathway. GPI-minus variants accumulate in the ER, with only a minor fraction being ultimately released to the medium as anchorless products. Secreted products, but not ER-accumulated ones, display several diagnostic features of mature mucin-type molecules including extensive O-type glycosylation, Galf-based epitopes recognized by monoclonal antibodies, and terminal Galp residues that become readily sialylated upon addition of parasite trans-sialidases. Processing of N-glycosylation site(s) is dispensable for the overall TcSMUG mucin-type maturation and secretion. Despite undergoing different O-glycosylation elaboration, TcMUC reporters yielded quite similar results, thus indicating that (i) molecular trafficking signals are structurally and functionally conserved between mucin families, and (ii) TcMUC and TcSMUG products are recognized and processed by a distinct repertoire of stage-specific glycosyltransferases. Thus, using the fidelity of a homologous expression system, we have defined some biosynthetic aspects of T. cruzi mucins, key molecules involved in parasite protection and virulence.	[Canepa, Gaspar E.; Mesias, Andrea C.; Buscaglia, Carlos A.] Inst Invest Biotecnol Dr Rodolfo Ugalde, RA-1650 Buenos Aires, DF, Argentina; [Yu, Hai; Chen, Xi] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California Davis	Buscaglia, CA (corresponding author), Inst Invest Biotecnol Dr Rodolfo Ugalde, Av 25 Mayo & Francia,Campus UNSAM, RA-1650 Buenos Aires, DF, Argentina.	cbusca@iib.unsam.edu.ar	Chen, Xi/H-1811-2018	Chen, Xi/0000-0002-3160-614X; Mesias, Andrea Cecilia/0000-0003-1205-0665; Buscaglia, Carlos/0000-0001-6466-4138; Canepa, Gaspar/0000-0002-4195-8835	UNICEF/UNDP/World Bank/WHO Special Programme for Research; Training in Tropical Diseases (TDR); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Fundacion Florencio Fiorini; UNSAM; Argentinean Research Council (CONICET)	UNICEF/UNDP/World Bank/WHO Special Programme for Research(World Health Organization); Training in Tropical Diseases (TDR); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Fundacion Florencio Fiorini; UNSAM; Argentinean Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This investigation received financial support from the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Fundacion Florencio Fiorini, and UNSAM (to C. A. B.).; Holds a post-doctoral fellowship from the Argentinean Research Council (CONICET).	Almeida IC, 2000, EMBO J, V19, P1476, DOI 10.1093/emboj/19.7.1476; Bangs JD, 1997, EMBO J, V16, P4285, DOI 10.1093/emboj/16.14.4285; Bohme U, 2002, J CELL SCI, V115, P805; Bonnon C, 2010, J CELL SCI, V123, P1705, DOI 10.1242/jcs.062950; Buscaglia CA, 2006, NAT REV MICROBIOL, V4, P229, DOI 10.1038/nrmicro1351; Buscaglia CA, 2004, J BIOL CHEM, V279, P15860, DOI 10.1074/jbc.M314051200; Butikofer P, 2001, FASEB J, V15, P545, DOI 10.1096/fj.00-0415hyp; Campo V, 2004, MOL BIOCHEM PARASIT, V133, P81, DOI 10.1016/j.molbiopara.2003.09.006; Campo VA, 2006, MICROBES INFECT, V8, P401, DOI 10.1016/j.micinf.2005.07.008; Canepa GE, 2012, BIOCHEM J, V444, P211, DOI 10.1042/BJ20120074; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; Castillon GA, 2011, MOL BIOL CELL, V22, P2924, DOI 10.1091/mbc.E11-04-0294; Cordero EM, 2009, J PROTEOME RES, V8, P3642, DOI 10.1021/pr800887u; de Lederkremer RM, 2009, ADV CARBOHYD CHEM BI, V62, P311, DOI 10.1016/S0065-2318(09)00007-9; Di Noia JM, 2000, J BIOL CHEM, V275, P10218, DOI 10.1074/jbc.275.14.10218; Di Noia JM, 1998, J BIOL CHEM, V273, P10843, DOI 10.1074/jbc.273.18.10843; Di Noia JM, 2002, J EXP MED, V195, P401, DOI 10.1084/jem.20011433; DINOIA JM, 1995, J BIOL CHEM, V270, P24146, DOI 10.1074/jbc.270.41.24146; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; Erdmann H, 2009, CELL MICROBIOL, V11, P1600, DOI 10.1111/j.1462-5822.2009.01350.x; Ferella M, 2008, PROTEOMICS, V8, P2735, DOI 10.1002/pmic.200700940; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; FIELD MC, 1994, J BIOL CHEM, V269, P10830; Fraering P, 2001, MOL BIOL CELL, V12, P3295, DOI 10.1091/mbc.12.10.3295; Gazzinelli RT, 2006, NAT REV IMMUNOL, V6, P895, DOI 10.1038/nri1978; He CY, 2005, SCIENCE, V310, P1196, DOI 10.1126/science.1119969; Heske J, 2004, J BIOL CHEM, V279, P5435, DOI 10.1074/jbc.M309570200; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hughes H, 2008, HISTOCHEM CELL BIOL, V129, P129, DOI 10.1007/s00418-007-0363-x; Kawagoe K, 1996, BLOOD, V87, P3600, DOI 10.1182/blood.V87.9.3600.bloodjournal8793600; Labriola CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013141; MacRae JI, 2005, J BIOL CHEM, V280, P12201, DOI 10.1074/jbc.M412939200; Maeda Y, 2011, PROG LIPID RES, V50, P411, DOI 10.1016/j.plipres.2011.05.002; McDowell MA, 1998, BIOCHEM J, V335, P681, DOI 10.1042/bj3350681; McGwire BS, 2002, J BIOL CHEM, V277, P8802, DOI 10.1074/jbc.M109072200; McGwire BS, 1996, J BIOL CHEM, V271, P7903, DOI 10.1074/jbc.271.14.7903; Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nakayasu ES, 2012, J PROTEOME RES, V11, P237, DOI 10.1021/pr200806s; Nakayasu ES, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.13; Pitcovsky TA, 2002, J INFECT DIS, V186, P397, DOI 10.1086/341463; Pollevick GD, 2000, J BIOL CHEM, V275, P27671; Previato JO, 1998, J BIOL CHEM, V273, P14982, DOI 10.1074/jbc.273.24.14982; Ralton JE, 2002, BIOCHEM J, V363, P365, DOI 10.1042/0264-6021:3630365; Rivier AS, 2010, TRAFFIC, V11, P1017, DOI 10.1111/j.1600-0854.2010.01081.x; SCHENKMAN S, 1993, MOL BIOCHEM PARASIT, V59, P293, DOI 10.1016/0166-6851(93)90227-O; Schuck S, 2006, J CELL BIOL, V172, P963, DOI 10.1083/jcb.200603015; Schwartz KJ, 2005, J CELL SCI, V118, P5499, DOI 10.1242/jcs.02667; Sevova ES, 2009, MOL BIOL CELL, V20, P4739, DOI 10.1091/mbc.E09-07-0542; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Taylor MC, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-32; Urban I, 2011, BIOCHEM J, V438, P303, DOI 10.1042/BJ20110683; Vazquez MP, 1999, GENE, V239, P217, DOI 10.1016/S0378-1119(99)00386-8; Yoshida N, 2006, AN ACAD BRAS CIENC, V78, P87, DOI 10.1590/S0001-37652006000100010; Yu H, 2005, J AM CHEM SOC, V127, P17618, DOI 10.1021/ja0561690	57	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26365	26376		10.1074/jbc.M112.354696	http://dx.doi.org/10.1074/jbc.M112.354696			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22707724	hybrid, Green Published			2022-12-25	WOS:000306916300062
J	Park, YN; Morales, D; Rubinson, EH; Masison, D; Eisenberg, E; Greene, LE				Park, Yang-Nim; Morales, David; Rubinson, Emily H.; Masison, Daniel; Eisenberg, Evan; Greene, Lois E.			Differences in the Curing of [PSI+] Prion by Various Methods of Hsp104 Inactivation	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; GUANIDINE-HYDROCHLORIDE; PROTEIN AGGREGATION; CELL-DIVISION; LIVING CELLS; PROPAGATION; CHAPERONE; PSI(+); OVEREXPRESSION; SUP35	[PSI+] yeast, containing the misfolded amyloid conformation of Sup35 prion, is cured by inactivation of Hsp104. There has been controversy as to whether inactivation of Hsp104 by guanidine treatment or by overexpression of the dominant negative Hsp104 mutant, Hsp104-2KT, cures [PSI+] by the same mechanism- inhibition of the severing of the prion seeds. Using live cell imaging of Sup35-GFP, overexpression of Hsp104-2KT caused the foci to increase in size, then decrease in number, and finally disappear when the cells were cured, similar to that observed in cells cured by depletion of Hsp104. In contrast, guanidine initially caused an increase in foci size but then the foci disappeared before the cells were cured. By starving the yeast to make the foci visible in cells grown with guanidine, the number of cells with foci was found to correlate exactly with the number of [PSI+] cells, regardless of the curing method. Therefore, the fluorescent foci are the prion seeds required for maintenance of [PSI+] and inactivation of Hsp104 cures [PSI+] by preventing severing of the prion seeds. During curing with guanidine, the reduction in seed size is an Hsp104-dependent effect that cannot be explained by limited severing of the seeds. Instead, in the presence of guanidine, Hsp104 retains an activity that trims or reduces the size of the prion seeds by releasing Sup35 molecules that are unable to form new prion seeds. This Hsp104 activity may also occur in propagating yeast.	[Park, Yang-Nim; Morales, David; Rubinson, Emily H.; Eisenberg, Evan; Greene, Lois E.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Masison, Daniel] NIDDKD, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Park, YN (corresponding author), NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	greenel@helix.nih.gov			National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was entirely funded by the "National Institutes of Health," through the employment of YP, D. Morales, ER, LG, D. Masison and EE, who designed and performed the experiments, analyzed the data and wrote the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagriantsev SN, 2008, MOL BIOL CELL, V19, P2433, DOI 10.1091/mbc.E08-01-0078; Borchsenius AS, 2001, EMBO J, V20, P6683, DOI 10.1093/emboj/20.23.6683; Byrne LJ, 2007, P NATL ACAD SCI USA, V104, P11688, DOI 10.1073/pnas.0701392104; Byrne LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004670; Chernoff YO, 2004, PRIONS AND PRION DISEASES: CURRENT PERSPECTIVES, P257; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Cox B, 2003, GENETICS, V165, P23; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derdowski A, 2010, SCIENCE, V330, P680, DOI 10.1126/science.1197785; Eaglestone SS, 2000, P NATL ACAD SCI USA, V97, P240, DOI 10.1073/pnas.97.1.240; Elsner M, 2003, EMBO REP, V4, P1000, DOI 10.1038/sj.embor.embor942; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; Greene LE, 2009, PROTEIN PEPTIDE LETT, V16, P635, DOI 10.2174/092986609788490221; Grimminger V, 2004, J BIOL CHEM, V279, P7378, DOI 10.1074/jbc.M312403200; Hung GC, 2006, GENETICS, V173, P611, DOI 10.1534/genetics.106.056820; Jung G, 2000, GENETICS, V156, P559; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Kawai-Noma S, 2006, GENES CELLS, V11, P1085, DOI 10.1111/j.1365-2443.2006.01004.x; Kawai-Noma S, 2009, GENES CELLS, V14, P1045, DOI 10.1111/j.1365-2443.2009.01333.x; Lee S, 2004, J STRUCT BIOL, V146, P99, DOI 10.1016/j.jsb.2003.11.016; Mathur V, 2009, J MOL BIOL, V390, P155, DOI 10.1016/j.jmb.2009.04.063; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Park YN, 2011, YEAST, V28, P673, DOI 10.1002/yea.1895; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Satpute-Krishnan P, 2005, NATURE, V437, P262, DOI 10.1038/nature03981; Satpute-Krishnan P, 2007, PLOS BIOL, V5, P251, DOI 10.1371/journal.pbio.0050024; Schirmer EC, 2001, P NATL ACAD SCI USA, V98, P914, DOI 10.1073/pnas.031568098; Song YT, 2005, EUKARYOT CELL, V4, P289, DOI 10.1128/EC.4.2.289-297.2005; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; TUITE MF, 1981, GENETICS, V98, P691; Wang ZF, 2004, J BIOMED OPT, V9, P395, DOI 10.1117/1.1646416; Wegrzyn RD, 2001, MOL CELL BIOL, V21, P4656, DOI 10.1128/MCB.21.14.4656-4669.2001; Wickner RB, 1999, J BIOL CHEM, V274, P555, DOI 10.1074/jbc.274.2.555; Wu YX, 2005, P NATL ACAD SCI USA, V102, P12789, DOI 10.1073/pnas.0506384102; Zhou P, 2001, MOL MICROBIOL, V39, P37, DOI 10.1046/j.1365-2958.2001.02224.x	42	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37692	10.1371/journal.pone.0037692	http://dx.doi.org/10.1371/journal.pone.0037692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719845	gold, Green Published, Green Submitted			2022-12-25	WOS:000305583300011
J	Senatore, A; Spafford, JD				Senatore, Adriano; Spafford, J. David			Gene Transcription and Splicing of T-Type Channels Are Evolutionarily-Conserved Strategies for Regulating Channel Expression and Gating	PLOS ONE			English	Article							I-II LOOP; CALCIUM-CHANNEL; SURFACE EXPRESSION; SODIUM-CHANNELS; NERVOUS-SYSTEM; MUSCLE CELLS; LYMNAEA; ALPHA(1G); ISOFORMS; VARIANTS	T-type calcium channels operate within tightly regulated biophysical constraints for supporting rhythmic firing in the brain, heart and secretory organs of invertebrates and vertebrates. The snail T-type gene, LCa(v)3 from Lymnaea stagnalis, possesses alternative, tandem donor splice sites enabling a choice of a large exon 8b (201 aa) or a short exon 25c (9 aa) in cytoplasmic linkers, similar to mammalian homologs. Inclusion of optional 25c exons in the III-IV linker of T-type channels speeds up kinetics and causes hyperpolarizing shifts in both activation and steady-state inactivation of macroscopic currents. The abundant variant lacking exon 25c is the workhorse of embryonic Ca(v)3 channels, whose high density and right-shifted activation and availability curves are expected to increase pace-making and allow the channels to contribute more significantly to cellular excitation in prenatal tissue. Presence of brain-enriched, optional exon 8b conserved with mammalian Ca(v)3.1 and encompassing the proximal half of the I-II linker, imparts a similar to 50% reduction in total and surface-expressed LCa(v)3 channel protein, which accounts for reduced whole-cell calcium currents of +8b variants in HEK cells. Evolutionarily conserved optional exons in cytoplasmic linkers of Ca(v)3 channels regulate expression (exon 8b) and a battery of biophysical properties (exon 25c) for tuning specialized firing patterns in different tissues and throughout development.	[Senatore, Adriano; Spafford, J. David] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Senatore, A (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	spafford@uwaterloo.ca			Natural Sciences and Engineering Research Council (NSERC) Discovery grant; NSERC Canada Graduate Scholarship award	Natural Sciences and Engineering Research Council (NSERC) Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Canada Graduate Scholarship award	This work was funded through a Natural Sciences and Engineering Research Council (NSERC) Discovery grant to JDS and a NSERC Canada Graduate Scholarship award to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anderson D, 2010, NAT NEUROSCI, V13, P333, DOI 10.1038/nn.2493; Arias-Olguin II, 2008, J BIOL CHEM, V283, P8136, DOI 10.1074/jbc.M708761200; Astori S, 2011, P NATL ACAD SCI USA, V108, P13823, DOI 10.1073/pnas.1105115108; Baumgart JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002976; Broicher T, 2007, MOL CELL NEUROSCI, V36, P132, DOI 10.1016/j.mcn.2007.05.013; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Chemin J, 2001, BIOPHYS J, V80, P1238, DOI 10.1016/S0006-3495(01)76100-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Crandall SR, 2010, J NEUROSCI, V30, P15419, DOI 10.1523/JNEUROSCI.3636-10.2010; David LS, 2010, CHANNELS, V4, P375, DOI 10.4161/chan.4.5.12874; Di Biase V, 2005, J CELL BIOL, V171, P695, DOI 10.1083/jcb.200503077; EAHOLTZ G, 1994, NEURON, V12, P1041, DOI 10.1016/0896-6273(94)90312-3; Emerick MC, 2006, PROTEINS, V64, P320, DOI 10.1002/prot.20877; Groome JR, 2007, BIOPHYS J, V93, P1519, DOI 10.1529/biophysj.106.102079; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; Hildebrand ME, 2009, J NEUROSCI, V29, P9668, DOI 10.1523/JNEUROSCI.0362-09.2009; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kang HW, 2008, BBA-BIOMEMBRANES, V1778, P2740, DOI 10.1016/j.bbamem.2008.08.002; Kim T, 2009, BIOCHEM BIOPH RES CO, V378, P15, DOI 10.1016/j.bbrc.2008.09.034; Latour I, 2004, GLIA, V48, P112, DOI 10.1002/glia.20063; Liebeskind BJ, 2011, P NATL ACAD SCI USA, V108, P9154, DOI 10.1073/pnas.1106363108; Lin YCJ, 2001, J EXP BIOL, V204, P3717; Liu JH, 2003, DEVELOPMENT, V130, P3437, DOI 10.1242/dev.00562; MACKIE GO, 1985, NATURE, V313, P791, DOI 10.1038/313791a0; MAROIS R, 1992, J COMP NEUROL, V322, P255, DOI 10.1002/cne.903220211; McComb C, 2005, J EXP BIOL, V208, P1459, DOI 10.1242/jeb.01544; McKay BE, 2006, EUR J NEUROSCI, V24, P2581, DOI 10.1111/j.1460-9568.2006.05136.x; McRory JE, 2001, J BIOL CHEM, V276, P3999, DOI 10.1074/jbc.M008215200; Mezghrani A, 2008, J NEUROSCI, V28, P4501, DOI 10.1523/JNEUROSCI.2844-07.2008; Monteil A, 2000, J BIOL CHEM, V275, P6090, DOI 10.1074/jbc.275.9.6090; Ohkubo T, 2005, CELL PHYSIOL BIOCHEM, V16, P245, DOI 10.1159/000089850; Ono K, 2010, J MOL CELL CARDIOL, V48, P65, DOI 10.1016/j.yjmcc.2009.08.021; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Perez-Reyes E, 2010, MOL PHARMACOL, V77, P136, DOI 10.1124/mol.109.062133; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Senatore A., 2012, WIRES MEMBR TRANSP S, V1, P467, DOI DOI 10.1002/WMTS.41; Senatore A, 2011, JOVE-J VIS EXP, DOI 10.3791/2314; Senatore A, 2010, J BIOL CHEM, V285, P7447, DOI 10.1074/jbc.M109.090753; Shcheglovitov A, 2008, FEBS LETT, V582, P3765, DOI 10.1016/j.febslet.2008.10.013; Spafford JD, 2006, J NEUROPHYSIOL, V95, P42, DOI 10.1152/jn.00658.2005; Spafford JD, 2003, J BIOL CHEM, V278, P21178, DOI 10.1074/jbc.M302212200; Steger KA, 2005, J EXP BIOL, V208, P2191, DOI 10.1242/jeb.01616; Taylor JT, 2008, WORLD J GASTROENTERO, V14, P4984, DOI 10.3748/wjg.14.4984; Tscherter A, 2011, J PHYSIOL-LONDON, V589, P1707, DOI 10.1113/jphysiol.2010.203836; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Yeoman MS, 1999, J NEUROPHYSIOL, V82, P2428, DOI 10.1152/jn.1999.82.5.2428; Zhong XL, 2006, HUM MOL GENET, V15, P1497, DOI 10.1093/hmg/ddl068	49	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e37409	10.1371/journal.pone.0037409	http://dx.doi.org/10.1371/journal.pone.0037409			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719839	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350000005
J	Jones, COH; Wasunna, B; Sudoi, R; Githinji, S; Snow, RW; Zurovac, D				Jones, Caroline O. H.; Wasunna, Beatrice; Sudoi, Raymond; Githinji, Sophie; Snow, Robert W.; Zurovac, Dejan			"Even if You Know Everything You Can Forget": Health Worker Perceptions of Mobile Phone Text-Messaging to Improve Malaria Case-Management in Kenya	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; LUMEFANTRINE TREATMENT POLICY; ARTEMETHER-LUMEFANTRINE; CLINICAL MANAGEMENT; GUIDELINES; PERFORMANCE; ADHERENCE; IMPLEMENTATION; MINDLINES; TANZANIA	This paper presents the results of a qualitative study to investigate the perceptions and experiences of health workers involved in a a cluster-randomized controlled trial of a novel intervention to improve health worker malaria case-management in 107 government health facilities in Kenya. The intervention involved sending text-messages about paediatric outpatient malaria case-management accompanied by "motivating" quotes to health workers' mobile phones. Ten malaria messages were developed reflecting recommendations from the Kenyan national guidelines. Two messages were delivered per day for 5 working days and the process was repeated for 26 weeks (May to October 2009). The accompanying quotes were unique to each message. The intervention was delivered to 119 health workers and there were significant improvements in correct artemether-lumefantrine (AL) management both immediately after the intervention (November 2009) and 6 months later (May 2010). In-depth interviews with 24 health workers were undertaken to investigate the possible drivers of this change. The results suggest high acceptance of all components of the intervention, with the active delivery of information in an on the job setting, the ready availability of new and stored text messages and the perception of being kept 'up to date' as important factors influencing practice. Applying the construct of stages of change we infer that in this intervention the SMS messages were operating primarily at the action and maintenance stages of behaviour change achieving their effect by creating an enabling environment and providing a prompt to action for the implementation of case management practices that had already been accepted as the clinical norm by the health workers. Future trials testing the effectiveness of SMS reminders in creating an enabling environment for the establishment of new norms in clinical practice as well as in providing a prompt to action for the implementation of the new case-management guidelines are justified.	[Jones, Caroline O. H.] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Jones, Caroline O. H.; Snow, Robert W.; Zurovac, Dejan] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Jones, Caroline O. H.] Univ Oxford, Dept Publ Hlth & Primary Care, Oxford OX3 7LF, England; [Wasunna, Beatrice; Sudoi, Raymond; Githinji, Sophie; Snow, Robert W.; Zurovac, Dejan] KEMRI Wellcome Trust Res Programme, Malaria Publ Hlth & Epidemiol Grp, Nairobi, Kenya; [Zurovac, Dejan] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA	University of Oxford; University of Oxford; Boston University	Jones, COH (corresponding author), KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.	cjones@kilifi.kemri-wellcome.org	Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088	Wellcome Trust, UK [084253]; Wellcome Trust [084253, 079080, 092654/Z/10/A]	Wellcome Trust, UK(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission)	The study was funded by the Wellcome Trust, UK (#084253). Dr. Snow is supported by the Wellcome Trust as Principal Research Fellow [#079080] which also supports Dr. Githinji. Dr. Zurovac and Dr. Sudoi are supported by the Welcome Trust project grant [#084253]. All authors acknowledge support from the Wellcome Trust core grant [#092654/Z/10/A]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2005, HEALTH EDUC RES, V20, P237, DOI 10.1093/her/cyg105; Bisoffi Z, 2009, TROP MED INT HEALTH, V14, P491, DOI 10.1111/j.1365-3156.2009.02246.x; Chandler CIR, 2008, HEALTH POLICY PLANN, V23, P170, DOI 10.1093/heapol/czm046; Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53; Chilvers R, 2002, BRIT J PSYCHIAT, V181, P99; Chinkhumba J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-209; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; DeRenzi B, 2012, INT C INF COMM TECHN; Felch WC, 1997, JAMA-J AM MED ASSOC, V277, P155, DOI 10.1001/jama.277.2.155; Fjeldsoe BS, 2009, AM J PREV MED, V36, P165, DOI 10.1016/j.amepre.2008.09.040; Gabbay J, 2004, BRIT MED J, V329, P1013, DOI 10.1136/bmj.329.7473.1013; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Hayward RSA, 1996, J GEN INTERN MED, V11, P176, DOI 10.1007/BF02600272; Kyabayinze D, 2010, MALARIA J, V9, pP18; Moulding NT, 1999, QUAL HEALTH CARE, V8, P177, DOI 10.1136/qshc.8.3.177; Nyandigisi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024781; OforiAdjei D, 1996, SOC SCI MED, V42, P1169, DOI 10.1016/0277-9536(95)00389-4; Pariyo GW, 2005, HEALTH POLICY PLANN, V20, pI58, DOI 10.1093/heapol/czi051; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037//0022-006X.51.3.390; QSR International, 2010, NVIVO; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Robertson R., 2006, INTERVENTIONS CHANGE; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Rowe AK, 2010, 1 GLOB S HLTH SYST R; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-275; Rowe AK, 2009, AM J PUBLIC HEALTH, V99, P837, DOI 10.2105/AJPH.2008.134411; Skarbinski J, 2009, AM J TROP MED HYG, V80, P919; Sutton S, 2000, PSYCHOL HEALTH, V15, P163, DOI 10.1080/08870440008400298; Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419; Treatman D, 2012, STRENGTHENING COMMUN; Uzochukwu BSC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014627; Wasunna B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-261; World Health Organization, 2010, MAL TREATM GUID; Zurovac D, 2008, TROP MED INT HEALTH, V13, P99, DOI 10.1111/j.1365-3156.2007.01980.x; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6; Zurovac D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-181	37	45	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38636	10.1371/journal.pone.0038636	http://dx.doi.org/10.1371/journal.pone.0038636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UV	22719911	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900039
J	Kumar, A; Majid, M; Kunisch, R; Rani, PS; Qureshi, IA; Lewin, A; Hasnain, SE; Ahmed, N				Kumar, Ashutosh; Majid, Mohammad; Kunisch, Ralph; Rani, Pittu Sandhya; Qureshi, Insaf A.; Lewin, Astrid; Hasnain, Seyed E.; Ahmed, Niyaz			Mycobacterium tuberculosis DosR Regulon Gene Rv0079 Encodes a Putative, 'Dormancy Associated Translation Inhibitor (DATIN)'	PLOS ONE			English	Article							CONSENSUS PREDICTION; PROTEIN; PERSISTENCE; TOPOLOGY; DOCKING; LATENCY; SERVER; BCG	Mycobacterium tuberculosis is a major human pathogen that has evolved survival mechanisms to persist in an immune-competent host under a dormant condition. The regulation of M. tuberculosis metabolism during latent infection is not clearly known. The dormancy survival regulon (DosR regulon) is chiefly responsible for encoding dormancy related functions of M. tuberculosis. We describe functional characterization of an important gene of DosR regulon, Rv0079, which appears to be involved in the regulation of translation through the interaction of its product with bacterial ribosomal subunits. The protein encoded by Rv0079, possibly, has an inhibitory role with respect to protein synthesis, as revealed by our experiments. We performed computational modelling and docking simulation studies involving the protein encoded by Rv0079 followed by in vitro translation and growth curve analysis experiments, involving recombinant E. coli and Bacille Calmette Guerin (BCG) strains that overexpressed Rv0079. Our observations concerning the interaction of the protein with the ribosomes are supportive of its role in regulation/inhibition of translation. We propose that the protein encoded by locus Rv0079 is a 'dormancy associated translation inhibitor' or DATIN.	[Kumar, Ashutosh; Majid, Mohammad; Rani, Pittu Sandhya; Ahmed, Niyaz] Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Pathogen Biol Lab, Hyderabad 500134, Andhra Pradesh, India; [Kunisch, Ralph; Lewin, Astrid] Robert Koch Inst, Berlin, Germany; [Hasnain, Seyed E.] Indian Inst Technol, Sch Biol Sci, New Delhi, India; [Hasnain, Seyed E.] Inst Life Sci, Hyderabad, Andhra Pradesh, India; [Hasnain, Seyed E.] King Saud Univ, Riyadh, Saudi Arabia; [Ahmed, Niyaz] Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia	University of Hyderabad; Robert Koch Institute; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; King Saud University; Universiti Malaya	Kumar, A (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Pathogen Biol Lab, Hyderabad 500134, Andhra Pradesh, India.	ahmed.nizi@gmail.com	Qureshi, Insaf Ahmed/W-1957-2019	Qureshi, Insaf Ahmed/0000-0001-7720-7067; Hasnain, Seyed/0000-0002-2967-0791	Centre of Excellence Grant from the Department of Biotechnology of the Indian Government [BT/01/C0E/07/02]; German Research Foundation (DFG); international research training group (IRTG) [GRK1673 (Berlin-Hyderabad)]; University of Malaya High Impact Research (HIR) [UM.C/625/1HIR/MOHE/CHAN-02]; University of Malaya (HIRG) [UM.C/625/1/HIR/MOHE/CHAN-02 [A000002-5000 1]]	Centre of Excellence Grant from the Department of Biotechnology of the Indian Government; German Research Foundation (DFG)(German Research Foundation (DFG)); international research training group (IRTG); University of Malaya High Impact Research (HIR); University of Malaya (HIRG)	This work was primarily supported by a Centre of Excellence Grant from the Department of Biotechnology of the Indian Government entitled 'Multidisciplinary approaches aimed at interventions against Mycobacterium tuberculosis' [BT/01/C0E/07/02] to NA (component B2b). The authors would like to also acknowledge support from the German Research Foundation (DFG) sponsored international research training group (IRTG) entitled 'Internationales Graduiertenkolleg - functional molecular infection epidemiology - GRK1673 (Berlin-Hyderabad)' of which NA is a speaker, and partial support through the University of Malaya High Impact Research (HIR) grant (Ref. UM.C/625/1HIR/MOHE/CHAN-02). SEH is a J. C. Bose National Fellow (India) and a Robert Koch Fellow of the Robert Koch Institute, Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Elisabeth Kamal for excellent technical assistance and Sven Maurischat for providing materials and help. We acknowledge support from University of Malaya (HIRG, reference UM.C/625/1/HIR/MOHE/CHAN-02 [A000002-5000 1]) - Molecular Genetics. We would like to convey our acknowledgement of help received from Syed Asif Hasan and Priyadarshini Yerra in carrying out additional confirmatory growth curve experiments involving DATIN and Hsp65.	Arai M, 2004, NUCLEIC ACIDS RES, V32, pW390, DOI 10.1093/nar/gkh380; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chauhan S, 2011, NUCLEIC ACIDS RES, V39, P7400, DOI 10.1093/nar/gkr375; Cserzo M, 2002, PROTEIN ENG, V15, P745, DOI 10.1093/protein/15.9.745; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dumon-Seignovert L, 2004, PROTEIN EXPRES PURIF, V37, P203, DOI 10.1016/j.pep.2004.04.025; El-Sharoud Walid M., 2004, Science Progress, V87, P137, DOI 10.3184/003685004783238517; Flores Valdez MA, 2010, TUBERCULOSIS EDINB, V90, P197, DOI DOI 10.1016/J.TUBE.2010.04.001; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Mishra S, 2009, J BIOMOL STRUCT DYN, V27, P283, DOI 10.1080/07391102.2009.10507316; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sharbati-Tehrani S, 2004, INT J MED MICROBIOL, V294, P235, DOI 10.1016/j.ijmm.2004.02.001; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; WAYNE LG, 1994, EUR J CLIN MICROBIOL, V13, P908, DOI 10.1007/BF02111491; WAYNE LG, 1982, INFECT IMMUN, V37, P1042, DOI 10.1128/IAI.37.3.1042-1049.1982; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	28	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38709	10.1371/journal.pone.0038709	http://dx.doi.org/10.1371/journal.pone.0038709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719925	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341900043
J	Malik-Kale, P; Winfree, S; Steele-Mortimer, O				Malik-Kale, Preeti; Winfree, Seth; Steele-Mortimer, Olivia			The Bimodal Lifestyle of Intracellular Salmonella in Epithelial Cells: Replication in the Cytosol Obscures Defects in Vacuolar Replication	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; III SECRETION SYSTEM; LYSOSOMAL MEMBRANE-GLYCOPROTEINS; PATHOGENICITY ISLAND 2; MURINE MACROPHAGES; EFFECTOR PROTEINS; HOST-CELLS; INFECTION; SURVIVAL; SIFA	Salmonella enterica serovar Typhimurium invades and proliferates within epithelial cells. Intracellular bacteria replicate within a membrane bound vacuole known as the Salmonella containing vacuole. However, this bacterium can also replicate efficiently in the cytosol of epithelial cells and net intracellular growth is a product of both vacuolar and cytosolic replication. Here we have used semi-quantitative single-cell analyses to investigate the contribution of each of these replicative niches to intracellular proliferation in cultured epithelial cells. We show that cytosolic replication can account for the majority of net replication even though it occurs in less than 20% of infected cells. Consequently, assays for net growth in a population of infected cells, for example by recovery of colony forming units, are not good indicators of vacuolar proliferation. We also show that the Salmonella Type III Secretion System 2, which is required for SCV biogenesis, is not required for cytosolic replication. Altogether this study illustrates the value of single cell analyses when studying intracellular pathogens.	[Malik-Kale, Preeti; Winfree, Seth; Steele-Mortimer, Olivia] Natl Inst Allergy & Infect Dis, Salmonella Host Cell Interact Sect, Intracellular Parasites Lab, Rocky Mt Labs,NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Malik-Kale, P (corresponding author), Natl Inst Allergy & Infect Dis, Salmonella Host Cell Interact Sect, Intracellular Parasites Lab, Rocky Mt Labs,NIH, Hamilton, MT USA.	omortimer@niaid.nih.gov		Winfree, Seth/0000-0002-2396-5871	National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000909] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was entirely supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams GL, 2006, TRAFFIC, V7, P950, DOI 10.1111/j.1600-0854.2006.00454.x; Bakowski MA, 2008, TRAFFIC, V9, P2022, DOI 10.1111/j.1600-0854.2008.00827.x; Beuzon CR, 2002, MICROBIOL-SGM, V148, P2705, DOI 10.1099/00221287-148-9-2705; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Brumell JH, 2001, TRAFFIC, V2, P643, DOI 10.1034/j.1600-0854.2001.20907.x; Brumell JH, 2001, CELL MICROBIOL, V3, P75, DOI 10.1046/j.1462-5822.2001.00087.x; Buckner MMC, 2011, VIRULENCE, V2, P208, DOI 10.4161/viru.2.3.15894; Bujny MV, 2008, J CELL SCI, V121, P2027, DOI 10.1242/jcs.018432; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Coombes BK, 2003, MICROBES INFECT, V5, P561, DOI 10.1016/S1286-4579(03)00094-7; Deiwick J, 2006, INFECT IMMUN, V74, P6965, DOI 10.1128/IAI.00648-06; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Drecktrah D, 2008, TRAFFIC, V9, P2117, DOI 10.1111/j.1600-0854.2008.00830.x; Freeman JA, 2003, INFECT IMMUN, V71, P418, DOI 10.1128/IAI.71.1.418-427.2003; GARCIADELPORTILLO F, 1993, P NATL ACAD SCI USA, V90, P10544, DOI 10.1073/pnas.90.22.10544; GARCIADELPORTILLO F, 1995, J CELL BIOL, V129, P81, DOI 10.1083/jcb.129.1.81; Guignot J, 2008, MICROB PATHOGENESIS, V45, P415, DOI 10.1016/j.micpath.2008.09.007; Guy RL, 2000, MOL MICROBIOL, V37, P1417, DOI 10.1046/j.1365-2958.2000.02092.x; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Hensel M, 1997, MOL MICROBIOL, V24, P155, DOI 10.1046/j.1365-2958.1997.3271699.x; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Ibarra JA, 2010, MICROBIOL-SGM, V156, P1120, DOI 10.1099/mic.0.032896-0; Kerr MC, 2010, EMBO J, V29, P1331, DOI 10.1038/emboj.2010.28; Knodler LA, 2003, MOL MICROBIOL, V49, P685, DOI 10.1046/j.1365-2958.2003.03598.x; Knodler LA, 2010, P NATL ACAD SCI USA, V107, P17733, DOI 10.1073/pnas.1006098107; Marlovits TC, 2010, CURR OPIN MICROBIOL, V13, P47, DOI 10.1016/j.mib.2009.11.001; Meresse S, 1999, EMBO J, V18, P4394, DOI 10.1093/emboj/18.16.4394; Mota LJ, 2009, CELL MICROBIOL, V11, P1236, DOI 10.1111/j.1462-5822.2009.01329.x; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Rathman M, 1997, INFECT IMMUN, V65, P1475, DOI 10.1128/IAI.65.4.1475-1485.1997; Ruiz-Albert J, 2002, MOL MICROBIOL, V44, P645, DOI 10.1046/j.1365-2958.2002.02912.x; Steele-Mortimer O, 2002, CELL MICROBIOL, V4, P43, DOI 10.1046/j.1462-5822.2002.00170.x; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002	36	86	86	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38732	10.1371/journal.pone.0038732	http://dx.doi.org/10.1371/journal.pone.0038732			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719929	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341900044
J	Raina, SA; Tsai, J; Samso, M; Fessenden, JD				Raina, Shweta A.; Tsai, Jeffrey; Samso, Montserrat; Fessenden, James D.			FRET-Based Localization of Fluorescent Protein Insertions Within the Ryanodine Receptor Type 1	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; MUTATION HOT-SPOT; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; SITE; DOMAIN; CHANNEL; COMPLEX; LIGAND; REGION	Fluorescent protein (FP) insertions have often been used to localize primary structure elements in mid-resolution 3D cryo electron microscopic (EM) maps of large protein complexes. However, little is known as to the precise spatial relationship between the location of the fused FP and its insertion site within a larger protein. To gain insights into these structural considerations, Forster resonance energy transfer (FRET) measurements were used to localize green fluorescent protein (GFP) insertions within the ryanodine receptor type 1 (RyR1), a large intracellular Ca2+ release channel that plays a key role in skeletal muscle excitation contraction coupling. A series of full-length His-tagged GFP-RyR1 fusion constructs were created, expressed in human embryonic kidney (HEK)-293T cells and then complexed with Cy3NTA, a His-tag specific FRET acceptor. FRET efficiency values measured from each GFP donor to Cy3NTA bound to each His tag acceptor site were converted into intermolecular distances and the positions of each inserted GFP were then triangulated relative to a previously published X-ray crystal structure of a 559 amino acid RyR1 fragment. We observed that the chromophoric centers of fluorescent proteins inserted into RyR1 can be located as far as 45 angstrom from their insertion sites and that the fused proteins can also be located in internal cavities within RyR1. These findings should prove useful in interpreting structural results obtained in cryo EM maps using fusions of small fluorescent proteins. More accurate point-to-point distance information may be obtained using complementary orthogonal labeling systems that rely on fluorescent probes that bind directly to amino acid side chains.	[Raina, Shweta A.; Tsai, Jeffrey; Fessenden, James D.] Boston Biomed Res Inst, Watertown, MA USA; [Samso, Montserrat] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA USA	Boston Biomedical Research Institute; Virginia Commonwealth University	Raina, SA (corresponding author), Boston Biomed Res Inst, Watertown, MA USA.	jfessenden@partners.org		Samso, Montserrat/0000-0002-2788-3283	NIH [R21ARO56406, 1R01AR059124]; Virginia Commonwealth University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Commonwealth University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	JDF was supported by NIH grants R21ARO56406 and 1R01AR059124. MS acknowledges Virginia Commonwealth University start-up funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador FJ, 2009, P NATL ACAD SCI USA, V106, P11040, DOI 10.1073/pnas.0905186106; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Charpilienne A, 2001, J BIOL CHEM, V276, P29361, DOI 10.1074/jbc.M101935200; Conway JF, 2010, J MOL BIOL, V397, P575, DOI 10.1016/j.jmb.2010.01.043; Fessenden JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007338; Fessenden JD, 2003, J BIOL CHEM, V278, P28727, DOI 10.1074/jbc.M303821200; Guignet EG, 2004, NAT BIOTECHNOL, V22, P440, DOI 10.1038/nbt954; John CM, 2007, EMBO J, V26, P3296, DOI 10.1038/sj.emboj.7601775; Kapanidis AN, 2001, J AM CHEM SOC, V123, P12123, DOI 10.1021/ja017074a; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lata S, 2005, J AM CHEM SOC, V127, P10205, DOI 10.1021/ja050690c; Liu Z, 2005, J BIOL CHEM, V280, P37941, DOI 10.1074/jbc.M505714200; Liu Z, 2004, J MOL BIOL, V338, P533, DOI 10.1016/j.jmb.2004.03.011; Liu Z, 2001, P NATL ACAD SCI USA, V98, P6104, DOI 10.1073/pnas.111382798; Liu Z, 2010, J CELL SCI, V123, P1775, DOI 10.1242/jcs.064071; Lobo PA, 2009, STRUCTURE, V17, P1505, DOI 10.1016/j.str.2009.08.016; Lorenzon NM, 2001, ARCH BIOCHEM BIOPHYS, V388, P13, DOI 10.1006/abbi.2000.2263; Meng X, 2007, J BIOL CHEM, V282, P25929, DOI 10.1074/jbc.M704474200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rost B, 2001, J STRUCT BIOL, V134, P204, DOI 10.1006/jsbi.2001.4336; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Serysheva II, 2008, P NATL ACAD SCI USA, V105, P9610, DOI 10.1073/pnas.0803189105; Toropova K, 2011, J VIROL, V85, P7513, DOI 10.1128/JVI.00837-11; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Wang RW, 2007, J BIOL CHEM, V282, P17785, DOI 10.1074/jbc.M700660200; Wang RW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194316; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zhang J, 2003, J BIOL CHEM, V278, P14211, DOI 10.1074/jbc.M213164200; Zhong X, 2012, BIOPH SOC M	31	9	9	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38594	10.1371/journal.pone.0038594	http://dx.doi.org/10.1371/journal.pone.0038594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719904	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341900036
J	Wylie, KM; Truty, RM; Sharpton, TJ; Mihindukulasuriya, KA; Zhou, YJ; Gao, HY; Sodergren, E; Weinstock, GM; Pollard, KS				Wylie, Kristine M.; Truty, Rebecca M.; Sharpton, Thomas J.; Mihindukulasuriya, Kathie A.; Zhou, Yanjiao; Gao, Hongyu; Sodergren, Erica; Weinstock, George M.; Pollard, Katherine S.			Novel Bacterial Taxa in the Human Microbiome	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; HUMAN GUT; MAXIMUM-LIKELIHOOD; FAST PROGRAM; SP NOV.; SEQUENCES; PROJECT; GENERATION; PROTEIN; SPACE	The human gut harbors thousands of bacterial taxa. A profusion of metagenomic sequence data has been generated from human stool samples in the last few years, raising the question of whether more taxa remain to be identified. We assessed metagenomic data generated by the Human Microbiome Project Consortium to determine if novel taxa remain to be discovered in stool samples from healthy individuals. To do this, we established a rigorous bioinformatics pipeline that uses sequence data from multiple platforms (Illumina GAIIX and Roche 454 FLX Titanium) and approaches (whole-genome shotgun and 16S rDNA amplicons) to validate novel taxa. We applied this approach to stool samples from 11 healthy subjects collected as part of the Human Microbiome Project. We discovered several low-abundance, novel bacterial taxa, which span three major phyla in the bacterial tree of life. We determined that these taxa are present in a larger set of Human Microbiome Project subjects and are found in two sampling sites (Houston and St. Louis). We show that the number of false-positive novel sequences (primarily chimeric sequences) would have been two orders of magnitude higher than the true number of novel taxa without validation using multiple datasets, highlighting the importance of establishing rigorous standards for the identification of novel taxa in metagenomic data. The majority of novel sequences are related to the recently discovered genus Barnesiella, further encouraging efforts to characterize the members of this genus and to study their roles in the microbial communities of the gut. A better understanding of the effects of less-abundant bacteria is important as we seek to understand the complex gut microbiome in healthy individuals and link changes in the microbiome to disease.	[Wylie, Kristine M.; Mihindukulasuriya, Kathie A.; Zhou, Yanjiao; Gao, Hongyu; Sodergren, Erica; Weinstock, George M.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63130 USA; [Truty, Rebecca M.; Sharpton, Thomas J.; Pollard, Katherine S.] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Inst Human Genet, Div Biostat, San Francisco, CA 94143 USA	Washington University (WUSTL); University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Wylie, KM (corresponding author), Washington Univ, Sch Med, Genome Inst, St Louis, MO 63130 USA.	kwylie@genome.wustl.edu; rebecca.truty@gladstone.ucsf.edu	Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592; Sharpton, Thomas/0000-0002-5996-7764; Mihindukulasuriya, Kathie/0000-0001-9372-3758	National Institutes of Health [NIH-NHGRI U54HG004968]; Gordon & Betty Moore Foundation; J. David Gladstone Institutes; Direct For Mathematical & Physical Scien [1069303] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon & Betty Moore Foundation(Gordon and Betty Moore Foundation); J. David Gladstone Institutes(University of California System); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Institutes of Health grant NIH-NHGRI U54HG004968 to George M. Weinstock and funding from the Gordon & Betty Moore Foundation and the J. David Gladstone Institutes to Katherine S. Pollard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARONSSON B, 1981, MED MICROBIOL IMMUN, V170, P27, DOI 10.1007/BF02123794; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Goldstein EJC, 2003, J CLIN MICROBIOL, V41, P2752, DOI 10.1128/JCM.41.6.2752-2754.2003; Green P, 1994, CROSS MATCH UNPUB; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hajishengallis G, 2011, CELL HOST MICROBE; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hugenholtz P, 2003, INT J SYST EVOL MICR, V53, P289, DOI 10.1099/ijs.0.02441-0; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Morotomi M, 2008, INT J SYST EVOL MICR, V58, P2716, DOI 10.1099/ijs.0.2008/000810-0; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Sakamoto M, 2007, INT J SYST EVOL MICR, V57, P342, DOI 10.1099/ijs.0.64709-0; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sharpton TJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001061; Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wylie TN, REFCOV VERSION 2 0	34	63	66	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e35294	10.1371/journal.pone.0035294	http://dx.doi.org/10.1371/journal.pone.0035294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719826	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341900008
J	Chen, X; Pan, LQ; Naranmandura, H; Zeng, S; Chen, SQ				Chen, Xuan; Pan, Li Qiang; Naranmandura, Hua; Zeng, Su; Chen, Shu Qing			Influence of Various Polymorphic Variants of Cytochrome P450 Oxidoreductase (POR) on Drug Metabolic Activity of CYP3A4 and CYP2B6	PLOS ONE			English	Article							ANTLEY-BIXLER-SYNDROME; MUTANT P450 OXIDOREDUCTASE; GENETIC-VARIATION; DISORDERED STEROIDOGENESIS; NADPH-P450 OXIDOREDUCTASE; HEME OXYGENASE; IN-VITRO; REDUCTASE; MUTATIONS; SYSTEM	Cytochrome P450 oxidoreductase (POR) is known as the sole electron donor in the metabolism of drugs by cytochrome P450 (CYP) enzymes in human. However, little is known about the effect of polymorphic variants of POR on drug metabolic activities of CYP3A4 and CYP2B6. In order to better understand the mechanism of the activity of CYPs affected by polymorphic variants of POR, six full-length mutants of POR (e.g., Y181D, A287P, K49N, A115V, S244C and G413S) were designed and then co-expressed with CYP3A4 and CYP2B6 in the baculovirus-Sf9 insect cells to determine their kinetic parameters. Surprisingly, both mutants, Y181D and A287P in POR completely inhibited the CYP3A4 activity with testosterone, while the catalytic activity of CYP2B6 with bupropion was reduced to approximately similar to 70% of wild-type activity by Y181D and A287P mutations. In addition, the mutant K49N of POR increased the CLint (Vmax/Km) of CYP3A4 up to more than 31% of wild-type, while it reduced the catalytic efficiency of CYP2B6 to 74% of wild-type. Moreover, CLint values of CYP3A4-POR (A115V, G413S) were increased up to 36% and 65% of wild-type respectively. However, there were no appreciable effects observed by the remaining two mutants of POR (i.e., A115V and G413S) on activities of CYP2B6. In conclusion, the extent to which the catalytic activities of CYP were altered did not only depend on the specific POR mutations but also on the isoforms of different CYP redox partners. Thereby, we proposed that the POR-mutant patients should be carefully monitored for the activity of CYP3A4 and CYP2B6 on the prescribed medication.	[Chen, Xuan; Pan, Li Qiang; Naranmandura, Hua; Chen, Shu Qing] Zhejiang Univ, Coll Pharmaceut Sci, Dept Pharmacol Toxicol & Biochem Pharmaceut, Hangzhou 310003, Zhejiang, Peoples R China; [Zeng, Su] Zhejiang Univ, Coll Pharmaceut Sci, Dept Drug Metab & Pharmaceut Anal, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Chen, X (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Dept Pharmacol Toxicol & Biochem Pharmaceut, Hangzhou 310003, Zhejiang, Peoples R China.	narenman@zju.edu.cn; chenshuqing@zju.edu.cn	Naranmandura, Hua/C-6499-2015	Naranmandura, Hua/0000-0003-0799-2340; Chen, Shuqing/0000-0002-0792-3735	National Natural Science Foundation of China [81001477]; National Science and Technology Major Projects for "Major New Drugs Innovation and Development" of China [2012ZX09506001-004]; Zhejiang Provincial Natural Science Foundation of China [R2110231]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects for "Major New Drugs Innovation and Development" of China; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The authors wish to acknowledge the National Natural Science Foundation of China (No. 81001477), National Science and Technology Major Projects for "Major New Drugs Innovation and Development" of China (No. 2012ZX09506001-004) and Zhejiang Provincial Natural Science Foundation of China (No. R2110231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal V, 2008, PHARMACOGENET GENOM, V18, P569, DOI 10.1097/FPC.0b013e32830054ac; Agrawal V, 2010, PHARMACOGENET GENOM, V20, P611, DOI 10.1097/FPC.0b013e32833e0cb5; Arlt W, 2004, LANCET, V363, P2128, DOI 10.1016/S0140-6736(04)16503-3; BLACK SD, 1982, J BIOL CHEM, V257, P5929; Bonina TA, 2005, BIOCHEMISTRY-MOSCOW+, V70, P357, DOI 10.1007/s10541-005-0122-3; Dhir V, 2007, MOL ENDOCRINOL, V21, P1958, DOI 10.1210/me.2007-0066; Eichelbaum M, 2006, ANNU REV MED, V57, P119, DOI 10.1146/annurev.med.56.082103.104724; Faucette SR, 2000, DRUG METAB DISPOS, V28, P1222; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; Fluck CE, 2007, FUND CLIN PHARMACOL, V21, P399, DOI 10.1111/j.1472-8206.2007.00520.x; Fluck CE, 2010, BIOCHEM BIOPH RES CO, V401, P149, DOI 10.1016/j.bbrc.2010.09.035; Gu J, 2003, J BIOL CHEM, V278, P25895, DOI 10.1074/jbc.M303125200; Guengerich FP, 2004, DRUG METAB REV, V36, P159, DOI 10.1081/DMR-120033996; Han JF, 2006, TOXICOL SCI, V91, P42, DOI 10.1093/toxsci/kfj139; Hart SN, 2008, EXPERT OPIN DRUG MET, V4, P439, DOI [10.1517/17425255.4.4.439, 10.1517/17425255.4.4.439 ]; Hart SN, 2007, DRUG METAB PHARMACOK, V22, P322, DOI 10.2133/dmpk.22.322; Henderson CJ, 2003, J BIOL CHEM, V278, P13480, DOI 10.1074/jbc.M212087200; Huang N, 2008, P NATL ACAD SCI USA, V105, P1733, DOI 10.1073/pnas.0711621105; Huang NW, 2005, AM J HUM GENET, V76, P729, DOI 10.1086/429417; ILAN Z, 1981, J BIOL CHEM, V256, P66; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; Kranendonk M, 2008, ARCH BIOCHEM BIOPHYS, V475, P93, DOI 10.1016/j.abb.2008.04.014; Lo HR, 2004, BIOTECHNOL PROGR, V20, P354, DOI 10.1021/bp034132i; Marohnic CC, 2006, J BIOL CHEM, V281, P35975, DOI 10.1074/jbc.M607095200; Marohnic CC, 2010, DRUG METAB DISPOS, V38, P332, DOI 10.1124/dmd.109.030445; Meyer UA, 2004, NAT REV GENET, V5, P669, DOI 10.1038/nrg1428; Miller WL, 2009, MOL CELL ENDOCRINOL, V300, P180, DOI 10.1016/j.mce.2008.09.017; Miller WL, 2011, MOL CELL ENDOCRINOL, P174; Moutinho D, 2012, DRUG METAB DISPOS, DOI [10.1124/dmd.1111.042820, DOI 10.1124/DMD.1111.042820]; Moutinho D, 2012, DRUG METAB DISPOS, V40, P754, DOI 10.1124/dmd.111.042820; OMURA T, 1964, J BIOL CHEM, V239, P2370; Oneda B, 2009, PHARMACOGENET GENOM, V19, P877, DOI 10.1097/FPC.0b013e32833225e7; Otto DME, 2003, MOL CELL BIOL, V23, P6103, DOI 10.1128/MCB.23.17.6103-6116.2003; Ozdemir V, 2000, PHARMACOGENETICS, V10, P373, DOI 10.1097/00008571-200007000-00001; Panda SP, 2006, J BIOL CHEM, V281, P34246, DOI 10.1074/jbc.M601041200; Pandey AV, 2007, MOL ENDOCRINOL, V21, P2579, DOI 10.1210/me.2007-0245; Pandey AV, 2010, BIOCHEM BIOPH RES CO, V400, P374, DOI 10.1016/j.bbrc.2010.08.072; Sandee D, 2010, PHARMACOGENET GENOM, V20, P677, DOI 10.1097/FPC.0b013e32833f4f9b; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; Sim SC, 2009, PHARMACOGENET GENOM, V19, P565, DOI 10.1097/FPC.0b013e32832af5b7; Wang HN, 2011, BIOCHEM PHARMACOL, V82, P1757, DOI 10.1016/j.bcp.2011.08.004; Wang RW, 1997, DRUG METAB DISPOS, V25, P502; Wang SL, 2007, DRUG METAB DISPOS, V35, P176, DOI 10.1124/dmd.106.011056; Zanger UM, 2008, ANAL BIOANAL CHEM, V392, P1093, DOI 10.1007/s00216-008-2291-6; Zhang HM, 2011, J PHARMACOL EXP THER, V338, P803, DOI 10.1124/jpet.111.183111; Zhang XL, 2011, DRUG METAB DISPOS, V39, P1433, DOI 10.1124/dmd.111.038836; Zhou SF, 2008, CURR DRUG METAB, V9, P310, DOI 10.2174/138920008784220664	48	26	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38495	10.1371/journal.pone.0038495	http://dx.doi.org/10.1371/journal.pone.0038495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719896	Green Submitted, gold, Green Published			2022-12-25	WOS:000305340000026
J	Osterholt, HCD; Dannevig, I; Wyckoff, MH; Liao, J; Akgul, Y; Ramgopal, M; Mija, DS; Cheong, N; Longoria, C; Mahendroo, M; Nakstad, B; Saugstad, OD; Savani, RC				Osterholt, Helene C. D.; Dannevig, Ingrid; Wyckoff, Myra H.; Liao, Jie; Akgul, Yucel; Ramgopal, Mrithyunjay; Mija, Dan S.; Cheong, Naeun; Longoria, Christopher; Mahendroo, Mala; Nakstad, Britt; Saugstad, Ola D.; Savani, Rashmin C.			Antioxidant Protects against Increases in Low Molecular Weight Hyaluronan and Inflammation in Asphyxiated Newborn Pigs Resuscitated with 100% Oxygen	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; N-ACETYLCYSTEINE IMPROVES; ROOM-AIR RESUSCITATION; LESS OXIDATIVE STRESS; NITRIC-OXIDE; NEONATAL RESUSCITATION; SUPEROXIDE-DISMUTASE; PEROXYNITRITE; INJURY; ACID	Background: Newborn resuscitation with 100% oxygen is associated with oxidative-nitrative stresses and inflammation. The mechanisms are unclear. Hyaluronan (HA) is fragmented to low molecular weight (LMW) by oxidative-nitrative stresses and can promote inflammation. We examined the effects of 100% oxygen resuscitation and treatment with the antioxidant, N-acetylcysteine (NAC), on lung 3-nitrotyrosine (3-NT), LMW HA, inflammation, TNF alpha and IL1 beta in a newborn pig model of resuscitation. Methods & Principal Findings: Newborn pigs (n = 40) were subjected to severe asphyxia, followed by 30 min ventilation with either 21% or 100% oxygen, and were observed for the subsequent 150 minutes in 21% oxygen. One 100% oxygen group was treated with NAC. Serum, bronchoalveolar lavage (BAL), lung sections, and lung tissue were obtained. Asphyxia resulted in profound hypoxia, hypercarbia and metabolic acidosis. In controls, HA staining was in airway subepithelial matrix and no 3-NT staining was seen. At the end of asphyxia, lavage HA decreased, whereas serum HA increased. At 150 minutes after resuscitation, exposure to 100% oxygen was associated with significantly higher BAL HA, increased 3NT staining, and increased fragmentation of lung HA. Lung neutrophil and macrophage contents, and serum TNF alpha and IL1 beta were higher in animals with LMW than those with HMW HA in the lung. Treatment of 100% oxygen animals with NAC blocked nitrative stress, preserved HMW HA, and decreased inflammation. In vitro, peroxynitrite was able to fragment HA, and macrophages stimulated with LMW HA increased TNF alpha and IL1 beta expression. Conclusions & Significance: Compared to 21%, resuscitation with 100% oxygen resulted in increased peroxynitrite, fragmentation of HA, inflammation, as well as TNF alpha and IL1 beta expression. Antioxidant treatment prevented the expression of peroxynitrite, the degradation of HA, and also blocked increases in inflammation and inflammatory cytokines. These findings provide insight into potential mechanisms by which exposure to hyperoxia results in systemic inflammation.	[Osterholt, Helene C. D.; Dannevig, Ingrid; Nakstad, Britt] Akershus Univ Hosp, Dept Pediat, Lorenskog, Norway; [Osterholt, Helene C. D.; Dannevig, Ingrid; Nakstad, Britt] Univ Oslo, Inst Clin Med, Oslo, Norway; [Osterholt, Helene C. D.; Dannevig, Ingrid] Univ Oslo, Rikshosp, Oslo Univ Hosp, Inst Surg Res, N-0027 Oslo, Norway; [Saugstad, Ola D.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Pediat Res, N-0027 Oslo, Norway; [Akgul, Yucel; Mahendroo, Mala] Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA; [Wyckoff, Myra H.; Liao, Jie; Ramgopal, Mrithyunjay; Mija, Dan S.; Cheong, Naeun; Longoria, Christopher; Savani, Rashmin C.] Univ Texas SW Med Ctr Dallas, Div Pulm & Vasc Biol, Dept Pediat, Dallas, TX 75390 USA; [Wyckoff, Myra H.; Liao, Jie; Ramgopal, Mrithyunjay; Mija, Dan S.; Cheong, Naeun; Longoria, Christopher; Savani, Rashmin C.] Univ Texas SW Med Ctr Dallas, Div Neonatal Perinatal Med, Dept Pediat, Dallas, TX 75390 USA	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Osterholt, HCD (corresponding author), Akershus Univ Hosp, Dept Pediat, Lorenskog, Norway.	rashmin.savani@utsouthwestern.edu	Rashmin C. Savani, MBChB/AAG-2041-2021; Akgul, Yucel/M-1745-2013; Saugstad, Ola/AAS-9041-2021	Rashmin C. Savani, MBChB/0000-0002-9533-5422; Saugstad, Ola/0000-0002-3166-5254; akgul, yucel/0000-0001-8880-9821	Norwegian South East Health Trust; William Buchanan Chair awarded; Ikaria Therapeutics	Norwegian South East Health Trust; William Buchanan Chair awarded; Ikaria Therapeutics	This project was funded by the Norwegian South East Health Trust, The William Buchanan Chair awarded to RCS and a research grant award to MHW and RCS from Ikaria Therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKATSUKA M, 1993, J PHARM PHARMACOL, V45, P110, DOI 10.1111/j.2042-7158.1993.tb03693.x; Akgul Y, 2012, ENDOCRINOLO IN PRESS; Alonso-Spilsbury M, 2005, ANIM REPROD SCI, V90, P1, DOI 10.1016/j.anireprosci.2005.01.007; ANDERSON B, 1991, AM REV RESPIR DIS, V143, P284, DOI 10.1164/ajrccm/143.2.284; Andresen JH, 2008, NEONATOLOGY, V94, P279, DOI 10.1159/000151647; Ara J, 1998, P NATL ACAD SCI USA, V95, P7659, DOI 10.1073/pnas.95.13.7659; Banks BA, 1998, PEDIATRICS, V101, P870, DOI 10.1542/peds.101.5.870; Beckman JS, 2000, SEMIN PERINATOL, V24, P37, DOI 10.1016/S0146-0005(00)80053-1; BECKMAN JS, 1993, BIOCHEM SOC T, V21, P330, DOI 10.1042/bst0210330; BJERMER L, 1987, BRIT MED J, V295, P803, DOI 10.1136/bmj.295.6602.803; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Chan Emily, 2007, Proc West Pharmacol Soc, V50, P53; Cheung PY, 2011, JOVE-J VIS EXP, DOI 10.3791/3166; CROSS CE, 1994, LANCET, V344, P930, DOI 10.1016/S0140-6736(94)92275-6; Deguine V, 1998, INT J BIOL MACROMOL, V22, P17, DOI 10.1016/S0141-8130(97)00084-6; Doroszko A, 2010, SHOCK, V34, P592, DOI 10.1097/SHK.0b013e3181e14f1d; Ducrocq C, 1999, CELL MOL LIFE SCI, V55, P1068, DOI 10.1007/s000180050357; Ezaki S, 2009, J CLIN BIOCHEM NUTR, V44, P111, DOI 10.3164/jcbn.08-221; FREEMAN BA, 1982, LAB INVEST, V47, P412; Gao F, 2008, J BIOL CHEM, V283, P6058, DOI 10.1074/jbc.M709273200; Gow AJ, 2001, J CELL PHYSIOL, V187, P277, DOI 10.1002/jcp.1085; Gow AJ, 1996, FEBS LETT, V385, P63, DOI 10.1016/0014-5793(96)00347-X; HADDAD IY, 1993, AM J PHYSIOL, V265, pL555, DOI 10.1152/ajplung.1993.265.6.L555; HALLGREN R, 1985, BRIT MED J, V290, P1778, DOI 10.1136/bmj.290.6484.1778; HALLGREN R, 1989, AM REV RESPIR DIS, V139, P682; HELLSTROM S, 1987, ACTA OTO-LARYNGOL, P54; Hrabarova E, 2011, GEN PHYSIOL BIOPHYS, V30, P223, DOI 10.4149/gpb_2011_03_223; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Johnson ST, 2007, SHOCK, V28, P484, DOI 10.1097/shk.0b013e31804f775d; Johnson ST, 2009, NEONATOLOGY, V96, P162, DOI 10.1159/000210089; Kattwinkel J, 2010, CIRCULATION, V122, pS909, DOI 10.1161/CIRCULATIONAHA.110.971119; KING SR, 1991, SURGERY, V109, P76; Lee TF, 2011, SHOCK, V35, P428, DOI 10.1097/SHK.0b013e3181fffec2; LEVINE S, 1990, CRIT CARE CLIN, V6, P505; Li M, 1997, ARCH BIOCHEM BIOPHYS, V341, P245, DOI 10.1006/abbi.1997.9970; Liu JQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015322; Liu JQ, 2010, J NEUROTRAUM, V27, P1865, DOI 10.1089/neu.2010.1325; MACLEAN D, 1976, SCIENCE, V194, P199, DOI 10.1126/science.959848; MacMillanCrow LA, 1996, P NATL ACAD SCI USA, V93, P11853, DOI 10.1073/pnas.93.21.11853; Manzanares D, 2007, AM J RESP CELL MOL, V37, P160, DOI 10.1165/rcmb.2006-0413OC; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; McKee CM, 1997, J BIOL CHEM, V272, P8013, DOI 10.1074/jbc.272.12.8013; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Moseley R, 1997, BBA-MOL BASIS DIS, V1362, P221, DOI 10.1016/S0925-4439(97)00083-5; Munkeby BH, 2005, PEDIATR RES, V58, P542, DOI 10.1203/01.PDR.0000179407.46810.2D; Munkeby BH, 2004, PEDIATR RES, V56, P783, DOI 10.1203/01.PDR.0000141988.89820.E3; NETTELBLADT O, 1989, AM REV RESPIR DIS, V140, P1028, DOI 10.1164/ajrccm/140.4.1028; NETTELBLADT O, 1989, AM REV RESPIR DIS, V139, P759, DOI 10.1164/ajrccm/139.3.759; NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469; Obladen M, 2009, NEONATOLOGY, V95, P91, DOI 10.1159/000151761; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Richmond S, 2008, SEMIN FETAL NEONAT M, V13, P368, DOI 10.1016/j.siny.2008.04.002; RIPELLINO JA, 1985, J HISTOCHEM CYTOCHEM, V33, P1060, DOI 10.1177/33.10.4045184; Royall J A, 1995, New Horiz, V3, P113; Saugstad OD, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e1; Saugstad OD, 2003, PEDIATRICS, V112, P296, DOI 10.1542/peds.112.2.296; Saugstad OD, 2008, NEONATOLOGY, V94, P176, DOI 10.1159/000143397; Savani RC, 2000, AM J RESP CELL MOL, V23, P475, DOI 10.1165/ajrcmb.23.4.3944; Savani RC, 2000, AM J PHYSIOL-LUNG C, V279, pL743, DOI 10.1152/ajplung.2000.279.4.L743; SAVANI RC, 1995, P W PHARMACOL SOC, V38, P131; SAVANI RC, 2003, LUNG BIOL HEALTH DIS, V168, P73; Solberg R, 2010, PEDIATR RES, V67, P250, DOI 10.1203/PDR.0b013e3181cde843; Souza JM, 1999, ARCH BIOCHEM BIOPHYS, V371, P169, DOI 10.1006/abbi.1999.1480; STRACHAN RK, 1990, ANN RHEUM DIS, V49, P949, DOI 10.1136/ard.49.11.949; Sugiura H, 2011, NITRIC OXIDE-BIOL CH, V25, P138, DOI 10.1016/j.niox.2011.03.079; SUZUKI Y, 1993, AGENTS ACTIONS, V38, P32, DOI 10.1007/BF02027210; Tabima DM, 2012, FREE RADICAL BIOL ME; TAMOTO K, 1994, MICROBIOL IMMUNOL, V38, P73, DOI 10.1111/j.1348-0421.1994.tb01746.x; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Teder P, 1997, AM J RESP CELL MOL, V17, P376, DOI 10.1165/ajrcmb.17.3.2698; Turanlahti M, 2000, ACTA PAEDIATR, V89, P966, DOI 10.1080/080352500750043440; Tyree MM, 2006, PEDIATR RES, V59, P423, DOI 10.1203/01.pdr.0000199908.30751.ef; URMAN B, 1991, FERTIL STERIL, V56, P563; Vento M, 2005, AM J RESP CRIT CARE, V172, P1393, DOI 10.1164/rccm.200412-1740OC; Vento M, 2009, PEDIATRICS, V124, pE439, DOI 10.1542/peds.2009-0434; WALDENSTROM A, 1991, J CLIN INVEST, V88, P1622, DOI 10.1172/JCI115475; WELLS AF, 1990, TRANSPLANTATION, V50, P240, DOI 10.1097/00007890-199008000-00014; WELLS AF, 1992, ARTHRITIS RHEUM, V35, P391, DOI 10.1002/art.1780350405; Wyckoff M, 2007, PEDIATR RES, V61, P415, DOI 10.1203/pdr.0b013e3180332c45; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200	82	22	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38839	10.1371/journal.pone.0038839	http://dx.doi.org/10.1371/journal.pone.0038839			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701723	Green Published, Green Submitted, gold			2022-12-25	WOS:000305337600050
J	Kaplan, F; Alborn, HT; von Reuss, SH; Ajredini, R; Ali, JG; Akyazi, F; Stelinski, LL; Edison, AS; Schroeder, FC; Teal, PE				Kaplan, Fatma; Alborn, Hans T.; von Reuss, Stephan H.; Ajredini, Ramadan; Ali, Jared G.; Akyazi, Faruk; Stelinski, Lukasz L.; Edison, Arthur S.; Schroeder, Frank C.; Teal, Peter E.			Interspecific Nematode Signals Regulate Dispersal Behavior	PLOS ONE			English	Article							DAUER PHEROMONE COMPONENT; SMALL-MOLECULE SIGNALS; CAENORHABDITIS-ELEGANS; ENTOMOPATHOGENIC NEMATODES; TEMPERATURE; EVOLUTION; PATTERNS; MODE	Background: Dispersal is an important nematode behavior. Upon crowding or food depletion, the free living bacteriovorus nematode Caenorhabditis elegans produces stress resistant dispersal larvae, called dauer, which are analogous to second stage juveniles (J2) of plant parasitic Meloidogyne spp. and infective juveniles (IJ)s of entomopathogenic nematodes (EPN), e.g., Steinernema feltiae. Regulation of dispersal behavior has not been thoroughly investigated for C. elegans or any other nematode species. Based on the fact that ascarosides regulate entry in dauer stage as well as multiple behaviors in C. elegans adults including mating, avoidance and aggregation, we hypothesized that ascarosides might also be involved in regulation of dispersal behavior in C. elegans and for other nematodes such as IJ of phylogenetically related EPNs. Methodology/Principal Findings: Liquid chromatography-mass spectrometry analysis of C. elegans dauer conditioned media, which shows strong dispersing activity, revealed four known ascarosides (ascr#2, ascr#3, ascr#8, icas#9). A synthetic blend of these ascarosides at physiologically relevant concentrations dispersed C. elegans dauer in the presence of food and also caused dispersion of IJs of S. feltiae and J2s of plant parasitic Meloidogyne spp. Assay guided fractionation revealed structural analogs as major active components of the S. feltiae (ascr#9) and C. elegans (ascr#2) dispersal blends. Further analysis revealed ascr#9 in all Steinernema spp. and Heterorhabditis spp. infected insect host cadavers. Conclusions/Significance: Ascaroside blends represent evolutionarily conserved, fundamentally important communication systems for nematodes from diverse habitats, and thus may provide sustainable means for control of parasitic nematodes.	[Kaplan, Fatma; Alborn, Hans T.; Teal, Peter E.] ARS, Ctr Med Agr & Vet Entomol, USDA, Gainesville, FL USA; [von Reuss, Stephan H.; Schroeder, Frank C.] Cornell Univ, Boyce Thompson Inst, Ithaca, NY USA; [von Reuss, Stephan H.; Schroeder, Frank C.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Ajredini, Ramadan; Edison, Arthur S.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Ajredini, Ramadan; Edison, Arthur S.] Univ Florida, Natl High Magnet Field Lab, Gainesville, FL USA; [Ali, Jared G.; Stelinski, Lukasz L.] Univ Florida, Dept Entomol & Nematol, Citrus Res & Educ Ctr, Lake Alfred, FL USA; [Akyazi, Faruk] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Akyazi, Faruk] Ordu Univ, Dept Plant Protect, Ordu, Turkey	United States Department of Agriculture (USDA); Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Ordu University	Kaplan, F (corresponding author), ARS, Ctr Med Agr & Vet Entomol, USDA, Gainesville, FL USA.	fkaplan@ufl.edu	Kaplan, Fatma/AAJ-7666-2020; Schroeder, Frank/H-5026-2012	Kaplan, Fatma/0000-0002-9565-0211; Edison, Arthur/0000-0002-5686-2350; Schroeder, Frank/0000-0002-4420-0237; Ali, Jareg/0000-0002-5794-9554; von Reuss, Stephan/0000-0003-4325-5495; Ali, Jared/0000-0001-9870-0299	National Institutes of Health [R01 GM085285]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085285, R01GM088290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work is partially supported by the National Institutes of Health R01 GM085285. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Brito JA, 2008, NEMATOLOGY, V10, P757, DOI 10.1163/156854108785787253; Butcher RA, 2008, P NATL ACAD SCI USA, V105, P14288, DOI 10.1073/pnas.0806676105; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Butcher RA, 2009, ORG LETT, V11, P3100, DOI 10.1021/ol901011c; Campos-Herrera R, 2011, ANN APPL BIOL, V158, P55, DOI 10.1111/j.1744-7348.2010.00433.x; De Ley P., 2006, COMMUNITY TCER, P1, DOI [10.1895/wormbook.1.41.1, DOI 10.1895/WORMBOOK.1.41.1]; Eisenback J. D., 1985, An advanced treatise on Meloidogyne. Volume 1: Biology and control., P95; Esbenshade P. R., 1985, An advanced treatise on Meloidogyne.Volume II: Methodology., P115; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Kaplan F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017804; Kaya Harry K., 1997, P281, DOI 10.1016/B978-012432555-5/50016-6; KAYA HK, 1993, ANNU REV ENTOMOL, V38, P181, DOI 10.1146/annurev.en.38.010193.001145; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Pungaliya C, 2009, P NATL ACAD SCI USA, V106, P7708, DOI 10.1073/pnas.0811918106; Rolston AN, 2006, J NEMATOL, V38, P221; Shapiro-Ilan DI, 2003, J INVERTEBR PATHOL, V83, P270, DOI 10.1016/S0022-2011(03)00101-0; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Srinivasan J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001237; Symonds MRE, 2005, J EVOLUTION BIOL, V18, P1253, DOI 10.1111/j.1420-9101.2005.00971.x; Symonds MRE, 2004, P ROY SOC B-BIOL SCI, V271, P839, DOI 10.1098/rspb.2003.2647; von Reuss SH, 2011, J AM CHEM SOC UNPUB; von Reuss SH, 2012, J AM CHEM SOC, V134, P1817, DOI 10.1021/ja210202y; Yamada K, 2010, SCIENCE, V329, P1647, DOI 10.1126/science.1192020	29	64	69	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38735	10.1371/journal.pone.0038735	http://dx.doi.org/10.1371/journal.pone.0038735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701701	Green Published, Green Submitted, gold			2022-12-25	WOS:000305348400091
J	Kawamori, A; Shimaji, K; Yamaguchi, M				Kawamori, Akihito; Shimaji, Kouhei; Yamaguchi, Masamitsu			Dynamics of Endoreplication during Drosophila Posterior Scutellar Macrochaete Development	PLOS ONE			English	Article							CELL-CYCLE CONTROL; GLIAL-CELL; S-PHASE; MICROCHAETE LINEAGE; DNA-REPLICATION; ENDOCYCLE; NOTUM; POLYPLOIDY; EMERGENCE; DIVISION	Endoreplication is a variant type of DNA replication, consisting only of alternating G1 and S phases. Many types of Drosophila tissues undergo endoreplication. However, the timing and the extent to which a single endocycling macrochaete undergoes temporally programmed endoreplication during development are unclear. Here, we focused on the dynamics of endoreplication during posterior scutellar (pSC) macrochaete development. Quantitative analyses of C values in shaft cells and socket cells revealed a gradual rise from 8C and 4C at 8 hours after pupal formation (APF) to 72C and 24C at 29 hours APF, respectively. The validity of the values was further confirmed by the measurement of DNA content with a confocal laser microscope. BrdU incorporation assays demonstrated that shaft cells undergo four rounds of endoreplication from 18 to 29.5 hours APF. In contrast, socket cells undergo two rounds of endoreplication during the same period. Statistical analyses showed that the theoretical C values, based on BrdU assays, nearly coincide with the actually measured C values in socket cells, but not in shaft cells after 22 hours APF. These analyses suggest that socket cells undergo two rounds of endoreplication. However, the mechanism of endoreplication in the shaft cells may change from 22 hours APF, suggesting the possibility that shaft cells undergo two or four rounds of endoreplication during the periods. We also found that the timing of endoreplication differs, depending on the type of macrochaete. Moreover, endocycling in shaft cells of both the left and right sides of pSC bristle lineages occurs in the same pattern, indicating that the process is synchronized for specific types of macrochaete. Our findings suggest that endocycling in macrochaete cell lineages can be a model for understanding mechanisms of endoreplication at the single-cell level.	[Kawamori, Akihito; Shimaji, Kouhei; Yamaguchi, Masamitsu] Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 606, Japan; [Kawamori, Akihito; Shimaji, Kouhei; Yamaguchi, Masamitsu] Kyoto Inst Technol, Insect Biomed Res Ctr, Sakyo Ku, Kyoto 606, Japan	Kyoto Institute of Technology; Kyoto Institute of Technology	Kawamori, A (corresponding author), Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 606, Japan.	myamaguc@kit.ac.jp		Yamaguchi, Masamitsu/0000-0002-6321-9750; Shimaji, Kouhei/0000-0002-8121-7257	JSPS; Ministry of Education, Culture, Sports, Science and Technology of Japan	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grants-in-Aid from JSPS and the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano M, 2009, FLY, V3, P173, DOI 10.4161/fly.8087; Audibert A, 2005, DEVELOPMENT, V132, P2287, DOI 10.1242/dev.01797; Calvi BR, 1998, GENE DEV, V12, P734, DOI 10.1101/gad.12.5.734; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; FEGER G, 1995, EMBO J, V14, P5387, DOI 10.1002/j.1460-2075.1995.tb00223.x; Fichelson P, 2003, DEVELOPMENT, V130, P123, DOI 10.1242/dev.00198; Follette PJ, 1998, CURR BIOL, V8, P235, DOI 10.1016/S0960-9822(98)70089-2; Gho M, 1999, DEVELOPMENT, V126, P3573; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; HUANG F, 1991, DEVELOPMENT, V111, P1087; Jacobs HW, 1998, GENE DEV, V12, P3741, DOI 10.1101/gad.12.23.3741; Kawamori A, 2011, CELL STRUCT FUNCT, V36, P103, DOI 10.1247/csf.11004; Klusza S, 2011, BIOESSAYS, V33, P124, DOI 10.1002/bies.201000089; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; LEHNER CF, 1990, EMBO J, V9, P3573, DOI 10.1002/j.1460-2075.1990.tb07568.x; Lilly MA, 2005, ONCOGENE, V24, P2765, DOI 10.1038/sj.onc.1208610; Lilly MA, 1996, GENE DEV, V10, P2514, DOI 10.1101/gad.10.19.2514; Park SY, 2008, P NATL ACAD SCI USA, V105, P12343, DOI 10.1073/pnas.0805189105; Reddy GV, 1999, DEVELOPMENT, V126, P4617; Salle J, 2012, DEVELOPMENT, V139, P547, DOI 10.1242/dev.069823; Shermoen AW, 2010, CURR BIOL, V20, P2067, DOI 10.1016/j.cub.2010.10.021; Simpson P, 1999, DEVELOPMENT, V126, P1349; SIMPSON P, 1990, DEVELOPMENT, V109, P509; SMITH J M, 1961, J Embryol Exp Morphol, V9, P661; STERN B, 1993, DEVELOPMENT, V117, P219; URATA Y, 1995, J CELL BIOL, V131, P279, DOI 10.1083/jcb.131.2.279; USUI K, 1993, ROUX ARCH DEV BIOL, V203, P151, DOI 10.1007/BF00365054; Weiss A, 1998, CURR BIOL, V8, P239, DOI 10.1016/S0960-9822(98)70090-9; WHITFIELD WGF, 1990, EMBO J, V9, P2563, DOI 10.1002/j.1460-2075.1990.tb07437.x; Zimmet J, 2000, EXP HEMATOL, V28, P3, DOI 10.1016/S0301-472X(99)00124-1	30	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38714	10.1371/journal.pone.0038714	http://dx.doi.org/10.1371/journal.pone.0038714			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701699	Green Published, gold, Green Submitted			2022-12-25	WOS:000305348400089
J	Mileyko, Y; Edelsbrunner, H; Price, CA; Weitz, JS				Mileyko, Yuriy; Edelsbrunner, Herbert; Price, Charles A.; Weitz, Joshua S.			Hierarchical Ordering of Reticular Networks	PLOS ONE			English	Article							COMMUNITY STRUCTURE; GENERAL-MODEL; SCALING LAWS; LEAF; VENATION; EXTRACTION; DESIGN; LEAVES; ORIGIN; TREES	The structure of hierarchical networks in biological and physical systems has long been characterized using the Horton-Strahler ordering scheme. The scheme assigns an integer order to each edge in the network based on the topology of branching such that the order increases from distal parts of the network (e. g., mountain streams or capillaries) to the "root" of the network (e. g., the river outlet or the aorta). However, Horton-Strahler ordering cannot be applied to networks with loops because they they create a contradiction in the edge ordering in terms of which edge precedes another in the hierarchy. Here, we present a generalization of the Horton-Strahler order to weighted planar reticular networks, where weights are assumed to correlate with the importance of network edges, e. g., weights estimated from edge widths may correlate to flow capacity. Our method assigns hierarchical levels not only to edges of the network, but also to its loops, and classifies the edges into reticular edges, which are responsible for loop formation, and tree edges. In addition, we perform a detailed and rigorous theoretical analysis of the sensitivity of the hierarchical levels to weight perturbations. In doing so, we show that the ordering of the reticular edges is more robust to noise in weight estimation than is the ordering of the tree edges. We discuss applications of this generalized Horton-Strahler ordering to the study of leaf venation and other biological networks.	[Mileyko, Yuriy] Duke Univ, Dept Math, Durham, NC 27706 USA; [Edelsbrunner, Herbert] IST Austria, Klosterneuburg, Austria; [Edelsbrunner, Herbert] Duke Univ, Dept Comp Sci, Durham, NC 27706 USA; [Edelsbrunner, Herbert] Geomagic, Res Triangle Pk, NC USA; [Price, Charles A.] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Weitz, Joshua S.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA	Duke University; Institute of Science & Technology - Austria; Duke University; University of Western Australia; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Mileyko, Y (corresponding author), Duke Univ, Dept Math, Durham, NC 27706 USA.	yury@math.duke.edu; jsweitz@gatech.edu	Price, Chuck A/HIK-1431-2022; Weitz, Joshua S/I-6696-2012; Price, Charles A/B-1171-2011	Weitz, Joshua S/0000-0002-3433-8312; 	National Science Foundation Plant Genome Research Program [0820624]; Defense Advanced Projects Research Agency [HR0011-09-1-0055]; European Science Foundation (under the Research Networking Programme on "Applied and Computational Algebraic Topology" run); Scientific Interface from the Burroughs Wellcome Fund	National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Defense Advanced Projects Research Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); European Science Foundation (under the Research Networking Programme on "Applied and Computational Algebraic Topology" run); Scientific Interface from the Burroughs Wellcome Fund(Burroughs Wellcome Fund)	This work was supported by the National Science Foundation Plant Genome Research Program (grant 0820624 to H. E. and J.S.W.), the Defense Advanced Projects Research Agency (grant HR0011-09-1-0055 to H. E. and J.S.W.), and the European Science Foundation (under the Research Networking Programme on "Applied and Computational Algebraic Topology" run by H. E.). Joshua S. Weitz, Ph.D., holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Allesina S, 2008, SCIENCE, V320, P658, DOI 10.1126/science.1156269; Alon U, 2007, INTRO SYSTEMS BIOL D; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Banavar JR, 2010, P NATL ACAD SCI USA, V107, P15816, DOI 10.1073/pnas.1009974107; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Blonder B, 2011, ECOL LETT, V14, P91, DOI 10.1111/j.1461-0248.2010.01554.x; Bollobas B, 1998, MODERN GRAPH THEORY; Brodribb TJ, 2007, PLANT PHYSIOL, V144, P1890, DOI 10.1104/pp.107.101352; Brodribb TJ, 2010, FUNCT PLANT BIOL, V37, P488, DOI 10.1071/FP10010; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Chartrand G, 1985, INTRO GRAPH THEORY; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Cochard H, 2004, PLANT CELL ENVIRON, V27, P1257, DOI 10.1111/j.1365-3040.2004.01233.x; Corson F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.048703; Dodds PS, 2001, J THEOR BIOL, V209, P9, DOI 10.1006/jtbi.2000.2238; Dodds PS, 2003, SCIENCE, V301, P827, DOI 10.1126/science.1081058; Dodds PS, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.016117; Dodds PS, 2000, ANNU REV EARTH PL SC, V28, P571, DOI 10.1146/annurev.earth.28.1.571; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Flores CO, 2011, P NATL ACAD SCI USA, V108, pE288, DOI 10.1073/pnas.1101595108; Gastner MT, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016117; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; HORTON RE, 1945, GEOL SOC AM BULL, V56, P275, DOI 10.1130/0016-7606(1945)56[275:edosat]2.0.co;2; Kassab GS, 2006, AM J PHYSIOL-HEART C, V290, pH894, DOI 10.1152/ajpheart.00579.2005; Katifori E, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.048704; Kolokotrones T, 2010, NATURE, V464, P753, DOI 10.1038/nature08920; LABARBERA M, 1990, SCIENCE, V249, P992, DOI 10.1126/science.2396104; Lafferty KD, 2006, P NATL ACAD SCI USA, V103, P11211, DOI 10.1073/pnas.0604755103; Latty T, 2011, J R SOC INTERFACE, V8, P1298, DOI 10.1098/rsif.2010.0612; Masucci AP, 2009, EUR PHYS J B, V71, P259, DOI 10.1140/epjb/e2009-00290-4; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Nardini A, 2001, PLANT PHYSIOL, V125, P1700, DOI 10.1104/pp.125.4.1700; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; PASCUAL M, 2006, ECOLOGICAL NETWORKS; PECKHAM SD, 1995, WATER RESOUR RES, V31, P1023, DOI 10.1029/94WR03155; Pelletier JD, 2000, PHILOS T ROY SOC B, V355, P307, DOI 10.1098/rstb.2000.0566; Price CA, 2007, ECOLOGY, V88, P1132, DOI 10.1890/06-1158; Price CA, 2011, PLANT PHYSIOL, V155, P236, DOI 10.1104/pp.110.162834; Rashevsky N, 1962, PHYSICOMATHEMATICAL, P493; Rodriguez-Iturbe I., 1997, FRACTAL RIVER NETWOR; Sack L, 2008, P NATL ACAD SCI USA, V105, P1567, DOI 10.1073/pnas.0709333105; Sack L, 2006, ANNU REV PLANT BIOL, V57, P361, DOI 10.1146/annurev.arplant.56.032604.144141; Savage VM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000171; Strahler AN., 1957, EOS T AM GEOPHYS UN, V38, P913, DOI DOI 10.1029/TR038I006P00913; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; TARBOTON DG, 1991, HYDROL PROCESS, V5, P81, DOI 10.1002/hyp.3360050107; Tokunaga E, 1978, GEOGRAPHICAL REPORTS, V13, P1; Turcotte DL, 1998, J THEOR BIOL, V193, P577, DOI 10.1006/jtbi.1998.0723; Waisel Y, 2002, PLANT ROOTS HIDDEN H, P157, DOI DOI 10.1201/9780203909423; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197	59	35	35	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e36715	10.1371/journal.pone.0036715	http://dx.doi.org/10.1371/journal.pone.0036715			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701559	Green Published, gold, Green Submitted			2022-12-25	WOS:000305348400006
J	Reddy, SDN; Pakala, SB; Molli, PR; Sahni, N; Karanam, NK; Mudvari, P; Kumar, R				Reddy, Sirigiri Divijendra Natha; Pakala, Suresh B.; Molli, Poonam R.; Sahni, Neil; Karanam, Narasimha Kumar; Mudvari, Prakriti; Kumar, Rakesh			Metastasis-associated Protein 1/Histone Deacetylase 4-Nucleosome Remodeling and Deacetylase Complex Regulates Phosphatase and Tensin Homolog Gene Expression and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PTEN; NF-KAPPA-B; CELL-MIGRATION; TRANSCRIPTIONAL REPRESSION; MTA1; KINASE; INVASION; ACTIVATION; PROMOTER; FAMILY	Metastasis-associated protein 1 (MTA1) is widely overexpressed in human cancers and is associated with malignant phenotypic changes contributing to morbidity in the associated diseases. Here we discovered for the first time that MTA1, a master chromatin modifier, transcriptionally represses the expression of phosphatase and tensin homolog (PTEN), a tumor suppressor gene, by recruiting class II histone deacetylase 4 (HDAC4) along with the transcription factor Yin-Yang 1 (YY1) onto the PTEN promoter. We also found evidence of an inverse correlation between the expression levels of MTA1 and PTEN in physiologically relevant breast cancer microarray datasets. We found that MTA1 up-regulation leads to a decreased expression of PTEN protein and stimulation of PI3K as well as phosphorylation of its signaling targets. Accordingly, selective down-regulation of MTA1 in breast cancer cells increases PTEN expression and inhibits stimulation of the PI3K/AKT signaling. Collectively, these findings provide a mechanistic role for MTA1 in transcriptional repression of PTEN, leading to modulation of the resulting signaling pathways.	[Reddy, Sirigiri Divijendra Natha; Pakala, Suresh B.; Molli, Poonam R.; Sahni, Neil; Karanam, Narasimha Kumar; Mudvari, Prakriti; Kumar, Rakesh] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA	George Washington University	Kumar, R (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmrxk@gwu.edu	Kumar, Rakesh/ABD-1065-2020; sirigiri, divijendra reddy/E-1031-2017	Kumar, Rakesh/0000-0001-7664-0803; sirigiri, divijendra reddy/0000-0003-4657-2285; Pakala, Suresh Babu/0000-0002-5679-4837; Karanam, Narasimha Kumar/0000-0002-7575-243X	National Institutes of Health [CA 988023]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported, in whole or in part, by National Institutes of Health Grant CA 988023 (to R.K.).	Anderson DH, 2010, CELL CYCLE, V9, P2055, DOI 10.4161/cc.9.11.11926; Bagheri-Yarmand R, 2004, DEVELOPMENT, V131, P3469, DOI 10.1242/dev.01213; Balasenthil S, 2007, CANCER RES, V67, P7132, DOI 10.1158/0008-5472.CAN-07-0750; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Carracedo A, 2008, CELL, V133, P550, DOI 10.1016/j.cell.2008.04.023; Cenni V, 2003, CELL MOL LIFE SCI, V60, P2710, DOI 10.1007/s00018-003-3349-4; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chow JYC, 2010, AM J PHYSIOL-GASTR L, V298, pG275, DOI 10.1152/ajpgi.00344.2009; Dey N, 2008, CANCER RES, V68, P1862, DOI 10.1158/0008-5472.CAN-07-1182; Garcia JM, 2004, GENE CHROMOSOME CANC, V41, P117, DOI 10.1002/gcc.20062; Goel A, 2004, CANCER RES, V64, P3014, DOI 10.1158/0008-5472.CAN-2401-2; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; He JM, 2010, BIOCHEM BIOPH RES CO, V397, P513, DOI 10.1016/j.bbrc.2010.05.146; Hlobilkova Alice, 2003, Biomedical Papers (Olomouc), V147, P19; Ikenoue T, 2008, CANCER RES, V68, P6908, DOI 10.1158/0008-5472.CAN-08-1107; Kawasaki G, 2008, INT J ORAL MAX SURG, V37, P1039, DOI 10.1016/j.ijom.2008.05.020; Khan S, 2004, INT J CANCER, V112, P407, DOI 10.1002/ijc.20447; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Leslie NR, 2002, CELL SIGNAL, V14, P285, DOI 10.1016/S0898-6568(01)00234-0; Li DQ, 2010, J BIOL CHEM, V285, P10044, DOI 10.1074/jbc.M109.079095; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Lim MA, 2004, ONCOGENE, V23, P9348, DOI 10.1038/sj.onc.1208147; Lu JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005577; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Marzook H, 2012, J BIOL CHEM, V287, P5615, DOI 10.1074/jbc.M111.314088; Mise-Omata S, 2005, BIOCHEM BIOPH RES CO, V328, P1034, DOI 10.1016/j.bbrc.2005.01.066; Molli PR, 2008, ONCOGENE, V27, P1971, DOI 10.1038/sj.onc.1210839; Nicolson GL, 2003, CLIN EXP METASTAS, V20, P19, DOI 10.1023/A:1022534217769; Pakala SB, 2010, J BIOL CHEM, V285, P23590, DOI 10.1074/jbc.M110.139469; Pan LN, 2007, CANCER, V109, P1676, DOI 10.1002/cncr.22585; Rabinovsky R, 2009, MOL CELL BIOL, V29, P5377, DOI 10.1128/MCB.01649-08; Ren GL, 2009, INT J BIOCHEM CELL B, V41, P1094, DOI 10.1016/j.biocel.2008.10.015; Saga Y, 2003, INT J ONCOL, V23, P1109; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Salot S., 2010, J CANC SCI THERAPY, V2, P114; Sankaran D, 2012, J BIOL CHEM, V287, P5483, DOI 10.1074/jbc.M111.324632; Sasaki AT, 2006, EUR J CELL BIOL, V85, P873, DOI 10.1016/j.ejcb.2006.04.007; Subramanian KK, 2007, BLOOD, V109, P4028, DOI 10.1182/blood-2006-10-055319; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Talukder AH, 2003, J BIOL CHEM, V278, P11676, DOI 10.1074/jbc.M209570200; Tamura M, 1999, CANCER RES, V59, P442; TOH Y, 1994, J BIOL CHEM, V269, P22958; Tolkacheva T, 2001, CANCER RES, V61, P4985; Venkateswarlu K, 2004, J BIOL CHEM, V279, P6205, DOI 10.1074/jbc.C300482200; Wang XJ, 2008, CELL RES, V18, P807, DOI 10.1038/cr.2008.83; Xia DR, 2007, J BIOL CHEM, V282, P3507, DOI 10.1074/jbc.M610141200; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yamada KM, 2001, J CELL SCI, V114, P2375; Yao YL, 2003, J BIOL CHEM, V278, P42560, DOI 10.1074/jbc.M302955200; Yoo YG, 2008, ONCOGENE, V27, P3405, DOI 10.1038/sj.onc.1211000	52	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27843	27850		10.1074/jbc.M112.348474	http://dx.doi.org/10.1074/jbc.M112.348474			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22700976	hybrid, Green Published			2022-12-25	WOS:000307840700058
J	Liu, TF; Vachharajani, VT; Yoza, BK; McCall, CE				Liu, Tie Fu; Vachharajani, Vidula T.; Yoza, Barbara K.; McCall, Charles E.			NAD(+)-dependent Sirtuin 1 and 6 Proteins Coordinate a Switch from Glucose to Fatty Acid Oxidation during the Acute Inflammatory Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE-MEDIATED INFLAMMATION; T-CELL MEMORY; ENDOTOXIN TOLERANCE; INSULIN-RESISTANCE; SEPSIS; METABOLISM; IMMUNOSUPPRESSION; DIFFERENTIATION; ADIPONECTIN; HOMEOSTASIS	The early initiation phase of acute inflammation is anabolic and primarily requires glycolysis with reduced mitochondrial glucose oxidation for energy, whereas the later adaptation phase is catabolic and primarily requires fatty acid oxidation for energy. We reported previously that switching from the early to the late acute inflammatory response following TLR4 stimulation depends on NAD(+) activation of deacetylase sirtuin 1 (SirT1). Here, we tested whether NAD(+) sensing by sirtuins couples metabolic polarity with the acute inflammatory response. We found in TLR4-stimulated THP-1 promonocytes that SirT1 and SirT 6 support a switch from increased glycolysis to increased fatty acid oxidation as early inflammation converts to late inflammation. Glycolysis enhancement required hypoxia-inducing factor-1 alpha to up-regulate glucose transporter Glut1, phospho-fructose kinase, and pyruvate dehydrogenase kinase 1, which interrupted pyruvate dehydrogenase and reduced mitochondrial glucose oxidation. The shift to late acute inflammation and elevated fatty acid oxidation required peroxisome proliferator-activated receptor gamma coactivators PGC-1 alpha and beta to increase external membrane CD36 and fatty acid mitochondrial transporter carnitine palmitoyl transferase 1. Metabolic coupling between early and late responses also required NAD(+) production from nicotinamide phosphoryltransferase (Nampt) and activation of SirT6 to reduce glycolysis and SirT1 to increase fatty oxidation. We confirmed similar shifts in metabolic polarity during the late immuno-suppressed stage of human sepsis blood leukocytes and murine sepsis splenocytes. We conclude that NAD(+)-dependent bioenergy shifts link metabolism with the early and late stages of acute inflammation.	[Liu, Tie Fu; Yoza, Barbara K.; McCall, Charles E.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Vachharajani, Vidula T.] Wake Forest Univ, Bowman Gray Sch Med, Dept Anesthesiol, Winston Salem, NC 27157 USA; [Yoza, Barbara K.] Wake Forest Univ, Bowman Gray Sch Med, Div Surg Sci, Winston Salem, NC 27157 USA; [McCall, Charles E.] Wake Forest Univ, Bowman Gray Sch Med, Translat Sci Inst, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Liu, TF (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Mol Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	tliu@wfubmc.edu; chmccall@wfubmc.edu	Vachharajani, Vidula/AAX-3640-2021	Vachharajani, Vidula/0000-0002-0892-7084	National Institutes of Health [AI-065791, AI-079144, GM086470, MO-1RR 007122]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR007122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065791, R56AI079144, R56AI065791, R01AI079144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM086470, R01GM102497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health RO1 Grants AI-065791 and AI-079144 (to C. E. M.), K08 Grant GM086470 (to V. V.), and MO-1RR 007122 (to the Wake Forest University General Clinical Research Center). The research on human participants was endorsed by Wake Forest University Institutional Review Board protocol BG174. The animal sepsis model was approved by the Institutional Animal Care and Use Committee of the Wake Forest University School of Medicine.	Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Gao J, 2000, J CELL PHYSIOL, V182, P297; Gerriets VA, 2012, TRENDS IMMUNOL, V33, P168, DOI 10.1016/j.it.2012.01.010; Gleyzer N, 2011, J BIOL CHEM, V286, P39715, DOI 10.1074/jbc.M111.291575; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Imler JL, 2003, NAT IMMUNOL, V4, P105, DOI 10.1038/ni0203-105; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; LARUE KEA, 1994, J EXP MED, V180, P2269, DOI 10.1084/jem.180.6.2269; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Liu TF, 2011, J BIOL CHEM, V286, P9856, DOI 10.1074/jbc.M110.196790; McCall CE, 2011, J LEUKOCYTE BIOL, V90, P439, DOI 10.1189/jlb.0211075; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Munford RS, 2001, J ENDOTOXIN RES, V7, P327, DOI 10.1177/09680519010070040501; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sambandam N, 2003, PROG LIPID RES, V42, P238, DOI 10.1016/S0163-7827(02)00065-6; Schumer W, 1974, Surg Annu, V6, P1; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Singer M, 2008, CLIN CHEST MED, V29, P655, DOI 10.1016/j.ccm.2008.06.003; Vachharajani V, 2012, OBESITY, V20, P498, DOI 10.1038/oby.2011.316; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Wu XD, 2003, DIABETES, V52, P1355, DOI 10.2337/diabetes.52.6.1355; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Yumoto H, 2005, INFECT IMMUN, V73, P8050, DOI 10.1128/IAI.73.12.8050-8059.2005; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhang ZY, 2010, J BIOL CHEM, V285, P41391, DOI 10.1074/jbc.M110.174482; Zhong L, 2010, TRANSCR-AUSTIN, V1, P17, DOI 10.4161/trns.1.1.12143; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	39	228	240	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25758	25769		10.1074/jbc.M112.362343	http://dx.doi.org/10.1074/jbc.M112.362343			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22700961	Green Published, hybrid			2022-12-25	WOS:000306916300007
J	Xiao, W; Bao, ZX; Zhang, CY; Zhang, XY; Shi, LJ; Zhou, ZT; Jiang, WW				Xiao, Wen; Bao, Zhe-Xuan; Zhang, Chen-Yang; Zhang, Xiao-Yun; Shi, Lin-Jun; Zhou, Zeng-Tong; Jiang, Wei-Wen			Upregulation of miR-31*Is Negatively Associated with Recurrent/Newly Formed Oral Leukoplakia	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; IN-SITU HYBRIDIZATION; HEPATOCELLULAR-CARCINOMA; NASOPHARYNGEAL CARCINOMA; 11Q13 AMPLIFICATION; GENE AMPLIFICATION; EPITHELIAL-CELLS; THYROID-CANCER; MICRORNA; EXPRESSION	Background: Oral leukoplakia (OLK) is a potentially malignant disorder of the oral cavity. However, the underlying mechanism of OLK is still unclear. In this study, we explore possible miRNAs involved in OLK. Methodology/Principal Findings: Using miRNA microarrays, we profiled miRNA expression in OLK and malignantly transformed OLK (mtOLK) tissue samples. The upregulation of miR-31*, miR-142-5p, miR-33a, miR-1259, miR-146b-5p, miR-886-3p, miR-886-5p, miR-519d, and miR-301a along with the downregulation of miR-572, miR-611, miR-602, miR-675, miR-585, miR-623, miR-637, and miR-1184 in mtOLK were new observations. Fluorescence in situ hybridization (FISH) analyses confirmed that miR-31* is highly expressed in mtOLK. There was a significant difference between the FISH score (p<0.05) in patients with or without recurrent/newly formed OLK. Functional analyses demonstrated that a miR-31* inhibitor decreased apoptosis in the Leuk-1, which is an immortalized oral epithelial cell line spontaneously derived from an oral leukoplakia lesion. miR-31* regulated apoptosis, cell proliferation, migration, and invasion in the HOIEC, which is a HPV E6/E7-immortalized oral epithelial cell line. Furthermore, miR-31* modulated the biological functions of apoptosis, cell proliferation, cell cycle, migration, and invasion in the oral squamous cell carcinoma cell line, Cal-27. Using bioinformatic analyses and dual luciferase reporter assays, we determined that the 3' untranslated region of fibroblast growth factor 3 (FGF3) is the target of miR-31*. Expression of FGF3 was downregulated or upregulated in the presence of a miR-31* mimic or inhibitor, respectively. Conclusions/Significance: Upregulation of miR-31* is negatively associated with recurrent/newly formed OLK. MiR-31* may exert similar but distinguishable effects on biological function in oral cells with different malignant potential. FGF3 is the target of miR-31*. miR-31* may play an important role during OLK progression through regulating FGF3. MiRNA* strands may also have prominent roles in oral carcinogenesis.	[Xiao, Wen; Bao, Zhe-Xuan; Zhang, Chen-Yang; Zhang, Xiao-Yun; Shi, Lin-Jun; Zhou, Zeng-Tong; Jiang, Wei-Wen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Stomatol, Dept Oral Mucosal Dis,Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Xiao, W (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Stomatol, Dept Oral Mucosal Dis,Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China.	wwjiang33@hotmail.com			Science and Technology Commission of Shanghai [07PJ14067, 08DZ2271100]; Shanghai Leading Academic Discipline Project [S30206]; National and Natural Foundation of China [30872887]	Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National and Natural Foundation of China	This work was supported by Science and Technology Commission of Shanghai (www.stcsm.gov.cn) Grants No. 07PJ14067 and 08DZ2271100, Shanghai Leading Academic Discipline Project No. S30206, and National and Natural Foundation of China (www.nsfc.gov.cn) Grant No. 30872887. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axell T, 1996, J ORAL PATHOL MED, V25, P49, DOI 10.1111/j.1600-0714.1996.tb00191.x; BENHARROCH D, 1990, ISRAEL J MED SCI, V26, P212; Califano J, 1996, CANCER RES, V56, P2488; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Chen CZ, 2005, NEW ENGLAND J MED, P353; Chen YJ, 2004, J PATHOL, V204, P326, DOI 10.1002/path.1640; Chua SS, 2002, ONCOGENE, V21, P1899, DOI 10.1038/sj.onc.1205096; DICKSON C, 1990, J CELL SCI, P87; ESTELLER M, 1995, CANCER-AM CANCER SOC, V75, P2139, DOI 10.1002/1097-0142(19950415)75:8<2139::AID-CNCR2820750817>3.0.CO;2-6; Fan CS, 2000, HUM PATHOL, V31, P169, DOI 10.1016/S0046-8177(00)80216-6; Freier K, 2006, GENE CHROMOSOME CANC, V45, P118, DOI 10.1002/gcc.20270; Fujii T, 2005, DIAGN MOL PATHOL, V14, P103, DOI 10.1097/01.pas.0000162755.84026.9f; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Habbe N, 2009, MICRORNA MIR 155 IS, P1; Hajitou A, 1998, ONCOGENE, V17, P2059, DOI 10.1038/sj.onc.1202126; Hollmann CA, 2001, ONCOGENE, V20, P7645, DOI 10.1038/sj.onc.1204980; Hu L, 2007, CANCER LETT, V252, P36, DOI 10.1016/j.canlet.2006.12.003; Hu Y, 2011, INT J CANC; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Jakymiw A, 2010, GENE CHROMOSOME CANC, V49, P549, DOI 10.1002/gcc.20765; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; KRAMER I R H, 1978, Oral Surgery Oral Medicine Oral Pathology, V46, P518; LESE CM, 1995, GENE CHROMOSOME CANC, V12, P288, DOI 10.1002/gcc.2870120409; Liu CJ, 2010, ORAL DIS, V16, P360, DOI 10.1111/j.1601-0825.2009.01646.x; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Liu XQ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/837514; Neville BW, 2002, CA-CANCER J CLIN, V52, P195, DOI 10.3322/canjclin.52.4.195; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Sdek P, 2006, INT J ORAL MAX SURG, V35, P653, DOI 10.1016/j.ijom.2006.01.017; Seki A, 2000, INT J ONCOL, V17, P103; SHACKLEFORD GM, 1993, P NATL ACAD SCI USA, V90, P740, DOI 10.1073/pnas.90.2.740; Shuster MI, 2000, GENE CHROMOSOME CANC, V28, P153, DOI 10.1002/(SICI)1098-2264(200006)28:2<153::AID-GCC4>3.0.CO;2-9; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Sobin, 2009, UICC TNM CLASSIFICAT; Takakura S, 2008, CANCER SCI, V99, P1147, DOI 10.1111/j.1349-7006.2008.00800.x; van der Hem PS, 2005, ORAL ONCOL, V41, P31, DOI 10.1016/j.oraloncology.2004.06.010; VINDELOV LL, 1983, CYTOMETRY, V3, P328, DOI 10.1002/cyto.990030504; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; William WN, 2009, CANCER PREV RES, V2, P22, DOI 10.1158/1940-6207.CAPR-08-0100; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Xu CF, 2009, OMICS, V13, P513, DOI 10.1089/omi.2009.0035; Xu J, 1996, GENE CHROMOSOME CANC, V17, P172, DOI 10.1002/(SICI)1098-2264(199611)17:3<172::AID-GCC5>3.0.CO;2-1; Yu JW, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-55; Zhang CN, 2010, CLIN CHEM, V56, P1871, DOI 10.1373/clinchem.2010.147553; Zhang LM, 2010, CARCINOGENESIS, V31, P559, DOI 10.1093/carcin/bgp335; Zhong LP, 2008, ARCH ORAL BIOL, V53, P443, DOI 10.1016/j.archoralbio.2007.12.002	50	45	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38648	10.1371/journal.pone.0038648	http://dx.doi.org/10.1371/journal.pone.0038648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719913	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300037
J	Marangolo, P; Cipollari, S; Fiori, V; Razzano, C; Caltagirone, C				Marangolo, Paola; Cipollari, Susanna; Fiori, Valentina; Razzano, Carmela; Caltagirone, Carlo			Walking but Not Barking Improves Verb Recovery: Implications for Action Observation Treatment in Aphasia Rehabilitation	PLOS ONE			English	Article							PREMOTOR CORTEX; MIRROR NEURONS; MOTOR; INTENSITY; RETRIEVAL; LANGUAGE; GESTURE; SPEECH; MOTION; WORDS	Recent studies have shown that action observation treatment without concomitant verbal cue has a positive impact on the recovery of verb retrieval deficits in aphasic patients. In agreement with an embodied cognition viewpoint, a hypothesis has been advanced that gestures and language form a single communication system and words whose retrieval is facilitated by gestures are semantically represented through sensory-motor features. However, it is still an open question as to what extent this treatment approach works. Results from the recovery of motor deficits have suggested that action observation promotes motor recovery only for actions that are part of the motor repertoire of the observer. The aim of the present experiment was to further investigate the role of action observation treatment in verb recovery. In particular, we contrasted the effects induced by observing human actions (e.g. dancing, kicking, pointing, eating) versus non human actions (e. g. barking, printing). Seven chronic aphasic patients with a selective deficit in verb retrieval underwent an intensive rehabilitation training that included five daily sessions over two consecutive weeks. Each subject was asked to carefully observe 115 video-clips of actions, one at a time and, after observing them, they had to produce the corresponding verb. Two groups of actions were randomly presented: humans versus nonhuman actions. In all patients, significant improvement in verb retrieval was found only by observing video-clips of human actions. Moreover, follow-up testing revealed long-term verb recovery that was still present two months after the two treatments had ended. In support of the multimodal concept representation's proposal, we suggest that just the observation of actions pertaining to the human motor repertoire is an effective rehabilitation approach for verb recovery.	[Marangolo, Paola] Univ Politecn Marche, Fac Med, Ancona, Italy; [Marangolo, Paola; Cipollari, Susanna; Fiori, Valentina; Razzano, Carmela; Caltagirone, Carlo] IRCCS Fdn Santa Lucia, Rome, Italy; [Caltagirone, Carlo] Univ Roma, Rome, Italy	Marche Polytechnic University; IRCCS Santa Lucia; Sapienza University Rome; University of Rome Tor Vergata	Marangolo, P (corresponding author), Univ Politecn Marche, Fac Med, Ancona, Italy.	p.marangolo@univpm.it	Caltagirone, Carlo/B-4930-2013	fiori, valentina/0000-0002-3468-221X; MARANGOLO, Paola/0000-0002-1516-9832				Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bellelli G, 2010, ARCH PHYS MED REHAB, V91, P1489, DOI 10.1016/j.apmr.2010.07.013; Bhogal SK, 2003, STROKE, V34, P987, DOI 10.1161/01.STR.0000062343.64383.D0; Binkofski F, 2006, J PHYSIOL-PARIS, V99, P396, DOI 10.1016/j.jphysparis.2006.03.005; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Buccino G, 2011, MOVEMENT DISORD, V26, P1963, DOI 10.1002/mds.23745; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Capitani E, 2003, COGN NEUROPSYCHOL, V20, P213, DOI 10.1080/02643290244000266; Chaminade T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011577; Cross ES, 2009, EUR J NEUROSCI, V30, P1383, DOI 10.1111/j.1460-9568.2009.06941.x; Cross ES, 2009, CEREB CORTEX, V19, P315, DOI 10.1093/cercor/bhn083; Della Sala S, 2004, J NEUROL NEUROSUR PS, V75, P196; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; DERENZI E, 1980, ARCH NEUROL-CHICAGO, V37, P6, DOI 10.1001/archneur.1980.00500500036003; Ertelt D, 2007, NEUROIMAGE, V36, pT164, DOI 10.1016/j.neuroimage.2007.03.043; Fadiga L, 2002, EUR J NEUROSCI, V15, P399, DOI 10.1046/j.0953-816x.2001.01874.x; Franceschini M, 2010, EUR J PHYS REHAB MED, V46, P517; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Hadar U, 1998, BRAIN LANG, V62, P107, DOI 10.1006/brln.1997.1890; HANLON RE, 1990, BRAIN LANG, V38, P298, DOI 10.1016/0093-934X(90)90116-X; Hauk O, 2004, HUM BRAIN MAPP, V21, P191, DOI 10.1002/hbm.10157; Hornby TG, 2011, TOP STROKE REHABIL, V18, P293, DOI 10.1310/tsr1804-293; Krauss R., 2000, LANGUAGE GESTURE WIN, P228; Krauss RobertM., 1999, GESTURE SPEECH SIGN, P93, DOI [10.1093/acprof:oso/9780198524519.003.0006, DOI 10.1093/ACPROF:OSO/9780198524519.003.0006]; Marangolo P, 2010, NEUROPSYCHOLOGIA, V48, P3824, DOI 10.1016/j.neuropsychologia.2010.09.025; Martin A. C, 2000, NEW COGNITIVE NEUROS, P1023; Miceli G., 1994, BATTERIA LANALISI DE; Miura N, 2010, SOC NEUROSCI-UK, V5, P40, DOI 10.1080/17470910903083256; Moore JL, 2010, STROKE, V41, P129, DOI 10.1161/STROKEAHA.109.563247; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pashek G, 1998, BRAIN LANG, V65, P177; Pashek GV, 1997, J COMMUN DISORD, V30, P349, DOI 10.1016/S0021-9924(96)00079-2; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Raymer AM, 2006, J INT NEUROPSYCH SOC, V12, P867, DOI 10.1017/S1355617706061042; Richards K, 2002, J REHABIL RES DEV, V39, P445; Rizzolatti G, 2009, NAT CLIN PRACT NEURO, V5, P24, DOI 10.1038/ncpneuro0990; Rodriguez AD, 2006, APHASIOLOGY, V20, P286, DOI 10.1080/02687030500474898; Rose M, 2002, APHASIOLOGY, V16, P1001, DOI 10.1080/02687030143000825; Shimada S, 2010, BRAIN COGNITION, V72, P394, DOI 10.1016/j.bandc.2009.11.005; Tai YF, 2004, CURR BIOL, V14, P117, DOI 10.1016/j.cub.2004.01.005	40	33	33	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38610	10.1371/journal.pone.0038610	http://dx.doi.org/10.1371/journal.pone.0038610			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UV	22719906	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341900037
J	Wei, H; Kamat, A; Chen, M; Ke, HL; Chang, DW; Yin, JK; Grossman, HB; Dinney, CP; Wu, XF				Wei, Hua; Kamat, Ashish; Chen, Meng; Ke, Hung-Lung; Chang, David W.; Yin, Jikai; Grossman, H. Barton; Dinney, Colin P.; Wu, Xifeng			Association of Polymorphisms in Oxidative Stress Genes with Clinical Outcomes for Bladder Cancer Treated with Bacillus Calmette-Guerin	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; HUMAN DNA GLYCOSYLASE; NITRIC-OXIDE; RECURRENCE; SURVIVAL; PATHWAY; DISEASE; REPAIR; DAMAGE; TA	Genetic polymorphisms in oxidative stress pathway genes may contribute to carcinogenesis, disease recurrence, treatment response, and clinical outcomes. We applied a pathway-based approach to determine the effects of multiple single nucleotide polymorphisms (SNPs) within this pathway on clinical outcomes in non-muscle-invasive bladder cancer (NMIBC) patients treated with Bacillus Calmette-Guerin (BCG). We genotyped 276 SNPs in 38 genes and evaluated their associations with clinical outcomes in 421 NMIBC patients. Twenty-eight SNPs were associated with recurrence in the BCG-treated group (P<0.05). Six SNPs, including five in NEIL2 gene from the overall and BCG group remained significantly associated with recurrence after multiple comparison adjustments (q<0.1). Cumulative unfavorable genotype analysis showed that the risk of recurrence increased with increasing number of unfavorable genotypes. In the analysis of risk factors associated with progression to disease, rs3890995 in UNG, remained significant after adjustment for multiple comparison (q<0.1). These results support the hypothesis that genetic variations in host oxidative stress genes in NMIBC patients may affect response to therapy with BCG.	[Wei, Hua; Chen, Meng; Ke, Hung-Lung; Chang, David W.; Yin, Jikai; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Kamat, Ashish; Grossman, H. Barton; Dinney, Colin P.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wei, H (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	xwu@mdanderson.org	Ke, Hung-Lung/HCH-9079-2022	Dinney, Colin/0000-0002-8969-711X	National Institutes of Health/National Cancer Institute [U01 CA 127615, R01 CA 74880, P50 CA 91846, R01 CA 131335]; NATIONAL CANCER INSTITUTE [U01CA127615, R01CA131335, R01CA074880, P50CA091846] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by grants from National Institutes of Health/National Cancer Institute: U01 CA 127615, R01 CA 74880, P50 CA 91846, and R01 CA 131335 (http://www.cancer.gov/researchandfunding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babjuk M, 2008, EUR UROL, V54, P303, DOI 10.1016/j.eururo.2008.04.051; Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Brausi M, 2002, EUR UROL, V41, P523, DOI 10.1016/S0302-2838(02)00068-4; Chen M, 2010, CANC PREV RES PHILA; Chen M, 2010, CANCER PREV RES, V3, P1235, DOI 10.1158/1940-6207.CAPR-10-0035; Chen M, 2009, CARCINOGENESIS, V30, P2047, DOI 10.1093/carcin/bgp258; Chiong E, 2011, CLIN CANCER RES, V17, P2863, DOI 10.1158/1078-0432.CCR-09-3202; Choi JY, 2009, CLIN CANCER RES, V15, P5258, DOI 10.1158/1078-0432.CCR-09-0685; FARIASEISNER R, 1994, P NATL ACAD SCI USA, V91, P9407, DOI 10.1073/pnas.91.20.9407; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Kinslow CJ, 2008, GENE CHROMOSOME CANC, V47, P923, DOI 10.1002/gcc.20594; Kinslow CJ, 2009, MUTAGENESIS; Lamm DL, 2000, J UROLOGY, V163, P1124, DOI 10.1016/S0022-5347(05)67707-5; Lurie G, 2008, CANCER EPIDEM BIOMAR, V17, P2070, DOI 10.1158/1055-9965.EPI-08-0145; Mena S, 2009, MUTAT RES-GEN TOX EN, V674, P36, DOI 10.1016/j.mrgentox.2008.09.017; Mikhak B, 2008, CARCINOGENESIS, V29, P2335, DOI 10.1093/carcin/bgn212; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Ropolo M, 2006, INT J CANCER, V118, P1628, DOI 10.1002/ijc.21554; Siegel R., 2011, CA CANC J CLIN; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Udler M, 2007, J CLIN ONCOL, V25, P3015, DOI 10.1200/JCO.2006.10.0099; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; van Rhijn BWG, 2009, EUR UROL, V56, P430, DOI 10.1016/j.eururo.2009.06.028; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	26	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38533	10.1371/journal.pone.0038533	http://dx.doi.org/10.1371/journal.pone.0038533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701660	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340000029
J	Tang, YM; Luo, DH; Rong, XM; Shi, XL; Peng, Y				Tang, Yamei; Luo, Donghua; Rong, Xiaoming; Shi, Xiaolei; Peng, Ying			Psychological Disorders, Cognitive Dysfunction and Quality of Life in Nasopharyngeal Carcinoma Patients with Radiation-Induced Brain Injury	PLOS ONE			English	Article							EMOTIONAL STATUS; CANCER-PATIENTS; RADIOTHERAPY; THERAPY; IMPACT; RADIONECROSIS; DEPRESSION; ANXIETY	Purpose: To evaluate factors affecting psychology, cognitive function and quality of life (QOL) of nasopharyngeal carcinoma (NPC) patients with radiation-induced brain injury (RI). Methods and Materials: 46 recurrence-free NPC patients with RI and 46 matched control patients without RI were recruited in our study. Subjective and objective symptoms of RI were evaluated with the LENT/SOMA systems. Psychological assessment was measured with Self-Rating Anxiety Scale (SAS) and Self-Rating Depression Scale (SDS). Montreal Cognitive Assessment (MoCA) was carried out in these patients for assessing their cognitive function. QOL was evaluated by means of WHOQOL BREF. Results: Of the patients with RI, 39(84.8%) had depression and 40(87.0%) had anxiety. The patients with RI got higher scores both in SDS and SAS than those without RI (SDS, 63.48 +/- 8.11vs. 58.67 +/- 7.52, p = 0.008; SAS, 67.36 +/- 10.41vs. 60.34 +/- 9.76, p = 0.005). Score in MoCA of patients with RI was significantly lower than that of patients without RI (21.32 +/- 2.45vs. 25.98 +/- 1.73, p<0.001). SAS was positive correlated with post-radiotherapy interval. Both SAS and SDS had a significantly positive correlation with the rank of SOMA, while MoCA had a significantly negative correlation with SOMA. Chemotherapy was a risk factor for cognitive dysfunction. In addition, patients with RI got significantly lower scores in physical health (16.50 +/- 11.05 vs. 35.02 +/- 10.43, p<0.001), psychological health (17.70 +/- 10.33 vs. 39.48 +/- 12.00, p<0.001) and social relationship (48.00 +/- 18.65 vs. 67.15 +/- 19.70, p<0.001) compared with those in patients without RI. Multiple linear regression analysis revealed that anxiety and cognitive impairment were significant predictors of global QOL. Conclusions: NPC patients with RI exhibit negative emotions, impaired cognitive function and QOL. The severity of clinical symptoms of RI plays an important role in both emotions and cognitive function. Anxiety and cognitive impairment are associated with decreased QOL.	[Tang, Yamei; Rong, Xiaoming; Shi, Xiaolei; Peng, Ying] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Tang, Yamei; Rong, Xiaoming; Shi, Xiaolei; Peng, Ying] Sun Yat Sen Univ, Key Lab Malignant Tumor Gene Regulat & Target The, Guangdong Higher Educ Inst, Guangzhou 510275, Guangdong, Peoples R China; [Luo, Donghua] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Tang, YM (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	yameitang@hotmail.com		Tang, Yamei/0000-0002-6353-6107	National Natural Science Foundation of China (NSFC) [30600164, 81072242, NSFC 30973479]; Yat-Sen Scholarship of Sun Yat-Sen Memorial Hospital for Young Scientist	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Yat-Sen Scholarship of Sun Yat-Sen Memorial Hospital for Young Scientist	The current project was supported by the National Natural Science Foundation of China (NSFC No. 30600164, NSFC No. 81072242 to Y.T. and NSFC 30973479 to Y.P.) and Yat-Sen Scholarship of Sun Yat-Sen Memorial Hospital for Young Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behin A, 2004, SEMIN NEUROL, V24, P405, DOI 10.1055/s-2004-861535; Chang HT, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-70; Chen PR, 2005, INT J RADIAT ONCOL, V61, P466, DOI 10.1016/j.ijrobp.2004.05.016; Cheung MC, 2003, CANCER-AM CANCER SOC, V97, P2019, DOI 10.1002/cncr.11295; Cheung MC, 2000, ARCH NEUROL-CHICAGO, V57, P1347, DOI 10.1001/archneur.57.9.1347; Fang FM, 2002, INT J RADIAT ONCOL, V53, P959, DOI 10.1016/S0360-3016(02)02838-9; Frick E, 2007, EUR J CANCER CARE, V16, P130, DOI 10.1111/j.1365-2354.2006.00720.x; Hammerlid E, 2001, HEAD NECK-J SCI SPEC, V23, P113, DOI 10.1002/1097-0347(200102)23:2<113::AID-HED1006>3.0.CO;2-W; Heinonen H, 2004, QUAL LIFE RES, V13, P1347, DOI 10.1023/B:QURE.0000040788.12947.b9; Hsiao KY, 2010, INT J RADIAT ONCOL, V77, P722, DOI 10.1016/j.ijrobp.2009.06.080; Karasawa Kumiko, 2005, Radiat Med, V23, P478; Ku PKM, 2010, LARYNGOSCOPE, V120, P223, DOI 10.1002/lary.20701; Lam LCW, 2003, J NEUROPSYCH CLIN N, V15, P90, DOI 10.1176/appi.neuropsych.15.1.90; Lee PWH, 2007, CANCER-AM CANCER SOC, V109, P1344, DOI 10.1002/cncr.22539; Lue BH, 2008, INT J RADIAT ONCOL, V70, P28, DOI 10.1016/j.ijrobp.2007.06.053; Mystakidou K, 2005, QUAL LIFE RES, V14, P1825, DOI 10.1007/s11136-005-4324-3; Routledge JA, 2003, INT J RADIAT ONCOL, V56, P502, DOI 10.1016/S0360-3016(02)04578-9; Sehlen S, 2000, ONKOLOGIE, V23, P565, DOI 10.1159/000055007; Shin HR, 2010, ASIAN PAC J CANCER P, V11, P11; Tang Y, 2011, STRAHLENTHER ONKOL, V187, P39, DOI 10.1007/s00066-010-2151-0; Wan LS, 2011, BMC CANCER, V11, P128; World Health Organization (WHO), 1998, WHOQOL US MAN; Young YH, 2004, OTOL NEUROTOL, V25, P366, DOI 10.1097/00129492-200405000-00027; Zhang M, 1998, HDB PSYCHIAT SCALES	24	66	76	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e36529	10.1371/journal.pone.0036529	http://dx.doi.org/10.1371/journal.pone.0036529			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TU	22701557	Green Published, Green Submitted, gold			2022-12-25	WOS:000305337600004
J	Hasemann, MS; Schuster, MB; Frank, AK; Theilgaard-Monch, K; Pedersen, TA; Nerlov, C; Porse, BT				Hasemann, Marie S.; Schuster, Mikkel B.; Frank, Anne-Katrine; Theilgaard-Monch, Kim; Pedersen, Thomas A.; Nerlov, Claus; Porse, Bo T.			Phosphorylation of Serine 248 of C/EBP alpha Is Dispensable for Myelopoiesis but Its Disruption Leads to a Low Penetrant Myeloid Disorder with Long Latency	PLOS ONE			English	Article							BINDING PROTEIN-ALPHA; HEMATOPOIETIC STEM-CELLS; GRANULOCYTIC DIFFERENTIATION; TRANSCRIPTION FACTORS; GENE-EXPRESSION; SELF-RENEWAL; PROLIFERATION; LEUKEMIA; PU.1; MUTATION	Background: Transcription factors play a key role in lineage commitment and differentiation of stem cells into distinct mature cells. In hematopoiesis, they regulate lineage-specific gene expression in a stage-specific manner through various physical and functional interactions with regulatory proteins that are simultanously recruited and activated to ensure timely gene expression. The transcription factor CCAAT/enhancer binding protein alpha (C/EBP alpha) is such a factor and is essential for the development of granulocytic/monocytic cells. The activity of C/EBP alpha is regulated on several levels including gene expression, alternative translation, protein interactions and posttranslational modifications, such as phosphorylation. In particular, the phosphorylation of serine 248 of the transactivation domain has been shown to be of crucial importance for granulocytic differentiation of 32Dcl3 cells in vitro. Methodology/Principal Findings: Here, we use mouse genetics to investigate the significance of C/EBP alpha serine 248 in vivo through the construction and analysis of Cebpa(S248A/S248A) knock-in mice. Surprisingly, 8-week old Cebpa(S248A/S248A) mice display normal steady-state hematopoiesis including unaltered development of mature myeloid cells. However, over time some of the animals develop a hematopoietic disorder with accumulation of multipotent, megakaryocytic and erythroid progenitor cells and a mild impairment of differentiation along the granulocytic-monocytic lineage. Furthermore, BM cells from Cebpa(S248A/S248A) animals display a competitive advantage compared to wild type cells in a transplantation assay. Conclusions/Significance: Taken together, our data shows that the substitution of C/EBP alpha serine 248 to alanine favors the selection of the megakaryocytic/erythroid lineage over the monocytic/granulocytic compartment in old mice and suggests that S248 phosphorylation may be required to maintain proper hematopoietic homeostasis in response to changes in the wiring of cellular signalling networks. More broadly, the marked differences between the phenotype of the S248A variant in vivo and in vitro highlight the need to exert caution when extending in vitro phenotypes to the more appropriate in vivo context.	[Hasemann, Marie S.; Schuster, Mikkel B.; Frank, Anne-Katrine; Theilgaard-Monch, Kim; Porse, Bo T.] Univ Copenhagen, Rigshosp, Fac Hlth Sci, Finsen Lab, DK-2100 Copenhagen, Denmark; [Hasemann, Marie S.; Schuster, Mikkel B.; Frank, Anne-Katrine; Theilgaard-Monch, Kim; Porse, Bo T.] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Hasemann, Marie S.; Schuster, Mikkel B.; Frank, Anne-Katrine; Porse, Bo T.] Univ Copenhagen, Fac Hlth Sci, Danish Stem Cell Ctr DanStem, Copenhagen, Denmark; [Theilgaard-Monch, Kim] Lund Univ, Skanes Univ Hosp, Deptartment Hematol, Lund, Sweden; [Pedersen, Thomas A.; Nerlov, Claus] Mouse Biol Unit, EMBL, Monterotondo, Italy; [Nerlov, Claus] Univ Edinburgh, Inst Stem Cell Res, Ctr Regenerat Med, MRC, Edinburgh, Midlothian, Scotland	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Lund University; European Molecular Biology Laboratory (EMBL); University of Edinburgh	Hasemann, MS (corresponding author), Univ Copenhagen, Rigshosp, Fac Hlth Sci, Finsen Lab, DK-2100 Copenhagen, Denmark.	bo.porse@finsenlab.dk		Frank, Anne-Katrine/0000-0001-6635-6104; Porse, Bo/0000-0001-6043-0844; Schuster, Mikkel Bruhn/0000-0003-1742-5550; Theilgaard-Monch, Kim/0000-0002-4239-4939	Lundbeck Foundation; The NovoNordisk Foundation; Danish Cancer Society; Lundbeck Foundation [R34-2009-3620, R19-2007-830] Funding Source: researchfish; Medical Research Council [G0700711B] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC1015986] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); The NovoNordisk Foundation(Novo Nordisk Foundation); Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Lundbeck Foundation, The NovoNordisk Foundation and the Danish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behre G, 2002, J BIOL CHEM, V277, P26293, DOI 10.1074/jbc.M202301200; Bereshchenko O, 2009, CANCER CELL, V16, P390, DOI 10.1016/j.ccr.2009.09.036; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; Fukuchi Y, 2006, EMBO J, V25, P3398, DOI 10.1038/sj.emboj.7601199; Fukuchi Y, 2008, STEM CELLS, V26, P3172, DOI 10.1634/stemcells.2008-0320; Guchhait P, 2003, J IMMUNOL METHODS, V283, P195, DOI 10.1016/j.jim.2003.09.013; Hasemann MS, 2008, BLOOD, V111, P4309, DOI 10.1182/blood-2007-06-097790; Hattori T, 2003, ONCOGENE, V22, P1273, DOI 10.1038/sj.onc.1206204; Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Kirstetter P, 2008, CANCER CELL, V13, P299, DOI 10.1016/j.ccr.2008.02.008; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; MAHONEY CW, 1992, J BIOL CHEM, V267, P19396; McKnight SL, 2001, CELL, V107, P259, DOI 10.1016/S0092-8674(01)00543-8; Pedersen TA, 2001, GENE DEV, V15, P3208, DOI 10.1101/gad.209901; Pedersen TA, 2007, EMBO J, V26, P1081, DOI 10.1038/sj.emboj.7601563; Porse BT, 2006, MOL CELL BIOL, V26, P1028, DOI 10.1128/MCB.26.3.1028-1037.2006; Porse BT, 2005, J EXP MED, V202, P85, DOI 10.1084/jem.20050067; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Reddy VA, 2002, BLOOD, V100, P483, DOI 10.1182/blood.V100.2.483; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Ross SE, 2004, MOL CELL BIOL, V24, P675, DOI 10.1128/MCB.24.2.675-686.2004; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Schuster MB, 2006, BBA-REV CANCER, V1766, P88, DOI 10.1016/j.bbcan.2006.02.003; Singh SM, 2008, BIOCHEM BIOPH RES CO, V369, P692, DOI 10.1016/j.bbrc.2008.02.090; Subramanian L, 2003, J BIOL CHEM, V278, P9134, DOI 10.1074/jbc.M210440200; Suh HC, 2006, BLOOD, V107, P4308, DOI 10.1182/blood-2005-06-2216; Twu YC, 2010, BLOOD, V115, P2491, DOI 10.1182/blood-2009-07-231993; Wang GL, 2006, MOL CELL BIOL, V26, P2570, DOI 10.1128/MCB.26.7.2570-2582.2006; Wang GL, 2005, MOL CELL BIOL, V25, P1325, DOI 10.1128/MCB.25.4.1325-1338.2005; Wang XP, 1999, BLOOD, V94, P560, DOI 10.1182/blood.V94.2.560.414k41_560_571; Warren LA, 2009, MECH AGEING DEV, V130, P46, DOI 10.1016/j.mad.2008.03.010; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	36	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38841	10.1371/journal.pone.0038841	http://dx.doi.org/10.1371/journal.pone.0038841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715416	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336800058
J	Lepage, JF; Morin-Moncet, O; Beaule, V; de Beaumont, L; Champoux, F; Theoret, H				Lepage, Jean-Francois; Morin-Moncet, Olivier; Beaule, Vincent; de Beaumont, Louis; Champoux, Francois; Theoret, Hugo			Occlusion of LTP-Like Plasticity in Human Primary Motor Cortex by Action Observation	PLOS ONE			English	Article							CORTICAL PLASTICITY; MODULATION; FACILITATION; EXCITABILITY; MEMORY; STIMULATION; CONNECTIONS; ACQUISITION; MUSCLE	Passive observation of motor actions induces cortical activity in the primary motor cortex (M1) of the onlooker, which could potentially contribute to motor learning. While recent studies report modulation of motor performance following action observation, the neurophysiological mechanism supporting these behavioral changes remains to be specifically defined. Here, we assessed whether the observation of a repetitive thumb movement - similarly to active motor practice - would inhibit subsequent long-term potentiation-like (LTP) plasticity induced by paired-associative stimulation (PAS). Before undergoing PAS, participants were asked to either 1) perform abductions of the right thumb as fast as possible; 2) passively observe someone else perform thumb abductions; or 3) passively observe a moving dot mimicking thumb movements. Motor evoked potentials (MEP) were used to assess cortical excitability before and after motor practice (or observation) and at two time points following PAS. Results show that, similarly to participants in the motor practice group, individuals observing repeated motor actions showed marked inhibition of PAS-induced LTP, while the "moving dot" group displayed the expected increase in MEP amplitude, despite differences in baseline excitability. Interestingly, LTP occlusion in the action-observation group was present even if no increase in cortical excitability or movement speed was observed following observation. These results suggest that mere observation of repeated hand actions is sufficient to induce LTP, despite the absence of motor learning.	[Lepage, Jean-Francois; Morin-Moncet, Olivier; Beaule, Vincent; Theoret, Hugo] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Lepage, Jean-Francois; Theoret, Hugo] Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [de Beaumont, Louis] McGill Univ, Douglas Mental Hlth Univ Hopsital, Montreal, PQ, Canada; [Champoux, Francois] Univ Montreal, Dept Audiol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; McGill University; Universite de Montreal	Lepage, JF (corresponding author), Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada.	hugo.theoret@umontreal.ca		Lepage, Jean-Francois/0000-0002-1181-6043; Theoret, Hugo/0000-0002-7458-8797	National Sciences and Engineering Research Council of Canada; Fonds de la Recherche en Sante du Quebec (FRSQ); FRSQ	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); FRSQ(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the National Sciences and Engineering Research Council of Canada and the Fonds de la Recherche en Sante du Quebec (FRSQ) awarded to HT; JFL is supported by a postdoctoral fellowship from FRSQ; VB is supported by a scholarship from FRSQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts K, 2009, CORTEX, V45, P1148, DOI 10.1016/j.cortex.2008.10.005; Avenanti A, 2007, CURR BIOL, V17, P2129, DOI 10.1016/j.cub.2007.11.045; Avenanti A, 2013, CEREB CORTEX, V23, P570, DOI 10.1093/cercor/bhs040; Aziz-Zadeh L, 2002, EXP BRAIN RES, V144, P127, DOI 10.1007/s00221-002-1037-5; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Cantarero G, 2011, J COGNITIVE NEUROSCI, V23, P3757, DOI 10.1162/jocn_a_00051; Celnik P, 2006, NEUROIMAGE, V29, P677, DOI 10.1016/j.neuroimage.2005.07.039; Celnik P, 2008, STROKE, V39, P1814, DOI 10.1161/STROKEAHA.107.508184; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Delvendahl I, 2010, CLIN NEUROPHYSIOL, V121, P594, DOI 10.1016/j.clinph.2009.09.034; Dum RP, 2002, PHYSIOL BEHAV, V77, P677, DOI 10.1016/S0031-9384(02)00929-0; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Heyes CM, 2002, Q J EXP PSYCHOL-A, V55, P593, DOI 10.1080/02724980143000389; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Koch G, 2010, NEUROPSYCHOLOGIA, V48, P3513, DOI 10.1016/j.neuropsychologia.2010.07.037; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Mattar AAG, 2005, NEURON, V46, P153, DOI 10.1016/j.neuron.2005.02.009; Meunier S, 2007, J NEUROPHYSIOL, V97, P3131, DOI 10.1152/jn.01086.2006; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Muellbacher W, 2001, EXP BRAIN RES, V136, P431, DOI 10.1007/s002210000614; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Press C, 2011, J NEUROSCI, V31, P2792, DOI 10.1523/JNEUROSCI.1595-10.2011; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rosenkranz K, 2007, J NEUROSCI, V27, P12058, DOI 10.1523/JNEUROSCI.2663-07.2007; Rossi S, 2011, CLIN NEUROPHYSIOL, V122, P1686, DOI 10.1016/j.clinph.2010.12.037; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Shimazu H, 2004, J NEUROSCI, V24, P1200, DOI 10.1523/JNEUROSCI.4731-03.2004; Small SL, 2012, DEV PSYCHOBIOL, V54, P293, DOI 10.1002/dev.20504; Stefan K, 2008, EUR J NEUROSCI, V27, P730, DOI 10.1111/j.1460-9568.2008.06035.x; Stefan K, 2004, J NEUROPHYSIOL, V92, P66, DOI 10.1152/jn.00383.2003; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Stefan K, 2006, CEREB CORTEX, V16, P376, DOI 10.1093/cercorbhi116; Stefan K, 2005, J NEUROSCI, V25, P9339, DOI 10.1523/JNEUROSCI.2282-05.2005; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Urgesi C, 2006, EUR J NEUROSCI, V23, P2522, DOI 10.1111/j.1460-9568.2006.04772.x; Urgesi C, 2010, CEREB CORTEX, V20, P2511, DOI 10.1093/cercor/bhp292; Wolters A, 2003, J NEUROPHYSIOL, V89, P2339, DOI 10.1152/jn.00900.2002; Ziemann U, 2004, J NEUROSCI, V24, P1666, DOI 10.1523/JNEUROSCI.5016-03.2004; Ziemann U, 2001, BRAIN, V124, P1171, DOI 10.1093/brain/124.6.1171	45	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38754	10.1371/journal.pone.0038754	http://dx.doi.org/10.1371/journal.pone.0038754			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701704	gold, Green Published, Green Submitted			2022-12-25	WOS:000305348400093
J	Wang, HJ; Giambini, H; Zhang, WJ; Ye, GH; Zhao, CF; An, KN; Li, YK; Lan, WR; Li, JY; Jiang, XS; Zou, QL; Zhang, XY; Chen, C				Wang, Hua-Jun; Giambini, Hugo; Zhang, Wen-Jun; Ye, Gan-Hu; Zhao, Chunfeng; An, Kai-Nan; Li, Yi-Kai; Lan, Wen-Rui; Li, Jian-You; Jiang, Xue-Sheng; Zou, Qiu-Lan; Zhang, Xiao-Ying; Chen, Chao			A Modified Sagittal Spine Postural Classification and Its Relationship to Deformities and Spinal Mobility in a Chinese Osteoporotic Population	PLOS ONE			English	Article							QUALITY-OF-LIFE; BACK EXTENSOR STRENGTH; VERTEBRAL FRACTURES; KYPHOSIS; ALIGNMENT; BALANCE; PAIN; IMPACT; WOMEN; RISK	Background: Abnormal posture and spinal mobility have been demonstrated to cause functional impairment in the quality of life, especially in the postmenopausal osteoporotic population. Most of the literature studies focus on either thoracic kyphosis or lumbar lordosis, but not on the change of the entire spinal alignment. Very few articles reported the spinal alignment of Chinese people. The purpose of this study was threefold: to classify the spinal curvature based on the classification system defined by Satoh consisting of the entire spine alignment; to identify the change of trunk mobility; and to relate spinal curvature to balance disorder in a Chinese population. Methodology/Principal Findings: 450 osteoporotic volunteers were recruited for this study. Spinal range of motion and global curvature were evaluated noninvasively using the Spinal-Mouse (R) system and sagittal postural deformities were characterized. Results: We found a new spine postural alignment consisting of an increased thoracic kyphosis and decreased lumbar lordosis which we classified as our modified round back. We did not find any of Satoh's type 5 classification in our population. Type 2 sagittal alignment was the most common spinal deformity (38.44%). In standing, thoracic kyphosis angles in types 2 (58.34 degrees) and 3 (58.03 degrees) were the largest and lumbar lordosis angles in types 4 (13.95 degrees) and 5 (-8.61 degrees) were the smallest. The range of flexion (ROF) and range of flexion-extension (ROFE) of types 2 and 3 were usually greater than types 4 and 5, with type 1 being the largest. Conclusions/Significance: The present study classified and compared for the first time the mobility, curvature and balance in a Chinese population based on the entire spine alignment and found types 4 and 5 to present the worst balance and mobility. This study included a new spine postural alignment classification that should be considered in future population studies.	[Wang, Hua-Jun; Zhang, Wen-Jun; Li, Yi-Kai; Lan, Wen-Rui; Chen, Chao] So Med Univ, Sch Tradit Chinese Med, Dept Orthoped, Guangzhou, Guangdong, Peoples R China; [Wang, Hua-Jun; Giambini, Hugo; Zhao, Chunfeng; An, Kai-Nan] Mayo Clin, Div Orthoped Res, Biomech Lab, Rochester, MN USA; [Ye, Gan-Hu] Chang Ping Hosp, Dongguan, Peoples R China; [Li, Jian-You; Jiang, Xue-Sheng] Huzhou Cent Hosp, Dept Orthoped, Huzhou, Peoples R China; [Zou, Qiu-Lan; Zhang, Xiao-Ying] You Hao Residential Care Home, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Mayo Clinic; Huzhou University	Wang, HJ (corresponding author), So Med Univ, Sch Tradit Chinese Med, Dept Orthoped, Guangzhou, Guangdong, Peoples R China.	chenchao@smu.edu.cn			National Natural Science Foundation of China [30700893, 31171024]; Huzhou Science and Technology RD Fund [2009YS04, 2010GS01]; third phase of important subject construction programme of "211 Project" of Guangdong province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huzhou Science and Technology RD Fund; third phase of important subject construction programme of "211 Project" of Guangdong province	This study is funded by the grant from National Natural Science Foundation of China (30700893 and 31171024), Huzhou Science and Technology R&D Fund (2009YS04 and 2010GS01) and the third phase of important subject construction programme of "211 Project" of Guangdong province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrey C, 2007, EUR SPINE J, V16, P1459, DOI 10.1007/s00586-006-0294-6; Berthonnaud E, 2011, EUR SPINE J, V20, pS572; Briggs AM, 2007, OSTEOPOROSIS INT, V18, P575, DOI 10.1007/s00198-006-0304-x; Cheung E, 2011, MATURITAS, V69, P50, DOI 10.1016/j.maturitas.2011.01.010; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; Hinman Martha R, 2004, Spine J, V4, P413, DOI 10.1016/j.spinee.2004.01.002; Hongo M, 2007, OSTEOPOROSIS INT, V18, P1389, DOI 10.1007/s00198-007-0398-9; Hongo M, 2012, OSTEOPOROSIS INT, V23, P1029, DOI 10.1007/s00198-011-1624-z; Huang MH, 2006, J BONE MINER RES, V21, P419, DOI 10.1359/JBMR.051201; Imagama S, 2011, EUR SPINE J, V20, P954, DOI 10.1007/s00586-010-1606-4; Ishikawa Y, 2009, OSTEOPOROSIS INT, V20, P2049, DOI 10.1007/s00198-009-0919-9; ITOI E, 1991, SPINE, V16, P750, DOI 10.1097/00007632-199107000-00011; JACKSON RP, 1994, SPINE, V19, P1611, DOI 10.1097/00007632-199407001-00010; Jang JS, 2007, J NEUROSURG-SPINE, V7, P387, DOI 10.3171/SPI-07/10/387; Kado DM, 2009, ANN INTERN MED, V150, P681, DOI 10.7326/0003-4819-150-10-200905190-00005; Kalfopulos Baron Zarate-, 2012, J NEUROSURG-SPINE, V2, P1; Kasukawa Y, 2010, J BONE MINER METAB, V28, P82, DOI 10.1007/s00774-009-0107-1; Katzman WB, 2011, OSTEOPOROSIS INT, V22, P85, DOI 10.1007/s00198-010-1265-7; Lee CS, 2011, SPINE, V36, pE1648, DOI 10.1097/BRS.0b013e318216b0fd; Legaye J, 2005, EUR SPINE J, V71, P213; Lynn SG, 1997, ARCH PHYS MED REHAB, V78, P273, DOI 10.1016/S0003-9993(97)90033-2; Mannion AF, 2004, EUR SPINE J, V13, P122, DOI 10.1007/s00586-003-0618-8; Martin AR, 2002, BONE, V31, P32, DOI 10.1016/S8756-3282(02)00787-1; Mendoza-Lattes S, 2010, SPINE, V35, pE792, DOI 10.1097/BRS.0b013e3181d35ca9; Mika A, 2005, SPINE, V30, P241, DOI 10.1097/01.brs.0000150521.10071.df; Miyakoshi N, 2007, OSTEOPOROSIS INT, V18, P1397, DOI 10.1007/s00198-007-0383-3; Miyakoshi N, 2005, OSTEOPOROSIS INT, V16, P1871, DOI 10.1007/s00198-005-1953-x; Miyakoshi N, 2003, OSTEOPOROSIS INT, V14, P1007, DOI 10.1007/s00198-003-1510-4; Nevitt MC, 1998, ANN INTERN MED, V128, P793, DOI 10.7326/0003-4819-128-10-199805150-00001; Obeid Ibrahim, 2011, Eur Spine J, V20 Suppl 5, P681, DOI 10.1007/s00586-011-1936-x; Post RB, 2004, ARCH ORTHOP TRAUM SU, V124, P187, DOI 10.1007/s00402-004-0641-1; Reginster JY, 2006, BONE, V38, P4, DOI 10.1016/j.bone.2005.11.024; Roussouly P, 2005, SPINE, V30, P346, DOI 10.1097/01.brs.0000152379.54463.65; Ryan SD, 1997, J AM GERIATR SOC, V45, P1479, DOI 10.1111/j.1532-5415.1997.tb03199.x; Satoh K, 1988, CONT ORTHOP, V16, P23; Schneider DL, 2004, J RHEUMATOL, V31, P747; Sinaki M, 1996, MAYO CLIN PROC, V71, P951, DOI 10.4065/71.10.951; Sinaki M, 2005, OSTEOPOROSIS INT, V16, P1004, DOI 10.1007/s00198-004-1791-2; Sinaki M, 2005, MAYO CLIN PROC, V80, P849, DOI 10.4065/80.7.849; Smith A, 2008, SPINE, V33, P2101, DOI 10.1097/BRS.0b013e31817ec3b0; Staffel F., 1889, MENSCHLICHEN HALTUNG; STAGNARA P, 1982, SPINE, V7, P335, DOI 10.1097/00007632-198207000-00003; Takahashi T, 2005, OSTEOPOROSIS INT, V16, P273, DOI 10.1007/s00198-004-1669-3; TAKEMITSU Y, 1988, SPINE, V13, P1317, DOI 10.1097/00007632-198811000-00019; Tuzun C, 1999, CLIN RHEUMATOL, V18, P308, DOI 10.1007/s100670050107; Wiles P., 1937, LANCET, V229, P911, DOI [10.1016/S0140-6736(00)82825-1, DOI 10.1016/S0140-6736(00)82825-1]	46	16	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38560	10.1371/journal.pone.0038560	http://dx.doi.org/10.1371/journal.pone.0038560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693647	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343900059
J	Currie, MA; Adams, JJ; Faucher, F; Bayer, EA; Jia, ZC; Smith, SP				Currie, Mark A.; Adams, Jarrett J.; Faucher, Frederick; Bayer, Edward A.; Jia, Zongchao; Smith, Steven P.			Scaffoldin Conformation and Dynamics Revealed by a Ternary Complex from the Clostridium thermocellum Cellulosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL BINDING MODE; CRYSTAL-STRUCTURE; COHESIN DOMAIN; II COHESIN; CELL-WALL; DOCKERIN DOMAIN; LAYER PROTEIN; MECHANISM; INSIGHTS; CELLULOLYTICUM	Cellulosomes are multienzyme complexes responsible for efficient degradation of plant cell wall polysaccharides. The nonenzymatic scaffoldin subunit provides a platform for cellulolytic enzyme binding that enhances the overall activity of the bound enzymes. Understanding the unique quaternary structural elements responsible for the enzymatic synergy of the cellulosome is hindered by the large size and inherent flexibility of these multiprotein complexes. Herein, we have used x-ray crystallography and small angle x-ray scattering to structurally characterize a ternary protein complex from the Clostridium thermocellum cellulosome that comprises a C-terminal trimodular fragment of the CipA scaffoldin bound to the SdbA type II cohesin module and the type I dockerin module from the Cel9D glycoside hydrolase. This complex represents the largest fragment of the cellulosome solved by x-ray crystallography to date and reveals two rigid domains formed by the type I cohesin.dockerin complex and by the X module-type II cohesin.dockerin complex, which are separated by a 13-residue linker in an extended conformation. The type I dockerin modules of the four structural models found in the asymmetric unit are in an alternate orientation to that previously observed that provides further direct support for the dual mode of binding. Conserved intermolecular contacts between symmetry-related complexes were also observed and may play a role in higher order cellulosome structure. SAXS analysis of the ternary complex revealed that the 13-residue intermodular linker of the scaffoldin subunit is highly dynamic in solution. These studies provide fundamental insights into modular positioning, linker flexibility, and higher order organization of the cellulosome.	[Currie, Mark A.; Adams, Jarrett J.; Faucher, Frederick; Jia, Zongchao; Smith, Steven P.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Jia, Zongchao; Smith, Steven P.] Queens Univ, Prot Funct Discovery Grp, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Weizmann Institute of Science; Queens University - Canada	Jia, ZC (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Botterell Hall,18 Stuart St, Kingston, ON K7L 3N6, Canada.	jia@queensu.ca; steven.smith@queensu.ca		Smith, Steven/0000-0003-2710-4400	Israel Science Foundation; Natural Science and Engineering Research Council of Canada; Canadian Institutes of Health Research	Israel Science Foundation(Israel Science Foundation); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by research grants from the Israel Science Foundation (to E. A. B.), the Natural Science and Engineering Research Council of Canada (to S. P. S.), and the Canadian Institutes of Health Research (to Z.J.).	Adams JJ, 2010, J MOL BIOL, V396, P833, DOI 10.1016/j.jmb.2010.01.015; Adams JJ, 2006, P NATL ACAD SCI USA, V103, P305, DOI 10.1073/pnas.0507109103; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; BAYER EA, 1994, TRENDS BIOTECHNOL, V12, P379, DOI 10.1016/0167-7799(94)90039-6; Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065; BAYER EA, 1986, J BACTERIOL, V167, P828, DOI 10.1128/jb.167.3.828-836.1986; Beguin P, 1998, BIOCHEM SOC T, V26, P178, DOI 10.1042/bst0260178; Bomble YJ, 2011, J BIOL CHEM, V286, P5614, DOI 10.1074/jbc.M110.186031; Carvalho AL, 2005, J MOL BIOL, V349, P909, DOI 10.1016/j.jmb.2005.04.037; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Correia MAS, 2008, J MOL BIOL, V379, P64, DOI 10.1016/j.jmb.2008.03.037; Currie MA, 2010, ACTA CRYSTALLOGR F, V66, P327, DOI 10.1107/S1744309110001375; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925; Fierobe HP, 2005, J BIOL CHEM, V280, P16325, DOI 10.1074/jbc.M414449200; Fierobe HP, 2002, J BIOL CHEM, V277, P49621, DOI 10.1074/jbc.M207672200; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Garcia-Alvarez B, 2011, J MOL BIOL, V407, P571, DOI 10.1016/j.jmb.2011.01.060; GERNGROSS UT, 1993, MOL MICROBIOL, V8, P325, DOI 10.1111/j.1365-2958.1993.tb01576.x; Gilbert HJ, 2007, MOL MICROBIOL, V63, P1568, DOI 10.1111/j.1365-2958.2007.05640.x; Guimaraes BG, 2002, J MOL BIOL, V320, P587, DOI 10.1016/S0022-2836(02)00497-7; Hammel M, 2005, J BIOL CHEM, V280, P38562, DOI 10.1074/jbc.M503168200; Hammel M, 2004, J BIOL CHEM, V279, P55985, DOI 10.1074/jbc.M408979200; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Kitago Y, 2007, J BIOL CHEM, V282, P35703, DOI 10.1074/jbc.M706835200; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; LAMED R, 1983, BIOTECHNOL BIOENG, P163; LAMED R, 1983, J BACTERIOL, V156, P828, DOI 10.1128/JB.156.2.828-836.1983; Leibovitz E, 1997, J BACTERIOL, V179, P2519, DOI 10.1128/jb.179.8.2519-2523.1997; Leibovitz E, 1996, J BACTERIOL, V178, P3077, DOI 10.1128/jb.178.11.3077-3084.1996; Lemaire M, 1998, MICROBIOL-UK, V144, P211, DOI 10.1099/00221287-144-1-211; LEMAIRE M, 1995, J BACTERIOL, V177, P2451, DOI 10.1128/jb.177.9.2451-2459.1995; Lytle BL, 2001, J MOL BIOL, V307, P745, DOI 10.1006/jmbi.2001.4522; MAYER F, 1987, APPL ENVIRON MICROB, V53, P2785, DOI 10.1128/AEM.53.12.2785-2792.1987; Molinier AL, 2011, J MOL BIOL, V405, P143, DOI 10.1016/j.jmb.2010.10.013; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Noach I, 2005, J MOL BIOL, V348, P1, DOI 10.1016/j.jmb.2005.02.024; Noach I, 2010, J MOL BIOL, V399, P294, DOI 10.1016/j.jmb.2010.04.013; Noach I, 2009, J MOL BIOL, V391, P86, DOI 10.1016/j.jmb.2009.06.006; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Pinheiro BA, 2008, J BIOL CHEM, V283, P18422, DOI 10.1074/jbc.M801533200; POOLE DM, 1992, FEMS MICROBIOL LETT, V99, P181, DOI 10.1111/j.1574-6968.1992.tb05563.x; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Schaeffer F, 2002, BIOCHEMISTRY-US, V41, P2106, DOI 10.1021/bi011853m; Shimon LJW, 1997, STRUCTURE, V5, P381, DOI 10.1016/S0969-2126(97)00195-0; Spinelli S, 2000, J MOL BIOL, V304, P189, DOI 10.1006/jmbi.2000.4191; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tavares GA, 1997, J MOL BIOL, V273, P701, DOI 10.1006/jmbi.1997.1326; Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x; Warren RAJ, 1996, ANNU REV MICROBIOL, V50, P183, DOI 10.1146/annurev.micro.50.1.183	56	27	27	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26953	26961		10.1074/jbc.M112.343897	http://dx.doi.org/10.1074/jbc.M112.343897			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707718	hybrid, Green Published			2022-12-25	WOS:000307386000043
J	Poth, AG; Mylne, JS; Grassl, J; Lyons, RE; Millar, AH; Colgrave, ML; Craik, DJ				Poth, Aaron G.; Mylne, Joshua S.; Grassl, Julia; Lyons, Russell E.; Millar, A. Harvey; Colgrave, Michelle L.; Craik, David J.			Cyclotides Associate with Leaf Vasculature and Are the Products of a Novel Precursor in Petunia (Solanaceae)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BACKBONE-CYCLIZED PEPTIDES; SEED STORAGE PROTEINS; CIRCULAR PROTEINS; ASPARAGINYL ENDOPEPTIDASE; MACROCYCLIC PEPTIDES; PLANT CYCLOTIDES; KNOTTED PROTEINS; BIOSYNTHESIS; MINIPROTEINS; EXPRESSION	Cyclotides are a large family of plant peptides that are structurally defined by their cyclic backbone and a trifecta of disulfide bonds, collectively known as the cyclic cystine knot (CCK) motif. Structurally similar cyclotides have been isolated from plants within the Rubiaceae, Violaceae, and Fabaceae families and share the CCK motif with trypsin-inhibitory knottins from a plant in the Cucurbitaceae family. Cyclotides have previously been reported to be encoded by dedicated genes or as a domain within a knottin-encoding PA1-albumin-like gene. Here we report the discovery of cyclotides and related non-cyclic peptides we called "acyclotides" from petunia of the agronomically important Solanaceae plant family. Transcripts for petunia cyclotides and acyclotides encode the shortest known cyclotide precursors. Despite having a different precursor structure, their sequences suggest that petunia cyclotides mature via the same biosynthetic route as other cyclotides. We assessed the spatial distribution of cyclotides within a petunia leaf section by MALDI imaging and observed that the major cyclotide component Phyb A was non-uniformly distributed. Dissected leaf midvein extracts contained significantly higher concentrations of this cyclotide compared with the lamina and outer margins of leaves. This is the third distinct type of cyclotide precursor, and Solanaceae is the fourth phylogenetically disparate plant family to produce these structurally conserved cyclopeptides, suggesting either convergent evolution upon the CCK structure or movement of cyclotide-encoding sequences within the plant kingdom.	[Poth, Aaron G.; Mylne, Joshua S.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Poth, Aaron G.; Lyons, Russell E.; Colgrave, Michelle L.] CSIRO Div Livestock Ind, St Lucia, Qld 4067, Australia; [Grassl, Julia; Millar, A. Harvey] Univ Western Australia, Ctr Comparat Anal Biomol Networks, Crawley, WA 6009, Australia; [Grassl, Julia; Millar, A. Harvey] Univ Western Australia, Australian Res Council, Ctr Excellence Plant Energy Biol, Crawley, WA 6009, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; University of Western Australia	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Mylne, Josh/GMX-4544-2022; Lyons, Russell/H-7942-2013; Grassl, Julia/O-9417-2016; Poth, Aaron G/D-2060-2017; Lyons, Russell E/A-7051-2011; Grassl, Julia/D-1047-2011; Lyons, Russell E/AAH-4097-2020; Mylne, Joshua S/A-5581-2009; Millar, A. Harvey/A-5452-2008; Craik, David/B-1695-2010; Grassl, Julia/O-9773-2019; Colgrave, Michelle/A-5710-2012	Mylne, Josh/0000-0003-4957-6388; Lyons, Russell/0000-0002-0795-7994; Grassl, Julia/0000-0001-8653-4983; Poth, Aaron G/0000-0002-1497-8347; Lyons, Russell E/0000-0002-0795-7994; Mylne, Joshua S/0000-0003-4957-6388; Millar, A. Harvey/0000-0001-9679-1473; Craik, David/0000-0003-0007-6796; Grassl, Julia/0000-0001-8653-4983; Colgrave, Michelle/0000-0001-8463-805X	Australian Research Council (ARC) [DP0984390, DP0985873, LE0775603, DP0879133, DP0771156]	Australian Research Council (ARC)(Australian Research Council)	This work was supported by an Australian Research Council (ARC) grant for cyclotide analysis (Grant DP0984390), an ARC Grant for development of MALDI-MSI in plants (Grant DP0985873), and equipment purchased under ARC Linkage Grant LE0775603 housed in the ARC Centre of Excellence in Plant Energy Biology at the University of Western Australia.; An ARC Queen Elizabeth II Fellow (Grant DP0879133) and the John S. Mattick Fellow.; An ARC Australian Professorial Fellow (Grant DP0771156).	ABE Y, 1993, J BIOL CHEM, V268, P3525; Ahmad A, 2012, CRIT REV FOOD SCI, V52, P201, DOI 10.1080/10408398.2010.499806; Barry DG, 2003, BIOCHEMISTRY-US, V42, P6688, DOI 10.1021/bi027323n; BECERRA JX, 1990, BIOTROPICA, V22, P320, DOI 10.2307/2388545; Beck A, 2001, J PEPT RES, V57, P528, DOI 10.1034/j.1399-3011.2001.00895.x; Bokesch HR, 2001, J NAT PROD, V64, P249, DOI 10.1021/np000372l; Box MS, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-7; Broussalis AM, 2001, PHYTOCHEMISTRY, V58, P47, DOI 10.1016/S0031-9422(01)00173-X; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Castellino S, 2011, BIOANALYSIS, V3, P2427, DOI [10.4155/bio.11.232, 10.4155/BIO.11.232]; Chan LY, 2011, BLOOD, V118, P6709, DOI 10.1182/blood-2011-06-359141; Chughtai K, 2010, CHEM REV, V110, P3237, DOI 10.1021/cr100012c; Colgrave ML, 2008, BIOCHEMISTRY-US, V47, P5581, DOI 10.1021/bi800223y; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Conlan BF, 2011, AM J BOT, V98, P2018, DOI 10.3732/ajb.1100382; Craik DJ, 2006, CURR OPIN DRUG DISC, V9, P251; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2006, BIOPOLYMERS, V84, P250, DOI 10.1002/bip.20451; Daly NL, 2004, FEBS LETT, V574, P69, DOI 10.1016/j.febslet.2004.08.007; Dannenhoffer JM, 2001, PLANTA, V212, P155, DOI 10.1007/s004250000405; DHONDT K, 1993, J BIOL CHEM, V268, P20884; Do HM, 2004, PLANT SCI, V166, P1297, DOI 10.1016/j.plantsci.2004.01.008; Dutton JL, 2004, J BIOL CHEM, V279, P46858, DOI 10.1074/jbc.M407421200; Gemoll T, 2011, MOL MED REP, V4, P1045, DOI 10.3892/mmr.2011.566; Gerlach SL, 2010, J NAT PROD, V73, P1207, DOI 10.1021/np9007365; Giang KTN, 2011, J BIOL CHEM, V286, P44833, DOI 10.1074/jbc.M111.290296; Giang KTN, 2011, J BIOL CHEM, V286, P24275, DOI 10.1074/jbc.M111.229922; Gillon AD, 2008, PLANT J, V53, P505, DOI 10.1111/j.1365-313X.2007.03357.x; GRAN L, 1973, ACTA PHARMACOL TOX, V33, P400; Gran L., 1970, MEDDELELSER NORSK FA, V12, P173; Grassl J, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-21; Greer T, 2011, J PROTEOMICS, V74, P2617, DOI 10.1016/j.jprot.2011.03.032; Gruis DF, 2004, PLANT CELL, V16, P270, DOI 10.1105/tpc.016378; Gunasekera S, 2008, J MED CHEM, V51, P7697, DOI 10.1021/jm800704e; GUSTAFSON KR, 1994, J AM CHEM SOC, V116, P9337, DOI 10.1021/ja00099a064; HARAHISHIMURA I, 1993, PLANT J, V4, P793, DOI 10.1046/j.1365-313X.1993.04050793.x; Heitz A, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-54; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; HIGGINS TJV, 1986, J BIOL CHEM, V261, P1124; Hiraiwa N, 1997, EUR J BIOCHEM, V246, P133, DOI 10.1111/j.1432-1033.1997.00133.x; Ireland DC, 2006, J MOL BIOL, V357, P1522, DOI 10.1016/j.jmb.2006.01.051; IUPAC, 1979, NOM ORG CHEM F; IUPAC, 1979, NOM ORG CHEM A; IUPAC, 1979, NOM ORG CHEM C; IUPAC, 1979, NOM ORG CHEM E; IUPAC, 1979, NOM ORG CHEM B; IUPAC, 1979, NOM ORG CHEM D; IUPAC, 1979, NOM ORG CHEM H; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jennings CV, 2005, BIOCHEMISTRY-US, V44, P851, DOI 10.1021/bi047837h; Kaas Q, 2010, BIOPOLYMERS, V94, P584, DOI 10.1002/bip.21424; Kondo T, 2006, SCIENCE, V313, P845, DOI 10.1126/science.1128439; Lindholm P, 2002, MOL CANCER THER, V1, P365; Ljungdahl A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025653; Lopez L, 2007, PLANTA, V226, P517, DOI 10.1007/s00425-007-0501-7; Menger RF, 2012, ANAL CHEM, V84, P1117, DOI 10.1021/ac202779h; MIN W, 1994, NAT STRUCT BIOL, V1, P502, DOI 10.1038/nsb0894-502; Murata N., 1987, PROGR PHOTOSYNTHESIS; Mylne JS, 2011, NAT CHEM BIOL, V7, P257, DOI 10.1038/nchembio.542; Nguyen GKT, 2012, J BIOL CHEM, V287, P17598, DOI 10.1074/jbc.M111.338970; Nilsson A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011411; Ntanios F, 2001, EUR J LIPID SCI TECH, V103, P102, DOI 10.1002/1438-9312(200102)103:2<102::AID-EJLT102>3.0.CO;2-A; Otegui MS, 2006, PLANT CELL, V18, P2567, DOI 10.1105/tpc.106.040931; Ovesen RG, 2011, J CHROMATOGR A, V1218, P7964, DOI 10.1016/j.chroma.2011.08.095; Pinto MFS, 2012, J EVID-BASED INTEGR, V17, P40, DOI 10.1177/2156587211428077; Plan MRR, 2008, J AGR FOOD CHEM, V56, P5237, DOI 10.1021/jf800302f; Poth AG, 2011, P NATL ACAD SCI USA, V108, P10127, DOI 10.1073/pnas.1103660108; Poth AG, 2011, ACS CHEM BIOL, V6, P345, DOI 10.1021/cb100388j; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; Saska I, 2008, J CHROMATOGR B, V872, P107, DOI 10.1016/j.jchromb.2008.07.023; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; Shimada T, 2003, J BIOL CHEM, V278, P32292, DOI 10.1074/jbc.M305740200; Shroff R, 2008, P NATL ACAD SCI USA, V105, P6196, DOI 10.1073/pnas.0711730105; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Sommerhoff CP, 2010, J MOL BIOL, V395, P167, DOI 10.1016/j.jmb.2009.10.028; Thurnham DI, 1999, BRIT J NUTR, V82, P255, DOI 10.1017/S0007114599001440; Trabi M, 2004, PLANT CELL, V16, P2204, DOI 10.1105/tpc.104.021790; WITHERUP KM, 1994, J NAT PRODUCTS, V57, P1619, DOI 10.1021/np50114a002	78	104	110	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27033	27046		10.1074/jbc.M112.370841	http://dx.doi.org/10.1074/jbc.M112.370841			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700981	hybrid, Green Published			2022-12-25	WOS:000307386000053
J	Verma, NK; Dempsey, E; Long, AD; Davies, A; Barry, SP; Fallon, PG; Volkov, Y; Kelleher, D				Verma, Navin K.; Dempsey, Eugene; Long, Aideen; Davies, Anthony; Barry, Sean P.; Fallon, Padraic G.; Volkov, Yuri; Kelleher, Dermot			Leukocyte Function-associated Antigen-1/Intercellular Adhesion Molecule-1 Interaction Induces a Novel Genetic Signature Resulting in T-cells Refractory to Transforming Growth Factor-beta Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; AP-1 ACTIVITY; SMAD7; LFA-1; TRANSDUCTION; INFLAMMATION; DISEASE; SKI; IDENTIFICATION; DEGRADATION	The immunesuppressive cytokine TGF-beta plays crucial regulatory roles in the induction and maintenance of immunologic tolerance and prevention of immunopathologies. However, it remains unclear how circulating T-cells can escape from the quiescent state maintained by TGF-beta. Here, we report that the T-cell integrin leukocyte function-associated antigen-1 (LFA-1) interaction with its ligand intercellular adhesion molecule-1 (ICAM-1) induces a genetic signature associated with reduced TGF-beta responsiveness via up-regulation of SKI, E3 ubiquitin-protein ligase SMURF2, and SMAD7 (mothers against decapentaplegic homolog 7) genes and proteins. We confirmed that the expression of these TGF-beta inhibitory molecules was dependent on STAT3 and/or JNK activation. Increased expression of SMAD7 and SMURF2 in LFA-1/ICAM-1 cross-linked T-cells resulted in impaired TGF-beta mediated phosphorylation of SMAD2 and suppression of IL-2 secretion. Expression of SKI caused resistance to TGF-beta-mediated suppression of IL-2, but SMAD2 phosphorylation was unaffected. Blocking LFA-1 by neutralizing antibody or specific knockdown of TGF-beta inhibitory molecules by siRNA substantially restored LFA-1/ICAM-1-mediated alteration in TGF-beta signaling. LFA-1/ICAM-1-stimulated human and mouse T-cells were refractory to TGF-beta-mediated induction of FOXP3(+) (forkhead box P3) and ROR gamma t(+) (retinoic acid-related orphan nuclear receptor gamma t) Th17 differentiation. These mechanistic data suggest an important role for LFA-1/ICAM-1 interactions in immunoregulation concurrent with lymphocyte migration that may have implications at the level of local inflammatory response and for anti-LFA-1-based therapies.	[Kelleher, Dermot] Trinity Coll Dublin, Inst Mol Med, Trinity Ctr Hlth Sci, Dept Clin Med, Dublin 8, Ireland; [Fallon, Padraic G.] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin 12, Ireland	Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin	Kelleher, D (corresponding author), Trinity Coll Dublin, Inst Mol Med, Trinity Ctr Hlth Sci, Dept Clin Med, Dublin 8, Ireland.	kellehdp@tcd.ie	Verma, Navin Kumar/B-7641-2008; Fallon, Padraic/Y-2711-2019; Volkov, Yuri/N-6774-2014	Verma, Navin Kumar/0000-0002-5940-6633; Fallon, Padraic/0000-0002-8401-7293; Volkov, Yuri/0000-0001-7406-518X; Dempsey, Eugene/0000-0003-2373-689X	Enterprise Ireland; Higher Education Authority of Ireland under the Program for Research in Third Level Institutions (PRTLI) Cycle 3; Science Foundation Ireland (SFI); Health Research Board (HRB) of Ireland	Enterprise Ireland; Higher Education Authority of Ireland under the Program for Research in Third Level Institutions (PRTLI) Cycle 3; Science Foundation Ireland (SFI)(Science Foundation Ireland); Health Research Board (HRB) of Ireland	This work was supported by grants from the Enterprise Ireland, Higher Education Authority of Ireland under the Program for Research in Third Level Institutions (PRTLI) Cycle 3, Science Foundation Ireland (SFI), and the Health Research Board (HRB) of Ireland.	Amu S, 2010, J ALLERGY CLIN IMMUN, V125, P1114, DOI 10.1016/j.jaci.2010.01.018; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Boirivant M, 2006, GASTROENTEROLOGY, V131, P1786, DOI 10.1053/j.gastro.2006.09.016; Carson KR, 2009, LANCET ONCOL, V10, P816, DOI 10.1016/S1470-2045(09)70161-5; Chang JH, 2012, NAT IMMUNOL, V13, P481, DOI 10.1038/ni.2267; Das L, 2008, J IMMUNOL, V180, P1490, DOI 10.4049/jimmunol.180.3.1490; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Gotea V, 2008, NUCLEIC ACIDS RES, V36, pW133, DOI 10.1093/nar/gkn300; Guttman-Yassky E, 2008, J INVEST DERMATOL, V128, P1182, DOI 10.1038/jid.2008.4; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Koszik F, 2010, J DERMATOL SCI, V60, P159, DOI 10.1016/j.jdermsci.2010.10.003; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Monteleone G, 2008, MUCOSAL IMMUNOL, V1, pS50, DOI 10.1038/mi.2008.55; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; Monteleone G, 2004, TRENDS IMMUNOL, V25, P513, DOI 10.1016/j.it.2004.07.008; Monteleone G, 2005, GASTROENTEROLOGY, V129, P1420, DOI 10.1053/j.gastro.2005.09.005; Moustakas A, 2001, J CELL SCI, V114, P4359; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nakao A, 2002, TRENDS MOL MED, V8, P361, DOI 10.1016/S1471-4914(02)02376-6; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Reisman NM, 2011, BLOOD, V118, P5851, DOI 10.1182/blood-2011-04-347252; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shimizu Y, 2003, NAT IMMUNOL, V4, P1052, DOI 10.1038/ni1103-1052; Smart NG, 2006, PLOS BIOL, V4, P200, DOI 10.1371/journal.pbio.0040039; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Verma NK, 2008, J MOL MED-JMM, V86, P457, DOI 10.1007/s00109-008-0312-8; Verma NK, 2011, J CELL PHYSIOL, V226, P1489, DOI 10.1002/jcp.22478; Verma NK, 2010, CELL MOL BIOL LETT, V15, P342, DOI 10.2478/s11658-010-0008-2; Verma NK, 2009, J BIOL CHEM, V284, P12349, DOI 10.1074/jbc.M807761200; Volkov Y, 1998, J IMMUNOL, V161, P6487; Volkov Y, 2001, NAT IMMUNOL, V2, P508, DOI 10.1038/88700; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Wang YN, 2007, BIOCHEM BIOPH RES CO, V353, P857, DOI 10.1016/j.bbrc.2006.12.104; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; Yamagiwa S, 2001, J IMMUNOL, V166, P7282, DOI 10.4049/jimmunol.166.12.7282; Zhang XK, 1999, MOL CELL BIOL, V19, P7138	49	25	27	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27204	27216		10.1074/jbc.M112.376616	http://dx.doi.org/10.1074/jbc.M112.376616			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707713	Green Published, hybrid			2022-12-25	WOS:000307386000072
J	Kallo, I; Mohacsik, P; Vida, B; Zeold, A; Bardoczi, Z; Zavacki, AM; Farkas, E; Kadar, A; Hrabovszky, E; Drigo, RAE; Dong, LP; Barna, L; Palkovits, M; Borsay, BA; Herczeg, L; Lechan, RM; Bianco, AC; Liposits, Z; Fekete, C; Gereben, B				Kallo, Imre; Mohacsik, Petra; Vida, Barbara; Zeoeld, Aniko; Bardoczi, Zsuzsanna; Zavacki, Ann Marie; Farkas, Erzsebet; Kadar, Andrea; Hrabovszky, Erik; Arrojo e Drigo, Rafael; Dong, Liping; Barna, Laszlo; Palkovits, Miklos; Borsay, Beata A.; Herczeg, Laszlo; Lechan, Ronald M.; Bianco, Antonio C.; Liposits, Zsolt; Fekete, Csaba; Gereben, Balazs			A Novel Pathway Regulates Thyroid Hormone Availability in Rat and Human Hypothalamic Neurosecretory Neurons	PLOS ONE			English	Article							TYPE-2 IODOTHYRONINE DEIODINASE; GONADOTROPIN-RELEASING-HORMONE; MESSENGER-RIBONUCLEIC-ACID; MONOCARBOXYLATE TRANSPORTER-8; PSYCHOMOTOR RETARDATION; MEDIAN-EMINENCE; BRAIN; THYROTROPIN; SYSTEM; EXPRESSION	Hypothalamic neurosecretory systems are fundamental regulatory circuits influenced by thyroid hormone. Monocarboxylate-transporter-8 (MCT8)-mediated uptake of thyroid hormone followed by type 3 deiodinase (D3)-catalyzed inactivation represent limiting regulatory factors of neuronal T3 availability. In the present study we addressed the localization and subcellular distribution of D3 and MCT8 in neurosecretory neurons and addressed D3 function in their axons. Intense D3-immunoreactivity was observed in axon varicosities in the external zone of the rat median eminence and the neurohaemal zone of the human infundibulum containing axon terminals of hypophysiotropic parvocellular neurons. Immuno-electronmicroscopy localized D3 to dense-core vesicles in hypophysiotropic axon varicosities. N-STORM-superresolution-microscopy detected the active center containing C-terminus of D3 at the outer surface of these organelles. Double-labeling immunofluorescent confocal microscopy revealed that D3 is present in the majority of GnRH, CRH and GHRH axons but only in a minority of TRH axons, while absent from somatostatin-containing neurons. Bimolecular-Fluorescence-Complementation identified D3 homodimers, a prerequisite for D3 activity, in processes of GT1-7 cells. Furthermore, T3-inducible D3 catalytic activity was detected in the rat median eminence. Triple-labeling immunofluorescence and immuno-electronmicroscopy revealed the presence of MCT8 on the surface of the vast majority of all types of hypophysiotropic terminals. The presence of MCT8 was also demonstrated on the axon terminals in the neurohaemal zone of the human infundibulum. The unexpected role of hypophysiotropic axons in fine-tuned regulation of T3 availability in these cells via MCT8-mediated transport and D3-catalyzed inactivation may represent a novel regulatory core mechanism for metabolism, growth, stress and reproduction in rodents and humans.	[Kallo, Imre; Mohacsik, Petra; Vida, Barbara; Zeoeld, Aniko; Bardoczi, Zsuzsanna; Farkas, Erzsebet; Kadar, Andrea; Hrabovszky, Erik; Liposits, Zsolt; Fekete, Csaba; Gereben, Balazs] Hungarian Acad Sci, Dept Endocrine Neurobiol, Inst Expt Med, Budapest, Hungary; [Kallo, Imre; Liposits, Zsolt] Pazmany Peter Catholic Univ, Dept Neurosci, Fac Informat Technol, Budapest, Hungary; [Zavacki, Ann Marie] Brigham & Womens Hosp, Thyroid Sect, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Zavacki, Ann Marie] Harvard Univ, Sch Med, Boston, MA USA; [Arrojo e Drigo, Rafael; Dong, Liping; Bianco, Antonio C.; Gereben, Balazs] Univ Miami, Div Endocrinol Diabet & Metab, Miller Sch Med Miami, Coral Gables, FL 33124 USA; [Barna, Laszlo] Hungarian Acad Sci, Inst Expt Med, Nikon Microscopy Ctr, Budapest, Hungary; [Palkovits, Miklos] Semmelweis Univ, Human Brain Tissue Bank, Budapest, Hungary; [Borsay, Beata A.; Herczeg, Laszlo] Univ Debrecen, Dept Forens Med, Fac Med, Debrecen, Hungary; [Lechan, Ronald M.; Fekete, Csaba] Tufts Med Ctr, Tupper Res Inst, Boston, MA USA; [Lechan, Ronald M.; Fekete, Csaba] Tufts Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA USA	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Miami; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Semmelweis University; University of Debrecen; Tufts Medical Center; Tufts Medical Center	Kallo, I (corresponding author), Hungarian Acad Sci, Dept Endocrine Neurobiol, Inst Expt Med, Budapest, Hungary.	gereben.balazs@koki.mta.hu	Palkovits, Miklos/F-2707-2013; Liposits, Zsolt/K-8145-2019; Kalló, Imre/C-6262-2016; Bianco, Antonio/AAK-6336-2020	Palkovits, Miklos/0000-0003-0578-0387; Kalló, Imre/0000-0003-3412-4100; Bianco, Antonio/0000-0001-7737-6813; Hrabovszky, Erik/0000-0001-6927-0015; Liposits, Zsolt/0000-0002-3508-2750; Fekete, Csaba/0000-0002-8206-562X; Barna, Laszlo/0000-0002-3856-5774; Arrojo e Drigo, Rafael/0000-0001-7712-013X	National Science Foundation of Hungary [OTKA K81226, K81845, K69127]; Medical Research Council [02-121/2009]; European Community [259772, 245009]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077148] Funding Source: NIH RePORTER	National Science Foundation of Hungary; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community(European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Science Foundation of Hungary (OTKA K81226, K81845, K69127), the Medical Research Council (ETT Grant 02-121/2009) and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 259772 and 245009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkemade A, 2005, J CLIN ENDOCR METAB, V90, P4322, DOI 10.1210/jc.2004-2567; Araki O, 2003, ENDOCRINOLOGY, V144, P4459, DOI 10.1210/en.2003-0419; Baumgartner A, 1998, J NEUROCHEM, V71, P817; Bernal J, 2003, THYROID, V13, P1005, DOI 10.1089/105072503770867174; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Bluet-Pajot MT, 1998, CELL MOL NEUROBIOL, V18, P101, DOI 10.1023/A:1022579327647; Callebaut I, 2003, J BIOL CHEM, V278, P36887, DOI 10.1074/jbc.M305725200; CECCATELLI S, 1992, NEUROENDOCRINOLOGY, V56, P694, DOI 10.1159/000126295; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Chou KC, 1999, PROTEINS, V34, P137, DOI 10.1002/(SICI)1097-0134(19990101)34:1<137::AID-PROT11>3.3.CO;2-F; CROTEAU W, 1995, J BIOL CHEM, V270, P16569, DOI 10.1074/jbc.270.28.16569; Curcio-Morelli C, 2003, ENDOCRINOLOGY, V144, P937, DOI 10.1210/en.2002-220960; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; DAWSON A, 1993, J ENDOCRINOL, V139, P51, DOI 10.1677/joe.0.1390051; Dentice M, 2011, J ENDOCRINOL, V209, P273, DOI 10.1530/JOE-11-0002; Du JL, 2009, P NATL ACAD SCI USA, V106, P18890, DOI 10.1073/pnas.0910659106; Dumitrescu AM, 2004, AM J HUM GENET, V74, P168, DOI 10.1086/380999; Fekete C, 2004, ENDOCRINOLOGY, V145, P1649, DOI 10.1210/en.2003-1439; Fekete C, 2007, FRONT NEUROENDOCRIN, V28, P97, DOI 10.1016/j.yfrne.2007.04.002; Freitas BCG, 2010, J CLIN INVEST, V120, P2206, DOI 10.1172/JCI41977; Friesema ECH, 2004, LANCET, V364, P1435, DOI 10.1016/S0140-6736(04)17226-7; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; Giustina A, 1995, EUR J ENDOCRINOL, V133, P646, DOI 10.1530/eje.0.1330646; GuadanoFerraz A, 1997, P NATL ACAD SCI USA, V94, P10391, DOI 10.1073/pnas.94.19.10391; Hernandez A, 2006, J CLIN INVEST, V116, P476, DOI 10.1172/JCI26240; Heuer H, 2005, ENDOCRINOLOGY, V146, P1701, DOI 10.1210/en.2004-1179; Horvath TL, 1999, J NEUROSCI, V19, P10417; Hrabovszky E, 2005, EUR J NEUROSCI, V21, P2120, DOI 10.1111/j.1460-9568.2005.04076.x; Hrabovszky E, 2011, FRONTIERS ENDOCRINOL, P2; Hynes TR, 2004, J BIOL CHEM, V279, P30279, DOI 10.1074/jbc.M401432200; Jansen HT, 1997, ENDOCRINOLOGY, V138, P5039, DOI 10.1210/en.138.11.5039; Johnson EO, 2005, EUR J ENDOCRINOL, V153, P177, DOI 10.1530/eje.1.01923; Kallo I, 2001, J NEUROENDOCRINOL, V13, P741, DOI 10.1046/j.1365-2826.2001.00708.x; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; LECHAN RM, 1976, NATURE, V264, P463, DOI 10.1038/264463a0; Lechan RM, 2005, THYROID, V15, P883, DOI 10.1089/thy.2005.15.883; Lechan RM, 2006, PROG BRAIN RES, V153, P209, DOI 10.1016/S0079-6123(06)53012-2; Lehman MN, 1997, BRAIN RES BULL, V44, P445, DOI 10.1016/S0361-9230(97)00225-6; LIPOSITS Z, 1984, NEUROSCIENCE, V13, P513, DOI 10.1016/0306-4522(84)90245-8; Mann DR, 2010, BRAIN RES, V1364, P175, DOI 10.1016/j.brainres.2010.09.082; Martinez B, 2009, ENDOCRINOLOGY, V150, P3953, DOI 10.1210/en.2008-1755; Meldolesi J, 2004, TRENDS CELL BIOL, V14, P13, DOI 10.1016/j.tcb.2003.11.006; MERCHENTHALER I, 1984, CELL TISSUE RES, V237, P15; Mohacsik P, 2011, J THYROID R IN PRESS; Murphy M, 2011, J THYROID R IN PRESS; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; RETHELYI M, 1982, ACTA BIOL ACAD SCI H, V33, P289; RISKIND PN, 1987, BRAIN RES, V420, P194, DOI 10.1016/0006-8993(87)90260-5; Roberts LM, 2008, ENDOCRINOLOGY, V149, P6251, DOI 10.1210/en.2008-0378; Sagar GDV, 2008, MOL ENDOCRINOL, V22, P1382, DOI 10.1210/me.2007-0490; Sanchez E, 2001, NEUROENDOCRINOLOGY, V74, P407, DOI 10.1159/000054707; Simonides WS, 2008, J CLIN INVEST, V118, P975, DOI 10.1172/JCI32824; Trajkovic M, 2007, J CLIN INVEST, V117, P627, DOI 10.1172/JCI28253; Tu HM, 1997, ENDOCRINOLOGY, V138, P3359, DOI 10.1210/en.138.8.3359; Tu HM, 1999, ENDOCRINOLOGY, V140, P784, DOI 10.1210/en.140.2.784; Visser WE, 2008, TRENDS ENDOCRIN MET, V19, P50, DOI 10.1016/j.tem.2007.11.003; WETSEL WC, 1991, ENDOCRINOLOGY, V129, P1584, DOI 10.1210/endo-129-3-1584; WIEGAND SJ, 1980, J COMP NEUROL, V192, P1, DOI 10.1002/cne.901920102; Williams GR, 2008, J NEUROENDOCRINOL, V20, P784, DOI 10.1111/j.1365-2826.2008.01733.x; Wittmann G, 2009, J COMP NEUROL, V517, P825, DOI 10.1002/cne.22180; Yoshimura T, 2010, ANIM SCI J, V81, P403, DOI 10.1111/j.1740-0929.2010.00777.x; Zeold A, 2006, J BIOL CHEM, V281, P31538, DOI 10.1074/jbc.M604728200	62	34	34	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37860	10.1371/journal.pone.0037860	http://dx.doi.org/10.1371/journal.pone.0037860			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719854	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300015
J	Mefford, D; Mefford, J				Mefford, Dwain; Mefford, Joel			Stromal Genes Add Prognostic Information to Proliferation and Histoclinical Markers: A Basis for the Next Generation of Breast Cancer Gene Signatures	PLOS ONE			English	Article							EXPRESSION SIGNATURES; IMMUNE-RESPONSE; MICROARRAY DATA; PREDICTS; CLASSIFICATION; CARCINOMA; SUBTYPES; THERAPY; SURVIVAL; INDEX	Background: First-generation gene signatures that identify breast cancer patients at risk of recurrence are confined to estrogen-positive cases and are driven by genes involved in the cell cycle and proliferation. Previously we induced sets of stromal genes that are prognostic for both estrogen-positive and estrogen-negative samples. Creating risk-management tools that incorporate these stromal signatures, along with existing proliferation-based signatures and established clinicopathological measures such as lymph node status and tumor size, should better identify women at greatest risk for metastasis and death. Methodology/Principal Findings: To investigate the strength and independence of the stromal and proliferation factors in estrogen-positive and estrogen-negative patients we constructed multivariate Cox proportional hazards models along with tree-based partitions of cancer cases for four breast cancer cohorts. Two sets of stromal genes, one consisting of DCN and FBLN1, and the other containing LAMA2, add substantial prognostic value to the proliferation signal and to clinical measures. For estrogen receptor-positive patients, the stromal-decorin set adds prognostic value independent of proliferation for three of the four datasets. For estrogen receptor-negative patients, the stromal-laminin set significantly adds prognostic value in two datasets, and marginally in a third. The stromal sets are most prognostic for the unselected population studies and may depend on the age distribution of the cohorts. Conclusion: The addition of stromal genes would measurably improve the performance of proliferation-based first-generation gene signatures, especially for older women. Incorporating indicators of the state of stromal cell types would mark a conceptual shift from epithelial-centric risk assessment to assessment based on the multiple cell types in the cancer-altered tissue.	[Mefford, Joel] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco		dwainmefford@gmail.com						Abba MC, 2004, BREAST CANCER RES, V6, pR499, DOI 10.1186/bcr899; Alexe G, 2007, CANCER RES, V67, P10669, DOI 10.1158/0008-5472.CAN-07-0539; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; [Anonymous], ARRAYEXPRESS; Beck AH, 2008, LAB INVEST, V88, P591, DOI 10.1038/labinvest.2008.31; Beck AH, 2009, CLIN CANCER RES, V15, P778, DOI 10.1158/1078-0432.CCR-08-1283; Bergamaschi A, 2008, J PATHOL, V214, P357, DOI 10.1002/path.2278; Bianchini G, 2010, J CLIN ONCOL, V28, P4316, DOI 10.1200/JCO.2009.27.2419; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Colombo PE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2890; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Dai HY, 2005, CANCER RES, V65, P4059, DOI 10.1158/0008-5472.CAN-04-3953; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Desmedt C, 2006, CELL CYCLE, V5, P2198, DOI 10.4161/cc.5.19.3254; Drier Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017795; Dunkler D, 2007, EUR J CANCER, V43, P745, DOI 10.1016/j.ejca.2006.11.018; Eden P, 2004, EUR J CANCER, V40, P1837, DOI 10.1016/j.ejca.2004.02.025; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fournier MV, 2006, CANCER RES, V66, P7095, DOI 10.1158/0008-5472.CAN-06-0515; Gene Expression Omnibus, GENE EXPRESSION OMNI; Geyer FC, 2012, ADV ANAT PATHOL, V19, P39, DOI 10.1097/PAP.0b013e31823fafa0; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Haibe-Kains B, 2008, BIOINFORMATICS, V24, P2200, DOI 10.1093/bioinformatics/btn374; Haibe-Kains B, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-394; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Karn T, 2010, BREAST CANCER RES TR, V120, P567, DOI 10.1007/s10549-009-0416-z; Loi S, 2007, CRIT REV ONCOL HEMAT, V61, P187, DOI 10.1016/j.critrevonc.2006.09.005; Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994; Mefford D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-482; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Myhre S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014002; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Perou CM, 2010, LANCET ONCOL, V11, P718, DOI 10.1016/S1470-2045(10)70176-5; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Rody A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2234; Ross JS, 2008, ONCOLOGIST, V13, P477, DOI 10.1634/theoncologist.2007-0248; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Sorlie T, 2010, LANCET ONCOL, V11, P719, DOI 10.1016/S1470-2045(10)70174-1; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Symmans WF, 2010, J CLIN ONCOL, V28, P4111, DOI 10.1200/JCO.2010.28.4273; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weigelt B, 2010, LANCET ONCOLOGY; Weigelt B, 2012, NAT REV CLIN ONCOL, V9, P58, DOI 10.1038/nrclinonc.2011.125; Weigelt B, 2010, J PATHOL, V220, P263, DOI 10.1002/path.2648; West RB, 2005, PLOS BIOL, V3, P1101, DOI 10.1371/journal.pbio.0030187; West RB, 2007, LAB INVEST, V87, P967, DOI 10.1038/labinvest.3700666; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Zhao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017845	57	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37646	10.1371/journal.pone.0037646	http://dx.doi.org/10.1371/journal.pone.0037646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719844	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300009
J	Meltzer, L; Blinick, NS; Fleishman, AB				Meltzer, Lorayne; Blinick, Naomi S.; Fleishman, Abram B.			Management Implications of the Biodiversity and Socio-Economic Impacts of Shrimp Trawler By-Catch in Bahia de Kino, Sonora, Mexico	PLOS ONE			English	Article							GULF-OF-CALIFORNIA; FISHERY; BYCATCH	The shrimp fishery is the most economically important fishery in Mexico. The trawler-based portion of this fishery results in high rates of by-catch. This study quantifies and describes the biodiversity of by-catch associated with trawling in the Bahia de Kino region of Sonora, Mexico. Data were collected from 55 trawls, on six boats, over 14 nights, during November of 2003, 2004, 2006-2009. By-catch rates within trawl samples averaged 85.9% measured by weight. A total of 183 by-catch species were identified during the course of this study, including 97 species of bony fish from 43 families, 19 species of elasmobranchs from 12 families, 66 species of invertebrates from eight phyla, and one species of marine turtle; seven of the documented by-catch species are listed on the IUCN Red List, CITES, or the Mexican NOM-059-ECOL-2010; 35 species documented in the by-catch are also targeted by local artisanal fishers. Some of the species frequently captured as juveniles in the by-catch are economically important to small-scale fishers in the region, and are particularly sensitive to overexploitation due to their life histories. This study highlights the need for further research quantifying the impacts of high levels of by-catch upon small-scale fishing economies in the region and presents strong ecological and economic rationale for by-catch management within the shrimp fishery of the Gulf of California. Site-specific by-catch management plans should be piloted in the Bahia de Kino region to address the growing momentum in national and international fisheries policy regimes toward the reduction of by-catch in shrimp fisheries.	[Meltzer, Lorayne] Prescott Coll, Environm Studies Fac, Prescott, AZ USA; [Meltzer, Lorayne; Blinick, Naomi S.; Fleishman, Abram B.] Prescott Coll, Res & Conservat Program, Kino Bay Ctr Cultural & Ecol Studies, Bahia De Kino, Sonora, Mexico		Meltzer, L (corresponding author), Prescott Coll, Environm Studies Fac, Prescott, AZ USA.	lmeltzer@prescott.edu			David and Lucile Packard Foundation; Prescott College	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Prescott College	The David and Lucile Packard Foundation and Prescott College fund the program that conducted this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balton DA, 2010, FED REGISTER, V75, P27855; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Brusca R. C., 2004, SEA SHORE GUIDE NO G; [CITES] Convention on the International Trade of Endangered Species of Wild Flora and Fauna, UNEP WCMC SPEC DAT C; [CONAPESCA] Comision Nacional de Acuacultura y Pesca, 2011, DISM CON NUM EMB CAM; Davies RWD, 2009, MAR POLICY, V33, P661, DOI 10.1016/j.marpol.2009.01.003; FAO, 2010, 934 FAO; Garcia-Caudillo JM, 2000, BIOL CONSERV, V92, P199, DOI 10.1016/S0006-3207(99)00053-1; Garcia-Caudillo JM, 2005, PESCA IND CAMERON GO; Gillet R., 2008, FAO FISH TECH PAP, V475, P331; Glenn EP, 2006, AQUAT CONSERV, V16, P5, DOI 10.1002/aqc.681; Heredia Quevedo JA, 2001, THESIS UN U REYKJAVI; Rabago-Quiroz CH, 2011, REV BIOL TROP, V59, P255; [INP] Instituto Nacional de la Pesca, 2000, CAT SIST CAPT PRINC; IUCN, 2019, IUCN RED LIST THREAT; Kelleher Kieran, 2005, FAO FISHERIES TECHNI; Lopez-Martinez J, 2010, REV BIOL TROP, V58, P925; Madrid-Vera J, 2007, FISH RES, V83, P81, DOI 10.1016/j.fishres.2006.08.026; Madrid-Vera J, 2010, MAR ECOL PROG SER, V403, P145, DOI 10.3354/meps08434; MAGALLON-BARAJAS F J, 1987, California Cooperative Oceanic Fisheries Investigations Reports, V28, P43; Mark Freeberg J.G.Pope, 1994, GLOBAL ASSESSMENT FI; Marquez F, 2006, IUCN 2010 IUCN RED L; Marquez-Farias JF, 2007, MAR BIOL, V151, P1445, DOI 10.1007/s00227-006-0599-3; Meltzer L, 2006, OCEAN COAST MANAGE, V49, P222, DOI 10.1016/j.ocecoaman.2006.02.009; Moreno C., 2005, DIAGNOSTICO AMBIENTA; Moreno-Baez M, 2010, THESIS U ARIZONA TUC; Nava Romero JM, 1994, THESIS I TECNOLOGICO; Perez-Mellado J, 1985, RECURSOS PESQUERAS P, V5, P201; [SAGARPA] Secretaria de Agricultura Ganaderia Desarrollo Rural Pesca y Alimentacion, 2009, AN EST PESC 2009; Salomon-Aguilar CA, 2009, CIENC MAR, V35, P369, DOI 10.7773/cm.v35i4.1435; [SEMARNAT] Secretaria de Medio Ambiente y Recursos Naturales, 2010, DIARIO OFICIAL  1230, V2, P1; [WRI] World Resources Institute, 2004, FISH ANSW MAK SENS G; Young RH, 1979, TROP SCI, V21, P249	33	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e35609	10.1371/journal.pone.0035609	http://dx.doi.org/10.1371/journal.pone.0035609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719827	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300003
J	Liu, F; Lunsford, EP; Tong, JL; Ashitate, Y; Gibbs, SL; Yu, J; Choi, HS; Henske, EP; Frangioni, JV				Liu, Fangbing; Lunsford, Elaine P.; Tong, Jingli; Ashitate, Yoshitomo; Gibbs, Summer L.; Yu, Jane; Choi, Hak Soo; Henske, Elizabeth P.; Frangioni, John V.			Real-Time Monitoring of Tumorigenesis, Dissemination, & Drug Response in a Preclinical Model of Lymphangioleiomyomatosis/Tuberous Sclerosis Complex	PLOS ONE			English	Article							TUBEROUS SCLEROSIS; SMOOTH-MUSCLE; RENAL ANGIOMYOLIPOMA; NA+/I-SYMPORTER; MATRIX METALLOPROTEINASES; TSC2(+/-) MICE; TUMOR-CELLS; TSC2; MTOR; LAM	Background: TSC2-deficient cells can proliferate in the lungs, kidneys, and other organs causing devastating progressive multisystem disorders such as lymphangioleiomyomatosis (LAM) and tuberous sclerosis complex (TSC). Preclinical models utilizing LAM patient-derived cells have been difficult to establish. We developed a novel animal model system to study the molecular mechanisms of TSC/LAM pathogenesis and tumorigenesis and provide a platform for drug testing. Methods and Findings: TSC2-deficient human cells, derived from the angiomyolipoma of a LAM patient, were engineered to co-express both sodium-iodide symporter (NIS) and green fluorescent protein (GFP). Cells were inoculated intraparenchymally, intravenously, or intratracheally into athymic NCr nu/nu mice and cells were tracked and quantified using single photon emission computed tomography (SPECT) and computed tomography (CT). Surprisingly, TSC2-deficient cells administered intratracheally resulted in rapid dissemination to lymph node basins throughout the body, and histopathological changes in the lung consistent with LAM. Estrogen was found to be permissive for tumor growth and dissemination. Rapamycin inhibited tumor growth, but tumors regrew after the drug treatment was withdrawn. Conclusions: We generated homogeneous NIS/GFP co-expressing TSC2-deficient, patient-derived cells that can proliferate and migrate in vivo after intratracheal instillation. Although the animal model we describe has some limitations, we demonstrate that systemic tumors formed from TSC2-deficient cells can be monitored and quantified noninvasively over time using SPECT/CT, thus providing a much needed model system for in vivo drug testing and mechanistic studies of TSC2-deficient cells and their related clinical syndromes.	[Liu, Fangbing; Ashitate, Yoshitomo; Gibbs, Summer L.; Choi, Hak Soo; Frangioni, John V.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02115 USA; [Tong, Jingli] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02115 USA; [Yu, Jane; Henske, Elizabeth P.] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Yu, Jane; Henske, Elizabeth P.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Frangioni, John V.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Liu, F (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02115 USA.	jfrangio@bidmc.harvard.edu	Choi, Hak Soo/C-9954-2011		United States National Institutes of Health (High-End Instrumentation Grant) [S10-RR-023010]; Ellison Foundation; Tuberous Sclerosis Alliance; NATIONAL CANCER INSTITUTE [R01CA115296] Funding Source: NIH RePORTER	United States National Institutes of Health (High-End Instrumentation Grant); Ellison Foundation(Lawrence Ellison Foundation); Tuberous Sclerosis Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by grants to JVF from the United States National Institutes of Health (High-End Instrumentation Grant #S10-RR-023010), the Ellison Foundation, and the Tuberous Sclerosis Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Arbiser JL, 2001, AM J PATHOL, V159, P483, DOI 10.1016/S0002-9440(10)61720-8; Astrinidis A, 2005, ONCOGENE, V24, P7475, DOI 10.1038/sj.onc.1209090; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; CAPRON F, 1983, CANCER, V52, P851, DOI 10.1002/1097-0142(19830901)52:5<851::AID-CNCR2820520518>3.0.CO;2-M; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; CORNOG JL, 1966, CANCER-AM CANCER SOC, V19, P1909, DOI 10.1002/1097-0142(196612)19:12<1909::AID-CNCR2820191219>3.0.CO;2-R; CRAWFORD HC, 1994, INVAS METAST, V14, P234; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dadachova E, 2004, SEMIN NUCL MED, V34, P23, DOI 10.1053/j.semnuclmed.2003.09.004; Darling TN, 2010, LYMPHAT RES BIOL, V8, P59, DOI 10.1089/lrb.2009.0031; El-Hashemite N, 2005, CANCER RES, V65, P2474, DOI 10.1158/0008-5472.CAN-04-3840; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Finlay GA, 2009, MOL CANCER THER, V8, P1799, DOI 10.1158/1535-7163.MCT-09-0055; Franz DN, 2010, NEUROPEDIATRICS, V41, P199, DOI 10.1055/s-0030-1269906; Glasgow CG, 2008, ANN NY ACAD SCI, V1131, P206, DOI 10.1196/annals.1413.018; Goncharova EA, 2006, AM J RESP CELL MOL, V34, P473, DOI 10.1165/rcmb.2005-0374OC; Henske EP, 2003, GENE CHROMOSOME CANC, V38, P376, DOI 10.1002/gcc.10252; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Juvet SC, 2007, AM J RESP CELL MOL, V36, P398, DOI 10.1165/rcmb.2006-0372TR; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Knudson AG, 1996, J CANCER RES CLIN, V122, P135, DOI 10.1007/BF01366952; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Krymskaya VP, 2003, CELL SIGNAL, V15, P729, DOI 10.1016/S0898-6568(03)00040-8; Kwiatkowski DJ, 2010, LYMPHAT RES BIOL, V8, P51, DOI 10.1089/lrb.2009.0013; Lacroix L, 2001, EUR J ENDOCRINOL, V144, P297, DOI 10.1530/eje.0.1440297; Lesma E, 2005, AM J PATHOL, V167, P1093, DOI 10.1016/S0002-9440(10)61198-4; Lesma E, 2009, AM J PATHOL, V174, P2150, DOI 10.2353/ajpath.2009.080799; Lesma E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003558; Marsee DK, 2004, CANCER GENE THER, V11, P121, DOI 10.1038/sj.cgt.7700661; Matsui K, 2000, ARCH PATHOL LAB MED, V124, P267; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Moss J, 2001, AM J RESP CRIT CARE, V164, P669, DOI 10.1164/ajrccm.164.4.2101154; Nurok M, 2010, LYMPHAT RES BIOL, V8, P81, DOI 10.1089/lrb.2009.0028; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Smolarek TA, 1998, AM J HUM GENET, V62, P810, DOI 10.1086/301804; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Strizheva GD, 2001, AM J RESP CRIT CARE, V163, P253, DOI 10.1164/ajrccm.163.1.2005004; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Vayre L, 1999, EUR J ENDOCRINOL, V141, P382, DOI 10.1530/eje.0.1410382; Walker CL, 2003, GENE CHROMOSOME CANC, V38, P349, DOI 10.1002/gcc.10281; Wlodarski PK, 2008, INT J MOL MED, V21, P245; Woodrum C, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-14; Yu J, 2004, AM J PHYSIOL-LUNG C, V286, pL694, DOI 10.1152/ajplung.00204.2003; Yu J, 2010, LYMPHAT RES BIOL, V8, P43, DOI 10.1089/lrb.2009.0020; Yu JJ, 2009, P NATL ACAD SCI USA, V106, P2635, DOI 10.1073/pnas.0810790106; Zhe XN, 2004, J HISTOCHEM CYTOCHEM, V52, P1537, DOI 10.1369/jhc.4A6438.2004	49	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38589	10.1371/journal.pone.0038589	http://dx.doi.org/10.1371/journal.pone.0038589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719903	gold, Green Submitted, Green Published			2022-12-25	WOS:000305350000017
J	Noblanc, A; Peltier, M; Damon-Soubeyrand, C; Kerchkove, N; Chabory, E; Vernet, P; Saez, F; Cadet, R; Janny, L; Pons-Rejraji, H; Conrad, M; Drevet, JR; Kocer, A				Noblanc, Anais; Peltier, Manon; Damon-Soubeyrand, Christelle; Kerchkove, Nicolas; Chabory, Eleonore; Vernet, Patrick; Saez, Fabrice; Cadet, Remi; Janny, Laurent; Pons-Rejraji, Hanae; Conrad, Marcus; Drevet, Joel R.; Kocer, Ayhan			Epididymis Response Partly Compensates for Spermatozoa Oxidative Defects in snGPx4 and GPx5 Double Mutant Mice	PLOS ONE			English	Article							SPERM DNA INTEGRITY; HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; DAMAGE; THIOREDOXIN; FRAGMENTATION; SUPPRESSION; PROTAMINES; EXPRESSION; MECHANISM; ENZYMES	We report here that spermatozoa of mice lacking both the sperm nucleaus glutathione peroxidase 4 (snGPx4) and the epididymal glutathione peroxidase 5 (GPx5) activities display sperm nucleus structural abnormalities including delayed and defective nuclear compaction, nuclear instability and DNA damage. We show that to counteract the GPx activity losses, the epididymis of the double KO animals mounted an antioxydant response resulting in a strong increase in the global H2O2-scavenger activity especially in the cauda epididymis. Quantitative RT-PCR data show that together with the up-regulation of epididymal scavengers (of the thioredoxin/peroxiredoxin system as well as glutathione-S-transferases) the epididymis of double mutant animals increased the expression of several disulfide isomerases in an attempt to recover normal disulfide-bridging activity. Despite these compensatory mechanisms cauda-stored spermatozoa of double mutant animals show high levels of DNA oxidation, increased fragmentation and greater susceptibility to nuclear decondensation. Nevertheless, the enzymatic epididymal salvage response is sufficient to maintain full fertility of double KO males whatever their age, crossed with young WT female mice.	[Noblanc, Anais; Damon-Soubeyrand, Christelle; Kerchkove, Nicolas; Vernet, Patrick; Saez, Fabrice; Cadet, Remi; Janny, Laurent; Pons-Rejraji, Hanae; Drevet, Joel R.; Kocer, Ayhan] Clermont Univ, INSERM, CNRS, Genet Reprod & Dev Lab,UMR 6293,U1103, Aubiere, France; [Peltier, Manon] Inst Curie, Paris, France; [Chabory, Eleonore] Hop Porte Madeleine Orleans, Dept Obstet Gynecol, Lab Assistance Med Procreat, Orleans, France; [Janny, Laurent; Pons-Rejraji, Hanae] CHU Estaing, Clermont Ferrand, France; [Conrad, Marcus] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Dev Genet, Munich, Germany; [Conrad, Marcus] German Ctr Neurodegenerat Dis, Munich, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; CHU Clermont Ferrand; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Noblanc, A (corresponding author), Clermont Univ, INSERM, CNRS, Genet Reprod & Dev Lab,UMR 6293,U1103, Aubiere, France.	joel.drevet@univ-bpclermont.fr	Kocer, Ayhan/N-7927-2014; VERNET, Patrick/F-1681-2018; Conrad, Marcus/E-8792-2015; Drevet, Joël/W-2692-2019; PONS, HANAE/X-8673-2019	VERNET, Patrick/0000-0003-0170-7545; Conrad, Marcus/0000-0003-1140-5612; Drevet, Joël/0000-0003-3077-6558; PONS, HANAE/0000-0002-9779-9693	CNRS; INSERM; French Ministry of Higher Education	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Ministry of Higher Education	Institutional funding from the CNRS, the INSERM and The French Ministry of Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2009, INT J ANDROL, V32, P46, DOI 10.1111/j.1365-2605.2008.00943.x; Anelli T, 2002, EMBO J, V21, P835, DOI 10.1093/emboj/21.4.835; Aoki VW, 2005, J ANDROL, V26, P741, DOI 10.2164/jandrol.05063; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Balhorn R, 2001, BIOCHEMISTRY-US, V30, P175; Bartoov B, 2003, FERTIL STERIL, V80, P1413, DOI 10.1016/j.fertnstert.2003.05.016; BEDFORD JM, 1974, J EXP ZOOL, V188, P137, DOI 10.1002/jez.1401880203; Berggren MI, 2001, ARCH BIOCHEM BIOPHYS, V392, P103, DOI 10.1006/abbi.2001.2435; Calvin H. I, 1971, Journal Reprod Fertil, VNo. 13, P65; Chabory E, 2009, J CLIN INVEST, V119, P2074, DOI 10.1172/JCI38940; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; Cocuzza Marcello, 2007, Int. braz j urol., V33, P603, DOI 10.1590/S1677-55382007000500002; Conrad M, 2005, MOL CELL BIOL, V25, P7637, DOI 10.1128/MCB.25.17.7637-7644.2005; Fernandez JL, 2003, J ANDROL, V24, P59; Flohe L, 2011, ANTIOXID REDOX SIGN, V15, P763, DOI 10.1089/ars.2010.3397; Golan R, 1996, HUM REPROD, V11, P1457; Herbette S, 2002, EUR J BIOCHEM, V269, P2414, DOI 10.1046/j.1432-1033.2002.02905.x; Herbette S, 2007, FEBS J, V274, P2163, DOI 10.1111/j.1742-4658.2007.05774.x; HUANG HFS, 1984, J REPROD FERTIL, V70, P31, DOI 10.1530/jrf.0.0700031; Johnston DS, 2005, BIOL REPROD, V73, P404, DOI 10.1095/biolreprod.105.039719; Kodama H, 1997, FERTIL STERIL, V68, P519, DOI 10.1016/S0015-0282(97)00236-7; Lee W, 2007, MOL VIS, V13, P1469; Lewis SEM, 2005, CELL TISSUE RES, V322, P33, DOI 10.1007/s00441-005-1097-5; Marchesi DE, 2007, ARCH ANDROLOGY, V53, P239, DOI 10.1080/01485010701569858; Meseguer M, 2011, FERTIL STERIL, V95, P124, DOI 10.1016/j.fertnstert.2010.05.055; Miller D, 2010, REPRODUCTION, V139, P287, DOI 10.1530/REP-09-0281; Montiel EE, 2003, ARCH ANDROLOGY, V49, P95, DOI 10.1080/01485010390129296; Noblanc A, 2011, J ANDROL, V32, P641, DOI 10.2164/jandrol.110.012823; O'Brien J, 2005, UROLOGY, V65, P16, DOI 10.1016/j.urology.2004.07.015; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Pfeifer H, 2001, FASEB J, V15, P1236, DOI 10.1096/fj.00-0655fje; Puglisi R, 2012, J CELL PHYSIOL, V227, P1420, DOI 10.1002/jcp.22857; Quan X, 2011, FEBS LETT, V585, P3436, DOI 10.1016/j.febslet.2011.09.035; Sakkas D, 2009, FERTIL STERIL, V93, P1027; Satake N, 2006, J EXP BIOL, V209, P1560, DOI 10.1242/jeb.02136; SELIGMAN J, 1994, J REPROD FERTIL, V101, P435; SHALGI R, 1989, BIOL REPROD, V40, P1037, DOI 10.1095/biolreprod40.5.1037; Simon L, 2011, REPROD BIOMED ONLINE, V23, P724, DOI 10.1016/j.rbmo.2011.08.010; Simon L, 2010, HUM REPROD, V25, P1594, DOI 10.1093/humrep/deq103; Spano M, 2000, FERTIL STERIL, V73, P43, DOI 10.1016/S0015-0282(99)00462-8; Speyer BE, 2010, HUM REPROD, V25, P1609, DOI 10.1093/humrep/deq116; Tesarik J, 2004, HUM REPROD, V19, P611, DOI 10.1093/humrep/deh127; Tesarik J, 2006, REPROD BIOMED ONLINE, V12, P715, DOI 10.1016/S1472-6483(10)61083-8; WARD WS, 1991, BIOL REPROD, V44, P569, DOI 10.1095/biolreprod44.4.569; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yeung CH, 2006, MOL CELL ENDOCRINOL, V250, P98, DOI 10.1016/j.mce.2005.12.030; Zini A, 2001, FERTIL STERIL, V75, P674, DOI 10.1016/S0015-0282(00)01796-9; Zini A, 2006, CURR OPIN UROL, V16, P428, DOI 10.1097/01.mou.0000250283.75484.dd; Zini A, 2008, HUM REPROD, V23, P2663, DOI 10.1093/humrep/den321	49	32	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38565	10.1371/journal.pone.0038565	http://dx.doi.org/10.1371/journal.pone.0038565			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719900	gold, Green Published, Green Submitted			2022-12-25	WOS:000305347800008
J	Lyon, C; Nehaniv, CL; Saunders, J				Lyon, Caroline; Nehaniv, Chrystopher L.; Saunders, Joe			Interactive Language Learning by Robots: The Transition from Babbling to Word Forms	PLOS ONE			English	Article							SOCIAL CONTINGENCY; SPEECH-PERCEPTION; ACQUISITION; INFANTS; DORSAL; SOUNDS; MEMORY	The advent of humanoid robots has enabled a new approach to investigating the acquisition of language, and we report on the development of robots able to acquire rudimentary linguistic skills. Our work focuses on early stages analogous to some characteristics of a human child of about 6 to 14 months, the transition from babbling to first word forms. We investigate one mechanism among many that may contribute to this process, a key factor being the sensitivity of learners to the statistical distribution of linguistic elements. As well as being necessary for learning word meanings, the acquisition of anchor word forms facilitates the segmentation of an acoustic stream through other mechanisms. In our experiments some salient one-syllable word forms are learnt by a humanoid robot in real-time interactions with naive participants. Words emerge from random syllabic babble through a learning process based on a dialogue between the robot and the human participant, whose speech is perceived by the robot as a stream of phonemes. Numerous ways of representing the speech as syllabic segments are possible. Furthermore, the pronunciation of many words in spontaneous speech is variable. However, in line with research elsewhere, we observe that salient content words are more likely than function words to have consistent canonical representations; thus their relative frequency increases, as does their influence on the learner. Variable pronunciation may contribute to early word form acquisition. The importance of contingent interaction in real-time between teacher and learner is reflected by a reinforcement process, with variable success. The examination of individual cases may be more informative than group results. Nevertheless, word forms are usually produced by the robot after a few minutes of dialogue, employing a simple, real-time, frequency dependent mechanism. This work shows the potential of human-robot interaction systems in studies of the dynamics of early language acquisition.	[Lyon, Caroline; Nehaniv, Chrystopher L.; Saunders, Joe] Univ Hertfordshire, Adapt Syst Res Grp, Hertford, England	University of Hertfordshire	Lyon, C (corresponding author), Univ Hertfordshire, Adapt Syst Res Grp, Hertford, England.	c.lyon@herts.ac.uk		Nehaniv, Chrystopher L./0000-0002-7807-1875	European Commission [FP7-214668]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work is supported by the European Commission under project grant FP7-214668 for ITALK: Integration and Transfer of Action and Language Knowledge in Robots. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, TALKING HEADS EXPT; [Anonymous], 1890, HISTORY; [Anonymous], 2009, 1 LANGUAGE ACQUISITI, DOI DOI 10.1017/CBO9780511806698; Aslin RN, 1996, SIGNAL TO SYNTAX: BOOTSTRAPPING FROM SPEECH TO GRAMMAR IN EARLY ACQUISITION, P117; Bigelow AE, 2003, INFANCY, V4, P111, DOI 10.1207/S15327078IN0401_6; Bortfeld H, 2005, PSYCHOL SCI, V16, P298, DOI 10.1111/j.0956-7976.2005.01531.x; Breazeal, 2002, DESIGNING SOCIABLE R; Brent M, BRENT CORPUS; Brent MR, 2001, COGNITION, V81, pB33, DOI 10.1016/S0010-0277(01)00122-6; Cairns P, 1997, COGNITIVE PSYCHOL, V33, P111, DOI 10.1006/cogp.1997.0649; Cangelosi A, 2010, IEEE T AUTON MENT DE, V2, P167, DOI 10.1109/TAMD.2010.2053034; Cangelosi A, 2010, PHYS LIFE REV, V7, P139, DOI 10.1016/j.plrev.2010.02.001; Chomsky N, 2005, LINGUIST INQ, V36, P1, DOI 10.1162/0024389052993655; Chomsky N, 1980, RULES REPRESENTATION; CMU, 2008, PRON DICT; Cunillera T, 2010, EXP PSYCHOL, V57, P134, DOI 10.1027/1618-3169/a000017; Daland R, 2011, COGNITIVE SCI, V35, P119, DOI 10.1111/j.1551-6709.2010.01160.x; de Boer B, 2000, J PHONETICS, V27, P1; de Boisson-Bardies B., 1999, LANGUAGE COMES CHILD; Dominey PF, 2004, IEEE-RAS INT C HUMAN, P168; Dominey PF, 2004, J NEUROLINGUIST, V17, P121, DOI 10.1016/S0911-6044(03)00056-3; Fernald A., 2006, HDB PSYCHOLINGUISTIC, P1027, DOI DOI 10.1016/B978-012369374-7/50028-6; Fischer K, 2011, INTERACT STUD, V12, P134, DOI 10.1075/is.12.1.06fis; Greenberg S, 1999, SPEECH COMMUN, V29, P159, DOI 10.1016/S0167-6393(99)00050-3; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; Gupta P, 2009, PHILOS T R SOC B, V364, P3755, DOI 10.1098/rstb.2009.0132; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2010, LANG COGNITIVE PROC, V25, P749, DOI 10.1080/01690961003595572; Hickok G, 2010, BRAIN LANG, V112, P1, DOI 10.1016/j.bandl.2009.10.006; Houston-Price C, 2004, INFANT CHILD DEV, V13, P341, DOI 10.1002/icd.364; ITALK, 2008, EU FRAM 7 PROJ INT; JUSCZYK PW, 1995, COGNITIVE PSYCHOL, V29, P1, DOI 10.1006/cogp.1995.1010; Kuhl PK, 2007, DEVELOPMENTAL SCI, V10, P110, DOI 10.1111/j.1467-7687.2007.00572.x; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; Lyon C, 2006, PLAGIARISM IS EASY A; Lyon C, 2009, IEEE T AUTON MENT DE, V1, P187, DOI 10.1109/TAMD.2009.2037731; MacWhinney B, 2010, J CHILD LANG, V37, P477, DOI 10.1017/S0305000910000139; Manning C. D., 2001, FDN STAT NATURAL LAN; Manning C.D., 2008, INTRO INFORM RETRIEV; Monaghan P, 2010, J CHILD LANG, V37, P545, DOI 10.1017/S0305000909990511; Morse AF, 2010, P 2010 ANN M COGN SC, P1362; Naatanen R, 2001, PSYCHOPHYSIOLOGY, V38, P1, DOI 10.1017/S0048577201000208; Nadel J, 1999, DEVELOPMENTAL SCI, V2, P164, DOI 10.1111/1467-7687.00065; Nowak MA, 2002, NATURE, V417, P611, DOI 10.1038/nature00771; Oudeyer P.-Y., 2006, SELF ORG EVOLUTION S; Oudeyer PY, 2001, LECT NOTES COMPUTER, V2130, P143; PIERREHUMBERT J, 1990, SYS DEV FDN, P271; Port R, 2007, NEW IDEAS PSYCHOL, V25, P143, DOI 10.1016/j.newideapsych.2007.02.001; Rothwell A., 2011, 2011 IEEE SSCI Symposium on Artificial Life (ALIFE), P86, DOI 10.1109/ALIFE.2011.5954641; Rytting CA, 2010, J CHILD LANG, V37, P513, DOI 10.1017/S0305000910000085; S Johansson, 1989, AAAI FALL S SERIES, P56; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Samuelson LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028095; Saunders J, 2011, ADV INTERACT STUD, V2, P211; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; SCRIBE, 2004, SCRIBE SPOKEN CORPUS; Steels L., 2001, EVOLUTION COMMUNICAT, V4, P3; Stilp CE, 2010, P NATL ACAD SCI USA, V107, P21914, DOI 10.1073/pnas.1009020107; Stoel-Gammon C, 2011, J CHILD LANG, V38, P1, DOI 10.1017/S0305000910000425; Tomasello M., 2003, CONSTRUCTING LANGUAG; Vihman M. M., 2002, MIRROR NEURONS EVOLU, P305, DOI DOI 10.1075/AICR.42; Vihman M. M., 1996, PHONOLOGICAL DEV ORI; Vihman MM, 2009, CAMB HB LANG LINGUIS, P163; VIHMAN MM, 1993, NATO ADV SCI INST SE, V69, P411; Werker JF, 2002, INFANT BEHAV DEV, V25, P121, DOI 10.1016/S0163-6383(02)00093-0; White AM, 2011, P IEEE S SECUR PRIV, P3, DOI 10.1109/SP.2011.34; Wittgenstein L., 2009, PHILOS INVESTIGATION, V4; Wrede B, 2010, J PRAGMATICS, V42, P2369, DOI 10.1016/j.pragma.2010.01.003; Wrede B, 2009, LECT NOTES ARTIF INT, V5436, P139, DOI 10.1007/978-3-642-00616-6_8; Yeung HH, 2009, COGNITION, V113, P234, DOI 10.1016/j.cognition.2009.08.010; Zue V. W., 1996, Recent research towards advanced man-machine interface through spoken language, P515, DOI 10.1016/B978-044481607-8/50088-8	72	22	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38236	10.1371/journal.pone.0038236	http://dx.doi.org/10.1371/journal.pone.0038236			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UV	22719871	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341900022
J	Banfield, S; Pascoe, E; Thambiran, A; Siafarikas, A; Burgner, D				Banfield, Sally; Pascoe, Elaine; Thambiran, Aesen; Siafarikas, Aris; Burgner, David			Factors Associated with the Performance of a Blood-Based Interferon-gamma Release Assay in Diagnosing Tuberculosis	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; MYCOBACTERIUM-TUBERCULOSIS; LATENT TUBERCULOSIS; INFECTION; REFUGEES; MALARIA; PREVENTION; MANAGEMENT; CHILDREN; IMMUNITY	Background: Indeterminate results are a recognised limitation of interferon-c release assays (IGRA) in the diagnosis of latent tuberculosis (TB) infection (LTBI) and TB disease, especially in children. We investigated whether age and common comorbidities were associated with IGRA performance in an unselected cohort of resettled refugees. Methods: A retrospective cross-sectional study of refugees presenting for their post-resettlement health assessment during 2006 and 2007. Refugees were investigated for prevalent infectious diseases, including TB, and for common nutritional deficiencies and haematological abnormalities as part of standard clinical screening protocols. Tuberculosis screening was performed by IGRA; QuantiFERON-TB Gold in 2006 and QuantiFERON-TBGold In-Tube in 2007. Results: Complete data were available on 1130 refugees, of whom 573 (51%) were children less than 17 years and 1041 (92%) were from sub-Saharan Africa. All individuals were HIV negative. A definitive IGRA result was obtained in 1004 (89%) refugees, 264 (26%) of which were positive; 256 (97%) had LTBI and 8 (3%) had TB disease. An indeterminate IGRA result was obtained in 126 (11%) refugees (all failed positive mitogen control). In multivariate analysis, younger age (linear OR = 0.93 [95% CI 0.91-0.95], P<0.001), iron deficiency anaemia (2.69 [1.51-4.80], P = 0.001), malaria infection (3.04 [1.51-6.09], P = 0.002), and helminth infection (2.26 [1.48-3.46], P<0.001), but not vitamin D deficiency or insufficiency, were associated with an indeterminate IGRA result. Conclusions: Younger age and a number of common co-morbidities are significantly and independently associated with indeterminate IGRA results in resettled predominantly African refugees.	[Banfield, Sally; Pascoe, Elaine; Siafarikas, Aris; Burgner, David] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Siafarikas, Aris] Princess Margaret Hosp Children, Perth, WA, Australia; [Siafarikas, Aris] Univ Notre Dame, Inst Hlth & Rehabil Res, Fremantle, WA, Australia; [Thambiran, Aesen] Migrant Hlth Unit, Perth, WA, Australia; [Pascoe, Elaine] Univ Queensland, Sch Med, Brisbane, Qld 4072, Australia; [Burgner, David] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	University of Western Australia; University of Western Australia; University of Notre Dame Australia; University of Queensland; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Banfield, S (corresponding author), Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia.	david.burgner@mcri.edu.au		Burgner, David/0000-0002-8304-4302; Pascoe, Elaine/0000-0003-1653-5803	National Health and Medical Research Council, Australia	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	No specific funding was sourced for this research. DB is supported by a Career Development Award from the National Health and Medical Research Council, Australia (www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, Commun Dis Intell Q Rep, V26, P238; Babu S, 2009, J INFECT DIS, V200, P288, DOI 10.1086/599797; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Bergamini BM, 2009, PEDIATRICS, V123, pe419, DOI 10.1542/peds.2008-1722; Cain KP, 2007, AM J RESP CRIT CARE, V175, P75, DOI 10.1164/rccm.200608-1178OC; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P269; Cherian S, 2007, ARCH DIS CHILD, V92, P983, DOI 10.1136/adc.2006.114801; Cherian S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004030; Chih DT, 2006, MED J AUSTRALIA, V185, P598, DOI 10.5694/j.1326-5377.2006.tb00723.x; Co DO, 2006, J IMMUNOL, V177, P8456, DOI 10.4049/jimmunol.177.12.8456; Connell TG, 2006, THORAX, V61, P616, DOI 10.1136/thx.2005.048033; Connell TG, 2010, PEDIATR INFECT DIS J, V29, P285, DOI 10.1097/INF.0b013e3181c4822f; Connell TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002624; DHUR A, 1989, COMP BIOCHEM PHYS A, V94, P11, DOI 10.1016/0300-9629(89)90776-7; Elias D, 2008, VACCINE, V26, P3897, DOI 10.1016/j.vaccine.2008.04.083; Enwere GC, 1999, ANN TROP MED PARASIT, V93, P669, DOI 10.1080/00034989957907; Gauvain S, 1948, TUBERCLE, P259; Glaziou P, 2011, B WORLD HEALTH ORGAN, V89, P573, DOI 10.2471/BLT.11.087510; Haustein T, 2009, PEDIATR INFECT DIS J, V28, P669, DOI 10.1097/INF.0b013e3181a16394; Herrera V, 2011, CLIN INFECT DIS, V52, P1031, DOI 10.1093/cid/cir068; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Jia Zhongwei, 2011, J Evid Based Med, V4, P48, DOI 10.1111/j.1756-5391.2011.01116.x; Khanh VQL, 2011, AM J MED SCI, V341, P493, DOI 10.1097/MAJ.0b013e3182070f47; Lucas M, 2010, THORAX, V65, P442, DOI 10.1136/thx.2009.127555; Mant D, 2007, LANCET, V369, P1493, DOI 10.1016/S0140-6736(07)60684-9; Marks GB, 2000, AM J RESP CRIT CARE, V162, P1851, DOI 10.1164/ajrccm.162.5.2004154; Martineau AR, 2010, EUR RESPIR J, V35, P1106, DOI 10.1183/09031936.00087009; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; McPherson ME, 2008, COMMUN DIS INTELL, V32, P237; MULLER K, 1993, IMMUNOL LETT, V35, P177, DOI 10.1016/0165-2478(93)90088-J; Murray RJ, 2009, MED J AUSTRALIA, V190, P421, DOI 10.5694/j.1326-5377.2009.tb02489.x; Mutch RC, 2011, J PAEDIAT C IN PRESS; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pearce EJ, 2004, IMMUNOL REV, V201, P117, DOI 10.1111/j.0105-2896.2004.00187.x; Potian JA, 2011, J EXP MED, V208, P1863, DOI 10.1084/jem.20091473; Rook GAW, 2009, IMMUNOLOGY, V126, P3, DOI 10.1111/j.1365-2567.2008.03007.x; Rowe J, 2001, J INFECT DIS, V184, P80, DOI 10.1086/320996; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Stephan C, 2008, AIDS, V22, P2471, DOI 10.1097/QAD.0b013e3283188415; Verver S, 2001, INT J TUBERC LUNG D, V5, P419; White GP, 2002, J IMMUNOL, V168, P2820, DOI 10.4049/jimmunol.168.6.2820; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6	43	43	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38556	10.1371/journal.pone.0038556	http://dx.doi.org/10.1371/journal.pone.0038556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701664	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340000031
J	Humbert, S; Zhong, SH; Deng, Y; Howell, SH; Rothstein, SJ				Humbert, Sabrina; Zhong, Sihui; Deng, Yan; Howell, Stephen H.; Rothstein, Steven J.			Alteration of the bZIP60/IRE1 Pathway Affects Plant Response to ER Stress in Arabidopsis thaliana	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; BIP; IRE1; ATBZIP60; ACCUMULATION; TOLERANCE; EFFICIENT	The Unfolded Protein Response (UPR) is elicited under cellular and environmental stress conditions that disrupt protein folding in the endoplasmic reticulum (ER). Through the transcriptional induction of genes encoding ER resident chaperones and proteins involved in folding, the pathway contributes to alleviating ER stress by increasing the folding capacity in the ER. Similarly to other eukaryotic systems, one arm of the UPR in Arabidopsis is set off by a non-conventional splicing event mediated by ribonuclease kinase IRE1b. The enzyme specifically targets mature bZIP60 RNA for cleavage, which results in a novel splice variant encoding a nuclear localized transcription factor. Although it is clear that this molecular switch widely affects the transcriptome, its exact role in overall plant response to stress has not been established and mutant approaches have not provided much insight. In this study, we took a transgenic approach to manipulate the pathway in positive and negative fashions. Our data show that the ER-resident chaperone BiP accumulates differentially depending on the level of activation of the pathway. In addition, phenotypes of the transgenic lines suggest that BiP accumulation is positively correlated with plant tolerance to chronic ER stress.	[Humbert, Sabrina; Zhong, Sihui; Rothstein, Steven J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Deng, Yan; Howell, Stephen H.] Iowa State Univ, Inst Plant Sci, Ames, IA USA	University of Guelph; Iowa State University	Humbert, S (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	shumbert@uoguelph.ca	Rothstein, Steven J/A-4947-2013	Rothstein, Steven J/0000-0003-0737-1878				Alvim FC, 2001, PLANT PHYSIOL, V126, P1042, DOI 10.1104/pp.126.3.1042; Chen Y, 2011, PLANT J; Cheng NH, 2003, PLANT CELL, V15, P347, DOI 10.1105/tpc.007385; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deng Y, 2011, P NATL ACAD SCI USA, V108, P7247, DOI 10.1073/pnas.1102117108; Gillikin JW, 1997, PLANT PHYSIOL, V114, P345, DOI 10.1104/pp.114.1.345; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Iwata Y, 2005, P NATL ACAD SCI USA, V102, P5280, DOI 10.1073/pnas.0408941102; Iwata Y, 2008, PLANT BIOTECHNOL, V25, P397, DOI 10.5511/plantbiotechnology.25.397; Iwata Y, 2009, BIOSCI BIOTECH BIOCH, V73, P865, DOI 10.1271/bbb.80779; Iwata Y, 2008, PLANT CELL, V20, P3107, DOI 10.1105/tpc.108.061002; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Jin H, 2009, P NATL ACAD SCI USA, V106, P13612, DOI 10.1073/pnas.0906144106; Kamauchi S, 2005, FEBS J, V272, P3461, DOI 10.1111/j.1742-4658.2005.04770.x; Koiwa H, 2003, PLANT CELL, V15, P2273, DOI 10.1105/tpc.013862; Koizumi N, 2001, PLANT PHYSIOL, V127, P949, DOI 10.1104/pp.010636; Liu JX, 2008, PLANT CELL ENVIRON, V31, P1735, DOI 10.1111/j.1365-3040.2008.01873.x; Lu DP, 2008, PHYSIOL PLANTARUM, V134, P360, DOI 10.1111/j.1399-3054.2008.01133.x; Lu DP, 2008, MOL GENET GENOMICS, V280, P199, DOI 10.1007/s00438-008-0356-z; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Maruyama D, 2010, P NATL ACAD SCI USA, V107, P1684, DOI 10.1073/pnas.0905795107; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Morris J, 2008, PLANT PHYSIOL, V148, P1474, DOI 10.1104/pp.108.118810; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; Noh SJ, 2003, GENE, V311, P81, DOI 10.1016/S0378-1119(03)00559-6; Noh SJ, 2002, BBA-GENE STRUCT EXPR, V1575, P130, DOI 10.1016/S0167-4781(02)00237-3; Pontier D, 2002, PLANT J, V30, P499, DOI 10.1046/j.1365-313X.2002.01307.x; Sung DY, 2001, PLANT PHYSIOL, V126, P789, DOI 10.1104/pp.126.2.789; Tajima H, 2008, BIOCHEM BIOPH RES CO, V374, P242, DOI 10.1016/j.bbrc.2008.07.021; Valente MAS, 2009, J EXP BOT, V60, P533, DOI 10.1093/jxb/ern296; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Yasuda H, 2009, PLANT CELL PHYSIOL, V50, P1532, DOI 10.1093/pcp/pcp098; Ye CM, 2011, PLANT PHYSIOL, V156, P741, DOI 10.1104/pp.111.174110; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145	34	34	38	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e39023	10.1371/journal.pone.0039023	http://dx.doi.org/10.1371/journal.pone.0039023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701744	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340000061
J	O'Brien, SP; DeLisa, MP				O'Brien, Sean P.; DeLisa, Matthew P.			Functional Reconstitution of a Tunable E3-Dependent Sumoylation Pathway in Escherichia coli	PLOS ONE			English	Article							SUMO E3 LIGASE; MASS-SPECTROMETRY; UBIQUITIN; NUCLEAR; PROTEIN; SMAD4; UBC9; CONJUGATION; SITES; PIASX	SUMO (small ubiquitin-related modifier) is a reversible post-translational protein modifier that alters the localization, activity, or stability of proteins to which it is attached. Many enzymes participate in regulated SUMO-conjugation and SUMO-deconjugation pathways. Hundreds of SUMO targets are currently known, with the majority being nuclear proteins. However, the dynamic and reversible nature of this modification and the large number of natively sumoylated proteins in eukaryotic proteomes makes molecular dissection of sumoylation in eukaryotic cells challenging. Here, we have reconstituted a complete mammalian SUMO-conjugation cascade in Escherichia coli cells that involves a functional SUMO E3 ligase, which effectively biases the sumoylation of both native and engineered substrate proteins. Our sumo-engineered E. coli cells have several advantages including efficient protein conjugation and physiologically relevant sumoylation patterns. Overall, this system provides a rapid and controllable platform for studying the enzymology of the entire sumoylation cascade directly in living cells.	[O'Brien, Sean P.; DeLisa, Matthew P.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA	Cornell University	O'Brien, SP (corresponding author), Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.	md255@cornell.edu	DeLisa, Matthew/AAE-7361-2019	DeLisa, Matthew/0000-0003-3226-1566	National Science Foundation Career Award [CBET-0449080]; New York State Office of Science, Technology and Academic Research Distinguished Faculty Award; Cornell Genomics Fellowship	National Science Foundation Career Award(National Science Foundation (NSF)); New York State Office of Science, Technology and Academic Research Distinguished Faculty Award; Cornell Genomics Fellowship	This work was supported by the National Science Foundation Career Award CBET-0449080 (to M. P. D.); the New York State Office of Science, Technology and Academic Research Distinguished Faculty Award (to M. P. D.); and a Cornell Genomics Fellowship (to S.P.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora T, 2003, J BIOL CHEM, V278, P21327, DOI 10.1074/jbc.C300119200; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Lee PSW, 2003, J BIOL CHEM, V278, P27853, DOI 10.1074/jbc.M301755200; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Liang M, 2004, J BIOL CHEM, V279, P22857, DOI 10.1074/jbc.M401554200; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Lin X, 2003, J BIOL CHEM, V278, P18714, DOI 10.1074/jbc.M302243200; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Liu B, 2001, P NATL ACAD SCI USA, V98, P3203, DOI 10.1073/pnas.051489598; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Mencia M, 2004, PROTEIN EXPRES PURIF, V37, P409, DOI 10.1016/j.pep.2004.07.001; Ohshima T, 2003, J BIOL CHEM, V278, P50833, DOI 10.1074/jbc.M307533200; Okada S, 2009, PLANT CELL PHYSIOL, V50, P1049, DOI 10.1093/pcp/pcp056; Pedrioli PGA, 2006, NAT METHODS, V3, P533, DOI 10.1038/NMETH891; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Roth W, 2004, J IMMUNOL, V173, P6189, DOI 10.4049/jimmunol.173.10.6189; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Santti H, 2005, J MOL ENDOCRINOL, V34, P645, DOI 10.1677/jme.1.01666; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Takahashi Y, 2005, J BIOL CHEM, V280, P35822, DOI 10.1074/jbc.M506794200; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Uchimura Y, 2004, FEBS LETT, V564, P85, DOI 10.1016/S0014-5793(04)00321-7; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; Wang YG, 2009, J CELL SCI, V122, P4249, DOI 10.1242/jcs.050542; Wilson VG, 2009, SUMO REGULATION OF CELLULAR PROCESSES, P1, DOI 10.1007/978-90-481-2649-1_1; Yang Y, 2007, ELECTROPHORESIS, V28, P2080, DOI 10.1002/elps.200600524; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013	42	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38671	10.1371/journal.pone.0038671	http://dx.doi.org/10.1371/journal.pone.0038671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701689	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340000039
J	Bonnefond, A; Philippe, J; Durand, E; Dechaume, A; Huyvaert, M; Montagne, L; Marre, M; Balkau, B; Fajardy, I; Vambergue, A; Vatin, V; Delplanque, J; Le Guilcher, D; De Graeve, F; Lecoeur, C; Sand, O; Vaxillaire, M; Froguel, P				Bonnefond, Amelie; Philippe, Julien; Durand, Emmanuelle; Dechaume, Aurelie; Huyvaert, Marlene; Montagne, Louise; Marre, Michel; Balkau, Beverley; Fajardy, Isabelle; Vambergue, Anne; Vatin, Vincent; Delplanque, Jerome; Le Guilcher, David; De Graeve, Franck; Lecoeur, Cecile; Sand, Olivier; Vaxillaire, Martine; Froguel, Philippe			Whole-Exome Sequencing and High Throughput Genotyping Identified KCNJ11 as the Thirteenth MODY Gene	PLOS ONE			English	Article							NEONATAL DIABETES-MELLITUS; INSULIN GENE; YOUNG MODY; RARE CAUSE; MUTATIONS; ONSET; CHILDHOOD; ADULTHOOD; FAMILIES; INS	Background: Maturity-onset of the young (MODY) is a clinically heterogeneous form of diabetes characterized by an autosomal-dominant mode of inheritance, an onset before the age of 25 years, and a primary defect in the pancreatic beta-cell function. Approximately 30% of MODY families remain genetically unexplained (MODY-X). Here, we aimed to use whole-exome sequencing (WES) in a four-generation MODY-X family to identify a new susceptibility gene for MODY. Methodology: WES (Agilent-SureSelect capture/Illumina-GAIIx sequencing) was performed in three affected and one non-affected relatives in the MODY-X family. We then performed a high-throughput multiplex genotyping (Illumina-GoldenGate assay) of the putative causal mutations in the whole family and in 406 controls. A linkage analysis was also carried out. Principal Findings: By focusing on variants of interest (i.e. gains of stop codon, frameshift, non-synonymous and splice-site variants not reported in dbSNP130) present in the three affected relatives and not present in the control, we found 69 mutations. However, as WES was not uniform between samples, a total of 324 mutations had to be assessed in the whole family and in controls. Only one mutation (p. Glu227Lys in KCNJ11) co-segregated with diabetes in the family (with a LOD-score of 3.68). No KCNJ11 mutation was found in 25 other MODY-X unrelated subjects. Conclusions/Significance: Beyond neonatal diabetes mellitus (NDM), KCNJ11 is also a MODY gene ('MODY13'), confirming the wide spectrum of diabetes related phenotypes due to mutations in NDM genes (i.e. KCNJ11, ABCC8 and INS). Therefore, the molecular diagnosis of MODY should include KCNJ11 as affected carriers can be ideally treated with oral sulfonylureas.	[Bonnefond, Amelie; Philippe, Julien; Durand, Emmanuelle; Dechaume, Aurelie; Huyvaert, Marlene; Montagne, Louise; Vatin, Vincent; Delplanque, Jerome; Le Guilcher, David; De Graeve, Franck; Lecoeur, Cecile; Sand, Olivier; Vaxillaire, Martine; Froguel, Philippe] Lille Pasteur Inst, CNRS UMR8199, Lille, France; [Bonnefond, Amelie; Philippe, Julien; Durand, Emmanuelle; Dechaume, Aurelie; Huyvaert, Marlene; Montagne, Louise; Fajardy, Isabelle; Vambergue, Anne; Vatin, Vincent; Delplanque, Jerome; Le Guilcher, David; De Graeve, Franck; Lecoeur, Cecile; Sand, Olivier; Vaxillaire, Martine; Froguel, Philippe] Lille Nord France Univ, Lille, France; [Montagne, Louise] Catholic Univ Lille, St Vincent de Paul Hosp, St Antoine Pediat Hosp, Dept Pediat, Lille, France; [Marre, Michel] Bichat Claude Bernard Univ Hosp, AP HP, Dept Endocrinol Diabetol & Nutr, Paris, France; [Marre, Michel] Univ Paris 07, Inserm U695, Paris, France; [Balkau, Beverley] Ctr Res Epidemiol & Populat Hlth, Inserm U1018, Villejuif, France; [Balkau, Beverley] Univ Paris 11, Villejuif, France; [Vambergue, Anne] Huriez Hosp, CHRU Lille, Dept Diabetol, EA Perinatal Environm & Fetal Growth 4489, Lille, France; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Publ Hlth, Dept Genom Common Dis, London, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Universite de Lille - ISITE; CHU Lille; Imperial College London	Bonnefond, A (corresponding author), Lille Pasteur Inst, CNRS UMR8199, Lille, France.	p.froguel@imperial.ac.uk	Philippe, Julien/R-5183-2019; FROGUEL, Philippe/O-6799-2017; Bonnefond, Amélie/O-2784-2017	FROGUEL, Philippe/0000-0003-2972-0784; Bonnefond, Amélie/0000-0001-9976-3005; Marre, Michel/0000-0002-3071-1837; Philippe, Julien/0000-0003-1906-7259; Sand, Olivier/0000-0003-1465-1640	transnational European research grant on Rare Diseases [ERANET-09-RARE-005]; French Agence Nationale de la Recherche [ANR-10-LABX-46, ANR-10-EQPX-07-01]	transnational European research grant on Rare Diseases; French Agence Nationale de la Recherche(French National Research Agency (ANR))	The study was supported by the transnational European research grant on Rare Diseases (ERANET-09-RARE-005) and by the French Agence Nationale de la Recherche (ANR-10-LABX-46 and ANR-10-EQPX-07-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Bryan L, 2008, ENDOCR REV, V29, P265, DOI 10.1210/er.2007-0029; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Babenko AP, 1998, ANNU REV PHYSIOL, V60, P667, DOI 10.1146/annurev.physiol.60.1.667; Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Boesgaard TW, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-42; Bonnefond A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013630; Bonnefond A, 2010, TRENDS MOL MED, V16, P407, DOI 10.1016/j.molmed.2010.06.004; Bowman P, 2012, DIABETOLOGIA, V55, P123, DOI 10.1007/s00125-011-2319-x; Chevre JC, 1998, DIABETOLOGIA, V41, P1017, DOI 10.1007/s001250051025; D'Amato E, 2008, DIABETIC MED, V25, P651, DOI 10.1111/j.1464-5491.2008.02443.x; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Edghill EL, 2007, J CLIN ENDOCR METAB, V92, P1773, DOI 10.1210/jc.2006-2817; Fajans SS, 2011, DIABETES CARE, V34, P1878, DOI 10.2337/dc11-0035; Flanagan SE, 2007, DIABETES, V56, P1930, DOI 10.2337/db07-0043; Frayling TM, 2003, DIABETES, V52, P872, DOI 10.2337/diabetes.52.3.872; Girard CAJ, 2006, PFLUG ARCH EUR J PHY, V453, P323, DOI 10.1007/s00424-006-0112-3; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Iafusco D, 2011, DIABETOLOGIA, V54, P2736, DOI 10.1007/s00125-011-2273-7; Kochar IPS, 2010, INDIAN PEDIATR, V47, P359; Landau Z, 2007, J PEDIATR-US, V150, P553, DOI 10.1016/j.jpeds.2007.03.004; Meur G, 2010, DIABETES, V59, P653, DOI 10.2337/db09-1091; Molven A, 2008, DIABETES, V57, P1131, DOI 10.2337/db07-1467; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Rica I, 2007, DIABETIC MED, V24, P707, DOI 10.1111/j.1464-5491.2007.02140.x; Riveline JP, 2012, DIABETES CARE, V35, P248, DOI 10.2337/dc11-1469; Stoy J, 2008, PEDIATR DIABETES, V9, P450, DOI 10.1111/j.1399-5448.2008.00433.x; VAXILLAIRE M, 1995, NAT GENET, V9, P418, DOI 10.1038/ng0495-418; Vaxillaire M, 2006, ENDOCRIN METAB CLIN, V35, P371, DOI 10.1016/j.ecl.2006.02.009; Yorifuji T, 2005, J CLIN ENDOCR METAB, V90, P3174, DOI 10.1210/jc.2005-0096	31	138	149	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e37423	10.1371/journal.pone.0037423	http://dx.doi.org/10.1371/journal.pone.0037423			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701567	Green Submitted, Green Published, gold			2022-12-25	WOS:000305337600008
J	Boudjenah, R; Molina-Gomes, D; Torre, A; Bergere, M; Bailly, M; Boitrelle, F; Taieb, S; Wainer, R; Benahmed, M; de Mazancourt, P; Selva, J; Vialard, F				Boudjenah, Radia; Molina-Gomes, Denise; Torre, Antoine; Bergere, Marianne; Bailly, Marc; Boitrelle, Florence; Taieb, Stephane; Wainer, Robert; Benahmed, Mohamed; de Mazancourt, Philippe; Selva, Jacqueline; Vialard, Francois			Genetic Polymorphisms Influence the Ovarian Response to rFSH Stimulation in Patients Undergoing In Vitro Fertilization Programs with ICSI	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; ESTROGEN-RECEPTOR-BETA; LEUKEMIA INHIBITORY FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ENDOTHELIAL GROWTH-FACTOR; HUMAN OOCYTES INVITRO; IMPLANTATION FAILURE; EMBRYO IMPLANTATION; REDUCTASE MTHFR; WOMEN	Introduction: Obtaining an adequate number of high-quality oocytes is a major challenge in controlled ovarian hyperstimulation (COH). To date, a range of hormonal and clinical parameters have been used to optimize COH but none have significant predictive value. This variability could be due to the genetic predispositions of single-nucleotide polymorphisms (SNPs). Here, we assessed the individual and combined impacts of thirteen SNPs that reportedly influence the outcome of in vitro fertilisation (IVF) on the ovarian response to rFSH stimulation for patients undergoing intracytoplasmic sperm injection program (ICSI). Results: Univariate analysis revealed that only FSHR, ESR2 and p53 SNPs influenced the number of mature oocytes. The association was statistically significant for FSHR (p = 0.0047) and ESR2 (0.0017) in the overall study population and for FSHR (p = 0.0009) and p53 (p = 0.0048) in subgroup that was more homogeneous in terms of clinical variables. After Bonferroni correction and a multivariate analysis, only the differences for FSHR and ESR2 polymorphisms were still statistically significant. In a multilocus analysis, only the FSHR and AMH SNP combination significantly influenced oocyte numbers in both population (p < 0.01). Discussion: We confirmed the impact of FSHR and ESR2 polymorphisms on the IVF outcome. Furthermore, we showed for the first time that a p53 polymorphism (which is already known to impact embryo implantation) could influence the ovarian response. However, given that this result lost its statistical significance after multivariate analysis, more data are needed to draw firm conclusions. Only the FSHR and AMH polymorphism combination appears to influence mature oocyte numbers but this finding also needs to be confirmed. Materials and Methods: A 13 gene polymorphisms: FSHR(Asn680Ser), p53(Arg72Pro), AMH(Ile49Ser), ESR2(+1730G>A), ESR1(-397T>C), BMP15(-9C>G), MTHFR1(677C>T), MTHFR2(1298A>C), HLA-G(-725C>G), VEGF(+405G>C), TNF alpha(-308A>G), AMHR(-482 A>G), PAI-1 (4 G/5 G), multiplex PCR assay was designed to genotype women undergoing ICSI program. We analyzed the overall study population (n = 427) and a subgroup with homogeneous characteristics (n = 112).	[Boudjenah, Radia; Molina-Gomes, Denise; Torre, Antoine; Bergere, Marianne; Bailly, Marc; Boitrelle, Florence; Wainer, Robert; Selva, Jacqueline; Vialard, Francois] Poissy St Germain Med Ctr, Dept Reprod Biol Cytogenet Gynaecol & Obstet, Poissy, France; [Boudjenah, Radia; Molina-Gomes, Denise; Torre, Antoine; Bergere, Marianne; Bailly, Marc; Boitrelle, Florence; Taieb, Stephane; Wainer, Robert; de Mazancourt, Philippe; Selva, Jacqueline; Vialard, Francois] Versailles St Quentin Univ, EA 2493, Versailles, France; [Benahmed, Mohamed] Nice Univ Hosp, Dept Reprod Biol, Nice, France	UDICE-French Research Universities; Universite Paris Saclay; CHU Nice	Boudjenah, R (corresponding author), Poissy St Germain Med Ctr, Dept Reprod Biol Cytogenet Gynaecol & Obstet, Poissy, France.	boudjenahradia@yahoo.fr; fvialard@chi-psg.com		BOITRELLE, Florence/0000-0002-5322-0141; Vialard, Francois/0000-0002-5774-2756	FARO (Fonds d'Aide a la Recherche Organon); AMMR-PSG (Association Maternite et Medecine de la Reproduction-Poissy St Germain en Laye)	FARO (Fonds d'Aide a la Recherche Organon); AMMR-PSG (Association Maternite et Medecine de la Reproduction-Poissy St Germain en Laye)	Grants have been obtained by Radia Boudjenah for her PhD and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Grants were obtained from the FARO (Fonds d'Aide a la Recherche Organon) and AMMR-PSG (Association Maternite et Medecine de la Reproduction-Poissy St Germain en Laye). No additional external funding was received for this study.	Achrekar SK, 2009, FERTIL STERIL, V91, P432, DOI 10.1016/j.fertnstert.2007.11.093; Aghajanova L, 2004, ANN NY ACAD SCI, V1034, P176, DOI 10.1196/annals.1335.020; Altmae S, 2011, HUM REPROD UPDATE, V17, P813, DOI 10.1093/humupd/dmr034; Altmae S, 2007, MOL HUM REPROD, V13, P521, DOI 10.1093/molehr/gam035; Anagnostou E, CURR PHARM BIOTECHNO; Azem F, 2004, HUM REPROD, V19, P368, DOI 10.1093/humrep/deh069; Behre HM, 2005, PHARMACOGENET GENOM, V15, P451, DOI 10.1097/01.fpc.0000167330.92786.5e; BOTERORUIZ W, 1984, FERTIL STERIL, V41, P820; Byers M, 1997, MOL ENDOCRINOL, V11, P172, DOI 10.1210/me.11.2.172; Carlsson IB, 2006, HUM REPROD, V21, P2223, DOI 10.1093/humrep/del165; Conway GS, 1999, CLIN ENDOCRINOL, V51, P97, DOI 10.1046/j.1365-2265.1999.00745.x; Coulam CB, 2006, AM J REPROD IMMUNOL, V55, P360, DOI 10.1111/j.1600-0897.2006.00376.x; Daelemans C, 2004, J CLIN ENDOCR METAB, V89, P6310, DOI 10.1210/jc.2004-1044; de Castro F, 2004, PHARMACOGENETICS, V14, P285, DOI 10.1097/00008571-200405000-00003; de Castro F, 2003, FERTIL STERIL, V80, P571, DOI 10.1016/S0015-0282(03)00795-7; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Drummond AE, 1999, MOL CELL ENDOCRINOL, V151, P57, DOI 10.1016/S0303-7207(99)00038-6; Durlinger ALL, 2002, REPRODUCTION, V124, P601, DOI 10.1530/reprod/124.5.601; Durlinger ALL, 2001, ENDOCRINOLOGY, V142, P4891, DOI 10.1210/en.142.11.4891; Ficicioglu C, 2006, FERTIL STERIL, V85, P592, DOI 10.1016/j.fertnstert.2005.09.019; FISHEL SB, 1983, J ENDOCRINOL, V99, P335, DOI 10.1677/joe.0.0990335; Gigli I, 2005, MOL REPROD DEV, V71, P480, DOI 10.1002/mrd.20338; Goodman C, 2008, REPROD BIOMED ONLINE, V16, P720, DOI 10.1016/S1472-6483(10)60487-7; Grady R, 2012, FERTIL STERIL, V97, P324, DOI 10.1016/j.fertnstert.2011.11.033; Greb RR, 2005, REPROD BIOMED ONLINE, V11, P589, DOI 10.1016/S1472-6483(10)61167-4; Greb RR, 2005, J CLIN ENDOCR METAB, V90, P4866, DOI 10.1210/jc.2004-2268; Haggarty P, 2006, LANCET, V367, P1513, DOI 10.1016/S0140-6736(06)68651-0; Hanevik HI, REPROD BIOMED ONLINE, V21, P616; Hegele-Hartung C, 2004, P NATL ACAD SCI USA, V101, P5129, DOI 10.1073/pnas.0306720101; Hendriks DJ, 2005, FERTIL STERIL, V83, P291, DOI 10.1016/j.fertnstert.2004.10.011; Hofmann GE, 1998, FERTIL STERIL, V69, P474, DOI 10.1016/S0015-0282(97)00531-1; HOLM S, 1979, SCAND J STAT, V6, P65; IRELAND JJ, 1978, ENDOCRINOLOGY, V102, P876, DOI 10.1210/endo-102-3-876; Jun JK, 2006, J HUM GENET, V51, P665, DOI 10.1007/s10038-006-0005-5; Kang HJ, 2008, FERTIL STERIL, V92, pS21; Kay C, 2006, REPROD BIOMED ONLINE, V13, P492, DOI 10.1016/S1472-6483(10)60635-9; Kevenaar ME, 2008, J CLIN ENDOCR METAB, V93, P1310, DOI 10.1210/jc.2007-2205; Kevenaar ME, 2007, HUM REPROD, V22, P1547, DOI 10.1093/humrep/dem036; Klinkert ER, 2006, REPROD BIOMED ONLINE, V13, P687, DOI 10.1016/S1472-6483(10)60660-8; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Laird SM, 1997, HUM REPROD, V12, P569; Laven JSE, 2003, FERTIL STERIL, V80, P986, DOI 10.1016/S0015-0282(03)01115-4; LICCIARDI FL, 1995, FERTIL STERIL, V64, P991, DOI 10.1016/S0015-0282(16)57916-3; Loutradis D, 2006, GYNECOL OBSTET INVES, V61, P56, DOI 10.1159/000088658; Martinelli I, 2003, HAEMATOLOGICA, V88, P789; Mayorga MP, 2000, J CLIN ENDOCR METAB, V85, P3365, DOI 10.1210/jc.85.9.3365; Mikolajczyk M, 2007, AM J REPROD IMMUNOL, V58, P65, DOI 10.1111/j.1600-0897.2007.00492.x; Moron FJ, 2006, PHARMACOGENET GENOM, V16, P485, DOI 10.1097/01.fpc.0000215073.44589.96; Ocal P, 2004, EUR J OBSTET GYN R B, V115, P194, DOI 10.1016/j.ejogrb.2004.01.034; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Putnik M, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-55; Rosen MP, 2007, FERTIL STERIL, V88, P632, DOI 10.1016/j.fertnstert.2006.11.165; Roussev RG, 2007, J ASSIST REPROD GEN, V24, P288, DOI 10.1007/s10815-007-9148-3; SCHWARTZ D, 1982, NEW ENGL J MED, V306, P404, DOI 10.1056/NEJM198202183060706; SCOTT RT, 1989, FERTIL STERIL, V51, P651; SCOTT RT, 1990, FERTIL STERIL, V54, P297; Scully KM, 1997, MOL ENDOCRINOL, V11, P674, DOI 10.1210/me.11.6.674; Simoni M, 2002, HUM REPROD UPDATE, V8, P413, DOI 10.1093/humupd/8.5.413; Srouji SS, 2005, FERTIL STERIL, V84, P795, DOI 10.1016/j.fertnstert.2005.02.042; Sudo S, 2002, MOL HUM REPROD, V8, P893, DOI 10.1093/molehr/8.10.893; Sundarrajan C, 2001, J CLIN ENDOCR METAB, V86, P135, DOI 10.1210/jc.86.1.135; Sundarrajan C, 1999, MOL HUM REPROD, V5, P797, DOI 10.1093/molehr/5.9.797; Thaler CJ, 2006, AM J REPROD IMMUNOL, V55, P251, DOI 10.1111/j.1600-0897.2005.00357.x; Vialard F, INCREASED EMBR UNPUB; Visser JA, 2007, ENDOCRINOLOGY, V148, P2301, DOI 10.1210/en.2006-1265; Windahl SH, 2002, TRENDS ENDOCRIN MET, V13, P195, DOI 10.1016/S1043-2760(02)00594-5	66	54	74	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38700	10.1371/journal.pone.0038700	http://dx.doi.org/10.1371/journal.pone.0038700			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701696	Green Published, Green Submitted, gold			2022-12-25	WOS:000305337600038
J	Urasaki, Y; Johlfs, MG; Fiscus, RR; Le, TT				Urasaki, Yasuyo; Johlfs, Mary G.; Fiscus, Ronald R.; Le, Thuc T.			Imaging Immune and Metabolic Cells of Visceral Adipose Tissues with Multimodal Nonlinear Optical Microscopy	PLOS ONE			English	Article							LIPID DROPLETS; OBESITY; INFLAMMATION; FLUORESCENCE; MACROPHAGES; LIPOLYSIS; PROTEINS; CANCER	Visceral adipose tissue (VAT) inflammation is recognized as a mechanism by which obesity is associated with metabolic diseases. The communication between adipose tissue macrophages (ATMs) and adipocytes is important to understanding the interaction between immunity and energy metabolism and its roles in obesity-induced diseases. Yet visualizing adipocytes and macrophages in complex tissues is challenging to standard imaging methods. Here, we describe the use of a multimodal nonlinear optical (NLO) microscope to characterize the composition of VATs of lean and obese mice including adipocytes, macrophages, and collagen fibrils in a label-free manner. We show that lipid metabolism processes such as lipid droplet formation, lipid droplet microvesiculation, and free fatty acids trafficking can be dynamically monitored in macrophages and adipocytes. With its versatility, NLO microscopy should be a powerful imaging tool to complement molecular characterization of the immunity-metabolism interface.	[Urasaki, Yasuyo; Le, Thuc T.] Desert Res Inst, Human Hlth & Environm Program, Las Vegas, NV USA; [Urasaki, Yasuyo; Le, Thuc T.] Nevada Canc Inst, Dept Drug Dev, Las Vegas, NV USA; [Johlfs, Mary G.; Fiscus, Ronald R.] Roseman Univ Hlth Sci, Ctr Diabet & Obes Prevent Treatment Res & Educ, Henderson, NV USA; [Johlfs, Mary G.; Fiscus, Ronald R.] Roseman Univ Hlth Sci, Coll Pharm, Henderson, NV USA	Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; University of California System; University of California San Diego	Urasaki, Y (corresponding author), Desert Res Inst, Human Hlth & Environm Program, Las Vegas, NV USA.	thuc.le@dri.edu			Nevada INBRE Program of the National Center for Research Resources [P20RR-016464]; American Cancer Society [IRG-08-062-04]; Vons Breast Cancer Research Award; Roseman University of Health Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER	Nevada INBRE Program of the National Center for Research Resources; American Cancer Society(American Cancer Society); Vons Breast Cancer Research Award; Roseman University of Health Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a Nevada INBRE Program of the National Center for Research Resources (P20RR-016464, TTL), the American Cancer Society (IRG-08-062-04, TTL), the Vons Breast Cancer Research Award (TTL), and startup funding from Roseman University of Health Sciences (RRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariotti N, 2012, MOL BIOL CELL, V23, P1826, DOI 10.1091/mbc.E11-10-0847; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Engeli S, 2004, J LIPID RES, V45, P1640, DOI 10.1194/jlr.M300322-JLR200; Fiscus RR, 2012, PROTEIN KIN IN PRESS, V68; Fiscus RR, 2012, OVARIAN CANC BASIC S, P315; Fukumura D, 2003, CIRC RES, V93, pE88, DOI 10.1161/01.RES.0000099243.20096.FA; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X; JEFFERIES WA, 1985, J EXP MED, V162, P117, DOI 10.1084/jem.162.1.117; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Le TT, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2795437; Le TT, 2007, MOL IMAGING, V6, P205, DOI 10.2310/7290.2007.00018; Le TT, 2010, J LIPID RES, V51, P3091, DOI 10.1194/jlr.R008730; Le TT, 2010, J LIPID RES, V51, P672, DOI 10.1194/jlr.D000638; Le TT, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-42; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Paar M, 2012, J BIOL CHEM, V287, P11164, DOI 10.1074/jbc.M111.316794; Slipchenko MN, 2009, J PHYS CHEM B, V113, P7681, DOI 10.1021/jp902231y; SMITH MJ, 1987, J CELL SCI, V87, P113; Stahl A, 2001, TRENDS ENDOCRIN MET, V12, P266, DOI 10.1016/S1043-2760(01)00427-1; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Yan HY, 2002, J LIPID RES, V43, P2123, DOI 10.1194/jlr.M200305-JLR200; Yen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012810; Zhu JB, 2009, J LIPID RES, V50, P1080, DOI 10.1194/jlr.M800555-JLR200; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100	37	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38418	10.1371/journal.pone.0038418	http://dx.doi.org/10.1371/journal.pone.0038418			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701636	Green Published, gold, Green Submitted			2022-12-25	WOS:000305337600022
J	Claus, J; Chavarria-Krauser, A				Claus, Juliane; Chavarria-Krauser, Andres			Modeling Regulation of Zinc Uptake via ZIP Transporters in Yeast and Plant Roots	PLOS ONE			English	Article							ZAP1 TRANSCRIPTIONAL ACTIVATOR; MOLECULAR-MECHANISMS; HIGH-AFFINITY; GENE ENCODES; ARABIDOPSIS; HOMEOSTASIS; ADAPTATION; HYPERACCUMULATION; TOLERANCE; SENSORS	In yeast (Saccharomyces cerevisiae) and plant roots (Arabidopsis thaliana) zinc enters the cells via influx transporters of the ZIP family. Since zinc is both essential for cell function and toxic at high concentrations, tight regulation is essential for cell viability. We provide new insight into the underlying mechanisms, starting from a general model based on ordinary differential equations and adapting it to the specific cases of yeast and plant root cells. In yeast, zinc is transported by the transporters ZRT1 and ZRT2, which are both regulated by the zinc-responsive transcription factor ZAP1. Using biological data, parameters were estimated and analyzed, confirming the different affinities of ZRT1 and ZRT2 reported in the literature. Furthermore, our model suggests that the positive feedback in ZAP1 production has a stabilizing function at high influx rates. In plant roots, various ZIP transporters play a role in zinc uptake. Their regulation is largely unknown, but bZIP transcription factors are thought to be involved. We set up three putative models based on: an activator only, an activator with dimerization and an activator-inhibitor pair. These were fitted to measurements and analyzed. Simulations show that the activator-inhibitor model outperforms the other two in providing robust and stable homeostasis at reasonable parameter ranges.	[Claus, Juliane; Chavarria-Krauser, Andres] Heidelberg Univ, Ctr Modelling & Simulat Biosci, Heidelberg, Germany; [Claus, Juliane; Chavarria-Krauser, Andres] Heidelberg Univ, Interdisciplinary Ctr Sci Comp, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Claus, J (corresponding author), Heidelberg Univ, Ctr Modelling & Simulat Biosci, Heidelberg, Germany.	andres.chavarria@bioquant.uni-heidelberg.de			German Research Foundation [CH 958/1-1]	German Research Foundation(German Research Foundation (DFG))	This work was funded by the German Research Foundation grant number CH 958/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2002, MOL BIOL CELL; Assuncao AGL, 2010, PLANT SIGNAL BEHAV, V5, P1553, DOI 10.4161/psb.5.12.13469; Assuncao AGL, 2010, P NATL ACAD SCI USA, V107, P10296, DOI 10.1073/pnas.1004788107; Bevington P.R., 2003, DATA REDUCTION ERROR; Bird AJ, 2004, EMBO J, V23, P1123, DOI 10.1038/sj.emboj.7600122; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Cakmak I, 2000, NEW PHYTOL, V146, P185, DOI 10.1046/j.1469-8137.2000.00630.x; Chaney RL, 1997, CURR OPIN BIOTECH, V8, P279, DOI 10.1016/S0958-1669(97)80004-3; Clemens S, 2001, PLANTA, V212, P475, DOI 10.1007/s004250000458; Cook DL, 1998, P NATL ACAD SCI USA, V95, P15641, DOI 10.1073/pnas.95.26.15641; Deppmann CD, 2006, MOL BIOL EVOL, V23, P1480, DOI 10.1093/molbev/msl022; Dittmer PJ, 2009, J BIOL CHEM, V284, P16289, DOI 10.1074/jbc.M900501200; Eide DJ, 2003, J NUTR, V133, p1532S, DOI 10.1093/jn/133.5.1532S; GEGENFURTNER KR, 1992, BEHAV RES METH INSTR, V24, P560, DOI 10.3758/BF03203605; Gitan RS, 2003, J BIOL CHEM, V278, P39558, DOI 10.1074/jbc.M302760200; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Hacisalihoglu G, 2001, PLANT PHYSIOL, V125, P456, DOI 10.1104/pp.125.1.456; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jolma IW, 2010, BIOPHYS J, V98, P743, DOI 10.1016/j.bpj.2009.11.013; Keener J., 2009, MATH PHYSL, V1; Macnair MR, 1999, P ROY SOC B-BIOL SCI, V266, P2175, DOI 10.1098/rspb.1999.0905; Ni XY, 2009, BIOPHYS J, V97, P1244, DOI 10.1016/j.bpj.2009.06.030; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Palmer CM, 2009, NAT CHEM BIOL, V5, P333, DOI 10.1038/nchembio.166; Schutze K, 2008, TRENDS PLANT SCI, V13, P247, DOI 10.1016/j.tplants.2008.03.002; Sommer AL, 1926, PLANT PHYSIOL, V1, P231, DOI 10.1104/pp.1.3.231; Talke IN, 2006, PLANT PHYSIOL, V142, P148, DOI 10.1104/pp.105.076232; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/NMETH.1368, 10.1038/nmeth.1368]; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Zhao FJ, 2000, PLANT CELL ENVIRON, V23, P507, DOI 10.1046/j.1365-3040.2000.00569.x; Zhao H, 1998, J BIOL CHEM, V273, P28713, DOI 10.1074/jbc.273.44.28713; Zhao H, 1996, J BIOL CHEM, V271, P23203, DOI 10.1074/jbc.271.38.23203; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	34	16	16	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e37193	10.1371/journal.pone.0037193	http://dx.doi.org/10.1371/journal.pone.0037193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715365	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336800006
J	Cardanobile, S; Pernice, V; Deger, M; Rotter, S				Cardanobile, Stefano; Pernice, Volker; Deger, Moritz; Rotter, Stefan			Inferring General Relations between Network Characteristics from Specific Network Ensembles	PLOS ONE			English	Article							SMALL-WORLD; SYNCHRONIZATION	Different network models have been suggested for the topology underlying complex interactions in natural systems. These models are aimed at replicating specific statistical features encountered in real-world networks. However, it is rarely considered to which degree the results obtained for one particular network class can be extrapolated to real-world networks. We address this issue by comparing different classical and more recently developed network models with respect to their ability to generate networks with large structural variability. In particular, we consider the statistical constraints which the respective construction scheme imposes on the generated networks. After having identified the most variable networks, we address the issue of which constraints are common to all network classes and are thus suitable candidates for being generic statistical laws of complex networks. In fact, we find that generic, not model-related dependencies between different network characteristics do exist. This makes it possible to infer global features from local ones using regression models trained on networks with high generalization power. Our results confirm and extend previous findings regarding the synchronization properties of neural networks. Our method seems especially relevant for large networks, which are difficult to map completely, like the neural networks in the brain. The structure of such large networks cannot be fully sampled with the present technology. Our approach provides a method to estimate global properties of under-sampled networks in good approximation. Finally, we demonstrate on three different data sets (C. elegans neuronal network, R. prowazekii metabolic network, and a network of synonyms extracted from Roget's Thesaurus) that real-world networks have statistical relations compatible with those obtained using regression models.	[Cardanobile, Stefano; Pernice, Volker; Deger, Moritz; Rotter, Stefan] Univ Freiburg, Bernstein Ctr Freiburg, D-79106 Freiburg, Germany; [Cardanobile, Stefano; Pernice, Volker; Deger, Moritz; Rotter, Stefan] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Cardanobile, S (corresponding author), Univ Freiburg, Bernstein Ctr Freiburg, Hugstetter Str 55, D-79106 Freiburg, Germany.	stefan.rotter@biologie.uni-freiburg.de		Deger, Moritz/0000-0002-2775-2611	German Federal Ministry of Education and Research (BMBF) [01GQ0420, 01GQ0830, 01GW0730]; German Research Foundation (DFG) [CRC 780]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG))	Supported by the German Federal Ministry of Education and Research (BMBF; grant 01GQ0420 "BCCN Freiburg", grant 01GQ0830 "BFNT Freiburg*Tubingen", grant 01GW0730 "Impulse Control"), and the German Research Foundation (DFG; CRC 780, subproject C4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Artzy-Randrup Yael, 2004, Science, V305, P1107; Atay FM, 2006, PHYSICA D, V224, P35, DOI 10.1016/j.physd.2006.09.018; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batagelj V., PAJEK DATASETS; Bianconi G, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/28005; Bogacz L, 2006, PHYSICA A; Boguna M, 2009, NAT PHYS, V5, P74, DOI 10.1038/NPHYS1130; Chen WL, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00014; Chung F., 2002, ANN COMB, V6, P125, DOI [10.1007/PL00012580, 10.1007/PL00012580.pdf, DOI 10.1007/PL00012580.PDF]; Erdos P, 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Gerhard F, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI [10.3389/fncom.2011.00004, 10.3389/fncom.2011.00023]; Grabow C, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/48002; Jarvis Sarah, 2010, Front Neuroinform, V4, DOI 10.3389/fninf.2010.00011; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kotter R, 2000, PHILOS T ROY SOC B, V355, P127, DOI 10.1098/rstb.2000.0553; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Lovasz L, 2006, J COMB THEORY B, V96, P933, DOI 10.1016/j.jctb.2006.05.002; Maki-Marttunen T, 2011, FRONT COMPUT NEUROSC, V5, P1; McGraw P, 2005, PHYS REV E, V72, P1; Milo R, 2004, SCIENCE, V305; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Palla G, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/02/P02003; Palla G, 2010, P NATL ACAD SCI USA, V107, P7640, DOI 10.1073/pnas.0912983107; Prettejohn BJ, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI 10.3389/fncom.2011.00011; Rocha LEC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001109; Roxin A, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI 10.3389/fncom.2011.00008; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sporns O, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00005; Tarjan R., 1972, SIAM Journal on Computing, V1, P146, DOI 10.1137/0201010; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu XY, 2008, PHYSICA A, V387, P623, DOI 10.1016/j.physa.2007.09.039; Zhan CJ, 2010, PHYSICA A, V389, P1779, DOI 10.1016/j.physa.2009.12.005; Zhao L, 2011, FRONT COMPUT NEUROSC, V5	43	5	5	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37911	10.1371/journal.pone.0037911	http://dx.doi.org/10.1371/journal.pone.0037911			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701586	gold, Green Published, Green Submitted			2022-12-25	WOS:000305348400024
J	Mongeau, JM; McRae, B; Jusufi, A; Birkmeyer, P; Hoover, AM; Fearing, R; Full, RJ				Mongeau, Jean-Michel; McRae, Brian; Jusufi, Ardian; Birkmeyer, Paul; Hoover, Aaron M.; Fearing, Ronald; Full, Robert J.			Rapid Inversion: Running Animals and Robots Swing like a Pendulum under Ledges	PLOS ONE			English	Article							ROTATIONAL INERTIA; LOCOMOTION; WALKING; MODEL; BEHAVIOR; MECHANICS; MOVEMENTS; MANEUVERS; DYNAMICS; COST	Escaping from predators often demands that animals rapidly negotiate complex environments. The smallest animals attain relatively fast speeds with high frequency leg cycling, wing flapping or body undulations, but absolute speeds are slow compared to larger animals. Instead, small animals benefit from the advantages of enhanced maneuverability in part due to scaling. Here, we report a novel behavior in small, legged runners that may facilitate their escape by disappearance from predators. We video recorded cockroaches and geckos rapidly running up an incline toward a ledge, digitized their motion and created a simple model to generalize the behavior. Both species ran rapidly at 12-15 body lengths-per-second toward the ledge without braking, dove off the ledge, attached their feet by claws like a grappling hook, and used a pendulum-like motion that can exceed one meter-per-second to swing around to an inverted position under the ledge, out of sight. We discovered geckos in Southeast Asia can execute this escape behavior in the field. Quantification of these acrobatic behaviors provides biological inspiration toward the design of small, highly mobile search-and-rescue robots that can assist us during natural and human-made disasters. We report the first steps toward this new capability in a small, hexapedal robot.	[Mongeau, Jean-Michel] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [McRae, Brian] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Jusufi, Ardian; Full, Robert J.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Birkmeyer, Paul; Fearing, Ronald] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Hoover, Aaron M.] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Mongeau, JM (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.	jmmongeau@berkeley.edu		Fearing, Ronald/0000-0001-6242-5379; Jusufi, Ardian/0000-0003-4250-2984	National Science Foundation (NSF) [EF-0425878]; Micro Autonomous Systems and Technology Collaborative Technology Alliance Grant [W911NF-08-2-0004]; NSF Graduate Research Fellowship; Integrative Graduate Education and Research Traineeship (IGERT) [0903711]; NSF Center of Integrated Nanomechanical Systems [EEC-0304730]; Swiss NSF Fellowship	National Science Foundation (NSF)(National Science Foundation (NSF)); Micro Autonomous Systems and Technology Collaborative Technology Alliance Grant; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Integrative Graduate Education and Research Traineeship (IGERT)(National Science Foundation (NSF)); NSF Center of Integrated Nanomechanical Systems; Swiss NSF Fellowship	Research supported by a National Science Foundation (NSF) Frontiers in Integrative Biological Research Grant to RJF (EF-0425878), Micro Autonomous Systems and Technology Collaborative Technology Alliance Grant to RF, RJF and AMH (W911NF-08-2-0004), a NSF Graduate Research Fellowship and Integrative Graduate Education and Research Traineeship (IGERT) to JMM (0903711), NSF Center of Integrated Nanomechanical Systems support to PB (EEC-0304730) and a Swiss NSF Fellowship to AJ supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1985, J EXP BIOL, V115, P231; Asbeck AT, 2006, INT J ROBOT RES, V25, P1165, DOI 10.1177/0278364906072511; Autumn K, 2006, J EXP BIOL, V209, P260, DOI 10.1242/jeb.01980; Bassler U, 1998, BRAIN RES REV, V27, P65, DOI 10.1016/S0165-0173(98)00006-X; Bertram JEA, 1999, J EXP BIOL, V202, P2609; Bertram JEA, 2004, YEARB PHYS ANTHROPOL, V47, P100, DOI 10.1002/ajpa.20156; Birkmeyer P, 2009, IEEE INT C INTELLIGE; BLICKHAN R, 1987, J EXP BIOL, V130, P155; Brackenbury J, 1999, J INSECT PHYSIOL, V45, P525, DOI 10.1016/S0022-1910(98)00157-7; Brackenbury J, 1997, NATURE, V390, P453, DOI 10.1038/37253; Carrier DR, 2001, J EXP BIOL, V204, P3917; Dickinson MH, 2005, INTEGR COMP BIOL, V45, P274, DOI 10.1093/icb/45.2.274; Evangelista C, 2010, J EXP BIOL, V213, P262, DOI 10.1242/jeb.037465; Farley CT, 1997, J EXP BIOL, V200, P2177; Frazier SF, 1999, J COMP PHYSIOL A, V185, P157, DOI 10.1007/s003590050374; FULL RJ, 1995, J EXP BIOL, V198, P2441; Goldman DI, 2006, J EXP BIOL, V209, P2990, DOI 10.1242/jeb.02322; Gomes MW, 2005, J THEOR BIOL, V237, P265, DOI 10.1016/j.jtbi.2005.04.014; Higham TE, 2001, J EXP BIOL, V204, P4141; Hoover A, 2008, IEEE INT C INTELLIGE; Hoover AM, 2008, IEEE INT C ROBOTICS; HYZER WG, 1962, SCIENCE, V137, P609, DOI 10.1126/science.137.3530.609; Jusufi A, 2008, P NATL ACAD SCI USA, V105, P4215, DOI 10.1073/pnas.0711944105; Jusufi A, 2011, INTEGR COMP BIOL, V51, P937, DOI 10.1093/icb/icr114; Kohlsdorf T, 2006, J ZOOL, V270, P359, DOI 10.1111/j.1469-7998.2006.00150.x; Kral K, 2010, PHYSIOL ENTOMOL, V35, P240, DOI 10.1111/j.1365-3032.2010.00735.x; LARSEN GS, 1995, J COMP PHYSIOL A, V176, P229, DOI 10.1007/BF00239925; Libby T, 2012, NATURE, V481, P181, DOI 10.1038/nature10710; Moya-Larano J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001841; Ruina A, 2005, J THEOR BIOL, V237, P170, DOI 10.1016/j.jtbi.2005.04.004; Spagna JC, 2007, BIOINSPIR BIOMIM, V2, P9, DOI 10.1088/1748-3182/2/1/002; Srinivasan M, 2006, NATURE, V439, P72, DOI 10.1038/nature04113; TING LH, 1994, J EXP BIOL, V197, P251; Walter RM, 2002, J EXP BIOL, V205, P2135; Wood RJ, 2008, J MECH DESIGN, V130, DOI 10.1115/1.2885509; Zug George R., 2007, Proceedings of the California Academy of Sciences, V58, P387	36	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38003	10.1371/journal.pone.0038003	http://dx.doi.org/10.1371/journal.pone.0038003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701594	Green Published, Green Submitted, gold			2022-12-25	WOS:000305348400029
J	van de Sande, WWJ				van de Sande, Wendy W. J.			Phylogenetic Analysis of the Complete Mitochondrial Genome of Madurella mycetomatis Confirms Its Taxonomic Position within the Order Sordariales	PLOS ONE			English	Article							TRANSFER-RNA GENES; IN-VITRO SUSCEPTIBILITIES; DNA-SEQUENCE; PODOSPORA-ANSERINA; TRNASCAN-SE; NEUROSPORA; IDENTIFICATION; INTRONS; PROGRAM; AGENTS	Background: Madurella mycetomatis is the most common cause of human eumycetoma. The genus Madurella has been characterized by overall sterility on mycological media. Due to this sterility and the absence of other reliable morphological and ultrastructural characters, the taxonomic classification of Madurella has long been a challenge. Mitochondria are of monophyletic origin and mitochondrial genomes have been proven to be useful in phylogenetic analyses. Results: he first complete mitochondrial DNA genome of a mycetoma-causative agent was sequenced using 454 sequencing. The mitochondrial genome of M. mycetomatis is a circular DNA molecule with a size of 45,590 bp, encoding for the small and the large subunit rRNAs, 27 tRNAs, 11 genes encoding subunits of respiratory chain complexes, 2 ATP synthase subunits, 5 hypothetical proteins, 6 intronic proteins including the ribosomal protein rps3. In phylogenetic analyses using amino acid sequences of the proteins involved in respiratory chain complexes and the 2 ATP synthases it appeared that M. mycetomatis clustered together with members of the order Sordariales and that it was most closely related to Chaetomium thermophilum. Analyses of the gene order showed that within the order Sordariales a similar gene order is found. Furthermore also the tRNA order seemed mostly conserved. Conclusion: Phylogenetic analyses of fungal mitochondrial genomes confirmed that M. mycetomatis belongs to the order of Sordariales and that it was most closely related to Chaetomium thermophilum, with which it also shared a comparable gene and tRNA order.	Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	van de Sande, WWJ (corresponding author), Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	w.vandesande@erasmusmc.nl	van de Sande, Wendy/AAS-4545-2021	van de Sande, Wendy/0000-0002-8652-8783	VENI grant of the Netherlands Organisation of Scientific Research (NWO) [91611178]	VENI grant of the Netherlands Organisation of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was financially supported by VENI grant 91611178 of the Netherlands Organisation of Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2003, J CLIN MICROBIOL, V41, P4537, DOI 10.1128/JCM.41.10.4537-4541.2003; Ahmed A, 2002, J CLIN MICROBIOL, V40, P1031, DOI 10.1128/JCM.40.3.1031-1036.2002; Ahmed AO, 2003, FEMS IMMUNOL MED MIC, V37, P29, DOI 10.1016/S0928-8244(03)00096-8; Ahmed AOA, 2004, LANCET INFECT DIS, V4, P566, DOI 10.1016/S1473-3099(04)01131-4; Ahmed AOA, 2004, ANTIMICROB AGENTS CH, V48, P2742, DOI 10.1128/AAC.48.7.2742-2746.2004; Ahmed AOA, 1999, J CLIN MICROBIOL, V37, P3175, DOI 10.1128/JCM.37.10.3175-3178.1999; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Basse CW, 2010, CURR OPIN MICROBIOL, V13, P712, DOI 10.1016/j.mib.2010.09.003; Bullerwell CE, 2005, CURR OPIN MICROBIOL, V8, P362, DOI 10.1016/j.mib.2005.06.009; Cardoso MAG, 2007, YEAST, V24, P607, DOI 10.1002/yea.1500; COLLINS RA, 1983, PLASMID, V9, P53, DOI 10.1016/0147-619X(83)90031-8; CUMMINGS DJ, 1990, CURR GENET, V17, P375, DOI 10.1007/BF00334517; CUMMINGS DJ, 1985, J MOL BIOL, V185, P659, DOI 10.1016/0022-2836(85)90052-X; de Hoog GS, 2012, J CLIN MICROBIOL, V50, P988, DOI 10.1128/JCM.05477-11; de Hoog GS, 2004, MYCOSES, V47, P121, DOI 10.1111/j.1439-0507.2004.00964.x; Edgell DR, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-22; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; Gautheret D, 2001, J MOL BIOL, V313, P1003, DOI 10.1006/jmbi.2001.5102; Jacobson DJ, 2006, MYCOLOGIA, V98, P550, DOI 10.3852/mycologia.98.4.550; Kleidon J, 2003, MITOCHONDRION, V2, P345, DOI 10.1016/S1567-7249(03)00002-3; Kouvelis VN, 2004, FUNGAL GENET BIOL, V41, P930, DOI 10.1016/j.fgb.2004.07.003; KUBELIK AR, 1990, J BIOL CHEM, V265, P4515; Laforest MJ, 1997, NUCLEIC ACIDS RES, V25, P626, DOI 10.1093/nar/25.3.626; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Nowrousian M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000891; Paoletti M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-223; Paquin B, 1996, J MOL BIOL, V255, P688, DOI 10.1006/jmbi.1996.0056; Pramateftaki PV, 2008, FEMS YEAST RES, V8, P311, DOI 10.1111/j.1567-1364.2007.00332.x; Pramateftaki PV, 2006, FEMS YEAST RES, V6, P77, DOI 10.1111/j.1567-1364.2005.00018.x; Prochazka E, 2010, FEMS YEAST RES, V10, P545, DOI 10.1111/j.1567-1364.2010.00644.x; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; SEKITO T, 1995, CURR GENET, V28, P39, DOI 10.1007/BF00311880; Sethuraman J, 2009, MOL BIOL EVOL, V26, P2299, DOI 10.1093/molbev/msp145; SILLIKER ME, 1990, GENETICS, V125, P775; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAYLOR JW, 1985, CURR GENET, V9, P597, DOI 10.1007/BF00381173; Torriani SFF, 2008, FUNGAL GENET BIOL, V45, P628, DOI 10.1016/j.fgb.2007.12.005; van de Sande WWJ, 2011, MOLECULAR DETECTION OF HUMAN FUNGAL PATHOGENS, P117; van de Sande WWJ, 2005, ANTIMICROB AGENTS CH, V49, P1364, DOI 10.1128/AAC.49.4.1364-1368.2005; van Diepeningen AD, 2010, MECH AGEING DEV, V131, P315, DOI 10.1016/j.mad.2010.03.001; Woo PCY, 2003, FEBS LETT, V555, P469, DOI 10.1016/S0014-5793(03)01307-3; Wu Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-238; Zhang N, 2006, MYCOLOGIA, V98, P1076, DOI 10.3852/mycologia.98.6.1076	48	26	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38654	10.1371/journal.pone.0038654	http://dx.doi.org/10.1371/journal.pone.0038654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701687	Green Published, gold			2022-12-25	WOS:000305348400081
J	Springer, SA; Qiu, JJ; Saber-Tehrani, AS; Altice, FL				Springer, Sandra A.; Qiu, Jingjun; Saber-Tehrani, Ali Shabahang; Altice, Frederick L.			Retention on Buprenorphine Is Associated with High Levels of Maximal Viral Suppression among HIV-Infected Opioid Dependent Released Prisoners	PLOS ONE			English	Article							ADMINISTERED ANTIRETROVIRAL THERAPY; MEDICATION-ASSISTED TREATMENT; ALCOHOL-USE DISORDERS; DRUG-ABUSE TREATMENT; METHADONE-MAINTENANCE; TREATMENT OUTCOMES; PUBLIC-HEALTH; CLINICAL CARE; PREVENTION; ADDICTION	Introduction: HIV-infected prisoners lose viral suppression within the 12 weeks after release to the community. This prospective study evaluates the use of buprenorphine/naloxone (BPN/NLX) as a method to reduce relapse to opioid use and sustain viral suppression among released HIV-infected prisoners meeting criteria for opioid dependence (OD). Methods: From 2005-2010, 94 subjects meeting DSM-IV criteria for OD were recruited from a 24-week prospective trial of directly administered antiretroviral therapy (DAART) for released HIV-infected prisoners; 50 (53%) selected BPN/NLX and were eligible to receive it for 6 months; the remaining 44 (47%) selected no BPN/NLX therapy. Maximum viral suppression (MVS), defined as HIV-1 RNA<50 copies/mL, was compared for the BPN/NLX and non-BPN/NLX (N = 44) groups. Results: The two groups were similar, except the BPN/NLX group was significantly more likely to be Hispanic (56.0% v 20.4%), from Hartford (74.4% v 47.7%) and have higher mean global health quality of life indicator scores (54.18 v 51.40). MVS after 24 weeks of being released was statistically correlated with 24-week retention on BPN/NLX [AOR = 5.37 (1.15, 25.1)], having MVS at the time of prison-release [AOR = 10.5 (3.21, 34.1)] and negatively with being Black [AOR = 0.13 (0.03, 0.68)]. Receiving DAART or methadone did not correlate with MVS. Conclusions: In recognition that OD is a chronic relapsing disease, strategies that initiate and retain HIV-infected prisoners with OD on BPN/NLX is an important strategy for improving HIV treatment outcomes as a community transition strategy.	[Springer, Sandra A.; Qiu, Jingjun; Saber-Tehrani, Ali Shabahang; Altice, Frederick L.] Yale Univ, Sch Med, AIDS Program, Infect Dis Sect, New Haven, CT 06520 USA; [Altice, Frederick L.] Yale Univ, Sch Publ Hlth, Div Epidemiol Microbial Dis, New Haven, CT USA; [Altice, Frederick L.] Univ Malaya, Fac Med, Ctr Excellence Res AIDS, Kuala Lumpur, Malaysia	Yale University; Yale University; Universiti Malaya	Springer, SA (corresponding author), Yale Univ, Sch Med, AIDS Program, Infect Dis Sect, New Haven, CT 06520 USA.	Sandra.springer@yale.edu	Springer, Sandra/ABC-4569-2020	springer, sandra/0000-0002-6318-1000	National Institutes of Health, National Institutes on Drug Abuse for research [R21 DA019843, R01 DA017059, K24 DA017072, K02 DA032322, K23 DA019381]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017059, K23DA019381, K02DA032322, R21DA019843, K24DA017072] Funding Source: NIH RePORTER	National Institutes of Health, National Institutes on Drug Abuse for research; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this work was provided by the National Institutes of Health, National Institutes on Drug Abuse for research (R21 DA019843, R01 DA017059 for FLA), and career development (K24 DA017072 for FLA, K02 DA032322 and K23 DA019381 for SAS) support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altice F, 2011, 18 C RETR OPP INF BO; Altice FL, 2011, JAIDS-J ACQ IMM DEF, V56, pS22, DOI 10.1097/QAI.0b013e318209751e; Altice FL, 2010, LANCET, V376, P367, DOI 10.1016/S0140-6736(10)60829-X; Azar MM, 2010, DRUG ALCOHOL DEPEN, V112, P178, DOI 10.1016/j.drugalcdep.2010.06.014; Bae JW, 2011, AIDS, V25, P279, DOI 10.1097/QAD.0b013e328340feb0; Baillargeon J, 2010, AIDS PATIENT CARE ST, V24, P389, DOI 10.1089/apc.2009.0303; Baillargeon J, 2009, JAMA-J AM MED ASSOC, V301, P848, DOI 10.1001/jama.2009.202; Barta WD, 2009, J STUD ALCOHOL DRUGS, V70, P735, DOI 10.15288/jsad.2009.70.735; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Chandler RK, 2009, JAMA-J AM MED ASSOC, V301, P183, DOI 10.1001/jama.2008.976; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Copenhaver MM, 2007, AM J DRUG ALCOHOL AB, V33, P643, DOI 10.1080/00952990701522674; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Friedmann PD, 2012, SUBST ABUS, V33, P9, DOI 10.1080/08897077.2011.611460; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gordon MS, 2011, BEHAV SCI LAW, V29, P829, DOI 10.1002/bsl.1015; Hammer SM, 1996, AIDS, V10, pS1; Ing EC, 2011, AIDS BEHAV      1122; KARBERG JENNIFER C., 2002, SUBSTANCE DEPENDENCE, P1; Kinlock TW, 2010, J OFFENDER REHABIL, V49, P91, DOI 10.1080/10509670903534951; Kinlock TW, 2009, J SUBST ABUSE TREAT, V37, P277, DOI 10.1016/j.jsat.2009.03.002; Kinlock TW, 2002, J SUBST ABUSE TREAT, V22, P141, DOI 10.1016/S0740-5472(02)00226-X; Krupitsky E, 2011, LANCET, V377, P1506, DOI 10.1016/S0140-6736(11)60358-9; Lucas GM, 2006, CLIN INFECT DIS, V42, P1628, DOI 10.1086/503905; Magura S, 2009, DRUG ALCOHOL DEPEN, V99, P222, DOI 10.1016/j.drugalcdep.2008.08.006; Maruschak LM, 2009, HIV PRISONS 2008; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Mumola C, 1999, SUBSTANCE ABUSE TREA, P1; Nunn A, 2009, DRUG ALCOHOL DEPEN, V105, P83, DOI 10.1016/j.drugalcdep.2009.06.015; Rich JD, 2005, J URBAN HEALTH, V82, P411, DOI 10.1093/jurban/jti072; Rich Josiah D, 2011, Curr HIV/AIDS Rep, V8, P288, DOI 10.1007/s11904-011-0095-3; Rosen CS, 2000, ADDICTION, V95, P419, DOI 10.1046/j.1360-0443.2000.95341912.x; Saber-Tehrani AS, 2012, CONTEMP CLIN TRIALS, V33, P436, DOI 10.1016/j.cct.2011.11.002; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X; Smith-Rohrberg D, 2004, J DRUG ISSUES, V34, P451, DOI 10.1177/002204260403400210; Spaulding AC, 2009, PLOS ONE, V4, pA16, DOI 10.1371/journal.pone.0007558; Springer SA, 2004, CLIN INFECT DIS, V38, P1754, DOI 10.1086/421392; Springer SA, 2011, CLIN INFECT DIS, V53, P469, DOI 10.1093/cid/cir446; Springer SA, 2011, AM J DRUG ALCOHOL AB, V37, P12, DOI 10.3109/00952990.2010.540280; Springer SA, 2010, ADDICTION, V105, P224, DOI 10.1111/j.1360-0443.2009.02893.x; Springer Sandra A, 2008, J Opioid Manag, V4, P81; Springer SA, 2010, J URBAN HEALTH, V87, P592, DOI 10.1007/s11524-010-9438-4; Stephenson BL, 2006, INT J STD AIDS, V17, P103, DOI 10.1258/095646206775455775; Stephenson BL, 2005, PUBLIC HEALTH REP, V120, P84, DOI 10.1177/003335490512000114; Sullivan LE, 2006, CLIN INFECT DIS, V43, pS184, DOI 10.1086/508182; Sullivan LE, 2011, JAIDS-J ACQ IMM DEF, V56, pS54, DOI 10.1097/QAI.0b013e3182097576; Thompson MA, 2012, ANN INTERNAL ME 0305; Wexler HK, 2007, PRISON J, V87, P9, DOI 10.1177/0032885506299036; Zaccarelli M, 2009, INFECTION, V37, P203, DOI 10.1007/s15010-008-8142-8	53	96	97	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38335	10.1371/journal.pone.0038335	http://dx.doi.org/10.1371/journal.pone.0038335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22719814	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500133
J	Guo, ST; Jiang, CC; Wang, GP; Li, YP; Wang, CY; Guo, XY; Yang, RH; Feng, Y; Wang, FH; Tseng, HY; Thorne, RF; Jin, L; Zhang, XD				Guo, S. T.; Jiang, C. C.; Wang, G. P.; Li, Y. P.; Wang, C. Y.; Guo, X. Y.; Yang, R. H.; Feng, Y.; Wang, F. H.; Tseng, H-Y; Thorne, R. F.; Jin, L.; Zhang, X. D.			MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer	ONCOGENE			English	Article						colorectal cancer; miR-497; IGF1-R; Akt; copy number variations	FACTOR-I-RECEPTOR; EXPRESSION PROFILES; IGF-1; INHIBITION; MUTATIONS; APOPTOSIS; GENES; CELLS; IGF1R	Past studies have shown that amplified insulin-like growth factor 1 (IGF1)/IGF1 receptor (IGF1-R) signalling has an important role in colorectal cancer (CRC) development, progression and resistance to treatment. In this report, we demonstrate that downregulation of microRNA-497 (miR-497) as a result of DNA copy number reduction is involved in upregulation of IGF1-R in CRC cells. MiR-497 and miR-195 of the miR-15/16/195/424/497 family that share the same 3' untranslated region (3'UTR) binding seed sequence and are predicted to target IGF1-R were concurrently downregulated in the majority of CRC tissues relative to paired adjacent normal mucosa. However, only overexpression of miR-497 led to suppression of the IGF1-R 3'UTR activity and downregulation of the endogenous IGF1-R protein in CRC cells. This was associated with inhibition of cell survival, proliferation and invasion, and increased sensitivity to apoptosis induced by various stimuli including the chemotherapeutic drugs cisplatin and 5-fluorouracil, and the death ligand tumour necrosis factor-related apoptosis-inducing ligand. The biological effect of miR-497 on CRC cells was largely mediated by inhibition of phosphatidylinositol 3-kinase/Akt signalling, as overexpression of an active form of Akt reversed its impact on cell survival and proliferation, recapitulating the effect of overexpression of IGF1-R. Downregulation of miR-497 and miR-195 appeared to associate with copy number loss of a segment of chromosome 17p13.1, where these miRs are located at proximity. Similarly to miR-195, the members of the same miR family, miR-424 that was upregulated, and miR-15a, miR-15b and miR-16 that were unaltered in expression in CRC tissues compared with paired adjacent normal mucosa, did not appear to have a role in regulating the expression of IGF1-R. Taken together, these results identify downregulation of miR-497 as an important mechanism of upregulation of IGF1-R in CRC cells that contributes to malignancy of CRC. Oncogene (2013) 32, 1910-1920; doi:10.1038/onc.2012.214; published online 18 June 2012	[Guo, S. T.; Wang, G. P.; Wang, C. Y.; Guo, X. Y.; Yang, R. H.; Feng, Y.; Wang, F. H.; Zhang, X. D.] Shanxi Canc Hosp & Inst, Dept Mol Biol, Taiyuan, Peoples R China; [Jiang, C. C.; Tseng, H-Y; Thorne, R. F.; Zhang, X. D.] Univ Newcastle, Prior Res Ctr Canc Res, Newcastle, NSW 2300, Australia; [Jiang, C. C.; Tseng, H-Y; Thorne, R. F.; Zhang, X. D.] Hunter Med Res Inst, Canc Res Program, Newcastle, NSW, Australia; [Li, Y. P.] Shanxi Canc Hosp & Inst, Dept Colorectal Surg, Taiyuan, Peoples R China; [Thorne, R. F.] Univ Newcastle, Sch Biomed Sci, Canc Res Unit, Newcastle, NSW 2300, Australia; [Jin, L.] Univ Sydney, Kolling Inst Med Res, Immunol & Oncol Lab, Sydney, NSW 2006, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Sydney; Kolling Institute of Medical Research	Zhang, XD (corresponding author), Univ Newcastle, Prior Res Ctr Canc Res, David Maddison Bldg,Cnr King & Watt St, Newcastle, NSW 2300, Australia.	Xu.Zhang@newcastle.edu.au	Tseng, Cindy Hsin-Yi/AAB-8958-2022; Jin, Lei/J-1896-2019; zhang, xu/GRX-9733-2022; zhang, xu/GYE-3558-2022; Jiang, Chenchen/C-2902-2014; Zhang, xiaoyu/GXA-3206-2022; zhang, xian/GYA-0290-2022	Tseng, Cindy Hsin-Yi/0000-0002-7499-7515; Jin, Lei/0000-0001-7187-9671; Zhang, Xu Dong/0000-0001-9457-8003	NSW State Cancer Council; Cancer Institute NSW; National Health and Medical Research Council (NHMRC), Australia; Shanxi Scholarship Council; National '863' High Technology Program, China; NHMRC	NSW State Cancer Council(Cancer Council New South Wales); Cancer Institute NSW; National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); Shanxi Scholarship Council; National '863' High Technology Program, China(National High Technology Research and Development Program of China); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the NSW State Cancer Council, Cancer Institute NSW, and National Health and Medical Research Council (NHMRC), Australia, and the Shanxi Scholarship Council and National '863' High Technology Program, China. CCJ is a recipient of postdoctoral training Fellowship of NHMRC. XDZ is supported by a senior research fellowship of NHMRC.	Alberobello AT, 2010, J BIOL CHEM, V285, P6563, DOI 10.1074/jbc.M109.097410; Board RE, 2008, CLIN CHEM, V54, P757, DOI 10.1373/clinchem.2007.098376; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; DEANGELIS T, 1995, J CELL PHYSIOL, V164, P214, DOI 10.1002/jcp.1041640126; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Dong L, 2011, ONCOGENE, V30, P3716, DOI 10.1038/onc.2011.87; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Ferte C, 2010, NAT REV CLIN ONCOL, V7, P367, DOI 10.1038/nrclinonc.2010.84; Flavin RJ, 2009, MODERN PATHOL, V22, P197, DOI 10.1038/modpathol.2008.135; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hart LS, 2011, CELL CYCLE, V10, P2331, DOI 10.4161/cc.10.14.16418; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ibrahim AF, 2011, CANCER RES, V71, P5214, DOI 10.1158/0008-5472.CAN-10-4645; Jiang CC, 2011, CLIN CANCER RES, V17, P721, DOI 10.1158/1078-0432.CCR-10-2225; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Jin L, 2011, P NATL ACAD SCI USA, V108, P15840, DOI 10.1073/pnas.1019312108; Kong KL, 2012, GUT, V61, P33, DOI 10.1136/gutjnl-2011-300178; La Rocca G, 2009, J CELL PHYSIOL, V220, P485, DOI 10.1002/jcp.21796; Lerman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020916; LeRoith D, 2004, CANCER CELL, V5, P201, DOI 10.1016/S1535-6108(04)00054-6; Liang RQ, 2011, AGING CELL, V10, P1080, DOI 10.1111/j.1474-9726.2011.00751.x; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Liu L, 2010, BIOCHEM BIOPH RES CO, V400, P236, DOI 10.1016/j.bbrc.2010.08.046; McKinley ET, 2011, CLIN CANCER RES, V17, P3332, DOI 10.1158/1078-0432.CCR-10-2274; Nakajima Go, 2006, Cancer Genomics & Proteomics, V3, P317; Patel B, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.e14131; Pereira PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011780; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Quek R, 2011, CLIN CANCER RES, V17, P871, DOI 10.1158/1078-0432.CCR-10-2621; Schee K, 2010, AM J PATHOL, V177, P1592, DOI 10.2353/ajpath.2010.100024; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schetter AJ, 2011, SEMIN ONCOL, V38, P734, DOI 10.1053/j.seminoncol.2011.08.009; Sekharam M, 2003, CANCER RES, V63, P7708; Sekharam M, 2011, CANCER RES, V63, P7708; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Wang XQ, 2012, MED ONCOL, V29, P919, DOI 10.1007/s12032-011-9880-5; Weber MM, 2002, CANCER-AM CANCER SOC, V95, P2086, DOI 10.1002/cncr.10945; Wilmott JS, 2011, PATHOLOGY, V43, P657, DOI 10.1097/PAT.0b013e32834a7358; Wu WKK, 2011, CARCINOGENESIS, V32, P247, DOI 10.1093/carcin/bgq243; Yadav S, 2011, J BIOL CHEM, V286, P37347, DOI 10.1074/jbc.M111.235531; Yang F, 2010, CELL DEATH DIFFER, V17, P1354, DOI 10.1038/cdd.2010.29; Yin KJ, 2010, NEUROBIOL DIS, V38, P17, DOI 10.1016/j.nbd.2009.12.021; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhu W, 2012, MED ONCOL, V29, P384, DOI 10.1007/s12032-010-9797-4	53	185	195	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 11	2013	32	15					1910	1920		10.1038/onc.2012.214	http://dx.doi.org/10.1038/onc.2012.214			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	126GB	22710713	Green Published			2022-12-25	WOS:000317599900005
J	Bar-On, D; Wolter, S; van de Linde, S; Heilemann, M; Nudelman, G; Nachliel, E; Gutman, M; Sauer, M; Ashery, U				Bar-On, Dana; Wolter, Steve; van de Linde, Sebastian; Heilemann, Mike; Nudelman, German; Nachliel, Esther; Gutman, Menachem; Sauer, Markus; Ashery, Uri			Super-resolution Imaging Reveals the Internal Architecture of Nano-sized Syntaxin Clusters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; NATIVE PLASMA-MEMBRANES; LIPID RAFTS; CHROMAFFIN CELLS; FLUORESCENT-PROBES; SNARE PROTEINS; FUSION; EXOCYTOSIS; 1A; TRAFFICKING	Key synaptic proteins from the soluble SNARE (N-ethylma-leimide-sensitive factor attachment protein receptor) family, among many others, are organized at the plasma membrane of cells as clusters containing dozens to hundreds of protein copies. However, the exact membranal distribution of proteins into clusters or as single molecules, the organization of molecules inside the clusters, and the clustering mechanisms are unclear due to limitations of the imaging and analytical tools. Focusing on syntaxin 1 and SNAP-25, we implemented direct stochastic optical reconstruction microscopy together with quantitative clustering algorithms to demonstrate a novel approach to explore the distribution of clustered and nonclustered molecules at the membrane of PC12 cells with single-molecule precision. Direct stochastic optical reconstruction microscopy images reveal, for the first time, solitary syntaxin/SNAP-25 molecules and small clusters as well as larger clusters. The nonclustered syntaxin or SNAP-25 molecules are mostly concentrated in areas adjacent to their own clusters. In the clusters, the density of the molecules gradually decreases from the dense cluster core to the periphery. We further detected large clusters that contain several density gradients. This suggests that some of the clusters are formed by unification of several clusters that preserve their original organization or reorganize into a single unit. Although syntaxin and SNAP-25 share some common distributional features, their clusters differ markedly from each other. SNAP-25 clusters are significantly larger, more elliptical, and less dense. Finally, this study establishes methodological tools for the analysis of single-molecule-based super-resolution imaging data and paves the way for revealing new levels of membranal protein organization.	[Wolter, Steve; van de Linde, Sebastian; Heilemann, Mike; Sauer, Markus] Univ Wurzburg, Dept Biotechnol & Biophys, D-97074 Wurzburg, Germany; [Nudelman, German] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Bar-On, Dana; Nachliel, Esther; Gutman, Menachem] Tel Aviv Univ, Dept Biochem, Laser Lab Fast React Biol, IL-69978 Tel Aviv, Israel; [Bar-On, Dana; Ashery, Uri] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Ashery, Uri] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	University of Wurzburg; Icahn School of Medicine at Mount Sinai; Tel Aviv University; Tel Aviv University; Tel Aviv University	Sauer, M (corresponding author), Univ Wurzburg, Dept Biotechnol & Biophys, D-97074 Wurzburg, Germany.	m.sauer@uni-wuerzburg.de; uria@post.tau.ac.il	Sauer, Markus/C-4378-2017	Sauer, Markus/0000-0002-1692-3219; Heilemann, Mike/0000-0002-9821-3578; Ashery, Uri/0000-0001-6338-7888	Biophotonics Initiative of the Bundesministerium fur Bildung und Forschung; Israel Science Foundation Grant [1211/07]; National Institutes of Health Grant [RO1 NS053978]; German-Israeli Foundation (GIF) Grant [1125-145.1/2010]; Minerva and European Molecular Biology Organization (EMBO) short-term research fellowships; "Converging Technologies" scholarship of the Israeli council for higher education; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053978] Funding Source: NIH RePORTER	Biophotonics Initiative of the Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Israel Science Foundation Grant(Israel Science Foundation); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German-Israeli Foundation (GIF) Grant; Minerva and European Molecular Biology Organization (EMBO) short-term research fellowships; "Converging Technologies" scholarship of the Israeli council for higher education; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Biophotonics Initiative of the Bundesministerium fur Bildung und Forschung (to M. S.), the Israel Science Foundation Grant 1211/07 (to U. A.), National Institutes of Health Grant RO1 NS053978 (to U. A.), and German-Israeli Foundation (GIF) Grant 1125-145.1/2010 (to U. A. and M. S.).; A recipient of the Minerva and European Molecular Biology Organization (EMBO) short-term research fellowships and the "Converging Technologies" scholarship of the Israeli council for higher education.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ashery U, 2009, TRENDS NEUROSCI, V32, P275, DOI 10.1016/j.tins.2009.01.004; Bar-On D, 2008, FEBS LETT, V582, P3563, DOI 10.1016/j.febslet.2008.08.040; Bar-On D, 2009, J NEUROSCI, V29, P12292, DOI 10.1523/JNEUROSCI.0710-09.2009; Barg S, 2010, P NATL ACAD SCI USA, V107, P20804, DOI 10.1073/pnas.1014823107; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Daily NJ, 2010, J BIOL CHEM, V285, P35320, DOI 10.1074/jbc.M110.145169; Davies JN, 2011, BIOCHEM BIOPH RES CO, V411, P562, DOI 10.1016/j.bbrc.2011.06.185; Dun AR, 2010, CELL MOL NEUROBIOL, V30, P1321, DOI 10.1007/s10571-010-9599-4; Fan J, 2007, BIOCHEM BIOPH RES CO, V359, P245, DOI 10.1016/j.bbrc.2007.05.065; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kentner D, 2006, MOL MICROBIOL, V61, P407, DOI 10.1111/j.1365-2958.2006.05250.x; Klein T, 2011, NAT METHODS, V8, P7, DOI 10.1038/nmeth0111-7b; Lang T, 2002, J CELL BIOL, V158, P751, DOI 10.1083/jcb.200203088; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Lang T, 2007, J PHYSIOL-LONDON, V585, P693, DOI 10.1113/jphysiol.2007.134346; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Locantore NW, 2004, ENVIRON MONIT ASSESS, V94, P249, DOI 10.1023/B:EMAS.0000016892.67527.4c; Lopez I, 2009, TRAFFIC, V10, P172, DOI 10.1111/j.1600-0854.2008.00861.x; Mezer A, 2004, J NEUROSCI, V24, P8838, DOI 10.1523/JNEUROSCI.2815-04.2004; Mezer A, 2006, BBA-MOL CELL RES, V1763, P345, DOI 10.1016/j.bbamcr.2006.02.011; Murray DH, 2009, BIOCHEMISTRY-US, V48, P4617, DOI 10.1021/bi9003217; Nudelman G, 2009, MOL IMMUNOL, V46, P3141, DOI 10.1016/j.molimm.2009.03.027; Rickman C, 2010, J BIOL CHEM, V285, P13535, DOI 10.1074/jbc.M109.091058; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Shaw AS, 2006, NAT IMMUNOL, V7, P1139, DOI 10.1038/ni1405; Sieber JJ, 2006, BIOPHYS J, V90, P2843, DOI 10.1529/biophysj.105.079574; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Torregrosa-Hetland CJ, 2010, CELL MOL NEUROBIOL, V30, P1315, DOI 10.1007/s10571-010-9565-1; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Weiss N, 2012, J BIOL CHEM, V287, P2810, DOI 10.1074/jbc.M111.290882; Wolter S, 2010, J MICROSC-OXFORD, V237, P12, DOI 10.1111/j.1365-2818.2009.03287.x; Wombacher R, 2010, NAT METHODS, V7, P717, DOI [10.1038/NMETH.1489, 10.1038/nmeth.1489]; Xu XW, 1998, PROC INT CONF DATA, P324, DOI 10.1109/ICDE.1998.655795; Yang XF, 2006, J BIOL CHEM, V281, P15457, DOI 10.1074/jbc.M513246200	44	91	92	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27158	27167		10.1074/jbc.M112.353250	http://dx.doi.org/10.1074/jbc.M112.353250			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700970	hybrid, Green Published			2022-12-25	WOS:000307386000068
J	Wilhelmsen, K; Mesa, KR; Lucero, J; Xu, FY; Hellman, J				Wilhelmsen, Kevin; Mesa, Kailin R.; Lucero, Jennifer; Xu, Fengyun; Hellman, Judith			ERK5 Protein Promotes, whereas MEK1 Protein Differentially Regulates, the Toll-like Receptor 2 Protein-dependent Activation of Human Endothelial Cells and Monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; GENE-EXPRESSION DATA; TRANSCRIPTIONAL REGULATION; STAPHYLOCOCCUS-AUREUS; KINASE PATHWAYS; SIGNALING SPECIFICITY; TLR2 EXPRESSION; INFLAMMATION; MACROPHAGES	Endothelial cell (EC) Toll-like receptor 2 (TLR2) activation up-regulates the expression of inflammatory mediators and of TLR2 itself and modulates important endothelial functions, including coagulation and permeability. We defined TLR2 signaling pathways in EC and tested the hypothesis that TLR2 signaling differs in EC and monocytes. We found that ERK5, heretofore unrecognized as mediating TLR2 activation in any cell type, is a central mediator of TLR2-dependent inflammatory signaling in human umbilical vein endothelial cells, primary human lung microvascular EC, and human monocytes. Additionally, we observed that, although MEK1 negatively regulates TLR2 signaling in EC, MEK1 promotes TLR2 signaling in monocytes. We also noted that activation of TLR2 led to the up-regulation of intracellularly expressed TLR2 and inflammatory mediators via NF-kappa B, JNK, and p38-MAPK. Finally, we found that p38-MAPK, JNK, ERK5, and NF-kappa B promote the attachment of human neutrophils to lung microvascular EC that were pretreated with TLR2 agonists. This study newly identifies ERK5 as a key regulator of TLR2 signaling in EC and monocytes and indicates that there are fundamental differences in TLR signaling pathways between EC and monocytes.	[Wilhelmsen, Kevin; Mesa, Kailin R.; Lucero, Jennifer; Xu, Fengyun; Hellman, Judith] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Hellman, Judith] Univ Calif San Francisco, Div Crit Care Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wilhelmsen, K (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA.	wilhelmsenk@anesthesia.ucsf.edu		Mesa, Kailin/0000-0003-4452-9048	National Institutes of Health Grant [R01AI058106]; University of California San Francisco Department of Anesthesia and Perioperative Care; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058106] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco Department of Anesthesia and Perioperative Care; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI058106 (NIAID; to J. Hellman). This work was also supported by the University of California San Francisco Department of Anesthesia and Perioperative Care.	Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Beekhuizen H, 1997, J IMMUNOL, V158, P774; Bertelsen T, 2011, EXP DERMATOL, V20, P140, DOI 10.1111/j.1600-0625.2010.01153.x; Bhattacharya R, 2005, J BIOL CHEM, V280, P28848, DOI 10.1074/jbc.C500200200; Cameron SJ, 2003, J BIOL CHEM, V278, P18682, DOI 10.1074/jbc.M213283200; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fan J, 2003, J CLIN INVEST, V112, P1234, DOI 10.1172/JCI200318696; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; Faure E, 2001, J IMMUNOL, V166, P2018, DOI 10.4049/jimmunol.166.3.2018; Grote K, 2010, BLOOD, V115, P2543, DOI 10.1182/blood-2009-05-224402; Haehnel V, 2002, J IMMUNOL, V168, P5629, DOI 10.4049/jimmunol.168.11.5629; HAN TH, 1995, MOL CELL BIOL, V15, P2907; Hickey MJ, 2009, NAT REV IMMUNOL, V9, P364, DOI 10.1038/nri2532; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kato Y, 2000, J BIOL CHEM, V275, P18534, DOI 10.1074/jbc.M001573200; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li YH, 2009, AM J PHYSIOL-REG I, V297, pR1670, DOI 10.1152/ajpregu.00445.2009; Lin Q, 2011, INT IMMUNOPHARMACOL, V11, P1422, DOI 10.1016/j.intimp.2011.04.026; Lin ZY, 2005, CIRC RES, V96, pE48, DOI 10.1161/01.RES.0000159707.05637.a1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Menzies BE, 1998, INFECT IMMUN, V66, P5994, DOI 10.1128/IAI.66.12.5994-5998.1998; Miller M, 2009, CURR PROTEIN PEPT SC, V10, P244, DOI 10.2174/138920309788452164; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Nuzzi Paul A, 2007, Methods Mol Biol, V370, P23; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Petersen B, 2008, AM J PHYSIOL-LUNG C, V294, pL300, DOI 10.1152/ajplung.00243.2007; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Roberts OL, 2009, BIOCHEM SOC T, V37, P1254, DOI 10.1042/BST0371254; Rovida E, 2008, J IMMUNOL, V180, P4166, DOI 10.4049/jimmunol.180.6.4166; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Satta N, 2008, MOL IMMUNOL, V46, P145, DOI 10.1016/j.molimm.2008.07.017; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Schmidt RR, 2011, ORG BIOMOL CHEM, V9, P2040, DOI 10.1039/c0ob00794c; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Shin HS, 2011, J IMMUNOL, V186, P1119, DOI 10.4049/jimmunol.1001647; Sohn SJ, 2005, MOL CELL BIOL, V25, P8553, DOI 10.1128/MCB.25.19.8553-8566.2005; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Talreja J, 2004, IMMUNOLOGY, V113, P224, DOI 10.1111/j.1365-2567.2004.01946.x; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Verstak B, 2009, J BIOL CHEM, V284, P24192, DOI 10.1074/jbc.M109.023044; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; Wilhelmsen K., 2011, INNATE IMMUN IN PRES; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Ye XB, 2008, J EXP MED, V205, P1303, DOI 10.1084/jem.20071393; YEN J, 1991, J IMMUNOTHER, V10, P174, DOI 10.1097/00002371-199106000-00003; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005; Zhu W, 2000, J IMMUNOL, V164, P6349, DOI 10.4049/jimmunol.164.12.6349	70	29	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26478	26494		10.1074/jbc.M112.359489	http://dx.doi.org/10.1074/jbc.M112.359489			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707717	hybrid, Green Published			2022-12-25	WOS:000307386000002
J	States, JC; Singh, AV; Knudsen, TB; Rouchka, EC; Ngalame, NO; Arteel, GE; Piao, YL; Ko, MSH				States, J. Christopher; Singh, Amar V.; Knudsen, Thomas B.; Rouchka, Eric C.; Ngalame, Ntube O.; Arteel, Gavin E.; Piao, Yulan; Ko, Minoru S. H.			Prenatal Arsenic Exposure Alters Gene Expression in the Adult Liver to a Proinflammatory State Contributing to Accelerated Atherosclerosis	PLOS ONE			English	Article							SYSTEMIC ARTERIAL-DISEASE; DRINKING-WATER; RHEUMATOID-ARTHRITIS; CARDIOVASCULAR-DISEASE; EPIDEMIOLOGIC EVIDENCE; HEPATIC EXPRESSION; TRAUMA-HEMORRHAGE; OXIDATIVE STRESS; IN-UTERO; MICE	The mechanisms by which environmental toxicants alter developmental processes predisposing individuals to adult onset chronic disease are not well-understood. Transplacental arsenic exposure promotes atherogenesis in apolipoprotein E-knockout (ApoE(-/-)) mice. Because the liver plays a central role in atherosclerosis, diabetes and metabolic syndrome, we hypothesized that accelerated atherosclerosis may be linked to altered hepatic development. This hypothesis was tested in ApoE(-/-) mice exposed to 49 ppm arsenic in utero from gestational day (GD) 8 to term. GD18 hepatic arsenic was 1.2 mu g/g in dams and 350 ng/g in fetuses. The hepatic transcriptome was evaluated by microarray analysis to assess mRNA and microRNA abundance in control and exposed pups at postnatal day (PND) 1 and PND70. Arsenic exposure altered postnatal developmental trajectory of mRNA and microRNA profiles. We identified an arsenic exposure related 51-gene signature at PND1 and PND70 with several hubs of interaction (Hspa8, IgM and Hnf4a). Gene ontology (GO) annotation analyses indicated that pathways for gluconeogenesis and glycolysis were suppressed in exposed pups at PND1, and pathways for protein export, ribosome, antigen processing and presentation, and complement and coagulation cascades were induced by PND70. Promoter analysis of differentially-expressed transcripts identified enriched transcription factor binding sites and clustering to common regulatory sites. SREBP1 binding sites were identified in about 16% of PND70 differentially-expressed genes. Western blot analysis confirmed changes in the liver at PND70 that included increases of heat shock protein 70 (Hspa8) and active SREBP1. Plasma AST and ALT levels were increased at PND70. These results suggest that transplacental arsenic exposure alters developmental programming in fetal liver, leading to an enduring stress and proinflammatory response postnatally that may contribute to early onset of atherosclerosis. Genes containing SREBP1 binding sites also suggest pathways for diabetes mellitus and rheumatoid arthritis, both diseases that contribute to increased cardiovascular disease in humans.	[States, J. Christopher; Ngalame, Ntube O.; Arteel, Gavin E.] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [States, J. Christopher; Singh, Amar V.; Knudsen, Thomas B.; Rouchka, Eric C.; Arteel, Gavin E.] Univ Louisville, Ctr Environm Genom & Integrat Biol, Louisville, KY 40292 USA; [States, J. Christopher; Knudsen, Thomas B.; Rouchka, Eric C.; Arteel, Gavin E.] Univ Louisville, Ctr Genet & Mol Med, Louisville, KY 40292 USA; [Singh, Amar V.; Knudsen, Thomas B.] Univ Louisville, Dept Mol Cellular & Craniofacial Biol, Louisville, KY 40292 USA; [Rouchka, Eric C.] Univ Louisville, Dept Comp Engn & Comp Sci, Louisville, KY 40292 USA; [Piao, Yulan; Ko, Minoru S. H.] Natl Inst Aging, Genet Lab, Baltimore, MD USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of Louisville; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	States, JC (corresponding author), Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA.	jcstates@louisville.edu	Arteel, Gavin/AAE-2440-2022; Ko, Minoru S. H./B-7969-2009; Singh, Amar/K-4400-2013; States, J. Christopher/H-4246-2011	Arteel, Gavin/0000-0002-2253-5984; Ko, Minoru S. H./0000-0002-3530-3015; Singh, Amar/0000-0003-3780-8233; States, J. Christopher/0000-0003-4717-4422; Ngalame, Ntube/0000-0003-4482-7272	National Institutes of Health [R01ES011314, R21ES015812, P20RR016481, P20RR016481S1, P30ES014443]; University of Louisville Center for Genetics and Molecular Medicine; University of Louisville Collaborative Planning and Development Grant; Intramural Research Program of NIA/NIH; Bioinformatics, Biostatistics and Computational Biology Core of the Center for Environmental Genomics and Integrative Biology [P30ES014443]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011314, P30ES014443, R21ES015812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Louisville Center for Genetics and Molecular Medicine; University of Louisville Collaborative Planning and Development Grant; Intramural Research Program of NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Bioinformatics, Biostatistics and Computational Biology Core of the Center for Environmental Genomics and Integrative Biology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health (http://projectreporter.nih.gov/reporter.cfm) grants R01ES011314 (JCS), R21ES015812 (JCS), P20RR016481 (ECR), P20RR016481S1 (ECR), P30ES014443, a pilot grant from University of Louisville Center for Genetics and Molecular Medicine (JCS), a University of Louisville Collaborative Planning and Development Grant (TBK), and the Intramural Research Program of NIA/NIH (MSHK). Bioinformatics support was provided by the Bioinformatics, Biostatistics and Computational Biology Core of the Center for Environmental Genomics and Integrative Biology (P30ES014443). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham IM, 2003, MOL CELL BIOL, V23, P1470, DOI 10.1128/MCB.23.4.1470-1476.2003; Anand PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010136; Argos M, 2010, LANCET, V376, P252, DOI 10.1016/S0140-6736(10)60481-3; Arteel GE, 2008, TOXICOL APPL PHARM, V226, P128, DOI 10.1016/j.taap.2007.08.020; Binet F, 2010, INT IMMUNOPHARMACOL, V10, P508, DOI 10.1016/j.intimp.2010.01.013; Calderon RL, 2000, FOOD CHEM TOXICOL, V38, pS13, DOI 10.1016/S0278-6915(99)00133-7; Carter MG, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r61; Cave M, 2010, HEPATOLOGY, V51, P474, DOI 10.1002/hep.23321; Chen TY, 2010, EUR J IMMUNOL, V40, P1541, DOI 10.1002/eji.201040616; Christodoulou A, 2006, J CELL SCI, V119, P2035, DOI 10.1242/jcs.02922; Diehl JA, 2003, MOL CELL BIOL, V23, P1764, DOI 10.1128/MCB.23.5.1764-1774.2003; Doran M, 2007, J RHEUMATOL, V34, P460; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; ENGEL RR, 1994, EPIDEMIOL REV, V16, P184, DOI 10.1093/oxfordjournals.epirev.a036150; ENGEL RR, 1994, ARCH ENVIRON HEALTH, V49, P418, DOI 10.1080/00039896.1994.9954996; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Frink M, 2007, MOL IMMUNOL, V44, P2625, DOI 10.1016/j.molimm.2006.12.009; Fry RC, 2007, PLOS GENET, V3, P2180, DOI 10.1371/journal.pgen.0030207; Gremese E, 2011, AUTOIMMUN REV, V10, P582, DOI 10.1016/j.autrev.2011.04.018; Gruss HJ, 1996, ANN ONCOL, V7, P19; Guha Mazumder D N, 2001, J Indian Med Assoc, V99, P314; Hildebrand F, 2006, AM J PATHOL, V169, P784, DOI 10.2353/ajpath.2006.060010; Hill DS, 2008, BIRTH DEFECTS RES B, V83, P40, DOI 10.1002/bdrb.20142; Hollan I, 2007, ARTHRITIS RHEUM, V56, P2072, DOI 10.1002/art.22690; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Medrano MJ, 2010, ENVIRON RES, V110, P448, DOI 10.1016/j.envres.2009.10.002; Khalil S, 2006, J CELL PHYSIOL, V207, P562, DOI 10.1002/jcp.20599; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Ku IA, 2009, CIRC J, V73, P977, DOI 10.1253/circj.CJ-09-0274; Lau Christopher, 2004, Birth Defects Res C Embryo Today, V72, P300, DOI 10.1002/bdrc.20029; Lewis DR, 1999, ENVIRON HEALTH PERSP, V107, P359, DOI 10.2307/3434539; Lindholm E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002546; Liu J, 2004, TOXICOL SCI, V77, P249, DOI 10.1093/toxsci/kfh055; Love-Gregory L, 2007, CURR OPIN CLIN NUTR, V10, P397, DOI 10.1097/MCO.0b013e3281e3888d; Lu KP, 2002, ATHEROSCLEROSIS, V160, P273, DOI 10.1016/S0021-9150(01)00581-0; Lu TH, 2011, TOXICOL LETT, V201, P15, DOI 10.1016/j.toxlet.2010.11.019; Ma TH, 1996, GENOMICS, V35, P543, DOI 10.1006/geno.1996.0396; Salazar AM, 2010, CHEM RES TOXICOL, V23, P357, DOI 10.1021/tx900353v; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; MAZUMDER DNG, 2001, J INDIAN MED ASSOC, V99, P320; MILATOVICH A, 1991, GENOMICS, V11, P1040, DOI 10.1016/0888-7543(91)90030-I; National Research Council, 1999, ARS DRINK WAT; Navas-Acien A, 2006, ENVIRON HEALTH PERSP, V114, P641, DOI 10.1289/ehp.8551; NRC (National Research Council), 2001, ARSENIC DRINKING WAT; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Punthakee Z, 2007, REV CARDIOVASC MED, V8, P145; Rahman MM, 2005, CLIN TOXICOL, V43, P823, DOI 10.1080/15563650500357461; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; ROSENBERG HG, 1973, CIRCULATION, V47, P270, DOI 10.1161/01.CIR.47.2.270; ROSENBERG HG, 1974, ARCH PATHOL, V97, P360; Salbaum JM, 2009, BIRTH DEFECTS RES A, V85, P303, DOI 10.1002/bdra.20537; Schindhelm RK, 2007, ATHEROSCLEROSIS, V191, P391, DOI 10.1016/j.atherosclerosis.2006.04.006; Schnabl B, 2008, BIOCHEM BIOPH RES CO, V375, P210, DOI 10.1016/j.bbrc.2008.07.150; Sewter C, 2002, DIABETES, V51, P1035, DOI 10.2337/diabetes.51.4.1035; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Sharan R, 2003, BIOINFORMATICS, V19, P1787, DOI 10.1093/bioinformatics/btg232; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Sookoian S, 2010, ATHEROSCLEROSIS, V209, P585, DOI 10.1016/j.atherosclerosis.2009.10.011; Srivastava S, 2002, AM J PHYSIOL-HEART C, V283, pH2612, DOI 10.1152/ajpheart.00592.2002; Srivastava S, 2007, REPROD TOXICOL, V23, P449, DOI 10.1016/j.reprotox.2007.01.005; Srivastava S, 2009, TOXICOL APPL PHARM, V241, P90, DOI 10.1016/j.taap.2009.08.004; States JC, 2011, ENVIRON HEALTH PERSP, V119, P1356, DOI 10.1289/ehp.1103441; States JC, 2009, TOXICOL SCI, V107, P312, DOI 10.1093/toxsci/kfn236; Straub AC, 2007, HEPATOLOGY, V45, P205, DOI 10.1002/hep.21444; Tang CH, 2009, TOXICOL APPL PHARM, V241, P173, DOI 10.1016/j.taap.2009.08.011; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tokar EJ, 2011, TOXICOL SCI, V119, P73, DOI 10.1093/toxsci/kfq315; Tokar EJ, 2010, JNCI-J NATL CANCER I, V102, P638, DOI 10.1093/jnci/djq093; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; Tseng CH, 2002, TOXICOL LETT, V133, P69, DOI 10.1016/S0378-4274(02)00085-1; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Waalkes MP, 2003, TOXICOL APPL PHARM, V186, P7, DOI 10.1016/S0041-008X(02)00022-4; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Wlodarczyk BJ, 2006, NEUROTOXICOLOGY, V27, P547, DOI 10.1016/j.neuro.2006.02.005; Yang YZ, 2004, ATHEROSCLEROSIS, V173, P211, DOI 10.1016/j.atherosclerosis.2003.12.023; Zhang H, 2007, EXP EYE RES, V85, P825, DOI 10.1016/j.exer.2007.08.018; Zhang XM, 2010, CELL STRESS CHAPERON, V15, P675, DOI 10.1007/s12192-010-0180-3	79	47	47	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38713	10.1371/journal.pone.0038713	http://dx.doi.org/10.1371/journal.pone.0038713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719926	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350000021
J	El Agha, E; Al Alam, D; Carraro, G; MacKenzie, B; Goth, K; De Langhe, SP; Voswinckel, R; Hajihosseini, MK; Rehan, VK; Bellusci, S				El Agha, Elie; Al Alam, Denise; Carraro, Gianni; MacKenzie, BreAnne; Goth, Kerstin; De Langhe, Stijn P.; Voswinckel, Robert; Hajihosseini, Mohammad K.; Rehan, Virender K.; Bellusci, Saverio			Characterization of a Novel Fibroblast Growth Factor 10 (Fgf10) Knock-In Mouse Line to Target Mesenchymal Progenitors during Embryonic Development	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-10; FGF10-EXPRESSING CELLS; INDUCTION; LIMB; ATRESIA; GENES; FGFR2	Fibroblast growth factor 10 (Fgf10) is a key regulator of diverse organogenetic programs during mouse development, particularly branching morphogenesis. Fgf10-null mice suffer from lung and limb agenesis as well as cecal and colonic atresia and are thus not viable. To date, the Mlcv1v-nLacZ-24 transgenic mouse strain (referred to as Fgf10(LacZ)), which carries a LacZ insertion 114 kb upstream of exon 1 of Fgf10 gene, has been the only strain to allow transient lineage tracing of Fgf10-positive cells. Here, we describe a novel Fgf10(Cre-ERT2) knock-in line (Fgf10(iCre)) in which a Cre-ERT2-IRES-YFP cassette has been introduced in frame with the ATG of exon 1 of Fgf10 gene. Our studies show that Cre-ERT2 insertion disrupts Fgf10 function. However, administration of tamoxifen to Fgf10(iCre); Tomato(flox) double transgenic embryos or adult mice results in specific labeling of Fgf10-positive cells, which can be lineage-traced temporally and spatially. Moreover, we show that the Fgf10(iCre) line can be used for conditional gene inactivation in an inducible fashion during early developmental stages. We also provide evidence that transcription factors located in the first intron of Fgf10 gene are critical for maintaining Fgf10 expression over time. Thus, the Fgf10(iCre) line should serve as a powerful tool to explore the functions of Fgf10 in a controlled and stage-specific manner.	[El Agha, Elie; Carraro, Gianni; MacKenzie, BreAnne; Goth, Kerstin; Bellusci, Saverio] UGMLC, Giessen, Hessen, Germany; [Al Alam, Denise; Bellusci, Saverio] Univ So Calif, Childrens Hosp Los Angeles, Saban Res Inst, Dev Biol & Regenerat Med Program, Los Angeles, CA USA; [De Langhe, Stijn P.] Natl Jewish Hlth, Dept Pediat, Div Cell Biol, Denver, CO USA; [Voswinckel, Robert] Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodelling, Bad Nauheim, Hessen, Germany; [Hajihosseini, Mohammad K.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Rehan, Virender K.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles Biomed Res Inst Harbor UCLA, Harbor UCLA Med Ctr,Dept Pediat, Torrance, CA USA	Children's Hospital Los Angeles; University of Southern California; National Jewish Health; Max Planck Society; University of East Anglia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Lundquist Institute	El Agha, E (corresponding author), UGMLC, Giessen, Hessen, Germany.	saverio.bellusci@innere.med.uni-giessen.de	De Langhe, Stijn/ABH-6876-2020; MacKenzie, BreAnne/F-5700-2014; Alam, Denise Al/AAG-9406-2019	De Langhe, Stijn/0000-0003-3867-4572; MacKenzie, BreAnne/0000-0002-8336-6408; Carraro, Gianni/0000-0003-0824-7692; El Agha, Elie/0000-0001-7504-3417	National Institutes of Health (NIH) [RO1]; Excellence Cluster in Cardio-Pulmonary system; Deutsche Forschungsgemeinschaft (DFG), LOEWE; American Heart Association (AHA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092967] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Excellence Cluster in Cardio-Pulmonary system(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG), LOEWE(German Research Foundation (DFG)); American Heart Association (AHA)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Bellusci received funding from the National Institutes of Health (NIH) RO1 grants as well as Excellence Cluster in Cardio-Pulmonary system, Deutsche Forschungsgemeinschaft (DFG), LOEWE. Dr. Al Alam received funding from the American Heart Association (AHA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler LL, 2009, DEV DYNAM, V238, P1999, DOI 10.1002/dvdy.22032; Al Alam D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023139; Alvarez Y, 2003, DEVELOPMENT, V130, P6329, DOI 10.1242/dev.00881; Brocard J, 1998, NUCLEIC ACIDS RES, V26, P4086, DOI 10.1093/nar/26.17.4086; Cebra-Thomas JA, 2003, DEV DYNAM, V226, P82, DOI 10.1002/dvdy.10208; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Fairbanks TJ, 2005, J PEDIATR SURG, V40, P390, DOI 10.1016/j.jpedsurg.2004.10.023; Fairbanks TJ, 2004, J SURG RES, V120, P201, DOI 10.1016/j.jss.2003.12.017; Golzio C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030677; Gupte VV, 2009, AM J RESP CRIT CARE, V180, P424, DOI 10.1164/rccm.200811-1794OC; Hajihosseini MK, 2008, MOL CELL NEUROSCI, V37, P857, DOI 10.1016/j.mcn.2008.01.008; Hamada K, 1999, Exp Dermatol, V8, P347; Kanard RC, 2005, J PEDIATR SURG, V40, P313, DOI 10.1016/j.jpedsurg.2004.10.057; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Liu Y, 2002, DEVELOPMENT, V129, P5289; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mailleux AA, 2005, DEVELOPMENT, V132, P2157, DOI 10.1242/dev.01795; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Ramasamy SK, 2007, DEV BIOL, V307, P237, DOI 10.1016/j.ydbio.2007.04.033; Sala FG, 2011, DEVELOPMENT, V138, P273, DOI 10.1242/dev.051680; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Tiozzo C, 2009, PEDIATR RES, V66, P386, DOI 10.1203/PDR.0b013e3181b45580; Urness LD, 2010, DEV BIOL, V340, P595, DOI 10.1016/j.ydbio.2010.02.016; Veltmaat JM, 2006, DEVELOPMENT, V133, P2325, DOI 10.1242/dev.02394	26	40	40	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38452	10.1371/journal.pone.0038452	http://dx.doi.org/10.1371/journal.pone.0038452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719891	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000305341900029
J	Horimatsu, T; Muto, M; Yoda, Y; Yano, T; Ezoe, Y; Miyamoto, S; Chiba, T				Horimatsu, Takahiro; Muto, Manabu; Yoda, Yusuke; Yano, Tomonori; Ezoe, Yasumasa; Miyamoto, Shinichi; Chiba, Tsutomu			Tissue Damage in the Canine Normal Esophagus by Photoactivation with Talaporfin Sodium (Laserphyrin): A Preclinical Study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PHOTODYNAMIC THERAPY; NPE6; CANCER; CHEMORADIOTHERAPY; ESOPHAGECTOMY; LUNG	Background: Treatment failure at the primary site after chemoradiotherapy is a major problem in achieving a complete response. Photodynamic therapy (PDT) with porfimer sodium (Photofrin (R)) has some problems such as the requirement for shielding from light for several weeks and a high incidence of skin phototoxicity. PDT with talaporfin sodium (Laserphyrin) is less toxic and is expected to have a better effect compared with Photofrin PDT. However, Laserphyrin PDT is not approved for use in the esophagus. In this preclinical study, we investigated tissue damage of the canine normal esophagus caused by photoactivation with Laserphyrin. Methodology/Principal Findings: Diode laser irradiation was performed at 60 min after administration. An area 5 cm oral to the esophagogastric junction was irradiated at 25 J/cm(2), 50 J/cm(2), and 100 J/cm(2) using a three-step escalation. The irradiated areas were evaluated endoscopically on postirradiation days 1 and 7, and were subjected to histological examination after autopsy. The areas injured by photoactivation were 52 mm(2), 498 mm(2), and 831 mm(2) after irradiation at 25 J/cm(2), 50 J/cm(2), and 100 J/cm(2), respectively. Tissue injury was observed in the muscle layer or even deeper at any irradiation level and became more severe as the irradiation dose increased. At 100 J/cm(2) both inflammatory changes and necrosis were seen histologically in extra-adventitial tissue. Conclusions/Significance: To minimize injury of the normal esophagus by photoactivation with Laserphyrin, diode laser irradiation at 25 J/cm(2) appears to be safe. For human application, it would be desirable to investigate the optimal laser dose starting from this level.	[Horimatsu, Takahiro; Muto, Manabu; Yoda, Yusuke; Yano, Tomonori; Ezoe, Yasumasa; Miyamoto, Shinichi; Chiba, Tsutomu] Kyoto Univ, Grad Sch Med, Dept Gastroenterol, Kyoto, Japan	Kyoto University	Horimatsu, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol, Kyoto, Japan.	thorimat@kuhp.kyoto-u.ac.jp		Horimatsu, Takahiro/0000-0002-4188-9059	Ministry of Health, Labor, and Welfare of Japan [H21-Rinshokenkyu-Ippan-018]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by grants-in-aid for cancer research from the Ministry of Health (H21-Rinshokenkyu-Ippan-018), Labor, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZAWA K, 1987, PHOTOCHEM PHOTOBIOL, V46, P789, DOI 10.1111/j.1751-1097.1987.tb04849.x; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; DOUGHERTY TJ, 1992, EUR J CANCER, V28A, P1734, DOI 10.1016/0959-8049(92)90080-L; DOUGHERTY TJ, 1990, LASER SURG MED, V10, P485, DOI 10.1002/lsm.1900100514; Kato H, 2003, LUNG CANCER, V42, P103, DOI 10.1016/S0169-5002(03)00242-3; MANYAK MJ, 1988, J CLIN ONCOL, V6, P380, DOI 10.1200/JCO.1988.6.2.380; NELSON JS, 1987, CANCER RES, V47, P4681; Overholt BF, 1999, GASTROINTEST ENDOSC, V49, P1, DOI 10.1016/S0016-5107(99)70437-2; PASS HI, 1993, JNCI-J NATL CANCER I, V85, P443, DOI 10.1093/jnci/85.6.443; Savary JF, 1998, ENDOSCOPY, V30, P258, DOI 10.1055/s-2007-1001252; Swisher SG, 2002, J THORAC CARDIOV SUR, V123, P175, DOI 10.1067/mtc.2002.119070; Swisher SG, 2000, J THORAC CARDIOV SUR, V119, P1126, DOI 10.1067/mtc.2000.105644; Usuda J, 2007, LUNG CANCER, V58, P317, DOI 10.1016/j.lungcan.2007.06.026; Usuda J, 2010, CLIN CANCER RES, V16, P2198, DOI 10.1158/1078-0432.CCR-09-2520; Yano T, 2005, GASTROINTEST ENDOSC, V62, P31, DOI 10.1016/S0016-5107(05)00545-6; Yano T, 2011, ENDOSCOPY, V43, P657, DOI 10.1055/s-0030-1256373; Yoshida K, 1993, Gan To Kagaku Ryoho, V20, P2063	17	17	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38308	10.1371/journal.pone.0038308	http://dx.doi.org/10.1371/journal.pone.0038308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719875	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900023
J	Wan, OW; Chung, KKK				Wan, Oi Wan; Chung, Kenny K. K.			The Role of Alpha-Synuclein Oligomerization and Aggregation in Cellular and Animal Models of Parkinson's Disease	PLOS ONE			English	Article							INCLUSION FORMATION; ALZHEIMERS-DISEASE; IN-VITRO; PROTEIN; MUTATION; FIBRILLIZATION; MUTANT; NACP; E46K	alpha-synuclein (alpha-syn) is a synaptic protein in which four mutations (A53T, A30P, E46K and gene triplication) have been found to cause an autosomal dominant form of Parkinson's disease (PD). It is also the major component of intraneuronal protein aggregates, designated as Lewy bodies (LBs), a prominent pathological hallmark of PD. How alpha-syn contributes to LB formation and PD is still not well-understood. It has been proposed that aggregation of alpha-syn contributes to the formation of LBs, which then leads to neurodegeneration in PD. However, studies have also suggested that aggregates formation is a protective mechanism against more toxic alpha-syn oligomers. In this study, we have generated alpha-syn mutants that have increased propensity to form aggregates by attaching a CL1 peptide to the C-terminal of alpha-syn. Data from our cellular study suggest an inverse correlation between cell viability and the amount of alpha-syn aggregates formed in the cells. In addition, our animal model of PD indicates that attachment of CL1 to alpha-syn enhanced its toxicity to dopaminergic neurons in an age-dependent manner and induced the formation of Lewy body-like alpha-syn aggregates in the substantia nigra. These results provide new insights into how alpha-syn-induced toxicity is related to its aggregation.	[Wan, Oi Wan; Chung, Kenny K. K.] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Wan, OW (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China.	bckchung@ust.hk			Research Grants Council of Hong Kong [HIA05/06.SC04, AoE/B-15/01, SBI09/10.SC01]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work is supported by Research Grants Council of Hong Kong (HIA05/06.SC04, AoE/B-15/01, SBI09/10.SC01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Breydo L, 2011, BIOCH BIOPHYS ACTA; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chen L, 2009, J CLIN INVEST, V119, P3257, DOI 10.1172/JCI39088; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Devine MJ, 2011, MOV DISORD; FAUVET B, 2012, J BIOL CHEM; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Galvin J E, 1999, Adv Neurol, V80, P313; Gao HM, 2008, J NEUROSCI, V28, P7687, DOI 10.1523/JNEUROSCI.0143-07.2008; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Hong DP, 2009, BBA-PROTEINS PROTEOM, V1794, P282, DOI 10.1016/j.bbapap.2008.09.026; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Hoyer WG, 2004, J MOL BIOL, V340, P127, DOI 10.1016/j.jmb.2004.04.051; Jin WY, 2006, J NEUROSCI, V26, P2380, DOI 10.1523/JNEUROSCI.3503-05.2006; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kim J, 1997, MOL CELLS, V7, P78; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Link CD, 2006, J BIOL CHEM, V281, P1808, DOI 10.1074/jbc.M505581200; Lou HY, 2010, J BIOL CHEM, V285, P17648, DOI 10.1074/jbc.M110.100867; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; POLLANEN MS, 1993, J NEUROPATH EXP NEUR, V52, P183, DOI 10.1097/00005072-199305000-00001; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Wang J, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.004; Waxman EA, 2009, BBA-MOL BASIS DIS, V1792, P616, DOI 10.1016/j.bbadis.2008.09.013; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Xie WL, 2010, BBA-MOL BASIS DIS, V1802, P935, DOI 10.1016/j.bbadis.2010.07.014; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	48	64	66	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38545	10.1371/journal.pone.0038545	http://dx.doi.org/10.1371/journal.pone.0038545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701661	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340000030
J	White, JR; Patel, J; Ottesen, A; Arce, G; Blackwelder, P; Lopez, JV				White, James R.; Patel, Jignasa; Ottesen, Andrea; Arce, Gabriela; Blackwelder, Patricia; Lopez, Jose V.			Pyrosequencing of Bacterial Symbionts within Axinella corrugata Sponges: Diversity and Seasonal Variability	PLOS ONE			English	Article							SULFUR-OXIDIZING BACTERIA; MARINE SPONGE; DEEP-SEA; EMENDED DESCRIPTION; GEN. NOV.; CELL; ECTOTHIORHODOSPIRACEAE; AMPLIFICATION; PORIBACTERIA; DEMOSPONGIAE	Background: Marine sponge species are of significant interest to many scientific fields including marine ecology, conservation biology, genetics, host-microbe symbiosis and pharmacology. One of the most intriguing aspects of the sponge "holobiont" system is the unique physiology, interaction with microbes from the marine environment and the development of a complex commensal microbial community. However, intraspecific variability and temporal stability of sponge-associated bacterial symbionts remain relatively unknown. Methodology/Principal Findings: We have characterized the bacterial symbiont community biodiversity of seven different individuals of the Caribbean reef sponge Axinella corrugata, from two different Florida reef locations during variable seasons using multiplex 454 pyrosequencing of 16 S rRNA amplicons. Over 265,512 high-quality 16 S rRNA sequences were generated and analyzed. Utilizing versatile bioinformatics methods and analytical software such as the QIIME and CloVR packages, we have identified 9,444 distinct bacterial operational taxonomic units (OTUs). Approximately 65,550 rRNA sequences (24%) could not be matched to bacteria at the class level, and may therefore represent novel taxa. Differentially abundant classes between seasonal Axinella communities included Gammaproteobacteria, Flavobacteria, Alphaproteo-bacteria, Cyanobacteria, Acidobacter and Nitrospira. Comparisons with a proximal outgroup sponge species (Amphimedon compressa), and the growing sponge symbiont literature, indicate that this study has identified approximately 330 A. corrugata-specific symbiotic OTUs, many of which are related to the sulfur-oxidizing Ectothiorhodospiraceae. This family appeared exclusively within A. corrugata, comprising >34.5% of all sequenced amplicons. Other A. corrugata symbionts such as Deltaproteobacteria, Bdellovibrio, and Thiocystis among many others are described. Conclusions/Significance: Slight shifts in several bacterial taxa were observed between communities sampled during spring and fall seasons. New 16 S rDNA sequences and concomitant identifications greatly expand the microbial community profile for this model reef sponge, and will likely be useful as a baseline for any future comparisons regarding sponge microbial community dynamics.	[White, James R.; Patel, Jignasa; Blackwelder, Patricia; Lopez, Jose V.] Nova SE Univ, Oceanog Ctr, Dania, FL USA; [Ottesen, Andrea; Arce, Gabriela] US FDA, Off Regulatory Sci, Div Microbiol, College Pk, MD USA; [Blackwelder, Patricia] Univ Miami, Ctr Adv Microscopy & Marine Geol & Geophys, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL USA	Nova Southeastern University; US Food & Drug Administration (FDA); University of Miami	White, JR (corresponding author), Nova SE Univ, Oceanog Ctr, Dania, FL USA.	joslo@nova.edu	Lopez, Jose V/F-8809-2011	Lopez, Jose V/0000-0002-1637-4125; Blackwelder, Patricia/0000-0003-0989-2976	National Science Foundation [DEB-0829271]; NSU President's Faculty Research Development Grant; Direct For Biological Sciences [0829791] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NSU President's Faculty Research Development Grant; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	PI Lopez is funded through National Science Foundation grant DEB-0829271, and an internal NSU President's Faculty Research Development Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelzaher AM, 2010, APPL ENVIRON MICROB, V76, P724, DOI 10.1128/AEM.02127-09; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez B, 1998, SMITHSONIAN CONTRIBU, P598; Andrade P, 1999, TETRAHEDRON LETT, V40, P4775, DOI 10.1016/S0040-4039(99)00881-3; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; [Anonymous], 2002, HIST PHIL LIFE SCI; Banks Kenneth W., 2008, V1, P175, DOI 10.1007/978-1-4020-6847-8_5; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Bernardet JF, 2002, INT J SYST EVOL MICR, V52, P1049, DOI 10.1099/00207713-52-3-1049; BRAEKMAN JC, 1989, PURE APPL CHEM, V61, P509, DOI 10.1351/pac198961030509; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cassler M, 2008, MICROB ECOL, V55, P384, DOI 10.1007/s00248-007-9283-5; Chen VB, 2009, PROTEIN SCI, V18, P2403, DOI 10.1002/pro.250; Cho JC, 2003, INT J SYST EVOL MICR, V53, P1031, DOI 10.1099/ijs.0.02566-0; Diaz MC, 2004, B MUS I BIOL U GEN, V68, P279; Duckworth AR, 2003, MAR BIOTECHNOL, V5, P519, DOI 10.1007/s10126-002-0111-0; Fieseler L, 2004, APPL ENVIRON MICROB, V70, P3724, DOI 10.1128/aem.70.6.3724-3732.2004; Foti M, 2006, FEMS MICROBIOL ECOL, V56, P95, DOI 10.1111/j.1574-6941.2006.00068.x; Galkiewicz JP, 2008, APPL ENVIRON MICROB, V74, P7828, DOI 10.1128/AEM.01303-08; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Hill M, 2006, MAR BIOL, V148, P1221, DOI 10.1007/s00227-005-0164-5; Hill R, 2004, MICROBIAL DIVERSITY; Hoffmann F, 2009, ENVIRON MICROBIOL, V11, P2228, DOI 10.1111/j.1462-2920.2009.01944.x; Hooper John N. A., 1993, Invertebrate Taxonomy, V7, P1395, DOI 10.1071/IT9931395; IMHOFF JF, 1984, INT J SYST BACTERIOL, V34, P338, DOI 10.1099/00207713-34-3-338; Imhoff JF, 1996, ARCH MICROBIOL, V165, P106, DOI 10.1007/s002030050304; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Lafi FF, 2009, APPL ENVIRON MICROB, V75, P5695, DOI 10.1128/AEM.00035-09; Lopez JV, 2002, J HERED, V93, P27, DOI 10.1093/jhered/93.1.27; Lopez JV, 1999, MEMOIRS QUEENSLAND M, P44; Lopez JV, 2010, P 11 INT COR REEF S, P1362; Lu Z, 2011, ISME J; Messing CG, 2010, TAXON PAGE AXINELLA; Middelburg JJ, 1996, GLOBAL BIOGEOCHEM CY, V10, P661, DOI 10.1029/96GB02562; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P2910, DOI 10.1111/j.1462-2920.2008.01704.x; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Munro MHG, 1994, SEABED SICKBED WHAT; Negandhi K, 2010, SYMBIOSIS, V51, P117, DOI 10.1007/s13199-010-0059-1; Pile AJ, 1996, MAR ECOL PROG SER, V141, P95, DOI 10.3354/meps141095; Pomponi S, 1997, DEV TECHNIQUES IN VI; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; REISWIG HM, 1971, MAR BIOL, V9, P38, DOI 10.1007/BF00348816; Ruetzler K., 2004, BOLL MUS IST BIOL UN, V68, P85; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sambrook J, 2001, MOL CLONING LAB MANU; SANTAVY DL, 1990, APPL ENVIRON MICROB, V56, P1750, DOI 10.1128/AEM.56.6.1750-1762.1990; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmitt S, 2011, ISME J; Sfanos K, 2005, SYST APPL MICROBIOL, V28, P242, DOI 10.1016/j.syapm.2004.12.002; Simpson T., 1984, CELL BIOL SPONGES; Sipkema D, 2005, BIOTECHNOL BIOENG, V90, P201, DOI 10.1002/bit.20404; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sorokin DY, 2005, FEMS MICROBIOL REV, V29, P685, DOI 10.1016/j.femsre.2004.10.005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Tsuihij H, 2006, J BIOSCI BIOENG, V101, P263, DOI 10.1263/jbb.101.263; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Wilderen LJGW, 2006, P NATL ACAD SCI USA, V103, P15050, DOI 10.1073/pnas.0603476103; VOGEL S, 1977, P NATL ACAD SCI USA, V74, P2069, DOI 10.1073/pnas.74.5.2069; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Webster NS, 2009, ISME J, V3, P1, DOI 10.1038/ismej.2008.102; Webster NS, 2011, ENV MICROBIOLOGY; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; WILKINSON CR, 1981, MICROBIAL ECOL, V7, P13, DOI 10.1007/BF02010474; Willoughby R, 2000, IN VITRO CELL DEV-AN, V36, P194; Wilson DM, 1999, J CHEM ECOL, V25, P2811, DOI 10.1023/A:1020811810223; WRIGHT AE, 1991, J NAT PROD, V54, P1684, DOI 10.1021/np50078a034; Ying JY, 2007, INT J SYST EVOL MICR, V57, P1711, DOI 10.1099/ijs.0.64825-0	72	61	61	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38204	10.1371/journal.pone.0038204	http://dx.doi.org/10.1371/journal.pone.0038204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701613	Green Published, gold			2022-12-25	WOS:000305340000013
J	Fung, ICH; Antia, R; Handel, A				Fung, Isaac Chun-Hai; Antia, Rustom; Handel, Andreas			How to Minimize the Attack Rate during Multiple Influenza Outbreaks in a Heterogeneous Population	PLOS ONE			English	Article							PANDEMIC INFLUENZA; SCHOOL CLOSURE; ANTIVIRAL RESISTANCE; DRUG-RESISTANCE; TRANSMISSION; STRATEGIES; SPREAD; INFECTION; VIRUS; MODEL	Background: If repeated interventions against multiple outbreaks are not feasible, there is an optimal level of control during the first outbreak. Any control measures above that optimal level will lead to an outcome that may be as sub-optimal as that achieved by an intervention that is too weak. We studied this scenario in more detail. Method: An age-stratified ordinary-differential-equation model was constructed to study infectious disease outbreaks and control in a population made up of two groups, adults and children. The model was parameterized using influenza as an example. This model was used to simulate two consecutive outbreaks of the same infectious disease, with an intervention applied only during the first outbreak, and to study how cumulative attack rates were influenced by population composition, strength of inter-group transmission, and different ways of triggering and implementing the interventions. We assumed that recovered individuals are fully immune and the intervention does not confer immunity. Results/Conclusion: The optimal intervention depended on coupling between the two population sub-groups, the length, strength and timing of the intervention, and the population composition. Population heterogeneity affected intervention strategies only for very low cross-transmission between groups. At more realistic values, coupling between the groups led to synchronization of outbreaks and therefore intervention strategies that were optimal in reducing the attack rates for each subgroup and the population overall coincided. For a sustained intervention of low efficacy, early intervention was found to be best, while at high efficacies, a delayed start was better. For short interventions, a delayed start was always advantageous, independent of the intervention efficacy. For most scenarios, starting the intervention after a certain cumulative proportion of children were infected seemed more robust in achieving close to optimal outcomes compared to a strategy that used a specified duration after an outbreak's beginning as the trigger.	[Fung, Isaac Chun-Hai; Handel, Andreas] Univ Georgia, Dept Epidemiol & Biostat, Coll Publ Hlth, Athens, GA 30602 USA; [Antia, Rustom] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	University System of Georgia; University of Georgia; Emory University	Fung, ICH (corresponding author), Univ Georgia, Dept Epidemiol & Biostat, Coll Publ Hlth, Athens, GA 30602 USA.	ichfung@gmail.com	Handel, Andreas/F-6056-2012	Handel, Andreas/0000-0002-4622-1146; Fung, Isaac Chun-Hai/0000-0001-5496-2529	National Institute of General Medical Sciences MIDAS [U01-GM070749]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070749] Funding Source: NIH RePORTER	National Institute of General Medical Sciences MIDAS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Rustom Antia was partially supported by the National Institute of General Medical Sciences MIDAS grant U01-GM070749. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alexander ME, 2007, P R SOC B, V274, P1675, DOI 10.1098/rspb.2007.0422; Alexander ME, 2009, J THEOR BIOL, V259, P253, DOI 10.1016/j.jtbi.2009.03.029; ANDERSON R M, 1991; Boelle PY, 2009, EUROSURVEILLANCE, V14, P10; Brown ST, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-353; Camacho A, 2011, P BIOL SCI; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Coburn BJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-30; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2003, J ANTIMICROB CHEMOTH, V51, P977, DOI 10.1093/jac/dkg136; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; FRANK AL, 1981, J INFECT DIS, V144, P433, DOI 10.1093/infdis/144.5.433; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Hahne S., 2009, EUROSURVEILLANCE, V14; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Handel A, 2007, P ROY SOC B-BIOL SCI, V274, P833, DOI 10.1098/rspb.2006.0015; Handel A, 2009, J THEOR BIOL, V256, P117, DOI 10.1016/j.jtbi.2008.09.021; Hansen Elsa, 2010, Can J Infect Dis Med Microbiol, V21, pe28; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; House T, 2009, PLOS CURR, V1, DOI DOI 10.1371/CURRENTS.RRN1119; House T, 2011, P BIOL SCI; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ., 2008, MODELING INFECT DIS, DOI [DOI 10.1515/9781400841035, 10.1515/9781400841035]; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Lee BY, 2010, J PUBLIC HEALTH MAN, V16, P252, DOI 10.1097/PHH.0b013e3181ce594e; Lipsitch M, 2006, SCIENCE, V312, P845; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mathews JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001220; Mills CE, 2006, PLOS MED, V3, P769, DOI 10.1371/journal.pmed.0030135; Moghadas SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001839; Moghadas SM, 2008, P ROY SOC B-BIOL SCI, V275, P1163, DOI 10.1098/rspb.2008.0016; Munayco CV, 2009, EUROSURVEILLANCE, V14, P6; Nishiura H, 2009, EUROSURVEILLANCE, V14; Nishiura H, 2009, NEW ZEAL MED J, V122, P73; Perez CM, 2010, EMERG INFECT DIS, V16, P156, DOI 10.3201/eid1601.091420; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Sadique MZ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-135; Wessel L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S2; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216; Wu JT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000085; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	48	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e36573	10.1371/journal.pone.0036573	http://dx.doi.org/10.1371/journal.pone.0036573			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701558	Green Submitted, Green Published, gold			2022-12-25	WOS:000305337600005
J	Grommes, J; Vijayan, S; Drechsler, M; Hartwig, H; Morgelin, M; Dembinski, R; Jacobs, M; Koeppel, TA; Binnebosel, M; Weber, C; Soehnlein, O				Grommes, Jochen; Vijayan, Santosh; Drechsler, Maik; Hartwig, Helene; Moergelin, Matthias; Dembinski, Rolf; Jacobs, Michael; Koeppel, Thomas Andreas; Binneboesel, Marcel; Weber, Christian; Soehnlein, Oliver			Simvastatin Reduces Endotoxin-Induced Acute Lung Injury by Decreasing Neutrophil Recruitment and Radical Formation	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; PULMONARY INFLAMMATION; NADPH OXIDASE; ADHESION; REDUCTASE; STATINS; PROTEIN; INHIBITION; MONOCYTES; BARRIER	Introduction: Treatment of acute lung injury (ALI) remains an unsolved problem in intensive care medicine. As simvastatin exerts protective effects in inflammatory diseases we explored its effects on development of ALI and due to the importance of neutrophils in ALI also on neutrophil effector functions. Methods: C57Bl/6 mice were exposed to aerosolized LPS (500 mg/ml) for 30 min. The count of alveolar, interstitial, and intravasal neutrophils were assessed 4 h later by flow cytometry. Lung permeability changes were assessed by FITC-dextran clearance and albumin content in the BAL fluid. In vitro, we analyzed the effect of simvastatin on neutrophil adhesion, degranulation, apoptosis, and formation of reactive oxygen species. To monitor effects of simvastatin on bacterial clearance we performed phagocytosis and bacterial killing studies in vitro as well as sepsis experiments in mice. Results: Simvastatin treatment before and after onset of ALI reduces neutrophil influx into the lung as well as lung permeability indicating the protective role of simvastatin in ALI. Moreover, simvastatin reduces the formation of ROS species and adhesion of neutrophils without affecting apoptosis, bacterial phagocytosis and bacterial clearance. Conclusion: Simvastatin reduces recruitment and activation of neutrophils hereby protecting from LPS-induced ALI. Our results imply a potential role for statins in the management of ALI.	[Grommes, Jochen; Vijayan, Santosh; Weber, Christian; Soehnlein, Oliver] Rhein Westfal TH Aachen, IMCAR, D-52062 Aachen, Germany; [Grommes, Jochen; Jacobs, Michael; Koeppel, Thomas Andreas] Rhein Westfal TH Aachen, European Vasc Ctr Aachen Maastricht, D-52062 Aachen, Germany; [Grommes, Jochen; Jacobs, Michael; Koeppel, Thomas Andreas] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Hartwig, Helene; Weber, Christian; Soehnlein, Oliver] Univ Munich, Inst Cardiovasc Prevent, Munich, Germany; [Moergelin, Matthias] Lund Univ, Dept Clin Sci, Div Infect Med, Lund, Sweden; [Dembinski, Rolf] Rhein Westfal TH Aachen, Dept Intens Care Med, D-52062 Aachen, Germany; [Binneboesel, Marcel] Rhein Westfal TH Aachen, Dept Gen Visceral & Transplantat Surg, D-52062 Aachen, Germany; [Weber, Christian; Soehnlein, Oliver] Maastricht Univ, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands	RWTH Aachen University; Maastricht University; RWTH Aachen University; Maastricht University; University of Munich; Lund University; RWTH Aachen University; RWTH Aachen University; Maastricht University	Grommes, J (corresponding author), Rhein Westfal TH Aachen, IMCAR, D-52062 Aachen, Germany.	jgrommes@ukaachen.de; oliver.soehnlein@med.uni-muenchen.de	Dembinski, Rolf/Q-3060-2019; Weber, Christian/AAW-2153-2020; Drechsler, Maik/C-3829-2008	Weber, Christian/0000-0003-4610-8714; Grommes, Jochen/0000-0002-6419-6802	Deutsche Forschungsgemeinschaft [SO876/3-1, FOR809 TP2, TP9]; German Heart Foundation; Else-Kroner-Fresenius Foundation; B. Braun Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Heart Foundation; Else-Kroner-Fresenius Foundation; B. Braun Foundation	This study was supported by the Deutsche Forschungsgemeinschaft (SO876/3-1, FOR809 TP2, TP9), the German Heart Foundation, the Else-Kroner-Fresenius Foundation, and the B. Braun Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auten RL, 2002, AM J RESP CELL MOL, V26, P391, DOI 10.1165/ajrcmb.26.4.4708; Auten RL, 2001, J PHARMACOL EXP THER, V299, P90; Bdeir K, 2010, AM J RESP CRIT CARE, V181, P935, DOI 10.1164/rccm.200907-1128OC; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; Carnesecchi S, 2009, AM J RESP CRIT CARE, V180, P972, DOI 10.1164/rccm.200902-0296OC; Chen WG, 2008, AM J PHYSIOL-LUNG C, V295, pL575, DOI 10.1152/ajplung.00428.2007; Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118; Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005; Craig TR, 2010, AM J RESP CRIT CARE; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Fessler MB, 2005, AM J RESP CRIT CARE, V171, P606, DOI 10.1164/rccm.200406-729OC; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; Grommes J, 2012, EUR RESP J; Grommes J, 2012, AM J RESP CRIT CARE; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Jacobson JR, 2005, AM J PHYSIOL-LUNG C, V288, pL1026, DOI 10.1152/ajplung.00354.2004; Jacobson JR, 2004, AM J RESP CELL MOL, V30, P662, DOI 10.1165/rcmb.2003-0267OC; Kopterides P, 2009, CLIN MICROBIOL INFEC, V15, P325, DOI 10.1111/j.1469-0691.2009.02750.x; Kubo H, 1996, J CLIN INVEST, V97, P2680, DOI 10.1172/JCI118718; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; LAUFE MD, 1986, AM J MED, V80, P1022, DOI 10.1016/0002-9343(86)90659-5; Looney MR, 2006, J CLIN INVEST, V116, P1615, DOI 10.1172/JCI27238; Maher BM, 2009, J LEUKOCYTE BIOL, V85, P186, DOI 10.1189/jlb.0608382; MARTIN MA, 1992, CLIN INFECT DIS, V14, P1213, DOI 10.1093/clinids/14.6.1213; Massberg S, 2010, NAT MED; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Moreland JG, 2002, AM J RESP CELL MOL, V27, P474, DOI 10.1165/rcmb.4694; OGNIBENE FP, 1986, NEW ENGL J MED, V315, P547, DOI 10.1056/NEJM198608283150904; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004; Shyamsundar M, 2009, AM J RESP CRIT CARE, V179, P1107, DOI 10.1164/rccm.200810-1584OC; Soehnlein O, 2008, EUR RESPIR J, V32, P405, DOI 10.1183/09031936.00173207; Soehnlein O, 2008, CLIN EXP IMMUNOL, V151, P139, DOI 10.1111/j.1365-2249.2007.03532.x; Soehnlein O, 2008, J CLIN INVEST, V118, P3491, DOI 10.1172/JCI35740; Soehnlein O, 2008, BLOOD, V112, P1461, DOI 10.1182/blood-2008-02-139634; Soehnlein O, 2009, J MOL MED-JMM, V87, P1157, DOI 10.1007/s00109-009-0508-6; Soehnlein O, 2009, TRENDS IMMUNOL, V30, P546, DOI 10.1016/j.it.2009.06.006; Terblanche M, 2007, LANCET INFECT DIS, V7, P358, DOI 10.1016/S1473-3099(07)70111-1; Walter T, 2010, IN VIVO, V24, P189; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; WANG XZ, 1994, AM J RESP CRIT CARE, V150, P1449, DOI 10.1164/ajrccm.150.5.7952574; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weber C, 1997, J AM COLL CARDIOL, V30, P1212, DOI 10.1016/S0735-1097(97)00324-0; Zeng LX, 2005, FASEB J, V19, P1845, DOI 10.1096/fj.05-4240fje; Zhang S, 2011, AM J PHYSL LUNG CELL	48	64	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38917	10.1371/journal.pone.0038917	http://dx.doi.org/10.1371/journal.pone.0038917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701728	Green Submitted, Green Published, gold			2022-12-25	WOS:000305337600055
J	Liu, S; Fu, R; Zhou, LH; Chen, SP				Liu, Shu; Fu, Rao; Zhou, Li-Hua; Chen, Sheng-Ping			Application of Consensus Scoring and Principal Component Analysis for Virtual Screening against beta-Secretase (BACE-1)	PLOS ONE			English	Article							PROTEIN-LIGAND INTERACTIONS; STRUCTURE-BASED DESIGN; X-RAY CRYSTALLOGRAPHY; BINDING FREE-ENERGIES; APP CLEAVING ENZYME; MOLECULAR DOCKING; AUTOMATED DOCKING; FLEXIBLE DOCKING; CHEMICAL DATABASES; ACCURATE DOCKING	Background: In order to identify novel chemical classes of beta-secretase (BACE-1) inhibitors, an alternative scoring protocol, Principal Component Analysis (PCA), was proposed to summarize most of the information from the original scoring functions and re-rank the results from the virtual screening against BACE-1. Method: Given a training set (50 BACE-1 inhibitors and 9950 inactive diverse compounds), three rank-based virtual screening methods, individual scoring, conventional consensus scoring and PCA, were judged by the hit number in the top 1% of the ranked list. The docking poses were generated by Surflex, five scoring functions (Surflex_Score, D_Score, G_Score, ChemScore, and PMF_Score) were used for pose extraction. For each pose group, twelve scoring functions (Surflex_Score, D_Score, G_Score, ChemScore, PMF_Score, LigScore1, LigScore2, PLP1, PLP2, jain, Ludi_1, and Ludi_2) were used for the pose rank. For a test set, 113,228 chemical compounds (Sigma-Aldrich (R) corporate chemical directory) were docked by Surflex, then ranked by the same three ranking methods motioned above to select the potential active compounds for experimental test. Results: For the training set, the PCA approach yielded consistently superior rankings compared to conventional consensus scoring and single scoring. For the test set, the top 20 compounds according to conventional consensus scoring were experimentally tested, no inhibitor was found. Then, we relied on PCA scoring protocol to test another different top 20 compounds and two low micromolar inhibitors (S450588 and 276065) were emerged through the BACE-1 fluorescence resonance energy transfer (FRET) assay. Conclusion: The PCA method extends the conventional consensus scoring in a quantitative statistical manner and would appear to have considerable potential for chemical screening applications.	[Liu, Shu; Fu, Rao; Zhou, Li-Hua] Sun Yat Sen Univ, Zhong Shan Sch Med, Dept Anat, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Sheng-Ping] Sun Yat Sen Univ, Zhong Shan Sch Med, Guangdong Prov Key Lab Funct Mol Ocean Microorgan, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Liu, S (corresponding author), Sun Yat Sen Univ, Zhong Shan Sch Med, Dept Anat, Guangzhou 510275, Guangdong, Peoples R China.	chenshp@mail.sysu.edu.cn		Liu, Shu/0000-0002-6072-6036	National Natural Science Foundation of China [31171290, 41176128, 81070995]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present work was supported by the National Natural Science Foundation of China. Number of foundation: 31171290; 41176128; 81070995 (http://159.226.244.22/portal/Proj_List.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SYBYL VERS 8 1; [Anonymous], DISC STUD VERS 2 1; Ballester PJ, 2010, BIOINFORMATICS, V26, P1169, DOI 10.1093/bioinformatics/btq112; Baxter EW, 2007, J MED CHEM, V50, P4261, DOI 10.1021/jm0705408; Bea I, 2006, J ORG CHEM, V71, P2056, DOI 10.1021/jo052469o; Belyaev ND, 2010, J BIOL CHEM, V285, P41443, DOI 10.1074/jbc.M110.141390; BEVERIDGE DL, 1989, ANNU REV BIOPHYS BIO, V18, P431, DOI 10.1146/annurev.bb.18.060189.002243; Bissantz C, 2003, PROTEINS, V50, P5, DOI 10.1002/prot.10237; Bissantz C, 2000, J MED CHEM, V43, P4759, DOI 10.1021/jm001044l; Bohm HJ, 1998, J COMPUT AID MOL DES, V12, P309, DOI 10.1023/A:1007999920146; BOHM HJ, 1994, J COMPUT AID MOL DES, V8, P243, DOI 10.1007/BF00126743; Bortolato A, 2007, J CHEM INF MODEL, V47, P572, DOI 10.1021/ci600369n; Charifson PS, 1999, J MED CHEM, V42, P5100, DOI 10.1021/jm990352k; Chen LL, 2006, J BIOMOL SCREEN, V11, P915, DOI 10.1177/1087057106293295; Cheng TJ, 2009, J CHEM INF MODEL, V49, P1079, DOI 10.1021/ci9000053; Coburn CA, 2004, J MED CHEM, V47, P6117, DOI 10.1021/jm049388p; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Eriksson MAL, 1999, J MED CHEM, V42, P868, DOI 10.1021/jm980277y; Ewig CS, 2001, J COMPUT CHEM, V22, P1782, DOI 10.1002/jcc.1131; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GEHLHAAR DK, 1995, CHEM BIOL, V2, P317, DOI 10.1016/1074-5521(95)90050-0; Ghosh AK, 2008, NEUROTHERAPEUTICS, V5, P399, DOI 10.1016/j.nurt.2008.05.007; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Guo JX, 2004, J MED CHEM, V47, P5492, DOI 10.1021/jm049695v; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; Heberger K, 2003, J AGR FOOD CHEM, V51, P8055, DOI 10.1021/jf034851c; Heberger K, 1999, LIPIDS, V34, P83, DOI 10.1007/s11745-999-341-4; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Huang DZ, 2006, J AM CHEM SOC, V128, P5436, DOI 10.1021/ja0573108; Jacobsson M, 2003, J MED CHEM, V46, P5781, DOI 10.1021/jm030896t; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Jain AN, 1996, J COMPUT AID MOL DES, V10, P427, DOI 10.1007/BF00124474; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Konstantinou-Kirtay C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-27; Krammer A, 2005, J MOL GRAPH MODEL, V23, P395, DOI 10.1016/j.jmgm.2004.11.007; Lyne PD, 2002, DRUG DISCOV TODAY, V7, P1047, DOI 10.1016/S1359-6446(02)02483-2; Malnar M, 2010, BBA-MOL BASIS DIS, V1802, P682, DOI 10.1016/j.bbadis.2010.05.006; Mancini F, 2011, ANAL BIOANAL CHEM, V400, P1979, DOI 10.1007/s00216-011-4963-x; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Mooij WTM, 2005, PROTEINS, V61, P272, DOI 10.1002/prot.20588; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Muegge I, 1999, J MED CHEM, V42, P2498, DOI 10.1021/jm990073x; Muegge I, 1999, J MED CHEM, V42, P791, DOI 10.1021/jm980536j; Murray CW, 2007, J MED CHEM, V50, P1116, DOI 10.1021/jm0611962; Owens J, 2003, DRUG DISCOV TODAY, V8, P12, DOI 10.1016/S1359-6446(02)02556-4; Patel S, 2004, J MOL BIOL, V343, P407, DOI 10.1016/j.jmb.2004.08.018; Polgar T, 2005, J MED CHEM, V48, P3749, DOI 10.1021/jm049133b; Polgar T, 2007, J CHEM INF MODEL, V47, P2366, DOI 10.1021/ci700223p; Polgar T, 2006, J CHEM INF MODEL, V46, P1795, DOI 10.1021/ci050412x; Prakash MK, 2011, J AM CHEM SOC, V133, P9976, DOI 10.1021/ja201500z; Prathipati P, 2006, J CHEM INF MODEL, V46, P39, DOI 10.1021/ci050120w; Rahaman O, 2011, J CHEM INF MODEL; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Rastelli G, 2010, J COMPUT CHEM, V31, P797, DOI 10.1002/jcc.21372; Rosenfeld RJ, 2003, J COMPUT AID MOL DES, V17, P525, DOI 10.1023/B:JCAM.0000004604.87558.02; Ryan AJ, 2003, J MED CHEM, V46, P3448, DOI 10.1021/jm0340896; Seeliger D, 2010, BIOPHYS J, V98, P2309, DOI 10.1016/j.bpj.2010.01.051; Skrbic B, 2005, J AGR FOOD CHEM, V53, P2171, DOI 10.1021/jf0402577; Spitzer R., 2012, J COMPUT AIDED MOL D; Terp GE, 2001, J MED CHEM, V44, P2333, DOI 10.1021/jm001090l; Tuccinardi T, 2009, COMB CHEM HIGH T SCR, V12, P303, DOI 10.2174/138620709787581666; Vassar R, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt82; Verdonk ML, 2004, J CHEM INF COMP SCI, V44, P793, DOI 10.1021/ci034289q; Vilar S, 2011, J MOL GRAPH MODEL, V29, P614, DOI 10.1016/j.jmgm.2010.11.005; Wang RX, 2001, J CHEM INF COMP SCI, V41, P1422, DOI 10.1021/ci010025x; Wang RX, 2003, J MED CHEM, V46, P2287, DOI 10.1021/jm0203783; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Wang YS, 2010, J MED CHEM, V53, P942, DOI 10.1021/jm901472u; Wilton D, 2003, J CHEM INF COMP SCI, V43, P469, DOI 10.1021/ci025586i; Wilton DJ, 2006, J CHEM INF MODEL, V46, P471, DOI 10.1021/ci050397w; Xie QQ, 2011, EUR J MED CHEM, V46, P3675, DOI 10.1016/j.ejmech.2011.05.031; Xing L, 2004, J COMPUT AID MOL DES, V18, P333, DOI 10.1023/B:JCAM.0000047812.39758.ab	77	28	30	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38086	10.1371/journal.pone.0038086	http://dx.doi.org/10.1371/journal.pone.0038086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701601	Green Submitted, gold, Green Published			2022-12-25	WOS:000305337600014
J	He, JJ; Gu, H; Liu, WQ				He, Jianjun; Gu, Hong; Liu, Wenqi			Imbalanced Multi-Modal Multi-Label Learning for Subcellular Localization Prediction of Human Proteins with Both Single and Multiple Sites	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PROTEASE CLEAVAGE SITES; LOCATION PREDICTION; FUNCTIONAL DOMAIN; WEB SERVER; FUSION CLASSIFIER; EUK-MPLOC; VIRUS; SCALE; ENSEMBLE	It is well known that an important step toward understanding the functions of a protein is to determine its subcellular location. Although numerous prediction algorithms have been developed, most of them typically focused on the proteins with only one location. In recent years, researchers have begun to pay attention to the subcellular localization prediction of the proteins with multiple sites. However, almost all the existing approaches have failed to take into account the correlations among the locations caused by the proteins with multiple sites, which may be the important information for improving the prediction accuracy of the proteins with multiple sites. In this paper, a new algorithm which can effectively exploit the correlations among the locations is proposed by using Gaussian process model. Besides, the algorithm also can realize optimal linear combination of various feature extraction technologies and could be robust to the imbalanced data set. Experimental results on a human protein data set show that the proposed algorithm is valid and can achieve better performance than the existing approaches.	[He, Jianjun; Gu, Hong; Liu, Wenqi] Dalian Univ Technol, Sch Control Sci & Engn, Dalian, Liaoning, Peoples R China	Dalian University of Technology	He, JJ (corresponding author), Dalian Univ Technol, Sch Control Sci & Engn, Dalian, Liaoning, Peoples R China.	guhong@dlut.edu.cn			National Major Project of China [2009ZX09306-005, 2009ZX10004-701]; Liaoning Provincial Natural Science Foundation of China [20102025]	National Major Project of China; Liaoning Provincial Natural Science Foundation of China	This work is supported by National Major Project during the 11st Five-Year Plan Period of China (Grant No. 2009ZX09306-005, 2009ZX10004-701), and Liaoning Provincial Natural Science Foundation of China (Grant No. 20102025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briesemeister S, 2010, BIOINFORMATICS, V26, P1232, DOI 10.1093/bioinformatics/btq115; Chen L, 2010, MOLECULES, V15, P8177, DOI 10.3390/molecules15118177; Chen L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-293; Chen YL, 2007, J THEOR BIOL, V248, P377, DOI 10.1016/j.jtbi.2007.05.019; Chen YL, 2007, J THEOR BIOL, V245, P775, DOI 10.1016/j.jtbi.2006.11.010; Chou K.-C., 2010, NAT SCI IRVINE, V2, P1090, DOI [10.4236/ns.2010.210136, DOI 10.4236/NS.2010.210136]; Chou KC, 2005, BIOINFORMATICS, V21, P944, DOI 10.1093/bioinformatics/bti104; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; Chou KC, 1996, ANAL BIOCHEM, V233, P1, DOI 10.1006/abio.1996.0001; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; Chou KC, 1999, PROTEIN ENG, V12, P107, DOI 10.1093/protein/12.2.107; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1993, J BIOL CHEM, V268, P16938; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; CHOU KC, 2009, NAT SCI, V2, P63, DOI DOI 10.4236/NS.2009.12011; Chou KC, 2008, BIOCHEM BIOPH RES CO, V376, P321, DOI 10.1016/j.bbrc.2008.08.125; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2007, BIOCHEM BIOPH RES CO, V360, P339, DOI 10.1016/j.bbrc.2007.06.027; Chou KC, 2007, BIOCHEM BIOPH RES CO, V357, P633, DOI 10.1016/j.bbrc.2007.03.162; Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025297; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022940; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Imai K, 2010, PROTEOMICS, V10, P3970, DOI 10.1002/pmic.201000274; Jiang XY, 2008, PROTEIN PEPTIDE LETT, V15, P392, DOI 10.2174/092986608784246443; Lee K, 2006, NUCLEIC ACIDS RES, V34, P4655, DOI 10.1093/nar/gkl638; Li FM, 2008, PROTEIN PEPTIDE LETT, V15, P612, DOI 10.2174/092986608784966930; Liao B, 2011, PROTEIN PEPTIDE LETT, V18, P1086, DOI 10.2174/092986611797200931; Lin HN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S8; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; Liu T, 2010, PROTEIN PEPTIDE LETT, V17, P1263, DOI 10.2174/092986610792231528; Lu Z, 2004, BIOINFORMATICS, V20, P547, DOI 10.1093/bioinformatics/btg447; Ma JW, 2010, INT J INNOV COMPUT I, V6, P5093; Ma JW, 2010, BMB REP, V43, P670, DOI [10.3858/BMBRep.2010.43.10.670, 10.5483/BMBRep.2010.43.10.670]; Mei SY, 2012, J THEOR BIOL, V293, P121, DOI 10.1016/j.jtbi.2011.10.015; Mei SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-44; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; Rasmussen C. E., 2006, GAUSSIAN PROCESS MAC; Schapire RE, 2000, MACH LEARN, V39, P135, DOI 10.1023/A:1007649029923; Scott MS, 2004, GENOME RES, V14, P1957, DOI 10.1101/gr.2650004; Shen HB, 2008, ANAL BIOCHEM, V373, P386, DOI 10.1016/j.ab.2007.10.012; Shen HB, 2007, BIOCHEM BIOPH RES CO, V355, P1006, DOI 10.1016/j.bbrc.2007.02.071; Shen HB, 2010, J BIOMOL STRUCT DYN, V28, P175, DOI 10.1080/07391102.2010.10507351; Shen HB, 2009, ANAL BIOCHEM, V394, P269, DOI 10.1016/j.ab.2009.07.046; Shi JY, 2008, AMINO ACIDS, V35, P321, DOI 10.1007/s00726-007-0623-z; Tian J, 2011, COMPUT BIOL MED, V41, P648, DOI 10.1016/j.compbiomed.2011.05.016; Tsoumakas G., 2007, INT J DATA WAREHOUS, V3, P1; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018476; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505; Wu ZC, 2011, PROTEIN PEPTIDE LETT, DOI BSP/PPL/E pub/0380; Wu ZC, 2011, MOL BIOSYST, V7, P3287, DOI 10.1039/c1mb05232b; Xiao X, 2011, J THEOR BIOL, V284, P42, DOI 10.1016/j.jtbi.2011.06.005; Xiao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020592; Xiao XA, 2011, MOL BIOSYST, V7, P911, DOI 10.1039/c0mb00170h; Yin JB, 2011, NEUROCOMPUTING, V74, P3816, DOI 10.1016/j.neucom.2011.07.017; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zhang S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-127; Zhou GP, 2003, PROTEINS, V50, P44, DOI 10.1002/prot.10251	74	25	28	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e37155	10.1371/journal.pone.0037155	http://dx.doi.org/10.1371/journal.pone.0037155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715364	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336800005
J	Cesar, KR; Romero, EC; de Braganca, AC; Blanco, RM; Abreu, PAE; Magaldi, AJ				Cesar, Katia Regina; Romero, Eliete Calo; de Braganca, Ana Carolina; Blanco, Roberta Morozetti; Estima Abreu, Patricia Antonia; Magaldi, Antonio Jose			Renal Involvement in Leptospirosis: The Effect of Glycolipoprotein on Renal Water Absorption	PLOS ONE			English	Article							INTERROGANS SEROVAR COPENHAGENI; KIDNEY; ACTIVATION; LIVER; EXPRESSION; TUBULES; BLOOD; LUNG	Background: Leptospirotic renal lesions frequently produce a polyuric form of acute kidney injury with a urinary concentration defect. Our study investigated a possible effect of the glycolipoprotein, (GLPc) extracted from L. interrogans, on vasopressin (Vp) action in the guinea pig inner medullary collecting duct (IMCD). Methods: The osmotic water permeability (Pf mu m/s) was measured by the microperfusion in vitro technique. AQP2 protein abundance was determined by Western Blot. Three groups were established for study as follows: Group I, IMCD from normal (ngp, n = 5) and from leptospirotic guinea-pigs (lgp-infected with L. interrogans serovar Copenhageni, GLPc, n = 5); Group II, IMCD from normal guinea-pigs in the presence of GLPc (GLPc group, n = 54); Group III, IMCD from injected animals with GLPc ip (n = 8). Results: In Group I, Pfs were: ngp-61.8 +/- 22.1 and lgp-8.8 +/- 12.4, p<0.01 and the urinary osmolalities were: lgp-735 +/- 64 mOsm/Kg and ngp-1,632 +/- 120 mOsm/Kg. The lgp BUN was higher (176 +/- 36 mg%) than the ngp (56 +/- 9 mg%). In Group II, the Pf was measured under GLPc (250 mu g/ml) applied directly to the bath solution of the microperfused normal guinea-pig IMCDs. GLPc blocked Vp (200 pg/ml, n = 5) action, did not block cAMP (10(-4) M,) and Forskolin (Fors-10(-9) M) action, but partially blocked Cholera Toxin (ChT-10(-9) M) action. GLP from L. biflexa serovar patoc (GLPp, non pathogenic, 250 mu g) did not alter Vp action. In Group III, GLPc (250 mg) injected intraperitoneally produced a decrease of about 20% in IMCD Aquaporin 2 expression. Conclusion: The IMCD Pf decrease caused by GLP is evidence, at least in part, towards explaining the urinary concentrating incapacity observed in infected guinea-pigs.	[Cesar, Katia Regina; de Braganca, Ana Carolina; Magaldi, Antonio Jose] Nephrol HCFMUSP, Basic Res Lab LIM, Sao Paulo, SP, Brazil; [Romero, Eliete Calo; Blanco, Roberta Morozetti] Adolfo Lutz Inst, Sao Paulo, SP, Brazil; [Estima Abreu, Patricia Antonia] Inst Butantan, Bacteriol Lab, Sao Paulo, SP, Brazil	Instituto Adolfo Lutz; Instituto Butantan	Cesar, KR (corresponding author), Nephrol HCFMUSP, Basic Res Lab LIM, Sao Paulo, SP, Brazil.	biomag@usp.br	Abreu, Patricia/C-4682-2012; Blanco, Roberta M/H-7254-2012; de Braganca, Ana Carolina/E-7892-2014; Romero, Eliete C/H-6976-2012	Abreu, Patricia/0000-0002-7541-0341; Blanco, Roberta M/0000-0002-8853-6795; Romero, Eliete C/0000-0002-8635-439X; de Braganca, Ana Carolina/0000-0002-1398-2512	CNPq (National Counsel for Scientific and Technological Development); FAPESP (Foundation for the Support of Research in the State of Sao Paulo); FFM (School of Medicine Foundation); LIM-HCFMUSP (Clinic Hospital Medical Investigation Laboratories-University of Sao Paulo); FAPESP fellowships	CNPq (National Counsel for Scientific and Technological Development); FAPESP (Foundation for the Support of Research in the State of Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FFM (School of Medicine Foundation); LIM-HCFMUSP (Clinic Hospital Medical Investigation Laboratories-University of Sao Paulo); FAPESP fellowships(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was sponsored by the CNPq (National Counsel for Scientific and Technological Development), the FAPESP (Foundation for the Support of Research in the State of Sao Paulo), the FFM (School of Medicine Foundation) and the LIM-HCFMUSP (Clinic Hospital Medical Investigation Laboratories-University of Sao Paulo). AJM was the recipient of CNPq and FAPESP fellowships. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALZAHID G, 1977, J MEMBRANE BIOL, V31, P103, DOI 10.1007/BF01869401; Andrade L, 2007, AM J PHYSIOL-RENAL, V292, pF586, DOI 10.1152/ajprenal.00102.2006; Araujo ER, 2010, VIRCHOWS ARCH, V456, P367, DOI 10.1007/s00428-010-0894-8; AREAN VM, 1962, LAB INVEST, V11, P273; Arriaga AJD, 1982, J PATHOL, V138, P145; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Daher ED, 2004, NEPHRON CLIN PRACT, V98, pC8, DOI 10.1159/000079922; De Brito T, 2006, VIRCHOWS ARCH, V448, P576, DOI 10.1007/s00428-006-0163-z; DEBRITO T, 1966, VIRCHOWS ARCH A, V341, P64; Diament D, 2002, INFECT IMMUN, V70, P1677, DOI 10.1128/IAI.70.4.1677-1683.2002; Dorigatti F, 2005, BRAZ J MED BIOL RES, V38, P909, DOI 10.1590/S0100-879X2005000600013; Faine S, 1957, BRIT J EXPT PATHOLOG, V37, P1; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, P11; HOLT SC, 1978, MICROBIOL REV, V42, P114, DOI 10.1128/MMBR.42.1.114-160.1978; MAGALDI AJ, 1992, NEPHRON, V62, P332, DOI 10.1159/000187069; MARSHALL RB, 1974, J MED MICROBIOL, V7, P505, DOI 10.1099/00222615-7-4-505; Nascimento ALTO, 2004, BRAZ J MED BIOL RES, V37, P459, DOI 10.1590/S0100-879X2004000400003; Pereira MM, 1997, EXP TOXICOL PATHOL, V49, P505, DOI 10.1016/S0940-2993(97)80155-8; POH SC, 1970, THORAX, V25, P751, DOI 10.1136/thx.25.6.751; ROCHA AS, 1974, KIDNEY INT, V6, P379, DOI 10.1038/ki.1974.123; SANTOS RTM, 1989, REV I MED TROP, V31, P235; SEGURO AC, 1990, NEPHRON, V55, P146, DOI 10.1159/000185943; SITPRIJA V, 1970, American Journal of Medicine, V49, P780, DOI 10.1016/S0002-9343(70)80059-6; STALHEIM OH, 1968, J BACTERIOL, V95, P465, DOI 10.1128/JB.95.2.465-468.1968; VINH T, 1986, J GEN MICROBIOL, V132, P111; Wu MS, 2004, NEPHROL DIAL TRANSPL, V19, P2472, DOI 10.1093/ndt/gfh452; Yang CW, 2007, KIDNEY INT, V72, P918, DOI 10.1038/sj.ki.5002393; YOUNESIBRAHIM M, 1995, CR ACAD SCI III-VIE, V318, P619	29	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37625	10.1371/journal.pone.0037625	http://dx.doi.org/10.1371/journal.pone.0037625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701573	Green Submitted, Green Published, gold			2022-12-25	WOS:000305348400014
J	Downs, I; Liu, JF; Aw, TY; Adegboyega, PA; Ajuebor, MN				Downs, Isaac; Liu, Jianfeng; Aw, Tak Yee; Adegboyega, Patrick A.; Ajuebor, Maureen N.			The ROS Scavenger, NAC, Regulates Hepatic V alpha 14iNKT Cells Signaling during Fas mAb-Dependent Fulminant Liver Failure	PLOS ONE			English	Article							KILLER T-CELLS; MITOCHONDRIAL PERMEABILITY TRANSITION; INDUCED APOPTOSIS; NKT CELLS; IMMUNE-SYSTEM; GLUTATHIONE DEPLETION; MICROBIAL INFECTION; CELLULAR REDOX; CUTTING EDGE; PC-12 CELLS	Uncontrolled systemic activation of the immune system is an early initiating event that leads to development of acute fulminant liver failure (FLF) in mice after treatment with agonistic Fas mAb. In this study, we demonstrate that treatment of mice with N-acetylcysteine (NAC), an ROS scavenger and glutathione (GSH) precursor, almost completely abolished Fas mAb-induced FLF through suppression of V alpha 14iNKT cell activation, IFN-gamma signaling, apoptosis and nitrotyrosine formation in liver. In addition, enrichment of the liver with GSH due to V alpha 14iNKT cells deficiency, induced an anti-inflammatory response in the liver of J alpha 18(-/-) mice that inhibited apoptosis, nitrotyrosine formation, IFN-gamma signaling and effector functions. In summary, we propose a novel and previously unrecognized pro-inflammatory and pro-apoptotic role for endogenous ROS in stimulating Th1 signaling in V alpha 14iNKT cells to promote the development of FLF. Therefore, our study provides critical new insights into how NAC, a ROS scavenger, regulates Th1 signaling in intrahepatic V alpha 14iNKT cells to impact inflammatory and pathological responses.	[Downs, Isaac; Liu, Jianfeng; Aw, Tak Yee; Ajuebor, Maureen N.] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Mol & Cellular Physiol, Shreveport, LA 71105 USA; [Adegboyega, Patrick A.] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Pathol, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Downs, I (corresponding author), Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Mol & Cellular Physiol, Shreveport, LA 71105 USA.	majueb@lsuhsc.edu			NIH [NIAID R56AI085150]; TYA [NIDDK DK44510]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044510] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TYA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by NIH grants to MNA (NIAID R56AI085150) and TYA (NIDDK DK44510). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuebor MN, 2008, J VIROL, V82, P9564, DOI 10.1128/JVI.00927-08; Ajuebor MN, 2007, AM J PATHOL, V170, P1975, DOI 10.2353/ajpath.2007.060690; Ajuebor MN, 2010, J VIROL, V84, P8520, DOI 10.1128/JVI.00605-10; Ajuebor MN, 2005, J IMMUNOL, V174, P8027, DOI 10.4049/jimmunol.174.12.8027; Atkuri KR, 2007, CURR OPIN PHARMACOL, V7, P355, DOI 10.1016/j.coph.2007.04.005; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brutkiewicz RR, 2006, J IMMUNOL, V177, P769, DOI 10.4049/jimmunol.177.2.769; Carnaud C, 1999, J IMMUNOL, V163, P4647; Cazanave S, 2008, TOXICOL APPL PHARM, V231, P336, DOI 10.1016/j.taap.2008.05.010; Cazanave S, 2007, J HEPATOL, V46, P858, DOI 10.1016/j.jhep.2006.11.015; Chiba A, 2008, J IMMUNOL, V181, P2292, DOI 10.4049/jimmunol.181.4.2292; Cobb D, J LEUKOC BIOL, V88, P965; Crowe NY, 2003, J IMMUNOL, V171, P4020, DOI 10.4049/jimmunol.171.8.4020; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Ding WX, 2004, HEPATOLOGY, V40, P403, DOI 10.1002/hep.20310; Faouzi S, 2001, J BIOL CHEM, V276, P49077, DOI 10.1074/jbc.M109791200; Gardner TR, 2010, AM J PATHOL, V176, P1779, DOI 10.2353/ajpath.2010.090738; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Haouzi D, 2001, HEPATOLOGY, V33, P1181, DOI 10.1053/jhep.2001.24235; Harada M, 2004, INT IMMUNOL, V16, P241, DOI 10.1093/intimm/dxh023; Hatano E, 2000, J BIOL CHEM, V275, P11814, DOI 10.1074/jbc.275.16.11814; Hobbs JA, 2001, J VIROL, V75, P10746, DOI 10.1128/JVI.75.22.10746-10754.2001; Johansson S, 2005, TRENDS IMMUNOL, V26, P613, DOI 10.1016/j.it.2005.08.008; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Malassagne B, 2001, GASTROENTEROLOGY, V121, P1451, DOI 10.1053/gast.2001.29590; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2003, P NATL ACAD SCI USA, V100, P8395, DOI 10.1073/pnas.1332805100; Matsuda JL, 2001, P NATL ACAD SCI USA, V98, P12636, DOI 10.1073/pnas.221445298; Matute-Bello G, 2001, AM J PATHOL, V158, P153, DOI 10.1016/S0002-9440(10)63953-3; Minagawa M, 2004, GASTROENTEROLOGY, V126, P1387, DOI 10.1053/j.gastro.2004.01.022; Musallam L, 2002, AM J PHYSIOL-GASTR L, V283, pG709, DOI 10.1152/ajpgi.00013.2002; Nagarajan NA, 2007, J IMMUNOL, V178, P2706, DOI 10.4049/jimmunol.178.5.2706; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Okouchi M, 2005, CURR NEUROVASC RES, V2, P375, DOI 10.2174/156720205774962665; Okouchi M, 2005, CURR NEUROVASC RES, V2, P13, DOI 10.2174/1567202052773535; Porubsky S, 2007, P NATL ACAD SCI USA, V104, P5977, DOI 10.1073/pnas.0611139104; REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9; RENSINGEHL A, 1995, J INFLAMM, V45, P161; Robinson RT, 2009, J IMMUNOL, V182, P3278, DOI 10.4049/jimmunol.0803417; Ryo K, 2000, AM J GASTROENTEROL, V95, P2047; Saas P, 1999, J IMMUNOL, V162, P2326; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Seino K, 2004, FRONT BIOSCI-LANDMRK, V9, P2577, DOI 10.2741/1418; Sironi JJ, 2004, J BIOL CHEM, V279, P4066, DOI 10.1074/jbc.M307774200; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Speak AO, 2007, P NATL ACAD SCI USA, V104, P5971, DOI 10.1073/pnas.0607285104; Taieb J, 1998, LANCET, V351, P1930, DOI 10.1016/S0140-6736(05)78614-1; Taniguchi M, 2003, NAT IMMUNOL, V4, P1164, DOI 10.1038/ni1203-1164; Tyznik AJ, 2008, J IMMUNOL, V181, P4452, DOI 10.4049/jimmunol.181.7.4452; Van Kaer L, 2005, NAT REV IMMUNOL, V5, P31, DOI 10.1038/nri1531; vandenDobbelsteen DJ, 1996, J BIOL CHEM, V271, P15420, DOI 10.1074/jbc.271.26.15420; Wang XD, 2005, HEPATOLOGY, V42, P400, DOI 10.1002/hep.20792; Wesley JD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000106; Wilson MT, 2003, P NATL ACAD SCI USA, V100, P10913, DOI 10.1073/pnas.1833166100	57	32	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38051	10.1371/journal.pone.0038051	http://dx.doi.org/10.1371/journal.pone.0038051			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701598	Green Submitted, Green Published, gold			2022-12-25	WOS:000305348400032
J	Wang, HC; Tsai, YL; Wu, YC; Chang, FR; Liu, MH; Chen, WY; Wu, CC				Wang, Hui-Chun; Tsai, Yi-Ling; Wu, Yang-Chang; Chang, Fang-Rong; Liu, Mei-Hsin; Chen, Wen-Ying; Wu, Chin-Chung			Withanolides-Induced Breast Cancer Cell Death Is Correlated with Their Ability to Inhibit Heat Protein 90	PLOS ONE			English	Article							NF-KAPPA-B; COMPOUND WITHAFERIN-A; APOPTOSIS; ACTIVATION; HSP90; PROLIFERATION; EXPRESSION; THERAPY; TARGET; GROWTH	Withanolides are a large group of steroidal lactones found in Solanaceae plants that exhibit potential anticancer activities. We have previously demonstrated that a withanolide, tubocapsenolide A, induced cycle arrest and apoptosis in human breast cancer cells, which was associated with the inhibition of heat shock protein 90 (Hsp90). To investigate whether other withanolides are also capable of inhibiting Hsp90 and to analyze the structure-activity relationships, nine withanolides with different structural properties were tested in human breast cancer cells MDA-MB-231 and MCF-7 in the present study. Our data show that the 2,3-unsaturated double bond-containing withanolides inhibited Hsp90 function, as evidenced by selective depletion of Hsp90 client proteins and induction of Hsp70. The inhibitory effect of the withanolides on Hsp90 chaperone activity was further confirmed using in vivo heat shock luciferase activity recovery assays. Importantly, Hsp90 inhibition by the withanolides was correlated with their ability to induce cancer cell death. In addition, the withanolides reduced constitutive NF-kappa B activation by depleting I kappa B kinase complex (IKK) through inhibition of Hsp90. In estrogen receptor (ER)-positive MCF-7 cells, the withanolides also reduced the expression of ER, and this may be partly due to Hsp90 inhibition. Taken together, our results suggest that Hsp90 inhibition is a general feature of cytotoxic withanolides and plays an important role in their anticancer activity.	[Wang, Hui-Chun; Tsai, Yi-Ling; Chang, Fang-Rong; Liu, Mei-Hsin; Wu, Chin-Chung] Kaohsiung Med Univ, Grad Inst Nat Prod, Kaohsiung, Taiwan; [Wu, Yang-Chang] China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan; [Wu, Yang-Chang; Chang, Fang-Rong] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Chen, Wen-Ying] Fooyin Univ, Basic Med Sci Educ Ctr, Kaohsiung, Taiwan	Kaohsiung Medical University; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Fooyin University	Wang, HC (corresponding author), Kaohsiung Med Univ, Grad Inst Nat Prod, Kaohsiung, Taiwan.	ccwu@kmu.edu.tw	Wang, Hui-Chun/C-5680-2009; Wu, Yang-Chang/C-5682-2009	Wu, Yang-Chang/0000-0001-7815-2686; Wu, Chin-Chung/0000-0003-4203-4084; Chang, Fang-Rong/0000-0003-2549-4193; Wang, Hui-Chun/0000-0003-1414-1595	National Science Council of Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagatell R, 2001, CLIN CANCER RES, V7, P2076; Bharti AC, 2002, BIOCHEM PHARMACOL, V64, P883, DOI 10.1016/S0006-2952(02)01154-1; Biswas DK, 2000, P NATL ACAD SCI USA, V97, P8542, DOI 10.1073/pnas.97.15.8542; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Broemer M, 2004, ONCOGENE, V23, P5378, DOI 10.1038/sj.onc.1207705; Castoria G, 2010, STEROIDS, V75, P524, DOI 10.1016/j.steroids.2009.10.007; Chen LX, 2011, NAT PROD REP, V28, P705, DOI 10.1039/c0np00045k; Chen WY, 2008, J BIOL CHEM, V283, P17184, DOI 10.1074/jbc.M709447200; Chen WY, 2011, INVEST NEW DRUG, V29, P1347, DOI 10.1007/s10637-010-9497-0; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; Falsey RR, 2006, NAT CHEM BIOL, V2, P33, DOI 10.1038/nchembio755; FUSKA J, 1984, NEOPLASMA, V31, P31; Grover A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S30; Guo F, 2005, CANCER RES, V65, P10536, DOI 10.1158/0008-5472.CAN-05-1799; Hernandez A, 2008, MOL CANCER THER, V7, P474, DOI 10.1158/1535-7163.MCT-07-0457; Hertlein E, 2010, BLOOD, V116, P45, DOI 10.1182/blood-2010-01-263756; Hsieh PW, 2007, J NAT PROD, V70, P747, DOI 10.1021/np0605541; Ichikawa H, 2006, MOL CANCER THER, V5, P1434, DOI 10.1158/1535-7163.MCT-06-0096; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; LEE YC, 1995, J CELL BIOCHEM, V57, P150, DOI 10.1002/jcb.240570115; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Mishra L C, 2000, Altern Med Rev, V5, P334; Mitsiades CS, 2006, BLOOD, V107, P1092, DOI 10.1182/blood-2005-03-1158; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Pan MR, 2009, J BIOL CHEM, V284, P2746, DOI 10.1074/jbc.M806223200; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Sabzevari O, 2004, CHEM-BIOL INTERACT, V148, P57, DOI 10.1016/j.cbi.2004.04.004; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Segnitz B, 1997, J BIOL CHEM, V272, P18694, DOI 10.1074/jbc.272.30.18694; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; Yang HJ, 2007, MOL PHARMACOL, V71, P426, DOI 10.1124/mol.106.030015; Yen CY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-46; Yu YK, 2010, BIOCHEM PHARMACOL, V79, P542, DOI 10.1016/j.bcp.2009.09.017	40	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37764	10.1371/journal.pone.0037764	http://dx.doi.org/10.1371/journal.pone.0037764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701533	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500054
J	Bolderson, E; Savage, KI; Mahen, R; Pisupati, V; Graham, ME; Richard, DJ; Robinson, PJ; Venkitaraman, AR; Khanna, KK				Bolderson, Emma; Savage, Kienan I.; Mahen, Robert; Pisupati, Venkat; Graham, Mark E.; Richard, Derek J.; Robinson, Phillip J.; Venkitaraman, Ashok R.; Khanna, Kum Kum			Kruppel-associated Box (KRAB)-associated Co-repressor (KAP-1) Ser-473 Phosphorylation Regulates Heterochromatin Protein 1 beta (HP1-beta) Mobilization and DNA Repair in Heterochromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION REPAIR; IN-VIVO; DAMAGE RESPONSE; HP1 PROTEINS; DYNAMIN-I; BINDING; COREPRESSOR; DOMAIN; ATM	The DNA damage response encompasses a complex series of signaling pathways that function to regulate and facilitate the repair of damaged DNA. Recent studies have shown that the repair of transcriptionally inactive chromatin, named heterochromatin, is dependent upon the phosphorylation of the co-repressor, Kruppel-associated box (KRAB) domain-associated protein (KAP-1), by the ataxia telangiectasia-mutated (ATM) kinase. Co-repressors, such as KAP-1, function to regulate the rigid structure of heterochromatin by recruiting histone-modifying enzymes, such HDAC1/2, SETDB1, and nucleosome-remodeling complexes such as CHD3. Here, we have characterized a phosphorylation site in the HP1-binding domain of KAP-1, Ser-473, which is phosphorylated by the cell cycle checkpoint kinase Chk2. Expression of a nonphosphorylatable S473A mutant conferred cellular sensitivity to DNA-damaging agents and led to defective repair of DNA double-strand breaks in heterochromatin. In addition, cells expressing S473A also displayed defective mobilization of the HP1-beta chromodomain protein. The DNA repair defect observed in cells expressing S473A was alleviated by depletion of HP1-beta, suggesting that phosphorylation of KAP-1 on Ser-473 promotes the mobilization of HP1-beta from heterochromatin and subsequent DNA repair. These results suggest a novel mechanism of KAP-1-mediated chromatin restructuring via Chk2-regulated HP1-beta exchange from heterochromatin, promoting DNA repair.	[Bolderson, Emma; Savage, Kienan I.; Khanna, Kum Kum] Queensland Inst Med Res, Signal Transduct Lab, Brisbane, Qld 4029, Australia; [Savage, Kienan I.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland; [Mahen, Robert; Pisupati, Venkat; Venkitaraman, Ashok R.] Hutchison MRC Res Ctr, Med Res Council MRC Canc Cell Unit, Cambridge CB2 OXZ, England; [Graham, Mark E.; Robinson, Phillip J.] Univ Sydney, Cell Signalling Unit, Childrens Med Res Inst, Westmead, NSW 2145, Australia; [Bolderson, Emma; Richard, Derek J.] Queensland Univ Technol, Fac Hlth, Brisbane, Qld 4059, Australia	QIMR Berghofer Medical Research Institute; Queens University Belfast; Children's Medical Research Institute - Australia; University of Sydney; Queensland University of Technology (QUT)	Khanna, KK (corresponding author), Queensland Inst Med Res, Signal Transduct Lab, Brisbane, Qld 4029, Australia.	kumkumk@qimr.edu.au	Robinson, Phillip J/G-4008-2011; Graham, Mark E/A-6480-2014; Richard, Derek/J-1338-2012; Bolderson, Emma/B-8743-2013; Khanna, Kum Kum/I-1747-2013	Robinson, Phillip J/0000-0002-7878-0313; Graham, Mark E/0000-0002-7290-1217; Richard, Derek/0000-0002-4839-8471; Bolderson, Emma/0000-0002-2849-1177; Savage, Kienan/0000-0002-4898-899X; Khanna, Kum Kum/0000-0001-8650-5381	Australian Research Council; United Kingdom Medical Research Council; Medical Research Council [G1001521, G0600332, MC_U105359877, G0700651] Funding Source: researchfish; MRC [G0600332, MC_U105359877, G0700651, G1001521] Funding Source: UKRI	Australian Research Council(Australian Research Council); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a discovery grant from the Australian Research Council and by a grant from the United Kingdom Medical Research Council (to A.R.V.).	Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Ayoub N, 2009, CELL CYCLE, V8, P2945; Baldeyron C, 2011, J CELL BIOL, V193, P81, DOI 10.1083/jcb.201101030; Blasius M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r78; Bolderson E, 2010, NUCLEIC ACIDS RES, V38, P1821, DOI 10.1093/nar/gkp1164; Cann KL, 2011, BIOCHEM CELL BIOL, V89, P45, DOI 10.1139/O10-113; Chang CW, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-61; Dinant C, 2009, MOL CELL BIOL, V29, P6335, DOI 10.1128/MCB.01048-09; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goodarzi AA, 2011, NAT STRUCT MOL BIOL, V18, P831, DOI 10.1038/nsmb.2077; Goodarzi AA, 2010, DNA REPAIR, V9, P1273, DOI 10.1016/j.dnarep.2010.09.013; Graham ME, 2007, J BIOL CHEM, V282, P14695, DOI 10.1074/jbc.M609713200; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Hu C, 2012, J BIOL CHEM, V287, P18937, DOI 10.1074/jbc.M111.313262; Khanna KK, 2006, METH MOLEC MED, V120, P441; Larsen MR, 2004, MOL CELL PROTEOMICS, V3, P456, DOI 10.1074/mcp.M300105-MCP200; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Luijsterburg MS, 2009, J CELL BIOL, V185, P577, DOI 10.1083/jcb.200810035; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Murray JM, 2012, BIOCHEM SOC T, V40, P173, DOI 10.1042/BST20110631; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; Peng HZ, 2002, J MOL BIOL, V320, P629, DOI 10.1016/S0022-2836(02)00477-1; Richard DJ, 2008, NATURE, V453, P677, DOI 10.1038/nature06883; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; White D, 2012, MOL CANCER RES, V10, P401, DOI 10.1158/1541-7786.MCR-11-0134; Xu Y, 2011, CELL CYCLE, V10, P261, DOI 10.4161/cc.10.2.14543; Young DB, 2005, J BIOL CHEM, V280, P27587, DOI 10.1074/jbc.M411689200; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zeng W, 2010, EPIGENETICS-US, V5, P287, DOI 10.4161/epi.5.4.11683; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	36	39	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28122	28131		10.1074/jbc.M112.368381	http://dx.doi.org/10.1074/jbc.M112.368381			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22715096	Green Published, hybrid			2022-12-25	WOS:000307840700085
J	Martinelli, S; Nardozza, AP; Delle Vigne, S; Sabetta, G; Torreri, P; Bocchinfuso, G; Flex, E; Venanzi, S; Palleschi, A; Gelb, BD; Cesareni, G; Stella, L; Castagnoli, L; Tartaglia, M				Martinelli, Simone; Nardozza, Aurelio P.; Delle Vigne, Silvia; Sabetta, Gilda; Torreri, Paola; Bocchinfuso, Gianfranco; Flex, Elisabetta; Venanzi, Serenella; Palleschi, Antonio; Gelb, Bruce D.; Cesareni, Gianni; Stella, Lorenzo; Castagnoli, Luisa; Tartaglia, Marco			Counteracting Effects Operating on Src Homology 2 Domain-containing Protein-tyrosine Phosphatase 2 (SHP2) Function Drive Selection of the Recurrent Y62D and Y63C Substitutions in Noonan Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOMATIC PTPN11 MUTATIONS; ACUTE MYELOID-LEUKEMIA; LEOPARD-SYNDROME; PHOSPHORYLATION SITES; SH2 DOMAINS; BINDING; DISORDERS; SEQUENCE; MUTANTS; CONSEQUENCES	Activating mutations in PTPN11 cause Noonan syndrome, the most common nonchromosomal disorder affecting development and growth. PTPN11 encodes SHP2, an Src homology 2 (SH2) domain-containing protein-tyrosine phosphatase that positively modulates RAS function. Here, we characterized functionally all possible amino acid substitutions arising from single-base changes affecting codons 62 and 63 to explore the molecular mechanisms lying behind the largely invariant occurrence of the Y62D and Y63C substitutions recurring in Noonan syndrome. We provide structural and biochemical data indicating that the autoinhibitory interaction between the N-SH2 and protein-tyrosine phosphatase (PTP) domains is perturbed in both mutants as a result of an extensive structural rearrangement of the N-SH2 domain. Most mutations affecting Tyr(63) exerted an unpredicted disrupting effect on the structure of the N-SH2 phosphopeptide-binding cleft mediating the interaction of SHP2 with signaling partners. Among all the amino acid changes affecting that codon, the disease-causing mutation was the only substitution that perturbed the stability of the inactive conformation of SHP2 without severely impairing proper phosphopeptide binding of N-SH2. On the other hand, the disruptive effect of the Y62D change on the autoinhibited conformation of the protein was balanced, in part, by less efficient binding properties of the mutant. Overall, our data demonstrate that the selection-by-function mechanism acting as driving force for PTPN11 mutations affecting codons 62 and 63 implies balancing of counteracting effects operating on the allosteric control of the function of SHP2.	[Martinelli, Simone; Delle Vigne, Silvia; Flex, Elisabetta; Venanzi, Serenella; Tartaglia, Marco] Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, I-00161 Rome, Italy; [Nardozza, Aurelio P.; Cesareni, Gianni; Castagnoli, Luisa] Univ Roma Tor Vergata, Dipartimento Biol, I-00133 Rome, Italy; [Sabetta, Gilda; Bocchinfuso, Gianfranco; Palleschi, Antonio; Stella, Lorenzo] Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, I-00133 Rome, Italy; [Palleschi, Antonio; Stella, Lorenzo] Ist Ricovero & Cura Carattere Sci Neuromed, I-86077 Pozzilli, IS, Italy; [Torreri, Paola] Ist Super Sanita, Ctr Nazl Malattie Rare, I-00161 Rome, Italy; [Gelb, Bruce D.] Mt Sinai Sch Med, Child Hlth & Dev Inst, New York, NY 10029 USA; [Cesareni, Gianni] IRCCS Fdn Santa Lucia, I-00143 Rome, Italy	Istituto Superiore di Sanita (ISS); University of Rome Tor Vergata; University of Rome Tor Vergata; IRCCS Neuromed; Istituto Superiore di Sanita (ISS); Icahn School of Medicine at Mount Sinai; IRCCS Santa Lucia	Tartaglia, M (corresponding author), Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, Viale Regina Elena 299, I-00161 Rome, Italy.	mtartaglia@iss.it	Martinelli, Simone/J-9432-2018; Cesareni, Gianni/AAW-1382-2020; Bocchinfuso, Gianfranco/E-9014-2011; Stella, Lorenzo/A-7996-2010; TORRERI, PAOLA/A-6656-2015; palleschi, antonio/G-5464-2012; Tartaglia, Marco/K-2955-2018; Flex, Elisabetta/A-5958-2017	Martinelli, Simone/0000-0002-5843-419X; Bocchinfuso, Gianfranco/0000-0002-5556-7691; Stella, Lorenzo/0000-0002-5489-7381; TORRERI, PAOLA/0000-0002-0488-956X; Tartaglia, Marco/0000-0001-7736-9672; Flex, Elisabetta/0000-0002-6802-1356; Cesareni, Gianni/0000-0002-9528-6018; Castagnoli, Luisa/0000-0001-5283-8671; Delle Vigne, Silvia/0000-0001-8571-6662	Telethon-Italy [GGP10020, GGP09243]; ERANet for research programs on rare diseases (NSEuroNet); Programma di collaborazione Italia-USA [11US/10]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 13360]; European Network of Excellence Experimental Network for Functional Integration (ENFIN)	Telethon-Italy(Fondazione Telethon); ERANet for research programs on rare diseases (NSEuroNet); Programma di collaborazione Italia-USA; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); European Network of Excellence Experimental Network for Functional Integration (ENFIN)	This work was supported by grants from Telethon-Italy (GGP10020), ERANet for research programs on rare diseases 2009 (NSEuroNet), Programma di collaborazione Italia-USA 2010 (11US/10), and Associazione Italiana per la Ricerca sul Cancro (AIRC) (IG 13360) (to M. T.) and by grants from Telethon-Italy (GGP09243) and European Network of Excellence Experimental Network for Functional Integration (ENFIN) (to G. C.).	Allanson JE, 2007, AM J MED GENET C, V145C, P274, DOI 10.1002/ajmg.c.30138; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bocchinfuso G, 2007, PROTEINS, V66, P963, DOI 10.1002/prot.21050; Chan RJ, 2005, BLOOD, V105, P3737, DOI 10.1182/blood-2004-10-4002; DECHERT U, 1994, J BIOL CHEM, V269, P5602; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; Gremer L, 2010, HUM MOL GENET, V19, P790, DOI 10.1093/hmg/ddp548; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guvench O, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-14; Hanna N, 2006, FEBS LETT, V580, P2477, DOI 10.1016/j.febslet.2006.03.088; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LEE CH, 1994, STRUCTURE, V2, P423, DOI 10.1016/S0969-2126(00)00044-7; Martinelli S, 2008, HUM MOL GENET, V17, P2018, DOI 10.1093/hmg/ddn099; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; O'Reilly AM, 2000, MOL CELL BIOL, V20, P299, DOI 10.1128/MCB.20.1.299-311.2000; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qin CG, 2005, BIOCHEMISTRY-US, V44, P12196, DOI 10.1021/bi050669o; Qu CK, 1997, MOL CELL BIOL, V17, P5499, DOI 10.1128/MCB.17.9.5499; Sacco F, 2009, J BIOL CHEM, V284, P22048, DOI 10.1074/jbc.M109.002758; Sarkozy A, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-13; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Schubbert S, 2005, BLOOD, V106, P311, DOI 10.1182/blood-2004-11-4207; Sweeney MC, 2005, BIOCHEMISTRY-US, V44, P14932, DOI 10.1021/bi051408h; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2005, BRIT J HAEMATOL, V129, P333, DOI 10.1111/j.1365-2141.2005.05457.x; Tartaglia M, 2004, BLOOD, V104, P307, DOI 10.1182/blood-2003-11-3876; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; Tartaglia M, 2011, BEST PRACT RES CL EN, V25, P161, DOI 10.1016/j.beem.2010.09.002; Tartaglia M, 2010, ANN NY ACAD SCI, V1214, P99, DOI 10.1111/j.1749-6632.2010.05790.x; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; van der Burgt I, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-4; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	48	20	21	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27066	27077		10.1074/jbc.M112.350231	http://dx.doi.org/10.1074/jbc.M112.350231			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22711529	hybrid, Green Published			2022-12-25	WOS:000307386000059
J	Scherrer, AU; Ledergerber, B; von Wyl, V; Boni, J; Yerly, S; Klimkait, T; Cellerai, C; Furrer, H; Calmy, A; Cavassini, M; Elzi, L; Vernazza, PL; Bernasconi, E; Gunthard, HF				Scherrer, Alexandra U.; Ledergerber, Bruno; von Wyl, Viktor; Boeni, Juerg; Yerly, Sabine; Klimkait, Thomas; Cellerai, Cristina; Furrer, Hansjakob; Calmy, Alexandra; Cavassini, Matthias; Elzi, Luigia; Vernazza, Pietro L.; Bernasconi, Enos; Guenthard, Huldrych F.		Swiss HIV Cohort Study SHCS	Minor Protease Inhibitor Mutations at Baseline Do Not Increase the Risk for a Virological Failure in HIV-1 Subtype B Infected Patients	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DRUG-RESISTANCE MUTATIONS; ANTIRETROVIRAL THERAPY; REVERSE-TRANSCRIPTASE; PROPENSITY SCORE; NATURAL POLYMORPHISMS; IMPACT; REGRESSION; SELECTION; STRAINS	Background: Minor protease inhibitor (PI) mutations often exist as polymorphisms in HIV-1 sequences from treatment-naive patients. Previous studies showed that their presence impairs the antiretroviral treatment (ART) response. Evaluating these findings in a larger cohort is essential. Methods: To study the impact of minor PI mutations on time to viral suppression and time to virological failure, we included patients from the Swiss HIV Cohort Study infected with HIV-1 subtype B who started first-line ART with a PI and two nucleoside reverse transcriptase inhibitors. Cox regression models were performed to compare the outcomes among patients with 0 and >= 1 minor PI mutation. Models were adjusted for baseline HIV-1 RNA, CD4 cell count, sex, transmission category, age, ethnicity, year of ART start, the presence of nucleoside reverse transcriptase inhibitor mutations, and stratified for the administered PIs. Results: We included 1199 patients of whom 944 (78.7%) received a boosted PI. Minor PI mutations associated with the administered PI were common: 41.7%, 16.1%, 4.7% and 1.9% had 1, 2, 3 or >= 4 mutations, respectively. The time to viral suppression was similar between patients with 0 (reference) and >= 1 minor PI mutation (multivariable hazard ratio (HR): 1.1 [95% confidence interval (CI): 1.0-1.3], P =.196). The time to virological failure was also similar (multivariable HR:.9 [95% CI:.5-1.6], P =.765). In addition, the impact of each single minor PI mutation was analyzed separately: none was significantly associated with the treatment outcome. Conclusions: The presence of minor PI mutations at baseline has no effect on the therapy outcome in HIV infected individuals.	[Scherrer, Alexandra U.; Ledergerber, Bruno; von Wyl, Viktor; Guenthard, Huldrych F.] Univ Zurich, Div Infect Dis & Hosp Epidemiol, Univ Hosp Zurich, Zurich, Switzerland; [Boeni, Juerg] Univ Zurich, Inst Med Virol, Swiss Natl Ctr Retroviruses, Zurich, Switzerland; [Yerly, Sabine] Univ Hosp Geneva, Virol Lab, Geneva, Switzerland; [Klimkait, Thomas] Univ Basel, Inst Med Microbiol, Basel, Switzerland; [Cellerai, Cristina] Univ Lausanne Hosp, Div Immunol & Allergy, Lausanne, Switzerland; [Furrer, Hansjakob] Univ Bern, Div Infect Dis, Univ Hosp Berne, Bern, Switzerland; [Calmy, Alexandra] Univ Hosp Geneva, Div Infect Dis, Geneva, Switzerland; [Cavassini, Matthias] Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland; [Elzi, Luigia] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland; [Elzi, Luigia] Univ Basel Hosp, Hosp Epidemiol, CH-4031 Basel, Switzerland; [Vernazza, Pietro L.] Cantonal Hosp St Gallen, Div Infect Dis, St Gallen, Switzerland; [Bernasconi, Enos] Reg Hosp Lugano, Div Infect Dis, Lugano, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Geneva; University of Basel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University Hospital of Bern; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel; University of Basel; Kantonsspital St. Gallen	Scherrer, AU (corresponding author), Univ Zurich, Div Infect Dis & Hosp Epidemiol, Univ Hosp Zurich, Zurich, Switzerland.	alexandra.scherrer@usz.ch	Furrer, Hansjakob/G-6768-2013; Ledergerber, Bruno/B-5656-2009; Boeni, Juerg/B-8386-2015; Pantaleo, Giuseppe/K-6163-2016; gunthard, huldrych f/F-1724-2011; cavassini, matthias/F-8987-2017	Furrer, Hansjakob/0000-0002-1375-3146; Ledergerber, Bruno/0000-0002-6881-4401; gunthard, huldrych f/0000-0002-1142-6723; von Wyl, Viktor/0000-0002-8754-9797; Klimkait, Thomas/0000-0003-4945-6511; cavassini, matthias/0000-0003-0933-7833	Swiss National Science Foundation (SNF) [33CS30-134277, 3247B0-112594, 324730-130865]; SHCS [470, 528, 569, 683]; European Community under Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN) [223131]; Novartis Foundation; SHCS Research Foundation	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); SHCS; European Community under Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN); Novartis Foundation(Novartis); SHCS Research Foundation	This work was supported in the framework of the Swiss HIV Cohort Study, by the Swiss National Science Foundation (SNF grant # 33CS30-134277). Further support was provided by SNF grant # 3247B0-112594 (to HFG, SY and BL), SNF grant # 324730-130865 and the SHCS projects # 470, 528, 569, 683 the SHCS Research Foundation, the European Community's Seventh Framework Programme (grant FP7/2007-2013), under the Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN; grant 223131). VvW was supported by a fellowship of the Novartis Foundation (formerly Ciba-Geigy Jubilee Foundation). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Brumme CJ, 2005, J INFECT DIS, V191, P1778, DOI 10.1086/429672; Cepeda MS, 2003, AM J EPIDEMIOL, V158, P280, DOI 10.1093/aje/kwg115; Champenois K, 2008, J MED VIROL, V80, P1871, DOI 10.1002/jmv.21315; Frater AJ, 2001, AIDS, V15, P1493, DOI 10.1097/00002030-200108170-00006; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Holguin A, 2004, J CLIN VIROL, V31, P215, DOI 10.1016/j.jcv.2004.03.015; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Kantor R, 2005, PLOS MED, V2, P325, DOI 10.1371/journal.pmed.0020112; Kinomoto M, 2005, CLIN INFECT DIS, V41, P243, DOI 10.1086/431197; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; Nijhuis M, 1999, AIDS, V13, P2349, DOI 10.1097/00002030-199912030-00006; Perno CF, 2004, J INFECT DIS, V189, P1983, DOI 10.1086/386307; Perno CF, 2001, J INFECT DIS, V184, P983, DOI 10.1086/323604; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Rhee SY, 2006, AIDS, V20, P643, DOI 10.1097/01.aids.0000216363.36786.2b; Ribaudo H, 2011, RACE DIFFERENCES EFF; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Schoeni-Affolter F, 2010, INT J EPIDEMIOL, V39, P1179, DOI 10.1093/ije/dyp321; Servais J, 2001, ANTIVIR THER, V6, P239; Shafer RW, 2008, AIDS REV, V10, P67; Staehelin C, 2011, J ACQ IMMUN DEF SYND, V59, P79; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; van Maarseveen NM, 2006, JAIDS-J ACQ IMM DEF, V42, P162, DOI 10.1097/01.qai.0000219787.65915.56; Velazquez-Campoy A, 2001, P NATL ACAD SCI USA, V98, P6062, DOI 10.1073/pnas.111152698; Vergne L, 2003, AIDS, V17, P1105, DOI 10.1097/00002030-200305020-00028; Vergne L, 2000, J CLIN MICROBIOL, V38, P3919, DOI 10.1128/JCM.38.11.3919-3925.2000; Vergne L, 2006, J CLIN VIROL, V36, P43, DOI 10.1016/j.jcv.2006.01.012; Von Wyl V, 2007, ARCH INTERN MED, V167, P1782, DOI 10.1001/archinte.167.16.1782; Weitzen S, 2005, PHARMACOEPIDEM DR S, V14, P227, DOI 10.1002/pds.986; Young J, 2011, CLIN INFECT DIS, V52, P154, DOI 10.1093/cid/ciq079	32	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37983	10.1371/journal.pone.0037983	http://dx.doi.org/10.1371/journal.pone.0037983			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719859	gold, Green Published, Green Accepted			2022-12-25	WOS:000305583300016
J	Benesova, M; Hola, D; Fischer, L; Jedelsky, PL; Hnilicka, F; Wilhelmova, N; Rothova, O; Kocova, M; Prochazkova, D; Honnerova, J; Fridrichova, L; Hnilickova, H				Benesova, Monika; Hola, Dana; Fischer, Lukas; Jedelsky, Petr L.; Hnilicka, Frantisek; Wilhelmova, Nada; Rothova, Olga; Kocova, Marie; Prochazkova, Dagmar; Honnerova, Jana; Fridrichova, Lenka; Hnilickova, Helena			The Physiology and Proteomics of Drought Tolerance in Maize: Early Stomatal Closure as a Cause of Lower Tolerance to Short-Term Dehydration?	PLOS ONE			English	Article							WATER-DEFICIT; GLUTATHIONE-REDUCTASE; OXIDATIVE STRESS; WHEAT CULTIVARS; RICE LEAVES; DIFFERENTIAL RESPONSES; SUPEROXIDE-DISMUTASE; PROGRESSIVE DROUGHT; GENE-EXPRESSION; ABSCISIC-ACID	Understanding the response of a crop to drought is the first step in the breeding of tolerant genotypes. In our study, two maize (Zea mays L.) genotypes with contrasting sensitivity to dehydration were subjected to moderate drought conditions. The subsequent analysis of their physiological parameters revealed a decreased stomatal conductance accompanied by a slighter decrease in the relative water content in the sensitive genotype. In contrast, the tolerant genotype maintained open stomata and active photosynthesis, even under dehydration conditions. Drought-induced changes in the leaf proteome were analyzed by two independent approaches, 2D gel electrophoresis and iTRAQ analysis, which provided compatible but only partially overlapping results. Drought caused the up-regulation of protective and stress-related proteins (mainly chaperones and dehydrins) in both genotypes. The differences in the levels of various detoxification proteins corresponded well with the observed changes in the activities of antioxidant enzymes. The number and levels of up-regulated protective proteins were generally lower in the sensitive genotype, implying a reduced level of proteosynthesis, which was also indicated by specific changes in the components of the translation machinery. Based on these results, we propose that the hypersensitive early stomatal closure in the sensitive genotype leads to the inhibition of photosynthesis and, subsequently, to a less efficient synthesis of the protective/detoxification proteins that are associated with drought tolerance.	[Benesova, Monika; Hola, Dana; Rothova, Olga; Kocova, Marie; Honnerova, Jana; Fridrichova, Lenka] Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic; [Fischer, Lukas] Charles Univ Prague, Fac Sci, Dept Expt Plant Biol, Prague, Czech Republic; [Jedelsky, Petr L.] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic; [Jedelsky, Petr L.] Charles Univ Prague, Fac Sci, Dept Parasitol, Prague, Czech Republic; [Jedelsky, Petr L.] Charles Univ Prague, Fac Sci, Lab Mass Spectrometry, Prague, Czech Republic; [Hnilicka, Frantisek; Hnilickova, Helena] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Bot & Plant Physiol, Prague, Czech Republic; [Wilhelmova, Nada] Acad Sci Czech Republ, Inst Expt Bot, Prague, Czech Republic	Charles University Prague; Charles University Prague; Charles University Prague; Charles University Prague; Charles University Prague; Czech University of Life Sciences Prague; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Benesova, M (corresponding author), Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic.	danahola@natur.cuni.cz	Fischer, Lukáš/M-6516-2017; Hnilička, František/E-3932-2018; Holá, Dana/H-9344-2016; Kočová, Marie/S-7733-2017; Procházková, Dagmar/F-7806-2014; Jedelsky, Petr/C-5879-2009; Wilhelmova, Nada/G-7239-2014; Hniličková, Helena/E-2314-2018; Rothova, Olga/S-7688-2017	Fischer, Lukáš/0000-0003-1852-0461; Hnilička, František/0000-0002-3223-9062; Holá, Dana/0000-0002-2080-8774; Kočová, Marie/0000-0001-7354-7937; Jedelsky, Petr/0000-0003-3813-2343; Wilhelmova, Nada/0000-0002-5546-5513; Hniličková, Helena/0000-0003-0057-8139; Rothova, Olga/0000-0002-2811-6967	Czech Science Foundation [521/07/0470]; Grant Agency of Charles University [101808 B-BIO, SVV-2012-265202]; Ministry of Education, Youth, and Sports of the Czech Republic [LC06034, MSM0021620858, MSM6046070901]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of Charles University; Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This study was financially supported by grants No. 521/07/0470 of the Czech Science Foundation, Nos. 101808 B-BIO and SVV-2012-265202 of the Grant Agency of Charles University, and Nos. LC06034, MSM0021620858, and MSM6046070901 from the Ministry of Education, Youth, and Sports of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali GM, 2006, J PROTEOME RES, V5, P396, DOI 10.1021/pr050291g; Alvarez S, 2009, PROTEOMICS, V9, P3220, DOI [10.1002/pmic.200800478, 10.1002/pmic.200990042]; Huerta-Ocampo JA, 2009, INT J PLANT SCI, V170, P990, DOI 10.1086/605119; Aranjuelo I, 2011, J EXP BOT, V62, P111, DOI 10.1093/jxb/erq249; Ashraf M, 2010, Biotechnol Adv, V28, P169, DOI 10.1016/j.biotechadv.2009.11.005; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bogeat-Triboulot MB, 2007, PLANT PHYSIOL, V143, P876, DOI 10.1104/pp.106.088708; Bonhomme L, 2009, PROTEOMICS, V9, P4121, DOI 10.1002/pmic.200900047; Bonhomme L, 2009, PHYTOCHEMISTRY, V70, P988, DOI 10.1016/j.phytochem.2009.05.013; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bray E. A., 2007, ADV MOL BREEDING DRO, P121; Caruso G, 2009, PLANT SCI, V177, P570, DOI 10.1016/j.plantsci.2009.08.007; Cattivelli L, 2008, FIELD CROP RES, V105, P1, DOI 10.1016/j.fcr.2007.07.004; Cellier F, 1998, PLANT PHYSIOL, V116, P319, DOI 10.1104/pp.116.1.319; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; Chernyad'ev II, 2005, APPL BIOCHEM MICRO+, V41, P115, DOI 10.1007/s10438-005-0021-9; Close TJ, 1996, PHYSIOL PLANTARUM, V97, P795, DOI 10.1111/j.1399-3054.1996.tb00546.x; Cohen D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-630; Contour-Ansel D, 2006, ANN BOT-LONDON, V98, P1279, DOI 10.1093/aob/mcl217; Cornic G, 2002, ANN BOT-LONDON, V89, P887, DOI 10.1093/aob/mcf064; D'Arcy-Lameta A, 2006, ANN BOT-LONDON, V97, P133, DOI 10.1093/aob/mcj010; de Vienne D, 1999, J EXP BOT, V50, P303, DOI 10.1093/jexbot/50.332.303; Edjolo A, 2001, J PLANT PHYSIOL, V158, P1511, DOI 10.1078/0176-1617-00544; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI [10.1007/978-90-481-2666-8_12, 10.1051/agro:2008021]; Fenta BA, 2012, J AGRON CROP SCI, V198, P92, DOI 10.1111/j.1439-037X.2011.00491.x; FISCHER RA, 1978, AUST J AGR RES, V29, P897, DOI 10.1071/AR9780897; Flexas J, 2004, PLANT BIOLOGY, V6, P269, DOI 10.1055/s-2004-820867; Flexas J, 2002, ANN BOT-LONDON, V89, P183, DOI 10.1093/aob/mcf027; Fulda S, 2011, PLANT BIOLOGY, V13, P632, DOI 10.1111/j.1438-8677.2010.00426.x; Ghannoum O, 2009, ANN BOT-LONDON, V103, P635, DOI 10.1093/aob/mcn093; Gong PJ, 2010, J EXP BOT, V61, P3563, DOI 10.1093/jxb/erq167; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Grzesiak MT, 2007, PHOTOSYNTHETICA, V45, P280, DOI 10.1007/s11099-007-0045-x; Grzesiak MT, 2006, PHOTOSYNTHETICA, V44, P561, DOI 10.1007/s11099-006-0072-z; Guo Z, 2006, PLANT PHYSIOL BIOCH, V44, P828, DOI 10.1016/j.plaphy.2006.10.024; Hajheidari M, 2005, PROTEOMICS, V5, P950, DOI 10.1002/pmic.200401101; Hajheidari M, 2007, J PROTEOME RES, V6, P1451, DOI 10.1021/pr060570j; Hayano-Kanashiro C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007531; Hola D, 2007, J PLANT PHYSIOL, V164, P868, DOI 10.1016/j.jplph.2006.04.016; Ke YQ, 2009, BIOCHEM BIOPH RES CO, V379, P133, DOI 10.1016/j.bbrc.2008.12.067; Kottapalli KR, 2009, PLANT CELL ENVIRON, V32, P380, DOI 10.1111/j.1365-3040.2009.01933.x; Kumari Meena, 2004, Indian Journal of Plant Physiology, V9, P203; Langridge Peter, 2006, Briefings in Functional Genomics & Proteomics, V4, P343, DOI 10.1093/bfgp/eli005; Lascano HR, 2001, AUST J PLANT PHYSIOL, V28, P1095, DOI 10.1071/PP01061; Lawlor DW, 2009, ANN BOT-LONDON, V103, P561, DOI [10.1093/aob/mcn244, 10.1093/aob/mcn256]; Lawlor DW, 2002, ANN BOT-LONDON, V89, P871, DOI 10.1093/aob/mcf110; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; Loggini B, 1999, PLANT PHYSIOL, V119, P1091, DOI 10.1104/pp.119.3.1091; Lopes MS, 2011, J EXP BOT, V62, P3135, DOI 10.1093/jxb/err105; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; Mechin V, 2004, PHYTOCHEMISTRY, V65, P1609, DOI 10.1016/j.phytochem.2004.04.035; Medrano H, 2002, ANN BOT-LONDON, V89, P895, DOI 10.1093/aob/mcf079; Mohammadkhani N, 2008, TURK J BIOL, V32, P23; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Oliver MJ, 2011, PHYTOCHEMISTRY, V72, P1273, DOI 10.1016/j.phytochem.2010.10.020; Parida AK, 2007, PLANT BIOTECHNOL REP, V1, P37, DOI 10.1007/s11816-006-0004-1; Parry MAJ, 2002, ANN BOT-LONDON, V89, P833, DOI 10.1093/aob/mcf103; PASTORI GM, 1992, PLANT CELL PHYSIOL, V33, P957; Peng ZY, 2009, MOL CELL PROTEOMICS, V8, P2676, DOI 10.1074/mcp.M900052-MCP200; PETERS HI, 1995, EUR J BIOCHEM, V234, P550, DOI 10.1111/j.1432-1033.1995.550_b.x; Pinheiro C, 2005, PLANTA, V221, P716, DOI 10.1007/s00425-004-1478-0; Pinheiro C, 2011, J EXP BOT, V62, P869, DOI 10.1093/jxb/erq340; Pospisilova J, 2005, BIOL PLANTARUM, V49, P533, DOI 10.1007/s10535-005-0047-0; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Ribaut JM, 2012, HDB MAIZE ITS BIOL, P311; Riccardi F, 1998, PLANT PHYSIOL, V117, P1253, DOI 10.1104/pp.117.4.1253; Riccardi F, 2004, PLANT PHYSIOL BIOCH, V42, P1003, DOI 10.1016/j.plaphy.2004.09.009; ROSIELLE AA, 1981, CROP SCI, V21, P943, DOI 10.2135/cropsci1981.0011183X002100060033x; Sairam RK, 2000, J AGRON CROP SCI, V184, P55, DOI 10.1046/j.1439-037x.2000.00358.x; Salekdeh GH, 2002, PROTEOMICS, V2, P1131, DOI 10.1002/1615-9861(200209)2:9<1131::AID-PROT1131>3.0.CO;2-1; Salekdeh GH, 2002, FIELD CROP RES, V76, P199, DOI 10.1016/S0378-4290(02)00040-0; Salekdeh GH, 2007, PROTEOMICS, V7, P2976, DOI 10.1002/pmic.200700181; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Seki M., 2007, PLANT GENE, V12, P261, DOI [10.1007/978-1-4020-5578-2_11, DOI 10.1007/978-1-4020-5578-2_11]; Shao HB, 2009, CRIT REV BIOTECHNOL, V29, P131, DOI 10.1080/07388550902869792; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Shu LB, 2010, J INTEGR PLANT BIOL, V52, P981, DOI 10.1111/j.1744-7909.2010.00986.x; SMITH IK, 1988, ANAL BIOCHEM, V175, P408, DOI 10.1016/0003-2697(88)90564-7; Tai FJ, 2011, PLANT OMICS, V4, P250; Tardieu F, 2012, J EXP BOT, V63, P25, DOI 10.1093/jxb/err269; Taylor NL, 2009, J PROTEOMICS, V72, P367, DOI 10.1016/j.jprot.2008.11.006; Thomas DJ, 1998, PLANT PHYSIOL, V116, P1593, DOI 10.1104/pp.116.4.1593; Torres-Franklin ML, 2008, J PLANT PHYSIOL, V165, P514, DOI 10.1016/j.jplph.2007.03.011; TRACHSEL H, 1979, BIOCHIM BIOPHYS ACTA, V565, P305, DOI 10.1016/0005-2787(79)90207-7; Turkan I, 2005, PLANT SCI, V168, P223, DOI 10.1016/j.plantsci.2004.07.032; Ukeda H, 1997, ANAL BIOCHEM, V251, P206, DOI 10.1006/abio.1997.2273; Valliyodan B, 2006, CURR OPIN PLANT BIOL, V9, P189, DOI 10.1016/j.pbi.2006.01.019; Veeranagamallaiah G, 2011, J PLANT PHYSIOL, V168, P671, DOI 10.1016/j.jplph.2010.09.007; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Vincent D, 2005, PLANT PHYSIOL, V137, P949, DOI 10.1104/pp.104.050815; Vincent D, 2007, J EXP BOT, V58, P1873, DOI 10.1093/jxb/erm012; Wilkinson S, 2002, PLANT CELL ENVIRON, V25, P195, DOI 10.1046/j.0016-8025.2001.00824.x; Wilkinson S, 2010, PLANT CELL ENVIRON, V33, P510, DOI 10.1111/j.1365-3040.2009.02052.x; Wood AJ, 1997, PHYSIOL PLANTARUM, V99, P144, DOI 10.1034/j.1399-3054.1997.990120.x; Wu WW, 2006, J PROTEOME RES, V5, P651, DOI 10.1021/pr050405o; Xiao XW, 2009, PHYSIOL PLANTARUM, V136, P150, DOI 10.1111/j.1399-3054.2009.01222.x; Xiong JH, 2010, BOT STUD, V51, P137; Xu CP, 2010, CROP SCI, V50, P2543, DOI 10.2135/cropsci2010.03.0152; Xu CP, 2010, J PLANT PHYSIOL, V167, P1477, DOI 10.1016/j.jplph.2010.05.006; Yang F, 2010, PHYSIOL PLANTARUM, V139, P388, DOI 10.1111/j.1399-3054.2010.01375.x; Yordanov I., 2003, Bulgarian Journal of Plant Physiology, P187; Zarco-Perello E, 2005, AGROCIENCIA-MEXICO, V39, P517; Zhao Y, 2011, PHYSIOL PLANTARUM, V141, P40, DOI 10.1111/j.1399-3054.2010.01419.x; Zheng J, 2004, PLANT MOL BIOL, V55, P807, DOI 10.1007/s11103-005-1969-9	106	151	161	1	142	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38017	10.1371/journal.pone.0038017	http://dx.doi.org/10.1371/journal.pone.0038017			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719860	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341900017
J	Koster, A; Caserotti, P; Patel, KV; Matthews, CE; Berrigan, D; Van Domelen, DR; Brychta, RJ; Chen, KY; Harris, TB				Koster, Annemarie; Caserotti, Paolo; Patel, Kushang V.; Matthews, Charles E.; Berrigan, David; Van Domelen, Dane R.; Brychta, Robert J.; Chen, Kong Y.; Harris, Tamara B.			Association of Sedentary Time with Mortality Independent of Moderate to Vigorous Physical Activity	PLOS ONE			English	Article							TELEVISION VIEWING TIME; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; UNITED-STATES; LIFE-STYLE; ALL-CAUSE; RISK; OBESITY; BEHAVIORS; AUSDIAB	Background: Sedentary behavior has emerged as a novel health risk factor independent of moderate to vigorous physical activity (MVPA). Previous studies have shown self-reported sedentary time to be associated with mortality; however, no studies have investigated the effect of objectively measured sedentary time on mortality independent of MVPA. The objective our study was to examine the association between objectively measured sedentary time and all-cause mortality. Methods: 7-day accelerometry data of 1906 participants aged 50 and over from the U. S. nationally representative National Health and Nutrition Examination Survey (NHANES) 2003-2004 were analyzed. All-cause mortality was assessed from the date of examination through December 31, 2006. Results: Over an average follow-up of 2.8 years, there were 145 deaths reported. In a model adjusted for sociodemographic factors, lifestyle factors, multiple morbidities, mobility limitation, and MVPA, participants in third quartile (hazard ratio (HR):4.05; 95% CI:1.55-10.60) and fourth quartile (HR:5.94; 95% CI: 2.49-14.15) of having higher percent sedentary time had a significantly increased risk of death compared to those in the lowest quartile. Conclusions: Our study suggests that sedentary behavior is a risk factor for mortality independent of MVPA. Further investigation, including studies with longer follow-up, is needed to address the health consequences of sedentary behavior.	[Koster, Annemarie; Caserotti, Paolo; Patel, Kushang V.; Van Domelen, Dane R.; Harris, Tamara B.] NIA, Intramural Res Program, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Koster, Annemarie] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Social Med, Maastricht, Netherlands; [Caserotti, Paolo] Univ So Denmark, Inst Sports Sci & Clin Biomech, Odense, Denmark; [Matthews, Charles E.] NCI, Div Canc Epidemiol & Genet Nutrit Epidemiol, Rockville, MD USA; [Berrigan, David] NCI, Div Canc Control & Populat Sci, Appl Res Program, Bethesda, MD USA; [Brychta, Robert J.; Chen, Kong Y.] NIDDKD, Bethesda, MD 20892 USA; [Brychta, Robert J.; Chen, Kong Y.] Obes Branch, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Maastricht University; University of Southern Denmark; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Koster, A (corresponding author), NIA, Intramural Res Program, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA.	a.koster@maastrichtuniversity.nl	Chen, Kong/P-1685-2019; Berrigan, David/AAF-1576-2020; Koster, Annemarie/E-7438-2010; Chen, Kong Y/L-6972-2017; matthews, Charles e/E-8073-2015	Chen, Kong/0000-0002-0306-1904; Koster, Annemarie/0000-0003-1583-7391; Chen, Kong Y/0000-0002-0306-1904; matthews, Charles e/0000-0001-8037-3103; Berrigan, David/0000-0002-5333-179X; Van Domelen, Dane/0000-0003-0051-7790	NATIONAL CANCER INSTITUTE [ZIACP010197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK071013, ZIADK071014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG006020] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bankoski A, 2011, DIABETES CARE, V34, P497, DOI 10.2337/dc10-0987; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Kujala UM, 1998, JAMA-J AM MED ASSOC, V279, P440, DOI 10.1001/jama.279.6.440; Leitzmann MF, 2007, ARCH INTERN MED, V167, P2453, DOI 10.1001/archinte.167.22.2453; Lollgen H, 2009, INT J SPORTS MED, V30, P213, DOI 10.1055/s-0028-1128150; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; National Cancer Institute, RISK FACT MON METH S; NHANES, 1999, LINK MORT FIL; Owen N, 2010, MAYO CLIN PROC, V85, P1138, DOI 10.4065/mcp.2010.0444; Patel AV, 2010, AM J EPIDEMIOL, V172, P419, DOI 10.1093/aje/kwq155; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID AM; Safdar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010778; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Warren TY, 2010, MED SCI SPORT EXER, V42, P879, DOI 10.1249/MSS.0b013e3181c3aa7e; Wijndaele K, 2011, INT J EPIDEMIOL, V40, P150, DOI 10.1093/ije/dyq105	21	204	208	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e37696	10.1371/journal.pone.0037696	http://dx.doi.org/10.1371/journal.pone.0037696			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719846	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341900012
J	Pillai, AG; de Jong, D; Kanatsou, S; Krugers, H; Knapman, A; Heinzmann, JM; Holsboer, F; Landgraf, R; Joels, M; Touma, C				Pillai, Anup G.; de Jong, Danielle; Kanatsou, Sofia; Krugers, Harm; Knapman, Alana; Heinzmann, Jan-Michael; Holsboer, Florian; Landgraf, Rainer; Joels, Marian; Touma, Chadi			Dendritic Morphology of Hippocampal and Amygdalar Neurons in Adolescent Mice Is Resilient to Genetic Differences in Stress Reactivity	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; RECURRENT MAJOR DEPRESSION; PITUITARY-ADRENAL AXIS; CHRONIC PSYCHOSOCIAL STRESS; CA3 PYRAMIDAL NEURONS; HIGH FAMILIAL RISK; AFFECTIVE-DISORDERS; MUNICH VULNERABILITY; JUVENILE STRESS; ADRENOCORTICAL REGULATION	Many studies have shown that chronic stress or corticosterone over-exposure in rodents leads to extensive dendritic remodeling, particularly of principal neurons in the CA3 hippocampal area and the basolateral amygdala. We here investigated to what extent genetic predisposition of mice to high versus low stress reactivity, achieved through selective breeding of CD-1 mice, is also associated with structural plasticity in Golgi-stained neurons. Earlier, it was shown that the highly stress reactive (HR) compared to the intermediate (IR) and low (LR) stress reactive mice line presents a phenotype, with respect to neuroendocrine parameters, sleep architecture, emotional behavior and cognition, that recapitulates some of the features observed in patients suffering from major depression. In late adolescent males of the HR, IR, and LR mouse lines, we observed no significant differences in total dendritic length, number of branch points and branch tips, summated tip order, number of primary dendrites or dendritic complexity of either CA3 pyramidal neurons (apical as well as basal dendrites) or principal neurons in the basolateral amygdala. Apical dendrites of CA1 pyramidal neurons were also unaffected by the differences in stress reactivity of the animals; marginally higher length and complexity of the basal dendrites were found in LR compared to IR but not HR mice. In the same CA1 pyramidal neurons, spine density of distal apical tertiary dendrites was significantly higher in LR compared to IR or HR animals. We tentatively conclude that the dendritic complexity of principal hippocampal and amygdala neurons is remarkably stable in the light of a genetic predisposition to high versus low stress reactivity, while spine density seems more plastic. The latter possibly contributes to the behavioral phenotype of LR versus HR animals.	[Pillai, Anup G.; Kanatsou, Sofia; Joels, Marian] Univ Med Ctr, Dept Neurosci & Pharmacol, RMI, Utrecht, Netherlands; [Knapman, Alana; Heinzmann, Jan-Michael; Holsboer, Florian; Landgraf, Rainer; Touma, Chadi] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Pillai, Anup G.; de Jong, Danielle; Kanatsou, Sofia; Krugers, Harm; Joels, Marian] Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, NL-1012 WX Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Max Planck Society; University of Amsterdam	Pillai, AG (corresponding author), Univ Med Ctr, Dept Neurosci & Pharmacol, RMI, Utrecht, Netherlands.	A.G.Pillai@umcutrecht.nl	Touma, Chadi/G-4677-2011; de Jong - Bolm, Danielle/AAT-6112-2020; Joëls, Marian/P-6415-2016	de Jong - Bolm, Danielle/0000-0002-7422-1725; Pillai, Anup/0000-0001-9788-1286; Joels, Marian/0000-0002-4826-6209	Max Planck society	Max Planck society(Max Planck Society)	The research was supported by a grant from Max Planck society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam EK, 2008, DEV PSYCHOPATHOL, V20, P975, DOI 10.1017/S0954579408000461; Adam EK, 2010, PSYCHONEUROENDOCRINO, V35, P921, DOI 10.1016/j.psyneuen.2009.12.007; Alfarez DN, 2009, HIPPOCAMPUS, V19, P828, DOI 10.1002/hipo.20566; Avital A, 2005, INT J NEUROPSYCHOPH, V8, P163, DOI 10.1017/S1461145704004808; Bersani G, 2010, EUR PSYCHIAT, V25, P461, DOI 10.1016/j.eurpsy.2010.01.002; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Checkley S, 1996, BRIT MED BULL, V52, P597; Choi SJ, 1997, DEV BRAIN RES, V98, P134, DOI 10.1016/S0165-3806(96)00179-4; Coplan JD, 1996, P NATL ACAD SCI USA, V93, P1619, DOI 10.1073/pnas.93.4.1619; Dallmann R, 2006, J COMP PHYSIOL A, V192, P769, DOI 10.1007/s00359-006-0114-9; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; DEBELLIS MD, 1993, AM J PSYCHIAT, V150, P656; DEBELLIS MD, 1994, J CLIN ENDOCR METAB, V78, P249, DOI 10.1210/jc.78.2.249; Deuschle M, 1997, J CLIN ENDOCR METAB, V82, P234, DOI 10.1210/jc.82.1.234; Donohue HS, 2006, NEUROSCIENCE, V140, P597, DOI 10.1016/j.neuroscience.2006.02.072; Engeland WC, 2005, ENDOCRINE, V28, P325, DOI 10.1385/ENDO:28:3:325; Fenzl T, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-29; Friess E, 2008, EUR ARCH PSY CLIN N, V258, P285, DOI 10.1007/s00406-007-0795-2; Frodl T, 2002, BIOL PSYCHIAT, V51, P708, DOI 10.1016/S0006-3223(01)01359-2; Frodl T, 2010, J PSYCHIATR RES, V44, P799, DOI 10.1016/j.jpsychires.2010.01.006; HALBERG F, 1959, AM J PHYSIOL, V197, P1083, DOI 10.1152/ajplegacy.1959.197.5.1083; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Heinzmann JM, 2010, J NEUROENDOCRINOL, V22, P1187, DOI 10.1111/j.1365-2826.2010.02062.x; Heuser IJE, 1996, AM J PSYCHIAT, V153, P93; HOLSBOER F, 1995, NEUROENDOCRINOLOGY, V62, P340, DOI 10.1159/000127023; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Holsboer F, 1996, ENDOCR REV, V17, P187, DOI 10.1210/er.17.2.187; HOLSBOER F, 1987, BIOL PSYCHIAT, V22, P228, DOI 10.1016/0006-3223(87)90237-X; HOLSBOERTRACHSLER E, 1994, J PSYCHIATR RES, V28, P381, DOI 10.1016/0022-3956(94)90020-5; HORNER CH, 1991, J ANAT, V177, P179; Ising M, 2005, J PSYCHIATR RES, V39, P21, DOI 10.1016/j.jpsychires.2004.04.009; Ising M, 2005, PROG NEURO-PSYCHOPH, V29, P1085, DOI 10.1016/j.pnpbp.2005.03.014; Johnson SA, 2009, NEUROSCIENCE, V163, P34, DOI 10.1016/j.neuroscience.2009.06.005; Keller J, 2008, AM J PSYCHIAT, V165, P872, DOI 10.1176/appi.ajp.2008.07081257; Keller J, 2006, BIOL PSYCHIAT, V60, P275, DOI 10.1016/j.biopsych.2005.10.014; Kellogg CK, 1998, NEUROSCIENCE, V83, P681, DOI 10.1016/S0306-4522(97)00408-9; Knapman A, 2010, NEUROBIOL LEARN MEM, V94, P145, DOI 10.1016/j.nlm.2010.04.010; Knapman A, 2010, J PSYCHIATR RES, V44, P566, DOI 10.1016/j.jpsychires.2009.11.014; Lauer CJ, 1998, J PSYCHIAT RES, V32, P393, DOI 10.1016/S0022-3956(98)00026-0; Lenze SN, 2008, PSYCHIAT RES-NEUROIM, V162, P39, DOI 10.1016/j.pscychresns.2007.04.004; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; Magarinos AM, 1996, J NEUROSCI, V16, P3534; Manji HK, 2003, BIOL PSYCHIAT, V53, P707, DOI 10.1016/S0006-3223(03)00117-3; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mervaala E, 2000, PSYCHOL MED, V30, P117, DOI 10.1017/S0033291799001567; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Modell S, 1998, NEUROPSYCHOPHARMACOL, V18, P253; Modell S, 1997, NEUROENDOCRINOLOGY, V65, P216, DOI 10.1159/000127275; Morales-Medina JC, 2009, J CHEM NEUROANAT, V38, P266, DOI 10.1016/j.jchemneu.2009.05.009; Ohl F, 2000, PSYCHONEUROENDOCRINO, V25, P357, DOI 10.1016/S0306-4530(99)00062-1; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P18201, DOI 10.1073/pnas.0509232102; Peleg-Raibstein D, 2011, PSYCHOPHARMACOLOGY, V214, P339, DOI 10.1007/s00213-010-1991-8; Rao U, 2010, BIOL PSYCHIAT, V67, P357, DOI 10.1016/j.biopsych.2009.10.017; RUBIN RT, 1987, ARCH GEN PSYCHIAT, V44, P328; Sheline YI, 2000, BIOL PSYCHIAT, V48, P791, DOI 10.1016/S0006-3223(00)00994-X; Sheline YI, 1998, NEUROREPORT, V9, P2023, DOI 10.1097/00001756-199806220-00021; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Sheline YI, 2003, BIOL PSYCHIAT, V54, P338, DOI 10.1016/S0006-3223(03)00347-0; Sheline YI, 1999, J NEUROSCI, V19, P5034; Sousa N, 2000, NEUROSCIENCE, V97, P253, DOI 10.1016/S0306-4522(00)00050-6; Touma C, 2008, PSYCHONEUROENDOCRINO, V33, P839, DOI 10.1016/j.psyneuen.2008.03.013; Touma C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004325; Tsoory M, 2007, EUR NEUROPSYCHOPHARM, V17, P245, DOI 10.1016/j.euroneuro.2006.06.007; Vazquez DM, 1998, PSYCHONEUROENDOCRINO, V23, P663; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Vyas A, 2002, J NEUROSCI, V22, P6810; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Wong ML, 2000, P NATL ACAD SCI USA, V97, P325, DOI 10.1073/pnas.97.1.325; Zobel AW, 1999, AM J PSYCHIAT, V156, P949, DOI 10.1176/ajp.156.6.949	69	63	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38971	10.1371/journal.pone.0038971	http://dx.doi.org/10.1371/journal.pone.0038971			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701737	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340000057
J	Zhao, YL; Wang, H; Gustafsson, M; Muraro, A; Bruhn, S; Benson, M				Zhao, Yelin; Wang, Hui; Gustafsson, Mika; Muraro, Antonella; Bruhn, Soren; Benson, Mikael			Combined Multivariate and Pathway Analyses Show That Allergen-Induced Gene Expression Changes in CD4(+) T Cells Are Reversed by Glucocorticoids	PLOS ONE			English	Article							RHINITIS; APOPTOSIS; RESPONSES; MECHANISM; CYTOKINES; PROTEIN	Background: Glucocorticoids (GCs) play a key role in the treatment of allergy. However, the genome-wide effects of GCs on gene expression in allergen-challenged CD4(+) T cells have not been described. The aim of this study was to perform a genome-wide analysis to investigate whether allergen-induced gene expression changes in CD4(+) T cells could be reversed by GCs. Methodology/Principal Findings: Gene expression microarray analysis was performed to profile gene expression in diluent( D), allergen- (A), and allergen + hydrocortisone- (T) challenged CD4(+) T cells from patients with seasonal allergic rhinitis. Principal component analysis (PCA) showed good separation of the three groups. To identify the correlation between changes in gene expression in allergen-challenged CD4(+) T cells before and after GC treatment, we performed orthogonal partial least squares discriminant analysis (OPLS-DA) followed by Pearson correlation analysis. This revealed that allergen-induced genes were widely reversed by GC treatment (r = -0.77, P<0.0001). We extracted 547 genes reversed by GC treatment from OPLS-DA models based on their high contribution to the discrimination and found that those genes belonged to several different inflammatory pathways including TNFR2 Signalling, Interferon Signalling, Glucocorticoid Receptor Signalling and T Helper Cell Differentiation. The results were supported by gene expression microarray analyses of two independent materials. Conclusions/Significance: Allergen-induced gene expression changes in CD4(+) T cells were reversed by treatment with glucocorticoids. The top allergen-induced genes that reversed by GC treatment belonged to several inflammatory pathways and genes of known or potential relevance for allergy.	[Zhao, Yelin; Wang, Hui; Gustafsson, Mika; Bruhn, Soren; Benson, Mikael] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden; [Wang, Hui] Univ Gothenburg, Dept Pediat, Gothenburg, Sweden; [Muraro, Antonella] Univ Padua, Dept Pediat, Ctr Food Allergy Diag & Treatment, Padua, Italy	Linkoping University; University of Gothenburg; University of Padua	Zhao, YL (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden.	mikael.benson@liu.se			European Commission [223367]; Swedish Medical Research Council	European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	This research has been supported by the European Commission under the Seventh Framework Programme, grant agreement number 223367, MultiMod, the Swedish Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Barnes Peter J, 2009, Lancet, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Barrenas F, 2008, CYTOKINE, V42, P325, DOI 10.1016/j.cyto.2008.03.004; Benson M, 2004, J ALLERGY CLIN IMMUN, V113, P1137, DOI 10.1016/j.jaci.2004.02.028; Benson M, 2000, J ALLERGY CLIN IMMUN, V106, P307, DOI 10.1067/mai.2000.108111; Bosco A, 2009, J IMMUNOL, V182, P6011, DOI 10.4049/jimmunol.0804125; Bousquet J, 2010, ALLERGY, V65, P1212, DOI [10.1111/j.1398-9995.2010.02439.x, 10.1111/j.1398-9995.2010.02480.x]; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Damsted SK, 2011, EUR J PAEDIATR NEURO, V15, P465, DOI 10.1016/j.ejpn.2011.05.002; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Erin EM, 2005, CLIN EXP ALLERGY, V35, P1608, DOI 10.1111/j.1365-2222.2005.02381.x; Frohlich A, 2007, BLOOD, V109, P2023, DOI 10.1182/blood-2006-05-021600; Goleva E, 2012, J ALLERGY CLIN IMMUN; Greiner AN, 2011, LANCET, V378, P2112, DOI 10.1016/S0140-6736(11)60130-X; Hattori H, 2006, AM J RHINOL, V20, P165, DOI 10.1177/194589240602000208; Ishida A, 2010, AURIS NASUS LARYNX, V37, P584, DOI 10.1016/j.anl.2009.12.002; Ito K, 2006, J ALLERGY CLIN IMMUN, V117, P522, DOI 10.1016/j.jaci.2006.01.032; Jin HL, 2009, J CLIN INVEST, V119, P47, DOI 10.1172/JCI32310; KleinJan A, 2006, J ALLERGY CLIN IMMUN, V118, P1117, DOI 10.1016/j.jaci.2006.05.030; Malmhall C, 2007, ALLERGY, V62, P1007, DOI 10.1111/j.1398-9995.2007.01420.x; Maurer M, 2001, HORM METAB RES, V33, P691, DOI 10.1055/s-2001-19142; Moazzami AA, 2010, NMR BIOMED; Niinuma T, 2012, CANC RES; Obexer P, 2001, ONCOGENE, V20, P4324, DOI 10.1038/sj.onc.1204573; Okano M, 2000, ALLERGY, V55, P723, DOI 10.1034/j.1398-9995.2000.00429.x; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Thysell E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014175; Tonko M, 2001, FASEB J, V15, P693, DOI 10.1096/fj.00-0327com; Venge P, 2009, MONITORING ALLERGIC, P453; Wang H, 2011, ALLERGY, V66, P132, DOI 10.1111/j.1398-9995.2010.02444.x; Wang H, 2010, CLIN EXP ALLERGY, V40, P1194, DOI 10.1111/j.1365-2222.2010.03542.x; Wang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023563; Wang H, 2009, J ALLERGY CLIN IMMUN, V124, P1360, DOI 10.1016/j.jaci.2009.09.037; Webster JC, 2002, ENDOCRINOLOGY, V143, P3866, DOI 10.1210/en.2002-220188; Whelehan OP, 2006, CHEMOMETR INTELL LAB, V84, P82, DOI 10.1016/j.chemolab.2006.03.008; Yoshida NL, 2002, BIOCHEM BIOPH RES CO, V293, P1254; Ziegler SF, 2009, MICROBES INFECT, V11, P594, DOI 10.1016/j.micinf.2009.04.002	38	10	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e39016	10.1371/journal.pone.0039016	http://dx.doi.org/10.1371/journal.pone.0039016			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701743	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340000060
J	Di Paola, S; Micaroni, M; Di Tullio, G; Buccione, R; Di Girolamo, M				Di Paola, Simone; Micaroni, Massimo; Di Tullio, Giuseppe; Buccione, Roberto; Di Girolamo, Maria			PARP16/ARTD15 Is a Novel Endoplasmic-Reticulum-Associated Mono-ADP-Ribosyltransferase That Interacts with, and Modifies Karyopherin-beta 1	PLOS ONE			English	Article							39-KDA POLY(ADP-RIBOSE) GLYCOHYDROLASE; NUCLEAR-PROTEIN IMPORT; NUCLEOCYTOPLASMIC TRANSPORT; RIBOSYLATING TOXINS; POLYMERASE-ACTIVITY; FAMILY; BETA; RIBOSE; CELLS; PARP	Background: Protein mono-ADP-ribosylation is a reversible post-translational modification that modulates the function of target proteins. The enzymes that catalyze this reaction in mammalian cells are either bacterial pathogenic toxins or endogenous cellular ADP-ribosyltransferases. The latter include members of three different families of proteins: the well characterized arginine-specific ecto-enzymes ARTCs, two sirtuins and, more recently, novel members of the poly(ADPribose) polymerase (PARP/ARTD) family that have been suggested to act as cellular mono-ADP-ribosyltransferases. Here, we report on the characterisation of human ARTD15, the only known ARTD family member with a putative C-terminal transmembrane domain. Methodology/Principal Findings: Immunofluorescence and electron microscopy were performed to characterise the subcellular localisation of ARTD15, which was found to be associated with membranes of the nuclear envelope and endoplasmic reticulum. The orientation of ARTD15 was determined using protease protection assay, and is shown to be a tail-anchored protein with a cytosolic catalytic domain. Importantly, by combining immunoprecipitation with mass spectrometry and using cell lysates from cells over-expressing FLAG-ARTD15, we have identified karyopherin-beta 1, a component of the nuclear trafficking machinery, as a molecular partner of ARTD15. Finally, we demonstrate that ARTD15 is a mono-ADP-ribosyltransferase able to induce the ADP-ribosylation of karyopherin-beta 1, thus defining the first substrate for this enzyme. Conclusions/Significance: Our data reveal that ARTD15 is a novel ADP-ribosyltransferase enzyme with a new intracellular location. Finally, the identification of karyopherin-beta 1 as a target of ARTD15-mediated ADP-ribosylation, hints at a novel regulatory mechanism of karyopherin-beta 1 functions.	[Di Paola, Simone; Micaroni, Massimo; Di Tullio, Giuseppe; Buccione, Roberto; Di Girolamo, Maria] Consorzio Mario Negri Sud, Chieti, Italy	Consorzio Mario Negri Sud	Di Paola, S (corresponding author), Consorzio Mario Negri Sud, Chieti, Italy.	mdigirolamo@negrisud.it	Di Paola, Simone/GYU-0514-2022	Di Paola, Simone/0000-0003-3753-5722; Buccione, Roberto/0000-0001-9210-5261; Micaroni, Massimo/0000-0001-6405-0451	Fondazione Negri Sud; Italian Association for Cancer Research (AIRC)	Fondazione Negri Sud; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	We gratefully acknowledge the financial support of the Fondazione Negri Sud and the Italian Association for Cancer Research (AIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar RCT, 2005, J BIOL CHEM, V280, P33756, DOI 10.1074/jbc.M505408200; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Boehler C, 2011, CELL CYCLE, V10, P1023, DOI 10.4161/cc.10.7.15169; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; CERVANTESLAUREAN D, 1995, J BIOL CHEM, V270, P7929, DOI 10.1074/jbc.270.14.7929; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Chou HYE, 2006, J BIOL CHEM, V281, P15201, DOI 10.1074/jbc.M506745200; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; Corda D, 2003, EMBO J, V22, P1953, DOI 10.1093/emboj/cdg209; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dani N, 2011, J BIOL CHEM, V286, P5995, DOI 10.1074/jbc.M110.112466; Dania N, 2009, P NATL ACAD SCI USA, V106, P4243, DOI 10.1073/pnas.0900066106; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Di Girolamo M, 2005, FEBS J, V272, P4565, DOI 10.1111/j.1742-4658.2005.04876.x; DOMENIGHINI M, 1994, MOL MICROBIOL, V14, P41, DOI 10.1111/j.1365-2958.1994.tb01265.x; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Glowacki G, 2002, PROTEIN SCI, V11, P1657, DOI 10.1110/ps.0200602; Goenka S, 2006, P NATL ACAD SCI USA, V103, P4210, DOI 10.1073/pnas.0506981103; Gorlich D, 1995, COLD SPRING HARB SYM, V60, P695, DOI 10.1101/SQB.1995.060.01.075; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Herrero-Yraola A, 2001, EMBO J, V20, P2404, DOI 10.1093/emboj/20.10.2404; Hottiger MO, 2010, UNIFIED NOMENCLATURE; HSIA JA, 1985, J BIOL CHEM, V260, P6187; JUST I, 1995, BIOCHEMISTRY-US, V34, P326, DOI 10.1021/bi00001a040; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; Kanai M, 2007, NAT CELL BIOL, V9, P1175, DOI 10.1038/ncb1638; Kerns JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040021; Kickhoefer VA, 1999, J CELL BIOL, V146, P917, DOI 10.1083/jcb.146.5.917; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; KOZLOWSKI JM, 1984, J NATL CANCER I, V72, P913; KRUEGER KM, 1995, CLIN MICROBIOL REV, V8, P34, DOI 10.1128/CMR.8.1.34; LENO GH, 1989, EUR J BIOCHEM, V186, P205, DOI 10.1111/j.1432-1033.1989.tb15196.x; Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015; LOESBERG C, 1990, BIOCHIM BIOPHYS ACTA, V1037, P92, DOI 10.1016/0167-4838(90)90106-P; Lupi R, 2000, J BIOL CHEM, V275, P9418, DOI 10.1074/jbc.275.13.9418; Ma Q, 2001, BIOCHEM BIOPH RES CO, V289, P499, DOI 10.1006/bbrc.2001.5987; Malanga M, 2011, METHODS MOL BIOL, V780, P67, DOI 10.1007/978-1-61779-270-0_5; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Moss J, 1997, ADV EXP MED BIOL, V419, P25; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Oka S, 2006, J BIOL CHEM, V281, P705, DOI 10.1074/jbc.M510290200; Ono T, 2006, P NATL ACAD SCI USA, V103, P16687, DOI 10.1073/pnas.0607911103; Otto H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-139; PANZETER PL, 1990, NUCLEIC ACIDS RES, V18, P2194, DOI 10.1093/nar/18.8.2194; Paone G, 2002, P NATL ACAD SCI USA, V99, P8231, DOI 10.1073/pnas.122238899; PAYNE DM, 1985, BIOCHEMISTRY-US, V24, P7540, DOI 10.1021/bi00347a006; PIRON KJ, 1990, BIOCHEM J, V270, P591, DOI 10.1042/bj2700591; Polishchuk R S, 2001, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0408s11; Polishchuk V P, 2000, Mikrobiol Z, V62, P40; Raval-Fernandes S, 2005, CANCER RES, V65, P8846, DOI 10.1158/0008-5472.CAN-05-0770; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Seman M, 2004, CURR MED CHEM, V11, P857, DOI 10.2174/0929867043455611; Seman M, 2003, IMMUNITY, V19, P571, DOI 10.1016/S1074-7613(03)00266-8; Stilla A, 2011, EUR J CELL BIOL, V90, P665, DOI 10.1016/j.ejcb.2011.03.007; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; WADA I, 1991, J BIOL CHEM, V266, P19599; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Yates SP, 2005, BIOCHEM J, V385, P667, DOI 10.1042/BJ20041480; Yu M, 2005, ONCOGENE, V24, P1982, DOI 10.1038/sj.onc.1208410; Zhang J, 1997, METHOD ENZYMOL, V280, P255; Zhong YW, 2011, J BIOL CHEM, V286, P33921, DOI 10.1074/jbc.M111.272906; ZOLKIEWSKA A, 1993, J BIOL CHEM, V268, P25273	72	69	70	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e37352	10.1371/journal.pone.0037352	http://dx.doi.org/10.1371/journal.pone.0037352			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701565	gold, Green Published, Green Submitted			2022-12-25	WOS:000305337600007
J	Thornbrough, JM; Hundley, T; Valdivia, R; Worley, MJ				Thornbrough, Joshua M.; Hundley, Tom; Valdivia, Raphael; Worley, Micah J.			Human Genome-Wide RNAi Screen for Host Factors That Modulate Intracellular Salmonella Growth	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; PATHOGENICITY ISLAND 2; III SECRETION SYSTEM; EPITHELIAL-CELLS; MYCOBACTERIUM-TUBERCULOSIS; VIRULENCE PROTEIN; APEE GENE; MACROPHAGES; SURVIVAL; NETWORK	Salmonella enterica is a bacterial pathogen of humans that can proliferate within epithelial cells as well as professional phagocytes of the immune system. While much has been learned about the microbial genes that influence the infectious process through decades of intensive research, relatively little is known about the host factors that affect infection. We performed a genome-wide siRNA screen to identify host genes that Salmonella enterica serovar Typhimurium (S. typhimurium) utilizes to facilitate growth within human epithelial cells. In this screen, with siRNAs targeting every predicted gene in the human genome, we identified 252 new human-host-susceptibility factors (HSFs) for S. typhimurium. We also identified 39 genes whose silencing results in increased intracellular growth of S. typhimurium. The HSFs identified are regulated most centrally by NFkB and associate with each other through an extremely dense network of interactions that center around a group of kinases. Most genes identified were not previously appreciated as playing roles in the intracellular lifecycle of S. enterica. Numerous HSFs identified with interesting characteristics that could play plausible roles in mediating intracellular microbial growth are discussed. Importantly, this study reveals significant overlap between the host network that supports S. typhimurium growth within human epithelial cells and the one that promotes the growth of Mycobacterium tuberculosis within human macrophages. In addition to providing much new information about the molecular mechanisms underlying S. enterica-host cell interplay, all 252 HSFs identified are candidates for new anti-microbial targets for controlling S. enterica infections, and some may provide broad-spectrum anti-microbial activity.	[Thornbrough, Joshua M.; Hundley, Tom; Worley, Micah J.] Univ Louisville, Dept Biol, Louisville, KY 40292 USA; [Worley, Micah J.] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Valdivia, Raphael] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA	University of Louisville; University of Louisville; Duke University	Thornbrough, JM (corresponding author), Univ Louisville, Dept Biol, Louisville, KY 40292 USA.	micah.worley@louisville.edu	Valdivia, Raphael/R-5377-2019	Valdivia, Raphael/0000-0003-0961-073X	National Institutes of Health grant from Southeastern Regional Center of Excellence for Emerging Infections and Biodefense [U54 AI057157]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157] Funding Source: NIH RePORTER	National Institutes of Health grant from Southeastern Regional Center of Excellence for Emerging Infections and Biodefense; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by National Institutes of Health grant #U54 AI057157 from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audia JP, 2006, J BACTERIOL, V188, P6261, DOI 10.1128/JB.00371-06; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Barr FA, 1999, CURR BIOL, V9, P381, DOI 10.1016/S0960-9822(99)80167-5; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Boyle EC, 2007, J BACTERIOL, V189, P1489, DOI 10.1128/JB.01730-06; Carinato ME, 1998, J BACTERIOL, V180, P3517, DOI 10.1128/JB.180.14.3517-3521.1998; Chen Y, 2008, MOL CELLS, V26, P415; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Conlin CA, 2001, J BACTERIOL, V183, P1784, DOI 10.1128/JB.183.5.1784-1786.2001; Das P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015466; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Dorer MS, 2006, PLOS PATHOG, V2, P315, DOI 10.1371/journal.ppat.0020034; Faherty CS, 2008, TRENDS MICROBIOL, V16, P173, DOI 10.1016/j.tim.2008.02.001; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Gaind R, 2006, J ANTIMICROB CHEMOTH, V58, P1139, DOI 10.1093/jac/dkl391; Galyov EE, 1997, MOL MICROBIOL, V25, P903, DOI 10.1111/j.1365-2958.1997.mmi525.x; GROISMAN EA, 1993, EMBO J, V12, P3779, DOI 10.1002/j.1460-2075.1993.tb06056.x; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Hobbie S, 1997, J IMMUNOL, V159, P5550; Janakiraman A, 2000, MOL MICROBIOL, V35, P1146, DOI 10.1046/j.1365-2958.2000.01783.x; Janecek S, 2002, BIOINFORMATICS, V18, P1534, DOI 10.1093/bioinformatics/18.11.1534; Jiang SX, 2010, J BIOL CHEM, V285, P34960, DOI 10.1074/jbc.M110.150839; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Keestra AM, 2011, MBIO, V2; Kuhle V, 2006, TRAFFIC, V7, P716, DOI 10.1111/j.1600-0854.2006.00422.x; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Leonard AE, 2000, BIOCHEM J, V350, P765, DOI 10.1042/0264-6021:3500765; Campoy EM, 2011, INFECT IMMUN, V79, P402, DOI 10.1128/IAI.00688-10; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; McLaughlin LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000671; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Okazaki H, 2008, J BIOL CHEM, V283, P33357, DOI 10.1074/jbc.M802686200; Oswald E, 2005, CURR OPIN MICROBIOL, V8, P83, DOI 10.1016/j.mib.2004.12.011; PANG T, 1995, TRENDS MICROBIOL, V3, P253, DOI 10.1016/S0966-842X(00)88937-4; Patel JC, 2009, CELL, V137, P283, DOI 10.1016/j.cell.2009.01.056; Ray K, 2009, NAT REV MICROBIOL, V7, P333, DOI 10.1038/nrmicro2112; RIKIHISA Y, 1984, ANAT REC, V208, P319, DOI 10.1002/ar.1092080302; Rowe B, 1997, CLIN INFECT DIS, V24, pS106, DOI 10.1093/clinids/24.Supplement_1.S106; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; Schroder B, 2007, TRAFFIC, V8, P1676, DOI 10.1111/j.1600-0854.2007.00643.x; Smith AC, 2007, J CELL BIOL, V176, P263, DOI 10.1083/jcb.200611056; Steele-Mortimer O, 2000, INFECT IMMUN, V68, P5401, DOI 10.1128/IAI.68.9.5401-5404.2000; Thomas M, 2009, CELL HOST MICROBE, V5, P309, DOI 10.1016/j.chom.2009.03.010; van der Velden AWM, 2000, INFECT IMMUN, V68, P5702, DOI 10.1128/IAI.68.10.5702-5709.2000; Walker DH, 1997, LAB INVEST, V76, P129; Walker DM, 2001, CURR BIOL, V11, P1600, DOI 10.1016/S0960-9822(01)00501-2; Weinrauch Y, 1999, ANNU REV MICROBIOL, V53, P155, DOI 10.1146/annurev.micro.53.1.155; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Worley MJ, 2006, P NATL ACAD SCI USA, V103, P17915, DOI 10.1073/pnas.0604054103; Worley MJ, 2000, MOL MICROBIOL, V36, P749, DOI 10.1046/j.1365-2958.2000.01902.x	59	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38097	10.1371/journal.pone.0038097	http://dx.doi.org/10.1371/journal.pone.0038097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701604	gold, Green Submitted, Green Published			2022-12-25	WOS:000305337600015
J	Sivakumar, L; Dehmer, M				Sivakumar, Lavanya; Dehmer, Matthias			Towards Information Inequalities for Generalized Graph Entropies	PLOS ONE			English	Article							COMPLEX NETWORKS; BOUNDS	In this article, we discuss the problem of establishing relations between information measures for network structures. Two types of entropy based measures namely, the Shannon entropy and its generalization, the Renyi entropy have been considered for this study. Our main results involve establishing formal relationships, by means of inequalities, between these two kinds of measures. Further, we also state and prove inequalities connecting the classical partition-based graph entropies and partition-independent entropy measures. In addition, several explicit inequalities are derived for special classes of graphs.	[Sivakumar, Lavanya] Inst Math Sci, Madras 600113, Tamil Nadu, India; [Dehmer, Matthias] UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria	Institute of Mathematical Sciences (IMSc) India	Sivakumar, L (corresponding author), Inst Math Sci, Madras 600113, Tamil Nadu, India.	matthias.dehmer@umit.at	Selvaganesh, Lavanya/AAX-8445-2021	Selvaganesh, Lavanya/0000-0002-8208-5372	FWF (Austrian Sciences Fund) [PN22029-N13]; Austrian Science Fund (FWF) [P 22029] Funding Source: researchfish	FWF (Austrian Sciences Fund); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Matthias Dehmer and Lavanya Sivakumar thank the FWF (Austrian Sciences Fund) (Project No. PN22029-N13) for supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand K, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.045102; [Anonymous], 2005, COMPLEXITY CHEM BIOL, DOI DOI 10.1007/B136300; Arndt C., 2004, INFORM MEASURES INFO; BALABAN AT, 1991, J MATH CHEM, V8, P383, DOI 10.1007/BF01166951; BASAK SC, 1988, DISCRETE APPL MATH, V19, P17, DOI 10.1016/0166-218X(88)90004-2; Bertz SH, 1983, CHEM APPL TOPOLOGY G, P206; BONCHEV D, 1977, J CHEM PHYS, V67, P4517, DOI 10.1063/1.434593; Bonchev D., 2003, COMPLEXITY CHEM INTR, V7; Bonchev D, 2009, ENCY COMPLEXITY SYST, V5, P4820, DOI [10.1007/978-0-387-30440-3_285, DOI 10.1007/978-0-387-30440-3_285]; Bonchev D, 1983, INFORM THEORETIC IND; Butts CT, 2001, SOC NETWORKS, V23, P31, DOI 10.1016/S0378-8733(01)00030-2; Claussen JC, 2007, PHYSICA A, V375, P365, DOI 10.1016/j.physa.2006.08.067; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Cover T.M, 2006, WILEY SERIES TELECOM; DAROCZY Z, 1979, ACTA MATH ACAD SCI H, V34, P105, DOI 10.1007/BF01902599; Dehmer M, 2008, APPL ARTIF INTELL, V22, P684, DOI 10.1080/08839510802164101; Dehmer M, 2008, APPL MATH COMPUT, V201, P82, DOI 10.1016/j.amc.2007.12.010; Dehmer M, 2008, COMPUT BIOL CHEM, V32, P131, DOI 10.1016/j.compbiolchem.2007.09.007; Dehmer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031395; Dehmer M, 2011, COMPLEXITY, V17, P45, DOI 10.1002/cplx.20379; Dehmer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015733; Dehmer M, 2011, INFORM SCIENCES, V181, P57, DOI 10.1016/j.ins.2010.08.041; Dehmer M, 2010, APPL MATH COMPUT, V215, P4263, DOI 10.1016/j.amc.2009.12.051; Dehmer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008057; Dehmer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003079; Delgado-Soler L, 2009, J CHEM INF MODEL, V49, P2457, DOI 10.1021/ci900275w; DEMBO A, 1991, IEEE T INFORM THEORY, V37, P1501, DOI 10.1109/18.104312; Dragomir SS, 1997, APPL MATH LETT, V10, P23, DOI 10.1016/S0893-9659(97)00028-1; Harary F., 1969, GRAPH THEORY; HARDY G. H., 1988, CAMBRIDGE MATH LIB; Kim J, 2008, PHYSICA A, V387, P2637, DOI 10.1016/j.physa.2008.01.015; Korner J., 1973, T 6 PRAG C INF THEOR, P411; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; RASHEVSKY N., 1955, BULL MATH BIOPHYS, V17, P229, DOI 10.1007/BF02477860; Renyi A, 1961, P 4 BERK S MATH STAT, V1; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shannon CE, 1997, MATH THEORY COMMUNIC; Skorobogatov VA, 1988, MATCH-COMMUN MATH CO, V23, P105; Yeung RW, 1997, IEEE T INFORM THEORY, V43, P1924, DOI 10.1109/18.641556	40	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38159	10.1371/journal.pone.0038159	http://dx.doi.org/10.1371/journal.pone.0038159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715375	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336800016
J	Frank, MG; Waldrop, RH; Dumoulin, M; Aton, S; Boal, JG				Frank, Marcos G.; Waldrop, Robert H.; Dumoulin, Michelle; Aton, Sara; Boal, Jean G.			A Preliminary Analysis of Sleep-Like States in the Cuttlefish Sepia officinalis	PLOS ONE			English	Article							BEHAVIORAL EVIDENCE; CEPHALOPODA; DROSOPHILA; EVOLUTION; PHARAONIS; BRAIN; REST; EYE	Sleep has been observed in several invertebrate species, but its presence in marine invertebrates is relatively unexplored. Rapid-eye-movement (REM) sleep has only been observed in vertebrates. We investigated whether the cuttlefish Sepia officinalis displays sleep-like states. We find that cuttlefish exhibit frequent quiescent periods that are homeostatically regulated, satisfying two criteria for sleep. In addition, cuttlefish transiently display a quiescent state with rapid eye movements, changes in body coloration and twitching of the arms, that is possibly analogous to REM sleep. Our findings thus suggest that at least two different sleep-like states may exist in Sepia officinalis.	[Frank, Marcos G.; Dumoulin, Michelle; Aton, Sara] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Waldrop, Robert H.; Boal, Jean G.] Millersville Univ, Dept Biol, Lancaster, PA USA	University of Pennsylvania; Pennsylvania Medicine; Pennsylvania State System of Higher Education (PASSHE); Millersville University of Pennsylvania	Frank, MG (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.	mgf@mail.med.upenn.edu; Jean.Boal@millersville.edu		Aton, Sara/0000-0002-2921-0509; Bridi, Michelle/0000-0001-5533-5092	NEI NIH HHS [T32 EY007143, F32 EY017766] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY007143, F32EY017766] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABBOT NJ, 1995, CEPHALOPOD NEUROBIOL; Adamo SA, 2006, BIOL BULL-US, V210, P192, DOI 10.2307/4134557; Alves C, 2007, ANIM COGN, V10, P29, DOI 10.1007/s10071-006-0027-6; Boal JG, 2004, BEHAVIOUR, V141, P837, DOI 10.1163/1568539042265662; Brown ER, 2006, BEHAV BRAIN RES, V172, P355, DOI 10.1016/j.bbr.2006.05.009; Budelmann B, 1994, MICROSCOPIC ANATOMY, P119; Cajochen C, 2006, CHRONOBIOL INT, V23, P461, DOI 10.1080/07420520500545813; CHICHERY MP, 1992, BRAIN RES, V574, P77, DOI 10.1016/0006-8993(92)90802-G; Crook AC, 2002, PHILOS T ROY SOC B, V357, P1617, DOI 10.1098/rstb.2002.1070; Duntley SP, 2004, ANN NEUROL, V56, pS68; Duntley SP, 2003, SLEEP, V26, pA118; Duntley SP, 2002, SLEEP, V25, pA159; Frank MG, 1999, RAPID EYE MOVEMENT SLEEP, P17; Guibe M, 2008, ETUDE FONCTIONS COGN; Hanlon R. T., 1996, CEPHALOPOD BEHAV; HANLON RT, 1988, PHILOS T ROY SOC B, V320, P437, DOI 10.1098/rstb.1988.0087; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hvorecny LM, 2007, ANIM COGN, V10, P449, DOI 10.1007/s10071-007-0085-4; Jouvet-Mounier D, 1970, Dev Psychobiol, V2, P216; Langridge KV, 2009, ANIM BEHAV, V77, P847, DOI 10.1016/j.anbehav.2008.11.023; Lesku JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023203; Mahowald MW, 2004, ARCH ITAL BIOL, V142, P469; MATHER JA, 1995, ADV STUD BEHAV, V24, P317, DOI 10.1016/S0065-3454(08)60398-8; MESSENGER JB, 1973, BRAIN RES, V58, P519, DOI 10.1016/0006-8993(73)90025-5; Raizen DM, 2008, NATURE, V451, P569, DOI 10.1038/nature06535; Ramon F, 2004, P NATL ACAD SCI USA, V101, P11857, DOI 10.1073/pnas.0402015101; SASTRE JP, 1979, PHYSIOL BEHAV, V22, P979; Shashar N, 1998, BIOL BULL, V195, P187, DOI 10.2307/1542830; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2003, J NEUROBIOL, V54, P179, DOI 10.1002/neu.10167; Siegel JA, 2005, METH NE FRO NEUROSCI, P163; Siegel JM, 1998, PHILOS T ROY SOC B, V353, P1147, DOI 10.1098/rstb.1998.0272; Stephenson R, 2011, J EXP BIOL, V214, P747, DOI 10.1242/jeb.050591; Tobler I., 2005, PRINCIPLES PRACTICE, P77, DOI [10.1016/B0-72-160797-7/50014-8, DOI 10.1016/B0-72-160797-7/50014-8]	34	32	32	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38125	10.1371/journal.pone.0038125	http://dx.doi.org/10.1371/journal.pone.0038125			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701609	gold, Green Published			2022-12-25	WOS:000305348400038
J	Freundlieb, N; Ridder, V; Dobel, C; Enriquez-Geppert, S; Baumgaertner, A; Zwitserlood, P; Gerloff, C; Hummel, FC; Liuzzi, G				Freundlieb, Nils; Ridder, Volker; Dobel, Christian; Enriquez-Geppert, Stefanie; Baumgaertner, Annette; Zwitserlood, Pienie; Gerloff, Christian; Hummel, Friedhelm C.; Liuzzi, Gianpiero			Associative Vocabulary Learning: Development and Testing of Two Paradigms for the (Re-) Acquisition of Action- and Object-Related Words	PLOS ONE			English	Article							CONSTRAINT-INDUCED APHASIA; MOTOR CORTEX; BROCAS AREA; LANGUAGE; THERAPY; STROKE; VERB; STIMULATION; RECOVERY; ERRORLESS	Despite a growing number of studies, the neurophysiology of adult vocabulary acquisition is still poorly understood. One reason is that paradigms that can easily be combined with neuroscientfic methods are rare. Here, we tested the efficiency of two paradigms for vocabulary (re-) acquisition, and compared the learning of novel words for actions and objects. Cortical networks involved in adult native-language word processing are widespread, with differences postulated between words for objects and actions. Words and what they stand for are supposed to be grounded in perceptual and sensorimotor brain circuits depending on their meaning. If there are specific brain representations for different word categories, we hypothesized behavioural differences in the learning of action-related and object-related words. Paradigm A, with the learning of novel words for body-related actions spread out over a number of days, revealed fast learning of these new action words, and stable retention up to 4 weeks after training. The single-session Paradigm B employed objects and actions. Performance during acquisition did not differ between action-related and object-related words (time*word category: p = 0.01), but the translation rate was clearly better for object-related (79%) than for action-related words (53%, p = 0.002). Both paradigms yielded robust associative learning of novel action-related words, as previously demonstrated for object-related words. Translation success differed for action-and object-related words, which may indicate different neural mechanisms. The paradigms tested here are well suited to investigate such differences with neuroscientific means. Given the stable retention and minimal requirements for conscious effort, these learning paradigms are promising for vocabulary re-learning in brain-lesioned people. In combination with neuroimaging, neuro-stimulation or pharmacological intervention, they may well advance the understanding of language learning to optimize therapeutic strategies.	[Freundlieb, Nils; Ridder, Volker; Gerloff, Christian; Hummel, Friedhelm C.; Liuzzi, Gianpiero] Univ Hosp Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Dobel, Christian; Enriquez-Geppert, Stefanie; Zwitserlood, Pienie] Univ Munster, Psychol Inst 2, Munster, Germany; [Baumgaertner, Annette] Univ Appl Sci Fresenius, Hamburg, Germany; [Liuzzi, Gianpiero] Univ Zurich Hosp, Dept Neurosurg, CH-8091 Zurich, Switzerland	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; University of Zurich; University Zurich Hospital	Freundlieb, N (corresponding author), Univ Hosp Hamburg Eppendorf, Dept Neurol, Hamburg, Germany.	f.hummel@uke.uni-hamburg.de; liuzzi@ganglion.de		Gerloff, Christian/0000-0002-6484-8882; Hummel, Friedhelm/0000-0002-4746-4633	Deutsche Forschungsgemeinschaft [DFG LI 1892/1-1]; Forschungsforderungsfonds Medizin of the University of Hamburg [NWF08/07]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungsforderungsfonds Medizin of the University of Hamburg	This research was supported by the Deutsche Forschungsgemeinschaft (DFG LI 1892/1-1 to G. L.; www.dfg.de) and by the Forschungsforderungsfonds Medizin of the University of Hamburg (NWF08/07 to G. L., www.uke.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Beck AT, 1995, BECK DEPRESSIONS INV; Berthier ML, 2009, ANN NEUROL, V65, P577, DOI 10.1002/ana.21597; Bird H, 2000, BRAIN LANG, V72, P246, DOI 10.1006/brln.2000.2292; Breitenstein C, 2005, NEUROIMAGE, V25, P958, DOI 10.1016/j.neuroimage.2004.12.019; Breitenstein C, 2004, RESTOR NEUROL NEUROS, V22, P445; Breitenstein C, 2002, J NEUROSCI METH, V114, P173, DOI 10.1016/S0165-0270(01)00525-8; Breitenstein C, 2009, NERVENARZT, V80, P149, DOI 10.1007/s00115-008-2571-6; Brickenkamp R., 1981, HDB PSYCHOL PADAGOGI, P270; Conroy P, 2009, APHASIOLOGY, V23, P1311, DOI 10.1080/02687030902756439; de Vries MH, 2010, J COGNITIVE NEUROSCI, V22, P2427, DOI 10.1162/jocn.2009.21385; Dienes Z, 2008, PROG BRAIN RES, V168, P49, DOI 10.1016/S0079-6123(07)68005-4; Dobel C, 2010, J COGNITIVE NEUROSCI, V22, P1251, DOI 10.1162/jocn.2009.21297; Enticott PG, 2010, NEUROPSYCHOLOGIA, V48, P2675, DOI 10.1016/j.neuropsychologia.2010.05.014; Fillingham JK, 2003, NEUROPSYCHOL REHABIL, V13, P337, DOI 10.1080/09602010343000020; FLOEL A, 2008, J COGN NEUROSCI; Floel A, 2010, NEUROBIOL DIS, V37, P243, DOI 10.1016/j.nbd.2009.05.027; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hebb D. O., 1949, ORG BEHAV NEUROPHYSI; Helmstaedter C, 2001, VERBALER LERN MERKFA, V1; Horn W., 1983, L P S LEISTUNGSPR FS, V2; Hummel FC, 2006, LANCET NEUROL, V5, P708, DOI 10.1016/S1474-4422(06)70525-7; Kelly-Hayes Margaret, 2003, J Stroke Cerebrovasc Dis, V12, P119, DOI 10.1016/S1052-3057(03)00042-9; Knecht S, 2004, ANN NEUROL, V56, P20, DOI 10.1002/ana.20125; Liuzzi G, 2008, NEUROPSYCHOLOGIA, V46, P2824, DOI 10.1016/j.neuropsychologia.2008.05.015; Liuzzi G, 2010, CURR BIOL, V20, P1745, DOI 10.1016/j.cub.2010.08.034; Matzig S, 2009, CORTEX, V45, P738, DOI 10.1016/j.cortex.2008.10.003; MILLER GA, 1991, COGNITION, V41, P197, DOI 10.1016/0010-0277(91)90036-4; Musso M, 2003, NAT NEUROSCI, V6, P774, DOI 10.1038/nn1077; Nickels L, 2002, APHASIOLOGY, V16, P1047, DOI 10.1080/02687040143000618; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PEDERSEN PM, 1995, ANN NEUROL, V38, P659, DOI 10.1002/ana.410380416; Pulvermuller F, 1999, BEHAV BRAIN SCI, V22, P253, DOI 10.1017/S0140525X9900182X; Pulvermuller F, 2000, NEUROREPORT, V11, P2789, DOI 10.1097/00001756-200008210-00036; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Pulvermuller F, 2001, STROKE, V32, P1621, DOI 10.1161/01.STR.32.7.1621; Pulvermuller F, 2001, BRAIN LANG, V78, P143, DOI 10.1006/brln.2000.2390; Pulvermuller F, 2008, APHASIOLOGY, V22, P563, DOI 10.1080/02687030701612213; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; Rey A., 1959, MANUEL TEST COPIE FI; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; SCHWARTZ RG, 1984, J SPEECH HEAR RES, V27, P119, DOI 10.1044/jshr.2701.119; Szaflarski JP, 2008, MED SCI MONITOR, V14, pCR243	43	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37033	10.1371/journal.pone.0037033	http://dx.doi.org/10.1371/journal.pone.0037033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WK	22701562	Green Published, gold, Green Submitted			2022-12-25	WOS:000305348400009
J	Khapare, N; Kundu, ST; Sehgal, L; Sawant, M; Priya, R; Gosavi, P; Gupta, N; Alam, H; Karkhanis, M; Naik, N; Vaidya, MM; Dalal, SN				Khapare, Nileema; Kundu, Samrat T.; Sehgal, Lalit; Sawant, Mugdha; Priya, Rashmi; Gosavi, Prajakta; Gupta, Neha; Alam, Hunain; Karkhanis, Madhura; Naik, Nishigandha; Vaidya, Milind M.; Dalal, Sorab N.			Plakophilin3 Loss Leads to an Increase in PRL3 Levels Promoting K8 Dephosphorylation, Which Is Required for Transformation and Metastasis	PLOS ONE			English	Article							O-LINKED GLYCOSYLATION; CANCER-CELL MIGRATION; INTERMEDIATE-FILAMENTS; EPITHELIAL-CELLS; CULTURED-CELLS; PLAQUE PROTEIN; EXPRESSION; KERATIN-8; PHOSPHORYLATION; INVASION	The desmosome anchors keratin filaments in epithelial cells leading to the formation of a tissue wide IF network. Loss of the desmosomal plaque protein plakophilin3 (PKP3) in HCT116 cells, leads to an increase in neoplastic progression and metastasis, which was accompanied by an increase in K8 levels. The increase in levels was due to an increase in the protein levels of the Phosphatase of Regenerating Liver 3 (PRL3), which results in a decrease in phosphorylation on K8. The increase in PRL3 and K8 protein levels could be reversed by introduction of an shRNA resistant PKP3 cDNA. Inhibition of K8 expression in the PKP3 knockdown clone S10, led to a decrease in cell migration and lamellipodia formation. Further, the K8 PKP3 double knockdown clones showed a decrease in colony formation in soft agar and decreased tumorigenesis and metastasis in nude mice. These results suggest that a stabilisation of K8 filaments leading to an increase in migration and transformation may be one mechanism by which PKP3 loss leads to tumor progression and metastasis.	[Khapare, Nileema; Kundu, Samrat T.; Sehgal, Lalit; Sawant, Mugdha; Priya, Rashmi; Gosavi, Prajakta; Gupta, Neha; Alam, Hunain; Vaidya, Milind M.; Dalal, Sorab N.] Tata Mem Hosp, KS215, ACTREC, Navi Mumbai, Maharashtra, India; [Karkhanis, Madhura; Naik, Nishigandha] Piramal Life Sci Ltd, Dept Pharmacol, Mumbai, Maharashtra, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Piramal Life Sciences Ltd	Khapare, N (corresponding author), Tata Mem Hosp, KS215, ACTREC, Navi Mumbai, Maharashtra, India.	sdalal@actrec.gov.in	Alam, Hunain/H-2984-2019	Alam, Hunain/0000-0002-6183-3677; Sehgal, lalit/0000-0002-1151-5427; Priya, Rashmi/0000-0002-0510-7515; Kundu, Samrat/0000-0002-0117-6986	Department of Biotechnology [BT/PR11537/BRB/10/661/2008]; Advanced Centre for Treatment Reserach and Education in Cancer (ACTREC); Council for Scientific and Industrial Research; University Grants Commission	Department of Biotechnology; Advanced Centre for Treatment Reserach and Education in Cancer (ACTREC); Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission(University Grants Commission, India)	This work was supported by grants from the Department of Biotechnology (grant BT/PR11537/BRB/10/661/2008) and Advanced Centre for Treatment Reserach and Education in Cancer (ACTREC) (SND) and fellowships from Council for Scientific and Industrial Research (HA) and the University Grants Commission (PG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner K, 2007, FEBS LETT; Alam H, 2011, PLOS ONE UNPUB; Alam H, 2011, J CELL SCI, V124, P2096, DOI 10.1242/jcs.073585; Bardelli A, 2003, CLIN CANCER RES, V9, P5607; BARIBAULT H, 1993, GENE DEV, V7, P1191, DOI 10.1101/gad.7.7a.1191; Bonne S, 2003, J CELL BIOL, V161, P403, DOI 10.1083/jcb.200303036; Bonne S, 1999, J CELL SCI, V112, P2265; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chidgey M, 2007, BRIT J CANCER, V96, P1783, DOI 10.1038/sj.bjc.6603808; CHOU CF, 1993, J BIOL CHEM, V268, P4465; CHOU CF, 1992, J BIOL CHEM, V267, P3901; CLAUSEN H, 1986, J INVEST DERMATOL, V86, P249, DOI 10.1111/1523-1747.ep12285369; Dalal SN, 1999, MOL CELL BIOL, V19, P4465; Fillies T, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-10; FRANKE WW, 1983, P NATL ACAD SCI-BIOL, V80, P7113, DOI 10.1073/pnas.80.23.7113; Garrod D, 2007, BIOCH BIOPHYS ACTA; Garrod DR, 2002, MOL MEMBR BIOL, V19, P81, DOI 10.1080/09687680210132476; Getsios S, 2009, J CELL BIOL, V185, P1243, DOI 10.1083/jcb.200809044; Gillio-Tos A, 2007, PATHOLOGY, V39, P345, DOI 10.1080/00313020701329757; Gosavi P, 2011, CELL MOL LIFE SCI, V68, P1439, DOI 10.1007/s00018-010-0531-3; Green KJ, 2000, NAT REV MOL CELL BIO, V1, P208, DOI 10.1038/35043032; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; Hesse M, 2004, EUR J CELL BIOL, V83, P19, DOI 10.1078/0171-9335-00354; Hofmann I, 2006, MOL BIOL CELL, V17, P1388, DOI 10.1091/mbc.e05-08-0708; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Jaitovich A, 2008, J BIOL CHEM, V283, P25348, DOI 10.1074/jbc.M801635200; Jiang YJ, 2011, CANCER RES, V71, P234, DOI 10.1158/0008-5472.CAN-10-1487; Just L, 2003, J NEUROSCI METH, V126, P69, DOI 10.1016/S0165-0270(03)00065-7; Karpova Tatiana, 2006, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1207s35; Krubasik D, 2006, BRIT J CANCER, V94, P1326, DOI 10.1038/sj.bjc.6603101; Ku NO, 1996, CANCER METAST REV, V15, P429, DOI 10.1007/BF00054011; Ku NO, 2000, J CELL BIOL, V149, P547, DOI 10.1083/jcb.149.3.547; Ku NO, 2002, J BIOL CHEM, V277, P10775, DOI 10.1074/jbc.M107623200; Kundu ST, 2008, INT J CANCER, V123, P2303, DOI 10.1002/ijc.23797; LARCHER F, 1992, MOL CARCINOGEN, V6, P112, DOI 10.1002/mc.2940060206; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mizuuchi E, 2009, INT J CANCER, V124, P1802, DOI 10.1002/ijc.24111; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Oshima RG, 1996, CANCER METAST REV, V15, P445, DOI 10.1007/BF00054012; Papagerakis S, 2003, HUM PATHOL, V34, P565, DOI 10.1016/S0046-8177(03)00174-6; Potiron VA, 2007, CANCER RES, V67, P8708, DOI 10.1158/0008-5472.CAN-06-3612; Raul U, 2004, INT J CANCER, V111, P662, DOI 10.1002/ijc.20349; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Roger L, 2010, J CELL SCI, V123, P1295, DOI 10.1242/jcs.061002; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; SCHAAFSMA HE, 1993, J PATHOL, V170, P77, DOI 10.1002/path.1711700113; Schmidt A, 1999, DIFFERENTIATION, V64, P291, DOI 10.1046/j.1432-0436.1999.6450291.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwarz J, 2006, HUM PATHOL, V37, P613, DOI 10.1016/j.humpath.2006.01.013; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Spector D. L., 1998, CELLS LAB MANUAL; Srikanth B, 2010, J BIOL CHEM, V285, P34062, DOI 10.1074/jbc.M109.098996; STEINERT PM, 1976, J MOL BIOL, V108, P547, DOI 10.1016/S0022-2836(76)80136-2; STEINERT PM, 1976, BIOCHEM BIOPH RES CO, V70, P221, DOI 10.1016/0006-291X(76)91131-1; Tao GZ, 2003, J CELL SCI, V116, P4629, DOI 10.1242/jcs.00782; Vaidya MM, 1996, ORAL ONCOL, V32B, P333, DOI 10.1016/0964-1955(96)00012-7; Vignjevic D, 2008, SEMIN CANCER BIOL, V18, P12, DOI 10.1016/j.semcancer.2007.08.001; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang HH, 2010, CANCER CELL, V18, P52, DOI 10.1016/j.ccr.2010.04.028; Woll S, 2007, J CELL BIOL, V177, P795, DOI 10.1083/jcb.200703174; Wolf A, 2010, J CELL BIOL, V188, P463, DOI 10.1083/jcb.200908135; Xiang RH, 2002, CANCER RES, V62, P2637; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; ZALVIDE J, 1995, MOL CELL BIOL, V15, P5800	64	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38561	10.1371/journal.pone.0038561	http://dx.doi.org/10.1371/journal.pone.0038561			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701666	gold, Green Published			2022-12-25	WOS:000305348400071
J	Scorza, FB; Colucci, AM; Maggiore, L; Sanzone, S; Rossi, O; Ferlenghi, I; Pesce, I; Caboni, M; Norais, N; Di Cioccio, V; Saul, A; Gerke, C				Scorza, Francesco Berlanda; Colucci, Anna Maria; Maggiore, Luana; Sanzone, Silvia; Rossi, Omar; Ferlenghi, Ilaria; Pesce, Isabella; Caboni, Mariaelena; Norais, Nathalie; Di Cioccio, Vito; Saul, Allan; Gerke, Christiane			High Yield Production Process for Shigella Outer Membrane Particles	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; PROTECTIVE IMMUNITY; NUCLEOTIDE-SEQUENCE; CHROMOSOMAL GENES; VESICLES; VACCINE; FLEXNERI; IMMUNIZATION; VIRULENCE; PROTEINS	Gram-negative bacteria naturally shed particles that consist of outer membrane lipids, outer membrane proteins, and soluble periplasmic components. These particles have been proposed for use as vaccines but the yield has been problematic. We developed a high yielding production process of genetically derived outer membrane particles from the human pathogen Shigella sonnei. Yields of approximately 100 milligrams of membrane-associated proteins per liter of fermentation were obtained from cultures of S. sonnei Delta tolR Delta galU at optical densities of 30-45 in a 5 L fermenter. Proteomic analysis of the purified particles showed the preparation to primarily contain predicted outer membrane and periplasmic proteins. These were highly immunogenic in mice. The production of these outer membrane particles from high density cultivation of bacteria supports the feasibility of scaling up this approach as an affordable manufacturing process. Furthermore, we demonstrate the feasibility of using this process with other genetic manipulations e. g. abolition of O antigen synthesis and modification of the lipopolysaccharide structure in order to modify the immunogenicity or reactogenicity of the particles. This work provides the basis for a large scale manufacturing process of Generalized Modules of Membrane Antigens (GMMA) for production of vaccines from Gram-negative bacteria.	[Ferlenghi, Ilaria; Norais, Nathalie] Novartis Vaccines & Diagnost, Siena, Italy; [Scorza, Francesco Berlanda; Colucci, Anna Maria; Maggiore, Luana; Sanzone, Silvia; Rossi, Omar; Pesce, Isabella; Caboni, Mariaelena; Di Cioccio, Vito; Saul, Allan; Gerke, Christiane] Novartis Vaccines Inst Global Hlth, Siena, Italy	Novartis; Novartis	Scorza, FB (corresponding author), Novartis Vaccines & Diagnost, Siena, Italy.	christiane.gerke@novartis.com	Saul, Allan/ABH-2091-2020; Di Cioccio, Vito/N-1296-2013; Saul, Allan J/I-6968-2013; Rossi, Omar/AAT-6743-2020	Saul, Allan/0000-0003-0665-4091; Di Cioccio, Vito/0000-0002-8063-9650; Saul, Allan J/0000-0003-0665-4091; Caboni, Mariaelena/0000-0002-9742-0022; Berlanda Scorza, Francesco/0000-0003-2307-7855; Maggiore, Luana/0000-0002-2147-5780; Gerke, Christiane/0000-0001-9446-8031	Bill & Melinda Gates Foundation through the Grant Challenges Explorations Initiative [51833]; Novartis Vaccines Institute for Global Health (NVGH)	Bill & Melinda Gates Foundation through the Grant Challenges Explorations Initiative; Novartis Vaccines Institute for Global Health (NVGH)	The work was funded in part by a grant (#51833) from the Bill & Melinda Gates Foundation through the Grant Challenges Explorations Initiative and in part by Novartis Vaccines Institute for Global Health (NVGH). Several of the authors are or were employed by NVGH and, as such, NVGH played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. The B&M Gates Foundation had no role in these activities.	Adu-Bobie J, 2004, INFECT IMMUN, V72, P1914, DOI 10.1128/IAI.72.4.1914-1919.2004; Alaniz RC, 2007, J IMMUNOL, V179, P7692, DOI 10.4049/jimmunol.179.11.7692; Bergman MA, 2005, INFECT IMMUN, V73, P1350, DOI 10.1128/IAI.73.3.1350-1356.2005; Bernadac A, 1998, J BACTERIOL, V180, P4872, DOI 10.1128/JB.180.18.4872-4878.1998; Berven FD, 2006, ARCH MICROBIOL, V184, P362, DOI 10.1007/s00203-005-0055-7; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Camacho AI, 2011, VACCINE, V29, P8222, DOI 10.1016/j.vaccine.2011.08.121; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Chen DJ, 2010, P NATL ACAD SCI USA, V107, P3099, DOI 10.1073/pnas.0805532107; Cohen D, 1996, Adv Exp Med Biol, V397, P159; d'Hauteville H, 2002, J IMMUNOL, V168, P5240, DOI 10.4049/jimmunol.168.10.5240; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Doherty NS, 1998, ELECTROPHORESIS, V19, P355, DOI 10.1002/elps.1150190234; Ferrari G, 2006, PROTEOMICS, V6, P1856, DOI 10.1002/pmic.200500164; FORMAL SB, 1966, J BACTERIOL, V92, P17, DOI 10.1128/JB.92.1.17-22.1966; GILMOUR NJL, 1991, VACCINE, V9, P137, DOI 10.1016/0264-410X(91)90271-7; Henry T, 2004, RES MICROBIOL, V155, P437, DOI 10.1016/j.resmic.2004.04.007; Jiang Y, 2005, PLASMID, V54, P149, DOI 10.1016/j.plasmid.2005.03.002; Kaminski RW, 2009, EXPERT REV VACCINES, V8, P1693, DOI 10.1586/ERV.09.127; Kaneshige T, 2009, AVIAN DIS, V53, P563, DOI 10.1637/8925-051309-Reg.1; Keenan JI, 2003, FEMS IMMUNOL MED MIC, V36, P199, DOI 10.1016/S0928-8244(03)00091-9; Koeberling O, 2008, J INFECT DIS, V198, P262, DOI 10.1086/589308; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Kweon MN, 2008, CURR OPIN INFECT DIS, V21, P313, DOI 10.1097/QCO.0b013e3282f88b92; Levine MM, 2007, NAT REV MICROBIOL, V5, P540, DOI 10.1038/nrmicro1662; Maxson ME, 2004, J BACTERIOL, V186, P4199, DOI 10.1128/JB.186.13.4199-4208.2004; Nichols WA, 1997, J ENDOTOXIN RES, V4, P163, DOI 10.1177/096805199700400301; Passwell JH, 2010, VACCINE, V28, P2231, DOI 10.1016/j.vaccine.2009.12.050; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; SANDLIN RC, 1995, INFECT IMMUN, V63, P229, DOI 10.1128/IAI.63.1.229-237.1995; Schild S, 2009, INFECT IMMUN, V77, P472, DOI 10.1128/IAI.01139-08; Schild S, 2008, INFECT IMMUN, V76, P4554, DOI 10.1128/IAI.00532-08; Scorza FB, 2008, MOL CELL PROTEOMICS, V7, P473, DOI 10.1074/mcp.M700295-MCP200; Somerville JE, 1999, INFECT IMMUN, V67, P6583; Somerville JE, 1996, J CLIN INVEST, V97, P359, DOI 10.1172/JCI118423; Sprong T, 2011, INNATE IMMUN-LONDON, V17, P517, DOI 10.1177/1753425910383999; TAYLOR LA, 1988, NUCLEIC ACIDS RES, V16, P358, DOI 10.1093/nar/16.1.358; TRIEUCUOT P, 1990, NUCLEIC ACIDS RES, V18, P3660, DOI 10.1093/nar/18.12.3660; van der Ley P, 2001, INFECT IMMUN, V69, P5981, DOI 10.1128/IAI.69.10.5981-5990.2001; Ying TY, 2005, PROTEOMICS, V5, P4777, DOI 10.1002/pmic.200401326; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	44	77	86	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e35616	10.1371/journal.pone.0035616	http://dx.doi.org/10.1371/journal.pone.0035616			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701551	gold, Green Published, Green Submitted			2022-12-25	WOS:000305348400002
J	Masaki, H; Murphy, TI; Kamijo, K; Yamazaki, K; Sommer, W				Masaki, Hiroaki; Murphy, Timothy I.; Kamijo, Keita; Yamazaki, Katuo; Sommer, Werner			Foreshadowing of Performance Accuracy by Event-Related Potentials: Evidence from a Minimal-Conflict Task	PLOS ONE			English	Article							COGNITIVE CONTROL; CINGULATE CORTEX; ERROR-DETECTION; CORRECT TRIALS; BRAIN ACTIVITY; COMPATIBILITY; INFORMATION; RESPONSES; ACTIVATION; COMPONENTS	Background: Recent studies employing stimulus-response compatibility tasks suggest that an increase in the amplitude of the positive deflection of the response-locked event-related potential (ERP) foreshadows errors on forthcoming trials. However, no studies have tested the generalizability of error-foreshadowing positivity to tasks without stimulus-response interference. Methodology/Principal Findings: The present study adopted an alternating-response task, in which the participants responded to the pointing direction of an arrowhead (up or down). Although the arrowhead direction alternated for the majority of trials (95%), occasionally this pattern was broken by a repeated stimulus, termed a lure trial. We compared the matched-reaction-time correct-preceding ERP with the error-preceding ERP on lure-preceding trials. There was no evidence that errors are foreshadowed by the increase of a positive electroencephalogram (EEG) deflection. To the contrary, analyses of ERPs time-locked to electromyogram (EMG) onset on the five consecutive lure-preceding trials showed larger positive deflections on correct-preceding than error-preceding trials. The post-response negativity did not differ between correct-preceding and error-preceding trials. Conclusions/Significance: These results suggest that in minimal conflict tasks a decreased positivity may foreshadow incorrect performance several trials prior to the error, possibly reflecting the waning of task-related efforts. Therefore, error-foreshadowing brain signals may be task-specific.	[Masaki, Hiroaki; Kamijo, Keita; Yamazaki, Katuo] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Murphy, Timothy I.] Brock Univ, Dept Psychol, St Catharines, ON L2S 3A1, Canada; [Sommer, Werner] Humboldt Univ, Inst Psychol, D-10099 Berlin, Germany	Waseda University; Brock University; Humboldt University of Berlin	Masaki, H (corresponding author), Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan.	masaki@waseda.jp	Sommer, Werner/H-4672-2011; Sommer, Werner/N-1945-2019; Kamijo, Keita/H-4530-2013	Sommer, Werner/0000-0001-5266-3445; Sommer, Werner/0000-0001-5266-3445; Kamijo, Keita/0000-0001-8828-4930	Japan Society for the Promotion of Science [21530774]; Ministry of Education, Culture, Sports, Science and Technology; Waseda University [2008A-505]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Waseda University	This study was supported by a Grant-in-Aid for Scientific Research(C) 21530774 from Japan Society for the Promotion of Science, two Grants-in-Aid [the Global Center of Excellence program and Kibankeisei (2010)] from the Ministry of Education, Culture, Sports, Science and Technology, and a Grant for Special Research Projects from Waseda University Projects (2008A-505) to H. Masaki. URLs: http://www.jsps.go.jp/english/e-grants/index.html. http://www.jsps.go.jp/english/e-globalcoe/. http://www.waseda.jp/rps/en/manual/tokutei.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain S, 2004, NEUROSCI LETT, V372, P161, DOI 10.1016/j.neulet.2004.09.036; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Burle B, 2005, J EXP PSYCHOL HUMAN, V31, P831, DOI 10.1037/0096-1523.31.4.831; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Casini L, 1996, NEUROSCI LETT, V219, P71, DOI 10.1016/S0304-3940(96)13188-8; Coles MGH, 2001, BIOL PSYCHOL, V56, P173, DOI 10.1016/S0301-0511(01)00076-X; Eichele T, 2008, P NATL ACAD SCI USA, V105, P6173, DOI 10.1073/pnas.0708965105; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Ford JM, 1999, PSYCHOPHYSIOLOGY, V36, P667, DOI 10.1111/1469-8986.3660667; FREUDE G, 1989, J PSYCHOPHYSIOL, V3, P377; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hajcak G, 2005, BIOL PSYCHOL, V70, P67, DOI 10.1016/j.biopsycho.2004.12.001; Hoffmann S, 2010, HUM BRAIN MAPP, V31, P1305, DOI 10.1002/hbm.20937; Jentzsch I, 2001, PSYCHOPHYSIOLOGY, V38, P607, DOI 10.1017/S0048577201000531; Kawabe S, 1982, JAPANESE J PHYS ED, V27, P217; Masaki H, 2000, PSYCHOPHYSIOLOGY, V37, P464, DOI 10.1017/S0048577200981976; Notebaert W, 2009, COGNITION, V111, P275, DOI 10.1016/j.cognition.2009.02.002; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Padilla ML, J COGNITIVE NEUROSCI, V18, P1477; Ridderinkhof KR, 2003, NEUROSCI LETT, V348, P1, DOI 10.1016/S0304-3940(03)00566-4; Scheffers MK, 2000, J EXP PSYCHOL HUMAN, V26, P141, DOI 10.1037/0096-1523.26.1.141; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; SMID HGOM, 1992, J EXP PSYCHOL HUMAN, V18, P1101, DOI 10.1037/0096-1523.18.4.1101; Sommer W, 1999, PERCEPT PSYCHOPHYS, V61, P342, DOI 10.3758/BF03206892; Sturmer B, 2002, J EXP PSYCHOL HUMAN, V28, P1345, DOI 10.1037//0096-1523.28.6.1345; Vidal F, 2003, BIOL PSYCHOL, V64, P265, DOI 10.1016/S0301-0511(03)00097-8	29	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e38006	10.1371/journal.pone.0038006	http://dx.doi.org/10.1371/journal.pone.0038006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TY	22701541	Green Submitted, gold, Green Published			2022-12-25	WOS:000305338500072
J	Dikovskaya, D; Khoudoli, G; Newton, IP; Chadha, GS; Klotz, D; Visvanathan, A; Lamond, A; Swedlow, JR; Nathke, IS				Dikovskaya, Dina; Khoudoli, Guennadi; Newton, Ian P.; Chadha, Gaganmeet S.; Klotz, Daniel; Visvanathan, Ashwat; Lamond, Angus; Swedlow, Jason R.; Naethke, Inke S.			The Adenomatous Polyposis Coli Protein Contributes to Normal Compaction of Mitotic Chromatin	PLOS ONE			English	Article							TOPOISOMERASE-II; CHROMOSOME ARCHITECTURE; CONDENSIN-I; APC MUTATIONS; EGG EXTRACTS; LIVING CELLS; REVEALS; VITRO; DECONDENSATION; PROLIFERATION	The tumour suppressor Adenomatous Polyposis Coli (APC) is required for proper mitosis; however, the exact role of APC in mitosis is not understood. Using demembranated sperm chromatin exposed to meiotic Xenopus egg extract and HeLa cells expressing fluorescently labelled histones, we established that APC contributes to chromatin compaction. Sperm chromatin in APC-depleted Xenopus egg extract frequently formed tight round or elongated structures. Such abnormally compacted chromatin predominantly formed spindles with low microtubule content. Furthermore, in mitotic HeLa cells expressing GFP- and mCherry-labelled H2B histones, depletion of APC caused a decrease in the donor fluorescence lifetime of neighbouring fluorophores, indicative of excessive chromatin compaction. Profiling the chromatin-associated proteome of sperm chromatin incubated with Xenopus egg extracts revealed temporal APC-dependent changes in the abundance of histones, closely mirrored by chromatin-associated Topoisomerase IIa, condensin I complex and Kif4. In the absence of APC these factors initially accumulated on chromatin, but then decreased faster than in controls. We also found and validated significant APC-dependent changes in chromatin modifiers Set-a and Rbbp7. Both were decreased on chromatin in APC-depleted extract; in addition, the kinetics of association of Set-a with chromatin was altered in the absence of APC.	[Dikovskaya, Dina; Newton, Ian P.; Klotz, Daniel; Naethke, Inke S.] Univ Dundee, Dundee, Scotland; [Khoudoli, Guennadi; Chadha, Gaganmeet S.; Visvanathan, Ashwat; Lamond, Angus; Swedlow, Jason R.] Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Dundee, Scotland	University of Dundee; University of Dundee	Dikovskaya, D (corresponding author), Univ Glasgow, Canc Res UK Beatson Labs, Glasgow, Lanark, Scotland.	i.s.nathke@lifesci.dundee.ac.uk	Chadha, Gaganmeet Singh/G-8843-2013	Chadha, Gaganmeet Singh/0000-0003-2921-3504; Lamond, Angus/0000-0001-6204-6045; Nathke, Inke/0000-0003-2420-4385; Swedlow, Jason/0000-0002-2198-1958	Cancer Research UK [C430/A11243, C303/A7399]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H013024/1]; BBSRC [BB/H013024/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H013024/1] Funding Source: researchfish; Cancer Research UK [11243] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK program grant C430/A11243 to ISN and by Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/H013024/1 and Cancer Research UK grant C303/A7399. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1991, CELL, V64, P137, DOI 10.1016/0092-8674(91)90215-K; Andreu P, 2005, DEVELOPMENT, V132, P1443, DOI 10.1242/dev.01700; Buchert M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000816; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Chang CJ, 2003, J CELL SCI, V116, P4715, DOI 10.1242/jcs.00797; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daban JR, 2011, MICRON; Desai A, 1999, METHOD CELL BIOL, V61, P385; Dikovskaya D, 2004, MOL BIOL CELL, V15, P2978, DOI 10.1091/mbc.E03-08-0613; Dikovskaya D, 2007, J CELL BIOL, V176, P183, DOI 10.1083/jcb.200610099; Dikovskaya D, 2010, J CELL SCI, V123, P736, DOI 10.1242/jcs.060806; Draviam VM, 2006, EMBO J, V25, P2814, DOI 10.1038/sj.emboj.7601168; Freedman BS, 2010, CURR BIOL, V20, P1048, DOI 10.1016/j.cub.2010.04.025; GASSER SM, 1986, J MOL BIOL, V188, P613, DOI 10.1016/S0022-2836(86)80010-9; Gillespie PJ, 2007, CURR BIOL, V17, P1657, DOI 10.1016/j.cub.2007.08.041; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; HIRANO T, 1993, J CELL BIOL, V120, P601, DOI 10.1083/jcb.120.3.601; Karetsou Z, 2004, FEBS LETT, V577, P496, DOI 10.1016/j.febslet.2004.09.091; KATAGIRI C, 1994, INT J DEV BIOL, V38, P209; Khoudoli GA, 2008, CURR BIOL, V18, P838, DOI 10.1016/j.cub.2008.04.075; Kireeva N, 2004, J CELL BIOL, V166, P775, DOI 10.1083/jcb.200406049; Konig P, 2007, CHROMOSOMA, V116, P349, DOI 10.1007/s00412-007-0101-0; Kutney SN, 2004, J BIOL CHEM, V279, P30850, DOI 10.1074/jbc.M404969200; Leung JW, 2011, J BIOL CHEM, V286, P21393, DOI 10.1074/jbc.M110.208793; Lleres D, 2009, J CELL BIOL, V187, P481, DOI 10.1083/jcb.200907029; Maeshima K, 2003, DEV CELL, V4, P467, DOI 10.1016/S1534-5807(03)00092-3; Maresca TJ, 2005, J CELL BIOL, V169, P859, DOI 10.1083/jcb.200503031; Martin RM, 2010, FASEB J, V24, P1066, DOI 10.1096/fj.08-128959; Matsumoto K, 1999, MOL CELL BIOL, V19, P6940; Mazumdar M, 2004, J CELL BIOL, V166, P613, DOI 10.1083/jcb.200401142; McCartney BM, 2008, CURR OPIN CELL BIOL, V20, P186, DOI 10.1016/j.ceb.2008.02.001; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; Mora-Bermudez F, 2007, METHODS, V41, P158, DOI 10.1016/j.ymeth.2006.07.035; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Nishijima H, 2000, Prog Cell Cycle Res, V4, P145; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; PHILPOTT A, 1991, CELL, V65, P569, DOI 10.1016/0092-8674(91)90089-H; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ribeiro SA, 2009, MOL BIOL CELL, V20, P2371, DOI 10.1091/mbc.E08-11-1127; Rusan NM, 2008, J CELL BIOL, V181, P719, DOI 10.1083/jcb.200802107; Samoshkin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006831; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Scrittori L, 2001, J BIOL CHEM, V276, P30002, DOI 10.1074/jbc.M102701200; Shintomi K, 2011, GENE DEV, V25, P1464, DOI 10.1101/gad.2060311; Steigerwald K, 2005, MOL CANCER RES, V3, P78, DOI 10.1158/1541-7786.MCR-03-0189; Swedlow JR, 1999, PRACT APPROACH SER, P165; Tighe A, 2004, J CELL SCI, V117, P6339, DOI 10.1242/jcs.01556; UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]	55	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38102	10.1371/journal.pone.0038102	http://dx.doi.org/10.1371/journal.pone.0038102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719865	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000305341900019
J	Gomes, J; Magalhaes, A; Carvalho, AS; Hernandez, GE; Papp, SL; Head, SR; Michel, V; David, L; Gartner, F; Touati, E; Reis, CA				Gomes, Joana; Magalhaes, Ana; Carvalho, Ana S.; Hernandez, Gilberto E.; Papp, Suzanne L.; Head, Steven R.; Michel, Valerie; David, Leonor; Gaertner, Fatima; Touati, Eliette; Reis, Celso A.			Glycophenotypic Alterations Induced by Pteridium aquilinum in Mice Gastric Mucosa: Synergistic Effect with Helicobacter pylori Infection	PLOS ONE			English	Article							SIALYL-LEWIS-X; MONOCLONAL-ANTIBODIES; MOLECULAR-CLONING; UDP-GALACTOSE; BRACKEN FERN; INTESTINAL METAPLASIA; EPITHELIAL-CELLS; EXPRESSION; CANCER; FAMILY	The bracken fern Pteridium aquilinum is a plant known to be carcinogenic to animals. Epidemiological studies have shown an association between bracken fern exposure and gastric cancer development in humans. The biological effects of exposure to this plant within the gastric carcinogenesis process are not fully understood. In the present work, effects in the gastric mucosa of mice treated with Pteridium aquilinum were evaluated, as well as molecular mechanisms underlying the synergistic role with Helicobacter pylori infection. Our results showed that exposure to Pteridium aquilinum induces histomorphological modifications including increased expression of acidic glycoconjugates in the gastric mucosa. The transcriptome analysis of gastric mucosa showed that upon exposure to Pteridium aquilinum several glycosyltransferase genes were differently expressed, including Galntl4, C1galt1 and St3gal2, that are mainly involved in the biosynthesis of simple mucin-type carbohydrate antigens. Concomitant treatment with Pteridium aquilinum and infection with Helicobacter pylori also resulted in differently expressed glycosyltransferase genes underlying the biosynthesis of terminal sialylated Lewis antigens, including Sialyl-Lewis x. These results disclose the molecular basis for the altered pattern of glycan structures observed in the mice gastric mucosa. The gene transcription alterations and the induced glycophenotypic changes observed in the gastric mucosa contribute for the understanding of the molecular mechanisms underlying the role of Pteridium aquilinum in the gastric carcinogenesis process.	[Gomes, Joana; Magalhaes, Ana; Carvalho, Ana S.; David, Leonor; Gaertner, Fatima; Reis, Celso A.] Univ Porto, Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Gomes, Joana; Michel, Valerie; Touati, Eliette] Inst Pasteur, Unite Pathogenese Helicobacter, Paris, France; [Hernandez, Gilberto E.; Papp, Suzanne L.; Head, Steven R.] Scripps Res Inst, La Jolla, CA 92037 USA; [David, Leonor; Reis, Celso A.] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Gaertner, Fatima; Reis, Celso A.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal	Universidade do Porto; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Scripps Research Institute; Universidade do Porto; Universidade do Porto	Gomes, J (corresponding author), Univ Porto, Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	celsor@ipatimup.pt	REIS, Celso A/B-9969-2008; de Fátima Gärtner, Maria/A-3530-2010; Magalhaes, Ana/I-1510-2013; Gomes, Joana/K-9031-2013; Magalhaes, Ana/O-9990-2019; David, Leonor/A-4829-2008	REIS, Celso A/0000-0002-0286-6639; de Fátima Gärtner, Maria/0000-0002-5302-0086; Magalhaes, Ana/0000-0003-4863-6668; Gomes, Joana/0000-0002-8832-2703; Magalhaes, Ana/0000-0003-4863-6668; David, Leonor/0000-0003-4207-9258; Touati, Eliette/0000-0002-3450-1773; Carvalho, Ana Sofia/0000-0003-0657-1907	Fundacao para a Ciencia e a Tecnologia - [FCT] [PIC/IC/82716/2007, SFRH/BD/40563/2007, SFRH/BPD/75871/2011]; Programa de Accoes Universitarias Integradas Luso-Francesas - PAULIF [LC/HS/ED/2010-308, F-TC04/11];  [NIGMS-GM62116]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Fundacao para a Ciencia e a Tecnologia - [FCT](Portuguese Foundation for Science and Technology); Programa de Accoes Universitarias Integradas Luso-Francesas - PAULIF; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Fundacao para a Ciencia e a Tecnologia - [FCT (PIC/IC/82716/2007), grant number SFRH/BD/40563/2007 to J.G and SFRH/BPD/75871/2011 to A. M.]; and the Programa de Accoes Universitarias Integradas Luso-Francesas - PAULIF [grant number LC/HS/ED/2010-308; F-TC04/11]. The resources and collaborative efforts provided by the Consortium for Functional Glycomics were funded by grant NIGMS-GM62116. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida R, 1997, J BIOL CHEM, V272, P31979, DOI 10.1074/jbc.272.51.31979; Alonso-Amelot ME, 2001, INT J CANCER, V91, P252, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1028&gt;3.0.CO;2-; AlonsoAmelot ME, 1997, NUTRITION, V13, P694, DOI 10.1016/S0899-9007(97)83017-1; Amado M, 1998, J BIOL CHEM, V273, P12770, DOI 10.1074/jbc.273.21.12770; Amado M, 1998, GASTROENTEROLOGY, V114, P462, DOI 10.1016/S0016-5085(98)70529-3; [Anonymous], 1986, IARC Monogr Eval Carcinog Risk Chem Hum, V40, P47; [Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P177; [Anonymous], 2010, GLOBOCAN 2008 CANC I; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carvalho AS, 2010, INT J BIOCHEM CELL B, V42, P80, DOI 10.1016/j.biocel.2009.09.010; Chandrasekaran EV, 2011, BIOCHEMISTRY-US, V50, P9475, DOI 10.1021/bi200301w; CORREA P, 1992, CANCER RES, V52, P6735; Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; DAVID L, 1992, APMIS, V100, P162; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Ferrero RL, 1998, INFECT IMMUN, V66, P1349, DOI 10.1128/IAI.66.4.1349-1355.1998; Fieger CB, 2003, J BIOL CHEM, V278, P27390, DOI 10.1074/jbc.M304204200; Filipe MI, 1990, HISTOCHEMISTRY PATHO, P451; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; GALPIN OP, 1990, BRIT J CANCER, V61, P737, DOI 10.1038/bjc.1990.165; Gomes J, 2012, TOXICOL SCI, V126, P60, DOI 10.1093/toxsci/kfr329; Gornes J, 2009, J HISTOCHEM CYTOCHEM, V57, P79, DOI 10.1369/jhc.2008.952283; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Hennet T, 1998, J BIOL CHEM, V273, P58, DOI 10.1074/jbc.273.1.58; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jensen PH, 2008, J AGR FOOD CHEM, V56, P9848, DOI 10.1021/jf801986u; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; KJELDSEN T, 1988, CANCER RES, V48, P2214; LEE YC, 1993, EUR J BIOCHEM, V216, P377, DOI 10.1111/j.1432-1033.1993.tb18155.x; LEE YC, 1994, J BIOL CHEM, V269, P10028; Linden S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040002; Liu H, 2009, GASTROENTEROLOGY, V137, P1367, DOI 10.1053/j.gastro.2009.07.041; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Magalhaes A, 2010, BRAZ J MED BIOL RES, V43, P611, DOI 10.1590/S0100-879X2010007500049; Magalhaes A, 2009, GLYCOBIOLOGY, V19, P1525, DOI 10.1093/glycob/cwp131; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Mandel U, 1999, GLYCOBIOLOGY, V9, P43, DOI 10.1093/glycob/9.1.43; Marcos NT, 2008, J CLIN INVEST, V118, P2325, DOI [10.1172/JC134324, 10.1172/JCI34324]; MARLIERE C, 1999, BRACKEN FERN TOXICIT, P144; Matsuda M, 2011, J GASTROEN HEPATOL, V26, P1451, DOI 10.1111/j.1440-1746.2011.06779.x; Ohno T, 2011, J INFECT DIS, V203, P726, DOI 10.1093/infdis/jiq090; Okajima T, 2000, J BIOL CHEM, V275, P6717, DOI 10.1074/jbc.275.10.6717; Ota H, 1998, VIRCHOWS ARCH, V433, P419, DOI 10.1007/s004280050269; Ozawa M, 1996, J BIOCHEM-TOKYO, V119, P302; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pinho S, 2007, CANCER LETT, V249, P157, DOI 10.1016/j.canlet.2006.08.010; Raman J, 2012, GLYCOBIOLOGY, V22, P768, DOI 10.1093/glycob/cwr183; Rasmussen LH, 2005, CHEMOSPHERE, V58, P823, DOI 10.1016/j.chemosphere.2004.08.088; Reis CA, 1999, CANCER RES, V59, P1003; Reis CA, 2010, J CLIN PATHOL, V63, P322, DOI 10.1136/jcp.2009.071035; ROYSTON P, 1995, APPL STAT-J ROY ST C, V44, P547, DOI 10.2307/2986146; Shahin M, 1999, MUTAT RES-GEN TOX EN, V443, P69, DOI 10.1016/S1383-5742(99)00011-3; Silva E, 2002, VIRCHOWS ARCH, V440, P311, DOI 10.1007/s004280100531; Smith BL, 2004, POISONOUS PLANTS AND RELATED TOXINS, P227, DOI 10.1079/9780851996141.0227; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Solnick JV, 2004, P NATL ACAD SCI USA, V101, P2106, DOI 10.1073/pnas.0308573100; Takashima S, 2008, BIOSCI BIOTECH BIOCH, V72, P1155, DOI 10.1271/bbb.80025; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Vetter J, 2009, ACTA VET HUNG, V57, P183, DOI 10.1556/AVet.57.2009.1.18; Yamada K, 2007, NAT PROD REP, V24, P798, DOI 10.1039/b614160a; Yasukawa Z, 2005, GLYCOBIOLOGY, V15, P827, DOI 10.1093/glycob/cwi068; Zen K, 1998, AM J PHYSIOL-LUNG C, V275, pL172, DOI 10.1152/ajplung.1998.275.1.L172	66	15	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38353	10.1371/journal.pone.0038353	http://dx.doi.org/10.1371/journal.pone.0038353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719879	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900025
J	Tian, J; Qi, WB; Li, XK; He, J; Jiao, PR; Zhang, CH; Liu, GQ; Liao, M				Tian, Jin; Qi, Wenbao; Li, Xiaokang; He, Jun; Jiao, Peirong; Zhang, Changhui; Liu, Guo-Qian; Liao, Ming			A Single E627K Mutation in the PB2 Protein of H9N2 Avian Influenza Virus Increases Virulence by Inducing Higher Glucocorticoids (GCs) Level	PLOS ONE			English	Article							CD8 T-CELLS; A VIRUS; THYMOCYTE APOPTOSIS; IMMUNE FUNCTION; AMINO-ACID; TRANSMISSION; INFECTION; ADAPTATION; REPLICATION; LYMPHOCYTES	While repeated infection of humans and enhanced replication and transmission in mice has attracted more attention to it, the pathogenesis of H9N2 virus was less known in mice. PB2 residue 627 as the virulent determinant of H5N1 virus is associated with systemic infection and impaired TCR activation, but the impact of this position in H9N2 virus on the host immune response has not been evaluated. In this study, we quantified the cellular immune response to infection in the mouse lung and demonstrate that V-K627 and rTs(E627K) infection caused a significant reduction in the numbers of T cells and inflammatory cells (Macrophage, Neutrophils, Dendritic cells) compared to mice infected with rV(K627E) and Ts-E627. Further, we discovered (i) a high level of thymocyte apoptosis resulted in impaired T cell development, which led to the reduced amount of mature T cells into lung, and (ii) the reduced inflammatory cells entering into lung was attributed to the diminished levels in pro-inflammatory cytokines and chemokines. Thereafter, we recognized that higher GCs level in plasma induced by V-K627 and rTs(E627K) infection was associated with the increased apoptosis in thymus and the reduced pro-inflammatory cytokines and chemokines levels in lung. These data demonstrated that V-K627 and rTs(E627K) infection contributing to higher GCs level would decrease the magnitude of antiviral response in lung, which may be offered as a novel mechanism of enhanced pathogenicity for H9N2 AIV.	[Tian, Jin; Qi, Wenbao; He, Jun; Jiao, Peirong; Zhang, Changhui; Liu, Guo-Qian; Liao, Ming] S China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Tian, Jin; Qi, Wenbao; He, Jun; Jiao, Peirong; Zhang, Changhui; Liu, Guo-Qian; Liao, Ming] MOA Key Lab Anim Vaccine Dev, Guangzhou, Guangdong, Peoples R China; [Li, Xiaokang] Henan Univ Sci & Technol, Coll Anim Sci & Technol, Luoyang, Henan, Peoples R China	South China Agricultural University; Henan University of Science & Technology	Tian, J (corresponding author), S China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China.	mliao@scau.edu.cn	Jiao, Peirong/R-3060-2019	Jiao, Peirong/0000-0001-7750-239X	National Natural Science Foundation of China [81001375]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81001375). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2011, J BIOL CHEM, V286, P34504, DOI 10.1074/jbc.M111.262048; Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Berg RE, 2006, CURR OPIN IMMUNOL, V18, P338, DOI 10.1016/j.coi.2006.03.010; Bhattacharyya S, 2011, P NATL ACAD SCI USA, V108, P9554, DOI 10.1073/pnas.1017296108; Bi JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013063; Bot A, 1998, J VIROL, V72, P6637, DOI 10.1128/JVI.72.8.6637-6645.1998; Brewer JA, 2002, J IMMUNOL, V169, P1837, DOI 10.4049/jimmunol.169.4.1837; Brincks EL, 2008, J IMMUNOL, V181, P4918, DOI 10.4049/jimmunol.181.7.4918; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Chrousos GP, 2000, ANN NY ACAD SCI, V917, P38, DOI 10.1111/j.1749-6632.2000.tb05371.x; Deng GC, 2010, ARCH VIROL, V155, P187, DOI 10.1007/s00705-009-0560-0; Elftman MD, 2010, J IMMUNOL, V184, P1867, DOI 10.4049/jimmunol.0902469; Fornek JL, 2009, J VIROL, V83, P11102, DOI 10.1128/JVI.00994-09; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Han K, 2011, CLIN INFECT DIS, V53, P326, DOI 10.1093/cid/cir398; Herold MJ, 2006, CELL MOL LIFE SCI, V63, P60, DOI 10.1007/s00018-005-5390-y; Hossain MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003170; Hughes FM, 1998, J STEROID BIOCHEM, V65, P207, DOI 10.1016/S0960-0760(97)00188-X; Jamieson AM, 2010, CELL HOST MICROBE, V7, P103, DOI 10.1016/j.chom.2010.01.010; Julkunen I, 2001, VACCINE, V19, P6; Kim HR, 2010, J GEN VIROL, V91, P1978, DOI 10.1099/vir.0.021238-0; Lee DCW, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-71; Li JW, 2009, VIRUS RES, V144, P123, DOI 10.1016/j.virusres.2009.04.008; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Park KJ, 2011, J GEN VIROL, V92, P36, DOI 10.1099/vir.0.024992-0; Peiris JSK, 2009, CELL REV, V747, P11; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Silverman MN, 2005, VIRAL IMMUNOL, V18, P41, DOI 10.1089/vim.2005.18.41; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Takizawa T, 2010, OPEN ANTIMICROB AGEN, V2, P22; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Teodoro JG, 1997, J VIROL, V71, P1739, DOI 10.1128/JVI.71.3.1739-1746.1997; Tumpey TM, 2000, J VIROL, V74, P6105, DOI 10.1128/JVI.74.13.6105-6116.2000; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vogel AB, 2010, J IMMUNOL, V185, P4824, DOI 10.4049/jimmunol.0903631; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wiegers GJ, 2001, EUR J IMMUNOL, V31, P2293, DOI 10.1002/1521-4141(200108)31:8<2293::AID-IMMU2293>3.0.CO;2-I; Wilckens T, 1997, IMMUNOL TODAY, V18, P418, DOI 10.1016/S0167-5699(97)01111-0; Wu R, 2010, VET MICROBIOL, V142, P211, DOI 10.1016/j.vetmic.2009.09.068; Wu R, 2009, VET MICROBIOL, V138, P85, DOI 10.1016/j.vetmic.2009.03.010; Xie DX, 2009, INT IMMUNOL, V21, P1251, DOI 10.1093/intimm/dxp087; Zhang PH, 2009, J VIROL, V83, P8428, DOI 10.1128/JVI.00659-09	46	33	36	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38233	10.1371/journal.pone.0038233	http://dx.doi.org/10.1371/journal.pone.0038233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719870	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900021
J	Croak, BM; Pike, DA; Webb, JK; Shine, R				Croak, Benjamin M.; Pike, David A.; Webb, Jonathan K.; Shine, Richard			Habitat Selection in a Rocky Landscape: Experimentally Decoupling the Influence of Retreat Site Attributes from That of Landscape Features	PLOS ONE			English	Article							HOPLOCEPHALUS-BUNGAROIDES SERPENTES; HOT ROCKS; ENDANGERED SNAKE; SANDSTONE OUTCROPS; ARTIFICIAL ROCKS; CLIMATE-CHANGE; LIZARD; THERMOREGULATION; CONSEQUENCES; MICROCLIMATE	Organisms selecting retreat sites may evaluate not only the quality of the specific shelter, but also the proximity of that site to resources in the surrounding area. Distinguishing between habitat selection at these two spatial scales is complicated by co-variation among microhabitat factors (i.e., the attributes of individual retreat sites often correlate with their proximity to landscape features). Disentangling this co-variation may facilitate the restoration or conservation of threatened systems. To experimentally examine the role of landscape attributes in determining retreat-site quality for saxicolous ectotherms, we deployed 198 identical artificial rocks in open (sun-exposed) sites on sandstone outcrops in southeastern Australia, and recorded faunal usage of those retreat sites over the next 29 months. Several landscape-scale attributes were associated with occupancy of experimental rocks, but different features were important for different species. For example, endangered broad-headed snakes (Hoplocephalus bungaroides) preferred retreat sites close to cliff edges, flat rock spiders (Hemicloea major) preferred small outcrops, and velvet geckos (Oedura lesueurii) preferred rocks close to the cliff edge with higher-than-average sun exposure. Standardized retreat sites can provide robust experimental data on the effects of landscape-scale attributes on retreat site selection, revealing interspecific divergences among sympatric taxa that use similar habitats.	[Croak, Benjamin M.; Shine, Richard] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Pike, David A.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia; [Webb, Jonathan K.] Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia	University of Sydney; James Cook University; University of Technology Sydney	Croak, BM (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	benjamin.croak@sydney.edu.au	Pike, David A/B-2032-2012	Webb, Jonathan/0000-0003-4822-6829; Croak, Benjamin/0000-0003-4191-5891	a linkage grant (ARC) [LP0776647]; Australian research council; Australian National Parks and Wildlife Service; Australian Reptile Park; Forestry New South Wales; Hawksbury/Nepean Catchment Authority; Zoos Victoria	a linkage grant (ARC)(Australian Research Council); Australian research council(Australian Research Council); Australian National Parks and Wildlife Service; Australian Reptile Park; Forestry New South Wales; Hawksbury/Nepean Catchment Authority; Zoos Victoria	Funding was provided by a linkage grant (ARC grant number: LP0776647) between the following institutions: The Australian research council URL - http://www.arc.gov.au/, Australian National Parks and Wildlife Service URL - http://www.environment.nsw.gov.au/, the Australian Reptile Park URL - http://www.reptilepark.com.au/, Forestry New South Wales http://www.dpi.nsw.gov.au/forests, the Hawksbury/Nepean Catchment Authority http://www.hn.cma.nsw.gov.au/, and Zoos Victoria http://www.zoo.org.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUER A M, 1990, Herpetological Review, V21, P83; Bell TP, 2009, HERPETOL CONSERV BIO, V4, P415; Briones-Fourzan P, 2007, OECOLOGIA, V151, P401, DOI 10.1007/s00442-006-0595-9; Clark RW, 2004, J CHEM ECOL, V30, P607, DOI 10.1023/B:JOEC.0000018632.27010.1e; Cogger H, 2000, REPTILES AMPHIBIANS; Crawley M. J., 2009, R BOOK; Croak BM, 2010, RESTOR ECOL, V18, P428, DOI 10.1111/j.1526-100X.2008.00476.x; Croak BM, 2008, ANIM BEHAV, V76, P1875, DOI 10.1016/j.anbehav.2008.08.011; Doody J. Sean, 2006, Herpetological Review, V37, P49; Downes S, 1998, ANIM BEHAV, V55, P1387, DOI 10.1006/anbe.1997.0705; Downes S, 1998, ANIM BEHAV, V55, P1373, DOI 10.1006/anbe.1997.0704; Downes S, 1999, J HERPETOL, V33, P156, DOI 10.2307/1565560; Du Weiguo, 2009, Current Zoology, V55, P266; Dunlap KD, 2002, J COMP PHYSL, V188, P496; Frazer G.W., 2000, B ECOL SOC AM, V81, P191, DOI DOI 10.1890/0012-9623(2000)081[0190:TT]2.0.CO;2; Goldsbrough CL, 2006, AUSTRAL ECOL, V31, P326, DOI 10.1111/j.1442-9993.2006.01561.x; Goldsbrough CL, 2003, BIOL CONSERV, V109, P85, DOI 10.1016/S0006-3207(02)00139-8; Goldsrough CL, 2004, ECOLOGY, V85, P1635, DOI 10.1890/02-0770; Head ML, 2002, J CHEM ECOL, V28, P541, DOI 10.1023/A:1014592028693; Hersey F, 1980, ENDANGERED ANIMALS N, P30; HUEY RB, 1981, ECOLOGY, V62, P991, DOI 10.2307/1936998; HUEY RB, 1989, ECOLOGY, V70, P931, DOI 10.2307/1941360; HUEY RB, 1991, AM NAT, V137, pS91, DOI 10.1086/285141; Indermaur L, 2009, ECOLOGY, V90, P3430, DOI 10.1890/08-0886.1; Isaac JL, 2008, ANIM CONSERV, V11, P281, DOI 10.1111/j.1469-1795.2008.00177.x; Isaia M, 2006, ENVIRON ENTOMOL, V35, P1654, DOI 10.1603/0046-225X(2006)35[1654:COPBWA]2.0.CO;2; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; Kearney M, 2002, J THERM BIOL, V27, P205, DOI 10.1016/S0306-4565(01)00085-7; Kearney M, 2000, ECOLOGY, V81, P2984, DOI 10.1890/0012-9658(2000)081[2984:DNETAS]2.0.CO;2; Krefft G., 1869, SNAKES AUSTR ILLUSTR; Lettink Marieke, 2006, New Zealand Entomologist, V29, P99; Martin TE, 2001, ECOLOGY, V82, P175, DOI 10.2307/2680095; Penman TD, 2010, DIVERS DISTRIB, V16, P109, DOI 10.1111/j.1472-4642.2009.00619.x; Pike DA, 2012, FUNCT ECOL, V26, P469, DOI 10.1111/j.1365-2435.2011.01946.x; Pike DA, 2011, ECOL APPL, V21, P274, DOI 10.1890/09-2394.1; Pike DA, 2010, BEHAVIOUR, V147, P397, DOI 10.1163/000579509X12578482408448; Pringle RM, 2003, ECOLOGY, V84, P2668, DOI 10.1890/02-0482; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2009, R FDN STAT COMP; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; Rudolf VHW, 2005, OECOLOGIA, V142, P316, DOI 10.1007/s00442-004-1668-2; Sabo JL, 2003, OECOLOGIA, V136, P329, DOI 10.1007/s00442-003-1292-6; Scharf I, 2006, J INSECT BEHAV, V19, P197, DOI 10.1007/s10905-006-9017-4; SCHLESINGER CA, 1994, BIOL CONSERV, V67, P49, DOI 10.1016/0006-3207(94)90008-6; SCHLESINGER CA, 1994, HERPETOLOGICA, V50, P156; SHINE R, 1989, Australian Zoologist, V25, P65; Shine R, 1998, WILDLIFE RES, V25, P285, DOI 10.1071/WR97022; Smith BW, 2001, J WILDLIFE MANAGE, V65, P318, DOI 10.2307/3802911; Souter NJ, 2004, BIOL CONSERV, V116, P403, DOI 10.1016/S0006-3207(03)00232-5; Uraguchi Kohji, 1998, Mammal Study, V23, P31, DOI 10.3106/mammalstudy.23.31; Webb JK, 2004, COPEIA, P919, DOI 10.1643/CH-04-039R1; Webb JK, 1998, PHYSIOL ZOOL, V71, P680, DOI 10.1086/515979; Webb JK, 2000, BIOL CONSERV, V92, P93, DOI 10.1016/S0006-3207(99)00056-7; Webb JK, 1998, BIOL CONSERV, V86, P233, DOI 10.1016/S0006-3207(97)00180-8; Webb JK, 1998, ANIM CONSERV, V1, P185, DOI 10.1111/j.1469-1795.1998.tb00028.x; Webb JK, 2009, BEHAV ECOL, V20, P271, DOI 10.1093/beheco/arp011; Wilson S., 2017, COMPLETE GUIDE REPTI, VFifth	57	19	19	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e37982	10.1371/journal.pone.0037982	http://dx.doi.org/10.1371/journal.pone.0037982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701592	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000305340000008
J	Magnussen, GI; Holm, R; Emilsen, E; Rosnes, AKR; Slipicevic, A; Florenes, VA				Magnussen, Gry Irene; Holm, Ruth; Emilsen, Elisabeth; Rosnes, Anne Katrine Ree; Slipicevic, Ana; Florenes, Vivi Ann			High Expression of Wee1 Is Associated with Poor Disease-Free Survival in Malignant Melanoma: Potential for Targeted Therapy	PLOS ONE			English	Article							CELL-CYCLE REGULATION; KINASE INHIBITOR; DNA-DAMAGE; PROTEIN; CANCER; P53; PD0166285; MITOSIS; PHASE	Notoriously resistant malignant melanoma is one of the most increasing forms of cancer worldwide; there is thus a precarious need for new treatment options. The Wee1 kinase is a major regulator of the G(2)/M checkpoint, and halts the cell cycle by adding a negative phosphorylation on CDK1 (Tyr15). Additionally, Wee1 has a function in safeguarding the genome integrity during DNA synthesis. To assess the role of Wee1 in development and progression of malignant melanoma we examined its expression in a panel of paraffin-embedded patient derived tissue of benign nevi and primary-and metastatic melanomas, as well as in agarose-embedded cultured melanocytes. We found that Wee1 expression increased in the direction of malignancy, and showed a strong, positive correlation with known biomarkers involved in cell cycle regulation: Cyclin A (p<0.0001), Ki67 (p<0.0001), Cyclin D3 (p=0.001), p21(Cip1/WAF1) (p=0.003), p53 (p=0.025). Furthermore, high Wee1 expression was associated with thicker primary tumors (p=0.001), ulceration (p=0.005) and poor disease-free survival (p=0.008). Transfections using siWee1 in metastatic melanoma cell lines; WM239(WTp53), WM45.1(MUTp53) and LOXWTp53, further support our hypothesis of a tumor promoting role of Wee1 in melanomas. Whereas no effect was observed in LOX cells, transfection with siWee1 led to accumulation of cells in G(1)/S and S phase of the cell cycle in WM239 and WM45.1 cells, respectively. Both latter cell lines displayed DNA damage and induction of apoptosis, in the absence of Wee1, indicating that the effect of silencing Wee1 may not be solely dependent of the p53 status of the cells. Together these results reveal the importance of Wee1 as a prognostic biomarker in melanomas, and indicate a potential role for targeted therapy, alone or in combination with other agents.	[Magnussen, Gry Irene; Holm, Ruth; Emilsen, Elisabeth; Rosnes, Anne Katrine Ree; Slipicevic, Ana; Florenes, Vivi Ann] Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Slipicevic, Ana] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	University of Oslo; The Wistar Institute	Magnussen, GI (corresponding author), Norwegian Radium Hosp, Dept Pathol, Oslo, Norway.	vivi.ann.florenes@radiumhospitalet.no			South-Eastern Norway Regional Health Authority (Helse Sor-Ost); Norwegian Cancer Cluster	South-Eastern Norway Regional Health Authority (Helse Sor-Ost); Norwegian Cancer Cluster	This work was financially supported by The South-Eastern Norway Regional Health Authority (Helse Sor-Ost) and The Norwegian Cancer Cluster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Beck H, 2010, J CELL BIOL, V188, P629, DOI 10.1083/jcb.200905059; Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208; Cancer Registry of Norway, 2011, CANC NORW 2009; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Dominguez-Kelly R, 2011, J CELL BIOL, V194, P567, DOI 10.1083/jcb.201101047; Essner R, 1998, CANCER, V82, P309, DOI 10.1002/(SICI)1097-0142(19980115)82:2<317::AID-CNCR10>3.0.CO;2-1; Florenes VA, 1999, ONCOGENE, V18, P1023, DOI 10.1038/sj.onc.1202382; Florenes VA, 2004, MELANOMA RES, V14, P173, DOI 10.1097/01.cmr.0000129579.49313.26; FLORENES VA, 1995, MELANOMA RES, V5, P183, DOI 10.1097/00008390-199506000-00007; Florenes VA, 2001, J PATHOL, V195, P530; Florenes VA, 2000, CLIN CANCER RES, V6, P3614; Florenes VA, 1998, AM J PATHOL, V153, P305, DOI 10.1016/S0002-9440(10)65572-1; FODSTAD O, 1988, INT J CANCER, V41, P442, DOI 10.1002/ijc.2910410322; Gwosdz C, 2006, INT J CANCER, V118, P577, DOI 10.1002/ijc.21366; Hamer PCD, 2011, CLIN CANCER RES, V17, P4200, DOI 10.1158/1078-0432.CCR-10-2537; Hashimoto O, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-292; HERLYN M, 1985, J NATL CANCER I, V74, P283; Iorns E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005120; Leijen S, 2010, CURR CLIN PHARMACOL, V5, P186, DOI 10.2174/157488410791498824; Li W, 2006, PATHOLOGY, V38, P287, DOI 10.1080/00313020600817951; Ma HT, 2011, BIOCHEM J, V435, P17, DOI 10.1042/BJ20100284; Maelandsmo GM, 1996, AM J PATHOL, V149, P1813; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Mir SE, 2010, CANCER CELL, V18, P244, DOI 10.1016/j.ccr.2010.08.011; Panek RL, 1997, J PHARMACOL EXP THER, V283, P1433; PosthumaDeBoer J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-156; Rajeshkumar NV, 2011, CLIN CANCER RES, V17, P2799, DOI 10.1158/1078-0432.CCR-10-2580; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Sorensen CS, 2011, NUCL ACIDS RES; Tanaka T, 2006, CELL CYCLE, V5, P1940, DOI 10.4161/cc.5.17.3191; very-Kiejda KA, 2011, BMC CANCER, V11, P203; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang YL, 2001, CANCER RES, V61, P8211; Yoshida T, 2004, ANN ONCOL, V15, P252, DOI 10.1093/annonc/mdh073	37	91	95	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38254	10.1371/journal.pone.0038254	http://dx.doi.org/10.1371/journal.pone.0038254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719872	Green Submitted, Green Published, gold			2022-12-25	WOS:000305340000016
J	Lima, VLA; Dias, F; Nunes, RD; Pereira, LO; Santos, TSR; Chiarini, LB; Ramos, TD; Silva-Mendes, BJ; Perales, J; Valente, RH; Oliveira, PL				Lima, Vitor L. A.; Dias, Felipe; Nunes, Rodrigo D.; Pereira, Luiza O.; Santos, Tiago S. R.; Chiarini, Luciana B.; Ramos, Tadeu D.; Silva-Mendes, Bernardo J.; Perales, Jonas; Valente, Richard H.; Oliveira, Pedro L.			The Antioxidant Role of Xanthurenic Acid in the Aedes aegypti Midgut during Digestion of a Blood Meal	PLOS ONE			English	Article							PERITROPHIC MATRIX; HEME; EXPRESSION; IDENTIFICATION; ALPHA; IRON	In the midgut of the mosquito Aedes aegypti, a vector of dengue and yellow fever, an intense release of heme and iron takes place during the digestion of a blood meal. Here, we demonstrated via chromatography, light absorption and mass spectrometry that xanthurenic acid (XA), a product of the oxidative metabolism of tryptophan, is produced in the digestive apparatus after the ingestion of a blood meal and reaches milimolar levels after 24 h, the period of maximal digestive activity. XA formation does not occur in the White Eye (WE) strain, which lacks kynurenine hydroxylase and accumulates kynurenic acid. The formation of XA can be diminished by feeding the insect with 3,4-dimethoxy-N-[ 4-(3-nitrophenyl) thiazol-2-yl] benzenesulfonamide (Ro-61-8048), an inhibitor of XA biosynthesis. Moreover, XA inhibits the phospholipid oxidation induced by heme or iron. A major fraction of this antioxidant activity is due to the capacity of XA to bind both heme and iron, which occurs at a slightly alkaline pH (7.5-8.0), a condition found in the insect midgut. The midgut epithelial cells of the WE mosquito has a marked increase in occurrence of cell death, which is reversed to levels similar to the wild type mosquitoes by feeding the insects with blood supplemented with XA, confirming the protective role of this molecule. Collectively, these results suggest a new role for XA as a heme and iron chelator that provides protection as an antioxidant and may help these animals adapt to a blood feeding habit.	[Lima, Vitor L. A.] Univ Fed Alagoas, Inst Quim & Biotecnol, Maceio, Alagoas, Brazil; [Dias, Felipe; Nunes, Rodrigo D.; Santos, Tiago S. R.; Ramos, Tadeu D.; Silva-Mendes, Bernardo J.; Oliveira, Pedro L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Mol & Biotecnol, Rio De Janeiro, Brazil; [Pereira, Luiza O.] Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, BR-20001 Rio De Janeiro, Brazil; [Chiarini, Luciana B.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Perales, Jonas; Valente, Richard H.] Inst Oswaldo Cruz, Lab Toxinol, BR-20001 Rio De Janeiro, Brazil; [Oliveira, Pedro L.] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil	Universidade Federal de Alagoas; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Lima, VLA (corresponding author), Univ Fed Alagoas, Inst Quim & Biotecnol, Maceio, Alagoas, Brazil.	pedro@bioqmed.ufrj.br	Nunes, Rodrigo/J-6859-2012; Pereira, Luiza O R/P-7606-2018; Dias, Felipe/L-7390-2013; Chiarini, Luciana B/J-3644-2015; Valente, Richard Hemmi/I-5300-2012; L. Oliveira, Pedro/A-9438-2010	Nunes, Rodrigo/0000-0003-1346-291X; Pereira, Luiza O R/0000-0002-8132-1724; Dias, Felipe/0000-0003-2074-1052; L. Oliveira, Pedro/0000-0003-0307-354X; Diniz Ramos, Tadeu/0000-0002-8523-4361; Valente, Richard Hemmi/0000-0002-6562-7571	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, INCT de Entomologia Molecular); Fundacao de Coordenacao de Aperfeicoamento do Pessoal de nivel Superior (CAPES); Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ); Howard Hughes Medical Institute (HHMI)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, INCT de Entomologia Molecular)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Coordenacao de Aperfeicoamento do Pessoal de nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute)	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, INCT de Entomologia Molecular), Fundacao de Coordenacao de Aperfeicoamento do Pessoal de nivel Superior (CAPES), Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ) and the Howard Hughes Medical Institute (HHMI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHALLA SC, 1968, MOSQ NEWS, V28, P380; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Britan A, 2006, CELL TISSUE RES, V324, P301, DOI 10.1007/s00441-005-0151-7; CHRISTEN S, 1990, P NATL ACAD SCI USA, V87, P2506, DOI 10.1073/pnas.87.7.2506; Devenport M, 2006, BIOCHEMISTRY-US, V45, P9540, DOI 10.1021/bi0605991; Dunkov Boris C, 2002, J Insect Sci, V2, P7; Gobaille S, 2008, J NEUROCHEM, V105, P982, DOI 10.1111/j.1471-4159.2008.05219.x; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; GUTTERIDGE JMC, 1988, BIOCHEM J, V256, P861, DOI 10.1042/bj2560861; Halliwell B., 2007, FREE RADICALS BIOL M; Han Q, 2007, J INSECT PHYSIOL, V53, P254, DOI 10.1016/j.jinsphys.2006.09.004; Harizanova N, 2005, INSECT MOL BIOL, V14, P79, DOI 10.1111/j.1365-2583.2004.00533.x; Hazan R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000810; Kayser H., 1985, P367; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; Lopez-Burillo S, 2003, J PINEAL RES, V34, P269, DOI 10.1034/j.1600-079X.2003.00041.x; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; MILLER EC, 1945, J BIOL CHEM, V157, P551; Mossialos D, 2000, APPL ENVIRON MICROB, V66, P487, DOI 10.1128/AEM.66.2.487-492.2000; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Murakami K, 2001, J NUTR SCI VITAMINOL, V47, P306, DOI 10.3177/jnsv.47.306; NORIEGA FG, 1994, INSECT BIOCHEM MOLEC, V24, P627, DOI 10.1016/0965-1748(94)90099-X; Okuda S, 1998, J NEUROCHEM, V70, P299; Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320; Pascoa V, 2002, INSECT BIOCHEM MOLEC, V32, P517, DOI 10.1016/S0965-1748(01)00130-8; Pereira LOR, 2007, BIOCHEMISTRY-US, V46, P6822, DOI 10.1021/bi700011d; Raabe AC, 2011, CELL MICROBIOL, V13, P955, DOI 10.1111/j.1462-5822.2011.01591.x; Rover S, 1997, J MED CHEM, V40, P4378, DOI 10.1021/jm970467t; SCHMITT TH, 1993, ARCH BIOCHEM BIOPHYS, V307, P96, DOI 10.1006/abbi.1993.1566; Shahabuddin M, 1995, EXP PARASITOL, V81, P386, DOI 10.1006/expr.1995.1129; Suzuki S, 2001, BIOCHEM J, V355, P425, DOI 10.1042/0264-6021:3550425; TAPPEL AL, 1955, J BIOL CHEM, V217, P721; VINCENT SH, 1989, SEMIN HEMATOL, V26, P105; Watson RJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-177; Zhou GL, 2007, J INSECT PHYSIOL, V53, P1169, DOI 10.1016/j.jinsphys.2007.06.009	35	41	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38349	10.1371/journal.pone.0038349	http://dx.doi.org/10.1371/journal.pone.0038349			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701629	gold, Green Submitted, Green Published			2022-12-25	WOS:000305337600020
J	Greenlee, JJ; Smith, JD; Greenlee, MHW; Nicholson, EM				Greenlee, Justin J.; Smith, Jodi D.; Greenlee, M. Heather West; Nicholson, Eric M.			Clinical and Pathologic Features of H-Type Bovine Spongiform Encephalopathy Associated with E211K Prion Protein Polymorphism	PLOS ONE			English	Article							SUFFOLK SHEEP; ATYPICAL BSE; SCRAPIE; CATTLE; IDENTIFICATION; TRANSMISSION; ACCUMULATION; VARIANT; SIMILARITIES; DISEASE	The majority of bovine spongiform encephalopathy (BSE) cases have been ascribed to the classical form of the disease. H-type and L-type BSE cases have atypical molecular profiles compared to classical BSE and are thought to arise spontaneously. However, one case of H-type BSE was associated with a heritable E211K mutation in the prion protein gene. The purpose of this study was to describe transmission of this unique isolate of H-type BSE when inoculated into a calf of the same genotype by the intracranial route. Electroretinograms were used to demonstrate preclinical deficits in retinal function, and optical coherence tomography was used to demonstrate an antemortem decrease in retinal thickness. The calf rapidly progressed to clinical disease (9.4 months) and was necropsied. Widespread distribution of abnormal prion protein was demonstrated within neural tissues by western blot and immunohistochemistry. While this isolate is categorized as BSE-H due to a higher molecular mass of the unglycosylated PrPSc isoform, a strong labeling of all 3 PrPSc bands with monoclonal antibodies 6H4 and P4, and a second unglycosylated band at approximately 14 kDa when developed with antibodies that bind in the C-terminal region, it is unique from other described cases of BSE-H because of an additional band 23 kDa demonstrated on western blots of the cerebellum. This work demonstrates that this isolate is transmissible, has a BSE-H phenotype when transmitted to cattle with the K211 polymorphism, and has molecular features that distinguish it from other cases of BSE-H described in the literature.	[Greenlee, Justin J.; Smith, Jodi D.; Nicholson, Eric M.] Agr Res Serv, Natl Anim Dis Ctr, USDA, Ames, IA USA; [Greenlee, M. Heather West] Iowa State Univ, Ames, IA USA	United States Department of Agriculture (USDA); Iowa State University	Greenlee, JJ (corresponding author), Agr Res Serv, Natl Anim Dis Ctr, USDA, Ames, IA USA.	justin.greenlee@ars.usda.gov	Greenlee, Justin/Y-5732-2019	Greenlee, Justin/0000-0003-2202-3054; Smith, Jodi/0000-0001-7952-8024	congressionally appropriated funds	congressionally appropriated funds	This research was funded in its entirety by congressionally appropriated funds to the United States Department of Agriculture, Agriculture Research Service. The funders of the work did not influence study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Balkema-Buschmann A, 2011, PREV VET MED, V102, P112, DOI 10.1016/j.prevetmed.2011.04.006; Balkema-Buschmann A, 2011, J TOXICOL ENV HEAL A, V74, P103, DOI 10.1080/15287394.2011.529060; Balkema-Buschmann A, 2011, J GEN VIROL, V92, P467, DOI 10.1099/vir.0.025387-0; Baron T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015839; Beringue V, 2006, PLOS PATHOG, V2, P956, DOI 10.1371/journal.ppat.0020112; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Biacabe AG, 2008, EMERG INFECT DIS, V14, P298, DOI 10.3201/eid1402.071141; Biacabe AG, 2007, PRION, V1, P61, DOI 10.4161/pri.1.1.3828; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Brunelle BW, 2007, J ANIM SCI, V85, P3142, DOI 10.2527/jas.2007-0208; Buschmann A, 2006, VET MICROBIOL, V117, P103, DOI 10.1016/j.vetmic.2006.06.016; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; CUTLIP RC, 1994, J INFECT DIS, V169, P814, DOI 10.1093/infdis/169.4.814; Cutlip RC, 2001, CAN J VET RES, V65, P131; Donnelly CA, 1997, NATURE, V389, P903, DOI 10.1038/39982; Dudas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010638; Gavier-Widen D, 2008, J VET DIAGN INVEST, V20, P2, DOI 10.1177/104063870802000102; Gonzalez L, 2002, J COMP PATHOL, V126, P17, DOI 10.1053/jcpa.2001.0516; Greenlee JJ, 2006, VET PATHOL, V43, P733, DOI 10.1354/vp.43-5-733; Hamir AN, 2006, VET PATHOL, V43, P118, DOI 10.1354/vp.43-2-118; Hamir AN, 2005, J VET DIAGN INVEST, V17, P3, DOI 10.1177/104063870501700103; Hortells P, 2006, BRAIN RES, V1108, P188, DOI 10.1016/j.brainres.2006.06.021; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; Konold T, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-22; Nicholson EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002912; O'Rourke KI, 2000, J CLIN MICROBIOL, V38, P3254, DOI 10.1128/JCM.38.9.3254-3259.2000; Okada H, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-79; Polak MP, 2012, VET J; Regnier A, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-25; Richt JA, 2007, J VET DIAGN INVEST, V19, P142, DOI 10.1177/104063870701900202; Richt JA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000156; Smith JD, 2008, J COMP PATHOL, V138, P12, DOI 10.1016/j.jcpa.2007.09.002; Smith JD, 2009, VET PATHOL, V46, P810, DOI 10.1354/vp.08-VP-0206-W-FL; Smith JD, 2009, VET REC, V165, P179, DOI 10.1136/vr.165.6.179; Stack M, 2009, ZOONOSES PUBLIC HLTH, V56, P376, DOI 10.1111/j.1863-2378.2008.01202.x; Sugiura K, 2009, REV SCI TECH OIE, V28, P945; Tester S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-64; Torres JM, 2011, EMERG INFECT DIS, V17, P1636, DOI 10.3201/eid1709.101403; Torres M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015658; WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199; WILESMITH JW, 1988, VET REC, V123, P638; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9	44	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38678	10.1371/journal.pone.0038678	http://dx.doi.org/10.1371/journal.pone.0038678			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715405	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336800047
J	Wachter, B; Blanc, AS; Melzheimer, J; Honer, OP; Jago, M; Hofer, H				Wachter, Bettina; Blanc, Anne-Sophie; Melzheimer, Joerg; Hoener, Oliver P.; Jago, Mark; Hofer, Heribert			An Advanced Method to Assess the Diet of Free-Ranging Large Carnivores Based on Scats	PLOS ONE			English	Article							BIALOWIEZA PRIMEVAL FOREST; WOLF SCATS; FEEDING ECOLOGY; AFRICAN SAVANNA; CANIS-ADUSTUS; FOOD-HABITS; PREY; WOLVES; PREDATION; POLAND	Background: The diet of free-ranging carnivores is an important part of their ecology. It is often determined from prey remains in scats. In many cases, scat analyses are the most efficient method but they require correction for potential biases. When the diet is expressed as proportions of consumed mass of each prey species, the consumed prey mass to excrete one scat needs to be determined and corrected for prey body mass because the proportion of digestible to indigestible matter increases with prey body mass. Prey body mass can be corrected for by conducting feeding experiments using prey of various body masses and fitting a regression between consumed prey mass to excrete one scat and prey body mass (correction factor 1). When the diet is expressed as proportions of consumed individuals of each prey species and includes prey animals not completely consumed, the actual mass of each prey consumed by the carnivore needs to be controlled for (correction factor 2). No previous study controlled for this second bias. Methodology/Principal Findings: Here we use an extended series of feeding experiments on a large carnivore, the cheetah (Acinonyx jubatus), to establish both correction factors. In contrast to previous studies which fitted a linear regression for correction factor 1, we fitted a biologically more meaningful exponential regression model where the consumed prey mass to excrete one scat reaches an asymptote at large prey sizes. Using our protocol, we also derive correction factor 1 and 2 for other carnivore species and apply them to published studies. We show that the new method increases the number and proportion of consumed individuals in the diet for large prey animals compared to the conventional method. Conclusion/Significance: Our results have important implications for the interpretation of scat-based studies in feeding ecology and the resolution of human-wildlife conflicts for the conservation of large carnivores.	[Wachter, Bettina; Melzheimer, Joerg; Hoener, Oliver P.; Hofer, Heribert] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Blanc, Anne-Sophie] Univ Neuchatel, Inst Zool, CH-2007 Neuchatel, Switzerland; [Jago, Mark] AfriCat Fdn, Otjiwarongo, Namibia	Leibniz Institut fur Zoo und Wildtierforschung; University of Neuchatel	Wachter, B (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	wachter@izw-berlin.de	Hofer, Heribert/AAF-7854-2021; Wachter, Bettina/AAJ-9663-2020; Höner, Oliver P./N-3224-2014	Hofer, Heribert/0000-0002-2813-7442; Höner, Oliver P./0000-0002-0658-3417; Wachter, Bettina/0000-0002-0414-2298	Messerli Stiftung; Universite Neuchatel; Fond Wuthrich et Mathey-Dupraz (all Switzerland); Leibniz Institute for Zoo and Wildlife Research, Germany	Messerli Stiftung; Universite Neuchatel; Fond Wuthrich et Mathey-Dupraz (all Switzerland); Leibniz Institute for Zoo and Wildlife Research, Germany	This study was financed by the Messerli Stiftung, the Universite Neuchatel, the Fond Wuthrich et Mathey-Dupraz (all Switzerland) and the Leibniz Institute for Zoo and Wildlife Research, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN BB, 1984, J WILDLIFE MANAGE, V48, P147, DOI 10.2307/3808462; Andheria AP, 2007, J ZOOL, V273, P169, DOI 10.1111/j.1469-7998.2007.00310.x; Ansorge H, 2006, ACTA THERIOL, V51, P99, DOI 10.1007/BF03192661; Atkinson RPD, 2002, J ZOOL, V257, P129, DOI 10.1017/S0952836902000729; Caro T., 1994, CHEETAHS SERENGETI P; Ciucci P, 1996, WILDLIFE BIOL, V2, P37, DOI 10.2981/wlb.1996.006; Eaton R.L., 1974, CHEETAH BIOL ECOLOGY; FLOYD TJ, 1978, J WILDLIFE MANAGE, V42, P528, DOI 10.2307/3800814; Godbois IA, 2005, WILDLIFE SOC B, V33, P149, DOI 10.2193/0091-7648(2005)33[149:EODOML]2.0.CO;2; GOSZCZYNSKI J, 1974, Acta Theriologica, V19, P1; JDuP Bothma, 1989, GAME RANCH MANAGEMEN; Jedrzejewski W, 2002, ECOLOGY, V83, P1341, DOI 10.2307/3071948; Jedrzejewski W, 2000, J MAMMAL, V81, P197, DOI 10.1644/1545-1542(2000)081&lt;0197:PSAPBW&gt;2.0.CO;2; Jethva BD, 2004, ZOO BIOL, V23, P513, DOI 10.1002/zoo.20030; Kingdom J, 1997, KINGDON FIELD GUIDE; LOCKIE J. D., 1959, JOUR WILDLIFE MANAGEMENT, V23, P224, DOI 10.2307/3797647; Loveridge AJ, 2003, J ZOOL, V259, P143, DOI 10.1017/S0952836902003114; Marker LL, 2003, S AFR J WILDL RES, V33, P43; Marker-Kraus L., 1996, CHEETAH SURVIVAL NAM; Mech LD., 1970, WOLF ECOLOGY BEHAV E; Meza AD, 2002, AM MIDL NAT, V148, P146; Mills M.G.L., 1984, Koedoe, V27, P281; Mills MGL, 2004, WILDLIFE BIOL, V10, P177, DOI 10.2981/wlb.2004.024; Napolitano C, 2008, MOL ECOL, V17, P678, DOI 10.1111/j.1365-294X.2007.03606.x; Pienaar U. de V., 1969, Koedoe, VNo. 12, P108; Radloff FGT, 2004, J ANIM ECOL, V73, P410, DOI 10.1111/j.0021-8790.2004.00817.x; REYNOLDS JC, 1991, MAMMAL REV, V21, P97, DOI 10.1111/j.1365-2907.1991.tb00113.x; Robbins CT, 1993, WILDLIFE FEEDING NUT, P288; Ruehe F, 2003, ACTA THERIOL, V48, P527, DOI 10.1007/BF03192498; Ruhe F, 2007, ACTA THERIOL, V52, P317, DOI 10.1007/BF03194228; Ruhe F, 2008, WILDLIFE BIOL, V14, P500, DOI 10.2981/0909-6396-14.4.500; Wachter Bettina, 2006, Cat News, V44, P8; WEAVER JL, 1993, J WILDLIFE MANAGE, V57, P534, DOI 10.2307/3809278	33	44	46	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38066	10.1371/journal.pone.0038066	http://dx.doi.org/10.1371/journal.pone.0038066			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715373	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336800014
J	Aguilar-Mahecha, A; Kuzyk, MA; Domanski, D; Borchers, CH; Basik, M				Aguilar-Mahecha, Adriana; Kuzyk, Michael A.; Domanski, Dominik; Borchers, Christoph H.; Basik, Mark			The Effect of Pre-Analytical Variability on the Measurement of MRM-MS-Based Mid- to High-Abundance Plasma Protein Biomarkers and a Panel of Cytokines	PLOS ONE			English	Article							ADVIA-120 HEMATOLOGY SYSTEM; HUMAN PLATELETS; PROTEOMIC BIOMARKER; MASS-SPECTROMETRY; HUMAN BLOOD; COLLECTION; CANCER; SERUM; ANTICOAGULANTS; ACTIVATION	Blood sample processing and handling can have a significant impact on the stability and levels of proteins measured in biomarker studies. Such pre-analytical variability needs to be well understood in the context of the different proteomics platforms available for biomarker discovery and validation. In the present study we evaluated different types of blood collection tubes including the BD P100 tube containing protease inhibitors as well as CTAD tubes, which prevent platelet activation. We studied the effect of different processing protocols as well as delays in tube processing on the levels of 55 mid and high abundance plasma proteins using novel multiple-reaction monitoring-mass spectrometry (MRM-MS) assays as well as 27 low abundance cytokines using a commercially available multiplexed bead-based immunoassay. The use of P100 tubes containing protease inhibitors only conferred proteolytic protection for 4 cytokines and only one MRM-MS-measured peptide. Mid and high abundance proteins measured by MRM are highly stable in plasma left unprocessed for up to six hours although platelet activation can also impact the levels of these proteins. The levels of cytokines were elevated when tubes were centrifuged at cold temperature, while low levels were detected when samples were collected in CTAD tubes. Delays in centrifugation also had an impact on the levels of cytokines measured depending on the type of collection tube used. Our findings can help in the development of guidelines for blood collection and processing for proteomic biomarker studies.	[Aguilar-Mahecha, Adriana; Basik, Mark] McGill Univ, Dept Oncol, Lady Davis Inst, Montreal, PQ, Canada; [Kuzyk, Michael A.; Domanski, Dominik; Borchers, Christoph H.] Univ Victoria, Genome BC Prote Ctr, Victoria, BC, Canada; [Borchers, Christoph H.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada	Lady Davis Institute; McGill University; University of Victoria; University of Victoria	Aguilar-Mahecha, A (corresponding author), McGill Univ, Dept Oncol, Lady Davis Inst, Montreal, PQ, Canada.	mark.basik@mcgill.ca	BORCHERS, Christoph/U-5964-2019; Aguilar, Adriana/GRF-2369-2022	Domanski, Dominik/0000-0003-2549-1064	Jewish General Hospital Foundation; Weekend to end breast cancer; Fondation de Recherche en Sante du Quebec (FRSQ) Reseau Cancer; Genome BC; Genome Canada	Jewish General Hospital Foundation; Weekend to end breast cancer; Fondation de Recherche en Sante du Quebec (FRSQ) Reseau Cancer; Genome BC; Genome Canada(Genome Canada)	This work was supported by the Jewish General Hospital Foundation, The Weekend to end breast cancer and Fondation de Recherche en Sante du Quebec (FRSQ) Reseau Cancer. The University of Victoria-Genome BC Proteomics Centre is partially supported by platform grants from Genome BC and Genome Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnadi CE, 2003, THROMB HAEMOSTASIS, V90, P940, DOI 10.1160/TH03-02-0097; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Banks RE, 2005, CLIN CHEM, V51, P1637, DOI 10.1373/clinchem.2005.051417; Banks RE, 1998, BRIT J CANCER, V77, P956, DOI 10.1038/bjc.1998.158; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; de Jager W, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-52; Fu Q, 2010, CLIN CHEM, V56, P314, DOI 10.1373/clinchem.2009.135087; Hanash SM, 2011, NAT REV CLIN ONCOL, V8, P142, DOI 10.1038/nrclinonc.2010.220; Hanash SM, 2007, BIOMARK INSIGHTS, V1, P1; Hsu J., 1996, MULTIPLE COMP THEORY; Jackson DH, 2010, PROTEOM CLIN APPL, V4, P250, DOI 10.1002/prca.200900220; Kuzyk MA, 2009, MOL CELL PROTEOMICS, V8, P1860, DOI 10.1074/mcp.M800540-MCP200; Macey M, 2002, CLIN CHEM, V48, P891; Oliver AE, 1999, BBA-BIOMEMBRANES, V1416, P349, DOI 10.1016/S0005-2736(98)00239-9; Proc JL, 2010, J PROTEOME RES, V9, P5422, DOI 10.1021/pr100656u; Qureshi AH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007627; Rai AJ, 2005, PROTEOMICS, V5, P3262, DOI 10.1002/pmic.200401245; Rai AJ, 2006, EXPERT REV PROTEOMIC, V3, P409, DOI 10.1586/14789450.3.4.409; Randall SA, 2010, PROTEOMICS, V10, P2050, DOI 10.1002/pmic.200900517; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Rodriguez H, 2010, PROTEOM CLIN APPL, V4, P904, DOI 10.1002/prca.201000057; Tammen H, 2005, PROTEOMICS, V5, P3414, DOI 10.1002/pmic.200401219; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Wildes D, 2010, P NATL ACAD SCI USA, V107, P4561, DOI 10.1073/pnas.0914495107; WINOKUR R, 1995, BLOOD, V85, P1796, DOI 10.1182/blood.V85.7.1796.bloodjournal8571796; Yi JZ, 2007, J PROTEOME RES, V6, P1768, DOI 10.1021/pr060550h; Yi JZ, 2008, J PROTEOME RES, V7, P5112, DOI 10.1021/pr800396c; Zimmermann R, 2005, CLIN CHEM, V51, P2365, DOI 10.1373/clinchem.2005.055558; Zimmermann R, 2009, J IMMUNOL METHODS, V347, P91, DOI 10.1016/j.jim.2009.04.010	29	49	49	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38290	10.1371/journal.pone.0038290	http://dx.doi.org/10.1371/journal.pone.0038290			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701622	gold, Green Published, Green Submitted			2022-12-25	WOS:000305348400046
J	Buchser, WJ; Smith, RP; Pardinas, JR; Haddox, CL; Hutson, T; Moon, L; Hoffman, SR; Bixby, JL; Lemmon, VP				Buchser, William J.; Smith, Robin P.; Pardinas, Jose R.; Haddox, Candace L.; Hutson, Thomas; Moon, Lawrence; Hoffman, Stanley R.; Bixby, John L.; Lemmon, Vance P.			Peripheral Nervous System Genes Expressed in Central Neurons Induce Growth on Inhibitory Substrates	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; AXON REGENERATION; PROTEIN-SYNTHESIS; NEURITE OUTGROWTH; SERINE-PROTEASE; MYELIN; BRAIN; CNS; DIFFERENTIATION; RECEPTOR	Trauma to the spinal cord and brain can result in irreparable loss of function. This failure of recovery is in part due to inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans (CSPGs). Peripheral nervous system (PNS) neurons exhibit increased regenerative ability compared to central nervous system neurons, even in the presence of inhibitory environments. Previously, we identified over a thousand genes differentially expressed in PNS neurons relative to CNS neurons. These genes represent intrinsic differences that may account for the PNS's enhanced regenerative ability. Cerebellar neurons were transfected with cDNAs for each of these PNS genes to assess their ability to enhance neurite growth on inhibitory (CSPG) or permissive (laminin) substrates. Using high content analysis, we evaluated the phenotypic profile of each neuron to extract meaningful data for over 1100 genes. Several known growth associated proteins potentiated neurite growth on laminin. Most interestingly, novel genes were identified that promoted neurite growth on CSPGs (GPX3, EIF2B5, RBMX). Bioinformatic approaches also uncovered a number of novel gene families that altered neurite growth of CNS neurons.	[Buchser, William J.; Smith, Robin P.; Haddox, Candace L.; Bixby, John L.; Lemmon, Vance P.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Pharmacol, Miami, FL 33136 USA; [Buchser, William J.; Smith, Robin P.; Haddox, Candace L.; Bixby, John L.; Lemmon, Vance P.] Univ Miami, Miller Sch Med, Neurosci Program, Dept Neurol Surg, Miami, FL 33136 USA; [Pardinas, Jose R.] Egea Biosci, La Jolla, CA USA; [Hoffman, Stanley R.] Med Univ S Carolina, Div Rheumatol & Immunol, Charleston, SC 29425 USA; [Hutson, Thomas; Moon, Lawrence] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England	University of Miami; University of Miami; Medical University of South Carolina; University of London; King's College London	Buchser, WJ (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Pharmacol, Miami, FL 33136 USA.	jbixby@miami.edu; vlemmon@miami.edu	Lemmon, Vance/A-7410-2010; Moon, Lawrence/C-4906-2008	Lemmon, Vance/0000-0003-3550-7576; Moon, Lawrence/0000-0001-9622-0312; Haddox, Candace/0000-0003-4223-0632; Buchser, William/0000-0002-6675-6359; Bixby, John/0000-0003-1633-5318	National Institutes of Health [HD057632, NS059866]; U.S. Army [W81XWH-05-1-0061]; Paralyzed Veterans of America; Henry Smith Charity; Buoniconti Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059866] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army; Paralyzed Veterans of America; Henry Smith Charity; Buoniconti Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (HD057632), (NS059866), U.S. Army (W81XWH-05-1-0061), Paralyzed Veterans of America, Henry Smith Charity, and the Buoniconti Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki T, 1998, J NEUROSCI RES, V53, P7, DOI 10.1002/(SICI)1097-4547(19980701)53:1<7::AID-JNR2>3.3.CO;2-H; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop AC, 2002, J BIOL CHEM, V277, P25090, DOI 10.1074/jbc.M203208200; Blackmore MG, 2010, MOL CELL NEUROSCI, V44, P43, DOI 10.1016/j.mcn.2010.02.002; Bolliger MF, 2010, J CELL SCI, V123, P3944, DOI 10.1242/jcs.072090; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Broude E, 1997, EXP NEUROL, V148, P367, DOI 10.1006/exnr.1997.6665; Bryan B, 2005, FEBS LETT, V579, P1015, DOI 10.1016/j.febslet.2004.12.074; Buchser WJ, 2006, BIOTECHNIQUES, V41, P619, DOI 10.2144/000112279; Buchser WJ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.52; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Cajal S., 1928, DEGENERATION REGENER; Camps M, 1998, FEBS LETT, V425, P271, DOI 10.1016/S0014-5793(98)00250-6; Chakravarti IM, 1967, HDB METHODS APPL STA, V1, P392; Chaudhry N, 2007, J CEREBR BLOOD F MET, V27, P1096, DOI 10.1038/sj.jcbfm.9600407; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Chivatakarn O, 2007, J NEUROSCI, V27, P7117, DOI 10.1523/JNEUROSCI.1541-07.2007; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Crack PJ, 2001, J NEUROCHEM, V78, P1389, DOI 10.1046/j.1471-4159.2001.00535.x; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Dey N, 2005, EXP CELL RES, V307, P1, DOI 10.1016/j.yexcr.2005.02.029; Dichmann DS, 2008, DEV DYNAM, V237, P1755, DOI 10.1002/dvdy.21590; Dill J, 2008, J NEUROSCI, V28, P8914, DOI 10.1523/JNEUROSCI.1178-08.2008; Drinjakovic J, 2010, NEURON, V65, P341, DOI 10.1016/j.neuron.2010.01.017; Efron B., 1994, CHAPMAN HALL CRC MON; ERNST H, 1995, J CELL SCI, V108, P3807; Fitch MT, 1999, J NEUROSCI, V19, P8182; FREDERICKSON RM, 1992, MOL CELL BIOL, V12, P1239, DOI 10.1128/MCB.12.3.1239; Frischknecht R, 2008, J NEUROSCI, V28, P1568, DOI 10.1523/JNEUROSCI.3398-07.2008; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Giuliano KA, 1997, J BIOMOL SCREEN, V2, P249, DOI 10.1177/108705719700200410; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Gutierrez H, 2008, J NEUROSCI, V28, P8246, DOI 10.1523/JNEUROSCI.1941-08.2008; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Herdegen T, 1997, TRENDS NEUROSCI, V20, P227, DOI 10.1016/S0166-2236(96)01000-4; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YF, 2007, P NATL ACAD SCI USA, V104, P4194, DOI 10.1073/pnas.0611609104; Inman DM, 2003, J COMP NEUROL, V462, P431, DOI 10.1002/cne.10768; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kawabe H, 2010, NEURON, V65, P358, DOI 10.1016/j.neuron.2010.01.007; Kleijn M, 1998, J BIOL CHEM, V273, P5536, DOI 10.1074/jbc.273.10.5536; Koprivica V, 2005, SCIENCE, V310, P106, DOI 10.1126/science.1115462; Langton JT, 2007, PROC SPIE, V6495, DOI 10.1117/12.706110; Lee JK, 2010, NEURON, V66, P663, DOI 10.1016/j.neuron.2010.05.002; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; LI D, 1995, EUR J NEUROSCI, V7, P1164, DOI 10.1111/j.1460-9568.1995.tb01106.x; Lin AC, 2008, CURR OPIN NEUROBIOL, V18, P60, DOI 10.1016/j.conb.2008.05.004; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Ng L, 2007, IEEE ACM T COMPUT BI, V4, P382, DOI 10.1109/TCBB.2007.1035; Numajiri T, 2006, J PLAST RECONSTR AES, V59, P393, DOI 10.1016/j.bjps.2005.04.018; Omura Y, 2009, BMB REP, V42, P232, DOI 10.5483/BMBRep.2009.42.4.232; Park KK, 2010, EXP NEUROL, V223, P45, DOI 10.1016/j.expneurol.2009.12.032; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Peeters PJ, 2006, PHYSIOL GENOMICS, V24, P252, DOI 10.1152/physiolgenomics.00169.2005; Poluha W, 1997, J BIOL CHEM, V272, P24002, DOI 10.1074/jbc.272.38.24002; Power JHT, 2009, ACTA NEUROPATHOL, V117, P63, DOI 10.1007/s00401-008-0438-3; REIER PJ, 1979, BRAIN RES, V164, P61, DOI 10.1016/0006-8993(79)90006-4; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; Smith RP, 2011, MOL CELL NEUROSCI, V46, P32, DOI 10.1016/j.mcn.2010.07.015; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Tcherkezian J, 2010, CELL, V141, P632, DOI 10.1016/j.cell.2010.04.008; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Tsend-Ayush E, 2005, DEV DYNAM, V234, P682, DOI 10.1002/dvdy.20432; Usher LC, 2010, J NEUROSCI, V30, P4693, DOI 10.1523/JNEUROSCI.0302-10.2010; WICTORIN K, 1990, NATURE, V347, P556, DOI 10.1038/347556a0; Zhang XHD, 2009, BIOINFORMATICS, V25, P841, DOI 10.1093/bioinformatics/btp082	79	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38101	10.1371/journal.pone.0038101	http://dx.doi.org/10.1371/journal.pone.0038101			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701605	Green Published, Green Submitted, gold			2022-12-25	WOS:000305348400035
J	Garcia-Rua, V; Otero, MF; Lear, PV; Rodriguez-Penas, D; Feijoo-Bandin, S; Noguera-Moreno, T; Calaza, M; Alvarez-Barred, M; Mosquera-Leal, A; Parrington, J; Brugada, J; Portoles, M; Rivera, M; Gonzalez-Juanatey, JR; Lago, F				Garcia-Rua, Vanessa; Otero, Manuel Francisco; Lear, Pamela Virginia; Rodriguez-Penas, Diego; Feijoo-Bandin, Sandra; Noguera-Moreno, Teresa; Calaza, Manuel; Alvarez-Barred, Maria; Mosquera-Leal, Ana; Parrington, John; Brugada, Josep; Portoles, Manuel; Rivera, Miguel; Gonzalez-Juanatey, Jose Ramon; Lago, Francisca			Increased Expression of Fatty-Acid and Calcium Metabolism Genes in Failing Human Heart	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE CAPACITY; SKELETAL-MUSCLE; MITOCHONDRIAL; FAILURE; PROTEIN; TRANSPORTERS; DEFICIENCY; PROMOTER	Background: Heart failure (HF) involves alterations in metabolism, but little is known about cardiomyopathy-(CM)-specific or diabetes-independent alterations in gene expression of proteins involved in fatty-acid (FA) uptake and oxidation or in calcium-(Ca2+)-handling in the human heart. Methods: RT-qPCR was used to quantify mRNA expression and immunoblotting to confirm protein expression in left-ventricular myocardium from patients with HF (n = 36) without diabetes mellitus of ischaemic (ICM, n = 16) or dilated (DCM, n = 20) cardiomyopathy aetiology, and non-diseased donors (CTL, n = 6). Results: Significant increases in mRNA of genes regulating FA uptake (CD36) and intracellular transport (Heart-FA-Binding Protein (HFABP)) were observed in HF patients vs CTL. Significance was maintained in DCM and confirmed at protein level, but not in ICM. mRNA was higher in DCM than ICM for peroxisome-proliferator-activated-receptor-alpha (PPARA), PPARgamma coactivator-1-alpha (PGC1A) and CD36, and confirmed at the protein level for PPARA and CD36. Transcript and protein expression of Ca2+-handling genes (Two-Pore-Channel 1 (TPCN1), Two-Pore-Channel 2 (TPCN2), and Inositol 1,4,5-triphosphate Receptor type-1 (IP3R1)) increased in HF patients relative to CTL. Increases remained significant for TPCN2 in all groups but for TPCN1 only in DCM. There were correlations between FA metabolism and Ca2+-handling genes expression. In ICM there were six correlations, all distinct from those found in CTL. In DCM there were also six (all also different from those found in CTL): three were common to and three distinct from ICM. Conclusion: DCM-specific increases were found in expression of several genes that regulate FA metabolism, which might help in the design of aetiology-specific metabolic therapies in HF. Ca2+-handling genes TPCN1 and TPCN2 also showed increased expression in HF, while HF- and CM-specific positive correlations were found among several FA and Ca2+-handling genes.	[Garcia-Rua, Vanessa; Otero, Manuel Francisco; Lear, Pamela Virginia; Rodriguez-Penas, Diego; Feijoo-Bandin, Sandra; Alvarez-Barred, Maria; Rivera, Miguel; Gonzalez-Juanatey, Jose Ramon] Univ Santiago de Compostela, Clin Hosp CHUS, Santiago Inst Biomed Res IDIS, Lab Cellular & Mol Cardiol, Santiago De Compostela, Spain; [Noguera-Moreno, Teresa] Univ Santiago Compostela, Clin Hosp CHUS, Lab 10, Santiago Inst Biomed Res IDIS, Santiago De Compostela, Spain; [Otero, Manuel Francisco] Univ Santiago Compostela, Dept Clin Chem, Clin Hosp CHUS, Santiago De Compostela, Spain; [Calaza, Manuel; Rivera, Miguel] Univ Santiago Compostela, Dept Cardiol, Clin Hosp CHUS, Santiago De Compostela, Spain; [Noguera-Moreno, Teresa] Univ Santiago Compostela, Unit Biostat Res, Santiago De Compostela, Spain; [Parrington, John] Univ Oxford, Dept Pharmacol, Oxford, England; [Brugada, Josep] Hosp Clin Barcelona, Thorax Inst, Dept Cardiol, Barcelona, Spain; [Portoles, Manuel; Rivera, Miguel] La Fe Univ Hosp, Valencia, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; University of Oxford; University of Barcelona; Hospital Clinic de Barcelona	Garcia-Rua, V (corresponding author), Univ Santiago de Compostela, Clin Hosp CHUS, Santiago Inst Biomed Res IDIS, Lab Cellular & Mol Cardiol, Santiago De Compostela, Spain.	francisca.lago.paz@sergas.es	PORTOLES, MANUEL/B-4789-2009; Feijóo-Bandín, Sandra/AAL-6787-2020	PORTOLES, MANUEL/0000-0002-4415-7160; Feijóo-Bandín, Sandra/0000-0002-3739-5806; Lear, Pamela/0000-0002-4297-5995; BRUGADA, JOSEP/0000-0002-5662-8302; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388; Calaza Cabanas, Manuel/0000-0003-3082-525X	Health Research Fund of Instituto de Salud Carlos III (ISCIII) [FIS08/0044, FIS11/00497]; University Professional Development Program (FPU) of the Spanish Ministry of Education; Rio Hortega Program of the Spanish Ministry of Economy and Competitiveness; Spanish Network of Collaborative Cardiological Research (REDINSCOR); IDICHUS Research Foundation; University of Santiago de Compostela Clinical Hospital; Xunta de Galicia (SERGAS); Wellcome Trust UK; SERGAS	Health Research Fund of Instituto de Salud Carlos III (ISCIII); University Professional Development Program (FPU) of the Spanish Ministry of Education(German Research Foundation (DFG)); Rio Hortega Program of the Spanish Ministry of Economy and Competitiveness; Spanish Network of Collaborative Cardiological Research (REDINSCOR); IDICHUS Research Foundation; University of Santiago de Compostela Clinical Hospital; Xunta de Galicia (SERGAS)(Xunta de Galicia); Wellcome Trust UK(Wellcome Trust); SERGAS	This work was funded by the Health Research Fund of Instituto de Salud Carlos III (ISCIII, FIS08/0044 and FIS11/00497); VG-R is funded by the University Professional Development Program (FPU) of the Spanish Ministry of Education; MFO is funded by the Rio Hortega Program of the Spanish Ministry of Economy and Competitiveness; PVL is funded by the Spanish Network of Collaborative Cardiological Research (REDINSCOR); DR-P, SF-B, MA-B, AM are funded by IDICHUS Research Foundation, University of Santiago de Compostela Clinical Hospital; MC is funded by Xunta de Galicia (SERGAS); JP is funded by the Wellcome Trust UK; and FL is funded by SERGAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer JD, 2010, HEART RHYTHM, V7, P1093, DOI 10.1016/j.hrthm.2010.04.008; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cortes R, 2009, TRANSPL P, V41, P2227, DOI 10.1016/j.transproceed.2009.06.013; Cortes R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030915; Cortes R, 2010, CARDIOVASC RES, V85, P464, DOI 10.1093/cvr/cvp336; Crossman DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017901; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Dulhunty AF, 2011, CURR DRUG TARGETS, V12, P709; Duncan JG, 2011, PEDIATR CARDIOL, V32, P323, DOI 10.1007/s00246-011-9889-8; Duncan JG, 2010, CIRCULATION, V121, P426, DOI 10.1161/CIRCULATIONAHA.109.888735; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Fu HY, 2010, CIRCULATION, V122, P361, DOI 10.1161/CIRCULATIONAHA.109.917914; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Galione A, 2011, COLD SPRING HARB PER, V3; Galione A, 2009, PFLUG ARCH EUR J PHY, V458, P869, DOI 10.1007/s00424-009-0682-y; Garnier A, 2003, J PHYSIOL-LONDON, V551, P491, DOI 10.1113/jphysiol.2003.045104; Garnier A, 2009, CIRC-HEART FAIL, V2, P342, DOI 10.1161/CIRCHEARTFAILURE.108.812099; Glatz JFC, 2006, CARDIOVASC DRUG THER, V20, P471, DOI 10.1007/s10557-006-0582-8; Glatz JFC, 2002, CURR OPIN CLIN NUTR, V5, P365, DOI 10.1097/00075197-200207000-00003; GO LO, 1995, J CLIN INVEST, V95, P888, DOI 10.1172/JCI117739; Goikoetxea MJ, 2006, CARDIOVASC RES, V69, P899, DOI 10.1016/j.cardiores.2005.11.016; Harzheim D, 2009, P NATL ACAD SCI USA, V106, P11406, DOI 10.1073/pnas.0905485106; Heather LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026326; Heather LC, 2011, J MOL CELL CARDIOL, V50, P598, DOI 10.1016/j.yjmcc.2011.01.007; Holloway GP, 2011, J PHYSIOL-LONDON, V589, P169, DOI 10.1113/jphysiol.2010.198663; Holloway GP, 2009, AM J CLIN NUTR, V89, p455S, DOI 10.3945/ajcn.2008.26717B; Hooper R, 2011, J BIOL CHEM, V286, P9141, DOI 10.1074/jbc.M110.189985; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; Jaswal JS, 2011, BBA-MOL CELL RES, V1813, P1333, DOI 10.1016/j.bbamcr.2011.01.015; Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753; Karbowska J, 2003, CELL MOL BIOL LETT, V8, P49; Kato T, 2010, CIRC-HEART FAIL, V3, P420, DOI 10.1161/CIRCHEARTFAILURE.109.888479; Lionetti V, 2011, CARDIOVASC RES, V90, P202, DOI 10.1093/cvr/cvr038; Luciani DS, 2009, DIABETES, V58, P422, DOI 10.2337/db07-1762; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; Mettaure B, 2001, J AM COLL CARDIOL, V38, P947, DOI 10.1016/S0735-1097(01)01460-7; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Murray AJ, 2005, DIABETES, V54, P3496, DOI 10.2337/diabetes.54.12.3496; Murray AJ, 2004, LANCET, V364, P1786, DOI 10.1016/S0140-6736(04)17402-3; Nakata T, 2003, CARDIOLOGY, V99, P96, DOI 10.1159/000069726; Opie LH, 2011, J AM COLL CARDIOL, V54, P1637; Pelsers MMAL, 2005, CLIN CHIM ACTA, V352, P15, DOI 10.1016/j.cccn.2004.09.001; Pohl J, 2000, Eur J Med Res, V5, P438; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Rennison JH, 2008, CARDIOVASC RES, V79, P331, DOI 10.1093/cvr/cvn066; Rosello-Lleti E, 2012, BIOCHEM BIOPH RES CO, V418, P222, DOI 10.1016/j.bbrc.2011.12.151; Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837; Sato O, 2002, J BIOL CHEM, V277, P15703, DOI 10.1074/jbc.M110158200; Schupp M, 2006, EUR J HEART FAIL, V8, P290, DOI 10.1016/j.ejheart.2005.09.003; Schwenk RW, 2008, CARDIOVASC RES, V79, P249, DOI 10.1093/cvr/cvn116; Sebastiani M, 2007, J AM COLL CARDIOL, V50, P1362, DOI 10.1016/j.jacc.2007.06.035; Sharma V, 2009, EUR J PHARMACOL, V607, P156, DOI 10.1016/j.ejphar.2009.02.016; Sihag S, 2009, J MOL CELL CARDIOL, V46, P201, DOI 10.1016/j.yjmcc.2008.10.025; Son NH, 2010, J CLIN INVEST, V120, P3443, DOI 10.1172/JCI40905; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Teboul L, 2001, BIOCHEM J, V360, P305, DOI 10.1042/0264-6021:3600305; Turer AT, 2010, CURR OPIN CLIN NUTR, V13, P458, DOI 10.1097/MCO.0b013e32833a55a5; Uray IP, 2003, CARDIOVASC RES, V59, P57, DOI 10.1016/S0008-6363(03)00352-3; van Bilsen M, 2009, CARDIOVASC RES, V81, P420, DOI 10.1093/cvr/cvn282; Wu PF, 2001, BIOCHEM BIOPH RES CO, V287, P391, DOI 10.1006/bbrc.2001.5608; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6; Yano M, 2005, J CLIN INVEST, V115, P556, DOI 10.1172/JCI200524159; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	64	37	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37505	10.1371/journal.pone.0037505	http://dx.doi.org/10.1371/journal.pone.0037505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701570	Green Published, gold, Green Submitted			2022-12-25	WOS:000305348400012
J	Massaoka, MH; Matsuo, AL; Figueiredo, CR; Farias, CF; Girola, N; Arruda, DC; Scutti, JAB; Romoff, P; Favero, OA; Ferreira, MJP; Lago, JHG; Travassos, LR				Massaoka, Mariana H.; Matsuo, Alisson L.; Figueiredo, Carlos R.; Farias, Camyla F.; Girola, Natalia; Arruda, Denise C.; Scutti, Jorge A. B.; Romoff, Paulete; Favero, Oriana A.; Ferreira, Marcelo J. P.; Lago, Joao H. G.; Travassos, Luiz R.			Jacaranone Induces Apoptosis in Melanoma Cells via ROS-Mediated Downregulation of Akt and p38 MAPK Activation and Displays Antitumor Activity In Vivo	PLOS ONE			English	Article							MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; CANCER-CELLS; PROTEIN-KINASE; CASPASE ACTIVATION; STRESS; PATHWAYS; GROWTH; LEADS; PHOSPHORYLATION; MECHANISMS	Background: Malignant melanoma is a deadly type of metastatic skin cancer with increased incidence over the past 30 years. Despite the advanced knowledge on the biology, immunobiology and molecular genetics of melanoma, the alternatives of treatment are limited with poor prognosis. On clinical trials, natural products and among them redox-active quinones have been tested in the attempt to control the growth of cancer cells. Recently, we isolated jacaranone from Pentacalia desiderabilis, a benzoquinone derivative that showed a broad antitumor activity and protective anti-melanoma effect in a syngeneic model. The purified substance is active at micromolar concentrations, is not hemolytic, and is not toxic in naive mice. Methodology/Principal Findings: The jacaranone antitumor activity was shown against several human cancer cell lines in vitro. Moreover, the induction of apoptosis in murine melanoma cells and jacaranone antitumor activity in vivo, in a melanoma experimental model, were also shown. Jacaranone renders antiproliferative and proapoptotic responses in tumor cells, by acting on Akt and p38 MAPK signaling pathways through generation of reactive oxygen species (ROS). The free radical scavenger N-acetyl-cysteine (NAC) was able to completely suppress cell death induced by jacaranone as it blocked Akt downregulation, p38 MAPK activation as well as upregulation of proapoptotic Bax. Notably, treatment of melanoma growing subcutaneously in mice with jacaranone significantly extended the mean survival times in a dose-dependent manner. Conclusions/Significance: The results provide evidence for the mechanisms of action of jacaranone and emphasize the potential use of this quinone for the treatment of melanoma.	[Massaoka, Mariana H.; Matsuo, Alisson L.; Figueiredo, Carlos R.; Farias, Camyla F.; Girola, Natalia; Arruda, Denise C.; Scutti, Jorge A. B.; Travassos, Luiz R.] Univ Fed Sao Paulo, Unidade Oncol Expt, Sao Paulo, Brazil; [Romoff, Paulete; Favero, Oriana A.; Ferreira, Marcelo J. P.] Univ Presbiteriana Mackenzie, Ctr Ciencias & Humanidades, Sao Paulo, Brazil; [Romoff, Paulete; Favero, Oriana A.; Ferreira, Marcelo J. P.] Univ Presbiteriana Mackenzie, Ctr Ciencias Biol & Saude, Sao Paulo, Brazil; [Lago, Joao H. G.] Univ Fed Sao Paulo, Inst Ciencias Ambientais Quim & Farmaceut, Diadema, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Presbiteriana Mackenzie; Universidade Presbiteriana Mackenzie; Universidade Federal de Sao Paulo (UNIFESP)	Massaoka, MH (corresponding author), Univ Fed Sao Paulo, Unidade Oncol Expt, Sao Paulo, Brazil.	luiztravassos@gmail.com	Travassos, Luiz R/J-3631-2012; Lago, Joao/W-5238-2019; Romoff, Paulete/AAD-3638-2021; Figueiredo, Carlos Rogerio de/H-1236-2014; Arruda, Denise C/E-2184-2013; Travassos, Luiz/V-2467-2019; , Denise/AAD-1162-2022; Girola, Natalia/L-9060-2017; Fapesp, Biota/F-8655-2017; Ferreira, Marcelo JP/G-6002-2014	Lago, Joao/0000-0002-1193-8374; Figueiredo, Carlos Rogerio de/0000-0003-3680-4070; Arruda, Denise C/0000-0002-8807-8835; Fapesp, Biota/0000-0002-9887-8449; Ferreira, Marcelo JP/0000-0003-1877-1762	State of Sao Paulo Research Support Foundation (FAPESP), Brazil [2010/51423-0]; Brazilian National Research Council (CNPq)	State of Sao Paulo Research Support Foundation (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The State of Sao Paulo Research Support Foundation (FAPESP), Brazil, supported this work through grant 2010/51423-0 as well as the Brazilian National Research Council (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berra E, 1998, J BIOL CHEM, V273, P10792, DOI 10.1074/jbc.273.17.10792; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai BB, 2006, J BIOL CHEM, V281, P25215, DOI 10.1074/jbc.M512627200; Chang CW, 2009, J BIOL CHEM, V284, P33195, DOI 10.1074/jbc.M109.020586; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chaudhuri L, 2010, ENVIRON INT, V36, P924, DOI 10.1016/j.envint.2010.01.001; Dai DL, 2005, J CLIN ONCOL, V23, P1473, DOI 10.1200/JCO.2005.07.168; Demain AL, 2011, MICROB BIOTECHNOL, V4, P687, DOI 10.1111/j.1751-7915.2010.00221.x; Dhawan P, 2002, CANCER RES, V62, P7335; Doughan AK, 2007, ANTIOXID REDOX SIGN, V9, P1825, DOI 10.1089/ars.2007.1693; FLUCKIGER R, 1995, METHOD ENZYMOL, V258, P140; Fulda S, 2011, ANTIOXID REDOX SIGN, V15, P2937, DOI 10.1089/ars.2011.4078; Garbe C, 2009, CLIN DERMATOL, V27, P3, DOI 10.1016/j.clindermatol.2008.09.001; Gogas HJ, 2007, CANCER-AM CANCER SOC, V109, P455, DOI 10.1002/cncr.22427; Govindarajan B, 2007, J CLIN INVEST, V117, P719, DOI 10.1172/JCI30102; Gratton JP, 2001, J BIOL CHEM, V276, P30359, DOI 10.1074/jbc.M009698200; Grossman D, 2001, CANCER METAST REV, V20, P3, DOI 10.1023/A:1013123532723; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Izeradjene K, 2005, CANCER RES, V65, P7436, DOI 10.1158/0008-5472.CAN-04-2628; Jerant AF, 2000, AM FAM PHYSICIAN, V62, P357; Jia YT, 2007, J IMMUNOL, V179, P7808, DOI 10.4049/jimmunol.179.11.7808; Jo Y, 2005, ARCH PHARM RES, V28, P885, DOI 10.1007/BF02973871; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Kim BM, 2011, APOPTOSIS, V16, P184, DOI 10.1007/s10495-010-0557-x; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Liao Y, 2003, MOL CELL BIOL, V23, P6836, DOI 10.1128/MCB.23.19.6836-6848.2003; Lin CF, 2004, J BIOL CHEM, V279, P40755, DOI 10.1074/jbc.M404726200; Loizzo MR, 2005, J PHARM PHARMACOL, V57, P897, DOI 10.1211/0022357056398; Lopez-Bergami P, 2011, PIGM CELL MELANOMA R, V24, P902, DOI 10.1111/j.1755-148X.2011.00908.x; Matsuo AL, 2011, BIOCHEM BIOPH RES CO, V411, P449, DOI 10.1016/j.bbrc.2011.06.176; Morais TR, 2012, PARASITOL RES, V110, P95, DOI 10.1007/s00436-011-2454-9; Nagy G, 2003, J IMMUNOL, V171, P5188, DOI 10.4049/jimmunol.171.10.5188; Ollinger Karin, 2002, Subcell Biochem, V36, P151; Park KR, 2011, CANCER LETT, V312, P178, DOI 10.1016/j.canlet.2011.08.001; Pasciu V, 2010, TOXICOL SCI, V114, P101, DOI 10.1093/toxsci/kfp301; PAZ MA, 1991, J BIOL CHEM, V266, P689; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Pfisterer PH, 2010, CURR PHARM DESIGN, V16, P1718; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; POWIS G, 1989, FREE RADICAL BIO MED, V6, P63, DOI 10.1016/0891-5849(89)90162-7; Prasad V, 2006, FREE RADICAL BIO MED, V41, P431, DOI 10.1016/j.freeradbiomed.2006.03.009; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Shin SW, 2009, CLIN CANCER RES, V15, P5414, DOI 10.1158/1078-0432.CCR-08-3101; Squadrito GL, 2001, FREE RADICAL BIO MED, V31, P1132, DOI 10.1016/S0891-5849(01)00703-1; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Verrax J, 2011, ANTI-CANCER AGENT ME, V11, P213, DOI 10.2174/187152011795255902; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Woldemichael GM, 2011, CANCER RES, V71, P134, DOI 10.1158/0008-5472.CAN-10-0757; Xavier CPR, 2009, CANCER LETT, V281, P162, DOI 10.1016/j.canlet.2009.02.041; Xu J, 2002, J BIOL CHEM, V277, P35561, DOI 10.1074/jbc.M203805200; Yin XM, 2000, CELL RES, V10, P161, DOI 10.1038/sj.cr.7290045; Yu DS, 2002, CHEM RES TOXICOL, V15, P832, DOI 10.1021/tx010177m; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029; Zuo Y, 2009, CELL RES, V19, P449, DOI 10.1038/cr.2009.19	60	44	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38698	10.1371/journal.pone.0038698	http://dx.doi.org/10.1371/journal.pone.0038698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701695	Green Published, gold, Green Submitted			2022-12-25	WOS:000305348400087
J	Ladiwala, U; Basu, H; Mathur, D				Ladiwala, Uma; Basu, Himanish; Mathur, Deepak			Assembling Neurospheres: Dynamics of Neural Progenitor/Stem Cell Aggregation Probed Using an Optical Trap	PLOS ONE			English	Article							RED-BLOOD-CELLS; NEURONAL GROWTH; IN-VITRO; ADHESION; INTEGRIN; FORCE; ASSAY; CYTOCHALASIN; ELONGATION; PHASE	Optical trapping (tweezing) has been used in conjunction with fluid flow technology to dissect the mechanics and spatio-temporal dynamics of how neural progenitor/stem cells (NSCs) adhere and aggregate. Hitherto unavailable information has been obtained on the most probable minimum time (similar to 5 s) and most probable minimum distance of approach (4-6 mu m) required for irreversible adhesion of proximate cells to occur. Our experiments also allow us to study and quantify the spatial characteristics of filopodial- and membrane-mediated adhesion, and to probe the functional dynamics of NSCs to quantify a lower limit of the adhesive force by which NSCs aggregate (similar to 18 pN). Our findings, which we also validate by computational modeling, have important implications for the neurosphere assay: once aggregated, neurospheres cannot disassemble merely by being subjected to shaking or by thermal effects. Our findings provide quantitative affirmation to the notion that the neurosphere assay may not be a valid measure of clonality and "stemness". Post-adhesion dynamics were also studied and oscillatory motion in filopodia-mediated adhesion was observed. Furthermore, we have also explored the effect of the removal of calcium ions: both filopodia-mediated as well as membrane-membrane adhesion were inhibited. On the other hand, F-actin disrupted the dynamics of such adhesion events such that filopodia-mediated adhesion was inhibited but not membrane-membrane adhesion.	[Ladiwala, Uma] Univ Mumbai, UM DAE Ctr Excellence Basic Sci, Bombay, Maharashtra, India; [Basu, Himanish; Mathur, Deepak] Tata Inst Fundamental Res, Bombay 400005, Maharashtra, India	UM-DAE Centre for Excellence in Basic Sciences; University of Mumbai; Tata Institute of Fundamental Research (TIFR)	Ladiwala, U (corresponding author), Univ Mumbai, UM DAE Ctr Excellence Basic Sci, Kalina Campus, Bombay, Maharashtra, India.	brainwave@cbs.ac.in; atmol1@tifr.res.in	Mathur, Deepak/K-5000-2019	Mathur, Deepak/0000-0002-2322-6331; Basu, Himanish/0000-0001-8236-1157	Tata Institute of Fundamental Research, Mumbai; Centre for Excellence in Basic Sciences, Mumbai	Tata Institute of Fundamental Research, Mumbai; Centre for Excellence in Basic Sciences, Mumbai	The research has been funded from Institutional funds of the Tata Institute of Fundamental Research, Mumbai and the Centre for Excellence in Basic Sciences, Mumbai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovici H, 2007, CELL MOTIL CYTOSKEL, V64, P549, DOI 10.1002/cm.20204; Alberts B, 2002, CELL CELL ADHESION M; Aplin AE, 1998, PHARMACOL REV, V50, P197; Bambardekar K, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3430732; Bambardekar K, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3037342; Bankapur A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035075; Bankapur A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010427; Basu H, 2011, BIOPHYS J, V101, P1604, DOI 10.1016/j.bpj.2011.08.043; Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697; Campos LS, 2004, J NEUROSCI RES, V78, P761, DOI 10.1002/jnr.20333; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Chang HP, 1999, LEARN MEMORY, V6, P448, DOI 10.1101/lm.6.5.448; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Clarke RJ, 2008, MOL VIS, V14, P706; Coles-Takabe BLK, 2008, STEM CELLS, V26, P2938, DOI 10.1634/stemcells.2008-0558; Dharmadhikari JA, 2004, CURR SCI INDIA, V86, P1432; Dharmadhikari JA, 2004, OPT EXPRESS, V12, P1179, DOI 10.1364/OPEX.12.001179; Dictus C, 2007, J NEUROSCI METH, V161, P250, DOI 10.1016/j.jneumeth.2006.11.012; Difato F, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3560268; Ehrlicher A, 2002, P NATL ACAD SCI USA, V99, P16024, DOI 10.1073/pnas.252631899; Erasmus J, 2010, BIOL CELL, V102, P13, DOI 10.1042/BC20090048; Fasen K, 2003, ACTA NEUROPATHOL, V106, P319, DOI 10.1007/s00401-003-0733-y; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Hall PE, 2006, STEM CELLS, V24, P2078, DOI 10.1634/stemcells.2005-0595; Hoffmann B, 2010, CELL ADHES MIGR, V4, P190, DOI 10.4161/cam.4.2.10899; Husainy AN, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-86; Jacinto A, 2000, CURR BIOL, V10, P1420, DOI 10.1016/S0960-9822(00)00796-X; Jessberger S, 2007, STEM CELLS, V25, P871, DOI 10.1634/stemcells.2006-0620; Karpowicz P, 2009, J NEUROSCI, V29, P3885, DOI 10.1523/JNEUROSCI.0037-09.2009; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Leone DP, 2005, J CELL SCI, V118, P2589, DOI 10.1242/jcs.02396; Liebau S, 2007, J NEUROCHEM, V101, P1338, DOI 10.1111/j.1471-4159.2006.04437.x; Liebau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018148; Lobo MVT, 2003, J HISTOCHEM CYTOCHEM, V51, P89, DOI 10.1177/002215540305100111; Marshall GP, 2007, CURR PHARM BIOTECHNO, V8, P141; Millard TH, 2008, DEVELOPMENT, V135, P621, DOI 10.1242/dev.014001; Mori H, 2006, J NEUROSCI RES, V84, P1682, DOI 10.1002/jnr.21082; Mori H, 2007, J BIOSCI BIOENG, V104, P231, DOI 10.1263/jbb.104.231; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; Park Y, 2010, P NATL ACAD SCI USA, V107, P6731, DOI 10.1073/pnas.0909533107; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Patla I, 2010, NAT CELL BIOL, V12, P909, DOI 10.1038/ncb2095; Pinkstaff JK, 1999, J NEUROSCI, V19, P1541; Raich WB, 1999, CURR BIOL, V9, P1139, DOI 10.1016/S0960-9822(00)80015-9; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Schafer C, 2011, CELL ADHES MIGR, V5, P431, DOI 10.4161/cam.5.5.17400; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Tamada A, 2010, J CELL BIOL, V188, P429, DOI 10.1083/jcb.200906043; TSUI HCT, 1985, P NATL ACAD SCI USA, V82, P8256, DOI 10.1073/pnas.82.23.8256; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Wu X, 2012, PHARMACOL THERAPEUT, V134, P68, DOI 10.1016/j.pharmthera.2011.12.008; YONEMURA S, 1995, J CELL SCI, V108, P127; Zachariah E, 2010, J PHOTOCH PHOTOBIO B, V100, P113, DOI 10.1016/j.jphotobiol.2010.05.009; Zhuravlev PI, 2009, P NATL ACAD SCI USA, V106, P11570, DOI 10.1073/pnas.0812746106	57	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38613	10.1371/journal.pone.0038613	http://dx.doi.org/10.1371/journal.pone.0038613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693648	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343900061
J	Madai, VI; von Samson-Himmelstjerna, FC; Bauer, M; Stengl, KL; Mutke, MA; Tovar-Martinez, E; Wuerfel, J; Endres, M; Niendorf, T; Sobesky, J				Madai, Vince I.; von Samson-Himmelstjerna, Federico C.; Bauer, Miriam; Stengl, Katharina L.; Mutke, Matthias A.; Tovar-Martinez, Elena; Wuerfel, Jens; Endres, Matthias; Niendorf, Thoralf; Sobesky, Jan			Ultrahigh-Field MRI in Human Ischemic Stroke - a 7 Tesla Study	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; VIRCHOW-ROBIN SPACES; DISEASE; IMAGES; BRAIN	Introduction: Magnetic resonance imaging (MRI) using field strengths up to 3 Tesla (T) has proven to be a powerful tool for stroke diagnosis. Recently, ultrahigh-field (UHF) MRI at 7 T has shown relevant diagnostic benefits in imaging of neurological diseases, but its value for stroke imaging has not been investigated yet. We present the first evaluation of a clinically feasible stroke imaging protocol at 7 T. For comparison an established stroke imaging protocol was applied at 3 T. Methods: In a prospective imaging study seven patients with subacute and chronic stroke were included. Imaging at 3 T was immediately followed by 7 T imaging. Both protocols included T1-weighted 3D Magnetization-Prepared Rapid-Acquired Gradient-Echo (3D-MPRAGE), T2-weighted 2D Fluid Attenuated Inversion Recovery (2D-FLAIR), T2-weighted 2D Fluid Attenuated Inversion Recovery (2D-T2-TSE), T2* weighted 2D Fast Low Angle Shot Gradient Echo (2D-HemoFLASH) and 3D Time-of-Flight angiography (3D-TOF). Results: The diagnostic information relevant for clinical stroke imaging obtained at 3 T was equally available at 7 T. Higher spatial resolution at 7 T revealed more anatomical details precisely depicting ischemic lesions and periinfarct alterations. A clear benefit in anatomical resolution was also demonstrated for vessel imaging at 7 T. RF power deposition constraints induced scan time prolongation and reduced brain coverage for 2D-FLAIR, 2D-T2-TSE and 3D-TOF at 7 T versus 3 T. Conclusions: The potential of 7 T MRI for human stroke imaging is shown. Our pilot study encourages a further evaluation of the diagnostic benefit of stroke imaging at 7 T in a larger study.	[Madai, Vince I.; von Samson-Himmelstjerna, Federico C.; Bauer, Miriam; Stengl, Katharina L.; Mutke, Matthias A.; Endres, Matthias; Sobesky, Jan] Charite, Dept Neurol, D-13353 Berlin, Germany; [Madai, Vince I.; von Samson-Himmelstjerna, Federico C.; Bauer, Miriam; Stengl, Katharina L.; Mutke, Matthias A.; Endres, Matthias; Sobesky, Jan] Charite, Ctr Stroke Res Berlin CSB, D-13353 Berlin, Germany; [von Samson-Himmelstjerna, Federico C.; Tovar-Martinez, Elena; Wuerfel, Jens; Niendorf, Thoralf] Max Delbruck Ctr Mol Med MDC, Berlin Ultra High Field Facil BUFF, Berlin, Germany; [Niendorf, Thoralf; Sobesky, Jan] Charite, ECRC, D-13353 Berlin, Germany; [Wuerfel, Jens] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Wuerfel, Jens] Univ Lubeck, Inst Neuroradiol, Lubeck, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Lubeck	Madai, VI (corresponding author), Charite, Dept Neurol, D-13353 Berlin, Germany.	jan.sobesky@charite.de	Niendorf, Thoralf/H-7738-2013; Madai, Vince/GYD-7365-2022; Madai, Vince/AAF-5525-2020	Niendorf, Thoralf/0000-0001-7584-6527; Madai, Vince/0000-0002-8552-6954; Madai, Vince/0000-0002-8552-6954; Endres, Matthias/0000-0001-6520-3720; Wuerfel, Jens/0000-0002-0034-8053; Sobesky, Jan/0000-0001-5459-3655	German Federal Ministry of Education and Research via "Center for Stroke Research Berlin'' [01 EO 0801]; German Research Foundation (DFG) (Excellence cluster NeuroCure) [SFB TR 43, KFO 247, KFO 213]; Federal Ministry of Education and Research (BMBF) (Centre for Stroke Research Berlin); EU (Eustroke, ARISE, WakeUp); Volkswagen Foundation (Lichtenberg Program); Corona Foundation	German Federal Ministry of Education and Research via "Center for Stroke Research Berlin''; German Research Foundation (DFG) (Excellence cluster NeuroCure); Federal Ministry of Education and Research (BMBF) (Centre for Stroke Research Berlin); EU (Eustroke, ARISE, WakeUp); Volkswagen Foundation (Lichtenberg Program); Corona Foundation	The research leading to these results has received funding from the German Federal Ministry of Education and Research via the grant "Center for Stroke Research Berlin'' (01 EO 0801; http://www.bmbf.de). M.E. receives funding from the German Research Foundation (DFG) (Excellence cluster NeuroCure; SFB TR 43, KFO 247, KFO 213; http://www.dfg.de), Federal Ministry of Education and Research (BMBF) (Centre for Stroke Research Berlin; http://www.bmbf.de), EU (Eustroke, ARISE, WakeUp), Volkswagen Foundation (Lichtenberg Program; http://www.volkswagenstiftung.de), Corona Foundation (http://www.stifterverband.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokura H, 2011, STROKE, V42, P1867, DOI 10.1161/STROKEAHA.110.601922; Brundel M, 2012, J CEREB BLOOD FLOW M; Busse RF, 2004, MAGN RESON MED, V51, P1031, DOI 10.1002/mrm.20056; Chen W, 2011, AM J NEURORADIOL, V32, P1490, DOI 10.3174/ajnr.A2541; Cizek J, 2004, NEUROIMAGE, V22, P434, DOI 10.1016/j.neuroimage.2004.01.016; Dammann P, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.6.FOCUS10130; de Graaf WL, 2012, EUR RADIOL, V22, P221, DOI 10.1007/s00330-011-2242-z; Hennig J, 2001, MAGNET RESON MED, V46, P6, DOI 10.1002/mrm.1153; Heverhagen JT, 2008, INVEST RADIOL, V43, P568, DOI 10.1097/RLI.0b013e31817e9b2c; Kang CK, 2010, INT J STROKE, V5, P374, DOI 10.1111/j.1747-4949.2010.00464.x; Kwon DH, 2012, ANN NEUROL, V71, P267, DOI 10.1002/ana.22592; Lupo JM, 2011, CURR OPIN NEUROL, V24, P605, DOI 10.1097/WCO.0b013e32834cd495; Merino JG, 2010, NAT REV NEUROL, V6, P560, DOI 10.1038/nrneurol.2010.129; Novak V, 2005, MAGN RESON IMAGING, V23, P539, DOI 10.1016/j.mri.2005.02.010; Nyberg E, 2012, AM J NEURORADIOL, V33, P77, DOI 10.3174/ajnr.A2737; Pipe JG, 1999, MAGNET RESON MED, V42, P963, DOI 10.1002/(SICI)1522-2594(199911)42:5<963::AID-MRM17>3.0.CO;2-L; Qian YX, 2012, MAGN RESON MED, V68, P227, DOI 10.1002/mrm.23225; Tallantyre EC, 2011, NEUROLOGY, V76, P534, DOI 10.1212/WNL.0b013e31820b7630; van der Kolk AG, 2011, STROKE, V42, P2478, DOI 10.1161/STROKEAHA.111.620443; Weber R, 2005, MAGN RESON MED, V54, P59, DOI 10.1002/mrm.20532; Wiggins G. C., 2011, MAGNETOM FLASH, V46, P32; Zhu YC, 2011, AM J NEURORADIOL, V32, P709, DOI 10.3174/ajnr.A2366; Zhu YC, 2010, STROKE, V41, P2483, DOI 10.1161/STROKEAHA.110.591586	23	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37631	10.1371/journal.pone.0037631	http://dx.doi.org/10.1371/journal.pone.0037631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701525	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000305338500046
J	Gomez-Casares, MT; Garcia-Alegria, E; Lopez-Jorge, CE; Ferrandiz, N; Blanco, R; Alvarez, S; Vaque, JP; Bretones, G; Caraballo, JM; Sanchez-Bailon, P; Delgado, MD; Martin-Perez, J; Cigudosa, JC; Leon, J				Gomez-Casares, M. T.; Garcia-Alegria, E.; Lopez-Jorge, C. E.; Ferrandiz, N.; Blanco, R.; Alvarez, S.; Vaque, J. P.; Bretones, G.; Caraballo, J. M.; Sanchez-Bailon, P.; Delgado, M. D.; Martin-Perez, J.; Cigudosa, J. C.; Leon, J.			MYC antagonizes the differentiation induced by imatinib in chronic myeloid leukemia cells through downregulation of p27(KIP1)	ONCOGENE			English	Article						Myc; imatinib; dasatinib; p27; chronic myeloid leukemia; differentiation	DEPENDENT KINASE INHIBITOR; BCR-ABL; C-MYC; ERYTHROID-DIFFERENTIATION; DEGRADATION; P27; EXPRESSION; MECHANISMS; SKP2; ASSOCIATION	Chronic myeloid leukemia (CML) progresses from a chronic to a blastic phase where the leukemic cells are proliferative and undifferentiated. The CML is nowadays successfully treated with BCR-ABL kinase inhibitors as imatinib and dasatinib. In the CML-derived K562 cell line, low concentrations of imatinib induce proliferative arrest and erythroid differentiation. We found that imatinib upregulated the cell cycle inhibitor p27(KIP1) (p27) in a time- and -concentration dependent manner, and that the extent of imatinib-mediated differentiation was severely decreased in cells with depleted p27. MYC (c-Myc) is a transcription factor frequently deregulated in human cancer. MYC is overexpressed in untreated CML and is associated to poor response to imatinib. Using K562 sublines with conditional MYC expression (induced by Zn2+ or activated by 4-hydroxy-tamoxifen) we show that MYC prevented the erythroid differentiation induced by imatinib and dasatinib. The differentiation inhibition is not due to increased proliferation of MYC-expressing clones or enhanced apoptosis of differentiated cells. As p27 overexpression is reported to induce erythroid differentiation in K562, we explored the effect of MYC on imatinib-dependent induction of p27. We show that MYC abrogated the imatinib-induced upregulation of p27 concomitantly with the differentiation inhibition, suggesting that MYC inhibits differentiation by antagonizing the imatinib-mediated upregulation of p27. This effect occurs mainly by p27 protein destabilization. This was in part due to MYC-dependent induction of SKP2, a component of the ubiquitin ligase complex that targets p27 for degradation. The results suggest that, although MYC deregulation does not directly confer resistance to imatinib, it might be a factor that contributes to progression of CML through the inhibition of differentiation. Oncogene (2013) 32, 2239-2246; doi:10.1038/onc.2012.246; published online 18 June 2012	[Gomez-Casares, M. T.; Lopez-Jorge, C. E.] Hosp Univ Dr Negrin, Serv Hematol, Las Palmas Gran Canaria, Spain; [Gomez-Casares, M. T.; Lopez-Jorge, C. E.] Hosp Univ Dr Negrin, Unidad Invest, Las Palmas Gran Canaria, Spain; [Garcia-Alegria, E.; Ferrandiz, N.; Blanco, R.; Vaque, J. P.; Bretones, G.; Caraballo, J. M.; Delgado, M. D.; Leon, J.] Univ Cantabria CSIC SODERCAN, Inst Biomed & Biotecnol Cantabria IBBTEC, Grp Transcript Control & Canc, Dept Biol Mol,Fac Med, Santander 39011, Cantabria, Spain; [Alvarez, S.; Cigudosa, J. C.] CNIO, Human Canc Genet Program, Madrid, Spain; [Sanchez-Bailon, P.; Martin-Perez, J.] CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Centro Nacional de Investigaciones Oncologicas (CNIO); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Leon, J (corresponding author), Univ Cantabria CSIC SODERCAN, Inst Biomed & Biotecnol Cantabria IBBTEC, Grp Transcript Control & Canc, Dept Biol Mol,Fac Med, Avda Cardenal Herrera Oria S-N, Santander 39011, Cantabria, Spain.	leonj@unican.es	Cigudosa, Juan C/E-4105-2016; CASARES, MARIA TERESA GOMEZ/R-6060-2018; Ferrandiz-Diaz, Nuria/V-4071-2017; Vaqué, José P/H-8413-2015; Bretones, Gabriel/AAB-4637-2021; ALEGRIA, EVA GARCIA/O-3498-2018; Leon, Javier/K-4615-2014; Martin-Perez, Jorge/A-3522-2008; Delgado, M. Dolores/K-9056-2014	CASARES, MARIA TERESA GOMEZ/0000-0003-0505-5126; Ferrandiz-Diaz, Nuria/0000-0002-7410-3470; Vaqué, José P/0000-0002-3913-2495; Bretones, Gabriel/0000-0002-1521-5544; ALEGRIA, EVA GARCIA/0000-0003-4159-0206; Martin-Perez, Jorge/0000-0002-2292-0057; Leon, Javier/0000-0001-5803-0112; Delgado, M. Dolores/0000-0003-4682-4040	Fundacion Mutua Madrilena;  [SAF11-23796];  [ISCIII-RETIC RD06/0020/0017];  [FIS 11/00397];  [SAF09-09254];  [FIS08-0878];  [FIS08-0440]	Fundacion Mutua Madrilena(Instituto de Salud Carlos III); ; ; ; ; ; 	We thank Pilar Frade, Maria Aramburu and Guillermo Santana for technical assistance, Robert Eisenman, Theodore Lee and Robert Sclafani for constructs, and M Teresa Molero and Carlos Richard for useful comments on the manuscript. Funding for this work was provided by grants SAF11-23796 and ISCIII-RETIC RD06/0020/0017 to JL, FIS 11/00397 to MDD, SAF09-09254 and Fundacion Mutua Madrilena to JMP, FIS08-0878 to SA and FIS08-0440 to JCC.	Acosta JC, 2008, MOL CELL BIOL, V28, P7286, DOI 10.1128/MCB.00752-08; Agarwal A, 2008, BLOOD, V112, P1960, DOI 10.1182/blood-2007-09-113860; Albajar M, 2008, CANCER LETT, V270, P328, DOI 10.1016/j.canlet.2008.05.024; Albajar M, 2011, MOL CANCER RES, V9, P564, DOI 10.1158/1541-7786.MCR-10-0356; Andreu EJ, 2005, CANCER RES, V65, P3264, DOI 10.1158/0008-5472.CAN-04-1357; Bretones G, 2011, J BIOL CHEM, V286, P9815, DOI 10.1074/jbc.M110.165977; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen JY, 2009, LEUKEMIA RES, V33, P1520, DOI 10.1016/j.leukres.2009.03.007; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; DELGADO MD, 1995, ONCOGENE, V10, P1659; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; Gesbert F, 2000, J BIOL CHEM, V275, P39223, DOI 10.1074/jbc.M007291200; Gomez-Casares MT, 2004, HAEMATOLOGICA, V89, P241; GOMEZCASARES MT, 1993, LEUKEMIA, V7, P1824; Hsieh FF, 2000, BLOOD, V96, P2746, DOI 10.1182/blood.V96.8.2746.h8002746_2746_2754; Jonuleit T, 2000, BLOOD, V96, P1933, DOI 10.1182/blood.V96.5.1933.h8001933_1933_1939; Kantarjian HM, 2011, CLIN CANCER RES, V17, P1674, DOI 10.1158/1078-0432.CCR-10-2922; Kavalerchik E, 2008, J CLIN ONCOL, V26, P2911, DOI 10.1200/JCO.2008.17.5745; Kossatz U, 2004, GENE DEV, V18, P2602, DOI 10.1101/gad.321004; Lee TC, 1999, J BIOL CHEM, V274, P595, DOI 10.1074/jbc.274.2.595; Leon J, 2009, CELL CYCLE, V8, P1148, DOI 10.4161/cc.8.8.8126; Lerga A, 1999, CELL GROWTH DIFFER, V10, P639; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Munoz-Alonso MJ, 2005, J BIOL CHEM, V280, P18120, DOI 10.1074/jbc.M500758200; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; O'Dwyer ME, 2002, ANNU REV MED, V53, P369, DOI 10.1146/annurev.med.53.082901.103853; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; ROWLEY PT, 1981, EXP HEMATOL, V9, P32; Roy S, 2008, CELL CYCLE, V7, P1828, DOI 10.4161/cc.7.12.6024; Rubbi L, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001314; Savona M, 2008, NAT REV CANCER, V8, P341, DOI 10.1038/nrc2368; Schenone S, 2010, EXPERT OPIN INV DRUG, V19, P931, DOI 10.1517/13543784.2010.499898; Shah NP, 2008, CANCER CELL, V14, P485, DOI 10.1016/j.ccr.2008.11.001; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Wu J, 2008, J NATL CANCER I, V100, P926, DOI 10.1093/jnci/djn188	47	47	48	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2013	32	17					2239	2246		10.1038/onc.2012.246	http://dx.doi.org/10.1038/onc.2012.246			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	132JD	22710719				2022-12-25	WOS:000318062800013
J	Makkinje, A; Vanden Borre, P; Near, RI; Patel, PS; Lerner, A				Makkinje, Anthony; Vanden Borre, Pierre; Near, Richard I.; Patel, Prayag S.; Lerner, Adam			Breast Cancer Anti-estrogen Resistance 3 (BCAR3) Protein Augments Binding of the c-Src SH3 Domain to Crk-associated Substrate (p130(cas))	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; GDP EXCHANGE FACTOR; CAS FAMILY-MEMBERS; CYCLIN D1 PROMOTER; CELL-MIGRATION; TYROSINE PHOSPHORYLATION; ADAPTER PROTEIN; TRANSFORMED CELLS; DEPENDENT MANNER; V-SRC	The focal adhesion adapter protein p130(cas) regulates adhesion and growth factor-related signaling, in part through Src-mediated tyrosine phosphorylation of p130(cas). AND-34/BCAR3, one of three NSP family members, binds the p130(cas) carboxyl terminus, adjacent to a bipartite p130(cas) Src-binding domain (SBD) and induces anti-estrogen resistance in breast cancer cell lines as well as phosphorylation of p130(cas). Only a subset of the signaling properties of BCAR3, specifically augmented motility, are dependent upon formation of the BCAR3-p130(cas) complex. Using GST pull-down and immunoprecipitation studies, we show that among NSP family members, only BCAR3 augments the ability of p130(cas) to bind the Src SH3 domain through an RPLPSPP motif in the p130(cas) SBD. Although our prior work identified phosphorylation of the serine within the p130(cas) RPLPSPP motif, mutation of this residue to alanine or glutamic acid did not alter BCAR3-induced Src SH3 domain binding to p130(cas). The ability of BCAR3 to augment Src SH3 binding requires formation of a BCAR3-p130(cas) complex because mutations that reduce association between these two proteins block augmentation of Src SH3 domain binding. Similarly, in MCF-7 cells, BCAR3-induced tyrosine phosphorylation of the p130(cas) substrate domain, previously shown to be Src-dependent, was reduced by an R743A mutation that blocks BCAR3 association with p130(cas). Immunofluorescence studies demonstrate that BCAR3 expression alters the intracellular location of both p130(cas) and Src and that all three proteins co-localize. Our work suggests that BCAR3 expression may regulate Src signaling in a BCAR3-p130(cas) complex-dependent fashion by altering the ability of the Src SH3 domain to bind the p130(cas) SBD.	[Lerner, Adam] Boston Univ, Hematol Oncol Sect, Dept Med, Sch Med,Boston Med Ctr, Boston, MA 02118 USA; [Lerner, Adam] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA	Boston Medical Center; Boston University; Boston University	Lerner, A (corresponding author), Boston Univ, Hematol Oncol Sect, Dept Med, Sch Med,Boston Med Ctr, EBRC 420,650 Albany St, Boston, MA 02118 USA.	lernwara@bu.edu		Near, Richard/0000-0003-3307-9619	National Institutes of Health, NCI [R01 CA114094]; Logica Foundation; Breast Cancer Alliance; NATIONAL CANCER INSTITUTE [R01CA114094] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Logica Foundation; Breast Cancer Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant R01 CA114094. This work was also supported by the Logica Foundation and the Breast Cancer Alliance.	Alexandropoulos K, 1996, GENE DEV, V10, P1341, DOI 10.1101/gad.10.11.1341; Borre PV, 2011, CELL SIGNAL, V23, P1030, DOI 10.1016/j.cellsig.2011.01.018; Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Brabek J, 2004, ONCOGENE, V23, P7406, DOI 10.1038/sj.onc.1207965; Brinkman A, 2000, JNCI-J NATL CANCER I, V92, P112, DOI 10.1093/jnci/92.2.112; Burnham MR, 2000, MOL CELL BIOL, V20, P5865, DOI 10.1128/MCB.20.16.5865-5878.2000; Burnham MR, 1999, MOL CARCINOGEN, V26, P20, DOI 10.1002/(SICI)1098-2744(199909)26:1<20::AID-MC3>3.0.CO;2-M; Cai DP, 1999, J IMMUNOL, V163, P2104; Cai DP, 2003, CANCER RES, V63, P6802; Cai DP, 2003, J IMMUNOL, V170, P969, DOI 10.4049/jimmunol.170.2.969; CHEADLE C, 1994, J BIOL CHEM, V269, P24034; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Dodelet VC, 1999, J BIOL CHEM, V274, P31941, DOI 10.1074/jbc.274.45.31941; Felekkis KN, 2005, MOL CANCER RES, V3, P32; Felekkis K, 2006, METHOD ENZYMOL, V407, P55, DOI 10.1016/S0076-6879(05)07006-0; Garron ML, 2009, J MOL BIOL, V386, P190, DOI 10.1016/j.jmb.2008.12.010; Gotoh T, 2000, J BIOL CHEM, V275, P30118, DOI 10.1074/jbc.M003074200; Harte MT, 1996, J BIOL CHEM, V271, P13649, DOI 10.1074/jbc.271.23.13649; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Huang JH, 2002, J BIOL CHEM, V277, P27265, DOI 10.1074/jbc.M203063200; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Lu YM, 1999, J BIOL CHEM, V274, P10047, DOI 10.1074/jbc.274.15.10047; Mace PD, 2011, NAT STRUCT MOL BIOL, V18, P1381, DOI 10.1038/nsmb.2152; Makkinje A, 2009, CELL SIGNAL, V21, P1423, DOI 10.1016/j.cellsig.2009.05.006; Nakamoto T, 1997, MOL CELL BIOL, V17, P3884, DOI 10.1128/MCB.17.7.3884; Nakamoto T, 1996, J BIOL CHEM, V271, P8959, DOI 10.1074/jbc.271.15.8959; Near RI, 2007, J CELL PHYSIOL, V212, P655, DOI 10.1002/jcp.21059; Near RI, 2009, MOL VIS, V15, P685; POLTE TR, 1995, P NATL ACAD SCI USA, V92, P10678, DOI 10.1073/pnas.92.23.10678; Riggins RB, 2003, J BIOL CHEM, V278, P28264, DOI 10.1074/jbc.M303535200; Ruest PJ, 2001, MOL CELL BIOL, V21, P7641, DOI 10.1128/MCB.21.22.7641-7652.2001; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Sakakibara A, 2000, J BIOL CHEM, V275, P6404, DOI 10.1074/jbc.275.9.6404; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schrecengost RS, 2007, CANCER RES, V67, P6174, DOI 10.1158/0008-5472.CAN-06-3455; Schuh NR, 2010, J BIOL CHEM, V285, P2309, DOI 10.1074/jbc.M109.046631; van Agthoven T, 1998, EMBO J, V17, P2799, DOI 10.1093/emboj/17.10.2799; Zhao ZS, 2000, MOL CELL BIOL, V20, P3906, DOI 10.1128/MCB.20.11.3906-3917.2000	40	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27703	27714		10.1074/jbc.M112.389981	http://dx.doi.org/10.1074/jbc.M112.389981			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22711540	hybrid, Green Published			2022-12-25	WOS:000307840700044
J	Gallo, A; Lo Sterzo, C; Mori, M; Di Matteo, A; Bertini, I; Banci, L; Brunori, M; Federici, L				Gallo, Angelo; Lo Sterzo, Carlo; Mori, Mirko; Di Matteo, Adele; Bertini, Ivano; Banci, Lucia; Brunori, Maurizio; Federici, Luca			Structure of Nucleophosmin DNA-binding Domain and Analysis of Its Complex with a G-quadruplex Sequence from the c-MYC Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR STRUCTURE DETERMINATION; AUTOMATED NOE ASSIGNMENT; BACKBONE DYNAMICS; DENATURED STATE; SMALL-MOLECULE; PROTEIN; IDENTIFICATION; RNA; PHOSPHORYLATION; RECOGNITION	Nucleophosmin (NPM1) is a nucleocytoplasmic shuttling protein, mainly localized at nucleoli, that plays a key role in several cellular functions, including ribosome maturation and export, centrosome duplication, and response to stress stimuli. More than 50 mutations at the terminal exon of the NPM1 gene have been identified so far in acute myeloid leukemia; the mutated proteins are aberrantly and stably localized in the cytoplasm due to high destabilization of the NPM1 C-terminal domain and the appearance of a new nuclear export signal. We have shown previously that the 70-residue NPM1 C-terminal domain (NPM1-C70) is able to bind with high affinity a specific region at the c-MYC gene promoter characterized by parallel G-quadruplex structure. Here we present the solution structure of the NPM1-C70 domain and NMR analysis of its interaction with a c-MYC-derived G-quadruplex. These data were used to calculate an experimentally restrained molecular docking model for the complex. The NPM1-C70 terminal three-helix bundle binds the G-quadruplex DNA at the interface between helices H1 and H2 through electrostatic interactions with the G-quadruplex phosphate backbone. Furthermore, we show that the 17-residue lysine-rich sequence at the N terminus of the three-helix bundle is disordered and, although necessary, does not participate directly in the contact surface in the complex.	[Gallo, Angelo; Mori, Mirko; Bertini, Ivano; Banci, Lucia] Univ Florence, Magnet Resonance Ctr, Dept Chem, I-50019 Sesto Fiorentino, Italy; [Lo Sterzo, Carlo; Di Matteo, Adele; Brunori, Maurizio] Univ Roma La Sapienza, Inst Biol & Mol Pathol, I-00185 Rome, Italy; [Lo Sterzo, Carlo; Di Matteo, Adele; Brunori, Maurizio] Univ Roma La Sapienza, Natl Res Council, Dept Biochem Sci A Rossi Fanelli, I-00185 Rome, Italy; [Federici, Luca] Univ G dAnnunzio, Dept Biomed Sci, I-66013 Chieti, Italy; [Federici, Luca] Univ G dAnnunzio, Ctr Excellence Aging, I-66013 Chieti, Italy	University of Florence; Sapienza University Rome; Sapienza University Rome; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Banci, L (corresponding author), Univ Florence, Magnet Resonance Ctr, Dept Chem, Via Sacconi 6, I-50019 Sesto Fiorentino, Italy.	banci@cerm.unifi.it; maurizio.brunori@uniroma1.it	Di Matteo, Adele/AAC-8338-2019; Gallo, Angelo/N-3781-2017	Di Matteo, Adele/0000-0002-5921-7365; Gallo, Angelo/0000-0001-9778-4822; BANCI, LUCIA/0000-0003-0562-5774; Brunori, Maurizio/0000-0002-7795-1635	Associazione Italiana Ricerca sul Cancro [IG2007-4798, IG2011-11712]; Ministero dell'Istruzione, Universita e Ricerca of Italy [RBRN07BMCT_007, RBRN07BMCT, PRIN2009FAKHZT_001]; WeNMR project (European FP7 e-Infrastructure grant) [261572]; national GRID Initiatives of Belgium, Italy, Germany, the Netherlands (via the Dutch BiG Grid project), Portugal, UK, South Africa, Taiwan; Latin America GRID infrastructure via the Gisela project	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione, Universita e Ricerca of Italy; WeNMR project (European FP7 e-Infrastructure grant); national GRID Initiatives of Belgium, Italy, Germany, the Netherlands (via the Dutch BiG Grid project), Portugal, UK, South Africa, Taiwan; Latin America GRID infrastructure via the Gisela project	This work was supported by Associazione Italiana Ricerca sul Cancro Grants IG2007-4798 (to M.B.) and IG2011-11712 (to L.F.) and by Ministero dell'Istruzione, Universita e Ricerca of Italy Grants RBRN07BMCT_007 (to M.B.), RBRN07BMCT (to L.B. and I.B.), and PRIN2009FAKHZT_001 (to L.B. and I.B.).; We sincerely thank Prof. Brunangelo Falini (University of Perugia, Italy) for the introduction to nucleophosmin and precious collaboration. The WeNMR project (European FP7 e-Infrastructure grant, Contract Number 261572, supported by the national GRID Initiatives of Belgium, Italy, Germany, the Netherlands (via the Dutch BiG Grid project), Portugal, UK, South Africa, Taiwan, and the Latin America GRID infrastructure via the Gisela project) is acknowledged for the use of web portals and computing and storage facilities.	BECKMANN R, 1992, EUR J BIOCHEM, V210, P45, DOI 10.1111/j.1432-1033.1992.tb17388.x; Bertini I, 2011, BIOINFORMATICS, V27, P2384, DOI 10.1093/bioinformatics/btr415; Brown RV, 2011, J BIOL CHEM, V286, P41018, DOI 10.1074/jbc.M111.274720; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Case D.A., 2022, AMBER 2020; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P71, DOI 10.1007/s10858-005-5705-1; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2011, BLOOD REV, V25, P247, DOI 10.1016/j.blre.2011.06.001; Falini B, 2009, CURR OPIN ONCOL, V21, P573, DOI 10.1097/CCO.0b013e3283313dfa; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Federici L, 2010, J BIOL CHEM, V285, P37138, DOI 10.1074/jbc.M110.166736; Gonzalez V, 2010, ANNU REV PHARMACOL, V50, P111, DOI 10.1146/annurev.pharmtox.48.113006.094649; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; Grand CL, 2002, MOL CANCER THER, V1, P565; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Grummitt Charles G, 2008, J Biol Chem, V283, P23326, DOI 10.1074/jbc.M801706200; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Guo X, 2012, BIOCOMPUT-PAC SYM, P104; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; Horvath MP, 2001, J MOL BIOL, V310, P367, DOI 10.1006/jmbi.2001.4766; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2008, CHEM SOC REV, V37, P1375, DOI 10.1039/b702491f; Keller R., 2004, COMPUTER AIDED RESON, V1; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lindstrom MS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/195209; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Neidle S, 2009, CURR OPIN STRUC BIOL, V19, P239, DOI 10.1016/j.sbi.2009.04.001; Okuwaki M, 2002, MOL BIOL CELL, V13, P2016, DOI 10.1091/mbc.02-03-0036; OREKHOV VY, 1994, EUR J BIOCHEM, V219, P887, DOI 10.1111/j.1432-1033.1994.tb18570.x; PADMANABHAN K, 1993, J BIOL CHEM, V268, P17651; Palaniswamy V, 2006, NAT STRUCT MOL BIOL, V13, P429, DOI 10.1038/nsmb1080; Phan AT, 2005, NAT CHEM BIOL, V1, P167, DOI 10.1038/nchembio723; Qin Y, 2008, BIOCHIMIE, V90, P1149, DOI 10.1016/j.biochi.2008.02.020; Scaloni F, 2010, P NATL ACAD SCI USA, V107, P5447, DOI 10.1073/pnas.0910516107; Scaloni F, 2009, FASEB J, V23, P2360, DOI 10.1096/fj.08-128306; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; Shandilya J, 2009, MOL CELL BIOL, V29, P5115, DOI 10.1128/MCB.01969-08; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sissi C, 2011, BIOCHIMIE, V93, P1219, DOI 10.1016/j.biochi.2011.04.018; Thakur RK, 2009, NUCLEIC ACIDS RES, V37, P172, DOI 10.1093/nar/gkn919; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wulff JE, 2007, J AM CHEM SOC, V129, P14444, DOI 10.1021/ja075327f; Xu Y, 2007, J BIOL CHEM, V282, P15981, DOI 10.1074/jbc.M608979200; Zor T, 2002, J BIOL CHEM, V277, P42241, DOI 10.1074/jbc.M207361200; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	53	44	46	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26539	26548		10.1074/jbc.M112.371013	http://dx.doi.org/10.1074/jbc.M112.371013			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707729	hybrid, Green Published			2022-12-25	WOS:000307386000007
J	Zhou, B; Arnett, DR; Yu, X; Brewster, A; Sowd, GA; Xie, CL; Vila, S; Gai, DH; Fanning, E; Chen, XJS				Zhou, Bo; Arnett, Diana R.; Yu, Xian; Brewster, Aaron; Sowd, Gregory A.; Xie, Charlies L.; Vila, Stefan; Gai, Dahai; Fanning, Ellen; Chen, Xiaojiang S.			Structural Basis for the Interaction of a Hexameric Replicative Helicase with the Regulatory Subunit of Human DNA Polymerase alpha-Primase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE T-ANTIGEN; LARGE TUMOR-ANTIGEN; C-TERMINAL DOMAIN; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PROTEIN-A; B-SUBUNIT; IN-VITRO; FUNCTIONAL INTERACTIONS; MOLECULAR ARCHITECTURE	DNApolymerase alpha-primase (Pol-prim) plays an essential role in eukaryotic DNA replication, initiating synthesis of the leading strand and of each Okazaki fragment on the lagging strand. Pol-prim is composed of a primase heterodimer that synthesizes an RNA primer, a DNA polymerase subunit that extends the primer, and a regulatory B-subunit (p68) without apparent enzymatic activity. Pol-prim is thought to interact with eukaryotic replicative helicases, forming a dynamic multiprotein assembly that displays primosome activity. At least three subunits of Pol-prim interact physically with the hexameric replicative helicase SV40 large T antigen, constituting a simple primosome that is active in vitro. However, structural understanding of these interactions and their role in viral chromatin replication in vivo remains incomplete. Here, we report the detailed largeTantigen-p68 interface, as revealed in a co-crystal structure and validated by site-directed mutagenesis, and we demonstrate its functional importance in activating the SV40 primosome in cell-free reactions with purified Pol-prim, as well as in monkey cells in vivo.	[Fanning, Ellen] Vanderbilt Univ, Dept Biol Sci, VU Stn B 1634, Nashville, TN 37232 USA; [Zhou, Bo; Yu, Xian; Brewster, Aaron; Vila, Stefan; Gai, Dahai; Chen, Xiaojiang S.] Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA; [Brewster, Aaron] Univ Calif Berkeley, Dept Biol Sci, Berkeley, CA 94720 USA; [Fanning, Ellen] Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA	Vanderbilt University; University of Southern California; University of California System; University of California Berkeley; Vanderbilt University	Fanning, E (corresponding author), Vanderbilt Univ, Dept Biol Sci, VU Stn B 1634, 2325 Stevenson Ctr,1161 21st Ave S, Nashville, TN 37232 USA.	ellen.fanning@vanderbilt.edu; xiaojiang.chen@usc.edu			National Institutes of Health [GM080338, AI055926, GM52948, T32-AI089554, P30 CA068485]; University of Southern California Wang Cancer Research Fellowship; Wise Fellowship; Vanderbilt Beckman Scholar Program; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055926, T32AI089554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052948, R01GM080338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Southern California Wang Cancer Research Fellowship; Wise Fellowship; Vanderbilt Beckman Scholar Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM080338 and AI055926 (to X. S. C.) and GM52948 (to E. F.).; Recipient of a University of Southern California Wang Cancer Research Fellowship and a Wise Fellowship.; Supported in part by National Institutes of Health Grant T32-AI089554.; Supported in part by the Vanderbilt Beckman Scholar Program.; We thank the staff at Advanced Light Source Beamlines 8.3.1, 8.2.1, and 5.0.2, the Lawrence Berkeley Laboratory, and the staff at beamline 23-IDD, Argonne National Laboratory, for assistance in data collection. We thank the Biophysics Core Laboratory, University of Southern California, for their support; W. J. Chazin for a p68N expression vector and discussions; J. M. Pipas for thoughtful contributions and support for this study; J. Hurwitz and V. Bermudez for p58-FLAG baculovirus; E. Kremmer for anti-p48 antibody, and U. Dadwal for assistance with mutagenesis. We also thank Dr. A. Brunger for giving us access to the pre-release version of the program DEN, designed for refining low resolution structures. The Vanderbilt-Ingram Cancer Center, Vanderbilt University, was the recipient of National Institutes of Health Grant P30 CA068485.	Agarkar VB, 2011, CELL CYCLE, V10, P926, DOI 10.4161/cc.10.6.15010; Arunkumar AI, 2005, NAT STRUCT MOL BIOL, V12, P332, DOI 10.1038/nsmb916; Ataide SF, 2011, SCIENCE, V331, P881, DOI 10.1126/science.1196473; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; BRAITHWAITE AW, 1987, NATURE, V329, P458, DOI 10.1038/329458a0; Brunger AT, 2012, ACTA CRYSTALLOGR D, V68, P391, DOI [10.1107/S090744491104978X, 10.1107/S09074449104978X]; COLLINS KL, 1991, MOL CELL BIOL, V11, P2108, DOI 10.1128/MCB.11.4.2108; COLLINS KL, 1993, EMBO J, V12, P4555, DOI 10.1002/j.1460-2075.1993.tb06144.x; Copeland WC, 1997, PROTEIN EXPRES PURIF, V9, P1, DOI 10.1006/prep.1996.0665; COPELAND WC, 1993, J BIOL CHEM, V268, P26179; Corn JE, 2008, NAT STRUCT MOL BIOL, V15, P163, DOI 10.1038/nsmb.1373; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Costa A, 2009, CRIT REV BIOCHEM MOL, V44, P326, DOI 10.1080/10409230903186012; Cuesta I, 2010, J MOL BIOL, V397, P1276, DOI 10.1016/j.jmb.2010.02.042; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P16, DOI 10.1073/pnas.84.1.16; DORNREITER I, 1990, EMBO J, V9, P3329, DOI 10.1002/j.1460-2075.1990.tb07533.x; DORNREITER I, 1993, MOL CELL BIOL, V13, P809, DOI 10.1128/MCB.13.2.809; Duderstadt KE, 2008, CRIT REV BIOCHEM MOL, V43, P163, DOI [10.1080/10409230802058296, 10.1080/10409230802058296 ]; Eichinger CS, 2009, J BIOL CHEM, V284, P30604, DOI 10.1074/jbc.M109.024760; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; FANNING E, 1982, EMBO J, V1, P1023, DOI 10.1002/j.1460-2075.1982.tb01290.x; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; FOIANI M, 1995, MOL CELL BIOL, V15, P883; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; GANNON JV, 1987, NATURE, V329, P456, DOI 10.1038/329456a0; Graham BW, 2011, NUCLEIC ACIDS RES, V39, P6585, DOI 10.1093/nar/gkr345; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Grossi S, 2004, GENE DEV, V18, P992, DOI 10.1101/gad.300004; GURNEY EG, 1986, J VIROL, V57, P1168, DOI 10.1128/JVI.57.3.1168-1172.1986; Hamdan SM, 2010, J BIOL CHEM, V285, P18979, DOI 10.1074/jbc.R109.022939; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Huang H, 2010, J BIOL CHEM, V285, P33475, DOI 10.1074/jbc.M110.156240; Huang H, 2010, J BIOL CHEM, V285, P17112, DOI 10.1074/jbc.M110.116830; Huang SG, 1998, BIOCHEMISTRY-US, V37, P15345, DOI 10.1021/bi9810959; ISHIMI Y, 1992, J BIOL CHEM, V267, P462; Jezewska MJ, 1998, BIOCHEMISTRY-US, V37, P3116, DOI 10.1021/bi972564u; Jiang XH, 2006, EMBO J, V25, P5516, DOI 10.1038/sj.emboj.7601432; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Langston LD, 2009, CELL CYCLE, V8, P2686, DOI 10.4161/cc.8.17.9390; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Lilyestrom W, 2006, GENE DEV, V20, P2373, DOI 10.1101/gad.1456306; Marceau AH, 2011, EMBO J, V30, P4236, DOI 10.1038/emboj.2011.305; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; MATSUMOTO T, 1990, P NATL ACAD SCI USA, V87, P9712, DOI 10.1073/pnas.87.24.9712; McClain B, 2010, J MOL BIOL, V397, P587, DOI 10.1016/j.jmb.2010.01.055; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; MELENDY T, 1993, J BIOL CHEM, V268, P3389; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; Mizuno T, 1998, MOL CELL BIOL, V18, P3552, DOI 10.1128/MCB.18.6.3552; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; MURAKAMI Y, 1993, J BIOL CHEM, V268, P11008; Nunez-Ramirez R, 2011, NUCLEIC ACIDS RES, V39, P8187, DOI 10.1093/nar/gkr534; Ott RD, 2002, J VIROL, V76, P5121, DOI 10.1128/JVI.76.10.5121-5130.2002; Ott RD, 2002, MOL CELL BIOL, V22, P5669, DOI 10.1128/MCB.22.16.5669-5678.2002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel SS, 2011, CURR OPIN CHEM BIOL, V15, P595, DOI 10.1016/j.cbpa.2011.08.003; Rothenberg E, 2007, J BIOL CHEM, V282, P34229, DOI 10.1074/jbc.M706300200; Sanchez-Berrondo J, 2012, NUCLEIC ACIDS RES, V40, P1366, DOI 10.1093/nar/gkr831; Sauguet L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010083; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Simpson AA, 1998, STRUCT FOLD DES, V6, P1355, DOI 10.1016/S0969-2126(98)00136-1; Stauffer ME, 2004, J BIOL CHEM, V279, P30915, DOI 10.1074/jbc.R400015200; Stewart L, 1999, METH MOL B, V94, P223; TANAKA S, 1982, J BIOL CHEM, V257, P8386; Vaithiyalingam S, 2010, P NATL ACAD SCI USA, V107, P13684, DOI 10.1073/pnas.1002009107; Voitenleitner C, 1999, MOL CELL BIOL, V19, P646; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356; Weisshart K, 2000, J BIOL CHEM, V275, P17328, DOI 10.1074/jbc.M000717200; YANG L, 1987, P NATL ACAD SCI USA, V84, P950, DOI 10.1073/pnas.84.4.950; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189; Zerbe LK, 2002, BIOCHEMISTRY-US, V41, P4891, DOI 10.1021/bi016030b; Zhao X, 2008, J VIROL, V82, P5316, DOI 10.1128/JVI.02677-07	80	26	26	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26854	26866		10.1074/jbc.M112.363655	http://dx.doi.org/10.1074/jbc.M112.363655			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700977	Green Published, hybrid			2022-12-25	WOS:000307386000034
J	Ido, K; Kakiuchi, S; Uno, C; Nishimura, T; Fukao, Y; Noguchi, T; Sato, F; Ifuku, K				Ido, Kunio; Kakiuchi, Shusuke; Uno, Chihiro; Nishimura, Taishi; Fukao, Yoichiro; Noguchi, Takumi; Sato, Fumihiko; Ifuku, Kentaro			The Conserved His-144 in the PsbP Protein Is Important for the Interaction between the PsbP N-terminus and the Cyt b(559) Subunit of Photosystem II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRINSIC 23-KDA PROTEIN; WATER OXIDIZING COMPLEX; OXYGEN-EVOLVING COMPLEX; 33 KDA PROTEIN; MANGANESE BINDING; CRYSTAL-STRUCTURE; RESOLUTION; ASSEMBLY/STABILITY; PHOTOAUTOTROPHY; CRYSTALLIZATION	The PsbP protein regulates the binding properties of Ca2+ and Cl-, and stabilizes the Mn cluster of photosystem II (PSII); however, the binding site and topology in PSII have yet to be clarified. Here we report that the structure around His-144 and Asp-165 in PsbP, which is suggested to be a metal binding site, has a crucial role for the functional interaction between PsbP and PSII. The mutated PsbP-H144A protein exhibits reduced ability to retain Cl- anions in PSII, whereas the D165V mutation does not affect PsbP function. Interestingly, H144A/D165V double mutation suppresses the effect of H144A mutation, suggesting that these residues have a role other than metal binding. FTIR difference spectroscopy suggests that H144A/D165V restores proper interaction with PSII and induces the conformational change around the Mn cluster during the S-1/S-2 transition. Cross-linking experiments show that the H144A mutation affects the direct interaction between PsbP and the Cyt b(559) alpha subunit of PSII (the PsbE protein). However, this interaction is restored in the H144A/D165V mutant. In the PsbP structure, His-144 and Asp-165 form a salt bridge. H144A mutation is likely to disrupt this bridge and liberate Asp-165, inhibiting the proper PsbP-PSII interaction. Finally, mass spectrometric analysis has identified the cross-linked sites of PsbP and PsbE as Ala-1 and Glu-57, respectively. Therefore His-144, in the C-terminal domain of PsbP, plays a crucial role in maintaining proper N terminus interaction. These data provide important information about the binding characteristics of PsbP in green plant PSII.	[Ido, Kunio; Kakiuchi, Shusuke; Sato, Fumihiko; Ifuku, Kentaro] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; [Uno, Chihiro; Noguchi, Takumi] Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648602, Japan; [Nishimura, Taishi; Sato, Fumihiko] Kyoto Univ, Fac Agr, Sakyo Ku, Kyoto 6068502, Japan; [Fukao, Yoichiro] Nara Inst Sci & Technol, Plant Global Educ Project, Ikoma 6300192, Japan; [Ifuku, Kentaro] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kyoto University; Nagoya University; Kyoto University; Nara Institute of Science & Technology; Japan Science & Technology Agency (JST)	Ifuku, K (corresponding author), Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan.	ifuku@kais.kyoto-u.ac.jp	Noguchi, Takumi/I-7105-2014; Fukao, Yoichiro/E-7137-2013; Ifuku, Kentaro/H-2455-2013; Sato, Fumihiko/C-1078-2011	Sato, Fumihiko/0000-0001-9497-4452; Ifuku, Kentaro/0000-0003-0241-8008	JST PRESTO; JSPS [18770032]; Grants-in-Aid for Scientific Research [23657099] Funding Source: KAKEN	JST PRESTO(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the grant from JST PRESTO (to K. I.) and by Grant-in-Aid for Young Scientists (B) from JSPS (Grant No. 18770032, to K. I.).	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BERNIER M, 1995, FEBS LETT, V360, P251, DOI 10.1016/0014-5793(95)00101-E; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Bondarava N, 2005, BBA-BIOENERGETICS, V1708, P63, DOI 10.1016/j.bbabio.2005.01.005; Bondarava N, 2003, J BIOL CHEM, V278, P13554, DOI 10.1074/jbc.M212842200; Bondarava N, 2007, BBA-BIOENERGETICS, V1767, P583, DOI 10.1016/j.bbabio.2007.01.001; Bricker TM, 2012, BBA-BIOENERGETICS, V1817, P121, DOI 10.1016/j.bbabio.2011.07.006; Bricker TM, 2011, J PHOTOCH PHOTOBIO B, V104, P165, DOI 10.1016/j.jphotobiol.2011.01.025; Bricker TM, 2005, ADV PHOTO RESPIRAT, V22, P95; DEBUS RJ, 1992, BIOCHIM BIOPHYS ACTA, V1102, P269, DOI 10.1016/0005-2728(92)90133-M; Fagerlund RD, 2011, J PHOTOCH PHOTOBIO B, V104, P191, DOI 10.1016/j.jphotobiol.2011.01.022; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Guskov A, 2010, CHEMPHYSCHEM, V11, P1160, DOI 10.1002/cphc.200900901; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hager M, 2002, J BIOL CHEM, V277, P14031, DOI 10.1074/jbc.M112053200; Ifuku K, 2005, PHOTOSYNTH RES, V84, P251, DOI 10.1007/s11120-004-7160-3; Ifuku K, 2004, EMBO REP, V5, P362, DOI 10.1038/sj.embor.7400113; Ifuku K, 2003, ACTA CRYSTALLOGR D, V59, P1462, DOI 10.1107/S0907444903011004; Ifuku K, 2002, PLANT CELL PHYSIOL, V43, P1244, DOI 10.1093/pcp/pcf136; Ifuku K, 2001, BBA-PROTEIN STRUCT M, V1546, P196, DOI 10.1016/S0167-4838(01)00139-X; Ifuku K, 2011, J PHOTOCH PHOTOBIO B, V104, P158, DOI 10.1016/j.jphotobiol.2011.02.006; Kakiuchi S, 2012, BBA-BIOENERGETICS, V1817, P1346, DOI 10.1016/j.bbabio.2012.01.009; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Kohoutova J, 2009, ACTA CRYSTALLOGR F, V65, P111, DOI 10.1107/S1744309108040578; Liu HJ, 2009, ARCH BIOCHEM BIOPHYS, V489, P34, DOI 10.1016/j.abb.2009.07.014; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Michoux F, 2010, BIOCHEMISTRY-US, V49, P7411, DOI 10.1021/bi1011145; MIYAO M, 1988, BIOCHIM BIOPHYS ACTA, V936, P465, DOI 10.1016/0005-2728(88)90024-2; MIYAO M, 1989, BIOCHIM BIOPHYS ACTA, V977, P315, DOI 10.1016/S0005-2728(89)80086-6; Nagao R, 2010, PLANT CELL PHYSIOL, V51, P718, DOI 10.1093/pcp/pcq042; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Nield J, 2006, BBA-BIOENERGETICS, V1757, P353, DOI 10.1016/j.bbabio.2006.03.019; NOGUCHI T, 1995, BBA-BIOENERGETICS, V1228, P189, DOI 10.1016/0005-2728(94)00171-Z; RASHID A, 1994, FEBS LETT, V350, P296, DOI 10.1016/0014-5793(94)00789-6; RASHID A, 1991, PHOTOSYNTH RES, V30, P123, DOI 10.1007/BF00042010; Renger G, 2008, PHOTOSYNTH RES, V98, P53, DOI 10.1007/s11120-008-9345-7; Rivalta I, 2011, BIOCHEMISTRY-US, V50, P6312, DOI 10.1021/bi200685w; Sato N, 2010, MOL PHYLOGENET EVOL, V56, P176, DOI 10.1016/j.ympev.2009.11.021; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Seidler A, 1996, BBA-BIOENERGETICS, V1277, P35, DOI 10.1016/S0005-2728(96)00102-8; Shen JR, 1998, BIOCHEMISTRY-US, V37, P1551, DOI 10.1021/bi971676i; SHEN JR, 1993, BIOCHEMISTRY-US, V32, P1825, DOI 10.1021/bi00058a017; Suorsa M, 2006, J BIOL CHEM, V281, P145, DOI 10.1074/jbc.M510600200; Thornton LE, 2004, PLANT CELL, V16, P2164, DOI 10.1105/tpc.104.023515; Tohri A, 2004, EUR J BIOCHEM, V271, P962, DOI 10.1111/j.1432-1033.2004.03998.x; Tomita M, 2009, BIOCHEMISTRY-US, V48, P6318, DOI 10.1021/bi9006308; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322; YAMAMOTO Y, 1987, BIOCHIM BIOPHYS ACTA, V893, P579, DOI 10.1016/0005-2728(87)90110-1; Yi XP, 2007, J BIOL CHEM, V282, P24833, DOI 10.1074/jbc.M705011200; Yi XP, 2005, J BIOL CHEM, V280, P16170, DOI 10.1074/jbc.M501550200; Yu H, 2006, BIOCHEMISTRY-US, V45, P3404, DOI 10.1021/bi051604o	52	32	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26377	26387		10.1074/jbc.M112.385286	http://dx.doi.org/10.1074/jbc.M112.385286			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22707728	Green Published, hybrid			2022-12-25	WOS:000306916300063
J	Pepper, DJ; Marais, S; Bhaijee, F; Wilkinson, RJ; De Azevedo, V; Meintjes, G				Pepper, Dominique J.; Marais, Suzaan; Bhaijee, Feriyl; Wilkinson, Robert J.; De Azevedo, Virginia; Meintjes, Graeme			Assessment at Antiretroviral Clinics during TB Treatment Reduces Loss to Follow-Up among HIV-Infected Patients	PLOS ONE			English	Article							CD4 CELL COUNTS; THERAPY; TUBERCULOSIS; INITIATION; OUTCOMES; RATES; START	Setting: A South African township clinic where loss to follow-up during TB treatment may prevent HIV-infected TB patients from receiving life-saving ART. Objective: To determine factors associated with loss to follow-up during TB treatment. Design: Regression analyses of a cohort of ART-eligible TB patients who commenced TB treatment and were followed for 24 weeks. Results: Of 111 ART-eligible TB patients, 15 (14%) died in the ensuing 24 weeks. Of the remaining 96 TB patients, 11 (11%) were lost to follow-up. All TB patients lost to follow-up did not initiate ART. Of 85 TB patients in follow-up, 62 (73%) initiated ART 56 days after TB diagnosis (median, IQR 33-77 days) and 31 days after initial assessment at an ART clinic (median, IQR: 18-55 days). The median duration from TB diagnosis to initial assessment at an ART clinic was 19 days (IQR: 7-48 days). At 24 weeks, 6 of 85 (7%) TB patients who presented to an ART clinic for assessment were lost to follow-up, compared to 5 of 11 (45%) TB patients who did not present to an ART clinic for assessment. Logistic regression analysis (adjusted odds ratio = 0.1, 95% confidence interval [95% CI]: 0.03-0.66) and our Cox proportional hazards model (hazard ratio = 0.2, 95% CI: 0.04-0.68) confirmed that assessment at an ART clinic during TB treatment reduced loss to follow-up. Conclusion: Assessment at antiretroviral clinics for HIV care by trained health-care providers reduces loss to follow-up among HIV-infected patients with TB.	[Pepper, Dominique J.; Marais, Suzaan; Wilkinson, Robert J.; Meintjes, Graeme] Univ Cape Town, Dept Med, Clin Infect Dis Res Initiat, Inst Infect Dis & Mol Med, ZA-7700 Rondebosch, Western Provinc, South Africa; [Pepper, Dominique J.; Bhaijee, Feriyl] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Marais, Suzaan; Wilkinson, Robert J.; Meintjes, Graeme] GF Jooste Hosp, Dept Med, Infect Dis Unit, Cape Town, South Africa; [Wilkinson, Robert J.; Meintjes, Graeme] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England; [De Azevedo, Virginia] City Hlth, Cape Town, South Africa; [Wilkinson, Robert J.] Natl Inst Med Res, MRC, London NW7 1AA, England	University of Cape Town; University of Mississippi; University of Mississippi Medical Center; Imperial College London; MRC National Institute for Medical Research	Pepper, DJ (corresponding author), Univ Cape Town, Dept Med, Clin Infect Dis Res Initiat, Inst Infect Dis & Mol Med, ZA-7700 Rondebosch, Western Provinc, South Africa.	dominiquepepper@gmail.com	Marais, Suzaan/AAG-2750-2019	Marais, Suzaan/0000-0002-8050-9610; Meintjes, Graeme/0000-0003-1196-4414; Wilkinson, Robert/0000-0002-2753-1800	Perinatal HIV Research Unit; US Agency for International Development; President's Emergency Plan for AIDS Relief; Wellcome Trust [WT 081667, 084323, 088316]; Fogarty International Center South Africa [NIH/FIC 1U2RTW007373-01A1, 1U2RTW007370]; European and Developing Countries Clinical Trials Partnership (EDCTP) [IP.07.32080.002]; Medical Research Council of the United Kingdom [U.1175.02.002.00014.01]; Medical Research Council [MC_U117588499] Funding Source: researchfish; MRC [MC_U117588499] Funding Source: UKRI; FOGARTY INTERNATIONAL CENTER [U2RTW007370, U2RTW007373] Funding Source: NIH RePORTER	Perinatal HIV Research Unit; US Agency for International Development(United States Agency for International Development (USAID)); President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Fogarty International Center South Africa(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); European and Developing Countries Clinical Trials Partnership (EDCTP); Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by The Perinatal HIV Research Unit, the US Agency for International Development, and the President's Emergency Plan for AIDS Relief (to DJP and SM); and Wellcome Trust (RJW and GM, WT 081667, 084323 and 088316). The data analysis was supported by a Fogarty International Center South Africa TB/AIDS Training Award (NIH/FIC 1U2RTW007373-01A1, 1U2RTW007370). RJW also receives support from The European and Developing Countries Clinical Trials Partnership (EDCTP) (IP.07.32080.002) and the Medical Research Council of the United Kingdom (U.1175.02.002.00014.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Boyles TH, 2012, NEW ENGL J MED, V366, P474, DOI 10.1056/NEJMc1113986; Business Trust & dplg, 2007, KHAYE NOD EC DEV PRO; Ciglenecki I, 2007, INT J TUBERC LUNG D, V11, P1121; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; ETR.NET of South Africa, 2010, EL TUB REG; Fox MP, 2010, AIDS, V24, P2041, DOI 10.1097/QAD.0b013e32833c703e; Greig J, 2011, J ACQ IMMUN DEF SYND, V59, pe92; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; MacPherson P, 2009, T ROY SOC TROP MED H, V103, P588, DOI 10.1016/j.trstmh.2008.10.001; Makombe SD, 2007, INT J TUBERC LUNG D, V11, P412; Middelkoop K, 2011, JAIDS-J ACQ IMM DEF, V56, P263, DOI 10.1097/QAI.0b013e31820413b3; Mossdorf E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-98; Pepper DJ, 2011, PLOS ONE, V6; Pepper DJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-83; South African Department of Health, 2004, S AFR NAT TUB CONTR; Varma JK, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-42	19	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37634	10.1371/journal.pone.0037634	http://dx.doi.org/10.1371/journal.pone.0037634			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719843	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300008
J	Pedergnana, V; Abdel-Hamid, M; Guergnon, J; Mohsen, A; Le Fouler, L; Theodorou, I; Mohamed, MK; Fontanet, A; Plancoulaine, S; Abel, L				Pedergnana, Vincent; Abdel-Hamid, Mohamed; Guergnon, Julien; Mohsen, Amira; Le Fouler, Lenaig; Theodorou, Ioannis; Mohamed, Mostafa Kamal; Fontanet, Arnaud; Plancoulaine, Sabine; Abel, Laurent			Analysis of IL28B Variants in an Egyptian Population Defines the 20 Kilobases Minimal Region Involved in Spontaneous Clearance of Hepatitis C Virus	PLOS ONE			English	Article							LIVER-DISEASE; INFECTION; CAIRO; TRANSMISSION; ASSOCIATION; COMMUNITY; HOST	Spontaneous clearance of hepatitis C virus (HCV) occurs in similar to 30% of acute infections. Host genetics play a major role in HCV clearance, with a strong effect of single nucleotide polymorphisms (SNPs) of the IL28B gene already found in different populations, mostly infected with viral genotypes 1 and 3. Egypt has the highest prevalence of HCV infection in the world, which is mostly due to viral genotype 4. We investigated the role of several IL28B SNPs in HCV spontaneous clearance in an Egyptian population. We selected nine SNPs within the IL28B genomic region covering the linkage disequilibrium (LD) block known to be associated with HCV clearance in European populations. These SNPs were genotyped in 261 HCV-infected Egyptian subjects (130 with spontaneous clearance and 131 with chronic infection). The most associated SNPs were rs12979860 (P = 1.6x10(-7)) and the non-synonymous IL28B SNP, rs8103142 (P = 1.6x10(-7)). Interestingly, three SNPs at the two bounds of the region were monomorphic, reducing the size of the LD block in which the causal variants are potentially located to similar to 20 kilobases. HCV clearance in Egypt was associated with a region of IL28B smaller than that identified in European populations, and involved the non-synonymous IL28B SNP, rs8103142.	[Pedergnana, Vincent; Plancoulaine, Sabine; Abel, Laurent] INSERM, Lab Human Genet Infect Dis, U980, Paris, France; [Pedergnana, Vincent; Plancoulaine, Sabine; Abel, Laurent] Univ Paris 05, Paris, France; [Abdel-Hamid, Mohamed] Natl Hepatol & Trop Med Res Inst, Viral Hepatitis Res Lab, Cairo, Egypt; [Abdel-Hamid, Mohamed] Minia Fac Med, Dept Microbiol, Al Minya, Egypt; [Guergnon, Julien] Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, Lab Immun & Infect,INSERM,UMR S 945, Paris, France; [Mohsen, Amira; Mohamed, Mostafa Kamal] Ain Shams Univ, Fac Med, Dept Commun Environm & Occupat Med, Cairo, Egypt; [Le Fouler, Lenaig; Fontanet, Arnaud] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France; [Fontanet, Arnaud] Conservatoire Natl Arts & Metiers Chaire Sante &, Paris, France; [Abel, Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10021 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Egyptian Knowledge Bank (EKB); National Hepatology & Tropical Medicine Research Institute (NHTMRI); Egyptian Knowledge Bank (EKB); Minia University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Egyptian Knowledge Bank (EKB); Ain Shams University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Rockefeller University	Pedergnana, V (corresponding author), INSERM, Lab Human Genet Infect Dis, U980, Paris, France.	laurent.abel@inserm.fr	Abel, Laurent/H-8888-2017; mohamed, mostafa/AFE-7371-2022; PLANCOULAINE, Sabine/E-2824-2017	Abel, Laurent/0000-0001-7016-6493; mohamed, mostafa/0000-0002-1421-2667; PLANCOULAINE, Sabine/0000-0003-0725-8306; Pedergnana, Vincent/0000-0002-7852-5339; Mohsen, Amira/0000-0003-4528-2243; , arnaud/0000-0002-5239-6110	EC FP7 Coordinated Actions - The SPHINX Consortium; Agence Nationale de Recherche sur le SIDA et les Hepatites Virales [ANRS 12107, 12122, 12210]	EC FP7 Coordinated Actions - The SPHINX Consortium; Agence Nationale de Recherche sur le SIDA et les Hepatites Virales(ANRSFrench National Research Agency (ANR))	This work was supported by grants from the EC FP7 Coordinated Actions - The SPHINX Consortium, and the Agence Nationale de Recherche sur le SIDA et les Hepatites Virales (Grant numbers ANRS 12107, 12122 and 12210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	1000 Genomes Project Consortium, 2010, Nature, V467, P1061, DOI 10.1038/nature09534; Balagopal A, 2010, GASTROENTEROLOGY, V139, P1865, DOI 10.1053/j.gastro.2010.10.004; Darwish MA, 2001, AM J TROP MED HYG, V64, P147, DOI 10.4269/ajtmh.2001.64.147; di Iulio J, 2011, HEPATOLOGY, V53, P1446, DOI 10.1002/hep.24263; El Gaafary MM, 2005, J MED VIROL, V76, P520, DOI 10.1002/jmv.20392; Guerra J, J VIRAL HEP IN PRESS; Jimenez AP, 2010, GUT, V59, P1554, DOI 10.1136/gut.2009.194266; Jimenez AP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007193; Kurbanov F, 2011, J INFECT DIS, V204, P1391, DOI 10.1093/infdis/jir536; Mohamed MK, 2006, J MED VIROL, V78, P1185, DOI 10.1002/jmv.20679; Plancoulaine S, 2008, GUT, V57, P1268, DOI 10.1136/gut.2007.140681; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rauch A, 2009, PHARMACOGENOMICS, V10, P1819, DOI 10.2217/PGS.09.121; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Soliman C, 2010, AIDS, V24, pS33, DOI 10.1097/01.aids.0000386731.94800.e6; Strickland GT, 2002, AM J TROP MED HYG, V67, P436, DOI 10.4269/ajtmh.2002.67.436; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450	21	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38578	10.1371/journal.pone.0038578	http://dx.doi.org/10.1371/journal.pone.0038578			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719902	Green Published, gold, Green Submitted			2022-12-25	WOS:000305347800009
J	Omura, DT; Clark, DA; Samuel, ADT; Horvitz, HR				Omura, Daniel T.; Clark, Damon A.; Samuel, Aravinthan D. T.; Horvitz, H. Robert			Dopamine Signaling Is Essential for Precise Rates of Locomotion by C. elegans	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; PARKINSONS-DISEASE; SENSORY NEURONS; SEROTONIN; TRANSPORTER; BEHAVIOR; RECEPTOR; IDENTIFICATION; CONTROVERSIES; CHEMOTAXIS	Dopamine is an important neuromodulator in both vertebrates and invertebrates. We have found that reduced dopamine signaling can cause a distinct abnormality in the behavior of the nematode C. elegans, which has only eight dopaminergic neurons. Using an automated particle-tracking system for the analysis of C. elegans locomotion, we observed that individual wild-type animals made small adjustments to their speed to maintain constant rates of locomotion. By contrast, individual mutant animals defective in the synthesis of dopamine made larger adjustments to their speeds, resulting in large fluctuations in their rates of locomotion. Mutants defective in dopamine signaling also frequently exhibited both abnormally high and abnormally low average speeds. The ability to make small adjustments to speed was restored to these mutants by treatment with dopamine. These behaviors depended on the D2-like dopamine receptor DOP-3 and the G-protein subunit GOA-1. We suggest that C. elegans and other animals, including humans, might share mechanisms by which dopamine restricts motor activity levels and coordinates movement.	[Omura, Daniel T.; Horvitz, H. Robert] MIT, Dept Biol, Cambridge, MA 02139 USA; [Omura, Daniel T.; Horvitz, H. Robert] MIT, Howard Hughes Med Inst, Cambridge, MA USA; [Omura, Daniel T.; Horvitz, H. Robert] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Clark, Damon A.; Samuel, Aravinthan D. T.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Clark, Damon A.; Samuel, Aravinthan D. T.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard University	Omura, DT (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	horvitz@mit.edu		Clark, Damon/0000-0001-8487-700X	National Science Foundation; Sloan; McKnight; National Institutes of Health (NIH) [GM24663]; NIH National Center for Research Resources; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024663, R37GM024663] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Sloan(Alfred P. Sloan Foundation); McKnight; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D.T.O. and D.A.C. were supported by the National Science Foundation (www.nsf.gov). H.R.H. is the David H.Koch Professor of Biology at MIT, a member of the McGovern Institute for Brain Research at MIT and an Investigator of the Howard Hughes Medical Institute (www.hhmi.org). A.D.T.S. was supported by the Sloan (www.sloan.org), McKnight (www.mcknight.org) and National Science Foundations. D.T.O. and H.R.H. were supported by National Institutes of Health (NIH) grant GM24663. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Niels Ringstad, Megan Gustafson, Joseph Paton, Hillel Schwartz, and Daniel Denning for comments concerning this manuscript. We thank Niels Ringstad for isolation of the cat-2(n4547) mutant strain. We also thank Andy Leifer for hosting our software. Some strains were provided by the Caenorhabditis Genetics Center, which is supported by the NIH National Center for Research Resources.	ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI [DOI 10.1126/SCIENCE.282.5396.2028, DOI 10.1126/science.282.5396.2028]; BRENNER S, 1974, GENETICS, V77, P71; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; Clark DA, 2007, J NEUROPHYSIOL, V97, P1903, DOI 10.1152/jn.00892.2006; COTZIAS GC, 1969, NEW ENGL J MED, V281, P272; CULOTTI JG, 1978, GENETICS, V90, P243; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dempsey CM, 2005, GENETICS, V169, P1425, DOI 10.1534/genetics.104.032540; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Gustafson MA, 2007, THESIS MIT CAMBRIDGE; Hamdan FF, 1999, J NEUROCHEM, V72, P1372, DOI 10.1046/j.1471-4159.1999.721372.x; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Hornykiewicz O, 2006, J NEURAL TRANSM-SUPP, P9; Kindt KS, 2007, NEURON, V55, P662, DOI 10.1016/j.neuron.2007.07.023; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Lints R, 1999, DEVELOPMENT, V126, P5819; McDonald PW, 2007, J NEUROSCI, V27, P14216, DOI 10.1523/JNEUROSCI.2992-07.2007; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Olanow CW, 2004, MOVEMENT DISORD, V19, P997, DOI 10.1002/mds.20243; Ranganathan R, 2001, J NEUROSCI, V21, P5871, DOI 10.1523/JNEUROSCI.21-16-05871.2001; Rex E, 2002, J NEUROCHEM, V82, P1352, DOI 10.1046/j.1471-4159.2002.01065.x; Sanyal S, 2004, EMBO J, V23, P473, DOI 10.1038/sj.emboj.7600057; Sawin E. R., 1996, THESIS MIT CAMBRIDGE; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Solanto MV, 2002, BEHAV BRAIN RES, V130, P65, DOI 10.1016/S0166-4328(01)00431-4; Stern MB, 1997, NEUROLOGY, V49, pS1, DOI 10.1212/WNL.49.1_Suppl_1.S1; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; Tolosa E, 2006, LANCET NEUROL, V5, P75, DOI 10.1016/S1474-4422(05)70285-4; Tulloch IF, 1997, NEUROLOGY, V49, pS58, DOI 10.1212/WNL.49.1_Suppl_1.S58; Vidal-Gadea A, 2011, P NATL ACAD SCI USA, V108, P17504, DOI 10.1073/pnas.1108673108; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; Watts RL, 1997, NEUROLOGY, V49, pS34, DOI 10.1212/WNL.49.1_Suppl_1.S34; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; WHITE JG, 1986, PHILOS T R SOC LON B, V314, P340; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	45	41	44	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38649	10.1371/journal.pone.0038649	http://dx.doi.org/10.1371/journal.pone.0038649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719914	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341900040
J	Yang, XJ; Liu, P; Sun, JB; Wang, GH; Zeng, F; Yuan, K; Liu, JX; Dong, MH; von Deneen, KM; Qin, W; Tian, J				Yang, Xuejuan; Liu, Peng; Sun, Jinbo; Wang, Guihong; Zeng, Fang; Yuan, Kai; Liu, Jixin; Dong, Minghao; von Deneen, Karen M.; Qin, Wei; Tian, Jie			Impact of Brain-Derived Neurotrophic Factor Val66Met Polymorphism on Cortical Thickness and Voxel-Based Morphometry in Healthy Chinese Young Adults	PLOS ONE			English	Article							OLD-WORLD MONKEY; SURFACE-BASED ANALYSIS; AMYGDALA VOLUME; CEREBRAL-CORTEX; RISK-FACTOR; BDNF GENE; SCHIZOPHRENIA; ASSOCIATION; INSULA; MEMORY	Background: Following voxel-based morphometry (VBM), brain-derived neurotrophic factor (BDNF) Val66Met polymorphism (rs6265) has been shown to affect human brain morphology in Caucasians. However, little is known about the specific role of the Met/Met genotype on brain structure. Moreover, the relationship between BDNF Val66Met polymorphism and Chinese brain morphology has not been studied. Methodology/Principal Findings: The present study investigated brain structural differences among three genotypes of BDNF (rs6265) for the first time in healthy young Chinese adults via cortical thickness analysis and VBM. Brain differences in Met carriers using another grouping method (combining Val/Met and Met/Met genotypes into a group of Met carriers as in most previous studies) were also investigated using VBM. Dual-approach analysis revealed less gray matter (GM) in the frontal, temporal, cingulate and insular cortices in the Met/Met group compared with the Val/Val group (corrected, P<0.05). Areas with less GM in the Val/Met group were included in the Met/Met group. VBM differences in Met carriers were only found in the middle cingulate cortex. Conclusions/Significance: The current results indicated a unique pattern of brain morphologic differences caused by BDNF (rs6265) in young Chinese adults, in which the Met/Met genotype markedly affected the frontal, temporal, cingulate, and insular regions. The grouping method with Met carriers was not suitable to detect the genetic effect of BDNF Val66Met polymorphism on brain morphology, at least in the Chinese population, because it may hide some specific roles of Met/Met and Val/Met genotypes on brain structure.	[Yang, Xuejuan; Liu, Peng; Sun, Jinbo; Wang, Guihong; Yuan, Kai; Liu, Jixin; Dong, Minghao; von Deneen, Karen M.; Qin, Wei; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China; [Zeng, Fang] Chengdu Univ Tradit Chinese Med, Teaching Hosp 3, Chengdu, Sichuan, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Chengdu University of Traditional Chinese Medicine; Chinese Academy of Sciences; Institute of Automation, CAS	Yang, XJ (corresponding author), Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China.	wqin@xidian.edu.cn; tian@ieee.org	Yuan, Kai/I-4150-2016; JinBo, Sun/GLT-2082-2022; tian, jie/M-6336-2013; 秦, 伟/J-9770-2016; Dong, Minghao/A-6425-2014; Life, PAM/M-9552-2013; Yuan, Kai/M-9403-2013; Tian, Jie/H-1190-2011	Yuan, Kai/0000-0002-3098-1124; 秦, 伟/0000-0003-4583-0406; Dong, Minghao/0000-0002-0190-6985; Tian, Jie/0000-0003-0498-0432	Project for the National Key Basic Research and Development Program (973) [2011CB707702, 2012CB518501]; National Natural Science Foundation of China [30930112, 30970774, 60901064, 30873462, 81000640, 81000641, 81071217, 81101036, 81101108, 31150110171]; Fundamental Research Funds for the Central Universities; Chinese Academy of Sciences [KGCX2-YW-129]	Project for the National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the Project for the National Key Basic Research and Development Program (973) under Grant Nos. 2011CB707702 and 2012CB518501, the National Natural Science Foundation of China under Grant Nos. 30930112, 30970774, 60901064, 30873462, 81000640, 81000641, 81071217, 81101036, 81101108 and 31150110171, the Fundamental Research Funds for the Central Universities and the Knowledge Innovation Program of the Chinese Academy of Sciences under Grant No. KGCX2-YW-129. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen QY, 2006, NEUROSCI LETT, V397, P285, DOI 10.1016/j.neulet.2005.12.033; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chen Zhe-Yu, 2008, Novartis Found Symp, V289, P180; Cole J., 2011, GENES BRAIN BEHAV; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Franke B, 2011, MOL PSYCHIAT; Frodl T, 2007, ARCH GEN PSYCHIAT, V64, P410, DOI 10.1001/archpsyc.64.4.410; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hajek T, 2011, WORLD J BIOL PSYCHIA; Ho BC, 2006, ARCH GEN PSYCHIAT, V63, P731, DOI 10.1001/archpsyc.63.7.731; Hong CJ, 2003, NEUROSCI LETT, V349, P206, DOI 10.1016/S0304-3940(03)00828-0; Hyde KL, 2010, HUM BRAIN MAPP, V31, P556, DOI 10.1002/hbm.20887; Im K, 2008, CEREB CORTEX, V18, P2181, DOI 10.1093/cercor/bhm244; Karnik MS, 2010, PSYCHIAT RES, V178, P425, DOI 10.1016/j.psychres.2009.09.008; Lehmann M, 2011, NEUROBIOL AGING, V32, P1466, DOI 10.1016/j.neurobiolaging.2009.08.017; Liu M SL, 2007, HEREDITAS, V29, P41; Lyoo IK, 2011, ARCH GEN PSYCHIAT, V68, P701, DOI 10.1001/archgenpsychiatry.2011.70; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Matsuo K, 2009, NEUROPSYCHOPHARMACOL, V34, P1904, DOI 10.1038/npp.2009.23; MESULAM MM, 1982, J COMP NEUROL, V212, P1, DOI 10.1002/cne.902120102; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Montag C, 2009, PSYCHOL MED, V39, P1831, DOI 10.1017/S0033291709005509; MUFSON EJ, 1982, J COMP NEUROL, V212, P23, DOI 10.1002/cne.902120103; Naoe Y, 2007, NEUROSCI LETT, V415, P108, DOI 10.1016/j.neulet.2007.01.006; Neves-Pereira M, 2005, MOL PSYCHIATR, V10, P208, DOI 10.1038/sj.mp.4001575; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Qian L, 2007, BIOCHEM BIOPH RES CO, V353, P738, DOI 10.1016/j.bbrc.2006.12.121; Raznahan A, 2009, J NEURODEV DISORD, V1, P215, DOI 10.1007/s11689-009-9012-0; Richter-Schmidinger T, 2011, J NEURAL TRANSM, V118, P249, DOI 10.1007/s00702-010-0539-8; Rosa A, 2006, AM J MED GENET B, V141B, P135, DOI 10.1002/ajmg.b.30266; Schofield PR, 2009, BIOL PSYCHOL, V80, P176, DOI 10.1016/j.biopsycho.2008.09.001; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sublette ME, 2008, PROG NEURO-PSYCHOPH, V32, P1652, DOI 10.1016/j.pnpbp.2008.06.009; Szeszko PR, 2005, MOL PSYCHIATR, V10, P631, DOI 10.1038/sj.mp.4001656; Takahashi T, 2008, NEUROSCI LETT, V435, P34, DOI 10.1016/j.neulet.2008.02.004; Thompson PM, 2010, CURR OPIN NEUROL, V23, P368, DOI 10.1097/WCO.0b013e32833b764c; Voineskos AN, 2011, ARCH GEN PSYCHIAT, V68, P198, DOI 10.1001/archgenpsychiatry.2010.194	49	39	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e37777	10.1371/journal.pone.0037777	http://dx.doi.org/10.1371/journal.pone.0037777			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719849	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341900014
J	Ferreira, DS; Amaral, FG; Mesquita, CC; Barbosa, APL; Lellis-Santos, C; Turati, AO; Santos, LR; Sollon, CS; Gomes, PR; Faria, JA; Cipolla-Neto, J; Bordin, S; Anhe, GF				Ferreira, Danilo S.; Amaral, Fernanda G.; Mesquita, Caroline C.; Barbosa, Ana Paula L.; Lellis-Santos, Camilo; Turati, Ariane O.; Santos, Laila R.; Sollon, Carolina S.; Gomes, Patricia R.; Faria, Juliana A.; Cipolla-Neto, Jose; Bordin, Silvana; Anhe, Gabriel F.			Maternal Melatonin Programs the Daily Pattern of Energy Metabolism in Adult Offspring	PLOS ONE			English	Article							INHIBITS INSULIN-SECRETION; CAUSES GLUCOSE-INTOLERANCE; RAT PANCREATIC-ISLETS; CORTISOL PRODUCTION; SIGNALING PATHWAYS; SKELETAL-MUSCLE; LIGHT EXPOSURE; ADRENAL-GLAND; SHIFT WORK; RECEPTOR	Background: Shift work was recently described as a factor that increases the risk of Type 2 diabetes mellitus. In addition, rats born to mothers subjected to a phase shift throughout pregnancy are glucose intolerant. However, the mechanism by which a phase shift transmits metabolic information to the offspring has not been determined. Among several endocrine secretions, phase shifts in the light/dark cycle were described as altering the circadian profile of melatonin production by the pineal gland. The present study addresses the importance of maternal melatonin for the metabolic programming of the offspring. Methodology/Principal Findings: Female Wistar rats were submitted to SHAM surgery or pinealectomy (PINX). The PINX rats were divided into two groups and received either melatonin (PM) or vehicle. The SHAM, the PINX vehicle and the PM females were housed with male Wistar rats. Rats were allowed to mate and after weaning, the male and female offspring were subjected to a glucose tolerance test (GTT), a pyruvate tolerance test (PTT) and an insulin tolerance test (ITT). Pancreatic islets were isolated for insulin secretion, and insulin signaling was assessed in the liver and in the skeletal muscle by western blots. We found that male and female rats born to PINX mothers display glucose intolerance at the end of the light phase of the light/dark cycle, but not at the beginning. We further demonstrate that impaired glucose-stimulated insulin secretion and hepatic insulin resistance are mechanisms that may contribute to glucose intolerance in the offspring of PINX mothers. The metabolic programming described here occurs due to an absence of maternal melatonin because the offspring born to PINX mothers treated with melatonin were not glucose intolerant. Conclusions/Significance: The present results support the novel concept that maternal melatonin is responsible for the programming of the daily pattern of energy metabolism in their offspring.	[Ferreira, Danilo S.; Mesquita, Caroline C.; Barbosa, Ana Paula L.; Sollon, Carolina S.; Faria, Juliana A.; Anhe, Gabriel F.] Univ Estadual Campinas, Fac Med Sci, Dept Pharmacol, Campinas, Brazil; [Amaral, Fernanda G.; Lellis-Santos, Camilo; Turati, Ariane O.; Santos, Laila R.; Gomes, Patricia R.; Cipolla-Neto, Jose; Bordin, Silvana] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo	Ferreira, DS (corresponding author), Univ Estadual Campinas, Fac Med Sci, Dept Pharmacol, Campinas, Brazil.	anhegf@fcm.unicamp.br	Gomes, Patricia RL/G-2484-2014; Cipolla-Neto, Jose/B-1619-2009; Anhe, Gabriel F/C-1980-2012; de Almeida Faria, Juliana/C-5931-2015; Lellis-Santos, Camilo/D-9195-2015; Amaral, Fernanda/O-3071-2019; Bordin, Silvana/G-3147-2012; Amaral, Fernanda G/K-5395-2017	Gomes, Patricia RL/0000-0003-2884-7599; Cipolla-Neto, Jose/0000-0003-3748-3731; de Almeida Faria, Juliana/0000-0002-7276-6924; Lellis-Santos, Camilo/0000-0002-7882-7548; Amaral, Fernanda/0000-0003-4492-4822; Bordin, Silvana/0000-0002-0192-8869; Amaral, Fernanda G/0000-0003-4492-4822; Mesquita, Caroline Costa/0000-0001-5471-2343; Anhe, Gabriel/0000-0002-7694-8397	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); CNPq (Conselho Nacional de Aperfeicoameno Cientifico)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Aperfeicoameno Cientifico)	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and CNPq (Conselho Nacional de Aperfeicoameno Cientifico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Vale MIC, 2005, AM J PHYSIOL-ENDOC M, V288, pE805, DOI 10.1152/ajpendo.00478.2004; Antunes LC, 2010, NUTR RES REV, V23, P155, DOI 10.1017/S0954422410000016; ARMSTRONG SM, 1989, EXPERIENTIA, V45, P932, DOI 10.1007/BF01953050; Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; BONADONNA RC, 1993, J CLIN INVEST, V92, P486, DOI 10.1172/JCI116592; BONORA E, 1987, DIABETES METAB, V13, P116; BORDIN S, 1995, J MEMBRANE BIOL, V148, P177; Borugian MJ, 2005, J OCCUP ENVIRON MED, V47, P1268, DOI 10.1097/01.jom.0000184855.87223.77; Caperuto LC, 2008, ENDOCRINOLOGY, V149, P6326, DOI 10.1210/en.2008-0655; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Dijk DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030037; Drijfhout WJ, 1997, NEUROSCIENCE, V80, P233, DOI 10.1016/S0306-4522(97)00080-8; Dumont M, 2012, CHRONOBIOL INT, V29, P203, DOI 10.3109/07420528.2011.647177; ERLICH SS, 1985, J NEUROSURG, V63, P321, DOI 10.3171/jns.1985.63.3.0321; Ha E, 2006, J PINEAL RES, V41, P67, DOI 10.1111/j.1600-079X.2006.00334.x; Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200; Kennaway DJ, 2003, AM J PHYSIOL-REG I, V284, pR1231, DOI 10.1152/ajpregu.00697.2002; Kivimaki M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001138; Li PM, 1996, J CELL BIOCHEM, V61, P31, DOI 10.1002/(SICI)1097-4644(19960401)61:1<31::AID-JCB5>3.0.CO;2-3; Lima FB, 1998, AM J PHYSIOL-ENDOC M, V275, pE934; LIMA FB, 1994, BRAZ J MED BIOL RES, V27, P995; Manenschijn L, 2011, J CLIN ENDOCR METAB, V96, pE1862, DOI 10.1210/jc.2011-1551; Martins E, 2001, J PINEAL RES, V31, P363, DOI 10.1034/j.1600-079X.2001.310412.x; Mauriz JL, 2007, J PINEAL RES, V42, P222, DOI 10.1111/j.1600-079X.2006.00409.x; McPherson M, 2011, J OCCUP ENVIRON MED, V53, P716, DOI 10.1097/JOM.0b013e31822282fd; Muhlbauer E, 2011, J PINEAL RES, V51, P361, DOI 10.1111/j.1600-079X.2011.00898.x; Nagai R, 2008, J PINEAL RES, V45, P271, DOI 10.1111/j.1600-079X.2008.00586.x; Nogueira TC, 2011, ENDOCRINOLOGY, V152, P1253, DOI 10.1210/en.2010-1088; Nyirenda MJ, 1998, J CLIN INVEST, V101, P2174, DOI 10.1172/JCI1567; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; Picinato MC, 2008, J PINEAL RES, V44, P88, DOI 10.1111/j.1600-079X.2007.00493.x; Picinato MC, 2002, J PINEAL RES, V33, P156, DOI 10.1034/j.1600-079X.2002.02903.x; Picinato MC, 2002, J PINEAL RES, V33, P172, DOI 10.1034/j.1600-079X.2002.02925.x; PLOS Medicine Editors, 2011, PLOS MED, V8; Richter HG, 2009, J PINEAL RES, V46, P357, DOI 10.1111/j.1600-079X.2009.00671.x; ROTHENBERG PL, 1991, J BIOL CHEM, V266, P8302; Tamura H, 2008, J PINEAL RES, V44, P335, DOI 10.1111/j.1600-079X.2007.00537.x; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Torres-Farfan C, 2004, J PHYSIOL-LONDON, V554, P841, DOI 10.1113/jphysiol.2003.056465; Torres-Farfan C, 2011, ENDOCRINOLOGY, V152, P1891, DOI 10.1210/en.2010-1260; Torres-Farfan C, 2003, J CLIN ENDOCR METAB, V88, P450, DOI 10.1210/jc.2002-021048; Varcoe TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018504; Zanquetta MM, 2003, J PINEAL RES, V35, P141, DOI 10.1034/j.1600-079X.2003.00067.x	43	57	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38795	10.1371/journal.pone.0038795	http://dx.doi.org/10.1371/journal.pone.0038795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719949	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340000045
J	Manasherob, R; Miller, C; Kim, KS; Cohen, SN				Manasherob, Robert; Miller, Christine; Kim, Kwang-sun; Cohen, Stanley N.			Ribonuclease E Modulation of the Bacterial SOS Response	PLOS ONE			English	Article							COLI RNA DEGRADOSOME; GROWING ESCHERICHIA-COLI; DNA-DAMAGE; STAPHYLOCOCCUS-AUREUS; PROTEIN INHIBITOR; CLPXP PROTEASE; BINDING-SITES; CELL-DIVISION; LEXA; RECOGNITION	Plants, animals, bacteria, and Archaea all have evolved mechanisms to cope with environmental or cellular stress. Bacterial cells respond to the stress of DNA damage by activation of the SOS response, the canonical RecA/LexA-dependent signal transduction pathway that transcriptionally derepresses a multiplicity of genes-leading to transient arrest of cell division and initiation of DNA repair. Here we report the previously unsuspected role of E. coli endoribonuclease RNase E in regulation of the SOS response. We show that RNase E deletion or inactivation of temperature-sensitive RNase E protein precludes normal initiation of SOS. The ability of RNase E to regulate SOS is dynamic, as down regulation of RNase E following DNA damage by mitomycin C resulted in SOS termination and restoration of RNase E function leads to resumption of a previously aborted response. Overexpression of the RraA protein, which binds to the C-terminal region of RNase E and modulates the actions of degradosomes, recapitulated the effects of RNase E deficiency. Possible mechanisms for RNase E effects on SOS are discussed.	[Manasherob, Robert; Miller, Christine; Kim, Kwang-sun; Cohen, Stanley N.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Cohen, Stanley N.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Kim, Kwang-sun] KRIBB, Syst & Synthet Biol Res Ctr, Taejon, South Korea	Stanford University; Stanford University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Manasherob, R (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	sncohen@stanford.edu	Kim, Kwang-sun/AAB-6478-2020	Kim, Kwang-sun/0000-0003-3703-5461	National Institutes of Health [GM54158, AI08619]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI008619, R01AI008619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM54158 and AI08619 to SNC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERG OG, 1988, J MOL BIOL, V200, P709, DOI 10.1016/0022-2836(88)90482-2; Bernstein JA, 2004, P NATL ACAD SCI USA, V101, P2758, DOI 10.1073/pnas.0308747101; Butala M, 2009, CELL MOL LIFE SCI, V66, P82, DOI 10.1007/s00018-008-8378-6; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; Cirz RT, 2007, J BACTERIOL, V189, P531, DOI 10.1128/JB.01464-06; Cohen SN, 1997, MOL MICROBIOL, V23, P1099, DOI 10.1111/j.1365-2958.1997.tb02593.x; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; DRI AM, 1994, MOL MICROBIOL, V12, P621, DOI 10.1111/j.1365-2958.1994.tb01049.x; Feng Y, 2001, J BIOL CHEM, V276, P31651, DOI 10.1074/jbc.M102855200; Frank EG, 1996, P NATL ACAD SCI USA, V93, P10291, DOI 10.1073/pnas.93.19.10291; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Gao JJ, 2006, MOL MICROBIOL, V61, P394, DOI 10.1111/j.1365-2958.2006.05246.x; GOLDBLUM K, 1981, J BACTERIOL, V146, P128, DOI 10.1128/JB.146.1.128-132.1981; Gonzalez M, 2000, EMBO J, V19, P5251, DOI 10.1093/emboj/19.19.5251; Gorna MW, 2010, RNA, V16, P553, DOI 10.1261/rna.1858010; Hastings PJ, 2004, PLOS BIOL, V2, P2220, DOI 10.1371/journal.pbio.0020399; HUISMAN O, 1984, P NATL ACAD SCI-BIOL, V81, P4490, DOI 10.1073/pnas.81.14.4490; KENYON CJ, 1980, P NATL ACAD SCI-BIOL, V77, P2819, DOI 10.1073/pnas.77.5.2819; Lee K, 2003, MOL MICROBIOL, V48, P349, DOI 10.1046/j.1365-2958.2003.03435.x; Lee K, 2002, MOL MICROBIOL, V43, P1445, DOI 10.1046/j.1365-2958.2002.02848.x; Lee KS, 2003, CELL, V114, P623, DOI 10.1016/j.cell.2003.08.003; LEWIS LK, 1994, J MOL BIOL, V241, P507, DOI 10.1006/jmbi.1994.1528; Little JW, 1983, CELLULAR RESPONSES D, P369; Maiques E, 2006, J BACTERIOL, V188, P2726, DOI 10.1128/JB.188.7.2726-2729.2006; McDowall KJ, 1996, J MOL BIOL, V255, P349, DOI 10.1006/jmbi.1996.0027; McKenzie GJ, 2001, CURR OPIN MICROBIOL, V4, P586, DOI 10.1016/S1369-5274(00)00255-1; Michel B, 2005, PLOS BIOL, V3, P1174, DOI 10.1371/journal.pbio.0030255; Miczak A, 1996, P NATL ACAD SCI USA, V93, P3865, DOI 10.1073/pnas.93.9.3865; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MIZUSAWA S, 1983, P NATL ACAD SCI-BIOL, V80, P358, DOI 10.1073/pnas.80.2.358; MOSTELLER RD, 1980, J BIOL CHEM, V255, P2524; Nebe-von-Caron G, 2000, J MICROBIOL METH, V42, P97, DOI 10.1016/S0167-7012(00)00181-0; Neher SB, 2003, P NATL ACAD SCI USA, V100, P13219, DOI 10.1073/pnas.2235804100; Neher SB, 2003, GENE DEV, V17, P1084, DOI 10.1101/gad.1078003; Pennington JM, 2007, NAT GENET, V39, P797, DOI 10.1038/ng2051; PINE MJ, 1970, J BACTERIOL, V103, P207, DOI 10.1128/JB.103.1.207-215.1970; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Radman M, 1975, Basic Life Sci, V5A, P355; Sambrook J., 2002, MOL CLONING LAB MANU; SASSANFAR M, 1990, J MOL BIOL, V212, P79, DOI 10.1016/0022-2836(90)90306-7; Seitz EM, 1998, GENE DEV, V12, P1248, DOI 10.1101/gad.12.9.1248; SIMMONS LA, 2008, ECOSAL ESCHERICHIA C; Tamura M, 2006, J BACTERIOL, V188, P5145, DOI 10.1128/JB.00367-06; TARASEVICIENE L, 1995, J BIOL CHEM, V270, P26391, DOI 10.1074/jbc.270.44.26391; WALKER GC, 1985, ENVIRON HEALTH PERSP, V62, P115, DOI 10.2307/3430102; Zhao M, 2006, J BACTERIOL, V188, P3257, DOI 10.1128/JB.188.9.3257-3263.2006	51	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38426	10.1371/journal.pone.0038426	http://dx.doi.org/10.1371/journal.pone.0038426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22719885	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336800023
J	Ghosh, N; McKillop, TJ; Jowitt, TA; Howard, M; Davies, H; Holmes, DF; Roberts, IS; Bella, J				Ghosh, Neelanjana; McKillop, Thomas J.; Jowitt, Thomas A.; Howard, Marjorie; Davies, Heather; Holmes, David F.; Roberts, Ian S.; Bella, Jordi			Collagen-Like Proteins in Pathogenic E. coli Strains	PLOS ONE			English	Article							ENTEROHEMORRHAGIC ESCHERICHIA-COLI; BACILLUS-ANTHRACIS EXOSPORIUM; HELICAL COILED-COIL; SHORT TAIL FIBER; TRIPLE-HELIX; SHIGA-TOXIN; MOLECULAR-STRUCTURE; CONVERTING BACTERIOPHAGES; CRYSTAL-STRUCTURE; GENOME SEQUENCE	The genome sequences of enterohaemorrhagic E. coli O157:H7 strains show multiple open-reading frames with collagen-like sequences that are absent from the common laboratory strain K-12. These putative collagens are included in prophages embedded in O157: H7 genomes. These prophages carry numerous genes related to strain virulence and have been shown to be inducible and capable of disseminating virulence factors by horizontal gene transfer. We have cloned two collagen-like proteins from E. coli O157: H7 into a laboratory strain and analysed the structure and conformation of the recombinant proteins and several of their constituting domains by a variety of spectroscopic, biophysical, and electron microscopy techniques. We show that these molecules exhibit many of the characteristics of vertebrate collagens, including trimer formation and the presence of a collagen triple helical domain. They also contain a C-terminal trimerization domain, and a trimeric a-helical coiled-coil domain with an unusual amino acid sequence almost completely lacking leucine, valine or isoleucine residues. Intriguingly, these molecules show high thermal stability, with the collagen domain being more stable than those of vertebrate fibrillar collagens, which are much longer and post-translationally modified. Under the electron microscope, collagen-like proteins from E. coli O157: H7 show a dumbbell shape, with two globular domains joined by a hinged stalk. This morphology is consistent with their likely role as trimeric phage side-tail proteins that participate in the attachment of phage particles to E. coli target cells, either directly or through assembly with other phage tail proteins. Thus, collagen-like proteins in enterohaemorrhagic E. coli genomes may have a direct role in the dissemination of virulence-related genes through infection of harmless strains by induced bacteriophages.	[Ghosh, Neelanjana; Bella, Jordi] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England; [Ghosh, Neelanjana; McKillop, Thomas J.; Jowitt, Thomas A.; Howard, Marjorie; Davies, Heather; Holmes, David F.; Roberts, Ian S.; Bella, Jordi] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester; University of Manchester	Ghosh, N (corresponding author), Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England.	jordi.bella@manchester.ac.uk	Bella, Jordi/F-3794-2018	Bella, Jordi/0000-0003-0443-4562; Jowitt, Thomas/0000-0002-4045-0933	Dorothy Hodgkin Postgraduate Award [EP/P500966/1]; Research Councils UK; Masters in Biological Sciences Award [BB/E527355/1]; Biotechnology and Biological Sciences Research Council	Dorothy Hodgkin Postgraduate Award; Research Councils UK(UK Research & Innovation (UKRI)); Masters in Biological Sciences Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Neelanjana Ghosh was supported by a Dorothy Hodgkin Postgraduate Award to the University of Manchester (ref. EP/P500966/1), funded by Research Councils UK (http://www.rcuk.ac.uk). Thomas J. McKillop was supported by a Masters in Biological Sciences Award to the University of Manchester (ref. BB/E527355/1), funded by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison HE, 2003, INFECT IMMUN, V71, P3409, DOI 10.1128/IAI.71.6.3409-3418.2003; Armstrong CT, 2011, BIOINFORMATICS, V27, P1908, DOI 10.1093/bioinformatics/btr299; Asadulghani M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000408; BAMFORD JKH, 1990, VIROLOGY, V177, P445, DOI 10.1016/0042-6822(90)90508-O; Bann JG, 2000, FEBS LETT, V473, P237, DOI 10.1016/S0014-5793(00)01493-9; Bansal T, 2007, INFECT IMMUN, V75, P4597, DOI 10.1128/IAI.00630-07; Beck K, 1998, J STRUCT BIOL, V122, P17, DOI 10.1006/jsbi.1998.3965; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Bella J, 2010, J STRUCT BIOL, V170, P377, DOI 10.1016/j.jsb.2010.02.003; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Bergholz TM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-97; Blommel PG, 2007, BIOTECHNOL PROGR, V23, P585, DOI 10.1021/bp070011x; Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Caswell CC, 2010, FEMS MICROBIOL LETT, V303, P61, DOI 10.1111/j.1574-6968.2009.01864.x; Chen SM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-320; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Daubenspeck JM, 2004, J BIOL CHEM, V279, P30945, DOI 10.1074/jbc.M401613200; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Eppinger M, 2007, ANNOTATION ESCHERICH; Feng P, 1998, J INFECT DIS, V177, P1750, DOI 10.1086/517438; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Greenfield NJ, 2006, NAT PROTOC, V1, P2891, DOI 10.1038/nprot.2006.244; HAGGARDLJUNGQUIST E, 1992, J BACTERIOL, V174, P1462, DOI 10.1128/jb.174.5.1462-1477.1992; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; HENDRIX RW, 1992, SCIENCE, V258, P1145, DOI 10.1126/science.1439823; Herold S, 2005, ANTIMICROB AGENTS CH, V49, P931, DOI 10.1128/AAC.49.3.931-944.2005; Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901; Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Imamovic L, 2010, APPL ENVIRON MICROB, V76, P5693, DOI 10.1128/AEM.00107-10; JIMENEZ S, 1973, BIOCHEM BIOPH RES CO, V52, P106, DOI 10.1016/0006-291X(73)90960-1; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Kammerer RA, 1998, J BIOL CHEM, V273, P10602, DOI 10.1074/jbc.273.17.10602; Karmali MA, 2010, VET MICROBIOL, V140, P360, DOI 10.1016/j.vetmic.2009.04.011; Kuhnel K, 2004, P NATL ACAD SCI USA, V101, P17027, DOI 10.1073/pnas.0403069101; Lee J, 2007, APPL ENVIRON MICROB, V73, P4100, DOI 10.1128/AEM.00360-07; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Leiman PG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-355; Lim JY, 2010, J MICROBIOL BIOTECHN, V20, P5, DOI 10.4014/jmb.0908.08007; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Mane SP, 2011, ESCHERICHIA COLI EC4; Mane SP, 2011, SHIGELLA FLEXNERI CD; McAlinden A, 2003, J BIOL CHEM, V278, P42200, DOI 10.1074/jbc.M302429200; Mitraki A, 2002, J STRUCT BIOL, V137, P236, DOI 10.1006/jsbi.2002.4447; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; MOULD AP, 1985, J ULTRA MOL STRUCT R, V91, P66, DOI 10.1016/0889-1605(85)90077-1; Muniesa M, 2004, MICROBIOL-SGM, V150, P2959, DOI 10.1099/mic.0.27188-0; Muniesa M, 2003, INFECT IMMUN, V71, P4554, DOI 10.1128/IAI.71.8.4554-4562.2003; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; OBRIEN AD, 1989, MICROB PATHOGENESIS, V6, P381, DOI 10.1016/0882-4010(89)90080-6; Ogura Y, 2006, DNA RES, V13, P3, DOI 10.1093/dnares/dsi026; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Ohnishi M, 2001, TRENDS MICROBIOL, V9, P481, DOI 10.1016/S0966-842X(01)02173-4; Oliva CR, 2008, P NATL ACAD SCI USA, V105, P1261, DOI 10.1073/pnas.0709321105; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Pennington H, 2010, LANCET, V376, P1428, DOI 10.1016/S0140-6736(10)60963-4; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Plunkett G, 1999, J BACTERIOL, V181, P1767, DOI 10.1128/JB.181.6.1767-1778.1999; RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0; Ramshaw JAM, 1998, J STRUCT BIOL, V122, P86, DOI 10.1006/jsbi.1998.3977; Rasko DA, 2008, COMPLETE SEQUENCE SH; Rasmussen M, 2000, INFECT IMMUN, V68, P6370, DOI 10.1128/IAI.68.11.6370-6377.2000; Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200; RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8; RIETRA PJGM, 1989, J GEN MICROBIOL, V135, P2307; Sandt CH, 2000, INFECT IMMUN, V68, P2205, DOI 10.1128/IAI.68.4.2205-2214.2000; Sato T, 2003, GENE, V309, P35, DOI 10.1016/S0378-1119(03)00487-6; Smith DL, 2007, J BACTERIOL, V189, P7223, DOI 10.1128/JB.00824-07; Smith MCM, 1998, SCIENCE, V279, P1834; SREERAMA N, 1994, BIOCHEMISTRY-US, V33, P10022, DOI 10.1021/bi00199a028; Sylvestre P, 2002, MOL MICROBIOL, V45, P169, DOI 10.1046/j.1365-2958.2000.03000.x; Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5; Thomassen E, 2003, J MOL BIOL, V331, P361, DOI 10.1016/s0022-2836(03)00755-1; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Uniprot, 2011, NUCLEIC ACIDS RES, V39, pD214; van Raaij MJ, 2001, J MOL BIOL, V314, P1137, DOI 10.1006/jmbi.2000.5204; Weigele PR, 2003, J BACTERIOL, V185, P4022, DOI 10.1128/JB.185.14.4022-4030.2003; Wick LM, 2005, J BACTERIOL, V187, P1783, DOI 10.1128/JB.187.5.1783-1791.2005; WILLSHAW GA, 1987, J GEN MICROBIOL, V133, P1309; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Xiang Y, 2011, P NATL ACAD SCI USA, V108, P4806, DOI 10.1073/pnas.1018097108; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yamamoto T, 2006, STX2 PHAGE ENTEROHEM; Zhang Y, 2008, ENTEROBACTERIA PHAGE	88	28	29	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37872	10.1371/journal.pone.0037872	http://dx.doi.org/10.1371/journal.pone.0037872			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701585	gold, Green Submitted, Green Published			2022-12-25	WOS:000305348400023
J	Mennigen, JA; Panserat, S; Larquier, M; Plagnes-Juan, E; Medale, F; Seiliez, I; Skiba-Cassy, S				Mennigen, Jan A.; Panserat, Stephane; Larquier, Melanie; Plagnes-Juan, Elisabeth; Medale, Francoise; Seiliez, Iban; Skiba-Cassy, Sandrine			Postprandial Regulation of Hepatic MicroRNAs Predicted to Target the Insulin Pathway in Rainbow Trout	PLOS ONE			English	Article							IN-VIVO; GENE-EXPRESSION; NUTRITIONAL REGULATION; GLUCOSE-HOMEOSTASIS; SIGNALING PATHWAYS; LIPID-METABOLISM; LIVER; AUTOPHAGY; ACTIVATION; MUSCLE	Rainbow trout are carnivorous fish and poor metabolizers of carbohydrates, which established this species as a model organism to study the comparative physiology of insulin. Following the recent characterisation of key roles of several miRNAs in the insulin action on hepatic intermediary metabolism in mammalian models, we investigated the hypothesis that hepatic miRNA expression is postprandially regulated in the rainbow trout and temporally coordinated in the context of insulin-mediated regulation of metabolic gene expression in the liver. To address this hypothesis, we used a time-course experiment in which rainbow trout were fed a commercial diet after short-term fasting. We investigated hepatic miRNA expression, activation of the insulin pathway, and insulin regulated metabolic target genes at several time points. Several miRNAs which negatively regulate hepatic insulin signaling in mammalian model organisms were transiently increased 4 h after the meal, consistent with a potential role in acute postprandial negative feed-back regulation of the insulin pathway and attenuation of gluconeogenic gene expression. We equally observed a transient increase in omy-miRNA-33 and omy-miRNA-122b 4 h after feeding, whose homologues have potent lipogenic roles in the liver of mammalian model systems. A concurrent increase in the activity of the hepatic insulin signaling pathway and the expression of lipogenic genes (srebp1c, fas, acly) was equally observed, while lipolytic gene expression (cpt1a and cpt1b) decreased significantly 4 h after the meal. This suggests lipogenic roles of omy-miRNA-33 and omy-miRNA-122b may be conserved between rainbow trout and mammals and that these miRNAs may furthermore contribute to acute postprandial regulation of de novo hepatic lipid synthesis in rainbow trout. These findings provide a framework for future research of miRNA regulation of hepatic metabolism in trout and will help to further elucidate the metabolic phenotype of rainbow trout.	[Mennigen, Jan A.; Panserat, Stephane; Larquier, Melanie; Plagnes-Juan, Elisabeth; Medale, Francoise; Seiliez, Iban; Skiba-Cassy, Sandrine] INRA, Nutr UMR1067, St Pee Sur Nivelle, Pyrenees Atlant, France	INRAE; Universite de Pau et des Pays de l'Adour	Mennigen, JA (corresponding author), INRA, Nutr UMR1067, St Pee Sur Nivelle, Pyrenees Atlant, France.	skiba@st.pee.inra.fr		Medale, Francoise/0000-0002-8083-1298; Panserat, Stephane/0000-0002-4479-9868	A Marie-Curie post-doctoral fellowship [273840]	A Marie-Curie post-doctoral fellowship	A Marie-Curie post-doctoral fellowship (project reference 273840, Seventh Framework Programme of the European Commission, http://cordis.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Bizuayehu TT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-11; Caruso MA, 2011, GEN COMP ENDOCR, V173, P227, DOI 10.1016/j.ygcen.2011.06.014; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chi W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023549; COWEY CB, 1977, BRIT J NUTR, V38, P463, DOI 10.1079/BJN19770111; Cowey DJ, 1993, FISH PHYSIOL BIOCHEM, V11, P421; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; Drummond MJ, 2009, J NUTR, V139, P2279, DOI 10.3945/jn.109.112797; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Enes P, 2009, FISH PHYSIOL BIOCHEM, V35, P519, DOI 10.1007/s10695-008-9259-5; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Ezaki J, 2011, AUTOPHAGY, V7, P727, DOI 10.4161/auto.7.7.15371; Fernandez-Hernando C, 2011, CURR OPIN LIPIDOL, V22, P86, DOI 10.1097/MOL.0b013e3283428d9d; Fu YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022957; Gao CP, 2010, CANCER-AM CANCER SOC, V116, P41, DOI 10.1002/cncr.24743; Granjon A, 2009, DIABETES, V58, P2555, DOI 10.2337/db09-0165; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Her GM, 2011, BBA-MOL CELL BIOL L, V1811, P536, DOI 10.1016/j.bbalip.2011.06.011; Herrera BM, 2010, DIABETOLOGIA, V53, P1099, DOI 10.1007/s00125-010-1667-2; Hinske LCG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-533; Iliopoulos D, 2010, J LIPID RES, V51, P1513, DOI 10.1194/jlr.M004812; Jegga AG, 2011, AUTOPHAGY, V7, P477, DOI 10.4161/auto.7.5.14811; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kanazawa T, 2004, J BIOL CHEM, V279, P8452, DOI 10.1074/jbc.M306337200; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lansard M, 2010, AMINO ACIDS, V39, P801, DOI 10.1007/s00726-010-0533-3; Latasa MJ, 2000, P NATL ACAD SCI USA, V97, P10619, DOI 10.1073/pnas.180306597; Leavens KF, 2011, CRIT REV BIOCHEM MOL, V46, P200, DOI 10.3109/10409238.2011.562481; Leonardi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011107; Li SJ, 2009, J LIPID RES, V50, P1756, DOI 10.1194/jlr.M800509-JLR200; Lian S, 2009, BIOORGAN MED CHEM, V17, P7085, DOI 10.1016/j.bmc.2009.09.004; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Minghetti M, 2011, BBA-MOL CELL BIOL L, V1811, P194, DOI 10.1016/j.bbalip.2010.12.008; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Pandey AK, 2011, MOL CELL ENDOCRINOL, V332, P125, DOI 10.1016/j.mce.2010.10.004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plagnes-Juan E, 2008, J EXP BIOL, V211, P2510, DOI 10.1242/jeb.018374; Polakof S, 2011, AM J PHYSIOL-REG I, V300, pR166, DOI 10.1152/ajpregu.00619.2010; Polakof S, 2010, J EXP BIOL, V213, P4151, DOI 10.1242/jeb.050807; Polakof S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020228; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Ramachandra RK, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-41; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Ryu HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017343; Salem M, 2008, MAR BIOTECHNOL NY, V12, P410; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Seiliez I, 2008, AM J PHYSIOL-REG I, V295, pR329, DOI 10.1152/ajpregu.00146.2008; Seiliez I, 2011, GEN COMP ENDOCR, V172, P363, DOI 10.1016/j.ygcen.2011.03.026; Seiliez I, 2011, AM J PHYSIOL-REG I, V300, pR733, DOI 10.1152/ajpregu.00579.2010; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Skiba-Cassy S, 2009, AM J PHYSIOL-REG I, V297, pR1421, DOI 10.1152/ajpregu.00312.2009; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Xia JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017537; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhang YM, 2007, CHEM BIOL, V14, P291, DOI 10.1016/j.chembiol.2007.01.013; Zhao EP, 2009, MAMM GENOME, V20, P476, DOI 10.1007/s00335-009-9217-2	64	63	69	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38604	10.1371/journal.pone.0038604	http://dx.doi.org/10.1371/journal.pone.0038604			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701681	Green Submitted, gold, Green Published			2022-12-25	WOS:000305348400080
J	Phillips, NJ; Steichen, CT; Schilling, B; Post, DMB; Niles, RK; Bair, TB; Falsetta, ML; Apicella, MA; Gibson, BW				Phillips, Nancy J.; Steichen, Christopher T.; Schilling, Birgit; Post, Deborah M. B.; Niles, Richard K.; Bair, Thomas B.; Falsetta, Megan L.; Apicella, Michael A.; Gibson, Bradford W.			Proteomic Analysis of Neisseria gonorrhoeae Biofilms Shows Shift to Anaerobic Respiration and Changes in Nutrient Transport and Outermembrane Proteins	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA BIOFILMS; ESCHERICHIA-COLI BIOFILMS; OUTER-MEMBRANE PROTEIN; CELL-CULTURE SILAC; GENE-EXPRESSION; IV PILI; QUANTITATIVE PROTEOMICS; AMINO-ACIDS; GONOCOCCAL BIOFILMS; MICROARRAY ANALYSIS	Neisseria gonorrhoeae, the causative agent of gonorrhea, can form biofilms in vitro and in vivo. In biofilms, the organism is more resistant to antibiotic treatment and can serve as a reservoir for chronic infection. We have used stable isotope labeling by amino acids in cell culture (SILAC) to compare protein expression in biofilm and planktonic organisms. Two parallel populations of N. gonorrhoeae strain 1291, which is an arginine auxotroph, were grown for 48 h in continuous- flow chambers over glass, one supplemented with C-13(6)-arginine for planktonic organisms and the other with unlabeled arginine for biofilm growth. The biofilm and planktonic cells were harvested and lysed separately, and fractionated into three sequential protein extracts. Corresponding heavy ( H) planktonic and light ( L) biofilm protein extracts were mixed and separated by 1D SDS-PAGE gels, and samples were extensively analyzed by liquid chromatography-mass spectrometry. Overall, 757 proteins were identified, and 152 unique proteins met a 1.5-fold cutoff threshold for differential expression with p-values <0.05. Comparing biofilm to planktonic organisms, this set included 73 upregulated and 54 downregulated proteins. Nearly a third of the upregulated proteins were involved in energy metabolism, with cell envelope proteins making up the next largest group. Of the downregulated proteins, the largest groups were involved in protein synthesis and energy metabolism. These proteomics results were compared with our previously reported results from transcriptional profiling of gonococcal biofilms using microarrays. Nitrite reductase and cytochrome c peroxidase, key enzymes required for anaerobic growth, were detected as highly upregulated in both the proteomic and transcriptomic datasets. These and other protein expression changes observed in the present study were consistent with a shift to anaerobic respiration in gonococcal biofilms, although changes in membrane proteins not explicitly related to this shift may have other functions.	[Phillips, Nancy J.; Gibson, Bradford W.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Steichen, Christopher T.; Bair, Thomas B.; Falsetta, Megan L.; Apicella, Michael A.] Univ Iowa, Coll Med, Dept Microbiol, Iowa City, IA 52242 USA; [Schilling, Birgit; Post, Deborah M. B.; Gibson, Bradford W.] Buck Inst Res Aging, Novato, CA USA; [Niles, Richard K.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Biol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of Iowa; Buck Institute for Research on Aging; University of California System; University of California San Francisco	Phillips, NJ (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	bgibson@buckinstitute.org	Falsetta, Megan L./AAE-1586-2020		NIH [AI045728]; shared instrumentation grant [S10 RR024615]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045728] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); shared instrumentation grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIH grant AI045728 (M.A.A.) and by the shared instrumentation grant S10 RR024615. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barken KB, 2008, ENVIRON MICROBIOL, V10, P2331, DOI 10.1111/j.1462-2920.2008.01658.x; Beloin C, 2005, TRENDS MICROBIOL, V13, P16, DOI 10.1016/j.tim.2004.11.008; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Bernardini G, 2011, PROTEOMICS, V11, P1351, DOI 10.1002/pmic.201000406; Cardinale JA, 2000, INFECT IMMUN, V68, P4368, DOI 10.1128/IAI.68.7.4368-4369.2000; Cole MJ, 2010, SEX TRANSM INFECT, V86, P427, DOI 10.1136/sti.2010.044164; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; DORWARD DW, 1989, J BACTERIOL, V171, P4196, DOI 10.1128/JB.171.8.4196-4201.1989; DORWARD DW, 1989, J BACTERIOL, V171, P2499, DOI 10.1128/jb.171.5.2499-2505.1989; Dreisbach A, 2008, PROTEOMICS, V8, P2062, DOI 10.1002/pmic.200701081; Ducey TF, 2005, J BACTERIOL, V187, P4865, DOI 10.1128/JB.187.14.4865-4874.2005; Falsetta ML, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00075; Falsetta ML, 2010, INFECT IMMUN, V78, P2320, DOI 10.1128/IAI.01312-09; Falsetta ML, 2009, INFECT IMMUN, V77, P3522, DOI 10.1128/IAI.00036-09; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Goodman SD, 2011, MUCOSAL IMMUNOL, V4, P625, DOI 10.1038/mi.2011.27; Graham Ciaren, 2011, Bioeng Bugs, V2, P17, DOI 10.4161/bbug.2.1.14413; Greiner LL, 2005, INFECT IMMUN, V73, P1964, DOI 10.1128/IAI.73.4.1964-1970.2005; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Hook Er., 1999, SEX TRANSM DIS; Hopper A, 2009, FEMS MICROBIOL LETT, V301, P232, DOI 10.1111/j.1574-6968.2009.01824.x; Johnson M, 2008, INFECT IMMUN, V76, P1756, DOI 10.1128/IAI.01635-07; Jurcisek JA, 2007, MOL MICROBIOL, V65, P1288, DOI 10.1111/j.1365-2958.2007.05864.x; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Lazazzera BA, 2005, CURR OPIN MICROBIOL, V8, P222, DOI 10.1016/j.mib.2005.02.015; Luke NR, 2007, INFECT IMMUN, V75, P5559, DOI 10.1128/IAI.00946-07; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; MORSE SA, 1980, CAN J MICROBIOL, V26, P13, DOI 10.1139/m80-003; Mukherjee J, 2011, PROTEOMICS, V11, P339, DOI 10.1002/pmic.201000386; Nigaud Y, 2010, BBA-PROTEINS PROTEOM, V1804, P957, DOI 10.1016/j.bbapap.2010.01.008; Nudleman E, 2004, J MOL MICROB BIOTECH, V7, P52, DOI 10.1159/000077869; O'Dwyer CA, 2009, MICROBIOL-SGM, V155, P1940, DOI 10.1099/mic.0.026559-0; Ohnishi M, 2011, ANTIMICROB AGENTS CH, V55, P3538, DOI 10.1128/AAC.00325-11; Ong SE, 2003, METHODS, V29, P124, DOI 10.1016/S1046-2023(02)00303-1; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2003, J PROTEOME RES, V2, P173, DOI 10.1021/pr0255708; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Orme R, 2006, PROTEOMICS, V6, P4269, DOI 10.1002/pmic.200600193; Pitcher RS, 2004, BBA-BIOENERGETICS, V1655, P388, DOI 10.1016/j.bbabio.2003.09.017; Resch A, 2006, PROTEOMICS, V6, P1867, DOI 10.1002/pmic.200500531; Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005; Rey S, 2005, NUCLEIC ACIDS RES, V33, pD164, DOI 10.1093/nar/gki027; Ruiz L, 2009, MICROBIOL-SGM, V155, P957, DOI 10.1099/mic.0.024273-0; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Sauer K, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-219; Schembri MA, 2003, MOL MICROBIOL, V48, P253, DOI 10.1046/j.1365-2958.2003.03432.x; Schryvers AB, 1999, MOL MICROBIOL, V32, P1117, DOI 10.1046/j.1365-2958.1999.01411.x; Seib KL, 2006, MICROBIOL MOL BIOL R, V70, P344, DOI 10.1128/MMBR.00044-05; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Shin JH, 2009, J MICROBIOL, V47, P728, DOI 10.1007/s12275-009-0158-y; Soufi B, 2010, J PROTEOME RES, V9, P3638, DOI 10.1021/pr100150w; Steichen CT, 2011, INFECT IMMUN, V79, P1504, DOI 10.1128/IAI.01162-10; Steichen CT, 2008, J INFECT DIS, V198, P1856, DOI 10.1086/593336; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Tang WH, 2008, J PROTEOME RES, V7, P3661, DOI 10.1021/pr070492f; Teal TK, 2006, APPL ENVIRON MICROB, V72, P7324, DOI 10.1128/AEM.01163-06; Unemo M, 2010, EUROPEAN COMMUNICABL, V15; van Alen T, 2010, PROTEOMICS, V10, P4512, DOI 10.1002/pmic.201000267; Vilain S, 2004, ANAL BIOCHEM, V329, P120, DOI 10.1016/j.ab.2004.02.014; Wackwitz B, 1999, MOL GEN GENET, V262, P876, DOI 10.1007/s004380051153; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Yu NY, 2011, NUCLEIC ACIDS RES, V39, pD241, DOI 10.1093/nar/gkq1093	66	50	50	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38303	10.1371/journal.pone.0038303	http://dx.doi.org/10.1371/journal.pone.0038303			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701624	Green Published, Green Submitted, gold			2022-12-25	WOS:000305348400048
J	Schoening, T; Bergmann, M; Ontrup, J; Taylor, J; Dannheim, J; Gutt, J; Purser, A; Nattkemper, TW				Schoening, Timm; Bergmann, Melanie; Ontrup, Joerg; Taylor, James; Dannheim, Jennifer; Gutt, Julian; Purser, Autun; Nattkemper, Tim W.			Semi-Automated Image Analysis for the Assessment of Megafaunal Densities at the Arctic Deep-Sea Observatory HAUSGARTEN	PLOS ONE			English	Article							CONTINENTAL-SLOPE; BENTHIC MACROFAUNA; ASSEMBLAGES; COMMUNITIES; DIVERSITY; ABUNDANCE; ECOLOGY; IMPACT; SCALE; WEST	Megafauna play an important role in benthic ecosystem function and are sensitive indicators of environmental change. Non-invasive monitoring of benthic communities can be accomplished by seafloor imaging. However, manual quantification of megafauna in images is labor-intensive and therefore, this organism size class is often neglected in ecosystem studies. Automated image analysis has been proposed as a possible approach to such analysis, but the heterogeneity of megafaunal communities poses a non-trivial challenge for such automated techniques. Here, the potential of a generalized object detection architecture, referred to as iSIS (intelligent Screening of underwater Image Sequences), for the quantification of a heterogenous group of megafauna taxa is investigated. The iSIS system is tuned for a particular image sequence (i.e. a transect) using a small subset of the images, in which megafauna taxa positions were previously marked by an expert. To investigate the potential of iSIS and compare its results with those obtained from human experts, a group of eight different taxa from one camera transect of seafloor images taken at the Arctic deep-sea observatory HAUSGARTEN is used. The results show that inter-and intra-observer agreements of human experts exhibit considerable variation between the species, with a similar degree of variation apparent in the automatically derived results obtained by iSIS. Whilst some taxa (e. g. Bathycrinus stalks, Kolga hyalina, small white sea anemone) were well detected by iSIS (i.e. overall Sensitivity: 87%, overall Positive Predictive Value: 67%), some taxa such as the small sea cucumber Elpidia heckeri remain challenging, for both human observers and iSIS.	[Schoening, Timm; Ontrup, Joerg; Nattkemper, Tim W.] Univ Bielefeld, Fac Technol, Biodata Min Grp, D-33615 Bielefeld, Germany; [Bergmann, Melanie; Dannheim, Jennifer; Gutt, Julian] Alfred Wegener Inst Polar & Marine Res, HGF MPG Grp Deep Sea Ecol & Technol, Bremerhaven, Germany; [Taylor, James] Univ Glasgow, Glasgow, Lanark, Scotland; [Purser, Autun] Jacobs Univ, Sch Sci & Engn, Bremen, Germany	University of Bielefeld; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Glasgow; Jacobs University	Schoening, T (corresponding author), Univ Bielefeld, Fac Technol, Biodata Min Grp, D-33615 Bielefeld, Germany.	tschoeni@cebitec.uni-bielefeld.de	Nattkemper, Tim W/F-3332-2017; Bergmann, Melanie/H-3347-2015	Nattkemper, Tim W/0000-0002-7986-1158; Bergmann, Melanie/0000-0001-5212-9808; Dannheim, Jennifer/0000-0002-3737-5872; Gutt, Julian/0000-0003-3773-9370; Purser, Autun/0000-0001-5427-0151	DFG Leibniz program; European Communitys Seventh Framework programme under the HERMIONE project [226354]; Kongsfjord-HAUSGARTEN	DFG Leibniz program(German Research Foundation (DFG)); European Communitys Seventh Framework programme under the HERMIONE project; Kongsfjord-HAUSGARTEN	This study was funded by the DFG Leibniz program to Antje Boetius. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Special thanks go to Muhammet Bastan for providing us the source code of the MPEG7 feature extractors. Thomas Soltwedel provided the map of HAUSGARTEN. We thank Antje Boetius for comments to the manuscript and financial support by the DFG Leibniz program. Three anonymous reviewers improved an earlier draft of this paper. This is publication 10013/epic.39189 of the Alfred Wegener Institute for Polar and Marine Research. MB was funded by KongHAU (The Kongsfjord-HAUSGARTEN transect case study: Impact of climate change on Arctic marine community structures and food webs). KongHAU is closely linked to the EU project HERMIONE. AP was funded by the European Communitys Seventh Framework programme (FP7/2007-2013) under the HERMIONE project (grant agreement no. 226354).	AFANASEV IF, 1978, OKEANOLOGIYA+, V18, P950; [Anonymous], 2006, IEEE OCEANS; Bandyopadhyay S, 2007, IEEE T GEOSCI REMOTE, V45, P1506, DOI 10.1109/TGRS.2007.892604; Barat C, 2006, OCEANS 2006, V2006, P1, DOI [DOI 10.1109/OCEANS.2006.306810, 10.1109/OCEANS.2006.306810]; Bastan M, 2010, IEEE MULTIMEDIA, V17, P62, DOI 10.1109/MMUL.2010.5692184; Bergmann M, 2011, DEEP-SEA RES PT I, V58, P711, DOI 10.1016/j.dsr.2011.03.007; Bergmann M, 2011, MAR BIOL RES, V7, P525, DOI 10.1080/17451000.2010.535834; Bett BJ, 2001, PROG OCEANOGR, V50, P349, DOI 10.1016/S0079-6611(01)00066-0; Billett DSM, 2010, DEEP-SEA RES PT II, V57, P1406, DOI 10.1016/j.dsr2.2009.02.001; Bishop C. M., 2006, J ELECT IMAG, V16, P140; Bluhm BA, 2005, POLAR BIOL, V28, P218, DOI 10.1007/s00300-004-0675-4; Calinski T., 1974, COMMUNICATIONS STAT, V3, P1, DOI [DOI 10.1080/03610927408827101, 10.1080/03610927408827101]; Carney RS, 1997, BIODIVERS CONSERV, V6, P1463, DOI 10.1023/A:1018310302215; CHEN YQ, 1995, PATTERN RECOGN, V28, P537, DOI 10.1016/0031-3203(94)00116-4; CHRISTIANSEN B, 1992, NATO ADV SCI I C-MAT, V360, P125; Clement R, 2005, AUSTR C ROB AUT AUST; Collie JS, 1997, MAR ECOL PROG SER, V155, P159, DOI 10.3354/meps155159; Cristianini N, 2000, INTRO SUPPORT VECTOR; Culverhouse PF, 2003, MAR ECOL PROG SER, V247, P17, DOI 10.3354/meps247017; DAUGMAN JG, 1988, IEEE T ACOUST SPEECH, V36, P1169, DOI 10.1109/29.1644; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; de Groot S.J, 1998, 19981 NIOZ; Di Gesu V, 2003, 12TH INTERNATIONAL CONFERENCE ON IMAGE ANALYSIS AND PROCESSING, PROCEEDINGS, P504, DOI 10.1109/ICIAP.2003.1234100; FEDER HM, 1988, J EXP MAR BIOL ECOL, V116, P99, DOI 10.1016/0022-0981(88)90050-0; Foresti GL, 2002, IEEE J OCEANIC ENG, V27, P66, DOI 10.1109/48.989889; Frauenheim K., 1989, Senckenbergiana Maritima, V20, P101; Freire J, 1996, MAR BIOL, V126, P297, DOI 10.1007/BF00347454; Gage JD, 2004, DEEP-SEA RES PT II, V51, P1689, DOI 10.1016/j.dsr2.2004.07.013; Gallucci F, 2008, DEEP-SEA RES PT I, V55, P332, DOI 10.1016/j.dsr.2007.12.001; Gallucci F, 2008, J EXP MAR BIOL ECOL, V354, P39, DOI 10.1016/j.jembe.2007.10.006; Gordan M, 2006, 2006 IEEE-TTTC INTERNATIONAL CONFERENCE ON AUTOMATION, QUALITY AND TESTING, ROBOTICS, VOL 2, PROCEEDINGS, P327; GRASSLE JF, 1975, DEEP-SEA RES, V22, P457, DOI 10.1016/0011-7471(75)90020-0; GRAY JS, 1981, MAR POLLUT BULL, V12, P173, DOI 10.1016/0025-326X(81)90230-7; Guilini K, 2010, LIMNOL OCEANOGR, V55, P1977, DOI 10.4319/lo.2010.55.5.1977; Guillen J, 2008, CONT SHELF RES, V28, P2382, DOI 10.1016/j.csr.2008.05.003; Hartmut Bluhm, 2001, DEEP SEA RES 2, V48, P3841; Hasemann Christiane, 2006, Berichte zur Polar- und Meeresforschung, V527, P1; HECKER B, 1994, DEEP-SEA RES PT II, V41, P809, DOI 10.1016/0967-0645(94)90050-7; Howland J., 2006, OCEANS 2006, P1, DOI [10.1109/OCEANS.2006.307098, DOI 10.1109/OCEANS.2006.307098]; HUETTEL M, 1992, MAR ECOL PROG SER, V89, P253, DOI 10.3354/meps089253; Huettel M, 1992, MARINE ECOLOGY PROGR, V89, P267; HUNKINS KL, 1960, LIMNOL OCEANOGR, V5, P154, DOI 10.4319/lo.1960.5.2.0154; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; Jones DOB, 2007, MAR BIOL RES, V3, P191, DOI 10.1080/17451000701455287; Kaiser MJ, 1998, AM FISH S S, V22, P212; Kanzog C, 2009, MAR ECOL-EVOL PERSP, V30, P391, DOI 10.1111/j.1439-0485.2009.00290.x; Kanzog C, 2009, POLAR BIOL, V32, P105, DOI 10.1007/s00300-008-0510-4; Kaufmann RS, 1997, DEEP-SEA RES PT I, V44, P559, DOI 10.1016/S0967-0637(97)00005-8; Kogan I, 2006, CONT SHELF RES, V26, P771, DOI 10.1016/j.csr.2006.01.010; LAMPITT RS, 1986, MAR BIOL, V93, P69, DOI 10.1007/BF00428656; Lauerman LML, 1996, DEEP-SEA RES PT I, V43, P1075, DOI 10.1016/0967-0637(96)00045-3; Lochte K, 2003, PROCESSES DRIVEN SMA; MacDonald IR, 2010, DEEP-SEA RES PT II, V57, P136, DOI 10.1016/j.dsr2.2009.08.012; MacLeod N, 2010, NATURE, V467, P154, DOI 10.1038/467154a; Mayer M, 1996, MAR ECOL PROG SER, V143, P151, DOI 10.3354/meps143151; Nybakken J, 1998, DEEP-SEA RES PT II, V45, P1753, DOI 10.1016/S0967-0645(98)80016-7; Ontrup J., 2009, OCEANS 2009 EUROPE, V17, DOI [10.1109/OCEANSE.2009.5278332, DOI 10.1109/OCEANSE.2009.5278332]; Ontrup J., 2004, COGN PROCESS, V5, P31; PAUL AZ, 1974, MAR BIOL, V27, P251, DOI 10.1007/BF00391950; Piepenburg D, 1996, POLAR BIOL, V16, P431, DOI 10.1007/BF02390425; PIEPENBURG D, 1995, MAR ECOL PROG SER, V118, P199, DOI 10.3354/meps118199; Platt JC, 2000, ADV NEUR IN, P61; Powell JR, 2003, OCEANS 2003 MTS/IEEE: CELEBRATING THE PAST...TEAMING TOWARD THE FUTURE, P175; Premke K, 2003, J EXP MAR BIOL ECOL, V285, P283, DOI 10.1016/S0022-0981(02)00533-6; Premke K, 2006, MAR ECOL PROG SER, V325, P121, DOI 10.3354/meps325121; Purser A., 2009, MARINE ECOLOGY PROGR; Queric NV, 2007, MAR ECOL-EVOL PERSP, V28, P66, DOI 10.1111/j.1439-0485.2007.00177.x; Quric N, 2008, MARINE ECOLOGY PROGR, P87; Reiss H, 2006, ICES J MAR SCI, V63, P1453, DOI 10.1016/j.icesjms.2006.06.001; REX MA, 1981, ANNU REV ECOL SYST, V12, P331, DOI 10.1146/annurev.es.12.110181.001555; Rigby P, 2010, J FIELD ROBOT, V27, P741, DOI 10.1002/rob.20372; Robertson P, 2009, WORKSH APPL COMP VIS, P1, DOI [10.1109/WACV.2009.5403037, DOI 10.1109/WACV.2009.5403037]; Rosenfeld A., 1982, DIGITAL PICTURE PROC; Rova A, 2007, IAPR C MACH VIS APPL; Ruhl HA, 2007, ECOLOGY, V88, P1250, DOI 10.1890/06-0890; Sarda R, 1998, ESTUAR COAST SHELF S, V46, P657, DOI 10.1006/ecss.1997.0322; Schulz M, 2010, POLAR BIOL, V33, P1359, DOI 10.1007/s00300-010-0825-9; SCHWINGHAMER P, 1981, CAN J FISH AQUAT SCI, V38, P1255, DOI 10.1139/f81-167; Sikora T, 2001, IEEE T CIRC SYST VID, V11, P696, DOI 10.1109/76.927422; Smith KL, 2009, P NATL ACAD SCI USA, V106, P19211, DOI 10.1073/pnas.0908322106; SMITH KL, 1993, DEEP-SEA RES PT I, V40, P2307, DOI 10.1016/0967-0637(93)90106-D; Solan M, 2003, J EXP MAR BIOL ECOL, V285, P313, DOI 10.1016/S0022-0981(02)00535-X; Soltwedel T, 2001, MAR ECOL PROG SER, V219, P291, DOI 10.3354/meps219291; Soltwedel T., 2005, OCEANOGRAPHY, V18, P46, DOI [10.5670/oceanog.2005.24, DOI 10.5670/0CEAN0G.2005.24]; Soltwedel T, 2009, DEEP-SEA RES PT I, V56, P1856, DOI 10.1016/j.dsr.2009.05.012; Spampinato C., 2010, P 1 ACM INT WORKSH A, P45, DOI [DOI 10.1145/1877868.1877881, 10.1145/1877868.1877881]; Starmans A, 2002, MAR ECOL PROG SER, V225, P45, DOI 10.3354/meps225045; Sumida PYG, 2008, DEEP-SEA RES PT II, V55, P2465, DOI 10.1016/j.dsr2.2008.06.006; TAYLOR R, 2008, OCEANS, V2008, P1, DOI DOI 10.1109/OCEANS.2008.5152032; Teixido N, 2011, MAR ECOL PROG SER, V431, P45, DOI 10.3354/meps09127; Thomson J, 1987, M MAR STUD GROUP GEO; Tyler P, 2003, ECOSYSTEMS DEEP OCEA, V28; van Leeuwen P, 1994, VARIATIONS ABUNDANCE; van Oevelen D, 2011, DEEP-SEA RES PT I, V58, P1069, DOI 10.1016/j.dsr.2011.08.002; Vapnik V.N., 1995, NATURE STAT LEARNING; White OR, METHODS ESTIMATING E; York A., 2008, OCEANS 2008, P19, DOI [10.1109/OCEANS.2008.5152001, DOI 10.1109/OCEANS.2008.5152001]	97	72	72	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38179	10.1371/journal.pone.0038179	http://dx.doi.org/10.1371/journal.pone.0038179			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22719868	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343900020
J	Su, K; Sabeva, NS; Liu, JJ; Wang, YH; Bhatnagar, S; van der Westhuyzen, DR; Graf, GA				Su, Kai; Sabeva, Nadezhda S.; Liu, Jingjing; Wang, Yuhuan; Bhatnagar, Saloni; van der Westhuyzen, Deneys R.; Graf, Gregory A.			The ABCG5 ABCG8 Sterol Transporter Opposes the Development of Fatty Liver Disease and Loss of Glycemic Control Independently of Phytosterol Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILIARY CHOLESTEROL SECRETION; DIETARY-CHOLESTEROL; SCAVENGER RECEPTOR; SR-BI; PLANT STEROLS; ER STRESS; MICE; SITOSTEROLEMIA; EZETIMIBE; ABSORPTION	ABCG5 and ABCG8 form a complex (G5G8) that opposes the absorption of plant sterols but is also expressed in liver where it promotes the excretion of cholesterol into bile. Hepatic G5G8 is transcriptionally regulated by a number of factors implicated in the development of insulin resistance and nonalcoholic fatty liver disease. Therefore, we hypothesized that G5G8 may influence the development of diet-induced obesity phenotypes independently of its role in opposing phytosterol absorption. G5G8 knock-out (KO) mice and their wild type (WT) littermates were challenged with a plant sterol-free low fat or high fat (HF) diet. Weight gain and the rise in fasting glucose were accelerated in G5G8 KO mice following HF feeding. HF-fed G5G8 KO mice had increased liver weight, hepatic lipids, and plasma alanine aminotransferase compared with WT controls. Consistent with the development of nonalcoholic fatty liver disease, macrophage infiltration, the number of TUNEL-positive cells, and the expression of proinflammatory cytokines were also increased in G5G8 KO mice. Hepatic lipid accumulation was associated with increased peroxisome proliferator activated receptor gamma, CD36, and fatty acid uptake. Phosphorylation of eukaryotic translation initiation factor 2 alpha (eiF2 alpha) and expression of activating transcription factor 4 and tribbles 3 were elevated in HF-fed G5G8 KO mice, a pathway that links the unfolded protein response to the development of insulin resistance through inhibition of protein kinase B (Akt) phosphorylation. Phosphorylation of Akt and insulin receptor was reduced, whereas serine phosphorylation of insulin receptor substrate 1 was elevated.	[Graf, Gregory A.] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA; [Bhatnagar, Saloni] Univ Kentucky, Dept Pediat, Lexington, KY 40536 USA; [van der Westhuyzen, Deneys R.] Univ Kentucky, Dept Internal Med, Lexington, KY 40536 USA; [Su, Kai; Sabeva, Nadezhda S.; Liu, Jingjing; Wang, Yuhuan; van der Westhuyzen, Deneys R.; Graf, Gregory A.] Univ Kentucky, Grad Ctr Nutr Sci, Lexington, KY 40536 USA; [Su, Kai; Sabeva, Nadezhda S.; Liu, Jingjing; Wang, Yuhuan; van der Westhuyzen, Deneys R.; Graf, Gregory A.] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Graf, GA (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, 345 Biol Pharmaceut Complex,789 S Limestone, Lexington, KY 40536 USA.	Gregory.Graf@uky.edu		Graf, Gregory/0000-0002-0130-9929; Sabeva, Nadezhda/0000-0002-7714-4884	National Institutes of Health [R01DK080874]; National Center for Research Resources [5P20RR021954-05]; NIGMS [8 P20 GM103527-05]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024598, P20RR021954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK080874 (to G. A. G.), 5P20RR021954-05 from the National Center for Research Resources, and 8 P20 GM103527-05 from the NIGMS.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Bao LP, 2006, J BIOL CHEM, V281, P33635, DOI 10.1074/jbc.M606339200; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Biddinger SB, 2008, NAT MED, V14, P778, DOI 10.1038/nm1785; BOTHAM KM, 1995, PROG LIPID RES, V34, P71, DOI 10.1016/0163-7827(94)00007-9; Brufau G, 2011, ARTERIOSCL THROM VAS, V31, P1726, DOI 10.1161/ATVBAHA.108.181206; Carter BA, 2007, PEDIATR RES, V62, P301, DOI 10.1203/PDR.0b013e3181256492; de Bari O, 2012, J LIPIDS, V2012, DOI 10.1155/2012/302847; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Dikkers A, 2010, WORLD J GASTROENTERO, V16, P5936, DOI 10.3748/wjg.v16.i47.5936; Djouadi F, 2003, PEDIATR RES, V54, P446, DOI 10.1203/01.PDR.0000083001.91588.BB; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Freeman LA, 2004, J LIPID RES, V45, P1197, DOI 10.1194/jlr.C400002-JLR200; Graewin SJ, 2004, J SURG RES, V122, P145, DOI 10.1016/j.jss.2004.04.012; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Graf GA, 2002, J CLIN INVEST, V110, P659, DOI 10.1172/JCI200216000; Hyogo H, 2003, J LIPID RES, V44, P1232, DOI 10.1194/jlr.M300029-JLR200; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Lee MH, 2001, NAT GENET, V27, P79, DOI 10.1038/83799; Liu J, 2010, J LIPID RES, V51, P162, DOI 10.1194/jlr.M900237-JLR200; Lutjohann D, 2008, INT J CLIN PRACT, V62, P1499, DOI 10.1111/j.1742-1241.2008.01841.x; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Mendez-Gonzalez J, 2011, BBA-MOL CELL BIOL L, V1811, P1186, DOI 10.1016/j.bbalip.2011.07.019; Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Sabeva NS, 2007, J BIOL CHEM, V282, P22397, DOI 10.1074/jbc.M702236200; Sabeva NS, 2011, J NUTR BIOCHEM, V22, P777, DOI 10.1016/j.jnutbio.2010.07.002; Salen G, 2006, GASTROENTEROLOGY, V130, P1853, DOI 10.1053/j.gastro.2006.02.027; Salen G, 2004, CIRCULATION, V109, P966, DOI 10.1161/01.CIR.0000116766.31036.03; SALEN G, 1992, J LIPID RES, V33, P945; Shetty S, 2006, ARTERIOSCL THROM VAS, V26, P2125, DOI 10.1161/01.ATV.0000233335.26362.37; Subramanian S, 2011, J LIPID RES, V52, P1626, DOI 10.1194/jlr.M016246; Sumi K, 2007, MOL CELL BIOL, V27, P4248, DOI 10.1128/MCB.01894-06; van Rooyen DM, 2011, GASTROENTEROLOGY, V141, P1393, DOI 10.1053/j.gastro.2011.06.040; Wiersma H, 2009, J LIPID RES, V50, P1571, DOI 10.1194/jlr.M800434-JLR200; Wilund KR, 2004, J LIPID RES, V45, P1429, DOI 10.1194/jlr.M400167-JLR200; Yang CD, 2004, J CLIN INVEST, V114, P813, DOI 10.1172/JCI200422186; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Yu LQ, 2005, J LIPID RES, V46, P1739, DOI 10.1194/jlr.M500124-JLR200; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]	41	36	39	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28564	28575		10.1074/jbc.M112.360081	http://dx.doi.org/10.1074/jbc.M112.360081			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22715101	hybrid, Green Published			2022-12-25	WOS:000308074600031
J	Okamoto, N; Horak, A; Keeling, PJ				Okamoto, Noriko; Horak, Ales; Keeling, Patrick J.			Description of Two Species of Early Branching Dinoflagellates, Psammosa pacifica n. g., n. sp and P. atlantica n. sp	PLOS ONE			English	Article							INTRACELLULAR PARASITE; MICROBIAL EUKARYOTES; GENETIC DIVERSITY; OXYRRHIS-MARINA; FINE-STRUCTURE; PHYLOGENETIC POSITION; EVOLUTIONARY HISTORY; PERKINSUS-MARINUS; NOV; ULTRASTRUCTURE	In alveolate evolution, dinoflagellates have developed many unique features, including the cell that has epicone and hypocone, the undulating transverse flagellum. However, it remains unclear how these features evolved. The early branching dinoflagellates so far investigated such as Hematodinium, Amoebophrya and Oxyrrhis marina differ in many ways from of core dinoflagellates, or dinokaryotes. Except those handful of well studied taxa, the vast majority of early branching dinoflagellates are known only by environmental sequences, and remain enigmatic. In this study we describe two new species of the early branching dinoflagellates, Psammosa pacifica n. g., n. sp. and P. atlantica n. sp. from marine intertidal sandy beach. Molecular phylogeny of the small subunit (SSU) ribosomal RNA and Hsp90 gene places Psammosa spp. as an early branch among the dinoflagellates. Morphologically (1) they lack the typical dinoflagellate epicone-hypocone structure, and (2) undulation in either flagella. Instead they display a mosaic c of dinokaryotes traits, i.e. (3) presence of bipartite trychocysts; Oxyrrhis marina-like traits, i.e. (4) presence of flagellar hairs, (5) presence of two-dimensional cobweb scales ornamenting both flagella (6) transversal cell division; a trait shared with some syndineansand Parvilucifera spp. i.e. (7) a nucleus with a conspicuous nucleolus and condensed chromatin distributed beneath the nuclear envelope; as well as Perkinsus marinus -like features i.e. (8) separate ventral grooves where flagella emerge and (9) lacking dinoflagellate-type undulating flagellum. Notably Psammosa retains an apical complex structure, which is shared between perkinsids, colpodellids, chromerids and apicomplexans, but is not found in dinokaryotic dinoflagellates.	[Okamoto, Noriko; Horak, Ales; Keeling, Patrick J.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Horak, Ales] Acad Sci Czech Republ, Inst Parasitol, Lab Mol Taxon, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Horak, Ales] Univ S Bohemia, Fac Sci, Dept Evolutionary Protistol, Ceske Budejovice, Czech Republic	University of British Columbia; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Okamoto, N (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	okamoton@ubc.mail.ca	Horak, Ales/H-6723-2012; Okamoto, Noriko/J-6570-2012	Horak, Ales/0000-0002-3364-7383; Okamoto, Noriko/0000-0001-5493-8051; Keeling, Patrick/0000-0002-7644-0745	Tula Foundation; Canadian Institutes for Health Research [MOP-42517]; Canadian Institute for Advanced Research; Biology Centre of Academy of Sciences of the Czech Republic, Institute of Parasitology [Z60220518]	Tula Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Biology Centre of Academy of Sciences of the Czech Republic, Institute of Parasitology	This work was supported by a grant from the Tula Foundation to the Centre for Microbial Diversity and Evolution, and grants from the Canadian Institutes for Health Research (MOP-42517) to PJK. PJK is supported by the Canadian Institute for Advanced Research. AH was partly supported by Biology Centre of Academy of Sciences of the Czech Republic, Institute of Parasitology (Grant Number Z60220518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qassab S, 2002, ACTA PROTOZOOL, V41, P91; Alexander E, 2009, ENVIRON MICROBIOL, V11, P360, DOI 10.1111/j.1462-2920.2008.01777.x; Appleton PL, 1998, PARASITOLOGY, V116, P115, DOI 10.1017/S0031182097002096; AZEVEDO C, 1989, J PARASITOL, V75, P627, DOI 10.2307/3282915; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Botte CY, 2011, J BIOL CHEM, V286, P29893, DOI 10.1074/jbc.M111.254979; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; Brugerolle G, 2002, EUR J PROTISTOL, V38, P113, DOI 10.1078/0932-4739-00864; Cachon J., 1987, Botanical Monographs (Oxford), V21, P571; Cavalier-Smith T, 2004, EUR J PROTISTOL, V40, P185, DOI 10.1016/j.ejop.2004.01.002; Cavalier-Smith T, 2004, P ROY SOC B-BIOL SCI, V271, P1251, DOI 10.1098/rspb.2004.2705; Clarke K.J, 1972, British phycol J, V7, P357; CLARKE KJ, 1976, BRIT PHYCOL J, V11, P345, DOI 10.1080/00071617600650391; Coats DW, 2012, J EUKARYOT MICROBIOL, V59, P1, DOI 10.1111/j.1550-7408.2011.00588.x; Cuvelier ML, 2008, ENVIRON MICROBIOL, V10, P1621, DOI 10.1111/j.1462-2920.2008.01580.x; DODGE J D, 1971, Protistologica, V7, P399; DODGE JD, 1971, BOT REV, V37, P481, DOI 10.1007/BF02868686; FOISSNER W, 1984, PROTISTOLOGICA, V20, P635; FRITZ L, 1992, J PHYCOL, V28, P312, DOI 10.1111/j.0022-3646.1992.00312.x; Garces E, 2010, HARMFUL ALGAE, V10, P64, DOI 10.1016/j.hal.2010.07.001; Gestal C, 2006, ENVIRON MICROBIOL, V8, P1105, DOI 10.1111/j.1462-2920.2006.01008.x; Gomez F, 2010, PROTIST, V161, P466, DOI 10.1016/j.protis.2009.12.005; Gomez F, 2009, SYST PARASITOL, V74, P65, DOI 10.1007/s11230-009-9199-1; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Green BR, 2004, PROTIST, V155, P23, DOI 10.1078/1434461000161; Groisillier A, 2006, AQUAT MICROB ECOL, V42, P277, DOI 10.3354/ame042277; Guillou L, 2008, ENVIRON MICROBIOL, V10, P3349, DOI 10.1111/j.1462-2920.2008.01731.x; Gunderson JH, 1999, J EUKARYOT MICROBIOL, V46, P194, DOI 10.1111/j.1550-7408.1999.tb04603.x; Hansen G, 1998, EUR J PHYCOL, V33, P281; Hansen G, 2007, PHYCOL RES, V55, P25, DOI 10.1111/j.1440-1835.2006.00442.x; Harada A, 2007, PROTIST, V158, P337, DOI 10.1016/j.protis.2007.03.005; Hoppenrath M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013220; Jackson CJ, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-41; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Janson S, 2000, PARASITOL RES, V86, P929, DOI 10.1007/s004360000272; Janssen PH, 2009, NATURE, V458, P831, DOI 10.1038/458831a; Kato KH, 2000, BIOL CELL, V92, P583, DOI 10.1016/S0248-4900(00)01106-0; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; KELLER MD, 1987, J PHYCOL, V23, P633; Kim E, 2006, MOL BIOL EVOL, V23, P2455, DOI 10.1093/molbev/msl120; Kim S, 2008, J EUKARYOT MICROBIOL, V55, P1, DOI 10.1111/j.1550-7408.2007.00295.x; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; LEADBEATER BS, 1971, J CELL SCI, V9, P443; Leander BS, 2008, EUR J PROTISTOL, V44, P55, DOI 10.1016/j.ejop.2007.08.004; Leander BS, 2004, J PHYCOL, V40, P341, DOI 10.1111/j.1529-8817.2004.03129.x; Leander BS, 2003, TRENDS ECOL EVOL, V18, P395, DOI 10.1016/S0169-5347(03)00152-6; Lidie KB, 2007, J EUKARYOT MICROBIOL, V54, P427, DOI 10.1111/j.1550-7408.2007.00282.x; Lin SJ, 2011, RES MICROBIOL, V162, P551, DOI 10.1016/j.resmic.2011.04.006; Lin SJ, 2002, J MOL BIOL, V320, P727, DOI 10.1016/S0022-2836(02)00468-0; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Lopez-Garcia P, 2007, ENVIRON MICROBIOL, V9, P546, DOI 10.1111/j.1462-2920.2006.01158.x; Lovejoy C, 2006, APPL ENVIRON MICROB, V72, P3085, DOI 10.1128/AEM.72.5.3085-3095.2006; Mangot JF, 2011, HYDROBIOLOGIA, V659, P37, DOI 10.1007/s10750-010-0268-x; Maranda L, 2001, J PHYCOL, V37, P245, DOI 10.1046/j.1529-8817.2001.037002245.x; Massana R, 2008, ENVIRON MICROBIOL, V10, P1335, DOI 10.1111/j.1462-2920.2007.01549.x; Massana R, 2008, CURR OPIN MICROBIOL, V11, P213, DOI 10.1016/j.mib.2008.04.004; Miller JJ, 2011, PROTIST; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; MORRILL L C, 1981, Journal of Plankton Research, V3, P53, DOI 10.1093/plankt/3.1.53; Myl'nikova ZM, 2009, INLAND WATER BIOL, V2, P199, DOI 10.1134/S199508290903002X; Mylnikov AP, 2009, BIOL BULL+, V36, P582, DOI 10.1134/S1062359009060065; Noren F, 1999, EUR J PROTISTOL, V35, P233, DOI 10.1016/S0932-4739(99)80001-7; Obornik M, 2009, INT J PARASITOL, V39, P1, DOI 10.1016/j.ijpara.2008.07.010; Okamoto N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007080; Patterson DJ, 1996, EUR J PROTISTOL, V32, P423, DOI 10.1016/S0932-4739(96)80003-4; PERKINS FO, 1976, J PARASITOL, V62, P959, DOI 10.2307/3279192; Perkins FO, 1996, J SHELLFISH RES, V15, P67; PERKINS FO, 1976, MAR FISH REV, V38, P19; Pfiester L.A., 1987, Botanical Monographs (Oxford), V21, P611; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; ROBERTS KR, 1987, PROTOPLASMA, V137, P65, DOI 10.1007/BF01281178; Saldarriaga JF, 2004, EUR J PROTISTOL, V40, P85, DOI 10.1016/j.ejop.2003.11.003; Saldarriaga JF, 2003, INT J SYST EVOL MICR, V53, P355, DOI 10.1099/ijs.0.02328-0; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2004, ANN STAT, V32, P2616, DOI 10.1214/009053604000000823; Silberman JD, 2004, J EUKARYOT MICROBIOL, V51, P246, DOI 10.1111/j.1550-7408.2004.tb00555.x; Skovgaard A, 2005, PROTIST, V156, P413, DOI 10.1016/j.protis.2005.08.002; Skovgaard A, 2008, PROTIST, V159, P401, DOI 10.1016/j.protis.2008.02.003; Skovgaard A, 2009, ENVIRON MICROBIOL, V11, P2030, DOI 10.1111/j.1462-2920.2009.01924.x; Slamovits CH, 2007, J MOL BIOL, V372, P356, DOI 10.1016/j.jmb.2007.06.085; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stern RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013991; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P5656, DOI 10.1128/AEM.69.9.5656-5663.2003; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P2657, DOI 10.1128/AEM.69.5.2657-2663.2003; Stoeck T, 2007, MICROB ECOL, V53, P328, DOI 10.1007/s00248-006-9166-1; Stoeck T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-72; Takishita K, 2010, J EUKARYOT MICROBIOL, V57, P76, DOI 10.1111/j.1550-7408.2009.00457.x; Tamura M, 2009, PHYCOL RES, V57, P304, DOI 10.1111/j.1440-1835.2009.00550.x; Taylor FJR, 2008, BIODIVERS CONSERV, V17, P407, DOI 10.1007/s10531-007-9258-3; Taylor FJR, 2004, PHYCOL RES, V52, P308, DOI 10.1111/j.1440-1835.2004.tb00341.x; TAYLOR FJR, 1980, BIOSYSTEMS, V13, P65, DOI 10.1016/0303-2647(80)90006-4; TIPPIT DH, 1977, J CELL BIOL, V73, P705, DOI 10.1083/jcb.73.3.705; Waller RF, 2009, BIOESSAYS, V31, P237, DOI 10.1002/bies.200800164; WATANABE MM, 1990, J PHYCOL, V26, P741, DOI 10.1111/j.0022-3646.1990.00741.x; Yuasa K, 2007, FISH PATHOL, V42, P59, DOI 10.3147/jsfp.42.59; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhang H, 2009, MOL BIOL EVOL, V26, P1757, DOI 10.1093/molbev/msp083; Zhang ZD, 1999, NATURE, V400, P155, DOI 10.1038/22099	99	29	32	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e34900	10.1371/journal.pone.0034900	http://dx.doi.org/10.1371/journal.pone.0034900			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719825	Green Submitted, gold, Green Published			2022-12-25	WOS:000305583300002
J	Triplett, JK; Wang, YJ; Zhong, JS; Kellogg, EA				Triplett, Jimmy K.; Wang, Yunjing; Zhong, Jinshun; Kellogg, Elizabeth A.			Five Nuclear Loci Resolve the Polyploid History of Switchgrass (Panicum virgatum L.) and Relatives	PLOS ONE			English	Article							CHROMOSOME-NUMBERS; CHLOROPLAST DNA; PHYLOGENETIC-RELATIONSHIPS; PANICOIDEAE POACEAE; MOLECULAR PHYLOGENY; SEQUENCES; DIVERSITY; EVOLUTION; ORIGINS; PLANTS	Polyploidy poses challenges for phylogenetic reconstruction because of the need to identify and distinguish between homoeologous loci. This can be addressed by use of low copy nuclear markers. Panicum s.s. is a genus of about 100 species in the grass tribe Paniceae, subfamily Panicoideae, and is divided into five sections. Many of the species are known to be polyploids. The most well-known of the Panicum polyploids are switchgrass (Panicum virgatum) and common or Proso millet (P. miliaceum). Switchgrass is in section Virgata, along with P. tricholaenoides, P. amarum, and P. amarulum, whereas P. miliaceum is in sect. Panicum. We have generated sequence data from five low copy nuclear loci and two chloroplast loci and have clarified the origin of P. virgatum. We find that all members of sects. Virgata and Urvilleana are the result of diversification after a single allopolyploidy event. The closest diploid relatives of switchgrass are in sect. Rudgeana, native to Central and South America. Within sections Virgata and Urvilleana, P. tricholaenoides is sister to the remaining species. Panicum racemosum and P. urvilleanum form a clade, which may be sister to P. chloroleucum. Panicum amarum, P. amarulum, and the lowland and upland ecotypes of P. virgatum together form a clade, within which relationships are complex. Hexaploid and octoploid plants are likely allopolyploids, with P. amarum and P. amarulum sharing genomes with P. virgatum. Octoploid P. virgatum plants are formed via hybridization between disparate tetraploids. We show that polyploidy precedes diversification in a complex set of polyploids; our data thus suggest that polyploidy could provide the raw material for diversification. In addition, we show two rounds of allopolyploidization in the ancestry of switchgrass, and identify additional species that may be part of its broader gene pool. This may be relevant for development of the crop for biofuels.	[Triplett, Jimmy K.; Wang, Yunjing; Zhong, Jinshun; Kellogg, Elizabeth A.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA	University of Missouri System; University of Missouri Saint Louis	Triplett, JK (corresponding author), Jacksonville State Univ, Dept Biol, Jacksonville, AL 36265 USA.	jtriplett@jsu.edu; kellogge@umsl.edu	Kellogg, Elizabeth/M-2845-2013	Kellogg, Elizabeth/0000-0003-1671-7447; Zhong, Jinshun/0000-0001-7086-5470	University of Missouri-Research Board; E. Desmond Lee and Family Endowment for Botanical Studies	University of Missouri-Research Board; E. Desmond Lee and Family Endowment for Botanical Studies	This work was funded by the University of Missouri-Research Board, and the E. Desmond Lee and Family Endowment for Botanical Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2004, BIOL J LINN SOC, V82, P467, DOI 10.1111/j.1095-8312.2004.00333.x; AHSAN SMN, 1994, ANN MO BOT GARD, V81, P775, DOI 10.2307/2399922; Ainouche ML, 2004, NEW PHYTOL, V161, P165, DOI 10.1046/j.1469-8137.2003.00926.x; Alderson J. S, 1995, GRASS VARIETIES US; Aliscioni SS, 2003, AM J BOT, V90, P796, DOI 10.3732/ajb.90.5.796; [Anonymous], 1991, VERH ZOOL BOT GES OS; Avdulov N., 1931, T PRIKL BOT SELEKTS, V44, P1, DOI [10.1017/cbo9780511525445.002, DOI 10.1017/CBO9780511525445.002]; BARNETT FL, 1967, CROP SCI, V7, P301, DOI 10.2135/cropsci1967.0011183X000700040005x; Bradley RD, 1997, MOL BIOL EVOL, V14, P592, DOI 10.1093/oxfordjournals.molbev.a025797; Brassac J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033808; BROWN WV, 1948, AM J BOT, V35, P382, DOI 10.2307/2437938; BRUNKEN J N, 1975, Southwestern Naturalist, V19, P379, DOI 10.2307/3670396; Christin PA, 2008, CURR BIOL, V18, P37, DOI 10.1016/j.cub.2007.11.058; Cronn R, 2004, NEW PHYTOL, V161, P133, DOI [10.1111/j.1469-8137.2004.00947.x, 10.1046/j.1469-8137.2003.00947.x]; Devesa J. A., 1991, Boletim da Sociedade Broteriana, V64, P35; Doust AN, 2007, SYST BOT, V32, P531, DOI 10.1600/036364407782250670; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Doyle JJ, 2004, NEW PHYTOL, V161, P121, DOI 10.1046/j.1469-8137.2003.00949.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Feltus FA, 2006, PLANT PHYSIOL, V140, P1183, DOI 10.1104/pp.105.074203; Freckmann RW, 2003, FLORA N AM N MEXIC 2; Frey L., 1981, FRAGM FLORIST GEOBOT, V27, P581; Gadberry MD, 2005, BIOINFORMATICS, V21, P1263, DOI 10.1093/bioinformatics/bti134; Giussani LM, 2001, AM J BOT, V88, P1993, DOI 10.2307/3558427; GOULD FW, 1958, AM J BOT, V45, P757, DOI 10.2307/2439737; Gunter LE, 1996, CROP SCI, V36, P1017, DOI 10.2135/cropsci1996.0011183X003600040034x; HAMOUD MA, 1994, BIOL PLANTARUM, V36, P37, DOI 10.1007/BF02921265; Haroun Soliman A., 1995, Cytologia (Tokyo), V60, P347, DOI 10.1508/cytologia.60.347; Hattersley PW, 1987, GRASS SYSTEMATICS EV; Hilden L, 2004, BIOTECHNOL LETT, V26, P1683, DOI 10.1007/s10529-004-4579-8; Hitchcock A. S., 1971, MANUAL GRASSES US; Hopkins AA, 1996, CROP SCI, V36, P1192, DOI 10.2135/cropsci1996.0011183X003600050021x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hultquist SJ, 1997, CROP SCI, V37, P595, DOI 10.2135/cropsci1997.0011183X003700020047x; Hultquist SJ, 1996, CROP SCI, V36, P1049, DOI 10.2135/cropsci1996.0011183X003600040039x; Hunziker Juan H., 1998, Darwiniana (San Isidro), V35, P29; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; JUNG GA, 1990, AGRON J, V82, P21, DOI 10.2134/agronj1990.00021962008200010005x; JUNGHANS H, 1990, BIOTECHNIQUES, V8, P176; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Libertini E, 2004, J MOL EVOL, V58, P506, DOI 10.1007/s00239-003-2571-x; Liu B, 1998, GENOME, V41, P272, DOI 10.1139/gen-41-2-272; Liu B, 2003, MOL PHYLOGENET EVOL, V29, P365, DOI 10.1016/S1055-7903(03)00213-6; Love A., 1981, Taxon, V30, P508; Love A, 1980, TAXON, V29, P709; Lu K., 1998, GREAT PLAINS RES, V8, P269; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Maddison WP, 2005, MACCLADE ANAL PHYLOG; Martinez-Reyna JM, 2002, CROP SCI, V42, P1800, DOI 10.2135/cropsci2002.1800; Martinez-Reyna JM, 2001, CROP SCI, V41, P1579, DOI 10.2135/cropsci2001.4151579x; Mason-Gamer RJ, 2002, GENOME, V45, P991, DOI [10.1139/g02-065, 10.1139/G02-065]; Mason-Gamer RJ, 2004, SYST BIOL, V53, P25, DOI 10.1080/10635150490424402; Mason-Gamer RJ, 2010, MOL PHYLOGENET EVOL, V54, P10, DOI 10.1016/j.ympev.2009.10.002; McLaughlin SB, 2005, BIOMASS BIOENERG, V28, P515, DOI 10.1016/j.biombioe.2004.05.006; MCMILLAN C, 1959, AM J BOT, V46, P590, DOI 10.2307/2439303; Missaoui AM, 2006, GENET RESOUR CROP EV, V53, P1291, DOI 10.1007/s10722-005-3878-9; Missaoui AM, 2005, THEOR APPL GENET, V110, P1372, DOI 10.1007/s00122-005-1935-6; Molhoj M, 2002, PLANT CELL PHYSIOL, V43, P1399, DOI 10.1093/pcp/pcf163; Morris GP, 2011, MOL ECOL, V20, P4938, DOI 10.1111/j.1365-294X.2011.05335.x; Morrone O, 2008, SYST BOT, V33, P66, DOI 10.1600/036364408783887393; Morrone O, 2007, TAXON, V56, P521, DOI 10.1002/tax.562023; Moser LE, 1995, FORAGES INTRO GRASSL, V1, P409; MURIN A, 1993, BIOLOGIA, V48, P441; Murin Augustin, 1999, Thaiszia, V9, P31; Nielson EL, 1944, J AGRIC RES, V69, P0327; NORRMANN GA, 1994, ANN MO BOT GARD, V81, P768, DOI 10.2307/2399921; Nunez O., 1952, REV FAC AGRON U NAC, V28, P229; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; PALMER PG, 1975, BRITTONIA, V27, P142, DOI 10.2307/2805475; Parodi LR, 1946, GRAMINEAS BONARIENSE; POHL RW, 1971, BRITTONIA, V23, P293, DOI 10.2307/2805632; PORTER CL, 1966, ECOLOGY, V47, P980, DOI 10.2307/1935646; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; PROBATOVA N S, 1983, Botanicheskii Zhurnal (St. Petersburg), V68, P1683; RILEY RD, 1982, CROP SCI, V22, P1082, DOI 10.2135/cropsci1982.0011183X002200050047x; Robert S, 2005, PLANT CELL, V17, P3378, DOI 10.1105/tpc.105.036228; Saggoo MIS, 1981, TAXON, V30, P515; Sambrook J., 1989, MOL CLONING LAB MANU; Sang T, 1999, SYST BOT, V24, P148, DOI 10.2307/2419546; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Simon Bryan K., 2003, Austrobaileya, V6, P571; Sinha RRP, 1990, J CYTOLOGY GENETICS, V25, P140; Soltis DE, 2004, BIOL J LINN SOC, V82, P485, DOI 10.1111/j.1095-8312.2004.00335.x; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; TALBERT LE, 1983, CROP SCI, V23, P725, DOI 10.2135/cropsci1983.0011183X002300040029x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Triplett JK, 2010, SYST BOT, V35, P102, DOI 10.1600/036364410790862678; Urbani MH, 1990, B SOC ARGENT BOT, V26, P205; VAHIDY AA, 1987, ANN MO BOT GARD, V74, P432, DOI 10.2307/2399415; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; Vogel K.P., 2004, WARM SEASON C4 GRASS, P561, DOI DOI 10.2134/AGRONMONOGR45.C16; VOGEL KP, 1991, CROP SCI, V31, P1388, DOI 10.2135/cropsci1991.0011183X003100050080x; Vogel KP, 2001, CRIT REV PLANT SCI, V20, P15, DOI 10.1016/S0735-2689(01)80011-3; Vogel KP, 1985, P M SOC RANG MAN SAL; Warwick SI, 1997, NEWSL INT ORGAN PLAN, V27, P25; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Yamane K, 2005, AM J BOT, V92, P1887, DOI 10.3732/ajb.92.11.1887; Young HA, 2010, BIOENERG RES, V3, P305, DOI 10.1007/s12155-010-9081-7; Zhu QH, 2005, NEW PHYTOL, V167, P249, DOI 10.1111/j.1469-8137.2005.01406.x; Zuloaga F. O., 2000, Grasses: systematics and evolution., P123; Zuloaga FO, 2006, SYST BOT, V31, P497, DOI 10.1600/036364406778388548; Zuloaga FO, 2011, SYST BOTANY MONOGR, V94, P1; ZULOAGA FO, 1987, ANN MO BOT GARD, V74, P463, DOI 10.2307/2399313; Zuloaga FO, 1998, ANN MO BOT GARD, V85, P631, DOI 10.2307/2992019; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI	108	50	50	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38702	10.1371/journal.pone.0038702	http://dx.doi.org/10.1371/journal.pone.0038702			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719924	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300041
J	Peterson, AE; Davis, MF; Julian, KG; Awantang, G; Greene, WH; Price, LB; Waters, A; Doppalapudi, A; Krain, LJ; Nelson, K; Silbergeld, EK; Whitener, CJ				Peterson, Amy E.; Davis, Meghan F.; Julian, Kathleen G.; Awantang, Grace; Greene, Wallace H.; Price, Lance B.; Waters, Andrew; Doppalapudi, Avanthi; Krain, Lisa J.; Nelson, Kenrad; Silbergeld, Ellen K.; Whitener, Cynthia J.			Molecular and Phenotypic Characteristics of Healthcare- and Community-Associated Methicillin-Resistant Staphylococcus aureus at a Rural Hospital	PLOS ONE			English	Article							SINGLE-DISK METHOD; UNITED-STATES; RISK-FACTORS; ANTIBIOTIC SUSCEPTIBILITY; NASAL COLONIZATION; INFECTIONS; PREVALENCE; MRSA; SURVEILLANCE; EMERGENCE	Background: While methicillin-resistant Staphylococcus aureus (MRSA) originally was associated with healthcare, distinct strains later emerged in patients with no prior hospital contact. The epidemiology of MRSA continues to evolve. Methods: To characterize the current epidemiology of MRSA-colonized patients entering a hospital serving both rural and urban communities, we interviewed patients with MRSA-positive admission nasal swabs between August 2009 and March 2010. We applied hospitalization risk factor, antimicrobial resistance phenotype, and multi-locus sequence genotype (MLST) classification schemes to 94 case-patients. Results: By MLST analysis, we identified 15 strains with two dominant clonal complexes (CCs)-CC5 (51 isolates), historically associated with hospitals, and CC8 (27 isolates), historically of community origin. Among patients with CC5 isolates, 43% reported no history of hospitalization within the past six months; for CC8, 67% reported the same. Classification by hospitalization risk factor did not correlate strongly with genotypic classification. Sensitivity of isolates to ciprofloxacin, clindamycin, or amikacin was associated with the CC8 genotype; however, among CC8 strains, 59% were resistant to ciprofloxacin, 15% to clindamycin, and 15% to amikacin. Conclusions: Hospitalization history was not a strong surrogate for the CC5 genotype. Conversely, patients with a history of hospitalization were identified with the CC8 genotype. Although ciprofloxacin, clindamycin, and amikacin susceptibility distinguished CC8 strains, the high prevalence of ciprofloxacin resistance limited its predictive value. As CC8 strains become established in healthcare settings and CC5 strains disseminate into the community, community-associated MRSA definitions based on case-patient hospitalization history may prove less valuable in tracking community MRSA strains.	[Peterson, Amy E.; Davis, Meghan F.; Awantang, Grace; Krain, Lisa J.; Nelson, Kenrad; Silbergeld, Ellen K.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Julian, Kathleen G.; Greene, Wallace H.; Doppalapudi, Avanthi; Whitener, Cynthia J.] Penn State Hershey Med Ctr, Hershey, PA USA; [Price, Lance B.; Waters, Andrew] Translat Genom Res Inst, Flagstaff, AZ USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Translational Genomics Research Institute	Peterson, AE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	mdavis@jhsph.edu	Davis, Meghan F./C-1494-2013	Davis, Meghan F./0000-0002-3475-4578; Krain, Lisa/0000-0002-8498-7177	Johns Hopkins Center for a Livable Future; Heinz Foundation; Johns Hopkins Center for a Livable Future Predoctoral Fellowships; Sommer Scholarship	Johns Hopkins Center for a Livable Future; Heinz Foundation; Johns Hopkins Center for a Livable Future Predoctoral Fellowships; Sommer Scholarship	Research was supported by grants from the Johns Hopkins Center for a Livable Future (http://www.jhsph.edu/clf/) and the Heinz Foundation (http://www.heinzfamily.org/aboutus/philanthropies_02.html). AEP and MFD were supported by Johns Hopkins Center for a Livable Future Predoctoral Fellowships. Additionally, MFD was supported by a Sommer Scholarship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CA, 2010, AM J INFECT CONTROL, V38, P315, DOI 10.1016/j.ajic.2009.05.013; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; BARRY AL, 1970, AM J CLIN PATHOL, V53, P149; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Carleton HA, 2004, J INFECT DIS, V190, P1730, DOI 10.1086/425019; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P707; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Clinical and Laboratory Standards Institute, 2006, M2A9 CLIN LAB STAND; David MZ, 2008, J INFECT DIS, V197, P1235, DOI 10.1086/533502; Deddens JA, 2008, OCCUP ENVIRON MED, V65, P501, DOI 10.1136/oem.2007.034777; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Freitas EAF, 2010, INFECT CONT HOSP EP, V31, P469, DOI 10.1086/651672; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Huang SS, 2003, CLIN INFECT DIS, V36, P281, DOI 10.1086/345955; Klein E, 2009, EMERG INFECT DIS, V15, P1925, DOI 10.3201/eid1512.081341; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Klevens RM, 2006, EMERG INFECT DIS, V12, P1991; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; Maree CL, 2007, EMERG INFECT DIS, V13, P236, DOI 10.3201/eid1302.060781; Marschall J, 2006, INFECT CONT HOSP EP, V27, P1206, DOI 10.1086/507917; McDougal LK, 2010, ANTIMICROB AGENTS CH, V54, P3804, DOI 10.1128/AAC.00351-10; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Millar BC, 2007, J HOSP INFECT, V67, P109, DOI 10.1016/j.jhin.2007.06.003; Miller R, 2010, EPIDEMIOL INFECT, V138, P655, DOI 10.1017/S0950268809991294; Milstone AM, 2010, EMERG INFECT DIS, V16, P647, DOI 10.3201/eid1604.090107; Moet GJ, 2007, DIAGN MICR INFEC DIS, V57, P7, DOI 10.1016/j.diagmicrobio.2006.05.009; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Nakagawa S, 2005, BIOCHEM BIOPH RES CO, V328, P995, DOI 10.1016/j.bbrc.2005.01.054; Nonhoff C, 2009, EUR J CLIN MICROBIOL, V28, P363, DOI 10.1007/s10096-008-0637-9; Oberdorfer K, 2006, EUR J CLIN MICROBIOL, V25, P657, DOI 10.1007/s10096-006-0203-2; Orendi JM, 2010, J HOSP INFECT, V75, P258, DOI 10.1016/j.jhin.2010.03.023; Otter JA, 2011, J HOSP INFECT, V79, P189, DOI 10.1016/j.jhin.2011.04.028; Pan ES, 2003, CLIN INFECT DIS, V37, P1384, DOI 10.1086/379019; Paule SM, 2007, J CLIN MICROBIOL, V45, P2993, DOI 10.1128/JCM.00670-07; Popovich K, 2007, J CLIN MICROBIOL, V45, P2293, DOI 10.1128/JCM.00044-07; Popovich KJ, 2008, CLIN INFECT DIS, V46, P787, DOI 10.1086/528716; Salgado CD, 2003, CLIN INFECT DIS, V36, P131, DOI 10.1086/345436; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Skov RL, 2009, J HOSP INFECT, V73, P364, DOI 10.1016/j.jhin.2009.07.004	43	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38354	10.1371/journal.pone.0038354	http://dx.doi.org/10.1371/journal.pone.0038354			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719880	gold, Green Submitted, Green Published			2022-12-25	WOS:000305350000013
J	Li, E; Hamm, CM; Gulati, AS; Sartor, RB; Chen, HY; Wu, X; Zhang, TY; Rohlf, FJ; Zhu, W; Gu, C; Robertson, CE; Pace, NR; Boedeker, EC; Harpaz, N; Yuan, J; Weinstock, GM; Sodergren, E; Frank, DN				Li, Ellen; Hamm, Christina M.; Gulati, Ajay S.; Sartor, R. Balfour; Chen, Hongyan; Wu, Xiao; Zhang, Tianyi; Rohlf, F. James; Zhu, Wei; Gu, Chi; Robertson, Charles E.; Pace, Norman R.; Boedeker, Edgar C.; Harpaz, Noam; Yuan, Jeffrey; Weinstock, George M.; Sodergren, Erica; Frank, Daniel N.			Inflammatory Bowel Diseases Phenotype, C. difficile and NOD2 Genotype Are Associated with Shifts in Human Ileum Associated Microbial Composition	PLOS ONE			English	Article							ILEAL CROHNS-DISEASE; CLOSTRIDIUM-DIFFICILE; COMMENSAL MICROBIOTA; DEFENSIN EXPRESSION; GENE ATG16L1; PANETH CELLS; SUSCEPTIBILITY; SMOKING; RISK; MUTATION	We tested the hypothesis that Crohn's disease (CD)-related genetic polymorphisms involved in host innate immunity are associated with shifts in human ileum-associated microbial composition in a cross-sectional analysis of human ileal samples. Sanger sequencing of the bacterial 16S ribosomal RNA (rRNA) gene and 454 sequencing of 16S rRNA gene hypervariable regions (V1-V3 and V3-V5), were conducted on macroscopically disease-unaffected ileal biopsies collected from 52 ileal CD, 58 ulcerative colitis and 60 control patients without inflammatory bowel diseases (IBD) undergoing initial surgical resection. These subjects also were genotyped for the three major NOD2 risk alleles (Leu1007fs, R708W, G908R) and the ATG16L1 risk allele (T300A). The samples were linked to clinical metadata, including body mass index, smoking status and Clostridia difficile infection. The sequences were classified into seven phyla/subphyla categories using the Naive Bayesian Classifier of the Ribosome Database Project. Centered log ratio transformation of six predominant categories was included as the dependent variable in the permutation based MANCOVA for the overall composition with stepwise variable selection. Polymerase chain reaction (PCR) assays were conducted to measure the relative frequencies of the Clostridium coccoides - Eubacterium rectales group and the Faecalibacterium prausnitzii spp. Empiric logit transformations of the relative frequencies of these two microbial groups were included in permutation-based ANCOVA. Regardless of sequencing method, IBD phenotype, Clostridia difficile and NOD2 genotype were selected as associated (FDR <= 0.05) with shifts in overall microbial composition. IBD phenotype and NOD2 genotype were also selected as associated with shifts in the relative frequency of the C. coccoides - E. rectales group. IBD phenotype, smoking and IBD medications were selected as associated with shifts in the relative frequency of F. prausnitzii spp. These results indicate that the effects of genetic and environmental factors on IBD are mediated at least in part by the enteric microbiota.	[Li, Ellen; Hamm, Christina M.; Zhang, Tianyi] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Li, Ellen] SUNY Stony Brook, Dept Microbiol & Mol Genet, Stony Brook, NY 11794 USA; [Chen, Hongyan; Wu, Xiao; Zhang, Tianyi; Zhu, Wei] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Rohlf, F. James] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Robertson, Charles E.; Pace, Norman R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Gulati, Ajay S.] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; [Sartor, R. Balfour] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Sartor, R. Balfour] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Boedeker, Edgar C.] Univ New Mexico, Dept Med, Albuquerque, NM 87131 USA; [Harpaz, Noam] Mt Sinai Sch Med, Dept Pathol, New York, NY USA; [Li, Ellen; Yuan, Jeffrey] Washington Univ, Dept Med, St Louis, MO USA; [Weinstock, George M.; Sodergren, Erica] Washington Univ, Genome Inst, St Louis, MO USA; [Gu, Chi] Washington Univ, Div Biostat, St Louis, MO USA; [Frank, Daniel N.] Univ Colorado Anschutz Med Campus, Dept Med, Aurora, CO USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Colorado System; University of Colorado Boulder; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of New Mexico; Icahn School of Medicine at Mount Sinai; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Colorado System; University of Colorado Anschutz Medical Campus	Li, E (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.	ellen.li@stonybrook.edu; Daniel.frank@ucdenver.edu	Harpaz, Noam/L-3411-2017; Rohlf, F./AAR-6717-2021; Weinstock, George M/C-6314-2013; Gu, C. Charles/A-7934-2010	Harpaz, Noam/0000-0003-4923-2200; Rohlf, F./0000-0003-0522-3679; Weinstock, George M/0000-0002-2997-4592; ROBERTSON, CHARLES/0000-0002-4136-4121; Gu, C. Charles/0000-0002-8527-8145	National Institutes of Health (NIH) [UH2DK083994]; Crohn's and Colitis Foundation of America; Simons Foundation; Leona M. and Harry B. Helmsley charitable trust through the Sinai-Helmsley Alliance for Research Excellence Network; NIH [R21HG005964]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG005964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH2DK083994, P30DK052574] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Simons Foundation; Leona M. and Harry B. Helmsley charitable trust through the Sinai-Helmsley Alliance for Research Excellence Network; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported partially by National Institutes of Health (NIH) UH2DK083994, the Crohn's and Colitis Foundation of America, the Simons Foundation, and the Leona M. and Harry B. Helmsley charitable trust through the Sinai-Helmsley Alliance for Research Excellence Network and NIH R21HG005964. We acknowledge use of the Washington University Digestive Diseases Research Core Center Tissue Procurement Facility (P30 DK52574). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 1986, STAT ANAL COMPOSITIO; Aldhous MC, 2007, AM J GASTROENTEROL, V102, P577, DOI 10.1111/j.1572-0241.2007.01064.x; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Anderson MJ, 1999, J STAT COMPUT SIM, V62, P271, DOI 10.1080/00949659908811936; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bevins CL, 2009, GUT, V58, P882; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Chen HY, 2011, DIS COLON RECTUM, V54, P1020, DOI 10.1007/DCR.0b013e31821b94b3; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Croswell A, 2009, INFECT IMMUN, V77, P2741, DOI 10.1128/IAI.00006-09; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Delima SL, 2010, J CLIN MICROBIOL, V48, P2344, DOI 10.1128/JCM.01821-09; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2007, CLIN INFECT DIS, V44, P256, DOI 10.1086/510385; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2011, TRENDS MICROBIOL, V19, P427, DOI 10.1016/j.tim.2011.06.005; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Geboes K, 2009, J CLIN PATHOL, V62, P201, DOI 10.1136/jcp.2008.059311; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamm CM, 2010, INFLAMM BOWEL DIS, V16, P1649, DOI 10.1002/ibd.21208; Hancock L, 2008, INFLAMM BOWEL DIS, V14, P1667, DOI 10.1002/ibd.20517; Hopkins MJ, 2002, J MED MICROBIOL, V51, P448, DOI 10.1099/0022-1317-51-5-448; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Issa M, 2007, CLIN GASTROENTEROL H, V5, P345, DOI 10.1016/j.cgh.2006.12.028; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mahid SS, 2006, MAYO CLIN PROC, V81, P1462, DOI 10.4065/81.11.1462; Manly BFJ, 1997, RANDOMIZATION BOOTST; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nelson RL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001181.pub3; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Prescott NJ, 2007, GASTROENTEROLOGY, V132, P1665, DOI 10.1053/j.gastro.2007.03.034; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rehman A, 2011, GUT, V60, P1354, DOI 10.1136/gut.2010.216259; Rim SH, 2009, CANCER-AM CANCER SOC, V115, P1967, DOI 10.1002/cncr.24216; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rodemann JF, 2007, CLIN GASTROENTEROL H, V5, P339, DOI 10.1016/j.cgh.2006.12.027; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Simms LA, 2008, GUT, V57, P903, DOI 10.1136/gut.2007.142588; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sokol H, 2008, INFLAMM BOWEL DIS, V14, P858, DOI 10.1002/ibd.20392; Stange EF, 2006, GUT, V55, DOI 10.1136/gut.2005.081950a; Unkart JT, 2008, DIS COLON RECTUM, V51, P1211, DOI 10.1007/s10350-008-9348-7; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Waterman M, 2011, INFLAMM BOWEL DIS, V17, P1936, DOI 10.1002/ibd.21579; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049	67	159	161	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e26284	10.1371/journal.pone.0026284	http://dx.doi.org/10.1371/journal.pone.0026284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719818	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341900001
J	Tasca, G; Pescatori, M; Monforte, M; Mirabella, M; Iannaccone, E; Frusciante, R; Cubeddu, T; Laschena, F; Ottaviani, P; Ricci, E				Tasca, Giorgio; Pescatori, Mario; Monforte, Mauro; Mirabella, Massimiliano; Iannaccone, Elisabetta; Frusciante, Roberto; Cubeddu, Tiziana; Laschena, Francesco; Ottaviani, Pierfrancesco; Ricci, Enzo			Different Molecular Signatures in Magnetic Resonance Imaging-Staged Facioscapulohumeral Muscular Dystrophy Muscles	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEIN-1; GENE-EXPRESSION; ADIPOSE-TISSUE; SKELETAL-MUSCLE; FSHD PATIENTS; FACTOR-ALPHA; IN-VITRO; OBESITY; MRI; ADIPONECTIN	Background: Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common muscular dystrophies and is characterized by a non-conventional genetic mechanism activated by pathogenic D4Z4 repeat contractions. By muscle Magnetic Resonance Imaging (MRI) we observed that T2-short tau inversion recovery (T2-STIR) sequences identify two different conditions in which each muscle can be found before the irreversible dystrophic alteration, marked as T1-weighted sequence hyperintensity, takes place. We studied these conditions in order to obtain further information on the molecular mechanisms involved in the selective wasting of single muscles or muscle groups in this disease. Methods: Histopathology, gene expression profiling and real time PCR were performed on biopsies from FSHD muscles with different MRI pattern (T1-weighted normal/T2-STIR normal and T1-weighted normal/T2-STIR hyperintense). Data were compared with those from inflammatory myopathies, dysferlinopathies and normal controls. In order to validate obtained results, two additional FSHD samples with different MRI pattern were analyzed. Results: Myopathic and inflammatory changes characterized T2-STIR hyperintense FSHD muscles, at variance with T2-STIR normal muscles. These two states could be easily distinguished from each other by their transcriptional profile. The comparison between T2-STIR hyperintense FSHD muscles and inflammatory myopathy muscles showed peculiar changes, although many alterations were shared among these conditions. Conclusions: At the single muscle level, different stages of the disease correspond to the two MRI patterns. T2-STIR hyperintense FSHD muscles are more similar to inflammatory myopathies than to T2-STIR normal FSHD muscles or other muscular dystrophies, and share with them upregulation of genes involved in innate and adaptive immunity. Our data suggest that selective inflammation, together with perturbation in biological processes such as neoangiogenesis, lipid metabolism and adipokine production, may contribute to the sequential bursts of muscle degeneration that involve individual muscles in an asynchronous manner in this disease.	[Tasca, Giorgio] Don Carlo Gnocchi Onlus Fdn, Milan, Italy; [Pescatori, Mario] Erasmus MC, Dept Bioinformat, Rotterdam, Netherlands; [Pescatori, Mario] Crosslinks BV, Rotterdam, Netherlands; [Pescatori, Mario; Cubeddu, Tiziana] Porto Conte Ric Srl, Alghero, SS, Italy; [Monforte, Mauro; Mirabella, Massimiliano; Iannaccone, Elisabetta; Frusciante, Roberto; Ricci, Enzo] Univ Cattolica Sacro Cuore, Sch Med, Inst Neurol, Rome, Italy; [Laschena, Francesco; Ottaviani, Pierfrancesco] Ist Dermopat Immacolata IRCCS, Dept Radiol, Rome, Italy	IRCCS Fondazione Don Carlo Gnocchi Onlus; Erasmus University Rotterdam; Erasmus MC; Porto Conte Ricerche; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Istituto Dermopatico dell'Immacolata (IDI)	Tasca, G (corresponding author), Don Carlo Gnocchi Onlus Fdn, Milan, Italy.	ericci@rm.unicatt.it	Monforte, Mauro/J-2918-2018; MIRABELLA, Massimiliano/AAC-4016-2020; Ricci, Enzo/AAC-4448-2020; Monforte, Mauro/AAS-7120-2021; Tasca, Giorgio/J-5153-2018	Monforte, Mauro/0000-0002-4327-6969; MIRABELLA, Massimiliano/0000-0002-7783-114X; Monforte, Mauro/0000-0002-4327-6969; Tasca, Giorgio/0000-0003-0849-9144; RICCI, Enzo/0000-0003-3092-3597	Don Carlo Gnocchi Onlus Foundation (Ricerca Corrente)	Don Carlo Gnocchi Onlus Foundation (Ricerca Corrente)	This work was supported by funding from Don Carlo Gnocchi Onlus Foundation (Ricerca Corrente) to E.R. and G.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arashiro P, 2009, P NATL ACAD SCI USA, V106, P6220, DOI 10.1073/pnas.0901573106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Celegato B, 2006, PROTEOMICS, V6, P5303, DOI 10.1002/pmic.200600056; Cheng BH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-103; Delaigle AM, 2004, ENDOCRINOLOGY, V145, P5589, DOI 10.1210/en.2004-0503; Dempsey PW, 2003, CELL MOL LIFE SCI, V60, P2604, DOI 10.1007/s00018-003-3180-y; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Dobbin K, 2005, BIOSTATISTICS, V6, P27, DOI 10.1093/biostatistics/kxh015; Dufourcq P, 2008, AM J PATHOL, V172, P37, DOI 10.2353/ajpath.2008.070130; Dufourcq P, 2008, STEM CELLS, V26, P2991, DOI 10.1634/stemcells.2008-0372; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Ezan J, 2004, CARDIOVASC RES, V63, P731, DOI 10.1016/j.cardiores.2004.05.006; Frisullo G, 2011, J CLIN IMMUNOL, V31, P155, DOI 10.1007/s10875-010-9474-6; Frommer KW, 2010, ARTHRITIS RHEUM-US, V62, P2886, DOI 10.1002/art.27616; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Greenberg SA, 2002, NEUROLOGY, V59, P1170, DOI 10.1212/WNL.59.8.1170; Gummesson A, 2007, J CLIN ENDOCR METAB, V92, P4759, DOI 10.1210/jc.2007-1136; Haslett JN, 2002, P NATL ACAD SCI USA, V99, P15000, DOI 10.1073/pnas.192571199; Kan HE, 2010, NMR BIOMED, V23, P563, DOI 10.1002/nbm.1494; Kan HE, 2009, NEUROMUSCULAR DISORD, V19, P357, DOI 10.1016/j.nmd.2009.02.009; Kim KY, 2006, FEBS LETT, V580, P3953, DOI 10.1016/j.febslet.2006.06.034; Klooster R, 2009, EUR J HUM GENET, V17, P1615, DOI 10.1038/ejhg.2009.62; Lagathu C, 2010, INT J OBESITY, V34, P1695, DOI 10.1038/ijo.2010.107; Laufer J, 2001, MOL IMMUNOL, V38, P221, DOI 10.1016/S0161-5890(01)00044-X; Laurencikiene J, 2008, CANCER RES, V68, P9247, DOI 10.1158/0008-5472.CAN-08-1343; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Mercuri E, 2007, J MAGN RESON IMAGING, V25, P433, DOI 10.1002/jmri.20804; Nordstrom EA, 2005, DIABETES, V54, P1726, DOI 10.2337/diabetes.54.6.1726; Olsen DB, 2006, J NEUROL, V253, P1437, DOI 10.1007/s00415-006-0230-z; Osborne RJ, 2007, NEUROLOGY, V68, P569, DOI 10.1212/01.wnl.0000251269.31442.d9; Padberg GW, 2009, CURR OPIN NEUROL, V22, P539, DOI 10.1097/WCO.0b013e328330a572; Pescatori M, 2007, FASEB J, V21, P1210, DOI 10.1096/fj.06-7285com; Ricci E, 1999, ANN NEUROL, V45, P751, DOI 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M; Sanoudou D, 2003, P NATL ACAD SCI USA, V100, P4666, DOI 10.1073/pnas.0330960100; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Song WC, 2000, IMMUNOPHARMACOLOGY, V49, P187, DOI 10.1016/S0162-3109(00)80303-3; Straub V, NEUROMUSCUL IN PRESS; Tasca G, 2011, NEUROMUSCULAR DISORD, V21, P671, DOI 10.1016/j.nmd.2011.06.860; Tawil R, 2008, NEUROTHERAPEUTICS, V5, P601, DOI 10.1016/j.nurt.2008.07.005; Tournadre A, 2010, ARTHRITIS RHEUM-US, V62, P2144, DOI 10.1002/art.27465; Wattjes MP, 2010, EUR RADIOL, V20, P2447, DOI 10.1007/s00330-010-1799-2; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327	44	74	74	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38779	10.1371/journal.pone.0038779	http://dx.doi.org/10.1371/journal.pone.0038779			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719944	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341900050
J	Wylie, KM; Mihindukulasuriya, KA; Sodergren, E; Weinstock, GM; Storch, GA				Wylie, Kristine M.; Mihindukulasuriya, Kathie A.; Sodergren, Erica; Weinstock, George M.; Storch, Gregory A.			Sequence Analysis of the Human Virome in Febrile and Afebrile Children	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; METAGENOMIC DETECTION; VIRAL PATHOGENS; VIRUSES; INFANTS; FEVER; ERA	Unexplained fever (UF) is a common problem in children under 3 years old. Although virus infection is suspected to be the cause of most of these fevers, a comprehensive analysis of viruses in samples from children with fever and healthy controls is important for establishing a relationship between viruses and UF. We used unbiased, deep sequencing to analyze 176 nasopharyngeal swabs (NP) and plasma samples from children with UF and afebrile controls, generating an average of 4.6 million sequences per sample. An analysis pipeline was developed to detect viral sequences, which resulted in the identification of sequences from 25 viral genera. These genera included expected pathogens, such as adenoviruses, enteroviruses, and roseoloviruses, plus viruses with unknown pathogenicity. Viruses that were unexpected in NP and plasma samples, such as the astrovirus MLB-2, were also detected. Sequencing allowed identification of virus subtype for some viruses, including roseoloviruses. Highly sensitive PCR assays detected low levels of viruses that were not detected in approximately 5 million sequences, but greater sequencing depth improved sensitivity. On average NP and plasma samples from febrile children contained 1.5- to 5-fold more viral sequences, respectively, than samples from afebrile children. Samples from febrile children contained a broader range of viral genera and contained multiple viral genera more frequently than samples from children without fever. Differences between febrile and afebrile groups were most striking in the plasma samples, where detection of viral sequence may be associated with a disseminated infection. These data indicate that virus infection is associated with UF. Further studies are important in order to establish the range of viral pathogens associated with fever and to understand of the role of viral infection in fever. Ultimately these studies may improve the medical treatment of children with UF by helping avoid antibiotic therapy for children with viral infections.	[Wylie, Kristine M.; Mihindukulasuriya, Kathie A.; Sodergren, Erica; Weinstock, George M.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63130 USA; [Storch, Gregory A.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Wylie, KM (corresponding author), Washington Univ, Sch Med, Genome Inst, St Louis, MO 63130 USA.	kwylie@genome.wustl.edu	Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592; Mihindukulasuriya, Kathie/0000-0001-9372-3758	National Institute of Allergy and Infectious Diseases [1UAH2AI083266-01]; Demonstration Project of the Human Microbiome Project; National Institutes of Health (NIH)-National Center for Research Resources [UL1RR024992]; National Institutes of Health-National Human Genome Research Institute (NIH-NHGRI) [U54HG003079]; NIH-NHGRI [U54HG004968]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, U54HG004968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UH2AI083266] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Demonstration Project of the Human Microbiome Project; National Institutes of Health (NIH)-National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health-National Human Genome Research Institute (NIH-NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH-NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grant number 1UAH2AI083266-01 from the National Institute of Allergy and Infectious Diseases, a Demonstration Project of the Human Microbiome Project to GS, grant number UL1RR024992 from the National Institutes of Health (NIH)-National Center for Research Resources to GS, grant number U54HG003079 from the National Institutes of Health-National Human Genome Research Institute (NIH-NHGRI) to The Genome Institute, and grant number U54HG004968 from the NIH-NHGRI to The Genome Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Baraff LJ, 2000, ANN EMERG MED, V36, P602, DOI 10.1067/mem.2000.110820; Breitbart M, 2005, BIOTECHNIQUES, V39, P729, DOI 10.2144/000112019; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Finkbeiner SR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-161; Green P, 1994, CROSS MATCH UNPUB; Holtz LR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-159; Holtz LR, 2011, EMERG INF D IN PRESS; Hormozdi DJ, 2010, PEDIATR INFECT DIS J, V29, P329, DOI 10.1097/INF.0b013e3181c1795c; KRAUSS B S, 1991, Pediatric Emergency Care, V7, P67, DOI 10.1097/00006565-199104000-00001; Loh J, 2009, J VIROL, V83, P13019, DOI 10.1128/JVI.00638-09; McErlean P, 2007, J CLIN VIROL, V39, P67, DOI 10.1016/j.jcv.2007.03.012; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Ninomiya M, 2008, J CLIN MICROBIOL, V46, P507, DOI 10.1128/JCM.01703-07; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rudinsky SL, 2009, ACAD EMERG MED, V16, P585, DOI 10.1111/j.1553-2712.2009.00444.x; Sumino KC, 2010, THORAX, V65, P639, DOI 10.1136/thx.2009.132480; Vasilyev EV, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-134; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Waddle E, 2009, ARCH DIS CHILD, V94, P144, DOI 10.1136/adc.2007.130583; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Watt K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012448; Wilkinson M, 2009, ACAD EMERG MED, V16, P220, DOI 10.1111/j.1553-2712.2008.00328.x; Willner D, 2011, P NATL ACAD SCI USA, V108, P4547, DOI 10.1073/pnas.1000089107; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370	31	130	133	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e27735	10.1371/journal.pone.0027735	http://dx.doi.org/10.1371/journal.pone.0027735			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719819	Green Published, gold			2022-12-25	WOS:000305341900002
J	Nyholm, SV; Song, PF; Dang, JN; Bunce, C; Girguis, PR				Nyholm, Spencer V.; Song, Pengfei; Dang, Jeanne; Bunce, Corey; Girguis, Peter R.			Expression and Putative Function of Innate Immunity Genes under in situ Conditions in the Symbiotic Hydrothermal Vent Tubeworm Ridgeia piscesae	PLOS ONE			English	Article							RIFTIA-PACHYPTILA JONES; CARBONIC-ANHYDRASE; METABOLITE UPTAKE; SULFIDE BINDING; RECOGNITION; WORM; HOST; TRANSCRIPTOME; LOCALIZATION; ENDOSYMBIONT	The relationships between hydrothermal vent tubeworms and sulfide-oxidizing bacteria have served as model associations for understanding chemoautotrophy and endosymbiosis. Numerous studies have focused on the physiological and biochemical adaptations that enable these symbioses to sustain some of the highest recorded carbon fixation rates ever measured. However, far fewer studies have explored the molecular mechanisms underlying the regulation of host and symbiont interactions, specifically those mediated by the innate immune system of the host. To that end, we conducted a series of studies where we maintained the tubeworm, Ridgeia piscesae, in high-pressure aquaria and examined global and quantitative changes in gene expression via high-throughput transcriptomics and quantitative real-time PCR (qPCR). We analyzed over 32,000 full-length expressed sequence tags as well as 26 Mb of transcript sequences from the trophosome (the organ that houses the endosymbiotic bacteria) and the plume (the gas exchange organ in contact with the free-living microbial community). R. piscesae maintained under conditions that promote chemoautotrophy expressed a number of putative cell signaling and innate immunity genes, including pattern recognition receptors (PRRs), often associated with recognizing microbe-associated molecular patterns (MAMPs). Eighteen genes involved with innate immunity, cell signaling, cell stress and metabolite exchange were further analyzed using qPCR. PRRs, including five peptidoglycan recognition proteins and a Toll-like receptor, were expressed significantly higher in the trophosome compared to the plume. Although PRRs are often associated with mediating host responses to infection by pathogens, the differences in expression between the plume and trophosome also implicate similar mechanisms of microbial recognition in interactions between the host and symbiont. We posit that regulation of this association involves a molecular "dialogue'' between the partners that includes interactions between the host's innate immune system and the symbiont.	[Nyholm, Spencer V.; Bunce, Corey] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Song, Pengfei; Dang, Jeanne; Girguis, Peter R.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	University of Connecticut; Harvard University	Nyholm, SV (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	spencer.nyholm@uconn.edu; pgirguis@oeb.harvard.edu		Girguis, Peter/0000-0002-3599-8160	National Science Foundation (NSF) [NSF OCE-0732369, NSF OCE-0426109]; University of Connecticut Research Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); University of Connecticut Research Foundation	The sequence data were obtained by the United States Department of Energy Joint Genome Institute (http://www.jgi.doe.gov) in collaboration with the user community. This material is based upon work supported by the National Science Foundation (NSF) under Grant Nos. NSF OCE-0732369 and NSF OCE-0426109 (nsf.gov) to PRG and the University of Connecticut Research Foundation (research.uconn.edu) to SVN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altincicek B, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-18; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Armstrong PB, 1999, DEV COMP IMMUNOL, V23, P375, DOI 10.1016/S0145-305X(99)00018-X; ARP AJ, 1981, SCIENCE, V213, P342, DOI 10.1126/science.213.4505.342; ARP AJ, 1983, SCIENCE, V219, P295, DOI 10.1126/science.219.4582.295; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Bettencourt R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-559; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Bittel P, 2007, CURR OPIN PLANT BIOL, V10, P335, DOI 10.1016/j.pbi.2007.04.021; Bosch CG, 1984, CR HEBD ACAD SCI, V9, P413; Bosch CG, 1984, CR HEBD ACAD SCI, V9, P371; Bright M, 2000, MAR BIOL, V136, P621, DOI 10.1007/s002270050722; Bright M, 2003, INVERTEBR BIOL, V122, P347; Bright M, 2010, OCEANOGR MAR BIOL, V48, P213; Carney SL, 2007, COMP BIOCHEM PHYS B, V146, P326, DOI 10.1016/j.cbpb.2006.11.002; CAVANAUGH CM, 1981, SCIENCE, V213, P340, DOI 10.1126/science.213.4505.340; Chaput C, 2007, MICROBES INFECT, V9, P637, DOI 10.1016/j.micinf.2007.01.022; CHILDRESS JJ, 1991, BIOL BULL-US, V180, P135, DOI 10.2307/1542437; CHILDRESS JJ, 1984, MAR BIOL, V83, P109, DOI 10.1007/BF00394718; Cooper EL, 2001, ADV EXP MED BIOL, V484, P169; Davidson CR, 2008, DEV COMP IMMUNOL, V32, P608, DOI 10.1016/j.dci.2007.11.004; De Cian MC, 2000, J EXP BIOL, V203, P2907; De Cian MC, 2003, J EXP BIOL, V206, P399, DOI 10.1242/jeb.00074; DEBURGH ME, 1989, MAR BIOL, V101, P97, DOI 10.1007/BF00393482; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Dunn SR, 2009, ENVIRON MICROBIOL, V11, P268, DOI 10.1111/j.1462-2920.2008.01774.x; Dziarski R, 2010, INNATE IMMUN-LONDON, V16, P168, DOI 10.1177/1753425910366059; Felbeck H, 1998, PHYSIOL ZOOL, V71, P294, DOI 10.1086/515931; FELBECK H, 1981, SCIENCE, V213, P336, DOI 10.1126/science.213.4505.336; FISHER CR, 1988, DEEP-SEA RES, V35, P1745, DOI 10.1016/0198-0149(88)90047-7; FISHER CR, 1989, BIOL BULL, V177, P372, DOI 10.2307/1541597; Fitt WK, 2000, BIOL BULL, V198, P110, DOI 10.2307/1542809; Flores JF, 2005, P NATL ACAD SCI USA, V102, P2713, DOI 10.1073/pnas.0407455102; Gagniere N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-634; Girguis PR, 2006, J EXP BIOL, V209, P3516, DOI 10.1242/jeb.02404; Girguis PR, 2000, APPL ENVIRON MICROB, V66, P2783, DOI 10.1128/AEM.66.7.2783-2790.2000; Girguis PR, 2002, J EXP BIOL, V205, P3055; Goffredi SK, 1999, PHYSIOL BIOCHEM ZOOL, V72, P296, DOI 10.1086/316664; Goffredi SK, 1999, BIOL BULL-US, V196, P257, DOI 10.2307/1542950; Goodson MS, 2005, APPL ENVIRON MICROB, V71, P6934, DOI 10.1128/AEM.71.11.6934-6946.2005; Govenar B, 2005, MAR ECOL PROG SER, V305, P67, DOI 10.3354/meps305067; HEARD J, 1995, P NATL ACAD SCI USA, V92, P5273, DOI 10.1073/pnas.92.12.5273; Henry MS, 2008, DEEP-SEA RES PT I, V55, P679, DOI 10.1016/j.dsr.2008.02.001; HENTSCHEL U, 1993, NATURE, V366, P338, DOI 10.1038/366338a0; Hessler R, 1983, DISTRIBUTION COMMUNI, P735; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hurtado LA, 2004, MOL ECOL, V13, P2603, DOI 10.1111/j.1365-294X.2004.02287.x; Jeanthon C, 2000, ANTON LEEUW INT J G, V77, P117, DOI 10.1023/A:1002463825025; Kochevar RE, 1996, MAR BIOL, V125, P375, DOI 10.1007/BF00346318; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; Kurata S, 2010, INT IMMUNOL, V22, P143, DOI 10.1093/intimm/dxp128; Kvennefors ECE, 2010, DEV COMP IMMUNOL, V34, P1219, DOI 10.1016/j.dci.2010.06.016; Laue BE, 1997, MOL MAR BIOL BIOTECH, V6, P180; Leulier F, 2008, NAT REV GENET, V9, P165, DOI 10.1038/nrg2303; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macagno ER, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-407; Markert S, 2007, SCIENCE, V315, P247, DOI 10.1126/science.1132913; Marsh AG, 2001, NATURE, V411, P77, DOI 10.1038/35075063; McFall-Ngai M, 2010, SEMIN IMMUNOL, V22, P48, DOI 10.1016/j.smim.2009.11.003; Messenguy F, 2003, GENE, V316, P1, DOI 10.1016/S0378-1119(03)00747-9; Miyake K, 2006, J ENDOTOXIN RES, V12, P195, DOI 10.1179/096805106X118807; Moharikar S, 2007, J BIOSCIENCES, V32, P261, DOI 10.1007/s12038-007-0026-z; Murphy TD, 2003, J CELL SCI, V116, P2321, DOI 10.1242/jcs.00463; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Nussbaumer AD, 2006, NATURE, V441, P345, DOI 10.1038/nature04793; Nyholm SV, 2008, BIOL BULL-US, V214, P255, DOI 10.2307/25470667; Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957; Pal S, 2009, ADV EXP MED BIOL, V653, P162; Peng XT, 2009, BIOMETALS, V22, P723, DOI 10.1007/s10534-009-9216-5; Pflugfelder B, 2009, CELL TISSUE RES, V337, P149, DOI 10.1007/s00441-009-0811-0; Reid R.G., 2007, BIOL EMERGENCES EVOL; Robidart JC, 2008, ENVIRON MICROBIOL, V10, P727, DOI 10.1111/j.1462-2920.2007.01496.x; Robidart JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021692; Rosenstiel P, 2009, J INNATE IMMUN, V1, P291, DOI 10.1159/000211193; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Ruan LW, 2008, EXTREMOPHILES, V12, P735, DOI 10.1007/s00792-008-0172-8; Sanchez S, 2007, FEBS J, V274, P5311, DOI 10.1111/j.1742-4658.2007.06050.x; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; Stewart Frank J., 2006, V41, P197; Troll JV, 2010, ENVIRON MICROBIOL, V12, P2190, DOI 10.1111/j.1462-2920.2009.02121.x; Troll JV, 2009, CELL MICROBIOL, V11, P1114, DOI 10.1111/j.1462-5822.2009.01315.x; Tsuchiya A, 2007, FEBS J, V274, P1818, DOI 10.1111/j.1742-4658.2007.05730.x; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; Young CR, 2008, MOL ECOL, V17, P1718, DOI 10.1111/j.1365-294X.2008.03609.x	86	16	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38267	10.1371/journal.pone.0038267	http://dx.doi.org/10.1371/journal.pone.0038267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701617	gold, Green Submitted, Green Published			2022-12-25	WOS:000305337600018
J	Smyth, D; Leung, G; Fernando, M; McKay, DM				Smyth, David; Leung, Gabriella; Fernando, Maria; McKay, Derek M.			Reduced Surface Expression of Epithelial E-Cadherin Evoked by Interferon-Gamma Is Fyn Kinase-Dependent	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; BARRIER FUNCTION; ESCHERICHIA-COLI; PROINFLAMMATORY CYTOKINES; ADHERENS JUNCTIONS; INDUCED INCREASES; P120 CATENIN; SRC; PHOSPHORYLATION; BINDING	Interferon gamma (IFN gamma) is an important regulatory cytokine that can exert a pro-inflammatory effect in the gut, where it has been shown to increase epithelial permeability via disruption of the tight junctions. Here we investigated the potential for IFN gamma to regulate the adherens junction protein E-cadherin, an important mediator of normal epithelial tissue function, using the model T84 human colonic epithelial cell line. IFN gamma (10 ng/ml) stimulated increased internalization of E-cadherin as assessed by immunofluorescence microscopy; internalization was reversed when cells were treated with PP1 (125 nM), a Src kinase-selective inhibitor. Immunoprecipitation studies demonstrated loss of E-cadherin from membrane fractions following IFN gamma treatment and a corresponding increase in cytosolic E-cadherin and its binding partners, p120-catenin and beta-catenin: effects that were Src-kinase dependent. E-cadherin and p120-catenin phosphorylation was increased by IFN gamma treatment and siRNA studies showed this was dependent upon the Src-kinase isoform Fyn. E-cadherin ubiquitinylation and subsequent proteasomal degradation stimulated by IFN gamma was found to be dependent upon Fyn and the E-cadherin-selective ubiquitin ligase, Hakai. Use of Fyn and Hakai siRNA inhibited the internalization of E-cadherin as shown by immunoblotting and confocal fluorescence microscopy. Finally, IFN gamma treatment resulted in a more fragile T84 cell monolayer with increased cell detachment in response to physical stress, which was prevented by PP1 and siRNA targeting Fyn or Hakai. Collectively, these results demonstrate a Fyn kinase-dependent mechanism through which IFN gamma regulates E-cadherin stability and suggest a novel mechanism of disruption of epithelial cell contact, which could contribute to perturbed epithelial barrier function.	[Smyth, David] Univ Calgary, Gastrointestinal Res Grp, Dept Physiol & Pharmacol, Calgary, AB, Canada; Univ Calgary, Calvin Phoebe & Joan Snyder Inst Chron Dis, Calgary, AB, Canada	University of Calgary; University of Calgary	Smyth, D (corresponding author), Univ Calgary, Gastrointestinal Res Grp, Dept Physiol & Pharmacol, Calgary, AB, Canada.	dmckay@ucalgary.ca	McKay, Derek/HCH-3240-2022	Leung, Gabriella/0000-0002-8754-1621	CIHR/Crohn's and Colitis Foundation of Canada (CCFC)/Canadian Association of Gastroenterology (CAG); Alberta Innovates-Health Solutions (AI-HS); AI-HS Graduate Studentships; CIHR M.Sc. Studentship; Canada Research Chair (Tier 1)	CIHR/Crohn's and Colitis Foundation of Canada (CCFC)/Canadian Association of Gastroenterology (CAG)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions (AI-HS); AI-HS Graduate Studentships; CIHR M.Sc. Studentship(Canadian Institutes of Health Research (CIHR)); Canada Research Chair (Tier 1)(Canada Research Chairs)	D. Smyth was awarded post-doctoral research fellowships from CIHR/Crohn's and Colitis Foundation of Canada (CCFC)/Canadian Association of Gastroenterology (CAG) and the Alberta Innovates-Health Solutions (AI-HS). G. Leung and M. Fernando are recipients of AI-HS Graduate Studentships and a CIHR M.Sc. Studentship (M. Fernando). D. McKay is an AI-HS Scientist and recipient of a Canada Research Chair (Tier 1) in Intestinal Immunophysiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilleos A, 2010, DEVELOPMENT, V137, P1833, DOI 10.1242/dev.047647; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Avizienyte E, 2005, CELLS TISSUES ORGANS, V179, P73, DOI 10.1159/000084511; Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; Beaurepaire C, 2009, J INTERF CYTOK RES, V29, P133, DOI 10.1089/jir.2008.0057; Benati D, 2008, CURR MED CHEM, V15, P1154, DOI 10.2174/092986708784310404; Boivin MA, 2009, J INTERF CYTOK RES, V29, P45, DOI 10.1089/jir.2008.0128; Bonazzi M, 2008, CELL MICROBIOL, V10, P2208, DOI 10.1111/j.1462-5822.2008.01200.x; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Chen Y, 2009, J CELL BIOCHEM, V108, P851, DOI 10.1002/jcb.22313; Clark E, 2005, GASTROENTEROLOGY, V128, P1258, DOI 10.1053/j.gastro.2005.01.046; Daniel JM, 1997, BIOESSAYS, V19, P883, DOI 10.1002/bies.950191008; Dorman SE, 2000, CYTOKINE GROWTH F R, V11, P321, DOI 10.1016/S1359-6101(00)00010-1; Feng W, 2008, J BIOL CHEM, V283, P23440, DOI 10.1074/jbc.M802482200; Ferber EC, 2008, J BIOL CHEM, V283, P12691, DOI 10.1074/jbc.M708887200; Figueroa A, 2009, CELL CYCLE, V8, P3648, DOI 10.4161/cc.8.22.9909; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Fukumoto Y, 2008, EXP CELL RES, V314, P52, DOI 10.1016/j.yexcr.2007.07.024; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Ito R, 2006, CLIN EXP IMMUNOL, V146, P330, DOI 10.1111/j.1365-2249.2006.03214.x; Janda E, 2006, ONCOGENE, V25, P7117, DOI 10.1038/sj.onc.1209701; Kaser A, 2011, GASTROENTEROLOGY, V140, P1738, DOI 10.1053/j.gastro.2011.02.048; Kim AN, 2011, BIOCHEM BIOPH RES CO, V407, P181, DOI 10.1016/j.bbrc.2011.02.134; Kotelevets L, 2004, FASEB J, V18, P115, DOI 10.1096/fj.04-1942fje; Lewis K, 2008, AM J PHYSIOL-GASTR L, V294, pG669, DOI 10.1152/ajpgi.00382.2007; Lugli A, 2007, HISTOPATHOLOGY, V50, P453, DOI 10.1111/j.1365-2559.2007.02620.x; Lukas M, 2010, DIGEST DIS, V28, P619, DOI 10.1159/000320276; MADARA JL, 1989, J CLIN INVEST, V83, P724, DOI 10.1172/JCI113938; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Mariner DJ, 2001, J BIOL CHEM, V276, P28006, DOI 10.1074/jbc.M102443200; Mashukova A, 2011, MOL CELL BIOL, V31, P756, DOI 10.1128/MCB.00811-10; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; McKay DM, 2007, J PHARMACOL EXP THER, V320, P1013, DOI 10.1124/jpet.106.113639; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Muise AM, 2009, GUT, V58, P1121, DOI 10.1136/gut.2008.175117; Ngan CY, 2007, J SURG ONCOL, V95, P652, DOI 10.1002/jso.20638; Pizarro-Cerda J, 2006, J PATHOL, V208, P215, DOI 10.1002/path.1888; Pories SE, 1998, GASTROENTEROLOGY, V114, P1287, DOI 10.1016/S0016-5085(98)70435-4; Posadas EM, 2009, BJU INT, V103, P171, DOI 10.1111/j.1464-410X.2008.08009.x; Rovedatti L, 2009, GUT, V58, P1629, DOI 10.1136/gut.2009.182170; Saito YD, 2010, CANCER-AM CANCER SOC, V116, P1629, DOI 10.1002/cncr.24879; Smyth D, 2011, LAB INVEST, V91, P764, DOI 10.1038/labinvest.2010.208; Strauman MC, 2010, INFECT IMMUN, V78, P4958, DOI 10.1128/IAI.00580-10; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Tunggal JA, 2005, EMBO J, V24, P1146, DOI 10.1038/sj.emboj.7600605; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Yu D, 2010, P NATL ACAD SCI USA, V107, P8237, DOI 10.1073/pnas.0908869107	49	29	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38441	10.1371/journal.pone.0038441	http://dx.doi.org/10.1371/journal.pone.0038441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715382	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336800024
J	Ayres, KL; Booth, RK; Hempelmann, JA; Koski, KL; Emmons, CK; Baird, RW; Balcomb-Bartok, K; Hanson, MB; Ford, MJ; Wasser, SK				Ayres, Katherine L.; Booth, Rebecca K.; Hempelmann, Jennifer A.; Koski, Kari L.; Emmons, Candice K.; Baird, Robin W.; Balcomb-Bartok, Kelley; Hanson, M. Bradley; Ford, Michael J.; Wasser, Samuel K.			Distinguishing the Impacts of Inadequate Prey and Vessel Traffic on an Endangered Killer Whale (Orcinus orca) Population	PLOS ONE			English	Article							BRITISH-COLUMBIA; THYROID-HORMONE; CHINOOK SALMON; GROWTH-HORMONE; DETECTION DOGS; DIVERSE ARRAY; PACIFIC; STRESS; SEX; MANAGEMENT	Managing endangered species often involves evaluating the relative impacts of multiple anthropogenic and ecological pressures. This challenge is particularly formidable for cetaceans, which spend the majority of their time underwater. Noninvasive physiological approaches can be especially informative in this regard. We used a combination of fecal thyroid (T3) and glucocorticoid (GC) hormone measures to assess two threats influencing the endangered southern resident killer whales (SRKW; Orcinus orca) that frequent the inland waters of British Columbia, Canada and Washington, U. S. A. Glucocorticoids increase in response to nutritional and psychological stress, whereas thyroid hormone declines in response to nutritional stress but is unaffected by psychological stress. The inadequate prey hypothesis argues that the killer whales have become prey limited due to reductions of their dominant prey, Chinook salmon (Oncorhynchus tshawytscha). The vessel impact hypothesis argues that high numbers of vessels in close proximity to the whales cause disturbance via psychological stress and/or impaired foraging ability. The GC and T3 measures supported the inadequate prey hypothesis. In particular, GC concentrations were negatively correlated with short-term changes in prey availability. Whereas, T3 concentrations varied by date and year in a manner that corresponded with more long-term prey availability. Physiological correlations with prey overshadowed any impacts of vessels since GCs were lowest during the peak in vessel abundance, which also coincided with the peak in salmon availability. Our results suggest that identification and recovery of strategic salmon populations in the SRKW diet are important to effectively promote SRKW recovery.	[Ayres, Katherine L.; Booth, Rebecca K.; Wasser, Samuel K.] Univ Washington, Ctr Conservat Biol, Despartment Biol, Seattle, WA 98195 USA; [Hempelmann, Jennifer A.; Emmons, Candice K.; Hanson, M. Bradley; Ford, Michael J.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA 98112 USA; [Koski, Kari L.] Whale Museum, Soundwatch Boater Educ Program, Friday Harbor, WA USA; [Baird, Robin W.] Cascadia Res Collect, Olympia, WA USA	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA	Ayres, KL (corresponding author), HT Harvey & Associates, Fresno, CA USA.	kayres@harveyecology.com	Wasser, Samuel K/I-5542-2015; Baird, Robin/Y-8230-2019	Baird, Robin/0000-0002-9419-6336	National Oceanic and Atmospheric Administration-Northwest Fisheries Science Center; Joint Institute for the Study of the Atmosphere and Ocean, Washington Sea Grant [NA10OAR417005]; Canadian Consulate General, Northwest Science Association; University of Washington Department of Biology; Center for Conservation Biology; Northwest Fisheries Science Center; NOAA	National Oceanic and Atmospheric Administration-Northwest Fisheries Science Center; Joint Institute for the Study of the Atmosphere and Ocean, Washington Sea Grant; Canadian Consulate General, Northwest Science Association; University of Washington Department of Biology(University of Washington); Center for Conservation Biology; Northwest Fisheries Science Center; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	This work has been funded by the National Oceanic and Atmospheric Administration-Northwest Fisheries Science Center, the Joint Institute for the Study of the Atmosphere and Ocean, Washington Sea Grant No. NA10OAR417005, the Canadian Consulate General, Northwest Science Association, University of Washington Department of Biology, Lynn Riddiford and Jim Truman, Elizabeth Welch and the Center for Conservation Biology. M.J. Ford, M. B. Hanson, J. Hempelmann, and C. Emmons are employees of Northwest Fisheries Science Center. All authors were involved in the preparation of the manuscript. M. B. Hanson, J. Hempelmann, and C. Emmons were involved in data collection and analysis. K. L. Ayres, R. K. Booth are employees with the Center for Conservation Biology, a nonprofit directed by S. K. Wasser. K. L. Ayres and S. K. Wasser designed the study, applied for funding, collected data and did most of the analysis, decision to publish and preparation of the manuscript. R. K. Booth was involved in study design/methods and data analysis. The other funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors Michael J. Ford and M. Bradley Hanson were partially responsible for funding decisions from Northwest Fisheries Science Center. Washington SeaGrant is also administered by NOAA, however the NOAA employees that are authors on this paper were not directly involved with SeaGrant funding decisions. Funding from this agency was a major part of funding this research. Authors Katherine Ayres, Rebecca Booth and Samuel Wasser work for the Center for Conservation Biology, which also partially funded this work. Author Kari Koski is an employee for the Soundwatch Boater Education program that provided the vessel traffic data for this research. Soundwatch is a boater education program that often consults on vessel regulations decisions based on their monitoring research. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aguilar A., 1999, Journal of Cetacean Research and Management Special Issue, V1, P83; Baird RW, 2001, CAN FIELD NAT, V115, P676; Baird RW, 2000, CETACEAN SOCIETIES, P127; Balcomb III KC, 1980, MM1300731 US MAR MAM; Barrett-Lennard LG, 2001, 2001065 CAN SCI ADV; Bigg M., 1982, REP INT WHALING COMM, V32, P655; Bigg M.A., 1990, Reports of the International Whaling Commission Special Issue, P383; BIGG MA, 1975, J FISH RES BOARD CAN, V32, P1213, DOI 10.1139/f75-140; Brett J.R., 1995, P3; Diamandis E.P., 1996, IMMUNOASSAY; Douyon L, 2002, ENDOCRIN METAB CLIN, V31, P173, DOI 10.1016/S0889-8529(01)00023-8; EALES JG, 1988, AM ZOOL, V28, P351; Ellifrit D, 2006, OFFICIAL ORCA SURVEY; Ellifrit D, 2008, OFFICIAL ORCA SURVEY; Felleman F.L., 1991, P113; *FISH OC CAN, 2008, REC STRAT NO SO RES; Flier JS, 2000, J CLIN INVEST, V105, P859, DOI 10.1172/JCI9725; Ford J. K. B., 2000, KILLER WHALES NATURA; Ford J.K.B., 2002, ENCY MARINE MAMMALS, P669; Ford J.K.B., 1999, TRANSIENTS MAMMAL HU; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; Ford JKB, 2006, MAR ECOL PROG SER, V316, P185, DOI 10.3354/meps316185; Ford JKB, 2010, BIOL LETTERS, V6, P139, DOI 10.1098/rsbl.2009.0468; Ford MJ, 2011, J HERED, V102, P537, DOI 10.1093/jhered/esr067; Foster EA, 2012, ANIM BEHAV, V83, P731, DOI 10.1016/j.anbehav.2011.12.021; Geris KL, 1999, DOMEST ANIM ENDOCRIN, V16, P231, DOI 10.1016/S0739-7240(99)00016-8; Gustafson RG, 2007, CONSERV BIOL, V21, P1009, DOI 10.1111/j.1523-1739.2007.00693.x; Hanson M. Bradley, 2010, Endangered Species Research, V11, P69, DOI 10.3354/esr00263; Hayward LS, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00199.1; Hayward LS, 2010, GEN COMP ENDOCR, V169, P117, DOI 10.1016/j.ygcen.2010.08.004; Heimlich-Boran J.R., 1986, Zoo Biology Monographs, V1, P113; Hoelzel AR, 1998, J HERED, V89, P121, DOI 10.1093/jhered/89.2.121; Holt MM, 2009, J ACOUST SOC AM, V125, pEL27, DOI 10.1121/1.3040028; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.1093/biomet/76.2.297; JEFFERSON TA, 1991, MAMMAL REV, V21, P151, DOI 10.1111/j.1365-2907.1991.tb00291.x; Kitaysky AS, 2005, HORM BEHAV, V47, P606, DOI 10.1016/j.yhbeh.2005.01.005; Koski K, 2010, SOUNDWATCH PROGRAM A; Krahn MM, 2007, MAR POLLUT BULL, V54, P1903, DOI 10.1016/j.marpolbul.2007.08.015; Krahn MM, 2009, MAR POLLUT BULL, V58, P1522, DOI 10.1016/j.marpolbul.2009.05.014; Levine S, 1972, Ciba Found Symp, V8, P281; Mesa MG, 2006, RIVER RES APPL, V22, P1085, DOI 10.1002/rra.955; Millspaugh JJ, 2004, GEN COMP ENDOCR, V138, P189, DOI 10.1016/j.ygcen.2004.07.002; Myers JM, 1998, NMESNWFSC35 NOAA; National Marine Fisheries Service, 2008, REC PLAN SO RES KILL; Nelson RJ., 2005, INTRO BEHAV ENDOCRIN; Noren D. P., 2009, Endangered Species Research, V8, P179, DOI 10.3354/esr00205; O'Shea Thomas J., 1999, P485; Olesiuk P.F., 1990, Reports of the International Whaling Commission Special Issue, P209; Ortiz RM, 2010, MAR MAMMAL SCI, V26, P409, DOI 10.1111/j.1748-7692.2009.00309.x; Pacific Fishery Management Council, 2011, REV 2010 OC SALM FIS; Parken CK, 2008, N AM J FISH MANAGE, V28, P328, DOI 10.1577/M06-110.1; Parsons KM, 2009, ANIM BEHAV, V77, P963, DOI 10.1016/j.anbehav.2009.01.018; Pilot M, 2010, J EVOLUTION BIOL, V23, P20, DOI 10.1111/j.1420-9101.2009.01887.x; Quinn TP, 1999, CAN J ZOOL, V1169, P1161; Rolland Rosalind M., 2006, Journal of Cetacean Research and Management, V8, P121; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Rosel PE, 2003, CONSERV GENET, V4, P647, DOI 10.1023/A:1025666212967; Ross PS, 2006, CAN J FISH AQUAT SCI, V63, P224, DOI 10.1139/F05-244; Ross PS, 2000, MAR POLLUT BULL, V40, P504, DOI 10.1016/S0025-326X(99)00233-7; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schew WA, 1996, GEN COMP ENDOCR, V101, P304, DOI 10.1006/gcen.1996.0033; StAubin DJ, 1996, MAR MAMMAL SCI, V12, P1, DOI 10.1111/j.1748-7692.1996.tb00301.x; Taylor M., 2004, SC56E32 INT WHAL COM; Walpita CN, 2007, GEN COMP ENDOCR, V150, P18, DOI 10.1016/j.ygcen.2006.07.002; Ward EJ, 2009, J APPL ECOL, V46, P632, DOI 10.1111/j.1365-2664.2009.01647.x; Wasser SK, 2011, FRONT ECOL ENVIRON, V9, P546, DOI 10.1890/100071; Wasser SK, 2010, GEN COMP ENDOCR, V168, P1, DOI 10.1016/j.ygcen.2010.04.004; WASSER SK, 1994, J REPROD FERTIL, V101, P213; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; WASSER SK, 1993, J REPROD FERTIL, V97, P569, DOI 10.1530/jrf.0.0970569; WEISS JM, 1968, J COMP PHYSIOL PSYCH, V65, P251, DOI 10.1037/h0025562; Weitkamp LA, 2010, T AM FISH SOC, V139, P147, DOI 10.1577/T08-225.1; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; WILES GJ, 2004, WASHINGTON STATE STA; Williams R, 2007, J ZOOL, V272, P390, DOI 10.1111/j.1469-7998.2006.00280.x; Williams R, 2006, BIOL CONSERV, V133, P301, DOI 10.1016/j.biocon.2006.06.010; Williams R, 2009, MAR MAMMAL SCI, V25, P327, DOI 10.1111/j.1748-7692.2008.00255.x; Williams Rob, 2009, Endangered Species Research, V6, P199, DOI 10.3354/esr00150; Zamon Jeannette E., 2007, Northwestern Naturalist, V88, P193, DOI 10.1898/1051-1733(2007)88[193:WOOSRK]2.0.CO;2	80	98	100	2	178	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e36842	10.1371/journal.pone.0036842	http://dx.doi.org/10.1371/journal.pone.0036842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701560	Green Published, Green Submitted, gold			2022-12-25	WOS:000305348400007
J	Staropoli, JF; Haliw, L; Biswas, S; Garrett, L; Holter, SM; Becker, L; Skosyrski, S; Da Silva-Buttkus, P; Calzada-Wack, J; Neff, F; Rathkolb, B; Rozman, J; Schrewe, A; Adler, T; Puk, O; Sun, MX; Favor, J; Racz, I; Bekeredjian, R; Busch, DH; Graw, J; Klingenspor, M; Klopstock, T; Wolf, E; Wurst, W; Zimmer, A; Lopez, E; Harati, H; Hill, E; Krause, DS; Guide, J; Dragileva, E; Gale, E; Wheeler, VC; Boustany, RM; Brown, DE; Breton, S; Ruether, K; Gailus-Durner, V; Fuchs, H; de Angelis, MH; Cotman, SL				Staropoli, John F.; Haliw, Larissa; Biswas, Sunita; Garrett, Lillian; Hoelter, Sabine M.; Becker, Lore; Skosyrski, Sergej; Da Silva-Buttkus, Patricia; Calzada-Wack, Julia; Neff, Frauke; Rathkolb, Birgit; Rozman, Jan; Schrewe, Anja; Adler, Thure; Puk, Oliver; Sun, Minxuan; Favor, Jack; Racz, Ildiko; Bekeredjian, Raffi; Busch, Dirk H.; Graw, Jochen; Klingenspor, Martin; Klopstock, Thomas; Wolf, Eckhard; Wurst, Wolfgang; Zimmer, Andreas; Lopez, Edith; Harati, Hayat; Hill, Eric; Krause, Daniela S.; Guide, Jolene; Dragileva, Ella; Gale, Evan; Wheeler, Vanessa C.; Boustany, Rose-Mary; Brown, Diane E.; Breton, Sylvie; Ruether, Klaus; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe; Cotman, Susan L.			Large-Scale Phenotyping of an Accurate Genetic Mouse Model of JNCL Identifies Novel Early Pathology Outside the Central Nervous System	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; ATRIAL-NATRIURETIC-PEPTIDE; BATTEN-DISEASE GENE; KNOCK-IN MICE; INDEPENDENT MECHANISMS; BETA-HEXOSAMINIDASE; V-ATPASE; JUVENILE; PROTEIN; MITOCHONDRIAL	Cln3(Delta ex7/8) mice harbor the most common genetic defect causing juvenile neuronal ceroid lipofuscinosis (JNCL), an autosomal recessive disease involving seizures, visual, motor and cognitive decline, and premature death. Here, to more thoroughly investigate the manifestations of the common JNCL mutation, we performed a broad phenotyping study of Cln3(Delta ex7/8) mice. Homozygous Cln3(Delta ex7/8) mice, congenic on a C57BL/6N background, displayed subtle deficits in sensory and motor tasks at 10-14 weeks of age. Homozygous Cln3(Delta ex7/8) mice also displayed electroretinographic changes reflecting cone function deficits past 5 months of age and a progressive decline of retinal post- receptoral function. Metabolic analysis revealed increases in rectal body temperature and minimum oxygen consumption in 12- 13 week old homozygous Cln3(Delta ex7/8) mice, which were also seen to a lesser extent in heterozygous Cln3(Delta ex7/8) mice. Heart weight was slightly increased at 20 weeks of age, but no significant differences were observed in cardiac function in young adults. In a comprehensive blood analysis at 15-16 weeks of age, serum ferritin concentrations, mean corpuscular volume of red blood cells (MCV), and reticulocyte counts were reproducibly increased in homozygous Cln3(Delta ex7/8) mice, and male homozygotes had a relative T- cell deficiency, suggesting alterations in hematopoiesis. Finally, consistent with findings in JNCL patients, vacuolated peripheral blood lymphocytes were observed in homozygous Cln3(Delta ex7/8) neonates, and to a greater extent in older animals. Early onset, severe vacuolation in clear cells of the epididymis of male homozygous Cln3(Delta ex7/8) mice was also observed. These data highlight additional organ systems in which to study CLN3 function, and early phenotypes have been established in homozygous Cln3(Delta ex7/8) mice that merit further study for JNCL biomarker development.	[Staropoli, John F.; Haliw, Larissa; Biswas, Sunita; Lopez, Edith; Harati, Hayat; Guide, Jolene; Dragileva, Ella; Gale, Evan; Wheeler, Vanessa C.; Cotman, Susan L.] Massachusetts Gen Hosp, Mol Neurogenet Unit, Ctr Human Genet Res, Boston, MA 02114 USA; [Staropoli, John F.; Krause, Daniela S.; Brown, Diane E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Garrett, Lillian; Hoelter, Sabine M.; Puk, Oliver; Sun, Minxuan; Graw, Jochen; Wurst, Wolfgang] Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Becker, Lore; Klopstock, Thomas] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80804 Munich, Germany; [Becker, Lore; Rathkolb, Birgit; Rozman, Jan; Schrewe, Anja; Adler, Thure; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, German Mouse Clin, Inst Expt Genet, Neuherberg, Germany; [Skosyrski, Sergej] Campus Virchow Klinikum, Charite Eye Hosp, Berlin, Germany; [Da Silva-Buttkus, Patricia; Calzada-Wack, Julia; Neff, Frauke] Helmholtz Zentrum Munchen, Inst Pathol, Neuherberg, Germany; [Rathkolb, Birgit; Wolf, Eckhard] Univ Munich, Chair Mol Anim Breeding & Biotechnol, Gene Ctr, Munich, Germany; [Rozman, Jan; Klingenspor, Martin] TUM, Else Kroner Fresenius Ctr, Freising Weihenstephan, Germany; [Adler, Thure; Busch, Dirk H.] TUM, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Favor, Jack] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Racz, Ildiko; Zimmer, Andreas] Univ Bonn, Inst Mol Psychiat, Bonn, Germany; [Bekeredjian, Raffi] Heidelberg Univ, Dept Med 3, Div Cardiol, Otto Meyerhof Zentrum, Heidelberg, Germany; [Wurst, Wolfgang] TUM, Lehrstuhl Entwicklungsgenet, Freising Weihenstephan, Germany; [Wurst, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Wurst, Wolfgang] Deutsch Zentrum Neurodegenerat Erkrankungen eV Si, Munich, Germany; [Harati, Hayat; Boustany, Rose-Mary] Amer Univ Beirut, Neurogenet Program, Beirut, Lebanon; [Harati, Hayat; Boustany, Rose-Mary] Amer Univ Beirut, Div Pediat Neurol, Dept Pediat, Beirut, Lebanon; [Harati, Hayat; Boustany, Rose-Mary] Amer Univ Beirut, Div Pediat Neurol, Dept Biochem, Beirut, Lebanon; [Hill, Eric; Breton, Sylvie] Massachusetts Gen Hosp, Ctr Syst Biol, Program Membrane Biol, Div Nephrol, Boston, MA 02114 USA; [Brown, Diane E.] Massachusetts Gen Hosp, Ctr Comparat Med, Boston, MA 02114 USA; [Ruether, Klaus] Augenabt Sankt Gertrauden Krankenhaus, Berlin, Germany; [de Angelis, Martin Hrabe] TUM, Lehrstuhl Expt Genet, Freising Weihenstephan, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bonn; Ruprecht Karls University Heidelberg; Technical University of Munich; Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); American University of Beirut; American University of Beirut; American University of Beirut; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Technical University of Munich	Staropoli, JF (corresponding author), Massachusetts Gen Hosp, Mol Neurogenet Unit, Ctr Human Genet Res, Boston, MA 02114 USA.	cotman@helix.mgh.harvard.edu	Gailus-Durner, Valerie/M-7337-2014; Puk, Oliver/E-1443-2013; Rozman, Jan/A-2540-2010; Klingenspor, Martin/D-6930-2011; Becker, Lore/E-3717-2010; Becker, Lore/AAJ-1203-2020; de Angelis, Martin Hrabe/F-5531-2012; Racz, I./C-3074-2009; Fuchs, Helmut/M-7347-2014; Graw, Jochen/D-9336-2013; Hölter, Sabine M./N-5868-2014; Klingenspor, Martin/K-5033-2019; Rathkolb, Birgit/F-7041-2013; Zimmer, Andreas/B-8357-2009	Rozman, Jan/0000-0002-8035-8904; Klingenspor, Martin/0000-0002-4502-6664; Becker, Lore/0000-0002-6890-4984; de Angelis, Martin Hrabe/0000-0002-7898-2353; Racz, I./0000-0002-1549-3616; Fuchs, Helmut/0000-0002-5143-2677; Hölter, Sabine M./0000-0003-4878-5241; Calzada, Julia/0000-0003-0816-9305; Garrett, Lillian/0000-0003-4880-7076; Graw, Jochen/0000-0003-0298-9660; Wolf, Eckhard/0000-0002-0430-9510; Wurst, Wolfgang/0000-0003-4422-7410	Dubai-Harvard Foundation for Medical Research; NCL Stiftung; Batten Disease Support and Research Association; National Institutes of Health: National1380 Institute of Neurological Disorders Stroke [NS073813, NS049206]; German Federal Ministry of Education and Research [01GS0850, 01GS0851, 01GS0852, 01GS0853, 01GS0854, GS0868, 01GS0869]; EU [LSHG-2006-037188]; Initiative and Networking Fund of the Helmholtz Association [T(HA-215]; National Institute of Diabetes and Digestive and Kidney Diseases in the form of an Inflammatory Bowel Disease [DK43351]; Boston Area Diabetes and Endocrinology Research Center (BADERC) [DK57521]; NATIONAL CANCER INSTITUTE [K08CA138916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, P30DK057521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073813, R01NS049206] Funding Source: NIH RePORTER	Dubai-Harvard Foundation for Medical Research; NCL Stiftung; Batten Disease Support and Research Association; National Institutes of Health: National1380 Institute of Neurological Disorders Stroke; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); EU(European Commission); Initiative and Networking Fund of the Helmholtz Association; National Institute of Diabetes and Digestive and Kidney Diseases in the form of an Inflammatory Bowel Disease; Boston Area Diabetes and Endocrinology Research Center (BADERC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Dubai-Harvard Foundation for Medical Research [to SLC and R-MB]; NCL Stiftung [to KR]; the Batten Disease Support and Research Association [to JFS]; the National Institutes of Health: National1380 Institute of Neurological Disorders & Stroke [NS073813 to SLC and NS049206 to VCW]; the German Federal Ministry of Education and Research [DZD E.V. to the German Center for Diabetes Research and NGFN-Plus grants 01GS0850, 01GS0851, 01GS0852, 01GS0853, 01GS0854, GS0868, 01GS0869 to the German Mouse Clinic]; EU grant [EUMODIC, LSHG-2006-037188 to the German Mouse Clinic]; and by the Initiative and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Research in an Ageing Society [T(HA-215) to Systems Biology/Program in Membrane Biology is partially supported National Institute of Diabetes and Digestive and Kidney Diseases in the form of an Inflammatory Bowel Disease Grant [DK43351] and a Boston Area Diabetes and Endocrinology Research Center (BADERC) Award [DK57521]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 2003, MOVEMENT DISORD, V18, P231, DOI 10.1002/mds.10327; Adamali HI, 1999, J ANDROL, V20, P803; Adamali HI, 1999, J ANDROL, V20, P779; Adams HR, 2007, J CHILD NEUROL, V22, P621, DOI 10.1177/0883073807302603; Ahtiainen L, 2007, NEUROBIOL DIS, V28, P52, DOI 10.1016/j.nbd.2007.06.012; Aleman TS, 2011, INVEST OPHTH VIS SCI, V52, P6898, DOI 10.1167/iovs.11-7701; Anderson G, 2005, J CLIN PATHOL, V58, P1305, DOI 10.1136/jcp.2005.027045; [Anonymous], 1995, Cell, V82, P949; Asano T, 2011, MOL CELL BIOL, V31, P2040, DOI 10.1128/MCB.01437-10; Backman ML, 2005, J INTELL DISABIL RES, V49, P25, DOI 10.1111/j.1365-2788.2005.00659.x; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bronson RT, 1998, AM J MED GENET, V77, P289, DOI 10.1002/(SICI)1096-8628(19980526)77:4<289::AID-AJMG8>3.0.CO;2-I; Brown DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009441; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Cao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017118; Castaneda JA, 2008, NEUROBIOL DIS, V29, P92, DOI 10.1016/j.nbd.2007.08.007; Chattopadhyay S, 2002, HUM MOL GENET, V11, P1421, DOI 10.1093/hmg/11.12.1421; Cialone J, 2012, J INHERIT METAB DIS, V35, P549, DOI 10.1007/s10545-011-9421-6; Codlin S, 2008, J CELL SCI, V121, P2860, DOI 10.1242/jcs.030122; Codlin S, 2009, J CELL SCI, V122, P1163, DOI 10.1242/jcs.038323; Cooper JD, 2006, BBA-MOL BASIS DIS, V1762, P873, DOI 10.1016/j.bbadis.2006.08.002; Cotman SL, 2002, HUM MOL GENET, V11, P2709, DOI 10.1093/hmg/11.22.2709; Cotman SL, 2012, CLIN LIPIDOL, V7, P79, DOI 10.2217/CLP.11.70; Da Silva N, 2007, AM J PHYSIOL-CELL PH, V293, pC199, DOI 10.1152/ajpcell.00596.2006; EDDY NB, 1953, J PHARMACOL EXP THER, V107, P385; Eliason SL, 2007, J NEUROSCI, V27, P9826, DOI 10.1523/JNEUROSCI.1710-07.2007; FAVOR J, 1983, MUTAT RES, V110, P367, DOI 10.1016/0027-5107(83)90153-7; Finn R, 2011, NEUROCHEM INT, V58, P648, DOI 10.1016/j.neuint.2011.02.003; Fox J.G., MOUSE BIOMEDICAL RES; Fuchs H, 2009, CURR PHARM BIOTECHNO, V10, P236, DOI 10.2174/138920109787315051; Fuchs H, 2011, METHODS, V53, P120, DOI 10.1016/j.ymeth.2010.08.006; GADOTH N, 1975, J NEUROL SCI, V25, P197, DOI 10.1016/0022-510X(75)90140-9; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Gailus-Durner Valerie, 2009, V530, P463, DOI 10.1007/978-1-59745-471-1_25; Gao HL, 2002, AM J HUM GENET, V70, P324, DOI 10.1086/338190; Hanninen A, 2011, EUR J IMMUNOL, V41, P634, DOI 10.1002/eji.201040760; Herrmann P, 2008, J NEUROSCI RES, V86, P1857, DOI 10.1002/jnr.21630; Hofman I L, 2001, Eur J Paediatr Neurol, V5 Suppl A, P213; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Kama R, 2011, J CELL BIOL, V195, P203, DOI 10.1083/jcb.201102115; Katz M L, 2001, Eur J Paediatr Neurol, V5 Suppl A, P109, DOI 10.1053/ejpn.2000.0445; Katz ML, 2008, NEUROBIOL DIS, V29, P242, DOI 10.1016/j.nbd.2007.08.017; KETTUNEN RVJ, 1994, AM HEART J, V127, P1449, DOI 10.1016/0002-8703(94)90369-7; Kielar C, 2009, HUM MOL GENET, V18, P4066, DOI 10.1093/hmg/ddp355; Knutson M, 2003, CRIT REV BIOCHEM MOL, V38, P61, DOI 10.1080/713609210; Kohlschutter A, 2009, BRAIN DEV-JPN, V31, P499, DOI 10.1016/j.braindev.2008.12.008; KOHLSCHUTTER A, 1988, ACTA PAEDIATR SCAND, V77, P867, DOI 10.1111/j.1651-2227.1988.tb10770.x; Kyttala A, 2006, BBA-MOL BASIS DIS, V1762, P920, DOI 10.1016/j.bbadis.2006.05.007; Lebrun AH, 2011, MOL MED, V17, P1253, DOI 10.2119/molmed.2010.00241; LERMAN A, 1993, LANCET, V341, P1105, DOI 10.1016/0140-6736(93)93125-K; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Luiro K, 2001, HUM MOL GENET, V10, P2123, DOI 10.1093/hmg/10.19.2123; Luiro K, 2006, J NEUROSCI RES, V84, P1124, DOI 10.1002/jnr.21015; Mandillo S, 2008, PHYSIOL GENOMICS, V34, P243, DOI 10.1152/physiolgenomics.90207.2008; Marshall FJ, 2005, NEUROLOGY, V65, P275, DOI 10.1212/01.wnl.0000169019.41332.8a; Mattapallil MJ, 2012, INVESTIGATIVE OPHTHA; Mitchison HM, 1999, NEUROBIOL DIS, V6, P321, DOI 10.1006/nbdi.1999.0267; Mole S., 2011, NEURONAL CEROID LIPO, DOI DOI 10.1093/MED/9780199590018.003.0018; Mole SE, 2005, NEUROGENETICS, V6, P107, DOI 10.1007/s10048-005-0218-3; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Moran JL, 2006, GENOME RES, V16, P436, DOI 10.1101/gr.4563306; Munroe PB, 1997, AM J HUM GENET, V61, P310, DOI 10.1086/514846; Narayan SB, 2006, ANN NEUROL, V60, P570, DOI 10.1002/ana.20975; Osorio NS, 2009, GENES BRAIN BEHAV, V8, P337, DOI 10.1111/j.1601-183X.2009.00478.x; Ostergaard JR, 2011, NEUROLOGY, V76, P1245, DOI 10.1212/WNL.0b013e31821435bd; PALMER DN, 1992, AM J MED GENET, V42, P561, DOI 10.1002/ajmg.1320420428; Partanen S, 2008, J NEUROPATH EXP NEUR, V67, P16, DOI 10.1097/nen.0b013e31815f3899; Pasche B, 2005, INFECT IMMUN, V73, P5952, DOI 10.1128/IAI.73.9.5952-5960.2005; Pearce DA, 1999, MOL GENET METAB, V66, P320, DOI 10.1006/mgme.1999.2819; Perlman I, 2011, ORG RETINA VISUAL SY; Petkova SB, 2008, PHYSIOL GENOMICS, V34, P304, DOI 10.1152/physiolgenomics.00185.2007; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; Pietrement C, 2008, J BIOL CHEM, V283, P2986, DOI 10.1074/jbc.M704678200; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Pontikis CC, 2005, NEUROBIOL DIS, V20, P823, DOI 10.1016/j.nbd.2005.05.018; Pontikis CC, 2004, BRAIN RES, V1023, P231, DOI 10.1016/j.brainres.2004.07.030; Pouretemad HR, 1998, EPILEPSY RES, V31, P1, DOI 10.1016/S0920-1211(98)00014-X; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Rusyn E, 2008, PEDIATR RES, V63, P625, DOI 10.1203/PDR.0b013e31816fdc17; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Schmucker C, 2004, VISION RES, V44, P2445, DOI 10.1016/j.visres.2004.05.018; Schneider I, 2006, J NEUROSCI METH, V157, P82, DOI 10.1016/j.jneumeth.2006.04.002; Shum WWC, 2009, J EXP BIOL, V212, P1753, DOI 10.1242/jeb.027284; Siintola E, 2006, BRAIN, V129, P1438, DOI 10.1093/brain/awl107; Song JW, 2008, J NEUROSCI, V28, P8993, DOI 10.1523/JNEUROSCI.0720-08.2008; Stephenson LM, 2009, AUTOPHAGY, V5, P625, DOI 10.4161/auto.5.5.8133; Stiedl O, 1999, BEHAV BRAIN RES, V104, P1, DOI 10.1016/S0166-4328(99)00047-9; SWERDLOW NR, 1995, J NEUROL NEUROSUR PS, V58, P192, DOI 10.1136/jnnp.58.2.192; TEICHHOLZ LE, 1974, NEW ENGL J MED, V291, P1220, DOI 10.1056/NEJM197412052912304; Virmani T, 2005, NEUROBIOL DIS, V20, P314, DOI 10.1016/j.nbd.2005.03.012; Weimer JM, 2006, NEUROBIOL DIS, V22, P284, DOI 10.1016/j.nbd.2005.11.008; Weleber RG, 1998, EYE, V12, P580, DOI 10.1038/eye.1998.148; Wheeler RB, 2002, AM J HUM GENET, V70, P537, DOI 10.1086/338708; Woloszynek JC, 2007, J BIOL CHEM, V282, P35765, DOI 10.1074/jbc.M705124200; Zhang J, 2009, BLOOD, V114, P157, DOI 10.1182/blood-2008-04-151639	97	48	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38310	10.1371/journal.pone.0038310	http://dx.doi.org/10.1371/journal.pone.0038310			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701626	Green Published, Green Submitted, gold			2022-12-25	WOS:000305348400050
J	Ueki, Y; Reh, TA				Ueki, Yumi; Reh, Thomas A.			Activation of BMP-Smad1/5/8 Signaling Promotes Survival of Retinal Ganglion Cells after Damage In Vivo	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; BONE MORPHOGENETIC PROTEIN; LEUKEMIA INHIBITORY FACTOR; FIBROBLAST-GROWTH-FACTOR; FACTOR PREVENTS DEGENERATION; LONG-TERM SURVIVAL; SPINAL-CORD-INJURY; RAT RETINA; NERVOUS-SYSTEM; UP-REGULATION	While the essential role of bone morphogenetic protein (BMP) signaling in nervous system development is well established, its function in the adult CNS is poorly understood. We investigated the role of BMP signaling in the adult mouse retina following damage in vivo. Intravitreal injection of N-Methyl-D-aspartic acid (NMDA) induced extensive retinal ganglion cell death by 2 days. During this period, BMP2, -4 and -7 were upregulated, leading to phosphorylation of the downstream effector, Smad1/5/8 in the inner retina, including in retinal ganglion cells. Expression of Inhibitor of differentiation 1 (Id1; a known BMP-Smad1/5/8 target) was also upregulated in the retina. This activation of BMP-Smad1/5/8 signaling was also observed following light damage, suggesting that it is a general response to retinal injuries. Co-injection of BMP inhibitors with NMDA effectively blocked the damage-induced BMP-Smad1/5/8 activation and led to further cell death of retinal ganglion cells, when compared with NMDA injection alone. Moreover, treatment of the retina with exogenous BMP4 along with NMDA damage led to a significant rescue of retinal ganglion cells. These data demonstrate that BMP-Smad1/5/8 signaling is neuroprotective for retinal ganglion cells after damage, and suggest that stimulation of this pathway can serve as a potential target for neuroprotective therapies in retinal ganglion cell diseases, such as glaucoma.	[Ueki, Yumi; Reh, Thomas A.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Ueki, Y (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	tomreh@uw.edu			 [1R01EY021482]; NATIONAL EYE INSTITUTE [P30EY001730, R01EY021482] Funding Source: NIH RePORTER	; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors are grateful to the imaging core of the Vision Core Grant to the University of Washington, P30EY01730. This work was supported by 1R01EY021482 to TAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KD, 1996, P NATL ACAD SCI USA, V93, P7346, DOI 10.1073/pnas.93.14.7346; Basak O, 2007, EUR J NEUROSCI, V25, P1006, DOI 10.1111/j.1460-9568.2007.05370.x; Behesti H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-62; Blanco RE, 2008, J NEUROSCI RES, V86, P3382, DOI 10.1002/jnr.21793; Burgi S, 2009, MOL VIS, V15, P1631; Cao W, 1997, EXP EYE RES, V65, P241, DOI 10.1006/exer.1997.0328; Cayouette M, 1998, J NEUROSCI, V18, P9282; Chang B, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-18; Charytoniuk DA, 2000, NEUROSCIENCE, V100, P33, DOI 10.1016/S0306-4522(00)00246-3; CHEEMA SS, 1994, J NEUROSCI RES, V37, P213, DOI 10.1002/jnr.490370207; Crews L, 2010, J NEUROSCI, V30, P12252, DOI 10.1523/JNEUROSCI.1305-10.2010; Du Y, 2010, INVEST OPHTH VIS SCI, V51, P3764, DOI 10.1167/iovs.09-4906; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Dudley AT, 1997, DEV DYNAM, V208, P349; EISENFELD AJ, 1984, INVEST OPHTH VIS SCI, V25, P1321; Ekstrom P, 2003, DEV BRAIN RES, V145, P1, DOI 10.1016/S0165-3806(03)00170-6; FAKTOROVICH EG, 1992, J NEUROSCI, V12, P3554; Fischer AJ, 2004, MOL CELL NEUROSCI, V27, P531, DOI 10.1016/j.mcn.2004.08.007; Franke AG, 2006, J COMP NEUROL, V495, P263, DOI 10.1002/cne.20869; Frasson M, 1999, INVEST OPHTH VIS SCI, V40, P2724; Fukuda S, 2007, MOL CELL BIOL, V27, P4931, DOI 10.1128/MCB.02435-06; Fuller ML, 2007, ANN NEUROL, V62, P288, DOI 10.1002/ana.21179; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; Gadient RA, 1998, BRAIN RES, V798, P140, DOI 10.1016/S0006-8993(98)00236-4; Gao H, 1996, EXP EYE RES, V62, P181, DOI 10.1006/exer.1996.0022; HAGG T, 1993, P NATL ACAD SCI USA, V90, P6315, DOI 10.1073/pnas.90.13.6315; Honjo M, 2000, INVEST OPHTH VIS SCI, V41, P552; Karl MO, 2008, P NATL ACAD SCI USA, V105, P19508, DOI 10.1073/pnas.0807453105; Kawamata T, 1998, NEUROREPORT, V9, P1441, DOI 10.1097/00001756-199805110-00035; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Leaver SG, 2006, GENE THER, V13, P1328, DOI 10.1038/sj.gt.3302791; Lin SZ, 1999, STROKE, V30, P126, DOI 10.1161/01.STR.30.1.126; Liu J, 2003, DEV BIOL, V256, P34, DOI 10.1016/S0012-1606(02)00115-X; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; MacLaren RE, 2006, EXP EYE RES, V83, P1118, DOI 10.1016/j.exer.2006.05.019; Mehler MF, 1997, TRENDS NEUROSCI, V20, P309, DOI 10.1016/S0166-2236(96)01046-6; MEY J, 1993, BRAIN RES, V602, P304, DOI 10.1016/0006-8993(93)90695-J; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Murali D, 2005, DEVELOPMENT, V132, P913, DOI 10.1242/dev.01673; Murali D, 2011, INVEST OPHTH VIS SCI, V52, P2930, DOI 10.1167/iovs.10-5940; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nelson BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022817; Nonner D, 2001, J NEUROCHEM, V77, P691, DOI 10.1046/j.1471-4159.2001.00273.x; Qi XA, 2010, EXP NEUROL, V221, P353, DOI 10.1016/j.expneurol.2009.12.003; Sahni V, 2010, J NEUROSCI, V30, P1839, DOI 10.1523/JNEUROSCI.4459-09.2010; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Samardzija M, 2006, FASEB J, V20, P2411, DOI 10.1096/fj.06-5895fje; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; Setoguchi T, 2001, BRAIN RES, V921, P219, DOI 10.1016/S0006-8993(01)03123-7; Soto I, 2006, J NEUROCHEM, V96, P82, DOI 10.1111/j.1471-4159.2005.03510.x; Sucher NJ, 1997, VISION RES, V37, P3483, DOI 10.1016/S0042-6989(97)00047-3; Takahata K, 2003, INVEST OPHTH VIS SCI, V44, P1760, DOI 10.1167/iovs.02-0471; Trousse F, 2001, J NEUROSCI, V21, P1292; Ueki Y, 2008, J NEUROCHEM, V105, P784, DOI 10.1111/j.1471-4159.2007.05180.x; UNOKI K, 1994, INVEST OPHTH VIS SCI, V35, P907; Vaccari JPD, 2009, NEUROSCI LETT, V465, P226, DOI 10.1016/j.neulet.2009.09.013; van Adel BA, 2005, J NEUROBIOL, V63, P215, DOI 10.1002/neu.20117; WEN R, 1995, J NEUROSCI, V15, P7377	59	37	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38690	10.1371/journal.pone.0038690	http://dx.doi.org/10.1371/journal.pone.0038690			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701694	Green Published, Green Submitted, gold			2022-12-25	WOS:000305348400086
J	Coppinger, JA; Hutt, DM; Razvi, A; Koulov, AV; Pankow, S; Yates, JR; Balch, WE				Coppinger, Judith A.; Hutt, Darren M.; Razvi, Abbas; Koulov, Atanas V.; Pankow, Sandra; Yates, John R., III; Balch, William E.			A Chaperone Trap Contributes to the Onset of Cystic Fibrosis	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; RETICULUM-ASSOCIATED DEGRADATION; HEAT-SHOCK PROTEINS; ENDOPLASMIC-RETICULUM; DELTA-F508 CFTR; MOLECULAR CHAPERONES; SHOTGUN PROTEOMICS; HSP70 CHAPERONES; HSP90; DISEASE	Protein folding is the primary role of proteostasis network (PN) where chaperone interactions with client proteins determine the success or failure of the folding reaction in the cell. We now address how the Phe508 deletion in the NBD1 domain of the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) protein responsible for cystic fibrosis (CF) impacts the binding of CFTR with cellular chaperones. We applied single ion reaction monitoring mass spectrometry (SRM-MS) to quantitatively characterize the stoichiometry of the heat shock proteins (Hsps) in CFTR folding intermediates in vivo and mapped the sites of interaction of the NBD1 domain of CFTR with Hsp90 in vitro. Unlike folding of WT-CFTR, we now demonstrate the presence of Delta F508-CFTR in a stalled folding intermediate in stoichiometric association with the core Hsps 40, 70 and 90, referred to as a 'chaperone trap'. Culturing cells at 30 C resulted in correction of Delta F508-CFTR trafficking and function, restoring the sub-stoichiometric association of core Hsps observed for WT-CFTR. These results support the interpretation that Delta F508-CFTR is restricted to a chaperone-bound folding intermediate, a state that may contribute to its loss of trafficking and increased targeting for degradation. We propose that stalled folding intermediates could define a critical proteostasis pathway branch-point(s) responsible for the loss of function in misfolding diseases as observed in CF.	[Coppinger, Judith A.; Hutt, Darren M.; Razvi, Abbas; Koulov, Atanas V.; Pankow, Sandra; Yates, John R., III; Balch, William E.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Yates, John R., III; Balch, William E.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Coppinger, JA (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	jyates@scripps.edu; webalch@scripps.edu		coppinger, judith/0000-0001-6813-9840; Pankow, Sandra/0000-0003-3213-9886; Koulov, Atanas/0000-0003-0262-7002	National Institute of Health (NIH) [HL 079442, GM42336, DK785483, P41 RR011823]; Cystic Fibrosis Foundation (CFF); Cystic Fibrosis Consortium (CFC); Canadian Cystic Fibrosis Foundation (CCFF); Canadian Institutes for Health Research (CIHR); NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095524, R01HL079442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042336] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation (CFF); Cystic Fibrosis Consortium (CFC); Canadian Cystic Fibrosis Foundation (CCFF); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of Health (NIH) (HL 079442 (WEB/JRY), GM42336 (WEB), DK785483 (WEB), P41 RR011823 (JRY), by fellowships from the Cystic Fibrosis Foundation (CFF) and funding from the Cystic Fibrosis Consortium (CFC). DMH was supported by fellowships from the Canadian Cystic Fibrosis Foundation (CCFF) and the Canadian Institutes for Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Andreasson C, 2010, J BIOL CHEM, V285, P12445, DOI 10.1074/jbc.M109.096735; Balch W. E., 2011, COLD SPRING HARB PER, V3; Balch WE, 2011, COLD SPRING IN PRESS; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bannykh SI, 2000, TRAFFIC, V1, P852, DOI 10.1034/j.1600-0854.2000.011105.x; Bourgault S, 2011, BIOCHEM BIOPH RES CO, V410, P707, DOI 10.1016/j.bbrc.2011.04.133; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Brodsky JL, 2009, CURR OPIN CELL BIOL, V21, P516, DOI 10.1016/j.ceb.2009.04.006; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; Carra S, 2009, J BIOL CHEM, V284, P5523, DOI 10.1074/jbc.M807440200; Chang XB, 2008, J CELL SCI, V121, P2814, DOI 10.1242/jcs.028951; Connelly S, 2010, CURR OPIN STRUC BIOL, V20, P54, DOI 10.1016/j.sbi.2009.12.009; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Elschenbroich S, 2011, MOL BIOSYST, V7, P292, DOI 10.1039/c0mb00159g; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Garrido C., 2012, INT J BIOCH CELL BIO; Gelman MS, 2002, J BIOL CHEM, V277, P11709, DOI 10.1074/jbc.M111958200; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Gidalevitz T., 2011, COLD SPRING HARB PER, V3; Grove DE, 2011, MOL BIOL CELL, V22, P301, DOI 10.1091/mbc.E10-09-0760; Hageman J, 2011, BIOCHEM J, V435, P127, DOI 10.1042/BJ20101247; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Hoelen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015458; Huang SY, 2009, J MOL GRAPH MODEL, V27, P822, DOI 10.1016/j.jmgm.2008.12.005; Hutt DM, 2009, FEBS LETT, V583, P2639, DOI 10.1016/j.febslet.2009.07.014; Hutt DH, 2010, NAT CHEM BI IN PRESS; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Johnson SM, 2012, J MOL BIOL; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Klaic L, 2012, ACS CHEM BIOL; Koulov AV, 2010, MOL BIOL CELL; Lee MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003871; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; MacCoss MJ, 2003, ANAL CHEM, V75, P6912, DOI 10.1021/ac034790h; MacCoss MJ, 2002, ANAL CHEM, V74, P5593, DOI 10.1021/ac025826t; Marozkina NV, 2010, P NATL ACAD SCI USA, V107, P11393, DOI 10.1073/pnas.0909128107; Mendoza JL, 2007, J BIOENERG BIOMEMBR, V39, P499, DOI 10.1007/s10863-007-9117-7; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Mendoza JL, 2011, METHODS MOL BIOL, V741, P321, DOI 10.1007/978-1-61779-117-8_21; Miyata Y, 2011, FUTURE MED CHEM, V3, P1523, DOI [10.4155/fmc.11.88, 10.4155/FMC.11.88]; Morimoto RI, 2012, COLD SPRING HARB S Q; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Ong DST, 2011, CURR OPIN CELL BIOL, V23, P231, DOI 10.1016/j.ceb.2010.11.002; Park SK, 2010, CURR PROTOC BIOINFOR, DOI 10.1002/0471250953.bi1312s29; Patrick AE, 2011, MOL BIOL CELL, V22, P4461, DOI 10.1091/mbc.E11-05-0396; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Prahlad V, 2009, TRENDS CELL BIOL, V19, P52, DOI 10.1016/j.tcb.2008.11.002; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Qu BH, 1997, J BIOENERG BIOMEMBR, V29, P483, DOI 10.1023/A:1022439108101; Qu BH, 1997, J BIOL CHEM, V272, P15739, DOI 10.1074/jbc.272.25.15739; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosser MFN, 2008, MOL BIOL CELL, V19, P4570, DOI 10.1091/mbc.E08-04-0357; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; Schmidt A, 2011, METHODS MOL BIOL, V741, P365, DOI 10.1007/978-1-61779-117-8_24; Serohijos AWR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000008; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sun F, 2008, FASEB J, V22, P3255, DOI 10.1096/fj.07-105338; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; Turnbull EL, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S11; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vos MJ, 2011, AUTOPHAGY, V7, P101, DOI 10.4161/auto.7.1.13935; Vos MJ, 2010, HUM MOL GENET, V19, P4677, DOI 10.1093/hmg/ddq398; Walter GM, 2011, J BIOL CHEM, V286, P40486, DOI 10.1074/jbc.M111.284448; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wang AM, 2010, J BIOL CHEM, V285, P15714, DOI 10.1074/jbc.M109.098806; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Wiseman RL, 2007, CELL, V131, P809, DOI 10.1016/j.cell.2007.10.025; Wisen S, 2010, ACS CHEM BIOL, V5, P611, DOI 10.1021/cb1000422; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zijlstra MP, 2010, EUR J NEUROSCI, V32, P760, DOI 10.1111/j.1460-9568.2010.07352.x	101	48	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37682	10.1371/journal.pone.0037682	http://dx.doi.org/10.1371/journal.pone.0037682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701530	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338500051
J	Morag, N; Klement, E; Saroya, Y; Lensky, I; Gottlieb, Y				Morag, Neta; Klement, Eyal; Saroya, Yonatan; Lensky, Itamar; Gottlieb, Yuval			Prevalence of the symbiont Cardinium in Culicoides (Diptera: Ceratopogonidae) vector species is associated with land surface temperature	FASEB JOURNAL			English	Article						biting midges; insect symbiosis; satellite imagery data	CYTOPLASMIC INCOMPATIBILITY; BACTERIAL SYMBIONT; BEMISIA-TABACI; NATURAL-POPULATIONS; PEA APHID; WOLBACHIA; ENDOSYMBIONTS; BLUETONGUE; DIVERSITY; INFECTION	Prevalence of infection by bacterial symbionts may reflect their interactions with the host and has been shown to be correlated with environmental factors. Yet, it is still unclear whether infection by symbionts is determined by environmental factors affecting the early or imago stage of the host. Here, we identified and localized the symbiont Candidatus Cardinium hertigii (Bacteroidetes) in sympatric Culicoides biting midge species, examined its abundance, and studied its association with environmental factors. The prevalence of adult infection differed, with 50.7% from C. imicola, 31.4% from C. oxystoma, and 0% from C. schultzei gp., although phylogenetic analyses showed that Cardinium in these species is almost identical. In addition, prevalence of infection differed between climate regions, with lowest prevalence in the arid region and highest prevalence in the Mediterranean region. Multivariate linear regression analysis of Cardinium prevalence together with climatic and satellite imagery data-derived environmental variables revealed that infection prevalence is significantly associated with land surface temperature and explained up to 89.7% of infection prevalence variability. These findings suggest that the observed variation of Cardinium infection of the imago stage of Culicoides may be influenced by environmental conditions during the latter's early developmental stages.-Morag, N., Klement, E., Saroya, Y., Lensky, I., Gottlieb, Y. Prevalence of the symbiont Cardinium in Culicoides (Diptera: Ceratopogonidae) vector species is associated with land surface temperature. FASEB J. 26, 4025-4034 (2012). www.fasebj.org	[Morag, Neta; Klement, Eyal; Saroya, Yonatan; Gottlieb, Yuval] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Koret Sch Vet Med, IL-76100 Rehovot, Israel; [Lensky, Itamar] Bar Ilan Univ, Dept Geog & Environm, Ramat Gan, Israel	Hebrew University of Jerusalem; Bar Ilan University	Gottlieb, Y (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Koret Sch Vet Med, POB 12, IL-76100 Rehovot, Israel.	yuvalgd@yahoo.com	Gottlieb, Yuval/H-6461-2013; Klement, Eyal/H-8388-2019; Lensky, Itamar/B-5285-2014	Klement, Eyal/0000-0002-2384-2345; Lensky, Itamar/0000-0001-7594-5277	U.S.-Israel Binational Agricultural Research and Development (BARD) [IS-4185-09, IS-4380-11C]; Robert H. Smith scholarship for outstanding Ph.D. students	U.S.-Israel Binational Agricultural Research and Development (BARD)(US-Israel Binational Science Foundation); Robert H. Smith scholarship for outstanding Ph.D. students	The authors thank Prof. Yehuda Braverman profusely for help with Culicoides working methods. The authors thank Karin Aharonson-Raz for her assistance with Culicoides trapping, and Yifat Guthmann and Navot Morag for assistance with the map construction. This research was supported by U.S.-Israel Binational Agricultural Research and Development (BARD) research grants IS-4185-09 and IS-4380-11C to Y.G. and by The Robert H. Smith scholarship for outstanding Ph.D. students to N.M. DNA sequences used were from GenBank (accession nos. JN166961-JN166964).	Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Bensadia F, 2006, J INSECT PHYSIOL, V52, P146, DOI 10.1016/j.jinsphys.2005.09.011; BIRLEY M H, 1987, Israel Journal of Entomology, V21, P39; Boorman J., 2006, GUIDE BRIT CULICOIDE; Boyd D. S., 1998, REMOTE SENSING REV, V16, P293, DOI DOI 10.1080/02757259809532357; BRAVERMAN Y, 1974, MOSQ NEWS, V34, P303; Braverman Y, 1996, J AM MOSQUITO CONTR, V12, P437; BRAVERMAN Y, 1985, P191; Breeuwer H, 2012, FRONT MICROBIOL SER, P207; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; Burke G, 2010, ISME J, V4, P242, DOI 10.1038/ismej.2009.114; Cetre-Sossah C, 2004, VET RES, V35, P325, DOI 10.1051/vetres:2004015; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Dallas JF, 2003, MED VET ENTOMOL, V17, P379, DOI 10.1111/j.1365-2915.2003.00454.x; Duron O, 2008, MOL ECOL, V17, P1427, DOI 10.1111/j.1365-294X.2008.03689.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; Goldreich Y., 2012, CLIMATE ISRAEL OBSER; Gotoh T, 2007, HEREDITY, V98, P13, DOI 10.1038/sj.hdy.6800881; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; Guay JF, 2009, J INSECT PHYSIOL, V55, P919, DOI 10.1016/j.jinsphys.2009.06.006; Gueguen G, 2010, MOL ECOL, V19, P4365, DOI 10.1111/j.1365-294X.2010.04775.x; Haine ER, 2008, P ROY SOC B-BIOL SCI, V275, P353, DOI 10.1098/rspb.2007.1211; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hunter MS, 2003, P ROY SOC B-BIOL SCI, V270, P2185, DOI 10.1098/rspb.2003.2475; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kedmi M, 2010, J DAIRY SCI, V93, P2486, DOI 10.3168/jds.2009-2850; Kurtti TJ, 1996, J INVERTEBR PATHOL, V67, P318, DOI 10.1006/jipa.1996.0050; Liu Y, 2006, J APPL ENTOMOL, V130, P523, DOI 10.1111/j.1439-0418.2006.01112.x; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; MELLOR PS, 1984, J HYG-CAMBRIDGE, V93, P621, DOI 10.1017/S0022172400065190; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Morag N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033610; Mullen G.R., 2009, MED ENTOMOL, P163; Mullens BA, 1999, J INVERTEBR PATHOL, V73, P231, DOI 10.1006/jipa.1998.4838; Muyzer G, 1998, MOL MICROBIAL ECOLOG; Nakamura Y, 2009, APPL ENVIRON MICROB, V75, P6757, DOI 10.1128/AEM.01583-09; Neelakanta G, 2010, J CLIN INVEST, V120, P3179, DOI 10.1172/JCI42868; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; Simon JC, 2003, P ROY SOC B-BIOL SCI, V270, P1703, DOI 10.1098/rspb.2003.2430; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Suzuki M, 1999, INT J SYST BACTERIOL, V49, P1551, DOI 10.1099/00207713-49-4-1551; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatem Andrew J, 2004, Int J Appl Earth Obs Geoinf, V6, P33, DOI 10.1016/j.jag.2004.07.001; Toju H, 2011, MOL ECOL, V20, P853, DOI 10.1111/j.1365-294X.2010.04980.x; Tsuchida T, 2002, MOL ECOL, V11, P2123, DOI 10.1046/j.1365-294X.2002.01606.x; Van Opijnen T, 1999, EXP APPL ACAROL, V23, P871, DOI 10.1023/A:1006363604916; Velthuis AGJ, 2010, PREV VET MED, V93, P294, DOI 10.1016/j.prevetmed.2009.11.007; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Weeks AR, 2001, SCIENCE, V292, P2479, DOI 10.1126/science.1060411; Weeks AR, 2003, P ROY SOC B-BIOL SCI, V270, P1857, DOI 10.1098/rspb.2003.2425; Weeks AR, 2004, P ROY SOC B-BIOL SCI, V271, pS193, DOI 10.1098/rsbl.2003.0137; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; White JA, 2011, HEREDITY, V106, P585, DOI 10.1038/hdy.2010.89; Zchori-Fein E, 2004, MOL ECOL, V13, P2009, DOI 10.1111/j.1365-294X.2004.02203.x; Zchori-Fein E, 2001, P NATL ACAD SCI USA, V98, P12555, DOI 10.1073/pnas.221467498; Zindel R, 2011, J APPL ECOL, V48, P864, DOI 10.1111/j.1365-2664.2011.01984.x	60	37	39	0	33	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2012	26	10					4025	4034		10.1096/fj.12-210419	http://dx.doi.org/10.1096/fj.12-210419			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22700874				2022-12-25	WOS:000309704000010
J	van de Wetering, K; Sapthu, S				van de Wetering, Koen; Sapthu, Sunny			ABCG2 functions as a general phytoestrogen sulfate transporter in vivo	FASEB JOURNAL			English	Article						metabolomics; BCRP; phase II metabolism; vesicular transport	GLUCURONIDE; METABOLISM; GENISTEIN; ACETAMINOPHEN; DISPOSITION; INFERTILITY; EXPRESSION; EXCRETION; BCRP	ABCG2 is an ATP-dependent efflux transporter that limits the systemic exposure of its substrates. The preferred substrates of ABCG2 in vivo are largely unknown. We aimed to identify the compounds transported by ABCG2 under physiological conditions. In vitro, ABCG2 transports several sulfate conjugates at high rates. We therefore used targeted metabolomics, specifically detecting compounds conjugated to sulfate, to search in plasma, urine, and bile samples of wild-type and Abcg2(-/-) mice for differentially present compounds, which are likely to represent in vivo ABCG2 substrates. Levels of many sulfate conjugates were up to 15-fold higher in plasma and urine of Abcg2(-/-) than of wild-type mice, with the opposite effect seen in bile. These differentially present compounds were identified as the sulfate conjugates of phytoestrogens, compounds with weak pro- or antiestrogenic properties. We confirmed that these sulfate conjugates were ABCG2 substrates using transportomics, a method that uses vesicular transport assays to screen for substrates of ABC transporters in body fluids. In conclusion, our results show that ABCG2 limits the systemic exposure to many different phytoestrogens, a class of compounds to which mammals are exposed on a daily basis via food of plant origin, by directing their sulfate conjugates for excretion via the feces.-Van de Wetering, K., Sapthu, S. ABCG2 functions as a general phytoestrogen sulfate transporter in vivo. FASEB J. 26, 4014-4024 (2012). www.fasebj.org	[van de Wetering, Koen; Sapthu, Sunny] Netherlands Canc Inst, Div Mol Oncol, Amsterdam, Netherlands	Netherlands Cancer Institute	van de Wetering, K (corresponding author), Div Mol Oncol H5, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	k.vd.wetering@nki.nl			ZonMw (TOP grant) [40-00812-98-07-028]	ZonMw (TOP grant)	The authors thank their colleagues Alfred Schinkel, Robert Jansen, Serge Zander, and Piet Borst for fruitful discussions and critical reading of the manuscript. The experimental work in the authors' laboratory is supported by ZonMw (TOP grant 40-00812-98-07-028, to K.V.D.W.). The authors declare no conflicts of interest.	Adachi Y, 2005, MOL PHARMACOL, V67, P923, DOI 10.1124/mol.104.007393; ADAMS NR, 1990, AUST VET J, V67, P197, DOI 10.1111/j.1751-0813.1990.tb07758.x; Alvarez AI, 2011, DRUG METAB DISPOS, V39, P2008, DOI 10.1124/dmd.111.040881; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Breedveld P, 2007, MOL PHARMACOL, V71, P240, DOI 10.1124/mol.106.028167; D'Alessandro TL, 2005, METHOD ENZYMOL, V400, P316, DOI 10.1016/S0076-6879(05)00019-4; de Loor H, 2005, CLIN CHEM, V51, P1535, DOI 10.1373/clinchem.2005.050781; Dixon RA, 2004, ANNU REV PLANT BIOL, V55, P225, DOI 10.1146/annurev.arplant.55.031903.141729; Eeckhaut E, 2008, J AGR FOOD CHEM, V56, P4806, DOI 10.1021/jf800101s; Enokizono J, 2007, DRUG METAB DISPOS, V35, P922, DOI 10.1124/dmd.106.011239; Jansen GHE, 2005, ARCH BIOCHEM BIOPHYS, V435, P74, DOI 10.1016/j.abb.2004.12.015; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238; Krumpochova P, 2012, FASEB J, V26, P738, DOI 10.1096/fj.11-195743; Lafaye A, 2004, J MASS SPECTROM, V39, P655, DOI 10.1002/jms.635; Lee JK, 2009, DRUG METAB DISPOS, V37, P1916, DOI 10.1124/dmd.109.026815; Lewis RW, 2003, TOXICOL SCI, V71, P74, DOI 10.1093/toxsci/71.1.74; Pal A, 2007, J PHARMACOL EXP THER, V321, P1085, DOI 10.1124/jpet.106.119289; Robey RW, 2009, ADV DRUG DELIVER REV, V61, P3, DOI 10.1016/j.addr.2008.11.003; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; SETCHELL KDR, 1987, GASTROENTEROLOGY, V93, P225, DOI 10.1016/0016-5085(87)91006-7; Suzuki M, 2003, J BIOL CHEM, V278, P22644, DOI 10.1074/jbc.M212399200; van de Wetering K, 2007, MOL PHARMACOL, V72, P387, DOI 10.1124/mol.107.035592; Van De Wetering K, 2009, GASTROENTEROLOGY, V137, P1725, DOI 10.1053/j.gastro.2009.06.052; van de Wetering K, 2009, MOL PHARMACOL, V75, P876, DOI 10.1124/mol.108.052019; Vlaming MLH, 2009, ADV DRUG DELIVER REV, V61, P14, DOI 10.1016/j.addr.2008.08.007; WHITTEN PL, 1993, BIOL REPROD, V49, P1117, DOI 10.1095/biolreprod49.5.1117; Zamek-Gliszczynski MJ, 2006, MOL PHARMACOL, V70, P2127, DOI 10.1124/mol.106.026955; Zhu W, 2010, AAPS J, V12, P525, DOI 10.1208/s12248-010-9209-x	30	26	26	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2012	26	10					4014	4024		10.1096/fj.12-210039	http://dx.doi.org/10.1096/fj.12-210039			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22707564				2022-12-25	WOS:000309704000009
J	Dey, S; Bindu, S; Goyal, M; Pal, C; Alam, A; Iqbal, MS; Kumar, R; Sarkar, S; Bandyopadhyay, U				Dey, Sumanta; Bindu, Samik; Goyal, Manish; Pal, Chinmay; Alam, Athar; Iqbal, Mohd Shameel; Kumar, Rahul; Sarkar, Souvik; Bandyopadhyay, Uday			Impact of Intravascular Hemolysis in Malaria on Liver Dysfunction INVOLVEMENT OF HEPATIC FREE HEME OVERLOAD, NF-kappa B ACTIVATION, AND NEUTROPHIL INFILTRATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OXIDATIVE STRESS; NECROSIS-FACTOR-ALPHA; DRUG-INDUCED GASTROPATHY; REACTIVE OXYGEN; IN-VITRO; APOPTOSIS; MECHANISMS; HEMOGLOBIN; HEMOPEXIN; INJURY	We have investigated the impact of persistent intravascular hemolysis on liver dysfunction using the mouse malaria model. Intravascular hemolysis showed a positive correlation with liver damage along with the increased accumulation of free heme and reactive oxidants in liver. Hepatocytes overinduced heme oxygenase-1 (HO-1) to catabolize free heme in building up defense against this pro-oxidant milieu. However, in a condition of persistent free heme overload in malaria, the overactivity of HO-1 resulted in continuous transient generation of free iron to favor production of reactive oxidants as evident from 2',7'-dichlorofluorescein fluorescence studies. Electrophoretic mobility shift assay documented the activation of NF-kappa B, which in turn up-regulated intercellular adhesion molecule 1 as evident from chromatin immunoprecipitation studies. NF-kappa B activation also induced vascular cell adhesion molecule 1, keratinocyte chemoattractant, and macrophage inflammatory protein 2, which favored neutrophil extravasation and adhesion in liver. The infiltration of neutrophils correlated positively with the severity of hemolysis, and neutrophil depletion significantly prevented liver damage. The data further documented the elevation of serum TNF alpha in infected mice, and the treatment of anti-TNF alpha antibodies also significantly prevented neutrophil infiltration and liver injury. Deferoxamine, which chelates iron, interacts with free heme and bears antioxidant properties that prevented oxidative stress, NF-kappa B activation, neutrophil infiltration, hepatocyte apoptosis, and liver damage. Furthermore, the administration of N-acetylcysteine also prevented NF-kappa B activation, neutrophil infiltration, hepatocyte apoptosis, and liver damage. Thus, hepatic free heme accumulation, TNF alpha release, oxidative stress, and NF-kappa B activation established a link to favor neutrophil infiltration in inducing liver damage during hemolytic conditions in malaria.	[Dey, Sumanta; Bindu, Samik; Goyal, Manish; Pal, Chinmay; Alam, Athar; Iqbal, Mohd Shameel; Kumar, Rahul; Sarkar, Souvik; Bandyopadhyay, Uday] Indian Inst Chem Biol, Council Sci & Ind Res, Div Infect Dis & Immunol, Kolkata 700032, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Bandyopadhyay, U (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, Div Infect Dis & Immunol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	ubandyo_1964@yahoo.com	Goyal, Manish/O-2183-2015; Alam, Athar/B-3642-2010; Iqbal, Mohd Shameel/AAD-9641-2021	Goyal, Manish/0000-0003-2383-5409; Iqbal, Mohd Shameel/0000-0002-0353-3561; /0000-0002-5945-976X; Bindu, Samik/0000-0003-1416-2003	Suprainstitutional Project grants from the Council of Scientific and Industrial Research, New Delhi; Council of Scientific and Industrial Research, New Delhi	Suprainstitutional Project grants from the Council of Scientific and Industrial Research, New Delhi; Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Suprainstitutional Project grants from the Council of Scientific and Industrial Research, New Delhi.; Recipient of a senior research fellowship from the Council of Scientific and Industrial Research, New Delhi.	Adams DH, 2010, TOXICOL SCI, V115, P307, DOI 10.1093/toxsci/kfq009; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Balla J, 2007, ANTIOXID REDOX SIGN, V9, P2119, DOI 10.1089/ars.2007.1787; Baniasadi S, 2010, EUR J GASTROEN HEPAT, V22, P1235, DOI 10.1097/MEG.0b013e32833aa11b; Belcher JD, 2010, ANTIOXID REDOX SIGN, V12, P233, DOI 10.1089/ars.2009.2822; Bindu S, 2011, J BIOL CHEM, V286, P39387, DOI 10.1074/jbc.M111.279893; Biswas K, 2003, J BIOL CHEM, V278, P10993, DOI 10.1074/jbc.M210328200; Bombini G, 2004, EUR J PHARMACOL, V496, P197, DOI 10.1016/j.ejphar.2004.06.003; Breman Joel G., 2009, Science Progress, V92, P1, DOI 10.3184/003685009X440290; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Buehler PW, 2010, ANTIOXID REDOX SIGN, V12, P275, DOI 10.1089/ars.2009.2799; Buffet PA, 2011, BLOOD, V117, P381, DOI 10.1182/blood-2010-04-202911; CARACENI P, 1995, AM J PHYSIOL-GASTR L, V269, pG132, DOI 10.1152/ajpgi.1995.269.1.G132; Cianciulli P, 2009, MEDITERR J HEMATOL I, V1, DOI 10.4084/MJHID.2009.034; Dey S, 2009, FREE RADICAL BIO MED, V46, P271, DOI 10.1016/j.freeradbiomed.2008.10.032; Dienes HP, 2010, DIGEST DIS, V28, P57, DOI 10.1159/000282065; Eskew JD, 1999, J BIOL CHEM, V274, P638, DOI 10.1074/jbc.274.2.638; Farombi EO, 2008, FOOD CHEM TOXICOL, V46, P1279, DOI 10.1016/j.fct.2007.09.095; Fendel R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010038; Fouad D, 2004, LIVER INT, V24, P227, DOI 10.1111/j.1478-3231.2004.00913.x; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Goncalves LA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-169; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Guha M, 2007, J PINEAL RES, V43, P372, DOI 10.1111/j.1600-079X.2007.00488.x; Guha M, 2006, FASEB J, V20, P1224, DOI 10.1096/fj.05-5338fje; Haldar K, 2005, TRENDS PARASITOL, V21, P402, DOI 10.1016/j.pt.2005.07.003; Haldar K, 2007, ANNU REV PATHOL-MECH, V2, P217, DOI 10.1146/annurev.pathol.2.010506.091913; Hao Q, 2007, J CEREBR BLOOD F MET, V27, P1853, DOI 10.1038/sj.jcbfm.9600485; Haque A, 2011, INFECT IMMUN, V79, P1882, DOI 10.1128/IAI.01210-10; Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005; Jaramillo M, 2004, J IMMUNOL, V172, P3101, DOI 10.4049/jimmunol.172.5.3101; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Kabe Y, 2005, ANTIOXID REDOX SIGN, V7, P395, DOI 10.1089/ars.2005.7.395; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kapralov A, 2009, J BIOL CHEM, V284, P30395, DOI 10.1074/jbc.M109.045567; Kato GJ, 2010, BRIT J HAEMATOL, V148, P690, DOI 10.1111/j.1365-2141.2009.08004.x; Kato GJ, 2009, J CLIN INVEST, V119, P2140, DOI 10.1172/JCI40258; Kim YM, 1997, J BIOL CHEM, V272, P1402, DOI 10.1074/jbc.272.2.1402; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Larkin D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000349; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liang Y, 2004, CELL MOL IMMUNOL, V1, P343; Lokuta MA, 2005, J LEUKOCYTE BIOL, V78, P210, DOI 10.1189/jlb.0205067; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maity P, 2009, J PINEAL RES, V46, P314, DOI 10.1111/j.1600-079X.2009.00663.x; Maity P, 2009, J BIOL CHEM, V284, P3058, DOI 10.1074/jbc.M805329200; McDonald B, 2012, TOXICOL PATHOL, V40, P157, DOI 10.1177/0192623311427570; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Nagababu E, 2004, ANTIOXID REDOX SIGN, V6, P967, DOI 10.1089/1523086042259823; Nanji AA, 1999, HEPATOLOGY, V30, P934, DOI 10.1002/hep.510300402; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; ORJIH AU, 1981, SCIENCE, V214, P667, DOI 10.1126/science.7027441; Pal C, 2012, ANTIOXID REDOX SIGN, V17, P555, DOI 10.1089/ars.2011.4436; Pal C, 2012, J BIOL CHEM, V287, P3495, DOI 10.1074/jbc.M111.307199; Pal C, 2011, BIOORG MED CHEM LETT, V21, P3563, DOI 10.1016/j.bmcl.2011.04.127; Pal C, 2010, FREE RADICAL BIO MED, V49, P258, DOI 10.1016/j.freeradbiomed.2010.04.013; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Perry BC, 2011, J INVEST SURG, V24, P178, DOI 10.3109/08941939.2011.568594; Porto BN, 2007, J BIOL CHEM, V282, P24430, DOI 10.1074/jbc.M703570200; Portugal S, 2011, NAT MED, V17, P732, DOI 10.1038/nm.2368; Postma NS, 1996, PHARM WORLD SCI, V18, P121, DOI 10.1007/BF00717727; Qian Q, 2010, AM J KIDNEY DIS, V56, P780, DOI 10.1053/j.ajkd.2010.03.025; Ramadori G, 2008, J PHYSIOL PHARMACOL, V59, P107; Reeder BJ, 2004, ANTIOXID REDOX SIGN, V6, P954, DOI 10.1089/ars.2004.6.954; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Russo-Carbolante E.M.S., 2002, COMP CLIN PATH, V11, P71, DOI [DOI 10.1007/S005800200001, 10.1007/s005800200001]; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Sajan MP, 2009, J LIPID RES, V50, P1133, DOI 10.1194/jlr.M800520-JLR200; Santos LC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-96; Sathish P, 2011, EUR J PHARMACOL, V654, P181, DOI 10.1016/j.ejphar.2010.10.080; SCHIEVEN GL, 1993, BLOOD, V82, P1212, DOI 10.1182/blood.V82.4.1212.bloodjournal8241212; Schoonbroodt S, 2000, J IMMUNOL, V164, P4292, DOI 10.4049/jimmunol.164.8.4292; Seixas E, 2008, PARASITOLOGY, V135, P683, DOI 10.1017/S0031182008004344; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Shimakura A, 2000, BRAIN RES, V858, P55, DOI 10.1016/S0006-8993(99)02431-2; SMITH A, 1985, J BIOL CHEM, V260, P8325; SMITH A, 1981, J BIOL CHEM, V256, P902; SMITH A, 1984, J BIOL CHEM, V259, P2049; SULLIVAN SG, 1992, BIOCHIM BIOPHYS ACTA, V1104, P38, DOI 10.1016/0005-2736(92)90129-A; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Takada Y, 2003, J BIOL CHEM, V278, P24233, DOI 10.1074/jbc.M212389200; Tolosano E, 2002, BLOOD, V100, P4201, DOI 10.1182/blood-2002-04-1270; Uday Bandyopadhyay, 2011, Apicomplexan parasites: molecular approaches toward targeted drug development, P205; Vasilyev N, 2005, CIRCULATION, V112, P2812, DOI 10.1161/CIRCULATIONAHA.105.542340; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; Wiemer AJ, 2010, MOL IMMUNOL, V47, P894, DOI 10.1016/j.molimm.2009.10.002; Woollard KJ, 2009, J BIOL CHEM, V284, P13110, DOI 10.1074/jbc.M809095200; Yang FM, 2003, AM J PHYSIOL-LUNG C, V284, pL402, DOI 10.1152/ajplung.00115.2002; Yoshimoto T, 1998, J IMMUNOL, V160, P5500	92	58	58	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26630	26646		10.1074/jbc.M112.341255	http://dx.doi.org/10.1074/jbc.M112.341255			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22696214	hybrid, Green Published			2022-12-25	WOS:000307386000015
J	Gulshan, K; Thommandru, B; Moye-Rowley, WS				Gulshan, Kailash; Thommandru, Bernice; Moye-Rowley, W. Scott			Proteolytic Degradation of the Yap1 Transcription Factor Is Regulated by Subcellular Localization and the E3 Ubiquitin Ligase Not4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS-RESPONSE; SACCHAROMYCES-CEREVISIAE; MULTIDRUG-RESISTANCE; GENE-EXPRESSION; NUCLEAR EXPORT; YEAST-CELLS; CANDIDA-ALBICANS; FACTOR GCN4; PROTEIN; ACTIVATION	Saccharomyces cerevisiae Yap1 is a transcriptional regulatory protein that serves as a central determinant of oxidative stress tolerance. Activity of this factor is regulated in large part by control of its subcellular location. In the absence of oxidants, Yap1 is primarily located in the cytoplasm. Upon oxidant challenge, Yap1 accumulates rapidly in the nucleus where it activates expression of genes required for oxidative stress tolerance such as the thioredoxin TRX2. Here, we demonstrate that Yap1 degradation is accelerated in response to oxidative stress. Yap1 is folded differently depending on the oxidant used to induce its nuclear localization but is degraded similarly, irrespective of its folded status. Mutant forms of Yap1 that are constitutively trapped in the nucleus are degraded in the absence of an oxidant signal. Degradation requires the ability of the protein to bind DNA and a domain in the amino-terminal region of the factor. Inhibition of the proteasome prevents Yap1 turnover. Screening a variety of mutants involved in ubiquitin-mediated proteolysis demonstrated an important role for the nuclear ubiquitin ligase Not4 in Yap1 degradation. Not4 was found to bind to Yap1 in an oxidant-stimulated fashion. The Candida albicans Yap1 homologue (Cap1) also was degraded after oxidant challenge. These data uncover a new, conserved pathway for regulation of the oxidative stress response that serves to temporally limit the duration of Yap1-dependent transcriptional activation.	[Gulshan, Kailash; Thommandru, Bernice; Moye-Rowley, W. Scott] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa	Moye-Rowley, WS (corresponding author), Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, 6-530 Bowen Sci Bldg, Iowa City, IA 52242 USA.	scott-moye-rowley@uiowa.edu	Moye-Rowley, Scott/AFL-7135-2022	Moye-Rowley, Scott/0000-0002-7163-1120	National Institutes of Health [GM49825]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by GM49825 from the National Institutes of Health.	Alarco AM, 1999, J BACTERIOL, V181, P700, DOI 10.1128/JB.181.3.700-708.1999; Alarco AM, 1997, J BIOL CHEM, V272, P19304, DOI 10.1074/jbc.272.31.19304; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; Bose S, 2005, GENETICS, V169, P1215, DOI 10.1534/genetics.104.034603; Carmel-Harel O, 2001, MOL MICROBIOL, V39, P595, DOI 10.1046/j.1365-2958.2001.02255.x; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Coleman ST, 1999, MOL CELL BIOL, V19, P8302; COLLART MA, 1994, GENE DEV, V8, P525, DOI 10.1101/gad.8.5.525; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Collins GA, 2010, YEAST, V27, P965, DOI 10.1002/yea.1805; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Gulshan K, 2005, J BIOL CHEM, V280, P40524, DOI 10.1074/jbc.M504716200; Gulshan K, 2004, EUKARYOT CELL, V3, P318, DOI 10.1128/EC.3.2.318-330.2004; Haworth J, 2010, MOL BIOL CELL, V21, P3205, DOI 10.1091/mbc.E09-06-0452; Herrero E, 2008, BBA-GEN SUBJECTS, V1780, P1217, DOI 10.1016/j.bbagen.2007.12.004; Isoyama T, 2001, J BIOL CHEM, V276, P21863, DOI 10.1074/jbc.M009258200; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Izawa S, 1999, J BIOL CHEM, V274, P28459, DOI 10.1074/jbc.274.40.28459; KATZMANN DJ, 1994, MOL CELL BIOL, V14, P4653, DOI 10.1128/MCB.14.7.4653; Kitamura K, 2011, MOL MICROBIOL, V80, P739, DOI 10.1111/j.1365-2958.2011.07605.x; KORNITZER D, 1994, EMBO J, V13, P6021, DOI 10.1002/j.1460-2075.1994.tb06948.x; Kuge S, 1998, GENES CELLS, V3, P521, DOI 10.1046/j.1365-2443.1998.00209.x; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Kuge S, 2001, MOL CELL BIOL, V21, P6139, DOI 10.1128/MCB.21.18.6139-6150.2001; Lallet S, 2004, MOL GENET GENOMICS, V272, P353, DOI 10.1007/s00438-004-1063-z; Meimoun A, 2000, MOL BIOL CELL, V11, P915, DOI 10.1091/mbc.11.3.915; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Michel JJ, 2003, J BIOL CHEM, V278, P22828, DOI 10.1074/jbc.M210358200; Morgan BA, 1997, EMBO J, V16, P1035, DOI 10.1093/emboj/16.5.1035; Moye-Rowley WS, 2003, EUKARYOT CELL, V2, P381, DOI 10.1128/EC.2.3.381-389.2003; Nelson C, 2003, NATURE, V421, P187, DOI 10.1038/nature01243; Pal B, 2007, MOL BIOL CELL, V18, P426, DOI 10.1091/mbc.E06-04-0304; Panasenko O, 2006, J BIOL CHEM, V281, P31389, DOI 10.1074/jbc.M604986200; Poppek D, 2006, ANTIOXID REDOX SIGN, V8, P173, DOI 10.1089/ars.2006.8.173; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Rodrigues-Pousada C, 2010, YEAST, V27, P245, DOI 10.1002/yea.1752; Shahi P, 2010, MOL BIOL CELL, V21, P2469, DOI 10.1091/mbc.E09-10-0899; Sherman F, 1979, METHODS YEAST GENETI; Takeuchi T, 1997, FEBS LETT, V416, P339, DOI 10.1016/S0014-5793(97)01233-7; TODA T, 1991, GENE DEV, V5, P60, DOI 10.1101/gad.5.1.60; Tora L, 2010, TRENDS BIOCHEM SCI, V35, P309, DOI 10.1016/j.tibs.2010.01.007; Veal EA, 2003, J BIOL CHEM, V278, P30896, DOI 10.1074/jbc.M303542200; WEMMIE A, 1994, J BIOL CHEM, V269, P14690; Wemmie JA, 1997, J BIOL CHEM, V272, P7908, DOI 10.1074/jbc.272.12.7908; Wilcox AJ, 2009, NAT CELL BIOL, V11, P1481, DOI 10.1038/ncb1997; Yan C, 1998, EMBO J, V17, P7416, DOI 10.1093/emboj/17.24.7416; Yokoyama H, 2006, EMBO REP, V7, P519, DOI 10.1038/sj.embor.7400647; Zhang XT, 2000, MOL MICROBIOL, V36, P618, DOI 10.1046/j.1365-2958.2000.01877.x	55	29	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26796	26805		10.1074/jbc.M112.384719	http://dx.doi.org/10.1074/jbc.M112.384719			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707721	Green Published, hybrid			2022-12-25	WOS:000307386000029
J	Christensen, LC; Jensen, NW; Vala, A; Kamarauskaite, J; Johansson, L; Winther, JR; Hofmann, K; Teilum, K; Ellgaard, L				Christensen, Lea Cecilie; Jensen, Njal Winther; Vala, Andrea; Kamarauskaite, Jurate; Johansson, Linda; Winther, Jakob Rahr; Hofmann, Kay; Teilum, Kaare; Ellgaard, Lars			The Human Selenoprotein VCP-interacting Membrane Protein (VIMP) Is Non-globular and Harbors a Reductase Function in an Intrinsically Disordered Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; MISFOLDED GLYCOPROTEINS; MULTIPROTEIN COMPLEXES; TRANSMEMBRANE PROTEIN; DISULFIDE REDUCTASE; ERAD PATHWAY; DEGRADATION; THIOREDOXIN; DISLOCATION; MOTIF	The human selenoprotein VIMP (VCP-interacting membrane protein)/SelS (selenoprotein S) localizes to the endoplasmic reticulum (ER) membrane and is involved in the process of ER-associated degradation (ERAD). To date, little is known about the presumed redox activity of VIMP, its structure and how these features might relate to the function of the protein in ERAD. Here, we use the recombinantly expressed cytosolic region of VIMP where the selenocysteine (Sec) in position 188 is replaced with a cysteine (a construct named cVIMP-Cys) to characterize redox and structural properties of the protein. We show that Cys-188 in cVIMP-Cys forms a disulfide bond with Cys-174, consistent with the presence of a Cys174-Sec188 selenosulfide bond in the native sequence. For the disulfide bond in cVIMP-Cys we determined the reduction potential to -200 mV, and showed it to be a good substrate of thioredoxin. Based on a biochemical and structural characterization of cVIMP-Cys using analytical gel filtration, CD and NMR spectroscopy in conjunction with bioinformatics, we propose a comprehensive overall structural model for the cytosolic region of VIMP. The data clearly indicate the N-terminal half to be comprised of two extended alpha-helices followed by a C-terminal region that is intrinsically disordered. Redox-dependent conformational changes in cVIMP-Cys were observed only in the vicinity of the two Cys residues. Overall, the redox properties observed for cVIMP-Cys are compatible with a function as a reductase, and we speculate that the plasticity of the intrinsically disordered C-terminal region allows the protein to access many different and structurally diverse substrates.	[Christensen, Lea Cecilie; Jensen, Njal Winther; Vala, Andrea; Kamarauskaite, Jurate; Johansson, Linda; Winther, Jakob Rahr; Teilum, Kaare; Ellgaard, Lars] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark; [Hofmann, Kay] Univ Cologne, Inst Genet, D-50674 Cologne, Germany	University of Copenhagen; University of Cologne	Ellgaard, L (corresponding author), Univ Copenhagen, Dept Biol, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	lellgaard@bio.ku.dk	Teilum, Kaare/K-4340-2014; Ellgaard, Lars/I-9034-2014; Winther, Jakob R./K-4451-2014; Teilum, Kaare/S-8410-2019	Teilum, Kaare/0000-0001-6919-1982; Ellgaard, Lars/0000-0002-7018-0137; Winther, Jakob R./0000-0001-6995-9154; Christensen, Lea Cecilie/0000-0001-8594-952X	Danish Council for Independent Research (Natural Sciences); Novo Nordisk Fonden; Lundbeckfonden; Alfred Benzon Foundation; Novo Scholarship	Danish Council for Independent Research (Natural Sciences)(Det Frie Forskningsrad (DFF)); Novo Nordisk Fonden(Novo Nordisk Foundation); Lundbeckfonden(Lundbeckfonden); Alfred Benzon Foundation; Novo Scholarship	This work was funded by the Danish Council for Independent Research (Natural Sciences), Novo Nordisk Fonden, Lundbeckfonden, and the Alfred Benzon Foundation.; Recipient of a Novo Scholarship 2011.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arner ESJ, 2010, EXP CELL RES, V316, P1296, DOI 10.1016/j.yexcr.2010.02.032; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Beld J, 2007, BIOCHEMISTRY-US, V46, P5382, DOI 10.1021/bi700124p; Besse D, 1997, ANGEW CHEM INT EDIT, V36, P883, DOI 10.1002/anie.199708831; Brown C, 2002, EMBED SYST PROGRAM, V15, P55; Brown CJ, 2010, MOL BIOL EVOL, V27, P609, DOI 10.1093/molbev/msp277; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; CHAU MH, 1991, FEBS LETT, V291, P296, DOI 10.1016/0014-5793(91)81305-R; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Depuydt M, 2011, ANTIOXID REDOX SIGN, V15, P49, DOI 10.1089/ars.2010.3575; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Fagioli C, 2001, J BIOL CHEM, V276, P40962, DOI 10.1074/jbc.M107456200; Fomenko DE, 2012, ANTIOXID REDOX SIGN, V16, P193, DOI 10.1089/ars.2011.3980; Frickel EM, 2004, J BIOL CHEM, V279, P18277, DOI 10.1074/jbc.M314089200; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gromer S, 2003, P NATL ACAD SCI USA, V100, P12618, DOI 10.1073/pnas.2134510100; Hanzelmann P, 2011, J BIOL CHEM, V286, P38679, DOI 10.1074/jbc.M111.274506; Hagiwara M, 2011, MOL CELL, V41, P432, DOI 10.1016/j.molcel.2011.01.021; Haugstetter J, 2005, J BIOL CHEM, V280, P8371, DOI 10.1074/jbc.M413924200; HOLMGREN A, 1984, METHOD ENZYMOL, V107, P295; Isaacson RL, 2007, J BIOL CHEM, V282, P21361, DOI 10.1074/jbc.M610069200; Kim HY, 2005, PLOS BIOL, V3, P2080, DOI 10.1371/journal.pbio.0030375; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lopez-Mirabal HR, 2008, BBA-MOL CELL RES, V1783, P629, DOI 10.1016/j.bbamcr.2007.10.013; Mancini R, 2000, FASEB J, V14, P769, DOI 10.1096/fasebj.14.5.769; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Metanis N, 2006, J AM CHEM SOC, V128, P16684, DOI 10.1021/ja0661414; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; Neutzner A, 2011, J BIOL CHEM, V286, P8633, DOI 10.1074/jbc.M110.197459; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Riemer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017037; Riemer J, 2009, P NATL ACAD SCI USA, V106, P14831, DOI 10.1073/pnas.0900742106; Roseler A, 2012, ANTIOXID REDOX SIGN, V17, P534, DOI 10.1089/ars.2011.4276; Rosenbaum JC, 2011, NUCLEUS-PHILA, V2, P264, DOI 10.4161/nucl.2.4.16118; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Shchedrina VA, 2011, J BIOL CHEM, V286, P42937, DOI 10.1074/jbc.M111.310920; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Stapf C, 2011, J BIOL CHEM, V286, P38670, DOI 10.1074/jbc.M111.274472; Tortorella D, 1998, J CELL BIOL, V142, P365, DOI 10.1083/jcb.142.2.365; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Williams C. H, 1992, LIPAOMIDE DEHYDROGEN; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	58	33	37	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26388	26399		10.1074/jbc.M112.346775	http://dx.doi.org/10.1074/jbc.M112.346775			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22700979	hybrid, Green Published			2022-12-25	WOS:000306916300064
J	Chandramouli, KH; Reish, D; Qian, PY				Chandramouli, Kondethimmanahalli H.; Reish, Donald; Qian, Pei-Yuan			Gel-Based and Gel-Free Identification of Proteins and Phosphopeptides during Egg-to-Larva Transition in Polychaete Neanthes arenaceodentata	PLOS ONE			English	Article							SEA-URCHIN EGGS; PHOSPHOPROTEOME ANALYSIS; PROTEOMIC ANALYSIS; PHOSPHORYLATION; METAMORPHOSIS; EXPRESSION; DYNAMICS; ACTIVATION; ANNELIDA; CHAIN	The polychaete Neanthes arenaceodentata- is cosmopolitan in distribution-, has been used as a laboratory test animal. Life history of this species has several unique features; the female dies after spawning and the male incubates the fertilized eggs through the 21-segmented stage. The larvae leave the tube and commence feeding. Changes in protein abundance and phosphorylation were examined during early development of N. arenaceodentata. A gel-based approach and gel-free enrichment of phosphopeptides coupled with mass spectrometry were used to identify proteins and phosphopeptides in fertilized ova and larval stages. Patterns of proteins and phosphoproteins changed from fertilized ova to larval stages. Twelve proteins occurred in phosphorylated form and nine as stage specific proteins. Cytoskeletal proteins have exhibited differential phosphorylation from ova to larval stages; whereas, other proteins exhibited stage-specific phosphorylation patterns. Ten phosphopeptides were identified that showed phosphorylation sites on serine or threonine residues. Sixty percent of the identified proteins were related to structural reorganization and others with protein synthesis, stress response and attachment. The abundance and distribution of two cytoskeleton proteins were examined further by 2-DE Western blot analysis. This is the first report on changes in protein expression and phosphorylation sites at Thr/Ser in early development of N. arenaceodentata. The 2-DE proteome maps and identified phosphoproteins contributes toward understanding the state of fertilized ova and early larval stages and serves as a basis for further studies on proteomics changes under different developmental conditions in this and other polychaete species.	[Chandramouli, Kondethimmanahalli H.; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong Sar, Peoples R China; [Reish, Donald] Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA	Hong Kong University of Science & Technology; California State University System; California State University Long Beach	Chandramouli, KH (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong Sar, Peoples R China.	djreish@aol.com; boqianpy@ust.hk		Qian, Pei-Yuan/0000-0003-4074-9078	King Abdullah University of Science and Technology [SA-C0040/UK-C0016]; Research Grants Council of the Hong Kong Special Administrative Region [AoE/P-04/04-II]	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council)	This study was supported by an award from King Abdullah University of Science and Technology (SA-C0040/UK-C0016), and grants from the Research Grants Council of the Hong Kong Special Administrative Region (AoE/P-04/04-II) to P.-Y. Qian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barritt J A, 2002, Reprod Biomed Online, V4, P243; Bleidorn C, 2003, MOL PHYLOGENET EVOL, V29, P279, DOI 10.1016/S1055-7903(03)00107-6; Boore JL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-182; Carballido-Lopez R, 2003, TRENDS CELL BIOL, V13, P577, DOI 10.1016/j.tcb.2003.09.005; Carpizo-Ituarte E, 2003, BIOL BULL-US, V204, P114, DOI 10.2307/1543547; Chandramouli KH, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-51; Chandramouli KH, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-31; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; Christner M, 2010, MOL MICROBIOL, V75, P187, DOI 10.1111/j.1365-2958.2009.06981.x; CURCI A, 1991, DEV BIOL, V144, P362, DOI 10.1016/0012-1606(91)90428-6; DAVIDSON EH, 1982, SCIENCE, V217, P17, DOI 10.1126/science.6178156; Deng X, 2011, CELL PROLIFERAT, V44, P156, DOI 10.1111/j.1365-2184.2011.00743.x; EPEL D, 1967, P NATL ACAD SCI USA, V57, P899, DOI 10.1073/pnas.57.4.899; EPEL D, 1997, HDB PHYSIOL 14, P859; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Goldstone JV, 2006, DEV BIOL, V300, P366, DOI 10.1016/j.ydbio.2006.08.066; Herman IM, 1993, CURR OPIN CELL BIOL, V5, P48, DOI 10.1016/S0955-0674(05)80007-9; Herpin R, 1925, B SOC SCI NATURELLES, V5, P1; Heyland A, 2006, INTEGR COMP BIOL, V46, P743, DOI 10.1093/icb/icl023; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Jackson DJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-160; Janssen EML, 2010, ENVIRON SCI TECHNOL, V44, P2857, DOI 10.1021/es901632e; Joukov V, 2010, P NATL ACAD SCI USA, V107, P21022, DOI 10.1073/pnas.1014664107; KNECHT DA, 1987, SCIENCE, V236, P1081, DOI 10.1126/science.3576221; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; Lee RF, 2005, COMP BIOCHEM PHYS B, V140, P381, DOI 10.1016/j.cbpc.2004.11.002; Leese HJ, 1995, HUM REPROD UPDATE, V1, P63, DOI 10.1093/humupd/1.1.63; MANEJWALA FM, 1991, DEV BIOL, V144, P301, DOI 10.1016/0012-1606(91)90423-Z; Mann K, 2010, PROTEOME SCI, V8, DOI [10.1186/1477-5956-8-6, 10.1186/1477-5956-8-33]; Morandell S, 2006, PROTEOMICS, V6, P4047, DOI 10.1002/pmic.200600058; Raggiaschi R, 2006, PROTEOMICS, V6, P748, DOI 10.1002/pmic.200500064; RAMAGLI LS, 1985, ELECTROPHORESIS, V6, P559, DOI 10.1002/elps.1150061109; Reintsch WE, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-21; Reish DJ, 1997, B MAR SCI, V60, P584; Reish DJ, 2009, ZOOSYMPOSIA, V2, P391, DOI 10.11646/zoosymposia.2.1.27; REISH DONALD J., 1957, PACIFIC SCI, V11, P216; Rosen G, 2011, ENVIRON TOXICOL CHEM, V30, P730, DOI 10.1002/etc.438; Roux MM, 2008, DEV BIOL, V313, P630, DOI 10.1016/j.ydbio.2007.10.053; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Sun J, 2010, PROTEOMICS, V10, P2701, DOI 10.1002/pmic.200900846; Thiyagarajan V, 2009, J PROTEOME RES, V8, P2708, DOI 10.1021/pr800976u; Uehara R, 2008, CELL MOTIL CYTOSKEL, V65, P100, DOI 10.1002/cm.20246; Wang H, 2010, PROTEOMICS, V10, P2972, DOI 10.1002/pmic.201000056; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Whitaker M, 2006, PHYSIOL REV, V86, P25, DOI 10.1152/physrev.00023.2005; Winchell CJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-17; Wong GK, 1997, CELL MOTIL CYTOSKEL, V36, P30, DOI 10.1002/(SICI)1097-0169(1997)36:1<30::AID-CM3>3.0.CO;2-L; Yurttas P, 2010, REPRODUCTION, V139, P809, DOI 10.1530/REP-09-0538; Zhang Y, 2010, J PROTEOME RES, V9, P4851, DOI 10.1021/pr100645z	49	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38814	10.1371/journal.pone.0038814	http://dx.doi.org/10.1371/journal.pone.0038814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719953	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350000024
J	Aagaard, K; Riehle, K; Ma, J; Segata, N; Mistretta, TA; Coarfa, C; Raza, S; Rosenbaum, S; Van den Veyver, I; Milosavljevic, A; Gevers, D; Huttenhower, C; Petrosino, J; Versalovic, J				Aagaard, Kjersti; Riehle, Kevin; Ma, Jun; Segata, Nicola; Mistretta, Toni-Ann; Coarfa, Cristian; Raza, Sabeen; Rosenbaum, Sean; Van den Veyver, Ignatia; Milosavljevic, Aleksandar; Gevers, Dirk; Huttenhower, Curtis; Petrosino, Joseph; Versalovic, James			A Metagenomic Approach to Characterization of the Vaginal Microbiome Signature in Pregnancy	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; INTESTINAL MICROBIOTA; BODY HABITATS; COMMUNITIES; DIVERSITY; BACTERIAL; EVOLUTION; DELIVERY; INSIGHTS; TOOLS	While current major national research efforts (i.e., the NIH Human Microbiome Project) will enable comprehensive metagenomic characterization of the adult human microbiota, how and when these diverse microbial communities take up residence in the host and during reproductive life are unexplored at a population level. Because microbial abundance and diversity might differ in pregnancy, we sought to generate comparative metagenomic signatures across gestational age strata. DNA was isolated from the vagina (introitus, posterior fornix, midvagina) and the V5V3 region of bacterial 16S rRNA genes were sequenced (454FLX Titanium platform). Sixty-eight samples from 24 healthy gravidae (18 to 40 confirmed weeks) were compared with 301 non-pregnant controls (60 subjects). Generated sequence data were quality filtered, taxonomically binned, normalized, and organized by phylogeny and into operational taxonomic units (OTU); principal coordinates analysis (PCoA) of the resultant beta diversity measures were used for visualization and analysis in association with sample clinical metadata. Altogether, 1.4 gigabytes of data containing >2.5 million reads (averaging 6,837 sequences/sample of 493 nt in length) were generated for computational analyses. Although gravidae were not excluded by virtue of a posterior fornix pH >4.5 at the time of screening, unique vaginal microbiome signature encompassing several specific OTUs and higher-level clades was nevertheless observed and confirmed using a combination of phylogenetic, non-phylogenetic, supervised, and unsupervised approaches. Both overall diversity and richness were reduced in pregnancy, with dominance of Lactobacillus species (L. iners crispatus, jensenii and johnsonii, and the orders Lactobacillales (and Lactobacillaceae family), Clostridiales, Bacteroidales, and Actinomycetales. This intergroup comparison using rigorous standardized sampling protocols and analytical methodologies provides robust initial evidence that the vaginal microbial 16S rRNA gene catalogue uniquely differs in pregnancy, with variance of taxa across vaginal subsite and gestational age.	[Aagaard, Kjersti; Ma, Jun; Rosenbaum, Sean; Van den Veyver, Ignatia] Baylor Coll Med, Div Maternal Fetal Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Aagaard, Kjersti; Riehle, Kevin; Ma, Jun; Mistretta, Toni-Ann; Coarfa, Cristian; Raza, Sabeen; Rosenbaum, Sean; Van den Veyver, Ignatia; Milosavljevic, Aleksandar; Petrosino, Joseph; Versalovic, James] Texas Childrens Hosp, Houston, TX 77030 USA; [Mistretta, Toni-Ann; Raza, Sabeen; Versalovic, James] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Aagaard, Kjersti; Riehle, Kevin; Ma, Jun; Coarfa, Cristian; Milosavljevic, Aleksandar] Baylor Coll Med, Bioinformat Res Lab, Houston, TX 77030 USA; [Segata, Nicola; Huttenhower, Curtis] Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA; [Gevers, Dirk] MIT, Broad Inst, Cambridge, MA 02139 USA; [Petrosino, Joseph] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Baylor College of Medicine	Aagaard, K (corresponding author), Baylor Coll Med, Div Maternal Fetal Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.	aagaardt@bcm.edu	Gevers, Dirk/C-1451-2009; Van den Veyver, Ignatia B/AAF-4510-2021; Petrosino, Joseph F./AAF-1621-2019; Segata, Nicola/AAB-2980-2019; Segata, Nicola/K-7240-2016	Van den Veyver, Ignatia B/0000-0002-0651-5924; Riehle, Kevin/0000-0003-4888-2404; Huttenhower, Curtis/0000-0002-1110-0096; Segata, Nicola/0000-0002-1583-5794	National Institutes of Health [DP2120OD001500-01]; NICHD/NIDDK [R01DK080558-01, UH3 DK083990l]; NIH [1R01HG005969]; NIH Common Fund Human Microbiome-HMP [NIHU54HG004969]; Burroughs Welcome Fund (Burroughs Welcome Fund Preterm Birth Initiative); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004969, R01HG005969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080558] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD/NIDDK; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Common Fund Human Microbiome-HMP; Burroughs Welcome Fund (Burroughs Welcome Fund Preterm Birth Initiative); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institutes of Health (NIH Director New Innovator Award (DP2120OD001500-01 K.A.), NICHD/NIDDK #R01DK080558-01 (K.A.), UH3 DK083990l (J.V.), NIH 1R01HG005969 (C.H.), and the NIH Common Fund Human Microbiome-HMP (K.A., J.V., J.P., C.H., (NIHU54HG004969 D.G.)), and the Burroughs Welcome Fund (Burroughs Welcome Fund Preterm Birth Initiative (K.A. and J.V.)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard KJ, 2011, SCI TRANSL MED UNPUB; [Anonymous], 1986, MULTIVARIATE STAT ME; Brown CJ, 2007, J MED MICROBIOL, V56, P271, DOI 10.1099/jmm.0.46607-0; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1984, SCAND J STAT, V11, P265; Charlson ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015216; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dominguez-Bello MG, 2011, GASTROENTEROLOGY, V140, P1713, DOI 10.1053/j.gastro.2011.02.011; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Favier CF, 2003, ANAEROBE, V9, P219, DOI 10.1016/j.anaerobe.2003.07.001; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Forney LJ, 2006, J INFECT DIS, V194, P1468, DOI 10.1086/508497; Forney LJ, 2010, J CLIN MICROBIOL, V48, P1741, DOI 10.1128/JCM.01710-09; Gavin DG, 2003, QUATERNARY RES, V60, P356, DOI 10.1016/S0033-5894(03)00088-7; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Kim TK, 2009, J CLIN MICROBIOL, V47, P1181, DOI 10.1128/JCM.00854-08; Kindt R., 2005, WORLD; Knights D, 2011, ISME J, V5, P570, DOI 10.1038/ismej.2010.148; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Kurokawa K, 2006, DNA RES, V14, P169; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Oksanen J., 2007, VEGAN COMMUNITY ECOL; Oswald WW, 2003, J ECOL, V91, P1022, DOI 10.1046/j.1365-2745.2003.00823.x; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Pridmore RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/pnas.0307327101; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; R Core Team, 2016, R FDN STAT COMP; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Reinhardt C, 2009, J PEDIATR GASTR NUTR, V48, P249, DOI 10.1097/MPG.0b013e318183187c; Renyi A, 1961, P 4 BERK S MATH STAT, V1; Riehle KP, 2011, BMC BIOINFO IN PRESS; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; TOTHMERESZ B, 1995, J VEG SCI, V6, P283, DOI 10.2307/3236223; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Xhou X, 2010, INFECT DIS OBSTET GY; Ye YZ, 2010, IEEE INT C BIOINFORM, P153, DOI 10.1109/BIBM.2010.5706555; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	61	419	451	0	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e36466	10.1371/journal.pone.0036466	http://dx.doi.org/10.1371/journal.pone.0036466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719832	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341900010
J	Dai, L; Carter, CS; Ying, J; Bellugi, U; Pournajafi-Nazarloo, H; Korenberg, JR				Dai, Li; Carter, C. Sue; Ying, Jian; Bellugi, Ursula; Pournajafi-Nazarloo, Hossein; Korenberg, Julie R.			Oxytocin and Vasopressin Are Dysregulated in Williams Syndrome, a Genetic Disorder Affecting Social Behavior	PLOS ONE			English	Article							PLASMA OXYTOCIN; NEURAL BASIS; PSYCHOLOGICAL STRESS; AMYGDALA; RELEASE; RESPONSES; BRAIN; MUSIC; CIRCUITRY; ANXIETY	The molecular and neural mechanisms regulating human social-emotional behaviors are fundamentally important but largely unknown; unraveling these requires a genetic systems neuroscience analysis of human models. Williams Syndrome (WS), a condition caused by deletion of similar to 28 genes, is associated with a gregarious personality, strong drive to approach strangers, difficult peer interactions, and attraction to music. WS provides a unique opportunity to identify endogenous human gene-behavior mechanisms. Social neuropeptides including oxytocin (OT) and arginine vasopressin (AVP) regulate reproductive and social behaviors in mammals, and we reasoned that these might mediate the features of WS. Here we established blood levels of OT and AVP in WS and controls at baseline, and at multiple timepoints following a positive emotional intervention (music), and a negative physical stressor (cold). We also related these levels to standardized indices of social behavior. Results revealed significantly higher median levels of OT in WS versus controls at baseline, with a less marked increase in AVP. Further, in WS, OT and AVP increased in response to music and to cold, with greater variability and an amplified peak release compared to controls. In WS, baseline OT but not AVP, was correlated positively with approach, but negatively with adaptive social behaviors. These results indicate that WS deleted genes perturb hypothalamic-pituitary release not only of OT but also of AVP, implicating more complex neuropeptide circuitry for WS features and providing evidence for their roles in endogenous regulation of human social behavior. The data suggest a possible biological basis for amygdalar involvement, for increased anxiety, and for the paradox of increased approach but poor social relationships in WS. They also offer insight for translating genetic and neuroendocrine knowledge into treatments for disorders of social behavior.	[Dai, Li; Korenberg, Julie R.] Univ Utah, Ctr Integrated Neurosci & Human Behav, Salt Lake City, UT 84112 USA; [Dai, Li; Korenberg, Julie R.] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Carter, C. Sue; Pournajafi-Nazarloo, Hossein] Univ Illinois, Brain Body Ctr, Chicago, IL USA; [Ying, Jian] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Bellugi, Ursula] Salk Inst Biol Studies, Lab Cognit Neurosci, La Jolla, CA USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Utah System of Higher Education; University of Utah; Salk Institute	Dai, L (corresponding author), Univ Utah, Ctr Integrated Neurosci & Human Behav, Salt Lake City, UT 84112 USA.	julie.korenberg@hsc.utah.edu			National Institutes of Health (NIH) [P01 HD33113]; McDonnell Foundation; NIH [MH072935]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD033113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072935] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health (NIH) P01 HD33113, the McDonnell Foundation (Dr. Bellugi, Dr. Korenberg) and NIH MH072935 (Dr. Carter). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Bachner-Melman R, 2005, PLOS GENET, V1, P394, DOI 10.1371/journal.pgen.0010042; Balding DJ, 2004, APPL LONGITUDINAL AN; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; Bartz J, 2011, SOC COGN AFFECT NEUR, V6, P556, DOI 10.1093/scan/nsq085; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Bartz JA, 2010, P NATL ACAD SCI USA, V107, P21371, DOI 10.1073/pnas.1012669107; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Bellugi U, 1999, NEUROREPORT, V10, P1653, DOI 10.1097/00001756-199906030-00006; Belo CJ, 2010, J DAIRY SCI, V93, P63, DOI 10.3168/jds.2009-2084; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Bos PA, 2012, FRONT NEUROENDOCRIN, V33, P17, DOI 10.1016/j.yfrne.2011.01.002; BROWNSTEIN MJ, 1980, SCIENCE, V207, P373, DOI 10.1126/science.6153132; Bruininks RH., 1996, SCALES INDEPENDENT B; Brunton PJ, 2008, NAT REV NEUROSCI, V9, P11, DOI 10.1038/nrn2280; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Carter CS, 2007, BEHAV BRAIN RES, V176, P170, DOI 10.1016/j.bbr.2006.08.025; Carter CS, 2007, ANN NY ACAD SCI, V1098, P312, DOI 10.1196/annals.1384.006; Carter CS, 2008, PROG BRAIN RES, V170, P331, DOI 10.1016/S0079-6123(08)00427-5; Carter CS, 1998, PSYCHONEUROENDOCRINO, V23, P779; Cherniske EM, 2004, AM J MED GENET A, V131A, P255, DOI 10.1002/ajmg.a.30400; Cho MM, 1999, BEHAV NEUROSCI, V113, P1071, DOI 10.1037/0735-7044.113.5.1071; Choleris E, 2008, PROG BRAIN RES, V170, P291, DOI 10.1016/S0079-6123(08)00424-X; Cyranowski JM, 2008, PSYCHOSOM MED, V70, P967, DOI 10.1097/PSY.0b013e318188ade4; Dai L, 2009, AM J MED GENET A, V149A, P302, DOI 10.1002/ajmg.a.32652; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; Declerck CH, 2010, HORM BEHAV, V57, P368, DOI 10.1016/j.yhbeh.2010.01.006; Dykens EM, 2005, AM J MENT RETARD, V110, P346, DOI 10.1352/0895-8017(2005)110[346:MAAIWS]2.0.CO;2; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Engelmann M, 2000, EXP PHYSIOL, V85, p125S; FALKE N, 1989, NEUROPEPTIDES, V14, P269, DOI 10.1016/0143-4179(89)90056-5; FERRIS C, 1992, ANN NY ACAD SCI, V652, P212, DOI 10.1111/j.1749-6632.1992.tb34357.x; Gamer M, 2010, P NATL ACAD SCI USA, V107, P9400, DOI 10.1073/pnas.1000985107; Goldman M, 2008, SCHIZOPHR RES, V98, P247, DOI 10.1016/j.schres.2007.09.019; Goodson JL, 2010, CURR OPIN NEUROBIOL, V20, P784, DOI 10.1016/j.conb.2010.08.020; Gothelf D, 2008, AM J MED GENET A, V146A, P2753, DOI 10.1002/ajmg.a.32507; Gouin JP, 2010, PSYCHONEUROENDOCRINO, V35, P1082, DOI 10.1016/j.psyneuen.2010.01.009; Gregory SG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-62; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P3, DOI 10.1016/j.biopsych.2007.06.026; Guastella AJ, 2010, BIOL PSYCHIAT, V67, P1220, DOI 10.1016/j.biopsych.2010.03.014; Haas BW, 2009, J NEUROSCI, V29, P1132, DOI 10.1523/JNEUROSCI.5324-08.2009; Heinrichs M, 2003, BIOL PSYCHIAT, V54, P1389, DOI 10.1016/S0006-3223(03)00465-7; Heinrichs M, 2009, FRONT NEUROENDOCRIN, V30, P548, DOI 10.1016/j.yfrne.2009.05.005; Hirota H, 2003, GENET MED, V5, P311, DOI 10.1097/01.GIM.0000076975.10224.67; Hoge EA, 2008, CNS NEUROSCI THER, V14, P165, DOI 10.1111/j.1755-5949.2008.00051.x; Hurlemann R, 2010, J NEUROSCI, V30, P4999, DOI 10.1523/JNEUROSCI.5538-09.2010; Jansen LMC, 2006, J AUTISM DEV DISORD, V36, P891, DOI 10.1007/s10803-006-0124-z; Jarvinen-Pasley A, 2008, DEV PSYCHOPATHOL, V20, P1, DOI 10.1017/S0954579408000011; Jarvinen-Pasley A, 2010, NEUROPSYCHOLOGIA, V48, P456, DOI 10.1016/j.neuropsychologia.2009.10.003; Jones W, 2000, J COGNITIVE NEUROSCI, V12, P30, DOI 10.1162/089892900561968; Juslin PN, 2001, EMOTION, V1, P381, DOI 10.1037//1528-3542.1.4.381; Kennedy DP, 2010, NEUROPSYCHOLOGIA, V48, P3392, DOI 10.1016/j.neuropsychologia.2010.06.025; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; Koelsch S, 2010, TRENDS COGN SCI, V14, P131, DOI 10.1016/j.tics.2010.01.002; Korenberg J.R., 2008, INBORN ERRORS DEV MO, P1544; Korenberg JR, 2000, J COGNITIVE NEUROSCI, V12, P89, DOI 10.1162/089892900562002; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; LECKMAN JF, 1994, PSYCHONEUROENDOCRINO, V19, P723, DOI 10.1016/0306-4530(94)90021-3; Levitin DJ, 2005, ANN NY ACAD SCI, V1060, P325, DOI 10.1196/annals.1360.027; Levitin DJ, 2004, CHILD NEUROPSYCHOL, V10, P223, DOI 10.1080/09297040490909288; Levitin DJ, 2003, NEUROIMAGE, V18, P74, DOI 10.1006/nimg.2002.1297; Mervis CB, 2003, DEV NEUROPSYCHOL, V23, P243, DOI 10.1207/S15326942DN231&2_11; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P991, DOI 10.1038/nn1494; Meyer-Lindenberg A, 2008, PROG BRAIN RES, V170, P463, DOI 10.1016/S0079-6123(08)00436-6; Modahl C, 1998, BIOL PSYCHIAT, V43, P270, DOI 10.1016/S0006-3223(97)00439-3; Morin V, 2008, J PHARM PHARM SCI, V11, P12; Murphy DJ, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-36; Nilsson U, 2009, J CLIN NURS, V18, P2153, DOI 10.1111/j.1365-2702.2008.02718.x; Nishioka T, 1998, BRAIN RES, V781, P57, DOI 10.1016/S0006-8993(97)01159-1; PEDERSEN FA, 1964, AM J ORTHOPSYCHIAT, V34, P575, DOI 10.1111/j.1939-0025.1964.tb02228.x; Pober Barbara R, 2010, N Engl J Med, V362, P239, DOI 10.1056/NEJMra0903074; Reilly J., 1990, DEV PSYCHOPATHOL, V2, P367, DOI [DOI 10.1017/S0954579400005782, 10.1017/S0954579400005782]; Riby D, 2009, J INTELL DISABIL RES, V53, P169, DOI 10.1111/j.1365-2788.2008.01142.x; Riby DM, 2011, J AUTISM DEV DISORD, V41, P1228, DOI 10.1007/s10803-010-1141-5; Rimmele U, 2009, J NEUROSCI, V29, P38, DOI 10.1523/JNEUROSCI.4260-08.2009; Rosner S, 2003, UNDERSTANDING WILLIA; Ruble LH, 2010, SCHIZOPHR RES, V124, P13, DOI 10.1016/j.schres.2010.09.014; SANDERS G, 1990, PSYCHONEUROENDOCRINO, V15, P47, DOI 10.1016/0306-4530(90)90046-C; Seltzer LJ, 2010, P ROY SOC B-BIOL SCI, V277, P2661, DOI 10.1098/rspb.2010.0567; Semel E., 2003, UNDERSTANDING WILLIA, DOI [10.4324/9781410607416, DOI 10.4324/9781410607416]; Skwerer DP, 2009, SOC COGN AFFECT NEUR, V4, P93, DOI 10.1093/scan/nsn041; Sloboda J.A., 2001, SERIES AFFECTIVE SCI; Taylor SE, 2006, PSYCHOSOM MED, V68, P238, DOI 10.1097/01.psy.0000203242.95990.74; Taylor SE, 2010, PSYCHOL SCI, V21, P3, DOI 10.1177/0956797609356507; THAUT MH, 1993, J MUSIC THER, V30, P210, DOI 10.1093/jmt/30.4.210; Thompson R, 2004, PSYCHONEUROENDOCRINO, V29, P35, DOI 10.1016/S0306-4530(02)00133-6; Thompson RR, 2004, BEHAV NEUROSCI, V118, P620, DOI 10.1037/0735-7044.118.3.620; Trehub SE, 2001, ANN NY ACAD SCI, V930, P1; Turner RA, 1999, PSYCHIATRY, V62, P97, DOI 10.1080/00332747.1999.11024859; Ukkola LT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005534; Van Essen DC, 2006, J NEUROSCI, V26, P5470, DOI 10.1523/JNEUROSCI.4154-05.2006; WANG ZX, 1994, P NATL ACAD SCI USA, V91, P400, DOI 10.1073/pnas.91.1.400; Wotjak CT, 1998, NEUROSCIENCE, V85, P1209, DOI 10.1016/S0306-4522(97)00683-0; Yee J. R., 2010, Society for Neuroscience Abstract Viewer and Itinerary Planner, V40; Zak PJ, 2005, HORM BEHAV, V48, P522, DOI 10.1016/j.yhbeh.2005.07.009; Zarchi Omer, 2010, Isr J Psychiatry Relat Sci, V47, P125; Zink CF, 2010, J NEUROSCI, V30, P7017, DOI 10.1523/JNEUROSCI.4899-09.2010	103	65	65	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38513	10.1371/journal.pone.0038513	http://dx.doi.org/10.1371/journal.pone.0038513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719898	Green Published, gold			2022-12-25	WOS:000305340000027
J	Guo, J; Han, B; Qin, LJ; Li, B; You, HH; Yang, JW; Liu, DD; Wei, CX; Nanberg, E; Bornehag, CG; Yang, X				Guo, Jing; Han, Bing; Qin, Longjuan; Li, Bing; You, Huihui; Yang, Jiwen; Liu, Dandan; Wei, Chenxi; Nanberg, Eewa; Bornehag, Carl-Gustaf; Yang, Xu			Pulmonary Toxicity and Adjuvant Effect of Di-(2-exylhexyl) Phthalate in Ovalbumin-Immunized BALB/c Mice	PLOS ONE			English	Article							SUBCUTANEOUS INJECTION MODEL; DI-(2-ETHYLHEXYL) PHTHALATE; ASTHMA; CHILDREN; EXPOSURE; DISEASES; ASSOCIATION; ALLERGIES; DUST; HOME	Background: Asthma is a complex pulmonary inflammatory disease, which is characterized by airway hyperresponsiveness, variable airflow obstruction and inflammation in the airways. The majority of asthma is allergic asthma, which is a disease caused by type I hypersensitivity mediated by IgE. Exposures to a number of environmental chemicals are suspected to lead to asthma, one such pollutant is di-(2-ethylheyl) phthalate (DEHP). DEHP is a manufactured chemical that is commonly added in plastic products to make them flexible. Epidemiological studies have revealed a positive association between DEHP exposure and asthma prevalence. Methodology/Principal Findings: The present study was aimed to determine the underlying role of DEHP exposure in airway reactivity, especially when combined with allergen exposure. The biomarkers include pulmonary histopathology, airway hyperresponsiveness (lung function), IgE, IL-4, IFN-gamma and eosinophils. Healthy balb/c mice were randomly divided into eight exposure groups (n = 8 each): (1) saline control, (2) 30 mu g/(kg.d) DEHP, (3) 300 mu g/(kg.d) DEHP, (4) 3000 mu g/(kg.d) DEHP, and (5) ovalbumin (OVA)-sensitized group, (6) OVA-combined with 30 mu g/(kg.d) DEHP, (7) OVA-combined with 300 mu g/(kg.d) DEHP, and (8) OVA-combined with 3000 mu g/(kg.d) DEHP. Experimental tests were conducted after 52-day DEHP exposure and subsequently one week of challenge with aerosolized OVA. The principal findings include: (1) Strong postive associations exist between OVA-combined DEHP exposure and serum total IgE (T-IgE), as well as histological findings. These positive associations show a dose-dependent low dose sensitive effect of DEHP. (2) IL-4, eosinophil recruitment and lung function are also indicators for adjuvant effect of DEHP. Conclusions/Significance: Our results suggest that except the significant changes of immunological and inflammatory biomarkers (T-IgE, IL-4, IFN-gamma and eosinophils), the pulmonary histological (histopathological examination) and physiological (lung function) data also support that DEHP may promote and aggravate allergic asthma by adjuvant effect.	[Guo, Jing; Han, Bing; Qin, Longjuan; Li, Bing; You, Huihui; Yang, Jiwen; Liu, Dandan; Wei, Chenxi; Yang, Xu] Huazhong Normal Univ, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China; [You, Huihui; Nanberg, Eewa] Karlstad Univ, Dept Chem & Biomed Sci, Karlstad, Sweden; [Bornehag, Carl-Gustaf] Karlstad Univ, Dept Hlth & Environm, Karlstad, Sweden	Central China Normal University; Karlstad University; Karlstad University	Guo, J (corresponding author), Huazhong Normal Univ, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China.	carl-gustaf.bornehag@kau.se; yangxu@mail.ccnu.edu.cn	Wei, Chenxi/C-8630-2016	Wei, Chenxi/0000-0002-3837-1881; Bornehag, Carl-Gustaf/0000-0003-0417-1686	China National Natural Science Foundation [51136002, 51076079]; National Key Technologies R&D Program of China [2012BAJ02B03]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program of China(National Key Technology R&D Program)	This work was supported by the China National Natural Science Foundation (grant ID: 51136002, 51076079) and National Key Technologies R&D Program of China (grant ID: 2012BAJ02B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandan C, 2010, ALLERGY, V65, P152, DOI 10.1111/j.1398-9995.2009.02244.x; ATSDR(AgencyforToxicSubstancesandDiseaseRegistry), 2002, TOX PROF DI 2 ETH PH; Bornehag CG, 2010, INT J ANDROL, V33, P333, DOI 10.1111/j.1365-2605.2009.01023.x; Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187; Butala JH, 2004, TOXICOLOGY, V201, P77, DOI 10.1016/j.tox.2004.04.004; Dearman RJ, 2008, TOXICOLOGY, V244, P231, DOI 10.1016/j.tox.2007.11.017; Drazen JM, 1999, ANNU REV PHYSIOL, V61, P593, DOI 10.1146/annurev.physiol.61.1.593; Hansen JS, 2007, TOXICOLOGY, V232, P79, DOI 10.1016/j.tox.2006.12.011; Hirota JA, 2009, PULM PHARMACOL THER, V22, P370, DOI 10.1016/j.pupt.2008.12.004; Hirvonen A, 2009, MUTAT RES-FUND MOL M, V667, P132, DOI 10.1016/j.mrfmmm.2008.12.013; Jaakkola JJK, 2000, AM J PUBLIC HEALTH, V90, P797, DOI 10.2105/AJPH.90.5.797; Jaakkola JJK, 2004, AM J PUBLIC HEALTH, V94, P560, DOI 10.2105/AJPH.94.4.560; Jaakkola JJK, 2008, ENVIRON HEALTH PERSP, V116, P845, DOI 10.1289/ehp.10846; Kolarik B, 2008, ENVIRON HEALTH PERSP, V116, P98, DOI 10.1289/ehp.10498; Larsen Soren T, 2009, BMC Res Notes, V2, P225, DOI 10.1186/1756-0500-2-225; Larsen ST, 2007, TOXICOL LETT, V170, P223, DOI 10.1016/j.toxlet.2007.03.009; Larsen ST, 2007, TOXICOLOGY, V235, P119, DOI 10.1016/j.tox.2007.03.010; Larsen ST, 2001, TOXICOL LETT, V125, P11, DOI 10.1016/S0378-4274(01)00419-2; Larsen ST, 2001, TOXICOLOGY, V169, P37, DOI 10.1016/S0300-483X(01)00484-X; Lee MH, 2004, INT ARCH ALLERGY IMM, V134, P213, DOI 10.1159/000078768; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Nagata Y, 2007, INT ARCH ALLERGY IMM, V144, P305, DOI 10.1159/000106319; *NTP CERHR, 2000, NTP CERHR EXP PAN RE; Qiao Y, 2009, INHAL TOXICOL, V21, P1200, DOI 10.3109/08958370902806159; Simpson JL, 2009, PHARMACOL THERAPEUT, V124, P86, DOI 10.1016/j.pharmthera.2009.06.004; Subbarao P, 2009, CAN MED ASSOC J, V181, pE181, DOI 10.1503/cmaj.080612; Swindle EJ, 2009, J ALLERGY CLIN IMMUN, V124, P23, DOI 10.1016/j.jaci.2009.05.037; Tuomainen A, 2006, ENVIRON HEALTH PERSP, V114, P1409, DOI 10.1289/ehp.8965; US Food and Drug Administration, 2001, SAF ASS DI 2 ETH PHT; Yang GT, 2008, FOOD AGR IMMUNOL, V19, P351, DOI 10.1080/09540100802545869; You HH, 2011, J YULIN NORMAL U, V32, P15	31	69	69	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e39008	10.1371/journal.pone.0039008	http://dx.doi.org/10.1371/journal.pone.0039008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701742	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340000059
J	Monteleone, MC; Wusener, AEG; Burdisso, JE; Conde, C; Caceres, A; Arregui, CO				Monteleone, Melisa C.; Gonzalez Wusener, Ana E.; Burdisso, Juan E.; Conde, Cecilia; Caceres, Alfredo; Arregui, Carlos O.			ER-Bound Protein Tyrosine Phosphatase PTP1B Interacts with Src at the Plasma Membrane/Substrate Interface	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; CELL-ADHESION; C-SRC; INSULIN-RECEPTOR; N-CADHERIN; FAMILY; MEMBRANE; 1B; KINASE; ACTIN	PTP1B is an endoplasmic reticulum (ER) anchored enzyme whose access to substrates is partly dependent on the ER distribution and dynamics. One of these substrates, the protein tyrosine kinase Src, has been found in the cytosol, endosomes, and plasma membrane. Here we analyzed where PTP1B and Src physically interact in intact cells, by bimolecular fluorescence complementation (BiFC) in combination with temporal and high resolution microscopy. We also determined the structural basis of this interaction. We found that BiFC signal is displayed as puncta scattered throughout the ER network, a feature that was enhanced when the substrate trapping mutant PTP1B-D181A was used. Time-lapse and co-localization analyses revealed that BiFC puncta did not correspond to vesicular carriers; instead they localized at the tip of dynamic ER tubules. BiFC puncta were retained in ventral membrane preparations after cell unroofing and were also detected within the evanescent field of total internal reflection fluorescent microscopy (TIRFM) associated to the ventral membranes of whole cells. Furthermore, BiFC puncta often colocalized with dark spots seen by surface reflection interference contrast (SRIC). Removal of Src myristoylation and polybasic motifs abolished BiFC. In addition, PTP1B active site and negative regulatory tyrosine 529 on Src were primary determinants of BiFC occurrence, although the SH3 binding motif on PTP1B also played a role. Our results suggest that ER-bound PTP1B dynamically interacts with the negative regulatory site at the C-terminus of Src at random puncta in the plasma membrane/ substrate interface, likely leading to Src activation and recruitment to adhesion complexes. We postulate that this functional ER/plasma membrane crosstalk could apply to a wide array of protein partners, opening an exciting field of research.	[Monteleone, Melisa C.; Gonzalez Wusener, Ana E.; Burdisso, Juan E.; Arregui, Carlos O.] Univ San Martin, Inst Invest Biotecnol, Buenos Aires, DF, Argentina; [Conde, Cecilia; Caceres, Alfredo] Inst Invest Med Mercedes & Martin Ferreya INIMEC, Cordoba, Argentina		Monteleone, MC (corresponding author), Univ San Martin, Inst Invest Biotecnol, Buenos Aires, DF, Argentina.	carregui@iib.unsam.edu.ar		Arregui, Carlos/0000-0003-0704-3321; Monteleone, Melisa Carolina/0000-0002-6282-4019; Conde, Cecilia/0000-0002-5103-6391	Agencia Nacional para la Promocion Cientifica y Tecnologica, Argentina	Agencia Nacional para la Promocion Cientifica y Tecnologica, Argentina(ANPCyT)	This work was supported by grants from Agencia Nacional para la Promocion Cientifica y Tecnologica, Argentina http://www.agencia.gov.ar/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderie I, 2007, CELL SIGNAL, V19, P582, DOI 10.1016/j.cellsig.2006.08.007; Arias-Romero LE, 2009, CANCER RES, V69, P4582, DOI 10.1158/0008-5472.CAN-08-4001; Arias-Salgado EG, 2005, J CELL BIOL, V170, P837, DOI 10.1083/jcb.200503125; Arregui CO, 2000, NEUROCHEM RES, V25, P95, DOI 10.1023/A:1007595617447; Arregui CO, 1998, J CELL BIOL, V143, P861, DOI 10.1083/jcb.143.3.861; AVNUR Z, 1981, J MOL BIOL, V153, P361, DOI 10.1016/0022-2836(81)90283-7; Axelrod D, 2008, METHOD CELL BIOL, V89, P169, DOI 10.1016/S0091-679X(08)00607-9; Balsamo J, 1998, J CELL BIOL, V143, P523, DOI 10.1083/jcb.143.2.523; Bjorge JD, 2000, J BIOL CHEM, V275, P41439, DOI 10.1074/jbc.M004852200; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Boute N, 2003, EMBO REP, V4, P313, DOI 10.1038/sj.embor.embor767; Burridge K, 2006, J BIOL CHEM, V281, P15593, DOI 10.1074/jbc.R500030200; Chacon PJ, 2010, MOL CELL NEUROSCI, V43, P384, DOI 10.1016/j.mcn.2010.01.005; Cheng A, 2001, J BIOL CHEM, V276, P25848, DOI 10.1074/jbc.M009734200; Chong YP, 2005, BBA-PROTEINS PROTEOM, V1754, P210, DOI 10.1016/j.bbapap.2005.07.027; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; Dadke S, 2002, BIOCHEM J, V364, P377, DOI 10.1042/BJ20011372; Drees Frauke, 2004, V294, P303; Eden ER, 2010, NAT CELL BIOL, V12, P267, DOI 10.1038/ncb2026; FEIGUIN F, 1994, J CELL BIOL, V127, P1021, DOI 10.1083/jcb.127.4.1021; Fincham VJ, 1996, J CELL BIOL, V135, P1551, DOI 10.1083/jcb.135.6.1551; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Fuentes F, 2009, MOL BIOL CELL, V20, P1878, DOI 10.1091/mbc.E08-07-0675; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hernandez MV, 2010, MOL BIOL CELL, V21, P1387, DOI 10.1091/mbc.E09-10-0880; Hernandez MV, 2006, J CELL SCI, V119, P1233, DOI 10.1242/jcs.02846; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; KAPLAN KB, 1992, J CELL BIOL, V118, P321, DOI 10.1083/jcb.118.2.321; KAPLAN KB, 1994, EMBO J, V13, P4745, DOI 10.1002/j.1460-2075.1994.tb06800.x; Kasahara K, 2007, EXP CELL RES, V313, P2651, DOI 10.1016/j.yexcr.2007.05.001; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kostic A, 2006, MOL BIOL CELL, V17, P2684, DOI 10.1091/mbc.E05-12-1161; Krylyshkina O, 2003, J CELL BIOL, V161, P853, DOI 10.1083/jcb.200301102; LEE C, 1988, CELL, V54, P37, DOI 10.1016/0092-8674(88)90177-8; Lessard L, 2010, BBA-PROTEINS PROTEOM, V1804, P613, DOI 10.1016/j.bbapap.2009.09.018; Liang FB, 2005, J BIOL CHEM, V280, P24857, DOI 10.1074/jbc.M502780200; Lilien J, 2002, DEV DYNAM, V224, P18, DOI 10.1002/dvdy.10087; Liu F, 1996, J BIOL CHEM, V271, P31290, DOI 10.1074/jbc.271.49.31290; Mertins P, 2008, MOL CELL PROTEOMICS, V7, P1763, DOI 10.1074/mcp.M800196-MCP200; Nievergall E, 2010, J CELL BIOL, V191, P1189, DOI 10.1083/jcb.201005035; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Romsicki Y, 2004, J BIOL CHEM, V279, P12868, DOI 10.1074/jbc.M309600200; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Sallee JL, 2006, J BIOL CHEM, V281, P16189, DOI 10.1074/jbc.R600003200; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Sandilands E, 2008, TRENDS CELL BIOL, V18, P322, DOI 10.1016/j.tcb.2008.05.004; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Shvartsman DE, 2007, J CELL BIOL, V178, P675, DOI 10.1083/jcb.200701133; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Songyang Zhou, 2004, Cell, V116, pS41, DOI 10.1016/S0092-8674(04)00041-8; Stephens DJ, 2000, J CELL SCI, V113, P2177; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; vantHof W, 1997, J CELL BIOL, V136, P1023, DOI 10.1083/jcb.136.5.1023; Vedrenne C, 2006, TRAFFIC, V7, P639, DOI 10.1111/j.1600-0854.2006.00419.x; Waterman-Storer CM, 1998, CURR BIOL, V8, P798, DOI 10.1016/S0960-9822(98)70321-5; Weber I, 2003, METHOD ENZYMOL, V361, P34; Wolven A, 1997, MOL BIOL CELL, V8, P1159, DOI 10.1091/mbc.8.6.1159; Xie LP, 2002, BIOCHEMISTRY-US, V41, P4032, DOI 10.1021/bi015904r; Zhang X, 2010, J CELL SCI, V123, P3901, DOI 10.1242/jcs.069153	65	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38948	10.1371/journal.pone.0038948	http://dx.doi.org/10.1371/journal.pone.0038948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701734	gold, Green Submitted, Green Published			2022-12-25	WOS:000305337600061
J	Oldekop, JA; Bebbington, AJ; Truelove, NK; Tysklind, N; Villamarin, S; Preziosi, RF				Oldekop, Johan A.; Bebbington, Anthony J.; Truelove, Nathan K.; Tysklind, Niklas; Villamarin, Santiago; Preziosi, Richard F.			Co-Occurrence Patterns of Common and Rare Leaf-Litter Frogs, Epiphytic Ferns and Dung Beetles across a Gradient of Human Disturbance	PLOS ONE			English	Article							BIODIVERSITY INDICATORS; SPECIES RICHNESS; VASCULAR EPIPHYTES; RESERVE SELECTION; TROPICAL PRIMARY; CONSERVATION; DIVERSITY; FOREST; LANDSCAPE; TAXA	Indicator taxa are commonly used to identify priority areas for conservation or to measure biological responses to environmental change. Despite their widespread use, there is no general consensus about the ability of indicator taxa to predict wider trends in biodiversity. Many studies have focused on large-scale patterns of species co-occurrence to identify areas of high biodiversity, threat or endemism, but there is much less information about patterns of species co-occurrence at local scales. In this study, we assess fine-scale co-occurrence patterns of three indicator taxa (epiphytic ferns, leaf litter frogs and dung beetles) across a remotely sensed gradient of human disturbance in the Ecuadorian Amazon. We measure the relative contribution of rare and common species to patterns of total richness in each taxon and determine the ability of common and rare species to act as surrogate measures of human disturbance and each other. We find that the species richness of indicator taxa changed across the human disturbance gradient but that the response differed among taxa, and between rare and common species. Although we find several patterns of co-occurrence, these patterns differed between common and rare species. Despite showing complex patterns of species co-occurrence, our results suggest that species or taxa can act as reliable indicators of each other but that this relationship must be established and not assumed.	[Oldekop, Johan A.; Truelove, Nathan K.; Preziosi, Richard F.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Bebbington, Anthony J.] Univ Manchester, Inst Dev Policy & Management, Manchester, Lancs, England; [Bebbington, Anthony J.] Clark Univ, Grad Sch Geog, Worcester, MA 01610 USA; [Tysklind, Niklas] Bangor Univ, Coll Nat Sci, Bangor, Gwynedd, Wales; [Villamarin, Santiago] Museo Ecuatoriano Ciencias Natur, Quito, Ecuador	University of Manchester; University of Manchester; Clark University; Bangor University	Oldekop, JA (corresponding author), Washington State Univ, Sch Environm, Vancouver, WA 98686 USA.	j.oldekop@gmx.net	Tysklind, Niklas/A-5275-2017; Preziosi, Richard F/A-8626-2010	Tysklind, Niklas/0000-0002-6617-7875; Preziosi, Richard F/0000-0003-0468-6655; Oldekop, Johan/0000-0003-0565-812X	GIZ GmbH through their internship programme; Wingate Foundation scholarship	GIZ GmbH through their internship programme; Wingate Foundation scholarship	Johan A. Oldekop and Niklas Tysklind thank the GIZ GmbH for financial support through their internship programme. Johan A. Oldekop acknowledges the support of a Wingate Foundation scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; Arponen A, 2005, CONSERV BIOL, V19, P2009, DOI 10.1111/j.1523-1739.2005.00218.x; Balmford A, 1995, CONSERV BIOL, V9, P1539, DOI 10.1046/j.1523-1739.1995.09061539.x; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Barlow J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009609; Buckling A, 2000, NATURE, V408, P961, DOI 10.1038/35050080; Butchart SHM, 2006, CONSERV BIOL, V20, P579, DOI 10.1111/j.1523-1739.2006.00410.x; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Chazdon RL, 2003, PERSPECT PLANT ECOL, V6, P51, DOI 10.1078/1433-8319-00042; Chazdon RL, 1998, MAN BIOSPH, V20, P285; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Harvey CA, 2006, ECOL APPL, V16, P1986, DOI 10.1890/1051-0761(2006)016[1986:POADID]2.0.CO;2; Hess GR, 2006, BIOL CONSERV, V132, P448, DOI 10.1016/j.biocon.2006.04.037; Hopkins GW, 2002, ANIM CONSERV, V5, P245, DOI 10.1017/S1367943002002299; Howard PC, 1998, NATURE, V394, P472, DOI 10.1038/28843; INRA, 2007, CAN EYE V6 2; Kati V, 2004, CONSERV BIOL, V18, P667, DOI 10.1111/j.1523-1739.2004.00465.x; Kessler M, 2011, J APPL ECOL, V48, P330, DOI 10.1111/j.1365-2664.2010.01932.x; Kessler M, 2009, ECOL APPL, V19, P2142, DOI 10.1890/08-1074.1; Kluge J, 2011, PLANT ECOL, V212, P1109, DOI 10.1007/s11258-010-9891-x; Kromer T, 2007, PLANT ECOL, V189, P261, DOI 10.1007/s11258-006-9182-8; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Lawler JJ, 2003, CONSERV BIOL, V17, P875, DOI 10.1046/j.1523-1739.2003.01638.x; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Lennon JJ, 2004, ECOL LETT, V7, P81, DOI 10.1046/j.1461-0248.2004.00548.x; Lewandowski AS, 2010, CONSERV BIOL, V24, P1367, DOI 10.1111/j.1523-1739.2010.01513.x; Lwanga JS, 1998, BIODIVERS CONSERV, V7, P1387, DOI 10.1023/A:1008865518378; Mace GM, 2007, CONSERV BIOL, V21, P1406, DOI 10.1111/j.1523-1739.2007.00830.x; Maes D, 2005, BIODIVERS CONSERV, V14, P1345, DOI 10.1007/s10531-004-9662-x; Maes D, 2005, BIOL CONSERV, V123, P177, DOI 10.1016/j.biocon.2004.11.005; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; Mazaris A, 2008, BIODIVERS CONSERV, V17, P3567, DOI 10.1007/s10531-008-9480-7; McMorrow J, 2001, INT J REMOTE SENS, V22, P2243, DOI 10.1080/01431160117188; Mucunguzi P, 2007, AFR J ECOL, V45, P120, DOI 10.1111/j.1365-2028.2007.00868.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Navarrete D, 2008, BIODIVERS CONSERV, V17, P2869, DOI 10.1007/s10531-008-9402-8; Navarrete H, 2001, HELECHOS COMUNES AMA; Nichols E, 2009, OIKOS, V118, P481, DOI 10.1111/j.1600-0706.2009.17268.x; Oldekop JA, 2012, HUM ECOL, V40, P101, DOI 10.1007/s10745-011-9455-2; Oldekop JA, 2011, BIODIVERS CONSERV, V20, P2615, DOI 10.1007/s10531-011-0094-0; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Paciencia MLB, 2005, PLANT ECOL, V180, P87, DOI 10.1007/s11258-005-3025-x; Pardini R, 2009, BIOL CONSERV, V142, P1178, DOI 10.1016/j.biocon.2009.02.010; Parody JM, 2001, GLOBAL ECOL BIOGEOGR, V10, P305, DOI 10.1046/j.1466-822X.2001.00233.x; Pearman PB, 1997, CONSERV BIOL, V11, P1211, DOI 10.1046/j.1523-1739.1997.96202.x; Pearman PB, 2007, BIOL CONSERV, V138, P109, DOI 10.1016/j.biocon.2007.04.005; Pineda E, 2005, CONSERV BIOL, V19, P400, DOI 10.1111/j.1523-1739.2005.00531.x; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Rodriguez L. O., 1994, SPECIAL PUBLICATION; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Roxburgh JR, 1995, NEW ZEAL J ECOL, V19, P213; Roxburgh SH, 2004, ECOLOGY, V85, P359, DOI 10.1890/03-0266; Spector S, 2006, COLEOPTS BULL, V60, P71, DOI 10.1649/0010-065X(2006)60[71:SDBCSS]2.0.CO;2; Tognelli MF, 2005, BIOL CONSERV, V121, P409, DOI 10.1016/j.biocon.2004.05.013; Tscharntke T, 2008, ECOLOGY, V89, P944, DOI 10.1890/07-0455.1; Valencia J. H., 2008, GUIA CAMPO ANFIBIOS; van Jaarsveld AS, 1998, SCIENCE, V279, P2106, DOI 10.1126/science.279.5359.2106; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Werner FA, 2011, BASIC APPL ECOL, V12, P172, DOI 10.1016/j.baae.2010.11.002; Williams-Linera G, 2005, BIODIVERS CONSERV, V14, P119, DOI 10.1007/s10531-005-4053-5; Zotz G, 2007, J VEG SCI, V18, P123, DOI 10.1111/j.1654-1103.2007.tb02522.x; Zotz G, 2003, J TROP ECOL, V19, P81, DOI 10.1017/S0266467403003092	66	8	9	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38922	10.1371/journal.pone.0038922	http://dx.doi.org/10.1371/journal.pone.0038922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701730	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000305337600057
J	Song, F; Poljak, A; Crawford, J; Kochan, NA; Wen, W; Cameron, B; Lux, O; Brodaty, H; Mather, K; Smythe, GA; Sachdev, PS				Song, Fei; Poljak, Anne; Crawford, John; Kochan, Nicole A.; Wen, Wei; Cameron, Barbara; Lux, Ora; Brodaty, Henry; Mather, Karen; Smythe, George A.; Sachdev, Perminder S.			Plasma Apolipoprotein Levels Are Associated with Cognitive Status and Decline in a Community Cohort of Older Individuals	PLOS ONE			English	Article							ALZHEIMERS-DISEASE PATIENTS; CARDIOVASCULAR RISK-FACTORS; GENOME-WIDE ASSOCIATION; MINI-MENTAL-STATE; CEREBROSPINAL-FLUID; A-I; DENSITY-LIPOPROTEIN; IDENTIFIES VARIANTS; SERUM CONCENTRATION; VASCULAR DEMENTIA	Objectives: Apolipoproteins have recently been implicated in the etiology of Alzheimer's disease (AD). In particular, Apolipoprotein J (ApoJ or clusterin) has been proposed as a biomarker of the disease at the pre-dementia stage. We examined a group of apolipoproteins, including ApoA1, ApoA2, ApoB, ApoC3, ApoE, ApoH and ApoJ, in the plasma of a longitudinal community based cohort. Methods: 664 subjects (257 with Mild Cognitive Impairment [MCI] and 407 with normal cognition), mean age 78 years, from the Sydney Memory and Aging Study (MAS) were followed up over two years. Plasma apolipoprotein levels at baseline (Wave 1) were measured using a multiplex bead fluorescence immunoassay technique. Results: At Wave 1, MCI subjects had lower levels of ApoA1, ApoA2 and ApoH, and higher levels of ApoE and ApoJ, and a higher ApoB/ApoA1 ratio. Carriers of the apolipoprotein E epsilon 4 allele had significantly lower levels of plasma ApoE, ApoC3 and ApoH and a significantly higher level of ApoB. Global cognitive scores were correlated positively with ApoH and negatively with ApoJ levels. ApoJ and ApoE levels were correlated negatively with grey matter volume and positively with cerebrospinal fluid (CSF) volume on MRI. Lower ApoA1, ApoA2 and ApoH levels, and higher ApoB/ApoA1 ratio, increased the risk of cognitive decline over two years in cognitively normal individuals. ApoA1 was the most significant predictor of decline. These associations remained after statistically controlling for lipid profile. Higher ApoJ levels predicted white matter atrophy over two years. Conclusions: Elderly individuals with MCI have abnormal apolipoprotein levels, which are related to cognitive function and volumetric MRI measures cross-sectionally and are predictive of cognitive impairment in cognitively normal subjects. ApoA1, ApoH and ApoJ are potential plasma biomarkers of cognitive decline in non-demented elderly individuals.	[Song, Fei; Poljak, Anne; Crawford, John; Kochan, Nicole A.; Wen, Wei; Lux, Ora; Brodaty, Henry; Mather, Karen; Sachdev, Perminder S.] Univ New S Wales, Brain & Aging Res Program, Sydney, NSW, Australia; [Song, Fei; Crawford, John; Kochan, Nicole A.; Wen, Wei; Brodaty, Henry; Mather, Karen; Sachdev, Perminder S.] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Song, Fei; Poljak, Anne; Smythe, George A.] Univ New S Wales, Bioanalyt Mass Spectrometry Facil, Sydney, NSW, Australia; [Poljak, Anne; Cameron, Barbara; Smythe, George A.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Brodaty, Henry] Univ New S Wales, Dementia Collaborat Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Song, F (corresponding author), Univ New S Wales, Brain & Aging Res Program, Sydney, NSW, Australia.	p.sachdev@unsw.edu.au	Sachdev, Perminder/ABC-1137-2020; Karen, Mather A/O-9795-2016	Sachdev, Perminder/0000-0002-9595-3220; Karen, Mather A/0000-0003-4143-8941; Poljak, Anne/0000-0001-9953-1984; Wen, Wei/0000-0003-2753-3870	Australian National Health and Medical Research Council [350833, 568940]; Rebecca L Cooper Medical Research Foundation	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L Cooper Medical Research Foundation	This work was facilitated by the Australian National Health and Medical Research Council Program Grant 350833 and Capacity Building Grant 568940, and the generous financial support of the Rebecca L Cooper Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2009, J NEUROL SCI, V280, P79, DOI 10.1016/j.jns.2009.02.004; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Anderson TM, 2007, AM J GERIAT PSYCHIAT, V15, P467, DOI 10.1097/JGP.0b013e3180547053; [Anonymous], 2010, WORLD ALZHEIMER REPO; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bereczki E, 2008, J PROTEOME RES, V7, P2246, DOI 10.1021/pr7006329; Boyle PA, 2006, NEUROLOGY, V67, P441, DOI 10.1212/01.wnl.0000228244.10416.20; Caramelli P, 1999, ACTA NEUROL SCAND, V100, P61, DOI 10.1111/j.1600-0404.1999.tb00724.x; Castro A, 2010, ATHEROSCLEROSIS, V209, P201, DOI 10.1016/j.atherosclerosis.2009.09.072; CHOIMIURA NH, 1992, ACTA NEUROPATHOL, V83, P260, DOI 10.1007/BF00296787; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Darreh-Shori T, 2012, J ALZHEIMERS DIS, V28, P443, DOI 10.3233/JAD-2011-111088; Darreh-Shori T, 2011, NEUROBIOL AGING, V32, P1236, DOI 10.1016/j.neurobiolaging.2009.07.015; Darreh-Shori T, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.028; de Laat B, 2006, BLOOD, V107, P1916, DOI 10.1182/blood-2005-05-1943; DESILVA HV, 1990, BIOCHEMISTRY-US, V29, P5380, DOI 10.1021/bi00474a025; Dieterle F, 2010, NAT BIOTECHNOL, V28, P463, DOI 10.1038/nbt.1622; Dufouil C, 2005, NEUROLOGY, V64, P1531, DOI 10.1212/01.WNL.0000160114.42643.31; Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ganguli M, 2004, NEUROLOGY, V63, P115, DOI 10.1212/01.WNL.0000132523.27540.81; George D, 2009, PROG CARDIOVASC DIS, V52, P115, DOI 10.1016/j.pcad.2009.06.005; GHISO J, 1993, BIOCHEM J, V293, P27, DOI 10.1042/bj2930027; Giannakopoulos P, 1998, ACTA NEUROPATHOL, V95, P387, DOI 10.1007/s004010050815; Gupta VB, 2011, NEUROLOGY, V76, P1091, DOI 10.1212/WNL.0b013e318211c352; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hesse C, 2000, NEUROCHEM RES, V25, P511, DOI 10.1023/A:1007516210548; Hindmarch I, 1998, DEMENT GERIATR COGN, V9, P20, DOI 10.1159/000051195; Jellinger KA, 2003, J NEUROL, V250, P1050, DOI 10.1007/s00415-003-0142-0; JORDANSTARCK TC, 1994, J LIPID RES, V35, P194; Jorm AF, 2007, NEUROPSYCHOLOGY, V21, P1, DOI 10.1037/0894-4105.21.1.1; Katzav A, 2011, NEUROBIOL AGING, V32, P272, DOI 10.1016/j.neurobiolaging.2009.02.007; KAWANO M, 1995, CLIN CHIM ACTA, V239, P209, DOI 10.1016/0009-8981(95)06115-T; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Kullberg S, 2001, BRAIN RES, V899, P169, DOI 10.1016/S0006-8993(01)02222-3; Kuo YM, 1998, BIOCHEM BIOPH RES CO, V252, P711, DOI 10.1006/bbrc.1998.9652; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Laukka EJ, 2010, DEMENT GERIATR COGN, V29, P498, DOI 10.1159/000313978; Leduc MS, 2008, J LIPID RES, V49, P2648, DOI 10.1194/jlr.M800155-JLR200; Lewis TL, 2010, J BIOL CHEM, V285, P36958, DOI 10.1074/jbc.M110.127829; Lidstrom AM, 1998, EXP NEUROL, V154, P511, DOI 10.1006/exnr.1998.6892; Lindh M, 1997, NEUROSCI LETT, V229, P85, DOI 10.1016/S0304-3940(97)00429-1; Liu HC, 2006, DEMENT GERIATR COGN, V21, P155, DOI 10.1159/000090676; Martins IJ, 2006, MOL PSYCHIATR, V11, P721, DOI 10.1038/sj.mp.4001854; Martins IJ, 2009, J NEUROCHEM, V111, P1275, DOI 10.1111/j.1471-4159.2009.06408.x; Merched A, 2000, NEUROBIOL AGING, V21, P27, DOI 10.1016/S0197-4580(99)00103-7; Millan J, 2009, VASC HEALTH RISK MAN, V5, P757; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nilselid AM, 2006, NEUROCHEM INT, V48, P718, DOI 10.1016/j.neuint.2005.12.005; Nuutinen T, 2009, BRAIN RES REV, V61, P89, DOI 10.1016/j.brainresrev.2009.05.007; O'Bryant SE, 2010, ARCH NEUROL-CHICAGO, V67, P1077, DOI 10.1001/archneurol.2010.215; Ohrfelt A, 2011, DEMENT GER COGN D EX, V1, P31, DOI 10.1159/000323417; PETERSEN RC, 1995, JAMA-J AM MED ASSOC, V273, P1274, DOI 10.1001/jama.273.16.1274; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pirttila T, 1998, NEUROSCI LETT, V249, P21, DOI 10.1016/S0304-3940(98)00381-4; Roher AE, 2009, BIOMARKERS; Rountree SD, 2007, DEMENT GERIATR COGN, V24, P476, DOI 10.1159/000110800; Ruiz-Irastorza Guillermo, 2002, Autoimmunity Reviews, V1, P43, DOI 10.1016/S1568-9972(01)00005-2; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Scacchi R, 1998, DEMENT GERIATR COGN, V9, P186, DOI 10.1159/000017045; Sherman CB, 2010, CARDIOL REV, V18, P141, DOI 10.1097/CRD.0b013e3181c4b508; Siest G, 2000, CLIN CHEM LAB MED, V38, P721, DOI 10.1515/CCLM.2000.102; Sihlbom C, 2008, NEUROCHEM RES, V33, P1332, DOI 10.1007/s11064-008-9588-x; Slooter AJC, 1998, NEUROSCI LETT, V248, P21, DOI 10.1016/S0304-3940(98)00339-5; Sparks DL, 2005, ARCH NEUROL-CHICAGO, V62, P753, DOI 10.1001/archneur.62.5.753; Takechi R, 2010, BRIT J NUTR, V103, P652, DOI 10.1017/S0007114509992194; Takechi R, 2009, HISTOCHEM CELL BIOL, V131, P661, DOI 10.1007/s00418-009-0567-3; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; van Dijk KW, 2004, CURR OPIN LIPIDOL, V15, P239, DOI [10.1097/01.mol.00001300096.77252.1f, 10.1097/00041433-200406000-00002]; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Zhang RL, 2004, PROTEOMICS, V4, P244, DOI 10.1002/pmic.200300495; Zlokovic BV, 1996, P NATL ACAD SCI USA, V93, P4229, DOI 10.1073/pnas.93.9.4229; [No title captured], DOI DOI 10.1017/S1041610210001067	75	125	132	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e34078	10.1371/journal.pone.0034078	http://dx.doi.org/10.1371/journal.pone.0034078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701550	gold, Green Published, Green Submitted			2022-12-25	WOS:000305337600001
J	Lawlor, KT; O'Keefe, LV; Samaraweera, SE; van Eyk, CL; Richards, RI				Lawlor, Kynan T.; O'Keefe, Louise V.; Samaraweera, Saumya E.; van Eyk, Clare L.; Richards, Robert I.			Ubiquitous Expression of CUG or CAG Trinucleotide Repeat RNA Causes Common Morphological Defects in a Drosophila Model of RNA-Mediated Pathology	PLOS ONE			English	Article							MYOTONIC-DYSTROPHY; TRIPLET REPEAT; NUCLEAR FOCI; RCGG REPEATS; TOXICITY; NEURODEGENERATION; MUSCLEBLIND; EXPANSION; POLYGLUTAMINE; PROTEIN	Expanded DNA repeat sequences are known to cause over 20 diseases, including Huntington's disease, several types of spinocerebellar ataxia and myotonic dystrophy type 1 and 2. A shared genetic basis, and overlapping clinical features for some of these diseases, indicate that common pathways may contribute to pathology. Multiple mechanisms, mediated by both expanded homopolymeric proteins and expanded repeat RNA, have been identified by the use of model systems, that may account for shared pathology. The use of such animal models enables identification of distinct pathways and their 'molecular hallmarks' that can be used to determine the contribution of each pathway in human pathology. Here we characterise a tergite disruption phenotype in adult flies, caused by ubiquitous expression of either untranslated CUG or CAG expanded repeat RNA. Using the tergite phenotype as a quantitative trait we define a new genetic system in which to examine 'hairpin' repeat RNA-mediated cellular perturbation. Further experiments use this system to examine whether pathways involving Muscleblind sequestration or Dicer processing, which have been shown to mediate repeat RNA-mediated pathology in other model systems, contribute to cellular perturbation in this model.	[Lawlor, Kynan T.] Univ Adelaide, Discipline Genet, Sch Mol & Biomed Sci, Adelaide, SA, Australia; Univ Adelaide, Australian Res Council, Special Res Ctr Mol Genet Dev, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Lawlor, KT (corresponding author), Univ Adelaide, Discipline Genet, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	robert.richards@adelaide.edu.au	Lawlor, Kynan/AAC-2407-2021; O'Keefe, Louise V/B-9856-2008; van Eyk, Clare L/P-8334-2019; Richards, Robert/ABE-6423-2020	van Eyk, Clare L/0000-0003-0345-9944; Samaraweera, Saumya/0000-0002-9619-0624; Richards, Robert Ian/0000-0002-5978-6453; Lawlor, Kynan/0000-0003-4080-5439	Australian Postgraduate Awards; National Health and Medical Research Council Peter Doherty Fellowship [207830]; National Health and Medical Research Council [453674, 627183]; Australian Research Council Special Research Centre for the Molecular Genetics of Development	Australian Postgraduate Awards(Australian Government); National Health and Medical Research Council Peter Doherty Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Special Research Centre for the Molecular Genetics of Development(Australian Research Council)	This work was supported by Australian Postgraduate Awards (to KTL, SES and CLvE); a National Health and Medical Research Council Peter Doherty Fellowship (fellowship number 207830 to LVO); project grants from the National Health and Medical Research Council (grant numbers 453674, 627183 to RIR and LVO); and the Australian Research Council Special Research Centre for the Molecular Genetics of Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batra R, 2010, HUM MOL GENET, V19, pR77, DOI 10.1093/hmg/ddq132; Begemann G, 1997, DEVELOPMENT, V124, P4321; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; Daughters RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000600; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; de Haro M, 2006, HUM MOL GENET, V15, P2138, DOI 10.1093/hmg/ddl137; de Mezer M, 2011, NUCLEIC ACIDS RES, V39, P3852, DOI 10.1093/nar/gkq1323; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Garcia-Lopez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001595; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Houseley JM, 2005, HUM MOL GENET, V14, P873, DOI 10.1093/hmg/ddi080; Hsu RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016417; Ito K, 1997, DEVELOPMENT, V124, P761; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Jin P, 2003, NEURON, V39, P739, DOI 10.1016/S0896-6273(03)00533-6; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Kiliszek A, 2010, NUCLEIC ACIDS RES, V38, P8370, DOI 10.1093/nar/gkq700; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Krol J, 2007, MOL CELL, V25, P575, DOI 10.1016/j.molcel.2007.01.031; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; Ladd PD, 2007, HUM MOL GENET, V16, P3174, DOI 10.1093/hmg/ddm293; Lawlor KT, 2011, HUM MOL GENET, V20, P3757, DOI 10.1093/hmg/ddr292; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Li LB, 2010, TRENDS NEUROSCI, V33, P292, DOI 10.1016/j.tins.2010.03.004; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; MADHAVAN K, 1995, ROUX ARCH DEV BIOL, V204, P330, DOI 10.1007/BF02179501; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; McLeod CJ, 2005, HUM MOL GENET, V14, P1041, DOI 10.1093/hmg/ddi096; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Mutsuddi M, 2004, CURR BIOL, V14, P302, DOI 10.1016/j.cub.2004.01.034; Ninov N, 2007, DEVELOPMENT, V134, P367, DOI 10.1242/dev.02728; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pascual M, 2006, DIFFERENTIATION, V74, P65, DOI 10.1111/j.1432-0436.2006.00060.x; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Ranum LPW, 2004, TRENDS GENET, V20, P506, DOI 10.1016/j.tig.2004.08.004; Richards RI, 2001, HUM MOL GENET, V10, P2187, DOI 10.1093/hmg/10.20.2187; Rudnicki DD, 2007, ANN NEUROL, V61, P272, DOI 10.1002/ana.21081; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; Sellier C, 2010, EMBO J, V29, P1248, DOI 10.1038/emboj.2010.21; Shieh SY, 2011, HUM MOL GENET, V20, P4810, DOI 10.1093/hmg/ddr420; Sobczak K, 2010, J BIOL CHEM, V285, P12755, DOI 10.1074/jbc.M109.078790; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Sopher BL, 2011, NEURON, V70, P1071, DOI 10.1016/j.neuron.2011.05.027; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Todd PK, 2010, ANN NEUROL, V67, P291, DOI 10.1002/ana.21948; van Eyk CL, 2012, HUM MOL GENET, V21, P536, DOI 10.1093/hmg/ddr487; van Eyk CL, 2011, HUM MOL GENET, V20, P2783, DOI 10.1093/hmg/ddr177; Wang LC, 2011, CELL MOL LIFE SCI, V68, P1255, DOI 10.1007/s00018-010-0522-4; Wells R.D., 2006, GENETIC INSTABILITIE; White MC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000984; Wilburn B, 2011, NEURON, V70, P427, DOI 10.1016/j.neuron.2011.03.021; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Wojciechowska M, 2011, HUM MOL GENET, V20, P3811, DOI 10.1093/hmg/ddr299; Yu ZM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001340; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	65	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38516	10.1371/journal.pone.0038516	http://dx.doi.org/10.1371/journal.pone.0038516			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715390	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336800032
J	Liu, ZL; Myers, LC				Liu, Zhongle; Myers, Lawrence C.			Med5(Nut1) and Med17(Srb4) Are Direct Targets of Mediator Histone H4 Tail Interactions	PLOS ONE			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; YEAST MEDIATOR; TRANSCRIPTIONAL REGULATION; GENE DELETION; COMPLEX; PROTEIN; MODULE; SIN4; GENOME	The Mediator complex transmits activation signals from DNA bound transcription factors to the core transcription machinery. In addition to its canonical role in transcriptional activation, recent studies have demonstrated that S. cerevisiae Mediator can interact directly with nucleosomes, and their histone tails. Mutations in Mediator subunits have shown that Mediator and certain chromatin structures mutually impact each other structurally and functionally in vivo. We have taken a UV photo cross-linking approach to further delineate the molecular basis of Mediator chromatin interactions and help determine whether the impact of certain Mediator mutants on chromatin is direct. Specifically, by using histone tail peptides substituted with an amino acid analog that is a UV activatible crosslinker, we have identified specific subunits within Mediator that participate in histone tail interactions. Using Mediator purified from mutant yeast strains we have evaluated the impact of these subunits on histone tail binding. This analysis has identified the Med5 subunit of Mediator as a target for histone tail interactions and suggests that the previously observed effect of med5 mutations on telomeric heterochromatin and silencing is direct.	[Liu, Zhongle; Myers, Lawrence C.] Dartmouth Med Sch, Dept Biochem, Hanover, NH USA	Dartmouth College	Liu, ZL (corresponding author), Dartmouth Med Sch, Dept Biochem, Hanover, NH USA.	larry.myers@dartmouth.edu			National Institute of General Medical Sciences [R01 GM62483]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062483] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences grant R01 GM62483 (LCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; Baidoobonso SM, 2007, J BIOL CHEM, V282, P5551, DOI 10.1074/jbc.M609484200; Beve J, 2005, J BIOL CHEM, V280, P41366, DOI 10.1074/jbc.M511181200; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Borggrefe T, 2002, J BIOL CHEM, V277, P44202, DOI 10.1074/jbc.M207195200; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; de Bruin D, 2000, MOL CELL BIOL, V20, P7991, DOI 10.1128/MCB.20.21.7991-8000.2000; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Han SJ, 2001, J BIOL CHEM, V276, P37020, DOI 10.1074/jbc.M105596200; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Howard SC, 2001, GENETICS, V159, P77; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; Jiang YW, 1996, GENE DEV, V10, P604, DOI 10.1101/gad.10.5.604; JIANG YW, 1995, GENETICS, V140, P47; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Lee YC, 1999, MOL CELL BIOL, V19, P2967; Li LH, 2005, GENETICS, V171, P477, DOI 10.1534/genetics.105.043893; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; Linder T, 2004, J BIOL CHEM, V279, P49455, DOI 10.1074/jbc.M409046200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lorch Y, 2000, MOL CELL, V6, P197, DOI 10.1016/S1097-2765(00)00021-6; Macatee T, 1997, NUCLEIC ACIDS RES, V25, P1240, DOI 10.1093/nar/25.6.1240; Myers LC, 1997, METHODS, V12, P212, DOI 10.1006/meth.1997.0473; Myers LC, 1999, P NATL ACAD SCI USA, V96, P67, DOI 10.1073/pnas.96.1.67; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Peng J, 2012, NUCLEIC ACIDS RES, V40, P581, DOI 10.1093/nar/gkr757; Poux AN, 2003, BIOCHEMISTRY-US, V42, P14366, DOI 10.1021/bi035632n; Rani PG, 2004, MOL CELL BIOL, V24, P1709, DOI 10.1128/MCB.24.4.1709-1720.2004; Samuelsen CO, 2003, P NATL ACAD SCI USA, V100, P6422, DOI 10.1073/pnas.1030497100; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Singh H, 2006, GENETICS, V172, P2169, DOI 10.1534/genetics.105.052738; Song WJ, 1996, MOL CELL BIOL, V16, P115; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Wang X, 2004, GENETICS, V168, P747, DOI 10.1534/genetics.104.029611; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yu YX, 2000, MOL CELL BIOL, V20, P2350, DOI 10.1128/MCB.20.7.2350-2357.2000; Zhu XF, 2006, MOL CELL, V22, P169, DOI 10.1016/j.molcel.2006.03.032; Zhu XF, 2011, NUCLEIC ACIDS RES, V39, P8342, DOI 10.1093/nar/gkr551; Zhu XF, 2011, MOL CELL BIOL, V31, P2413, DOI 10.1128/MCB.05242-11	46	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38416	10.1371/journal.pone.0038416	http://dx.doi.org/10.1371/journal.pone.0038416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693636	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343900038
J	Frydrychowski, AF; Szarmach, A; Czaplewski, B; Winklewski, PJ				Frydrychowski, Andrzej F.; Szarmach, Arkadiusz; Czaplewski, Bartosz; Winklewski, Pawel J.			Subarachnoid Space: New Tricks by an Old Dog	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; SEXUAL-DIMORPHISM; CEREBROVASCULAR PULSATION; NONINVASIVE MEASUREMENT; HEMISPHERIC-ASYMMETRY; WIDTH; BRAIN; FOUNDATIONS; HANDEDNESS; PRESSURE	Purpose: The purpose of the study was to: (1) evaluate the subarachnoid space (SAS) width and pial artery pulsation in both hemispheres, and (2) directly compare magnetic resonance imaging (MRI) to near-infrared transillumination/backscattering sounding (NIR-T/BSS) measurements of SAS width changes in healthy volunteers. Methods: The study was performed on three separate groups of volunteers, consisting in total of 62 subjects (33 women and 29 men) aged from 16 to 39 years. SAS width was assessed by MRI and NIR-T/BSS, and pial artery pulsation by NIR-T/BSS. Results: In NIR-T/BSS, the right frontal SAS was 9.1% wider than the left (p<0.01). The SAS was wider in men (p<0.01), while the pial artery pulsation was higher in women (p<0.01). Correlation and regression analysis of SAS width changes between the back-and abdominal-lying positions measured with MRI and NIRT-B/SS demonstrated high interdependence between both methods (r = 0.81, p<0.001). Conclusions: NIR-T/BSS and MRI were comparable and gave equivalent modalities for the SAS width change measurements. The SAS width and pial artery pulsation results obtained with NIR-T/BSS are consistent with the MRI data in the literature related to sexual dimorphism and morphological asymmetries between the hemispheres. NIR-T/BSS is a potentially cheap and easy-to-use method for early screening in patients with brain tumours, increased intracranial pressures and other abnormalities. Further studies in patients with intracranial pathologies are warranted.	[Frydrychowski, Andrzej F.; Winklewski, Pawel J.] Med Univ Gdansk, Inst Human Physiol, Gdansk, Poland; [Szarmach, Arkadiusz] Med Univ Gdansk, Dept Radiol, Gdansk, Poland; [Czaplewski, Bartosz] Gdansk Univ Technol, Dept Teleinformat Networks, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Gdansk University of Technology	Frydrychowski, AF (corresponding author), Med Univ Gdansk, Inst Human Physiol, Gdansk, Poland.	pawelwinklewski@wp.pl	Winklewski, Pawel/E-9307-2013; Czaplewski, Bartosz/AFQ-1291-2022	Szarmach, Arkadiusz/0000-0003-3118-014X; Winklewski, Pawel/0000-0002-1671-2163; Czaplewski, Bartosz/0000-0001-7904-5567	Medical University of Gdansk; NIRT sp. z o. o., Wierzbice, Poland	Medical University of Gdansk(Medical University Gdansk); NIRT sp. z o. o., Wierzbice, Poland	Funding came from the Medical University of Gdansk and NIRT sp. z o. o., Wierzbice, Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucher Y, 1997, BRIT J CANCER, V75, P829, DOI 10.1038/bjc.1997.148; Cipolla MJ, 2007, HYPERTENSION, V50, P14, DOI 10.1161/HYPERTENSIONAHA.106.079442; Frydrychowski AE, 2002, IEEE T BIO-MED ENG, V49, P887, DOI 10.1109/TBME.2002.800786; Frydrychowski AF, 2001, OPTO-ELECTRON REV, V9, P397; Frydrychowski AF, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2753756; Frydrychowski AF, 2012, MICROVASC RES, V83, P229, DOI 10.1016/j.mvr.2011.08.005; Frydrychowski AF, 2011, ACTA NEUROBIOL EXP, V71, P313; Frydrychowski AF, 2011, MICROVASC RES, V82, P156, DOI 10.1016/j.mvr.2011.05.005; Frydrychowski AF, 2009, J ECT, V25, P99, DOI 10.1097/YCT.0b013e31818b1328; Gilmore JH, 2007, J NEUROSCI, V27, P1255, DOI 10.1523/JNEUROSCI.3339-06.2007; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Gravendeel J, 2010, PEDIATR RADIOL, V40, P1651, DOI 10.1007/s00247-010-1687-6; GUR RC, 1982, SCIENCE, V217, P659, DOI 10.1126/science.217.4560.657; Klingelhofer J, 1997, J CEREBR BLOOD F MET, V17, P577, DOI 10.1097/00004647-199705000-00013; Krause DN, 2006, J APPL PHYSIOL, V101, P1252, DOI 10.1152/japplphysiol.01095.2005; Lam WW, 2003, PEDIATR NEUROL, V25, P380; Li ZY, 2011, MICROVASC RES, V81, P81, DOI 10.1016/j.mvr.2010.09.011; Li ZY, 2010, MICROVASC RES, V80, P142, DOI 10.1016/j.mvr.2010.02.004; LIBICHER M, 1992, RADIOLOGY, V184, P749, DOI 10.1148/radiology.184.3.1509061; Maes M, 2000, ALCOHOL, V20, P117, DOI 10.1016/S0741-8329(99)00066-X; MAIER SE, 1994, RADIOLOGY, V193, P477, DOI 10.1148/radiology.193.2.7972766; MEYER JS, 1978, STROKE, V9, P195, DOI 10.1161/01.STR.9.3.195; Mills SJ, 2006, AM J NEURORADIOL, V27, P853; Nopoulos P, 2000, PSYCHIAT RES-NEUROIM, V98, P1, DOI 10.1016/S0925-4927(99)00044-X; PIVEN J, 1995, AM J PSYCHIAT, V152, P1145; Plucinski J, 2000, J BIOMED OPT, V5, P291, DOI 10.1117/1.429999; Plucinski J, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2757603; Raz N, 2004, NEUROBIOL AGING, V25, P377, DOI 10.1016/S0197-4580(03)00118-0; RODRIGUEZ G, 1988, J CEREBR BLOOD F MET, V8, P783, DOI 10.1038/jcbfm.1988.133; Sanderson TL, 1999, LANCET, V354, P1867, DOI 10.1016/S0140-6736(99)01049-1; Wagner BP, 2003, INTENS CARE MED, V29, P196, DOI 10.1007/s00134-002-1592-z; Wszedybyl-Winklewska M, 2012, ACTA NEUROBIOL EXP, V72, P80; Wszedybyl-Winklewska M, 2011, MICROVASC RES, V82, P369, DOI 10.1016/j.mvr.2011.08.003	33	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37529	10.1371/journal.pone.0037529	http://dx.doi.org/10.1371/journal.pone.0037529			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701518	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500040
J	Liu, MF; Boulouis, HJ; Biville, F				Liu, MaFeng; Boulouis, Henri-Jean; Biville, Francis			Heme Degrading Protein HemS Is Involved in Oxidative Stress Response of Bartonella henselae	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; IRON UPTAKE; CORYNEBACTERIUM-DIPHTHERIAE; HUMAN ERYTHROCYTES; YERSINIA-PESTIS; BINDING; OXYGENASE; GENE	Bartonellae are hemotropic bacteria, agents of emerging zoonoses. These bacteria are heme auxotroph Alphaproteobacteria which must import heme for supporting their growth, as they cannot synthesize it. Therefore, Bartonella genome encodes for a complete heme uptake system allowing the transportation of this compound across the outer membrane, the periplasm and the inner membranes. Heme has been proposed to be used as an iron source for Bartonella since these bacteria do not synthesize a complete system required for iron Fe3+ uptake. Similarly to other bacteria which use heme as an iron source, Bartonellae must transport this compound into the cytoplasm and degrade it to allow the release of iron from the tetrapyrrole ring. For Bartonella, the gene cluster devoted to the synthesis of the complete heme uptake system also contains a gene encoding for a polypeptide that shares homologies with heme trafficking or degrading enzymes. Using complementation of an E. coli mutant strain impaired in heme degradation, we demonstrated that HemS from Bartonella henselae expressed in E. coli allows the release of iron from heme. Purified HemS from B. henselae binds heme and can degrade it in the presence of a suitable electron donor, ascorbate or NADPH-cytochrome P450 reductase. Knocking down the expression of HemS in B. henselae reduces its ability to face H2O2 induced oxidative stress.	[Liu, MaFeng; Boulouis, Henri-Jean; Biville, Francis] Univ Paris Est, Ecole Natl Vet Alfort, UMR BIPAR INRA Anses UPEC ENVA, Maisons Alfort, France; [Liu, MaFeng] Jilin Univ, Minist Educ, Inst Zoonosis, Key Lab Zoonosis, Changchun 130023, Peoples R China; [Biville, Francis] Inst Pasteur, Dept Microbiol, Paris, France	Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Jilin University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Liu, MF (corresponding author), Univ Paris Est, Ecole Natl Vet Alfort, UMR BIPAR INRA Anses UPEC ENVA, Maisons Alfort, France.	fbiville@pasteur.fr			Pasteur Institute; Centre National de la Recherche Scientifique [URA2172]; Agence Nationale pour la Recherche [ANR-06-MIME-019-01]; China Scholarship Council	Pasteur Institute; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); China Scholarship Council(China Scholarship Council)	This work was supported by the Pasteur Institute, the Centre National de la Recherche Scientifique (URA2172), the Agence Nationale pour la Recherche[ANR-06-MIME-019-01]. MFL was supported by the grant of China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101; Anzaldi LL, 2010, INFECT IMMUN, V78, P4977, DOI 10.1128/IAI.00613-10; Breitschwerdt EB, 2010, J VET EMERG CRIT CAR, V20, P8, DOI 10.1111/j.1476-4431.2009.00496.x; Bruggemann H, 2004, ARCH MICROBIOL, V182, P259, DOI 10.1007/s00203-004-0721-1; Carroll JA, 2000, INFECT IMMUN, V68, P6750, DOI 10.1128/IAI.68.12.6750-6757.2000; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Coleman SA, 2003, MICROB PATHOGENESIS, V34, P179, DOI 10.1016/S0882-4010(03)00005-6; Dailey HA, MBIO, V2; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Derrick SC, 2001, BLOOD CELL MOL DIS, V27, P1013, DOI 10.1006/bcmd.2001.0475; Edouard S, 2010, MED MALADIES INFECT, V40, P319, DOI 10.1016/j.medmal.2009.11.004; Gillaspie D, 2009, APPL ENVIRON MICROB, V75, P5434, DOI 10.1128/AEM.00949-09; Guptill L, 2010, VET MICROBIOL, V140, P347, DOI 10.1016/j.vetmic.2009.11.011; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Kaur AP, 2009, J BIOL CHEM, V284, P56, DOI 10.1074/jbc.M806068200; Klotz SA, 2011, AM FAM PHYSICIAN, V83, P152; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lansky IB, 2006, J BIOL CHEM, V281, P13652, DOI 10.1074/jbc.M600824200; Letoffe S, 2003, MOL MICROBIOL, V50, P77, DOI 10.1046/j.1365-2958.2003.03686.x; Letoffe S, 2006, P NATL ACAD SCI USA, V103, P12891, DOI 10.1073/pnas.0605440103; Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106; Liu MF, 2012, MICROBIOL-SGM, V158, P886, DOI 10.1099/mic.0.054619-0; Maniatis T., 1989, MOL CLONING LAB MANU; Miller J.H., 1972, EXPT MOL GENETICS; MITCHELL SJ, 1995, INFECT IMMUN, V63, P1552, DOI 10.1128/IAI.63.4.1552-1562.1995; Oshima T, 2006, MICROBIOL-SGM, V152, P2129, DOI 10.1099/mic.0.28753-0; Parrow NL, 2009, INFECT IMMUN, V77, P307, DOI 10.1128/IAI.01194-08; Perrotte-Piquemal M, 1999, BIOCHIMIE, V81, P245, DOI 10.1016/S0300-9084(99)80058-3; Perry RD, 2007, BIOMETALS, V20, P699, DOI 10.1007/s10534-006-9051-x; Puri S, 2006, J BACTERIOL, V188, P6476, DOI 10.1128/JB.00737-06; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; Riess T, 2003, GENE, V313, P103, DOI 10.1016/S0378-1119(03)00636-X; Riess T, 2008, APPL ENVIRON MICROB, V74, P5224, DOI 10.1128/AEM.00621-08; Sander A, 2000, FEMS MICROBIOL LETT, V189, P55, DOI 10.1111/j.1574-6968.2000.tb09205.x; SCHERER DC, 1993, INFECT IMMUN, V61, P4962, DOI 10.1128/IAI.61.12.4962-4971.1993; Schmitt MP, 1997, J BACTERIOL, V179, P838, DOI 10.1128/jb.179.3.838-845.1997; Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x; Silver GM, 2002, ARCH INSECT BIOCHEM, V51, P136, DOI 10.1002/arch.10059; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Skaar EP, 2006, J BACTERIOL, V188, P1071, DOI 10.1128/JB.188.3.1071-1080.2006; STOJILJKOVIC I, 1994, MOL MICROBIOL, V13, P719, DOI 10.1111/j.1365-2958.1994.tb00465.x; Suits MDL, 2005, P NATL ACAD SCI USA, V102, P16955, DOI 10.1073/pnas.0504289102; Thompson JM, 1999, INFECT IMMUN, V67, P3879, DOI 10.1128/IAI.67.8.3879-3892.1999; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VARGAS C, 1993, ANAL BIOCHEM, V209, P323, DOI 10.1006/abio.1993.1127; Vayssier-Taussat M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000946; Watson RJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-177; Wilks A, 1998, J BIOL CHEM, V273, P837, DOI 10.1074/jbc.273.2.837; Wyckoff EE, 2005, J BACTERIOL, V187, P5658, DOI 10.1128/JB.187.16.5658-5664.2005; Wyckoff EE, 2004, J BACTERIOL, V186, P4142, DOI 10.1128/JB.186.13.4142-4151.2004; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000	52	10	12	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37630	10.1371/journal.pone.0037630	http://dx.doi.org/10.1371/journal.pone.0037630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701524	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338500045
J	Mandal, K; Balland, M; Bureau, L				Mandal, Kalpana; Balland, Martial; Bureau, Lionel			Thermoresponsive Micropatterned Substrates for Single Cell Studies	PLOS ONE			English	Article							POLYMER BRUSHES; SURFACES; DIFFERENTIATION; ORGANIZATION; DETACHMENT; INTERFACES; ANISOTROPY; COLLAPSE	We describe the design of micropatterned surfaces for single cell studies, based on thermoresponsive polymer brushes. We show that brushes made of poly(N-isopropylacrylamide) grafted at high surface density display excellent protein and cell anti-adhesive properties. Such brushes are readily patterned at the micron scale via deep UV photolithography. A proper choice of the adhesive pattern shapes, combined with the temperature-dependent swelling properties of PNIPAM, allow us to use the polymer brush as a microactuator which induces cell detachment when the temperature is reduced below 32 degrees C.	[Mandal, Kalpana; Balland, Martial; Bureau, Lionel] Univ Grenoble 1, CNRS, Lab Interdisciplinaire Phys, UMR 5588, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Mandal, K (corresponding author), Univ Grenoble 1, CNRS, Lab Interdisciplinaire Phys, UMR 5588, Grenoble, France.	martial.balland@ujf-grenoble.fr; lionel.bureau@ujf-grenoble.fr		Balland, martial/0000-0002-6585-9735	Fondation Nanosciences aux limites de la nanoelectronique [FCSN-2008-11JE]	Fondation Nanosciences aux limites de la nanoelectronique	Kalpana Mandal has a PhD grant from the "Fondation Nanosciences aux limites de la nanoelectronique" (contract number FCSN-2008-11JE; http://http://www.fondation-nanosciences.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing	Azioune A, 2009, LAB CHIP, V9, P1640, DOI 10.1039/b821581m; Cole MA, 2009, BIOMATERIALS, V30, P1827, DOI 10.1016/j.biomaterials.2008.12.026; DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009; Destaing O, 2010, MOL BIOL CELL, V21, P4108, DOI 10.1091/mbc.E10-07-0580; Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024; Gautrot JE, 2010, BIOMATERIALS, V31, P5030, DOI 10.1016/j.biomaterials.2010.02.066; Halperin A, 2011, MACROMOLECULES, V44, P6986, DOI 10.1021/ma201006h; Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b; Ishida N, 2007, LANGMUIR, V23, P11083, DOI 10.1021/la701461b; Iwanaga S, 2005, BIOMATERIALS, V26, P5395, DOI 10.1016/j.biomaterials.2005.01.021; Liu HC, 2002, LAB CHIP, V2, P175, DOI 10.1039/b204944a; Ma HW, 2004, ADV MATER, V16, P338, DOI 10.1002/adma.200305830; Malham IB, 2010, LANGMUIR, V26, P4762, DOI 10.1021/la9035387; Mizutani A, 2008, BIOMATERIALS, V29, P2073, DOI 10.1016/j.biomaterials.2008.01.004; Nagase K, 2011, MACROMOL BIOSCI, V11, P400, DOI 10.1002/mabi.201000312; Nagase K, 2009, J R SOC INTERFACE, V6, pS293, DOI 10.1098/rsif.2008.0499.focus; OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E; Pan Z, 2012, BIOMATERIALS, V33, P1730, DOI 10.1016/j.biomaterials.2011.11.023; Peng R, 2011, BIOMATERIALS, V32, P8048, DOI 10.1016/j.biomaterials.2011.07.035; Plunkett KN, 2006, LANGMUIR, V22, P4259, DOI 10.1021/la0531502; Racine J, 2011, BIOTECHNOL BIOENG, V108, P983, DOI 10.1002/bit.22997; Schmaljohann D, 2003, BIOMACROMOLECULES, V4, P1733, DOI 10.1021/bm034160p; SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320; Takahashi H, 2011, BIOMACROMOLECULES, V12, P1414, DOI 10.1021/bm2000956; Tang J, 2010, BIOMATERIALS, V31, P2470, DOI 10.1016/j.biomaterials.2009.12.006; Thery M, 2006, P NATL ACAD SCI USA, V103, P19771, DOI 10.1073/pnas.0609267103; Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150; Williams C, 2009, ADV MATER, V21, P2161, DOI 10.1002/adma.200801027; Yamato M, 2002, BIOMATERIALS, V23, P561, DOI 10.1016/S0142-9612(01)00138-7; Yan C, 2011, BIOMATERIALS, V32, P3931, DOI 10.1016/j.biomaterials.2011.01.078	30	48	48	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37548	10.1371/journal.pone.0037548	http://dx.doi.org/10.1371/journal.pone.0037548			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701519	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338500041
J	Wang, ZL; Parker, D; Meng, H; Wu, LO; Li, J; Zhao, Z; Zhang, RP; Fan, Q; Wang, HY; Cui, LW; Yang, ZQ				Wang, Zenglei; Parker, Daniel; Meng, Hao; Wu, Lanou; Li, Jia; Zhao, Zhen; Zhang, Rongping; Fan, Qi; Wang, Haiyan; Cui, Liwang; Yang, Zhaoqing			In Vitro Sensitivity of Plasmodium falciparum from China-Myanmar Border Area to Major ACT Drugs and Polymorphisms in Potential Target Genes	PLOS ONE			English	Article							ARTEMISININ-RESISTANT MALARIA; PFMDR1 COPY NUMBER; ARTEMETHER-LUMEFANTRINE; MEFLOQUINE RESISTANCE; ARTESUNATE-MEFLOQUINE; MOLECULAR ANALYSIS; CHLOROQUINE RESISTANCE; COMBINATION THERAPY; TYROSINE-86 ALLELE; QUININE RESISTANCE	Drug resistance has always been one of the most important impediments to global malaria control. Artemisinin resistance has recently been confirmed in the Greater Mekong Subregion (GMS) and efforts for surveillance and containment are intensified. To determine potential mechanisms of artemisinin resistance and monitor the emergence and spread of resistance in other regions of the GMS, we investigated the in vitro sensitivity of 51 culture-adapted parasite isolates from the China-Myanmar border area to four drugs. The 50% inhibitory concentrations (IC(50)s) of dihydroartemisinin, mefloquine and lumefantrine were clustered in a relatively narrow, 3- to 6-fold range, whereas the IC50 range of artesunate was 12-fold. We assessed the polymorphisms of candidate resistance genes pfcrt, pfmdr1, pfATP6, pfmdr6 and pfMT (a putative metabolite/drug transporter). The K76T mutation in pfcrt reached fixation in the study parasite population, whereas point mutations in pfmdr1 and pfATP6 had low levels of prevalence. In addition, pfmdr1 gene amplification was not detected. None of the mutations in pfmdr1 and pfATP6 was associated significantly with in vitro sensitivity to artemisinin derivatives. The ABC transporter gene pfmdr6 harbored two point mutations, two indels, and number variations in three simple repeats. Only the length variation in a microsatellite repeat appeared associated with altered sensitivity to dihydroartemisinin. The PfMT gene had two point mutations and one codon deletion; the I30N and N496-both reached high levels of prevalence. However, none of the SNPs or haplotypes in PfMT were correlated significantly with resistance to the four tested drugs. Compared with other parasite populations from the GMS, our studies revealed drastically different genotype and drug sensitivity profiles in parasites from the China-Myanmar border area, where artemisinins have been deployed extensively for over 30 years.	[Wang, Zenglei; Parker, Daniel; Meng, Hao; Cui, Liwang] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Meng, Hao; Li, Jia; Zhao, Zhen; Yang, Zhaoqing] Kunming Med Univ, Dept Parasitol, Kunming, Yunnan, Peoples R China; [Wu, Lanou] Kunming Med Univ, Dept Pharmacol, Kunming, Yunnan, Peoples R China; [Zhang, Rongping] Kunming Med Univ, Dept Pharmaceut Chem, Kunming, Yunnan, Peoples R China; [Fan, Qi] Dalian Inst Biotechnol, Dalian, Liaoning, Peoples R China; [Wang, Haiyan] Kansas State Univ, Dept Stat, Manhattan, KS 66506 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Kunming Medical University; Kunming Medical University; Kunming Medical University; Kansas State University	Wang, ZL (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	luc2@psu.edu; zhaoqingy92@hotmail.com	Parker, Daniel M./B-5471-2013	Parker, Daniel M./0000-0002-5352-7338	National Institutes of Health (NIH) [1R01AI075429]; National Natural Science Foundation of China [30960050]; National Institute of Allergy and Infectious Diseases, NIH [U19AI089672]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089672, R01AI075429] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health (NIH) international grant (1R01AI075429) to Z. Yang, National Natural Science Foundation of China (no. 30960050), and U19AI089672 from National Institute of Allergy and Infectious Diseases, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alker AP, 2007, AM J TROP MED HYG, V76, P641, DOI 10.4269/ajtmh.2007.76.641; Arnou B, 2011, BIOCHEM SOC T, V39, P823, DOI 10.1042/BST0390823; Bacon DJ, 2009, ANTIMICROB AGENTS CH, V53, P2042, DOI 10.1128/AAC.01677-08; Beez D, 2011, ANTIMICROB AGENTS CH, V55, P50, DOI 10.1128/AAC.00916-10; Bosman A, 2007, AM J TROP MED HYG, V77, P193, DOI 10.4269/ajtmh.2007.77.193; Cardi D, 2010, J BIOL CHEM, V285, P26406, DOI 10.1074/jbc.M109.090340; Carrara VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004551; Chaijaroenkul W, 2010, ACTA TROP, V113, P190, DOI 10.1016/j.actatropica.2009.10.016; Chavchich M, 2010, ANTIMICROB AGENTS CH, V54, P2455, DOI 10.1128/AAC.00947-09; Chen NH, 2010, ANTIMICROB AGENTS CH, V54, P3395, DOI 10.1128/AAC.01421-09; Cojean S, 2006, EMERG INFECT DIS, V12, P1798, DOI 10.3201/eid1211.060903; COWMAN AF, 1994, P NATL ACAD SCI USA, V91, P1143, DOI 10.1073/pnas.91.3.1143; Crespo MD, 2008, ANTIMICROB AGENTS CH, V52, P98, DOI 10.1128/AAC.00609-07; Cui L, 2012, ANTIMICROB IN PRESS; Cui LW, 2012, ACTA TROP, V121, P227, DOI 10.1016/j.actatropica.2011.02.016; Cui LW, 2009, EXPERT REV ANTI-INFE, V7, P999, DOI [10.1586/eri.09.68, 10.1586/ERI.09.68]; Cui LW, 2002, NUCLEIC ACIDS RES, V30, P4607, DOI 10.1093/nar/gkf600; Dahlstrom S, 2008, INFECT GENET EVOL, V8, P340, DOI 10.1016/j.meegid.2008.02.002; Delacollette C, 2009, SE ASIAN J TROP MED, V40, P674; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Duraisingh MT, 2000, MOL BIOCHEM PARASIT, V108, P13, DOI 10.1016/S0166-6851(00)00201-2; Duraisingh MT, 2005, ACTA TROP, V94, P181, DOI 10.1016/j.actatropica.2005.04.008; Duraisingh MT, 1997, PARASITOLOGY, V114, P205, DOI 10.1017/S0031182096008487; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Ferdig MT, 2004, MOL MICROBIOL, V52, P985, DOI 10.1111/j.1365-2958.2004.04035.x; Ferreira ID, 2007, TROP MED INT HEALTH, V12, P353, DOI 10.1111/j.1365-3156.2006.01789.x; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; Happi CT, 2009, ANTIMICROB AGENTS CH, V53, P888, DOI 10.1128/AAC.00968-08; Huttinger F, 2010, WIEN KLIN WOCHENSCHR, V122, P52, DOI 10.1007/s00508-010-1438-6; Hunt P, 2007, MOL MICROBIOL, V65, P27, DOI 10.1111/j.1365-2958.2007.05753.x; Ibrahim ML, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-28; Imwong M, 2010, ANTIMICROB AGENTS CH, V54, P2886, DOI 10.1128/AAC.00032-10; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Jambou R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009424; Kaneko O, 1997, EXP PARASITOL, V86, P45, DOI 10.1006/expr.1997.4147; Kavishe RA, 2006, AM J TROP MED HYG, V75, P827, DOI 10.4269/ajtmh.2006.75.827; Krishna S, 2006, TRENDS MOL MED, V12, P200, DOI 10.1016/j.molmed.2006.03.005; Lim P, 2010, ANTIMICROB AGENTS CH, V54, P2135, DOI 10.1128/AAC.01304-09; Lim P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-11; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; Meng H, 2010, ANTIMICROB AGENTS CH, V54, P4306, DOI 10.1128/AAC.00321-10; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Mu JB, 2003, MOL MICROBIOL, V49, P977, DOI 10.1046/j.1365-2958.2003.03627.x; Mu JB, 2010, NAT GENET, V42, P268, DOI 10.1038/ng.528; Mugittu K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-126; Mungthin M, 2010, AM J TROP MED HYG, V83, P1005, DOI 10.4269/ajtmh.2010.10-0339; Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Noedl H, 2009, NEW ENGL J MED, V361, P540, DOI 10.1056/NEJMc0900231; Phompradit P, 2011, ACTA TROP, V120, P130, DOI 10.1016/j.actatropica.2011.07.003; Pickard AL, 2003, ANTIMICROB AGENTS CH, V47, P2418, DOI 10.1128/AAC.47.8.2418-2423.2003; Preechapornkul P, 2009, ANTIMICROB AGENTS CH, V53, P1509, DOI 10.1128/AAC.00241-08; Price RN, 1999, ANTIMICROB AGENTS CH, V43, P2943, DOI 10.1128/AAC.43.12.2943; Price RN, 2006, CLIN INFECT DIS, V42, P1570, DOI 10.1086/503423; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Roper C, 1998, PARASITOLOGY, V116, P501, DOI 10.1017/S0031182098002650; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Sanchez CP, 2010, INT J PARASITOL, V40, P1109, DOI 10.1016/j.ijpara.2010.04.001; Shah NK, 2008, EMERG INFECT DIS, V14, P1637, DOI 10.3201/eid1410.080080; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Sidhu ABS, 2006, J INFECT DIS, V194, P528, DOI 10.1086/507115; Sisowath C, 2005, J INFECT DIS, V191, P1014, DOI 10.1086/427997; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Tanabe K, 2011, ANTIMICROB AGENTS CH, V55, P94, DOI 10.1128/AAC.01156-10; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Uhlemann AC, 2005, NAT STRUCT MOL BIOL, V12, P628, DOI 10.1038/nsmb947; Valderramos SG, 2010, ANTIMICROB AGENTS CH, V54, P3842, DOI 10.1128/AAC.00121-10; Veiga MI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020212; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; WHO, 2009, WHO TECH REP SER, V958, P1; WILSON CM, 1993, MOL BIOCHEM PARASIT, V57, P151, DOI 10.1016/0166-6851(93)90252-S; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601; Yang HL, 2003, T ROY SOC TROP MED H, V97, P226, DOI 10.1016/S0035-9203(03)90127-1; Yang ZQ, 2007, TROP MED INT HEALTH, V12, P1051, DOI 10.1111/j.1365-3156.2007.01882.x; Yang ZQ, 2011, EMERG INFECT DIS, V17, P498, DOI 10.3201/eid1703.100870; Zarocostas J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6558; Zhang GQ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-122	81	32	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e30927	10.1371/journal.pone.0030927	http://dx.doi.org/10.1371/journal.pone.0030927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701513	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338500001
J	Park, MH; Lee, HS; Lee, CS; You, ST; Kim, DJ; Park, BH; Kang, MJ; Heo, WD; Shin, EY; Schwartz, MA; Kim, EG				Park, M-H; Lee, H-S; Lee, C-S; You, S. T.; Kim, D-J; Park, B-H; Kang, M. J.; Heo, W. D.; Shin, E-Y; Schwartz, M. A.; Kim, E-G			p21-Activated kinase 4 promotes prostate cancer progression through CREB	ONCOGENE			English	Article						prostate cancer; p21-activated kinase 4; protein kinase A; CREB; neuroendocrine differentiation; chemoresistance	PROTEIN-KINASE; CELL-MIGRATION; IN-VITRO; PAK4; ACTIVATION; DOMAIN; BCL-2; TRANSDIFFERENTIATION; DIFFERENTIATION; EXPRESSION	Prostate cancer is initially androgen-dependent but, over time, usually develops hormone-and chemo-resistance. The present study investigated a role for p21-activated kinase 4 (PAK4) in prostate cancer progression. PAK4 activation was markedly inhibited by H89, a specific protein kinase A (PKA) inhibitor, and PAK4 was activated by the elevation of cAMP. The catalytic subunit of PKA interacted with the regulatory domain of PAK4, and directly phosphorylated PAK4 at serine 474 (S474). Catalytically active PAK4 enhanced the transcriptional activity of CREB independent of S133 phosphorylation. Stable knockdown of PAK4 in PC-3 and DU145 prostate cancer cells inhibited tumor formation in nude mice. Decreased tumorigenicity correlated with decreased expression of CREB and its targets, including Bcl-2 and cyclin A1. Additionally, in androgen-dependent LNCap-FGC cells, PAK4 regulated cAMP-induced neuroendocrine differentiation, which is known to promote tumor progression. Finally, PAK4 enhanced survival and decreased apoptosis following chemotherapy. These results suggested that PAK4 regulates progression toward hormone-and chemo-resistance in prostate cancer, and this study identified both a novel activation mechanism and potential downstream effector pathways. Therefore, PAK4 may be a promising therapeutic target in prostate cancer.	[Park, M-H; Lee, C-S; You, S. T.; Kim, D-J; Shin, E-Y; Kim, E-G] Chungbuk Natl Univ, Coll Med, Dept Biochem, Chonju 361763, Chungbuk, South Korea; [Park, M-H; Lee, C-S; You, S. T.; Kim, D-J; Shin, E-Y; Kim, E-G] Chungbuk Natl Univ, Coll Med, Med Res Ctr, Chonju 361763, Chungbuk, South Korea; [Lee, H-S; Park, B-H] Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju, Jeonbuk, South Korea; [Kang, M. J.] Chonbuk Natl Univ, Sch Med, Dept Pathol, Jeonju, Jeonbuk, South Korea; [Heo, W. D.] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Schwartz, M. A.] Yale Univ, Sch Med, Yale Cardiovasc Res Ctr, Dept Med, New Haven, CT USA; [Schwartz, M. A.] Yale Univ, Sch Med, Yale Cardiovasc Res Ctr, Dept Cell Biol, New Haven, CT USA	Chungbuk National University; Chungbuk National University; Jeonbuk National University; Jeonbuk National University; Korea Advanced Institute of Science & Technology (KAIST); Yale University; Yale University	Kim, EG (corresponding author), Chungbuk Natl Univ, Coll Med, Med Res Ctr, Chonju 361763, Chungbuk, South Korea.	eyshin@chungbuk.ac.kr; egkim@chungbuk.ac.kr	Heo, Won-Do/C-1696-2011	schwartz, martin/0000-0002-2071-1243	National Research Foundation of Korea [2012-0005747]; USPHS [RO1 CA14397]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075092] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	CRE-luciferase reporter gene containing 6x CRE binding sites was gift from Dr Jung EB at Chungbuk National University (Cheongju, Korea). This work was supported by a grant of the National Research Foundation of Korea (2012-0005747). MAS was supported by USPHS grant RO1 CA14397.	Ahmed T, 2008, CELL SIGNAL, V20, P1320, DOI 10.1016/j.cellsig.2008.02.021; Bagchi G, 2008, CANCER RES, V68, P3225, DOI 10.1158/0008-5472.CAN-07-5026; Baldassa S, 2010, J CELL PHYSIOL, V224, P722, DOI 10.1002/jcp.22172; BANG YJ, 1994, P NATL ACAD SCI USA, V91, P5330, DOI 10.1073/pnas.91.12.5330; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Burchardt T, 1999, J UROLOGY, V162, P1800, DOI 10.1016/S0022-5347(05)68241-9; Callow MG, 2002, J BIOL CHEM, V277, P550, DOI 10.1074/jbc.M105732200; Cox ME, 2000, J BIOL CHEM, V275, P13812, DOI 10.1074/jbc.275.18.13812; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Donkena KV, 2010, CURR CANCER DRUG TAR, V10, P402, DOI 10.2174/156800910791208544; Eswaran J, 2007, STRUCTURE, V15, P201, DOI 10.1016/j.str.2007.01.001; Eswaran J, 2009, CANCER METAST REV, V28, P209, DOI 10.1007/s10555-008-9181-4; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Lee KH, 2010, P NATL ACAD SCI USA, V107, P3412, DOI 10.1073/pnas.0911262107; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Liu YY, 2008, MOL CANCER RES, V6, P1215, DOI 10.1158/1541-7786.MCR-08-0087; MCDONNELL TJ, 1992, CANCER RES, V52, P6940; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Murray BW, 2010, P NATL ACAD SCI USA, V107, P9446, DOI 10.1073/pnas.0911863107; Paliouras GN, 2009, MOL CELL BIOL, V29, P3018, DOI 10.1128/MCB.01286-08; Qu J, 2001, MOL CELL BIOL, V21, P3523, DOI 10.1128/MCB.21.10.3523-3533.2001; RAFFO AJ, 1995, CANCER RES, V55, P4438; Shaywitz AJ, 1995, ANNU REV BIOCHEM, V68, P821; Siu MKY, 2010, P NATL ACAD SCI USA, V107, P18622, DOI 10.1073/pnas.0907481107; Wells CM, 2010, J CELL SCI, V123, P1663, DOI 10.1242/jcs.055707; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Wells CM, 2002, J CELL SCI, V115, P3947, DOI 10.1242/jcs.00080; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Xiao X, 2010, CURR CANCER DRUG TAR, V10, P384, DOI 10.2174/156800910791208535; Yuan TC, 2007, ENDOCR-RELAT CANCER, V14, P531, DOI 10.1677/ERC-07-0061	33	76	79	0	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 9	2013	32	19					2475	2482		10.1038/onc.2012.255	http://dx.doi.org/10.1038/onc.2012.255			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	140ZL	22710715				2022-12-25	WOS:000318694900011
J	Ling, A; Soares, F; Croitoru, DO; Tattoli, I; Carneiro, LAM; Boniotto, M; Benko, S; Philpott, DJ; Girardin, SE				Ling, Arthur; Soares, Fraser; Croitoru, David O.; Tattoli, Ivan; Carneiro, Leticia A. M.; Boniotto, Michele; Benko, Szilvia; Philpott, Dana J.; Girardin, Stephen E.			Post-transcriptional Inhibition of Luciferase Reporter Assays by the Nod-like Receptor Proteins NLRX1 and NLRC3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INDUCIBLE INFLAMMATORY MEDIATOR; I GENE-EXPRESSION; SIGNALING PATHWAYS; FAMILY-MEMBER; BACTERIAL PEPTIDOGLYCAN; HOST RECOGNITION; RIG-I; ACTIVATION; IDENTIFICATION	Luciferase reporter assays (LRAs) are widely used to assess the activity of specific signal transduction pathways. Although powerful, rapid and convenient, this technique can also generate artifactual results, as revealed for instance in the case of high throughput screens of inhibitory molecules. Here we demonstrate that the previously reported inhibitory effect of the Nod-like receptor (NLR) protein NLRX1 on NF-kappa B- and type I interferon-dependent pathways in LRAs was a nonspecific consequence of the overexpression of the NLRX1 leucine-rich repeat (LRR) domain. By comparing luciferase activity and luciferase gene expression using quantitative PCR from the same samples, we showed that NLRX1 inhibited LRAs in a post-transcriptional manner. In agreement, NLRX1 also repressed LRAs if luciferase was expressed under the control of a constitutive promoter, although the degree of inhibition by NLRX1 seemed to correlate with the dynamic inducibility of luciferase reporter constructs. Similarly, we observed that overexpression of another NLR protein, NLRC3, also resulted in artifactual inhibition of LRAs; thus suggesting that the capacity to inhibit LRAs at a post-transcriptional level is not unique to NLRX1. Finally, we demonstrate that host type I interferon response to Sendai virus infection was normal in NLRX1-silenced human HEK293T cells. Our results thus highlight the fact that LRAs are not a reliable technique to assess the inhibitory function of NLRs, and possibly other overexpressed proteins, on signal transduction pathways.	[Ling, Arthur; Soares, Fraser; Croitoru, David O.; Tattoli, Ivan; Carneiro, Leticia A. M.; Benko, Szilvia; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M6G 2T6, Canada; [Tattoli, Ivan; Philpott, Dana J.] Univ Toronto, Dept Immunol, Toronto, ON M6G 2T6, Canada; [Boniotto, Michele] Paris S Univ, Sch Med, INSERM, U1012, F-94276 Le Kremlin Bicetre, France	University of Toronto; University of Toronto; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte	Girardin, SE (corresponding author), Univ Toronto, Med Sci Bldg,Room 6336, Toronto, ON M5S 1A8, Canada.	stephen.girardin@utoronto.ca	Boniotto, Michele/AAB-4302-2020; Tattoli, Ivan/H-2600-2017; Boniotto, Michele/F-1857-2010; Carneiro, Leticia/T-8978-2019	Boniotto, Michele/0000-0002-9548-2254; Tattoli, Ivan/0000-0001-7925-4609; Boniotto, Michele/0000-0002-9548-2254; Carneiro, Leticia/0000-0001-5870-8288; Soares, Fraser/0000-0002-3977-7939	Canadian Institutes of Health Research (CIHR); Burroughs Wellcome Fund; Canadian Association for Gastroenterology (CAG)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Canadian Association for Gastroenterology (CAG)	This work was supported in part by grants from the Canadian Institutes of Health Research (CIHR) (to D. J. P.) and Burroughs Wellcome Fund (to S. E. G.).; Supported by fellowships from CIHR.; Received a Summer Studentship from the Canadian Association for Gastroenterology (CAG).	Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Arnoult D, 2009, J CELL SCI, V122, P3161, DOI 10.1242/jcs.051193; Auld DS, 2008, J MED CHEM, V51, P2372, DOI 10.1021/jm701302v; Benko S, 2010, J IMMUNOL, V185, P1681, DOI 10.4049/jimmunol.0903900; Bruey JM, 2004, J BIOL CHEM, V279, P51897, DOI 10.1074/jbc.M406741200; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Conti BJ, 2005, J BIOL CHEM, V280, P18375, DOI 10.1074/jbc.M413169200; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2005, J BIOL CHEM, V280, P38648, DOI 10.1074/jbc.M509537200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Meissner TB, 2012, MICROBES INFECT, V14, P477, DOI 10.1016/j.micinf.2011.12.007; Meissner TB, 2012, J IMMUNOL, V188, P4951, DOI 10.4049/jimmunol.1103160; Meissner TB, 2010, P NATL ACAD SCI USA, V107, P13794, DOI 10.1073/pnas.1008684107; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Neerincx A, 2012, J IMMUNOL, V188, P4940, DOI 10.4049/jimmunol.1103136; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Rebsamen M, 2011, CELL DEATH DIFFER, V18, P1387, DOI 10.1038/cdd.2011.64; Staehli F, 2012, J IMMUNOL, V188, P3820, DOI 10.4049/jimmunol.1102671; Straehle L, 2007, J VIROL, V81, P12227, DOI 10.1128/JVI.01300-07; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Thorne N, 2010, CURR OPIN CHEM BIOL, V14, P315, DOI 10.1016/j.cbpa.2010.03.020; Williams KL, 2005, J BIOL CHEM, V280, P39914, DOI 10.1074/jbc.M502820200; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Yao Y, 2012, CELL RES, V22, P836, DOI 10.1038/cr.2012.56	36	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28705	28716		10.1074/jbc.M111.333146	http://dx.doi.org/10.1074/jbc.M111.333146			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22718770	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000308074600044
J	Stauch, K; Kieken, F; Sorgen, P				Stauch, Kelly; Kieken, Fabien; Sorgen, Paul			Characterization of the Structure and Intermolecular Interactions between the Connexin 32 Carboxyl-terminal Domain and the Protein Partners Synapse-associated Protein 97 and Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARIE-TOOTH-DISEASE; GUANYLATE KINASE DOMAINS; GAP-JUNCTION CHANNELS; DICHROISM SPECTROSCOPIC DATA; SCHWANN-CELL PROLIFERATION; UNSTRUCTURED PROTEINS; RESONANCE ASSIGNMENTS; MULTIDIMENSIONAL NMR; SECONDARY STRUCTURE; MAGUK FAMILY	In Schwann cells, connexin 32 (Cx32) can oligomerize to form intracellular gap junction channels facilitating a shorter pathway for metabolite diffusion across the layers of the myelin sheath. The mechanisms of Cx32 intracellular channel regulation have not been clearly defined. However, Ca2+, pH, and the phosphorylation state can regulate Cx32 gap junction channels, in addition to the direct interaction of protein partners with the carboxyl-terminal (CT) domain. In this study, we used different biophysical methods to determine the structure and characterize the interaction of the Cx32CT domain with the protein partners synapse-associated protein 97 (SAP97) and calmodulin (CaM). Our results revealed that the Cx32CT is an intrinsically disordered protein that becomes alpha-helical upon binding CaM. We identified the GUK domain as the minimal SAP97 region necessary for the Cx32CT interaction. The Cx32CT residues affected by the binding of CaM and the SAP97 GUK domain were determined as well as the dissociation constants for these interactions. We characterized three Cx32CT Charcot-Marie-Tooth disease mutants (R219H, R230C, and F235C) and identified that whereas they all formed functional channels, they all showed reduced binding affinity for SAP97 and CaM. Additionally, we report that in RT4-D6P2T rat schwannoma cells, Cx32 is differentially phosphorylated and exists in a complex with SAP97 and CaM. Our studies support the importance of protein-protein interactions in the regulation of Cx32 gap junction channels and myelin homeostasis.	[Stauch, Kelly; Kieken, Fabien; Sorgen, Paul] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Sorgen, P (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	psorgen@unmc.edu			National Institutes of Health [2R01GM072631]; American Heart Association [11GRNT7820017]; Eppley Cancer Center [2P30CA036727]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Eppley Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01GM072631, American Heart Association Grant 11GRNT7820017, and Eppley Cancer Center Support Grant 2P30CA036727.	BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Bolis A, 2009, J NEUROSCI, V29, P8858, DOI 10.1523/JNEUROSCI.1423-09.2009; Bouvier D, 2007, BIOMOL NMR ASSIGM, V1, P155, DOI 10.1007/s12104-007-9044-x; Bouvier D, 2009, J BIOL CHEM, V284, P34257, DOI 10.1074/jbc.M109.039594; Brokx RD, 2004, J STRUCT BIOL, V146, P272, DOI 10.1016/j.jsb.2003.12.007; Castro C, 1999, J NEUROSCI, V19, P3752; Chakraborty S, 2010, J BIOL CHEM, V285, P10761, DOI 10.1074/jbc.M109.053348; Chen YY, 2011, BIOCHEM J, V435, P711, DOI 10.1042/BJ20101726; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deschenes SM, 1997, J NEUROSCI, V17, P9077; DEWAEGH S, 1990, J NEUROSCI, V10, P1855; Diez JA, 1995, ANN NY ACAD SCI, V766, P477, DOI 10.1111/j.1749-6632.1995.tb26699.x; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Dodd R, 2008, J BIOL CHEM, V283, P26911, DOI 10.1074/jbc.M801434200; Duffy HS, 2007, J BIOL CHEM, V282, P9789, DOI 10.1074/jbc.M605261200; Duffy HS, 2002, J BIOL CHEM, V277, P36706, DOI 10.1074/jbc.M207016200; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; ELVIRA M, 1993, J BIOL CHEM, V268, P14294; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Fansa H, 2000, RESTOR NEUROL NEUROS, V16, P77; Gifford JL, 2011, J BIOMOL NMR, V50, P71, DOI 10.1007/s10858-011-9495-3; Govindarajan R, 2002, J BIOL CHEM, V277, P50087, DOI 10.1074/jbc.M202652200; Hahn AF, 1999, ANN NY ACAD SCI, V883, P366, DOI 10.1111/j.1749-6632.1999.tb08598.x; Hibino H, 2000, EMBO J, V19, P78, DOI 10.1093/emboj/19.1.78; Huang Y, 2005, J NEUROSCI, V25, P7111, DOI 10.1523/JNEUROSCI.1319-05.2005; IKURA M, 1991, BIOCHEMISTRY-US, V30, P9216, DOI 10.1021/bi00102a013; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Jessen Kristjan R, 2010, F1000 Biol Rep, V2, DOI 10.3410/B2-19; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Lewis Kay E., 1992, J AM CHEM SOC, V114, P10663; Liang GSL, 2005, ANN NEUROL, V57, P749, DOI 10.1002/ana.20459; Lurtz MM, 2003, AM J PHYSIOL-CELL PH, V285, pC1475, DOI 10.1152/ajpcell.00361.2002; Mal TK, 2002, BIOCHEMISTRY-US, V41, P12899, DOI 10.1021/bi0264162; Massa R, 2006, MUSCLE NERVE, V33, P342, DOI 10.1002/mus.20460; MATA M, 1988, BRAIN RES, V475, P297, DOI 10.1016/0006-8993(88)90618-X; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; MCILROY BK, 1991, J BIOL CHEM, V266, P4959; Meier C, 2004, J NEUROSCI, V24, P3186, DOI 10.1523/JNEUROSCI.5146-03.2004; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; Nagy JI, 2004, BRAIN RES REV, V47, P191, DOI 10.1016/j.brainresrev.2004.05.005; Niemann A, 2006, NEUROMOL MED, V8, P217, DOI 10.1385/NMM:8:1:217; Nix SL, 2000, J BIOL CHEM, V275, P41192, DOI 10.1074/jbc.M002078200; Nobbio L, 2009, J BIOL CHEM, V284, P23146, DOI 10.1074/jbc.M109.027128; Ogura K, 2012, GENES CELLS, V17, P159, DOI 10.1111/j.1365-2443.2012.01580.x; Peracchia C, 2004, BBA-BIOMEMBRANES, V1662, P61, DOI 10.1016/j.bbamem.2003.10.020; Ponsaerts R, 2010, FASEB J, V24, P4378, DOI 10.1096/fj.09-153007; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Ressot C, 2000, BRAIN RES REV, V32, P192, DOI 10.1016/S0165-0173(99)00081-8; SAEZ JC, 1990, EUR J BIOCHEM, V192, P263, DOI 10.1111/j.1432-1033.1990.tb19223.x; Scherer SS, 2005, J NEUROSCI, V25, P1550, DOI 10.1523/JNEUROSCI.3082-04.2005; Scherer SS, 1998, GLIA, V24, P8, DOI 10.1002/(SICI)1098-1136(199809)24:1<8::AID-GLIA2>3.0.CO;2-3; SMITH KJ, 1988, J NEUROL SCI, V83, P37, DOI 10.1016/0022-510X(88)90018-4; Sotkis A, 2001, CELL COMMUN ADHES, V8, P277, DOI 10.3109/15419060109080737; Stevens B, 2000, SCIENCE, V287, P2267, DOI 10.1126/science.287.5461.2267; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Torok K, 1997, BIOCHEM J, V326, P479; Torok K, 2001, BIOCHEMISTRY-US, V40, P14878, DOI 10.1021/bi010920+; Verkhivker GM, 2003, P NATL ACAD SCI USA, V100, P5148, DOI 10.1073/pnas.0531373100; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740; Yamada KH, 2007, BIOCHEMISTRY-US, V46, P10039, DOI 10.1021/bi701169w; YANG JJ, 1995, J MOL BIOL, V252, P483, DOI 10.1006/jmbi.1995.0513; Yum SW, 2002, NEUROBIOL DIS, V11, P43, DOI 10.1006/nbdi.2002.0545; Zhou YB, 2007, J BIOL CHEM, V282, P35005, DOI 10.1074/jbc.M707728200; Zhou YB, 2009, BIOPHYS J, V96, P2832, DOI 10.1016/j.bpj.2008.12.3941; Zhu JW, 2011, EMBO J, V30, P4986, DOI 10.1038/emboj.2011.428	70	30	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27771	27788		10.1074/jbc.M112.382572	http://dx.doi.org/10.1074/jbc.M112.382572			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718765	Green Published, hybrid			2022-12-25	WOS:000307840700051
J	Wu, X; Wu, Z; Ning, G; Guo, Y; Ali, R; Macdonald, RL; De Blas, AL; Luscher, B; Chen, G				Wu, Xia; Wu, Zheng; Ning, Gang; Guo, Yao; Ali, Rashid; Macdonald, Robert L.; De Blas, Angel L.; Luscher, Bernhard; Chen, Gong			gamma-Aminobutyric Acid Type A (GABA(A)) Receptor alpha Subunits Play a Direct Role in Synaptic Versus Extrasynaptic Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL GABAERGIC SYNAPSES; CULTURED HIPPOCAMPAL-NEURONS; COLLYBISTIN-DEFICIENT MICE; GEPHYRIN-BINDING MOTIF; LONG-TERM POTENTIATION; INHIBITORY SYNAPSES; DELTA-SUBUNIT; DENTATE GYRUS; PYRAMIDAL NEURONS; TONIC INHIBITION	GABA(A) receptors (GABA(A)-Rs) are localized at both synaptic and extrasynaptic sites, mediating phasic and tonic inhibition, respectively. Previous studies suggest an important role of gamma 2 and delta subunits in synaptic versus extrasynaptic targeting of GABA(A)-Rs. Here, we demonstrate differential function of gamma 2 and alpha 6 subunits in guiding the localization of GABA(A)-Rs. To study the targeting of specific subtypes of GABA(A)-Rs, we used a molecularly engineered GABAergic synapse model to precisely control the GABA(A)-R subunit composition. We found that in neuron-HEK cell heterosynapses, GABAergic events mediated by alpha 2 beta 3 gamma 2 receptors were very fast (rise time similar to 2 ms), whereas events mediated by alpha 6 beta 3 delta receptors were very slow (rise time similar to 20 ms). Such an order of magnitude difference in rise time could not be attributed to the minute differences in receptor kinetics. Interestingly, synaptic events mediated by alpha 6 beta 3 or alpha 6 beta 3 gamma 2 receptors were significantly slower than those mediated by alpha 2 beta 3 or alpha 2 beta 3 gamma 2 receptors, suggesting a differential role of delta subunit in receptor targeting. This was confirmed by differential targeting of the same delta-gamma 2 chimeric subunits to synaptic or extrasynaptic sites, depending on whether it was co-assembled with the alpha 2 or alpha 6 subunit. In addition, insertion of a gephyrin-binding site into the intracellular domain of alpha 6 and delta subunits brought alpha 6 beta 3 delta receptors closer to synaptic sites. Therefore, the alpha subunits, together with the gamma 2 and delta subunits, play a critical role in governing synaptic versus extrasynaptic targeting of GABA(A)-Rs, possibly through differential interactions with gephyrin.	[Wu, Xia; Wu, Zheng; Ning, Gang; Guo, Yao; Luscher, Bernhard; Chen, Gong] Penn State Univ, Dept Biol, Huck Inst Life Sci, University Pk, PA 16802 USA; [Luscher, Bernhard] Penn State Univ, Dept Biochem & Mol Biol, Huck Inst Life Sci, University Pk, PA 16802 USA; [Ali, Rashid; De Blas, Angel L.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; [Macdonald, Robert L.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37212 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Connecticut; Vanderbilt University	Chen, G (corresponding author), Penn State Univ, Dept Biol, Huck Inst Life Sci, University Pk, PA 16802 USA.	gongchen@psu.edu	Wu, Zheng/H-3234-2019; Luscher, Bernhard/C-3528-2009	Luscher, Bernhard/0000-0003-1375-1906	National Institutes of Health from NINDS [NS054858]; NIMH [MH083911, MH062391]; NINDS [NS38752, NS33300]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062391, RC1MH089111, R01MH083911, R56MH062391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038752, R01NS033300, R21NS054858, R01NS051590] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS054858 from NINDS, MH083911 from NIMH (to G. C.), NS38752 (to A. L. D.) and NS33300 from NINDS (to R. L. M.), and MH062391 from NIMH (to B. L.).	Alldred MJ, 2005, J NEUROSCI, V25, P594, DOI 10.1523/JNEUROSCI.4011-04.2005; Andersen N, 2011, J NEUROSCI, V31, P3662, DOI 10.1523/JNEUROSCI.5940-10.2011; Bianchi MT, 2002, NEUROPHARMACOLOGY, V43, P492, DOI 10.1016/S0028-3908(02)00163-6; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Chandra D, 2006, P NATL ACAD SCI USA, V103, P15230, DOI 10.1073/pnas.0604304103; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chiou TT, 2011, J BIOL CHEM, V286, P22456, DOI 10.1074/jbc.M111.236190; Christie SB, 2006, MOL CELL NEUROSCI, V31, P1, DOI 10.1016/j.mcn.2005.08.014; Craig AM, 1996, J NEUROSCI, V16, P3166; Damgaard T, 2011, PSYCHOPHARMACOLOGY, V214, P403, DOI 10.1007/s00213-010-2039-9; Deng L, 2007, J NEUROSCI, V27, P10860, DOI 10.1523/JNEUROSCI.2744-07.2007; Dong N, 2007, MOL CELL NEUROSCI, V35, P14, DOI 10.1016/j.mcn.2007.01.013; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Feng HJ, 2006, J NEUROSCI, V26, P1499, DOI 10.1523/JNEUROSCI.2913-05.2006; Fu ZY, 2009, MOL CELL NEUROSCI, V42, P45, DOI 10.1016/j.mcn.2009.05.004; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; Glykys J, 2007, NAT NEUROSCI, V10, P40, DOI 10.1038/nn1813; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Holm MM, 2011, HIPPOCAMPUS, V21, P422, DOI 10.1002/hipo.20758; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jedlicka P, 2009, MOL CELL NEUROSCI, V41, P94, DOI 10.1016/j.mcn.2009.02.005; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Jiang M, 2009, J NEUROSCI, V29, P8063, DOI 10.1523/JNEUROSCI.6139-08.2009; Kalscheuer VM, 2009, HUM MUTAT, V30, P61, DOI 10.1002/humu.20814; Kim S, 2006, NAT NEUROSCI, V9, P1294, DOI 10.1038/nn1763; Kins S, 1999, EUR J NEUROSCI, V11, P740, DOI 10.1046/j.1460-9568.1999.00527.x; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kneussel M, 2001, MOL CELL NEUROSCI, V17, P973, DOI 10.1006/mcne.2001.0983; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; Krogsgaard-Larsen P, 2004, BIOCHEM PHARMACOL, V68, P1573, DOI 10.1016/j.bcp.2004.06.040; Levi S, 2004, J NEUROSCI, V24, P207, DOI 10.1523/JNEUROSCI.1661-03.2004; Li RW, 2005, J NEUROCHEM, V95, P756, DOI 10.1111/j.1471-4159.2005.03426.x; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; LIU Y, 1991, BIOPHYS J, V60, P424, DOI 10.1016/S0006-3495(91)82068-9; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Maguire J, 2008, NEURON, V59, P207, DOI 10.1016/j.neuron.2008.06.019; Maric HM, 2011, J BIOL CHEM, V286, P42105, DOI 10.1074/jbc.M111.303412; Martin LJ, 2010, J NEUROSCI, V30, P5269, DOI 10.1523/JNEUROSCI.4209-09.2010; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Mody I, 2005, J PHYSIOL-LONDON, V562, P37, DOI 10.1113/jphysiol.2004.077362; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Mukherjee J, 2011, J NEUROSCI, V31, P14677, DOI 10.1523/JNEUROSCI.2001-11.2011; Nagaya N, 2001, J PHYSIOL-LONDON, V532, P17, DOI 10.1111/j.1469-7793.2001.0017g.x; Nusser Z, 1998, J NEUROSCI, V18, P1693; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; Papadopoulos T, 2007, EMBO J, V26, P3888, DOI 10.1038/sj.emboj.7601819; Patrizi A, 2008, P NATL ACAD SCI USA, V105, P13151, DOI 10.1073/pnas.0802390105; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Saiepour L, 2010, J BIOL CHEM, V285, P29623, DOI 10.1074/jbc.M110.121368; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Sassoe-Pognetto M, 2000, EUR J NEUROSCI, V12, P2205, DOI 10.1046/j.1460-9568.2000.00106.x; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; Serwanski DR, 2006, J COMP NEUROL, V499, P458, DOI 10.1002/cne.21115; Sigel E, 2006, BIOCHEM SOC T, V34, P868, DOI 10.1042/BST0340868; Smith SS, 2007, PHARMACOL THERAPEUT, V116, P58, DOI 10.1016/j.pharmthera.2007.03.008; Studer R, 2006, EUR J NEUROSCI, V24, P1307, DOI 10.1111/j.1460-9568.2006.05006.x; Sun CC, 2011, HUM MOL GENET, V20, P3042, DOI 10.1093/hmg/ddr208; Swanwick CC, 2006, J COMP NEUROL, V495, P497, DOI 10.1002/cne.20897; Thomas P, 2005, NAT NEUROSCI, V8, P889, DOI 10.1038/nn1483; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Tretter V, 2011, J BIOL CHEM, V286, P37702, DOI 10.1074/jbc.M111.291336; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Wei WZ, 2003, J NEUROSCI, V23, P10650; Winsky-Sommerer R, 2009, EUR J NEUROSCI, V29, P1779, DOI 10.1111/j.1460-9568.2009.06716.x; Wohlfarth KM, 2002, J NEUROSCI, V22, P1541, DOI 10.1523/JNEUROSCI.22-05-01541.2002; Yu W, 2007, MOL CELL NEUROSCI, V36, P484, DOI 10.1016/j.mcn.2007.08.008	79	44	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27417	27430		10.1074/jbc.M112.360461	http://dx.doi.org/10.1074/jbc.M112.360461			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22711532	Green Published, hybrid			2022-12-25	WOS:000307840700015
J	Arora, G; Sajid, A; Arulanandh, MD; Singhal, A; Mattoo, AR; Pomerantsev, AP; Leppla, SH; Maiti, S; Singh, Y				Arora, Gunjan; Sajid, Andaleeb; Arulanandh, Mary Diana; Singhal, Anshika; Mattoo, Abid R.; Pomerantsev, Andrei P.; Leppla, Stephen H.; Maiti, Souvik; Singh, Yogendra			Unveiling the Novel Dual Specificity Protein Kinases in Bacillus anthracis IDENTIFICATION OF THE FIRST PROKARYOTIC DUAL SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE (DYRK)-LIKE KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; BACILLUS-SUBTILIS; MYCOBACTERIUM-TUBERCULOSIS; SIGNAL-TRANSDUCTION; SERINE/THREONINE KINASES; PHYSIOLOGICAL ROLES; ESCHERICHIA-COLI; PYRUVATE KINASES; DYRK FAMILY; PHOSPHORYLATION	Dual specificity protein kinases (DSPKs) are unique enzymes that can execute multiple functions in the cell, which are otherwise performed exclusively by serine/threonine and tyrosine protein kinases. In this study, we have characterized the protein kinases Bas2152 (PrkD) and Bas2037 (PrkG) from Bacillus anthracis. Transcriptional analyses of these kinases showed that they are expressed in all phases of growth. In a serendipitous discovery, both kinases were found to be DSPKs. PrkD was found to be similar to the eukaryotic dual specificity Tyr phosphorylation-regulated kinase class of dual specificity kinases, which autophosphorylates on Ser, Thr, and Tyr residues and phosphorylates Ser and Thr residues on substrates. PrkG was found to be a bona fide dual specificity protein kinase that mediates autophosphorylation and substrate phosphorylation on Ser, Thr, and Tyr residues. The sites of phosphorylation in both of the kinases were identified through mass spectrometry. Phosphorylation on Tyr residues regulates the kinase activity of PrkD and PrkG. PrpC, the only known Ser/Thr protein phosphatase, was also found to possess dual specificity. Genistein, a known Tyr kinase inhibitor, was found to inhibit the activities of PrkD and PrkG and affect the growth of B. anthracis cells, indicating a possible role of these kinases in cell growth and development. In addition, the glycolytic enzyme pyruvate kinase was found to be phosphorylated by PrkD on Ser and Thr residues but not by PrkG. Thus, this study provides the first evidence of DSPKs in B. anthracis that belong to different classes and have different modes of regulation.	[Arora, Gunjan; Sajid, Andaleeb; Arulanandh, Mary Diana; Singhal, Anshika; Mattoo, Abid R.; Maiti, Souvik; Singh, Yogendra] Inst Genom & Integrat Biol, Council Sci & Ind Res, Delhi 110007, India; [Pomerantsev, Andrei P.; Leppla, Stephen H.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Singh, Y (corresponding author), Inst Genom & Integrat Biol, Council Sci & Ind Res, Mall Rd, Delhi 110007, India.	ysingh@igib.res.in	Sajid, Andaleeb/AAI-2960-2020; Arora, Gunjan/AAL-3448-2020; MATTOO, ABID/AGI-4855-2022	Sajid, Andaleeb/0000-0001-6248-4985; Arora, Gunjan/0000-0003-0575-6205; Singhal, Anshika/0000-0001-7932-5809; MATTOO, ABID/0000-0002-4947-0113	National Institutes of Health, NIAID, Intramural Research Program; Council of Scientific and Industrial Research Grant [NWP-0038]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001030, ZIAAI001031] Funding Source: NIH RePORTER	National Institutes of Health, NIAID, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Council of Scientific and Industrial Research Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health, NIAID, Intramural Research Program. This work was also supported by Council of Scientific and Industrial Research Grant NWP-0038.	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Alber T, 2009, CURR OPIN STRUC BIOL, V19, P650, DOI 10.1016/j.sbi.2009.10.017; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Arora G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010772; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Bechet E, 2009, AMINO ACIDS, V37, P499, DOI 10.1007/s00726-009-0237-8; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Bryant-Hudson KM, 2011, J BACTERIOL, V193, P1833, DOI 10.1128/JB.01401-10; Canzonetta C, 2008, AM J HUM GENET, V83, P388, DOI 10.1016/j.ajhg.2008.08.012; Chakraborti PK, 2011, TUBERCULOSIS, V91, P432, DOI 10.1016/j.tube.2011.04.005; CHARDOT T, 1995, CR ACAD SCI III-VIE, V318, P937; Cozzone AJ, 2005, J MOL MICROB BIOTECH, V9, P198, DOI 10.1159/000089648; Danilenko VN, 2011, CURR TOP MED CHEM, V11, P1352; Dardick C, 2006, PLOS PATHOG, V2, P14, DOI 10.1371/journal.ppat.0020002; de Been M, 2006, MICROBIOL-SGM, V152, P3035, DOI 10.1099/mic.0.29137-0; Dhanasekaran N, 1998, ONCOGENE, V17, P1447, DOI 10.1038/sj.onc.1202251; Dias MB, 2010, P NATL ACAD SCI USA, V107, P9556, DOI 10.1073/pnas.0915002107; DOUVILLE E, 1994, CANCER METAST REV, V13, P1, DOI 10.1007/BF00690414; Fuhrmann J, 2009, SCIENCE, V324, P1323, DOI 10.1126/science.1170088; Gaidenko TA, 2002, J BACTERIOL, V184, P6109, DOI 10.1128/JB.184.22.6109-6114.2002; Grangeasse C, 2007, TRENDS BIOCHEM SCI, V32, P86, DOI 10.1016/j.tibs.2006.12.004; Grangeasse C, 2010, BBA-PROTEINS PROTEOM, V1804, P628, DOI 10.1016/j.bbapap.2009.08.018; Gupta M, 2009, J BIOL CHEM, V284, P34723, DOI 10.1074/jbc.M109.058834; Hachet O, 2011, CELL, V145, P1116, DOI 10.1016/j.cell.2011.05.014; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Hong HK, 2006, J BASIC MICROB, V46, P329, DOI 10.1002/jobm.200510073; Jadeau F, 2008, BIOINFORMATICS, V24, P2427, DOI 10.1093/bioinformatics/btn462; Jahn CE, 2008, J MICROBIOL METH, V75, P318, DOI 10.1016/j.mimet.2008.07.004; Johnsen U, 2003, J BIOL CHEM, V278, P25417, DOI 10.1074/jbc.M210288200; Johnson DL, 2007, J BACTERIOL, V189, P7549, DOI 10.1128/JB.00893-07; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Keim PS, 2009, NAT REV MICROBIOL, V7, P813, DOI 10.1038/nrmicro2219; Khan S, 2010, J BIOL CHEM, V285, P37860, DOI 10.1074/jbc.M110.143131; Kiley TB, 2010, MOL MICROBIOL, V78, P947, DOI 10.1111/j.1365-2958.2010.07382.x; Kirstein J, 2005, J MOL MICROB BIOTECH, V9, P182, DOI 10.1159/000089646; Kirstein J, 2005, EMBO J, V24, P3435, DOI 10.1038/sj.emboj.7600780; Koehler TM, 2009, MOL ASPECTS MED, V30, P386, DOI 10.1016/j.mam.2009.07.004; Koul A, 2001, MICROBIOL-SGM, V147, P2307, DOI 10.1099/00221287-147-8-2307; Lacour S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003053; Lai SM, 2005, MICROBIOL-SGM, V151, P1159, DOI 10.1099/mic.0.27585-0; Lee DC, 2008, EMBO J, V27, P1758, DOI 10.1038/emboj.2008.97; Lee DC, 2009, TRENDS BIOCHEM SCI, V34, P351, DOI 10.1016/j.tibs.2009.03.003; Liu HB, 2004, J BACTERIOL, V186, P164, DOI 10.1128/JB.186.1.164-178.2004; Low HY, 2012, CELL MOL LIFE SCI, V69, P1523, DOI 10.1007/s00018-011-0888-y; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; MALCOVATI M, 1982, METHOD ENZYMOL, V90, P170; Mattoo AR, 2008, FEBS J, V275, P6237, DOI 10.1111/j.1742-4658.2008.06748.x; McPherson SA, 2010, MOL MICROBIOL, V76, P1527, DOI 10.1111/j.1365-2958.2010.07182.x; Mijakovic I, 2005, J MOL MICROB BIOTECH, V9, P189, DOI 10.1159/000089647; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Niebisch A, 2006, J BIOL CHEM, V281, P12300, DOI 10.1074/jbc.M512515200; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Olivares-Illana V, 2008, PLOS BIOL, V6, P1321, DOI 10.1371/journal.pbio.0060143; OSTROVSKY PC, 1995, GENE DEV, V9, P2034, DOI 10.1101/gad.9.16.2034; PARKINSON JS, 1993, CELL, V73, P857, DOI 10.1016/0092-8674(93)90267-T; Passalacqua KD, 2006, J BACTERIOL, V188, P3837, DOI 10.1128/JB.00239-06; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Petranovic D, 2007, MOL MICROBIOL, V63, P1797, DOI 10.1111/j.1365-2958.2007.05625.x; Pomerantsev AP, 2011, PROTEIN EXPRES PURIF, V80, P80, DOI 10.1016/j.pep.2011.05.016; Reddy MM, 2006, ARCH BIOCHEM BIOPHYS, V455, P99, DOI 10.1016/j.abb.2006.09.009; Rokolya A, 2000, AM J PHYSIOL-CELL PH, V278, pC537, DOI 10.1152/ajpcell.2000.278.3.C537; Ruvolo VR, 2008, J BIOL CHEM, V283, P35474, DOI 10.1074/jbc.M800951200; Sajid A, 2011, J BACTERIOL, V193, P5347, DOI 10.1128/JB.05469-11; Sajid A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017871; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Shakir SM, 2010, J BACTERIOL, V192, P400, DOI 10.1128/JB.01221-09; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Tiwari D, 2009, J BIOL CHEM, V284, P27467, DOI 10.1074/jbc.M109.036095; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; Yang EJ, 2001, J BIOL CHEM, V276, P39819, DOI 10.1074/jbc.M104091200; Yang F, 2011, MOL BIOTECHNOL, V47, P144, DOI 10.1007/s12033-010-9322-1	77	28	28	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26749	26763		10.1074/jbc.M112.351304	http://dx.doi.org/10.1074/jbc.M112.351304			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22711536	hybrid, Green Published			2022-12-25	WOS:000307386000025
J	Gao, WQ; Zhu, J; Westfield, LA; Tuley, EA; Anderson, PJ; Sadler, JE				Gao, Weiqiang; Zhu, Jian; Westfield, Lisa A.; Tuley, Elodee A.; Anderson, Patricia J.; Sadler, J. Evan			Rearranging Exosites in Noncatalytic Domains Can Redirect the Substrate Specificity of ADAMTS Proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA; FACTOR-CLEAVING PROTEASE; SPACER DOMAIN; BINDING-SITE; A2 DOMAIN; PROTEOLYTIC ACTIVITIES; CRYSTAL-STRUCTURES; IN-VITRO; CLEAVAGE	ADAMTS proteases typically employ some combination of ancillary C-terminal disintegrin-like, thrombospondin-1, cysteine-rich, and spacer domains to bind substrates and facilitate proteolysis by an N-terminal metalloprotease domain. We constructed chimeric proteases and substrates to examine the role of C-terminal domains of ADAMTS13 and ADAMTS5 in the recognition of their physiological cleavage sites in von Willebrand factor (VWF) and aggrecan, respectively. ADAMTS5 cleaves Glu(373)-Ala(374) and Glu(1480)-Gly(1481) bonds in bovine aggrecan but does not cleave VWF. Conversely, ADAMTS13 cleaves the Tyr(1605)-Met(1606) bond of VWF, which is exposed by fluid shear stress but cannot cleave aggrecan. Replacing the thrombospondin-1/cysteine-rich/spacer domains of ADAMTS5 with those of ADAMTS13 conferred the ability to cleave the Glu(1615)-Ile(1616) bond of VWF domain A2 in peptide substrates or VWF multimers that had been sheared; native (unsheared) VWF-multimers were resistant. Thus, by recombining exosites, we engineered ADAMTS5 to cleave a new bond in VWF, preserving physiological regulation by fluid shear stress. The results demonstrate that noncatalytic thrombospondin-1/cysteine-rich/spacer domains are principal modifiers of substrate recognition and cleavage by both ADAMTS5 and ADAMTS13. Noncatalytic domains may perform similar functions in other ADAMTS family members.	[Sadler, J. Evan] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Sadler, JE (corresponding author), Washington Univ, Sch Med, Dept Med, 660 S Euclid Ave,Campus Box 8125, St Louis, MO 63110 USA.	esadler@dom.wustl.edu	Gao, Wei/GXH-0380-2022	Sadler, J. Evan/0000-0001-5705-469X; Zhu, Jian/0000-0001-6679-8498	National Institutes of Health [R01 HL72917, R01 HL89746, U54 HL112303]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072917, R01HL089746, U54HL112303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL72917, R01 HL89746, and U54 HL112303.	Ai JH, 2005, J BIOL CHEM, V280, P29428, DOI 10.1074/jbc.M505513200; Akiyama M, 2009, P NATL ACAD SCI USA, V106, P19274, DOI 10.1073/pnas.0909755106; Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Colige A, 2005, J BIOL CHEM, V280, P34397, DOI 10.1074/jbc.M506458200; de Groot R, 2009, BLOOD, V113, P5609, DOI 10.1182/blood-2008-11-187914; Feys HB, 2009, J THROMB HAEMOST, V7, P2088, DOI 10.1111/j.1538-7836.2009.03620.x; Fosang AJ, 2008, EUR CELLS MATER, V15, P11, DOI 10.22203/eCM.v015a02; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Fushimi K, 2008, J BIOL CHEM, V283, P6706, DOI 10.1074/jbc.M708647200; Gao WQ, 2008, BLOOD, V112, P1713, DOI 10.1182/blood-2008-04-148759; Gao WQ, 2006, P NATL ACAD SCI USA, V103, P19099, DOI 10.1073/pnas.0607264104; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; HUGHES CE, 1995, BIOCHEM J, V305, P799, DOI 10.1042/bj3050799; Jin SY, 2010, BLOOD, V115, P2300, DOI 10.1182/blood-2009-07-235101; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kokame K, 2005, BRIT J HAEMATOL, V129, P93, DOI 10.1111/j.1365-2141.2005.05420.x; Kokame K, 2004, BLOOD, V103, P607, DOI 10.1182/blood-2003-08-2861; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Lim NH, 2010, BIOCHEM J, V431, P113, DOI 10.1042/BJ20100725; Longpre JM, 2009, INT J BIOCHEM CELL B, V41, P1116, DOI 10.1016/j.biocel.2008.10.008; Luken BM, 2006, THROMB HAEMOSTASIS, V96, P295, DOI 10.1160/TH06-03-0135; Majerus EM, 2003, J BIOL CHEM, V278, P46643, DOI 10.1074/jbc.M309872200; Majerus EM, 2005, J BIOL CHEM, V280, P21773, DOI 10.1074/jbc.M502529200; Miller JA, 2003, ANAL BIOCHEM, V314, P260, DOI 10.1016/S0003-2697(02)00638-3; Mosyak L, 2008, PROTEIN SCI, V17, P16, DOI 10.1110/ps.073287008; Nicholson AC, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-11; Pos W, 2010, BLOOD, V115, P1640, DOI 10.1182/blood-2009-06-229203; Pruss CM, 2008, BRIT J HAEMATOL, V143, P552, DOI 10.1111/j.1365-2141.2008.07266.x; Soejima K, 2003, BLOOD, V102, P3232, DOI 10.1182/blood-2003-03-0908; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Wu JJ, 2006, P NATL ACAD SCI USA, V103, P18470, DOI 10.1073/pnas.0609190103; Wu JJ, 2006, J THROMB HAEMOST, V4, P129, DOI 10.1111/j.1538-7836.2005.01677.x; Xiang YZ, 2011, P NATL ACAD SCI USA, V108, P11602, DOI 10.1073/pnas.1018559108; Zanardelli S, 2006, J BIOL CHEM, V281, P1555, DOI 10.1074/jbc.M508316200; Zanardelli S, 2009, BLOOD, V114, P2819, DOI 10.1182/blood-2009-05-224915; Zhang P, 2007, BLOOD, V110, P1887, DOI 10.1182/blood-2007-04-083329; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zheng XL, 2003, J BIOL CHEM, V278, P30136, DOI 10.1074/jbc.M305331200	41	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26944	26952		10.1074/jbc.M112.380535	http://dx.doi.org/10.1074/jbc.M112.380535			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707719	Green Published, hybrid			2022-12-25	WOS:000307386000042
J	Chen, WT; Sun, SS; Li, Z				Chen, Wentian; Sun, Shisheng; Li, Zheng			Two Glycosylation Sites in H5N1 Influenza Virus Hemagglutinin That Affect Binding Preference by Computer-Based Analysis	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; RECEPTOR-BINDING; GLYCAN TOPOLOGY; PROTEIN; SPECIFICITY; RECOGNITION; FUSION; GLYCOPROTEIN; MUTATIONS; SEQUENCE	Increasing numbers of H5N1 influenza viruses (IVs) are responsible for human deaths, especially in North Africa and Southeast Asian. The binding of hemagglutinin (HA) on the viral surface to host sialic acid (SA) receptors is a requisite step in the infection process. Phylogenetic analysis reveals that H5N1 viruses can be divided into 10 clades based on their HA sequences, with most human IVs centered from clade 1 and clade 2.1 to clade 2.3. Protein sequence alignment in various clades indicates the high conservation in the receptor-binding domains (RBDs) is essential for binding with the SA receptor. Two glycosylation sites, 158N and 169N, also participate in receptor recognition. In the present work, we attempted to construct a serial H5N1 HA models including diverse glycosylated HAs to simulate the binding process with various SA receptors in silico. As the SA-alpha-2,3-Gal and SA-alpha-2,6-Gal receptor adopted two distinctive topologies, straight and fishhook-like, respectively, the presence of N-glycans at 158N would decrease the affinity of HA for all of the receptors, particularly SA-alpha-2,6-Gal analogs. The steric clashes of the huge glycans shown at another glycosylation site, 169N, located on an adjacent HA monomer, would be more effective in preventing the binding of SA-alpha-2,3-Gal analogs.	[Chen, Wentian; Li, Zheng] NW Univ Xian, Coll Life Sci, Lab Funct Glyc, Xian 710069, Peoples R China; [Sun, Shisheng] Johns Hopkins Univ, Div Clin Chem, Dept Pathol, Baltimore, MD USA	Northwest University Xi'an; Johns Hopkins University	Chen, WT (corresponding author), NW Univ Xian, Coll Life Sci, Lab Funct Glyc, Xian 710069, Peoples R China.	zhengli@nwu.edu.cn	Sun, Shisheng/P-5027-2019	Sun, Shisheng/0000-0002-7242-7164	International Science & Technology Cooperation Program [2009DFA32730]; Key Science and Technology Program of the Shaanxi Province of China [2010K12-02(5)]	International Science & Technology Cooperation Program; Key Science and Technology Program of the Shaanxi Province of China	This work was supported by the International Science & Technology Cooperation Program (2009DFA32730) and the Key Science and Technology Program (2010K12-02(5)) of the Shaanxi Province of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bohne A, 1999, BIOINFORMATICS, V15, P767, DOI 10.1093/bioinformatics/15.9.767; Bohne A, 2002, Pac Symp Biocomput, P285; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Chen JR, 2011, TRENDS BIOTECHNOL, V29, P426, DOI 10.1016/j.tibtech.2011.04.007; Chen RB, 2006, MOL BIOL EVOL, V23, P2336, DOI 10.1093/molbev/msl102; Das SR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001211; DeLano W.L., 2002, PYMOL OPEN SOURCE MO; DESHPANDE KL, 1987, P NATL ACAD SCI USA, V84, P36, DOI 10.1073/pnas.84.1.36; Donis R. O., 2008, Emerging Infectious Diseases, V14, pe1; Ducatez MF, 2007, J GEN VIROL, V88, P2297, DOI 10.1099/vir.0.82939-0; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gambaryan AS, 2004, VIROLOGY, V326, P310, DOI 10.1016/j.virol.2004.06.002; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iwata T, 2008, COMPUT BIOL CHEM, V32, P198, DOI 10.1016/j.compbiolchem.2008.03.006; Karthik V, 2002, PLOS ONE, V5; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; Khurana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011548; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leo F, 2010, BIOSCI BIOTECH BIOCH, V74, P298, DOI 10.1271/bbb.90614; Li MY, 2006, BIOCHEM BIOPH RES CO, V347, P662, DOI 10.1016/j.bbrc.2006.06.179; Lin TW, 2009, VIROLOGY, V392, P73, DOI 10.1016/j.virol.2009.06.028; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Morris GM, 2009, J COMPUT CHEM, V0, P1; Moustakas DT, 2006, J COMPUT AID MOL DES, V20, P601, DOI 10.1007/s10822-006-9060-4; Neu U, 2008, P NATL ACAD SCI USA, V105, P5219, DOI 10.1073/pnas.0710301105; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Ohuchi R, 1997, J VIROL, V71, P3719, DOI 10.1128/JVI.71.5.3719-3725.1997; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Raman EP, 2009, J CHEM THEORY COMPUT, V5, P23; Rebecca MD, 2010, J VIROL, V85, P865; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Salahuddin P, 2009, BIOINFORMATION, V4, P30, DOI 10.6026/97320630004030; Sammalkorpi M, 2007, BBA-BIOMEMBRANES, V1768, P30, DOI 10.1016/j.bbamem.2006.08.008; Senne DA, 1996, AVIAN DIS, V40, P425, DOI 10.2307/1592241; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Shriver Z, 2009, CHEM BIOL, V16, P803, DOI 10.1016/j.chembiol.2009.08.002; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Sun SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022844; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; Turner BG, 1999, J MOL BIOL, V285, P1, DOI 10.1006/jmbi.1998.2354; Vendome J, 2011, NAT STRUCT MOL BIOL, V18, P693, DOI 10.1038/nsmb.2051; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Wang K, 2006, VACCINE, V24, P2176, DOI 10.1016/j.vaccine.2005.11.005; Wang WJ, 2010, J VIROL, V84, P6570, DOI 10.1128/JVI.00221-10; WHO/OIE/FAO H5N1 Evolution Working Group, 2012, CUM NUMB CONF HUM CA; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; Xu D, 2009, J MOL BIOL, V387, P465, DOI 10.1016/j.jmb.2009.01.040; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264	61	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38794	10.1371/journal.pone.0038794	http://dx.doi.org/10.1371/journal.pone.0038794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719948	Green Published, Green Submitted, gold			2022-12-25	WOS:000305347800020
J	Ferrao, PM; de Oliveira, FL; Degrave, WM; Araujo-Jorge, TC; Mendonca-Lima, L; Waghabi, MC				Ferrao, Patricia M.; de Oliveira, Fabiane L.; Degrave, Wim M.; Araujo-Jorge, Tania C.; Mendonca-Lima, Leila; Waghabi, Mariana C.			A Phosphoproteomic Approach towards the Understanding of the Role of TGF-beta in Trypanosoma cruzi Biology	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MAJOR CYSTEINE PROTEINASE; PARASITE CYCLE COMPLETION; COLI RNA DEGRADOSOME; PROTEOMIC ANALYSIS; SIGNAL-TRANSDUCTION; LEISHMANIA-DONOVANI; CHAGAS-DISEASE; CRYSTAL-STRUCTURE; MAMMALIAN-CELLS	Transforming growth factor beta (TGF-beta) plays a pivotal role in Chagas disease, not only in the development of chagasic cardiomyopathy, but also in many stages of the T. cruzi life cycle and survival in the host cell environment. The intracellular signaling pathways utilized by T. cruzi to regulate these mechanisms remain unknown. To identify parasite proteins involved in the TGF-beta response, we utilized a combined approach of two-dimensional gel electrophoresis (2DE) analysis and mass spectrometry (MS) protein identification. Signaling via TGF-beta is dependent on events of phosphorylation, which is one of the most relevant and ubiquitous post-translational modifications for the regulation of gene expression, and especially in trypanosomatids, since they lack several transcriptional control mechanisms. Here we show a kinetic view of T. cruzi epimastigotes (Y strain) incubated with TGF-beta for 1, 5, 30 and 60 minutes, which promoted a remodeling of the parasite phosphorylation network and protein expression pattern. The altered molecules are involved in a variety of cellular processes, such as proteolysis, metabolism, heat shock response, cytoskeleton arrangement, oxidative stress regulation, translation and signal transduction. A total of 75 protein spots were up-or down-regulated more than twofold after TGF-beta treatment, and from these, 42 were identified by mass spectrometry, including cruzipain-the major T. cruzi papain-like cysteine proteinase that plays an important role in invasion and participates in the escape mechanisms used by the parasite to evade the host immune system. In our study, we observed that TGF-beta addition favored epimastigote proliferation, corroborating 2DE data in which proteins previously described to be involved in this process were positively stimulated by TGF-beta.	[Ferrao, Patricia M.; de Oliveira, Fabiane L.; Degrave, Wim M.; Mendonca-Lima, Leila; Waghabi, Mariana C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Genom Func & Bioinformat, Rio De Janeiro, Brazil; [Araujo-Jorge, Tania C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Inovacoes Terapias Ensino & Bioprod, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Ferrao, PM (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Genom Func & Bioinformat, Rio De Janeiro, Brazil.	lmlima@ioc.fiocruz.br; mariana@ioc.fiocruz.br	Araujo-Jorge, Tania/F-1030-2014; Degrave, Wim/B-4162-2009; Waghabi, Mariana C/J-3391-2014; Mendonça-Lima, Leila/J-3390-2014	Araujo-Jorge, Tania/0000-0002-8233-5845; Mendonça-Lima, Leila/0000-0003-4388-5083	Fundacao Oswaldo Cruz/Programa Estrategico de Apoio a Pesquisa em Saude; Instituto Oswaldo Cruz; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro	Fundacao Oswaldo Cruz/Programa Estrategico de Apoio a Pesquisa em Saude; Instituto Oswaldo Cruz; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work received financial support from Fundacao Oswaldo Cruz/Programa Estrategico de Apoio a Pesquisa em Saude, Instituto Oswaldo Cruz, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AD, 2003, INFECT IMMUN, V71, P4201, DOI 10.1128/IAI.71.7.4201-4205.2003; Andrade HM, 2008, J PROTEOME RES, V7, P2357, DOI 10.1021/pr700659m; Araujo-Jorge TC, 2002, J INFECT DIS, V186, P1823, DOI 10.1086/345882; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Bente M, 2003, PROTEOMICS, V3, P1811, DOI 10.1002/pmic.200300462; Berredo-Pinho M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-80; Carpousis AJ, 2002, BIOCHEM SOC T, V30, P150, DOI 10.1042/bst0300150; Cazzulo JJ, 1997, BIOL CHEM, V378, P1; Chin D, 2004, BRIT J PLAST SURG, V57, P215, DOI 10.1016/j.bjps.2003.12.012; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Clayton J, 2010, NATURE, V465, pS4, DOI 10.1038/nature09220; de Graauw M, 2006, ELECTROPHORESIS, V27, P2676, DOI 10.1002/elps.200600018; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Di Noia JM, 2000, J BIOL CHEM, V275, P10218, DOI 10.1074/jbc.275.14.10218; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Ellis J, 2004, MOL MICROBIOL, V53, P1487, DOI 10.1111/j.1365-2958.2004.04218.x; Ferella M, 2008, PROTEOMICS, V8, P2735, DOI 10.1002/pmic.200700940; Ghansah TJ, 2002, J EUKARYOT MICROBIOL, V49, P383, DOI 10.1111/j.1550-7408.2002.tb00216.x; Giotto MTD, 2003, J MOL BIOL, V331, P653, DOI 10.1016/S0022-2836(03)00752-6; Gnanasekar M, 2009, INT J ONCOL, V34, P1241, DOI 10.3892/ijo_00000252; Gull K, 2001, CURR OPIN MICROBIOL, V4, P427, DOI 10.1016/S1369-5274(00)00230-7; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Hall BS, 2000, INFECT IMMUN, V68, P2077, DOI 10.1128/IAI.68.4.2077-2081.2000; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Imamura T, 2004, BIOCHEM BIOPH RES CO, V318, P289, DOI 10.1016/j.bbrc.2004.04.029; Ayub MJ, 2009, BIOCHEM BIOPH RES CO, V382, P30, DOI 10.1016/j.bbrc.2009.02.095; Kohl L, 1998, MOL BIOCHEM PARASIT, V93, P1, DOI 10.1016/S0166-6851(98)00014-0; Kuhnel K, 2001, J MOL BIOL, V313, P583, DOI 10.1006/jmbi.2001.5065; LAWRENCE DA, 1995, KIDNEY INT, V47, pS19; Li YH, 2011, J GENET GENOMICS, V38, P111, DOI 10.1016/j.jgg.2011.02.001; Luckhart S, 2003, INFECT IMMUN, V71, P3000, DOI 10.1128/IAI.71.6.3000-3009.2003; Magalhaes AD, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-24; Marchini FK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025381; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MING M, 1995, CELL, V82, P287, DOI 10.1016/0092-8674(95)90316-X; Morales MA, 2008, PROTEOMICS, V8, P350, DOI 10.1002/pmic.200700697; Mottram JC, 1998, CURR OPIN MICROBIOL, V1, P455, DOI 10.1016/S1369-5274(98)80065-9; Moustakas A, 2001, J CELL SCI, V114, P4359; Muller IB, 2002, MOL BIOL CELL, V13, P3787, DOI 10.1091/mbc.E02-02-0093; Nagano-Ito M, 2009, FEBS LETT, V583, P1363, DOI 10.1016/j.febslet.2009.03.045; Nakayasu ES, 2009, PROTEOMICS, V9, P3489, DOI 10.1002/pmic.200800874; Nepomuceno-Silva JL, 2001, J BIOL CHEM, V276, P29711, DOI 10.1074/jbc.M102920200; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Nowicki C, 2008, COMP BIOCHEM PHYS A, V151, P381, DOI 10.1016/j.cbpa.2007.03.010; Paba J, 2004, PROTEOMICS, V4, P1052, DOI 10.1002/pmic.200300637; Parodi-Talice A, 2004, INT J PARASITOL, V34, P881, DOI 10.1016/j.ijpara.2004.05.002; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; Rosenzweig D, 2008, PROTEOMICS, V8, P1843, DOI 10.1002/pmic.200701043; Ruan L, 2010, MED ONCOL, V27, P1407, DOI 10.1007/s12032-009-9394-6; Samudio M, 1999, PARASITE IMMUNOL, V21, P451, DOI 10.1046/j.1365-3024.1999.00242.x; SILVA JS, 1991, J EXP MED, V174, P539, DOI 10.1084/jem.174.3.539; Sodre CL, 2009, ARCH MICROBIOL, V191, P177, DOI 10.1007/s00203-008-0439-6; Sowa MPK, 1999, GENE, V230, P155, DOI 10.1016/S0378-1119(99)00072-4; Stasyk T, 2005, MOL BIOL CELL, V16, P4765, DOI 10.1091/mbc.E05-03-0257; Stempin C, 2002, J LEUKOCYTE BIOL, V72, P727; TEIXEIRA SMR, 1995, J BIOL CHEM, V270, P22586, DOI 10.1074/jbc.270.38.22586; Tomas AM, 1997, EUR J BIOCHEM, V244, P596, DOI 10.1111/j.1432-1033.1997.t01-1-00596.x; TOMLINSON S, 1995, PARASITOLOGY, V110, P547, DOI 10.1017/S0031182000065264; Ulrich PN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018013; VANHAMME L, 1995, MICROBIOL REV, V59, P223, DOI 10.1128/MMBR.59.2.223-240.1995; Waghabi MC, 2007, ANTIMICROB AGENTS CH, V51, P2905, DOI 10.1128/AAC.00022-07; Waghabi MC, 2009, MEM I OSWALDO CRUZ, V104, P1083, DOI 10.1590/S0074-02762009000800004; Waghabi MC, 2009, ANTIMICROB AGENTS CH, V53, P4694, DOI 10.1128/AAC.00580-09; Waghabi MC, 2005, AM J PATHOL, V167, P993, DOI 10.1016/S0002-9440(10)61189-3; Waghabi MC, 2005, CELL MICROBIOL, V7, P511, DOI 10.1111/j.1462-5822.2004.00481.x; Waghabi MC, 2002, INFECT IMMUN, V70, P5115, DOI 10.1128/IAI.70.9.5115-5123.2002; Wang DJ, 2004, J BIOL CHEM, V279, P43725, DOI 10.1074/jbc.M407368200; Xiao Lin, 2008, Zhonghua Gan Zang Bing Za Zhi, V16, P854; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	70	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38736	10.1371/journal.pone.0038736	http://dx.doi.org/10.1371/journal.pone.0038736			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719930	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340000042
J	Conti, L; Crisafulli, L; Caldera, V; Tortoreto, M; Brilli, E; Conforti, P; Zunino, F; Magrassi, L; Schiffer, D; Cattaneo, E				Conti, Luciano; Crisafulli, Laura; Caldera, Valentina; Tortoreto, Monica; Brilli, Elisa; Conforti, Paola; Zunino, Franco; Magrassi, Lorenzo; Schiffer, Davide; Cattaneo, Elena			REST Controls Self-Renewal and Tumorigenic Competence of Human Glioblastoma Cells	PLOS ONE			English	Article							BREAST-CANCER; STEM-CELLS; IN-VIVO; GENE; TUMOR; TRANSCRIPTION; REST/NRSF; REPRESSOR; DIFFERENTIATION; PROTEIN	The Repressor Element 1 Silencing Transcription factor (REST/NRSF) is a master repressor of neuronal programs in non-neuronal lineages shown to function as a central regulator of developmental programs and stem cell physiology. Aberrant REST function has been associated with a number of pathological conditions. In cancer biology, REST has been shown to play a tumor suppressor activity in epithelial cancers but an oncogenic role in brain childhood malignancies such as neuroblastoma and medulloblastoma. Here we examined REST expression in human glioblastoma multiforme (GBM) specimens and its role in GBM cells carrying self-renewal and tumorigenic competence. We found REST to be expressed in GBM specimens, its presence being particularly enriched in tumor cells in the perivascular compartment. Significantly, REST is highly expressed in self-renewing tumorigenic-competent GBM cells and its knock down strongly reduces their self-renewal in vitro and tumor-initiating capacity in vivo and affects levels of miR-124 and its downstream targets. These results indicate that REST contributes to GBM maintenance by affecting its self-renewing and tumorigenic cellular component and that, hence, a better understanding of these circuitries in these cells might lead to new exploitable therapeutic targets.	[Conti, Luciano; Crisafulli, Laura; Brilli, Elisa; Conforti, Paola; Cattaneo, Elena] Univ Milan, Dept Pharmacol Sci, Milan, Italy; [Conti, Luciano; Crisafulli, Laura; Brilli, Elisa; Conforti, Paola; Cattaneo, Elena] Univ Milan, Ctr Stem Cell Res, Milan, Italy; [Caldera, Valentina; Schiffer, Davide] Policlin Monza Fdn, Neurobiooncol Ctr, Vercelli, Italy; [Tortoreto, Monica; Zunino, Franco] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Magrassi, Lorenzo] Univ Pavia, Fdn IRCCS Policlin S Matteo, Dipartimento Sci Chirurg, I-27100 Pavia, Italy	University of Milan; University of Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione San Matteo; University of Pavia	Conti, L (corresponding author), Univ Milan, Dept Pharmacol Sci, Milan, Italy.	Luciano.Conti@unimi.it	Crisafulli, Laura/Q-2271-2018; Crisafulli, Laura/ABI-1447-2020; Conti, Luciano/H-4184-2012; Magrassi, Lorenzo/AAJ-3105-2020	Crisafulli, Laura/0000-0002-1393-5652; Crisafulli, Laura/0000-0002-1393-5652; Conti, Luciano/0000-0002-2050-9846; Magrassi, Lorenzo/0000-0002-8308-2720; CATTANEO, ELENA/0000-0002-0755-4917	NeuroScreen (FP6, European Union Health) [2007-B-222943]; Progetto Giovani Ricercatori (Italian Ministry of Health); Progetto Oncologico "Characterization of the molecular mechanisms regulating brain tumors growth and chemioresistance'' (Italian Ministry of Health); NeuroStemcell (European Community's Seventh Framework Programme grant) [222943]	NeuroScreen (FP6, European Union Health); Progetto Giovani Ricercatori (Italian Ministry of Health); Progetto Oncologico "Characterization of the molecular mechanisms regulating brain tumors growth and chemioresistance'' (Italian Ministry of Health); NeuroStemcell (European Community's Seventh Framework Programme grant)	This work was supported by NeuroScreen (FP6, European Union Health-2007-B-222943) and Progetto Giovani Ricercatori (Italian Ministry of Health) to Luciano Conti and by Progetto Oncologico "Characterization of the molecular mechanisms regulating brain tumors growth and chemioresistance'' (Italian Ministry of Health, 2008-2011) and partially by NeuroStemcell (European Community's Seventh Framework Programme grant agreement nr. 222943) to EC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Blom T, 2006, ACTA NEUROPATHOL, V112, P483, DOI 10.1007/s00401-006-0102-8; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Calderone A, 2003, J NEUROSCI, V23, P2112; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Coulson JM, 2000, CANCER RES, V60, P1840; Fowler A, 2011, EUR J CANCER, V47, P953, DOI 10.1016/j.ejca.2010.11.026; Gao ZL, 2011, J NEUROSCI, V31, P9772, DOI 10.1523/JNEUROSCI.1604-11.2011; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Huang Z, 2011, NAT CELL BIOL, V13, P142, DOI 10.1038/ncb2153; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jones FS, 1999, BIOESSAYS, V21, P372, DOI 10.1002/(SICI)1521-1878(199905)21:5<372::AID-BIES3>3.0.CO;2-3; Kamal MM, 2012, STEM CELLS, V30, P405, DOI 10.1002/stem.1020; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lawinger P, 2000, NAT MED, V6, P826, DOI 10.1038/77565; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Mandel G, 2011, P NATL ACAD SCI USA, V108, P16789, DOI 10.1073/pnas.1113486108; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Palm K, 1999, MOL BRAIN RES, V72, P30, DOI 10.1016/S0169-328X(99)00196-5; Pellegatta S, 2006, CANCER RES, V66, P10247, DOI 10.1158/0008-5472.CAN-06-2048; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Qureshi IA, 2009, NEUROSCI LETT, V466, P73, DOI 10.1016/j.neulet.2009.07.093; Reddy BY, 2009, P NATL ACAD SCI USA, V106, P4408, DOI 10.1073/pnas.0809130106; SCHOENHERR CJ, 1995, CURR OPIN NEUROBIOL, V5, P566, DOI 10.1016/0959-4388(95)80060-3; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soldati C, 2011, STEM CELLS; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; Sun YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003656; Venere M, 2011, GLIA, V59, P1148, DOI 10.1002/glia.21185; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; Zhang P, 2011, P NATL ACAD SCI US; Zhang P, 2008, CURR BIOL, V18, P1489, DOI 10.1016/j.cub.2008.08.048; Zhang PS, 2009, TRENDS NEUROSCI, V32, P559, DOI 10.1016/j.tins.2009.07.005; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	44	71	73	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38486	10.1371/journal.pone.0038486	http://dx.doi.org/10.1371/journal.pone.0038486			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701651	Green Submitted, Green Published, gold			2022-12-25	WOS:000305337600026
J	Ong, RH; King, AJC; Mullins, BJ; Cooper, TF; Caley, MJ				Ong, Robert H.; King, Andrew J. C.; Mullins, Benjamin J.; Cooper, Timothy F.; Caley, M. Julian			Development and Validation of Computational Fluid Dynamics Models for Prediction of Heat Transfer and Thermal Microenvironments of Corals	PLOS ONE			English	Article							GREAT-BARRIER-REEF; MASSIVE CORALS; TEMPERATURE; FLOW; IRRADIANCE; PATTERNS; SURVIVAL; GROWTH; LIMITS	We present Computational Fluid Dynamics (CFD) models of the coupled dynamics of water flow, heat transfer and irradiance in and around corals to predict temperatures experienced by corals. These models were validated against controlled laboratory experiments, under constant and transient irradiance, for hemispherical and branching corals. Our CFD models agree very well with experimental studies. A linear relationship between irradiance and coral surface warming was evident in both the simulation and experimental result agreeing with heat transfer theory. However, CFD models for the steady state simulation produced a better fit to the linear relationship than the experimental data, likely due to experimental error in the empirical measurements. The consistency of our modelling results with experimental observations demonstrates the applicability of CFD simulations, such as the models developed here, to coral bleaching studies. A study of the influence of coral skeletal porosity and skeletal bulk density on surface warming was also undertaken, demonstrating boundary layer behaviour, and interstitial flow magnitude and temperature profiles in coral cross sections. Our models compliment recent studies showing systematic changes in these parameters in some coral colonies and have utility in the prediction of coral bleaching.	[Ong, Robert H.; King, Andrew J. C.; Mullins, Benjamin J.] Curtin Univ, Fluid Dynam Res Grp, Perth, WA, Australia; [Mullins, Benjamin J.] Griffith Univ, Atmospher Environm Res Ctr, Brisbane, Qld 4111, Australia; [Mullins, Benjamin J.] Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA, Australia; [Cooper, Timothy F.] Australian Inst Marine Sci, UWA Oceans Inst, Perth, WA, Australia; [Caley, M. Julian] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Curtin University; Griffith University; Curtin University; Australian Institute of Marine Science; Australian Institute of Marine Science	Ong, RH (corresponding author), Curtin Univ, Fluid Dynam Res Grp, Perth, WA, Australia.	robert.ong@postgrad.curtin.edu.au	; Caley, Julian/A-4042-2008	King, Andrew/0000-0003-0517-3712; Mullins, Benjamin/0000-0002-6722-1073; Caley, Julian/0000-0001-5739-749X	Western Australia Supercomputing Hub (iVEC); Society for Underwater Technology (SUT)	Western Australia Supercomputing Hub (iVEC); Society for Underwater Technology (SUT)	The authors acknowledge both the Western Australia Supercomputing Hub (iVEC) and the Society for Underwater Technology (SUT) for external funding sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, OPENFOAM US GUID VER; Anthony K, 2002, LIMNOLOGY OCEANOGRAP, P1417; BARNES DJ, 1992, J EXP MAR BIOL ECOL, V159, P113, DOI 10.1016/0022-0981(92)90261-8; Berkelmans R, 1999, CORAL REEFS, V18, P55, DOI 10.1007/s003380050154; Berkelmans R, 1999, CORAL REEFS, V18, P219, DOI 10.1007/s003380050186; Brown BE, 1997, CORAL REEFS, V16, P129; Chang S, 2009, LIMNOL OCEANOGR, V54, P1819, DOI DOI 10.4319/LO.2009.54.5.1819; COLES SL, 1991, CORAL REEFS, V9, P231, DOI 10.1007/BF00290427; Cooper TF, 2012, SCIENCE, V335, P593, DOI 10.1126/science.1214570; Davies JM, 1997, MAR FRESHWATER RES, V48, P513, DOI 10.1071/MF96128; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Fabricius KE, 2006, LIMNOL OCEANOGR, V51, P30, DOI 10.4319/lo.2006.51.1.0030; Ferziger J.H., 1999, COMPUTATIONAL METHOD; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; HIGHSMITH RC, 1983, MAR ECOL PROG SER, V13, P261, DOI 10.3354/meps013261; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOEGHGULDBERG O, 1989, J EXP MAR BIOL ECOL, V129, P279, DOI 10.1016/0022-0981(89)90109-3; HUBBARD DK, 1986, CORAL REEFS, V5, P117, DOI 10.1007/BF00298179; HUTCHINGS PA, 1988, P 6 INT COR REEF S A, V3, P263; Jell J.S., 1978, PAPERS DEP GEOLOGY U, V8, P1; Jimenez IM, 2008, LIMNOL OCEANOGR, V53, P1548, DOI 10.4319/lo.2008.53.4.1548; Jimenez IM, 2011, J R SOC INTERFACE, V8, P1785, DOI 10.1098/rsif.2011.0144; Kaandorp JA, 2003, PHILOS T R SOC B, V358, P1551, DOI 10.1098/rstb.2003.1339; KOBLUK DR, 1994, B MAR SCI, V54, P142; Laine J, 2008, MATER CHARACT, V59, P1522, DOI 10.1016/j.matchar.2007.12.002; LESSER MP, 1990, CORAL REEFS, V8, P225, DOI 10.1007/BF00265015; MUSCATINE L, 1991, MAR ECOL PROG SER, V77, P233, DOI 10.3354/meps077233; Nakamura T, 2001, MAR ECOL PROG SER, V212, P301, DOI 10.3354/meps212301; Patankar S., 2018, NUMERICAL HEAT TRANS, DOI DOI 10.1201/9781482234213; Roche R, 2010, J EXPT MARINE BIOL E; Shen CY, 2001, J GEOPHYS RES-OCEANS, V106, P6973, DOI 10.1029/2000JC000267; VanWoesik R, 1995, MAR ECOL PROG SER, V128, P261, DOI 10.3354/meps128261; Versteeg H.K., 2007, INTRO COMPUTATIONAL; Wu JS, 2007, INT J HEAT MASS TRAN, V50, P3925, DOI 10.1016/j.ijheatmasstransfer.2007.02.009	34	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e37842	10.1371/journal.pone.0037842	http://dx.doi.org/10.1371/journal.pone.0037842			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701582	Green Published, gold, Green Submitted			2022-12-25	WOS:000305337600011
J	Cao, GY; Liu, YJ; Zhang, SX; Yang, XW; Chen, RR; Zhang, YW; Lu, W; Liu, Y; Wang, JH; Lin, M; Wang, GY				Cao, Gaoyi; Liu, Yunjun; Zhang, Shengxue; Yang, Xuewen; Chen, Rongrong; Zhang, Yuwen; Lu, Wei; Liu, Yan; Wang, Jianhua; Lin, Min; Wang, Guoying			A Novel 5-Enolpyruvylshikimate-3-Phosphate Synthase Shows High Glyphosate Tolerance in Escherichia coli and Tobacco Plants	PLOS ONE			English	Article							HERBICIDE GLYPHOSATE; 3-PHOSPHATE SYNTHASE; 5-ENOPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE; CONFERS RESISTANCE; DIRECTED EVOLUTION; STRUCTURAL BASIS; MOLECULAR-BASIS; AROA GENE; IDENTIFICATION; EXPRESSION	A key enzyme in the shikimate pathway, 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) is the primary target of the broad-spectrum herbicide glyphosate. Identification of new aroA genes coding for EPSPS with a high level of glyphosate tolerance is essential for the development of glyphosate-tolerant crops. In the present study, the glyphosate tolerance of five bacterial aroA genes was evaluated in the E. coli aroA-defective strain ER2799 and in transgenic tobacco plants. All five aroA genes could complement the aroA-defective strain ER2799, and AM79 aroA showed the highest glyphosate tolerance. Although glyphosate treatment inhibited the growth of both WT and transgenic tobacco plants, transgenic plants expressing AM79 aroA tolerated higher concentration of glyphosate and had a higher fresh weight and survival rate than plants expressing other aroA genes. When treated with high concentration of glyphosate, lower shikimate content was detected in the leaves of transgenic plants expressing AM79 aroA than transgenic plants expressing other aroA genes. These results suggest that AM79 aroA could be a good candidate for the development of transgenic glyphosate-tolerant crops.	[Cao, Gaoyi; Zhang, Yuwen; Wang, Jianhua] China Agr Univ, Coll Agr & Biotechnol, Beijing 100094, Peoples R China; [Cao, Gaoyi; Liu, Yunjun; Zhang, Shengxue; Yang, Xuewen; Chen, Rongrong; Liu, Yan; Wang, Guoying] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China; [Lu, Wei; Lin, Min] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Cao, GY (corresponding author), China Agr Univ, Coll Agr & Biotechnol, Beijing 100094, Peoples R China.	gywang604@gmail.com	min, lin/AAJ-7325-2020		National Major Project for Transgenic Organism Breeding [2008ZX08003-001]; Scientific Research Foundation for Returned Overseas Chinese Scholars of the Ministry of Education of China	National Major Project for Transgenic Organism Breeding; Scientific Research Foundation for Returned Overseas Chinese Scholars of the Ministry of Education of China	This work was supported by the National Major Project for Transgenic Organism Breeding (2008ZX08003-001) and by the Scientific Research Foundation for Returned Overseas Chinese Scholars of the Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baerson SR, 2002, PLANT PHYSIOL, V129, P1265, DOI 10.1104/pp.001560; Barry G.F., 1992, World Patent, Patent No. [9204449, WO 9. 204: 449]; Belfiore NM, 2001, MUTAT RES-REV MUTAT, V489, P97, DOI 10.1016/S1383-5742(01)00065-5; BINAROVA P, 1994, BIOL PLANTARUM, V36, P65, DOI 10.1007/BF02921271; Bradshaw LD, 1997, WEED TECHNOL, V11, P189, DOI 10.1017/S0890037X00041567; Castle LA, 2004, SCIENCE, V304, P1151, DOI 10.1126/science.1096770; Chang HS, 2003, MOL CELLS, V15, P20; Chen LX, 2001, GENE, V263, P39, DOI 10.1016/S0378-1119(00)00568-0; COMAI L, 1985, NATURE, V317, P741, DOI 10.1038/317741a0; COMAI L, 1983, SCIENCE, V221, P370, DOI 10.1126/science.221.4608.370; DELLACIOPPA G, 1987, BIO-TECHNOL, V5, P579, DOI 10.1038/nbt0687-579; DELLACIOPPA G, 1986, P NATL ACAD SCI USA, V83, P6873, DOI 10.1073/pnas.83.18.6873; Du WS, 2000, EUR J BIOCHEM, V267, P222, DOI 10.1046/j.1432-1327.2000.00994.x; Dun BQ, 2007, APPL ENVIRON MICROB, V73, P7997, DOI 10.1128/AEM.00956-07; DYER WE, 1988, PLANT PHYSIOL, V88, P661, DOI 10.1104/pp.88.3.661; FITZGIBBON JE, 1990, APPL ENVIRON MICROB, V56, P3382, DOI 10.1128/AEM.56.11.3382-3388.1990; Foster PL, 2000, BIOESSAYS, V22, P1067, DOI 10.1002/1521-1878(200012)22:12<1067::AID-BIES4>3.0.CO;2-Q; Funke T, 2006, P NATL ACAD SCI USA, V103, P13010, DOI 10.1073/pnas.0603638103; Funke T, 2009, J BIOL CHEM, V284, P9854, DOI 10.1074/jbc.M809771200; He M, 2001, BBA-GEN SUBJECTS, V1568, P1, DOI 10.1016/S0304-4165(01)00181-7; Healy-Fried ML, 2007, J BIOL CHEM, V282, P32949, DOI 10.1074/jbc.M705624200; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Howe AR, 2002, MOL BREEDING, V10, P153, DOI 10.1023/A:1020396708088; Jin D, 2007, CURR MICROBIOL, V55, P350, DOI 10.1007/s00284-007-0268-x; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Liang AM, 2008, BIOTECHNOL LETT, V30, P1397, DOI 10.1007/s10529-008-9703-8; Lin M, 2007, World Patent, Patent No. [WO/2009/059485, 2009059485]; Liu Z, 2006, DNA SEQUENCE, V17, P208, DOI 10.1080/10425170600824186; Lopez-Rodas V, 2007, EVOL ECOL, V21, P535, DOI 10.1007/s10682-006-9134-8; PADGETTE SR, 1995, CROP SCI, V35, P1451, DOI 10.2135/cropsci1995.0011183X003500050032x; Pedotti M, 2009, J BIOL CHEM, V284, P36415, DOI 10.1074/jbc.M109.051631; POWELL HA, 1991, NEW PHYTOL, V119, P421, DOI 10.1111/j.1469-8137.1991.tb00042.x; Priestman MA, 2005, FEBS LETT, V579, P5773, DOI 10.1016/j.febslet.2005.09.066; Priestman MA, 2005, FEBS LETT, V579, P728, DOI 10.1016/j.febslet.2004.12.057; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; Shimizu M, 2002, APPL ENVIRON MICROB, V68, P4061, DOI 10.1128/AEM.68.8.4061-4066.2002; STALKER DM, 1985, J BIOL CHEM, V260, P4724; STEINRUCKEN HC, 1980, BIOCHEM BIOPH RES CO, V94, P1207, DOI 10.1016/0006-291X(80)90547-1; Stenoien HK, 2005, J MOL EVOL, V61, P306, DOI 10.1007/s00239-004-0271-9; Tian YS, 2010, APPL ENVIRON MICROB, V76, P6001, DOI 10.1128/AEM.00770-10; Wang HY, 2003, J PLANT RES, V116, P455, DOI 10.1007/s10265-003-0120-8; Ye GN, 2001, PLANT J, V25, P261, DOI 10.1046/j.1365-313x.2001.00958.x; Zhou M, 2006, PLANT PHYSIOL, V140, P184, DOI 10.1104/pp.105.068577	43	36	47	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38718	10.1371/journal.pone.0038718	http://dx.doi.org/10.1371/journal.pone.0038718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715408	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336800050
J	Kim, YW; Bae, SM; Battogtokh, G; Bang, HJ; Ahn, WS				Kim, Yong-Wan; Bae, Su Mi; Battogtokh, Gantumur; Bang, Hyo Joo; Ahn, Woong Shick			Synergistic Anti-Tumor Effects of Combination of Photodynamic Therapy and Arsenic Compound in Cervical Cancer Cells: In Vivo and In Vitro Studies	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OXIDATIVE STRESS; TETRAARSENIC OXIDE; CYCLE PROGRESSION; DRUG-COMBINATION; TUMOR RESPONSE; APOPTOSIS; EXPRESSION; TRIOXIDE; DEATH	The effects of As4O6 as adjuvant on photodynamic therapy (PDT) were studied. As4O6 is considered to have anticancer activity via several biological actions, such as free radical production and inhibition of VEGF expression. PDT or As4O6 significantly inhibited TC-1 cell proliferation in a dose-dependent manner (P<0.05) by MTT assay. The anti-proliferative effect of the combination treatment was significantly higher than in TC-1 cells treated with either photodynamic therapy or As4O6 alone (62.4 and 52.5% decrease compared to vehicle-only treated TC-1 cells, respectively, P<0.05). In addition, cell proliferation in combination of photodynamic therapy and As4O6 treatment significantly decreased by 77.4% (P<0.05). Cell survival pathway (Naip1, Tert and Aip1) and p53-dependent pathway (Bax, p21(Cip1), Fas, Gadd45, IGFBP-3 and Mdm-2) were markedly increased by combination treatment of photodynamic therapy and As4O6. In addition, the immune response in the NEAT pathway (Ly-12, CD178 and IL-2) was also modulated after combination treatment, suggesting improved antitumor effects by controlling unwanted growth-stimulatory pathways. The combination effect apparently reflected concordance with in vitro data, in restricting tumor growth in vivo and in relation to some common signaling pathways to those observed in vitro. These findings suggest the benefit of combinatory treatment with photodynamic therapy and As4O6 for inhibition of cervical cancer cell growth.	[Kim, Yong-Wan; Bae, Su Mi; Battogtokh, Gantumur; Bang, Hyo Joo] Catholic Univ Korea, Catholic Res Inst Med Sci, Seoul, South Korea; [Ahn, Woong Shick] Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Kim, YW (corresponding author), Catholic Univ Korea, Catholic Res Inst Med Sci, Seoul, South Korea.	ahnlab1@catholic.ac.kr			Catholic Harvard Wellman Photomedicine Core Technique Development Center, Seoul, Republic of Korea [5-2012-A0154-00001]	Catholic Harvard Wellman Photomedicine Core Technique Development Center, Seoul, Republic of Korea	The study was supported by The Catholic Harvard Wellman Photomedicine Core Technique Development Center, Seoul, Republic of Korea (Grant #5-2012-A0154-00001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn WS, 2004, ONCOL REP, V12, P573; Al-Waili NS, 2005, MED SCI MONITOR, V11, pRA279; Banerjee N, 2008, TOXICOLOGY, V246, P101, DOI 10.1016/j.tox.2007.12.029; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Chen GQ, 1996, BLOOD, V88, P1052; Cheung WMW, 2007, CANCER LETT, V246, P122, DOI 10.1016/j.canlet.2006.02.009; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Corti L, 1996, J PHOTOCH PHOTOBIO B, V36, P193, DOI 10.1016/S1011-1344(96)07371-X; Ferrario A, 2000, CANCER RES, V60, P4066; Ferrario A, 2005, CANCER RES, V65, P9473, DOI 10.1158/0008-5472.CAN-05-1659; Ferrario A, 2004, CANCER RES, V64, P2328, DOI 10.1158/0008-5472.CAN-04-0071; Ferrario A, 2002, CANCER RES, V62, P3956; Gao JJ, 2005, P NATL ACAD SCI USA, V102, P17207, DOI 10.1073/pnas.0506893102; Germolec DR, 1996, TOXICOL APPL PHARM, V141, P308, DOI 10.1016/S0041-008X(96)80037-8; Gomer CJ, 2006, LASER SURG MED, V38, P516, DOI 10.1002/lsm.20339; GOMER CJ, 1989, RADIAT RES, V120, P1, DOI 10.2307/3577632; Goodwin Scott C, 2003, J Vasc Interv Radiol, V14, pS467; Kammerer R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021834; Laparra JM, 2008, TOXICOL IN VITRO, V22, P444, DOI 10.1016/j.tiv.2007.11.004; Lew YS, 1999, CANCER RES, V59, P6033; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020858; Moserova I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032972; Nakagawa H, 2007, ORAL ONCOL, V43, P544, DOI 10.1016/j.oraloncology.2006.03.020; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Reynolds CP, 2005, METH MOLEC MED, V110, P173; Rigas B, 2008, BRIT J CANCER, V98, P1157, DOI 10.1038/sj.bjc.6604225; Rigas B, 2007, CURR OPIN GASTROEN, V23, P55, DOI 10.1097/MOG.0b013e32801145b0; Sagawa Y, 2001, CANCER LETT, V168, P45, DOI 10.1016/S0304-3835(01)00501-8; Separovic D, 2009, BRIT J CANCER, V100, P626, DOI 10.1038/sj.bjc.6604896; Shao WL, 1998, J NATL CANCER I, V90, P124, DOI 10.1093/jnci/90.2.124; Solban N, 2006, CANCER RES, V66, P5633, DOI 10.1158/0008-5472.CAN-06-0604; Sun Y, 2008, CANCER RES, V68, P8269, DOI 10.1158/0008-5472.CAN-08-2010; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tozer GM, 1999, CANCER RES, V59, P1626; Wang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022566; Wei YQ, 2007, PHOTOCHEM PHOTOBIOL, V83, P1319, DOI 10.1111/j.1751-1097.2007.00160.x; Woo SH, 2005, J CELL BIOCHEM, V95, P120, DOI 10.1002/jcb.20329; Yoo MH, 2004, J VET MED SCI, V66, P1091, DOI 10.1292/jvms.66.1091	40	14	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38583	10.1371/journal.pone.0038583	http://dx.doi.org/10.1371/journal.pone.0038583			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715393	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336800035
J	Eischer, L; Tscholl, V; Heinze, G; Traby, L; Kyrle, PA; Eichinger, S				Eischer, Lisbeth; Tscholl, Verena; Heinze, Georg; Traby, Ludwig; Kyrle, Paul A.; Eichinger, Sabine			Hematocrit and the Risk of Recurrent Venous Thrombosis: A Prospective Cohort Study	PLOS ONE			English	Article							THROMBOEMBOLISM; ERYTHROCYTES; MEN	Background: Venous thromboembolism (VTE) is a multicausal disease which recurs. Hematocrit is associated with a thrombotic risk. We aimed to investigate if hematocrit is associated with the recurrence risk. Methods: Patients with a first VTE were followed after anticoagulation. Patients with VTE provoked by a transient risk factor, natural inhibitor deficiency, lupus anticoagulant, homozygous or double heterozygous defects, cancer, or long-term antithrombotic treatment were excluded. The study endpoint was recurrent VTE. Results: 150 (23%) of 653 patients had recurrence. Only high hematocrit was significantly associated with recurrence risk [hazard ratio (HR) for 1% hematocrit increase with the third tertile 1.08; 95% CI 1.01-1.15]. No or only a weak association for hematocrits within the first and second tertile was seen (HR 1.03; 95% CI 0.97-1.09, and 1.07; 95% CI 1.00-1.13). Hematocrit was associated with recurrence risk only among women. After five years, the probability of recurrence was 9.9% (95% CI 3.7%-15.7%), 15.6% (95% CI 9.7%-21.2%) and 25.5% (95% CI 15.1%-34.6%) in women, and was 29.2% (95% CI 21.1%-36.5%), 30.1% (95% CI 24.1%-35.7%) and 30.8% (95% CI 22.0%-38.7%) in men for hematocrits in the first, second and third tertile, respectively. Men had a higher recurrence risk (1.9; 95% CI 1.1-2.7; p = 0.03), which dropped by 23.5% after adjustment for hematocrit. Hematocrit was not a significant mediator of the sex-difference in recurrence risk (p = 0.223). Conclusions: High hematocrit is associated with the recurrence only in women. The different recurrence risk between men and women is possibly partly explained by hematocrit.	[Eischer, Lisbeth; Tscholl, Verena; Traby, Ludwig; Kyrle, Paul A.; Eichinger, Sabine] Med Univ Vienna, Dept Med 1, Vienna, Austria; [Heinze, Georg] Med Univ Vienna, Core Unit Med Stat & Informat, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Eischer, L (corresponding author), Med Univ Vienna, Dept Med 1, Vienna, Austria.	sabine.eichinger@meduniwien.ac.at	Traby, Ludwig/ABC-2338-2020	Traby, Ludwig/0000-0003-2861-5771; , Verena/0000-0003-2748-2540; Heinze, Georg/0000-0003-1147-8491	Medizinisch-Wissenschaftlicher Fond des Burgermeisters der Bundeshauptstadt Wien [10019]	Medizinisch-Wissenschaftlicher Fond des Burgermeisters der Bundeshauptstadt Wien	This work was supported by "Medizinisch-Wissenschaftlicher Fond des Burgermeisters der Bundeshauptstadt Wien" - Project Number 10019 (http://www.wien.gv.at/gesundheit/einrichtungen/med-wiss-fonds/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloom ALCDF, 1994, EGD HAEMOSTASIS THRO, V2, P1169; Braekkan SK, 2010, HAEMATOL-HEMATOL J, V95, P270, DOI 10.3324/haematol.2009.008417; BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185; Douketis J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d813; Eichinger S, 2010, CIRCULATION, V121, P1630, DOI 10.1161/CIRCULATIONAHA.109.925214; Heinze G, 2001, BIOMETRICS, V57, P114, DOI 10.1111/j.0006-341X.2001.00114.x; Kalbfleisch J. D., 1980, WILEY SERIES PROBABI; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kyrle PA, 2004, NEW ENGL J MED, V350, P2558, DOI 10.1056/NEJMoa032959; Kyrle PA, 2010, LANCET, V376, P2032, DOI 10.1016/S0140-6736(10)60962-2; Lin DY, 1997, STAT MED, V16, P1515, DOI 10.1002/(SICI)1097-0258(19970715)16:13<1515::AID-SIM572>3.3.CO;2-T; Mcrae S, 2006, LANCET, V368, P371, DOI 10.1016/S0140-6736(06)69110-1; RIUNITI O, 1995, ANN INTERN MED, V123, P656, DOI 10.7326/0003-4819-123-9-199511010-00003; Rodger MA, 2008, CAN MED ASSOC J, V179, P417, DOI 10.1503/cmaj.080493; Royston P., 2008, MULTIVARIABLE MODEL; SANTOS MT, 1991, J CLIN INVEST, V87, P571, DOI 10.1172/JCI115032; SCHAFER AI, 1984, BLOOD, V64, P1; VALLES J, 1991, BLOOD, V78, P154; Vaya A, 2002, CLIN HEMORHEOL MICRO, V26, P41	19	25	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38705	10.1371/journal.pone.0038705	http://dx.doi.org/10.1371/journal.pone.0038705			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701697	gold, Green Published, Green Submitted			2022-12-25	WOS:000305348400088
J	Katifori, E; Magnasco, MO				Katifori, Eleni; Magnasco, Marcelo O.			Quantifying Loopy Network Architectures	PLOS ONE			English	Article							LEAF VENATION PATTERNS; COMPLEX NETWORKS; CHANNEL NETWORKS; ORIGIN; SYSTEMS; TREES	Biology presents many examples of planar distribution and structural networks having dense sets of closed loops. An archetype of this form of network organization is the vasculature of dicotyledonous leaves, which showcases a hierarchicallynested architecture containing closed loops at many different levels. Although a number of approaches have been proposed to measure aspects of the structure of such networks, a robust metric to quantify their hierarchical organization is still lacking. We present an algorithmic framework, the hierarchical loop decomposition, that allows mapping loopy networks to binary trees, preserving in the connectivity of the trees the architecture of the original graph. We apply this framework to investigate computer generated graphs, such as artificial models and optimal distribution networks, as well as natural graphs extracted from digitized images of dicotyledonous leaves and vasculature of rat cerebral neocortex. We calculate various metrics based on the asymmetry, the cumulative size distribution and the Strahler bifurcation ratios of the corresponding trees and discuss the relationship of these quantities to the architectural organization of the original graphs. This algorithmic framework decouples the geometric information (exact location of edges and nodes) from the metric topology (connectivity and edge weight) and it ultimately allows us to perform a quantitative statistical comparison between predictions of theoretical models and naturally occurring loopy graphs.	[Katifori, Eleni; Magnasco, Marcelo O.] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA	Rockefeller University	Katifori, E (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10021 USA.	ekatifori@rockefeller.edu	Liu, Andrea/K-3968-2017	Liu, Andrea/0000-0002-2295-2729; Katifori, Eleni/0000-0002-7332-4749	National Science Foundation [PHY-1058899]; Burroughs-Wellcome Career at Scientific Interface Award; Raymond and Beverly Sackler Fellowship; Direct For Mathematical & Physical Scien [1058899] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Burroughs-Wellcome Career at Scientific Interface Award; Raymond and Beverly Sackler Fellowship; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by the National Science Foundation under Grant PHY-1058899. http://www.nsf.gov/.EK would like to acknowledge support from the Burroughs-Wellcome Career at the Scientific Interface Award and the Raymond and Beverly Sackler Fellowship. http://www.bwfund.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Ang WK, 2005, ENG OPTIMIZ, V37, P277, DOI 10.1080/0305215512331328259; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Blinder P, 2010, P NATL ACAD SCI USA, V107, P12670, DOI 10.1073/pnas.1007239107; Blonder B, 2011, ECOL LETT, V14, P91, DOI 10.1111/j.1461-0248.2010.01554.x; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Corson F, 2009, J THEOR BIOL, V259, P440, DOI 10.1016/j.jtbi.2009.05.002; Corson F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.048703; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Couder Y, 2002, EUR PHYS J B, V28, P135, DOI 10.1140/epjb/e2002-00211-1; Dimitrov P, 2006, P NATL ACAD SCI USA, V103, P9363, DOI 10.1073/pnas.0603559103; Fujita H, 2006, DEV DYNAM, V235, P2710, DOI 10.1002/dvdy.20908; Horton RE, 1945, GEOL SOC AM BULL, V56, P275; Katifori E, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.048704; KIRCHNER JW, 1993, GEOLOGY, V21, P591, DOI 10.1130/0091-7613(1993)021<0591:SIOHSL>2.3.CO;2; MELVILLE R, 1969, NATURE, V224, P121, DOI 10.1038/224121a0; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Paik K, 2007, EUR PHYS J B, V60, P247, DOI 10.1140/epjb/e2007-00332-y; Perna A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066106; Rinaldo A, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004108; Rinaldo A, 1998, ANNU REV EARTH PL SC, V26, P289, DOI 10.1146/annurev.earth.26.1.289; Rolland-Lagan AG, 2009, PLANT J, V57, P195, DOI 10.1111/j.1365-313X.2008.03678.x; Roth-Nebelsick A, 2001, ANN BOT-LONDON, V87, P553, DOI 10.1006/anbo.2001.1391; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Shao J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036105; STRAHLER AN, 1952, GEOL SOC AM BULL, V63, P1117, DOI 10.1130/0016-7606(1952)63[1117:HAAOET]2.0.CO;2; TAKAYASU H, 1988, PHYS REV A, V37, P3110, DOI 10.1103/PhysRevA.37.3110; Tero A, 2010, SCIENCE, V327, P439, DOI 10.1126/science.1177894; VANPELT J, 1992, B MATH BIOL, V54, P759, DOI 10.1016/S0092-8240(05)80142-9	30	47	47	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37994	10.1371/journal.pone.0037994	http://dx.doi.org/10.1371/journal.pone.0037994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701593	Green Published, Green Submitted, gold			2022-12-25	WOS:000305348400028
J	Miller, EF; Vaish, S; Maier, RJ				Miller, Erica F.; Vaish, Soumya; Maier, Robert J.			Efficiency of Purine Utilization by Helicobacter pylori: Roles for Adenosine Deaminase and a NupC Homolog	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; COMPLETE GENOME SEQUENCE; NUTRITIONAL-REQUIREMENTS; NUCLEOTIDE BIOSYNTHESIS; PYRIMIDINE METABOLISM; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; DEFINED MEDIUM; HUMAN-BLOOD; GROWTH	The ability to synthesize and salvage purines is crucial for colonization by a variety of human bacterial pathogens. Helicobacter pylori colonizes the gastric epithelium of humans, yet its specific purine requirements are poorly understood, and the transport mechanisms underlying purine uptake remain unknown. Using a fully defined synthetic growth medium, we determined that H. pylori 26695 possesses a complete salvage pathway that allows for growth on any biological purine nucleobase or nucleoside with the exception of xanthosine. Doubling times in this medium varied between 7 and 14 hours depending on the purine source, with hypoxanthine, inosine and adenosine representing the purines utilized most efficiently for growth. The ability to grow on adenine or adenosine was studied using enzyme assays, revealing deamination of adenosine but not adenine by H. pylori 26695 cell lysates. Using mutant analysis we show that a strain lacking the gene encoding a NupC homolog (HP1180) was growth-retarded in a defined medium supplemented with certain purines. This strain was attenuated for uptake of radiolabeled adenosine, guanosine, and inosine, showing a role for this transporter in uptake of purine nucleosides. Deletion of the GMP biosynthesis gene guaA had no discernible effect on mouse stomach colonization, in contrast to findings in numerous bacterial pathogens. In this study we define a more comprehensive model for purine acquisition and salvage in H. pylori that includes purine uptake by a NupC homolog and catabolism of adenosine via adenosine deaminase.	[Miller, Erica F.; Vaish, Soumya; Maier, Robert J.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Miller, EF (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	rmaier@uga.edu			University of Georgia Research Foundation	University of Georgia Research Foundation	The University of Georgia Research Foundation supported this work, but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltrus DA, 2009, J BACTERIOL, V191, P447, DOI 10.1128/JB.01416-08; Chiang SL, 1998, MOL MICROBIOL, V27, P797, DOI 10.1046/j.1365-2958.1998.00726.x; COLONNA A, 1983, ANAL BIOCHEM, V130, P19, DOI 10.1016/0003-2697(83)90644-9; Duckworth M, 2006, HELICOBACTER, V11, P287, DOI 10.1111/j.1523-5378.2006.00409.x; HAM RG, 1965, P NATL ACAD SCI USA, V53, P288, DOI 10.1073/pnas.53.2.288; HAMMOND DJ, 1984, MOL BIOCHEM PARASIT, V13, P243, DOI 10.1016/0166-6851(84)90117-8; HARTWICK RA, 1979, J CHROMATOGR, V186, P659, DOI 10.1016/S0021-9673(00)95286-5; HOFFMEYE.I, 1971, J BACTERIOL, V106, P14, DOI 10.1128/JB.106.1.14-24.1971; IVANOVIC.G, 1968, J GEN MICROBIOL, V53, P147, DOI 10.1099/00221287-53-2-147; Jewett MW, 2009, J BACTERIOL, V191, P6231, DOI 10.1128/JB.00450-09; Kilstrup M, 2005, FEMS MICROBIOL REV, V29, P555, DOI 10.1016/j.femsre.2005.04.006; Kleanthous H., 1995, Gut, V37, pA94; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Liechti G, 2012, J BACTERIOL, V194, P839, DOI 10.1128/JB.05757-11; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Loewen SK, 1999, J BIOL CHEM, V274, P24475, DOI 10.1074/jbc.274.35.24475; Loewen SK, 2004, MOL MEMBR BIOL, V21, P1, DOI 10.1080/0968768031000140836; Makola D, 2007, J CLIN GASTROENTEROL, V41, P548, DOI 10.1097/MCG.0b013e318030e3c3; Martinussen J, 2003, J BACTERIOL, V185, P1503, DOI 10.1128/JB.185.5.1503-1508.2003; MCCLARTY G, 1993, J BACTERIOL, V175, P4652, DOI 10.1128/JB.175.15.4652-4661.1993; Mehta NS, 2005, INFECT IMMUN, V73, P5311, DOI 10.1128/IAI.73.9.5311-5318.2005; MENDZ GL, 1994, J APPL BACTERIOL, V77, P674, DOI 10.1111/j.1365-2672.1994.tb02818.x; Mendz GL, 1997, ARCH MICROBIOL, V168, P448, DOI 10.1007/s002030050521; NEDENSKOV P, 1994, APPL ENVIRON MICROB, V60, P3450, DOI 10.1128/AEM.60.9.3450-3453.1994; Nygaard P, 1996, J BACTERIOL, V178, P846, DOI 10.1128/jb.178.3.846-853.1996; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Patching SG, 2005, ORG BIOMOL CHEM, V3, P462, DOI 10.1039/b414739a; Pettersson J, 2007, INFECT IMMUN, V75, P3877, DOI 10.1128/IAI.00199-07; REYNOLDS DJ, 1994, MICROBIOL-UK, V140, P2649, DOI 10.1099/00221287-140-10-2649; Ritzel MWL, 2001, J BIOL CHEM, V276, P2914, DOI 10.1074/jbc.M007746200; Roodveldt C, 2005, BIOCHEMISTRY-US, V44, P12728, DOI 10.1021/bi051021e; Russo TA, 1996, MOL MICROBIOL, V22, P217, DOI 10.1046/j.1365-2958.1996.00096.x; Samant S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040037; Saxild HH, 1996, J BACTERIOL, V178, P424, DOI 10.1128/jb.178.2.424-434.1996; Schreiber S, 2004, P NATL ACAD SCI USA, V101, P5024, DOI 10.1073/pnas.0308386101; Seffernick JL, 2001, BIOCHEMISTRY-US, V40, P12747, DOI 10.1021/bi011293r; STRALEY SC, 1984, INFECT IMMUN, V45, P649, DOI 10.1128/IAI.45.3.649-654.1984; Tan SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000407; Testerman TL, 2001, J CLIN MICROBIOL, V39, P3842, DOI 10.1128/JCM.39.11.3842-3850.2001; Testerman TL, 2006, J CLIN MICROBIOL, V44, P1650, DOI 10.1128/JCM.44.5.1650-1658.2006; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Wang JY, 2001, INFECT IMMUN, V69, P4734, DOI 10.1128/IAI.69.8.4734-4741.2001; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; White RH, 1997, J BACTERIOL, V179, P563, DOI 10.1128/jb.179.2.563-566.1997; ZALKIN H, 1996, BIOSYNTHESIS PURINE	46	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38727	10.1371/journal.pone.0038727	http://dx.doi.org/10.1371/journal.pone.0038727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701700	Green Published, Green Submitted, gold			2022-12-25	WOS:000305348400090
J	Zhang, P; Guo, A; Possemato, A; Wang, C; Beard, L; Carlin, C; Markowitz, SD; Polakiewicz, RD; Wang, Z				Zhang, P.; Guo, A.; Possemato, A.; Wang, C.; Beard, L.; Carlin, C.; Markowitz, S. D.; Polakiewicz, R. D.; Wang, Z.			Identification and functional characterization of p130Cas as a substrate of protein tyrosine phosphatase nonreceptor 14	ONCOGENE			English	Article						PTPN14; p130Cas; tumorigenesis; colorectal cancer	HUMAN BREAST; TGF-BETA; SRC; RECEPTOR; ASSOCIATION; KINASE; PEZ; CAS; PHOSPHORYLATION; RESISTANCE	Protein tyrosine phosphatase nonreceptor type 14 (PTPN14) is frequently mutated in a variety of human cancers. However, the cell signaling pathways regulated by PTPN14 largely remain to be elucidated. Here, we identify a list of potential substrates of PTPN14 using a phospho-proteomic approach. We show that p130 Crk-associated substrate (p130Cas) is a direct substrate of PTPN14 and that PTPN14 specifically regulates p130Cas phosphorylation at tyrosine residue 128 (Y128) in colorectal cancer (CRC) cells. We engineered CRC cells homozygous for a p130Cas Y128F knock-in mutant and found that these cells exhibit significantly reduced migration and colony formation, impaired anchorage-independent growth, slower xenograft tumor growth in nude mice and have decreased phosphorylation of AKT. Furthermore, we demonstrate that SRC phosphorylates p130Cas Y128 and that CRC cell lines harboring high levels of pY128Cas are more sensitive to SRC family kinase inhibitor Dasatinib. These findings suggest that p130Cas Y128 phosphorylation may be exploited as a predictive marker for Dasatinib response in cancer patients. In aggregate, our studies reveal a novel signaling pathway that has an important role in colorectal tumorigenesis. Oncogene (2013) 32, 2087-2095; doi:10.1038/onc.2012.220; published online 18 June 2012	[Zhang, P.; Wang, C.; Wang, Z.] Case Western Reserve Univ, Dept Genet, Sch Med, Cleveland, OH 44106 USA; [Zhang, P.; Wang, C.; Beard, L.; Markowitz, S. D.; Wang, Z.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Sch Med, Cleveland, OH 44106 USA; [Guo, A.; Possemato, A.; Polakiewicz, R. D.] Cell Signaling Technol Inc, Danvers, MA USA; [Beard, L.; Markowitz, S. D.] Case Western Reserve Univ, Dept Genet, Sch Med, Case Med Ctr, Cleveland, OH 44106 USA; [Wang, Z.] Cleveland Clin Fdn, Genom Med Inst, Cleveland, OH 44195 USA; [Carlin, C.] Case Western Reserve Univ, Dept Microbiol & Mol Biol, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University	Wang, Z (corresponding author), Case Western Reserve Univ, Dept Genet, Sch Med, 10900 Euclid Ave, Cleveland, OH 44106 USA.	zhenghe.wang@case.edu			National Institutes of Health [R01-CA127590, R01-HG004722]; Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [P50CA150964, R01CA127590, P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Yueting Chen for excellent technical assistance, Drs Susann Brady-Kalnay, Hua Luo and CK Qu for helpful discussions, and Anthony Scott for critical reading of the manuscript. This research was supported by grants from the National Institutes of Health Grant R01-CA127590, R01-HG004722 and a pilot grant from the Case Comprehensive Cancer Center.	Akagi T, 2002, MOL CELL BIOL, V22, P7015, DOI 10.1128/MCB.22.20.7015-7023.2002; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bohnacker T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000259; Brognard J, 2011, CURR OPIN GENET DEV, V21, P4, DOI 10.1016/j.gde.2010.10.012; Burnham MR, 1996, ONCOGENE, V12, P2467; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; Montero JC, 2011, CLIN CANCER RES, V17, P5546, DOI 10.1158/1078-0432.CCR-10-2616; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; DORSSERS LCJ, 1993, MOL ENDOCRINOL, V7, P870, DOI 10.1210/me.7.7.870; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Goldberg GS, 2003, J BIOL CHEM, V278, P46533, DOI 10.1074/jbc.M307526200; Hirata R, 2002, NAT BIOTECHNOL, V20, P735, DOI 10.1038/nbt0702-735; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Kohli M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh009; Li EG, 2000, J BIOL CHEM, V275, P14729, DOI 10.1074/jbc.275.19.14729; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Liang FB, 2007, MOL BIOSYST, V3, P308, DOI 10.1039/b700704n; MATSUDA M, 1990, SCIENCE, V248, P1537, DOI 10.1126/science.1694307; Ogata M, 1999, J BIOL CHEM, V274, P12905, DOI 10.1074/jbc.274.18.12905; Patwardhan P, 2006, J BIOL CHEM, V281, P20689, DOI 10.1074/jbc.M602311200; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P3951, DOI 10.1128/MCB.9.9.3951; Riggins RB, 2003, MOL CANCER RES, V1, P428; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Wadham C, 2003, MOL BIOL CELL, V14, P2520, DOI 10.1091/mbc.E02-09-0577; Wadham C, 2000, J CELL SCI, V113, P3117; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wyatt L, 2008, CELL CYCLE, V7, P2290, DOI 10.4161/cc.6443; Wyatt L, 2007, J CELL BIOL, V178, P1223, DOI 10.1083/jcb.200705035; Yarom N, 2011, DISCOV MED, V11, P95; Zhang P, 2011, MOL CANCER RES, V9, P1418, DOI 10.1158/1541-7786.MCR-11-0147; Zhang XD, 2008, NAT METHODS, V5, P163, DOI [10.1038/nmeth1170, 10.1038/NMETH1170]; Zhang XD, 2007, P NATL ACAD SCI USA, V104, P4060, DOI 10.1073/pnas.0611665104; Zhao YQ, 2010, P NATL ACAD SCI USA, V107, P2592, DOI 10.1073/pnas.0914884107	43	28	31	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 18	2013	32	16					2087	2095		10.1038/onc.2012.220	http://dx.doi.org/10.1038/onc.2012.220			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	130LY	22710723	Green Accepted			2022-12-25	WOS:000317919900010
J	Borgeson, E; McGillicuddy, FC; Harford, KA; Corrigan, N; Higgins, DF; Maderna, P; Roche, HM; Godson, C				Boergeson, Emma; McGillicuddy, Fiona C.; Harford, Karen A.; Corrigan, Niamh; Higgins, Debra F.; Maderna, Paola; Roche, Helen M.; Godson, Catherine			Lipoxin A(4) attenuates adipose inflammation	FASEB JOURNAL			English	Article						resolution; proresolving eicosanoids; obesity; insulin resistance	NECROSIS-FACTOR-ALPHA; MACROPHAGE ACCUMULATION; APOPTOTIC NEUTROPHILS; INSULIN SENSITIVITY; TISSUE MACROPHAGES; LINOLEIC-ACID; CUTTING EDGE; BONE-MARROW; RESOLVIN D1; IN-VITRO	Aging and adiposity are associated with chronic low-grade inflammation, which underlies the development of obesity-associated complications, including type 2 diabetes mellitus (T2DM). The mechanisms underlying adipose inflammation may include macrophage infiltration and activation, which, in turn, affect insulin sensitivity of adipocytes. There is a growing appreciation that specific lipid mediators (including lipoxins, resolvins, and protectins) can promote the resolution of inflammation. Here, we investigated the effect of lipoxin A(4) (LXA(4)), the predominant endogenously generated lipoxin, on adipose tissue inflammation. Using adipose tissue explants from perigonadal depots of aging female C57BL/6J mice (Animalia, Chordata, Mus musculus) as a model of age-associated adipose inflammation, we report that LXA(4) (1 nM) attenuates adipose inflammation, decreasing IL-6 and increasing IL-10 expression (P<0.05). The altered cytokine milieu correlated with increased GLUT-4 and IRS-1 expression, suggesting improved insulin sensitivity. Further investigations revealed the ability of LXA(4) to rescue macrophage-induced desensitization to insulin-stimulated signaling and glucose uptake in cultured adipocytes, using vehicle-stimulated cells as controls. This was associated with preservation of Akt activation and reduced secretion of proinflammatory cytokines, including TNF-alpha. We therefore propose that LXA(4) may represent a potentially useful and novel therapeutic strategy to subvert adipose inflammation and insulin resistance, key components of T2DM.-Borgeson, E., McGillicuddy, F. C., Harford, K. A., Corrigan, N., Higgins, D. F., Maderna, P., Roche, H. M., Godson C. Lipoxin A(4) attenuates adipose inflammation. FASEB J. 26, 4287-4294 (2012). www.fasebj.org	[Boergeson, Emma; Corrigan, Niamh; Higgins, Debra F.; Maderna, Paola; Godson, Catherine] Univ Coll Dublin, Diabet Res Ctr, Conway Inst, Sch Med & Med Sci, Dublin 2, Ireland; [McGillicuddy, Fiona C.; Harford, Karen A.; Roche, Helen M.] Univ Coll Dublin, Nutrigen Res Grp, Conway Inst, Dublin 2, Ireland; [McGillicuddy, Fiona C.; Harford, Karen A.; Roche, Helen M.] Univ Coll Dublin, Sch Publ Hlth, Dublin 2, Ireland	University College Dublin; University College Dublin; University College Dublin	Godson, C (corresponding author), Univ Coll Dublin, Diabet Res Ctr, Conway Inst, Sch Med & Med Sci, Dublin 2, Ireland.	catherine.godson@ucd.ie	Borgeson, Emma/O-3128-2017; Roche, Helen M/AAF-4164-2019	Borgeson, Emma/0000-0002-2290-9472; Roche, Helen M/0000-0002-0628-3318; McGillicuddy, Fiona/0000-0003-3623-3503; Godson, Catherine/0000-0003-0655-1041	Science Foundation Ireland [06/IN.1/B114, 06/IN.1/B105]; Health Research Board; Government of Ireland Programme for Research in Third Level Institutions; Irish Research Council for Science, Engineering, and Technology Embark postgraduate research scholarship	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board; Government of Ireland Programme for Research in Third Level Institutions; Irish Research Council for Science, Engineering, and Technology Embark postgraduate research scholarship(Irish Research Council for Science, Engineering and Technology)	The authors acknowledge valuable advice from Prof. Mauro Perretti (William Harvey Research Institute, Queen Mary University, London, UK). The authors also acknowledge technical help of the University College Dublin (UCD) Conway Institute Transcriptomics Core facility and staff at the UCD Biomedical animal facility, as well as Dr. Deirdre Keane and Dr. Claire Kennedy. E.B. is a recipient of an Irish Research Council for Science, Engineering, and Technology Embark postgraduate research scholarship. Work in the C.G. laboratory is supported by Science Foundation Ireland (06/IN.1/B114), the Health Research Board, and the Government of Ireland Programme for Research in Third Level Institutions. The H.M.R. laboratory is supported by Science Foundation Ireland (06/IN.1/B105).	Bandeira-Melo C, 2000, J IMMUNOL, V164, P2267, DOI 10.4049/jimmunol.164.5.2267; Borgeson E, 2011, FASEB J, V25, P2967, DOI 10.1096/fj.11-185017; Borgeson E, 2010, THESCIENTIFICWORLDJO, V10, P1370, DOI 10.1100/tsw.2010.120; Borgeson E, 2011, INFECT IMMUN, V79, P1489, DOI 10.1128/IAI.00777-10; Brancaleone V, 2011, J IMMUNOL, V186, P4905, DOI 10.4049/jimmunol.1003145; Cevenini E, 2010, CURR PHARM DESIGN, V16, P609, DOI 10.2174/138161210790883840; Chen AR, 2005, OBES RES, V13, P1311, DOI 10.1038/oby.2005.159; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Cusi K, 2010, CURR DIABETES REP, V10, P306, DOI 10.1007/s11892-010-0122-6; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Decker Y, 2009, AM J PHYSIOL-CELL PH, V296, pC1420, DOI 10.1152/ajpcell.00380.2008; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Dragunow M, 2007, J BIOMOL SCREEN, V12, P999, DOI 10.1177/1087057107306502; Gangemi S, 2005, EXP GERONTOL, V40, P612, DOI 10.1016/j.exger.2005.04.004; GAO JL, 1993, J BIOL CHEM, V268, P25395; Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Goh J, 2001, J IMMUNOL, V167, P2772, DOI 10.4049/jimmunol.167.5.2772; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Gonzalez-Periz A, 2010, THESCIENTIFICWORLDJO, V10, P832, DOI 10.1100/tsw.2010.77; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Hachicha M, 1999, J EXP MED, V189, P1923, DOI 10.1084/jem.189.12.1923; Halade GV, 2011, J NUTR BIOCHEM, V22, P459, DOI 10.1016/j.jnutbio.2010.03.015; Harford KA, 2011, P NUTR SOC, V70, P408, DOI 10.1017/S0029665111000565; Hellmann J, 2011, FASEB J, V25, P2399, DOI 10.1096/fj.10-178657; Huggins A, 2009, FASEB J, V23, P985, DOI 10.1096/fj.08-119040; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Kure I, 2010, J PHARMACOL EXP THER, V332, P541, DOI 10.1124/jpet.109.159046; LEE TH, 1989, CLIN SCI, V77, P195, DOI 10.1042/cs0770195; Liu LF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-212; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Lumeng CN, 2011, J IMMUNOL, V187, P6208, DOI 10.4049/jimmunol.1102188; Maderna P, 2010, FASEB J, V24, P4240, DOI 10.1096/fj.10-159913; Maderna P, 2009, BRIT J PHARMACOL, V158, P947, DOI 10.1111/j.1476-5381.2009.00386.x; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mathew AV, 2011, CURR DIABETES REV, V7, P41, DOI 10.2174/157339911794273928; McMahon B, 2002, FASEB J, V16, P1817, DOI 10.1096/fj.02-0416fje; Mitchell D, 2004, AM J PATHOL, V164, P937, DOI 10.1016/S0002-9440(10)63181-1; Mitchell S, 2002, J AM SOC NEPHROL, V13, P2497, DOI 10.1097/01.ASN.0000032417.73640.72; Moloney F, 2007, DIABETES, V56, P574, DOI 10.2337/db06-0384; Nascimento-Silva V, 2007, THROMB HAEMOSTASIS, V97, P88, DOI 10.1160/TH06-06-0315; Nishiumi S, 2007, BIOSCI BIOTECH BIOCH, V71, P2343, DOI 10.1271/bbb.70342; Oliver E, 2012, J NUTR BIOCHEM, V23, P1192, DOI 10.1016/j.jnutbio.2011.06.014; Oliver E, 2010, P NUTR SOC, V69, P232, DOI 10.1017/S0029665110000042; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; Pouliot M, 1999, J PERIODONTAL RES, V34, P370, DOI 10.1111/j.1600-0765.1999.tb02268.x; Rachdaoui N, 2003, AM J PHYSIOL-ENDOC M, V285, pE545, DOI 10.1152/ajpendo.00160.2003; Rajakariarl R, 2008, BLOOD, V111, P4184, DOI 10.1182/blood-2007-08-108936; Reville K, 2006, J IMMUNOL, V176, P1878, DOI 10.4049/jimmunol.176.3.1878; Romano M, 2007, THESCIENTIFICWORLDJO, V7, P1393, DOI 10.1100/tsw.2007.186; Romano M, 2010, THESCIENTIFICWORLDJO, V10, P1048, DOI 10.1100/tsw.2010.113; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; SERHAN CN, 1984, P NATL ACAD SCI-BIOL, V81, P5335, DOI 10.1073/pnas.81.17.5335; Spencer M, 2010, AM J PHYSIOL-ENDOC M, V299, pE1016, DOI 10.1152/ajpendo.00329.2010; Stables MJ, 2011, PROG LIPID RES, V50, P35, DOI 10.1016/j.plipres.2010.07.005; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Vaughn MW, 2002, J IMMUNOL, V169, P3363, DOI 10.4049/jimmunol.169.6.3363; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Wu J, 2011, BIOCHEM BIOPH RES CO, V408, P382, DOI 10.1016/j.bbrc.2011.04.013; Wu SH, 2006, AM J RESP CELL MOL, V34, P65, DOI 10.1165/rcmb.2005-0184OC; Wu SH, 2005, KIDNEY INT, V68, P35, DOI 10.1111/j.1523-1755.2005.00379.x	67	78	85	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2012	26	10					4287	4294		10.1096/fj.12-208249	http://dx.doi.org/10.1096/fj.12-208249			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22700871	Bronze			2022-12-25	WOS:000309704000033
J	Roy, S; Short, MK; Stanley, ER; Jubinsky, PT				Roy, Soumit; Short, Mary K.; Stanley, E. Richard; Jubinsky, Paul T.			Essential role of Drosophila black-pearl is mediated by its effects on mitochondrial respiration	FASEB JOURNAL			English	Article						reactive oxygen species; electron transport chain; melanotic inclusions; Magmas; Pam 16	PROTEIN IMPORT MOTOR; CELL-CYCLE PROGRESSION; PRESEQUENCE TRANSLOCASE; INNER MEMBRANE; OXIDATIVE STRESS; HOST-DEFENSE; MAGMAS; MELANOGASTER; AUTOPHAGY; GENE	Black-pearl (Blp) is a highly conserved, essential inner-mitochondrial membrane protein. The yeast Blp homologue, Magmas/Pam16, is required for mitochondrial protein transport, growth, and survival. Our purpose was to determine the role of Drosophila Blp in mitochondrial function, cell survival, and proliferation. To this end, we performed mitotic recombination in Drosophila melanogaster, RNAi-mediated knockdown, MitoTracker staining, measurement of reactive oxygen species (ROS), flow cytometry, electron transport chain complex assays, and hemocyte isolation from Drosophila larvae. Proliferation-defective, Blp-deficient Drosophila Schneider cells exhibited mitochondrial membrane depolarization, a 60% decrease in ATP levels, increased amounts of ROS (3.5-fold), cell cycle arrest, and activation of autophagy that were associated with a selective 65% reduction of cytochrome c oxidase activity. N-acetyl cysteine (NAC) rescued Blp-RNAi-treated cells from cell cycle arrest, indicating that increased production of ROS is the primary cause of the proliferation and survival defects in Blp-depleted cells. blp hypomorph larvae had a 35% decreased number of plasmatocytes with a 45% reduced active mitochondrial staining and their viability was increased 2-fold by administration of NAC, which blocked melanotic lesions. Loss of Blp decreases cytochrome c oxidase activity and uncouples oxidative phosphorylation, causing ROS production, which selectively affects mitochondria-rich plasmatocyte survival and function, leading to melanotic lesions in Blp-deficient flies.-Roy, S., Short, M. K., Stanley, E. R., Jubinsky, P. T. Essential role of Drosophila black-pearl is mediated by its effects on mitochondrial respiration. FASEB J. 26, 3822-3833 (2012). www.fasebj.org	[Roy, Soumit; Short, Mary K.; Stanley, E. Richard; Jubinsky, Paul T.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Jubinsky, Paul T.] Yale Univ, Sch Med, Sect Pediat Hematol Oncol, New Haven, CT USA	Yeshiva University; Albert Einstein College of Medicine; Yale University	Stanley, ER (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA.	richard.stanley@einstein.yu.edu	Stanley, Evan R/J-9154-2013	Stanley, Evan R/0000-0002-2910-2065	U.S. National Institutes of Health [CA26504]; Albert Einstein College of Medicine Cancer Center [5P30-CA13330]; James B. Ax Family Foundation; SAS Foundation for Cancer Research; Magmas Research Fund; NATIONAL CANCER INSTITUTE [P30CA013330, R01CA026504, R37CA026504] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine Cancer Center; James B. Ax Family Foundation; SAS Foundation for Cancer Research; Magmas Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Nicholas Baker (Albert Einstein College of Medicine) for reagents and advice with the mosaic analysis and hemocyte isolation, Dr. Erich Buchner (Biozentrum der Universitat Wurzburg, Am Hubland, Wurzburg, Germany) for the Drosophila blp lines, the Einstein Analytical Imaging and Flow Cytometry Core Facilities, and Donna Alex, Pete Walker, and Mary and Robert Cancilla for their support. This work was supported by U.S. National Institutes of Health grant CA26504 (E. R. S.), the Albert Einstein College of Medicine Cancer Center grant 5P30-CA13330, the James B. Ax Family Foundation, The SAS Foundation for Cancer Research, and the Magmas Research Fund (P.T.J.).	Becker S, 2001, GENE, V262, P15, DOI 10.1016/S0378-1119(00)00548-5; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; D'Silva P, 2004, NAT STRUCT MOL BIOL, V11, P1084, DOI 10.1038/nsmb846; D'Silva PR, 2008, MOL BIOL CELL, V19, P424, DOI 10.1091/mbc.E07-08-0748; D'Silva PR, 2005, P NATL ACAD SCI USA, V102, P12419, DOI 10.1073/pnas.0505969102; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; HANRATTY WP, 1993, MOL GEN GENET, V238, P33, DOI 10.1007/BF00279527; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Jubinsky PT, 2011, BIOORG MED CHEM LETT, V21, P3479, DOI 10.1016/j.bmcl.2011.03.050; Jubinsky PT, 2005, J MOL HISTOL, V36, P69, DOI 10.1007/s10735-004-3840-8; Jubinsky PT, 2001, EXP HEMATOL, V29, P1392, DOI 10.1016/S0301-472X(01)00749-4; Ladha JS, 2005, CELL DEATH DIFFER, V12, P1417, DOI 10.1038/sj.cdd.4401668; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Levine B, 2008, NAT CELL BIOL, V10, P637, DOI 10.1038/ncb0608-637; Li YF, 2004, J BIOL CHEM, V279, P38047, DOI 10.1074/jbc.M404319200; Liang HL, 2010, FREE RADICAL BIO MED, V49, P1550, DOI 10.1016/j.freeradbiomed.2010.08.018; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Meister M, 2004, CURR OPIN IMMUNOL, V16, P10, DOI 10.1016/j.coi.2003.11.002; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Nemoto S, 2000, MOL CELL BIOL, V20, P7311, DOI 10.1128/MCB.20.19.7311-7318.2000; Pais JE, 2011, MOL BIOL CELL, V22, P4740, DOI 10.1091/mbc.E11-08-0715; Perrimon N, 1996, GENETICS, V144, P1681; Pile LA, 2003, J BIOL CHEM, V278, P37840, DOI 10.1074/jbc.M305996200; Poyton RO, 2009, TRENDS ENDOCRIN MET, V20, P332, DOI 10.1016/j.tem.2009.04.001; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Schwarze SR, 1998, FREE RADICAL BIO MED, V25, P740, DOI 10.1016/S0891-5849(98)00153-1; Sinha D, 2010, HUM MOL GENET, V19, P1248, DOI 10.1093/hmg/ddq002; Sirrenberg C, 1996, NATURE, V384, P582, DOI 10.1038/384582a0; Sriram V, 2003, J CELL BIOL, V161, P593, DOI 10.1083/jcb.200210166; Tagliati F, 2010, ENDOCRINOLOGY, V151, P4635, DOI 10.1210/en.2010-0441; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020; van der Laan M, 2010, BBA-MOL CELL RES, V1803, P732, DOI 10.1016/j.bbamcr.2010.01.013; VandenHoek TL, 1997, J MOL CELL CARDIOL, V29, P2571, DOI 10.1006/jmcc.1997.0497; Wang YC, 2011, J BIOL CHEM, V286, P21742, DOI 10.1074/jbc.M110.160697; Wang Z, 2001, MOL CELL BIOL, V21, P5742, DOI 10.1128/MCB.21.17.5742-5752.2001; WATSON KL, 1991, DEV GENET, V12, P173, DOI 10.1002/dvg.1020120302; Wiedemann N, 2007, J CELL BIOL, V179, P1115, DOI 10.1083/jcb.200709087; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; XU T, 1993, DEVELOPMENT, V117, P1223; Yu WF, 2008, J LEUKOCYTE BIOL, V84, P852, DOI 10.1189/jlb.0308171	50	10	10	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2012	26	9					3822	3833		10.1096/fj.11-193540	http://dx.doi.org/10.1096/fj.11-193540			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22700875	Green Published			2022-12-25	WOS:000308391600022
J	Conlan, BF; Colgrave, ML; Gillon, AD; Guarino, R; Craik, DJ; Anderso, MA				Conlan, Brendon F.; Colgrave, Michelle L.; Gillon, Amanda D.; Guarino, Rosemary; Craik, David J.; Anderso, Marilyn A.			Insights into Processing and Cyclization Events Associated with Biosynthesis of the Cyclic Peptide Kalata B1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR PROTEINS; CYSTINE KNOT; PLANT CYCLOTIDES; MACROCYCLIC PEPTIDES; DISCOVERY; MECHANISMS; SUNFLOWER	Plant cyclotides are the largest family of gene-encoded cyclic proteins. They act as host defense molecules to protect plants and are promising candidates as insecticidal and nematocidal agents in agriculture. For this promise to be realized a greater understanding of the post-translational processing of these proteins is needed. Cyclotides are cleaved from precursor proteins with subsequent ligation of the N and C termini to form a continuous peptide backbone. This cyclization step is inefficient in transgenic plants and our work aims to shed light on the specificity requirements at the excision sites for cyclic peptide production. Using the prototypic cyclotide kalata B1 (kB1) expressed from the Oak1 gene, MALDI-TOF mass spectrometry was used to examine the cyclization efficiency when mutants of the Oak1 gene were expressed in transgenic Nicotiana benthamiana. Cleavage at the N terminus of the cyclotide domain occurs rapidly with no strict specificity requirements for amino acids at the cleavage site. In contrast, the C-terminal region of the cyclotide domain in the P2, P1, P1', and P2' positions is highly conserved and only specific amino acids can occupy these positions. The cyclization reaction requires an Asn at position P1 followed by a small amino acid (Ala, Gly, Ser) at the P1' position. The P2' position must be filled by Leu or Ile; in their absence an unusual post-translational modification occurs. Substitution of the P2' Leu with Ala leads to hydroxylation of the neighboring proline. Through mutational analysis this novel proline hydroxylation motif was determined to be Gly-Ala-Pro-Ser.	[Conlan, Brendon F.; Gillon, Amanda D.; Guarino, Rosemary; Anderso, Marilyn A.] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Colgrave, Michelle L.] CSIRO Livestock Ind, Brisbane, Qld 4067, Australia; [Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	La Trobe University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	Anderso, MA (corresponding author), La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia.	m.anderson@latrobe.edu.au	Colgrave, Michelle/A-5710-2012; Conlan, Brendon F/A-7013-2012; Anderson, Marilyn A/A-4259-2012; Craik, David/B-1695-2010	Colgrave, Michelle/0000-0001-8463-805X; Conlan, Brendon F/0000-0002-0934-3865; Anderson, Marilyn A/0000-0002-8257-5128; Craik, David/0000-0003-0007-6796	Australian Research Council [DP0984390]	Australian Research Council(Australian Research Council)	This work was supported by Grant DP0984390 from the Australian Research Council.	Anderson M. A., 1997, J INSECT PHYSL, V43, P833, DOI [10.1016/S0022-1910(97)00026-7, DOI 10.1016/S0022-1910(97)00026-7]; Bajaj MS, 2011, J BIOL CHEM, V286, P4329, DOI 10.1074/jbc.M110.191163; Burman R, 2010, PHYTOCHEMISTRY, V71, P13, DOI 10.1016/j.phytochem.2009.09.023; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Conlan BF, 2011, CURR PHARM DESIGN, V17, P4318; Conlan BF, 2011, AM J BOT, V98, P2018, DOI 10.3732/ajb.1100382; Conlan BF, 2010, BIOPOLYMERS, V94, P573, DOI 10.1002/bip.21422; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2004, CURR PROTEIN PEPT SC, V5, P297, DOI 10.2174/1389203043379512; Craik DJ, 2003, J BACTERIOL, V185, P4011, DOI 10.1128/JB.185.14.4011-4021.2003; Craik DJ, 2001, LETT PEPT SCI, V8, P119, DOI 10.1007/BF02446507; Craik DJ, 2002, CURR OPIN DRUG DI DE, V5, P251; Dutton JL, 2004, J BIOL CHEM, V279, P46858, DOI 10.1074/jbc.M407421200; Gillon AD, 2008, PLANT J, V53, P505, DOI 10.1111/j.1365-313X.2007.03357.x; GRAN L, 1973, LLOYDIA, V36, P207; Gruber CW, 2007, J BIOL CHEM, V282, P20435, DOI 10.1074/jbc.M700018200; Gruber CW, 2007, TOXICON, V49, P561, DOI 10.1016/j.toxicon.2006.11.018; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Kaas Q, 2010, BIOPOLYMERS, V94, P584, DOI 10.1002/bip.21424; Mulvenna JP, 2005, J BIOL CHEM, V280, P32245, DOI 10.1074/jbc.M506060200; Mylne JS, 2011, NAT CHEM BIOL, V7, P257, DOI 10.1038/nchembio.542; Poth AG, 2011, P NATL ACAD SCI USA, V108, P10127, DOI 10.1073/pnas.1103660108; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; Shimizu M, 2005, PLANT J, V42, P877, DOI 10.1111/j.1365-313X.2005.02419.x; Tan NH, 2006, CHEM REV, V106, P840, DOI 10.1021/cr040699h; Yuasa K, 2005, PLANT J, V41, P81, DOI 10.1111/j.1365-313X.2004.02279.x; Zhang J, 2009, GENE, V431, P23, DOI 10.1016/j.gene.2008.11.005	27	32	33	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28037	28046		10.1074/jbc.M112.347823	http://dx.doi.org/10.1074/jbc.M112.347823			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22700963	Green Published, hybrid			2022-12-25	WOS:000307840700077
J	Hollingshead, S; Kopecna, J; Jackson, PJ; Canniffe, DP; Davison, PA; Dickman, MJ; Sobotka, R; Hunter, CN				Hollingshead, Sarah; Kopecna, Jana; Jackson, Philip J.; Canniffe, Daniel P.; Davison, Paul A.; Dickman, Mark J.; Sobotka, Roman; Hunter, C. Neil			Conserved Chloroplast Open-reading Frame ycf54 Is Required for Activity of the Magnesium Protoporphyrin Monomethylester Oxidative Cyclase in Synechocystis PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPHYLL ISOCYCLIC RING; RHODOBACTER-SPHAEROIDES; SP PCC-6803; IX; ESTER; BIOSYNTHESIS; PROTOCHLOROPHYLLIDE; SYSTEM; OXYGEN; BACTERIOCHLOROPHYLL	The cyclase step in chlorophyll (Chl) biosynthesis has not been characterized biochemically, although there are some plausible candidates for cyclase subunits. Two of these, Sll1214 and Sll1874 from the cyanobacterium Synechocystis 6803, were FLAG-tagged in vivo and used as bait in separate pulldown experiments. Mass spectrometry identified Ycf54 as an interaction partner in each case, and this interaction was confirmed by a reciprocal pulldown using FLAG-tagged Ycf54 as bait. Inactivation of the ycf54 gene (slr1780) in Synechocystis 6803 resulted in a strain that exhibited significantly reduced Chl levels. A detailed analysis of Chl precursors in the ycf54 mutant revealed accumulation of very high levels of Mg-protoporphyrin IX methyl ester and only traces of protochlorophyllide, the product of the cyclase, were detected. Western blotting demonstrated that levels of the cyclase component Sll1214 and the Chl biosynthesis enzymes Mg-protoporphyrin IX methyltransferase and protochlorophyllide reductase are significantly impaired in the ycf54 mutant. Ycf54 is, therefore, essential for the activity and stability of the oxidative cyclase. We discuss a possible role of Ycf54 as an auxiliary factor essential for the assembly of a cyclase complex or even a large multienzyme catalytic center.	[Kopecna, Jana; Sobotka, Roman] Inst Microbiol, Dept Phototroph Microorganisms, Trebon 37981, Czech Republic; [Hollingshead, Sarah; Jackson, Philip J.; Canniffe, Daniel P.; Davison, Paul A.; Hunter, C. Neil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Kopecna, Jana; Sobotka, Roman] Univ S Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Jackson, Philip J.; Dickman, Mark J.] Univ Sheffield, Dept Chem & Biol Engn, ChELSI Inst, Sheffield S1 3JD, S Yorkshire, England	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Sheffield; University of South Bohemia Ceske Budejovice; University of Sheffield	Sobotka, R (corresponding author), Inst Microbiol, Dept Phototroph Microorganisms, Trebon 37981, Czech Republic.	sobotka@alga.cz	Sobotka, Roman/J-3077-2014; kopecna, jana/H-2967-2014	Sobotka, Roman/0000-0001-5909-3879; kopecna, jana/0000-0003-2863-4139; Dickman, Mark/0000-0002-9236-0788; Canniffe, Daniel/0000-0002-5022-0437	University of Sheffield; Biotechnology and Biological Sciences Research Council (United Kingdom); Grant Agency of the Czech Republic [P501/10/1000]; projects Algatech [CZ.1.05/2.1.00/03.0110, RVO61388971]; BBSRC [BB/G021546/1] Funding Source: UKRI; EPSRC [EP/E036252/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G021546/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/E036252/1] Funding Source: researchfish	University of Sheffield; Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); projects Algatech; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by a doctoral studentship from the University of Sheffield.; Supported by a grant from the Biotechnology and Biological Sciences Research Council (United Kingdom).; Supported by postdoctoral funds from the University of Sheffield.; Supported by the Grant Agency of the Czech Republic (projects P501/10/1000) and by projects Algatech (CZ.1.05/2.1.00/03.0110) and RVO61388971.	Bollivar DW, 1996, PLANT PHYSIOL, V112, P105, DOI 10.1104/pp.112.1.105; CHERESKIN BM, 1982, PLANT PHYSIOL, V70, P987, DOI 10.1104/pp.70.4.987; COOMBER SA, 1990, MOL MICROBIOL, V4, P977, DOI 10.1111/j.1365-2958.1990.tb00670.x; Dobakova M, 2009, PLANT PHYSIOL, V149, P1076, DOI 10.1104/pp.108.130039; FUESLER TP, 1984, PLANT PHYSIOL, V75, P662, DOI 10.1104/pp.75.3.662; Granick S., 1948, HARVEY LECT, V44, P220; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; HUNTER CN, 1988, J GEN MICROBIOL, V134, P1491; McLean S, 2009, ANAL BIOCHEM, V394, P223, DOI 10.1016/j.ab.2009.07.036; Minamizaki K, 2008, J BIOL CHEM, V283, P2684, DOI 10.1074/jbc.M708954200; Moseley JL, 2002, PLANT CELL, V14, P673, DOI 10.1105/tpc.010420; NASRULHAQBOYCE A, 1987, BIOCHEM J, V243, P23, DOI 10.1042/bj2430023; Ouchane S, 2004, J BIOL CHEM, V279, P6385, DOI 10.1074/jbc.M309851200; Peter E, 2010, PLANT CELL PHYSIOL, V51, P1229, DOI 10.1093/pcp/pcq071; Peter E, 2009, BBA-BIOENERGETICS, V1787, P1458, DOI 10.1016/j.bbabio.2009.06.006; Pinta V, 2002, J BACTERIOL, V184, P746, DOI 10.1128/JB.184.3.746-753.2002; Pinto FL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-79; Porra R. J., 2004, FEBS J, V239, P85; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; PORRA RJ, 1995, FEBS LETT, V371, P21, DOI 10.1016/0014-5793(95)00854-3; REBEIZ CA, 1975, ARCH BIOCHEM BIOPHYS, V166, P446, DOI 10.1016/0003-9861(75)90408-7; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rzeznicka K, 2005, P NATL ACAD SCI USA, V102, P5886, DOI 10.1073/pnas.0501784102; Shepherd M, 2005, FEBS J, V272, P4532, DOI 10.1111/j.1742-4658.2005.04873.x; SMITH KM, 1986, J ORG CHEM, V51, P657, DOI 10.1021/jo00355a015; Sobotka R, 2005, J BIOL CHEM, V280, P31595, DOI 10.1074/jbc.M505976200; Sobotka R, 2011, PLANT PHYSIOL, V155, P1735, DOI 10.1104/pp.110.167528; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; TAYLOR DP, 1983, J BACTERIOL, V154, P580, DOI 10.1128/JB.154.2.580-590.1983; Tottey S, 2003, P NATL ACAD SCI USA, V100, P16119, DOI 10.1073/pnas.2136793100; Vavilin D, 2007, BBA-BIOENERGETICS, V1767, P920, DOI 10.1016/j.bbabio.2007.03.010; Viney J, 2007, BIOCHEMISTRY-US, V46, P12788, DOI 10.1021/bi701515y; WALKER CJ, 1991, BIOCHEM J, V276, P691, DOI 10.1042/bj2760691; WALKER CJ, 1988, BIOCHEM J, V255, P685; WALKER CJ, 1989, BIOCHEM J, V257, P599, DOI 10.1042/bj2570599; WONG YS, 1985, PLANT PHYSIOL, V79, P725, DOI 10.1104/pp.79.3.725; WONG YS, 1984, PLANT PHYSIOL, V75, P658, DOI 10.1104/pp.75.3.658	37	65	66	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27823	27833		10.1074/jbc.M112.352526	http://dx.doi.org/10.1074/jbc.M112.352526			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22711541	Green Published, hybrid			2022-12-25	WOS:000307840700056
J	Jonasson, JM; Cederholm, J; Eliasson, B; Zethelius, B; Eeg-Olofsson, K; Gudbjornsdottir, S				Jonasson, Junmei Miao; Cederholm, Jan; Eliasson, Bjorn; Zethelius, Bjorn; Eeg-Olofsson, Katarina; Gudbjornsdottir, Soffia			HbA1C and Cancer Risk in Patients with Type 2 Diabetes - A Nationwide Population-Based Prospective Cohort Study in Sweden	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; COLORECTAL-CANCER; GLYCOSYLATED HEMOGLOBIN; BREAST-CANCER; MEN; HYPERGLYCEMIA; CONSENSUS; ASSOCIATIONS; GLUCOSE; BLOOD	Background: Diabetes is associated with increased cancer risk. The underlying mechanisms remain unclear. Hyperglycemia might be one risk factor. HbA1c is an indicator of the blood glucose level over the latest 1 to 3 months. This study aimed to investigate association between HbA1c level and cancer risks in patients with type 2 diabetes based on real life situations. Methods: This is a cohort study on 25,476 patients with type 2 diabetes registered in the Swedish National Diabetes Register from 1997-1999 and followed until 2009. Follow-up for cancer was accomplished through register linkage. We calculated incidences of and hazard ratios (HR) for cancer in groups categorized by HbA1c <= 58 mmol/mol (7.5%) versus >58 mmol/mol, by quartiles of HbA1c, and by HbA1c continuously at Cox regression, with covariance adjustment for age, sex, diabetes duration, smoking and insulin treatment, or adjusting with a propensity score. Results: Comparing HbA1c >58 mmol/mol with <= 58 mmol/mol, adjusted HR for all cancer was 1.02 [95% CI 0.95-1.10] using baseline HbA1c, and 1.04 [95% CI 0.97-1.12] using updated mean HbA1c, and HRs were all non-significant for specific cancers of gastrointestinal, kidney and urinary organs, respiratory organs, female genital organs, breast or prostate. Similarly, no increased risks of all cancer or the specific types of cancer were found with higher quartiles of baseline or updated mean HbA1c, compared to the lowest quartile. HR for all cancer was 1.01 [0.98-1.04] per 1%-unit increase in HbA1c used as a continuous variable, with non-significant HRs also for the specific types of cancer per unit increase in HbA1c. Conclusions: In this study there were no associations between HbA1c and risks for all cancers or specific types of cancer in patients with type 2 diabetes.	[Jonasson, Junmei Miao; Gudbjornsdottir, Soffia] Ctr Registers Reg Vastra Gotaland, Gothenburg, Sweden; [Jonasson, Junmei Miao] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Oncol, Gothenburg, Sweden; [Cederholm, Jan] Uppsala Univ, Dept Publ Hlth & Caring Sci Family Med & Clin Epi, Uppsala, Sweden; [Eliasson, Bjorn; Eeg-Olofsson, Katarina; Gudbjornsdottir, Soffia] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Med, Gothenburg, Sweden; [Zethelius, Bjorn] Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, Uppsala, Sweden; [Zethelius, Bjorn] Med Prod Agcy, Uppsala, Sweden	University of Gothenburg; Uppsala University; Sahlgrenska University Hospital; University of Gothenburg; Uppsala University; Medical Products Agency	Jonasson, JM (corresponding author), Ctr Registers Reg Vastra Gotaland, Gothenburg, Sweden.	junmei.miao.jonasson@gmail.com	Miao Jonasson, Junmei/B-3242-2014; Eliasson, Bjorn/H-5783-2016	Miao Jonasson, Junmei/0000-0003-0206-8538; Eliasson, Bjorn/0000-0003-2569-4160	VINNMER; VINNOVA; Lion's Cancer Fund in Western Sweden; Konrad and Helfrid Johansson Foundation; Swedish Society of Medicine; Swedish Diabetes Fund; AGFOND	VINNMER; VINNOVA(Vinnova); Lion's Cancer Fund in Western Sweden; Konrad and Helfrid Johansson Foundation; Swedish Society of Medicine; Swedish Diabetes Fund; AGFOND	This study was funded by VINNMER fellow, VINNOVA (JMJ), Lion's Cancer Fund in Western Sweden (JMJ), Konrad and Helfrid Johansson Foundation (JMJ), Swedish Society of Medicine (JMJ), Swedish Diabetes Fund (JMJ, SG), and AGFOND (JMJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Best JD, 2000, DRUGS, V59, P1101, DOI 10.2165/00003495-200059050-00006; BUNN HF, 1978, SCIENCE, V200, P21, DOI 10.1126/science.635569; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Driver JA, 2010, AM J EPIDEMIOL, V172, P299, DOI 10.1093/aje/kwq127; Fowke JH, 2008, PROSTATE CANCER P D, V11, P264, DOI 10.1038/sj.pcan.4501022; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Ikeda F, 2009, GASTROENTEROLOGY, V136, P1234, DOI 10.1053/j.gastro.2008.12.045; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Johnson JA, 2011, DIABETOLOGIA, V54, P25, DOI 10.1007/s00125-010-1933-3; Jonasson JM, 2009, DIABETOLOGIA, V52, P1745, DOI 10.1007/s00125-009-1444-2; Khaw KT, 2004, CANCER EPIDEM BIOMAR, V13, P915; Lin J, 2006, CANCER RES, V66, P2869, DOI 10.1158/0008-5472.CAN-05-3922; Lin J, 2005, CANCER EPIDEM BIOMAR, V14, P3010, DOI 10.1158/1055-9965.EPI-05-0533; Lipscombe LL, 2006, BREAST CANCER RES TR, V98, P349, DOI 10.1007/s10549-006-9172-5; Ljung R, 2011, ACTA ONCOLOGICA; Muller H, 2009, CANCER EPIDEM BIOMAR, V18, P1350, DOI 10.1158/1055-9965.EPI-08-0794; Ohwaki K, 2011, EUR J CANCER, V47, P262, DOI 10.1016/j.ejca.2010.09.023; Pencina MJ, 2007, STAT MED, V26, P1343, DOI 10.1002/sim.2699; Platz EA, 1999, CANCER CAUSE CONTROL, V10, P379, DOI 10.1023/A:1008953611657; Rapp K, 2006, DIABETOLOGIA, V49, P945, DOI 10.1007/s00125-006-0207-6; Renehan A, 2010, LANCET, V375, P2201, DOI 10.1016/S0140-6736(10)60706-4; Rinaldi S, 2008, CANCER EPIDEM BIOMAR, V17, P3108, DOI 10.1158/1055-9965.EPI-08-0495; Rothman K., 1998, MODERN EPIDEMIOLOGY; Smith U, 2010, DIABETOLOGIA, V53, P1541, DOI 10.1007/s00125-010-1815-8; Stattin P, 2007, DIABETES CARE, V30, P561, DOI 10.2337/dc06-0922; Stefansdottir G, 2011, DIABETOLOGIA, V54, P1608, DOI 10.1007/s00125-011-2104-x; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; van Staa TP, 2011, DIABETOLOGIA; Yang XL, 2008, CAN MED ASSOC J, V179, P427, DOI 10.1503/cmaj.071474; Yang XL, 2010, DIABETES, V59, P1254, DOI 10.2337/db09-1371; Yang YX, 2010, CANCER EPIDEM BIOMAR, V19, P3027, DOI 10.1158/1055-9965.EPI-10-0486; Zhou XH, 2010, DIABETOLOGIA, V53, P1867, DOI 10.1007/s00125-010-1796-7	35	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38784	10.1371/journal.pone.0038784	http://dx.doi.org/10.1371/journal.pone.0038784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719946	Green Submitted, Green Published, gold			2022-12-25	WOS:000305347800018
J	Kross, SM; Tylianakis, JM; Nelson, XJ				Kross, Sara M.; Tylianakis, Jason M.; Nelson, Ximena J.			Translocation of Threatened New Zealand Falcons to Vineyards Increases Nest Attendance, Brooding and Feeding Rates	PLOS ONE			English	Article							CONSERVATION; BEHAVIOR; FOOD; BIRDS; PREY; NOVAESEELANDIAE; ELECTROCUTION; WILDLIFE; ECOLOGY; BIOLOGY	Anthropogenic landscapes can be rich in resources, and may in some cases provide potential habitat for species whose natural habitat has declined. We used remote videography to assess whether reintroducing individuals of the threatened New Zealand falcon Falco novaeseelandiae into a highly modified agricultural habitat affected the feeding rates of breeding falcons or related breeding behavior such as nest attendance and brooding rates. Over 2,800 recording hours of footage were used to compare the behavior of falcons living in six natural nests (in unmanaged, hilly terrain between 4 km and 20 km from the nearest vineyard), with that of four breeding falcon pairs that had been transported into vineyards and nested within 500 m of the nearest vineyard. Falcons in vineyard nests had higher feeding rates, higher nest attendance, and higher brooding rates. As chick age increased, parents in vineyard nests fed chicks a greater amount of total prey and larger prey items on average than did parents in hill nests. Parents with larger broods brought in larger prey items and a greater total sum of prey biomass. Nevertheless, chicks in nests containing siblings received less daily biomass per individual than single chicks. Some of these results can be attributed to the supplementary feeding of falcons in vineyards. However, even after removing supplementary food from our analysis, falcons in vineyards still fed larger prey items to chicks than did parents in hill nests, suggesting that the anthropogenic habitat may be a viable source of quality food. Although agricultural regions globally are rarely associated with raptor conservation, these results suggest that translocating New Zealand falcons into vineyards has potential for the conservation of this species.	[Kross, Sara M.; Tylianakis, Jason M.; Nelson, Ximena J.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand	University of Canterbury	Kross, SM (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand.	Saramaekross@gmail.com	Kross, Sara Mae/E-2747-2013; Tylianakis, Jason/B-6634-2011	Kross, Sara Mae/0000-0002-5650-5839; Tylianakis, Jason/0000-0001-7402-5620; Nelson, Ximena/0000-0003-4301-2928	University of Canterbury Doctoral Scholarship; Brian-Mason Scientific & Technical Trust; Canon New Zealand	University of Canterbury Doctoral Scholarship; Brian-Mason Scientific & Technical Trust; Canon New Zealand	This research was supported by a University of Canterbury Doctoral Scholarship (to S.M.K.) and grants from the Brian-Mason Scientific & Technical Trust (to S.M.K. and X.J.N.; www.brianmasontrust.org) and Canon New Zealand (to S.M.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Baayen RH, 2008, LANGUAGER DATA SETS; Berger-Tal O, 2011, BEHAV ECOL, V22, P236, DOI 10.1093/beheco/arq224; Bird DM, 1996, RAPTORS HUMAN LANDSC; Blumstein DT, 2004, CONSERV BIOL, V18, P1175, DOI 10.1111/j.1523-1739.2004.00587.x; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Cade Tom. J., 2000, P343; CARLIER P, 1995, BEHAV PROCESS, V33, P247, DOI 10.1016/0376-6357(94)00027-E; Daan S, 1996, J ANIM ECOL, V65, P539, DOI 10.2307/5734; Dai B., 2008, IME4 LINEAR MIXED EF; Edwards PJ, 1998, BIOL CONSERV, V83, P239, DOI 10.1016/S0006-3207(97)00141-9; Fischer J, 2011, SCIENCE, V334, P593, DOI 10.1126/science.334.6056.593-a; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fox NC, 1977, BIOL NZ FALCON; Fox Nick C., 2010, Notornis, V57, P71; Gaze Peter, 2004, Notornis, V51, P117; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Hudson R, 2011, DEV PSYCHOBIOL, V53, P564, DOI 10.1002/dev.20535; Knight J, 2001, NATURE, V414, P246, DOI 10.1038/35104708; Kross SM, 2012, CONSERV BIOL, V26, P142, DOI 10.1111/j.1523-1739.2011.01756.x; Kross SM, 2011, METHODS ECOL EVOL, V2, P191, DOI 10.1111/j.2041-210X.2010.00064.x; Lehman RN, 2007, BIOL CONSERV, V136, P159, DOI 10.1016/j.biocon.2006.09.015; Lewis SB, 2004, WILDLIFE SOC B, V32, P373, DOI 10.2193/0091-7648(2004)32[373:ACOMFA]2.0.CO;2; Lopez-Lopez P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017196; MacLeod CJ, 2008, NEW ZEAL J ECOL, V32, P240; MAF (Ministry of Agriculture and Forestry), 2009, SFF PROJ SUMM FALC G; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Miskelly Colin M., 2008, Notornis, V55, P117; Moore JA, 2008, BIOSCIENCE, V58, P454, DOI 10.1641/B580513; Negro JJ, 2007, RAPTOR RES MANAGEMEN; NEWTON I, 1981, ORNIS SCAND, V12, P224, DOI 10.2307/3676082; Newton I., 1979, POPULATION ECOLOGY R; Palmer AG, 2001, ARCTIC, V54, P105; R Core Development Team, 2008, R LANG ENV STAT COMP; Rands SA, 2000, J THEOR BIOL, V202, P161, DOI 10.1006/jtbi.1999.1048; RATCLIFF.DA, 1967, NATURE, V215, P208, DOI 10.1038/215208a0; Salafsky SR, 2007, J WILDLIFE MANAGE, V71, P2274, DOI 10.2193/2006-357; Seaton R, 2009, NEW ZEAL J ECOL, V33, P32; Thirgood S, 2008, J APPL ECOL, V45, P1550, DOI 10.1111/j.1365-2664.2008.01519.x; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Wiehn J, 1997, ECOLOGY, V78, P2043, DOI 10.1890/0012-9658(1997)078[2043:FLOBSE]2.0.CO;2; Wilson K. J., 2004, FLIGHT HUIA ECOLOGY	43	8	9	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38679	10.1371/journal.pone.0038679	http://dx.doi.org/10.1371/journal.pone.0038679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719921	Green Submitted, Green Published, gold			2022-12-25	WOS:000305347800013
J	Li, K; Bihan, M; Yooseph, S; Methe, BA				Li, Kelvin; Bihan, Monika; Yooseph, Shibu; Methe, Barbara A.			Analyses of the Microbial Diversity across the Human Microbiome	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; COMMUNITIES; SOIL; COVERAGE; EVENNESS	Analysis of human body microbial diversity is fundamental to understanding community structure, biology and ecology. The National Institutes of Health Human Microbiome Project (HMP) has provided an unprecedented opportunity to examine microbial diversity within and across body habitats and individuals through pyrosequencing-based profiling of 16 S rRNA gene sequences (16 S) from habits of the oral, skin, distal gut, and vaginal body regions from over 200 healthy individuals enabling the application of statistical techniques. In this study, two approaches were applied to elucidate the nature and extent of human microbiome diversity. First, bootstrap and parametric curve fitting techniques were evaluated to estimate the maximum number of unique taxa, S-max, and taxa discovery rate for habitats across individuals. Next, our results demonstrated that the variation of diversity within low abundant taxa across habitats and individuals was not sufficiently quantified with standard ecological diversity indices. This impact from low abundant taxa motivated us to introduce a novel rank-based diversity measure, the Tail statistic, ("tau"), based on the standard deviation of the rank abundance curve if made symmetric by reflection around the most abundant taxon. Due to tau's greater sensitivity to low abundant taxa, its application to diversity estimation of taxonomic units using taxonomic dependent and independent methods revealed a greater range of values recovered between individuals versus body habitats, and different patterns of diversity within habitats. The greatest range of tau values within and across individuals was found in stool, which also exhibited the most undiscovered taxa. Oral and skin habitats revealed variable diversity patterns, while vaginal habitats were consistently the least diverse. Collectively, these results demonstrate the importance, and motivate the introduction, of several visualization and analysis methods tuned specifically for next-generation sequence data, further revealing that low abundant taxa serve as an important reservoir of genetic diversity in the human microbiome.	[Li, Kelvin; Bihan, Monika; Yooseph, Shibu; Methe, Barbara A.] J Craig Venter Inst, Rockville, MD USA	J. Craig Venter Institute	Li, K (corresponding author), J Craig Venter Inst, Rockville, MD USA.	bmethe@jcvi.org	Bihan, Monika/C-7469-2014	Yooseph, Shibu/0000-0001-5581-5002	National Institute of Allergy and Infectious Diseases [AI084844]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI084844] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institute of Allergy and Infectious Diseases #AI084844. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; [Anonymous], 1958, STAT EXTREMES, DOI DOI 10.7312/GUMB92958; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; BULMER MG, 1974, BIOMETRICS, V30, P101, DOI 10.2307/2529621; Bunge J, 2011, BIOCOMPUT-PAC SYM, P121; Campbell BJ, 2010, ENVIRON MICROBIOL, V12, P1842, DOI 10.1111/j.1462-2920.2010.02189.x; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Cilia V, 1996, MOL BIOL EVOL, V13, P451, DOI 10.1093/oxfordjournals.molbev.a025606; CLAYTON RA, 1995, INT J SYST BACTERIOL, V45, P595, DOI 10.1099/00207713-45-3-595; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Crielaard W, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-22; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Fortunato CS, 2011, MICROB ECOL, V62, P374, DOI 10.1007/s00248-011-9805-z; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; GOOD IJ, 1956, BIOMETRIKA, V43, P45; Goodman AL, 2010, CELL METAB, V12, P111, DOI 10.1016/j.cmet.2010.07.001; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Mager DL, 2003, J CLIN PERIODONTOL, V30, P644, DOI 10.1034/j.1600-051X.2003.00376.x; Mirmonsef P, 2011, AM J REPROD IMMUNOL, V65, P190, DOI 10.1111/j.1600-0897.2010.00943.x; Morales SE, 2009, APPL ENVIRON MICROB, V75, P668, DOI 10.1128/AEM.01757-08; Myshrall KL, 2010, GEOBIOLOGY, V8, P337, DOI 10.1111/j.1472-4669.2010.00245.x; Nasidze I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023352; Ordovas JM, 2006, CURR OPIN LIPIDOL, V17, P157, DOI 10.1097/01.mol.0000217897.75068.ba; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ramos-Padron E, 2011, ENVIRON SCI TECHNOL, V45, P439, DOI 10.1021/es1028487; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Renyi A, 1961, P 4 BERK S MATH STAT, V1; Roling WFM, 2010, CURR OPIN BIOTECH, V21, P532, DOI 10.1016/j.copbio.2010.06.007; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Tamhane AC, 2000, STAT DATA ANAL ELEME; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wasserman L., 2004, ALL STAT CONCISE COU, V26	38	118	126	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e32118	10.1371/journal.pone.0032118	http://dx.doi.org/10.1371/journal.pone.0032118			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719823	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341900006
J	Anamika, K; Gyenis, A; Poidevin, L; Poch, O; Tora, L				Anamika, Krishanpal; Gyenis, Akos; Poidevin, Laetitia; Poch, Olivier; Tora, Laszlo			RNA Polymerase II Pausing Downstream of Core Histone Genes Is Different from Genes Producing Polyadenylated Transcripts	PLOS ONE			English	Article							PRE-MESSENGER-RNA; HUMAN-COMPLEMENT GENES; POLY(A) SIGNAL; 3' END; C-MYC; DROSOPHILA-MELANOGASTER; TERMINATION MACHINERIES; PROCESSING FACTORS; EXONUCLEASE XRN2; NUCLEAR-RNA	Recent genome-wide chromatin immunoprecipitation coupled high throughput sequencing (ChIP-seq) analyses performed in various eukaryotic organisms, analysed RNA Polymerase II (Pol II) pausing around the transcription start sites of genes. In this study we have further investigated genome-wide binding of Pol II downstream of the 3' end of the annotated genes (EAGs) by ChIP-seq in human cells. At almost all expressed genes we observed Pol II occupancy downstream of the EAGs suggesting that Pol II pausing 39 from the transcription units is a rather common phenomenon. Downstream of EAGs Pol II transcripts can also be detected by global run-on and sequencing, suggesting the presence of functionally active Pol II. Based on Pol II occupancy downstream of EAGs we could distinguish distinct clusters of Pol II pause patterns. On core histone genes, coding for non-polyadenylated transcripts, Pol II occupancy is quickly dropping after the EAG. In contrast, on genes, whose transcripts undergo polyA tail addition [poly(A)(+)], Pol II occupancy downstream of the EAGs can be detected up to 4-6 kb. Inhibition of polyadenylation significantly increased Pol II occupancy downstream of EAGs at poly(A)(+) genes, but not at the EAGs of core histone genes. The differential genome-wide Pol II occupancy profiles 3' of the EAGs have also been confirmed in mouse embryonic stem (mES) cells, indicating that Pol II pauses genome-wide downstream of the EAGs in mammalian cells. Moreover, in mES cells the sharp drop of Pol II signal at the EAG of core histone genes seems to be independent of the phosphorylation status of the C-terminal domain of the large subunit of Pol II. Thus, our study uncovers a potential link between different mRNA 39 end processing mechanisms and consequent Pol II transcription termination processes.	[Anamika, Krishanpal; Gyenis, Akos; Tora, Laszlo] Univ Strasbourg, Dept Funct Genom & Canc, Inst Genet & Biol Mol & Cellulaire IGBMC, CNRS,UMR 7104,INSERM,U964, Illkirch Graffenstaden, France; [Anamika, Krishanpal; Poidevin, Laetitia; Poch, Olivier] Univ Strasbourg, Dept Struct Biol & Genom, Inst Genet & Biol Mol & Cellulaire IGBMC, CNRS,UMR 7104,INSERM,U964, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Anamika, K (corresponding author), Univ Strasbourg, Dept Funct Genom & Canc, Inst Genet & Biol Mol & Cellulaire IGBMC, CNRS,UMR 7104,INSERM,U964, Illkirch Graffenstaden, France.	laszlo@igbmc.fr	Tora, Laszlo/E-9999-2018	Tora, Laszlo/0000-0001-7398-2250; Gyenis, Akos/0000-0002-8104-7681	Fondation pour la Recherche Medicale (FRM) France; EU (European Transcriptome Regulome & Cellular Commitment Consortium EUTRACC) [LSHG-CT-2007-037445, EPIDIACAN]; SkinChroma-CNRS; Institut National du Cancer (INCA); Agence nationale de la recherche [ANR-09-BLAN-0266]	Fondation pour la Recherche Medicale (FRM) France(Fondation pour la Recherche Medicale); EU (European Transcriptome Regulome & Cellular Commitment Consortium EUTRACC); SkinChroma-CNRS; Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France); Agence nationale de la recherche(French National Research Agency (ANR))	AG is supported by a fellowship from Fondation pour la Recherche Medicale (FRM) France. This work was supported by grants from the EU (European Transcriptome Regulome & Cellular Commitment Consortium EUTRACC, LSHG-CT-2007-037445 and EPIDIACAN), SkinChroma-CNRS and the Institut National du Cancer (INCA; 2008 Ubican) to LT and Agence nationale de la recherche (ANR-09-BLAN-0266) to LT and OP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHFIELD R, 1994, EMBO J, V13, P5656, DOI 10.1002/j.1460-2075.1994.tb06904.x; ASHFIELD R, 1991, EMBO J, V10, P4197, DOI 10.1002/j.1460-2075.1991.tb04998.x; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Buratowski S, 2005, CURR OPIN CELL BIOL, V17, P257, DOI 10.1016/j.ceb.2005.04.003; Calvo O, 2001, MOL CELL, V7, P1013, DOI 10.1016/S1097-2765(01)00236-2; CHODCHOY N, 1991, MOL CELL BIOL, V11, P497, DOI 10.1128/MCB.11.1.497; CONNELLY S, 1988, GENE DEV, V2, P440, DOI 10.1101/gad.2.4.440; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763; Dominski Z, 1999, GENE, V239, P1, DOI 10.1016/S0378-1119(99)00367-4; Dominski Z, 2007, GENE, V396, P373, DOI 10.1016/j.gene.2007.04.021; Dye MJ, 2001, CELL, V105, P669, DOI 10.1016/S0092-8674(01)00372-5; Dye MJ, 1999, MOL CELL, V3, P371, DOI 10.1016/S1097-2765(00)80464-5; El Kaderi B, 2009, J BIOL CHEM, V284, P25015, DOI 10.1074/jbc.M109.007948; ENRIQUEZHARRIS P, 1991, EMBO J, V10, P1833, DOI 10.1002/j.1460-2075.1991.tb07709.x; Eskiw CH, 2011, J CELL SCI, V124, P3676, DOI 10.1242/jcs.087981; GICK O, 1986, EMBO J, V5, P1319, DOI 10.1002/j.1460-2075.1986.tb04362.x; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Gromak N, 2006, MOL CELL BIOL, V26, P3986, DOI 10.1128/MCB.26.10.3986-3996.2006; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; HAGENBUCHLE O, 1984, CELL, V38, P737, DOI 10.1016/0092-8674(84)90269-1; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Hampsey M, 2011, ADV ENZYME REGUL, V51, P118, DOI 10.1016/j.advenzreg.2010.10.001; Hochheimer A, 2003, GENE DEV, V17, P1309, DOI 10.1101/gad.1099903; Ioannidis P, 1999, ONCOGENE, V18, P117, DOI 10.1038/sj.onc.1202255; Kaneko S, 2007, GENE DEV, V21, P1779, DOI 10.1101/gad.1565207; Kazerouninia A, 2010, RNA, V16, P197, DOI 10.1261/rna.1622010; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Krishnamurthy S, 2009, MOL CELL BIOL, V29, P2925, DOI 10.1128/MCB.01655-08; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Lian Z, 2008, GENOME RES, V18, P1224, DOI 10.1101/gr.075804.107; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; LOGAN J, 1987, P NATL ACAD SCI USA, V84, P8306, DOI 10.1073/pnas.84.23.8306; Luo WF, 2006, GENE DEV, V20, P954, DOI 10.1101/gad.1409106; Lykke-Andersen S, 2011, CELL CYCLE, V10, P863, DOI 10.4161/cc.10.6.14931; Mapendano CK, 2010, MOL CELL, V40, P410, DOI 10.1016/j.molcel.2010.10.012; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Mukundan B, 2011, J BIOL CHEM, V286, P37053, DOI 10.1074/jbc.C111.295915; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nag A, 2006, RNA, V12, P1534, DOI 10.1261/rna.103206; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; Orozco IJ, 2002, J BIOL CHEM, V277, P42899, DOI 10.1074/jbc.M207415200; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Park NJ, 2004, MOL CELL BIOL, V24, P4092, DOI 10.1128/MCB.24.10.4092-4103.2004; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; SCHAUFELE F, 1986, NATURE, V323, P777, DOI 10.1038/323777a0; SCHUMPERLI D, 1988, TRENDS GENET, V4, P187, DOI 10.1016/0168-9525(88)90074-1; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Sullivan KD, 2009, MOL CELL, V34, P322, DOI 10.1016/j.molcel.2009.04.024; TANTRAVAHI J, 1993, MOL CELL BIOL, V13, P578, DOI 10.1128/MCB.13.1.578; Tran DP, 2001, MOL CELL BIOL, V21, P7495, DOI 10.1128/MCB.21.21.7495-7508.2001; Wang YM, 2010, CURR BIOL, V20, P548, DOI 10.1016/j.cub.2010.01.052; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Yonaha M, 1999, MOL CELL, V3, P593, DOI 10.1016/S1097-2765(00)80352-4; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	70	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38769	10.1371/journal.pone.0038769	http://dx.doi.org/10.1371/journal.pone.0038769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701709	gold, Green Published, Green Submitted			2022-12-25	WOS:000305337600042
J	Zheng, Y; Wang, Q; Xiao, B; Lu, QJ; Wang, YZ; Wang, XM				Zheng, Yan; Wang, Qi; Xiao, Bing; Lu, Qingjun; Wang, Yizheng; Wang, Xiaomin			Involvement of Receptor Tyrosine Kinase Tyro3 in Amyloidogenic APP Processing and beta-Amyloid Deposition in Alzheimer's Disease Models	PLOS ONE			English	Article							LONG-TERM POTENTIATION; TRANSGENIC MICE; HIPPOCAMPAL-NEURONS; PRECURSOR PROTEIN; INDUCED APOPTOSIS; FAMILY RECEPTORS; MEMORY DEFICITS; NERVOUS-SYSTEM; MOUSE MODELS; PC12 CELLS	Alzheimer's disease (AD) is the most common progressive neurodegenerative disease known to humankind. It is characterized by brain atrophy, extracellular amyloid plaques, and intracellular neurofibril tangles. beta-amyloid cascade is considered the major causative player in AD. Up until now, the mechanisms underlying the process of A beta generation and accumulation in the brain have not been well understood. Tyro3 receptor belongs to the TAM receptor subfamily of receptor protein tyrosine kinases (RPTKs). It is specifically expressed in the neurons of the neocortex and hippocampus. In this study, we established a cell model stably expressing APPswe mutants and producing A beta. We found that overexpression of Tyro3 receptor in the cell model significantly decreased A beta generation and also down-regulated the expression of beta-site amyloid precursor protein cleaving enzyme (BACE1). However, the effects of Tyro3 were inhibited by its natural ligand, Gas6, in a concentration-dependent manner. In order to confirm the role of Tyro3 in the progression of AD development, we generated an AD transgenic mouse model accompanied by Tyro3 knockdown. We observed a significant increase in the number of amyloid plaques in the hippocampus in the mouse model. More plaque-associated clusters of astroglia were also detected. The present study may help researchers determine the role of Tyro3 receptor in the neuropathology of AD.	[Zheng, Yan; Wang, Qi; Xiao, Bing; Lu, Qingjun; Wang, Yizheng; Wang, Xiaomin] Capital Med Univ, Dept Physiol, Key Lab Neurodegenerat Disorders, Minist Educ, Beijing, Peoples R China	Capital Medical University	Zheng, Y (corresponding author), Capital Med Univ, Dept Physiol, Key Lab Neurodegenerat Disorders, Minist Educ, Beijing, Peoples R China.	xmwang@ccmu.edu.cn			National Basic Research Program of China [2011CB504100]; NSFC of China [30900421/c090201, 81030062]	National Basic Research Program of China(National Basic Research Program of China); NSFC of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (Xiaomin Wang, 2011CB504100) and the NSFC of China (Yan Zheng, 30900421/c090201; Xiaomin Wang, 81030062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MP, 1999, MOL ENDOCRINOL, V13, P191, DOI 10.1210/me.13.2.191; Babic T, 1999, J NEUROL NEUROSUR PS, V67, P558, DOI 10.1136/jnnp.67.4.558; Binder MD, 2008, J NEUROSCI, V28, P5195, DOI 10.1523/JNEUROSCI.1180-08.2008; Citron M, 2004, TRENDS PHARMACOL SCI, V25, P92, DOI 10.1016/j.tips.2003.12.004; Cuello AC, 2007, CURR ALZHEIMER RES, V4, P351, DOI 10.2174/156720507781788774; Funakoshi H, 2002, J NEUROSCI RES, V68, P150, DOI 10.1002/jnr.10211; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; GNAHN H, 1983, DEV BRAIN RES, V9, P45, DOI 10.1016/0165-3806(83)90107-4; Goedert M, 1986, Brain Res, V387, P85; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Grommes C, 2008, J NEUROIMMUNE PHARM, V3, P130, DOI 10.1007/s11481-007-9090-2; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hogan DB, 2002, CAN J NEUROL SCI, V29, P306, DOI 10.1017/S031716710000216X; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; JANSSEN JWG, 1991, ONCOGENE, V6, P2113; LAI C, 1994, ONCOGENE, V9, P2567; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; Lemke G, 2003, CURR OPIN IMMUNOL, V15, P31, DOI 10.1016/S0952-7915(02)00016-X; Li CY, 2011, CURR ALZHEIMER RES, V8, P67; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Ma GZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016964; McGowan E, 2006, TRENDS GENET, V22, P281, DOI 10.1016/j.tig.2006.03.007; Michaelis ML, 2003, J PHARMACOL EXP THER, V304, P897, DOI 10.1124/jpet.102.035840; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Prieto AL, 2007, NEUROSCIENCE, V150, P319, DOI 10.1016/j.neuroscience.2007.09.047; Prieto AL, 2000, J COMP NEUROL, V425, P295; RESCIGNO J, 1991, ONCOGENE, V6, P1909; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; SELKOE DJ, 1993, TRENDS NEUROSCI, V16, P403, DOI 10.1016/0166-2236(93)90008-A; Shankar SL, 2006, J NEUROSCI, V26, P5638, DOI 10.1523/JNEUROSCI.5063-05.2006; Shankar SL, 2003, J NEUROSCI, V23, P4208; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Suh YH, 2002, PHARMACOL REV, V54, P469, DOI 10.1124/pr.54.3.469; Vassar R, 2002, ADV DRUG DELIVER REV, V54, P1589, DOI 10.1016/S0169-409X(02)00157-6; Verkhratsky A, 2010, NEUROTHERAPEUTICS, V7, P399, DOI 10.1016/j.nurt.2010.05.017; Wang Q, 2011, NEUROSCI BULL, V27, P15, DOI 10.1007/s12264-011-1042-4; Weinger JG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-49; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wolfe MS, 2002, NAT REV DRUG DISCOV, V1, P859, DOI 10.1038/nrd938; Yagami T, 2002, NEUROPHARMACOLOGY, V43, P1289, DOI 10.1016/S0028-3908(02)00333-7; Ye F, 2011, INVEST OPHTH VIS SCI, V52, P4239, DOI 10.1167/iovs.10-6700; Zheng Y, 2009, BIOCHEM BIOPH RES CO, V378, P371, DOI 10.1016/j.bbrc.2008.11.049	52	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e39035	10.1371/journal.pone.0039035	http://dx.doi.org/10.1371/journal.pone.0039035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701746	gold, Green Published, Green Submitted			2022-12-25	WOS:000305337600066
J	Pendyala, G; Ninemire, C; Fox, HS				Pendyala, Gurudutt; Ninemire, Carly; Fox, Howard S.			Protective Role for the Disulfide Isomerase PDIA3 in Methamphetamine Neurotoxicity	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; ENDOPLASMIC-RETICULUM; DOPAMINERGIC DEFICITS; STRIATAL DOPAMINE; INFECTED MONKEYS; SUBSTANTIA-NIGRA; RHESUS-MONKEYS; BRAIN; EXPRESSION; ENRICHMENT	Methamphetamine abuse continues to be a worldwide problem, damaging the individual user as well as society. Only minimal information exists on molecular changes in the brain that result from methamphetamine administered in patterns typical of human abusers. In order to investigate such changes, we examined the effect of methamphetamine on the transcriptional profile in brains of monkeys. Gene expression profiling of caudate and hippocampus identified protein disulfide isomerase family member A3 (PDIA3) to be significantly up-regulated in the animals treated with methamphetamine as compared to saline treated control monkeys. Methamphetamine treatment of mice also increased striatal PDIA3 expression. Treatment of primary striatal neurons with methamphetamine revealed an up-regulation of PDIA3, showing a direct effect of methamphetamine on neurons to increase PDIA3. In vitro studies using a neuroblastoma cell line demonstrated that PDIA3 expression protects against methamphetamine-induced cell toxicity and methamphetamine-induced intracellular reactive oxygen species production, revealing a neuroprotective role for PDIA3. The current study implicates PDIA3 to be an important cellular neuroprotective mechanism against a toxic drug, and as a potential target for therapeutic investigations.	[Pendyala, Gurudutt; Ninemire, Carly; Fox, Howard S.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Pendyala, G (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.	hfox@unmc.edu		Fox, Howard/0000-0003-2032-374X	NIH [P30 MH062261, R01 MH073490, P01 DA026146, P20 RR16469, P20 RR018788]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018788, P20RR016469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073490, P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA026146] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants P30 MH062261, R01 MH073490 and P01 DA026146. The UNMC Microarray Core Facility receives partial support from NIH grants P20 RR16469 and P20 RR018788. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman S, 2008, ANN NY ACAD SCI, V1141, P195, DOI 10.1196/annals.1441.031; Burdo TH, 2005, AIDS, V19, P1704, DOI 10.1097/01.aids.0000186823.76230.33; Cadet JL, 2009, INT REV NEUROBIOL, V88, P101, DOI 10.1016/S0074-7742(09)88005-7; Degenhardt L, 2010, INT J DRUG POLICY, V21, P347, DOI 10.1016/j.drugpo.2009.11.007; Erickson RR, 2005, BIOCHEM BIOPH RES CO, V332, P50, DOI 10.1016/j.bbrc.2005.04.090; Harvey DC, 2000, EXP BRAIN RES, V133, P349, DOI 10.1007/s002210000386; Harvey DC, 2000, BRAIN RES, V871, P259, DOI 10.1016/S0006-8993(00)02439-2; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; HIRANO N, 1995, EUR J BIOCHEM, V234, P336, DOI 10.1111/j.1432-1033.1995.336_c.x; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jayanthi S, 2004, FASEB J, V18, P238, DOI 10.1096/fj.03-0295com; Jayanthi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006092; Kuroda KO, 2010, NEUROPSYCHOPHARMACOL, V35, P641, DOI 10.1038/npp.2009.169; Marcondes MCG, 2007, J IMMUNOL, V178, P5812, DOI 10.4049/jimmunol.178.9.5812; Marcondes MCG, 2010, AM J PATHOL, V177, P355, DOI 10.2353/ajpath.2010.090953; MAZZARELLA RA, 1994, ARCH BIOCHEM BIOPHYS, V308, P454, DOI 10.1006/abbi.1994.1064; Melega WP, 2008, NEUROPSYCHOPHARMACOL, V33, P1441, DOI 10.1038/sj.npp.1301502; WATRY D, 1995, AM J PATHOL, V146, P914; Wilson JM, 1996, NAT MED, V2, P699, DOI 10.1038/nm0696-699; Wilson JM, 1996, ANN NEUROL, V40, P428, DOI 10.1002/ana.410400312; WOOLVERTON WL, 1989, BRAIN RES, V486, P73, DOI 10.1016/0006-8993(89)91279-1; Xie T, 2002, J NEUROSCI, V22, P274, DOI 10.1523/JNEUROSCI.22-01-00274.2002; Yamamoto BK, 2010, ANN NY ACAD SCI, V1187, P101, DOI 10.1111/j.1749-6632.2009.05141.x	23	18	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38909	10.1371/journal.pone.0038909	http://dx.doi.org/10.1371/journal.pone.0038909			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715419	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336800061
J	Chen, CT; Peng, HP; Jian, JW; Tsai, KC; Chang, JY; Yang, EW; Chen, JB; Ho, SY; Hsu, WL; Yang, AS				Chen, Ching-Tai; Peng, Hung-Pin; Jian, Jhih-Wei; Tsai, Keng-Chang; Chang, Jeng-Yih; Yang, Ei-Wen; Chen, Jun-Bo; Ho, Shinn-Ying; Hsu, Wen-Lian; Yang, An-Suei			Protein-Protein Interaction Site Predictions with Three-Dimensional Probability Distributions of Interacting Atoms on Protein Surfaces	PLOS ONE			English	Article							INTERACTION PARTNERS; HOT-SPOTS; RECOGNITION; INTERFACES; PREFERENCES; CLASSIFIER; PRINCIPLES; IDENTIFY; REGIONS	Protein-protein interactions are key to many biological processes. Computational methodologies devised to predict protein-protein interaction (PPI) sites on protein surfaces are important tools in providing insights into the biological functions of proteins and in developing therapeutics targeting the protein-protein interaction sites. One of the general features of PPI sites is that the core regions from the two interacting protein surfaces are complementary to each other, similar to the interior of proteins in packing density and in the physicochemical nature of the amino acid composition. In this work, we simulated the physicochemical complementarities by constructing three-dimensional probability density maps of non-covalent interacting atoms on the protein surfaces. The interacting probabilities were derived from the interior of known structures. Machine learning algorithms were applied to learn the characteristic patterns of the probability density maps specific to the PPI sites. The trained predictors for PPI sites were cross-validated with the training cases (consisting of 432 proteins) and were tested on an independent dataset (consisting of 142 proteins). The residue-based Matthews correlation coefficient for the independent test set was 0.423; the accuracy, precision, sensitivity, specificity were 0.753, 0.519, 0.677, and 0.779 respectively. The benchmark results indicate that the optimized machine learning models are among the best predictors in identifying PPI sites on protein surfaces. In particular, the PPI site prediction accuracy increases with increasing size of the PPI site and with increasing hydrophobicity in amino acid composition of the PPI interface; the core interface regions are more likely to be recognized with high prediction confidence. The results indicate that the physicochemical complementarity patterns on protein surfaces are important determinants in PPIs, and a substantial portion of the PPI sites can be predicted correctly with the physicochemical complementarity features based on the non-covalent interaction data derived from protein interiors.	[Chen, Ching-Tai; Peng, Hung-Pin; Jian, Jhih-Wei; Tsai, Keng-Chang; Chang, Jeng-Yih; Yang, Ei-Wen; Chen, Jun-Bo; Yang, An-Suei] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Peng, Hung-Pin; Jian, Jhih-Wei] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Chen, Jun-Bo] Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 30043, Taiwan; [Chen, Ching-Tai; Ho, Shinn-Ying] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Chen, Ching-Tai; Peng, Hung-Pin; Jian, Jhih-Wei] Acad Sinica, Inst Informat Sci, Taiwan Int Grad Program, Bioinformat Program, Taipei, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Tsing Hua University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Chen, CT (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	hsu@iis.sinica.edu.tw; yangas@gate.sinica.edu.tw	Ho, Shinn-Ying/AAE-9394-2022; Ho, Shinn-Ying/AFD-8402-2022; Hsu, Wen-Lian/ABB-2851-2020	Ho, Shinn-Ying/0000-0002-1901-8353; Ho, Shinn-Ying/0000-0002-1901-8353; Hsu, Wen-Lian/0000-0001-7061-3513; Tsai, Keng-Chang/0000-0001-8277-9174; Yang, An-Suei/0000-0002-4699-873X	National Health Research Institutes [NHRI-EX98-9802EI]; National Science Council [NSC 99-2311-B-001-014-MY3]; Genomics Research Center at Academia Sinica [AS-100-TP2-B01]; NRPB program, NSC [NSC 100-2325-B-001-009, 100IDP006-3]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan); Genomics Research Center at Academia Sinica(Academia Sinica - Taiwan); NRPB program, NSC	This work was supported by National Health Research Institutes [NHRI-EX98-9802EI to A-S. Y.], National Science Council [NSC 99-2311-B-001-014-MY3 to A-S. Y.], Genomics Research Center at Academia Sinica [AS-100-TP2-B01 to A-S. Y.], and NRPB program, NSC. [NSC 100-2325-B-001-009; 100IDP006-3 to A-S. Y.] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chang DTH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S3; Chen CT, 2008, BIOINFORMATICS, V24, P2691, DOI 10.1093/bioinformatics/btn538; de Vries SJ, 2008, CURR PROTEIN PEPT SC, V9, P394, DOI 10.2174/138920308785132712; Elkins JM, 2002, BIOCHEMISTRY-US, V41, P5185, DOI 10.1021/bi016014e; Engelen S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000267; Ezkurdia L, 2009, BRIEF BIOINFORM, V10, P233, DOI 10.1093/bib/bbp021; Gallet X, 2000, J MOL BIOL, V302, P917, DOI 10.1006/jmbi.2000.4092; Glaser F, 2001, PROTEINS, V43, P89, DOI 10.1002/1097-0134(20010501)43:2<89::AID-PROT1021>3.3.CO;2-8; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; Hubbard S. J., 1993, NACCESS; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jiang L, 2005, PROTEINS, V58, P893, DOI 10.1002/prot.20347; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Koike A, 2004, PROTEIN ENG DES SEL, V17, P165, DOI 10.1093/protein/gzh020; Kufareva I, 2007, PROTEINS, V67, P400, DOI 10.1002/prot.21233; Kundrotas PJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000727; Laskowski RA, 1996, J MOL BIOL, V259, P175, DOI 10.1006/jmbi.1996.0311; Levy ED, 2010, J MOL BIOL, V403, P660, DOI 10.1016/j.jmb.2010.09.028; Li MH, 2007, BIOINFORMATICS, V23, P597, DOI 10.1093/bioinformatics/btl660; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Manning CD, 2007, INTRO INFORM RETRIEV; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; McConkey BJ, 2003, P NATL ACAD SCI USA, V100, P3215, DOI 10.1073/pnas.0535768100; Moont G, 1999, PROTEINS, V35, P364, DOI 10.1002/(SICI)1097-0134(19990515)35:3<364::AID-PROT11>3.0.CO;2-4; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Murakami Y, 2006, BIOINFORMATICS, V22, P1794, DOI 10.1093/bioinformatics/btl171; Murakami Y, 2010, BIOINFORMATICS, V26, P1841, DOI 10.1093/bioinformatics/btq302; Negi SS, 2007, J MOL MODEL, V13, P1157, DOI 10.1007/s00894-007-0237-0; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; Newman W S, 1993, Q APPL MATH, V2, P160; Wass MN, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.3; Ofran Y, 2003, J MOL BIOL, V325, P377, DOI 10.1016/S0022-2836(02)01223-8; Ofran Y, 2003, FEBS LETT, V544, P236, DOI 10.1016/S0014-5793(03)00456-3; Ofran Y, 2007, BIOINFORMATICS, V23, pE13, DOI 10.1093/bioinformatics/btl303; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Res I, 2005, BIOINFORMATICS, V21, P2496, DOI 10.1093/bioinformatics/bti340; RIEDMILLER M, 1993, 1993 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-3, P586, DOI 10.1109/ICNN.1993.298623; Riedmiller M., 1994, RPROP DESCRIPTION IM; Rodier F, 2005, PROTEINS, V60, P36, DOI 10.1002/prot.20478; Rumelhart D.E., 1985, LEARNING INTERNAL RE, DOI 10.1016/b978-1-4832-1446-7.50035-2; Sacquin-Mora S, 2008, J MOL BIOL, V382, P1276, DOI 10.1016/j.jmb.2008.08.002; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; Sikic M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000278; Tuncbag N, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035006; Wass MN, 2011, CURR OPIN STRUC BIOL, V21, P382, DOI 10.1016/j.sbi.2011.03.013; Yu CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033340; Zhang QC, 2011, NUCLEIC ACIDS RES, V39, pW283, DOI 10.1093/nar/gkr311; Zhang QC, 2010, P NATL ACAD SCI USA, V107, P10896, DOI 10.1073/pnas.1005894107; Zhou HX, 2007, BIOINFORMATICS, V23, P2203, DOI 10.1093/bioinformatics/btm323	55	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37706	10.1371/journal.pone.0037706	http://dx.doi.org/10.1371/journal.pone.0037706			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701576	Green Submitted, Green Published, gold			2022-12-25	WOS:000305348400017
J	Freudenberg, J; Gregersen, PK; Freudenberg-Hua, Y				Freudenberg, Jan; Gregersen, Peter K.; Freudenberg-Hua, Yun			A Simple Method for Analyzing Exome Sequencing Data Shows Distinct Levels of Nonsynonymous Variation for Human Immune and Nervous System Genes	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; NATURAL-SELECTION; CANDIDATE GENES; EVOLUTIONARY; SPECTRUM; DISEASES; REGIONS; EXCESS; RATES	To measure the strength of natural selection that acts upon single nucleotide variants (SNVs) in a set of human genes, we calculate the ratio between nonsynonymous SNVs (nsSNVs) per nonsynonymous site and synonymous SNVs (sSNVs) per synonymous site. We transform this ratio with a respective factor f that corrects for the bias of synonymous sites towards transitions in the genetic code and different mutation rates for transitions and transversions. This method approximates the relative density of nsSNVs (rdnsv) in comparison with the neutral expectation as inferred from the density of sSNVs. Using SNVs from a diploid genome and 200 exomes, we apply our method to immune system genes (ISGs), nervous system genes (NSGs), randomly sampled genes (RSGs), and gene ontology annotated genes. The estimate of rdnsv in an individual exome is around 20% for NSGs and 30-40% for ISGs and RSGs. This smaller rdnsv of NSGs indicates overall stronger purifying selection. To quantify the relative shift of nsSNVs towards rare variants, we next fit a linear regression model to the estimates of rdnsv over different SNV allele frequency bins. The obtained regression models show a negative slope for NSGs, ISGs and RSGs, supporting an influence of purifying selection on the frequency spectrum of segregating nsSNVs. The y-intercept of the model predicts rdnsv for an allele frequency close to 0. This parameter can be interpreted as the proportion of nonsynonymous sites where mutations are tolerated to segregate with an allele frequency notably greater than 0 in the population, given the performed normalization of the observed nsSNV to sSNV ratio. A smaller y-intercept is displayed by NSGs, indicating more nonsynonymous sites under strong negative selection. This predicts more monogenically inherited or de-novo mutation diseases that affect the nervous system.	[Freudenberg, Jan; Gregersen, Peter K.] Northshore LIJ Healthsyst, Feinstein Inst Med Res, Robert S Boas Ctr Human Genet & Genom, Manhasset, NY USA; [Freudenberg-Hua, Yun] Northshore LIJ Healthsyst, Div Geriatr Psychiat, Dept Psychiat, Glen Oaks, NY USA; [Freudenberg-Hua, Yun] Northshore LIJ Healthsyst, Feinstein Inst Med Res, Litwin Zucker Ctr Alzheimers Dis & Memory Disorde, Manhasset, NY USA	Northwell Health; Northwell Health; Northwell Health	Freudenberg, J (corresponding author), Northshore LIJ Healthsyst, Feinstein Inst Med Res, Robert S Boas Ctr Human Genet & Genom, Manhasset, NY USA.	jan.freudenberg@nshs.edu			Young Investigator Award of the National Alliance for Research in Schizophrenia and Depression (NARSAD); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR063340] Funding Source: NIH RePORTER	Young Investigator Award of the National Alliance for Research in Schizophrenia and Depression (NARSAD); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Part of this research has been supported by a Young Investigator Award of the National Alliance for Research in Schizophrenia and Depression (NARSAD) to JF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Emes RD, 2008, NAT NEUROSCI, V11, P799, DOI 10.1038/nn.2135; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freudenberg J, 2007, EUR J HUM GENET, V15, P1071, DOI 10.1038/sj.ejhg.5201876; Freudenberg J, 2007, NEUROGENETICS, V8, P159, DOI 10.1007/s10048-007-0082-4; Freudenberg-Hua Y, 2003, GENOME RES, V13, P2271, DOI 10.1101/gr.1299703; Freudenberg-Hua Y, 2005, PHARMACOGENOMICS J, V5, P183, DOI 10.1038/sj.tpj.6500306; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Gahl WA, 2011, JAMA-J AM MED ASSOC, V305, P1904, DOI 10.1001/jama.2011.613; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gilad Y, 2003, P NATL ACAD SCI USA, V100, P3324, DOI 10.1073/pnas.0535697100; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hughes AL, 2005, IMMUNOGENETICS, V57, P821, DOI 10.1007/s00251-005-0052-7; Hughes AL, 2003, P NATL ACAD SCI USA, V100, P15754, DOI 10.1073/pnas.2536718100; Jiang CZ, 2006, GENOMICS, V88, P527, DOI 10.1016/j.ygeno.2006.06.003; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Leabman MK, 2003, P NATL ACAD SCI USA, V100, P5896, DOI 10.1073/pnas.0730857100; Leulier F, 2008, NAT REV GENET, V9, P165, DOI 10.1038/nrg2303; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Livingston RJ, 2004, GENOME RES, V14, P1821, DOI 10.1101/gr.2730004; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Parmley JL, 2007, BIOESSAYS, V29, P515, DOI 10.1002/bies.20592; Piontkivska H, 2003, J MOL EVOL, V56, P277, DOI 10.1007/s00239-002-2399-9; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Roak BJO, 2012, NATURE, V485, P242; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Smith AV, 2005, GENOME RES, V15, P1519, DOI 10.1101/gr.4421405; STRACHAN T, 2003, HUMAN MOL GENETICS; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320	52	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38087	10.1371/journal.pone.0038087	http://dx.doi.org/10.1371/journal.pone.0038087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701602	Green Submitted, Green Published, gold			2022-12-25	WOS:000305348400034
J	Smathers, RL; Fritz, KS; Galligan, JJ; Shearn, CT; Reigan, P; Marks, MJ; Petersen, DR				Smathers, Rebecca L.; Fritz, Kristofer S.; Galligan, James J.; Shearn, Colin T.; Reigan, Philip; Marks, Michael J.; Petersen, Dennis R.			Characterization of 4-HNE Modified L-FABP Reveals Alterations in Structural and Functional Dynamics	PLOS ONE			English	Article							ACID-BINDING-PROTEIN; LIPID-PEROXIDATION PRODUCTS; ALCOHOLIC LIVER-DISEASE; FATTY-ACID; RAT-LIVER; COVALENT MODIFICATION; PEROXIREDOXIN 6; LIGAND-BINDING; MOUSE MODEL; IN-VITRO	4-Hydroxynonenal (4-HNE) is a reactive alpha, beta-unsaturated aldehyde produced during oxidative stress and subsequent lipid peroxidation of polyunsaturated fatty acids. The reactivity of 4-HNE towards DNA and nucleophilic amino acids has been well established. In this report, using proteomic approaches, liver fatty acid-binding protein (L-FABP) is identified as a target for modification by 4-HNE. This lipid binding protein mediates the uptake and trafficking of hydrophobic ligands throughout cellular compartments. Ethanol caused a significant decrease in L-FABP protein (P<0.001) and mRNA (P<0.05), as well as increased poly-ubiquitinated L-FABP (P, 0.001). Sites of 4-HNE adduction on mouse recombinant L-FABP were mapped using MALDI-TOF/TOF mass spectrometry on apo (Lys57 and Cys69) and holo (Lys6, Lys31, His43, Lys46, Lys57 and Cys69) L-FABP. The impact of 4-HNE adduction was found to occur in a concentration-dependent manner; affinity for the fluorescent ligand, anilinonaphthalene-8-sulfonic acid, was reduced from 0.347 mu M to Kd(1) = 0.395 mu M and Kd(2) = 34.20 mu M. Saturation analyses revealed that capacity for ligand is reduced by approximately 50% when adducted by 4-HNE. Thermal stability curves of apo L-FABP was also found to be significantly affected by 4-HNE adduction (Delta Tm = 5.44 degrees C, P<0.01). Computational-based molecular modeling simulations of adducted protein revealed minor conformational changes in global protein structure of apo and holo L-FABP while more apparent differences were observed within the internal binding pocket, revealing reduced area and structural integrity. New solvent accessible portals on the periphery of the protein were observed following 4-HNE modification in both the apo and holo state, suggesting an adaptive response to carbonylation. The results from this study detail the dynamic process associated with L-FABP modification by 4-HNE and provide insight as to how alterations in structural integrity and ligand binding may a contributing factor in the pathogenesis of ALD.	[Smathers, Rebecca L.; Fritz, Kristofer S.; Shearn, Colin T.; Reigan, Philip; Petersen, Dennis R.] Univ Colorado, Dept Pharmaceut Sci, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO 80045 USA; [Galligan, James J.] Univ Colorado, Dept Pharmacol, Sch Med, Aurora, CO USA; [Marks, Michael J.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder	Smathers, RL (corresponding author), Univ Colorado, Dept Pharmaceut Sci, Skaggs Sch Pharm & Pharmaceut Sci, Anschutz Med Campus, Aurora, CO 80045 USA.	dennis.petersen@ucdenver.edu	Galligan, James/A-5041-2015; McCullough, Rebecca/I-4081-2014	Fritz, Kristofer/0000-0002-1499-6174	National Institutes of Health/National Institutes of Alcoholism and Alcohol Abuse [R37AA09300, R01DK074487-01, F31AA018898-02]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA009300, F31AA018898] Funding Source: NIH RePORTER	National Institutes of Health/National Institutes of Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Studies were supported by the National Institutes of Health/National Institutes of Alcoholism and Alcohol Abuse under grant numbers R37AA09300 (DRP), R01DK074487-01 (DRP) and F31AA018898-02 (RLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteel GE, 2003, GASTROENTEROLOGY, V124, P778, DOI 10.1053/gast.2003.50087; Atshaves BP, 2010, J NUTR BIOCHEM, V21, P1015, DOI 10.1016/j.jnutbio.2010.01.005; Backos DS, 2011, FREE RADICAL BIO MED, V50, P14, DOI 10.1016/j.freeradbiomed.2010.10.694; Beier Juliane I, 2011, Curr Gastroenterol Rep, V13, P56, DOI 10.1007/s11894-010-0157-5; BENEDETTI A, 1984, BIOCHIM BIOPHYS ACTA, V792, P172, DOI 10.1016/0005-2760(84)90219-4; Bennaars-Eiden A, 2002, J BIOL CHEM, V277, P50693, DOI 10.1074/jbc.M209493200; Carbone DL, 2005, J PHARMACOL EXP THER, V315, P8, DOI 10.1124/jpet.105.088088; Carbone DL, 2005, CHEM RES TOXICOL, V18, P1324, DOI 10.1021/tx050078z; Carbone DL, 2004, CHEM RES TOXICOL, V17, P1459, DOI 10.1021/tx049838g; CHAM BE, 1976, J LIPID RES, V17, P176; Chuang S, 2008, J MED CHEM, V51, P3755, DOI 10.1021/jm701192w; Clugston RD, 2011, J LIPID RES; Codreanu SG, 2009, MOL CELL PROTEOMICS, V8, P670, DOI 10.1074/mcp.M800070-MCP200; Comporti MM, 1998, FREE RADICAL RES, V28, P623, DOI 10.3109/10715769809065818; Conde de la Rosa L, 2008, REV ESP ENFERM DIG, V100, P156, DOI 10.4321/s1130-01082008000300006; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Donohue TM, 2003, ALCOHOL RES HEALTH, V27, P317; Doorn JA, 2003, CHEM-BIOL INTERACT, V143, P93, DOI 10.1016/S0009-2797(02)00178-3; Doorn JA, 2002, CHEM RES TOXICOL, V15, P1445, DOI 10.1021/tx025590o; DORMANN P, 1993, J BIOL CHEM, V268, P16286; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fritz KS, 2011, CHEM RES TOXICOL, V24, P1411, DOI 10.1021/tx200169n; Fritz KS, 2011, CHEM RES TOXICOL, V24, P651, DOI 10.1021/tx100355a; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Galligan JJ, 2011, J PROTEOME RES, V10, P1837, DOI 10.1021/pr101101s; Galligan JJ, 2012, CHEM RES TOXICOL; Grimsrud PA, 2007, MOL CELL PROTEOMICS, V6, P624, DOI 10.1074/mcp.M600120-MCP200; He Y, 2007, BIOCHEMISTRY-US, V46, P12543, DOI 10.1021/bi701092r; HERR FM, 1995, BIOCHEMISTRY-US, V34, P11840, DOI 10.1021/bi00037a023; Kane CD, 1996, ANAL BIOCHEM, V233, P197, DOI 10.1006/abio.1996.0028; KIM HK, 1992, J BIOL CHEM, V267, P77; Koska J, 2008, J CHEM INF MODEL, V48, P1965, DOI 10.1021/ci800081s; LITTLE RG, 1983, COMP BIOCHEM PHYS C, V74, P271, DOI 10.1016/0742-8413(83)90101-9; Long D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006081; LoPachin RM, 2012, CHEM RES TOXICOL, V25, P239, DOI 10.1021/tx2003257; LoPachin RM, 2009, CHEM RES TOXICOL, V22, P1499, DOI 10.1021/tx900147g; Lu YK, 2008, HEPATOLOGY, V47, P1483, DOI 10.1002/hep.22222; Marnett LJ, 2003, J CLIN INVEST, V111, P583, DOI 10.1172/JCI200318022; Martin GG, 2005, BIOCHEM J, V391, P549, DOI 10.1042/BJ20050296; Martin GG, 2003, BIOCHEMISTRY-US, V42, P11520, DOI 10.1021/bi0346749; Martin GG, 2003, J BIOL CHEM, V278, P21429, DOI 10.1074/jbc.M300287200; McIntosh AL, 2009, ARCH BIOCHEM BIOPHYS, V485, P160, DOI 10.1016/j.abb.2009.03.004; Moller M, 2002, BIOCHEM MOL BIOL EDU, V30, P309, DOI 10.1002/bmb.2002.494030050089; Newton BW, 2009, J PROTEOME RES, V8, P1663, DOI 10.1021/pr800905w; OCKNER RK, 1982, J BIOL CHEM, V257, P7872; PALLEROS DR, 1994, J BIOL CHEM, V269, P13107; Paradis V, 1997, HEPATOLOGY, V26, P135; Petersen DR, 2004, FREE RADICAL BIO MED, V37, P937, DOI 10.1016/j.freeradbiomed.2004.06.012; PIGNON JP, 1987, HEPATOLOGY, V7, P865, DOI 10.1002/hep.1840070512; Poli G, 2008, MED RES REV, V28, P569, DOI 10.1002/med.20117; Poli G, 2008, MOL ASPECTS MED, V29, P67, DOI 10.1016/j.mam.2007.09.016; Purohit V, 2004, ALCOHOL, V34, P3, DOI 10.1016/j.alcohol.2004.06.008; Ramaiah SK, 2004, INT J TOXICOL, V23, P217, DOI 10.1080/10915810490502069; Richieri GV, 2000, BIOCHEMISTRY-US, V39, P7197, DOI 10.1021/bi000314z; Richieri GV, 1996, J BIOL CHEM, V271, P31068, DOI 10.1074/jbc.271.49.31068; Roede JR, 2008, CHEM RES TOXICOL, V21, P2289, DOI 10.1021/tx800244u; Roede JR, 2008, FREE RADICAL BIO MED, V45, P1551, DOI 10.1016/j.freeradbiomed.2008.08.032; Sampey BP, 2007, J BIOL CHEM, V282, P1925, DOI 10.1074/jbc.M610602200; Sato T, 1996, J BIOCHEM-TOKYO, V120, P908; Sayre LM, 2006, DRUG METAB REV, V38, P651, DOI 10.1080/03602530600959508; Schroeder F, 2008, LIPIDS, V43, P1, DOI 10.1007/s11745-007-3111-z; SCHULENBERGSCHELL H, 1988, EUR J BIOCHEM, V170, P565, DOI 10.1111/j.1432-1033.1988.tb13735.x; Seitz HK, 2005, ALCOHOL CLIN EXP RES, V29, P1276, DOI 10.1097/01.ALC.0000171896.37022.F7; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Smathers RL, 2011, CHEM-BIOL INTERACT, V192, P107, DOI 10.1016/j.cbi.2011.02.021; Smathers Rebecca L., 2011, Human Genomics, V5, P170; Stewart BJ, 2007, CHEM RES TOXICOL, V20, P1111, DOI 10.1021/tx700106v; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Thompson J, 1999, BBA-MOL CELL BIOL L, V1441, P117, DOI 10.1016/S1388-1981(99)00146-8; Thompson J, 1997, J BIOL CHEM, V272, P7140, DOI 10.1074/jbc.272.11.7140; Toyokuni S, 2000, ANTIOXID REDOX SIGN, V2, P681, DOI 10.1089/ars.2000.2.4-681; TSUKAMOTO H, 1995, J CLIN INVEST, V96, P620, DOI 10.1172/JCI118077; UCHIDA K, 1992, P NATL ACAD SCI USA, V89, P4544, DOI 10.1073/pnas.89.10.4544; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Wang W, 2005, INT J PHARMACEUT, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014; You Q, 2006, HEPATOLOGY, V44, P1421, DOI 10.1002/hep.21425; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y; Zimmerman AW, 2001, INT J BIOCHEM CELL B, V33, P865, DOI 10.1016/S1357-2725(01)00070-X; Zou XQ, 1999, J AM CHEM SOC, V121, P8033, DOI 10.1021/ja984102p	80	42	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38459	10.1371/journal.pone.0038459	http://dx.doi.org/10.1371/journal.pone.0038459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701647	gold, Green Published, Green Submitted			2022-12-25	WOS:000305348400062
J	Szameitat, AJ; McNamara, A; Shen, S; Sterr, A				Szameitat, Andre J.; McNamara, Adam; Shen, Shan; Sterr, Annette			Neural Activation and Functional Connectivity during Motor Imagery of Bimanual Everyday Actions	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PREMOTOR CORTEX; HAND MOVEMENTS; MENTAL REPRESENTATION; COORDINATION TASK; FINGER MOVEMENTS; BRAIN ACTIVATION; HEALTHY-SUBJECTS; ACTIONS SHARE; TIME-SERIES	Bimanual actions impose intermanual coordination demands not present during unimanual actions. We investigated the functional neuroanatomical correlates of these coordination demands in motor imagery (MI) of everyday actions using functional magnetic resonance imaging (fMRI). For this, 17 participants imagined unimanual actions with the left and right hand as well as bimanual actions while undergoing fMRI. A univariate fMRI analysis showed no reliable cortical activations specific to bimanual MI, indicating that intermanual coordination demands in MI are not associated with increased neural processing. A functional connectivity analysis based on psychophysiological interactions (PPI), however, revealed marked increases in connectivity between parietal and premotor areas within and between hemispheres. We conclude that in MI of everyday actions intermanual coordination demands are primarily met by changes in connectivity between areas and only moderately, if at all, by changes in the amount of neural activity. These results are the first characterization of the neuroanatomical correlates of bimanual coordination demands in MI. Our findings support the assumed equivalence of overt and imagined actions and highlight the differences between uni- and bimanual actions. The findings extent our understanding of the motor system and may aid the development of clinical neurorehabilitation approaches based on mental practice.	[Szameitat, Andre J.] Univ Munich, Dept Psychol, Munich, Germany; [Szameitat, Andre J.; McNamara, Adam; Shen, Shan; Sterr, Annette] Univ Surrey, Dept Psychol, Guildford GU2 5XH, Surrey, England	University of Munich; University of Surrey	Szameitat, AJ (corresponding author), Univ Munich, Dept Psychol, Munich, Germany.	szameitat@psy.lmu.de		Sterr, Annette/0000-0003-4490-985X	Medical Research Council, UK [CEG 61501]; MRC [G0200128] Funding Source: UKRI; Medical Research Council [G0200128] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Medical Research Council, UK (CEG 61501; Dr Sterr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Andres FG, 1999, BRAIN, V122, P855, DOI 10.1093/brain/122.5.855; Bakker M, 2008, NEUROIMAGE, V41, P998, DOI 10.1016/j.neuroimage.2008.03.020; Belardinelli MO, 2009, ACTA PSYCHOL, V132, P190, DOI 10.1016/j.actpsy.2009.06.009; Boecker H, 2002, NEUROIMAGE, V17, P999, DOI 10.1006/nimg.2002.1139; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cauraugh JH, 2004, RESTOR NEUROL NEUROS, V22, P337; Crammond DJ, 1997, TRENDS NEUROSCI, V20, P54, DOI 10.1016/S0166-2236(96)30019-2; Debaere F, 2004, NEUROIMAGE, V21, P1416, DOI 10.1016/j.neuroimage.2003.12.011; Debaere F, 2004, NEUROPSYCHOLOGIA, V42, P855, DOI 10.1016/j.neuropsychologia.2003.12.010; Decety J, 1996, BEHAV BRAIN RES, V72, P127; Decety J, 1996, COGNITIVE BRAIN RES, V3, P87, DOI 10.1016/0926-6410(95)00033-X; Dechent P, 2004, COGNITIVE BRAIN RES, V19, P138, DOI 10.1016/j.cogbrainres.2003.11.012; Deiber MP, 1998, NEUROIMAGE, V7, P73, DOI 10.1006/nimg.1997.0314; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Ertelt D, 2007, NEUROIMAGE, V36, pT164, DOI 10.1016/j.neuroimage.2007.03.043; Fleming MK, 2010, EXP BRAIN RES, V201, P499, DOI 10.1007/s00221-009-2062-4; Fourkas AD, 2008, CEREB CORTEX, V18, P2382, DOI 10.1093/cercor/bhn005; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gao Q, 2011, NEUROIMAGE, V54, P1280, DOI 10.1016/j.neuroimage.2010.08.071; Garrison KA, 2010, NEUROREHAB NEURAL RE, V24, P404, DOI 10.1177/1545968309354536; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Gerloff C, 2002, ACTA PSYCHOL, V110, P161, DOI 10.1016/S0001-6918(02)00032-X; Goldenberg G, 2009, NEUROPSYCHOLOGIA, V47, P1449, DOI 10.1016/j.neuropsychologia.2008.07.014; Gordon AM, 2007, DEV MED CHILD NEUROL, V49, P830, DOI 10.1111/j.1469-8749.2007.00830.x; Grefkes C, 2008, NEUROIMAGE, V41, P1382, DOI 10.1016/j.neuroimage.2008.03.048; GUIARD Y, 1987, J MOTOR BEHAV, V19, P486; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; Hou WS, 2005, P ANN INT IEEE EMBS, P3687; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Kranczioch C, 2009, HUM BRAIN MAPP, V30, P3275, DOI 10.1002/hbm.20748; Kuhtz-Buschbeck JP, 2003, EUR J NEUROSCI, V18, P3375, DOI 10.1111/j.1460-9568.2003.03066.x; Lorey B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020368; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Macuga KL, 2012, NEUROIMAGE, V59, P2798, DOI 10.1016/j.neuroimage.2011.09.083; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; Michelon P, 2006, J NEUROPHYSIOL, V95, P811, DOI 10.1152/jn.00488.2005; Miller KJ, 2010, P NATL ACAD SCI USA, V107, P4430, DOI 10.1073/pnas.0913697107; Naito E, 2002, J NEUROSCI, V22, P3683; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olsson CJ, 2010, SCAND J MED SCI SPOR, V20, P711, DOI 10.1111/j.1600-0838.2010.01101.x; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Pomeroy VM, 2005, NEUROREHAB NEURAL RE, V19, P4, DOI 10.1177/1545968304274351; Porro CA, 1996, J NEUROSCI, V16, P7688; Puttemans V, 2005, J NEUROSCI, V25, P4270, DOI 10.1523/JNEUROSCI.3866-04.2005; Renner CIE, 2005, J NEUROL SCI, V239, P25, DOI 10.1016/j.jns.2005.07.005; Sharma N, 2009, ANN NEUROL, V66, P604, DOI 10.1002/ana.21810; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Solodkin A, 2004, CEREB CORTEX, V14, P1246, DOI 10.1093/cercor/bhh086; Stelzel C, 2009, NEUROIMAGE, V48, P237, DOI 10.1016/j.neuroimage.2009.06.064; Stephan KM, 1999, BRAIN, V122, P351, DOI 10.1093/brain/122.2.351; STEPHAN KM, 1995, J NEUROPHYSIOL, V73, P373, DOI 10.1152/jn.1995.73.1.373; Stinear CM, 2007, CLIN NEUROPHYSIOL, V118, P1794, DOI 10.1016/j.clinph.2007.05.008; Stinear CM, 2006, EXP BRAIN RES, V168, P157, DOI 10.1007/s00221-005-0078-y; Stinear JW, 2002, J PHYSIOL-LONDON, V543, P307, DOI 10.1113/jphysiol.2002.023986; Sun FT, 2007, CEREB CORTEX, V17, P1227, DOI 10.1093/cercor/bhl033; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807; Szameitat AJ, 2002, J COGNITIVE NEUROSCI, V14, P1184, DOI 10.1162/089892902760807195; Szameitat AJ, 2007, EUR J NEUROSCI, V26, P3303, DOI 10.1111/j.1460-9568.2007.05920.x; Szameitat AJ, 2007, NEUROIMAGE, V34, P702, DOI 10.1016/j.neuroimage.2006.09.033; Szameitat AJ, 2011, NEUROIMAGE, V54, P1765, DOI 10.1016/j.neuroimage.2010.07.069; Toussaint L, 2010, J SPORT SCI, V28, P497, DOI 10.1080/02640410903555855; van den Berg FE, 2010, CEREB CORTEX, V20, P2842, DOI 10.1093/cercor/bhq034; Wenderoth N, 2006, NEUROIMAGE, V31, P264, DOI 10.1016/j.neuroimage.2005.11.033; Wolbers T, 2003, CEREB CORTEX, V13, P392, DOI 10.1093/cercor/13.4.392; Woldag H, 2004, STROKE, V35, P2556, DOI 10.1161/01.STR.0000144651.07122.da; Yoo SC, 2003, NEUROREPORT, V14, P581, DOI 10.1097/00001756-200303240-00011	74	26	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38506	10.1371/journal.pone.0038506	http://dx.doi.org/10.1371/journal.pone.0038506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701655	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000305348400066
J	Capraro, DT; Gosavi, S; Roy, M; Onuchic, JN; Jennings, PA				Capraro, Dominique T.; Gosavi, Shachi; Roy, Melinda; Onuchic, Jose N.; Jennings, Patricia A.			Folding Circular Permutants of IL-1 beta: Route Selection Driven by Functional Frustration	PLOS ONE			English	Article							NATIVE-STATE TOPOLOGY; BETA-TREFOIL PROTEIN; DIHYDROFOLATE-REDUCTASE; IMPROVED SENSITIVITY; ESCHERICHIA-COLI; ENERGY LANDSCAPE; TRANSITION-STATE; INTERLEUKIN-1-BETA; NMR; STABILITY	Interleukin-1 beta (IL-1 beta) is the cytokine crucial to inflammatory and immune response. Two dominant routes are populated in the folding to native structure. These distinct routes are a result of the competition between early packing of the functional loops versus closure of the beta-barrel to achieve efficient folding and have been observed both experimentally and computationally. Kinetic experiments on the WT protein established that the dominant route is characterized by early packing of geometrically frustrated functional loops. However, deletion of one of the functional loops, the beta-bulge, switches the dominant route to an alternative, yet, as accessible, route, where the termini necessary for barrel closure form first. Here, we explore the effect of circular permutation of the WT sequence on the observed folding landscape with a combination of kinetic and thermodynamic experiments. Our experiments show that while the rate of formation of permutant protein is always slower than that observed for the WT sequence, the region of initial nucleation for all permutants is similar to that observed for the WT protein and occurs within a similar timescale. That is, even permutants with significant sequence rearrangement in which the functional-nucleus is placed at opposing ends of the polypeptide chain, fold by the dominant WT "functional loop-packing route", despite the entropic cost of having to fold the N- and C-termini early. Taken together, our results indicate that the early packing of the functional loops dominates the folding landscape in active proteins, and, despite the entropic penalty of coalescing the termini early, these proteins will populate an entropically unfavorable route in order to conserve function. More generally, circular permutation can elucidate the influence of local energetic stabilization of functional regions within a protein, where topological complexity creates a mismatch between energetics and topology in active proteins.	[Capraro, Dominique T.; Onuchic, Jose N.] Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77251 USA; [Gosavi, Shachi] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Roy, Melinda; Jennings, Patricia A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	Rice University; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of California System; University of California San Diego	Capraro, DT (corresponding author), Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77251 USA.	pajennings@ucsd.edu			Center for Theoretical Biological Physics; National Science Foundation (NSF) [PHY-0822283, MCB-1051438]; National Institutes of Health (NIH) [GM54038]; Government of India-Department of Atomic Energy through the National Centre for Biological Sciences; Government of India-Department of Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054038, R29GM054038] Funding Source: NIH RePORTER; Division Of Physics [1308264] Funding Source: National Science Foundation	Center for Theoretical Biological Physics; National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Government of India-Department of Atomic Energy through the National Centre for Biological Sciences; Government of India-Department of Science and Technology(Department of Science & Technology (India)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	D.T.C. and J.N.O. are supported by the Center for Theoretical Biological Physics sponsored by the National Science Foundation (NSF) Grants PHY-0822283 and MCB-1051438. Additionally, this work was supported in part by National Institutes of Health (NIH) Grants GM54038. S. G. is supported by the Government of India-Department of Atomic Energy through the National Centre for Biological Sciences startup funds and the Government of India-Department of Science and Technology-Ramanujan Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PYMOL MOL GRAPH SYST; Arai M, 2003, J MOL BIOL, V328, P273, DOI 10.1016/S0022-2836(03)00212-2; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bulaj G, 2004, PROTEIN SCI, V13, P1182, DOI 10.1110/ps.03563704; Capraro DT, 2012, P NATL ACAD SCI USA, V109, P1490, DOI 10.1073/pnas.1114430109; Capraro DT, 2008, P NATL ACAD SCI USA, V105, P14844, DOI 10.1073/pnas.0807812105; Capraro DT, 2011, P NATL ACAD IN PRESS; Chavez LL, 2006, P NATL ACAD SCI USA, V103, P10254, DOI 10.1073/pnas.0510110103; CHRUNYK BA, 1993, J BIOL CHEM, V268, P18053; Clementi C, 2000, P NATL ACAD SCI USA, V97, P5871, DOI 10.1073/pnas.100547897; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Finke JM, 2001, J BIOL PHYS, V27, P119, DOI 10.1023/A:1013178505077; Finke JM, 2001, THESIS U CALIF, pxvii; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goddard T. D., 2008, SPARKY 3; Gosavi S, 2006, J MOL BIOL, V357, P986, DOI 10.1016/j.jmb.2005.11.074; Gosavi S, 2008, P NATL ACAD SCI USA, V105, P10384, DOI 10.1073/pnas.0801343105; GRZESIEK S, 1992, J MAGN RESON, V96, P215, DOI 10.1016/0022-2364(92)90307-S; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Haglund E, 2008, J BIOL CHEM, V283, P27904, DOI 10.1074/jbc.M801776200; Heidary DK, 1997, NAT STRUCT BIOL, V4, P725, DOI 10.1038/nsb0997-725; Heidary DK, 2005, J MOL BIOL, V353, P1187, DOI 10.1016/j.jmb.2005.08.072; Heidary DK, 2002, J MOL BIOL, V316, P789, DOI 10.1006/jmbi.2001.5270; Heinemann U, 1995, PROG BIOPHYS MOL BIO, V64, P121, DOI 10.1016/0079-6107(95)00013-5; HORLICK RA, 1992, PROTEIN ENG, V5, P427, DOI 10.1093/protein/5.5.427; JONES BE, 1994, BIOCHEMISTRY-US, V33, P15250, DOI 10.1021/bi00255a005; Klimov DK, 2005, J MOL BIOL, V353, P1171, DOI 10.1016/j.jmb.2005.09.029; Koussounadis AI, 2004, CURR PHARM DESIGN, V10, P3857, DOI 10.2174/1381612043382585; Latypov RF, 2007, J MOL BIOL, V368, P1187, DOI 10.1016/j.jmb.2007.02.031; Li L, 2001, J MOL BIOL, V306, P121, DOI 10.1006/jmbi.2000.4375; Lindberg M, 2002, NAT STRUCT BIOL, V9, P818, DOI 10.1038/nsb847; Lindberg MO, 2006, P NATL ACAD SCI USA, V103, P4083, DOI 10.1073/pnas.0508863103; Lindberg MO, 2001, J MOL BIOL, V314, P891, DOI 10.1006/jmbi.2001.5186; Lo WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031791; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Rees AR, 1992, PROTEIN ENG PRACTICA, Vxxv, P397; Roy M, 2005, J MOL BIOL, V348, P335, DOI 10.1016/j.jmb.2005.02.059; Roy M, 2003, J MOL BIOL, V328, P693, DOI 10.1016/S0022-2836(03)00340-1; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; SEMISOTNOV GV, 1987, FEBS LETT, V224, P9, DOI 10.1016/0014-5793(87)80412-X; Varley CL, 1997, CYTOKINE, V9, P577, DOI 10.1006/cyto.1997.0204; VARLEY P, 1993, SCIENCE, V260, P1110, DOI 10.1126/science.8493553; Vigers GPA, 1997, NATURE, V386, P190, DOI 10.1038/386190a0	45	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38512	10.1371/journal.pone.0038512	http://dx.doi.org/10.1371/journal.pone.0038512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693643	Green Published, gold			2022-12-25	WOS:000305343900053
J	Walters, M; Morrison, NI; Claus, J; Tang, GL; Phillips, CE; Young, R; Zink, RT; Alphey, L				Walters, Michelle; Morrison, Neil I.; Claus, John; Tang, Guolei; Phillips, Caroline E.; Young, Robin; Zink, Richard T.; Alphey, Luke			Field Longevity of a Fluorescent Protein Marker in an Engineered Strain of the Pink Bollworm, Pectinophora gossypiella (Saunders)	PLOS ONE			English	Article							LEPIDOPTERA; GELECHIIDAE; FITNESS; GENETICS	The cotton pest, pink bollworm (Pectinophora gossypiella (Saunders)), is a significant pest in most cotton-growing areas around the world. In southwestern USA and northern Mexico, pink bollworm is the target of the sterile insect technique (SIT), which relies on the mass-release of sterile pink bollworm adults to over-flood the wild population and thereby reduce it over time. Sterile moths reared for release are currently marked with a dye provided in their larval diet. There are concerns, however, that this marker fails from time to time, leading to sterile moths being misidentified in monitoring traps as wild moths. This can lead to expensive reactionary releases of sterile moths. We have developed a genetically marked strain that is engineered to express a fluorescent protein, DsRed2, which is easily screened under a specialised microscope. In order to test this marker under field conditions, we placed wild-type and genetically marked moths on traps and placed them in field cages. The moths were then screened, in a double-blind fashion, for DsRed2 fluorescence at regular intervals to determine marker reliability over time. The marker was shown to be robust in very high temperatures and generally proved reliable for a week or longer. More importantly, genotyping of moths on traps by PCR screening of the moths was 100% correct. Our findings indicate that this strain - and fluorescent protein markers in general - could make a valuable contribution to SIT.	[Walters, Michelle; Claus, John; Tang, Guolei; Zink, Richard T.] Anim Plant Hlth & Inspect Serv, Ctr Plant Hlth Sci & Technol, USDA, Phoenix, AZ USA; [Morrison, Neil I.; Phillips, Caroline E.; Alphey, Luke] Oxitec Ltd, Oxford, England; [Young, Robin] Univ Cambridge, Strangeways Res Lab, Cardiovasc Epidemiol Unit, Cambridge, England; [Zink, Richard T.] Anim Plant Hlth & Inspect Serv, Ctr Plant Hlth Sci & Technol, USDA, Ft Collins, CO USA; [Alphey, Luke] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	United States Department of Agriculture (USDA); University of Cambridge; United States Department of Agriculture (USDA); University of Oxford	Walters, M (corresponding author), Anim Plant Hlth & Inspect Serv, Ctr Plant Hlth Sci & Technol, USDA, Phoenix, AZ USA.	luke.alphey@oxitec.com	Tang, Guolei/H-7070-2017	Tang, Guolei/0000-0003-4565-0800; Alphey, Luke/0000-0002-2916-3802				BARTLETT AC, 1979, ANN ENTOMOL SOC AM, V72, P256, DOI 10.1093/aesa/72.2.256; BARTLETT AC, 1978, ANN ENTOMOL SOC AM, V71, P813, DOI 10.1093/aesa/71.6.813; BARTLETT AC, 1984, ENVIRON ENTOMOL, V13, P543, DOI 10.1093/ee/13.2.543; BARTLETT AC, 1980, ANN ENTOMOL SOC AM, V73, P164, DOI 10.1093/aesa/73.2.164; Carpenter JE, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P115, DOI 10.1007/1-4020-4051-2_5; Catteruccia F, 2003, SCIENCE, V299, P1225, DOI 10.1126/science.1081453; Common I. F. B., 1958, Australian Journal of Zoology, V6, P268, DOI 10.1071/ZO9580268; Edwards RH, 1996, T ASAE, V39, P1789, DOI 10.13031/2013.27655; Feldmann U, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P701, DOI 10.1007/1-4020-4051-2_27; GRAHAM HM, 1971, J ECON ENTOMOL, V64, P376, DOI 10.1093/jee/64.2.376; Grefenstette B., 2009, PINK BOLLWORM ERADIC; Hagler JR, 2002, ENTOMOL EXP APPL, V103, P1, DOI 10.1023/A:1019803106330; Henneberry T. J., 1998, Integrated Pest Management Reviews, V3, P31, DOI 10.1023/A:1009673622862; Henneberry T. J., 2007, P567, DOI 10.1007/978-1-4020-6059-5_53; HENNEBERRY TJ, 1981, J ECON ENTOMOL, V74, P19, DOI 10.1093/jee/74.1.19; Irvin N, 2004, P NATL ACAD SCI USA, V101, P891, DOI 10.1073/pnas.0305511101; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Marrelli MT, 2006, TRENDS PARASITOL, V22, P197, DOI 10.1016/j.pt.2006.03.004; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; MILLER E, 1994, J ECON ENTOMOL, V87, P1659, DOI 10.1093/jee/87.6.1659; MOSS JI, 1982, ENVIRON ENTOMOL, V11, P1264, DOI 10.1093/ee/11.6.1264; NCC, 2010, NAT COTT COUNC PINK; Simmons G. S., 2007, P119, DOI 10.1007/978-1-4020-6059-5_10; Simmons GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024110; Staten R. T., 1999, PROC BELTWIDE COTTON, P985; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; VANSTEENWYK RA, 1978, ANN ENTOMOL SOC AM, V71, P81, DOI 10.1093/aesa/71.1.81; WILSON AGL, 1972, J AUST I AGR SCI, V38, P95	29	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38547	10.1371/journal.pone.0038547	http://dx.doi.org/10.1371/journal.pone.0038547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693645	Green Published, gold, Green Submitted			2022-12-25	WOS:000305343900056
J	Akchiche, N; Bossenmeyer-Pourie, C; Kerek, R; Martin, N; Pourie, G; Koziel, V; Helle, D; Alberto, JM; Ortiou, S; Camadro, JM; Leger, T; Gueant, JL; Daval, JL				Akchiche, Nassila; Bossenmeyer-Pourie, Carine; Kerek, Racha; Martin, Nicolas; Pourie, Gregory; Koziel, Violette; Helle, Deborah; Alberto, Jean-Marc; Ortiou, Sandrine; Camadro, Jean-Michel; Leger, Thibaut; Gueant, Jean-Louis; Daval, Jean-Luc			Homocysteinylation of neuronal proteins contributes to folate deficiency-associated alterations of differentiation, vesicular transport, and plasticity in hippocampal neuronal cells	FASEB JOURNAL			English	Article						homocysteine; apoptosis; histone deacetylases; motor proteins; aggregation	NEURAL-TUBE DEFECTS; FOLIC-ACID SUPPLEMENTATION; B-VITAMIN DEFICIENCY; METHYLENETETRAHYDROFOLATE REDUCTASE; COGNITIVE IMPAIRMENT; IN-VITRO; ALZHEIMERS-DISEASE; RANDOMIZED-TRIALS; METABOLISM; HYPERHOMOCYSTEINEMIA	Despite the key role in neuronal development of a deficit in the methyl donor folate, little is known on the underlying mechanisms. We therefore studied the consequences of folate deficiency on proliferation, differentiation, and plasticity of the rat H19-7 hippocampal cell line. Folate deficit reduced proliferation (17%) and sensitized cells to differentiation-associated apoptosis (+16%). Decreased production (-58%) of S-adenosylmethionine (the universal substrate for transmethylation reactions) and increased expression of histone deacetylases (HDAC4,6,7) would lead to epigenomic changes that may impair the differentiation process. Cell polarity, vesicular transport, and synaptic plasticity were dramatically affected, with poor neurite outgrowth (-57%). Cell treatment by an HDAC inhibitor (SAHA) led to a noticeable improvement of cell polarity and morphology, with longer processes. Increased homocysteine levels (+55%) consecutive to folate shortage produced homocysteinylation, evidenced by coimmunoprecipitations and mass spectrometry, and aggregation of motor proteins dynein and kinesin, along with functional alterations, as reflected by reduced interactions with partner proteins. Prominent homocysteinylation of key neuronal proteins and subsequent aggregation certainly constitute major adverse effects of folate deficiency, affecting normal development with possible long-lasting consequences.-Akchiche, N., Bossenmeyer-Pourie, C., Kerek, R., Martin, N., Pourie, G., Koziel, V., Helle, D., Alberto, J.-M., Ortiou, S., Camadro, J.-M., Leger, T., Gueant, J.-L., Daval, J.-L. Homocysteinylation of neuronal proteins contributes to folate deficiency-associated alterations of differentiation, vesicular transport, and plasticity in hippocampal neuronal cells. FASEB J. 26, 3980-3992 (2012). www.fasebj.org	[Daval, Jean-Luc] Inserm U954, Fac Med, F-54500 Vandoeuvre Les Nancy, France; [Akchiche, Nassila; Bossenmeyer-Pourie, Carine; Kerek, Racha; Martin, Nicolas; Pourie, Gregory; Koziel, Violette; Helle, Deborah; Alberto, Jean-Marc; Ortiou, Sandrine; Gueant, Jean-Louis; Daval, Jean-Luc] Univ Lorraine, Fac Med, Vandoeuvre Les Nancy, France; [Gueant, Jean-Louis] Inst Res Mental Retardat & Brain Aging, Oasi Maria SS, IRCCS, Troina, Italy; [Camadro, Jean-Michel; Leger, Thibaut] Univ Paris Diderot, CNRS, Inst Jacques Monod, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Universite de Lorraine; IRCCS Oasi Maria SS; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Daval, JL (corresponding author), Inserm U954, Fac Med, 9 Ave Foret Haye, F-54500 Vandoeuvre Les Nancy, France.	jean-luc.daval@inserm.fr	Bossenmeyer-Pourié, Carine/F-7695-2019; Léger, Thibaut/GPP-5828-2022; Daval, Jean-Luc/G-6502-2014	Bossenmeyer-Pourié, Carine/0000-0003-3831-4809; Kerek, Racha/0000-0003-0159-5993; Camadro, Jean-Michel/0000-0002-8549-2707; Leger, Thibaut/0000-0002-6304-3433	French National Agency for Research [Agence Nationale de la Recherche (ANR) Nutrivigene]; Institut National de la Sante et de la Recherche Medicale; Region Lorraine	French National Agency for Research [Agence Nationale de la Recherche (ANR) Nutrivigene](French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Region Lorraine(Region Grand-Est)	The study was supported by a grant from the French National Agency for Research [Agence Nationale de la Recherche (ANR) Nutrivigene]. N.A. is indebted to the Institut National de la Sante et de la Recherche Medicale and the Region Lorraine for financial support.	Akchiche N, 2010, HIPPOCAMPUS, V20, P949, DOI 10.1002/hipo.20690; Amouzou EK, 2004, AM J CLIN NUTR, V79, P619; Andrabi S, 2007, P NATL ACAD SCI USA, V104, P19011, DOI 10.1073/pnas.0706696104; Balk EM, 2007, ARCH INTERN MED, V167, P21, DOI 10.1001/archinte.167.1.21; Battaglia-Hsu SF, 2009, P NATL ACAD SCI USA, V106, P21930, DOI 10.1073/pnas.0811794106; Bjorklund NK, 2006, INT J DEV BIOL, V50, P135, DOI 10.1387/ijdb.052102nb; Blaise S, 2005, PEDIATR RES, V57, P777, DOI 10.1203/01.PDR.0000161406.19231.98; Blaise SA, 2007, AM J PATHOL, V170, P667, DOI 10.2353/ajpath.2007.060339; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chery C, 2002, CLIN CHEM LAB MED, V40, P1105, DOI 10.1515/CCLM.2002.193; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Coppede F, 2010, CURR GENOMICS, V11, P246, DOI 10.2174/138920210791233090; Daval JL, 2009, P NATL ACAD SCI USA, V106, pE1, DOI 10.1073/pnas.0809217106; Durga J, 2007, LANCET, V369, P208, DOI 10.1016/S0140-6736(07)60109-3; Ellinson M, 2004, J HUM NUTR DIET, V17, P371, DOI 10.1111/j.1365-277X.2004.00532.x; Eves EM, 1996, J NEUROCHEM, V67, P1908; EVES EM, 1992, P NATL ACAD SCI USA, V89, P4373, DOI 10.1073/pnas.89.10.4373; Farias GG, 2009, J BIOL CHEM, V284, P15857, DOI 10.1074/jbc.M808986200; Finkelstein JD, 1998, EUR J PEDIATR, V157, pS40, DOI 10.1007/PL00014300; Frankfurt OS, 2001, J HISTOCHEM CYTOCHEM, V49, P369, DOI 10.1177/002215540104900311; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; Howell JM, 2006, PROTEOMICS, V6, P2050, DOI 10.1002/pmic.200500517; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Hubmacher D, 2010, J BIOL CHEM, V285, P1188, DOI 10.1074/jbc.M109.021246; Jakubowski H, 2008, FASEB J, V22, P4071, DOI 10.1096/fj.08-112086; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Kruman II, 2005, NEUROREPORT, V16, P1055, DOI 10.1097/00001756-200507130-00005; Kruman II, 2002, J NEUROSCI, V22, P1752, DOI 10.1523/JNEUROSCI.22-05-01752.2002; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; KUTZBACH C, 1971, BIOCHIM BIOPHYS ACTA, V250, P459, DOI 10.1016/0005-2744(71)90247-6; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Mattson MP, 1999, J NEUROSCI RES, V57, P577, DOI 10.1002/(SICI)1097-4547(19990901)57:5<577::AID-JNR1>3.0.CO;2-H; Mattson MP, 2003, TRENDS NEUROSCI, V26, P137, DOI 10.1016/S0166-2236(03)00032-8; McMillen IC, 2008, BASIC CLIN PHARMACOL, V102, P82, DOI 10.1111/j.1742-7843.2007.00188.x; Mocz G, 2001, STRUCTURE, V9, P93, DOI 10.1016/S0969-2126(00)00557-8; Obeid R, 2007, CLIN CHEM LAB MED, V45, P1590, DOI 10.1515/CCLM.2007.356; Obeid R, 2006, FEBS LETT, V580, P2994, DOI 10.1016/j.febslet.2006.04.088; Oliver M H, 2007, Soc Reprod Fertil Suppl, V64, P397; Paoli P, 2010, J MOL BIOL, V400, P889, DOI 10.1016/j.jmb.2010.05.039; Perna AF, 2006, KIDNEY INT, V69, P869, DOI 10.1038/sj.ki.5000070; Petralia RS, 2005, MOL CELL NEUROSCI, V29, P436, DOI 10.1016/j.mcn.2005.03.013; Pitkin RM, 2007, AM J CLIN NUTR, V85, p285S, DOI 10.1093/ajcn/85.1.285S; Ren D, 2009, ANAL BIOCHEM, V392, P12, DOI 10.1016/j.ab.2009.05.018; Schlager MA, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-25; Serra E, 2008, NAT CLIN PRACT NEURO, V4, P594, DOI 10.1038/ncpneuro0936; Sibrian-Vazquez M, 2010, P NATL ACAD SCI USA, V107, P551, DOI 10.1073/pnas.0909737107; Stroylova YY, 2011, BBA-PROTEINS PROTEOM, V1814, P1234, DOI 10.1016/j.bbapap.2011.05.017; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Troen AM, 2008, P NATL ACAD SCI USA, V105, P12474, DOI 10.1073/pnas.0805350105; van der Put NMJ, 2001, EXP BIOL MED, V226, P243, DOI 10.1177/153537020122600402; Wald DS, 2010, AM J MED, V123, P522, DOI 10.1016/j.amjmed.2010.01.017; Yan Y, 1999, J BIOL CHEM, V274, P31917, DOI 10.1074/jbc.274.45.31917; Yu IT, 2009, NEUROPHARMACOLOGY, V56, P473, DOI 10.1016/j.neuropharm.2008.09.019; Zhang XM, 2008, J NUTR SCI VITAMINOL, V54, P353, DOI 10.3177/jnsv.54.353	56	55	55	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2012	26	10					3980	3992		10.1096/fj.12-205757	http://dx.doi.org/10.1096/fj.12-205757			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22713523				2022-12-25	WOS:000309704000006
J	Krishnamurthy, N; Hu, YD; Siedlak, S; Doughman, YQ; Watanabe, M; Montano, MM				Krishnamurthy, Nirmala; Hu, Yanduan; Siedlak, Sandra; Doughman, Yong Qiu; Watanabe, Michiko; Montano, Monica M.			Induction of quinone reductase by tamoxifen or DPN protects against mammary tumorigenesis	FASEB JOURNAL			English	Article						aromatase; hyperplasia; oxidative DNA damage	ESTROGEN-RECEPTOR-BETA; BREAST-CANCER CELLS; SURGICAL ADJUVANT BREAST; BOWEL PROJECT P-1; TRANSGENIC MICE; ER-BETA; AROMATASE CYTOCHROME-P450; DNA-DAMAGE; HYPERPLASIA; APOPTOSIS	We have previously shown that estrogen receptor beta (ER beta)-mediated up-regulation of quinone reductase (QR) is involved in the protection against estrogen-induced mammary tumorigenesis. Our present study provides evidence that the ER beta agonist, 2,3-bis-(4-hydroxy-phenyl)-propionitrile (DPN), and the selective estrogen receptor modulator tamoxifen (Tam), inhibit estrogen-induced DNA damage and mammary tumorigenesis in the aromatase transgenic (Arom) mouse model. We also show that either DPN or Tam treatment increases QR levels and results in a decrease in ductal hyperplasia, proliferation, oxidative DNA damage (ODD), and an increase in apoptosis. To corroborate the role of QR, we provide additional evidence in triple transgenic MMTV/QR/Arom mice, wherein the QR expression is induced in the mammary glands via doxycycline, causing a decrease in ductal hyperplasia and ODD. Overall, we provide evidence that up-regulation of QR through induction by Tam or DPN can inhibit estrogen-induced ODD and mammary cell tumorigenesis, representing a novel mechanism of prevention against breast cancer. Thus, our data have important clinical implications in the management of breast cancer; our findings bring forth potentially new therapeutic strategies involving ER beta agonists. Krishnamurthy, N., Hu, Y., Siedlak, S., Doughman, Y. Q., Watanabe, M., Montano, M. M. Induction of quinone reductase by tamoxifen or DPN protects against mammary tumorigenesis. FASEB J. 26, 3993-4002 (2012). www.fasebj.org	[Montano, Monica M.] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Doughman, Yong Qiu; Watanabe, Michiko] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Siedlak, Sandra] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Montano, MM (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Sch Med, HG Wood Bldg W305,2109 Adelbert Rd, Cleveland, OH 44106 USA.	mxm126@case.edu			U.S. Department of Defense Breast Cancer Postdoctoral award [BC087610]; NATIONAL CANCER INSTITUTE [R01CA092440] Funding Source: NIH RePORTER	U.S. Department of Defense Breast Cancer Postdoctoral award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a U.S. Department of Defense Breast Cancer Postdoctoral award (BC087610) to N.K. The authors thank Dr. Rajeswar Tekmal (University of Texas Health Science Center, San Antonio, TX, USA) for providing the transgenic Arom mice.	Agarwal VR, 1996, J CLIN ENDOCR METAB, V81, P3843, DOI 10.1210/jc.81.11.3843; Asher G, 2001, P NATL ACAD SCI USA, V98, P1188, DOI 10.1073/pnas.021558898; Bianco NR, 2005, BIOCHEM J, V385, P279, DOI 10.1042/BJ20040959; Bianco NR, 2003, MOL ENDOCRINOL, V17, P1344, DOI 10.1210/me.2002-0382; Coombes RC, 2007, LANCET, V369, P559, DOI 10.1016/S0140-6736(07)60200-1; Cushman M, 2003, BRIT J HAEMATOL, V120, P109, DOI 10.1046/j.1365-2141.2003.03976.x; Cuzick J, 2007, JNCI-J NATL CANCER I, V99, P272, DOI 10.1093/jnci/djk049; Day R, 1999, J CLIN ONCOL, V17, P2659, DOI 10.1200/JCO.1999.17.9.2659; Dong LA, 1999, J BIOL CHEM, V274, P32099, DOI 10.1074/jbc.274.45.32099; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Frasor J, 2003, ENDOCRINOLOGY, V144, P3159, DOI 10.1210/en.2002-0143; Harris HA, 2007, MOL ENDOCRINOL, V21, P1, DOI 10.1210/me.2005-0459; Helguero LA, 2005, ONCOGENE, V24, P6605, DOI 10.1038/sj.onc.1208807; Hodges-Gallagher L, 2008, BREAST CANCER RES TR, V109, P241, DOI 10.1007/s10549-007-9640-6; Hopp TA, 2004, CLIN CANCER RES, V10, P7490, DOI 10.1158/1078-0432.CCR-04-1114; Iskander K, 2005, CANCER RES, V65, P2054, DOI 10.1158/0008-5472.CAN-04-3157; Iskander K, 2005, CHEM-BIOL INTERACT, V153, P147, DOI 10.1016/j.cbi.2005.03.019; JAIYESIMI IA, 1995, J CLIN ONCOL, V13, P513, DOI 10.1200/JCO.1995.13.2.513; Kirma N, 2001, CANCER RES, V61, P1910; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Liehr JG, 2000, ENDOCR REV, V21, P40, DOI 10.1210/er.21.1.40; Lu B, 2000, J MOL ENDOCRINOL, V25, P229, DOI 10.1677/jme.0.0250229; Mandava U, 2001, J STEROID BIOCHEM, V79, P27, DOI 10.1016/S0960-0760(01)00133-9; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Miller WR, 1997, J STEROID BIOCHEM, V61, P193; Montano MM, 2007, ONCOGENE, V26, P3587, DOI 10.1038/sj.onc.1210144; Montano MM, 1998, J BIOL CHEM, V273, P25443, DOI 10.1074/jbc.273.39.25443; Nair HB, 2011, STEROIDS, V76, P792, DOI 10.1016/j.steroids.2011.02.038; O'Regan RM, 1998, JNCI-J NATL CANCER I, V90, P1552, DOI 10.1093/jnci/90.20.1552; Omoto Y, 2003, ONCOGENE, V22, P5011, DOI 10.1038/sj.onc.1206787; Palmieri C, 2002, ENDOCR-RELAT CANCER, V9, P1, DOI 10.1677/erc.0.0090001; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Saji S, 2005, CANCER CHEMOTH PHARM, V56, pS21, DOI 10.1007/s0028-005-0107-3; Santen RJ, 2009, ENDOCR REV, V30, P343, DOI 10.1210/er.2008-0016; Schafer JM, 2000, CLIN CANCER RES, V6, P4373; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Smith IE, 2003, NEW ENGL J MED, V348, P2431, DOI 10.1056/NEJMra023246; Sollner S, 2009, FEMS YEAST RES, V9, P885, DOI 10.1111/j.1567-1364.2009.00546.x; Sripathy SP, 2008, ONCOGENE, V27, P6376, DOI 10.1038/onc.2008.235; Tekmal RR, 2005, J STEROID BIOCHEM, V95, P9, DOI 10.1016/j.jsbmb.2005.04.007; Tekmal RR, 1996, CANCER RES, V56, P3180; Tekmal RR, 1999, ENDOCR-RELAT CANCER, V6, P307, DOI 10.1677/erc.0.0060307; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; Walf AA, 2008, BEHAV NEUROSCI, V122, P974, DOI 10.1037/a0012749; Weiser MJ, 2009, ENDOCRINOLOGY, V150, P1817, DOI 10.1210/en.2008-1355; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776	48	2	2	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2012	26	10					3993	4002		10.1096/fj.12-208330	http://dx.doi.org/10.1096/fj.12-208330			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22700872	Green Published			2022-12-25	WOS:000309704000007
J	Ceholski, DK; Trieber, CA; Holmes, CFB; Young, HS				Ceholski, Delaine K.; Trieber, Catharine A.; Holmes, Charles F. B.; Young, Howard S.			Lethal, Hereditary Mutants of Phospholamban Elude Phosphorylation by Protein Kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; DILATED CARDIOMYOPATHY; HEART-FAILURE; CYTOPLASMIC DOMAIN; CONTRACTILE FUNCTION; CARDIAC-FUNCTION; CA2+-ATPASE; MUTATION; EXPRESSION; GENE	The sarcoplasmic reticulum calcium pump (SERCA) and its regulator, phospholamban, are essential components of cardiac contractility. Phospholamban modulates contractility by inhibiting SERCA, and this process is dynamically regulated by beta-adrenergic stimulation and phosphorylation of phospholamban. Herein we reveal mechanistic insight into how four hereditary mutants of phospholamban, Arg(9) to Cys, Arg(9) to Leu, Arg(9) to His, and Arg(14) deletion, alter regulation of SERCA. Deletion of Arg(14) disrupts the protein kinase A recognition motif, which abrogates phospholamban phosphorylation and results in constitutive SERCA inhibition. Mutation of Arg(9) causes more complex changes in function, where hydrophobic substitutions such as cysteine and leucine eliminate both SERCA inhibition and phospholamban phosphorylation, whereas an aromatic substitution such as histidine selectively disrupts phosphorylation. We demonstrate that the role of Arg(9) in phospholamban function is multifaceted: it is important for inhibition of SERCA, it increases the efficiency of phosphorylation, and it is critical for protein kinase A recognition in the context of the phospholamban pentamer. Given the synergistic consequences on contractility, it is not surprising that the mutants cause lethal, hereditary dilated cardiomyopathy.	[Ceholski, Delaine K.; Trieber, Catharine A.; Holmes, Charles F. B.; Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Trieber, Catharine A.; Young, Howard S.] Univ Alberta, Natl Inst Nanotechnol, Edmonton, AB T6G 2M9, Canada	University of Alberta; National Research Council Canada; University of Alberta	Young, HS (corresponding author), Univ Alberta, Dept Biochem, 327 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	hyoung@ualberta.ca		Young, Howard/0000-0002-5990-8422; Trieber, Catharine/0000-0002-1336-1126	Canadian Institutes of Health Research Grant [MOP53306]; Canadian Institutes of Health Research; Alberta Innovates Technology Futures	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Technology Futures	This work was supported by Canadian Institutes of Health Research Grant MOP53306.; Supported by Canadian Institutes of Health Research and Alberta Innovates Technology Futures.	Brittsan AG, 2000, J MOL CELL CARDIOL, V32, P2131, DOI 10.1006/jmcc.2000.1270; Ceholski DK, 2012, J BIOL CHEM, V287, P16521, DOI 10.1074/jbc.M112.360859; del Monte F, 1999, CIRCULATION, V100, P2308, DOI 10.1161/01.CIR.100.23.2308; DeWitt MM, 2006, J AM COLL CARDIOL, V48, P1396, DOI 10.1016/j.jacc.2006.07.016; Douglas JL, 2005, PROTEIN EXPRES PURIF, V40, P118, DOI 10.1016/j.pep.2004.11.015; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5; Frank KF, 2002, BASIC RES CARDIOL S1, V97, pI72, DOI DOI 10.1007/S003950200033; FUJII J, 1989, J BIOL CHEM, V264, P12950; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; Ha KN, 2011, P NATL ACAD SCI USA, V108, P2735, DOI 10.1073/pnas.1013987108; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Haghighi K, 2001, J BIOL CHEM, V276, P24145, DOI 10.1074/jbc.M102403200; Haghighi K, 2012, J MOL CELL CARDIOL, V52, P773, DOI 10.1016/j.yjmcc.2011.11.012; HASENFUSS G, 1994, CIRC RES, V75, P434, DOI 10.1161/01.RES.75.3.434; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Kass DA, 1998, CIRC RES, V82, P519, DOI 10.1161/01.RES.82.4.519; KEMP BE, 1977, J BIOL CHEM, V252, P4888; Kho C, 2011, NATURE, V477, P601, DOI 10.1038/nature10407; Kimura Y, 1996, J BIOL CHEM, V271, P21726, DOI 10.1074/jbc.271.36.21726; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; LI CF, 1990, BIOCHEMISTRY-US, V29, P4535, DOI 10.1021/bi00471a005; Luo WS, 1996, CIRC RES, V78, P839, DOI 10.1161/01.RES.78.5.839; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; Masterson LR, 2010, NAT CHEM BIOL, V6, P821, DOI 10.1038/NCHEMBIO.452; Medeiros A, 2011, AM HEART J, V162, P1088, DOI 10.1016/j.ahj.2011.07.028; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Moore MJ, 2003, J BIOL CHEM, V278, P10613, DOI 10.1074/jbc.M210807200; MORGAN JP, 1991, NEW ENGL J MED, V325, P625; Neuberger G, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-1; Paterlini MG, 2005, BIOPHYS J, V88, P3243, DOI 10.1529/biophysj.104.054460; Posch MG, 2009, HEART RHYTHM, V6, P480, DOI 10.1016/j.hrthm.2009.01.016; Schmidt AG, 2001, CARDIOVASC DRUG THER, V15, P387, DOI 10.1023/A:1013381204658; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tada M, 1976, Recent Adv Stud Cardiac Struct Metab, V9, P225; TOYOFUKU T, 1994, J BIOL CHEM, V269, P3088; Trieber CA, 2005, BIOCHEMISTRY-US, V44, P3289, DOI 10.1021/bi047878d; WARREN GB, 1974, P NATL ACAD SCI USA, V71, P622, DOI 10.1073/pnas.71.3.622; Young HS, 1997, BIOPHYS J, V72, P2545, DOI 10.1016/S0006-3495(97)78898-2; Young HS, 1998, ANN NY ACAD SCI, V853, P103, DOI 10.1111/j.1749-6632.1998.tb08260.x; Young HS, 2001, BIOPHYS J, V81, P884, DOI 10.1016/S0006-3495(01)75748-7; Zamoon J, 2003, BIOPHYS J, V85, P2589, DOI 10.1016/S0006-3495(03)74681-5; Zhai J, 2000, J BIOL CHEM, V275, P10538, DOI 10.1074/jbc.275.14.10538; Zvaritch E, 2000, J BIOL CHEM, V275, P14985, DOI 10.1074/jbc.275.20.14985	50	35	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26596	26605		10.1074/jbc.M112.382713	http://dx.doi.org/10.1074/jbc.M112.382713			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707725	Green Published, hybrid			2022-12-25	WOS:000307386000012
J	DeVore, NM; Scott, EE				DeVore, Natasha M.; Scott, Emily E.			Nicotine and 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Binding and Access Channel in Human Cytochrome P450 2A6 and 2A13 Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOBACCO-SPECIFIC CARCINOGEN; AMINO-ACID-RESIDUES; METABOLIC-ACTIVATION; CYP2A13; LUNG; COUMARIN; SITE; 2E1; IDENTIFICATION; DIFFERENCE	Cytochromes P450 (CYP) from the 2A subfamily are known for their roles in the metabolism of nicotine, the addictive agent in tobacco, and activation of the tobacco procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Although both the hepatic CYP2A6 and respiratory CYP2A13 enzymes metabolize these compounds, CYP2A13 does so with much higher catalytic efficiency, but the structural basis for this has been unclear. X-ray structures of nicotine complexes with CYP2A13 (2.5 angstrom) and CYP2A6 (2.3 angstrom) yield a structural rationale for the preferential binding of nicotine to CYP2A13. Additional structures of CYP2A13 with NNK reveal either a single NNK molecule in the active site with orientations corresponding to metabolites known to form DNA adducts and initiate lung cancer (2.35 angstrom) or with two molecules of NNK bound (2.1 angstrom): one in the active site and one in a more distal staging site. Finally, in contrast to prior CYP2A structures with enclosed active sites, CYP2A13 conformations were solved that adopt both open and intermediate conformations resulting from an similar to 2.5 angstrom movement of the F to G helices. This channel occurs in the same region where the second, distal NNK molecule is bound, suggesting that the channel may be used for ligand entry and/or exit from the active site. Altogether these structures provide multiple new snapshots of CYP2A13 conformations that assist in understanding the binding and activation of an important human carcinogen, as well as critical comparisons in the binding of nicotine, one of the most widely used and highly addictive drugs in human use.	[DeVore, Natasha M.; Scott, Emily E.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA	University of Kansas	Scott, EE (corresponding author), 1251 Wescoe Hall Dr, Lawrence, KS 66045 USA.	eescott@ku.edu		DeVore, Natasha/0000-0003-0772-8929	National Institutes of Health Grant [GM076343]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; National Center for Research Resources [P41RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708, P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM076343, R01GM076343, P20GM103420, P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM076343.; Thanks are due to Linda Blake who made the CYP2A6 V117A/I208S/I300F/G301A/S369G mutant and protein. Crystals were grown using the facilities of the Protein Structure Laboratory core facility at The University of Kansas (National Institutes of Health RR017708 and GM103420). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393) and the National Center for Research Resources (P41RR001209).	American Cancer Society, 2011, CANC FACTS FIGURES; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bao ZP, 2005, DRUG METAB DISPOS, V33, P258, DOI 10.1124/dmd.104.002105; Centers for Disease Control and Prevention, 2011, MORBIDITY MORTALITY, V61, P38; Cloutier JF, 2001, J MOL BIOL, V313, P539, DOI 10.1006/jmbi.2001.4997; Davydov DR, 2012, J BIOL CHEM, V287, P6797, DOI 10.1074/jbc.M111.325654; DeVore NM, 2009, DRUG METAB DISPOS, V37, P1319, DOI 10.1124/dmd.109.026765; DeVore NM, 2012, FEBS J, V279, P1621, DOI 10.1111/j.1742-4658.2011.08412.x; DeVore NM, 2008, DRUG METAB DISPOS, V36, P2582, DOI 10.1124/dmd.108.023770; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gay SC, 2009, BIOCHEMISTRY-US, V48, P4762, DOI 10.1021/bi9003765; He XY, 2006, INT J CANCER, V118, P2665, DOI 10.1002/ijc.21665; He XY, 2004, DRUG METAB DISPOS, V32, P1516, DOI 10.1124/dmd.104.001370; He XY, 2004, ARCH BIOCHEM BIOPHYS, V427, P143, DOI 10.1016/j.abb.2004.03.016; Hecht SS, 2000, P NATL ACAD SCI USA, V97, P12493, DOI 10.1073/pnas.220207697; Hecht SS, 1999, MUTAT RES-FUND MOL M, V424, P127, DOI 10.1016/S0027-5107(99)00014-7; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; Jalas JR, 2003, DRUG METAB DISPOS, V31, P1199, DOI 10.1124/dmd.31.10.1199; Kleywegt G. J., 2001, INT TABLES CRYSTALLO, VF, P353, DOI DOI 10.1107/97809553602060000111; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie A. G., 1998, MOSFLM 6 0; Malaiyandi V, 2005, CLIN PHARMACOL THER, V77, P145, DOI 10.1016/j.clpt.2004.10.011; Murphy SE, 2005, DRUG METAB DISPOS, V33, P1166, DOI 10.1124/dmd.105.004549; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Porubsky PR, 2010, J BIOL CHEM, V285, P22282, DOI 10.1074/jbc.M110.109017; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; Rowland P, 2006, J BIOL CHEM, V281, P7614, DOI 10.1074/jbc.M511232200; Schlicht KE, 2007, XENOBIOTICA, V37, P1439, DOI 10.1080/00498250701666265; Schlicht KE, 2009, DRUG METAB DISPOS, V37, P665, DOI 10.1124/dmd.108.025072; Schoch GA, 2008, J BIOL CHEM, V283, P17227, DOI 10.1074/jbc.M802180200; Smith BD, 2007, J BIOL CHEM, V282, P17306, DOI 10.1074/jbc.M702361200; Stephens E. S., 2012, DRUG METAB IN PRESS; Su T, 2000, CANCER RES, V60, P5074; Tan W, 2001, INT J CANCER, V95, P96, DOI 10.1002/1097-0215(20010320)95:2&lt;96::AID-IJC1017&gt;3.0.CO;2-2; von Weymarn LB, 2006, J PHARMACOL EXP THER, V316, P295, DOI 10.1124/jpet.105.091306; Wang HJ, 2003, CANCER RES, V63, P8057; Weng Y, 2007, CANCER RES, V67, P7825, DOI 10.1158/0008-5472.CAN-07-1006; Wu ZL, 2005, J BIOL CHEM, V280, P41090, DOI 10.1074/jbc.M508182200; Xu Y, 2011, J MOL GRAPH MODEL, V30, P1, DOI 10.1016/j.jmgm.2011.05.002; Yano JK, 2006, J MED CHEM, V49, P6987, DOI 10.1021/jm060519r; Yano JK, 2005, NAT STRUCT MOL BIOL, V12, P822, DOI 10.1038/nsmb971; Zhao B, 2012, J BIOL CHEM, V287, P10613, DOI 10.1074/jbc.M111.323501	44	61	62	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26576	26585		10.1074/jbc.M112.372813	http://dx.doi.org/10.1074/jbc.M112.372813			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700965	Green Published, hybrid			2022-12-25	WOS:000307386000010
J	Koeberle, A; Shindou, H; Harayama, T; Shimizu, T				Koeberle, Andreas; Shindou, Hideo; Harayama, Takeshi; Shimizu, Takao			Palmitoleate Is a Mitogen, Formed upon Stimulation with Growth Factors, and Converted to Palmitoleoyl-phosphatidylinositol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COA DESATURASE ACTIVITY; PANCREATIC BETA-CELLS; FATTY-ACIDS; LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; PALMITATE; GLUCOSE; OBESITY; HUMANS; INDUCE	Controversial correlations between biological activity and concentration of the novel lipokine palmitoleate (9Z-hexadecenoate, 16:1) might depend on the formation of an active 16:1 metabolite. For its identification, we analyzed the glycerophospholipid composition of mouse Swiss 3T3 fibroblasts in response to 16:1 using LC-MS/MS. 16:1 was either supplemented to the cell culture medium or endogenously formed when cells were stimulated with insulin or growth factors as suggested by the enhanced mRNA expression of 16:1-biosynthetic enzymes. The proportion of 1-acyl-2-16:1-sn-phosphatidylinositol (16:1-PI) was time-dependently and specifically increased relative to other glycerophospholipids under both conditions and correlated with the proliferation of fatty acid (16:1, palmitate, oleate, or arachidonate)-supplemented cells. Accordingly, cell proliferation was impaired by blocking 16:1 biosynthesis using the selective stearoyl-CoA desaturase-1 inhibitor CAY10566 and restored by supplementation of 16:1. The accumulation of 16:1-PI occurred throughout cellular compartments and within diverse mouse cell lines (Swiss 3T3, NIH-3T3, and 3T3-L1 cells). To elucidate further whether 16:1-PI is formed through the de novo or remodeling pathway of PI biosynthesis, phosphatidate levels and lyso-PI-acyltransferase activities were analyzed as respective markers. The proportion of 16:1-phosphatidate was significantly increased by insulin and growth factors, whereas lyso-PI-acyltransferases showed negligible activity for 16:1-coenzyme A. The relevance of the de novo pathway for 16:1-PI biosynthesis is supported further by the comparable incorporation rate of deuterium-labeled 16:1 and tritium-labeled inositol into PI for growth factor-stimulated cells. In conclusion, we identified 16:1 or 16:1-PI as mitogen whose biosynthesis is induced by growth factors.	[Koeberle, Andreas; Shindou, Hideo; Harayama, Takeshi; Shimizu, Takao] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Shimizu, T (corresponding author), Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan.	tshimizu@m.u-tokyo.ac.jp	Harayama, Takeshi/AAD-8852-2022; Koeberle, Andreas/ABB-2356-2020; Shimizu, Takao/AAV-7052-2021	Harayama, Takeshi/0000-0003-2255-4197; Koeberle, Andreas/0000-0001-6269-5088; 	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Global COE Program (The University of Tokyo) from the Japan Society for Promotion of Sciences; Takeda Science Foundation; Center for NanoBio Integration at The University of Tokyo; Ministry of Health, and Labour; MEXT of Japan; Uehara Memorial Foundation; Cell Science Research Foundation; Gushinkai Foundation	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program (The University of Tokyo) from the Japan Society for Promotion of Sciences; Takeda Science Foundation(Takeda Science Foundation (TSF)); Center for NanoBio Integration at The University of Tokyo; Ministry of Health, and Labour; MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Gushinkai Foundation	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (to T. S.) and a Global COE Program (The University of Tokyo) from the Japan Society for Promotion of Sciences (to T.S).; Recipient of a research fellowship from the Takeda Science Foundation.; Supported by the Center for NanoBio Integration at The University of Tokyo.; Supported by Health and Labour Sciences Research grants (Research on Allergic Disease and Immunology) of the Ministry of Health, and Labour and grant-in-aid for Young Scientists (B) from the MEXT of Japan and The Uehara Memorial Foundation, The Cell Science Research Foundation, and Gushinkai Foundation.	Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Diakogiannaki E, 2007, J ENDOCRINOL, V194, P283, DOI 10.1677/JOE-07-0082; Dimopoulos N, 2006, BIOCHEM J, V399, P473, DOI 10.1042/BJ20060244; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Gong JA, 2011, AM J CLIN NUTR, V93, P186, DOI 10.3945/ajcn.110.006502; GROVE RI, 1983, BIOCHEM BIOPH RES CO, V110, P200, DOI 10.1016/0006-291X(83)91280-9; Hvattum E, 1998, RAPID COMMUN MASS SP, V12, P1405, DOI 10.1002/(SICI)1097-0231(19981015)12:19<1405::AID-RCM338>3.0.CO;2-B; KENT C, 1995, ANNU REV BIOCHEM, V64, P315, DOI 10.1146/annurev.bi.64.070195.001531; Koeberle A, 2010, FASEB J, V24, P4929, DOI 10.1096/fj.10-162818; Kotani A, 2000, ANAL BIOCHEM, V284, P65, DOI 10.1006/abio.2000.4682; Liu G, 2007, J MED CHEM, V50, P3086, DOI 10.1021/jm070219p; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Mozaffarian D, 2010, AM J CLIN NUTR, V92, P1350, DOI 10.3945/ajcn.110.003970; Ogiso H, 2008, ANAL BIOCHEM, V375, P124, DOI 10.1016/j.ab.2007.12.027; Okada T, 2005, AM J CLIN NUTR, V82, P747, DOI 10.1093/ajcn/82.4.747; Paillard F, 2008, NUTR METAB CARDIOVAS, V18, P436, DOI 10.1016/j.numecd.2007.02.017; Perez-Chacon G, 2009, BBA-MOL CELL BIOL L, V1791, P1103, DOI 10.1016/j.bbalip.2009.08.007; Pettitt TR, 1998, FEBS LETT, V427, P371, DOI 10.1016/S0014-5793(98)00471-2; Riserus U, 2005, DIABETES, V54, P1379, DOI 10.2337/diabetes.54.5.1379; Salazar EP, 1999, J BIOL CHEM, V274, P28371, DOI 10.1074/jbc.274.40.28371; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Stefan N, 2010, DIABETES CARE, V33, P405, DOI [10.2337/dc10-0002, 10.2337/dc09-0544]; Tsuchiya Y, 2010, J BIOL CHEM, V285, P34371, DOI 10.1074/jbc.M110.128520; Warensjo E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001; Welters HJ, 2006, APOPTOSIS, V11, P1231, DOI 10.1007/s10495-006-7450-7; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Wong RHF, 2010, CURR OPIN PHARMACOL, V10, P684, DOI 10.1016/j.coph.2010.08.004; Yuki K, 2009, J LIPID RES, V50, P860, DOI 10.1194/jlr.M800468-JLR200	32	29	30	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27244	27254		10.1074/jbc.M111.274829	http://dx.doi.org/10.1074/jbc.M111.274829			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700983	Green Published, hybrid			2022-12-25	WOS:000307386000076
J	Lehrer, RI; Cole, AM; Selsted, ME				Lehrer, Robert I.; Cole, Alex M.; Selsted, Michael E.			theta-Defensins: Cyclic Peptides with Endless Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ANTIMICROBIAL PEPTIDES; RETROCYCLIN RC-101; ALPHA-DEFENSINS; BETA; INHIBIT; VIRUS; DISCOVERY; INFECTION; FUSION; RTD-1	theta-Defensins, the only cyclic peptides of animal origin, have been isolated from the leukocytes of rhesus macaques and baboons. Their biogenesis is unusual because each peptide is an 18-residue chimera formed by the head-to-tail splicing of nonapeptides derived from two separate precursors. theta-Defensins have multiple arginines and a ladder-like tridisulfide array spanning their two antiparallel beta-strands. Human theta-defensin genes contain a premature stop codon that prevents effective translation of the needed precursors; consequently, these peptides are not present in human leukocytes. Synthetic theta-defensins with sequences that correspond to those encoded within the human pseudogenes are called retrocyclins. Retrocyclin-1 inhibits the cellular entry of HIV-1, HSV, and influenza A virus. The rhesus theta-defensin RTD-1 protects mice from an experimental severe acute respiratory syndrome coronavirus infection, and retrocyclin- 1 protects mice from infection by Bacillus anthracis spores. The small size, unique structure, and multiple host defense activities of theta-defensins make them intriguing potential therapeutic agents.	[Lehrer, Robert I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Cole, Alex M.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Dept Mol Biol & Microbiol, Orlando, FL 32827 USA; [Selsted, Michael E.] Univ So Calif, Keck Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90089 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; State University System of Florida; University of Central Florida; University of Southern California	Lehrer, RI (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	rlehrer@mednet.ucla.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021341] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI022931] Funding Source: Medline; NIDCR NIH HHS [R01 DE021341] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Aboye TL, 2012, BIOORG MED CHEM LETT, V22, P2823, DOI 10.1016/j.bmcl.2012.02.080; Abuja PM, 2004, FEBS LETT, V566, P301, DOI 10.1016/j.febslet.2004.03.112; Aldred PMR, 2005, HUM MOL GENET, V14, P2045, DOI 10.1093/hmg/ddi209; Arnett E, 2011, CELL MICROBIOL, V13, P635, DOI 10.1111/j.1462-5822.2010.01563.x; Chen J, 2000, BIOPOLYMERS, V55, P88, DOI 10.1002/1097-0282(2000)55:1<88::AID-BIP80>3.3.CO;2-B; Cole AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015111; Cole AM, 2002, P NATL ACAD SCI USA, V99, P1813, DOI 10.1073/pnas.052706399; Cole AL, 2006, J IMMUNOL, V176, P6900, DOI 10.4049/jimmunol.176.11.6900; Daly NL, 2007, BIOCHEMISTRY-US, V46, P9920, DOI 10.1021/bi700720e; Doss M, 2009, J IMMUNOL, V182, P7878, DOI 10.4049/jimmunol.0804049; Fuhrman CA, 2007, FEBS J, V274, P6477, DOI 10.1111/j.1742-4658.2007.06165.x; Gallo SA, 2006, J BIOL CHEM, V281, P18787, DOI 10.1074/jbc.M602422200; Garcia AE, 2008, INFECT IMMUN, V76, P5883, DOI 10.1128/IAI.01100-08; Giles FJ, 2004, LEUKEMIA RES, V28, P559, DOI 10.1016/j.leukres.2003.10.021; Gould A, 2012, MOL BIOSYST, V8, P1359, DOI 10.1039/c2mb05451e; HARWIG SSL, 1994, FEBS LETT, V342, P281, DOI 10.1016/0014-5793(94)80517-2; Kim C, 2006, TRENDS MICROBIOL, V14, P428, DOI 10.1016/j.tim.2006.08.001; KOKRYAKOV VN, 1993, FEBS LETT, V327, P231, DOI 10.1016/0014-5793(93)80175-T; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Lehrer RI, 2009, INFECT IMMUN, V77, P4028, DOI 10.1128/IAI.00232-09; Leikina E, 2005, NAT IMMUNOL, V6, P995, DOI 10.1038/ni1248; Leonova L, 2001, J LEUKOCYTE BIOL, V70, P461; Liang QL, 2010, BIOTECHNOL LETT, V32, P387, DOI 10.1007/s10529-009-0167-2; Lynn DJ, 2007, DEV COMP IMMUNOL, V31, P963, DOI 10.1016/j.dci.2007.01.007; MIYATA T, 1989, J BIOCHEM, V106, P663, DOI 10.1093/oxfordjournals.jbchem.a122913; Munk C, 2003, AIDS RES HUM RETROV, V19, P875, DOI 10.1089/088922203322493049; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; NAKASHIMA H, 1992, ANTIMICROB AGENTS CH, V36, P1249, DOI 10.1128/AAC.36.6.1249; Nguyen TX, 2003, PEPTIDES, V24, P1647, DOI 10.1016/j.peptides.2003.07.023; Sassi AB, 2011, ANTIMICROB AGENTS CH, V55, P2282, DOI 10.1128/AAC.01190-10; Sassi AB, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-27; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Seidel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009737; Selsted ME, 2004, CURR PROTEIN PEPT SC, V5, P365, DOI 10.2174/1389203043379459; Simmons G, 2000, IMMUNOL REV, V177, P112, DOI 10.1034/j.1600-065X.2000.17719.x; Tam JP, 2000, EUR J BIOCHEM, V267, P3289, DOI 10.1046/j.1432-1327.2000.01359.x; Tang M, 2006, BIOPHYS J, V90, P3616, DOI 10.1529/biophysj.105.062075; TANG YQ, 1993, J BIOL CHEM, V268, P6649; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Tollner TL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002289; Tomasinsig L, 2005, CURR PROTEIN PEPT SC, V6, P23, DOI 10.2174/1389203053027520; Tongaonkar P, 2011, J LEUKOCYTE BIOL, V89, P283, DOI 10.1189/jlb.0910535; Trabi M, 2001, BIOCHEMISTRY-US, V40, P4211, DOI 10.1021/bi002028t; Tran D, 2002, J BIOL CHEM, V277, P3079, DOI 10.1074/jbc.M109117200; Tran D, 2008, ANTIMICROB AGENTS CH, V52, P944, DOI 10.1128/AAC.01090-07; Venkataraman N, 2009, PLOS BIOL, V7, P720, DOI 10.1371/journal.pbio.1000095; Wang W, 2006, J BIOL CHEM, V281, P32755, DOI 10.1074/jbc.M603614200; Welkos S, 2011, ANTIMICROB AGENTS CH, V55, P4238, DOI 10.1128/AAC.00267-11; Yasin B, 2004, J VIROL, V78, P5147, DOI 10.1128/JVI.78.10.5147-5156.2004; Zhao CQ, 2001, ANTIMICROB AGENTS CH, V45, P2695, DOI 10.1128/AAC.45.10.2695-2702.2001; Zhu SY, 2008, MOL IMMUNOL, V45, P828, DOI 10.1016/j.molimm.2007.06.354	51	109	114	0	46	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27014	27019		10.1074/jbc.R112.346098	http://dx.doi.org/10.1074/jbc.R112.346098			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700960	Green Published, hybrid			2022-12-25	WOS:000307386000050
J	Matsumura, H; Kusaka, N; Nakamura, T; Tanaka, N; Sagegami, K; Uegaki, K; Inoue, T; Mukai, Y				Matsumura, Hiroyoshi; Kusaka, Nanoha; Nakamura, Taichi; Tanaka, Naoko; Sagegami, Keita; Uegaki, Koichi; Inoue, Tsuyoshi; Mukai, Yukio			Crystal Structure of the N-terminal Domain of the Yeast General Corepressor Tup1p and Its Functional Implications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSOR; WD-REPEATS; SACCHAROMYCES-CEREVISIAE; GLUCOSE REPRESSION; PROTEIN-KINASE; HOMEO DOMAIN; COILED-COILS; BETA-SUBUNIT; COMPLEX; SSN6-TUP1	The yeast Cyc8p-Tup1p protein complex is a general transcriptional corepressor of genes involved in many different physiological processes. Herein, we present the crystal structure of the Tup1p N-terminal domain (residues 1-92), essential for Tup1p self-assembly and interaction with Cyc8p. This domain tetramerizes to form a novel antiparallel four-helix bundle. Coiled coil interactions near the helical ends hold each dimer together, whereas interdimeric association involves only two sets of two residues located toward the chain centers. A mutagenesis study confirmed that the nonpolar residues responsible for the association of the protomers as dimers are also required for transcriptional repression. An additional structural study demonstrated that the domain containing an Leu(62) -> Arg mutation that had been shown not to bind Cyc8p exhibits an altered structure, distinct from the wild type. This altered structure explains why the mutant cannot bind Cyc8p. The data presented herein highlight the importance of the architecture of the Tup1p N-terminal domain for self-association.	[Matsumura, Hiroyoshi; Nakamura, Taichi; Inoue, Tsuyoshi] Osaka Univ, Dept Appl Chem, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Kusaka, Nanoha; Tanaka, Naoko; Sagegami, Keita; Mukai, Yukio] Nagahama Inst Biosci & Technol, Fac Biosci, Dept Biosci, Nagahama, Shiga 5260829, Japan; [Uegaki, Koichi] Natl Inst Adv Ind Sci & Technol, Ikeda, Osaka 5638577, Japan	Osaka University; National Institute of Advanced Industrial Science & Technology (AIST)	Matsumura, H (corresponding author), Osaka Univ, Dept Appl Chem, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	matsumura@chem.eng.osaka-u.ac.jp		Mukai, Yukio/0000-0003-1265-0839; Matsumura, Hiroyoshi/0000-0003-0361-3796	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23121519, 2357104, 22550152, 17570093]; Science and Technology Incubation Program from the Japan Science and Technology Agency; Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Science and Technology Incubation Program from the Japan Science and Technology Agency; Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was in part supported by Grants-in-Aid for Scientific Research 23121519 and 2357104 (to H. M.), 22550152 (to T. I.), and 17570093 (to Y. M.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; in part by the Science and Technology Incubation Program from the Japan Science and Technology Agency (to H.M.); and in part by the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) initiated by the Council for Science and Technology Policy (to T. I.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amberg DC., 2005, METHODS YEAST GENETI; BALASUBRAMANIAN B, 1993, MOL CELL BIOL, V13, P6071, DOI 10.1128/MCB.13.10.6071; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Brown JT, 2000, RNA, V6, P449, DOI 10.1017/S1355838200991787; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrico PM, 1998, GENETICS, V148, P637; Cerveny KL, 2003, MOL BIOL CELL, V14, P4126, DOI 10.1091/mbc.E03-02-0092; Champion EA, 2008, MOL CELL BIOL, V28, P6547, DOI 10.1128/MCB.00906-08; Chen GQ, 1998, MOL CELL BIOL, V18, P7259, DOI 10.1128/MCB.18.12.7259; CLORE GM, 1995, SCIENCE, V267, P1515, DOI 10.1126/science.7878474; Conlan RS, 2001, J MOL BIOL, V309, P1007, DOI 10.1006/jmbi.2001.4742; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; D'Angiolella V, 2003, GENE DEV, V17, P2520, DOI 10.1101/gad.267603; Ducker CE, 2000, EMBO J, V19, P400, DOI 10.1093/emboj/19.3.400; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fagerstrom-Billai F, 2007, MOL CELL BIOL, V27, P1069, DOI 10.1128/MCB.01674-06; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; Flores-Saaib RD, 2000, NUCLEIC ACIDS RES, V28, P4189, DOI 10.1093/nar/28.21.4189; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grbavec D, 1999, BIOCHEM J, V337, P13, DOI 10.1042/0264-6021:3370013; Gromoller A, 2000, EMBO J, V19, P6845, DOI 10.1093/emboj/19.24.6845; Guo L, 2007, P NATL ACAD SCI USA, V104, P4297, DOI 10.1073/pnas.0608041104; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Jabet C, 2000, J BIOL CHEM, V275, P9011, DOI 10.1074/jbc.275.12.9011; KELEHER CA, 1992, CELL, V68, P709, DOI 10.1016/0092-8674(92)90146-4; KOMACHI K, 1994, GENE DEV, V8, P2857, DOI 10.1101/gad.8.23.2857; Komachi K, 1997, MOL CELL BIOL, V17, P6023, DOI 10.1128/MCB.17.10.6023; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE WT, 1994, NAT STRUCT BIOL, V1, P877, DOI 10.1038/nsb1294-877; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Malave TM, 2006, BIOCHEM CELL BIOL, V84, P437, DOI 10.1139/O06-073; Marquez JA, 1998, EMBO J, V17, P2543, DOI 10.1093/emboj/17.9.2543; Matsumura H, 2011, J SYNCHROTRON RADIAT, V18, P16, DOI 10.1107/S090904951003445X; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mukai Y, 1999, MOL CELL BIOL, V19, P8461; MUKAI Y, 1991, MOL CELL BIOL, V11, P3773, DOI 10.1128/MCB.11.7.3773; Mukai Y, 2003, J BIOL CHEM, V278, P18895, DOI 10.1074/jbc.M302155200; Nakatsu Y, 2000, J BIOL CHEM, V275, P34931, DOI 10.1074/jbc.M004936200; NOLL M, 1980, NUCLEIC ACIDS RES, V8, P21, DOI 10.1093/nar/8.1.21; Nooren IMA, 1999, NAT STRUCT BIOL, V6, P755; Oakley MG, 2001, CURR OPIN STRUC BIOL, V11, P450, DOI 10.1016/S0959-440X(00)00232-3; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; Papamichos-Chronakis M, 2000, J BIOL CHEM, V275, P8397, DOI 10.1074/jbc.275.12.8397; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Park SH, 1999, MOL CELL BIOL, V19, P2044; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Proft M, 2001, EMBO J, V20, P1123, DOI 10.1093/emboj/20.5.1123; Sambrook J, 2001, MOL CLONING LAB MANU; SCHULTZ J, 1990, MOL CELL BIOL, V10, P4744, DOI 10.1128/MCB.10.9.4744; SCHULTZ J, 1987, MOL CELL BIOL, V7, P3637, DOI 10.1128/MCB.7.10.3637; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SMITH RL, 1995, GENE DEV, V9, P2903, DOI 10.1101/gad.9.23.2903; STIFANI S, 1992, NAT GENET, V2, P119, DOI 10.1038/ng1092-119; TOHE A, 1974, J BACTERIOL, V120, P608, DOI 10.1128/JB.120.2.608-617.1974; TREITEL MA, 1995, P NATL ACAD SCI USA, V92, P3132, DOI 10.1073/pnas.92.8.3132; TUGENDREICH S, 1995, CELL, V81, P261, DOI 10.1016/0092-8674(95)90336-4; TZAMARIAS D, 1995, GENE DEV, V9, P821, DOI 10.1101/gad.9.7.821; TZAMARIAS D, 1994, NATURE, V369, P758, DOI 10.1038/369758a0; VANDERVOORN L, 1992, FEBS LETT, V308, P75, DOI 10.1016/0014-5793(92)81054-P; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; Watson AD, 2000, GENE DEV, V14, P2737, DOI 10.1101/gad.829100; Weinstein J, 1997, J BIOL CHEM, V272, P28501, DOI 10.1074/jbc.272.45.28501; WILLIAMS FE, 1990, MOL CELL BIOL, V10, P6500, DOI 10.1128/MCB.10.12.6500; Wong KH, 2011, GENE DEV, V25, P2525, DOI 10.1101/gad.179275.111; Wu JS, 2001, MOL CELL, V7, P117, DOI 10.1016/S1097-2765(01)00160-5; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Zaman Z, 2001, P NATL ACAD SCI USA, V98, P2550, DOI 10.1073/pnas.041611198; Zhao H, 1999, CELL RES, V9, P255, DOI 10.1038/sj.cr.7290024; ZHOU Z, 1992, GENETICS, V131, P851; ZITOMER RS, 1992, MICROBIOL REV, V56, P1	83	14	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26528	26538		10.1074/jbc.M112.369652	http://dx.doi.org/10.1074/jbc.M112.369652			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707714	hybrid, Green Published			2022-12-25	WOS:000307386000006
J	Shapira, KE; Gross, A; Ehrlich, M; Henis, YI				Shapira, Keren E.; Gross, Avner; Ehrlich, Marcelo; Henis, Yoav I.			Coated Pit-mediated Endocytosis of the Type I Transforming Growth Factor-beta (TGF-beta) Receptor Depends on a Di-leucine Family Signal and Is Not Required for Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN; CYTOPLASMIC DOMAIN; DIRECT BINDING; SMAD; INTERNALIZATION; SPECIFICITY; ACTIVATION; INHIBITOR; ENDOSOMES; RESPONSES	The roles of transforming growth factor-beta (TGF-beta) receptor endocytosis in signaling have been investigated in numerous studies, mainly through the use of endocytosis inhibitory treatments, yielding conflicting results. Two potential sources for these discrepancies were the pleiotropic effects of a general blockade of specific internalization pathways and the scarce information on the regulation of the endocytosis of the signal-transducing type I TGF-beta receptor (T beta RI). Here, we employed extracellularly tagged myc-T beta RI (wild type, truncation mutants, and a series of endocytosis-defective and endocytosis-enhanced mutants) to directly investigate the relationship between T beta RI endocytosis and signaling. Our findings indicate that T beta RI is targeted for constitutive clathrin-mediated endocytosis via a di-leucine (Leu(180)-Ile(181)) signal and an acidic cluster motif. Using Smad-dependent transcriptional activation assays and following Smad2/3 nuclear translocation in response to TGF-beta stimulation, we show that T beta RI endocytosis is dispensable for TGF-beta signaling and may play a role in signal termination. Alanine replacement of Leu(180)-Ile(181) led to partial constitutive activation of T beta RI, resulting in part from its retention at the plasma membrane and in part from potential alterations of T beta RI regulatory interactions in the vicinity of the mutated residues.	[Ehrlich, Marcelo] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Shapira, Keren E.; Gross, Avner; Henis, Yoav I.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Ehrlich, M (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	marceloe@tauex.tau.ac.il; henis@post.tau.ac.il		Ehrlich, Marcelo/0000-0002-2352-1808; Henis, Yoav/0000-0002-1408-3877	Israel Science Foundation [158/09, 1592/11]; Israel Cancer Research Fund	Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund	This work was supported in part by Israel Science Foundation Grants 158/09 (to Y. I. H.) and 1592/11 (to M. E.) and the Israel Cancer Research Fund (to Y. I. H.).	Anders RA, 1997, MOL BIOL CELL, V8, P2133, DOI 10.1091/mbc.8.11.2133; Beppu H, 2008, ONCOGENE, V27, P1063, DOI 10.1038/sj.onc.1210720; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Bokel C, 2006, SCIENCE, V314, P1135, DOI 10.1126/science.1132524; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; Chen CL, 2009, J CELL SCI, V122, P1863, DOI 10.1242/jcs.038729; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Chetrit D, 2011, J BIOL CHEM, V286, P5392, DOI 10.1074/jbc.M110.161851; Clarke DC, 2009, MOL CELL BIOL, V29, P2443, DOI 10.1128/MCB.01443-08; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck Rik, 2008, P29; Di Fiore PP, 1999, CURR OPIN CELL BIOL, V11, P483, DOI 10.1016/S0955-0674(99)80069-6; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dore JJE, 2001, MOL BIOL CELL, V12, P675, DOI 10.1091/mbc.12.3.675; Dore JJE, 1998, J BIOL CHEM, V273, P31770, DOI 10.1074/jbc.273.48.31770; Ehrlich M, 2001, J CELL SCI, V114, P1777; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Feng XH, 1997, EMBO J, V16, P3912, DOI 10.1093/emboj/16.13.3912; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Finger EC, 2008, J BIOL CHEM, V283, P34808, DOI 10.1074/jbc.M804741200; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; Gatza CE, 2010, CELL SIGNAL, V22, P1163, DOI 10.1016/j.cellsig.2010.01.016; Gilboa L, 1998, J CELL BIOL, V140, P767, DOI 10.1083/jcb.140.4.767; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; HENIS YI, 1994, J CELL BIOL, V126, P139, DOI 10.1083/jcb.126.1.139; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Huse M, 2001, MOL CELL, V8, P671, DOI 10.1016/S1097-2765(01)00332-X; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; Johnson AO, 2001, MOL BIOL CELL, V12, P367, DOI 10.1091/mbc.12.2.367; Kfir S, 2005, MOL CELL BIOL, V25, P8239, DOI 10.1128/MCB.25.18.8239-8250.2005; LAIHO M, 1990, J BIOL CHEM, V265, P18518; Lin SJ, 2006, REPRODUCTION, V132, P179, DOI 10.1530/rep.1.01072; Liu C, 2009, MOL CELL, V35, P26, DOI 10.1016/j.molcel.2009.06.018; Liu XD, 2000, ONCOGENE, V19, P5926, DOI 10.1038/sj.onc.1203991; Lu ZX, 2002, J BIOL CHEM, V277, P29363, DOI 10.1074/jbc.M203495200; Lutz M, 2004, EUR J BIOCHEM, V271, P920, DOI 10.1111/j.1432-1033.2004.03994.x; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Meyer C, 2011, J HEPATOL, V55, P369, DOI 10.1016/j.jhep.2010.11.027; Mitchell H, 2004, MOL BIOL CELL, V15, P4166, DOI 10.1091/mbc.E04-03-0245; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Ravid T, 2004, J BIOL CHEM, V279, P37153, DOI 10.1074/jbc.M403210200; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247; Runyan CE, 2005, J BIOL CHEM, V280, P8300, DOI 10.1074/jbc.M407939200; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shvartsman DE, 2007, J CELL BIOL, V178, P675, DOI 10.1083/jcb.200701133; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Sousa LP, 2012, P NATL ACAD SCI USA, V109, P4419, DOI 10.1073/pnas.1200164109; Trowbridge IS, 1991, CURR OPIN CELL BIOL, V3, P1062, DOI 10.1016/0955-0674(91)90130-Q; Tugizov S, 1999, J VIROL, V73, P8677, DOI 10.1128/JVI.73.10.8677-8688.1999; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Xiang Y, 2000, MOL BIOL CELL, V11, P1257, DOI 10.1091/mbc.11.4.1257; Yao DY, 2002, MOL BIOL CELL, V13, P4001, DOI 10.1091/mbc.02-07-0104; Zuo W, 2009, MOL BIOL CELL, V20, P1020, DOI 10.1091/mbc.E08-09-0898; Zwart DE, 1996, J BIOL CHEM, V271, P907, DOI 10.1074/jbc.271.2.907	73	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26876	26889		10.1074/jbc.M112.362848	http://dx.doi.org/10.1074/jbc.M112.362848			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707720	Green Published, hybrid			2022-12-25	WOS:000307386000036
J	Muret, J; Hasmim, M; Stasik, I; Jalil, A; Mallavialle, A; Nanbakhsh, A; Lacroix, L; Billot, K; Baud, V; Thiery, J; Vielh, P; Terrier, P; Wiels, J; Vassilev, L; Lecesne, A; Bonvalot, S; Chouaib, S				Muret, Jane; Hasmim, Meriem; Stasik, Izabela; Jalil, Abdelali; Mallavialle, Aude; Nanbakhsh, Arash; Lacroix, Ludovic; Billot, Katy; Baud, Veronique; Thiery, Jerome; Vielh, Philippe; Terrier, Philippe; Wiels, Joelle; Vassilev, Lyubomir; Lecesne, Axel; Bonvalot, Sylvie; Chouaib, Salem			Attenuation of Soft-Tissue Sarcomas Resistance to the Cytotoxic Action of TNF-alpha by Restoring p53 Function	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ISOLATED LIMB PERFUSION; NF-KAPPA-B; ANTITUMOR-ACTIVITY; HUMAN-MELANOMA; CELL-DEATH; MDM2; ACTIVATION; MELPHALAN; PATHWAY	Background: Isolated limb perfusion with TNF-alpha and melphalan is used with remarkable efficiency to treat unresectable limb sarcomas. Here we tested the ability of TNF-alpha to directly induce apoptosis of sarcoma cells. In addition, we investigated the impact of p53 in the regulation of such effect. Methodology/Principal Findings: We first analysed the ability of TNF-alpha to induce apoptosis in freshly isolated tumour cells. For this purpose, sarcoma tumours (n = 8) treated ex vivo with TNF-alpha were processed for TUNEL staining. It revealed substantial endothelial cell apoptosis and levels of tumour cell apoptosis that varied from low to high. In order to investigate the role of p53 in TNF-alpha-induced cell death, human sarcoma cell lines (n = 9) with different TP53 and MDM2 status were studied for their sensitivity to TNF-alpha. TP53(Wt) cell lines were sensitive to TNF-alpha unless MDM2 was over-expressed. However, TP53(Mut) and TP53(Null) cell lines were resistant. TP53 suppression in TP53(Wt) cell lines abrogated TNF-alpha sensitivity and TP53 overexpression in TP53(Null) cell lines restored it. The use of small molecules that restore p53 activity, such as CP-31398 or Nutlin-3a, in association with TNF-alpha, potentiated the cell death of respectively TP53(Mut) and TP53(Wt) /MDM2(Ampl). In particular, CP-31398 was able to induce p53 as well as some of its apoptotic target genes in TP53(Mut) cells. In TP53(Wt)/MDM2(Ampl) cells, Nutlin-3a effects were associated with a decrease of TNF-alpha-induced NF-kappa B-DNA binding and correlated with a differential regulation of pro- and anti-apoptotic genes such as TP53BP2, GADD45, TGF-beta 1 and FAIM. Conclusion/Significance: More effective therapeutic approaches are critically needed for the treatment of unresectable limb sarcomas. Our results show that restoring p53 activity in sarcoma cells correlated with increased sensitivity to TNF-alpha, suggesting that this strategy may be an important determinant of TNF-alpha-based sarcomas treatment.	[Muret, Jane; Hasmim, Meriem; Stasik, Izabela; Jalil, Abdelali; Nanbakhsh, Arash; Thiery, Jerome; Chouaib, Salem] Inst Cancerol Gustave Roussy, Unite INSERM, U753, Villejuif, France; [Muret, Jane] Inst Cancerol Gustave Roussy, Dept Anesthesie, Villejuif, France; [Mallavialle, Aude] Grp Hosp Archet, Unite INSERM, U576, Nice, France; [Lacroix, Ludovic; Vielh, Philippe] Inst Cancerol Gustave Roussy, Lab Rech Translat, Villejuif, France; [Billot, Katy; Baud, Veronique] Inst Cochin, Unite INSERM, U1016, Paris, France; [Billot, Katy; Baud, Veronique] CNRS, UMR 8104, Paris, France; [Billot, Katy; Baud, Veronique] Univ Paris 05, Paris, France; [Terrier, Philippe] Inst Cancerol Gustave Roussy, Dept Pathol, Villejuif, France; [Wiels, Joelle] Univ Paris 11, CNRS, IGR, Inst Cancerol Gustave Roussy,UMR 8126, Villejuif, France; [Vassilev, Lyubomir] Hoffmann La Roche Inc, Roche Res Ctr, Discovery Oncol, Nutley, NJ 07110 USA; [Lecesne, Axel] Inst Cancerol Gustave Roussy, Dept Med, Villejuif, France; [Bonvalot, Sylvie] Inst Cancerol Gustave Roussy IGR, Dept Chirurg, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Roche Holding; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy	Muret, J (corresponding author), Inst Cancerol Gustave Roussy, Unite INSERM, U753, Villejuif, France.	muret@igr.fr	Baud, Veronique/F-7699-2013; Baud, Veronique/AAL-3950-2020; Wiels, Joëlle/AGL-2319-2022; THIERY, Jerome/N-2469-2018	Baud, Veronique/0000-0002-4090-718X; Baud, Veronique/0000-0002-4090-718X; Wiels, Joëlle/0000-0002-3313-2937; THIERY, Jerome/0000-0002-0998-3627; JALIL, Abdelali/0000-0003-2710-8735; Hasmim, Meriem/0000-0002-7920-2443; Stasik, Izabela/0000-0002-7756-4731; mallavialle, aude/0000-0002-9380-6788	Conticanet; Fondation de Recherche Gustave Roussy and Association pour la Recherche sur le Cancer; Agence Nationale pour la Recherche	Conticanet; Fondation de Recherche Gustave Roussy and Association pour la Recherche sur le Cancer; Agence Nationale pour la Recherche(French National Research Agency (ANR))	This research was supported by grants to JM from Conticanet, Fondation de Recherche Gustave Roussy and Association pour la Recherche sur le Cancer and to VB from Agence Nationale pour la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameyar M, 1999, ONCOGENE, V18, P5464, DOI 10.1038/sj.onc.1202919; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEYAERT R, 1994, FEBS LETT, V340, P9, DOI 10.1016/0014-5793(94)80163-0; Bezzi M, 2003, J BIOL CHEM, V278, P43603, DOI 10.1074/jbc.M308114200; Bonvalot S, 2005, ANN ONCOL, V16, P1061, DOI 10.1093/annonc/mdi229; Cai ZZ, 1997, ONCOGENE, V15, P2817, DOI 10.1038/sj.onc.1201445; Casali PG, 2010, ANN ONCOL, V21, pv198, DOI 10.1093/annonc/mdq209; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Chibon F, 2002, CANCER GENET CYTOGEN, V139, P24, DOI 10.1016/S0165-4608(02)00614-3; CORDONCARDO C, 1994, CANCER RES, V54, P794; de Wilt JHW, 2000, BRIT J CANCER, V82, P1000, DOI 10.1054/bjoc.1999.1032; Dey A, 2007, CELL CYCLE, V6, P2178, DOI 10.4161/cc.6.17.4643; Drane P, 2002, CELL DEATH DIFFER, V9, P527, DOI 10.1038/sj.cdd.4400983; Eggermont AMM, 1996, ANN SURG, V224, P756, DOI 10.1097/00000658-199612000-00011; Eggermont AMM, 1998, ANTICANCER RES, V18, P3899; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Grimer Robert, 2010, Sarcoma, V2010, P317462, DOI 10.1155/2010/317462; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; Kojima K, 2005, BLOOD, V106, P3150, DOI 10.1182/blood-2005-02-0553; Lee GH, 2011, INT J ONCOL, V39, P209, DOI 10.3892/ijo.2011.1024; LEJEUNE F, 1994, J CELL BIOCHEM, V56, P52, DOI 10.1002/jcb.240560110; Lejeune Ferdy J, 2006, Cancer Immun, V6, P6; Menon C, 2003, AM J PHYSIOL-HEART C, V284, pH317, DOI 10.1152/ajpheart.00971.2001; Menon C, 2006, ANN SURG, V244, P781, DOI 10.1097/01.sla.0000231723.81218.72; Muller CR, 2007, INT J CANCER, V121, P199, DOI 10.1002/ijc.22643; Muret J, 2008, ANN ONCOL, V19, P793, DOI 10.1093/annonc/mdm559; Nooijen PTGA, 1996, BRIT J CANCER, V74, P1908, DOI 10.1038/bjc.1996.652; Ohnstad HO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-211; Perot G, 2010, AM J PATHOL, V177, P2080, DOI 10.2353/ajpath.2010.100104; Perot G, 2009, CANCER RES, V69, P2269, DOI 10.1158/0008-5472.CAN-08-1443; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Plaat BEC, 1999, CLIN CANCER RES, V5, P1650; RENARD N, 1995, J PATHOL, V176, P279, DOI 10.1002/path.1711760310; Ruegg C, 1998, NAT MED, V4, P408, DOI 10.1038/nm0498-408; Scian MJ, 2005, MOL CELL BIOL, V25, P10097, DOI 10.1128/MCB.25.22.10097-10110.2005; SEKIGUCHI M, 1985, BIOMED PHARMACOTHER, V39, P372; SHERMAN ML, 1988, J CLIN ONCOL, V6, P344, DOI 10.1200/JCO.1988.6.2.344; SUGARMAN BJ, 1985, SCIENCE, V230, P943, DOI 10.1126/science.3933111; Takimoto R, 2002, CANCER BIOL THER, V1, P47, DOI 10.4161/cbt.1.1.41; Van Maerken T, 2009, JNCI-J NATL CANCER I, V101, P1562, DOI 10.1093/jnci/djp355; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Wang W, 2008, CURR OPIN ONCOL, V20, P90, DOI 10.1097/CCO.0b013e3282f31d6f; Wang WG, 2003, MOL CELL BIOL, V23, P2171, DOI 10.1128/MCB.23.6.2171-2181.2003; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425	46	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38808	10.1371/journal.pone.0038808	http://dx.doi.org/10.1371/journal.pone.0038808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719951	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000305583300051
J	Berthinussen, A; Altringham, J				Berthinussen, Anna; Altringham, John			Do Bat Gantries and Underpasses Help Bats Cross Roads Safely?	PLOS ONE			English	Article							PIPISTRELLUS-PIPISTRELLUS; ECHOLOCATION BEHAVIOR; CONNECTIVITY; CASUALTIES; ABUNDANCE; WILDLIFE; ECOLOGY; DESIGN; FLIGHT	Major roads can reduce bat abundance and diversity over considerable distances. To mitigate against these effects and comply with environmental law, many European countries install bridges, gantries or underpasses to make roads permeable and safer to cross. However, through lack of appropriate monitoring, there is little evidence to support their effectiveness. Three underpasses and four bat gantries were investigated in northern England. Echolocation call recordings and observations were used to determine the number of bats using underpasses in preference to crossing the road above, and the height at which bats crossed. At gantries, proximity to the gantry and height of crossing bats were measured. Data were compared to those from adjacent, severed commuting routes that had no crossing structure. At one underpass 96% of bats flew through it in preference to crossing the road. This underpass was located on a pre-construction commuting route that allowed bats to pass without changing flight height or direction. At two underpasses attempts to divert bats from their original commuting routes were unsuccessful and bats crossed the road at the height of passing vehicles. Underpasses have the potential to allow bats to cross roads safely if built on pre-construction commuting routes. Bat gantries were ineffective and used by a very small proportion of bats, even up to nine years after construction. Most bats near gantries crossed roads along severed, pre-construction commuting routes at heights that put them in the path of vehicles. Crossing height was strongly correlated with verge height, suggesting that elevated verges may have some value in mitigation, but increased flight height may be at the cost of reduced permeability. Green bridges should be explored as an alternative form of mitigation. Robust monitoring is essential to assess objectively the case for mitigation and to ensure effective mitigation.	[Berthinussen, Anna; Altringham, John] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England	University of Leeds	Berthinussen, A (corresponding author), Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England.	j.d.altringham@leeds.ac.uk			University of Leeds Research Postgraduate Scholarships Programme	University of Leeds Research Postgraduate Scholarships Programme	The work was supported by the University of Leeds Research Postgraduate Scholarships Programme. http://scholarships.leeds.ac.uk. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott IM, 2012, J ZOOLOGY; Altringham J. D., 2008, BAT ECOLOGY MITIGATI; [Anonymous], 2011, DAILY MAIL; Bach L, 2004, MAMMALIA, V68, P411, DOI 10.1515/mamm.2004.041; Bach L, 2005, 022202002LR FE; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Bellamy CC, 2011, THESIS U LEEDS UK; Berthinussen A, 2012, J APPL ECOL, V49, P82, DOI 10.1111/j.1365-2664.2011.02068.x; Clevenger AP, 2001, J APPL ECOL, V38, P1340, DOI 10.1046/j.0021-8901.2001.00678.x; Corlatti L, 2009, CONSERV BIOL, V23, P548, DOI 10.1111/j.1523-1739.2008.01162.x; Cumbria County Council, 2011, CUMBR TRAFF DAT; Entwistle AC, 2000, J ZOOL, V252, P11, DOI 10.1017/S095283690000902X; Fahrig L, 2009, ECOL SOC, V14; Gaisler J, 2009, ACTA THERIOL, V54, P147, DOI 10.1007/BF03193170; Glista DJ, 2009, LANDSCAPE URBAN PLAN, V91, P1, DOI 10.1016/j.landurbplan.2008.11.001; Grilo C, 2009, BIOL CONSERV, V142, P301, DOI 10.1016/j.biocon.2008.10.026; Highways Agency, 2008, ALL FIVEWAYS THETF 4, V2; Holderied MW, 2006, J EXP BIOL, V209, P1816, DOI 10.1242/jeb.02194; Hothorn T, 2008, J STAT SOFTW, V28, P1; Kerth G, 2009, BIOL CONSERV, V142, P270, DOI 10.1016/j.biocon.2008.10.022; Lambrechts J, 2006, MONITORING ECODUCT W; Lesinski G, 2007, MAMMALIA, V71, P138, DOI 10.1515/MAMM.2007.020; Lesinski G, 2011, EUR J WILDLIFE RES, V57, P217, DOI 10.1007/s10344-010-0414-9; Limpens H.J.G.A., 1991, Myotis, V29, P39; Limpens H.J.G.A., 2005, BATS ROAD CONSTRUCTI; Ng SJ, 2004, BIOL CONSERV, V115, P499, DOI 10.1016/S0006-3207(03)00166-6; O'Connor G., 2011, REV BAT MITIGATION R; Olsson MPO, 2008, LANDSCAPE URBAN PLAN, V85, P133, DOI 10.1016/j.landurbplan.2007.10.006; Papadatou E, 2011, OECOLOGIA, V165, P925, DOI 10.1007/s00442-010-1771-5; Parsons S, 2000, J EXP BIOL, V203, P2641; R Development Core Team, 2006, R LANG ENV STAT COMP; RACEY PA, 1985, J ANIM ECOL, V54, P205, DOI 10.2307/4631; Russell Amy L., 2009, Endangered Species Research, V8, P49, DOI 10.3354/esr00121; Schaub A, 2008, J EXP BIOL, V211, P3174, DOI 10.1242/jeb.022863; Schaub A, 2007, J COMP PHYSIOL A, V193, P1185, DOI 10.1007/s00359-007-0269-z; Senior P, 2005, P ROY SOC B-BIOL SCI, V272, P2467, DOI 10.1098/rspb.2005.3237; Slater F.M., 2002, Web Ecology, V3, P33; Stone EL, 2009, CURR BIOL, V19, P1123, DOI 10.1016/j.cub.2009.05.058; The Telegraph, 2011, TELEGRAPH       1015; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Van Der Ree R, 2006, REV MITIGATION MEASU; Verboom B, 1999, CAN J ZOOL, V77, P1393, DOI 10.1139/cjz-77-9-1393; Verboom B, 1997, LANDSCAPE ECOL, V12, P117, DOI 10.1007/BF02698211; Zurcher AA, 2010, ACTA CHIROPTEROL, V12, P337, DOI 10.3161/150811010X537918	44	39	44	4	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38775	10.1371/journal.pone.0038775	http://dx.doi.org/10.1371/journal.pone.0038775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719941	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341900048
J	Huse, SM; Ye, YZ; Zhou, YJ; Fodor, AA				Huse, Susan M.; Ye, Yuzhen; Zhou, Yanjiao; Fodor, Anthony A.			A Core Human Microbiome as Viewed through 16S rRNA Sequence Clusters	PLOS ONE			English	Article								We explore the microbiota of 18 body sites in over 200 individuals using sequences amplified V1-V3 and the V3-V5 small subunit ribosomal RNA (16S) hypervariable regions as part of the NIH Common Fund Human Microbiome Project. The body sites with the greatest number of core OTUs, defined as OTUs shared amongst 95% or more of the individuals, were the oral sites (saliva, tongue, cheek, gums, and throat) followed by the nose, stool, and skin, while the vaginal sites had the fewest number of OTUs shared across subjects. We found that commonalities between samples based on taxonomy could sometimes belie variability at the sub-genus OTU level. This was particularly apparent in the mouth where a given genus can be present in many different oral sites, but the sub-genus OTUs show very distinct site selection, and in the vaginal sites, which are consistently dominated by the Lactobacillus genus but have distinctly different sub-genus V1-V3 OTU populations across subjects. Different body sites show approximately a ten-fold difference in estimated microbial richness, with stool samples having the highest estimated richness, followed by the mouth, throat and gums, then by the skin, nasal and vaginal sites. Richness as measured by the V1-V3 primers was consistently higher than richness measured by V3-V5. We also show that when such a large cohort is analyzed at the genus level, most subjects fit the stool "enterotype" profile, but other subjects are intermediate, blurring the distinction between the enterotypes. When analyzed at the finer-scale, OTU level, there was little or no segregation into stool enterotypes, but in the vagina distinct biotypes were apparent. Finally, we note that even OTUs present in nearly every subject, or that dominate in some samples, showed orders of magnitude variation in relative abundance emphasizing the highly variable nature across individuals.	[Huse, Susan M.] Josephine Bay Paul Ctr, Marine Biol Lab, Woods Hole, MA USA; [Ye, Yuzhen] Indiana Univ, Sch Informat & Comp, Bloomington, IL USA; [Zhou, Yanjiao] Washington Univ, Sch Med, Genome Ctr, St Louis, MO USA; [Fodor, Anthony A.] Univ N Carolina, Dept Bioinformat & Gen, Charlotte, NC 28223 USA	Marine Biological Laboratory - Woods Hole; Indiana University System; Indiana University Bloomington; Washington University (WUSTL); University of North Carolina; University of North Carolina Charlotte	Huse, SM (corresponding author), Josephine Bay Paul Ctr, Marine Biol Lab, Woods Hole, MA USA.	shuse@mbl.edu			National Science Foundation [NSF-BDI 0960626]; National Institutes of Health (NIH) [1UH2DK083993-01]; NIH [1R01HG004908]; NIH-NHGRI [U54HG004968]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH2DK083993] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the following grants: National Science Foundation NSF-BDI 0960626 to Susan Huse, National Institutes of Health (NIH) 1UH2DK083993-01 to Vincent Young (SMH), NIH 1R01HG004908 to Yuzhen Ye, and NIH-NHGRI U54HG004968 to George Weinstock (YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aargaard K, NATURE IN PRESS; Arumugam M, 2011, NATURE, V474, DOI 10.1038/nature10187; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; Bunge J, 2011, P 2011 PAC S BIOC; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Knights D, 2011, CELL HOST MICROBE, V10, P292, DOI 10.1016/j.chom.2011.09.003; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Office of Portfolio Analysis and Strategic Initiatives NIoH, 2008, NIH ROADM MED RES HU; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Zhou X, 2010, INFECT DIS OBSTET GY	16	360	386	3	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e34242	10.1371/journal.pone.0034242	http://dx.doi.org/10.1371/journal.pone.0034242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719824	gold, Green Published			2022-12-25	WOS:000305341900007
J	Fawehinmi, TO; Ilomaki, J; Voutilainen, S; Kauhanen, J				Fawehinmi, Timothy O.; Ilomaeki, Jenni; Voutilainen, Sari; Kauhanen, Jussi			Alcohol Consumption and Dietary Patterns: The FinDrink Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MIDDLE-AGED MEN; RISK-FACTOR; NUTRITIONAL-STATUS; DRINKING PATTERNS; NUTRIENT INTAKE; WINE INTAKE; LIFE-STYLE; DANISH MEN; FOLLOW-UP	The aim of this population-based study was to investigate differences in dietary patterns in relation to the level of alcohol consumption among Finnish adults. This study was part of the FinDrink project, an epidemiologic study on alcohol use among Finnish population. It utilized data from the Kuopio Ischaemic Heart Disease Risk Factor Study. A total of 1720 subjects comprising of 816 men and 904 women aged 53-73 years were included in the study in 1998-2001. Food intake was collected via a 4-day food diary method. Self-reported alcohol consumption was assessed with quantity-frequency method based on the Nordic Alcohol Consumption Inventory. Weekly alcohol consumption was categorized into three groups: non-drinkers (<12 grams), moderate drinkers (12-167.9 grams for men, 12-83.9 grams for women) and heavy drinkers (>= 168 grams for men, >= 84 grams for women). Data were analyzed for men and women separately using multiple linear regression models, adjusted for age, occupational status, marital status, smoking, body mass index and leisure time physical activity. In women, moderate/heavy drinkers had lower fibre intake and moderate drinkers had higher vitamin D intake than non-drinkers. Male heavy drinkers had lower fibre, retinol, calcium and iron intake, and moderate/heavy drinkers had higher vitamin D intake than non-drinkers. Fish intake was higher among women moderate drinkers and men moderate/heavy drinkers than non-drinkers. In men, moderate drinkers had lower fruit intake and heavy drinkers had lower milk intake than non-drinkers. Moderate drinkers had higher energy intake from total fats and monosaturated fatty acids than non-drinkers. In contrast, energy intake from carbohydrates was lower among moderate/heavy drinkers than nondrinkers. In conclusion, especially male heavy drinkers had less favorable nutritional intake than moderate and non-drinkers. Further studies on the relationship between alcohol consumption and dietary habits are needed to plan a comprehensive dietary intervention programs in future.	[Fawehinmi, Timothy O.; Voutilainen, Sari; Kauhanen, Jussi] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Ilomaeki, Jenni] Univ S Australia, Sansom Inst, Sch Pharm & Med Sci, Qual Use Med & Pharm Res Ctr, Adelaide, SA 5001, Australia	University of Eastern Finland; University of South Australia	Fawehinmi, TO (corresponding author), Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland.	dapofawehinmi@gmail.com	Ilomaki, Jenni/E-7213-2011; Kauhanen, Jussi/ABC-4064-2021	FAWEHINMI, TIMOTHY/0000-0001-8578-8383; Ilomaki, Jenni/0000-0002-0348-9441	Academy of Finland [201688, 80185, 200942, 118551]	Academy of Finland(Academy of Finland)	This work was supported by the Academy of Finland (grants 201688 and 80185 to Dr. Voutilainen, grants 200942 and 118551 to Dr. Kauhanen) http://www.aka.fi/eng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barefoot JC, 2002, AM J CLIN NUTR, V76, P466, DOI 10.1093/ajcn/76.2.466; Berger K, 1999, NEW ENGL J MED, V341, P1557, DOI 10.1056/NEJM199911183412101; Breslow RA, 2006, AM J EPIDEMIOL, V163, P359, DOI 10.1093/aje/kwj050; Bunout D, 1999, NUTRITION, V15, P583, DOI 10.1016/S0899-9007(99)00090-8; COLDITZ GA, 1991, AM J CLIN NUTR, V54, P49, DOI 10.1093/ajcn/54.1.49; Fawehinmi T, 2011, ANN NUTR METAB, V58, P135; Gonzalez-Reimers E, 2008, ALCOHOL ALCOHOLISM, V43, P314, DOI 10.1093/alcalc/agn011; Gronbaek M, 2000, ANN INTERN MED, V133, P411, DOI 10.7326/0003-4819-133-6-200009190-00008; Hakala P, 2003, EUR J CLIN NUTR, V57, P1035, DOI 10.1038/sj.ejcn.1601639; Harkonen JT, 2011, ALCOHOL ALCOHOLISM, V46, P349, DOI 10.1093/alcalc/agr025; Ilomaki J, 2011, EUR J PUBLIC HL 0311; Ilomaki J, 2010, EUR J PUBLIC HEALTH, V20, P133, DOI 10.1093/eurpub/ckp079; Imhof A, 2003, ADDICT BIOL, V8, P271, DOI 10.1080/13556210310001602176; IRGENSJENSEN O, 1992, BRUK ALKOHOL NARKOTI; JACQUES PF, 1989, AM J CLIN NUTR, V50, P875, DOI 10.1093/ajcn/50.4.875; Jeeranun K, 2008, NUTR DIET, V65, P272, DOI 10.1111/j.1747-0080.2008.00313.x; Kauhanen J, 1997, BMJ-BRIT MED J, V315, P846, DOI 10.1136/bmj.315.7112.846; Kesse E, 2001, AM J CLIN NUTR, V74, P322; Kroke A, 2001, BRIT J NUTR, V85, P621, DOI 10.1079/BJN2000289; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lakka TA, 1996, INT J EPIDEMIOL, V25, P86, DOI 10.1093/ije/25.1.86; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Mannisto S, 1997, EUR J CLIN NUTR, V51, P326, DOI 10.1038/sj.ejcn.1600406; Matsui T, 2010, ALCOHOL CLIN EXP RES, V34, P869, DOI 10.1111/j.1530-0277.2010.01159.x; Menotti A, 1999, EUR J EPIDEMIOL, V15, P507, DOI 10.1023/A:1007529206050; Mezzano D, 2001, EUR J CLIN NUTR, V55, P444, DOI 10.1038/sj.ejcn.1601202; Official Statistics of Finland, 2011, CAUS DEATH 2010; Official Statistics of Finland, OFF STAT FINL EMPL 2; Official Statistics of Finland, OFF STAT FINL HOUS C; Osler M, 2001, BRIT J NUTR, V85, P219, DOI 10.1079/BJN2000240; Osterberg EL, 2011, DRUG ALCOHOL REV, V30, P124, DOI 10.1111/j.1465-3362.2010.00265.x; Panagiotakos D, 2007, J MED FOOD, V10, P615, DOI 10.1089/jmf.2007.414; Park Y, 2011, ARCH INTERN MED, V171, P1061, DOI 10.1001/archinternmed.2011.18; Piazza-Gardner Anna K, 2012, Am J Health Promot, V26, pe95, DOI 10.4278/ajhp.100929-LIT-328; Pietinen P, 1996, CIRCULATION, V94, P2720, DOI 10.1161/01.CIR.94.11.2720; Piirtola M, 2008, EUR J EPIDEMIOL, V23, P747, DOI 10.1007/s10654-008-9289-4; Rehm J, 2003, EUR ADDICT RES, V9, P157, DOI 10.1159/000072222; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Ruf T, 2005, ANN NUTR METAB, V49, P16, DOI 10.1159/000084173; Ruidavets JB, 2004, EUR HEART J, V25, P1153, DOI 10.1016/j.ehj.2003.12.022; Santolaria F, 2000, DRUG ALCOHOL DEPEN, V59, P295, DOI 10.1016/S0376-8716(99)00129-5; Schroder H, 2005, ANN NUTR METAB, V49, P100, DOI 10.1159/000084889; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; Tjonneland A, 1999, AM J CLIN NUTR, V69, P49; USDA, 2010, DIET GUID AM, DOI DOI 10.HTTP://WWW.CNPP.USDA.G0V/PUBLICATI0NS/DIETARYGUIDELINES/2010/P0LICYD0C/P0LICYD0C.PDF; Voutilainen S, 2001, CIRCULATION, V103, P2674, DOI 10.1161/01.CIR.103.22.2674; Willenbring ML, 2009, AM FAM PHYSICIAN, V80, P44; WILSON TW, 1993, AM J EPIDEMIOL, V137, P292, DOI 10.1093/oxfordjournals.aje.a116676; World Health Organization Department of Mental Health and Substance Dependence Noncommunicable Diseases and Mental Health Cluster, 2000, INT GUID MON ALC CON	49	43	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38607	10.1371/journal.pone.0038607	http://dx.doi.org/10.1371/journal.pone.0038607			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719905	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000305340000035
J	Assefa, Y; Worku, A; Wouters, E; Koole, O; Mariam, DH; Van Damme, W				Assefa, Yibeltal; Worku, Alemayehu; Wouters, Edwin; Koole, Olivier; Mariam, Damen Haile; Van Damme, Wim			Simplified Tools for Measuring Retention in Care in Antiretroviral Treatment Program in Ethiopia: Cohort and Current Retention in Care	PLOS ONE			English	Article							INITIATION; THERAPY	Introduction: Patient retention in care is a critical challenge for antiretroviral treatment programs. This is mainly because retention in care is related to adherence to treatment and patient survival. It is therefore imperative that health facilities and programs measure patient retention in care. However, the currently available tools, such as Kaplan Meier, for measuring retention in care have a lot of practical limitations. The objective of this study was to develop simplified tools for measuring retention in care. Methods: Retrospective cohort data were collected from patient registers in nine health facilities in Ethiopia. Retention in care was the primary outcome for the study. Tools were developed to measure "current retention'' in care during a specific period of time for a specific "ART-age group'' and "cohort retention'' in care among patients who were followed for the last "Y'' number of years on ART. "Probability of retention'' based on the tool for "cohort retention'' in care was compared with "probability of retention'' based on Kaplan Meier. Results: We found that the new tools enable to measure "current retention'' and "cohort retention'' in care. We also found that the tools were easy to use and did not require advanced statistical skills. Both "current retention'' and "cohort retention'' are lower among patients in the first two "ART-age groups'' and "ART-age cohorts'' than in subsequent "ART-age groups'' and "ART-age cohorts''. The "probability of retention'' based on the new tools were found to be similar to the "probability of retention'' based on Kaplan Meier. Conclusion: The simplified tools for "current retention'' and "cohort retention'' will enable practitioners and program managers to measure and monitor rates of retention in care easily and appropriately. We therefore recommend that health facilities and programs start to use these tools in their efforts to improve retention in care and patient outcomes.	[Assefa, Yibeltal] Fed HIV AIDS Prevent & Control Off, Addis Ababa, Ethiopia; [Worku, Alemayehu; Mariam, Damen Haile] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia; [Wouters, Edwin] Univ Antwerp, Dept Social Sci, B-2020 Antwerp, Belgium; [Koole, Olivier] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Assefa, Yibeltal; Van Damme, Wim] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	Addis Ababa University; University of Antwerp; Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM)	Assefa, Y (corresponding author), Fed HIV AIDS Prevent & Control Off, Addis Ababa, Ethiopia.	yibeltalassefa343@gmail.com	Wouters, Edwin/AAE-1649-2021; Assefa, Yibeltal/ABI-8057-2020; Assefa, Yibeltal/N-5984-2016; Van Damme, Wim/F-7404-2011	Wouters, Edwin/0000-0003-2268-3829; Assefa, Yibeltal/0000-0003-2393-1492; Assefa, Yibeltal/0000-0003-2393-1492; Van Damme, Wim/0000-0002-6344-3007; Koole, Olivier/0000-0002-1122-5382	Directorate General for Development and Cooperation of Belgium through the Institute of Tropical Medicine	Directorate General for Development and Cooperation of Belgium through the Institute of Tropical Medicine	The Directorate General for Development and Cooperation of Belgium supported this study through the Institute of Tropical Medicine. The funders had no role in study design, data collection, and analysis, decision to publish, or preparations of the manuscript.	Assefa Yibeltal, 2008, Ethiop Med J, V46, P401; Assefa Y, 2010, AIDS PATIENT CARE ST, V24, P521, DOI 10.1089/apc.2009.0286; Assefa Y, 2010, CURR OPIN HIV AIDS, V5, P78, DOI 10.1097/COH.0b013e328333b87a; Assefa Y, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000056; Berg MB, 2005, AIDS CARE, V17, P902, DOI 10.1080/09540120500101658; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Hsiej JJ, 1999, BIOMETRICAL J, V83, P143; Ministry of Health of Ethiopia, SINGL POINT HIV PREV; Pox MP, 2009, TROP MED INT HEALTH, V15, P1; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Schilder AJ, 2001, SOC SCI MED, V52, P1643, DOI 10.1016/S0277-9536(00)00274-4; Tassie JM, 2010, JAIDS-J ACQ IMM DEF, V54, P437, DOI 10.1097/QAI.0b013e3181d73e1b; *WHO, UN ACC SCAL PRIOR HI; *WHO, TREAT 3 MILL 2005 MA; WHO, COUNTR EXP IMPL PAT	15	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38555	10.1371/journal.pone.0038555	http://dx.doi.org/10.1371/journal.pone.0038555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TU	22701663	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000305337600029
J	Barbosa, HSC; Fernandes, TG; Dias, TP; Diogo, MM; Cabral, JMS				Barbosa, Helder S. C.; Fernandes, Tiago G.; Dias, Tiago P.; Diogo, Maria Margarida; Cabral, Joaquim M. S.			New Insights into the Mechanisms of Embryonic Stem Cell Self-Renewal under Hypoxia: A Multifactorial Analysis Approach	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; IN-VITRO; PLURIPOTENCY; WNT; ACTIVATION; BIOLOGY; OXYGEN; DIFFERENTIATION; PROLIFERATION	Previous reports have shown that culturing mouse embryonic stem (mES) cells at different oxygen tensions originated different cell proliferation patterns and commitment stages depending on which signaling pathways are activated or inhibited to support the pluripotency state. Herein we provide new insights into the mechanisms by which oxygen is influencing mES cell self-renewal and pluripotency. A multifactorial approach was developed to rationally evaluate the singular and interactive control of MEK/ERK pathway, GSK-3 inhibition, and LIF/STAT3 signaling at physiological and non-physiological oxygen tensions. Collectively, our methodology revealed a significant role of GSK-3-mediated signaling towards maintenance of mES cell pluripotency at lower O-2 tensions. Given the central role of this signaling pathway, future studies will need to focus on the downstream mechanisms involved in ES cell self-renewal under such conditions, and ultimately how these findings impact human models of pluripotency.	[Barbosa, Helder S. C.] Univ Tecn Lisboa, Inst Super Tecn, Ctr Biol & Chem Engn, Dept Bioengn, P-1096 Lisbon, Portugal; Univ Tecn Lisboa, Inst Super Tecn, Ctr Biol & Chem Engn, Inst Biotechnol & Bioengn, P-1096 Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico	Barbosa, HSC (corresponding author), Univ Tecn Lisboa, Inst Super Tecn, Ctr Biol & Chem Engn, Dept Bioengn, P-1096 Lisbon, Portugal.	joaquim.cabral@ist.utl.pt	Diogo, Maria Margarida/K-6117-2012; Dias, Tiago P./A-3371-2017; Cabral, Joaquim M S/G-2052-2010; Diogo, Margarida/ABF-4341-2020; Pillay, Nischalan/F-9536-2012; Fernandes, Tiago G./C-3865-2009	Dias, Tiago P./0000-0001-9133-8856; Cabral, Joaquim M S/0000-0002-2405-5845; Fernandes, Tiago G./0000-0002-4651-2832; Diogo, Maria Margarida/0000-0002-6270-4455	Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BPD/65834/2009, SFRH/BPD/65439/2009, SFRH/BD/78774/2011]; Fundacao para a Ciencia e Tecnologia (FCT) through the Compromisso para a Ciencia Program; MIT-Portugal Program;  [PTDC/EQU-ERQ/105277/2008];  [PTDC/EBB-BIO/101088/2008]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e Tecnologia (FCT) through the Compromisso para a Ciencia Program; MIT-Portugal Program; ; 	HSCB, TGF and TPD acknowledge support from Fundacao para a Ciencia e a Tecnologia, Portugal (SFRH/BPD/65834/2009, SFRH/BPD/65439/2009 and SFRH/BD/78774/2011, respectively). This work was financially supported by Fundacao para a Ciencia e Tecnologia (FCT) through the Compromisso para a Ciencia 2007 Program, the MIT-Portugal Program and projects PTDC/EQU-ERQ/105277/2008 and PTDC/EBB-BIO/101088/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade PZ, 2010, MOL BIOSYST, V6, P1207, DOI 10.1039/b922637k; Barker N, 2000, ADV CANCER RES, V77, P1; Bone HK, 2009, CHEM BIOL, V16, P15, DOI 10.1016/j.chembiol.2008.11.003; Box G.E.P., 2005, STAT EXPT DESIGN INN, V2nd ed.; Brantjes H, 2002, BIOL CHEM, V383, P255, DOI 10.1515/BC.2002.027; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Cameron CM, 2008, EXP BIOL MED, V233, P1044, DOI 10.3181/0709-RM-263; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Cimetta E, 2010, LAB CHIP, V10, P3277, DOI 10.1039/c0lc00033g; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Da Silva CL, 2009, J CELL PHYSIOL, V220, P102, DOI 10.1002/jcp.21736; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Fernandes TG, 2010, STEM CELL RES, V5, P76, DOI 10.1016/j.scr.2010.04.003; Fernandes TG, 2010, BIOTECHNOL BIOENG, V106, P106, DOI 10.1002/bit.22661; Fernandes TG, 2009, TRENDS BIOTECHNOL, V27, P342, DOI 10.1016/j.tibtech.2009.02.009; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Ivanovic Z, 2009, J CELL PHYSIOL, V219, P271, DOI 10.1002/jcp.21690; Jeong CH, 2007, J BIOL CHEM, V282, P13672, DOI 10.1074/jbc.M700534200; Jung JP, 2011, INTEGR BIOL-UK, V3, P185, DOI 10.1039/c0ib00112k; Kaufman DS, 2010, NAT CELL BIOL, V12, P926, DOI 10.1038/ncb1010-926; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Klimanskaya I, 2008, NAT REV DRUG DISCOV, V7, P131, DOI 10.1038/nrd2403; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lee YM, 2001, DEV DYNAM, V220, P175, DOI 10.1002/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F; MacArthur BD, 2008, COLD SH Q B, V73, P211, DOI 10.1101/sqb.2008.73.061; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Maltepe E, 1998, J MOL MED-JMM, V76, P391, DOI 10.1007/s001090050231; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Novak A, 1999, CELL MOL LIFE SCI, V56, P523, DOI 10.1007/s000180050449; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Pouton CW, 2005, ADV DRUG DELIVER REV, V57, P1918, DOI 10.1016/j.addr.2005.08.003; Powers DE, 2008, BIOTECHNOL BIOENG, V101, P241, DOI 10.1002/bit.21986; PULVERER BJ, 1994, ONCOGENE, V9, P59; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Woodgett J R, 2001, Sci STKE, V2001, pre12, DOI 10.1126/stke.2001.100.re12; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	53	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38963	10.1371/journal.pone.0038963	http://dx.doi.org/10.1371/journal.pone.0038963			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701736	Green Published, gold, Green Submitted			2022-12-25	WOS:000305337600062
J	Maddi, A; Fu, C; Free, SJ				Maddi, Abhiram; Fu, Ci; Free, Stephen J.			The Neurospora crassa dfg5 and dcw1 Genes Encode alpha-1,6-Mannanases That Function in the Incorporation of Glycoproteins into the Cell Wall	PLOS ONE			English	Article							GPI-ANCHORED PROTEINS; SACCHAROMYCES-CEREVISIAE; NEUROSPORA-CRASSA; CANDIDA-ALBICANS; FUNGAL CELL; LINKED OLIGOSACCHARIDES; CROSS-LINKING; OUTER CHAIN; GROWTH; OCH1	The covalent cross-linking of cell wall proteins into the cell wall glucan/chitin matrix is an important step in the biogenesis of the fungal cell wall. We demonstrate that the Neurospora crassa DFG5 (NCU03770) and DCW1 (NCU08127) enzymes function in vivo to cross-link glycoproteins into the cell wall. Mutants lacking DFG5 or DCW1 release slightly elevated levels of cell wall proteins into their growth medium. Mutants lacking both DFG5 and DCW1 have substantially reduced levels of cell wall proteins in their cell walls and release large amounts of known cell wall proteins into the medium. DFG5 and DCW1 are members of the GH76 family of glycosyl hydrolases, which have specificity to recognize and cleave alpha-1,6-mannans. A model for incorporation of glycoproteins into the cell wall through the alpha-1,6-mannan core of the N-linked galactomannan is presented. In this model, DFG5 and DCW1 recognize the N-linked galactomannan present on glycoproteins and cross-link it into the cell wall glucan/chitin matrix.	[Maddi, Abhiram] SUNY Buffalo, Sch Dent Med, Dept Periodont & Endodont, Buffalo, NY 14260 USA; [Fu, Ci; Free, Stephen J.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Maddi, A (corresponding author), SUNY Buffalo, Sch Dent Med, Dept Periodont & Endodont, Buffalo, NY 14260 USA.	free@buffalo.edu	Maddi, Abhiram/L-1696-2019; Maddi, Abhiram/B-3895-2018	Maddi, Abhiram/0000-0001-9565-408X; Maddi, Abhiram/0000-0001-9565-408X	National Institutes of Health [R01 GM078589]; UB Foundation; Department of Energy [DE-FG02-09ER-20097]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UB Foundation; Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grant R01 GM078589 from the National Institutes of Health and by funds from the UB Foundation. The research was supported in part by the Department of Energy-funded (DE-FG02-09ER-20097) Center for Plant and Microbial Complex Carbohydrates. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldabbous MS, 2010, MICROBIOL-SGM, V156, P2621, DOI 10.1099/mic.0.040147-0; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Bowman SM, 2006, EUKARYOT CELL, V5, P587, DOI 10.1128/EC.5.3.587-600.2006; Cabib E, 2007, MOL MICROBIOL, V63, P921, DOI 10.1111/j.1365-2958.2006.05565.x; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; de Groot PWJ, 2009, FUNGAL GENET BIOL, V46, pS72, DOI 10.1016/j.fgb.2008.07.022; Deshpande N, 2008, GLYCOBIOLOGY, V18, P626, DOI 10.1093/glycob/cwn044; Fujii T, 1999, BBA-GEN SUBJECTS, V1427, P133, DOI 10.1016/S0304-4165(99)00012-4; GOLDMAN RC, 1995, EUR J BIOCHEM, V227, P372, DOI 10.1111/j.1432-1033.1995.tb20399.x; Gonzalez M, 2010, YEAST, V27, P583, DOI 10.1002/yea.1797; Kitagaki H, 2004, EUKARYOT CELL, V3, P1297, DOI 10.1128/EC.3.5.1297-1306.2004; Kitagaki H, 2002, MOL MICROBIOL, V46, P1011, DOI 10.1046/j.1365-2958.2002.03244.x; Klis FM, 2009, FEMS YEAST RES, V9, P1013, DOI 10.1111/j.1567-1364.2009.00541.x; Lambou K, 2010, YEAST, V27, P625, DOI 10.1002/yea.1798; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; LU CF, 1995, J CELL BIOL, V128, P333, DOI 10.1083/jcb.128.3.333; Maddi A, 2010, EUKARYOT CELL, V9, P1766, DOI 10.1128/EC.00134-10; Maddi A, 2009, FUNGAL GENET BIOL, V46, P768, DOI 10.1016/j.fgb.2009.06.005; Maniatis T., 1982, MOL CLONING LAB MANU; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; Mosch HU, 1997, GENETICS, V145, P671; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; NAKAJIMA T, 1984, J BIOCHEM, V96, P1013, DOI 10.1093/oxfordjournals.jbchem.a134917; NAKANISHISHINDO Y, 1993, J BIOL CHEM, V268, P26338; NAKAYAMA K, 1992, EMBO J, V11, P2511, DOI 10.1002/j.1460-2075.1992.tb05316.x; Plaine A, 2008, FUNGAL GENET BIOL, V45, P1404, DOI 10.1016/j.fgb.2008.08.003; Selker EU, 1999, CELL, V97, P157, DOI 10.1016/S0092-8674(00)80725-4; Spreghini E, 2003, EUKARYOT CELL, V2, P746, DOI 10.1128/EC.2.4.746-755.2003	31	41	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38872	10.1371/journal.pone.0038872	http://dx.doi.org/10.1371/journal.pone.0038872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701726	gold, Green Submitted, Green Published			2022-12-25	WOS:000305337600053
J	Jensen-Smith, HC; Hallworth, R; Nichols, MG				Jensen-Smith, Heather C.; Hallworth, Richard; Nichols, Michael G.			Gentamicin Rapidly Inhibits Mitochondrial Metabolism in High-Frequency Cochlear Outer Hair Cells	PLOS ONE			English	Article							RIBOSOMAL-RNA; DEHYDROGENASE ACTIVITY; INTRACELLULAR ATP; INDUCED APOPTOSIS; IN-VITRO; DEATH; MECHANISMS; SUCCINATE; OTOTOXICITY; ANTIBIOTICS	Aminoglycosides (AG), including gentamicin (GM), are the most frequently used antibiotics in the world and are proposed to cause irreversible cochlear damage and hearing loss (HL) in 1/4 of the patients receiving these life-saving drugs. Akin to the results of AG ototoxicity studies, high-frequency, basal turn outer hair cells (OHCs) preferentially succumb to multiple HL pathologies while inner hair cells (IHCs) are much more resilient. To determine if endogenous differences in IHC and OHC mitochondrial metabolism dictate differential sensitivities to AG-induced HL, IHC- and OHC-specific changes in mitochondrial reduced nicotinamide adenine dinucleotide (NADH) fluorescence during acute (1 h) GM treatment were compared. GM-mediated decreases in NADH fluorescence and succinate dehydrogenase activity were observed shortly after GM application. High-frequency basal turn OHCs were found to be metabolically biased to rapidly respond to alterations in their microenvironment including GM and elevated glucose exposures. These metabolic biases may predispose high-frequency OHCs to preferentially produce cell-damaging reactive oxygen species during traumatic challenge. Noise-induced and age-related HL pathologies share key characteristics with AG ototoxicity, including preferential OHC loss and reactive oxygen species production. Data from this report highlight the need to address the role of mitochondrial metabolism in regulating AG ototoxicity and the need to illuminate how fundamental differences in IHC and OHC metabolism may dictate differences in HC fate during multiple HL pathologies.	[Jensen-Smith, Heather C.; Hallworth, Richard] Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA; [Nichols, Michael G.] Creighton Univ, Dept Phys, Omaha, NE 68178 USA	Creighton University; Creighton University	Jensen-Smith, HC (corresponding author), Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA.	heathersmith@creighton.edu		Nichols, Michael/0000-0002-6565-6743	NIGM, NIH [R15-GM085776]; National Center for Research Resources [5P20RR016469]; National Institute for General Medical Science (NIGMS), a component of the National Institutes of Health (NIH) [8P20GM103427]; Creighton University Medical School; Nebraska EPSCoR program; National Center for Research Resources, NIH, USA [RR17417-01]; NCRR, NIH [G20 RR024001]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017417, G20RR024001, P20RR016469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103427, R15GM085776, P20GM103471] Funding Source: NIH RePORTER	NIGM, NIH; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute for General Medical Science (NIGMS), a component of the National Institutes of Health (NIH); Creighton University Medical School; Nebraska EPSCoR program; National Center for Research Resources, NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MGN was supported by R15-GM085776 (NIGM, NIH). This publication was also made possible by grants from the National Center for Research Resources (5P20RR016469) and the National Institute for General Medical Science (NIGMS) (8P20GM103427), a component of the National Institutes of Health (NIH). This research was conducted at the Integrated Biomedical Imaging Facility at Creighton University (CUIBIF), Omaha, NE. This facility, supported by the Creighton University Medical School and Nebraska EPSCoR program, is part of a research space that was constructed with support from C06 Grant RR17417-01 from the National Center for Research Resources, NIH, USA. Animal care facilities for this project were supported by G20 RR024001 from the NCRR, NIH. This investigation is solely the responsibility of the author and does not necessarily represent the official views of NIGMS, NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Hachem Ralph N, 2010, Recent Pat CNS Drug Discov, V5, P147; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alharazneh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022347; Banfi B, 2004, J BIOL CHEM, V279, P46065, DOI 10.1074/jbc.M403046200; Bindu LH, 2008, INT J AUDIOL, V47, P702, DOI 10.1080/14992020802215862; Bottger EC, 2010, ANTIMICROB AGENTS CH, V54, P3073, DOI 10.1128/AAC.01819-09; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chen GD, 2000, HEARING RES, V145, P91, DOI 10.1016/S0378-5955(00)00076-9; Cheng AG, 2003, JARO, V4, P91, DOI 10.1007/s10162-002-3016-8; Cunningham LL, 2002, J NEUROSCI, V22, P8532; de Beeck KO, 2011, HEARING RES, V281, P18, DOI 10.1016/j.heares.2011.07.002; Dehne N, 2002, HEARING RES, V169, P47, DOI 10.1016/S0378-5955(02)00338-6; Ding DL, 2010, HEARING RES, V259, P16, DOI 10.1016/j.heares.2009.08.008; Ding DL, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P189, DOI 10.1201/9781420038736.ch13; Ding DL, 1999, ANN NY ACAD SCI, V884, P152, DOI 10.1111/j.1749-6632.1999.tb08640.x; Eguchi Y, 1997, CANCER RES, V57, P1835; Fischel-Ghodsian N, 1999, HUM MUTAT, V13, P261, DOI 10.1002/(SICI)1098-1004(1999)13:4<261::AID-HUMU1>3.0.CO;2-W; Forge A, 2000, HEARING RES, V139, P97, DOI 10.1016/S0378-5955(99)00177-X; Forkink M, 2010, BBA-BIOENERGETICS, V1797, P1034, DOI 10.1016/j.bbabio.2010.01.022; Fredelius L, 2001, ORL J OTO-RHINO-LARY, V63, P12, DOI 10.1159/000055700; Gropper S.S., 2008, CENGAGE LEARNING; Hashino E, 1995, BRAIN RES, V704, P135, DOI 10.1016/0006-8993(95)01198-6; Heikal AA, 2010, BIOMARK MED, V4, P241, DOI 10.2217/BMM.10.1; Hobbie SN, 2008, P NATL ACAD SCI USA, V105, P3244, DOI 10.1073/pnas.0707265105; Hobbie SN, 2008, P NATL ACAD SCI USA, V105, P20888, DOI 10.1073/pnas.0811258106; HORN KL, 1978, ARCH OTOLARYNGOL, V104, P42; Hu BH, 2008, HEARING RES, V236, P11, DOI 10.1016/j.heares.2007.11.002; Huth ME, 2011, INT J OTOLARYNGOL, V2011, DOI DOI 10.1155/2011/937861; Jiang H, 2006, CELL DEATH DIFFER, V13, P20, DOI 10.1038/sj.cdd.4401706; Jiang H, 2006, J NEUROSCI RES, V83, P1544, DOI 10.1002/jnr.20833; Karnes HE, 2010, J AM ACAD AUDIOL, V21, P204, DOI 10.3766/jaaa.21.3.9; Kim HJ, 2010, J NEUROSCI, V30, P3933, DOI 10.1523/JNEUROSCI.6054-09.2010; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Lancaster CRD, 2002, BBA-BIOENERGETICS, V1553, P1, DOI 10.1016/S0005-2728(01)00240-7; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Matsui JI, 2004, J NEUROBIOL, V61, P250, DOI 10.1002/neu.20054; Mayevsky A, 2007, AM J PHYSIOL-CELL PH, V292, pC615, DOI 10.1152/ajpcell.00249.2006; McFadden SL, 2004, BRAIN RES, V997, P40, DOI 10.1016/j.brainres.2003.10.031; Mukherjea D, 2008, J NEUROSCI, V28, P13056, DOI 10.1523/JNEUROSCI.1307-08.2008; Nicotera P, 1998, TOXICOL LETT, V103, P139; Nicotera TM, 2003, JARO-J ASSOC RES OTO, V4, P466, DOI 10.1007/s10162-002-3038-2; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P229, DOI 10.1159/000013846; Pandya A, 1993, NONSYNDROMIC HEARING; Poirrier AL, 2010, CURR MED CHEM, V17, P3591; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Qian YP, 2009, ANTIMICROB AGENTS CH, V53, P4612, DOI 10.1128/AAC.00965-08; Ralph SJ, 2011, PHARM RES-DORDR, V28, P2695, DOI 10.1007/s11095-011-0566-7; Rizzi Mark Douglas, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P352, DOI 10.1097/MOO.0b013e3282ef772d; Rybak LP, 2007, KIDNEY INT, V72, P931, DOI 10.1038/sj.ki.5002434; Rybak Leonard P, 2005, Int Tinnitus J, V11, P23; Rybak LP, 2005, DRUG DISCOV TODAY, V10, P1313, DOI 10.1016/S1359-6446(05)03552-X; Shadel GS, 2004, TRENDS GENET, V20, P513, DOI 10.1016/j.tig.2004.08.005; Shulman A, 1999, ANN NY ACAD SCI, V884, P433, DOI 10.1111/j.1749-6632.1999.tb08660.x; Sokolova IM, 2004, J EXP BIOL, V207, P3369, DOI 10.1242/jeb.01152; Someya S, 2010, MECH AGEING DEV, V131, P480, DOI 10.1016/j.mad.2010.04.006; Tabuchi K, 2011, CURR MED CHEM; Tiede L, 2009, BRAIN RES, V1277, P37, DOI 10.1016/j.brainres.2009.02.052; Tiede LM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2714777; Warchol ME, 2010, CURR OPIN OTOLARYNGO, V18, P454, DOI 10.1097/MOO.0b013e32833e05ec; Wirmer J, 2006, METHOD ENZYMOL, V415, P180, DOI 10.1016/S0076-6879(06)15012-0; Wu WJ, 2002, AUDIOL NEURO-OTOL, V7, P171, DOI 10.1159/000058305; Xie J, 2011, HEARING RES, V281, P28, DOI 10.1016/j.heares.2011.05.008; YANG FS, 1991, EUR ARCH OTO-RHINO-L, V248, P195; Yang WP, 2010, CHINESE MED J-PEKING, V123, P1633, DOI 10.3760/cma.j.issn.0366-6999.2010.13.004; Yorgason JG, 2011, EXPERT OPIN DRUG MET, V7, P1521, DOI 10.1517/17425255.2011.614231; Zhao LD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023729; Ziegler M, 2000, EUR J BIOCHEM, V267, P1550, DOI 10.1046/j.1432-1327.2000.01187.x	68	46	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38471	10.1371/journal.pone.0038471	http://dx.doi.org/10.1371/journal.pone.0038471			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715386	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336800028
J	Menoud, A; Welle, M; Tetens, J; Lichtner, P; Drogemuller, C				Menoud, Annie; Welle, Monika; Tetens, Jens; Lichtner, Peter; Droegemueller, Cord			A COL7A1 Mutation Causes Dystrophic Epidermolysis Bullosa in Rotes Hohenvieh Cattle	PLOS ONE			English	Article							VII COLLAGEN GENE; MECHANOBULLOUS DISEASE; ANIMAL-MODEL; CLASSIFICATION; DIAGNOSIS	We identified a congenital mechanobullous skin disorder in six calves on a single farm of an endangered German cattle breed in 2010. The condition presented as a large loss of skin distal to the fetlocks and at the mucosa of the muzzle. All affected calves were euthanized on humane grounds due to the severity, extent and progression of the skin and oral lesions. Examination of skin samples under light microscopy revealed detachment of the epidermis from the dermis at the level of the dermo epidermal junction, leading to the diagnosis of a subepidermal bullous dermatosis such as epidermolysis bullosa. The pedigree was consistent with monogenic autosomal recessive inheritance. We localized the causative mutation to an 18 Mb interval on chromosome 22 by homozygosity mapping. The COL7A1 gene encoding collagen type VII alpha 1 is located within this interval and COL7A1 mutations have been shown to cause inherited dystrophic epidermolysis bullosa (DEB) in humans. A SNP in the bovine COL7A1 exon 49 (c.4756C>T) was perfectly associated with the observed disease. The homozygous mutant T/T genotype was exclusively present in affected calves and their parents were heterozygous C/T confirming the assumed recessive mode of inheritance. All known cases and genotyped carriers were related to a single cow, which is supposed to be the founder animal. The mutant T allele was absent in 63 animals from 24 cattle breeds. The identified mutation causes a premature stop codon which leads to a truncated protein representing a complete loss of COL7A1 function (p.R1586*). We thus have identified a candidate causative mutation for this genetic disease using only three cases to unravel its molecular basis. Selection against this mutation can now be used to eliminate the mutant allele from the Rotes Hohenvieh breed.	[Menoud, Annie; Droegemueller, Cord] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Welle, Monika] Univ Bern, Vetsuisse Fac, Inst Anim Pathol, Bern, Switzerland; [Tetens, Jens] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany; [Lichtner, Peter] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Human Genet, Neuherberg, Germany; [Welle, Monika; Droegemueller, Cord] Univ Bern, Vetsuisse Fac, DermFocus, Bern, Switzerland	University of Bern; University of Bern; University of Kiel; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bern	Menoud, A (corresponding author), Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland.	cord.droegemueller@vetsuisse.unibe.ch	Welle, Monika Maria/ABF-6113-2021; Tetens, Jens/H-5344-2012	Tetens, Jens/0000-0001-5352-464X; Drogemuller, Cord/0000-0001-9773-522X	H.W. Schaumann Stiftung, Hamburg, Germany	H.W. Schaumann Stiftung, Hamburg, Germany	The project and AM were supported by a grant of the H.W. Schaumann Stiftung, Hamburg, Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr C, 2004, TIERAERZTL PRAX G N, V32, P205; Baldeschi C, 2003, HUM MOL GENET, V12, P1897, DOI 10.1093/hmg/ddg200; BRUCKNERTUDERMAN L, 1991, J INVEST DERMATOL, V96, P452, DOI 10.1111/1523-1747.ep12470130; CHRISTIANO AM, 1993, NAT GENET, V4, P62, DOI 10.1038/ng0593-62; CHRISTIANO AM, 1995, J CLIN INVEST, V95, P1328, DOI 10.1172/JCI117783; Drogemuller C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018931; Fine JD, 2000, J AM ACAD DERMATOL, V42, P1051, DOI 10.1016/S0190-9622(00)90302-5; Fine JD, 2008, J AM ACAD DERMATOL, V58, P931, DOI 10.1016/j.jaad.2008.02.004; Fine JD, 2010, CURR OPIN PEDIATR, V22, P453, DOI 10.1097/MOP.0b013e32833bb74f; Ford CA, 2005, J INVEST DERMATOL, V124, P1170, DOI 10.1111/j.0022-202X.2005.23610.x; Foster AP, 2010, J COMP PATHOL, V142, P336, DOI 10.1016/j.jcpa.2009.10.001; Fritsch A, 2008, J CLIN INVEST, V118, P1669, DOI 10.1172/JCI34292; Guaguere E, 2003, B ACAD VET FRANCE, V157, P47; HOVNANIAN A, 1994, AM J HUM GENET, V55, P289; Kehr C, 2010, ZUCHTUNGSKUNDE, V82, P387; Kern JS, 2009, BRIT J DERMATOL, V161, P1089, DOI 10.1111/j.1365-2133.2009.09333.x; Kern JS, 2006, J INVEST DERMATOL, V126, P1006, DOI 10.1038/sj.jid.5700219; Magnol JP, 2005, B ACAD NAT MED PARIS, V189, P107, DOI 10.1016/S0001-4079(19)33609-X; Medeiros GX, 2012, J VET DIAGN INVEST, V24, P231, DOI 10.1177/1040638711425953; Momke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018943; Olivry T, 1999, VET PATHOL, V36, P616, DOI 10.1354/vp.36-6-616; Palazzi X, 2000, J INVEST DERMATOL, V115, P135, DOI 10.1046/j.1523-1747.2000.00031-5.x; Spirito F, 2002, J INVEST DERMATOL, V119, P684, DOI 10.1046/j.1523-1747.2002.01852.x; THOMPSON KG, 1985, VET PATHOL, V22, P283, DOI 10.1177/030098588502200311; Uitto J, 2004, J INVEST DERMATOL, V123, pXII, DOI 10.1111/j.0022-202X.2004.23333.x	25	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38823	10.1371/journal.pone.0038823	http://dx.doi.org/10.1371/journal.pone.0038823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715415	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336800057
J	Tarnowski, LJ; Kowalec, P; Milewski, M; Jurek, M; Plochocka, D; Fronk, J; Kurlandzka, A				Tarnowski, Leszek J.; Kowalec, Piotr; Milewski, Michal; Jurek, Marta; Plochocka, Danuta; Fronk, Jan; Kurlandzka, Anna			Nuclear Import and Export Signals of Human Cohesins SA1/STAG1 and SA2/STAG2 Expressed in Saccharomyces cerevisiae	PLOS ONE			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; DNA-REPLICATION; MESSENGER-RNA; PROTEIN; COMPLEXES; MEIOSIS; YEAST; IDENTIFICATION; TRANSLOCATION; KARYOPHERINS	Background: Human SA/STAG proteins, homologues of the yeast Irr1/Scc3 cohesin, are the least studied constituents of the sister chromatid cohesion complex crucial for proper chromosome segregation. The two SA paralogues, SA1 and SA2, show some specificity towards the chromosome region they stabilize, and SA2, but not SA1, has been shown to participate in transcriptional regulation as well. The molecular basis of this functional divergence is unknown. Methodology/Principal Findings: In silico analysis indicates numerous putative nuclear localization (NLS) and export (NES) signals in the SA proteins, suggesting the possibility of their nucleocytoplasmic shuttling. We studied the functionality of those putative signals by expressing fluorescently tagged SA1 and SA2 in the yeast Saccharomyces cerevisiae. Only the N-terminal NLS turned out to be functional in SA1. In contrast, the SA2 protein has at least two functional NLS and also two functional NES. Depending on the balance between these opposing signals, SA2 resides in the nucleus or is distributed throughout the cell. Validation of the above conclusions in HeLa cells confirmed that the same N-terminal NLS of SA1 is functional in those cells. In contrast, in SA2 the principal NLS functioning in HeLa cells is different from that identified in yeast and is localized to the C-terminus. Conclusions/Significance: This is the first demonstration of the possibility of non-nuclear localization of an SA protein. The reported difference in the organization between the two SA homologues may also be relevant to their partially divergent functions. The mechanisms determining subcellular localization of cohesins are only partially conserved between yeast and human cells.	[Tarnowski, Leszek J.; Kowalec, Piotr; Plochocka, Danuta; Kurlandzka, Anna] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Kowalec, Piotr; Fronk, Jan] Univ Warsaw, Fac Biol, Inst Biochem, Warsaw, Poland; [Milewski, Michal; Jurek, Marta] Inst Mother & Child Hlth, Dept Med Genet, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw	Tarnowski, LJ (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	ania218@ibb.waw.pl	Milewski, Michal/C-7144-2012; Milewski, Michał/AAK-4243-2021; , Marta/H-4342-2017	Milewski, Michal/0000-0001-7982-2565; Milewski, Michał/0000-0001-7982-2565; Fronk, Jan/0000-0002-6564-4339; , Marta/0000-0003-2550-5745; Kowalec, Piotr/0000-0002-3301-384X; Tarnowski, Leszek/0000-0001-9673-2780; Kurlandzka, Anna/0000-0002-6395-0746	Ministry of Science and Higher Education, Poland [N N303 456838]	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland)	This work was supported by the Ministry of Science and Higher Education, Poland [grant N N303 456838]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Butterfield-Gerson KL, 2006, J VIROL, V80, P1798, DOI 10.1128/JVI.80.4.1798-1806.2006; Canudas S, 2009, J CELL BIOL, V187, P165, DOI 10.1083/jcb.200903096; Carramolino L, 1997, GENE, V195, P151, DOI 10.1016/S0378-1119(97)00121-2; Cena A, 2008, EUR J CELL BIOL, V87, P831, DOI 10.1016/j.ejcb.2008.05.002; Chu CT, 2007, J NEUROPATH EXP NEUR, V66, P873, DOI 10.1097/nen.0b013e318156a3d7; Fabbro M, 2003, EXP CELL RES, V282, P59, DOI 10.1016/S0014-4827(02)00019-8; Feldherr C, 2002, J CELL SCI, V115, P2997; Feng WQ, 1999, J CELL SCI, V112, P339; Ferrer M, 2005, HUM MOL GENET, V14, P1271, DOI 10.1093/hmg/ddi138; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Groner B, 2008, SEMIN CELL DEV BIOL, V19, P341, DOI 10.1016/j.semcdb.2008.06.005; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; HEATH IB, 1980, INT REV CYTOL, V64, P1, DOI 10.1016/S0074-7696(08)60235-1; Henderson BR, 2005, BIOESSAYS, V27, P884, DOI 10.1002/bies.20277; Hirano T, 2005, PHILOS T R SOC B, V360, P507, DOI 10.1098/rstb.2004.1606; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Holzmann J, 2011, J PROTEOME RES, V10, P780, DOI 10.1021/pr100927x; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lara-Pezzi E, 2004, J BIOL CHEM, V279, P6553, DOI 10.1074/jbc.M307663200; Lin WQ, 2011, GENETICS, V187, P1041, DOI 10.1534/genetics.110.122358; Losada A, 2007, CHROMOSOMA, V116, P321, DOI 10.1007/s00412-007-0104-x; Mager WH, 2005, TRENDS PHARMACOL SCI, V26, P265, DOI 10.1016/j.tips.2005.03.004; McNairn AJ, 2009, CHROMOSOME RES, V17, P155, DOI 10.1007/s10577-008-9007-9; MORELAND RB, 1987, MOL CELL BIOL, V7, P4048, DOI 10.1128/MCB.7.11.4048; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Mosammaparast N, 2002, EMBO J, V21, P6527, DOI 10.1093/emboj/cdf647; Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251; Neville M, 1999, EMBO J, V18, P3746, DOI 10.1093/emboj/18.13.3746; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; Prieto I, 2002, EMBO REP, V3, P543, DOI 10.1093/embo-reports/kvf108; Prieto I, 2001, NAT CELL BIOL, V3, P761, DOI 10.1038/35087082; Sazer S, 2005, CURR BIOL, V15, pR23, DOI 10.1016/j.cub.2004.12.015; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Suja J. A., 2009, V5, P94, DOI 10.1159/000166622; Sun YX, 2006, CELL CYCLE, V5, P2537, DOI 10.4161/cc.5.21.3407; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Waterham HR, 2007, METHOD MICROBIOL, V36, P577, DOI 10.1016/S0580-9517(06)36023-0; Weis K, 1998, TRENDS BIOCHEM SCI, V23, P185, DOI 10.1016/S0968-0004(98)01204-3; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Xiao TJ, 2011, MOL CELL BIOL, V31, P2174, DOI 10.1128/MCB.05093-11; Zhang NG, 2008, J CELL BIOL, V183, P1019, DOI 10.1083/jcb.200801157	58	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38740	10.1371/journal.pone.0038740	http://dx.doi.org/10.1371/journal.pone.0038740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715410	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336800052
J	Bendlin, BB; Carlsson, CM; Johnson, SC; Zetterberg, H; Blennow, K; Willette, AA; Okonkwo, OC; Sodhi, A; Ries, ML; Birdsill, AC; Alexander, AL; Rowley, HA; Puglielli, L; Asthana, S; Sager, MA				Bendlin, Barbara B.; Carlsson, Cynthia M.; Johnson, Sterling C.; Zetterberg, Henrik; Blennow, Kaj; Willette, Auriel A.; Okonkwo, Ozioma C.; Sodhi, Aparna; Ries, Michele L.; Birdsill, Alex C.; Alexander, Andrew L.; Rowley, Howard A.; Puglielli, Luigi; Asthana, Sanjay; Sager, Mark A.			CSF T-Tau/A beta(42) Predicts White Matter Microstructure in Healthy Adults at Risk for Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID BIOMARKERS; CORPUS-CALLOSUM ATROPHY; BRAIN ATROPHY; IN-VIVO; NEUROFILAMENT PROTEIN; PHOSPHORYLATED-TAU; MYELIN BREAKDOWN; TAU/BETA-AMYLOID(42) RATIO; AXONAL DEGENERATION	Cerebrospinal fluid (CSF) biomarkers T-Tau and A beta(42) are linked with Alzheimer's disease (AD), yet little is known about the relationship between CSF biomarkers and structural brain alteration in healthy adults. In this study we examined the extent to which AD biomarkers measured in CSF predict brain microstructure indexed by diffusion tensor imaging (DTI) and volume indexed by T1-weighted imaging. Forty-three middle-aged adults with parental family history of AD received baseline lumbar puncture and MRI approximately 3.5 years later. Voxel-wise image analysis methods were used to test whether baseline CSF A beta(42), total tau (T-Tau), phosphorylated tau (P-Tau) and neurofilament light protein predicted brain microstructure as indexed by DTI and gray matter volume indexed by T1-weighted imaging. T-Tau and T-Tau/A beta(42) were widely correlated with indices of brain microstructure (mean, axial, and radial diffusivity), notably in white matter regions adjacent to gray matter structures affected in the earliest stages of AD. None of the CSF biomarkers were related to gray matter volume. Elevated P-Tau and P-Tau/A beta(42) levels were associated with lower recognition performance on the Rey Auditory Verbal Learning Test. Overall, the results suggest that CSF biomarkers are related to brain microstructure in healthy adults with elevated risk of developing AD. Furthermore, the results clearly suggest that early pathological changes in AD can be detected with DTI and occur not only in cortex, but also in white matter.	[Bendlin, Barbara B.; Carlsson, Cynthia M.; Johnson, Sterling C.; Willette, Auriel A.; Okonkwo, Ozioma C.; Sodhi, Aparna; Ries, Michele L.; Birdsill, Alex C.; Puglielli, Luigi; Asthana, Sanjay; Sager, Mark A.] William S Middleton Mem Vet Adm Med Ctr, GRECC, Madison, WI USA; [Bendlin, Barbara B.; Carlsson, Cynthia M.; Johnson, Sterling C.; Willette, Auriel A.; Okonkwo, Ozioma C.; Sodhi, Aparna; Ries, Michele L.; Birdsill, Alex C.; Puglielli, Luigi; Asthana, Sanjay; Sager, Mark A.] Univ Wisconsin, Dept Med, Wisconsin Alzheimers Dis Res Ctr, Madison, WI USA; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Gothenburg, Sweden; [Alexander, Andrew L.] Univ Wisconsin, Dept Med Phys, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Alexander, Andrew L.] Univ Wisconsin, Dept Psychiat, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Alexander, Andrew L.] Waisman Lab Brain Imaging & Behav, Madison, WI USA; [Rowley, Howard A.] Univ Wisconsin, Dept Radiol, Sch Med & Publ Hlth, Madison, WI 53706 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison; University of Gothenburg; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bendlin, BB (corresponding author), William S Middleton Mem Vet Adm Med Ctr, GRECC, Madison, WI USA.	bbb@medicine.wisc.edu	Willette, Auriel/J-2143-2019	Willette, Auriel/0000-0001-5131-8199; Bendlin, Barbara/0000-0002-0580-9875; Birdsill, Alex/0000-0002-3778-9645	National Institute on Aging [R01 AG027161, K23 AG026752, ADRC P50 AG033514]; University of Wisconsin Institute for Clinical and Translational Research; National Center for Research Resources/National Institutes of Health Clinical and Translational Science Award [1UL1RR025011]; program of the National Center for Research Resources, United States National Institutes of Health; Swedish Research Council; Pfizer Inc.; Innogenetics; Vastra Gotalandsregionen, Sweden; Swedish Brain Power Project; Swedish Council for Working Life and Social Research; Swedish Alzheimer Foundation; Stiftelsen for Gamla Tjanarinnor; King Gustaf V and Queen Victoria Foundation; Alzheimer's Association; Royal Swedish Academy of Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027161, R01AG021155, P50AG033514, R01AG037639, K23AG026752] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Wisconsin Institute for Clinical and Translational Research; National Center for Research Resources/National Institutes of Health Clinical and Translational Science Award; program of the National Center for Research Resources, United States National Institutes of Health; Swedish Research Council(Swedish Research CouncilEuropean Commission); Pfizer Inc.(Pfizer); Innogenetics; Vastra Gotalandsregionen, Sweden; Swedish Brain Power Project; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Alzheimer Foundation; Stiftelsen for Gamla Tjanarinnor; King Gustaf V and Queen Victoria Foundation; Alzheimer's Association(Alzheimer's Association); Royal Swedish Academy of Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported in part by the National Institute on Aging (R01 AG027161 [MAS], K23 AG026752 [CMC]; ADRC P50 AG033514 [SA]), the University of Wisconsin Institute for Clinical and Translational Research, funded through a National Center for Research Resources/National Institutes of Health Clinical and Translational Science Award, 1UL1RR025011, a program of the National Center for Research Resources, United States National Institutes of Health, and the Swedish Research Council. The project was also facilitated by the facilities and resources at the Geriatric Research, Education, and Clinical Center (GRECC) of the William S. Middleton Memorial Veterans Hospital, Madison, WI. GRECC MS # 2011-19. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Blennow has served on scientific advisory boards for Adlyfe Inc., Bayer Schering Pharma, Bristol-Myers Squibb, and Merz Pharmaceuticals GmbH; received a speaker honorarium from Pfizer Inc.; serves as a consultant for Wyeth, AstraZeneca, Bristol-Myers Squibb, and Eli Lilly and Company; and has received research support from Pfizer Inc., Innogenetics, the Swedish Research Council, Vastra Gotalandsregionen, Sweden, the Swedish Brain Power Project, the Swedish Council for Working Life and Social Research, the Swedish Alzheimer Foundation, Stiftelsen for Gamla Tjanarinnor, and the King Gustaf V and Queen Victoria Foundation. Dr. Zetterberg has served on a scientific advisory board for GlaxoSmithKline; serves as an Associate Editor for the Journal of Alzheimer's Disease; and receives research support from the Swedish Research Council, the Alzheimer's Association, and the Royal Swedish Academy of Sciences. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Andersson C, 2007, DEMENT GERIATR COGN, V23, P87, DOI 10.1159/000097354; Andreasen N, 2001, J NEUROL NEUROSUR PS, V71, P557, DOI 10.1136/jnnp.71.4.557; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Balthazar MLF, 2009, EUR J NEUROL, V16, P468, DOI 10.1111/j.1468-1331.2008.02408.x; Bartzokis G, 2004, NEUROBIOL AGING, V25, P843, DOI 10.1016/j.neurobiolaging.2003.09.005; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Bartzokis G, 2007, BIOL PSYCHIAT, V62, P1380, DOI 10.1016/j.biopsych.2007.03.024; Bartzokis G, 2007, NEUROCHEM RES, V32, P1655, DOI 10.1007/s11064-007-9352-7; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Baxter LC, 2006, J ALZHEIMERS DIS, V9, P253; Bendlin BB, 2010, DEV NEUROPSYCHOL, V35, P257, DOI 10.1080/87565641003696775; Bendlin BB, 2010, ALZHEIMERS DEMENT, V6, P394, DOI 10.1016/j.jalz.2009.11.003; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benton AL, 1983, MULTILINGUAL APHASIA; Bozzali M, 2002, J NEUROL NEUROSUR PS, V72, P742, DOI 10.1136/jnnp.72.6.742; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Bronge L, 2002, DEMENT GERIATR COGN, V13, P205, DOI 10.1159/000057698; Budde MD, 2007, NMR BIOMED; Buerger K, 2007, BRAIN, V130, DOI 10.1093/brain/awm140; Canu E, 2009, J ALZHEIMERS DIS; Carlsson CM, 2010, ALZHEIMERS DEMENT S, V6, pS151; Carlsson CM, 2008, J ALZHEIMERS DIS, V13, P187; Chaim TM, 2007, PSYCHIAT RES-NEUROIM, V154, P59, DOI 10.1016/j.pscychresns.2006.04.003; Cho H, 2008, J KOREAN MED SCI, V23, P477, DOI 10.3346/jkms.2008.23.3.477; Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; DELAMONTE SM, 1989, ANN NEUROL, V25, P450, DOI 10.1002/ana.410250506; Desai MK, 2011, GLIA, V59, P627, DOI 10.1002/glia.21131; Desai MK, 2009, GLIA, V57, P54, DOI 10.1002/glia.20734; Desikan RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012853; Duan JH, 2006, SURG RADIOL ANAT, V28, P150, DOI 10.1007/s00276-006-0111-2; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fagan AM, 2009, ANN NEUROL, V65, P176, DOI 10.1002/ana.21559; Fellgiebel A, 2005, NEUROBIOL AGING, V26, P1193, DOI 10.1016/j.neurobiolaging.2004.11.006; Fellgiebel A, 2004, DEMENT GERIATR COGN, V18, P101, DOI 10.1159/000077817; Fellgiebel A, 2008, NEUROPSYCHOLOGIA, V46, P1698, DOI 10.1016/j.neuropsychologia.2007.12.010; Fjell AM, 2010, CEREB CORTEX, V20, P2069, DOI 10.1093/cercor/bhp279; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRIEDE RL, 1970, ANAT REC, V167, P379, DOI 10.1002/ar.1091670402; Galasko D, 1998, ARCH NEUROL-CHICAGO, V55, P937, DOI 10.1001/archneur.55.7.937; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Glodzik L, 2011, NEUROBIOL AGING; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Hampel H, 2004, MOL PSYCHIATR, V9, P705, DOI 10.1038/sj.mp.4001473; Hansson O, 2007, DEMENT GERIATR COGN, V23, P316, DOI 10.1159/000100926; Hanyu H, 1999, J NEUROL SCI, V167, P37, DOI 10.1016/S0022-510X(99)00135-5; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Herukka SK, 2008, J ALZHEIMERS DIS, V14, P51; Herukka SK, 2005, NEUROLOGY, V64, P1294, DOI 10.1212/01.WNL.0000156914.16988.56; Higuchi M, 2002, NEURON, V35, P433, DOI 10.1016/S0896-6273(02)00789-4; Hofling AA, 2009, NMR BIOMED; Hu YY, 2002, NEUROSCI LETT, V320, P156, DOI 10.1016/S0304-3940(02)00047-2; Huang J, 2007, AM J NEURORADIOL, V28, P1943, DOI 10.3174/ajnr.A0700; Im K, 2008, NEUROIMAGE, V43, P103, DOI 10.1016/j.neuroimage.2008.07.016; IWATSUBO T, 1994, ACTA NEUROPATHOL, V88, P129; Kantarci K, 2001, RADIOLOGY, V219, P101, DOI 10.1148/radiology.219.1.r01ap14101; Kester MI, 2009, J ALZHEIMERS DIS, V16, P601, DOI 10.3233/JAD-2009-0999; Li S, 2008, ACTA RADIOL, V49, P84, DOI 10.1080/02841850701627181; Lin WL, 2003, AM J PATHOL, V162, P213, DOI 10.1016/S0002-9440(10)63812-6; Lovblad KO, 2004, NEURORADIOLOGY, V46, P282, DOI 10.1007/s00234-004-1183-5; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; Menzler K, 2011, NEUROIMAGE, V54, P2557, DOI 10.1016/j.neuroimage.2010.11.029; Mielke MM, 2009, NEUROIMAGE, V46, P47, DOI 10.1016/j.neuroimage.2009.01.054; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Nierenberg J, 2005, NEUROREPORT, V16, P1369, DOI 10.1097/01.wnr.0000174058.49521.16; NISHIMURA M, 1995, AM J PATHOL, V146, P1052; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; Olsson A, 2005, CLIN CHEM, V51, P336, DOI 10.1373/clinchem.2004.039347; Olsson B, 2011, PROG NEUROBIOL; Ott BR, 2010, J ALZHEIMERS DIS, V20, P647, DOI 10.3233/JAD-2010-1406; Persson J, 2006, NEUROLOGY, V66, P1029, DOI 10.1212/01.wnl.0000204180.25361.48; Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6; Reitan R.M., 1993, HALSTEAD REITAN NEUR; Rey A, 1964, LEXAMEN CLINIQUE PSY; Richter-Landsberg C, 2008, J MOL NEUROSCI, V35, P55, DOI 10.1007/s12031-007-9017-7; Roher AE, 2002, BIOCHEMISTRY-US, V41, P11080, DOI 10.1021/bi026173d; Rose SE, 2006, J NEUROL NEUROSUR PS, V77, P1122, DOI 10.1136/jnnp.2005.074336; Rose SE, 2008, J MAGN RESON IMAGING, V27, P20, DOI 10.1002/jmri.21231; Rosengren LE, 1999, NEUROLOGY, V52, P1090, DOI 10.1212/WNL.52.5.1090; Rosengren LE, 1996, J NEUROCHEM, V67, P2013, DOI 10.1046/j.1471-4159.1996.67052013.x; Ryan L, 2011, NEUROIMAGE, V54, P1565, DOI 10.1016/j.neuroimage.2010.08.052; Sager MA, 2005, J GERIATR PSYCH NEUR, V18, P245, DOI 10.1177/0891988705281882; Salat DH, 2009, NEUROIMAGE, V44, P1247, DOI 10.1016/j.neuroimage.2008.10.030; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Salat DH, 2008, NEUROBIOL AGING; SCHELTENS P, 1995, NEUROLOGY, V45, P883, DOI 10.1212/WNL.45.5.883; Schott JM, 2010, ANN NEUROL, V68, P825, DOI 10.1002/ana.22315; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sjogren M, 2001, J NEUROSCI RES, V66, P510, DOI 10.1002/jnr.1242; Smach MA, 2009, EUR NEUROL, V62, P349, DOI 10.1159/000241881; Smith CD, 2010, NEUROBIOL AGING, V31, P1122, DOI 10.1016/j.neurobiolaging.2008.08.006; Sole-Padulles C, 2011, PSYCHIAT RES-NEUROIM, V192, P140, DOI 10.1016/j.pscychresns.2010.12.001; Song F, 2009, J MAGN RESON IMAGING, V30, P277, DOI 10.1002/jmri.21825; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Stahl R, 2007, RADIOLOGY, V243, P483, DOI 10.1148/radiol.2432051714; Stenset V, 2009, NEUROBIOL AGING; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Stomrud E, 2010, ARCH NEUROL-CHICAGO, V67, P217, DOI 10.1001/archneurol.2009.316; Stout JC, 1996, ARCH NEUROL-CHICAGO, V53, P742, DOI 10.1001/archneur.1996.00550080056013; Stricker NH, 2009, NEUROIMAGE, V45, P10, DOI 10.1016/j.neuroimage.2008.11.027; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Sunderland T, 2003, JAMA-J AM MED ASSOC, V289, P2094, DOI 10.1001/jama.289.16.2094; Sunderland T, 2004, BIOL PSYCHIAT, V56, P670, DOI 10.1016/j.biopsych.2004.07.021; Takahashi S, 2002, NEUROSCI LETT, V332, P45, DOI 10.1016/S0304-3940(02)00914-X; Tapiola T, 2009, ARCH NEUROL-CHICAGO, V66, P382, DOI 10.1001/archneurol.2008.596; Teipel SJ, 1998, NEUROLOGY, V51, P1381, DOI 10.1212/WNL.51.5.1381; Teipel SJ, 2002, ARCH NEUROL-CHICAGO, V59, P243, DOI 10.1001/archneur.59.2.243; Terry RD, 1998, J NEURAL TRANSM-SUPP, P141; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Umahara T, 2002, NEUROPATHOLOGY, V22, P9, DOI 10.1046/j.0919-6544.2002.00422.x; VANDERMEEREN M, 1993, J NEUROCHEM, V61, P1828, DOI 10.1111/j.1471-4159.1993.tb09823.x; VERMERSCH P, 1994, EUR NEUROL, V34, P83; Wang PJ, 2006, NEUROBIOL AGING, V27, P1613, DOI 10.1016/j.neurobiolaging.2005.09.035; Wechsler D., 1997, WECHSLER ADULT INTEL; Wu QZ, 2007, NEUROIMAGE, V37, P1138, DOI 10.1016/j.neuroimage.2007.06.029; Xie S, 2006, NEUROLOGY, V66, P1845, DOI 10.1212/01.wnl.0000219625.77625.aa; Xiong CJ, 2011, ARCH NEUROL-CHICAGO, V68, P1313, DOI 10.1001/archneurol.2011.208	123	71	71	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e37720	10.1371/journal.pone.0037720	http://dx.doi.org/10.1371/journal.pone.0037720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701578	Green Published, Green Submitted, gold			2022-12-25	WOS:000305348400018
J	Munoz, RC; Zgliczynski, BJ; Laughlin, JL; Teer, BZ				Munoz, Roldan C.; Zgliczynski, Brian J.; Laughlin, Joseph L.; Teer, Bradford Z.			Extraordinary Aggressive Behavior from the Giant Coral Reef Fish, Bolbometopon muricatum, in a Remote Marine Reserve	PLOS ONE			English	Article							SPAWNING BEHAVIOR; KNOWLEDGE; IMPACTS; SIZE	Human impacts to terrestrial and marine communities are widespread and typically begin with the local extirpation of large-bodied animals. In the marine environment, few pristine areas relatively free of human impact remain to provide baselines of ecosystem function and goals for restoration efforts. Recent comparisons of remote and/or protected coral reefs versus impacted sites suggest remote systems are dominated by apex predators, yet in these systems the ecological role of nonpredatory, large-bodied, highly vulnerable species such as the giant bumphead parrotfish (Bolbometopon muricatum) has received less attention. Overfishing of Bolbometopon has lead to precipitous declines in population density and avoidance of humans throughout its range, contributing to its status as a candidate species under the U. S. Endangered Species Act and limiting opportunities to study unexploited populations. Here we show that extraordinary ecological processes, such as violent headbutting contests by the world's largest parrotfish, can be revealed by studying unexploited ecosystems, such as the coral reefs of Wake Atoll where we studied an abundant population of Bolbometopon. Bolbometopon is among the largest of coral reef fishes and is a well known, charismatic species, yet to our knowledge, no scientific documentation of ritualized headbutting exists for marine fishes. Our observations of aggressive headbutting by Bolbometopon underscore that remote locations and marine reserves, by inhibiting negative responses to human observers and by allowing the persistence of historical conditions, can provide valuable opportunities to study ecosystems in their natural state, thereby facilitating the discovery, conservation, and interpretation of a range of sometimes remarkable behavioral and ecological processes.	[Munoz, Roldan C.; Teer, Bradford Z.] NOAA, Natl Marine Fisheries Serv, Beaufort Lab, Beaufort, NC USA; [Zgliczynski, Brian J.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Laughlin, Joseph L.] Mariculture Hawaii LLC, Ashland, OR USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California San Diego; Scripps Institution of Oceanography	Munoz, RC (corresponding author), NOAA, Natl Marine Fisheries Serv, Beaufort Lab, Beaufort, NC USA.	roldan.munoz@noaa.gov			NOAA Proactive Species Conservation Program	NOAA Proactive Species Conservation Program	Support was provided by the NOAA Proactive Species Conservation Program to RCM and BJZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, SO SUDAN ODYSSEY DIV; Aswani S, 2004, ENVIRON CONSERV, V31, P69, DOI 10.1017/S037689290400116X; Bellwood DR, 2011, CORAL REEFS, V30, P549, DOI 10.1007/s00338-011-0738-2; Bellwood DR, 2012, P ROY SOC B-BIOL SCI, V279, P1621, DOI 10.1098/rspb.2011.1906; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Choat J. Howard, 2002, P57; CLUTTONBROCK TH, 1979, BEHAVIOUR, V69, P145, DOI 10.1163/156853979X00449; Colin PL, 2012, FISH FISH SER, V35, P285, DOI 10.1007/978-94-007-1980-4_9; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Domeier ML, 2012, FISH FISH SER, V35, P1, DOI 10.1007/978-94-007-1980-4_1; Donaldson TJ, 2004, ENVIRON BIOL FISH, V70, P373, DOI 10.1023/B:EBFI.0000035509.89614.1e; Dulvy NK, 2004, ANIM CONSERV, V7, P365, DOI 10.1017/S1367943004001519; GLADSTONE W, 1986, JPN J ICHTHYOL, V33, P326, DOI 10.1007/BF02904171; Hamilton R, 2010, NO BOUGAINVILLE MARI; Hamilton RJ, 2008, CORAL REEFS, V27, P153, DOI 10.1007/s00338-007-0304-0; Hamilton RJ, 2012, FISH FISHERIES SERIE, P490; Hamilton RJ, 2004, THESIS U OTAGO NEW Z; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Johannes R.E., 1981, WORDS LAGOON FISHING; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Kortet R, 2004, ETHOLOGY, V110, P591, DOI 10.1111/j.1439-0310.2004.01002.x; Lammers MO, 2008, J ACOUST SOC AM, V123, P1720, DOI 10.1121/1.2836780; Lobel Phillip S., 2004, Pacific Science, V58, P65, DOI 10.1353/psc.2004.0007; Lobel Phillip S., 2008, V1, P655, DOI 10.1007/978-1-4020-6847-8_17; Lusseau D, 2003, J EVOLUTION BIOL, V16, P531, DOI 10.1046/j.1420-9101.2003.00541.x; Miranda A, 2005, J EXP BIOL, V208, P2037, DOI 10.1242/jeb.01584; Morrison JC, 2007, J MAMMAL, V88, P1363, DOI 10.1644/06-MAMM-A-124R2.1; Munoz RC, 2010, B MAR SCI, V86, P93; Myers RF, 1999, MICRONESIAN REEF FIS, V3rd; Nanami A, 2008, MAR BIOL, V153, P1103, DOI 10.1007/s00227-007-0882-y; Phillips CT, 2011, SOUTHWEST NAT, V56, P108, DOI 10.1894/RJE-07.1; Richards BL, 2011, B MAR SCI, V87, P55, DOI 10.5343/bms.2010.1019; Roberts C.M., 1991, Reviews in Fish Biology and Fisheries, V1, P65, DOI 10.1007/BF00042662; Sadovy Y., 2007, W PACIFIC FISHERY SU, V3; Suzuki S, 2008, J ETHOL, V26, P397, DOI 10.1007/s10164-008-0102-3; Terleph TA, 2004, J FISH BIOL, V64, P1373, DOI 10.1111/j.0022-1112.2004.00401.x; WARNER RR, 1980, EVOLUTION, V34, P508, DOI 10.1111/j.1558-5646.1980.tb04840.x; Warner RR., 1978, SMITHSON CONTRIB ZOO, V254, P1, DOI [10.5479/si.00810282.254, DOI 10.5479/SI.00810282.254]; Westneat MW, 2005, MOL PHYLOGENET EVOL, V36, P370, DOI 10.1016/j.ympev.2005.02.001; Zgliczynski BJ, DISTRIBUTIO IN PRESS	40	7	8	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38120	10.1371/journal.pone.0038120	http://dx.doi.org/10.1371/journal.pone.0038120			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701606	gold, Green Submitted, Green Published			2022-12-25	WOS:000305348400036
J	Chaudhury, S; Perelson, AS; Sinitstyn, NA				Chaudhury, Srabanti; Perelson, Alan S.; Sinitstyn, Nikolai A.			Spontaneous Clearance of Viral Infections by Mesoscopic Fluctuations	PLOS ONE			English	Article							C VIRUS-INFECTION; HIV-1 POPULATION-DYNAMICS; HEPATITIS-B-VIRUS; IN-VIVO; THERAPY; VIREMIA; CHIMPANZEES; INTERFERON; EFFICACY	Spontaneous disease extinction can occur due to a rare stochastic fluctuation. We explore this process, both numerically and theoretically, in two minimal models of stochastic viral infection dynamics. We propose a method that reduces the complexity in models of viral infections so that the remaining dynamics can be studied by previously developed techniques for analyzing epidemiological models. Using this technique, we obtain an expression for the infection clearance time as a function of kinetic parameters. We apply our theoretical results to study stochastic infection clearance for specific stages of HIV and HCV dynamics. Our results show that the typical time for stochastic clearance of a viral infection increases exponentially with the size of the population, but infection still can be cleared spontaneously within a reasonable time interval in a certain population of cells. We also show that the clearance time is exponentially sensitive to the viral decay rate and viral infectivity but only linearly dependent on the lifetime of an infected cell. This suggests that if standard drug therapy fails to clear an infection then intensifying therapy by adding a drug that reduces the rate of cell infection rather than immune modulators that hasten infected cell death may be more useful in ultimately clearing remaining pockets of infection.	[Chaudhury, Srabanti; Sinitstyn, Nikolai A.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; [Chaudhury, Srabanti; Sinitstyn, Nikolai A.] New Mexico Consortium, Los Alamos, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Chaudhury, S (corresponding author), Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA.	c.srabanti@gmail.com	Perelson, Alan S/Z-1959-2019	Perelson, Alan S/0000-0002-2455-0002	National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [P20-RR018754]; National Nuclear Security Administration of the U.S. Department of Energy at Los Alamos National Laboratory [DE-AC52-06NA25396]; NIH [R37-AI028433, R01-RR006555]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR006555, P20RR018754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI028433, R01AI028433] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011095] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Nuclear Security Administration of the U.S. Department of Energy at Los Alamos National Laboratory(National Nuclear Security Administration); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The project was supported by grant number P20-RR018754 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH). The work at LANL was carried out under the auspices of the National Nuclear Security Administration of the U.S. Department of Energy at Los Alamos National Laboratory under contract no. DE-AC52-06NA25396 and partially supported by NIH grants R37-AI028433 and R01-RR006555. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assaf M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.248102; Assaf M, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021116; Barnes E, 2002, VIRAL IMMUNOL, V15, P285, DOI 10.1089/08828240260066233; Bartlett MS., 1960, STOCHASTIC POPULATIO; Chen HY, 2007, P NATL ACAD SCI USA, V104, P19079, DOI 10.1073/pnas.0707449104; Cohen J, 2011, SCIENCE, V334, P1614, DOI 10.1126/science.334.6063.1614; Dahari H, 2007, J THEOR BIOL, V247, P371, DOI 10.1016/j.jtbi.2007.03.006; Elgart V, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041106; Forgoston E, 2011, B MATH BIOL, V73, P495, DOI 10.1007/s11538-010-9537-0; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Glynn SA, 2005, TRANSFUSION, V45, P994, DOI 10.1111/j.1537-2995.2005.04390.x; Guedj J, 2011, HEPATOLOGY, V53, P1801, DOI 10.1002/hep.24272; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Herrmann E, 2003, HEPATOLOGY, V37, P1351, DOI 10.1053/jhep.2003.50218; Jordan AN, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.260604; Kamenev A, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061107; Kamina A, 2001, MATH BIOSCI, V170, P187, DOI 10.1016/S0025-5564(00)00069-9; Kepler TB, 1998, P NATL ACAD SCI USA, V95, P11514, DOI 10.1073/pnas.95.20.11514; Khasin M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.068101; LEMON SM, 2007, FIELDS VIROLOGY, P1253; Li QS, 2009, SCIENCE, V323, P1726, DOI 10.1126/science.1168676; Liang YQ, 2009, GASTROENTEROLOGY, V137, P1448, DOI 10.1053/j.gastro.2009.07.050; Maheshwari A, 2008, LANCET, V372, P321, DOI 10.1016/S0140-6736(08)61116-2; Meyer MF, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-58; Murray JM, 2005, P NATL ACAD SCI USA, V102, P17780, DOI 10.1073/pnas.0508913102; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Nowak M. A., 2000, VIRUS DYNAMICS MATH; Pearson JE, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001058; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10; Rodriguez-Inigo E, 2005, J MOL DIAGN, V7, P535, DOI 10.1016/S1525-1578(10)60585-5; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Rong LB, 2009, J THEOR BIOL, V260, P308, DOI 10.1016/j.jtbi.2009.06.011; Sinitsyn NA, 2009, P NATL ACAD SCI USA, V106, P10546, DOI 10.1073/pnas.0809340106; Stafford MA, 2000, J THEOR BIOL, V203, P285, DOI 10.1006/jtbi.2000.1076; Tan WY, 1998, MATH BIOSCI, V147, P173, DOI 10.1016/S0025-5564(97)00094-1; Thomson M, 2003, J VIROL, V77, P862, DOI 10.1128/JVI.77.2.862-870.2003; Tuckwell HC, 1998, J THEOR BIOL, V195, P451, DOI 10.1006/jtbi.1998.0806; Veerapu NS, 2011, GASTROENTEROLOGY, V140, P676, DOI 10.1053/j.gastro.2010.10.048	42	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38549	10.1371/journal.pone.0038549	http://dx.doi.org/10.1371/journal.pone.0038549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693646	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343900058
J	Klein, K; Aeschlimann, A; Jordan, S; Gay, R; Gay, S; Sprott, H				Klein, Kerstin; Aeschlimann, Andre; Jordan, Suzana; Gay, Renate; Gay, Steffen; Sprott, Haiko			ATP Induced Brain-Derived Neurotrophic Factor Expression and Release from Osteoarthritis Synovial Fibroblasts Is Mediated by Purinergic Receptor P2X4	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; FACTOR MESSENGER-RNA; RHEUMATOID-ARTHRITIS; NEUROPATHIC PAIN; SPINAL MICROGLIA; KNEE-JOINT; IN-VITRO; BDNF; CELLS; RAT	Brain-derived neurotrophic factor (BDNF), a neuromodulator involved in nociceptive hypersensitivity in the central nervous system, is also expressed in synoviocytes of osteoarthritis (OA) and rheumatoid arthritis (RA) patients. We investigated the role of P2 purinoreceptors in the induction of BDNF expression in synovial fibroblasts (SF) of OA and RA patients. Cultured SF from patients with symptomatic knee OA and RA were stimulated with purinoreceptor agonists ATP, ADP, or UTP. The expression of BDNF mRNA was measured by quantitative TaqMan PCR. BDNF release into cell culture supernatants was monitored by ELISA. P2X4 expression in synovial tissue was detected by immunohistochemistry. Endogenous P2X4 expression was decreased by siRNA transfection before ATP stimulation. Kinase pathways were blocked before ATP stimulation. BDNF mRNA expression levels in OASF were increased 2 h and 5 h after ATP stimulation. Mean BDNF levels in cell culture supernatants of unstimulated OASF and RASF were 19 (+/- 9) and 67 (+/- 49) pg/ml, respectively. BDNF levels in SF supernatants were only elevated 5 h after ATP stimulation. BDNF mRNA expression in OASF was induced both by P2X receptor agonists ATP and ADP, but not by UTP, an agonist of P2Y purinergic receptors. The ATP-induced BDNF mRNA expression in OASF was decreased by siRNA-mediated reduction of endogenous P2X4 levels compared to scrambled controls. Inhibition of p38, but not p44/42 signalling reduced the ATP-mediated BDNF mRNA induction. Here we show a functional role of the purinergic receptor P2X4 and p38 kinase in the ATP-induced expression and release of the neurotrophin BDNF in SF.	[Klein, Kerstin; Jordan, Suzana; Gay, Renate; Gay, Steffen; Sprott, Haiko] Univ Zurich Hosp, Ctr Expt Rheumatol, Div Rheumatol, CH-8091 Zurich, Switzerland; [Klein, Kerstin; Jordan, Suzana; Gay, Renate; Gay, Steffen; Sprott, Haiko] Univ Zurich Hosp, Inst Med Phys, CH-8091 Zurich, Switzerland; [Klein, Kerstin; Jordan, Suzana; Gay, Renate; Gay, Steffen; Sprott, Haiko] Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Aeschlimann, Andre] RehaClinic, Bad Zurzach, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Klein, K (corresponding author), Univ Zurich Hosp, Ctr Expt Rheumatol, Div Rheumatol, CH-8091 Zurich, Switzerland.	haiko.sprott@painclinic.eu	Distler, Oliver/AAE-6225-2019	Distler, Oliver/0000-0002-0546-8310; Klein, Kerstin/0000-0001-5303-8027; Jordan, Suzana/0000-0002-8114-8239	Swiss National Science Foundation [3200B0_119892]; Zurzach Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Zurzach Foundation	This work was supported by the Swiss National Science Foundation (Project 3200B0_119892) and the Zurzach Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bai O, 2003, J NEUROSCI RES, V71, P127, DOI 10.1002/jnr.10440; Barthel C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2716; Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491; Caporali F, 2008, J MOL MED, V86, P937, DOI 10.1007/s00109-008-0365-8; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Delafoy L, 2006, GUT, V55, P940, DOI 10.1136/gut.2005.064063; Dowd E, 1998, BRIT J PHARMACOL, V125, P341, DOI 10.1038/sj.bjp.0702080; Forsgren S, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2754; Fukuoka T, 2001, J NEUROSCI, V21, P4891, DOI 10.1523/JNEUROSCI.21-13-04891.2001; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Grimsholm O, 2008, CLIN RHEUMATOL, V27, P1289, DOI 10.1007/s10067-008-0910-4; Grimsholm O, 2008, CELLS TISSUES ORGANS, V188, P299, DOI 10.1159/000121432; Gunosewoyo H, 2010, EXPERT OPIN THER PAT, V20, P625, DOI 10.1517/13543771003702424; Hatami H, 2007, NEUROPEPTIDES, V41, P321, DOI 10.1016/j.npep.2007.04.007; Heberlein A, 2010, PSYCHOPHARMACOLOGY, V209, P213, DOI 10.1007/s00213-010-1781-3; Hellweg R, 2008, PHARMACOPSYCHIATRY, V41, P66, DOI 10.1055/s-2007-1004594; Hutchinson AJ, 2009, NEUROCHEM INT, V54, P439, DOI 10.1016/j.neuint.2009.01.018; Jungel A, 2004, ARTHRITIS RHEUM, V50, P1468, DOI 10.1002/art.20218; Kawanokuchi J, 2008, J NEUROIMMUNOL, V194, P54, DOI 10.1016/j.jneuroim.2007.11.006; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Kidd BL, 2006, PAIN, V123, P6, DOI 10.1016/j.pain.2006.04.009; Kobayashi K, 2008, J NEUROSCI, V28, P2892, DOI 10.1523/JNEUROSCI.5589-07.2008; Kumahashi N, 2010, KNEE; Lee BH, 2010, J CLIN PSYCHOPHARM, V30, P623, DOI 10.1097/JCP.0b013e3181f13f0b; Miller LE, 2000, FASEB J, V14, P2097, DOI 10.1096/fj.99-1082com; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; Oddiah D, 1998, NEUROREPORT, V9, P1455, DOI 10.1097/00001756-199805110-00038; Ospelt C, 2008, BEST PRACT RES CL RH, V22, P239, DOI 10.1016/j.berh.2008.01.004; Ray FR, 2002, ATHEROSCLEROSIS, V162, P55, DOI 10.1016/S0021-9150(01)00681-5; Raychaudhuri SP, 2009, SCAND J RHEUMATOL, V38, P207, DOI 10.1080/03009740802448866; Ritchlin C, 2000, ARTHRITIS RES, V2, P356, DOI 10.1186/ar112; Schulte-Herbruggen O, 2005, J NEUROIMMUNOL, V160, P204, DOI 10.1016/j.jneuroim.2004.10.026; Shu XQ, 1999, PAIN, V80, P463, DOI 10.1016/S0304-3959(99)00042-1; Takasaki I, 2008, GLIA, V56, P1369, DOI 10.1002/glia.20704; Takayama N, 2005, J NEUROSCI, V25, P430, DOI 10.1523/JNEUROSCI.3170-04.2005; Tozaki-Saitoh H, 2008, J NEUROSCI, V28, P4949, DOI 10.1523/JNEUROSCI.0323-08.2008; Trang T, 2009, J NEUROSCI, V29, P3518, DOI 10.1523/JNEUROSCI.5714-08.2009; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2010, BRAIN RES REV, V63, P222, DOI 10.1016/j.brainresrev.2009.11.003; Ulmann L, 2010, EMBO J, V29, P2290, DOI 10.1038/emboj.2010.126; Vanelderen P, 2010, EUR J PAIN, V14, pe471; Varani K, 2010, CELL PHYSIOL BIOCHEM, V25, P325, DOI 10.1159/000276565; Weidler C, 2005, ANN RHEUM DIS, V64, P13, DOI 10.1136/ard.2003.016154; Yang J, 2010, EUR J PAIN, V14, P574, DOI 10.1016/j.ejpain.2009.10.007; Zhang HN, 2006, EUR J NEUROSCI, V23, P984, DOI 10.1111/j.1460-9568.2006.04621.x; Zhou XF, 2000, EUR J NEUROSCI, V12, P100, DOI 10.1046/j.1460-9568.2000.00884.x; Zhu ZW, 2001, DIGEST DIS SCI, V46, P1633, DOI 10.1023/A:1010684916863	51	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36693	10.1371/journal.pone.0036693	http://dx.doi.org/10.1371/journal.pone.0036693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22715356	Green Published, Green Accepted, gold			2022-12-25	WOS:000305342300014
J	Kumar, M; Ahmad, S; Ahmad, E; Saifi, MA; Khan, RH				Kumar, Manish; Ahmad, Shadab; Ahmad, Ejaz; Saifi, Muheet Alam; Khan, Rizwan Hasan			In Silico Prediction and Analysis of Caenorhabditis EF-hand Containing Proteins	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CALCIUM-BINDING; ELEGANS; DOMAIN; GENE; CALMODULIN; CALCINEURIN; PHOSPHATASE; POLARITY; FAMILY	Calcium (Ca+2) is a ubiquitous messenger in eukaryotes including Caenorhabditis. Ca+2-mediated signalling processes are usually carried out through well characterized proteins like calmodulin (CaM) and other Ca+2 binding proteins (CaBP). These proteins interact with different targets and activate it by bringing conformational changes. Majority of the EF-hand proteins in Caenorhabditis contain Ca+2 binding motifs. Here, we have performed homology modelling of CaM-like proteins using the crystal structure of Drosophila melanogaster CaM as a template. Molecular docking was applied to explore the binding mechanism of CaM-like proteins and IQ1 motif which is a similar to 25 residues and conform to the consensus sequence (I, L, V) QXXXRXXXX(R,K) to serve as a binding site for different EF hand proteins. We made an attempt to identify all the EF-hand (a helix-loop-helix structure characterized by a 12 residues loop sequence involved in metal coordination) containing proteins and their Ca+2 binding affinity in Caenorhabditis by analysing the complete genome sequence. Docking studies revealed that F165, F169, L29, E33, F44, L57, M61, M96, M97, M108, G65, V115, F93, N104, E144 of CaM-like protein is involved in the interaction with IQ1 motif. A maximum of 170 EF-hand proteins and 39 non-EF-hand proteins with Ca+2/metal binding motif were identified. Diverse proteins including enzyme, transcription, translation and large number of unknown proteins have one or more putative EF-hands. Phylogenetic analysis revealed seven major classes/groups that contain some families of proteins. Various domains that we identified in the EF-hand proteins (uncharacterized) would help in elucidating their functions. It is the first report of its kind where calcium binding loop sequences of EF-hand proteins were analyzed to decipher their calcium affinities. Variation in Ca+2-binding affinity of EF-hand CaBP could be further used to study the behaviour of these proteins. Our analyses postulated that Ca+2 is likely to be key player in Caenorhabditis cell signalling.	[Kumar, Manish] Jawaharlal Nehru Univ, Adv Instrumentat Res Facil, New Delhi 110067, India; [Ahmad, Shadab] Jawaharlal Nehru Univ, Ctr Computat Biol & Bioinformat, New Delhi 110067, India; [Ahmad, Ejaz; Khan, Rizwan Hasan] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Saifi, Muheet Alam] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; Aligarh Muslim University; King Saud University	Kumar, M (corresponding author), Jawaharlal Nehru Univ, Adv Instrumentat Res Facil, New Delhi 110067, India.	rizwanhkhan@hotmail.com	Khan, Rizwan/GXZ-5789-2022; Khan, Rizwan Hasan/F-8276-2014; Ahmad, Ejaz/L-1506-2013	Khan, Rizwan Hasan/0000-0002-9965-8982; Ahmad, Ejaz/0000-0002-5713-6713	Department of Science and Technology (DST), Government of India; Council of Scientific and Industrial Research (CSIR)	Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	Financial assistance to MK in the form of Research Associate was supported by Department of Science and Technology (DST), Government of India, and to EA was in the form of a Senior Research Fellowship by the Council of Scientific and Industrial Research (CSIR). SA is a trainee, MAS is an assistant professor in KSU, and RHK is an associate professor in AMU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Amata I, 2008, BIOCHEMISTRY-US, V47, P12332, DOI 10.1021/bi801178t; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Bandyopadhyay J, 2002, MOL BIOL CELL, V13, P3281, DOI 10.1091/mbc.E02-01-0005; Bandyopadhyay J, 2004, MOL CELLS, V18, P10; BARSTEAD RJ, 1991, CELL MOTIL CYTOSKEL, V20, P69, DOI 10.1002/cm.970200108; Berchtold MW, 1996, GUIDEBOOK CALCIUM BI, P123; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Boutet Emmanuel, 2007, V406, P89; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; DECASTRO E, 1995, BIOCHEM BIOPH RES CO, V216, P133, DOI 10.1006/bbrc.1995.2601; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; GODDARD JM, 1986, P NATL ACAD SCI USA, V83, P2172, DOI 10.1073/pnas.83.7.2172; Gower NJD, 2005, MOL BIOL CELL, V16, P3978, DOI 10.1091/mbc.E05-02-0096; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kilby PM, 1996, STRUCTURE, V4, P1041, DOI 10.1016/S0969-2126(96)00111-6; Klopfenstein DR, 2004, MOL BIOL CELL, V15, P3729, DOI 10.1091/mbc.E04-04-0326; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; LINSE S, 1991, J BIOL CHEM, V266, P8050; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; MELDRUM E, 1991, BIOCHIM BIOPHYS ACTA, V1092, P49, DOI 10.1016/0167-4889(91)90177-Y; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; Moorthy S, 2000, J CELL BIOL, V149, P915, DOI 10.1083/jcb.149.4.915; Moreno SNJ, 2003, CURR OPIN MICROBIOL, V6, P359, DOI 10.1016/S1369-5274(03)00091-2; Muller A, 1999, J MOL BIOL, V293, P1257, DOI 10.1006/jmbi.1999.3233; Nakayama N, 2000, TOP BIOL INORG CHEM, V3, P29; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Norman KR, 2002, J CELL BIOL, V157, P665, DOI 10.1083/jcb.200111051; Olsen R, 2005, J MOL EVOL, V61, P659, DOI 10.1007/s00239-005-0060-0; RHYNER JA, 1992, BIOCHEMISTRY-US, V31, P12826, DOI 10.1021/bi00166a017; Robatzek M, 2000, GENETICS, V156, P1069; Salcini AE, 2001, NAT CELL BIOL, V3, P755, DOI 10.1038/35087075; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shelton CA, 1999, J CELL BIOL, V146, P439, DOI 10.1083/jcb.146.2.439; Shen XC, 2008, CELL CALCIUM, V43, P444, DOI 10.1016/j.ceca.2007.07.008; Shi AB, 2010, MOL BIOL CELL, V21, P2930, DOI 10.1091/mbc.E10-02-0149; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; SPIETH J, 1985, MOL CELL BIOL, V5, P2495, DOI 10.1128/MCB.5.10.2495; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Symersky J, 2003, PROTEINS, V53, P947, DOI 10.1002/prot.10517; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terami H, 1999, J CELL BIOL, V146, P193, DOI 10.1083/jcb.146.1.193; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todorov PT, 2001, BIOCHEM J, V354, P267, DOI 10.1042/0264-6021:3540267; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; Ueda T, 2001, BBA-PROTEIN STRUCT M, V1548, P220, DOI 10.1016/S0167-4838(01)00234-5; Vazquez-Manrique RP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000043; WALTERS JRF, 1990, BIOCHEM BIOPH RES CO, V170, P603, DOI 10.1016/0006-291X(90)92134-L; Wang W, 2008, TRAFFIC, V9, P742, DOI 10.1111/j.1600-0854.2008.00712.x; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WONG WT, 1995, P NATL ACAD SCI USA, V92, P9530, DOI 10.1073/pnas.92.21.9530; YUAN JY, 1992, DEVELOPMENT, V116, P309	62	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e36770	10.1371/journal.pone.0036770	http://dx.doi.org/10.1371/journal.pone.0036770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22701514	Green Submitted, Green Published, gold			2022-12-25	WOS:000305342300016
J	Neyraud, V; Aushev, VN; Hatzoglou, A; Meunier, B; Cascone, I; Camonis, J				Neyraud, Vincent; Aushev, Vasily N.; Hatzoglou, Anastassia; Meunier, Brigitte; Cascone, Ilaria; Camonis, Jacques			RalA and RalB Proteins Are Ubiquitinated GTPases, and Ubiquitinated RalA Increases Lipid Raft Exposure at the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-PROLIFERATION; EFFECTOR COMPLEX; BINDING PROTEINS; RAS; CANCER; ACTIVATION; EXOCYST; MIGRATION; SURVIVAL; PROGRESSION	Ras GTPases signal by orchestrating a balance among several effector pathways, of which those driven by the GTPases RalA and RalB are essential to Ras oncogenic functions. RalA and RalB share the same effectors but support different aspects of oncogenesis. One example is the importance of active RalA in anchorage-independent growth and membrane raft trafficking. This study has shown a new post-translational modification of Ral GTPases: nondegradative ubiquitination. RalA (but not RalB) ubiquitination increases in anchorage-independent conditions in a caveolin-dependent manner and when lipid rafts are endocytosed. Forcing RalA mono-ubiquitination (by expressing a protein fusion consisting of ubiquitin fused N-terminally to RalA) leads to RalA enrichment at the plasma membrane and increases raft exposure. This study suggests the existence of an ubiquitination/de-ubiquitination cycle superimposed on the GDP/GTP cycle of RalA, involved in the regulation of RalA activity as well as in membrane raft trafficking.	[Neyraud, Vincent; Aushev, Vasily N.; Hatzoglou, Anastassia; Meunier, Brigitte; Cascone, Ilaria; Camonis, Jacques] INSERM, Inst Curie, U830, Anal Transduct Pathways ATP Grp, F-75248 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm)	Camonis, J (corresponding author), INSERM, Inst Curie, U830, Anal Transduct Pathways ATP Grp, 26 Rue Ulm, F-75248 Paris 05, France.	Jacques.camonis@curie.fr	Aushev, Vasily N./A-7209-2008; Cascone, Ilaria/Q-7844-2018	Aushev, Vasily N./0000-0001-8003-358X; Cascone, Ilaria/0000-0003-4903-8926	ANR; ARC; MRT; UICC [ICRETT 06/135]; EMBO; Curie Institute	ANR(French National Research Agency (ANR)); ARC(Australian Research Council); MRT; UICC; EMBO(European Molecular Biology Organization (EMBO)); Curie Institute	This research was supported by grants from ANR and ARC (to J. C.).; Supported by fellowships from MRT and ARC.; Supported by UICC Fellowship ICRETT 06/135. Present address: Oncogene Regulation Laboratory, Cancer Research Centre, 24 Kashyrskoye Shosse, 115478 Moscow, Russia. E-mail: vaushev@gmail.com.; Supported by fellowships from the EMBO and Curie Institute.	Balakireva M, 2006, MOL CELL BIOL, V26, P8953, DOI 10.1128/MCB.00506-06; Balasubramanian N, 2010, CURR BIOL, V20, P75, DOI 10.1016/j.cub.2009.11.016; Bauer B, 1999, J BIOL CHEM, V274, P17763, DOI 10.1074/jbc.274.25.17763; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; Camonis JH, 2005, TRENDS CELL BIOL, V15, P327, DOI 10.1016/j.tcb.2005.04.002; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; DEICHMAN GI, 1989, INT J CANCER, V44, P908, DOI 10.1002/ijc.2910440527; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Del Pozo MA, 2004, CELL CYCLE, V3, P725; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P306, DOI 10.1038/nrm2685; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kim SE, 2009, J CELL SCI, V122, P842, DOI 10.1242/jcs.040493; Laney Jeffrey D, 2002, Curr Protoc Protein Sci, VChapter 14, DOI 10.1002/0471140864.ps1405s29; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Lim KH, 2010, MOL CELL BIOL, V30, P508, DOI 10.1128/MCB.00916-08; Martin TD, 2011, CANCER RES, V71, P206, DOI 10.1158/0008-5472.CAN-10-1517; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Oxford G, 2005, CANCER RES, V65, P7111, DOI 10.1158/0008-5472.CAN-04-1957; Oxford G, 2003, CANCER LETT, V189, P117, DOI 10.1016/S0304-3835(02)00510-4; Rosse C, 2006, MOL CELL BIOL, V26, P727, DOI 10.1128/MCB.26.2.727-734.2006; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Sowalsky AG, 2010, ONCOGENE, V29, P45, DOI 10.1038/onc.2009.307; Wang H, 2010, CANCER RES, V70, P8760, DOI 10.1158/0008-5472.CAN-10-0952; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486; Wu JC, 2005, J BIOL CHEM, V280, P9013, DOI 10.1074/jbc.M411068200; Xu LZ, 2010, CURR BIOL, V20, P1372, DOI 10.1016/j.cub.2010.06.051; Yan H, 2010, CURR BIOL, V20, P1378, DOI 10.1016/j.cub.2010.06.058; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568	38	16	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29397	29405		10.1074/jbc.M112.357764	http://dx.doi.org/10.1074/jbc.M112.357764			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22700969	Green Published, hybrid			2022-12-25	WOS:000308286900018
J	Shaikhali, J; Noren, L; Barajas-Lopez, JD; Srivastava, V; Konig, J; Sauer, UH; Wingsle, G; Dietz, KJ; Strand, A				Shaikhali, Jehad; Noren, Louise; Barajas-Lopez, Juan de Dios; Srivastava, Vaibhav; Koenig, Janine; Sauer, Uwe H.; Wingsle, Gunnar; Dietz, Karl-Josef; Strand, Asa			Redox-mediated Mechanisms Regulate DNA Binding Activity of the G-group of Basic Region Leucine Zipper (bZIP) Transcription Factors in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; SIGNAL-TRANSDUCTION; NUCLEAR EXPRESSION; S-NITROSYLATION; SWISS-MODEL; HIGH LIGHT; PROTEIN; THALIANA; NETWORK; THIOREDOXINS	Plant genes that contain the G-box in their promoters are responsive to a variety of environmental stimuli. Bioinformatics analysis of transcriptome data revealed that the G-box element is significantly enriched in promoters of high light-responsive genes. From nuclear extracts of high light-treated Arabidopsis plants, we identified the AtbZIP16 transcription factor as a component binding to the G-box-containing promoter fragment of light-harvesting chlorophyll a/b-binding protein2.4 (LHCB2.4). AtbZIP16 belongs to the G-group of Arabidopsis basic region leucine zipper (bZIP) type transcription factors. Although AtbZIP16 and its close homologues AtbZIP68 and AtGBF1 bind the G-box, they do not bind the mutated half-sites of the G-box palindrome. In addition, AtbZIP16 interacts with AtbZIP68 and AtGBF1 in the yeast two-hybrid system. A conserved Cys residue was shown to be necessary for redox regulation and enhancement of DNA binding activity in all three proteins. Furthermore, transgenic Arabidopsis lines overexpressing the wild type version of bZIP16 and T-DNA insertion mutants for bZIP68 and GBF1 demonstrated impaired regulation of LHCB2.4 expression. Finally, overexpression lines for the mutated Cys variant of bZIP16 provided support for the biological significance of Cys330 in redox regulation of gene expression. Thus, our results suggest that environmentally induced changes in the redox state regulate the activity of members of the G-group of bZIP transcription factors.	[Shaikhali, Jehad; Noren, Louise; Barajas-Lopez, Juan de Dios; Strand, Asa] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, SE-90187 Umea, Sweden; [Sauer, Uwe H.] Umea Univ, Dept Chem, Ctr Chem Biol, SE-90187 Umea, Sweden; [Srivastava, Vaibhav; Wingsle, Gunnar] Swedish Univ Agr Sci SLU, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, SE-90187 Umea, Sweden; [Koenig, Janine; Dietz, Karl-Josef] Univ Bielefeld, Fac Biol, D-33501 Bielefeld, Germany	Umea University; Umea University; Swedish University of Agricultural Sciences; Umea University; University of Bielefeld	Strand, A (corresponding author), Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, SE-90187 Umea, Sweden.	Asa.Strand@plantphys.umu.se	Sauer, Uwe/Y-3556-2019; Srivastava, Vaibhav/H-1320-2015; Dietz, Karl-Josef/B-6029-2009	Srivastava, Vaibhav/0000-0003-1877-4154; Dietz, Karl-Josef/0000-0003-0311-2182; Barajas Lopez, Juan de Dios/0000-0003-1515-5059	Swedish research foundation Vetenskapsradet; Foundation for Strategic Research [FFL2]; Knut and Alice Wallenberg Foundation	Swedish research foundation Vetenskapsradet; Foundation for Strategic Research; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported in part by grants from the Swedish research foundation Vetenskapsradet and a Foundation for Strategic Research FFL2 grant (to A. S.).; A Royal Swedish Academy of Sciences research fellow supported by a grant from the Knut and Alice Wallenberg Foundation.	Amoutzias GD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-107; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Baier M, 2004, PLANT CELL PHYSIOL, V45, P997, DOI 10.1093/pcp/pch114; Berger C, 1998, FEBS LETT, V425, P14, DOI 10.1016/S0014-5793(98)00156-2; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brautigam K, 2009, PLANT CELL, V21, P2715, DOI 10.1105/tpc.108.062018; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cranz S, 2004, BIOCHEMISTRY-US, V43, P718, DOI 10.1021/bi0355793; Deppmann CD, 2004, NUCLEIC ACIDS RES, V32, P3435, DOI 10.1093/nar/gkh653; Despres C, 2003, PLANT CELL, V15, P2181, DOI 10.1105/tpc.012849; Vivancos PD, 2010, BIOCHEM J, V431, P169, DOI 10.1042/BJ20100409; Dietz KJ, 2003, INT REV CYTOL, V228, P141, DOI 10.1016/S0074-7696(03)28004-9; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; Fankhauser C, 2002, PLANTA, V216, P1, DOI 10.1007/s00425-002-0831-4; Fernandez AP, 2008, CURR OPIN PLANT BIOL, V11, P509, DOI 10.1016/j.pbi.2008.06.002; FOSTER R, 1994, FASEB J, V8, P192, DOI 10.1096/fasebj.8.2.8119490; FOYER CH, 1994, PLANT CELL ENVIRON, V17, P507, DOI 10.1111/j.1365-3040.1994.tb00146.x; GABRIELSEN OS, 1989, NUCLEIC ACIDS RES, V17, P6253, DOI 10.1093/nar/17.15.6253; GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heine GF, 2004, J BIOL CHEM, V279, P37878, DOI 10.1074/jbc.M405166200; Hernandez JM, 2004, J BIOL CHEM, V279, P48205, DOI 10.1074/jbc.M407845200; Hirasawa M, 1999, BIOCHEMISTRY-US, V38, P5200, DOI 10.1021/bi982783v; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Kindgren P, 2012, MOL PLANT, V5, P901, DOI 10.1093/mp/ssr112; Kindgren P, 2012, PLANT J, V70, P279, DOI 10.1111/j.1365-313X.2011.04865.x; Kleine T, 2007, PLANT PHYSIOL, V144, P1391, DOI 10.1104/pp.107.098293; Kohler JJ, 1999, P NATL ACAD SCI USA, V96, P11735, DOI 10.1073/pnas.96.21.11735; Mallappa C, 2006, J BIOL CHEM, V281, P22190, DOI 10.1074/jbc.M601172200; Metallo SJ, 1997, NAT STRUCT BIOL, V4, P115, DOI 10.1038/nsb0297-115; Montemartini M, 1998, BIOL CHEM, V379, P1137, DOI 10.1515/bchm.1998.379.8-9.1137; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; Piippo M, 2006, PHYSIOL GENOMICS, V25, P142, DOI 10.1152/physiolgenomics.00256.2005; Rey DA, 2003, J BIOTECHNOL, V103, P51, DOI 10.1016/S0168-1656(03)00073-7; Rossel JB, 2002, PLANT PHYSIOL, V130, P1109, DOI 10.1104/pp.005595; SCHINDLER U, 1992, EMBO J, V11, P1275, DOI 10.1002/j.1460-2075.1992.tb05171.x; SCHINDLER U, 1992, EMBO J, V11, P1261, DOI 10.1002/j.1460-2075.1992.tb05170.x; Serpa V, 2007, BIOCHEM BIOPH RES CO, V361, P1048, DOI 10.1016/j.bbrc.2007.07.133; Shaikhali J., 2012, PLANT CELL IN PRESS; Shaikhali J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-48; Shen HS, 2008, BMB REP, V41, P132, DOI 10.5483/BMBRep.2008.41.2.132; Smykowski A, 2010, PLANT PHYSIOL, V153, P1321, DOI 10.1104/pp.110.157180; Spoel SH, 2010, NEW PHYTOL, V186, P333, DOI 10.1111/j.1469-8137.2009.03125.x; Srivastava V, 2009, PLANT PHYSIOL, V149, P1848, DOI 10.1104/pp.108.133371; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Tron AE, 2002, J BIOL CHEM, V277, P34800, DOI 10.1074/jbc.M203297200; Vincentz M, 2003, J MOL EVOL, V56, P105, DOI 10.1007/s00239-002-2386-1; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Zhai ZY, 2009, PLANT PHYSIOL, V149, P642, DOI 10.1104/pp.108.130260	53	66	75	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27510	27525		10.1074/jbc.M112.361394	http://dx.doi.org/10.1074/jbc.M112.361394			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718771	Green Published, hybrid			2022-12-25	WOS:000307840700027
J	Stanyon, HF; Viles, JH				Stanyon, Helen F.; Viles, John H.			Human Serum Albumin Can Regulate Amyloid-beta Peptide Fiber Growth in the Brain Interstitium IMPLICATIONS FOR ALZHEIMER DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; CEREBROSPINAL-FLUID; NMR-SPECTROSCOPY; BINDING-SITES; PRION PROTEIN; P-COMPONENT; PLASMA; TOXICITY; THERAPEUTICS; QUANTITATION	Alzheimer disease is a neurodegenerative disorder characterized by extracellular accumulation of amyloid-beta peptide (A beta) in the brain interstitium. Human serum albumin (HSA) binds 95% of A beta in blood plasma and is thought to inhibit plaque formation in peripheral tissue. However, the role of albumin in binding A beta in the cerebrospinal fluid has been largely overlooked. Here we investigate the effect of HSA on both A beta (1-40) and A beta (1-42) fibril growth. We show that at micromolar cerebrospinal fluid levels, HSA inhibits the kinetics of A beta fibrillization, significantly increasing the lag time and decreasing the total amount of fibrils produced. Furthermore, we show that the amount of amyloid fibers generated directly correlates to the proportion of A beta not competitively bound to albumin. Our observations suggest a significant role for HSA regulating A beta fibril growth in the brain interstitium.	[Stanyon, Helen F.; Viles, John H.] Univ London, Sch Biol & Chem Sci, London E1 4NS, England	University of London	Viles, JH (corresponding author), Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	j.viles@qmul.ac.uk		Stanyon`, Helen/0000-0002-2329-6188	Biotechnology and Biological Sciences Research Council (BBSRC) Quota studentship; BBSRC [BB/D005027/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [978364, BB/D005027/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) Quota studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) Quota studentship.	Andreetto E, 2010, ANGEW CHEM INT EDIT, V49, P3081, DOI 10.1002/anie.200904902; Biere AL, 1996, J BIOL CHEM, V271, P32916, DOI 10.1074/jbc.271.51.32916; Boada M, 2009, DRUG NEWS PERSPECT, V22, P325, DOI 10.1358/dnp.2009.22.6.1395256; Bohrmann B, 1999, J BIOL CHEM, V274, P15990, DOI 10.1074/jbc.274.23.15990; Buxbaum JN, 2008, P NATL ACAD SCI USA, V105, P2681, DOI 10.1073/pnas.0712197105; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; CHRISTENSON RH, 1983, CLIN CHEM, V29, P1028; CORIA F, 1988, LAB INVEST, V58, P454; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; ELOVAARA I, 1986, ACTA NEUROL SCAND, V74, P245, DOI 10.1111/j.1600-0404.1986.tb07863.x; ELOVAARA I, 1987, EUR NEUROL, V26, P229, DOI 10.1159/000116341; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; KLONOFFCOHEN H, 1992, J CLIN EPIDEMIOL, V45, P207, DOI 10.1016/0895-4356(92)90080-7; Kuo YM, 2000, BIOCHEM BIOPH RES CO, V268, P750, DOI 10.1006/bbrc.2000.2222; Lame ME, 2011, ANAL BIOCHEM, V419, P133, DOI 10.1016/j.ab.2011.08.010; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; LICASTRO F, 1993, ADV BIOSCI, V87, P283; Liko I, 2007, NEUROSCI LETT, V412, P51, DOI 10.1016/j.neulet.2006.10.052; Mackic JB, 1998, J NEUROCHEM, V70, P210; Milojevic J, 2007, J AM CHEM SOC, V129, P4282, DOI 10.1021/ja067367+; Milojevic J, 2011, BIOPHYS J, V100, P183, DOI 10.1016/j.bpj.2010.11.037; Milojevic J, 2009, BIOPHYS J, V97, P2585, DOI 10.1016/j.bpj.2009.08.028; PATEL SU, 1993, J AM CHEM SOC, V115, P9285, DOI 10.1021/ja00073a053; Perrone L, 2010, CHEMBIOCHEM, V11, P110, DOI 10.1002/cbic.200900474; Reyes Barcelo Adriana A, 2009, J Biol Eng, V3, P5, DOI 10.1186/1754-1611-3-5; Rozga M, 2007, BIOCHEM BIOPH RES CO, V364, P714, DOI 10.1016/j.bbrc.2007.10.080; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; STEVENS RW, 1979, J CLIN MICROBIOL, V10, P346, DOI 10.1128/JCM.10.3.346-350.1979; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Viles J. H., 2012, COORD CHEM IN PRESS; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109	32	115	117	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28163	28168		10.1074/jbc.C112.360800	http://dx.doi.org/10.1074/jbc.C112.360800			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718756	Green Published, hybrid			2022-12-25	WOS:000307840700089
J	Gifford, JL; Ishida, H; Vogel, HJ				Gifford, Jessica L.; Ishida, Hiroaki; Vogel, Hans J.			Structural Insights into Calmodulin-regulated L-selectin Ectodomain Shedding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-BINDING PROTEIN-1; RESIDUAL DIPOLAR COUPLINGS; MOUSE L-SELECTIN; CYTOPLASMIC DOMAIN; ENDOPROTEOLYTIC RELEASE; LEUKOCYTE MIGRATION; CALCIUM; NMR; KINASE; ADHESION	The L-selectin glycoprotein receptor mediates the initial steps of leukocyte migration into secondary lymphoid organs and sites of inflammation. Following cell activation through the engagement of G-protein-coupled receptors or immunoreceptors, the extracellular domains of L-selectin are rapidly shed, a process negatively controlled via the binding of the ubiquitous eukaryotic calcium-binding protein calmodulin to the cytoplasmic tail of L-selectin. Here we present the solution structure of calcium-calmodulin bound to a peptide encompassing the cytoplasmic tail and part of the transmembrane domain of L-selectin. The structure and accompanying biophysical study highlight the importance of both calcium and the transmembrane segment of L-selectin in the interaction between these two proteins, suggesting that by binding this region, calmodulin regulates in an "inside-out" fashion the ectodomain shedding of the receptor. Our structure provides the first molecular insight into the emerging new role for calmodulin as a transmembrane signaling partner.	[Gifford, Jessica L.; Ishida, Hiroaki; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Biochem Res Grp, Calgary, AB T2N 1N4, Canada	University of Calgary	Vogel, HJ (corresponding author), Univ Calgary, Dept Biol Sci, Biochem Res Grp, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca			Canadian Institutes of Health Research; National Science and Engineering Research Council; Alberta Ingenuity Fund; Killam Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Ingenuity Fund; Killam Fellowship	This work was supported by an operating grant from the Canadian Institutes of Health Research.; Recipient of postgraduate scholarships from the National Science and Engineering Research Council and Alberta Ingenuity Fund as well as a Killam Fellowship.	Barry WT, 2002, J BIOL CHEM, V277, P28877, DOI 10.1074/jbc.M202983200; BAX A, 1994, J BIOMOL NMR, V4, P787, DOI 10.1007/BF00398409; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Brenner B, 1996, P NATL ACAD SCI USA, V93, P15376, DOI 10.1073/pnas.93.26.15376; CHEN AJ, 1995, J EXP MED, V182, P519, DOI 10.1084/jem.182.2.519; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chou JJ, 2000, J BIOMOL NMR, V18, P217, DOI 10.1023/A:1026563923774; Contessa GM, 2005, J BIOMOL NMR, V31, P185, DOI 10.1007/s10858-005-0165-1; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deng W, 2011, J MOL BIOL, V411, P220, DOI 10.1016/j.jmb.2011.05.041; DeNofrio JC, 2008, THROMB HAEMOSTASIS, V100, P847, DOI 10.1160/TH08-06-0351; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Furukawa Y, 2008, J BIOL CHEM, V283, P12112, DOI 10.1074/jbc.M801745200; Galkina E, 2003, J EXP MED, V198, P1323, DOI 10.1084/jem.20030485; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gifford JL, 2011, J BIOMOL NMR, V50, P71, DOI 10.1007/s10858-011-9495-3; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Haribabu B, 1997, J BIOL CHEM, V272, P13961, DOI 10.1074/jbc.272.21.13961; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Huang H, 2012, J AM CHEM SOC, V134, P3864, DOI 10.1021/ja2111306; Huang H, 2011, J BIOL CHEM, V286, P17181, DOI 10.1074/jbc.M110.179028; IKURA M, 1991, BIOCHEMISTRY-US, V30, P5498, DOI 10.1021/bi00236a024; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; Ishida H, 2009, J BIOL CHEM, V284, P28292, DOI 10.1074/jbc.M109.025080; Ivetic A, 2004, BIOCHEM SOC T, V32, P1118, DOI 10.1042/BST0321118; Ivetic A, 2004, J BIOL CHEM, V279, P33263, DOI 10.1074/jbc.M312212200; Ivetic A, 2002, J BIOL CHEM, V277, P2321, DOI 10.1074/jbc.M109460200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kahn J, 1998, CELL, V92, P809, DOI 10.1016/S0092-8674(00)81408-7; Kilian K, 2004, J BIOL CHEM, V279, P34472, DOI 10.1074/jbc.M405916200; Killock DJ, 2010, BIOCHEM J, V428, P293, DOI 10.1042/BJ20091611; Killock DJ, 2009, J BIOL CHEM, V284, P8824, DOI 10.1074/jbc.M806983200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krummel MF, 2010, J CLIN IMMUNOL, V30, P364, DOI 10.1007/s10875-010-9393-6; Lai ZW, 2009, ENDOCRINOLOGY, V150, P2376, DOI 10.1210/en.2008-1274; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAUDANNA C, 1994, J BIOL CHEM, V269, P4021; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li Y, 2006, BLOOD, V108, P2275, DOI 10.1182/blood-2006-02-005827; Lipsitz RS, 2004, ANNU REV BIOPH BIOM, V33, P387, DOI 10.1146/annurev.biophys.33.110502.140306; Locke D, 2003, J BIOL CHEM, V278, P15441, DOI 10.1074/jbc.M212338200; Mal TK, 2002, BIOCHEMISTRY-US, V41, P12899, DOI 10.1021/bi0264162; Matala E, 2001, J IMMUNOL, V167, P1617, DOI 10.4049/jimmunol.167.3.1617; Mattila PE, 2005, AM J PHYSIOL-CELL PH, V289, pC323, DOI 10.1152/ajpcell.00603.2004; MIGAKI GI, 1995, J EXP MED, V182, P549, DOI 10.1084/jem.182.2.549; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Naik UP, 2003, BLOOD, V102, P1355, DOI 10.1182/blood-2003-02-0591; Niggli V, 2003, INT J BIOCHEM CELL B, V35, P1619, DOI 10.1016/S1357-2725(03)00144-4; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Rainaldi M, 2007, J BIOL CHEM, V282, P6031, DOI 10.1074/jbc.M608970200; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Ruschak AM, 2010, J BIOMOL NMR, V46, P75, DOI 10.1007/s10858-009-9376-1; Schaff U, 2008, J LEUKOCYTE BIOL, V83, P99, DOI 10.1189/jlb.0507304; Smalley DM, 2005, J CELL MOL MED, V9, P255, DOI 10.1111/j.1582-4934.2005.tb00354.x; Strausbaugh HJ, 1999, NAT MED, V5, P1057, DOI 10.1038/12497; Thiel M, 1997, EUR SURG RES, V29, P160, DOI 10.1159/000129521; Tu L, 2002, J IMMUNOL, V169, P2034, DOI 10.4049/jimmunol.169.4.2034; Venturi GM, 2003, IMMUNITY, V19, P713, DOI 10.1016/S1074-7613(03)00295-4; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Wedepohl S, 2012, EUR J CELL BIOL, V91, P257, DOI 10.1016/j.ejcb.2011.02.007; Wong MX, 2004, FEBS LETT, V568, P70, DOI 10.1016/j.febslet.2004.04.094; Xu T, 2008, J LEUKOCYTE BIOL, V84, P1192, DOI 10.1189/jlb.0208084; Yamniuk AP, 2006, J BIOL CHEM, V281, P26455, DOI 10.1074/jbc.M603963200; Yamniuk AP, 2009, MOL IMMUNOL, V46, P2395, DOI 10.1016/j.molimm.2009.04.024; Yamniuk AP, 2009, BIOPHYS J, V96, P1495, DOI 10.1016/j.bpj.2008.10.060; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yuan T, 1998, BIOCHEMISTRY-US, V37, P3187, DOI 10.1021/bi9716579; Yuan WP, 2006, J CELL BIOL, V172, P169, DOI 10.1083/jcb.200505131; Zarbock A, 2008, AM J PATHOL, V172, P1, DOI 10.2353/ajpath.2008.070502; Zhao LC, 2001, J BIOL CHEM, V276, P30631, DOI 10.1074/jbc.M103748200; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	76	21	21	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26513	26527		10.1074/jbc.M112.373373	http://dx.doi.org/10.1074/jbc.M112.373373			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22711531	Green Published, hybrid			2022-12-25	WOS:000307386000005
J	Wu, SF; Levenson, A; Kharitonenkov, A; De Luca, F				Wu, Shufang; Levenson, Amy; Kharitonenkov, Alexei; De Luca, Francesco			Fibroblast Growth Factor 21 (FGF21) Inhibits Chondrocyte Function and Growth Hormone Action Directly at the Growth Plate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-GROWTH; BETA-KLOTHO; METABOLIC REGULATOR; TRANSGENIC MICE; EXPRESSION; FIBROBLAST-GROWTH-FACTOR-21; DIFFERENTIATION; CHONDROGENESIS; OSTEOGENESIS; ACTIVATION	Fibroblast growth factor 21 (FGF21) modulates glucose and lipid metabolism during fasting. In addition, previous evidence indicates that increased expression of FGF21 during chronic food restriction is associated with reduced bone growth and growth hormone (GH) insensitivity. In light of the inhibitory effects on growth plate chondrogenesis mediated by other FGFs, we hypothesized that FGF21 causes growth inhibition by acting directly at the long bones' growth plate. We first demonstrated the expression of FGF21, FGFR1 and FGFR3 (two receptors known to be activated by FGF21) and beta-klotho (a co-receptor required for the FGF21-mediated receptor binding and activation) in fetal and 3-week-old mouse growth plate chondrocytes. We then cultured mouse growth plate chondrocytes in the presence of graded concentrations of rhFGF21 (0.01-10 mu g/ml). Higher concentrations of FGF21 (5 and 10 mu g/ml) inhibited chondrocyte thymidine incorporation and collagen X mRNA expression. 10 ng/ml GH stimulated chondrocyte thymidine incorporation and collagen X mRNA expression, with both effects prevented by the addition in the culture medium of FGF21 in a concentration-dependent manner. In addition, FGF21 reduced GH binding in cultured chondrocytes. In cells transfected with FGFR1 siRNA or ERK 1 siRNA, the antagonistic effects of FGF21 on GH action were all prevented, supporting a specific effect of this growth factor in chondrocytes. Our findings suggest that increased expression of FGF21 during food restriction causes growth attenuation by antagonizing the GH stimulatory effects on chondrogenesis directly at the growth plate. In addition, high concentrations of FGF21 may directly suppress growth plate chondrocyte proliferation and differentiation.	[Wu, Shufang; De Luca, Francesco] Drexel Univ, St Christophers Hosp Children, Coll Med, Sect Endocrinol & Diabet, Philadelphia, PA 19134 USA; [Wu, Shufang; Levenson, Amy; De Luca, Francesco] Drexel Univ, Dept Pediat, Philadelphia, PA 19134 USA; [Kharitonenkov, Alexei] Lilly Res Labs, Indianapolis, IN 46225 USA	Drexel University; Drexel University; Eli Lilly	De Luca, F (corresponding author), Drexel Univ, St Christophers Hosp Children, Coll Med, Sect Endocrinol & Diabet, 3601 A St, Philadelphia, PA 19134 USA.	francesco.deluca@drexelmed.edu						AHARINEJAD S, 1995, ANAT REC, V242, P111, DOI 10.1002/ar.1092420115; COFFIN JD, 1995, MOL BIOL CELL, V6, P1861, DOI 10.1091/mbc.6.12.1861; De Luca F, 1999, TRENDS ENDOCRIN MET, V10, P61, DOI 10.1016/S1043-2760(98)00120-9; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; FARNUM CE, 1987, ANAT REC, V219, P221, DOI 10.1002/ar.1092190303; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Garofalo S, 1999, J BONE MINER RES, V14, P1909, DOI 10.1359/jbmr.1999.14.11.1909; Horton WA, 2009, TRENDS ENDOCRIN MET, V20, P341, DOI 10.1016/j.tem.2009.04.003; HUNZIKER EB, 1994, MICROSC RES TECHNIQ, V28, P505, DOI 10.1002/jemt.1070280606; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Johnson CL, 2009, GASTROENTEROLOGY, V137, P1795, DOI 10.1053/j.gastro.2009.07.064; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Kubicky RA, 2012, ENDOCRINOLOGY, V153, P2287, DOI 10.1210/en.2011-1909; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lazarus JE, 2007, BONE, V40, P577, DOI 10.1016/j.bone.2006.10.013; Leung KC, 2000, J CLIN ENDOCR METAB, V85, P4712, DOI 10.1210/jc.85.12.4712; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Reitman ML, 2007, CELL METAB, V5, P405, DOI 10.1016/j.cmet.2007.05.010; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Touvier T, 2009, J CLIN INVEST, V119, P3830, DOI 10.1172/JCI34997; Wang O, 2001, DEVELOPMENT, V128, P3867; Weinstein M, 1998, DEVELOPMENT, V125, P3615; White KE, 2005, AM J HUM GENET, V76, P361, DOI 10.1086/427956; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491	33	72	78	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26060	26067		10.1074/jbc.M112.343707	http://dx.doi.org/10.1074/jbc.M112.343707			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22696219	Green Published, hybrid			2022-12-25	WOS:000306916300033
J	Saravanaperumal, SA; Pediconi, D; Renieri, C; La Terza, A				Saravanaperumal, Siva Arumugam; Pediconi, Dario; Renieri, Carlo; La Terza, Antonietta			Skipping of Exons by Premature Termination of Transcription and Alternative Splicing within Intron-5 of the Sheep SCF Gene: A Novel Splice Variant	PLOS ONE			English	Article							STEM-CELL FACTOR; C-KIT LIGAND; MULTIPLE SEQUENCE ALIGNMENT; PROTEIN MESSENGER-RNAS; GROWTH-FACTOR; COAT COLOR; DOMINANT BLACK; MELANOCYTE DEVELOPMENT; TRANSLATIONAL CONTROL; MOLECULAR-CLONING	Stem cell factor (SCF) is a growth factor, essential for haemopoiesis, mast cell development and melanogenesis. In the hematopoietic microenvironment (HM), SCF is produced either as a membrane-bound (-) or soluble (+) forms. Skin expression of SCF stimulates melanocyte migration, proliferation, differentiation, and survival. We report for the first time, a novel mRNA splice variant of SCF from the skin of white merino sheep via cloning and sequencing. Reverse transcriptase (RT)-PCR and molecular prediction revealed two different cDNA products of SCF. Full-length cDNA libraries were enriched by the method of rapid amplification of cDNA ends (RACE-PCR). Nucleotide sequencing and molecular prediction revealed that the primary 1519 base pair (bp) cDNA encodes a precursor protein of 274 amino acids (aa), commonly known as 'soluble' isoform. In contrast, the shorter (835 and/or 725 bp) cDNA was found to be a `novel' mRNA splice variant. It contains an open reading frame (ORF) corresponding to a truncated protein of 181 aa (vs 245 aa) with an unique C-terminus lacking the primary proteolytic segment (28 aa) right after the D(175)G site which is necessary to produce 'soluble' form of SCF. This alternative splice (AS) variant was explained by the complete nucleotide sequencing of splice junction covering exon 5-intron (5)- exon 6 (948 bp) with a premature termination codon (PTC) whereby exons 6 to 9/10 are skipped (Cassette Exon, CE 6-9/10). We also demonstrated that the Northern blot analysis at transcript level is mediated via an intron-5 splicing event. Our data refine the structure of SCF gene; clarify the presence (+) and/or absence (2) of primary proteolytic-cleavage site specific SCF splice variants. This work provides a basis for understanding the functional role and regulation of SCF in hair follicle melanogenesis in sheep beyond what was known in mice, humans and other mammals.	[Saravanaperumal, Siva Arumugam; Pediconi, Dario; Renieri, Carlo; La Terza, Antonietta] Univ Camerino, Sch Environm Sci, I-62032 Camerino, MC, Italy	University of Camerino	Saravanaperumal, SA (corresponding author), Univ Camerino, Sch Environm Sci, Via Gentile III Varano, I-62032 Camerino, MC, Italy.	sivabiotech2002@yahoo.com; antonietta.laterza@unicam.it		La Terza, Antonietta/0000-0002-1244-1503	Faculty Research Grant; University of Camerino, Italy	Faculty Research Grant; University of Camerino, Italy	This huge in-house project on 'Molecular Characterization of Pigmentation Genes in Merino Sheep' was supported by the Faculty Research Grant to Dr. Antonietta La Terza and Dr. Carlo Renieri from the University of Camerino, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abyzov A, 2005, BIOINFORMATICS, V21, P3677, DOI 10.1093/bioinformatics/bti602; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON DM, 1990, CELL, V63, P235, DOI 10.1016/0092-8674(90)90304-W; ANDERSON DM, 1991, CELL GROWTH DIFFER, V2, P373; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], DES TOOL DNA OL MOD; BAIM SB, 1985, MOL CELL BIOL, V5, P1839, DOI 10.1128/MCB.5.8.1839; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Baxter LL, 2004, PIGM CELL RES, V17, P215, DOI 10.1111/j.1600-0749.2004.00147.x; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; BEDELL MA, 1995, GENE DEV, V9, P455, DOI 10.1101/gad.9.4.455; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Beraldi D, 2006, GENETICS, V173, P1521, DOI 10.1534/genetics.106.057141; BERNSTEIN A, 1990, CIBA F SYMP, V148, P158; BESMER P, 1993, DEVELOPMENT, P125; Botchkareva NV, 2001, FASEB J, V15, P645, DOI 10.1096/fj.00-0368com; BRANNAN CI, 1991, P NATL ACAD SCI USA, V88, P4671, DOI 10.1073/pnas.88.11.4671; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; CHENG HJ, 1994, MOL BIOL CELL, V5, P943, DOI 10.1091/mbc.5.9.943; COPELAND NG, 1990, CELL, V63, P175, DOI 10.1016/0092-8674(90)90298-S; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; DOLCI S, 1991, NATURE, V352, P809, DOI 10.1038/352809a0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engelen S, 2010, NUCLEIC ACIDS RES, V38, P2453, DOI 10.1093/nar/gkp1067; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T; Flicek Paul, 2010, Nucleic Acids Res, V38, pD557, DOI 10.1093/nar/gkp972; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fukuchi S, 2009, NUCLEIC ACIDS RES, V37, pD333, DOI 10.1093/nar/gkn855; GALLI SJ, 1994, ADV IMMUNOL, V55, P1; Gentry PC, 1996, BIOL REPROD, V54, P970, DOI 10.1095/biolreprod54.5.970; Geospiza Inc, FINCHTV; GRABBE J, 1994, ARCH DERMATOL RES, V287, P78, DOI 10.1007/BF00370723; GRAY NK, 1994, MOL BIOL REP, V19, P195, DOI 10.1007/BF00986961; Grichnik JM, 1998, J INVEST DERMATOL, V111, P233, DOI 10.1046/j.1523-1747.1998.00272.x; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Hachiya A, 2001, J INVEST DERMATOL, V116, P578, DOI 10.1046/j.1523-1747.2001.01290.x; Hachiya A, 2009, J PATHOL, V218, P30, DOI 10.1002/path.2503; Hadjiconstantouras C, 2008, ANIM GENET, V39, P217, DOI 10.1111/j.1365-2052.2008.01708.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Hsu YR, 1998, BIOCHEMISTRY-US, V37, P2251, DOI 10.1021/bi972372z; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; HUANG EJ, 1992, MOL BIOL CELL, V3, P349, DOI 10.1091/mbc.3.3.349; Huang HY, 2006, NUCLEIC ACIDS RES, V34, pW429, DOI 10.1093/nar/gkl333; Huelsenbeck JP, 2005, STAT BIOL HEALTH, P183, DOI 10.1007/0-387-27733-1_7; Hultman KA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030017; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Imokawa G, 2000, J BIOL CHEM, V275, P33321, DOI 10.1074/jbc.M004346200; Jablonski NG, 2004, ANNU REV ANTHROPOL, V33, P585, DOI 10.1146/annurev.anthro.33.070203.143955; Jaillon O, 2008, NATURE, V451, P359, DOI 10.1038/nature06495; Jiang XL, 2000, EMBO J, V19, P3192, DOI 10.1093/emboj/19.13.3192; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jukes T. H, 1969, MAMMALIAN PROTEIN ME, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; Kalendar R., 2010, JAVA WEB TOOLS PCR S; Kenneson A, 2001, HUM MOL GENET, V10, P1449, DOI 10.1093/hmg/10.14.1449; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kerns JA, 2003, J HERED, V94, P75, DOI 10.1093/jhered/esg016; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Koscielny G, 2009, GENOMICS, V93, P213, DOI 10.1016/j.ygeno.2008.11.003; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; LANGLEY KE, 1994, ARCH BIOCHEM BIOPHYS, V311, P55, DOI 10.1006/abbi.1994.1208; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; LEV S, 1992, J BIOL CHEM, V267, P15970; LEVY S, 1991, P NATL ACAD SCI USA, V88, P3319, DOI 10.1073/pnas.88.8.3319; LONGLEY BJ, 1993, NEW ENGL J MED, V328, P1302, DOI 10.1056/NEJM199305063281803; Longley BJ, 1999, J INVEST DERMATOL, V113, P139, DOI 10.1046/j.1523-1747.1999.00643.x; LU HS, 1991, J BIOL CHEM, V266, P8102; MAJUMDAR MK, 1994, J BIOL CHEM, V269, P1237; Margulies EH, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e60; MARTIN FH, 1990, CELL, V63, P203, DOI 10.1016/0092-8674(90)90301-T; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; MAYER TC, 1970, DEV BIOL, V23, P297, DOI 10.1016/0012-1606(70)90100-4; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Meyuhas Oded, 1996, V30, P363; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; MIYAZAWA K, 1995, BLOOD, V85, P641, DOI 10.1182/blood.V85.3.641.bloodjournal853641; Mytelka DS, 1996, NUCLEIC ACIDS RES, V24, P2774, DOI 10.1093/nar/24.14.2774; Nei M, 2000, MOL EVOLUTION PHYLOG; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; Odronitz Florian, 2008, BMC Genomics, V9, P422, DOI 10.1186/1471-2164-9-422; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Parsons YM, 1999, PIGM CELL RES, V12, P394, DOI 10.1111/j.1600-0749.1999.tb00524.x; Parsons YM, 1999, AUST J AGR RES, V50, P1099, DOI 10.1071/AR98099; Petitte JN, 1996, BBA-GENE STRUCT EXPR, V1307, P149, DOI 10.1016/0167-4781(96)00062-0; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Renieri C, 2008, SMALL RUMINANT RES, V74, P23, DOI 10.1016/j.smallrumres.2007.03.001; Rozen S, 2000, Methods Mol Biol, V132, P365; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 1989, MOL CLONING LAB MANU; SHARKEY A, 1992, MOL ENDOCRINOL, V6, P1235, DOI 10.1210/me.6.8.1235; SHULL RM, 1992, EXP HEMATOL, V20, P1118; Silvers W. K., 1979, The coat colours of mice. A model for mammalian gene action and interaction.; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tabaska JE, 1999, GENE, V231, P77, DOI 10.1016/S0378-1119(99)00104-3; Tachibana M, 2000, PIGM CELL RES, V13, P230, DOI 10.1034/j.1600-0749.2000.130404.x; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAN JC, 1990, SCIENCE, V247, P209, DOI 10.1126/science.1688471; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tisdall DJ, 1997, J MOL ENDOCRINOL, V18, P127, DOI 10.1677/jme.0.0180127; Tisdall DJ, 1996, MAMM GENOME, V7, P472, DOI 10.1007/s003359900142; TOKSOZ D, 1992, P NATL ACAD SCI USA, V89, P7350, DOI 10.1073/pnas.89.16.7350; Vage DI, 2003, PIGM CELL RES, V16, P693, DOI 10.1046/j.1600-0749.2003.00090.x; Vage DI, 1999, MAMM GENOME, V10, P39, DOI 10.1007/s003359900939; Wang M, 2006, GENE, V366, P219, DOI 10.1016/j.gene.2005.07.015; Wehrle-Haller B, 2003, PIGM CELL RES, V16, P287, DOI 10.1034/j.1600-0749.2003.00055.x; Welker P, 1999, SCAND J IMMUNOL, V49, P495; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; WILLIAMS DE, 1992, DEV BIOL, V151, P368, DOI 10.1016/0012-1606(92)90176-H; WITTE ON, 1990, CELL, V63, P5, DOI 10.1016/0092-8674(90)90280-R; Yoshida Y, 2007, FASEB J, V21, P2829, DOI 10.1096/fj.06-6845com; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055; Zhang HB, 2005, NUCLEIC ACIDS RES, V33, pD116, DOI 10.1093/nar/gki055; ZHANG Z, 1994, BIOL REPROD, V50, P95, DOI 10.1095/biolreprod50.1.95; Zhang ZT, 2000, P NATL ACAD SCI USA, V97, P7732, DOI 10.1073/pnas.97.14.7732; ZHOU JH, 1994, BBA-MOL CELL RES, V1223, P148, DOI 10.1016/0167-4889(94)90084-1; ZHOU JH, 1993, GENE, V127, P269, DOI 10.1016/0378-1119(93)90732-I; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	138	6	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38657	10.1371/journal.pone.0038657	http://dx.doi.org/10.1371/journal.pone.0038657			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719917	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350000019
J	Fuller, DM; Zhu, MH; Song, XH; Ou-Yang, CW; Sullivan, SA; Stone, JC; Zhang, WG				Fuller, Deirdre M.; Zhu, Minghua; Song, Xiaohua; Ou-Yang, Chih-Wen; Sullivan, Sarah A.; Stone, James C.; Zhang, Weiguo			Regulation of RasGRP1 Function in T Cell Development and Activation by Its Unique Tail Domain	PLOS ONE			English	Article							NEGATIVE SELECTION; THYMIC SELECTION; RAS ACTIVATION; IGE PRODUCTION; C1 DOMAINS; MEMBRANE; LYMPHOCYTES; BINDING; GAMMA; CD4	The Ras-guanyl nucleotide exchange factor RasGRP1 plays a critical role in T cell receptor-mediated Erk activation. Previous studies have emphasized the importance of RasGRP1 in the positive selection of thymocytes, activation of T cells, and control of autoimmunity. RasGRP1 consists of a number of well-characterized domains, which it shares with its other family members; however, RasGRP1 also contains an similar to 200 residue-long tail domain, the function of which is unknown. To elucidate the physiological role of this domain, we generated knock-in mice expressing RasGRP1 without the tail domain. Further analysis of these knock-in mice showed that thymocytes lacking the tail domain of RasGRP1 underwent aberrant thymic selection and, following TCR stimulation, were unable to activate Erk. Furthermore, the deletion of the tail domain led to enhanced CD4(+) T cell expansion in aged mice, as well as the production of autoantibodies. Mechanistically, the tail-deleted form of RasGRP1 was not able to traffic to the cell membrane following stimulation, indicating a potential reason for its inability to activate Erk. While the DAG-binding C1 domain of RasGRP1 has long been recognized as an important factor mediating Erk activation, we have revealed the physiological relevance of the tail domain in RasGRP1 function and control of Erk signaling.	[Fuller, Deirdre M.; Zhu, Minghua; Ou-Yang, Chih-Wen; Sullivan, Sarah A.; Zhang, Weiguo] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27706 USA; [Song, Xiaohua; Stone, James C.] Univ Alberta, Dept Biochem, Edmonton, AB, Canada	Duke University; University of Alberta	Fuller, DM (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27706 USA.	zhang033@mc.duke.edu	Zhu, Minghua/ABH-2671-2020		National Institutes of Health [AI048674, AI056156]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI056156, R56AI048674, R01AI056156, R01AI048674, T32AI052077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grants AI048674 and AI056156 to WZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; Beaulieu N, 2007, MOL BIOL CELL, V18, P3156, DOI 10.1091/mbc.E06-10-0932; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; BRINKMANN V, 1995, J IMMUNOL, V154, P3078; Carrasco S, 2004, MOL BIOL CELL, V15, P2932, DOI 10.1091/mbc.E03-11-0844; Chen XX, 2008, J IMMUNOL, V180, P5973, DOI 10.4049/jimmunol.180.9.5973; Coughlin JJ, 2006, IMMUNOL LETT, V105, P77, DOI 10.1016/j.imlet.2006.01.005; Coughlin JJ, 2005, J IMMUNOL, V175, P7179, DOI 10.4049/jimmunol.175.11.7179; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Ebinu JO, 2000, BLOOD, V95, P3199; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Johnson JE, 2007, BIOCHEM J, V406, P223, DOI 10.1042/BJ20070294; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kim R, 2003, J VIROL, V77, P2056, DOI 10.1128/JVI.77.3.2056-2062.2003; Kortum RL, 2011, P NATL ACAD SCI US; Liu Y, 2007, J EXP MED, V204, P93, DOI 10.1084/jem.20061598; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Priatel JJ, 2002, IMMUNITY, V17, P617, DOI 10.1016/S1074-7613(02)00451-X; Priatel JJ, 2007, J IMMUNOL, V179, P2143, DOI 10.4049/jimmunol.179.4.2143; Priatel JJ, 2006, J IMMUNOL, V177, P1470, DOI 10.4049/jimmunol.177.3.1470; Qi Q, 2009, BLOOD, V114, P564, DOI 10.1182/blood-2008-12-196345; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sugawara T, 1998, IMMUNITY, V9, P565, DOI 10.1016/S1074-7613(00)80639-1; Tazmini G, 2009, BBA-MOL CELL RES, V1793, P447, DOI 10.1016/j.bbamcr.2008.12.019; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995; Vassiliou GS, 2011, NAT GENET; Yasuda S, 2007, J IMMUNOL, V179, P4890, DOI 10.4049/jimmunol.179.7.4890; Zahedi B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.189605	35	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38796	10.1371/journal.pone.0038796	http://dx.doi.org/10.1371/journal.pone.0038796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719950	gold, Green Submitted, Green Published			2022-12-25	WOS:000305340000046
J	Meng, SR; Zhu, YZ; Guo, T; Liu, XL; Chen, J; Liang, Y				Meng, Sheng-Rong; Zhu, Ying-Zhu; Guo, Tong; Liu, Xiao-Ling; Chen, Jie; Liang, Yi			Fibril-Forming Motifs Are Essential and Sufficient for the Fibrillization of Human Tau	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; BETA-AMYLOID FIBRILS; ALZHEIMERS-DISEASE; PRION PROTEIN; IN-VITRO; SEQUENCE; SEGMENTS; BETA(2)-MICROGLOBULIN; BIOGENESIS; PREDICTION	Background: The misfolding of amyloidogenic proteins including human Tau protein, human prion protein, and human alpha-synuclein is involved in neurodegenerative diseases such as Alzheimer disease, prion disease, and Parkinson disease. Although a lot of research on such amyloidogenic proteins has been done, we do not know the determinants that drive these proteins to form fibrils and thereby induce neurodegenerative diseases. In this study, we want to know the role of fibril-forming motifs from such amyloidogenic proteins in the fibrillization of human Tau protein. Methodology/Principal Findings: As evidenced by thioflavin T binding and turbidity assays, transmission electron microscopy, and circular dichroism, fibril-forming motifs are essential and sufficient for the fibrillization of microtubule-associated protein Tau: only when both of its fibril-forming motifs, PHF6 and PHF6*, are deleted can recombinant human Tau fragment Tau(244-372) lose its ability to form fibrils, and the insertion of unrelated fibril-forming motifs from other amyloidogenic proteins, such as human prion protein, yeast prion protein, human alpha-synuclein, and human amyloid beta, into the disabled Tau protein can retrieve its ability to form fibrils. Furthermore, this retrieval is independent of the insertion location on Tau(244-372). Conclusions/Significance: We demonstrate for the first time that insertion of fibril-forming motifs can replace PHF6/PHF6* motifs, driving human Tau protein to form fibrils with different morphologies and different kinetic parameters. Our results suggest that fibril-forming motifs play a key role in the fibrillization of human Tau protein and could be the determinants of amyloidogenic proteins tending to misfold, thereby causing the initiation and development of neurodegenerative diseases. Our study also touches on the importance of amyloid "strains": changes to the amyloidgenic driver region results in altered structural morphologies at the macromolecular level.	[Meng, Sheng-Rong; Zhu, Ying-Zhu; Guo, Tong; Liu, Xiao-Ling; Chen, Jie; Liang, Yi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Meng, SR (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	liangyi@whu.edu.cn	Liang, Yi/V-1396-2017; Liu, Xiaoling/HGD-3566-2022	Liang, Yi/0000-0002-7349-8300; Yingzhu, Zhu/0000-0002-3041-3303	National Key Basic Research Foundation of China [2012CB911003]; National Natural Science Foundation of China [31170744, 30970599]; Fundamental Research Funds for the Central Universities of China [1104006]	National Key Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This study was supported by National Key Basic Research Foundation of China (http://www.most.gov.cn/, Grant no. 2012CB911003, YL), National Natural Science Foundation of China (http://www.nsfc.gov.cn/, Grant nos. 31170744 and 30970599, YL), and Fundamental Research Funds for the Central Universities of China (http://www.moe.edu.cn/, Grant no. 1104006, YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bibow S, 2011, ANGEW CHEM INT EDIT, V50, P11520, DOI 10.1002/anie.201105493; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Breydo L, 2012, BBA-MOL BASIS DIS, V1822, P261, DOI 10.1016/j.bbadis.2011.10.002; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Colby DW, 2006, NAT CHEM BIOL, V2, P319, DOI 10.1038/nchembio792; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Garbuzynskiy SO, 2010, BIOINFORMATICS, V26, P326, DOI 10.1093/bioinformatics/btp691; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Guest WC, 2011, J TOXICOL ENV HEAL A, V74, P1433, DOI 10.1080/15287394.2011.618967; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; Ivanova MI, 2006, P NATL ACAD SCI USA, V103, P4079, DOI 10.1073/pnas.0511298103; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Kong FL, 2011, CHEM-BIOL INTERACT, V194, P69, DOI 10.1016/j.cbi.2011.08.003; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Kuret J, 2005, BBA-MOL BASIS DIS, V1739, P167, DOI 10.1016/j.bbadis.2004.06.016; Landau M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001080; Li WK, 2006, BIOCHEMISTRY-US, V45, P15692, DOI 10.1021/bi061422+; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Makarava N, 2008, J BIOL CHEM, V283, P15988, DOI 10.1074/jbc.M800562200; MANDELKOW E, 1995, NEUROBIOL AGING, V16, P347, DOI 10.1016/0197-4580(95)00026-B; Men D, 2009, NANO LETT, V9, P2246, DOI 10.1021/nl9003464; MIYATA T, 1993, J CLIN INVEST, V92, P1243, DOI 10.1172/JCI116696; Mo ZY, 2009, J BIOL CHEM, V284, P34648, DOI 10.1074/jbc.M109.058883; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rossetti G, 2011, J MOL BIOL, V411, P700, DOI 10.1016/j.jmb.2011.06.008; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Teng PK, 2009, PROTEIN ENG DES SEL, V22, P531, DOI 10.1093/protein/gzp037; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Tjernberg LO, 1999, J BIOL CHEM, V274, P12619, DOI 10.1074/jbc.274.18.12619; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wang X, 2010, P NATL ACAD SCI USA, V107, P163, DOI 10.1073/pnas.0908714107; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008; Zhang ZQ, 2007, BIOINFORMATICS, V23, P2218, DOI 10.1093/bioinformatics/btm325; Zhou Z, 2011, BIOPHYS J, V101, P1483, DOI 10.1016/j.bpj.2011.08.018; Zhou Z, 2009, J BIOL CHEM, V284, P30148, DOI 10.1074/jbc.M109.002832; Zhu HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025020; Zhu HL, 2010, J BIOL CHEM, V285, P3592, DOI 10.1074/jbc.M109.035691	50	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38903	10.1371/journal.pone.0038903	http://dx.doi.org/10.1371/journal.pone.0038903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701727	Green Published, Green Submitted, gold			2022-12-25	WOS:000305337600054
J	Wren, L; Parsons, MS; Isitman, G; Center, RJ; Kelleher, AD; Stratov, I; Bernard, NF; Kent, SJ				Wren, Leia; Parsons, Matthew S.; Isitman, Gamze; Center, Robert J.; Kelleher, Anthony D.; Stratov, Ivan; Bernard, Nicole F.; Kent, Stephen J.			Influence of Cytokines on HIV-Specific Antibody-Dependent Cellular Cytotoxicity Activation Profile of Natural Killer Cells	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; NECROSIS-FACTOR-ALPHA; HUMAN NK CELLS; MHC CLASS-I; DISEASE PROGRESSION; MEDIATED CYTOTOXICITY; INFECTED INDIVIDUALS; EFFECTOR FUNCTIONS; TYPE-1 INFECTION; IFN-GAMMA	There is growing interest in HIV-specific antibody-dependent cellular cytotoxicity (ADCC) as an effective immune response to prevent or control HIV infection. ADCC relies on innate immune effector cells, particularly NK cells, to mediate control of virus-infected cells. The activation of NK cells (i.e., expression of cytokines and/or degranulation) by ADCC antibodies in serum is likely subject to the influence of other factors that are also present. We observed that the HIV-specific ADCC antibodies, within serum samples from a panel of HIV-infected individuals induced divergent activation profiles of NK cells from the same donor. Some serum samples primarily induced NK cell cytokine expression (i.e., IFN gamma), some primarily initiated NK cell expression of a degranulation marker (CD107a) and others initiated a similar magnitude of responses across both effector functions. We therefore evaluated a number of HIV-relevant soluble factors for their influence on the activation of NK cells by HIV-specific ADCC antibodies. Key findings were that the cytokines IL-15 and IL-10 consistently enhanced the ability of NK cells to respond to HIV-specific ADCC antibodies. Furthermore, IL-15 was demonstrated to potently activate "educated'' KIR3DL1(+) NK cells from individuals carrying its HLA-Bw4 ligand. The cytokine was also demonstrated to activate "uneducated'' KIR3DL1+ NK cells from HLA-Bw6 homozygotes, but to a lesser extent. Our results show that cytokines influence the ability of NK cells to respond to ADCC antibodies in vitro. Manipulating the immunological environment to enhance the potency of NK cell-mediated HIV-specific ADCC effector functions could be a promising immunotherapy or vaccine strategy.	[Wren, Leia; Parsons, Matthew S.; Isitman, Gamze; Center, Robert J.; Stratov, Ivan; Kent, Stephen J.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Parsons, Matthew S.; Bernard, Nicole F.] McGill Univ, Div Expt Med, Montreal, PQ, Canada; [Kelleher, Anthony D.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Stratov, Ivan; Kent, Stephen J.] Alfred Hlth, Melbourne Sexual Hlth Clin, Carlton, Vic, Australia	University of Melbourne; McGill University; University of New South Wales Sydney; Kirby Institute	Wren, L (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia.	skent@unimelb.edu.au	Stratov, Ivan/AAJ-4516-2020; Kent, Stephen/AAL-5101-2020	Kent, Stephen/0000-0002-8539-4891	Australian National Health and Medical Research Council awards [510448, 455350]; Australian Research Council award [LP0991498]; National Institutes of Health award [R21AI081541]; Canadian Institutes of Health Research Vanier Scholarship; Michael Smith Foreign Study Supplement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081541] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council awards(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council award(Australian Research Council); National Institutes of Health award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research Vanier Scholarship(Canadian Institutes of Health Research (CIHR)); Michael Smith Foreign Study Supplement(Canadian Institutes of Health Research (CIHR)Social Sciences and Humanities Research Council of Canada (SSHRC)Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Australian National Health and Medical Research Council awards 510448 and 455350, Australian Research Council award LP0991498, and National Institutes of Health award R21AI081541. MSP is supported by a Canadian Institutes of Health Research Vanier Scholarship and a Michael Smith Foreign Study Supplement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Baum LL, 1996, J IMMUNOL, V157, P2168; Boulet S, 2008, AIDS, V22, P595, DOI 10.1097/QAD.0b013e3282f56b23; Boulet S, 2010, J IMMUNOL, V184, P2057, DOI 10.4049/jimmunol.0902621; Boyer JD, 2007, P NATL ACAD SCI USA, V104, P18648, DOI 10.1073/pnas.0709198104; Brocca-Cofano E, 2011, VACCINE, V29, P3310, DOI 10.1016/j.vaccine.2011.02.066; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Brodin P, 2009, BLOOD, V113, P2434, DOI 10.1182/blood-2008-05-156836; Cai GF, 1999, EUR J IMMUNOL, V29, P2658, DOI 10.1002/(SICI)1521-4141(199909)29:09<2658::AID-IMMU2658>3.3.CO;2-7; Center RJ, 2009, VACCINE, V27, P6605, DOI 10.1016/j.vaccine.2009.08.016; Chatterjee A, 2009, J CLIN IMMUNOL, V29, P71, DOI 10.1007/s10875-008-9220-5; Chung AW, 2011, JAIDS-J ACQ IMM DEF, V58, P127, DOI 10.1097/QAI.0b013e31822c62b9; Chung AW, 2011, P NATL ACAD SCI USA, V108, P7505, DOI 10.1073/pnas.1016048108; Chung AW, 2009, J IMMUNOL, V182, P1202, DOI 10.4049/jimmunol.182.2.1202; d'Ettorre G, 2002, AIDS, V16, P181, DOI 10.1097/00002030-200201250-00006; DEBLAKERHOHE DF, 1995, CELL IMMUNOL, V165, P33, DOI 10.1006/cimm.1995.1184; Douek Daniel, 2007, Top HIV Med, V15, P114; Fauriat C, 2010, BLOOD, V115, P1166, DOI 10.1182/blood-2009-09-245746; Gregson JNS, 2009, AIDS, V23, P29, DOI 10.1097/QAD.0b013e3283199780; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; HOBER D, 1993, MICROBIOL IMMUNOL, V37, P785, DOI 10.1111/j.1348-0421.1993.tb01706.x; Hoglund P, 2010, NAT REV IMMUNOL, V10, P724, DOI 10.1038/nri2835; Iannello A, 2008, J LEUKOCYTE BIOL, V84, P27, DOI 10.1189/jlb.0907649; Isitman G, 2011, VIROLOGY, V412, P110, DOI 10.1016/j.virol.2010.12.044; Johansson SE, 2011, VIRAL IMMUNOL, V24, P359, DOI 10.1089/vim.2011.0025; Juelke K, 2009, EUR J IMMUNOL, V39, P2548, DOI 10.1002/eji.200939307; Karnasuta C, 2005, VACCINE, V23, P2522, DOI 10.1016/j.vaccine.2004.10.028; Lambotte O, 2009, AIDS, V23, P897, DOI 10.1097/QAD.0b013e328329f97d; Lin SJ, 1998, J CLIN IMMUNOL, V18, P335, DOI 10.1023/A:1023290932154; Loubeau M, 1997, J ACQ IMMUN DEF SYND, V16, P137, DOI 10.1097/00042560-199711010-00001; Marshall JD, 1999, BLOOD, V94, P1003, DOI 10.1182/blood.V94.3.1003.415a15_1003_1011; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Mocellin S, 2004, GENES IMMUN, V5, P621, DOI 10.1038/sj.gene.6364135; Moga E, 2011, EXP HEMATOL, V39, P1064, DOI 10.1016/j.exphem.2011.08.006; Mueller YM, 2008, J IMMUNOL, V180, P350, DOI 10.4049/jimmunol.180.1.350; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; NAVIKAS V, 1994, CLIN EXP IMMUNOL, V96, P59; Oleksyk TK, 2009, GENES IMMUN, V10, P309, DOI 10.1038/gene.2009.9; Parsons MS, 2010, J LEUKOCYTE BIOL, V88, P905, DOI 10.1189/jlb.1009687; Parsons MS, 2010, J INFECT DIS, V202, pS356, DOI 10.1086/655966; Parsons MS, 2012, J VIROL; Patel Dipa, 2010, Human Antibodies, V19, P89, DOI 10.3233/HAB-2010-0232; Peppa D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001227; RAUTONEN J, 1991, AIDS, V5, P1319, DOI 10.1097/00002030-199111000-00006; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Roda JM, 2007, CLIN CANCER RES, V13, P6419, DOI 10.1158/1078-0432.CCR-07-0865; Rosenblum LY, 2002, REGUL TOXICOL PHARM, V35, P56, DOI 10.1006/rtph.2001.1504; Scott-Algara D, 2003, J IMMUNOL, V171, P5663, DOI 10.4049/jimmunol.171.11.5663; Srikanth P, 2000, INT J STD AIDS, V11, P49, DOI 10.1258/0956462001914904; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Stratov I, 2008, J VIROL, V82, P5450, DOI 10.1128/JVI.01952-07; Sun Y, 2011, J VIROL, V85, P6906, DOI 10.1128/JVI.00326-11; Thobakgale CF, 2011, AIDS RES HUM RETROV, V27, P1005, DOI 10.1089/aid.2010.0227; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Walter J, 2009, J INFECT DIS, V200, P1498, DOI 10.1086/644603; Wren L, 2011, HUM VACCINES, V7, P467, DOI 10.4161/hv.7.4.14123	57	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38580	10.1371/journal.pone.0038580	http://dx.doi.org/10.1371/journal.pone.0038580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701674	Green Published, gold, Green Submitted			2022-12-25	WOS:000305337600031
J	Araki, M; Uehara, S; Sasaki, K; Monden, K; Tsugawa, M; Watanabe, T; Monga, M; Nasu, Y; Kumon, H				Araki, Motoo; Uehara, Shinya; Sasaki, Katsumi; Monden, Koichi; Tsugawa, Masaya; Watanabe, Toyohiko; Monga, Manoji; Nasu, Yasutomo; Kumon, Hiromi			Ureteroscopic Management of Chronic Unilateral Hematuria: A Single-Center Experience over 22 Years	PLOS ONE			English	Article							FLEXIBLE URETEROPYELOSCOPY; DIAGNOSIS; URETERORENOSCOPY	Objective: To analyze the short and long term safety and efficacy of ureteroscopic evaluation and management of chronic unilateral hematuria. Methods: We retrospectively reviewed patients with chronic unilateral hematuria from 1987 to 2008. The distal to middle ureter was evaluated with a semi-rigid ureteroscope without a guidewire. Subsequently, the flexible ureteroscope was advanced into the upper ureter to the renal pelvis using a low-pressure automated irrigant system (Uromat (TM)). Lesions identified ureteroscopically were treated with diathermy fulguration. Results: One hundred and four (56 male, 48 female) patients were identified, with a median age of 37 (14-80) years and median follow-up of 139 (34-277) months. The median preoperative duration of gross hematuria was 5 (1-144) months. Endoscopic findings included 61 (56%) minute venous rupture (MVR; a venous bleeding without clear abnormalities), 21 (20%) hemangioma (vascular tumor-like structure), 3 (3%) varix (tortuous vein), 1 (1%) calculus and 18 (17%) no lesions. The incidence of "no lesions" was less in the recent 12 years (9%) than the first 10 years (27%), while the incidence of MVR increased from 40 to 66% (p<0.05). All patients were treated endoscopically. Immediate success rate was 96% (100% in the recent 12 years). Long-term recurrent gross hematuria rate was 7%. Six resolved spontaneously and only 1 required ureteroscopy, revealing a different bleeding site. Conclusion: Ureteroscopy and diathermy fulguration is highly useful for evaluation and treatment of chronic unilateral hematuria. Sophisticated technique and improved instrumentation contributes to a better outcome.	[Araki, Motoo; Uehara, Shinya; Sasaki, Katsumi; Monden, Koichi; Tsugawa, Masaya; Watanabe, Toyohiko; Nasu, Yasutomo; Kumon, Hiromi] Okayama Univ, Dept Urol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Monga, Manoji] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA	Okayama University; Cleveland Clinic Foundation	Araki, M (corresponding author), Okayama Univ, Dept Urol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	motoosh@md.okayama-u.ac.jp	Araki, Motoo/AAK-9375-2021	Araki, Motoo/0000-0002-3172-2482; Watanabe, Toyohiko/0000-0002-1138-5642				BAGLEY DH, 1990, UROLOGY, V35, P412, DOI 10.1016/0090-4295(90)80083-Y; BAGLEY DH, 1990, J UROLOGY, V143, P549, DOI 10.1016/S0022-5347(17)40016-4; Brito AH, 2009, J ENDOUROL, V23, P1273, DOI 10.1089/end.2009.0064; KAVOUSSI L, 1989, J UROLOGY, V142, P949, DOI 10.1016/S0022-5347(17)38950-4; KUMON H, 1990, J UROLOGY, V143, P554, DOI 10.1016/S0022-5347(17)40017-6; LANO MD, 1979, MAYO CLIN PROC, V54, P88; Laucirica O, 1992, Actas Urol Esp, V16, P366; MCMURTRY JM, 1987, J ENDOUROL, V1, P145; Mugiya S, 2007, J UROLOGY, V178, P517, DOI 10.1016/j.juro.2007.03.098; Nakada SY, 1997, J UROLOGY, V157, P776, DOI 10.1016/S0022-5347(01)65038-9; Nandy PR, 2004, UROLOGY, V64, P1107, DOI 10.1016/j.urology.2004.07.035; PATTERSON DE, 1984, J UROLOGY, V132, P1199, DOI 10.1016/S0022-5347(17)50095-6; Rowbotham C, 2001, BJU INT, V88, P841, DOI 10.1046/j.1464-4096.2001.01228.x; Serrano Alvaro, 2007, Archivos Espanoles de Urologia, V60, P155; Tawfiek ER, 1998, J UROLOGY, V160, P700, DOI 10.1016/S0022-5347(01)62762-9; WALLACH JB, 1959, J UROLOGY, V81, P515, DOI 10.1016/S0022-5347(17)66057-9	16	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e36729	10.1371/journal.pone.0036729	http://dx.doi.org/10.1371/journal.pone.0036729			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715360	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336800001
J	Stoltzfus, JD; Massey, HC; Nolan, TJ; Griffith, SD; Lok, JB				Stoltzfus, Jonathan D.; Massey, Holman C., Jr.; Nolan, Thomas J.; Griffith, Sandra D.; Lok, James B.			Strongyloides stercoralis age-1: A Potential Regulator of Infective Larval Development in a Parasitic Nematode	PLOS ONE			English	Article							STRONGYLOIDES-STERCORALIS; CAENORHABDITIS-ELEGANS; C-ELEGANS; GENE-EXPRESSION; CHEMOSENSORY NEURONS; PROPOSED ORTHOLOG; DAUER FORMATION; DNA-BINDING; INSULIN; DAF-16	Infective third-stage larvae (L3i) of the human parasite Strongyloides stercoralis share many morphological, developmental, and behavioral attributes with Caenorhabditis elegans dauer larvae. The 'dauer hypothesis' predicts that the same molecular genetic mechanisms control both dauer larval development in C. elegans and L3i morphogenesis in S. stercoralis. In C. elegans, the phosphatidylinositol-3 (PI3) kinase catalytic subunit AGE-1 functions in the insulin/IGF-1 signaling (IIS) pathway to regulate formation of dauer larvae. Here we identify and characterize Ss-age-1, the S. stercoralis homolog of the gene encoding C. elegans AGE-1. Our analysis of the Ss-age-1 genomic region revealed three exons encoding a predicted protein of 1,209 amino acids, which clustered with C. elegans AGE-1 in phylogenetic analysis. We examined temporal patterns of expression in the S. stercoralis life cycle by reverse transcription quantitative PCR and observed low levels of Ss-age-1 transcripts in all stages. To compare anatomical patterns of expression between the two species, we used Ss-age-1 or Ce-age-1 promoter::enhanced green fluorescent protein reporter constructs expressed in transgenic animals for each species. We observed conservation of expression in amphidial neurons, which play a critical role in developmental regulation of both dauer larvae and L3i. Application of the PI3 kinase inhibitor LY294002 suppressed L3i in vitro activation in a dose-dependent fashion, with 100 mu M resulting in a 90% decrease (odds ratio: 0.10, 95% confidence interval: 0.08-0.13) in the odds of resumption of feeding for treated L3i in comparison to the control. Together, these data support the hypothesis that Ss-age-1 regulates the development of S. stercoralis L3i via an IIS pathway in a manner similar to that observed in C. elegans dauer larvae. Understanding the mechanisms by which infective larvae are formed and activated may lead to novel control measures and treatments for strongyloidiasis and other soil-transmitted helminthiases.	[Stoltzfus, Jonathan D.; Massey, Holman C., Jr.; Nolan, Thomas J.; Lok, James B.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Griffith, Sandra D.] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Stoltzfus, JD (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.	jlok@vet.upenn.edu	Stoltzfus, Jonathan D./AAU-6735-2020	Stoltzfus, Jonathan D./0000-0002-4006-5306; Nolan, Thomas/0000-0002-6860-7947	U.S. National Institutes of Health (NIH) [AI50688, AI22662, RR02512, AI082390]; NIH [AI007532]; Penn Genome Frontiers Institute; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [Z01BC010837] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022662, T32AI007532, R21AI082390] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn Genome Frontiers Institute; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U.S. National Institutes of Health (NIH) research grants AI50688 and AI22662 to JBL, RR02512 to Mark Haskins, and AI082390 to Robert Greenberg. JDS received support from NIH training grant AI007532. This work was supported in part by the Penn Genome Frontiers Institute and a grant with the Pennsylvania Department of Health. The Department of Health specifically disclaims responsibility for any analyses, interpretations, or conclusions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboobaker AA, 2000, ANN MED, V32, P23, DOI 10.3109/07853890008995906; Anderson R. C., 2000, Nematode parasites of vertebrates: their development and transmission., DOI 10.1079/9780851994215.0000; Ashton FT, 2007, EXP PARASITOL, V115, P92, DOI 10.1016/j.exppara.2006.08.010; Ashton FT, 1998, J PARASITOL, V84, P691, DOI 10.2307/3284571; Babar P, 1999, NEUROBIOL AGING, V20, P513, DOI 10.1016/S0197-4580(99)00094-9; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Baugh LR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018086; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; *BIOR LAB, 2006, REAL TIM PCR APPL GU; Biron D, 2008, P NATL ACAD SCI USA, V105, P11002, DOI 10.1073/pnas.0805004105; Blaxter M, 1998, SCIENCE, V282, P2041, DOI 10.1126/science.282.5396.2041; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Brand A, 2004, INT J PARASITOL, V34, P909, DOI 10.1016/j.ijpara.2004.04.003; Burglin TR, 1998, INT J PARASITOL, V28, P395, DOI 10.1016/S0020-7519(97)00208-7; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Castelletto ML, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000370; Chan MS, 1997, PARASITOL TODAY, V13, P438, DOI 10.1016/S0169-4758(97)01144-7; Cornils A, 2011, DEVELOPMENT, V138, P1183, DOI 10.1242/dev.060905; Dalzell JJ, 2012, PARASITOLOGY, V139, P589, DOI 10.1017/S0031182011001946; Dalzell JJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001176; Drummond AJAB, GENEIOUS V5 5; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Evans TC, TRANSFORMATION MICRO; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; Gao X, 2009, INT J PARASITOL, V39, P407, DOI 10.1016/j.ijpara.2008.09.005; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; GOTTLIEB S, 1994, GENETICS, V137, P107; Herbert DR, 2002, EXP PARASITOL, V100, P112, DOI 10.1016/S0014-4894(02)00008-5; HOTEZ P, 1993, PARASITOL TODAY, V9, P23, DOI 10.1016/0169-4758(93)90159-D; Hu M, 2010, INT J PARASITOL, V40, P405, DOI 10.1016/j.ijpara.2009.09.005; Hu PJDauer, DAUER; Huang SCC, 2010, INT J PARASITOL, V40, P1619, DOI 10.1016/j.ijpara.2010.06.004; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Junio AB, 2008, EXP PARASITOL, V118, P253, DOI 10.1016/j.exppara.2007.08.018; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lok JB, 2012, PARASITOLOGY, V139, P574, DOI 10.1017/S0031182011001387; Lok JB, STRONGYLOIDES STERCO; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Massey HC, 2006, INT J PARASITOL, V36, P347, DOI 10.1016/j.ijpara.2005.11.007; Massey HC, 2005, MOL BIOCHEM PARASIT, V142, P116, DOI 10.1016/j.molbiopara.2005.03.004; Massey HC, 2003, INT J PARASITOL, V33, P1537, DOI 10.1016/S0020-7519(03)00205-4; Massey HC, 2001, INT J PARASITOL, V31, P377, DOI 10.1016/S0020-7519(01)00117-5; McGhee JD, 2007, DEV BIOL, V302, P627, DOI 10.1016/j.ydbio.2006.10.024; McGhee JD, 2009, DEV BIOL, V327, P551, DOI 10.1016/j.ydbio.2008.11.034; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Montes M, 2010, CURR OPIN INFECT DIS, V23, P500, DOI 10.1097/QCO.0b013e32833df718; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; NOBLE ER, 1989, PARASITOLOGY BIOL AN; Nolan TJ, 2004, PARASITOLOGY, V129, P753, DOI 10.1017/S0031182004006092; NOLAN TJ, 1993, J INFECT DIS, V168, P1479, DOI 10.1093/infdis/168.6.1479; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; R Core Team, 2021, R LANG ENV STAT COMP; Ramanathan R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001039; Riddle DL., 1988, NEMATODE CAENORHABDI, P393; ROSE J, 1991, J MOL EVOL, V32, P340, DOI 10.1007/BF02102193; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Schad G.A., 1989, P85; SCHAD GA, 1984, EXP PARASITOL, V57, P287, DOI 10.1016/0014-4894(84)90103-6; Soblik H, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.010157-1, 10.1074/mcp.M111.010157]; Srinivasan J, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-52; Stiernagle T, MAINTENANCE C ELEGAN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tissenbaum HA, 2000, P NATL ACAD SCI USA, V97, P460, DOI 10.1073/pnas.97.1.460; Tissenbaum HA, 1998, GENETICS, V148, P703; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; TRIANTAPHYLLOU AC, 1977, J PARASITOL, V63, P961, DOI 10.2307/3279827; VINEY ME, 1994, PARASITOLOGY, V109, P511, DOI 10.1017/S0031182000080768; Viney ME, STRONGYLOIDES SPP; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; Wang Z, 2009, P NATL ACAD SCI USA, V106, P9138, DOI 10.1073/pnas.0904064106; Weinkove D, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-1; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Wolkow CA, 2002, J BIOL CHEM, V277, P49591, DOI 10.1074/jbc.M207866200; Zhu H, 2011, J COMP NEUROL, V519, P2493, DOI 10.1002/cne.22637	84	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38587	10.1371/journal.pone.0038587	http://dx.doi.org/10.1371/journal.pone.0038587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701676	Green Submitted, Green Published, gold			2022-12-25	WOS:000305348400078
J	Santos-Aberturas, J; Vicente, CM; Payero, TD; Martin-Sanchez, L; Canibano, C; Martin, JF; Aparicio, JF				Santos-Aberturas, Javier; Vicente, Claudia M.; Payero, Tamara D.; Martin-Sanchez, Lara; Canibano, Carmen; Martin, Juan F.; Aparicio, Jesus F.			Hierarchical Control on Polyene Macrolide Biosynthesis: PimR Modulates Pimaricin Production via the PAS-LuxR Transcriptional Activator PimM	PLOS ONE			English	Article							STREPTOMYCES-NATALENSIS; NIKKOMYCIN BIOSYNTHESIS; POLYOXIN BIOSYNTHESIS; CHOLESTEROL OXIDASES; ESCHERICHIA-COLI; REGULATORY GENES; DNA; BINDING; DOMAIN; IDENTIFICATION	Control of polyene macrolide production in Streptomyces natalensis is mediated by the transcriptional activator PimR. This regulator combines an N-terminal domain corresponding to the Streptomyces antibiotic regulatory protein (SARP) family of transcriptional activators with a C-terminal half homologous to guanylate cyclases and large ATP-binding regulators of the LuxR family. The PimR SARP domain (PimR(SARP)) was expressed in Escherichia coli as a glutathione S-transferase (GST)-fused protein. Electrophoretic mobility shift assays showed that GST-PimR(SARP) binds a single target, the intergenic region between the regulatory genes pimR and pimMs in the pimaricin cluster. The PimR(SARP)-binding site was investigated by DNaseI protection studies, revealing that it contains three heptameric direct repeats adjusting to the consensus 5'-CGGCAAG-3'. Transcription start points of pimM and pimR promoters were identified by 5'-RACE, revealing that unlike other SARPs, PimR(SARP) does not interact with the -35 region of its target promoter. Quantitative transcriptional analysis of these regulatory genes on mutants on each of them has allowed the identification of the pimM promoter as the transcriptional target for PimR. Furthermore, the constitutive expression of pimM restored pimaricin production in a pimaricin-deficient strain carrying a deletion mutant of pimR. These results reveal that PimR exerts its positive effect on pimaricin production by controlling pimM expression level, a regulator whose gene product activates transcription from eight different promoters of pimaricin structural genes directly.	[Santos-Aberturas, Javier; Payero, Tamara D.; Aparicio, Jesus F.] Univ Leon, Fac Biol, Area Microbiol, E-24071 Leon, Spain; [Santos-Aberturas, Javier; Vicente, Claudia M.; Payero, Tamara D.; Martin-Sanchez, Lara; Canibano, Carmen; Martin, Juan F.; Aparicio, Jesus F.] Inst Biotechnol INBIOTEC, Leon, Spain	Universidad de Leon	Santos-Aberturas, J (corresponding author), Univ Leon, Fac Biol, Area Microbiol, E-24071 Leon, Spain.	jesus.aparicio@unileon.es	Santos-Aberturas, Javier/AAE-8162-2021; Aparicio, Jesús F./K-8686-2014	Aparicio, Jesús F./0000-0003-4242-4701; Vicente, Claudia M./0000-0001-8205-6486	Spanish Ministerio de Ciencia e Innovacion [BIO2007-67585, BIO2010-19911]; Junta de Castilla y Leon (Grupo de Excelencia) [GR117]; Ministerio de Ciencia e Innovacion [AP2005-3644, AP2007-02055]; Portuguese Fundacao para a Ciencia e a Tecnologia [SFRH/BD/64006/2009]; contract Juan de la Cierva [JCI-2009-05157]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Castilla y Leon (Grupo de Excelencia)(Junta de Castilla y Leon); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Portuguese Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); contract Juan de la Cierva	This work was supported by the Spanish Ministerio de Ciencia e Innovacion (BIO2007-67585 and BIO2010-19911 to J.F.A.); and the Junta de Castilla y Leon (Grupo de Excelencia GR117); F. P. U. fellowships of the Ministerio de Ciencia e Innovacion (AP2005-3644 to J.S-A., AP2007-02055 to T. D. P.); a fellowship from the Portuguese Fundacao para a Ciencia e a Tecnologia (SFRH/BD/64006/2009 to C. M. V.); and a contract Juan de la Cierva (JCI-2009-05157 to C. C.). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Anton N, 2004, J BACTERIOL, V186, P2567, DOI 10.1128/JB.186.9.2567-2575.2004; Anton N, 2007, MICROBIOL-SGM, V153, P3174, DOI 10.1099/mic.0.2007/009126-0; Aparicio JF, 2008, MOL BIOSYST, V4, P804, DOI 10.1039/b717500k; Aparicio JF, 2004, CURR MED CHEM, V11, P1645; Aparicio JF, 1999, J BIOL CHEM, V274, P10133, DOI 10.1074/jbc.274.15.10133; Arias P, 1999, J BACTERIOL, V181, P6958, DOI 10.1128/JB.181.22.6958-6968.1999; Bate N, 2002, MOL MICROBIOL, V43, P449, DOI 10.1046/j.1365-2958.2002.02756.x; Beites T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027472; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; BOURN WR, 1995, NUCLEIC ACIDS RES, V23, P3696, DOI 10.1093/nar/23.18.3696; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Caffrey P, 2008, CURR TOP MED CHEM, V8, P639, DOI 10.2174/156802608784221479; Carmody M, 2004, GENE, V343, P107, DOI 10.1016/j.gene.2004.08.006; De Schrijver A, 1999, MICROBIOL-UK, V145, P1287, DOI 10.1099/13500872-145-6-1287; Du YL, 2011, MICROBIOL-SGM, V157, P1300, DOI 10.1099/mic.0.046607-0; Enriquez LL, 2006, FEMS MICROBIOL LETT, V257, P312, DOI 10.1111/j.1574-6968.2006.00189.x; Guerra SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031475; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; He XH, 2010, MICROBIOL-SGM, V156, P828, DOI 10.1099/mic.0.033605-0; Hefti MH, 2004, EUR J BIOCHEM, V271, P1198, DOI 10.1111/j.1432-1033.2004.04023.x; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Jang BY, 2011, J KOREAN SOC APPL BI, V54, P141, DOI 10.3839/jksabc.2011.022; Kells PM, 2010, CHEM BIOL, V17, P841, DOI 10.1016/j.chembiol.2010.05.026; Li R, 2010, MOL MICROBIOL, V75, P349, DOI 10.1111/j.1365-2958.2009.06968.x; Li R, 2009, MICROBIOL-SGM, V155, P1819, DOI 10.1099/mic.0.028639-0; Liu G, 2005, MOL MICROBIOL, V55, P1855, DOI 10.1111/j.1365-2958.2005.04512.x; Martin JF, 2009, METHOD ENZYMOL, V459, P215, DOI 10.1016/S0076-6879(09)04610-2; Mendes MV, 2007, CHEM BIOL, V14, P279, DOI 10.1016/j.chembiol.2007.01.010; Mendes MV, 2007, METAB ENG, V9, P217, DOI 10.1016/j.ymben.2006.10.003; Mendes MV, 2005, BIOCHEM J, V386, P57, DOI 10.1042/BJ20040490; Mendes MV, 2001, CHEM BIOL, V8, P635, DOI 10.1016/S1074-5521(01)00033-3; Mizuno T, 1997, MOL MICROBIOL, V24, P665, DOI 10.1046/j.1365-2958.1997.3571723.x; Perez-Rueda E, 2000, NUCLEIC ACIDS RES, V28, P1838, DOI 10.1093/nar/28.8.1838; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rasmussen R, 2000, RAPID CYCLE REAL TIM, P21; Recio E, 2004, J BIOL CHEM, V279, P41586, DOI 10.1074/jbc.M402340200; Recio E, 2006, MICROBIOL-SGM, V152, P3147, DOI 10.1099/mic.0.28953-0; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J, 2001, MOL CLONING LAB MANU; Santos-Aberturas J, 2011, METAB ENG, V13, P756, DOI 10.1016/j.ymben.2011.09.011; Santos-Aberturas J, 2011, J BIOL CHEM, V286, P9150, DOI 10.1074/jbc.M110.182428; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sekurova ON, 2004, J BACTERIOL, V186, P1345, DOI 10.1128/JB.186.5.1345-1354.2004; Tanaka A, 2007, J MOL BIOL, V369, P322, DOI 10.1016/j.jmb.2007.02.096; Tang L, 1996, MOL MICROBIOL, V22, P801, DOI 10.1046/j.1365-2958.1996.01528.x; Tunca S, 2009, FEBS J, V276, P4814, DOI 10.1111/j.1742-4658.2009.07182.x; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; Vicente CM, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-33; Wietzorrek A, 1997, MOL MICROBIOL, V25, P1181, DOI 10.1046/j.1365-2958.1997.5421903.x; Wilkinson CJ, 2002, J MOL MICROB BIOTECH, V4, P417	53	21	28	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38536	10.1371/journal.pone.0038536	http://dx.doi.org/10.1371/journal.pone.0038536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22693644	gold, Green Published, Green Submitted			2022-12-25	WOS:000305343900055
J	Su, B; Gao, L; Meng, F; Guo, LW; Rothschild, J; Gelman, IH				Su, B.; Gao, L.; Meng, F.; Guo, L-W; Rothschild, J.; Gelman, I. H.			Adhesion-mediated cytoskeletal remodeling is controlled by the direct scaffolding of Src from FAK complexes to lipid rafts by SSeCKS/AKAP12	ONCOGENE			English	Article						Src; SSeCKS/Gravin/AKAP12; FAK; caveolin-1; adhesion; actin-based cytoskeleton	RECEPTOR TYROSINE KINASES; GROWTH-FACTOR RECEPTOR; HUMAN COLON-CANCER; C-SRC; ONCOGENIC TRANSFORMATION; SIGNAL-TRANSDUCTION; PROSTATE-CANCER; CELL-MIGRATION; BREAST-CANCER; IN-VIVO	Metastatic cell migration and invasion are regulated by altered adhesion-mediated signaling to the actin-based cytoskeleton via activated Src-FAK complexes. Src-suppressed C-kinase substrate (SSeCKS, the rodent orthologue of human Gravin/AKAP12), whose expression is downregulated by oncogenic Src and in many human cancers, antagonizes oncogenic Src pathways including those driving neovascularization at metastatic sites, metastatic cell motility and invasiveness. This is likely manifested through its function as a scaffolder of F-actin and signaling proteins such as cyclins, calmodulin, protein kinase C and A. Here we show that in contrast to its ability to inhibit haptotaxis, SSeCKS increased prostate cancer cell adhesion to fibronectin and type I collagen in a FAK-dependent manner, correlating with a relative increase in FAK(poY397) levels. In contrast, SSeCKS suppressed adhesion-induced Src activation (Src(poY416)) and phosphorylation of FAK at Y925, a known Src substrate site. SSeCKS also induced increased cell spreading, cell flattening, integrin beta 1 clustering and formation of mature focal adhesion plaques. An in silico analysis identified a Src-binding domain on SSeCKS(aa 153-166) that is homologous to the Src-binding domain of caveolin-1, and this region is required for SSeCKS-Src interaction, for SSeCKS-enhanced Src activity and sequestration to lipid rafts and for SSeCKS-enhanced adhesion of MAT-LyLu and CWR22Rv1 prostate cancer cells. Our data suggest a model in which SSeCKS suppresses oncogenic motility by sequestering Src to caveolin-rich lipid rafts, thereby disengaging Src from FAK-associated adhesion and signaling complexes. Oncogene (2013) 32, 2016-2026; doi:10.1038/onc.2012.218; published online 18 June 2012	[Su, B.; Gao, L.; Rothschild, J.; Gelman, I. H.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Meng, F.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA; [Guo, L-W] Natl Ctr Toxicol Res, Jefferson, AR 72079 USA	Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; US Food & Drug Administration (FDA)	Gelman, IH (corresponding author), Roswell Pk Canc Inst, Dept Canc Genet, Elm & Carlton St,CGP L2-309, Buffalo, NY 14263 USA.	irwin.gelman@roswellpark.org			NIH/NCI [CA94108, CA116430]; DoD [PC074228, PC101210]; NCI Comprehensive Cancer funds [P30-CA016056]; NATIONAL CANCER INSTITUTE [R55CA094108, R01CA116430, R01CA094108, P30CA016056] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DoD(United States Department of Defense); NCI Comprehensive Cancer funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Toru Ouchi and Eugene Kandel for critical review of the manuscript, Kalle Saksela and Bruce Mayer for discussions on SH3 interactions and Bruce Mayer, Y Peter Wang and Tom Parsons for reagents. This work is supported by grants (IHG) CA94108, CA116430 (NIH/NCI), PC074228, PC101210 (DoD) and, in part, through NCI Comprehensive Cancer funds (P30-CA016056).	Akakura S, 2010, CELL CYCLE, V9, P4656, DOI 10.4161/cc.9.23.13974; Aoki M, 1998, P NATL ACAD SCI USA, V95, P14950, DOI 10.1073/pnas.95.25.14950; Bild AH, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2344; Biscardi JS, 1999, ADV CANCER RES, V76, P61; BOS JL, 1989, CANCER RES, V49, P4682; Brunton VG, 2008, CURR OPIN PHARMACOL, V8, P427, DOI 10.1016/j.coph.2008.06.012; Brunton VG, 2005, CANCER RES, V65, P1335, DOI 10.1158/0008-5472.CAN-04-1949; Bu Y, 2007, J BIOL CHEM, V282, P26725, DOI 10.1074/jbc.M702885200; CROSS FR, 1984, MOL CELL BIOL, V4, P1834, DOI 10.1128/MCB.4.9.1834; Damsky CH, 1991, CURR OPIN CELL BIOL, V3, P777, DOI 10.1016/0955-0674(91)90049-5; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Gelman IH, 2006, MOL CANCER RES, V4, P151, DOI 10.1158/1541-7786.MCR-05-0252; Gelman IH, 1998, CELL MOTIL CYTOSKEL, V41, P1; Gelman Irwin H, 2011, Front Biosci (Elite Ed), V3, P801; Gelman Irwin H, 2010, Genes Cancer, V1, P1147, DOI 10.1177/1947601910392984; GLENNEY JR, 1989, J BIOL CHEM, V264, P20163; Guo LW, 2011, J BIOL CHEM, V286, P38356, DOI 10.1074/jbc.M111.258830; Hiscox S, 2006, ENDOCR-RELAT CANCER, V13, pS53, DOI 10.1677/erc.1.01297; HUMPHRIES MJ, 1998, CURRENT PROTOCOLS CE; Iiizumi M, 2008, BBA-REV CANCER, V1786, P87, DOI 10.1016/j.bbcan.2008.07.002; ILLC D, 1995, NATURE, V377, P539; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Ischenko I, 2008, ONCOGENE, V27, P7212, DOI 10.1038/onc.2008.326; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Kumar CC, 1998, ONCOGENE, V17, P1365, DOI 10.1038/sj.onc.1202172; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Li SW, 1996, J BIOL CHEM, V271, P3863; Lin XY, 1997, CANCER RES, V57, P2304; Lin XY, 1996, J BIOL CHEM, V271, P28430, DOI 10.1074/jbc.271.45.28430; MACCALMAN CD, 1994, CLIN EXP METASTAS, V12, P101, DOI 10.1007/BF01753976; Malek RL, 2002, ONCOGENE, V21, P7256, DOI 10.1038/sj.onc.1205900; Mao WG, 1997, ONCOGENE, V15, P3083, DOI 10.1038/sj.onc.1201496; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Meng FJ, 2012, J CELL SCI, V125, P743, DOI 10.1242/jcs.093104; MILLIGAN G, 1995, TRENDS BIOCHEM SCI, V20, P181, DOI 10.1016/S0968-0004(00)89004-0; Mitra SK, 2006, ONCOGENE, V25, P5969, DOI 10.1038/sj.onc.1209588; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x; Moissoglu K, 2003, J BIOL CHEM, V278, P47946, DOI 10.1074/jbc.M302720200; Navarro A, 2004, FASEB J, V18, P1801, DOI 10.1096/fj.04-2516rev; Nethe M, 2011, CELL ADHES MIGR, V5, P59, DOI 10.4161/cam.5.1.13702; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Ross SH, 2011, J CELL SCI, V124, P1808, DOI 10.1242/jcs.079830; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; SCHALLER MD, 1993, MOL CELL BIOL, V13, P785, DOI 10.1128/MCB.13.2.785; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; Seong JY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1414; Seong JH, 2009, CHEM BIOL, V16, P48, DOI 10.1016/j.chembiol.2008.11.007; Shaul PW, 1998, AM J PHYSIOL-LUNG C, V275, pL843, DOI 10.1152/ajplung.1998.275.5.L843; Sieg DJ, 1999, J CELL SCI, V112, P2677; Song KS, 1997, CELL MOL BIOL, V43, P293; Sturge J, 2011, NAT REV CLIN ONCOL, V8, P357, DOI 10.1038/nrclinonc.2011.67; Su B, 2006, CANCER RES, V66, P5599, DOI 10.1158/0008-5472.CAN-05-4123; Su B, 2010, J BIOL CHEM, V285, P4578, DOI 10.1074/jbc.M109.073494; Sverdlov M, 2007, J CELL MOL MED, V11, P1239, DOI 10.1111/j.1582-4934.2007.00127.x; Tao JC, 2007, J BIOL CHEM, V282, P6597, DOI 10.1074/jbc.M608927200; Trevino JG, 2006, AM J PATHOL, V168, P962, DOI 10.2353/ajpath.2006.050570; Wanaski SP, 2003, BIOCHEMISTRY-US, V42, P42, DOI 10.1021/bi012097n; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Xia W, 2001, CANCER RES, V61, P5644; Xia W, 2002, EXP CELL RES, V277, P139, DOI 10.1006/excr.2002.5560; Yan XH, 2009, EXP CELL RES, V315, P1247, DOI 10.1016/j.yexcr.2008.12.026; Yeo MG, 2006, MOL CELL BIOL, V26, P4399, DOI 10.1128/MCB.01147-05; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yoshida T, 2010, CANCER SCI, V101, P167, DOI 10.1111/j.1349-7006.2009.01368.x; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	76	31	31	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 18	2013	32	16					2016	2026		10.1038/onc.2012.218	http://dx.doi.org/10.1038/onc.2012.218			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	130LY	22710722	Green Accepted			2022-12-25	WOS:000317919900003
J	Batters, C; Woodall, KA; Toseland, CP; Hundschell, C; Veigel, C				Batters, Christopher; Woodall, Katy A.; Toseland, Christopher P.; Hundschell, Christian; Veigel, Claudia			Cloning, Expression, and Characterization of a Novel Molecular Motor, Leishmania Myosin-XXI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE MYOSIN; LARGE WORKING STROKE; UBIQUITIN-BINDING; CALMODULIN; DOMAINS; ACTIN; VI; RECOGNITION; MOTILITY; COMPLEX	The genome of the Leishmania parasite contains two classes of myosin. Myosin-XXI, seemingly the only myosin isoform expressed in the protozoan parasite, has been detected in both the promastigote and amastigote stages of the Leishmania life cycle. It has been suggested to perform a variety of functions, including roles in membrane anchorage, but also long-range directed movements of cargo. However, nothing is known about the biochemical or mechanical properties of this motor. Here we designed and expressed various myosin-XXI constructs using a baculovirus expression system. Both full-length (amino acids 1-1051) and minimal motor domain constructs (amino acids 1-800) featured actin-activated ATPase activity. Myosin-XXI was soluble when expressed either with or without calmodulin. In the presence of calcium (pCa 4.1) the full-length motor could bind a single calmodulin at its neck domain (probably amino acids 809-823). Calmodulin binding was required for motility but not for ATPase activity. Once bound, calmodulin remained stably attached independent of calcium concentration (pCa 3-7). In gliding filament assays, myosin-XXI moved actin filaments at similar to 15 nm/s, insensitive to both salt (25-1000 mM KCl) and calcium concentrations (pCa 3-7). Calmodulin binding to the neck domain might be involved in regulating the motility of the myosin-XXI motor for its various cellular functions in the different stages of the Leishmania parasite life cycle.	[Veigel, Claudia] Univ Munich, Dept Cellular Physiol, D-80336 Munich, Germany; Univ Munich, Ctr Nanosci CeNS, D-80336 Munich, Germany	University of Munich; University of Munich	Veigel, C (corresponding author), Univ Munich, Dept Cellular Physiol, Schillerstr 44, D-80336 Munich, Germany.	claudia.veigel@med.uni-muenchen.de	Toseland, Chris/AAC-8517-2019	Toseland, Chris/0000-0002-1641-7535	Deutsche Forschungsgemeinschaft [SFB 863]; Friedrich-Baur Stiftung; Munich Centre for Nanoscience (CeNS); EMBO long-term fellowship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Baur Stiftung; Munich Centre for Nanoscience (CeNS); EMBO long-term fellowship(European Molecular Biology Organization (EMBO))	This work was funded by the Deutsche Forschungsgemeinschaft SFB 863, by the Friedrich-Baur Stiftung, and by the Munich Centre for Nanoscience (CeNS). This work was also supported by an EMBO long-term fellowship (to C. P. T.).	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; COLUCCIO LM, 1994, J CELL SCI, V107, P2279; CREMO CR, 1995, J BIOL CHEM, V270, P2171, DOI 10.1074/jbc.270.5.2171; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dunn AR, 2010, P NATL ACAD SCI USA, V107, P7746, DOI 10.1073/pnas.1002430107; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Heinen C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1179; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Katta SS, 2010, J CELL SCI, V123, P2034, DOI 10.1242/jcs.064725; Katta SS, 2009, MOL BIOCHEM PARASIT, V164, P105, DOI 10.1016/j.molbiopara.2008.12.002; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Kron S. J., 1991, METH ENZYMOL, V196, P399, DOI [10.1016/0076-6879(91)96035-P, DOI 10.1016/0076-6879(91)96035-P]; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Lister I, 2004, EMBO J, V23, P1729, DOI 10.1038/sj.emboj.7600180; Long J, 2010, J MOL BIOL, V396, P178, DOI 10.1016/j.jmb.2009.11.032; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Martin SR, 2004, FEBS LETT, V567, P166, DOI 10.1016/j.febslet.2004.04.053; Molloy JE, 2000, FEBS LETT, V480, P293, DOI 10.1016/S0014-5793(00)01937-2; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; OHNO H, 1986, BIOCHEM J, V235, P553, DOI 10.1042/bj2350553; ONEIL KT, 1990, SCIENCE, V249, P774, DOI 10.1126/science.2389143; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Post PL, 2002, J BIOL CHEM, V277, P11679, DOI 10.1074/jbc.M111173200; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; Santrich C, 1997, MOL BIOCHEM PARASIT, V90, P95, DOI 10.1016/S0166-6851(97)00149-7; Spink BJ, 2008, NAT STRUCT MOL BIOL, V15, P591, DOI 10.1038/nsmb.1429; TRYBUS KM, 1994, J CELL BIOL, V124, P963, DOI 10.1083/jcb.124.6.963; Uyeda TQP, 1996, P NATL ACAD SCI USA, V93, P4459, DOI 10.1073/pnas.93.9.4459; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wang B, 2004, PROTEIN SCI, V13, P3285, DOI 10.1110/ps.04928204	38	13	13	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27556	27566		10.1074/jbc.M112.381301	http://dx.doi.org/10.1074/jbc.M112.381301			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718767	Green Published, hybrid			2022-12-25	WOS:000307840700031
J	Roy, A; Cingolani, G				Roy, Ankoor; Cingolani, Gino			Structure of P22 Headful Packaging Nuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGES; DNA ENCAPSULATION; TERMINASE; PHAGE-P22; BINDING; BACTERIOPHAGE-P22; INITIATION; MOTOR; TRYPTOPHAN; MECHANISM	Packaging of viral genomes into preformed procapsids requires the controlled and synchronized activity of an ATPase and a genome-processing nuclease, both located in the large terminase (L-terminase) subunit. In this paper, we have characterized the structure and regulation of bacteriophage P22 L-terminase (gp2). Limited proteolysis reveals a bipartite organization consisting of an N-terminal ATPase core flexibly connected to a C-terminal nuclease domain. The 2.02 angstrom crystal structure of P22 headful nuclease obtained by in-drop proteolysis of full-length L-terminase (FL-L-terminase) reveals a central seven-stranded beta-sheet core that harbors two magnesium ions. Modeling studies with DNA suggest that the two ions are poised for two-metal ion-dependent catalysis, but the nuclease DNA binding surface is sterically hindered by a loop-helix (L-1-alpha(2)) motif, which is incompatible with catalysis. Accordingly, the isolated nuclease is completely inactive in vitro, whereas it exhibits endonucleolytic activity in the context of FL-L-terminase. Deleting the autoinhibitory L-1-alpha(2) motif (or just the loop L-1) restores nuclease activity to a level comparable with FL-L-terminase. Together, these results suggest that the activity of P22 headful nuclease is regulated by intramolecular cross-talk with the N-terminal ATPase domain. This cross-talk allows for precise and controlled cleavage of DNA that is essential for genome packaging.	[Roy, Ankoor; Cingolani, Gino] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Jefferson University	Cingolani, G (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	gino.cingolani@jefferson.edu			National Institutes of Health [1R56 AI095974-01, 1R01GM100888-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI095974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R56 AI095974-01 and 1R01GM100888-01A1 (to G.C.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhardwaj A, 2007, J MOL BIOL, V371, P374, DOI 10.1016/j.jmb.2007.05.051; BOTSTEIN D, 1968, COLD SPRING HARB SYM, V33, P659, DOI 10.1101/SQB.1968.033.01.075; BOTSTEIN D, 1973, J MOL BIOL, V80, P669, DOI 10.1016/0022-2836(73)90204-0; BRAVO A, 1990, NUCLEIC ACIDS RES, V18, P2881, DOI 10.1093/nar/18.10.2881; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Camacho AG, 2003, J BIOL CHEM, V278, P23251, DOI 10.1074/jbc.M301805200; CASJENS S, 1974, Journal of Supramolecular Structure, V2, P202, DOI 10.1002/jss.400020215; CASJENS S, 1987, J MOL BIOL, V194, P411, DOI 10.1016/0022-2836(87)90671-1; CASJENS S, 1992, J MOL BIOL, V227, P1086, DOI 10.1016/0022-2836(92)90523-M; Casjens Sherwood, 2005, P80; Casjens SR, 2011, NAT REV MICROBIOL, V9, P647, DOI 10.1038/nrmicro2632; Cingolani G, 2000, FEBS LETT, V484, P291, DOI 10.1016/S0014-5793(00)02154-2; EBELTSIPIS J, 1972, J MOL BIOL, V71, P433, DOI 10.1016/0022-2836(72)90361-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P16868, DOI 10.1073/pnas.0704008104; Ghosh-Kumar M, 2011, NUCLEIC ACIDS RES, V39, P2742, DOI 10.1093/nar/gkq1191; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Jain AA, 2003, BBA-GEN SUBJECTS, V1622, P73, DOI 10.1016/S0304-4165(03)00119-3; Kanamaru S, 2004, J BIOL CHEM, V279, P40795, DOI 10.1074/jbc.M403647200; LASKI F, 1982, J MOL BIOL, V154, P565, DOI 10.1016/S0022-2836(82)80015-6; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Lin HC, 1998, VIROLOGY, V242, P118, DOI 10.1006/viro.1997.9019; Lorenzen K, 2008, J MOL BIOL, V379, P385, DOI 10.1016/j.jmb.2008.02.017; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mitchell MS, 2004, VIROLOGY, V321, P217, DOI 10.1016/j.virol.2003.11.006; Moore SD, 2002, J MOL BIOL, V315, P975, DOI 10.1006/jmbi.2001.5275; Nadal M, 2010, P NATL ACAD SCI USA, V107, P16078, DOI 10.1073/pnas.1007144107; Nemecek D, 2008, J MOL BIOL, V383, P494, DOI 10.1016/j.jmb.2008.08.050; Nemecek D, 2007, J MOL BIOL, V374, P817, DOI 10.1016/j.jmb.2007.08.070; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Nowotny M, 2009, EMBO REP, V10, P144, DOI 10.1038/embor.2008.256; Olia AS, 2011, NAT STRUCT MOL BIOL, V18, P597, DOI 10.1038/nsmb.2023; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; Pedulla ML, 2003, J BACTERIOL, V185, P1475, DOI 10.1128/JB.185.4.1475-1477.2003; POTEETE AR, 1979, VIROLOGY, V95, P565, DOI 10.1016/0042-6822(79)90509-9; RAJ AS, 1974, MOL GEN GENET, V135, P175, DOI 10.1007/BF00264784; RAJESWARI MR, 1987, BIOCHEMISTRY-US, V26, P6825, DOI 10.1021/bi00395a036; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rao Venigalla B., 2005, P40; Roy A., 2011, STRUCTURE, DOI org/10.1016/j.str.2012.05.01; Roy A, 2011, ACTA CRYSTALLOGR F, V67, P104, DOI 10.1107/S174430911004697X; Smits C, 2009, EMBO REP, V10, P592, DOI 10.1038/embor.2009.53; Sun SY, 2007, MOL CELL, V25, P943, DOI 10.1016/j.molcel.2007.02.013; Sun SY, 2010, CURR OPIN STRUC BIOL, V20, P114, DOI 10.1016/j.sbi.2009.12.006; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; Teschke CM, 2010, VIROLOGY, V401, P119, DOI 10.1016/j.virol.2010.02.017; Wu H, 2002, MOL MICROBIOL, V45, P1631, DOI 10.1046/j.1365-2958.2002.03114.x; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181	52	37	38	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28196	28205		10.1074/jbc.M112.349894	http://dx.doi.org/10.1074/jbc.M112.349894			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22715098	Green Published, hybrid			2022-12-25	WOS:000307840700093
J	Lloris-Garcera, P; Bianchi, F; Slusky, JSG; Seppala, S; Daley, DO; von Heijne, G				Lloris-Garcera, Pilar; Bianchi, Frans; Slusky, Joanna S. G.; Seppala, Susanna; Daley, Daniel O.; von Heijne, Gunnar			Antiparallel Dimers of the Small Multidrug Resistance Protein EmrE Are More Stable Than Parallel Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; ESCHERICHIA-COLI; TRANSPORTER; TOPOLOGY; EVOLUTION; MODEL	The bacterial multidrug transporter EmrE is a dual-topology membrane protein and as such is able to insert into the membrane in two opposite orientations. The functional form of EmrE is a homodimer; however, the relative orientation of the subunits in the dimer is under debate. Using EmrE variants with fixed, opposite orientations in the membrane, we now show that, although the proteins are able to form parallel dimers, an antiparallel organization of the subunits in the dimer is preferred. Blue-native PAGE analyses of intact oligomers and disulfide cross-linking demonstrate that in membranes, the proteins form parallel dimers only if no oppositely orientated partner is present. Co-expression of oppositely orientated proteins almost exclusively yields antiparallel dimers. Finally, parallel dimers can be disrupted and converted into antiparallel dimers by heating of detergent-solubilized protein. Importantly, in vivo function is correlated clearly to the presence of antiparallel dimers. Our results suggest that an antiparallel arrangement of the subunits in the dimer is more stable than a parallel organization and likely corresponds to the functional form of the protein.	[Lloris-Garcera, Pilar; Bianchi, Frans; Slusky, Joanna S. G.; Seppala, Susanna; Daley, Daniel O.; von Heijne, Gunnar] Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [von Heijne, Gunnar] Stockholm Univ, Sci Life Lab, SE-17121 Solna, Sweden	Stockholm University; Stockholm University	von Heijne, G (corresponding author), Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se	Bianchi, Frans/E-8796-2018; von Heijne, Gunnar/AAH-9389-2019; von Heijne, Gunnar/F-5576-2011	Bianchi, Frans/0000-0002-9385-9695; von Heijne, Gunnar/0000-0002-4490-8569; Slusky, Joanna/0000-0003-0842-6340; Daley, Daniel/0000-0002-6425-5059; Seppala, Susanna/0000-0002-2983-3669	European Research Council [ERC-2008-AdG 232648]; Swedish Foundation for Strategic Research; Swedish Research Council; Swedish Cancer Foundation; European Communities TranSys Grant [PITN-2008-215524]; International Human Frontier Science Program Organization	European Research Council(European Research Council (ERC)European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; European Communities TranSys Grant; International Human Frontier Science Program Organization(Human Frontier Science Program)	This work was supported by European Research Council Grant ERC-2008-AdG 232648, the Swedish Foundation for Strategic Research, the Swedish Research Council, and the Swedish Cancer Foundation (to G. v. H.); the European Communities TranSys Grant PITN-2008-215524 (to P. L. G.); and the International Human Frontier Science Program Organization (to J. S. G. S.).	Bay DC, 2008, BBA-BIOMEMBRANES, V1778, P1814, DOI 10.1016/j.bbamem.2007.08.015; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Ito K, 2010, BIOCHEM BIOPH RES CO, V393, P1, DOI 10.1016/j.bbrc.2010.01.073; Nara T, 2007, J BIOCHEM, V142, P621, DOI 10.1093/jb/mvm169; Nasie I, 2010, J BIOL CHEM, V285, P15234, DOI 10.1074/jbc.M110.108746; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Rotem D, 2001, J BIOL CHEM, V276, P48243, DOI 10.1074/jbc.M108229200; Schuldiner S, 2012, TRENDS BIOCHEM SCI, V37, P215, DOI 10.1016/j.tibs.2012.02.006; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Soskine M, 2006, J BIOL CHEM, V281, P36205, DOI 10.1074/jbc.M607186200; Steiner-Mordoch S, 2008, EMBO J, V27, P17, DOI 10.1038/sj.emboj.7601951; Stenberg F, 2005, J BIOL CHEM, V280, P34409, DOI 10.1074/jbc.M506479200; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Tate CG, 2003, J MOL BIOL, V332, P229, DOI 10.1016/S0022-2836(03)00895-7; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611	17	31	32	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26052	26059		10.1074/jbc.M112.357590	http://dx.doi.org/10.1074/jbc.M112.357590			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22700980	Green Published, hybrid			2022-12-25	WOS:000306916300032
J	Tokhtaeva, E; Clifford, RJ; Kaplan, JH; Sachs, G; Vagin, O				Tokhtaeva, Elmira; Clifford, Rebecca J.; Kaplan, Jack H.; Sachs, George; Vagin, Olga			Subunit Isoform Selectivity in Assembly of Na,K-ATPase alpha-beta Heterodimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; NA+-K+-ATPASE; ADHESION MOLECULE; IDENTIFICATION; EXPRESSION; ISOZYMES; GLIA; AMOG; NA+,K+-ATPASES; HETEROGENEITY	To catalyze ion transport, the Na,K-ATPase must contain one alpha and one beta subunit. When expressed by transfection in various expression systems, each of the four alpha subunit isoforms can assemble with each of the three beta subunit isoforms and form an active enzyme, suggesting the absence of selective alpha-beta isoform assembly. However, it is unknown whether in vivo conditions the alpha-beta assembly is random or isoform-specific. The alpha(2)-beta(2) complex was selectively immunoprecipitated by both anti-alpha(2) and anti-beta(2) antibodies from extracts of mouse brain, which contains cells co-expressing multiple Na,K-ATPase isoforms. Neither alpha(1)-beta(2) nor alpha(2)-beta(1) complexes were detected in the immunoprecipitates. Furthermore, in MDCK cells co-expressing alpha(1), beta(1), and beta(2) isoforms, a greater fraction of the beta(2) subunits was unassembled with alpha(1) as compared with that of the beta(1) subunits, indicating preferential association of the alpha(1) isoform with the beta(1) isoform. In addition, the alpha(1)-beta(2) complex was less resistant to various detergents than the alpha(1)-beta(1) complex isolated from MDCK cells or the alpha(2)-beta(2) complex isolated from mouse brain. Therefore, the diversity of the alpha-beta Na,K-ATPase heterodimers in vivo is determined not only by cell-specific co-expression of particular isoforms, but also by selective association of the alpha and beta subunit isoforms.	[Tokhtaeva, Elmira; Sachs, George; Vagin, Olga] Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90073 USA; [Tokhtaeva, Elmira; Sachs, George; Vagin, Olga] Vet Affairs Greater Los Angeles Hlth Care Syst, Los Angeles, CA 90073 USA; [Clifford, Rebecca J.; Kaplan, Jack H.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Vagin, O (corresponding author), VAG LAHS W LA, 11301 Wilshire Blvd,Bldg 113,Rm 324, Los Angeles, CA 90073 USA.	olgav@ucla.edu		Kaplan, Jack/0000-0002-7048-6574	National Institutes of Health [DK077149, DK058333, GM39500]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058333, R01DK077149, R56DK058333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077149 (to O. V.), DK058333 (to G. S.), and GM39500 (to J. H. K.).	ANTONICEK H, 1987, J CELL BIOL, V104, P1587, DOI 10.1083/jcb.104.6.1587; Arystarkhova E, 1997, J BIOL CHEM, V272, P22405, DOI 10.1074/jbc.272.36.22405; Bagrov AY, 2008, NAT CLIN PRACT NEPHR, V4, P378, DOI 10.1038/ncpneph0848; Beggah AT, 1997, ANN NY ACAD SCI, V834, P537, DOI 10.1111/j.1749-6632.1997.tb52311.x; Blanco G, 2005, SEMIN NEPHROL, V25, P292, DOI 10.1016/j.semnephrol.2005.03.004; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Blaustein MP, 2009, HYPERTENSION, V53, P291, DOI 10.1161/HYPERTENSIONAHA.108.119974; Boer K, 2010, EPILEPSY RES, V91, P84, DOI 10.1016/j.eplepsyres.2010.06.015; Boer K, 2010, BRAIN PATHOL, V20, P234, DOI 10.1111/j.1750-3639.2009.00268.x; Bottger P, 2012, NEUROSCI BIOBEHAV R, V36, P855, DOI 10.1016/j.neubiorev.2011.10.005; CAMERON R, 1994, MOL BRAIN RES, V21, P333, DOI 10.1016/0169-328X(94)90264-X; Cereijido M, 2012, AM J PHYSIOL-CELL PH, V302, pC473, DOI 10.1152/ajpcell.00083.2011; Clifford RJ, 2008, AM J PHYSIOL-RENAL, V295, pF1314, DOI 10.1152/ajprenal.90406.2008; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Desfrere L, 2009, P NATL ACAD SCI USA, V106, P2212, DOI 10.1073/pnas.0809253106; Dobretsov M, 2005, FRONT BIOSCI-LANDMRK, V10, P2373, DOI 10.2741/1704; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Gatto C, 1998, J BIOL CHEM, V273, P10578, DOI 10.1074/jbc.273.17.10578; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; Geering K, 2000, BIOCHEMISTRY-US, V39, P12688, DOI 10.1021/bi0009791; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; GLOOR S, 1990, J CELL BIOL, V110, P165, DOI 10.1083/jcb.110.1.165; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; Harada K, 2006, J PHYSIOL SCI, V56, P113, DOI 10.2170/physiolsci.RP001905; Hirose S, 2006, EPILEPSY RES, V70, pS206, DOI 10.1016/j.eplepsyres.2005.12.007; Jimenez T, 2011, P NATL ACAD SCI USA, V108, P644, DOI 10.1073/pnas.1016902108; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kapri-Pardes E, 2011, J BIOL CHEM, V286, P42888, DOI 10.1074/jbc.M111.293852; Kroepfl JF, 2001, J NEUROCHEM, V77, P1301, DOI 10.1046/j.1471-4159.2001.00343.x; Leo L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002129; Lin H, 2005, J PHYSIOL-LONDON, V564, P161, DOI 10.1113/jphysiol.2004.081455; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Malik N, 1996, J BIOL CHEM, V271, P22754, DOI 10.1074/jbc.271.37.22754; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; McLean WJ, 2009, JARO-J ASSOC RES OTO, V10, P37, DOI 10.1007/s10162-008-0152-9; Molinari M, 2005, MOL CELL, V20, P503, DOI 10.1016/j.molcel.2005.09.027; Paschen W, 2003, CELL CALCIUM, V34, P365, DOI 10.1016/S0143-4160(03)00139-8; Peng L, 1997, J NEUROSCI, V17, P3488; Rajasekaran SA, 2009, FRONT BIOSCI-LANDMRK, V14, P2130, DOI 10.2741/3367; Rindler TN, 2011, AM J PHYSIOL-HEART C, V301, pH1396, DOI 10.1152/ajpheart.00121.2011; Ritter C, 2005, EMBO J, V24, P1730, DOI 10.1038/sj.emboj.7600645; Rose EM, 2009, J NEUROSCI, V29, P8143, DOI 10.1523/JNEUROSCI.1081-09.2009; Schmalzing G, 1997, P NATL ACAD SCI USA, V94, P1136, DOI 10.1073/pnas.94.4.1136; Senner V, 2003, NEUROPATH APPL NEURO, V29, P370, DOI 10.1046/j.1365-2990.2003.00473.x; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SUN Y, 1992, AM J PHYSIOL, V262, pC1491, DOI 10.1152/ajpcell.1992.262.6.C1491; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Tokbtaeva E, 2010, BIOCHEMISTRY-US, V49, P3116, DOI 10.1021/bi100115a; Tokhtaeva E, 2010, J BIOL CHEM, V285, P39289, DOI 10.1074/jbc.M110.172858; Tokhtaeva E, 2009, BIOCHEMISTRY-US, V48, P11421, DOI 10.1021/bi901438z; Vagin O, 2005, J BIOL CHEM, V280, P43159, DOI 10.1074/jbc.M508262200; Vagin O, 2012, AM J PHYSIOL-CELL PH, V302, pC1271, DOI 10.1152/ajpcell.00456.2011; Vagin O, 2006, J BIOL CHEM, V281, P39573, DOI 10.1074/jbc.M606507200; van den Boom J, 2006, INT J CANCER, V119, P2330, DOI 10.1002/ijc.22108; WATTS AG, 1991, P NATL ACAD SCI USA, V88, P7425, DOI 10.1073/pnas.88.16.7425; Woo AL, 2000, J BIOL CHEM, V275, P20693, DOI 10.1074/jbc.M002323200; Yamamoto A, 2006, J NEUROPATH EXP NEUR, V65, P217, DOI 10.1097/01.jnen.0000202886.22082.2a	58	48	49	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26115	26125		10.1074/jbc.M112.370734	http://dx.doi.org/10.1074/jbc.M112.370734			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22696220	Green Published, hybrid			2022-12-25	WOS:000306916300039
J	Andrianaivoarimanana, V; Telfer, S; Rajerison, M; Ranjalahy, MA; Andriamiarimanana, F; Rahaingosoamamitiana, C; Rahalison, L; Jambou, R				Andrianaivoarimanana, Voahangy; Telfer, Sandra; Rajerison, Minoarisoa; Ranjalahy, Michel A.; Andriamiarimanana, Fehivola; Rahaingosoamamitiana, Corinne; Rahalison, Lila; Jambou, Ronan			Immune Responses to Plague Infection in Wild Rattus rattus, in Madagascar: A Role in Foci Persistence?	PLOS ONE			English	Article							YERSINIA-PESTIS; PNEUMONIC PLAGUE; SUSCEPTIBILITY; PROTECTION; VACCINE; SERODIAGNOSIS; IMMUNIZATION; ANTIBODIES; RESERVOIR; ANTIGENS	Background: Plague is endemic within the central highlands of Madagascar, where its main reservoir is the black rat, Rattus rattus. Typically this species is considered susceptible to plague, rapidly dying after infection inducing the spread of infected fleas and, therefore, dissemination of the disease to humans. However, persistence of transmission foci in the same area from year to year, supposes mechanisms of maintenance among which rat immune responses could play a major role. Immunity against plague and subsequent rat survival could play an important role in the stabilization of the foci. In this study, we aimed to investigate serological responses to plague in wild black rats from endemic areas of Madagascar. In addition, we evaluate the use of a recently developed rapid serological diagnostic test to investigate the immune response of potential reservoir hosts in plague foci. Methodology/Principal Findings: We experimentally infected wild rats with Yersinia pestis to investigate short and long-term antibody responses. Anti-F1 IgM and IgG were detected to evaluate this antibody response. High levels of anti-F1 IgM and IgG were found in rats one and three weeks respectively after challenge, with responses greatly differing between villages. Plateau in anti-F1 IgM and IgG responses were reached for as few as 500 and 1500 colony forming units (cfu) inoculated respectively. More than 10% of rats were able to maintain anti-F1 responses for more than one year. This anti-F1 response was conveniently followed using dipsticks. Conclusion/Significance: Inoculation of very few bacteria is sufficient to induce high immune response in wild rats, allowing their survival after infection. A great heterogeneity of rat immune responses was found within and between villages which could heavily impact on plague epidemiology. In addition, results indicate that, in the field, anti-F1 dipsticks are efficient to investigate plague outbreaks several months after transmission.	[Andrianaivoarimanana, Voahangy; Rajerison, Minoarisoa; Ranjalahy, Michel A.; Andriamiarimanana, Fehivola; Rahaingosoamamitiana, Corinne; Rahalison, Lila] Inst Pasteur Madagascar, Unite Peste, Antananarivo, Madagascar; [Telfer, Sandra] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Jambou, Ronan] Inst Pasteur Madagascar, Unite Immunol, Antananarivo, Madagascar	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; University of Aberdeen; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Andrianaivoarimanana, V (corresponding author), Inst Pasteur Madagascar, Unite Peste, Antananarivo, Madagascar.	rjambou@pasteur.mg	JAMBOU, RONAN/CAG-3718-2022	Telfer, Sandra/0000-0002-9596-0711	Institut Pasteur de Madagascar; Wellcome Trust [081705/B/06/Z]	Institut Pasteur de Madagascar; Wellcome Trust(Wellcome TrustEuropean Commission)	This investigation was funded by the Institut Pasteur de Madagascar and the Wellcome Trust (081705/B/06/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GW, 1997, AM J TROP MED HYG, V56, P471, DOI 10.4269/ajtmh.1997.56.471; [Anonymous], 2009, Wkly Epidemiol Rec, V85, P40; Benner GE, 1999, INFECT IMMUN, V67, P1922; Bhattacharya D, 2010, VACCINE, V28, P7683, DOI 10.1016/j.vaccine.2010.09.039; BUTLER T, 1982, INFECT IMMUN, V36, P1160, DOI 10.1128/IAI.36.3.1160-1167.1982; Chanteau S, 1998, EMERG INFECT DIS, V4, P101, DOI 10.3201/eid0401.980114; Chanteau S, 2003, LANCET, V361, P211, DOI 10.1016/S0140-6736(03)12270-2; CHEN TH, 1974, J INFECT DIS, V129, pS62, DOI 10.1093/infdis/129.Supplement_1.S62; Dromigny J. A., 1998, Archives de l'Institut Pasteur de Madagascar, V64, P18; Duplantier JM, 2005, VET RES, V36, P437, DOI 10.1051/vetres:2005007; FRIEDLANDER AM, 1995, CLIN INFECT DIS, V21, pS178, DOI 10.1093/clinids/21.Supplement_2.S178; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Huang J, 2009, CLIN VACCINE IMMUNOL, V16, P719, DOI 10.1128/CVI.00447-08; Jones A, 2010, VACCINE, V28, P5924, DOI 10.1016/j.vaccine.2010.06.020; Keeling MJ, 2000, NATURE, V407, P903, DOI 10.1038/35038073; Leroy F., 1995, Archives de l'Institut Pasteur de Madagascar, V62, P165; Li B, 2008, INFECT IMMUN, V76, P1804, DOI 10.1128/IAI.01517-07; Lorange EA, 2005, J INFECT DIS, V191, P1907, DOI 10.1086/429931; Neubauer H, 2000, EPIDEMIOL INFECT, V125, P593, DOI 10.1017/S0950268800004647; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Philipovskiy AV, 2007, INFECT IMMUN, V75, P878, DOI 10.1128/IAI.01529-06; Quenee LE, 2008, INFECT IMMUN, V76, P2025, DOI 10.1128/IAI.00105-08; Quenee LE, 2009, HUM VACCINES, V5, P817, DOI 10.4161/hv.9866; Rahalison L, 2003, ADV EXP MED BIOL, V529, P439; Rahelinirina S, 2010, VECTOR-BORNE ZOONOT, V10, P77, DOI 10.1089/vbz.2009.0019; Rajerison M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000421; Sebbane F, 2009, INFECT IMMUN, V77, P1222, DOI 10.1128/IAI.00950-08; SHEPHERD AJ, 1986, J CLIN MICROBIOL, V24, P1075, DOI 10.1128/JCM.24.6.1075-1078.1986; Thullier P, 2003, AM J TROP MED HYG, V69, P450, DOI 10.4269/ajtmh.2003.69.450; Tollenaere C, 2008, INFECT GENET EVOL, V8, P891, DOI 10.1016/j.meegid.2008.07.005; Tollenaere C, 2011, MOL ECOL, V20, P1026, DOI 10.1111/j.1365-294X.2010.04633.x; Tollenaere C, 2010, ECOHEALTH, V7, P242, DOI 10.1007/s10393-010-0312-3; Vadyvaloo V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000783; WAKE A, 1978, IMMUNOLOGY, V34, P1045; Williamson ED, 2007, VACCINE, V25, P1142, DOI 10.1016/j.vaccine.2006.09.052; Williamson ED, 1999, CLIN EXP IMMUNOL, V116, P107	36	18	18	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38630	10.1371/journal.pone.0038630	http://dx.doi.org/10.1371/journal.pone.0038630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719908	Green Published, gold			2022-12-25	WOS:000305583300036
J	Guo, ZS; Zhang, HH; Rao, HY; Jiang, D; Cong, X; Feng, B; Wang, JH; Wei, L; Chen, HS				Guo, Zhongsheng; Zhang, Henghui; Rao, Huiying; Jiang, Dong; Cong, Xu; Feng, Bo; Wang, Jianghua; Wei, Lai; Chen, Hongsong			DCs Pulsed with Novel HLA-A2-Restricted CTL Epitopes against Hepatitis C Virus Induced a Broadly Reactive Anti-HCV-Specific T Lymphocyte Response	PLOS ONE			English	Article							DENDRITIC CELLS; THERAPEUTIC VACCINATION; IMMUNE-RESPONSES; INFECTION; CYTOKINES; IDENTIFICATION; DETERMINANTS; DYSFUNCTION; MATURATION; CD4(+)	Objective: To determine the capacity of dendritic cells (DCs) loaded with single or multiple-peptide mixtures of novel hepatitis C virus (HCV) epitopes to stimulate HCV-specific cytotoxic T lymphocyte (CTL) effector functions. Methods: A bioinformatics approach was used to predict HLA-A2-restricted HCV-specific CTL epitopes, and the predicted peptides identified from this screen were synthesized. Subsequent IFN-gamma ELISPOT analysis detected the stimulating function of these peptides in peripheral blood mononuclear cells (PBMCs) from both chronic and self-limited HCV infected subjects (subjects exhibiting spontaneous HCV clearance). Mature DCs, derived in vitro from CD14(+) monocytes harvested from the study subjects by incubation with appropriate cytokine cocktails, were loaded with novel peptide or epitope peptide mixtures and co-cultured with autologous T lymphocytes. Granzyme B (GrB) and IFN-gamma ELISPOT analysis was used to test for epitope-specific CTL responses. T-cell-derived cytokines contained in the co-cultured supernatant were detected by flow cytometry. Results: We identified 7 novel HLA-A2-restricted HCV-specific CTL epitopes that increased the frequency of IFN-gamma-producing T cells compared to other epitopes, as assayed by measuring spot forming cells (SFCs). Two epitopes had the strongest stimulating capability in the self-limited subjects, one found in the E2 and one in the NS2 region of HCV; five epitopes had a strong stimulating capacity in both chronic and self-limited HCV infection, but were stronger in the self-limited subjects. They were distributed in E2, NS2, NS3, NS4, and NS5 regions of HCV, respectively. We also found that mDCs loaded with novel peptide mixtures could significantly increase GrB and IFN-gamma SFCs as compared to single peptides, especially in chronic HCV infection subjects. Additionally, we found that DCs pulsed with multiple epitope peptide mixtures induced a Th1-biased immune response. Conclusions: Seven novel and strongly stimulating HLA-A2-restricted HCV-specific CTL epitopes were identified. Furthermore, DCs loaded with multiple-epitope peptide mixtures induced epitope-specific CTLs responses.	[Guo, Zhongsheng; Zhang, Henghui; Rao, Huiying; Jiang, Dong; Cong, Xu; Feng, Bo; Wang, Jianghua; Wei, Lai; Chen, Hongsong] Peking Univ, Inst Hepatol, Peoples Hosp, Beijing 100871, Peoples R China; [Guo, Zhongsheng; Zhang, Henghui; Rao, Huiying; Jiang, Dong; Cong, Xu; Feng, Bo; Wang, Jianghua; Wei, Lai; Chen, Hongsong] Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing, Peoples R China	Peking University	Guo, ZS (corresponding author), Peking Univ, Inst Hepatol, Peoples Hosp, Beijing 100871, Peoples R China.	weelai@163.com			National S&T Major Project for Infectious Diseases Control in China [2008ZX10002-012, 2008ZX10002-013]	National S&T Major Project for Infectious Diseases Control in China	The work was funded by National S&T Major Project for Infectious Diseases Control (grant nos: 2008ZX10002-012 and 2008ZX10002-013) in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Lajonchere L, 2009, J VIRAL HEPATITIS, V16, P156, DOI 10.1111/j.1365-2893.2008.01058.x; Averill L, 2007, CLIN IMMUNOL, V123, P40, DOI 10.1016/j.clim.2006.12.001; Bhasin M, 2004, VACCINE, V22, P3195, DOI 10.1016/j.vaccine.2004.02.005; Bi SL, 1993, COMPLETE HEPATITIS C; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Cacciarelli TV, 1996, HEPATOLOGY, V24, P6, DOI 10.1053/jhep.1996.v24.pm0008707283; Chaiken IM, 1996, TRENDS BIOTECHNOL, V14, P369, DOI 10.1016/0167-7799(96)10050-0; Cheever MA, 2011, CLIN CANCER RES, V17, P3520, DOI 10.1158/1078-0432.CCR-10-3126; Cox AL, 2005, HEPATOLOGY, V42, P104, DOI 10.1002/hep.20749; Dolganiuc A, 2011, J GASTROENTEROL, V46, P432, DOI 10.1007/s00535-011-0377-y; Eksioglu EA, 2010, J VIRAL HEPATITIS, V17, P757, DOI 10.1111/j.1365-2893.2009.01231.x; Ewen CL, 2006, J IMMUNOL METHODS, V308, P156, DOI 10.1016/j.jim.2005.10.009; Fan XG, 1998, MEDIAT INFLAMM, V7, P295, DOI 10.1080/09629359890992; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gowans EJ, 2004, J CLIN VIROL, V30, P283, DOI [10.1016/j.jcv.2004.03.006, 10.1016/j.cv.2004.03.006]; Gowans EJ, 2010, J HEPATOL, V53, P599, DOI 10.1016/j.jhep.2010.05.007; Hong X, 2005, WORLD J GASTROENTERO, V11, P7302, DOI 10.3748/wjg.v11.i46.7302; Jiang WZ, 2008, ANTIVIR RES, V77, P50, DOI 10.1016/j.antiviral.2007.08.004; Kim AY, 2011, GASTROENTEROLOGY, V140, P686, DOI 10.1053/j.gastro.2010.09.042; Kim HJ, 2010, VACCINE, V28, P2877, DOI 10.1016/j.vaccine.2010.01.061; Klade CS, 2009, VACCINE, V27, P3099, DOI 10.1016/j.vaccine.2009.02.088; Klade CS, 2008, GASTROENTEROLOGY, V134, P1385, DOI 10.1053/j.gastro.2008.02.058; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lauer GM, 2002, J VIROL, V76, P6104, DOI 10.1128/JVI.76.12.6104-6113.2002; Lauer GM, 2004, GASTROENTEROLOGY, V127, P924, DOI 10.1053/j.gastro.2004.06.015; Lee WC, 2005, J IMMUNOTHER, V28, P496, DOI 10.1097/01.cji.0000171291.72039.e2; Li W, 2006, J IMMUNOL, V176, P6065, DOI 10.4049/jimmunol.176.10.6065; Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Mashiba T, 2007, IMMUNOGENETICS, V59, P197, DOI 10.1007/s00251-006-0185-3; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Navabi H, 2009, VACCINE, V27, P107, DOI 10.1016/j.vaccine.2008.10.024; Neumann-Haefelin C, 2008, HEPATOLOGY, V47, P1824, DOI 10.1002/hep.22242; Neumann-Haefelin C, 2010, HEPATOLOGY, V51, P54, DOI 10.1002/hep.23275; Nevens F, 2003, HEPATOLOGY, V38, P1289, DOI 10.1053/jhep.2003.50474; Penna A, 2007, HEPATOLOGY, V45, P588, DOI 10.1002/hep.21541; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rodrigue-Gervais IG, 2010, J IMMUNOL, V184, P3134, DOI 10.4049/jimmunol.0902522; Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6; Shafer-Weaver K, 2004, J TRANSL MED, V1, P1; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shi M, 2007, CLIN EXP IMMUNOL, V147, P277, DOI 10.1111/j.1365-2249.2006.03281.x; Shoukry NH, 2004, ANNU REV MICROBIOL, V58, P391, DOI 10.1146/annurev.micro.58.030603.123836; Tian Y, 2007, VIRAL IMMUNOL, V20, P553, DOI 10.1089/vim.2007.0064; Torresi J, 2011, J HEPATOL, V54, P1273, DOI 10.1016/j.jhep.2010.09.040; Tsai SL, 1997, HEPATOLOGY, V25, P449; Tsubouchi E, 2004, CLIN EXP IMMUNOL, V137, P417, DOI 10.1111/j.1365-2249.2004.02544.x; Ulsenheimer A, 2005, HEPATOLOGY, V41, P643, DOI 10.1002/hep.20592; Urbani S, 2001, HEPATOLOGY, V33, P1533, DOI 10.1053/jhep.2001.25091; Wertheimer AM, 2003, HEPATOLOGY, V37, P577, DOI 10.1053/jhep.2003.50115; zur Wiesch JS, 2005, J IMMUNOL, V175, P3603, DOI 10.4049/jimmunol.175.6.3603	51	10	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38390	10.1371/journal.pone.0038390	http://dx.doi.org/10.1371/journal.pone.0038390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22701633	Green Submitted, gold, Green Published			2022-12-25	WOS:000305340000020
J	Corbin, M; Richiardi, L; Vermeulen, R; Kromhout, H; Merletti, F; Peters, S; Simonato, L; Steenland, K; Pearce, N; Maule, M				Corbin, Marine; Richiardi, Lorenzo; Vermeulen, Roel; Kromhout, Hans; Merletti, Franco; Peters, Susan; Simonato, Lorenzo; Steenland, Kyle; Pearce, Neil; Maule, Milena			Hierarchical Regression for Multiple Comparisons in a Case-Control Study of Occupational Risks for Lung Cancer	PLOS ONE			English	Article							SEMI-BAYES; EMPIRICAL-BAYES; EXPOSURES; SURVEILLANCE	Background: Occupational studies often involve multiple comparisons and therefore suffer from false positive findings. Semi-Bayes adjustment methods have sometimes been used to address this issue. Hierarchical regression is a more general approach, including Semi-Bayes adjustment as a special case, that aims at improving the validity of standard maximum-likelihood estimates in the presence of multiple comparisons by incorporating similarities between the exposures of interest in a second-stage model. Methodology/Principal Findings: We re-analysed data from an occupational case-control study of lung cancer, applying hierarchical regression. In the second-stage model, we included the exposure to three known lung carcinogens (asbestos, chromium and silica) for each occupation, under the assumption that occupations entailing similar carcinogenic exposures are associated with similar risks of lung cancer. Hierarchical regression estimates had smaller confidence intervals than maximum-likelihood estimates. The shrinkage toward the null was stronger for extreme, less stable estimates (e. g., "specialised farmers": maximum-likelihood OR: 3.44, 95% CI 0.90-13.17; hierarchical regression OR: 1.53, 95% CI 0.63-3.68). Unlike Semi-Bayes adjustment toward the global mean, hierarchical regression did not shrink all the ORs towards the null (e. g., "Metal smelting, converting and refining furnacemen": maximum-likelihood OR: 1.07, Semi-Bayes OR: 1.06, hierarchical regression OR: 1.26). Conclusions/Significance: Hierarchical regression could be a valuable tool in occupational studies in which disease risk is estimated for a large amount of occupations when we have information available on the key carcinogenic exposures involved in each occupation. With the constant progress in exposure assessment methods in occupational settings and the availability of Job Exposure Matrices, it should become easier to apply this approach.	[Corbin, Marine; Richiardi, Lorenzo; Merletti, Franco; Maule, Milena] Univ Turin, Dept Med Sci, Canc Epidemiol Unit, CeRMS,CPO Piemonte, Turin, Italy; [Corbin, Marine; Pearce, Neil] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand; [Vermeulen, Roel; Kromhout, Hans; Peters, Susan] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Simonato, Lorenzo] Univ Padua, Dept Environm Med & Publ Hlth, Padua, Italy; [Steenland, Kyle] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Pearce, Neil] London Sch Hyg & Trop Med, Fac Epidemiol & Publ Hlth, Dept Med Stat, London WC1, England	Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; University of Turin; Massey University; Utrecht University; University of Padua; Emory University; Rollins School Public Health; University of London; London School of Hygiene & Tropical Medicine	Corbin, M (corresponding author), Univ Turin, Dept Med Sci, Canc Epidemiol Unit, CeRMS,CPO Piemonte, Turin, Italy.	m.corbin@massey.ac.nz	Peters, Susan/A-5845-2013; Maule, Milena M/K-3858-2018; Kromhout, Hans/A-9159-2008; Vermeulen, Roel/F-8037-2011; richiardi, lorenzo/J-3480-2018	Maule, Milena M/0000-0003-2142-1288; Kromhout, Hans/0000-0002-4233-1890; Vermeulen, Roel/0000-0003-4082-8163; Peters, Susan/0000-0001-5662-1971; richiardi, lorenzo/0000-0003-0316-9402; Pearce, Neil/0000-0002-9938-7852; SIMONATO, LORENZO/0000-0002-9914-1000	Programme Grant from the Health Research Council of New Zealand	Programme Grant from the Health Research Council of New Zealand	The Centre for Public Health Research is supported by a Programme Grant from the Health Research Council of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], IARC MON CLASS; [Anonymous], 2006, R LANG ENV STAT COMP; Chen GK, 2007, AM J HUM GENET, V81, P397, DOI 10.1086/519794; Conti DV, 2003, AM J HUM GENET, V72, P351, DOI 10.1086/346117; Corbin M, 2008, EPIDEMIOL PREV, V32, P108; Corbin M, 2011, AM J IND MED, V54, P89, DOI 10.1002/ajim.20906; De Roos AJ, 2001, AM J IND MED, V39, P477, DOI 10.1002/ajim.1041; Greenland S, 2000, INT J EPIDEMIOL, V29, P158, DOI 10.1093/ije/29.1.158; GREENLAND S, 1992, STAT MED, V11, P219, DOI 10.1002/sim.4780110208; GREENLAND S, 1991, EPIDEMIOLOGY, V2, P387, DOI 10.1097/00001648-199109000-00015; GREENLAND S, 1994, ARCH ENVIRON HEALTH, V49, P9, DOI 10.1080/00039896.1994.9934409; Greenland S, 2007, INT J EPIDEMIOL, V36, P195, DOI 10.1093/ije/dyl289; Guha N, ENV HLTH PERSPECT, V118, P303; International Labour Office, 1968, INT STANDARD CLASSIF; McLean D, 2009, INT J EPIDEMIOL, V38, P594, DOI 10.1093/ije/dyn220; Momoli F, 2010, EPIDEMIOLOGY, V21, P144, DOI 10.1097/EDE.0b013e3181c297c7; Peters S, 2011, OCCUP ENVIRON MED, V68, P148, DOI 10.1136/oem.2010.055608; Richiardi L, 2004, CANCER CAUSE CONTROL, V15, P285, DOI 10.1023/B:CACO.0000024223.91059.ed; Richiardi L, INT J CANC IN PRESS; Steenland K, 2000, CANCER EPIDEM BIOMAR, V9, P895; t Mannetje A, 2008, OCCUP ENVIRON MED, V65, P354, DOI 10.1136/oem.2007.035014; *UN, 1971, INT STAND IND CLASS; WITTE JS, 1994, EPIDEMIOLOGY, V5, P612, DOI 10.1097/00001648-199411000-00009	23	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e38944	10.1371/journal.pone.0038944	http://dx.doi.org/10.1371/journal.pone.0038944			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701732	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000305337600059
J	Hagenfeld, D; Borkenhagen, B; Schulz, T; Schillers, H; Schumacher, U; Prehm, P				Hagenfeld, Daniel; Borkenhagen, Beatrice; Schulz, Tobias; Schillers, Hermann; Schumacher, Udo; Prehm, Peter			Hyaluronan Export through Plasma Membranes Depends on Concurrent K+ Efflux by K-ir Channels	PLOS ONE			English	Article							ION CHANNELS; POTASSIUM CHANNELS; MOLECULAR-MODEL; FIBROBLASTS; CELLS; ROPIVACAINE; MRP5; BUPIVACAINE; ASSOCIATION; VESICLES	Hyaluronan is synthesized within the cytoplasm and exported into the extracellular matrix through the cell membrane of fibroblasts by the MRP5 transporter. In order to meet the law of electroneutrality, a cation is required to neutralize the emerging negative hyaluronan charges. As we previously observed an inhibiting of hyaluronan export by inhibitors of K+ channels, hyaluronan export was now analysed by simultaneously measuring membrane potential in the presence of drugs. This was done by both hyaluronan import into inside-out vesicles and by inhibition with antisense siRNA. Hyaluronan export from fibroblast was particularly inhibited by glibenclamide, ropivacain and BaCl2 which all belong to ATP-sensitive inwardly-rectifying K-ir channel inhibitors. Import of hyaluronan into vesicles was activated by 150 mM KCl and this activation was abolished by ATP. siRNA for the K+ channels K(ir)3.4 and K(ir)6.2 inhibited hyaluronan export. Collectively, these results indicated that hyaluronan export depends on concurrent K+ efflux.	[Hagenfeld, Daniel; Borkenhagen, Beatrice; Schulz, Tobias; Prehm, Peter] Munster Univ Hosp, Inst Physiol Chem & Pathobiochem, Munster, Germany; [Schillers, Hermann] Muenster Univ Hosp, Inst Physiol 2, Munster, Germany; [Schumacher, Udo] Univ Klinikum Hamburg Eppendorf, Inst Anat Expt Morphol 2, Hamburg, Germany; [Hagenfeld, Daniel] Univ Heidelberg Hosp, Clin Oral Dent & Maxillofacial Dis, Dept Conservat Dent, Sect Periodontol, Heidelberg, Germany	University of Munster; University of Munster; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg	Hagenfeld, D (corresponding author), Munster Univ Hosp, Inst Physiol Chem & Pathobiochem, Munster, Germany.	prehm@uni-muenster.de	Hagenfeld, Daniel/ABA-9972-2021	Prehm, Peter/0000-0002-8063-311X; Schillers, Hermann/0000-0001-6090-4771	Deutsche Forschungsgemeinschaft [SFB 492]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (SFB 492). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonucci DE, 2001, NEUROSCIENCE, V108, P69, DOI 10.1016/S0306-4522(01)00476-6; Arcangeli A, 2009, CURR MED CHEM, V16, P66, DOI 10.2174/092986709787002835; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; BAKY SH, 1982, PHARMACOTHERAPY, V2, P328; BRECHT M, 1986, BIOCHEM J, V239, P445, DOI 10.1042/bj2390445; Chilton L, 2005, AM J PHYSIOL-HEART C, V288, pH2931, DOI 10.1152/ajpheart.01220.2004; Davison HR, 2011, BIOCONJUGATE CHEM, V22, P2593, DOI 10.1021/bc2004457; Dojo M, 2004, ANESTHESIOLOGY, V101, P251, DOI 10.1097/00000542-200407000-00040; ESTACION M, 1991, J PHYSIOL-LONDON, V436, P579, DOI 10.1113/jphysiol.1991.sp018568; Evanko SP, 2004, J HISTOCHEM CYTOCHEM, V52, P1525, DOI 10.1369/jhc.4A6356.2004; Franchini L, 2004, CELL CALCIUM, V35, P449, DOI 10.1016/j.ceca.2003.11.001; FRENCH RJ, 1985, J GEN PHYSIOL, V85, P669, DOI 10.1085/jgp.85.5.669; Friederich P, 2004, ANESTHESIOLOGY, V101, P1347; Gopalakrishnan M, 2003, BRIT J PHARMACOL, V138, P393, DOI 10.1038/sj.bjp.0705048; Hagenfeld D, 2010, J CELL BIOCHEM, V111, P858, DOI 10.1002/jcb.22772; Ishihara K, 2009, BIOCHEM BIOPH RES CO, V380, P832, DOI 10.1016/j.bbrc.2009.01.179; Joerges J, 2012, J CELL BIOCHEM, V113, P340, DOI 10.1002/jcb.23360; Jokela TA, 2008, CONNECT TISSUE RES, V49, P115, DOI 10.1080/03008200802148439; Katsuda Y, 1996, AM J PHYSIOL-HEART C, V270, pH2210; Kawano T, 2004, ANESTHESIOLOGY, V101, P390, DOI 10.1097/00000542-200408000-00020; KLEMPNER MS, 1980, J CELL BIOL, V86, P21, DOI 10.1083/jcb.86.1.21; KLEYMAN TR, 1988, SEMIN NEPHROL, V8, P242; Kochlamazashvili G, 2010, NEURON, V67, P116, DOI 10.1016/j.neuron.2010.05.030; KRASZNAI Z, 1995, J PHOTOCH PHOTOBIO B, V28, P93, DOI 10.1016/1011-1344(94)07099-A; LAURENT TC, 1964, BIOCHEM J, V93, P106, DOI 10.1042/bj0930106; Levite M, 2000, J EXP MED, V191, P1167, DOI 10.1084/jem.191.7.1167; Li GR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007307; LUPPA D, 1987, BIOMED BIOCHIM ACTA, V46, P341; Marcussen M, 1996, CELL MOTIL CYTOSKEL, V35, P94, DOI 10.1002/(SICI)1097-0169(1996)35:2<94::AID-CM2>3.0.CO;2-I; Meszar Z, 2008, BRAIN RES BULL, V75, P414, DOI 10.1016/j.brainresbull.2007.10.052; PHILIPSON LH, 1985, BIOCHEMISTRY-US, V24, P7899, DOI 10.1021/bi00348a008; Prehm P, 2004, BIOCHEM PHARMACOL, V68, P1401, DOI 10.1016/j.bcp.2004.06.017; PREHM P, 1984, BIOCHEM J, V220, P597, DOI 10.1042/bj2200597; Ravna AW, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-33; Ravna AW, 2008, EUR J MED CHEM, V43, P2557, DOI 10.1016/j.ejmech.2008.01.015; Rilla K, 2008, J HISTOCHEM CYTOCHEM, V56, P901, DOI 10.1369/jhc.2008.951665; SCHLEMMER SR, 1995, ANAL BIOCHEM, V228, P226, DOI 10.1006/abio.1995.1343; Schulz T, 2007, J BIOL CHEM, V282, P20999, DOI 10.1074/jbc.M700915200; Schulz T, 2010, PATHOBIOLOGY, V77, P200, DOI 10.1159/000295859; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; WILLERSHAUSENZONNCHEN B, 1991, J CLIN PERIODONTOL, V18, P190, DOI 10.1111/j.1600-051X.1991.tb01132.x	41	10	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e39096	10.1371/journal.pone.0039096	http://dx.doi.org/10.1371/journal.pone.0039096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701748	Green Published, gold, Green Submitted			2022-12-25	WOS:000305337600068
J	Said-Mohamed, R; Bernard, JY; Ndzana, AC; Pasquet, P				Said-Mohamed, Rihlat; Bernard, Jonathan Y.; Ndzana, Anne-Christine; Pasquet, Patrick			Is Overweight in Stunted Preschool Children in Cameroon Related to Reductions in Fat Oxidation, Resting Energy Expenditure and Physical Activity?	PLOS ONE			English	Article							NORTH-WEST PROVINCE; SAO-PAULO; BODY-COMPOSITION; METABOLIC-RATE; BIOELECTRICAL-IMPEDANCE; SEDENTARY BEHAVIOR; BIRTH-WEIGHT; OBESITY; SHANTYTOWNS; PREVALENCE	Background: Recent studies suggest that early modifications in metabolic pathways and behaviour, leading to energy conservation and reduced linear growth, could represent adaptations to nutritional constraints during foetal life and infancy. Impaired fat oxidation, low resting energy expenditure and reduced physical activity, resulting from these adaptations, could facilitate fat storage and development of overweight in growth-retarded children that consume more energy-dense food. This study aims at assessing whether: (1) dual-burden preschool children (simultaneously stunted and overweight) of Yaounde (Cameroon) have low birth-weight (indicator of foetal undernutrition) and reductions in fat oxidation, resting energy expenditure (REE) and physical activity, (2) fat oxidation, REE and physical activity are associated with foetal growth. Methodology/Principal Findings: 162 children (24-72 months) were considered: 22 stunted-overweight (SO), 40 stunted (S), 41 overweight (O), and 59 non stunted-non overweight (NSNO). Nutritional status and body composition were assessed using anthropometry and multifrequency bioimpedance analysis. Fasting respiratory quotient (RQ) and REE were measured by indirect calorimetry. Physical activity was determined using accelerometers, food questionnaires were used for diet assessment and birth-weight was noted. Mean RQs and REE (weight adjusted) did not differ between stunted children (SO and S) and non-stunted children (O and NSNO). SO and S children spent more time in sedentary activities than O children (p = 0.01 and p = 0.02, respectively) and less time in moderate-to-vigorous activities than NSNO children (p = 0.05 and p = 0.04, respectively). SO children's diet was less diverse (p = 0.01) with less animal products (p = 0.006). Multiple linear regressions model revealed that birth-weight is predictive of RQ (beta = 0.237, p < 0.01, R-2 = 0.08). Conclusions/Significance: This study showed that growth retardation in stunted-overweight children could be associated with postnatal nutritional deficiencies. Overweight in stunted children could be associated with reduced physical activity in the context of nutrition transition. High birth-weight was a predictor of reduced lipid oxidation, a risk factor of fat deposition.	[Said-Mohamed, Rihlat; Bernard, Jonathan Y.; Pasquet, Patrick] Paris Diderot Univ, Museum Natl Hist Nat, CNRS, UMR Ecoanthropol & Ethnobiol 7206, Paris, France; [Ndzana, Anne-Christine] Inst Med Res & Med Plant Studies, Ctr Food & Nutr Res, Yaounde, Cameroon	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite	Said-Mohamed, R (corresponding author), Paris Diderot Univ, Museum Natl Hist Nat, CNRS, UMR Ecoanthropol & Ethnobiol 7206, Paris, France.	rihlat@mnhn.fr	Bernard, Jonathan/T-7064-2017	Bernard, Jonathan/0000-0002-6418-983X; Patrick, Pasquet/0000-0002-7017-3068; SAID MOHAMED, Rihlat/0000-0003-1592-5412	French National Research Agency (ANR); Action Transversal du Museum national d'Histoire naturelle (ATM)	French National Research Agency (ANR)(French National Research Agency (ANR)); Action Transversal du Museum national d'Histoire naturelle (ATM)	This study was included in the project "Anthropologie nutritionnelle des migrants d'Afrique centrale a la ville et en France (ANTRAC)" and was funded by The French National Research Agency (ANR) and the Action Transversal du Museum national d'Histoire naturelle (ATM). Websites. ANR: http://www.agence-nationale-recherche.fr/en/about-us/project-based-funding-to-advance-research/; ATM: http://www.mnhn.fr/museum/foffice/science/science/Recherche/srubPlateformes/ssomPlateformes/fichePlateformes.xsp?ARTICLE_ARTICLE_ID = 21359&idx = 1&nav = liste. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008192; Arimond M., 2004, DIETARY DIVERSITY DI; Arnuna P, 2008, P NUTR SOC, V67, P82, DOI 10.1017/S0029665108006058; BARACNIETO M, 1978, AM J CLIN NUTR, V31, P23, DOI 10.1093/ajcn/31.1.23; Blond E., 2011, e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism, V6, pe7, DOI 10.1016/j.eclnm.2010.12.001; Bouchard C, 2007, INT J OBESITY, V31, P1337, DOI 10.1038/sj.ijo.0803610; Bouville JF, 1993, CAHIERS SANTE, V3, P433; Cliff DP, 2009, J SCI MED SPORT, V12, P557, DOI 10.1016/j.jsams.2008.10.008; DEHGHAN M, 2008, NUTR J, V7, DOI DOI 10.1186/1475-2891-7-26; DEURENBERG P, 1995, BRIT J NUTR, V73, P349, DOI 10.1079/BJN19950038; EMANUEL I, 1993, ISSUES REV TERATOL, V6, P47; Fernald LC, 2007, EUR J CLIN NUTR, V61, P623, DOI 10.1038/sj.ejcn.1602558; Fezeu LK, 2008, OBESITY, V16, P1144, DOI 10.1038/oby.2008.44; Friedman SM, 2006, NUTR RES, V26, P345, DOI 10.1016/j.nutres.2006.06.018; Frisancho AR, 2003, AM J HUM BIOL, V15, P522, DOI 10.1002/ajhb.10191; Gardner DS, 2009, ADV EXP MED BIOL, V646, P83, DOI 10.1007/978-1-4020-9173-5_9; Gartner A, 2003, EUR J CLIN NUTR, V57, P1097, DOI 10.1038/sj.ejcn.1601649; Grillo LP, 2005, EUR J CLIN NUTR, V59, P835, DOI 10.1038/sj.ejcn.1602150; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Haroun D, 2005, INT J OBESITY, V29, P29, DOI 10.1038/sj.ijo.0802834; Hemachandra AH, 2006, AM J HUM BIOL, V18, P791, DOI 10.1002/ajhb.20552; Hoffman DJ, 2007, NUTRITION, V23, P640, DOI 10.1016/j.nut.2007.06.006; Hoffman DJ, 2000, AM J CLIN NUTR, V72, P1025; Hoffman DJ, 2000, J NUTR, V130, P2265, DOI 10.1093/jn/130.9.2265; Hoffman DJ, 2000, AM J CLIN NUTR, V72, P702; Jinabhai CC, 2003, EUR J CLIN NUTR, V57, P358, DOI 10.1038/sj.ejcn.1601534; Kennedy G., 2006, FAO Food and Nutrition Paper, P1; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Mamabolo RL, 2007, PUBLIC HEALTH NUTR, V10, P1047, DOI 10.1017/S1368980007668724; Mamabolo RL, 2005, PUBLIC HEALTH NUTR, V8, P501, DOI 10.1079/PHN2005786; Matarese LE, 1997, J AM DIET ASSOC, V97, pS154, DOI 10.1016/S0002-8223(97)00754-2; Mitchell JA, 2009, OBESITY, V17, P1596, DOI 10.1038/oby.2009.42; Mukuddem-Petersen J, 2004, INT J OBESITY, V28, P842, DOI 10.1038/sj.ijo.0802586; Mvo Z, 1999, Curationis, V22, P27; Nielsen BM, 2007, DIABETES OBES METAB, V9, P521, DOI 10.1111/j.1463-1326.2006.00634.x; Oliver M, 2007, SPORTS MED, V37, P1045, DOI 10.2165/00007256-200737120-00004; Pasquet P, 2003, ANN HUM BIOL, V30, P551, DOI 10.1080/0301446032000112652; Pasquet P, 2001, B MEM SOC ANTHRO PAR, V13, P181; Popkin BM, 1996, J NUTR, V126, P3009, DOI 10.1093/jn/126.12.3009; Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Reilly JJ, 2008, ARCH DIS CHILD, V93, P614, DOI 10.1136/adc.2007.133272; Rivera JA, 2003, J NUTR, V133, p4010S, DOI 10.1093/jn/133.11.4010S; Said-Mohamed R, 2009, ANN HUM BIOL, V36, P146, DOI 10.1080/03014460802660526; Savy M, 2005, PUBLIC HEALTH NUTR, V10, P71; SAWAYA AL, 1995, OBES RES, V3, pS107, DOI 10.1002/j.1550-8528.1995.tb00453.x; Sichieri R, 2000, INT J OBESITY, V24, P614, DOI 10.1038/sj.ijo.0801205; Varela-Silva MI, 2007, COLLEGIUM ANTROPOL, V31, P39; Varela-Silva MI, 2012, COLLEGIUM ANTROPOL, V36, P39; Wadsworth MEJ, 2002, INT J EPIDEMIOL, V31, P383, DOI 10.1093/ije/31.2.383; Walker SP, 2002, PUBLIC HEALTH NUTR, V5, P391, DOI 10.1079/PHN2002275; WEIR JBD, 1990, NUTRITION, V6, P213; Wells JCK, 2007, P NUTR SOC, V66, P423, DOI 10.1017/S0029665107005691; Wren RE, 1997, AM J CLIN NUTR, V66, P406, DOI 10.1093/ajcn/66.2.406; Zhang X, 2009, PREV MED, V49, P172, DOI 10.1016/j.ypmed.2009.07.013	57	33	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2012	7	6							e39007	10.1371/journal.pone.0039007	http://dx.doi.org/10.1371/journal.pone.0039007			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TU	22701741	Green Published, gold, Green Submitted			2022-12-25	WOS:000305337600065
J	Claros, CS; Tramontano, A				Claros, Carmen Sanchez; Tramontano, Anna			Detecting Mutually Exclusive Interactions in Protein-Protein Interaction Maps	PLOS ONE			English	Article							DATABASE; RESOURCE; EVOLUTIONARY; SIMILARITIES; ANNOTATION; UNIPROT; SERVER	Comprehensive protein interaction maps can complement genetic and biochemical experiments and allow the formulation of new hypotheses to be tested in the system of interest. The computational analysis of the maps may help to focus on interesting cases and thereby to appropriately prioritize the validation experiments. We show here that, by automatically comparing and analyzing structurally similar regions of proteins of known structure interacting with a common partner, it is possible to identify mutually exclusive interactions present in the maps with a sensitivity of 70% and a specificity higher than 85% and that, in about three fourth of the correctly identified complexes, we also correctly recognize at least one residue (five on average) belonging to the interaction interface. Given the present and continuously increasing number of proteins of known structure, the requirement of the knowledge of the structure of the interacting proteins does not substantially impact on the coverage of our strategy that can be estimated to be around 25%. We also introduce here the Estrella server that embodies this strategy, is designed for users interested in validating specific hypotheses about the functional role of a protein-protein interaction and it also allows access to pre-computed data for seven organisms.	[Claros, Carmen Sanchez; Tramontano, Anna] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy; [Tramontano, Anna] Inst Pasteur Fdn Cenci Bolognetti, Rome, Italy; [Tramontano, Anna] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti; Istituto Italiano di Tecnologia - IIT	Claros, CS (corresponding author), Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy.	Anna.tramontano@uniroma1.it	Tramontano, anna/D-5378-2009	Tramontano, anna/0000-0002-5610-3338	King Abdullah University of Science and Technology (KAUST) [KUK-I1-012-43]	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology)	Award number KUK-I1-012-43 made by King Abdullah University of Science and Technology (KAUST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Aloy P, 2006, NAT REV MOL CELL BIO, V7, P188, DOI 10.1038/nrm1859; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Ausiello G, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S2; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, P345; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Henikoff S, 2000, ADV PROTEIN CHEM, V54, P73, DOI 10.1016/S0065-3233(00)54003-0; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Herraez A, 2006, BIOCHEM MOL BIOL EDU, V34, P255, DOI 10.1002/bmb.2006.494034042644; Keskin O, 2007, STRUCTURE, V15, P341, DOI 10.1016/j.str.2007.01.007; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Marcatili P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S11; Mihel J, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-21; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Moult K, 2011, PROTEIN-STRUCT FUNCT, V79, P1; Orengo CA, 2002, PROTEOMICS, V2, P11; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Tuncbag N, 2011, NAT PROTOC, V6, P1341, DOI 10.1038/nprot.2011.367; Tuncbag N, 2009, MOL BIOSYST, V5, P1770, DOI [10.1039/b905661k, 10.1039/B905661K]; von Eichborn J, 2011, BIOINFORMATICS, V27, P1725, DOI 10.1093/bioinformatics/btr195; Wang GL, 2005, NUCLEIC ACIDS RES, V33, pW94, DOI 10.1093/nar/gki402; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zhang AD, 2009, PROTEIN INTERACTION NETWORKS: COMPUTATIONAL ANALYSIS, pXIII, DOI 10.1017/CBO9780511626593.001	35	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38765	10.1371/journal.pone.0038765	http://dx.doi.org/10.1371/journal.pone.0038765			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715412	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336800054
J	Zhao, D; Zhang, X; Cui, DZ; Zhao, M				Zhao, Dan; Zhang, Xi; Cui, Daizong; Zhao, Min			Characterisation of a Novel White Laccase from the Deuteromycete Fungus Myrothecium verrucaria NF-05 and Its Decolourisation of Dyes	PLOS ONE			English	Article							BILIRUBIN OXIDASE; PURIFICATION; EXPRESSION; MUTANTS	A novel 'white' laccase was purified from the deuteromycete fungus, Myrothecium verrucaria NF-05, which was a high laccase-producing strain (40.2 U.ml(-1) on the thirteenth day during fermentation). SDS-PAGE and native-PAGE revealed a single band with laccase activity corresponding to a molecular weight of approximately 66 kDa. The enzyme had three copper and one iron atoms per protein molecule determined by ICP-AES. Furthermore, both UV/visible and EPR spectroscopy remained silence, indicating the enzyme a novel laccase with new metal compositions of active centre and spectral properties. The N-terminal amino acid sequence of the purified protein was APQISPQYPM. Together with MALDI-TOF analysis, the protein revealed a high homology of the protein with that from reported M. verrucaria. The highest activity was detected at pH 4.0 and at 30 degrees C. The enzyme activity was significantly enhanced by Na+, Mn2+, Cu2+ and Zn2+ while inhibited by DTT, NaN3 and halogen anions. The kinetic constant (Km) showed the enzyme was more affinitive to ABTS than other tested aromatic substrates. Twelve structurally different dyes could be effectively decolourised by the laccase within 10 min. The high production of the strain and novel properties of the laccase suggested its potential for biotechnological applications.	[Zhao, Dan; Zhang, Xi; Cui, Daizong; Zhao, Min] NE Forestry Univ, Life Sci Coll, Dept Microbiol, Harbin, Peoples R China; [Zhao, Dan] Heilongjiang Univ, Coll Life Sci, Microbiol Lab, Harbin, Peoples R China	Northeast Forestry University - China; Heilongjiang University	Zhao, D (corresponding author), NE Forestry Univ, Life Sci Coll, Dept Microbiol, Harbin, Peoples R China.	82191513@163.com	Zhao, Min/AAZ-9513-2021	Zhao, Min/0000-0001-9751-454X	National Nature Science Foundation of China [31170553, 30671702, 30170775]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the the National Nature Science Foundation of China (No. 31170553, 30671702, 30170775). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Bendl RF, 2008, ENZYME MICROB TECH, V43, P149, DOI 10.1016/j.enzmictec.2007.11.010; Chakroun H, 2010, PROCESS BIOCHEM, V45, P507, DOI 10.1016/j.procbio.2009.11.009; Couto SR, 2006, BIOTECHNOL ADV, V24, P500, DOI 10.1016/j.biotechadv.2006.04.003; Das N, 1997, APPL ENVIRON MICROB, V63, P4120, DOI 10.1128/AEM.63.10.4120-4122.1997; Halaburgi VM, 2011, PROCESS BIOCHEM, V46, P1146, DOI 10.1016/j.procbio.2011.02.002; Hao JJ, 2007, J IND MICROBIOL BIOT, V34, P233, DOI 10.1007/s10295-006-0191-3; KOIKEDA S, 1993, J BIOL CHEM, V268, P18801; LaFayette PR, 1999, PLANT MOL BIOL, V40, P23, DOI 10.1023/A:1026437406859; Liu ZY, 2010, BIOPROC BIOSYST ENG, V33, P639, DOI 10.1007/s00449-009-0389-7; Liu ZY, 2009, J IND MICROBIOL BIOT, V36, P1315, DOI 10.1007/s10295-009-0615-y; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Miele A, 2010, J APPL MICROBIOL, V108, P998, DOI 10.1111/j.1365-2672.2009.04505.x; Min KL, 2001, ARCH BIOCHEM BIOPHYS, V392, P279, DOI 10.1006/abbi.2001.2459; Minussi RC, 2007, AFR J BIOTECHNOL, V6, P1248; Morozova V, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1136, DOI 10.1134/S0006297907100112; Palmieri G, 1997, J BIOL CHEM, V272, P31301, DOI 10.1074/jbc.272.50.31301; Patrick F., 2009, African Journal of Biochemistry Research, V3, P250; Pozdniakova N N, 2006, Prikl Biokhim Mikrobiol, V42, P63; Sadhasivam S, 2008, PROCESS BIOCHEM, V43, P736, DOI 10.1016/j.procbio.2008.02.017; Sharma P, 2007, WORLD J MICROB BIOT, V23, P823, DOI 10.1007/s11274-006-9305-3; Shimizu A, 1999, BIOCHEMISTRY-US, V38, P3034, DOI 10.1021/bi9819531; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Sulistyaningdyah WT, 2004, FEMS MICROBIOL LETT, V230, P209, DOI 10.1016/S0378-1097(03)00892-9; Valls C, 2010, BIOCHEM ENG J, V49, P401, DOI 10.1016/j.bej.2010.02.002; Wang HT, 2006, ASIAN AUSTRAL J ANIM, V19, P1164, DOI 10.5713/ajas.2006.1164; Wu YR, 2010, BIORESOURCE TECHNOL, V101, P9772, DOI 10.1016/j.biortech.2010.07.091; Zhang GQ, 2010, PROCESS BIOCHEM, V45, P627, DOI 10.1016/j.procbio.2009.12.010; Zhao Min, 2011, Mycosystema, V30, P604	29	58	64	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2012	7	6							e38817	10.1371/journal.pone.0038817	http://dx.doi.org/10.1371/journal.pone.0038817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TQ	22715414	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336800056
J	Sharma, N; Castorena, CM; Cartee, GD				Sharma, Naveen; Castorena, Carlos M.; Cartee, Gregory D.			Tissue-Specific Responses of IGF-1/Insulin and mTOR Signaling in Calorie Restricted Rats	PLOS ONE			English	Article							SYNTHASE KINASE-3 ISOFORMS; SKELETAL-MUSCLE; GLYCOGEN-SYNTHASE; GLUCOSE-UPTAKE; INSULIN ACTION; LIFE-SPAN; INCREASES; LONGEVITY; PHOSPHORYLATION; TOR	Moderate calorie restriction (CR) (similar to 60% of ad libitum, AL, intake) has been associated with numerous favorable physiological outcomes in many species, and the insulin/IGF-1 and mTOR signaling pathways have each been proposed as potential mediators for many of CR's bioeffects. However, few studies have assessed the widely held idea that CR induces the down-regulation of the insulin/IGF-1 and/or mTOR pathways in multiple tissues. Accordingly, we analyzed the phosphorylation status of 11 key signaling proteins from the insulin/IGF-1 (IRTyr1162/1163, IGF-1R(Tyr1135/1136), IRS-1(Ser312), PTENSer380, Akt(Ser473), GSK3 alpha(Ser21), GSK3 beta(Ser9)) and mTOR (TSC2(Ser939), mTOR(Ser2448), P70S6K(Thr412), RPS6(Ser235/236)) pathways in 11 diverse tissues [liver, kidney, lung, aorta, two brain regions (cortex and cerebellum), and two slow-twitch and three fast-twitch skeletal muscles] from 9-month-old male AL and CR Fischer 344 x Brown Norway rats. The rats were studied under two conditions: with endogenous insulin levels (i.e., AL>CR) and with insulin infused during a hyperinsulinemic-euglycemic clamp so that plasma insulin concentrations were matched between the two diet groups. The most striking and consistent effect of CR was greater pAkt in 3 of the 5 skeletal muscles of CR vs. AL rats. There were no significant CR effects on the mTOR signaling pathway and no evidence that CR caused a general attenuation of mTOR signaling across the tissues studied. Rather than supporting the premise of a global downregulation of insulin/IGF-1 and/or mTOR signaling in many tissues, the current results revealed clear tissue-specific CR effects for the insulin signaling pathway without CR effects on the mTOR signaling pathway.	[Sharma, Naveen; Castorena, Carlos M.; Cartee, Gregory D.] Univ Michigan, Sch Kinesiol, Muscle Biol Lab, Ann Arbor, MI 48109 USA; [Cartee, Gregory D.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Cartee, Gregory D.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sharma, N (corresponding author), Univ Michigan, Sch Kinesiol, Muscle Biol Lab, Ann Arbor, MI 48109 USA.	gcartee@umich.edu	Sharma, Naveen/K-6672-2015	Sharma, Naveen/0000-0003-4705-5116; Cartee, Gregory/0000-0001-5311-1722	National Institute on Aging Grants [AG-010026, AG-013283]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R29AG010026, P30AG013283, R01AG010026] Funding Source: NIH RePORTER	National Institute on Aging Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institute on Aging Grants AG-010026 and AG-013283. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argentino DP, 2005, EXP GERONTOL, V40, P27, DOI 10.1016/j.exger.2004.09.005; Bjedov I, 2011, BIOCHEM SOC T, V39, P460, DOI 10.1042/BST0390460; Blagosklonny MV, 2010, CELL CYCLE, V9, P683, DOI 10.4161/cc.9.4.10766; Bonkowski MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004567; Cox LS, 2009, AGING CELL, V8, P607, DOI 10.1111/j.1474-9726.2009.00509.x; Davidson RT, 2002, AM J PHYSIOL-ENDOC M, V282, pE270, DOI 10.1152/ajpendo.00232.2001; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Dean DJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE957, DOI 10.1152/ajpendo.1998.275.6.E957; Dean DJ, 2000, ACTA PHYSIOL SCAND, V169, P133, DOI 10.1046/j.1365-201x.2000.00723.x; Feuers RJ, 1995, DIETARY RESTRICTION, P181; Gazdag AC, 1999, DIABETES, V48, P1930, DOI 10.2337/diabetes.48.10.1930; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hasty P, 2010, J MOL CELL BIOL, V2, P17, DOI 10.1093/jmcb/mjp033; Hay N, 2011, BBA-MOL CELL RES, V1813, P1965, DOI 10.1016/j.bbamcr.2011.03.013; Kaeberlein M, 2009, NATURE, V460, P331, DOI 10.1038/460331a; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Katewa SD, 2010, AGING CELL, V9, P105, DOI 10.1111/j.1474-9726.2010.00552.x; Katic M, 2005, CELL MOL LIFE SCI, V62, P320, DOI 10.1007/s00018-004-4297-y; Liang MH, 2007, J BIOL CHEM, V282, P3904, DOI 10.1074/jbc.M605178200; Liang MH, 2006, J BIOL CHEM, V281, P30479, DOI 10.1074/jbc.M607468200; Markou T, 2008, CELL SIGNAL, V20, P206, DOI 10.1016/j.cellsig.2007.10.004; Masoro EJ, 2005, MECH AGEING DEV; McCormick MA, 2011, PHILOS T R SOC B, V366, P17, DOI 10.1098/rstb.2010.0198; McCurdy CE, 2005, DIABETES, V54, P1349, DOI 10.2337/diabetes.54.5.1349; McCurdy CE, 2005, AM J PHYSIOL-ENDOC M, V288, pE996, DOI 10.1152/ajpendo.00566.2004; McCurdy CE, 2003, AM J PHYSIOL-ENDOC M, V285, pE693, DOI 10.1152/ajpendo.00224.2003; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Mora A, 2005, FEBS LETT, V579, P3632, DOI 10.1016/j.febslet.2005.05.040; Richardson A, 2004, BEST PRACT RES CL EN, V18, P393, DOI 10.1016/j.beem.2004.02.002; Sharma N, 2011, AM J PHYSIOL-ENDOC M, V300, pE966, DOI 10.1152/ajpendo.00659.2010; Sharp ZD, 2010, J GERONTOL A-BIOL, V65, P580, DOI 10.1093/gerona/glp212; Soutar MPM, 2010, J NEUROCHEM, V115, P974, DOI 10.1111/j.1471-4159.2010.06988.x; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492; Wanagat J, 1999, TOXICOL SCI, V52, P35; Wang ZQ, 2009, DIABETES, V58, P1488, DOI 10.2337/db08-0977; Weindruch R, 1996, SCI AM, V274, P46, DOI 10.1038/scientificamerican0196-46; Wetter TJ, 1999, AM J PHYSIOL-ENDOC M, V276, pE728; Zheng YB, 2009, J ENDOCRINOL, V203, P337, DOI 10.1677/JOE-09-0181; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	41	35	36	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38835	10.1371/journal.pone.0038835	http://dx.doi.org/10.1371/journal.pone.0038835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701721	Green Published, gold, Green Submitted			2022-12-25	WOS:000305348400096
J	Toseland, CP; Powell, B; Webb, MR				Toseland, Christopher P.; Powell, Ben; Webb, Martin R.			ATPase Cycle and DNA Unwinding Kinetics of RecG Helicase	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; STALLED REPLICATION FORKS; PCRA HELICASE; ESCHERICHIA-COLI; INORGANIC-PHOSPHATE; PLASMID REPLICATION; CRYSTAL-STRUCTURES; INITIATOR PROTEIN; OXYGEN-EXCHANGE; MECHANISM	The superfamily 2 bacterial helicase, RecG, is a monomeric enzyme with a role in DNA repair by reversing stalled replication forks. The helicase must act specifically and rapidly to prevent replication fork collapse. We have shown that RecG binds tightly and rapidly to four-strand oligonucleotide junctions, which mimic a stalled replication fork. The helicase unwinds such DNA junctions with a step-size of approximately four bases per ATP hydrolyzed. To gain an insight into this mechanism, we used fluorescent stopped-flow and quenched-flow to measure individual steps within the ATPase cycle of RecG, when bound to a DNA junction. The fluorescent ATP analogue, mantATP, was used throughout to determine the rate limiting steps, effects due to DNA and the main states in the cycle. Measurements, when possible, were also performed with unlabeled ATP to confirm the mechanism. The data show that the chemical step of hydrolysis is the rate limiting step in the cycle and that this step is greatly accelerated by bound DNA. The ADP release rate is similar to the cleavage rate, so that bound ATP and ADP would be the main states during the ATP cycle. Evidence is provided that the main structural rearrangements, which bring about DNA unwinding, are linked to these states.	[Toseland, Christopher P.; Powell, Ben; Webb, Martin R.] MRC Natl Inst Med Res, London, England	MRC National Institute for Medical Research	Toseland, CP (corresponding author), Univ Munich, Inst Zellulare Physiol, Munich, Germany.	mwebb@nimr.mrc.ac.uk	Toseland, Chris/AAC-8517-2019	Toseland, Chris/0000-0002-1641-7535; Webb, Martin/0000-0002-0134-9621	Medical Research Council, United Kingdom [U117512742]; Medical Research Council [MC_U117512742] Funding Source: researchfish; MRC [MC_U117512742] Funding Source: UKRI	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council, United Kingdom (ref. U117512742. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett RJ, 2004, CRIT REV BIOCHEM MOL, V39, P79, DOI 10.1080/10409230490460756; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dillingham MS, 2002, BIOCHEMISTRY-US, V41, P643, DOI 10.1021/bi011137k; Dillingham MS, 2001, P NATL ACAD SCI USA, V98, P8381, DOI 10.1073/pnas.131009598; ECCLESTON JF, 1991, BIOCHEM SOC T, V19, P432, DOI 10.1042/bst0190432; Flaus A, 2004, CURR OPIN GENET DEV, V14, P165, DOI 10.1016/j.gde.2004.01.007; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Forgacs E, 2006, BIOCHEMISTRY-US, V45, P13035, DOI 10.1021/bi060712n; Henn A, 2008, J MOL BIOL, V377, P193, DOI 10.1016/j.jmb.2007.12.046; Henn A, 2010, P NATL ACAD SCI USA, V107, P4046, DOI 10.1073/pnas.0913081107; HIBBERD MG, 1985, J BIOL CHEM, V260, P3496; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Hsieh J, 1999, J MOL BIOL, V288, P255, DOI 10.1006/jmbi.1999.2666; Jameson DM, 1997, METHOD ENZYMOL, V278, P363; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Leatherbarrow R J, 2007, GRAFIT VERSION 6; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Mahdi AA, 2003, EMBO J, V22, P724, DOI 10.1093/emboj/cdg043; Martinez-Senac MM, 2005, BIOCHEMISTRY-US, V44, P16967, DOI 10.1021/bi0512851; McGlynn P, 2000, NUCLEIC ACIDS RES, V28, P2324, DOI 10.1093/nar/28.12.2324; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8235, DOI 10.1073/pnas.121007798; MOORE KJM, 1994, BIOCHEMISTRY-US, V33, P14565, DOI 10.1021/bi00252a024; Niedziela-Majka A, 2007, J BIOL CHEM, V282, P27076, DOI 10.1074/jbc.M704399200; Nixon AE, 1998, ANAL BIOCHEM, V265, P299, DOI 10.1006/abio.1998.2916; Phillips RA, 2003, BIOCHEMISTRY-US, V42, P3956, DOI 10.1021/bi027316z; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; Slatter AF, 2009, BIOCHEMISTRY-US, V48, P6326, DOI 10.1021/bi900101h; Soultanas P, 1999, NUCLEIC ACIDS RES, V27, P1421, DOI 10.1093/nar/27.6.1421; Soultanas P, 1999, J MOL BIOL, V290, P137, DOI 10.1006/jmbi.1999.2873; Toseland CP, 2011, METHODS MOL BIOL, V778, P161, DOI 10.1007/978-1-61779-261-8_11; Toseland CP, 2010, METHODS, V51, P259, DOI 10.1016/j.ymeth.2010.02.012; Toseland CP, 2009, J MOL BIOL, V392, P1020, DOI 10.1016/j.jmb.2009.07.071; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Webb Martin R., 2003, P131; WEBB MR, 1981, J BIOL CHEM, V256, P910	40	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38270	10.1371/journal.pone.0038270	http://dx.doi.org/10.1371/journal.pone.0038270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701618	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000305348400043
J	Xu, PJ; Xu, J; Li, ZG; Yang, Z				Xu, Pengjuan; Xu, Jing; Li, Zhigui; Yang, Zhuo			Expression of TRPC6 in Renal Cortex and Hippocampus of Mouse during Postnatal Development	PLOS ONE			English	Article							CA2+ ENTRY; GLOMERULAR PROTEIN; CHANNELS; LOCALIZATION; ACTIVATION; MUTATION; DISEASE; GROWTH; CELLS; SLIT	TRPC6, a member of the TRPC family, attracts much attention from the public because of its relationship with the disease. In both the brain and kidney, TRPC6 serves a variety of functions. The aim of the present study was to observe the expression and effects of TRPC6 in renal cortex and hippocampus during early postnatal development of the mouse. In the present study, immunohistochemistry and Western blotting were used to detect the expression of TRPC6 in the mouse kidney and hippocampus of postnatal day 1, 3, 5, 7, 14, 21, 28 and 49 (P1, P3, P5, P7, P14, P21, P28 and P49). Results showed that the expression of TRPC6 was increased in the mouse hippocampus, and there was a significant increase between P7 and P14 during the postnatal development. Meanwhile, the expression of TRPC6 was also detected in glomerulus and tubules, and a decreased expression was found during postnatal maturation of mouse renal cortex. From these in vivo experiments, we concluded that the expression of TRPC6 was active in the developing mouse kidney cortex, and followed a loss of expression with the development of kidney. Meanwhile, an increased expression was found in the hippocampus with the development. Together, these data suggested that the developmental changes in TRPC6 expression might be required for proper postnatal kidney cortex development, and played a critical role in the hippocampus during development, which formed the basis for understanding the nephrogenesis and neurogenesis in mice and provided a practically useful knowledge to the clinical and related research.	[Xu, Pengjuan; Xu, Jing; Li, Zhigui; Yang, Zhuo] Nankai Univ, Coll Med, Tianjin 300071, Peoples R China	Nankai University	Xu, PJ (corresponding author), Nankai Univ, Coll Med, Tianjin 300071, Peoples R China.	zhuoyang@nankai.edu.cn	Jingjun, Xu/A-1282-2010; Li, Zhigui/I-9108-2019; xu, jing/GRR-8698-2022	Li, Zhigui/0000-0003-1317-8679; 	National Basic Research Program of China [2011CB944003]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by a grant from the National Basic Research Program of China (2011CB944003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Giampa C, 2007, NEUROSCI LETT, V424, P170, DOI 10.1016/j.neulet.2007.07.049; Goel M, 2006, AM J PHYSIOL-RENAL, V290, pF1241, DOI 10.1152/ajprenal.00376.2005; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang WC, 2007, CELL CALCIUM, V42, P1, DOI 10.1016/j.ceca.2006.11.002; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; Jordt S. E., 2007, V45, P253; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim EY, 2009, MOL PHARMACOL, V75, P466, DOI 10.1124/mol.108.051912; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; Krall P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012859; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Kuure S, 2000, MECH DEVELOP, V92, P31, DOI 10.1016/S0925-4773(99)00323-8; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Mukerji N, 2007, BBA-MOL BASIS DIS, V1772, P859, DOI 10.1016/j.bbadis.2007.03.005; Nicotera P, 2003, CELL, V115, P768, DOI 10.1016/S0092-8674(03)01019-5; Nilius B., 2004, NOVART FDN SYMP, V258, P149; Nilius B, 2004, NOVARTIS FDN S, V258, P263; Nilius Bernd, 2004, Novartis Found Symp, V258, P140; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Schlndorff JS, 2006, SEMIN CELL DEV BIOL, V17, P667, DOI 10.1016/j.semcdb.2006.11.003; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; SOROKIN L, 1992, KIDNEY INT, V41, P657, DOI 10.1038/ki.1992.101; Sweeney M, 2002, AM J PHYSIOL-LUNG C, V283, pL144, DOI 10.1152/ajplung.00412.2001; Tai YL, 2008, J CELL SCI, V121, P2301, DOI 10.1242/jcs.026906; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Walz G, 2005, NEPHROL DIAL TRANSPL, V20, P1777, DOI 10.1093/ndt/gfh961; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhou J, 2008, NAT NEUROSCI, V11, P741, DOI 10.1038/nn.2127; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	42	11	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38503	10.1371/journal.pone.0038503	http://dx.doi.org/10.1371/journal.pone.0038503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701654	gold, Green Published, Green Submitted			2022-12-25	WOS:000305348400065
J	Zhao, CJ; Liu, YM; Zhao, MZ; Liu, YL; Yu, Y; Chen, HB; Sun, QN; Chen, HW; Jiang, W; Liu, YD; Han, SM; Xu, YC; Chen, MJ; Cao, B; Wang, H				Zhao, Chunjiang; Liu, Yingmei; Zhao, Mingze; Liu, Yali; Yu, Yong; Chen, Hongbin; Sun, Qiuning; Chen, Huawei; Jiang, Wei; Liu, Yudong; Han, Shaomei; Xu, Yingchun; Chen, Minjun; Cao, Bin; Wang, Hui			Characterization of Community Acquired Staphylococcus aureus Associated with Skin and Soft Tissue Infection in Beijing: High Prevalence of PVL+ ST398	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; METHICILLIN-RESISTANT; CLONES; DISEASE; GENOME; GENES	Adult community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) and methicillin-susceptible S aureus (CA-MSSA) skin and soft tissue infection (SSTI) in China is not well described. A prospective cohort of adults with SSTI was established between January 2009 and August 2010 at 4 hospitals in Beijing. Susceptibility testing and molecular typing, including multilocus sequence typing, spa, agr typing, and toxin detection were assessed for all S. aureus isolates. Overall, 501 SSTI patients were enrolled. Cutaneous abscess (40.7%) was the most common infection, followed by impetigo (6.8%) and cellulitis (4.8%). S. aureus accounted for 32.7% (164/501) of SSTIs. Five isolates (5/164, 3.0%) were CA-MRSA. The most dominant ST in CA-MSSA was ST398 (17.6%). The prevalence of Panton-Valentine Leukocidin (pvl) gene was 41.5% (66/159) in MSSA. Female, younger patients and infections requiring incision or drainage were more commonly associated with pvl-positive S. aureus (P<0.03); sec gene was more often identified in CC5 (P<0.03); seh gene was more prevalent in CC1 (P = 0.001). Importantly, ST59 isolates showed more resistance to erythromycin, clindamycin and tetracycline, and needed more surgical intervention. In conclusion, CA-MRSA infections were rare among adult SSTI patients in Beijing. Six major MSSA clones were identified and associated with unique antimicrobial susceptibility, toxin profiles, and agr types. A high prevalence of livestock ST398 clone (17.1% of all S. aureus infections) was found with no apparent association to animal contact.	[Zhao, Chunjiang; Han, Shaomei; Wang, Hui] Peking Univ, Dept Clin Lab, Peking Univ Peoples Hosp, Beijing 100871, Peoples R China; [Zhao, Chunjiang; Liu, Yali; Chen, Hongbin; Sun, Qiuning; Xu, Yingchun; Chen, Minjun; Wang, Hui] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Liu, Yingmei; Cao, Bin] Capital Med Univ, Dept Infect Dis & Clin Microbiol, Beijing Chao Yang Hosp, Beijing, Peoples R China; [Zhao, Mingze; Chen, Huawei] Beijing Pinggu Hosp, Dept Clin Lab, Beijing, Peoples R China; [Yu, Yong; Jiang, Wei] Peoples Liberat Army Gen Hosp, Dept Clin Lab, Hosp 1, Beijing, Peoples R China; [Liu, Yudong] Univ Alabama Birmingham, Birmingham, AL USA	Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Capital Medical University; Chinese People's Liberation Army General Hospital; University of Alabama System; University of Alabama Birmingham	Zhao, CJ (corresponding author), Peking Univ, Dept Clin Lab, Peking Univ Peoples Hosp, Beijing 100871, Peoples R China.	caobin1999@gmail.com; whuibj@gmail.com	LIU, YUDONG/FZY-8468-2022; Sun, Qiuning/AAJ-3692-2021	LIU, YUDONG/0000-0002-5153-3400; Sun, Qiuning/0000-0002-1912-341X; Wang, Hui/0000-0001-9220-0357	Beijing Medical Scientific Development Foundation [2007-2015]; Programme for New Century Excellent Talents in University [NCET-10-0205]; National Natural Science Foundation of China [30971571]	Beijing Medical Scientific Development Foundation; Programme for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Beijing Medical Scientific Development Foundation (No. 2007-2015). It was partially supported by Programme for New Century Excellent Talents in University (NCET-10-0205) and the National Natural Science Foundation of China (No. 30971571). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Bocchini CE, 2006, PEDIATRICS, V117, P433, DOI 10.1542/peds.2005-0566; Chen HB, 2010, ANTIMICROB AGENTS CH, V54, P1842, DOI 10.1128/AAC.01563-09; CLSI, 2018, METHODS DILUTION ANT; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Du JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027328; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; ESSERS L, 1980, J CLIN MICROBIOL, V12, P641, DOI 10.1128/JCM.12.5.641-643.1980; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Holtfreter S, 2007, J CLIN MICROBIOL, V45, P2669, DOI 10.1128/JCM.00204-07; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Kaltsas A, 2011, J CLIN MICROBIOL, V49, P2992, DOI 10.1128/JCM.00704-11; Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Lindsay Jodi A., 2006, Functional & Integrative Genomics, V6, P186, DOI 10.1007/s10142-005-0019-7; Liu YD, 2009, ANTIMICROB AGENTS CH, V53, P512, DOI 10.1128/AAC.00804-08; Oliveira DC, 2006, ANTIMICROB AGENTS CH, V50, P3457, DOI 10.1128/AAC.00629-06; Sakoulas G, 2002, ANTIMICROB AGENTS CH, V46, P1492, DOI 10.1128/AAC.46.5.1492-1502.2002; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Wu DJ, 2010, DIAGN MICR INFEC DIS, V67, P1, DOI 10.1016/j.diagmicrobio.2009.12.006; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	24	85	98	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e38577	10.1371/journal.pone.0038577	http://dx.doi.org/10.1371/journal.pone.0038577			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22701673	Green Published, gold, Green Submitted			2022-12-25	WOS:000305348400076
J	Bellucci, CHS; Wollner, J; Gregorini, F; Birnbock, D; Kozomara, M; Mehnert, U; Kessler, TM				Bellucci, Carlos H. Suzuki; Woellner, Jens; Gregorini, Flavia; Birnboeck, Dorothee; Kozomara, Marko; Mehnert, Ulrich; Kessler, Thomas M.			External Urethral Sphincter Pressure Measurement: An Accurate Method for the Diagnosis of Detrusor External Sphincter Dyssynergia?	PLOS ONE			English	Article							STANDARDIZATION SUB-COMMITTEE; CONTINENCE-SOCIETY; ELECTROMYOGRAPHY	Background: Combined pelvic floor electromyography (EMG) and videocystourethrography (VCUG) during urodynamic investigation are the most acceptable and widely agreed methods for diagnosing detrusor external sphincter dyssynergia (DESD). Theoretically, external urethral sphincter pressure (EUSP) measurement would provide enough information for the diagnosis of DESD and could simplify the urodynamic investigation replacing combined pelvic floor EMG and VCUG. Thus, we evaluated the diagnostic accuracy of EUSP measurement for DESD. Patients & Methods: A consecutive series of 72 patients (36 women, 36 men) with neurogenic lower urinary tract dysfunction able to void spontaneously was prospectively evaluated at a single university spinal cord injury center. Diagnosis of DESD using EUSP measurement (index test) versus combined pelvic floor EMG and VCUG (reference standard) was assessed according to the recommendations of the Standards for Reporting of Diagnostic Accuracy Initiative. Results: Using EUSP measurement (index test) and combined pelvic floor EMG and VCUR (reference standard), DESD was diagnosed in 10 (14%) and in 41 (57%) patients, respectively. More than half of the patients presented discordant diagnosis between the index test and the reference standard. Among 41 patients with DESD diagnosed by combined pelvic floor EMG and VCUR, EUSP measurement identified only 6 patients. EUSP measurement had a sensitivity of 15% (95% CI 5%-25%), specificity of 87% (95% CI 76%-98%), positive predictive value of 60% (95% CI 30%-90%), and negative predictive value of 56% (95% CI 44%-68%) for the diagnosis of DESD. Conclusions: For diagnosis of DESD, EUSP measurement is inaccurate and cannot replace combined pelvic floor EMG and VCUR.	[Bellucci, Carlos H. Suzuki] Spinal Cord Injury Ctr, Zurich, Switzerland; Univ Zurich, Balgrist Univ Hosp, Zurich, Switzerland	University of Zurich	Bellucci, CHS (corresponding author), Spinal Cord Injury Ctr, Zurich, Switzerland.	tkessler@gmx.ch	Bellucci, Carlos HS/J-9698-2016	Bellucci, Carlos HS/0000-0002-3570-859X; Kozomara-Hocke, Marko/0000-0001-5126-9331	Swiss Continence Foundation	Swiss Continence Foundation	This study has been supported by an unrestricted grant from the Swiss Continence Foundation (www.swisscontinencefoundation.ch). The Swiss Continence Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; BLAIVAS JG, 1981, J UROLOGY, V125, P693, DOI 10.1016/S0022-5347(17)55165-4; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; De EJB, 2005, NEUROUROL URODYNAM, V24, P616, DOI 10.1002/nau.20191; Lose G, 2002, NEUROUROL URODYNAM, V21, P258, DOI 10.1002/nau.10051; MAYO ME, 1979, J UROLOGY, V122, P357, DOI 10.1016/S0022-5347(17)56405-8; Podnar S, 2007, CLIN NEUROPHYSIOL, V118, P1423, DOI 10.1016/j.clinph.2007.01.022; ROSSIER AB, 1986, UROLOGY, V27, P371, DOI 10.1016/0090-4295(86)90320-1; Sadananda P, 2011, NEUROUROL URODYNAM, V30, P708, DOI 10.1002/nau.21137; Sakakibara R, 2001, AUTON NEUROSCI-BASIC, V86, P208, DOI 10.1016/S1566-0702(00)00258-7; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066; Weld KJ, 2000, UROLOGY, V56, P565, DOI 10.1016/S0090-4295(00)00761-5; YALLA SV, 1977, J UROLOGY, V118, P1026, DOI 10.1016/S0022-5347(17)58286-5; YALLA SV, 1982, J UROLOGY, V128, P969, DOI 10.1016/S0022-5347(17)53305-4; Zehnder P, 2008, J UROLOGY, V180, P1013, DOI 10.1016/j.juro.2008.05.028	15	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2012	7	5							e37996	10.1371/journal.pone.0037996	http://dx.doi.org/10.1371/journal.pone.0037996			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TY	22701539	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000305338500069
J	Lu, C; Stewart, DJ; Lee, JJ; Ji, L; Ramesh, R; Jayachandran, G; Nunez, MI; Wistuba, II; Erasmus, JJ; Hicks, ME; Grimm, EA; Reuben, JM; Baladandayuthapani, V; Templeton, NS; McMannis, JD; Roth, JA				Lu, Charles; Stewart, David J.; Lee, J. Jack; Ji, Lin; Ramesh, Rajagopal; Jayachandran, Gitanjali; Nunez, Maria I.; Wistuba, Ignacio I.; Erasmus, Jeremy J.; Hicks, Marshall E.; Grimm, Elizabeth A.; Reuben, James M.; Baladandayuthapani, Veerabhadran; Templeton, Nancy S.; McMannis, John D.; Roth, Jack A.			Phase I Clinical Trial of Systemically Administered TUSC2(FUS1)-Nanoparticles Mediating Functional Gene Transfer in Humans	PLOS ONE			English	Article							HOMOZYGOUS DELETION REGION; HUMAN-CHROMOSOME 3P21.3; TUMOR-SUPPRESSOR GENES; LUNG-CANCER CELLS; ADENOVIRUS VECTOR; DNA COMPLEXES; FUS1 PROTEIN; EXPRESSION; P53; LIPOSOME	Background: Tumor suppressor gene TUSC2/FUS1 (TUSC2) is frequently inactivated early in lung cancer development. TUSC2 mediates apoptosis in cancer cells but not normal cells by upregulation of the intrinsic apoptotic pathway. No drug strategies currently exist targeting loss-of-function genetic abnormalities. We report the first in-human systemic gene therapy clinical trial of tumor suppressor gene TUSC2. Methods: Patients with recurrent and/or metastatic lung cancer previously treated with platinum-based chemotherapy were treated with escalating doses of intravenous N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium chloride (DOTAP): cholesterol nanoparticles encapsulating a TUSC2 expression plasmid (DOTAP: chol-TUSC2) every 3 weeks. Results: Thirty-one patients were treated at 6 dose levels (range 0.01 to 0.09 milligrams per kilogram). The MTD was determined to be 0.06 mg/kg. Five patients achieved stable disease (2.6-10.8 months, including 2 minor responses). One patient had a metabolic response on positron emission tomography (PET) imaging. RT-PCR analysis detected TUSC2 plasmid expression in 7 of 8 post-treatment tumor specimens but not in pretreatment specimens and peripheral blood lymphocyte controls. Proximity ligation assay, performed on paired biopsies from 3 patients, demonstrated low background TUSC2 protein staining in pretreatment tissues compared with intense (10-25 fold increase) TUSC2 protein staining in post-treatment tissues. RT-PCR gene expression profiling analysis of apoptotic pathway genes in two patients with high post-treatment levels of TUSC2 mRNA and protein showed significant post-treatment changes in the intrinsic apoptotic pathway. Twenty-nine genes of the 82 tested in the apoptosis array were identified by Igenuity Pathway Analysis to be significantly altered post-treatment in both patients (Pearson correlation coefficient 0.519; p<0.01). Conclusions: DOTAP: chol-TUSC2 can be safely administered intravenously in lung cancer patients and results in uptake of the gene by human primary and metastatic tumors, transgene and gene product expression, specific alterations in TUSC2-regulated pathways, and anti-tumor effects (to our knowledge for the first time for systemic DOTAP: cholesterol nanoparticle gene therapy).	[Lu, Charles; Stewart, David J.; Lee, J. Jack; Ji, Lin; Jayachandran, Gitanjali; Nunez, Maria I.; Wistuba, Ignacio I.; Erasmus, Jeremy J.; Hicks, Marshall E.; Grimm, Elizabeth A.; Reuben, James M.; Baladandayuthapani, Veerabhadran; McMannis, John D.; Roth, Jack A.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Ramesh, Rajagopal] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Ramesh, Rajagopal] Stephenson Canc Ctr, Oklahoma City, OK USA; [Templeton, Nancy S.] Gradalis Inc, Carrollton, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Lu, C (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.	clu@mdanderson.org	Templeton, Nancy S/C-9565-2011; Lee, Jack/P-7331-2019; Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019	Lee, Jack/0000-0002-4584-929X; Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214	National Institutes of Health through M. D. Anderson's Cancer Center [CA-016672]; Biostatistics Resource Group; Clinical Trials Support Resource; Clinical and Translational Research Center; Protocol Review and Monitoring Shared Resources, the Commonwealth Phase I Study IV DOTAP [RO1 CA 113450 RR]; Genprex, Inc.; NATIONAL CANCER INSTITUTE [P50CA070907, R01CA113450, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health through M. D. Anderson's Cancer Center; Biostatistics Resource Group; Clinical Trials Support Resource; Clinical and Translational Research Center; Protocol Review and Monitoring Shared Resources, the Commonwealth Phase I Study IV DOTAP; Genprex, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by the National Institutes of Health through M. D. Anderson's Cancer Center Support Grant CA-016672 - Lung Program, Research Histopathology Facility; Biostatistics Resource Group; Clinical Trials Support Resource; Clinical and Translational Research Center; and Protocol Review and Monitoring Shared Resources, the Commonwealth Phase I Study IV DOTAP (JAR), RO1 CA 113450 RR), and a generous donation from the Helen & Jin Ryu Fund for Gene Therapy (JAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CL: Patent-TUSC2 Therapeutic Response Markers (pending), Co-Inventor JAR: Consultancy, grants, stock: Genprex, Inc.; Patents pending and issued: TUSC2/FUS1 NST: Novel DNA: liposome complexes for increased systemic delivery and gene expression. United States Letters Patent No. 6,413,544 B1 issued July 2, 2002. United States Patent No. 6,770,291 B2 issued August 3, 2004. International Publication Number: WO 98/07408. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aksentijevich I, 1996, HUM GENE THER, V7, P1111, DOI 10.1089/hum.1996.7.9-1111; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; Buvoli M, 2002, GENE THER, V9, P227, DOI 10.1038/sj.gt.3301640; Clayman GL, 1998, J CLIN ONCOL, V16, P2221, DOI 10.1200/JCO.1998.16.6.2221; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Deng WG, 2007, CANCER RES, V67, P709, DOI 10.1158/0008-5472.CAN-06-3463; Du LQ, 2009, MOL CANCER RES, V7, P1234, DOI 10.1158/1541-7786.MCR-08-0507; Firozi P, 2010, GENE THER, V17, P1484, DOI 10.1038/gt.2010.97; HEARING P, 1983, CELL, V33, P695, DOI 10.1016/0092-8674(83)90012-0; Ito I, 2004, CANCER GENE THER, V11, P733, DOI 10.1038/sj.cgt.7700756; Ito I, 2003, MOL THER, V7, P409, DOI 10.1016/S1525-0016(03)00004-2; Ji L, 2002, CANCER RES, V62, P2715; Ji L, 2008, J THORAC ONCOL, V3, P327, DOI 10.1097/JTO.0b013e31816bce65; Ji Lin, 2005, Future Oncol, V1, P79, DOI 10.1517/14796694.1.1.79; Lerman MI, 2000, CANCER RES, V60, P6116; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; McLachlan G, 2000, GENE THER, V7, P384, DOI 10.1038/sj.gt.3301097; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; OQUIGLEY J, 1990, BIOMETRICS, V46, P33, DOI 10.2307/2531628; Prudkin L, 2008, CLIN CANCER RES, V14, P41, DOI 10.1158/1078-0432.CCR-07-1252; Puri A, 2009, CRIT REV THER DRUG, V26, P523, DOI 10.1615/CritRevTherDrugCarrierSyst.v26.i6.10; Ramesh R, 2001, MOL THER, V3, P337, DOI 10.1006/mthe.2001.0266; Roth JA, 2006, EXPERT OPIN BIOL TH, V6, P55, DOI 10.1517/14712598.6.1.55; Roth JA, 1996, NAT MED, V2, P985, DOI 10.1038/nm0996-985; Simberg D, 2005, HUM GENE THER, V16, P1087, DOI 10.1089/hum.2005.16.1087; Simberg D, 2007, P NATL ACAD SCI USA, V104, P932, DOI 10.1073/pnas.0610298104; Swisher SG, 1999, J NATL CANCER I, V91, P763, DOI 10.1093/jnci/91.9.763; Templeton NS, 1997, NAT BIOTECHNOL, V15, P647, DOI 10.1038/nbt0797-647; Tousignant JD, 2000, HUM GENE THER, V11, P2493, DOI 10.1089/10430340050207984; Uno F, 2004, CANCER RES, V64, P2969, DOI 10.1158/0008-5472.CAN-03-3702; WILKINSON GWG, 1992, NUCLEIC ACIDS RES, V20, P2233, DOI 10.1093/nar/20.9.2233; Wistuba II, 1999, ONCOGENE, V18, P643, DOI 10.1038/sj.onc.1202349; Yang JP, 1997, GENE THER, V4, P950, DOI 10.1038/sj.gt.3300485	33	213	218	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e34833	10.1371/journal.pone.0034833	http://dx.doi.org/10.1371/journal.pone.0034833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558101	gold, Green Submitted, Green Published			2022-12-25	WOS:000305345200014
J	Jin, HY; Song, B; Oudit, GY; Davidge, ST; Yu, HM; Jiang, YY; Gao, PJ; Zhu, DL; Ning, G; Kassiri, Z; Penninger, JM; Zhong, JC				Jin, Hai-Yan; Song, Bei; Oudit, Gavin Y.; Davidge, Sandra T.; Yu, Hui-Min; Jiang, Yan-Yan; Gao, Ping-Jin; Zhu, Ding-Liang; Ning, Guang; Kassiri, Zamaneh; Penninger, Josef M.; Zhong, Jiu-Chang			ACE2 Deficiency Enhances Angiotensin II-Mediated Aortic Profilin-1 Expression, Inflammation and Peroxynitrite Production	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CONVERTING ENZYME 2; SPONTANEOUSLY HYPERTENSIVE-RATS; VASCULAR INFLAMMATION; OXIDATIVE STRESS; NAD(P)H OXIDASE; NULL MICE; OVEREXPRESSION; HYPERTROPHY; DYSFUNCTION	Inflammation and oxidative stress play a crucial role in angiotensin (Ang) II-mediated vascular injury. Angiotensin-converting enzyme 2 (ACE2) has recently been identified as a specific Ang II-degrading enzyme but its role in vascular biology remains elusive. We hypothesized that loss of ACE2 would facilitate Ang II-mediated vascular inflammation and peroxynitrite production. 10-week wildtype (WT, Ace2(+/y)) and ACE2 knockout (ACE2KO, Ace2(-/y)) mice received with mini-osmotic pumps with Ang II (1.5 mg.kg(-1).d(-1)) or saline for 2 weeks. Aortic ACE2 protein was obviously reduced in WT mice in response to Ang II related to increases in profilin-1 protein and plasma levels of Ang II and Ang-(1-7). Loss of ACE2 resulted in greater increases in Ang II-induced mRNA expressions of inflammatory cytokines monocyte chemoattractant protein-1 (MCP-1), interleukin (IL)-1 beta, and IL-6 without affecting tumor necrosis factor-alpha in aortas of ACE2KO mice. Furthermore, ACE2 deficiency led to greater increases in Ang II-mediated profilin-1 expression, NADPH oxidase activity, and superoxide and peroxynitrite production in the aortas of ACE2KO mice associated with enhanced phosphorylated levels of Akt, p70S6 kinase, extracellular signal-regulated kinases (ERK1/2) and endothelial nitric oxide synthase (eNOS). Interestingly, daily treatment with AT1 receptor blocker irbesartan (50 mg/kg) significantly prevented Ang II-mediated aortic profilin-1 expression, inflammation, and peroxynitrite production in WT mice with enhanced ACE2 levels and the suppression of the Akt-ERK-eNOS signaling pathways. Our findings reveal that ACE2 deficiency worsens Ang II-mediated aortic inflammation and peroxynitrite production associated with the augmentation of profilin-1 expression and the activation of the Akt-ERK-eNOS signaling, suggesting potential therapeutic approaches by enhancing ACE2 action for patients with vascular diseases.	[Jin, Hai-Yan; Song, Bei; Gao, Ping-Jin; Zhu, Ding-Liang; Ning, Guang; Zhong, Jiu-Chang] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Jin, Hai-Yan; Song, Bei; Gao, Ping-Jin; Zhu, Ding-Liang; Zhong, Jiu-Chang] Shanghai Res Inst Hypertens, Shanghai Key Lab Vasc Biol, Shanghai, Peoples R China; [Oudit, Gavin Y.; Davidge, Sandra T.; Jiang, Yan-Yan; Kassiri, Zamaneh] Univ Alberta, Dept Med, Div Cardiol, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada; [Davidge, Sandra T.; Jiang, Yan-Yan] Univ Alberta, Dept Obstet, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Davidge, Sandra T.; Jiang, Yan-Yan] Univ Alberta, Dept Gynecol, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Yu, Hui-Min] Guangdong Gen Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Yu, Hui-Min] Guangdong Cardiovasc Inst, Guangzhou, Guangdong, Peoples R China; [Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria	Chinese Academy of Sciences; Shanghai Jiao Tong University; University of Alberta; University of Alberta; University of Alberta; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Jin, HY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China.	jiuchangzhong@yahoo.com.cn	Penninger, Josef M/I-6860-2013; Buchko, Garry/G-6173-2015	Penninger, Josef M/0000-0002-8194-3777; Davidge, Sandra/0000-0002-5559-4905; Buchko, Garry/0000-0002-3639-1061	National Natural Science Foundation of China [30973522, 81170246]; Shanghai Pujiang Talents Program [11PJ1408300]; Health Bureau of Shanghai [2011347]; Canadian Institute for Health Research [86602, 84279]; Alberta Innovates-Health Solutions; Shanghai Jiao Tong University School of Medicine	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Talents Program(Shanghai Pujiang Program); Health Bureau of Shanghai; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; Shanghai Jiao Tong University School of Medicine	This work was supported by National Natural Science Foundation of China (Grants. 30973522 & 81170246 to JCZ), Shanghai Pujiang Talents Program (11PJ1408300 to JCZ), Scientific Research Project of Health Bureau of Shanghai (2011347 to HYJ), the Canadian Institute for Health Research (Grants 86602 to GYO, 84279 to ZK), the Alberta Innovates-Health Solutions (JCZ and GYO), and "New Hundred Talents Program" of Shanghai Jiao Tong University School of Medicine to JCZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027923; Batlle D, 2010, CIRC RES, V107, P822, DOI 10.1161/CIRCRESAHA.110.229831; Bodiga S, 2011, CARDIOVASC RES, V91, P151, DOI 10.1093/cvr/cvr036; Briones AM, 2010, CURR HYPERTENS REP, V12, P135, DOI 10.1007/s11906-010-0100-z; Caglayan E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013608; Cheng JF, 2011, VASC PHARMACOL, V55, P34, DOI 10.1016/j.vph.2011.04.003; Clarke NE, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/307315; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Ebrahimian T, 2011, HYPERTENSION, V57, P245, DOI 10.1161/HYPERTENSIONAHA.110.159889; Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461; Gragasin FS, 2003, ARTERIOSCL THROM VAS, V23, P38, DOI 10.1161/01.ATV.0000047868.93732.B7; Guo YJ, 2008, ARCH MED RES, V39, P149, DOI 10.1016/j.arcmed.2007.07.010; Hassona MDH, 2011, J CARDIOVASC PHARM, V57, P550, DOI 10.1097/FJC.0b013e318212b1c2; Horrevoets AJG, 2007, CIRC RES, V101, P328, DOI 10.1161/CIRCRESAHA.107.158881; Ishibashi M, 2004, CIRC RES, V94, P1203, DOI 10.1161/01.RES.0000126924.23467.A3; Kagota S, 2009, J PHARMACOL SCI, V109, P556, DOI 10.1254/jphs.08273FP; Kasina S, 2006, NITRIC OXIDE-BIOL CH, V14, P65, DOI 10.1016/j.niox.2005.09.008; Kassiri Z, 2009, CIRC-HEART FAIL, V2, P446, DOI 10.1161/CIRCHEARTFAILURE.108.840124; Mollnau H, 2002, CIRC RES, V90, pE58, DOI 10.1161/01.RES.0000012569.55432.02; Moustafa-Bayoumi M, 2007, J BIOL CHEM, V282, P37632, DOI 10.1074/jbc.M703227200; Oudit GY, 2007, CARDIOVASC RES, V75, P29, DOI 10.1016/j.cardiores.2007.04.007; Oudit GY, 2010, DIABETES, V59, P529, DOI 10.2337/db09-1218; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Romeo GR, 2007, CIRC RES, V101, P357, DOI 10.1161/CIRCRESAHA.107.151399; Schiffrin EL, 2012, HYPERTENSION, V59, P367, DOI 10.1161/HYPERTENSIONAHA.111.187021; Sriramula S, 2011, CARDIOVASC RES, V92, P401, DOI 10.1093/cvr/cvr242; Wenzel P, 2011, CIRCULATION, V124, P1370, DOI 10.1161/CIRCULATIONAHA.111.034470; Wind S, 2010, HYPERTENSION, V56, P490, DOI 10.1161/HYPERTENSIONAHA.109.149187; Xia HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022682; Zhong JC, 2008, BRIT J PHARMACOL, V153, P66, DOI 10.1038/sj.bjp.0707482; Zhong JC, 2004, HYPERTENSION, V44, P907, DOI 10.1161/01.HYP.0000146400.57221.74; Zhong JC, 2007, CARDIOVASC RES, V74, P388, DOI 10.1016/j.cardiores.2007.02.002; Zhong JC, 2011, REGUL PEPTIDES, V166, P90, DOI 10.1016/j.regpep.2010.09.005; Zhong JC, 2011, HYPERTENSION, V57, P314, DOI 10.1161/HYPERTENSIONAHA.110.164244; Zhong JC, 2010, CIRCULATION, V122, P717, DOI 10.1161/CIRCULATIONAHA.110.955369	35	71	77	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2012	7	6							e38502	10.1371/journal.pone.0038502	http://dx.doi.org/10.1371/journal.pone.0038502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VI	22879982	Green Published, Green Submitted, gold			2022-12-25	WOS:000305343900051
J	Ou, JJ; Luan, W; Deng, J; Sa, R; Liang, HJ				Ou, Juanjuan; Luan, Wei; Deng, Jia; Sa, Rina; Liang, Houjie			alpha V Integrin Induces Multicellular Radioresistance in Human Nasopharyngeal Carcinoma via Activating SAPK/JNK Pathway	PLOS ONE			English	Article							CELL; INTEGRIN-ALPHA(V)BETA(3); RESISTANCE; APOPTOSIS; INVASION; THERAPY; STRESS; NECTIN; MATRIX; JNK	Background: Tumor cells acquire the capacity of resistance to chemotherapy or radiotherapy via cell-matrix and cell-cell crosstalk. Integrins are the most important cell adhesion molecules, in which alpha V integrin mainly mediating the tight contact between tumor cells. Methodology/Principal Findings: To investigate the role of alpha V integrin in multi-cellular radioresistance (MCR) of human nasopharyngeal carcinoma (NPC), we performed immunohistochemistry and Western blotting to find that the expression of alpha V integrin in the tumor tissue of radioresistant patients is much higher than that in radiosensitive patients. In vitro, we cultured human NPC cell line CNE-2 cells as multi-cellular spheroids (MCSs) or as monolayer cells (MCs), and found that the expression of alpha V integrin in MCSs is significantly higher than that in MCs. MTT, flow cytometry and clonogenic suvival assays showed that MCSs are less sensitive to X-ray irradiation than MCs while blocking of alpha V integrin in MCSs dramatically reversed their radioresistance. Furthermore, as detected by Western blotting, MCSs displayed sustained activation of the stress-activated protein kinase/c-Jun NH2-terminal kinase (SAPK/JNK) pathway in presence of irradiation. Blocking of alpha V integrin in MCSs decreased the expression of phosphorylated JNK. Additionally, blocking of SAPK/JNK signaling pathway synergistically induced apoptosis of MCSs exposed to irradiation by increasing the expression of cleaved caspase-3. In vivo, we found that irradiation combined with alpha V integrin blocking treatment significantly enhanced the radiosensitivity of NPC xenografts. Conclusions: Our results indicate a novel role of alpha V integrin in multi-cellular radioresistance of NPCs.	[Ou, Juanjuan] Third Mil Med Univ, Dept Oncol, Southwest Hosp, Chongqing, Peoples R China; Third Mil Med Univ, Southwest Hosp, SW Canc Ctr, Chongqing, Peoples R China	Army Medical University; Army Medical University	Ou, JJ (corresponding author), Third Mil Med Univ, Dept Oncol, Southwest Hosp, Chongqing, Peoples R China.	lianghoujie@sina.com	Liu, Juxiu/B-3400-2009; Deng, Qi/M-3341-2019	Deng, Qi/0000-0001-8208-9763; Hui, Dafeng/0000-0002-5284-2897	National Natural Science Foundation of China [81000965]; 973 Program, National Basic Research Program of China [2010cb529403]; Div Of Biological Infrastructure [0933958] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program, National Basic Research Program of China(National Basic Research Program of China); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by grant number 81000965 from the National Natural Science Foundation of China, and by 973 Program No. 2010cb529403 from the National Basic Research Program of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bates RC, 2000, CRIT REV ONCOL HEMAT, V36, P61, DOI 10.1016/S1040-8428(00)00077-9; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Canonici A, 2008, INT J CANCER, V122, P572, DOI 10.1002/ijc.23164; Cavallaro U, 2011, NAT REV MOL CELL BIO, V12, P189, DOI 10.1038/nrm3068; Chen QM, 2008, CLIN EXP METASTAS, V25, P139, DOI 10.1007/s10585-007-9132-4; Chen QM, 2007, CLIN CANCER RES, V13, P3689, DOI 10.1158/1078-0432.CCR-07-0026; Desoize B, 2000, CRIT REV ONCOL HEMAT, V36, P193, DOI 10.1016/S1040-8428(00)00086-X; Ellis SJ, 2010, CELL TISSUE RES, V339, P121, DOI 10.1007/s00441-009-0828-4; Feng XP, 2010, CANCER RES, V70, P3450, DOI 10.1158/0008-5472.CAN-09-4099; Folkins C, 2007, CANCER RES, V67, P3560, DOI 10.1158/0008-5472.CAN-06-4238; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; He JM, 2009, CANCER LETT, V284, P182, DOI 10.1016/j.canlet.2009.04.023; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hwang R, 2004, HEMATOL ONCOL CLIN N, V18, P991, DOI 10.1016/j.hoc.2004.09.010; Jean C, 2011, ONCOGENE, V30, P2697, DOI 10.1038/onc.2011.27; Le Tourneau C, 2010, B CANCER, V97, P1453, DOI 10.1684/bdc.2010.1226; Leclerc D, 2008, J BIOL CHEM, V283, P3151, DOI 10.1074/jbc.M708598200; MuellerKlieser W, 1997, AM J PHYSIOL-CELL PH, V273, pC1109, DOI 10.1152/ajpcell.1997.273.4.C1109; Pauwels B, 2010, FUTURE ONCOL, V6, P1485, DOI 10.2217/FON.10.104; Prowse ABJ, 2011, STEM CELL RES, V6, P1, DOI 10.1016/j.scr.2010.09.005; Sakamoto Y, 2008, J BIOL CHEM, V283, P496, DOI 10.1074/jbc.M704195200; Sakamoto Y, 2006, J BIOL CHEM, V281, P19631, DOI 10.1074/jbc.M600301200; Sandfort V, 2007, INT J RADIAT BIOL, V83, P727, DOI 10.1080/09553000701694335; Stulic M, 2007, CYTOKINE, V37, P163, DOI 10.1016/j.cyto.2007.03.010; Sun HY, 2011, EXP BIOL MED, V236, P352, DOI 10.1258/ebm.2010.010106; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Vellon L, 2006, MOL CARCINOGEN, V45, P795, DOI 10.1002/mc.20242; Zhang SY, 2004, CARCINOGENESIS, V25, P2191, DOI 10.1093/carcin/bgh234	31	90	102	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38737	10.1371/journal.pone.0038737	http://dx.doi.org/10.1371/journal.pone.0038737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22844484	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341900045
J	Deng, Q; Hui, DF; Zhang, DQ; Zhou, GY; Liu, JX; Liu, SZ; Chu, GW; Li, J				Deng, Qi; Hui, Dafeng; Zhang, Deqiang; Zhou, Guoyi; Liu, Juxiu; Liu, Shizhong; Chu, Guowei; Li, Jiong			Effects of Precipitation Increase on Soil Respiration: A Three-Year Field Experiment in Subtropical Forests in China	PLOS ONE			English	Article							CO2 EFFLUX; CARBON-DIOXIDE; TERRESTRIAL ECOSYSTEMS; EXPERIMENTAL DROUGHT; GRASSLAND ECOSYSTEM; ORGANIC-CARBON; TEMPERATURE; RESPONSES; VARIABILITY; DEPENDENCE	Background: The aim of this study was to determine response patterns and mechanisms of soil respiration to precipitation increases in subtropical regions. Methodology/Principal Findings: Field plots in three typical forests [i.e. pine forest (PF), broadleaf forest (BF), and pine and broadleaf mixed forest (MF)] in subtropical China were exposed under either Double Precipitation (DP) treatment or Ambient Precipitation (AP). Soil respiration, soil temperature, soil moisture, soil microbial biomass and fine root biomass were measured over three years. We tested whether precipitation treatments influenced the relationship of soil respiration rate (R) with soil temperature (T) and soil moisture (M) using R=(a+cM)exp(bT), where a is a parameter related to basal soil respiration; b and c are parameters related to the soil temperature and moisture sensitivities of soil respiration, respectively. We found that the DP treatment only slightly increased mean annual soil respiration in the PF (15.4%) and did not significantly change soil respiration in the MF and the BF. In the BF, the increase in soil respiration was related to the enhancements of both soil fine root biomass and microbial biomass. The DP treatment did not change model parameters, but increased soil moisture, resulting in a slight increase in soil respiration. In the MF and the BF, the DP treatment decreased soil temperature sensitivity b but increased basal soil respiration a, resulting in no significant change in soil respiration. Conclusion/Significance: Our results indicate that precipitation increasing in subtropical regions in China may have limited effects on soil respiration.	[Deng, Qi; Zhang, Deqiang; Zhou, Guoyi; Liu, Juxiu; Liu, Shizhong; Chu, Guowei; Li, Jiong] Chinese Acad Sci, S China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Deng, Qi] Chinese Acad Sci, Wuhan Bot Garden, Wuhan, Peoples R China; [Hui, Dafeng] Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Tennessee State University	Deng, Q (corresponding author), Chinese Acad Sci, S China Bot Garden, Guangzhou, Guangdong, Peoples R China.	dhui@tnstate.edu	Liu, Juxiu/B-3400-2009; Deng, Qi/M-3341-2019	Deng, Qi/0000-0001-8208-9763; Hui, Dafeng/0000-0002-5284-2897	National Basic Research Program of China [2009CB42110x]; Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of Chinese Academy of Sciences [XDA05050205]; Dinghushan Forest Ecosystem Research Station; National Science Foundation [0933958]; Div Of Biological Infrastructure [0933958] Funding Source: National Science Foundation	National Basic Research Program of China(National Basic Research Program of China); Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of Chinese Academy of Sciences; Dinghushan Forest Ecosystem Research Station; National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was financially supported by National Basic Research Program of China (2009CB42110x), Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of Chinese Academy of Sciences (XDA05050205), Dinghushan Forest Ecosystem Research Station, and the National Science Foundation (0933958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; Beier C, 2012, ECOL LETT, V15, P899, DOI 10.1111/j.1461-0248.2012.01793.x; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Borken W, 2006, GLOBAL CHANGE BIOL, V12, P177, DOI 10.1111/j.1365-2486.2005.001058.x; Brady NC, 2002, NATURE PROPERTY SOIL, V13; Chen Xiao-mei, 2010, Yingyong Shengtai Xuebao, V21, P1210; Cleveland CC, 2010, ECOLOGY, V91, P2313, DOI 10.1890/09-1582.1; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Davidson EA, 2008, GLOBAL CHANGE BIOL, V14, P2582, DOI 10.1111/j.1365-2486.2008.01694.x; Deng Q, 2010, BIOGEOSCIENCES, V7, P315, DOI 10.5194/bg-7-315-2010; Deng Q, 2011, ENVIRON MANAGE, V48, P1182, DOI 10.1007/s00267-011-9732-2; Ding M. M., 2001, IITF17 USDA FOR SERV; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; [方运霆 Fang Yun], 2003, [生态学报, Acta Ecologica Sinica], V23, P1685; Fay PA, 2008, GLOBAL CHANGE BIOL, V14, P1600, DOI 10.1111/j.1365-2486.2008.01605.x; Harper CW, 2005, GLOBAL CHANGE BIOL, V11, P322, DOI 10.1111/j.1365-2486.2005.00899.x; Hartley IP, 2006, GLOBAL CHANGE BIOL, V12, P1954, DOI 10.1111/j.1365-2486.2006.01214.x; He C., 1982, TROPICAL SUBTROPICAL, V1, P25; Hui D., 1996, PRACTICAL SAS USAGE; Hui DF, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002297; Hui DF, 2003, TREE PHYSIOL, V23, P433, DOI 10.1093/treephys/23.7.433; Ilstedt U, 2000, SOIL BIOL BIOCHEM, V32, P1591, DOI 10.1016/S0038-0717(00)00073-0; Jackson RB, 2009, ECOLOGY, V90, P3352, DOI 10.1890/08-1609.1; Jassal RS, 2008, GLOBAL CHANGE BIOL, V14, P1305, DOI 10.1111/j.1365-2486.2008.01573.x; Jenerette GD, 2008, FUNCT ECOL, V22, P924, DOI 10.1111/j.1365-2435.2008.01450.x; Jenkinson D. S., 1988, Advances in nitrogen cycling in agricultural ecosystems, P368; Kirschbaum MUF, 2010, GLOBAL CHANGE BIOL, V16, P2117, DOI 10.1111/j.1365-2486.2009.02093.x; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Liu JX, 2008, BIOGEOSCIENCES, V5, P1783, DOI 10.5194/bg-5-1783-2008; [刘申 LIU Shen], 2007, [生态科学, Ecologic Science], V26, P387; Liu WX, 2009, GLOBAL CHANGE BIOL, V15, P184, DOI 10.1111/j.1365-2486.2008.01728.x; Luo Y., 2006, SOIL RESP ENV, P35, DOI [10.1016/B978-012088782-8/50003-6, DOI 10.1016/B978-012088782-8/50003-6]; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Misson L, 2010, GLOBAL CHANGE BIOL, V16, P2461, DOI 10.1111/j.1365-2486.2009.02121.x; Noormets A, 2008, AGR FOREST METEOROL, V148, P216, DOI 10.1016/j.agrformet.2007.08.002; Palmroth S, 2005, GLOBAL CHANGE BIOL, V11, P421, DOI 10.1111/j.1365-2486.2005.00915.x; Peng Shao-Lin, 1995, Chinese Journal of Botany, V7, P75; Reichstein M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002035; Rustad LE, 2000, BIOGEOCHEMISTRY, V48, P1, DOI 10.1023/A:1006255431298; Schaefer K, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001928; Schwendenmann L, 2005, ECOSYSTEMS, V8, P339, DOI 10.1007/s10021-003-0088-1; Scotta ED, 2007, GLOBAL CHANGE BIOL, V13, P546; Shen CD, 2001, RADIOCARBON, V43, P671; Shen WJ, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000685; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sowerby A, 2008, GLOBAL CHANGE BIOL, V14, P2388, DOI 10.1111/j.1365-2486.2008.01643.x; Tang XL, 2006, GLOBAL CHANGE BIOL, V12, P546, DOI 10.1111/j.1365-2486.2006.01109.x; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; van Straaten O, 2010, BIOGEOSCIENCES, V7, P1223, DOI 10.5194/bg-7-1223-2010; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang B. S., 1982, Tropical and Subtropical Forest Ecosystem, Ding Hu Shan Forest Ecosystem Reserve, China, P142; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x; Xu M, 2001, GLOBAL BIOGEOCHEM CY, V15, P687, DOI 10.1029/2000GB001365; Yan J. H., 2009, SOIL BIOL BIOCHEM, V9, P1, DOI DOI 10.1016/J.S0ILBI0.2008.12.018; Yuste JC, 2003, TREE PHYSIOL, V23, P1263, DOI 10.1093/treephys/23.18.1263; Zhang DQ, 2006, SCI CHINA SER D, V49, P139, DOI 10.1007/s11430-006-8139-z; Zhou T, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000850; Zhou XH, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002526	61	90	102	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41493	10.1371/journal.pone.0041493	http://dx.doi.org/10.1371/journal.pone.0041493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844484	Green Published, Green Submitted, gold			2022-12-25	WOS:000306687700095
